data_2gov_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gov _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.562 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.2 p90 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 107.91 -1.144 . . . . 74.329999999999998 107.91 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 54.4 tt0 -106.0 109.24 21.12 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.057 -0.657 . . . . 71.510000000000005 109.646 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.8 p -93.31 131.92 38.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.247 -1.019 . . . . 71.510000000000005 108.247 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 33' ' ' GLU . 10.2 mt -89.25 -40.93 12.5 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.12 -1.067 . . . . 72.439999999999998 108.12 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 m -173.11 169.6 4.57 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.617 1.167 . . . . 74.239999999999995 108.313 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.77 165.59 24.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.562 -1.273 . . . . 75.329999999999998 107.562 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.31 89.87 0.17 Allowed Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 118.759 -1.686 . . . . 62.039999999999999 113.78 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.68 -134.11 4.25 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.757 -0.735 . . . . 54.329999999999998 111.912 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -115.27 173.81 6.32 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 123.821 0.848 . . . . 74.409999999999997 110.411 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -64.61 141.72 58.68 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.074 -1.084 . . . . 70.329999999999998 108.074 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 73.86 -62.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.673 1.189 . . . . 73.150000000000006 110.587 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.466 HG23 ' CD2' ' A' ' 147' ' ' HIS . 23.5 t -97.32 108.82 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.07 -1.085 . . . . 63.0 108.07 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.9 m -123.53 137.56 54.74 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.093 -1.077 . . . . 74.230000000000004 108.093 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -115.75 160.84 19.57 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.497 1.295 . . . . 71.129999999999995 114.497 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.5 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -147.0 125.85 12.7 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.126 -1.852 . . . . 73.329999999999998 106.682 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.49 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -104.66 122.1 44.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 119.169 -1.012 . . . . 74.310000000000002 108.676 175.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 31.7 ptt180 -141.37 153.86 45.32 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.123 -0.944 . . . . 75.099999999999994 111.445 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.05 136.33 36.65 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.093 -1.077 . . . . 54.119999999999997 108.093 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -61.58 149.24 39.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.315 1.228 . . . . 62.329999999999998 114.315 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 39' ' ' GLY . 4.4 tp10 -51.32 -50.7 58.89 Favored 'General case' 0 C--N 1.367 1.367 0 C-N-CA 124.151 0.981 . . . . 75.219999999999999 110.786 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.52 9.31 53.32 Favored Glycine 0 C--N 1.294 -1.763 0 C-N-CA 120.099 -1.048 . . . . 63.350000000000001 110.924 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.486 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -71.82 165.38 53.85 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.062 -0.569 . . . . 71.340000000000003 112.28 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 18.4 ptpt -88.54 129.69 35.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.471 -0.566 . . . . 64.340000000000003 109.471 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 58.1 m-85 -128.69 164.21 23.44 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.372 0.669 . . . . 74.409999999999997 110.549 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.97 116.87 33.02 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 108.652 -0.87 . . . . 61.310000000000002 108.652 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.4 t -125.43 143.46 50.98 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 121.141 0.496 . . . . 75.439999999999998 112.213 -175.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 14.8 m -129.65 127.74 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.077 -0.965 . . . . 71.430000000000007 109.906 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.76 128.08 56.1 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.711 0.767 . . . . 65.299999999999997 111.42 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 40.2 t -112.6 140.55 31.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.892 -1.049 . . . . 75.329999999999998 109.239 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 49' ' ' LYS . 40.9 p -132.37 172.73 12.09 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.264 -0.643 . . . . 63.25 109.264 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.22 -40.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.597 1.159 . . . . 73.120000000000005 111.626 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 47' ' ' THR . 36.3 mtmm -93.24 127.86 45.17 Favored Pre-proline 0 C--N 1.288 -2.066 0 CA-C-N 114.965 -1.016 . . . . 61.25 110.219 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.3 158.95 11.2 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 124.394 3.396 . . . . 65.019999999999996 112.37 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.45 HG12 HD11 ' A' ' 98' ' ' LEU . 53.0 t -46.53 -39.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.61 0.764 . . . . 71.030000000000001 112.189 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.28 -50.41 71.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.971 0.415 . . . . 72.319999999999993 111.061 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 32.4 mm-40 -75.18 -44.1 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.784 -0.644 . . . . 61.350000000000001 111.919 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -56.68 -42.97 79.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.295 0.638 . . . . 71.540000000000006 111.977 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 59' ' ' MET . 64.6 tp -63.8 -51.84 62.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.719 0.295 . . . . 41.229999999999997 110.703 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -65.82 -24.86 67.0 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 113.162 0.801 . . . . 74.099999999999994 113.162 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' CD ' ' HZ3' ' A' ' 61' ' ' LYS . 3.8 tm-20 -83.87 -33.85 24.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.657 0.741 . . . . 74.150000000000006 109.837 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.538 ' HA ' ' NZ ' ' A' ' 61' ' ' LYS . . . -75.88 -33.03 59.94 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 112.885 0.698 . . . . 65.200000000000003 112.885 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.533 ' HA ' ' HE3' ' A' ' 59' ' ' MET . 12.4 mmt -50.79 -51.31 67.54 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 112.738 0.644 . . . . 74.430000000000007 112.738 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -52.29 -39.11 73.21 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.482 2.121 . . . . 64.329999999999998 111.619 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.538 ' NZ ' ' HA ' ' A' ' 58' ' ' ALA . 35.2 mtmm -69.71 -32.19 70.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.422 . . . . 72.510000000000005 111.878 -177.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -76.3 -45.1 35.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.001 0.429 . . . . 74.430000000000007 110.823 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ptm -69.7 -30.68 68.38 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 112.275 0.472 . . . . 74.299999999999997 112.275 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 61' ' ' LYS . 20.2 ptmt -67.95 -30.52 69.83 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.704 -0.398 . . . . 72.409999999999997 109.936 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -63.11 -55.95 20.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.044 -0.525 . . . . 73.129999999999995 111.103 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.89 -15.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.894 0.378 . . . . 74.439999999999998 111.781 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.015 -0.539 . . . . 53.329999999999998 113.071 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.58 -12.75 2.71 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.438 -1.363 . . . . 72.299999999999997 113.495 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 116' ' ' SER . 21.5 m -82.77 29.55 0.45 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.724 1.25 . . . . 71.120000000000005 110.314 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.12 161.05 13.91 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.973 -1.121 . . . . 37.789999999999999 107.973 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -67.4 -33.21 74.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.724 0.639 . . . . 63.25 112.724 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -78.16 -12.47 60.0 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.266 0.555 . . . . 70.030000000000001 110.461 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 36.12 70.18 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.806 -0.634 . . . . 74.329999999999998 112.256 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -80.54 122.51 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.409 -0.589 . . . . 74.439999999999998 109.409 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.92 1.99 61.55 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.193 -0.527 . . . . 63.340000000000003 111.93 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.2 tpt -73.14 98.33 2.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.193 0.52 . . . . 74.450000000000003 110.621 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.79 89.3 0.86 Allowed Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.71 -0.956 . . . . 64.239999999999995 110.71 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.73 125.38 40.27 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.525 0.678 . . . . 62.420000000000002 111.11 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 m -127.86 118.46 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.867 1.062 . . . . 72.030000000000001 113.867 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.44 -179.62 0.66 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 104.602 -2.37 . . . . 74.109999999999999 104.602 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.27 137.8 67.96 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 122.582 1.958 . . . . 73.340000000000003 111.4 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 44.6 t -102.75 141.68 18.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.272 -1.381 . . . . 53.340000000000003 107.272 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 168' ' ' TYR . 26.1 t -126.32 146.23 50.11 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.605 -0.438 . . . . 61.229999999999997 109.859 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 43.9 p90 -135.36 142.69 45.79 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 110.135 -0.32 . . . . 74.310000000000002 110.135 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.479 ' HB3' ' CE2' ' A' ' 168' ' ' TYR . . . -93.11 134.89 34.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 123.785 0.678 . . . . 64.109999999999999 110.411 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 m -126.58 150.14 32.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.787 -1.097 . . . . 64.150000000000006 108.294 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.575 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 46.0 m-85 -120.87 104.1 42.25 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 120.371 -0.531 . . . . 75.219999999999999 110.288 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.58 133.58 3.79 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.037 1.824 . . . . 72.5 112.103 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -86.48 162.33 18.14 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.15 -1.055 . . . . 72.0 108.15 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.49 -12.95 61.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.513 0.673 . . . . 73.049999999999997 111.211 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.36 -6.09 56.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.857 -0.611 . . . . 72.340000000000003 109.917 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.88 -10.32 74.1 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 115.97 -0.559 . . . . 75.329999999999998 112.791 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.9 m -91.97 137.95 31.94 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 110.151 -0.314 . . . . 74.239999999999995 110.151 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 mp -75.14 138.68 42.21 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.266 0.555 . . . . 50.130000000000003 111.545 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.2 129.38 34.46 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.535 -2.024 . . . . 63.039999999999999 105.535 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -71.73 81.73 0.87 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.165 0.983 . . . . 74.129999999999995 113.27 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.575 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 37.8 ttmt -160.46 125.61 3.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.998 -2.223 . . . . 71.400000000000006 104.998 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD11 HG12 ' A' ' 51' ' ' VAL . 6.0 tt -135.5 129.28 32.85 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 108.669 -0.863 . . . . 63.229999999999997 108.669 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -122.3 114.84 21.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.244 -0.65 . . . . 75.310000000000002 109.244 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.5 t -92.4 129.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.958 -0.565 . . . . 63.229999999999997 109.579 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -110.79 123.35 49.9 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.904 -0.776 . . . . 75.049999999999997 108.904 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -102.53 112.48 25.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.939 -1.134 . . . . 74.450000000000003 107.939 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 39.7 ttp180 -76.91 121.26 23.19 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-N 114.376 -1.284 . . . . 61.439999999999998 109.901 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.0 mt -88.45 133.04 37.26 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 115.211 -0.904 . . . . 74.140000000000001 109.934 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.13 154.67 32.55 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.919 2.412 . . . . 74.349999999999994 111.562 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -53.42 -45.26 69.32 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.086 1.143 . . . . 73.140000000000001 114.086 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.97 -31.55 71.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.225 0.536 . . . . 55.039999999999999 111.161 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.89 -5.85 49.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.18 -0.464 . . . . 73.150000000000006 111.323 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.599 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.68 -38.26 73.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.728 -0.842 . . . . 74.409999999999997 108.728 174.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.96 93.56 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.281 -0.872 . . . . 72.230000000000004 112.138 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.2 m -154.27 92.88 2.96 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 122.534 0.334 . . . . 50.119999999999997 111.049 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -90.11 149.4 4.67 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.364 2.043 . . . . 70.420000000000002 111.535 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -65.9 146.33 82.66 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.592 2.195 . . . . 73.140000000000001 111.407 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.22 147.01 85.19 Favored Pre-proline 0 C--O 1.255 1.36 0 C-N-CA 120.634 -0.426 . . . . 72.430000000000007 110.413 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.45 113.38 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.604 2.203 . . . . 64.530000000000001 111.547 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 69' ' ' THR . 26.5 t -91.23 -12.52 35.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.563 0.697 . . . . 72.140000000000001 109.718 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 120' ' ' VAL . 9.5 t70 -100.67 136.78 40.0 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.52 -1.289 . . . . 73.430000000000007 107.52 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 121' ' ' LYS . 13.9 pt-20 -72.45 -19.12 61.63 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.234 0.827 . . . . 73.230000000000004 113.234 -173.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.8 m -86.36 -25.6 25.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.531 -0.468 . . . . 75.239999999999995 111.169 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 117' ' ' ASP . 10.7 p -97.13 129.09 47.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 120.402 -0.519 . . . . 63.409999999999997 109.627 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 118' ' ' GLU . 75.7 mmtt -124.21 143.19 50.66 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.255 -0.429 . . . . 74.409999999999997 110.22 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 23.6 mm -92.74 111.1 23.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.703 -1.221 . . . . 64.450000000000003 107.703 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -125.22 142.39 51.52 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.557 -0.747 . . . . 75.25 109.387 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 11.2 pt-20 -100.41 135.71 41.43 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.079 -0.711 . . . . 73.120000000000005 109.079 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.533 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 32.3 tpt180 -125.58 122.15 35.66 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.032 -0.667 . . . . 74.430000000000007 110.767 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.56 177.61 8.36 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.143 -1.058 . . . . 74.219999999999999 108.143 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.28 -12.8 68.75 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.514 -0.85 . . . . 63.299999999999997 114.68 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.265 2.6 pp -121.13 157.73 24.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 118.553 -1.259 . . . . 70.319999999999993 113.593 -176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.6 m -109.57 133.61 52.89 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.922 -1.49 . . . . 50.420000000000002 108.751 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.441 HG12 HG22 ' A' ' 188' ' ' VAL . 32.0 m -124.0 157.06 31.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-O 121.155 0.502 . . . . 72.209999999999994 110.454 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 69.4 m-85 -113.21 121.87 45.77 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 103.618 -2.734 . . . . 61.219999999999999 103.618 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.7 m -119.46 132.24 55.76 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 120.656 -0.418 . . . . 63.350000000000001 110.353 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.9 t -112.8 128.13 56.35 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.936 -0.764 . . . . 74.150000000000006 108.936 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.04 125.34 53.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.522 -1.658 . . . . 71.209999999999994 106.522 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 26.1 p90 -141.71 154.89 45.6 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.858 -0.61 . . . . 73.310000000000002 110.491 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.86 14.75 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.79 -0.719 . . . . 51.340000000000003 113.109 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 144.17 -176.92 23.14 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.202 -1.559 . . . . 53.450000000000003 109.202 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -81.36 107.7 14.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.014 0.907 . . . . 75.099999999999994 109.288 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -96.45 138.19 34.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.508 0.671 . . . . 70.310000000000002 112.483 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.495 ' HE3' ' OD1' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -109.98 176.66 4.98 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.562 -1.644 . . . . 74.510000000000005 106.562 172.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -36.19 80.36 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.261 0.467 . . . . 73.519999999999996 112.261 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.11 -32.56 73.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 73.430000000000007 111.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.495 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 5.4 m-20 -63.97 -34.42 77.95 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 116.365 -0.38 . . . . 64.510000000000005 111.52 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.17 -43.93 90.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.99 0.424 . . . . 74.129999999999995 110.022 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.447 HG22 ' HH ' ' A' ' 167' ' ' TYR . 41.1 t -66.17 -45.86 89.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.533 -0.758 . . . . 74.439999999999998 109.457 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.12 96.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 65.219999999999999 111.084 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.466 ' CD2' HG23 ' A' ' 29' ' ' VAL . 56.6 m80 -67.78 -33.88 75.69 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 120.729 -0.389 . . . . 73.400000000000006 111.97 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.71 82.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.505 -0.554 . . . . 70.010000000000005 109.505 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 56.3 m -60.37 -49.95 75.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.612 -0.722 . . . . 75.430000000000007 109.725 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.28 -29.73 66.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.969 -0.559 . . . . 73.340000000000003 112.16 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.46 ' HA ' HG21 ' A' ' 154' ' ' THR . 34.6 tp -65.69 -36.98 85.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.653 -0.499 . . . . 71.409999999999997 109.653 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.533 ' HG2' ' CE2' ' A' ' 162' ' ' TYR . 40.3 mtp180 -69.28 -37.22 77.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.917 -0.583 . . . . 74.420000000000002 110.218 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.1 m -69.02 -35.65 76.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.632 -0.713 . . . . 64.299999999999997 110.34 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 151' ' ' LEU . 14.7 t -78.18 -33.22 50.24 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 120.65 -0.42 . . . . 71.209999999999994 111.011 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.68 6.21 9.37 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.167 0.508 . . . . 71.310000000000002 111.495 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.49 132.02 44.92 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.329 -0.619 . . . . 73.420000000000002 109.329 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.34 11.74 50.84 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 121.139 -0.553 . . . . 51.119999999999997 111.993 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.7 p -123.38 165.48 22.58 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 108.386 -0.968 . . . . 74.430000000000007 108.386 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.63 12.67 1.58 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.573 2.182 . . . . 73.439999999999998 112.312 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.52 118.84 14.84 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.943 0.401 . . . . 74.219999999999999 111.041 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.7 p -121.18 164.65 16.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.701 -1.592 . . . . 75.340000000000003 106.701 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.533 ' CE2' ' HG2' ' A' ' 152' ' ' ARG . 12.2 m-85 -130.43 152.29 50.0 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.337 -0.945 . . . . 71.420000000000002 108.847 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 190' ' ' ALA 0.268 3.5 pp0? -102.53 115.08 29.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.295 0.569 . . . . 74.319999999999993 111.889 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.89 1.36 62.29 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.477 -0.783 . . . . 72.430000000000007 111.357 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.7 t70 59.96 20.62 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.609 1.564 . . . . 54.399999999999999 109.658 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.4 138.47 16.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 114.621 -1.172 . . . . 74.319999999999993 112.069 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.447 ' HH ' HG22 ' A' ' 145' ' ' VAL . 22.0 p90 -135.79 152.67 51.33 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.949 -1.023 . . . . 62.229999999999997 108.694 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 9.7 m-85 -115.15 140.75 48.81 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.231 -1.025 . . . . 74.430000000000007 108.231 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 83' ' ' SER . 61.9 m -114.22 119.54 37.38 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.85 -0.796 . . . . 74.310000000000002 108.85 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 82' ' ' VAL . . . -112.32 139.65 47.7 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.092 0.473 . . . . 73.219999999999999 111.818 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.109 0 N-CA-C 107.248 -2.341 . . . . 45.109999999999999 107.248 179.724 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 80.4 mtt180 . . . . . 0 N--CA 1.442 -0.853 0 CA-C-O 120.618 0.247 . . . . 73.420000000000002 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -112.97 127.83 56.33 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.596 -1.261 . . . . 74.010000000000005 107.596 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.46 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 8.6 m120 -143.76 158.86 43.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.744 -0.465 . . . . 73.230000000000004 109.744 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.461 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 43.9 mt-10 -137.08 145.15 43.6 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.02 -0.733 . . . . 64.450000000000003 109.02 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 81.7 t -125.6 121.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.786 -1.191 . . . . 74.310000000000002 107.786 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.431 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 24.7 m0 -110.21 122.15 46.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 110.617 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 87.6 mt -102.41 138.57 39.16 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.776 -1.194 . . . . 71.319999999999993 107.776 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.441 HG22 HG12 ' A' ' 130' ' ' VAL . 27.9 t -103.47 130.59 53.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.477 -0.564 . . . . 73.439999999999998 109.477 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.9 ttpt -69.25 132.54 46.64 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.82 -0.807 . . . . 70.209999999999994 108.82 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.468 1.105 . . . . 61.030000000000001 112.054 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.435 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 45.8 p90 . . . . . 0 N--CA 1.437 -1.105 0 CA-C-O 121.305 0.574 . . . . 72.239999999999995 109.868 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -105.58 109.16 21.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.253 -0.885 . . . . 73.150000000000006 110.038 -173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.13 128.22 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.724 -1.213 . . . . 75.109999999999999 107.724 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.258 0.5 OUTLIER -96.6 -32.45 12.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 113.747 1.017 . . . . 74.430000000000007 113.747 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 28.5 t -151.86 152.91 33.21 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.864 -0.735 . . . . 72.209999999999994 111.907 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 32' ' ' GLU . 27.2 p -133.81 152.91 52.01 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.171 -0.922 . . . . 72.109999999999999 110.578 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.04 -131.99 10.76 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 120.632 -0.794 . . . . 64.239999999999995 112.691 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -104.5 1.45 Allowed Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 121.116 -0.564 . . . . 65.049999999999997 112.077 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.13 171.67 7.66 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 122.827 0.451 . . . . 65.150000000000006 110.203 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.18 157.52 25.24 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.679 -1.23 . . . . 74.310000000000002 107.679 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t70 75.48 -49.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.436 1.494 . . . . 74.310000000000002 111.425 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.24 110.98 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.68 0.752 . . . . 73.0 110.03 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 p -110.8 135.9 50.66 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.731 -0.668 . . . . 73.409999999999997 109.495 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -112.1 162.25 15.62 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.129 0.49 . . . . 73.120000000000005 112.154 -175.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 22' ' ' SER . 13.1 pt-20 -153.0 129.83 10.94 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.554 -2.017 . . . . 71.230000000000004 105.554 170.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.49 141.61 47.47 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 118.898 -1.121 . . . . 74.430000000000007 109.518 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 157.11 46.26 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 119.535 -0.866 . . . . 72.209999999999994 109.261 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 133.89 35.41 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.466 -2.05 . . . . 52.420000000000002 105.466 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.6 m -58.38 141.65 50.68 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.87 1.063 . . . . 70.109999999999999 113.87 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -70.3 -16.53 63.02 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.47 -1.695 . . . . 53.420000000000002 112.137 -175.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.94 12.03 66.77 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.414 -1.851 . . . . 64.430000000000007 111.664 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.03 145.98 42.25 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 120.343 -0.932 . . . . 51.420000000000002 111.72 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -96.32 117.99 31.94 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.842 -0.799 . . . . 62.43 108.842 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.9 m-85 -122.69 163.86 19.34 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.512 -0.767 . . . . 72.420000000000002 110.826 -172.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.21 116.49 31.51 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.312 -0.625 . . . . 74.209999999999994 109.312 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.7 t -122.17 145.94 47.72 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 112.477 0.547 . . . . 65.430000000000007 112.477 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 16.0 m -129.95 140.89 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 125.104 1.361 . . . . 73.430000000000007 107.776 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.3 pt-20 -128.01 135.77 50.36 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.16 -1.416 . . . . 74.109999999999999 112.22 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 41.2 t -118.41 140.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 106.386 -1.709 . . . . 74.310000000000002 106.386 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 49' ' ' LYS . 38.6 p -126.26 167.17 15.84 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.727 -0.389 . . . . 73.510000000000005 110.537 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t70 73.72 -36.97 0.36 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.436 1.094 . . . . 52.219999999999999 112.108 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 47' ' ' THR . 95.0 mttt -85.75 138.14 35.63 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.53 -0.759 . . . . 71.230000000000004 110.841 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.96 157.14 25.67 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.002 2.468 . . . . 74.310000000000002 110.748 174.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 t -47.63 -43.88 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 114.952 1.464 . . . . 72.030000000000001 114.952 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.95 -33.11 74.03 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.048 -0.661 . . . . 75.129999999999995 110.675 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -74.85 -44.06 51.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.526 0.679 . . . . 73.120000000000005 110.129 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -65.23 -43.56 91.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.369 -0.832 . . . . 63.43 111.468 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.03 -40.13 82.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 111.694 0.257 . . . . 71.319999999999993 111.694 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.91 -24.82 66.92 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 121.013 -0.275 . . . . 64.010000000000005 111.431 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 30.2 tt0 -84.47 -44.72 13.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.506 0.67 . . . . 73.540000000000006 110.26 175.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.5 -40.45 70.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 114.67 1.359 . . . . 62.130000000000003 114.67 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.436 ' HE1' ' HB2' ' A' ' 59' ' ' MET . 42.5 ttm -57.83 -46.02 99.76 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 113.078 0.77 . . . . 72.329999999999998 113.078 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.34 -40.75 52.7 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.385 2.057 . . . . 72.109999999999999 111.923 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 48.2 mtmt -69.14 -34.5 75.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.862 -0.608 . . . . 63.130000000000003 110.81 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -70.96 -48.88 53.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.886 -0.597 . . . . 72.540000000000006 111.059 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.5 ptm -68.96 -30.3 68.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.069 0.766 . . . . 74.549999999999997 113.069 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -72.33 -27.98 62.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.325 -0.95 . . . . 73.200000000000003 109.989 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.428 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 93.4 t80 -63.07 -57.94 8.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.335 -0.848 . . . . 74.040000000000006 109.886 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.3 m -73.17 -20.79 18.78 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 CA-C-N 116.149 -0.478 . . . . 75.040000000000006 110.928 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.77 -25.68 69.29 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.08 -0.509 . . . . 37.810000000000002 113.264 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.22 -10.22 2.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.149 -1.024 . . . . 75.329999999999998 113.039 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 m -89.56 27.6 1.46 Allowed 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.115 0.959 . . . . 74.439999999999998 110.254 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.31 169.21 10.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 110.003 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.85 -32.86 73.23 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.904 0.705 . . . . 73.109999999999999 112.904 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 113' ' ' PRO . 99.5 mttt -91.23 -7.69 50.56 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.764 -0.775 . . . . 64.329999999999998 112.577 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.69 73.65 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.929 -0.578 . . . . 62.450000000000003 112.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.5 m -82.23 158.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.42 -0.512 . . . . 74.040000000000006 110.243 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.27 173.69 41.1 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 120.891 -0.671 . . . . 63.020000000000003 111.735 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 52.6 ttp -75.17 95.95 3.2 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.064 0.459 . . . . 71.430000000000007 110.154 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.65 10.3 9.77 Favored Glycine 0 N--CA 1.426 -1.971 0 CA-C-N 115.386 -0.824 . . . . 45.409999999999997 112.341 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -118.79 123.45 44.82 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.207 -0.597 . . . . 65.349999999999994 110.865 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.9 p -127.53 117.54 22.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.748 0.647 . . . . 70.299999999999997 112.748 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -152.99 172.82 5.17 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.503 -1.665 . . . . 65.409999999999997 106.503 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.76 139.94 25.57 Favored 'Trans proline' 0 C--O 1.253 1.225 0 C-N-CA 121.01 1.14 . . . . 73.219999999999999 110.505 175.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.86 141.43 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.815 -0.809 . . . . 73.230000000000004 108.815 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 p -119.46 145.41 46.3 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 110.203 -0.295 . . . . 70.099999999999994 110.203 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -144.44 140.62 29.08 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 122.048 -0.408 . . . . 71.329999999999998 110.822 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -92.68 134.55 34.91 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-N 115.68 -0.691 . . . . 74.239999999999995 109.287 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.25 159.21 30.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 114.779 -1.101 . . . . 74.450000000000003 109.158 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 97' ' ' LYS . 78.4 m-85 -125.23 106.16 28.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 110.03 -0.359 . . . . 75.120000000000005 110.03 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.07 136.15 11.47 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.502 2.135 . . . . 72.230000000000004 114.07 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' A' ' 96' ' ' LYS . 49.9 m-80 -95.3 161.51 14.06 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.252 -1.388 . . . . 74.430000000000007 107.252 172.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.59 -13.35 58.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.698 0.761 . . . . 72.400000000000006 111.005 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.24 -6.32 54.58 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.832 -1.076 . . . . 61.100000000000001 110.338 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.53 -9.73 69.79 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.338 -0.458 . . . . 45.350000000000001 112.247 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 m -90.19 132.6 35.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 110.163 -0.31 . . . . 65.209999999999994 110.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.87 96.11 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.46 -0.941 . . . . 74.0 108.46 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -147.44 114.34 6.12 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.571 -0.899 . . . . 72.430000000000007 108.571 -178.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 74.1 mmtt -176.63 -70.1 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.565 1.946 . . . . 52.200000000000003 106.478 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 87' ' ' PHE . 27.4 mtpp -153.16 159.33 42.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.279 -1.782 . . . . 72.340000000000003 107.586 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 98' ' ' LEU . 5.7 tt -143.77 128.43 18.18 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.135 -0.691 . . . . 72.409999999999997 109.135 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.7 mttt -117.56 115.55 25.35 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.592 -0.276 . . . . 74.439999999999998 110.781 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.1 t -89.09 127.02 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.039 -1.097 . . . . 53.409999999999997 108.039 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.552 ' CD1' ' HE2' ' A' ' 168' ' ' TYR . 70.1 m95 -113.97 120.59 41.18 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.734 -0.839 . . . . 75.230000000000004 108.734 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -102.78 113.28 26.57 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 108.317 -0.994 . . . . 75.400000000000006 108.317 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.542 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 81.7 mtm180 -75.12 137.91 41.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.535 -1.211 . . . . 72.400000000000006 111.803 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.558 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 63.9 mt -113.24 130.4 23.66 Favored Pre-proline 0 C--N 1.286 -2.193 0 CA-C-N 115.396 -0.82 . . . . 73.129999999999995 109.862 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.19 163.99 36.6 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.62 2.88 . . . . 74.230000000000004 112.921 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -46.46 -35.52 5.7 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.996 1.718 . . . . 75.219999999999999 112.976 -176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -46.52 86.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.968 0.413 . . . . 42.219999999999999 110.581 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -99.17 -4.5 31.99 Favored 'General case' 0 C--O 1.197 -1.666 0 N-CA-C 112.652 0.612 . . . . 75.439999999999998 112.652 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.558 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 24.5 mm-40 -70.77 -32.17 69.2 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.31 -0.556 . . . . 73.420000000000002 110.805 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.88 -35.7 90.77 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.778 -0.646 . . . . 44.140000000000001 111.598 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.8 p -161.0 92.22 1.52 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 C-N-CA 123.08 0.552 . . . . 73.239999999999995 110.117 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.99 162.33 8.82 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.203 1.935 . . . . 61.329999999999998 112.123 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 29.5 Cg_endo -68.17 156.43 65.79 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.751 1.634 . . . . 72.209999999999994 109.903 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 155.07 45.93 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.629 -0.26 . . . . 74.140000000000001 110.51 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.572 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 34.0 Cg_exo -60.48 111.55 1.06 Allowed 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.589 2.192 . . . . 62.030000000000001 111.724 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -88.0 -41.31 13.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.454 -0.793 . . . . 44.119999999999997 110.602 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.424 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.0 t70 -92.43 156.0 17.49 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.626 -1.25 . . . . 75.430000000000007 107.626 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.37 -20.29 48.08 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 120.93 0.395 . . . . 70.409999999999997 111.036 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 m -74.53 -39.71 62.19 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.944 -0.571 . . . . 63.119999999999997 110.536 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.572 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 3.2 p -107.15 116.41 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.516 0.674 . . . . 64.409999999999997 111.507 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -120.82 148.29 44.22 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.835 -1.075 . . . . 75.120000000000005 108.796 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 22.6 mm -92.82 111.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.263 -1.014 . . . . 72.400000000000006 108.263 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.267 -0.878 . . . . 73.120000000000005 109.005 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.78 140.91 46.03 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.41 -0.589 . . . . 74.420000000000002 109.41 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -122.78 123.33 40.81 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 119.841 -0.744 . . . . 74.340000000000003 110.474 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.76 165.8 26.67 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.538 -1.21 . . . . 74.049999999999997 110.48 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.95 -1.15 69.79 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.688 -0.767 . . . . 63.200000000000003 114.681 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.89 166.42 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-N 117.774 0.787 . . . . 71.519999999999996 110.24 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 55.3 m -120.63 138.39 53.94 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.895 -0.593 . . . . 65.329999999999998 109.855 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.436 HG23 ' CE3' ' A' ' 186' ' ' TRP . 19.1 m -124.66 153.54 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 109.12 -0.696 . . . . 55.43 109.12 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 51.8 m-85 -113.03 121.6 45.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.145 -2.168 . . . . 74.129999999999995 105.145 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 p -117.91 130.02 55.98 Favored 'General case' 0 C--N 1.269 -2.896 0 C-N-CA 120.252 -0.579 . . . . 71.340000000000003 111.162 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.446 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 7.8 t -116.06 126.06 53.25 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.689 -0.687 . . . . 74.510000000000005 110.168 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -111.1 130.53 55.59 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.925 -1.509 . . . . 72.019999999999996 106.925 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.96 146.06 44.94 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.502 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -125.92 128.4 6.45 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.513 -0.767 . . . . 53.340000000000003 111.335 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.59 -138.13 4.95 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.21 -0.756 . . . . 64.310000000000002 111.21 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -100.49 100.63 11.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.787 -1.561 . . . . 74.519999999999996 106.787 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 140.11 53.29 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.018 1.118 . . . . 62.210000000000001 114.018 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -115.68 176.86 4.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.583 -1.189 . . . . 74.310000000000002 108.318 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.71 -37.03 85.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.964 0.412 . . . . 73.120000000000005 111.356 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.07 67.2 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.236 0.541 . . . . 60.310000000000002 110.225 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.26 -30.53 71.18 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.834 -0.621 . . . . 72.239999999999995 110.642 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -61.03 -38.1 84.9 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.003 0.43 . . . . 75.439999999999998 110.565 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.63 -43.87 86.58 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 109.021 -0.733 . . . . 62.130000000000003 109.021 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -62.24 -47.79 82.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.202 -0.908 . . . . 63.219999999999999 110.266 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -66.83 -33.09 74.84 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 113.612 0.967 . . . . 72.120000000000005 113.612 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.5 80.89 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.432 0.634 . . . . 71.099999999999994 110.122 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.8 m -75.29 -44.61 44.76 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.494 -0.776 . . . . 73.530000000000001 109.641 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 53.2 mt-30 -63.85 -27.7 69.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.765 0.426 . . . . 74.329999999999998 111.486 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.432 ' HA ' HG21 ' A' ' 154' ' ' THR . 3.3 tm? -64.87 -37.05 86.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.328 -0.99 . . . . 74.409999999999997 108.328 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.33 -33.14 67.1 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.851 -0.613 . . . . 74.319999999999993 110.447 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -35.1 79.75 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.648 -0.706 . . . . 74.040000000000006 109.952 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 151' ' ' LEU . 8.9 t -77.86 -32.87 52.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.546 -0.462 . . . . 62.350000000000001 110.568 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.01 9.26 2.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.208 0.447 . . . . 74.140000000000001 112.208 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.43 24.51 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.664 -1.606 . . . . 65.109999999999999 106.664 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.38 47.74 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.263 -0.97 . . . . 64.549999999999997 111.374 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 55.8 p -118.82 158.17 48.31 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.84 -0.8 . . . . 74.420000000000002 108.84 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.95 20.3 1.18 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.179 1.919 . . . . 73.409999999999997 112.22 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.72 127.46 31.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.124 -0.489 . . . . 44.32 111.995 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.8 p -104.56 156.34 18.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.021 -1.103 . . . . 75.030000000000001 108.021 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.47 ' C ' ' HB3' ' A' ' 190' ' ' ALA . 31.4 m-85 -136.59 157.53 46.55 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.073 -0.651 . . . . 72.420000000000002 109.753 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -143.04 123.92 14.28 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.361 -0.536 . . . . 63.32 112.272 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.64 -0.27 28.19 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.535 -0.757 . . . . 64.349999999999994 114.417 175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 64.56 8.53 4.44 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.388 1.075 . . . . 74.099999999999994 111.765 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.504 ' HB ' ' CE1' ' A' ' 87' ' ' PHE . 7.3 p -66.17 139.42 21.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.701 0.763 . . . . 60.149999999999999 111.881 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -143.56 168.57 19.54 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.95 -1.023 . . . . 73.430000000000007 109.179 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.552 ' HE2' ' CD1' ' A' ' 101' ' ' TRP . 94.1 m-85 -114.93 147.6 39.78 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 120.951 0.405 . . . . 72.430000000000007 110.375 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 66.0 m -114.79 123.74 49.98 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.913 -1.884 . . . . 75.319999999999993 105.913 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 184' ' ' GLU . . . -128.98 131.41 47.45 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.498 0.666 . . . . 74.340000000000003 112.184 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.251 0 N-CA-C 108.779 -1.728 . . . . 65.439999999999998 108.779 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.572 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 71.9 ttt180 . . . . . 0 C--O 1.216 -0.708 0 N-CA-C 111.623 0.231 . . . . 73.109999999999999 111.623 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 182' ' ' ARG . 1.3 ppt_? -102.75 129.41 49.38 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.24 -0.984 . . . . 74.340000000000003 112.477 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -145.02 153.76 41.81 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.044 -0.525 . . . . 70.209999999999994 110.197 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 42.7 mt-10 -138.14 132.05 31.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.592 0.357 . . . . 72.239999999999995 110.288 173.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.446 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 96.5 t -128.95 118.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.271 -1.011 . . . . 74.120000000000005 108.271 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 11.3 m0 -107.65 121.03 43.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 108.918 -0.771 . . . . 72.219999999999999 108.918 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.58 134.82 42.97 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.678 -1.971 . . . . 72.530000000000001 105.678 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.04 124.79 45.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 120.619 -0.432 . . . . 53.240000000000002 112.068 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 161' ' ' THR . 82.8 tttt -75.45 133.27 41.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.103 -0.703 . . . . 72.549999999999997 109.103 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.47 ' HB3' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.255 1.353 0 CA-C-O 118.694 -0.669 . . . . 54.420000000000002 110.688 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.514 ' CD1' ' HG3' ' A' ' 34' ' ' ARG . 37.3 p90 . . . . . 0 N--CA 1.426 -1.64 0 N-CA-C 108.301 -1.0 . . . . 74.030000000000001 108.301 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.03 0.443 . . . . 61.439999999999998 110.791 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.52 123.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.528 -0.916 . . . . 73.340000000000003 108.528 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.6 -28.95 18.11 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.051 -0.66 . . . . 74.049999999999997 109.901 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t 179.08 158.74 0.59 Allowed 'General case' 0 C--O 1.248 1.011 0 CA-C-N 115.303 -0.862 . . . . 54.229999999999997 109.483 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.9 p -131.43 156.53 45.44 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.038 -1.468 . . . . 71.530000000000001 107.038 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.49 88.79 0.59 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.894 -1.622 . . . . 73.439999999999998 113.581 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.32 -139.94 10.02 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 109.248 -1.541 . . . . 37.109999999999999 109.248 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -104.84 110.03 22.23 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 102.582 -3.118 . . . . 73.310000000000002 102.582 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.93 133.04 49.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.327 -0.949 . . . . 75.239999999999995 112.565 -167.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 153.25 -45.77 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 101.844 -3.391 . . . . 53.299999999999997 101.844 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.04 111.85 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 111.788 -2.46 . . . . 72.150000000000006 104.699 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -100.48 140.2 35.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.96 -0.385 . . . . 60.219999999999999 109.96 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.45 157.71 34.54 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.579 -0.848 . . . . 71.430000000000007 112.535 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -134.0 126.67 30.72 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.172 -1.418 . . . . 75.219999999999999 107.172 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.45 113.89 26.06 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 106.69 -1.596 . . . . 74.040000000000006 106.69 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.514 ' HG3' ' CD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -138.5 145.88 41.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.791 -1.163 . . . . 74.0 113.382 -177.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 128' ' ' ILE . . . -86.77 138.35 31.68 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.065 -1.425 . . . . 75.530000000000001 107.784 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' SG ' HG13 ' A' ' 128' ' ' ILE . 25.6 p -57.89 168.57 0.92 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.25 0.833 . . . . 71.519999999999996 113.25 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -82.85 -18.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.304 -0.862 . . . . 61.329999999999998 111.483 -174.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.38 9.42 59.1 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 119.971 -1.109 . . . . 65.530000000000001 112.969 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.85 165.07 45.32 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.649 -0.786 . . . . 75.409999999999997 113.137 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -99.14 131.86 44.87 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.922 -0.399 . . . . 70.420000000000002 109.922 175.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.671 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 40.9 m-85 -127.89 165.27 20.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.527 -0.761 . . . . 71.230000000000004 112.101 -169.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.0 116.99 31.34 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.675 -0.861 . . . . 55.030000000000001 108.675 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 4.2 t -126.87 143.29 51.31 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-N 115.135 -0.938 . . . . 74.420000000000002 112.517 -175.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.437 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.2 m -133.32 146.11 32.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.4 -1.273 . . . . 72.030000000000001 108.366 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -127.88 126.31 41.32 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.63 -0.428 . . . . 70.340000000000003 110.367 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' CG1' ' HD2' ' A' ' 49' ' ' LYS . 33.2 t -120.74 130.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.988 -1.486 . . . . 74.549999999999997 106.988 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 49' ' ' LYS . 73.5 p -117.97 167.94 10.98 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.317 -0.553 . . . . 71.230000000000004 111.416 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 72.8 -25.31 0.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.898 1.279 . . . . 70.019999999999996 112.947 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.6 mttm -86.28 146.45 42.42 Favored Pre-proline 0 C--N 1.29 -1.985 0 CA-C-N 115.58 -0.736 . . . . 61.299999999999997 110.264 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.69 157.27 43.16 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.472 2.115 . . . . 64.310000000000002 110.032 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.0 t -47.49 -42.52 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 113.146 0.795 . . . . 73.019999999999996 113.146 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.668 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t70 -61.62 -50.9 70.71 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 120.164 -0.614 . . . . 73.209999999999994 110.617 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.42 -51.71 68.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.827 -0.624 . . . . 75.530000000000001 111.497 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.4 -34.84 77.51 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.875 -0.602 . . . . 72.519999999999996 110.932 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.01 -34.16 71.06 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.644 -0.253 . . . . 71.340000000000003 110.615 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 24.3 mmm180 -67.87 -36.16 79.8 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.099 -0.704 . . . . 75.409999999999997 109.099 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.5 mm-40 -73.47 -53.31 10.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.273 -0.876 . . . . 71.109999999999999 112.587 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.89 -36.14 62.25 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.372 1.619 . . . . 75.230000000000004 115.372 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.6 tpp -55.18 -54.16 53.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 112.681 0.622 . . . . 74.209999999999994 112.681 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -57.55 -30.57 88.93 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.472 2.115 . . . . 74.25 112.583 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 53.4 mtpt -65.45 -34.11 77.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.255 0.55 . . . . 73.510000000000005 110.913 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.12 -38.54 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.006 0.432 . . . . 61.439999999999998 110.824 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.6 mtp -66.86 -30.13 70.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.976 0.732 . . . . 73.329999999999998 112.976 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -67.75 -45.22 75.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 65.319999999999993 109.62 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -62.21 -60.95 2.84 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.16 -0.473 . . . . 75.030000000000001 112.072 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 76' ' ' MET . 16.5 m -77.13 -3.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.544 0.688 . . . . 74.430000000000007 110.759 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.57 -11.37 59.46 Favored Glycine 0 N--CA 1.418 -2.539 0 CA-C-N 114.984 -1.007 . . . . 52.020000000000003 112.392 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.33 -28.81 0.63 Allowed Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.455 -1.355 . . . . 60.109999999999999 113.518 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -81.58 55.14 2.56 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.235 1.017 . . . . 64.040000000000006 111.253 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -98.38 149.39 22.71 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 106.061 -1.829 . . . . 62.200000000000003 106.061 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.97 -26.95 65.3 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.966 -0.693 . . . . 72.200000000000003 111.543 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HB2' HG21 ' A' ' 74' ' ' VAL . 57.3 mtpt -80.43 0.14 34.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.114 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 34.06 66.7 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 121.075 -0.583 . . . . 64.519999999999996 112.278 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 72' ' ' LYS . 48.5 t -80.1 143.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 107.776 -1.194 . . . . 51.140000000000001 107.776 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.84 -172.77 37.67 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.745 -0.741 . . . . 70.200000000000003 112.656 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -78.99 103.68 9.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.406 -0.961 . . . . 71.340000000000003 108.406 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -161.13 19.42 0.2 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.335 -0.936 . . . . 53.409999999999997 112.478 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.2 ptm -123.1 122.78 39.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.066 -1.053 . . . . 71.209999999999994 109.687 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.9 m -127.11 117.85 23.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.621 -0.718 . . . . 70.439999999999998 110.365 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 2.9 m -150.46 166.79 14.33 Favored Pre-proline 0 C--N 1.298 -1.665 0 C-N-CA 124.723 1.209 . . . . 75.140000000000001 107.822 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 38.3 Cg_endo -66.23 140.92 60.78 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.291 1.327 . . . . 44.32 113.588 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.9 139.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.085 -1.416 . . . . 64.340000000000003 107.94 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 p -127.38 148.79 50.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.636 -0.505 . . . . 72.129999999999995 109.636 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 42.0 p90 -144.35 142.04 30.12 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.63 -0.428 . . . . 73.540000000000006 110.157 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -91.89 134.9 34.36 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 109.174 -0.676 . . . . 42.520000000000003 109.174 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.49 150.18 26.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-N 114.869 -1.06 . . . . 73.239999999999995 108.382 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -121.0 105.11 40.65 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.723 -0.473 . . . . 73.530000000000001 109.723 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 158.06 48.98 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.121 1.88 . . . . 75.030000000000001 112.984 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -118.09 160.7 21.07 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.578 -0.737 . . . . 71.349999999999994 110.453 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.63 -21.68 66.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.485 -0.78 . . . . 73.439999999999998 111.254 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.5 -6.92 57.97 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.552 0.691 . . . . 72.140000000000001 110.737 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.5 -0.48 85.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.761 -0.733 . . . . 74.150000000000006 113.272 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.6 m -96.9 136.31 37.63 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.565 -0.902 . . . . 73.129999999999995 108.565 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.4 mt -84.84 87.58 7.34 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.604 -0.438 . . . . 65.530000000000001 111.056 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -148.58 113.34 5.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.873 1.064 . . . . 64.109999999999999 113.873 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -168.77 -68.79 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.749 1.22 . . . . 62.009999999999998 108.013 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -148.87 153.93 38.75 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.837 -1.529 . . . . 73.310000000000002 108.743 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.16 127.44 16.74 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.634 -0.876 . . . . 74.430000000000007 108.634 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HE3' ' HE1' ' A' ' 101' ' ' TRP . 37.6 ttpt -130.01 115.58 17.33 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.081 0.467 . . . . 54.340000000000003 110.408 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' THR . 96.9 t -85.73 138.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.447 -0.797 . . . . 71.120000000000005 110.567 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.427 ' HE1' ' HE3' ' A' ' 99' ' ' LYS . 93.4 m95 -128.7 117.18 20.72 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.3 1.04 . . . . 74.329999999999998 108.278 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CE2' HG13 ' A' ' 66' ' ' VAL . 83.7 t80 -104.32 118.18 35.99 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.604 -0.517 . . . . 75.040000000000006 109.604 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.671 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 34.5 ttm180 -74.57 131.1 40.68 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.817 -0.808 . . . . 74.049999999999997 108.817 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.17 140.67 22.51 Favored Pre-proline 0 C--N 1.296 -1.754 0 N-CA-C 109.69 -0.485 . . . . 62.420000000000002 109.69 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.26 144.57 47.98 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.812 2.342 . . . . 72.299999999999997 111.523 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -55.01 -35.49 64.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.734 1.013 . . . . 55.329999999999998 113.734 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -61.34 -45.04 96.05 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.467 0.651 . . . . 75.319999999999993 109.987 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -78.82 -10.64 59.86 Favored 'General case' 0 C--O 1.196 -1.745 0 CA-C-N 115.456 -0.793 . . . . 73.349999999999994 111.141 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.592 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.0 -28.84 64.71 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.721 -0.392 . . . . 75.349999999999994 110.439 176.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.91 94.76 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.246 -0.742 . . . . 62.420000000000002 111.246 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 55.2 p -160.74 90.77 1.63 Allowed Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 109.454 -0.573 . . . . 61.299999999999997 109.454 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.29 146.61 36.05 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.346 2.031 . . . . 70.109999999999999 110.777 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 138.41 74.64 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.743 1.629 . . . . 73.430000000000007 110.109 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 140.34 96.31 Favored Pre-proline 0 C--O 1.256 1.414 0 CA-C-N 116.532 -0.304 . . . . 64.439999999999998 110.463 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.38 113.08 2.11 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.147 1.898 . . . . 74.430000000000007 110.703 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -90.69 29.89 1.25 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.603 -0.726 . . . . 65.239999999999995 109.988 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -138.53 145.98 41.36 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.379 -1.712 . . . . 62.210000000000001 106.379 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.71 -24.39 49.19 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.919 0.711 . . . . 64.420000000000002 112.919 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 61.1 p -102.95 -13.79 16.76 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.897 0.38 . . . . 71.409999999999997 111.851 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.42 116.38 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 105.399 -2.075 . . . . 75.140000000000001 105.399 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.71 146.4 50.23 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.238 -0.585 . . . . 50.240000000000002 111.212 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.0 mm -93.0 111.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.413 -0.958 . . . . 71.310000000000002 108.413 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -119.05 147.77 43.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.16 -0.927 . . . . 73.120000000000005 108.96 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.74 138.15 44.48 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.327 -0.397 . . . . 70.400000000000006 111.626 -174.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -131.15 122.36 26.5 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.185 0.517 . . . . 64.349999999999994 110.57 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -140.23 148.61 41.76 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.574 -0.739 . . . . 62.530000000000001 109.124 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.6 20.32 78.48 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.261 -0.971 . . . . 41.549999999999997 113.746 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.498 HG13 ' SG ' ' A' ' 36' ' ' CYS . 2.2 pp -119.16 151.91 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.34 -0.944 . . . . 70.530000000000001 109.073 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.4 m -121.49 133.54 55.05 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 115.549 -0.751 . . . . 62.119999999999997 111.809 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.17 155.8 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 108.324 -0.991 . . . . 64.150000000000006 108.324 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 160' ' ' ALA . 24.7 m-85 -113.57 122.25 46.68 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.794 -1.928 . . . . 75.319999999999993 105.794 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 59.4 p -117.17 147.34 42.55 Favored 'General case' 0 C--N 1.269 -2.92 0 C-N-CA 120.344 -0.542 . . . . 73.430000000000007 111.999 -173.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.464 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -126.01 130.57 51.44 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 115.231 -0.895 . . . . 64.530000000000001 108.954 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -113.81 126.37 55.13 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.978 0.894 . . . . 74.140000000000001 109.169 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -130.81 137.81 49.59 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 114.408 -1.269 . . . . 72.219999999999999 110.65 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.77 127.32 7.19 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.337 -0.705 . . . . 72.319999999999993 111.337 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 153.79 -143.13 9.78 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 109.029 -1.628 . . . . 37.109999999999999 109.029 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -99.83 110.57 22.94 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 117.412 0.606 . . . . 73.409999999999997 110.002 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.78 139.45 44.82 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.214 -0.662 . . . . 60.350000000000001 109.214 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -114.89 169.28 9.2 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.303 -2.11 . . . . 43.420000000000002 105.303 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.65 -39.8 58.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.207 0.527 . . . . 63.530000000000001 111.598 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.2 66.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.617 -0.72 . . . . 72.409999999999997 111.071 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.46 -30.29 63.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.147 -0.479 . . . . 74.340000000000003 111.01 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -59.0 -50.5 73.87 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.115 -0.698 . . . . 75.200000000000003 109.115 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.8 t -61.73 -42.09 93.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.85 -1.068 . . . . 72.239999999999995 109.459 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.39 -46.57 88.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.529 -0.76 . . . . 73.430000000000007 110.887 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.553 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 40.5 m80 -64.24 -39.81 94.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 112.489 0.551 . . . . 74.209999999999994 112.489 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -60.77 -43.22 98.31 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.242 0.544 . . . . 73.530000000000001 110.015 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.41 HG22 ' NH2' ' A' ' 152' ' ' ARG . 88.2 m -62.73 -47.12 84.94 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 123.822 0.849 . . . . 54.140000000000001 110.022 177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -58.79 -42.9 90.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.66 0.784 . . . . 73.019999999999996 109.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 77.5 mt -57.74 -40.89 80.73 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.431 -0.349 . . . . 74.439999999999998 111.744 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 20.8 mtm180 -65.2 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.34 0.591 . . . . 72.239999999999995 110.028 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 m -72.95 -36.91 67.26 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.267 -0.879 . . . . 74.540000000000006 109.709 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.5 m -77.77 -37.82 48.12 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 116.085 -0.507 . . . . 70.140000000000001 111.394 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.77 -5.11 41.56 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.344 0.593 . . . . 75.549999999999997 111.26 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.74 120.61 20.51 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.747 -1.205 . . . . 71.209999999999994 107.747 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.44 47.52 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.381 -0.914 . . . . 51.009999999999998 111.843 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.7 p -118.5 166.18 14.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.461 -0.941 . . . . 71.140000000000001 108.461 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 10.69 1.79 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.401 2.067 . . . . 63.219999999999999 112.759 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 131' ' ' TYR . . . -88.9 126.15 35.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.911 0.386 . . . . 51.530000000000001 111.9 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.4 p -100.98 151.97 21.14 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.458 -0.571 . . . . 74.0 109.458 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.81 148.0 33.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.183 0.447 . . . . 72.310000000000002 110.405 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -129.14 139.37 51.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.123 0.786 . . . . 75.349999999999994 113.123 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.68 -0.08 29.5 Favored Glycine 0 C--O 1.236 0.239 0 CA-C-N 115.444 -0.798 . . . . 70.310000000000002 114.33 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 61.92 10.71 3.71 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.198 0.999 . . . . 71.349999999999994 111.676 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.56 138.28 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.41 0.624 . . . . 74.430000000000007 110.292 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -145.62 169.91 17.5 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.545 -0.752 . . . . 73.450000000000003 110.027 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' A' ' 85' ' ' ALA . 85.5 m-85 -115.52 148.35 39.61 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 110.104 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.55 125.52 53.89 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.343 -1.725 . . . . 72.450000000000003 106.343 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -130.77 149.11 52.56 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 111.747 0.277 . . . . 70.340000000000003 111.747 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.164 0 N-CA-C 111.027 -0.829 . . . . 60.240000000000002 111.027 -178.465 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 . . . . . 0 C--O 1.236 0.392 0 N-CA-C 114.279 1.215 . . . . 73.420000000000002 114.279 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -128.97 127.41 41.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.325 -1.732 . . . . 71.409999999999997 106.325 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -145.17 156.2 43.73 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.116 -0.633 . . . . 74.120000000000005 109.865 -171.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.4 mt-10 -129.33 147.91 51.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.793 -0.447 . . . . 74.239999999999995 109.793 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 132' ' ' SER . 73.9 t -125.24 118.71 53.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.091 -1.448 . . . . 74.530000000000001 107.091 173.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.4 m0 -106.45 120.83 42.95 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.473 -0.936 . . . . 74.450000000000003 108.473 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 58.3 tp -98.29 128.65 44.83 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.519 -1.289 . . . . 63.039999999999999 107.519 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.08 135.27 27.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.119 0.485 . . . . 63.130000000000003 111.646 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 161' ' ' THR . 21.0 pttp -77.1 143.28 39.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.78 -0.645 . . . . 71.109999999999999 111.886 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.421 0 CA-C-O 118.062 -0.97 . . . . 73.439999999999998 109.007 176.07 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.9 p90 . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 108.588 -0.893 . . . . 73.439999999999998 108.588 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.79 107.96 19.22 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.027 -0.731 . . . . 62.329999999999998 109.027 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.34 116.91 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.657 -1.156 . . . . 73.319999999999993 109.711 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -90.3 -29.17 18.29 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.294 0.479 . . . . 64.519999999999996 112.294 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -173.55 154.94 2.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.049 0.452 . . . . 37.170000000000002 109.818 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.15 157.03 45.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.316 -0.994 . . . . 74.209999999999994 108.316 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.69 -158.8 27.83 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.499 -1.334 . . . . 63.229999999999997 113.017 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.02 -119.78 4.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.415 -0.674 . . . . 60.420000000000002 111.415 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -116.44 171.28 7.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 110.134 -0.321 . . . . 74.239999999999995 110.134 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 43.9 mt-10 -85.0 156.89 20.94 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.231 -1.766 . . . . 72.129999999999995 106.231 166.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 14.6 t70 78.15 -45.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.524 0.73 . . . . 73.420000000000002 110.533 -171.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.34 108.93 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 108.715 -0.846 . . . . 62.329999999999998 108.715 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.4 m -124.38 134.04 53.24 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.62 -1.252 . . . . 72.430000000000007 107.62 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -113.31 161.67 16.96 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.358 0.873 . . . . 75.129999999999995 113.358 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -133.08 125.13 28.92 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.478 -1.675 . . . . 74.439999999999998 106.478 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.45 114.0 26.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 106.989 -1.486 . . . . 75.200000000000003 106.989 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -141.39 144.34 34.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.402 0.519 . . . . 75.530000000000001 112.402 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.49 136.23 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.288 -1.745 . . . . 72.340000000000003 106.288 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.415 ' SG ' HG13 ' A' ' 128' ' ' ILE . 83.0 m -63.91 153.87 35.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.13 0.789 . . . . 72.239999999999995 113.13 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.09 -34.77 61.78 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.165 -0.925 . . . . 72.450000000000003 111.016 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 91.9 10.98 60.8 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 118.454 -1.831 . . . . 74.209999999999994 112.095 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.23 164.14 52.33 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 111.052 -0.819 . . . . 37.170000000000002 111.052 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.532 ' O ' HD11 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -88.64 129.67 35.46 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.939 -0.763 . . . . 74.209999999999994 108.939 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 36.3 m-85 -126.89 165.4 19.43 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.582 -0.735 . . . . 72.310000000000002 110.027 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.34 116.37 30.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.7 -1.222 . . . . 75.030000000000001 107.7 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.8 t -131.86 146.85 52.36 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.566 0.698 . . . . 72.219999999999999 112.137 -175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.492 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 7.5 p -133.28 138.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 107.366 -1.346 . . . . 73.25 107.366 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -126.71 139.07 53.42 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.264 -0.574 . . . . 62.32 111.19 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 50.0 t -127.5 140.08 50.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.385 -1.339 . . . . 74.310000000000002 107.385 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.1 p -125.49 163.22 23.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.989 0.737 . . . . 72.129999999999995 112.989 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 68.44 6.03 5.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.123 1.369 . . . . 74.439999999999998 112.877 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -124.87 147.25 55.88 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 116.513 -0.312 . . . . 75.200000000000003 110.361 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 46.9 Cg_exo -58.95 156.58 32.84 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.693 2.262 . . . . 70.019999999999996 110.829 173.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 25.1 t -48.12 -43.3 11.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 113.111 0.782 . . . . 71.230000000000004 113.111 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -59.54 -41.74 90.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.931 0.396 . . . . 37.170000000000002 111.449 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.46 -46.45 48.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 72.540000000000006 110.809 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -63.81 -44.02 94.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.482 -0.781 . . . . 62.299999999999997 111.073 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.1 -42.05 85.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.857 -0.611 . . . . 74.329999999999998 111.649 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -64.43 -28.11 69.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.033 0.753 . . . . 74.450000000000003 113.033 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.2 -33.8 24.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.02 0.438 . . . . 72.25 111.613 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.83 -32.7 59.91 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.556 0.576 . . . . 52.0 112.556 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.537 ' HE2' ' HA ' ' A' ' 59' ' ' MET . 5.9 mmt -53.0 -56.84 19.58 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.32 1.23 . . . . 73.329999999999998 114.32 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.15 -31.65 84.19 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.197 1.931 . . . . 72.120000000000005 111.841 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 119' ' ' SER . 91.3 mttt -65.45 -41.02 93.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.145 -0.479 . . . . 63.149999999999999 110.751 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.15 -38.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.343 0.592 . . . . 73.439999999999998 110.008 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.27 -30.66 71.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.207 0.817 . . . . 50.350000000000001 113.207 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.02 -29.69 60.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.218 0.533 . . . . 72.519999999999996 109.925 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -64.57 -60.97 2.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.533 -0.758 . . . . 74.010000000000005 110.957 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 p -75.48 -17.96 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.437 0.637 . . . . 72.310000000000002 110.485 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.4 -28.39 73.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.976 -0.556 . . . . 37.170000000000002 113.139 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.64 3.33 6.04 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.189 -1.005 . . . . 73.099999999999994 112.852 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.4 m -95.23 22.41 6.82 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.811 0.815 . . . . 64.450000000000003 109.948 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.412 ' HA ' ' OG ' ' A' ' 116' ' ' SER . 7.9 p30 -88.07 172.73 9.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 74.420000000000002 110.827 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . 9.2 t70 -67.72 -34.32 76.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.89 -0.595 . . . . 51.020000000000003 112.518 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -78.75 -12.45 60.02 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.434 0.635 . . . . 65.030000000000001 109.683 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.69 25.07 75.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.446 -0.797 . . . . 74.400000000000006 112.645 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 34.1 m -90.41 146.79 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 120.066 -0.653 . . . . 74.400000000000006 109.888 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.99 -153.46 19.86 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.945 -0.862 . . . . 64.5 110.945 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.6 ttt -80.57 72.08 7.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.007 0.908 . . . . 74.140000000000001 110.204 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.96 3.05 41.17 Favored Glycine 0 N--CA 1.438 -1.202 0 CA-C-N 114.729 -1.123 . . . . 71.349999999999994 110.976 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.8 ptm -125.11 121.66 34.89 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.667 -0.864 . . . . 71.349999999999994 108.667 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -126.84 116.22 20.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.218 -0.446 . . . . 64.540000000000006 111.81 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -150.47 139.39 13.01 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 105.52 -2.03 . . . . 71.540000000000006 105.52 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.97 138.97 88.51 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 121.344 1.363 . . . . 71.120000000000005 110.427 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.85 139.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.963 -0.754 . . . . 72.230000000000004 108.963 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 m -118.98 145.05 46.14 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.864 -0.791 . . . . 74.349999999999994 108.864 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -132.42 137.0 47.14 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 119.949 -0.7 . . . . 72.120000000000005 109.658 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.94 135.14 34.42 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.499 -0.773 . . . . 52.310000000000002 109.008 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.77 149.71 25.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 54.520000000000003 107.798 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.643 ' CE2' ' HE3' ' A' ' 97' ' ' LYS . 67.5 m-85 -119.19 99.78 50.48 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 107.186 -1.413 . . . . 74.450000000000003 107.186 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.49 158.9 50.29 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.543 2.162 . . . . 63.43 114.542 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -103.53 160.15 14.98 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.673 -1.603 . . . . 74.230000000000004 106.673 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.2 -17.5 64.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.061 0.458 . . . . 73.109999999999999 111.795 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.54 -7.3 56.08 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.957 -0.565 . . . . 71.129999999999995 110.983 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.72 -6.06 84.01 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.696 -0.764 . . . . 72.299999999999997 112.295 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.1 m -83.94 136.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.11 0.481 . . . . 62.32 110.332 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 89.0 mt -93.59 98.63 11.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.728 0.775 . . . . 74.010000000000005 111.193 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 29.6 tt0 -148.13 170.43 17.84 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.795 -1.187 . . . . 73.109999999999999 107.795 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 105.09 -65.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 126.697 1.999 . . . . 73.310000000000002 112.255 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.643 ' HE3' ' CE2' ' A' ' 87' ' ' PHE . 33.7 ttpt -159.24 150.05 19.72 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.482 -0.326 . . . . 74.310000000000002 110.649 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 99' ' ' LYS . 5.0 tt -142.84 136.56 28.86 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.022 -1.103 . . . . 71.409999999999997 108.022 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.405 ' N ' HD23 ' A' ' 98' ' ' LEU . 68.2 mttm -122.02 115.67 22.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.469 -0.567 . . . . 75.129999999999995 109.469 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' THR . 87.7 t -88.41 128.05 40.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.899 -1.149 . . . . 65.430000000000007 107.899 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.11 123.86 46.62 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.293 -0.632 . . . . 73.450000000000003 109.293 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -102.99 112.61 25.53 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.471 -1.677 . . . . 64.219999999999999 106.471 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.84 113.06 14.11 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.957 -1.498 . . . . 71.439999999999998 106.957 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.532 HD11 ' O ' ' A' ' 40' ' ' LYS . 76.8 mt -73.36 138.7 78.21 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 115.926 -0.579 . . . . 60.039999999999999 110.555 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.7 161.32 45.83 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.504 2.136 . . . . 73.319999999999993 112.002 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -35.22 27.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.296 1.438 . . . . 74.239999999999995 111.081 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.04 -42.96 99.47 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.419 0.688 . . . . 72.519999999999996 111.992 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -99.76 -1.74 36.93 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 114.011 1.115 . . . . 73.439999999999998 114.011 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.614 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -62.97 -28.75 70.3 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.421 1.267 . . . . 63.119999999999997 114.421 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -39.38 32.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.89 -1.147 . . . . 52.539999999999999 111.942 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.9 m -149.0 94.4 4.03 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 109.251 -0.648 . . . . 74.310000000000002 109.251 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.63 158.1 12.26 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.417 2.078 . . . . 74.230000000000004 111.638 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.46 131.68 46.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.985 1.79 . . . . 55.329999999999998 109.943 175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 71' ' ' ASP . . . -66.23 140.27 96.77 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.319 -0.401 . . . . 73.239999999999995 110.358 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.61 101.5 1.04 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.438 2.092 . . . . 70.329999999999998 111.952 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 11.4 p -81.02 2.19 28.08 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.605 1.162 . . . . 72.430000000000007 111.886 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.472 ' HB3' HG11 ' A' ' 120' ' ' VAL . 13.1 t70 -113.27 152.69 29.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.415 -0.957 . . . . 74.510000000000005 108.415 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -13.16 45.5 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 115.372 1.619 . . . . 70.439999999999998 115.372 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 71.9 m -97.85 -28.84 13.66 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.152 -0.619 . . . . 73.450000000000003 111.898 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' ' 117' ' ' ASP . 6.8 p -94.68 128.04 46.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.844 -0.743 . . . . 63.130000000000003 109.478 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -124.49 153.29 42.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.996 -0.742 . . . . 64.329999999999998 108.996 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.9 mm -92.45 111.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 74.120000000000005 107.793 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -127.0 145.74 50.6 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.519 -0.764 . . . . 60.420000000000002 109.887 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.45 144.99 33.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.845 -0.798 . . . . 55.450000000000003 108.845 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.543 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.6 tpt180 -134.85 123.06 22.91 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.445 -0.902 . . . . 63.130000000000003 109.901 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.56 173.79 11.22 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.529 -0.545 . . . . 64.129999999999995 109.529 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.11 19.03 70.64 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.822 -0.626 . . . . 51.140000000000001 112.617 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.415 HG13 ' SG ' ' A' ' 36' ' ' CYS . 43.3 pt -128.37 145.53 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 121.17 0.51 . . . . 73.5 111.02 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.0 m -104.07 129.72 51.74 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 107.449 -1.315 . . . . 62.130000000000003 107.449 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.25 151.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.43 -0.581 . . . . 63.450000000000003 109.43 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 72.0 m-85 -114.04 121.48 43.97 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.308 -1.738 . . . . 64.439999999999998 106.308 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.5 m -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 109.869 -0.419 . . . . 70.450000000000003 109.869 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.0 t -118.32 131.38 56.33 Favored 'General case' 0 N--CA 1.411 -2.4 0 C-N-CA 120.391 -0.523 . . . . 73.530000000000001 110.067 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.522 ' HG2' ' HG3' ' A' ' 184' ' ' GLU . 51.4 mt-30 -110.84 128.36 55.75 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.089 -1.078 . . . . 74.0 108.089 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.2 p90 -114.68 135.68 53.89 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 115.309 -0.86 . . . . 74.549999999999997 110.563 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.14 101.57 2.61 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.408 -1.077 . . . . 55.149999999999999 110.408 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.06 167.82 27.28 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.231 -0.748 . . . . 61.520000000000003 111.231 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -75.44 139.72 42.46 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 110.124 -0.324 . . . . 72.319999999999993 110.124 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -116.04 123.76 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.549 0.69 . . . . 74.230000000000004 112.246 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.447 ' HG2' ' OE2' ' A' ' 141' ' ' GLU . 26.3 ttpp -115.68 170.53 8.38 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 104.721 -2.326 . . . . 75.200000000000003 104.721 172.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.447 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -51.54 -42.86 62.11 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.901 0.773 . . . . 73.430000000000007 113.058 -174.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.5 67.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.469 -0.332 . . . . 64.329999999999998 111.828 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -69.07 -37.11 78.33 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.968 -0.293 . . . . 70.140000000000001 111.112 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.69 -42.55 88.83 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.672 -0.492 . . . . 73.329999999999998 109.672 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.72 -40.7 84.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.424 -0.807 . . . . 74.409999999999997 109.794 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -61.93 -47.6 84.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 74.329999999999998 111.24 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -69.04 -33.52 73.72 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 112.228 0.455 . . . . 74.310000000000002 112.228 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.29 92.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.177 0.513 . . . . 73.519999999999996 109.969 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 76.5 m -62.91 -46.93 85.49 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.675 -0.693 . . . . 64.420000000000002 110.125 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 25.8 mt-30 -59.92 -38.36 82.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.107 -0.497 . . . . 55.140000000000001 110.359 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.25 -43.58 96.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.845 -0.616 . . . . 71.530000000000001 110.995 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -63.39 -39.18 93.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 65.140000000000001 109.61 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -71.78 -30.81 65.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.203 -0.908 . . . . 74.209999999999994 111.133 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.7 m -76.74 -34.69 58.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.282 0.563 . . . . 70.540000000000006 109.67 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.96 7.71 12.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.928 -0.578 . . . . 62.509999999999998 111.027 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -74.49 130.64 39.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.331 -0.618 . . . . 64.530000000000001 109.331 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.23 3.45 58.81 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.939 -0.648 . . . . 52.520000000000003 112.128 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 54.5 p -112.18 165.64 12.55 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.764 -0.828 . . . . 73.319999999999993 108.764 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.28 14.93 0.53 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.764 2.31 . . . . 71.439999999999998 112.872 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.67 109.83 3.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.084 0.469 . . . . 44.509999999999998 110.562 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.6 p -95.97 156.54 16.29 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.909 -1.145 . . . . 74.129999999999995 107.909 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.507 ' C ' ' HB1' ' A' ' 190' ' ' ALA . 19.9 m-85 -132.64 151.27 52.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.595 -0.842 . . . . 75.310000000000002 109.277 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -127.3 122.33 33.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.002 0.43 . . . . 74.409999999999997 111.32 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.09 0.73 37.03 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.334 -0.848 . . . . 74.299999999999997 113.352 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.63 18.47 10.56 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.561 1.172 . . . . 54.109999999999999 109.366 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.27 139.22 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 113.724 -1.58 . . . . 74.219999999999999 112.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.453 ' OH ' HD23 ' A' ' 94' ' ' LEU . 11.4 p90 -149.41 167.66 25.56 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.194 -0.912 . . . . 74.219999999999999 110.747 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 2.8 m-85 -116.0 153.47 31.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 123.586 0.754 . . . . 74.239999999999995 109.557 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.9 m -124.03 131.41 53.55 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.252 -1.388 . . . . 63.350000000000001 107.252 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 184' ' ' GLU . . . -129.77 148.11 51.61 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.544 0.572 . . . . 74.319999999999993 112.544 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.688 0 N-CA-C 108.647 -1.781 . . . . 73.409999999999997 108.647 179.51 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 C--O 1.222 -0.37 0 N-CA-C 115.721 1.749 . . . . 75.239999999999995 115.721 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 0.7 OUTLIER -117.08 130.37 56.6 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 118.2 -1.4 . . . . 73.420000000000002 110.269 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 40.4 m-80 -144.16 148.02 34.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.854 -1.165 . . . . 74.150000000000006 107.854 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.522 ' HG3' ' HG2' ' A' ' 134' ' ' GLN . 2.5 mp0 -112.04 144.36 41.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.115 0.484 . . . . 71.109999999999999 110.873 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 57.8 t -125.52 118.84 53.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.366 -1.716 . . . . 73.140000000000001 106.366 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.517 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 27.9 m0 -106.52 120.77 42.81 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.131 -0.692 . . . . 74.329999999999998 109.131 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 tp -98.88 133.94 42.46 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.363 -1.347 . . . . 73.329999999999998 107.363 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.25 126.86 45.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.328 -0.549 . . . . 71.120000000000005 111.32 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.2 tttm -75.14 137.85 41.64 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.886 -0.597 . . . . 74.540000000000006 109.808 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.507 ' HB1' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.301 -1.528 0 CA-C-O 118.259 -0.877 . . . . 73.519999999999996 108.86 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.7 p90 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 108.47 -0.937 . . . . 74.209999999999994 108.47 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -106.63 115.44 30.21 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.371 -0.377 . . . . 73.510000000000005 111.397 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 121.05 41.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.739 0.781 . . . . 71.120000000000005 109.966 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.24 -24.16 15.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.608 -0.723 . . . . 71.310000000000002 111.754 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -165.93 148.5 7.33 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.868 0.366 . . . . 74.439999999999998 110.29 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.9 p -134.56 164.31 27.78 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.95 -1.023 . . . . 74.540000000000006 110.321 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.94 -136.34 12.86 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 119.964 -1.112 . . . . 64.549999999999997 113.809 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.31 -108.26 2.89 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.85 -1.3 . . . . 73.450000000000003 109.85 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -108.9 168.02 9.66 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.458 -1.312 . . . . 72.010000000000005 107.458 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.65 154.08 25.08 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 118.62 0.646 . . . . 65.25 111.223 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 72.58 -64.77 0.38 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.93 1.292 . . . . 74.349999999999994 110.321 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.9 t -92.6 109.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.756 -1.942 . . . . 73.129999999999995 105.756 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 m -133.4 154.31 50.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.907 -0.775 . . . . 52.329999999999998 108.907 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.32 160.56 18.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.513 0.673 . . . . 74.040000000000006 111.668 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.92 124.95 25.74 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.832 -1.914 . . . . 71.120000000000005 105.832 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.86 114.08 27.85 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.221 -1.77 . . . . 74.329999999999998 106.221 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.22 146.65 52.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.413 0.625 . . . . 72.329999999999998 111.652 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.82 136.14 33.51 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.745 -1.576 . . . . 71.430000000000007 106.745 172.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -60.44 162.57 6.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.53 0.937 . . . . 72.140000000000001 113.53 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -20.77 32.91 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.656 -0.702 . . . . 64.239999999999995 110.42 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.57 11.1 56.11 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 119.362 -1.399 . . . . 73.430000000000007 112.077 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.21 160.71 54.1 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 120.877 -0.678 . . . . 51.420000000000002 112.923 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 122' ' ' ILE . 17.1 ptpt -96.76 130.68 43.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.948 -0.76 . . . . 74.230000000000004 108.948 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 58.9 m-85 -130.66 164.43 25.02 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.056 -0.52 . . . . 74.420000000000002 110.509 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.34 120.09 38.14 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 107.762 -1.199 . . . . 62.109999999999999 107.762 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.634 ' OG1' ' HE2' ' A' ' 99' ' ' LYS . 9.4 t -135.19 150.49 50.14 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 119.911 -0.716 . . . . 61.32 112.038 -174.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.539 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 18.8 m -134.85 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.897 -1.047 . . . . 74.209999999999994 109.739 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -123.81 139.8 53.62 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.813 -0.439 . . . . 51.329999999999998 109.813 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.32 133.12 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.328 -1.36 . . . . 74.120000000000005 107.328 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 49' ' ' LYS . 36.2 m -133.14 157.1 46.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.336 -0.616 . . . . 73.120000000000005 109.336 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 79.6 -9.38 1.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.794 1.637 . . . . 64.209999999999994 109.359 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.5 mttm -111.22 131.53 22.18 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.16 -1.382 . . . . 70.230000000000004 109.049 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.24 158.48 35.03 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.053 2.502 . . . . 73.439999999999998 110.787 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG12 HD12 ' A' ' 98' ' ' LEU . 39.3 t -45.95 -37.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.06 0.944 . . . . 71.230000000000004 112.976 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.55 -51.11 69.82 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.216 0.532 . . . . 44.130000000000003 110.561 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -76.41 -37.44 57.08 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.176 -0.92 . . . . 62.340000000000003 112.237 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.82 91.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.006 -0.543 . . . . 71.510000000000005 112.01 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -48.18 77.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.339 -0.615 . . . . 73.310000000000002 109.339 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.69 -24.29 66.24 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.792 -0.64 . . . . 73.430000000000007 111.983 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 10.4 tp10 -84.5 -45.5 12.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.515 0.674 . . . . 73.439999999999998 110.291 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.74 -39.65 69.91 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.596 0.961 . . . . 72.420000000000002 113.596 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.415 ' HE3' ' HB2' ' A' ' 59' ' ' MET . 35.5 ttm -57.73 -46.72 99.72 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 114.196 1.184 . . . . 75.319999999999993 114.196 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 83.6 Cg_exo -50.89 -37.4 55.68 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.391 2.06 . . . . 74.150000000000006 111.233 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.565 ' HD2' ' CB ' ' A' ' 119' ' ' SER . 43.5 mtmt -68.77 -37.01 79.03 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.683 -0.69 . . . . 75.019999999999996 110.792 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.0 mm -76.39 -47.63 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 112.18 0.437 . . . . 74.430000000000007 112.18 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.425 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 25.0 ptm -62.59 -29.58 70.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.663 0.986 . . . . 71.230000000000004 113.663 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.67 -36.27 82.13 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.196 -0.602 . . . . 72.140000000000001 110.107 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -56.69 -59.43 5.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 111.813 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.85 -17.0 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 62.329999999999998 110.264 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.86 -14.27 82.53 Favored Glycine 0 C--O 1.24 0.508 0 CA-C-N 115.92 -0.582 . . . . 72.049999999999997 113.275 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.19 4.11 2.35 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.684 -1.246 . . . . 60.210000000000001 114.552 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.0 m -91.35 23.51 3.35 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 123.077 1.418 . . . . 73.420000000000002 110.412 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.73 170.28 8.89 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.099 -0.955 . . . . 75.439999999999998 110.228 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.94 -27.46 62.81 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 111.844 0.313 . . . . 72.200000000000003 111.844 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -86.05 -12.41 50.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.56 0.695 . . . . 74.109999999999999 110.525 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 31.84 63.2 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 115.319 -0.855 . . . . 63.119999999999997 112.518 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.11 123.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.319 -0.552 . . . . 72.299999999999997 110.758 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.37 -40.36 1.14 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 110.902 -0.879 . . . . 73.340000000000003 110.902 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.5 mtt -107.03 81.21 1.52 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.904 -1.517 . . . . 71.540000000000006 106.904 173.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.1 -79.32 0.54 Allowed Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.795 -1.193 . . . . 72.409999999999997 114.495 -172.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 24.1 ptt? -127.8 125.2 39.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.118 0.485 . . . . 75.310000000000002 111.945 -173.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 p -125.25 115.92 21.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.693 -0.685 . . . . 44.109999999999999 111.182 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.428 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 28.6 m -142.26 175.86 2.71 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.767 -1.568 . . . . 61.530000000000001 106.767 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' CD ' ' HB ' ' A' ' 80' ' ' VAL . 39.8 Cg_exo -59.89 140.11 91.4 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 121.55 1.5 . . . . 71.120000000000005 113.268 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.95 153.19 8.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.085 -1.45 . . . . 75.209999999999994 107.085 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -140.01 145.23 37.53 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.888 -0.508 . . . . 65.239999999999995 109.881 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 53.5 p90 -136.61 143.11 43.38 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.149 -0.62 . . . . 72.019999999999996 111.147 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.633 ' HB1' ' CE1' ' A' ' 168' ' ' TYR . . . -92.66 135.6 33.95 Favored 'General case' 0 CA--C 1.478 -1.819 0 O-C-N 123.801 0.688 . . . . 70.230000000000004 109.774 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.83 149.73 33.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.156 -1.053 . . . . 64.329999999999998 108.156 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 99.3 m-85 -112.25 108.06 55.16 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.176 -0.675 . . . . 72.329999999999998 109.176 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -83.6 151.67 13.25 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.626 1.55 . . . . 54.240000000000002 112.358 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.03 168.56 10.01 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.007 . . . . 72.120000000000005 108.282 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.55 -19.76 65.86 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.069 0.461 . . . . 64.120000000000005 111.626 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -81.07 -6.91 59.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 53.009999999999998 110.08 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.36 73.37 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.883 -0.599 . . . . 74.030000000000001 111.838 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.0 m -74.46 140.48 44.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.067 -0.716 . . . . 74.310000000000002 109.067 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.7 139.65 33.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.023 0.44 . . . . 73.219999999999999 111.036 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.3 167.82 19.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 124.225 1.01 . . . . 73.239999999999995 111.891 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.6 pttt -70.35 21.87 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 126.224 1.81 . . . . 71.409999999999997 114.879 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.553 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 24.2 ttmm -139.66 134.72 32.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 119.449 1.022 . . . . 71.310000000000002 110.972 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.484 HD12 HG12 ' A' ' 51' ' ' VAL . 6.0 tt -143.07 130.57 21.17 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 107.998 -1.112 . . . . 61.020000000000003 107.998 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.634 ' HE2' ' OG1' ' A' ' 43' ' ' THR . 23.6 tptm -116.11 115.3 25.81 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.466 -0.938 . . . . 71.219999999999999 108.466 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.539 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 99.3 t -94.25 126.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.893 -0.41 . . . . 72.049999999999997 109.893 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -113.04 124.99 53.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.151 0.581 . . . . 71.510000000000005 109.564 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -103.12 113.66 27.31 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.639 -1.615 . . . . 65.140000000000001 106.639 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -77.29 131.3 38.08 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.461 -0.79 . . . . 75.040000000000006 110.494 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.418 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 73.3 mt -100.17 133.86 21.22 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-N 115.031 -0.986 . . . . 70.310000000000002 108.556 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 31.9 Cg_exo -58.32 151.53 59.8 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.788 2.325 . . . . 62.219999999999999 111.229 175.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.31 -34.25 60.55 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.881 0.872 . . . . 42.109999999999999 110.076 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -59.68 -34.33 72.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.903 -0.589 . . . . 73.310000000000002 111.873 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.53 -3.98 32.24 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 120.816 -0.354 . . . . 70.299999999999997 111.521 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 97.7 mt-30 -70.55 -27.89 64.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.89 0.33 . . . . 72.219999999999999 111.89 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.87 -38.16 95.71 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.438 -0.665 . . . . 62.549999999999997 111.438 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 t -158.28 90.68 2.19 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 108.724 -0.843 . . . . 72.439999999999998 108.724 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -85.85 154.86 10.07 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.026 1.817 . . . . 65.209999999999994 112.06 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.5 149.23 83.17 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.193 1.929 . . . . 70.439999999999998 110.742 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.9 130.29 49.05 Favored Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 116.299 -0.409 . . . . 72.120000000000005 111.112 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 74.0 Cg_endo -76.89 112.59 3.47 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.904 2.403 . . . . 74.420000000000002 111.653 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 79.87 2.93 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.54 -0.864 . . . . 73.109999999999999 110.87 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.474 ' HB3' HG11 ' A' ' 120' ' ' VAL . 14.9 t70 -169.66 149.0 3.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.298 -1.742 . . . . 74.310000000000002 106.298 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.94 -14.97 59.35 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.944 0.72 . . . . 72.319999999999993 112.944 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.565 ' CB ' ' HD2' ' A' ' 61' ' ' LYS . 36.9 m -95.4 -29.71 14.29 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.88 -0.328 . . . . 65.409999999999997 111.836 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 117' ' ' ASP . 3.9 p -106.25 116.46 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.54 0 CA-C-O 121.821 0.819 . . . . 74.120000000000005 110.575 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -130.74 155.24 46.98 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.144 -1.389 . . . . 74.420000000000002 110.19 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.0 mm -91.37 112.64 25.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.56 -0.904 . . . . 74.010000000000005 108.56 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -115.58 141.84 47.53 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.157 -0.682 . . . . 72.299999999999997 109.157 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -111.18 145.84 37.95 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.575 -0.739 . . . . 71.420000000000002 109.756 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -146.98 126.93 13.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.309 0.576 . . . . 62.350000000000001 110.805 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.76 169.96 16.28 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.106 -0.952 . . . . 75.040000000000006 110.346 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 16.38 78.7 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.373 -0.441 . . . . 63.399999999999999 113.53 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pp -121.23 162.6 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 119.542 -0.863 . . . . 75.510000000000005 109.245 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.7 m -120.29 136.99 54.49 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 115.485 -0.78 . . . . 64.510000000000005 109.29 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.5 m -124.84 146.35 30.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.314 -0.995 . . . . 65.530000000000001 108.314 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.557 ' OH ' ' HB2' ' A' ' 160' ' ' ALA . 19.9 m-85 -114.95 121.54 43.47 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 105.932 -1.877 . . . . 75.010000000000005 105.932 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 p -117.4 131.5 56.75 Favored 'General case' 0 C--N 1.274 -2.712 0 C-N-CA 120.213 -0.595 . . . . 63.130000000000003 111.798 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.9 t -113.29 119.14 36.68 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 108.187 -1.042 . . . . 72.219999999999999 108.187 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -111.15 126.69 55.11 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 109.183 -0.673 . . . . 72.219999999999999 109.183 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 36.3 p90 -142.3 153.48 43.92 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 115.179 -0.918 . . . . 72.329999999999998 110.901 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.69 145.25 18.24 Favored Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 110.039 -1.224 . . . . 75.319999999999993 110.039 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.67 168.16 11.93 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 109.41 -1.476 . . . . 70.120000000000005 109.41 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -68.38 101.54 1.24 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.287 0.565 . . . . 74.230000000000004 111.574 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.33 130.85 53.3 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.618 -0.882 . . . . 72.310000000000002 108.618 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -89.74 176.91 6.66 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.754 -0.832 . . . . 75.030000000000001 108.754 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.41 -31.95 71.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.244 0.545 . . . . 71.200000000000003 109.911 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.09 -29.36 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.502 -0.772 . . . . 63.009999999999998 109.784 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -69.54 -29.81 67.48 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 116.037 -0.529 . . . . 62.329999999999998 111.268 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -59.26 -41.89 89.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.67 -0.412 . . . . 75.129999999999995 110.133 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.29 -49.1 84.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.451 -0.795 . . . . 73.109999999999999 110.102 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.04 -44.49 84.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.656 . . . . 37.729999999999997 111.79 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -63.53 -31.55 72.75 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 112.538 0.57 . . . . 73.25 112.538 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.63 85.3 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.352 -0.61 . . . . 73.019999999999996 109.352 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.427 HG21 ' NH2' ' A' ' 152' ' ' ARG . 22.1 m -66.83 -41.31 87.65 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 115.654 -0.703 . . . . 74.450000000000003 111.46 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.2 -37.48 85.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.428 . . . . 72.319999999999993 109.97 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.18 -41.99 98.86 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.723 -0.671 . . . . 72.230000000000004 110.224 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.525 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.8 mtm105 -62.22 -46.93 86.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.568 -0.287 . . . . 72.430000000000007 111.063 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.2 m -61.59 -34.37 75.5 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.877 0.736 . . . . 72.310000000000002 110.431 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 30.0 m -76.99 -35.43 57.16 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.86 -0.609 . . . . 75.200000000000003 110.164 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.1 mt -70.05 -31.4 69.0 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 113.354 0.872 . . . . 64.219999999999999 113.354 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 46.1 mt-10 -46.31 131.1 10.67 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.621 0.6 . . . . 72.109999999999999 112.621 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.64 12.64 43.5 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.516 -1.034 . . . . 52.229999999999997 110.516 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.9 t -102.56 149.72 36.98 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 109.06 -0.719 . . . . 64.120000000000005 109.06 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -75.18 -4.82 15.91 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.594 2.196 . . . . 74.319999999999993 111.173 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.557 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . . . -71.99 147.04 47.29 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.771 -0.65 . . . . 61.450000000000003 110.854 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 74.0 p -108.02 138.05 44.95 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.3 -0.63 . . . . 74.140000000000001 109.3 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -144.02 150.51 38.36 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 122.29 -0.256 . . . . 62.200000000000003 110.938 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.523 ' O ' HG12 ' A' ' 166' ' ' VAL . 29.0 pt20 -129.33 122.84 30.38 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.999 1.111 . . . . 71.340000000000003 113.999 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.71 12.79 62.5 Favored Glycine 0 C--N 1.309 -0.964 0 N-CA-C 115.207 0.843 . . . . 63.530000000000001 115.207 164.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.401 ' O ' ' HD1' ' A' ' 167' ' ' TYR . 25.4 t70 67.43 19.76 9.99 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.959 0.409 . . . . 61.140000000000001 110.641 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 163' ' ' GLN . 7.2 p -64.81 137.95 24.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 120.367 -0.533 . . . . 62.140000000000001 109.788 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' ASP . 26.9 p90 -151.12 170.83 18.46 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.701 0.762 . . . . 74.209999999999994 111.644 -173.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.633 ' CE1' ' HB1' ' A' ' 85' ' ' ALA . 97.2 m-85 -114.64 151.65 33.19 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.216 -1.356 . . . . 75.409999999999997 109.737 175.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.54 122.16 45.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.506 -1.294 . . . . 73.450000000000003 107.506 174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.18 142.41 44.69 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.153 0.283 . . . . 53.109999999999999 111.436 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.987 0 N-CA-C 110.039 -1.224 . . . . 72.230000000000004 110.039 179.79 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 CA--C 1.511 -0.548 0 CA-C-O 120.964 0.411 . . . . 73.25 110.069 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -109.13 132.94 53.64 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.739 -1.208 . . . . 73.329999999999998 107.739 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.7 m-80 -134.37 134.29 41.56 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.385 -0.969 . . . . 74.040000000000006 108.385 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -128.82 136.35 50.37 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.865 -0.42 . . . . 74.299999999999997 109.865 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.1 t -124.74 121.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.468 -0.938 . . . . 72.340000000000003 108.468 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.6 m0 -103.21 123.15 46.19 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 108.087 -1.079 . . . . 72.310000000000002 108.087 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 166' ' ' VAL . 1.7 tt -97.35 138.57 34.61 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.896 -1.52 . . . . 63.109999999999999 106.896 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.473 HG22 ' CE2' ' A' ' 168' ' ' TYR . 20.7 t -87.88 131.98 34.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 110.455 -0.202 . . . . 73.239999999999995 110.455 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.569 ' C ' ' HD2' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -70.39 143.38 51.9 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.204 -0.665 . . . . 74.310000000000002 109.204 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 118.551 -0.738 . . . . 65.439999999999998 109.333 176.504 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.6 p90 . . . . . 0 N--CA 1.431 -1.379 0 N-CA-C 105.3 -2.111 . . . . 75.430000000000007 105.3 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -106.03 114.98 29.44 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.997 -1.081 . . . . 74.25 111.963 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.51 121.16 35.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.311 -1.737 . . . . 61.450000000000003 106.311 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.3 -26.42 20.01 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.389 -0.924 . . . . 72.239999999999995 110.758 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -175.99 165.31 2.92 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.681 -0.859 . . . . 74.150000000000006 108.681 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.4 p -132.57 150.02 52.22 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.771 -1.196 . . . . 73.239999999999995 107.771 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.39 113.61 2.11 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.101 -1.523 . . . . 73.030000000000001 113.406 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.25 -99.49 0.49 Allowed Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 110.857 -0.897 . . . . 41.119999999999997 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -98.87 169.1 9.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.302 -0.999 . . . . 74.420000000000002 108.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.48 157.38 23.62 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.504 -0.554 . . . . 74.010000000000005 109.504 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 72.74 -58.28 0.6 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.408 1.083 . . . . 64.120000000000005 110.875 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.86 111.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.823 0.82 . . . . 70.010000000000005 108.791 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.5 m -106.37 136.91 45.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.826 -0.625 . . . . 72.430000000000007 109.809 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.49 160.14 18.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.597 -0.841 . . . . 75.120000000000005 111.405 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.61 124.29 25.17 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.646 -1.613 . . . . 63.240000000000002 106.646 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.8 115.66 30.86 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.042 0.925 . . . . 73.310000000000002 110.835 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -128.81 138.58 52.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 114.458 -1.246 . . . . 74.209999999999994 110.871 -174.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.22 136.94 32.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.407 -0.815 . . . . 73.099999999999994 109.071 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.01 148.92 28.98 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.945 0.778 . . . . 75.109999999999999 109.718 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -77.62 -13.55 59.88 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 112.496 0.554 . . . . 74.219999999999999 112.496 -175.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.29 61.68 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.219 -1.467 . . . . 53.210000000000001 113.253 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 163.65 40.17 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.616 -1.278 . . . . 72.540000000000006 112.337 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.497 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.4 ptpt -96.03 133.9 39.71 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 75.109999999999999 108.375 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 37.0 m-85 -124.52 163.12 22.54 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.269 -0.423 . . . . 73.209999999999994 111.922 -171.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.53 116.63 32.12 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.575 -0.898 . . . . 72.450000000000003 108.575 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.4 t -123.29 149.64 44.56 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 121.23 0.538 . . . . 75.319999999999993 110.978 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.4 m -127.09 123.27 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.098 -0.955 . . . . 63.229999999999997 109.41 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -109.89 132.57 54.03 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.44 0.638 . . . . 71.140000000000001 112.504 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.41 136.9 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.569 -1.271 . . . . 74.019999999999996 107.569 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.531 ' C ' ' H ' ' A' ' 49' ' ' LYS . 31.0 m -138.75 164.83 28.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.712 -1.218 . . . . 73.329999999999998 107.712 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG21 ' A' ' 47' ' ' THR . 14.1 t70 76.16 -26.47 0.19 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.012 1.325 . . . . 74.549999999999997 110.309 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 47' ' ' THR . 54.0 mtmt -103.16 122.59 44.83 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 114.483 -1.235 . . . . 72.420000000000002 108.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.48 158.79 1.57 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 124.596 3.531 . . . . 73.109999999999999 114.416 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.66 -41.47 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.452 1.101 . . . . 64.120000000000005 112.055 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.672 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 24.5 t70 -58.81 -43.45 90.56 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.638 -0.256 . . . . 70.019999999999996 110.517 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -73.77 -47.67 37.33 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.335 0.654 . . . . 64.200000000000003 110.85 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.77 -41.56 77.85 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.442 -0.799 . . . . 74.219999999999999 111.698 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.1 tp -68.72 -35.71 77.49 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.342 -0.39 . . . . 74.510000000000005 110.443 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 17.6 mtp180 -56.89 -46.0 82.18 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.206 0.527 . . . . 74.299999999999997 111.624 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 49' ' ' LYS . 40.0 mt-10 -79.58 -35.33 39.84 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.429 -0.805 . . . . 74.430000000000007 112.292 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.29 -32.91 59.03 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.37 0.878 . . . . 72.319999999999993 113.37 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.521 ' HE2' ' HA ' ' A' ' 59' ' ' MET . 5.2 mmt -56.26 -57.91 19.86 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.121 0.786 . . . . 75.530000000000001 113.121 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.604 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 28.9 Cg_endo -63.9 -32.49 66.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 121.867 1.712 . . . . 64.219999999999999 110.552 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -58.35 -45.65 87.78 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.923 -1.035 . . . . 54.420000000000002 110.796 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.5 mm -75.63 -47.63 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.389 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.423 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.292 3.7 ppp? -62.85 -32.23 73.41 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.667 1.358 . . . . 75.040000000000006 114.667 -174.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 60' ' ' PRO 0.295 0.0 OUTLIER -77.65 -29.09 51.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.697 -1.201 . . . . 71.230000000000004 112.504 176.347 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' THR . 62.2 t80 -65.07 -52.23 56.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.343 0.592 . . . . 74.409999999999997 110.207 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -72.19 -15.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.556 -0.747 . . . . 73.099999999999994 111.853 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.4 -11.58 68.82 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.439 -0.801 . . . . 70.340000000000003 112.458 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.0 -23.32 1.44 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.486 -1.34 . . . . 44.439999999999998 113.577 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 58.0 m -82.0 70.01 8.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.65 1.214 . . . . 74.239999999999995 111.976 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -98.36 170.16 9.05 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.528 -2.027 . . . . 72.299999999999997 105.528 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 36.6 t70 -69.31 -33.52 73.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 119.809 -0.756 . . . . 64.329999999999998 111.723 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.2 1.91 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 72.239999999999995 110.792 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.86 28.57 72.96 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.638 -0.71 . . . . 64.209999999999994 113.656 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.16 120.73 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 109.3 -0.629 . . . . 74.510000000000005 109.3 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.76 -135.3 1.85 Allowed Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 111.0 -0.84 . . . . 54.439999999999998 111.0 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.8 ttp 178.0 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.271 0.558 . . . . 74.450000000000003 111.284 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.54 65.58 0.58 Allowed Glycine 0 CA--C 1.491 -1.414 0 N-CA-C 106.291 -2.724 . . . . 60.530000000000001 106.291 -169.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.401 ' HE3' ' HD2' ' A' ' 105' ' ' PRO . 11.4 ptm -97.01 121.94 39.45 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.266 -0.967 . . . . 72.549999999999997 111.448 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -128.26 134.93 49.05 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.712 -0.676 . . . . 64.530000000000001 111.589 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -157.11 172.29 6.33 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 104.991 -2.226 . . . . 71.25 104.991 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.18 139.52 72.09 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 121.431 1.42 . . . . 75.439999999999998 113.161 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.83 142.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.421 -1.326 . . . . 42.100000000000001 107.421 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.6 p -138.33 144.5 40.41 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.952 -0.299 . . . . 64.25 110.234 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 50.4 p90 -131.01 143.73 50.94 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.582 -0.447 . . . . 73.219999999999999 110.96 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.5 ' HB3' ' CE2' ' A' ' 168' ' ' TYR . . . -93.35 134.24 35.78 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.602 0.564 . . . . 74.329999999999998 110.6 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.26 150.79 32.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.438 -0.801 . . . . 75.239999999999995 109.799 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -114.75 112.69 45.1 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.951 -0.389 . . . . 74.040000000000006 109.951 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.59 158.83 2.93 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.869 1.713 . . . . 63.530000000000001 111.289 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -104.67 160.76 14.7 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.279 -1.749 . . . . 72.209999999999994 106.279 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.01 -24.73 64.73 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.49 0.662 . . . . 74.109999999999999 111.058 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.57 -5.89 47.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.01 -0.995 . . . . 73.329999999999998 110.804 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.91 -10.67 74.29 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.846 -0.502 . . . . 44.399999999999999 111.846 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 m -77.22 136.01 38.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 109.032 -0.729 . . . . 74.129999999999995 109.032 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.3 mt -84.72 136.85 33.55 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.069 0.461 . . . . 74.400000000000006 111.037 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -81.9 144.97 30.6 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.769 -1.567 . . . . 71.530000000000001 106.769 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -92.29 80.12 5.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.364 1.246 . . . . 70.510000000000005 114.364 -174.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.623 ' HE2' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -160.42 122.37 3.18 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.434 -2.802 . . . . 73.329999999999998 103.434 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.623 ' N ' ' HE2' ' A' ' 97' ' ' LYS . 5.2 tt -144.11 137.62 27.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.77 0.319 . . . . 62.350000000000001 110.515 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -129.09 123.88 33.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.205 -0.598 . . . . 65.340000000000003 110.553 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.547 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 86.2 t -86.94 129.78 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.629 -0.714 . . . . 73.219999999999999 109.145 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -107.16 127.87 53.9 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.622 -0.51 . . . . 74.219999999999999 109.622 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -104.04 117.71 34.94 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.812 -1.181 . . . . 74.510000000000005 107.812 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 59.4 ttt-85 -75.34 129.46 37.42 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.023 -1.473 . . . . 74.019999999999996 107.023 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.7 mt -89.87 134.28 32.31 Favored Pre-proline 0 C--N 1.271 -2.831 0 N-CA-C 109.868 -0.419 . . . . 73.439999999999998 109.868 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.536 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 74.7 Cg_exo -53.59 158.84 7.34 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.021 2.481 . . . . 74.510000000000005 112.972 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -46.27 -54.32 9.08 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 126.137 1.775 . . . . 73.120000000000005 115.585 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -72.29 -28.15 62.91 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.053 -0.659 . . . . 72.120000000000005 112.456 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.89 -12.56 55.28 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.623 -0.431 . . . . 73.340000000000003 111.458 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 49.9 mt-30 -70.9 -28.53 64.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.748 0.309 . . . . 62.409999999999997 111.482 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -38.24 92.38 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.975 -0.631 . . . . 60.439999999999998 111.64 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -157.41 98.9 1.93 Allowed Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 107.748 -1.204 . . . . 75.310000000000002 107.748 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.6 158.95 10.73 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.75 2.3 . . . . 75.200000000000003 112.586 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.5 156.2 66.4 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.434 2.089 . . . . 74.120000000000005 111.511 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 71' ' ' ASP . . . -72.74 142.46 83.47 Favored Pre-proline 0 N--CA 1.426 -1.665 0 CA-C-N 115.958 -0.565 . . . . 61.240000000000002 110.011 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.74 114.74 3.43 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.844 2.362 . . . . 63.020000000000003 112.088 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -61.14 -42.65 98.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.739 -0.664 . . . . 75.299999999999997 109.498 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -91.19 161.07 15.23 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 63.32 110.256 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -87.18 -28.4 22.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.507 -0.77 . . . . 63.009999999999998 109.03 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.3 p -79.07 -12.25 60.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.657 -0.701 . . . . 55.109999999999999 112.025 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.14 116.99 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 105.833 -1.914 . . . . 63.130000000000003 105.833 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -128.78 143.43 50.92 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 120.701 -0.4 . . . . 74.530000000000001 110.316 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.0 mm -92.45 112.76 26.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.462 -0.94 . . . . 75.430000000000007 108.462 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.82 153.11 38.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.862 -0.792 . . . . 71.430000000000007 108.862 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 4.5 mp0 -98.45 146.87 25.3 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.994 0.426 . . . . 74.519999999999996 110.24 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -134.54 120.99 20.35 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.637 -0.71 . . . . 75.129999999999995 109.697 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.28 156.15 43.65 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.651 -0.87 . . . . 70.319999999999993 108.651 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.22 19.39 78.48 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.194 -1.003 . . . . 50.149999999999999 114.096 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -120.08 145.25 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 C-N-CA 119.92 -0.712 . . . . 71.310000000000002 109.588 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.0 m -112.59 138.46 49.34 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 105.646 -1.983 . . . . 75.519999999999996 105.646 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.88 148.33 26.73 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 108.3 -1.0 . . . . 65.329999999999998 108.3 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -112.56 121.05 43.66 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 103.646 -2.724 . . . . 75.420000000000002 103.646 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.2 m -122.34 135.2 54.67 Favored 'General case' 0 C--N 1.263 -3.162 0 C-N-CA 120.587 -0.445 . . . . 65.5 109.926 -174.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.6 t -112.51 136.81 51.59 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 108.727 -0.842 . . . . 65.109999999999999 108.727 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 9.3 pt20 -117.25 130.03 56.3 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.527 -0.761 . . . . 65.230000000000004 109.404 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.83 168.37 19.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.405 -0.816 . . . . 71.230000000000004 109.515 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -126.38 136.35 9.48 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.922 -0.656 . . . . 64.420000000000002 112.022 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 152.01 -163.22 30.06 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.203 -1.159 . . . . 54.420000000000002 110.203 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -99.13 107.71 20.14 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.562 -0.903 . . . . 75.030000000000001 108.562 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.18 133.38 35.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.203 1.186 . . . . 64.230000000000004 114.203 -172.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HB3' ' OE1' ' A' ' 141' ' ' GLU . 25.4 mtpp -112.33 177.5 4.62 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.941 -1.503 . . . . 73.340000000000003 106.941 170.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -63.27 -34.46 77.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.075 0.464 . . . . 54.130000000000003 109.98 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.57 -30.0 71.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.525 -0.762 . . . . 54.219999999999999 111.254 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.2 -31.72 71.43 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.968 0.413 . . . . 54.229999999999997 110.789 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -73.03 -43.98 61.39 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.047 -0.524 . . . . 71.450000000000003 109.935 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.22 -48.36 87.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 O-C-N 123.42 0.45 . . . . 74.329999999999998 110.38 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.51 87.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.574 -0.739 . . . . 50.140000000000001 111.546 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.441 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 65.1 m80 -71.08 -34.8 71.52 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.463 -0.495 . . . . 63.539999999999999 112.068 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.584 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.446 0.165 . . . . 73.040000000000006 110.76 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.2 t -68.73 -32.72 72.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 74.120000000000005 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -66.75 -40.61 88.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.334 0.587 . . . . 72.140000000000001 109.762 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 65.8 mt -65.05 -33.75 76.78 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 116.149 -0.478 . . . . 72.120000000000005 111.363 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 50.3 mtt180 -56.09 -49.04 74.95 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.483 0.489 . . . . 71.209999999999994 110.847 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.547 ' HA ' ' OE1' ' A' ' 156' ' ' GLU . 11.0 t -73.7 -29.56 62.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.922 -0.581 . . . . 71.299999999999997 110.807 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 34.1 m -71.14 -34.57 71.15 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.428 0.632 . . . . 65.450000000000003 109.691 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.45 0.52 16.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.491 0.716 . . . . 75.129999999999995 111.643 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.547 ' OE1' ' HA ' ' A' ' 153' ' ' THR . 46.5 mt-10 -84.16 140.22 31.89 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.55 -0.537 . . . . 71.530000000000001 109.55 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 96.88 -10.09 66.08 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.08 -0.581 . . . . 71.409999999999997 111.957 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 160' ' ' ALA . 12.2 t -122.2 155.59 61.32 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.198 . . . . 73.040000000000006 107.764 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 36.56 0.1 Allowed 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 124.351 3.367 . . . . 60.530000000000001 114.287 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 158' ' ' THR . . . -101.03 119.04 38.16 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.123 0.487 . . . . 75.120000000000005 110.631 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.5 p -123.83 144.54 49.66 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.011 -0.737 . . . . 62.200000000000003 109.011 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -131.31 150.61 52.08 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.353 -0.24 . . . . 75.120000000000005 110.353 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -120.06 148.77 43.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.752 0.649 . . . . 72.109999999999999 112.752 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.25 1.95 37.93 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 115.112 0.805 . . . . 74.450000000000003 115.112 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.429 ' HB3' HH22 ' A' ' 152' ' ' ARG . 21.3 m-20 65.88 0.47 1.56 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.748 0.819 . . . . 61.329999999999998 112.04 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.63 139.27 20.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.648 0.737 . . . . 53.119999999999997 112.706 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -136.24 164.0 29.09 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.095 -1.076 . . . . 60.119999999999997 108.095 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 50.8 m-85 -115.63 151.38 35.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.411 -0.588 . . . . 75.25 109.411 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 83' ' ' SER . 60.4 m -113.94 123.7 50.38 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.928 -1.508 . . . . 75.400000000000006 106.928 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.72 149.21 31.95 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.859 0.362 . . . . 74.409999999999997 111.324 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.06 0 N-CA-C 108.544 -1.823 . . . . 74.219999999999999 108.544 -178.4 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.6 ptp180 . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 121.19 0.519 . . . . 74.109999999999999 111.864 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -115.12 127.91 55.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.483 -2.414 . . . . 74.150000000000006 104.483 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 10.8 m120 -139.67 160.25 40.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.15 -0.62 . . . . 74.140000000000001 110.526 -171.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 133' ' ' THR . 49.6 mt-10 -132.45 145.9 51.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 123.753 0.658 . . . . 71.209999999999994 109.823 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 132' ' ' SER . 21.8 t -123.95 120.85 60.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 106.071 -1.826 . . . . 74.340000000000003 106.071 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 13.1 m0 -104.78 121.36 43.47 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.798 -0.361 . . . . 74.450000000000003 110.932 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 84.8 mt -99.1 131.18 45.32 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.03 -1.47 . . . . 54.340000000000003 107.03 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.35 135.21 38.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.506 -0.478 . . . . 63.520000000000003 110.563 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 161' ' ' THR . 19.9 pttp -72.0 143.24 49.26 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.563 -0.455 . . . . 73.420000000000002 110.854 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 115.062 -0.972 . . . . 74.349999999999994 110.505 178.26 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.1 p90 . . . . . 0 N--CA 1.423 -1.815 0 N-CA-C 104.378 -2.453 . . . . 74.140000000000001 104.378 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 91.8 mt-30 -106.17 109.28 21.16 Favored 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 118.648 -1.221 . . . . 73.400000000000006 111.542 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.91 115.87 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 108.089 -1.078 . . . . 74.230000000000004 108.089 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -96.08 -36.55 10.96 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.074 -0.966 . . . . 62.310000000000002 111.883 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.461 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 42.6 t -157.12 150.41 23.98 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.296 0.569 . . . . 73.329999999999998 111.009 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.6 p -132.45 162.45 31.13 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.431 -1.692 . . . . 74.450000000000003 106.431 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.5 99.66 0.97 Allowed Glycine 0 C--N 1.304 -1.209 0 C-N-CA 118.297 -1.906 . . . . 61.43 114.243 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.07 -147.49 5.76 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.707 -0.957 . . . . 61.409999999999997 110.707 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -86.76 170.89 11.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.065 -0.717 . . . . 65.409999999999997 109.065 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.15 155.01 39.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.551 -0.907 . . . . 72.409999999999997 108.551 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 74.35 -52.81 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.791 0.836 . . . . 72.310000000000002 111.464 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.04 109.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 122.441 1.115 . . . . 73.030000000000001 110.376 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.8 m -111.53 128.66 56.09 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.662 -0.866 . . . . 74.439999999999998 108.662 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.04 155.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.558 -1.257 . . . . 73.340000000000003 111.301 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.532 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 35.2 tt0 -134.36 125.63 27.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.796 -1.557 . . . . 70.310000000000002 106.796 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.461 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 36.2 mt-10 -94.73 114.86 26.83 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.436 -1.69 . . . . 62.100000000000001 106.436 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.532 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 30.2 ptt180 -140.27 132.37 27.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.435 0.636 . . . . 75.519999999999996 112.54 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 129' ' ' THR . . . -80.98 137.34 36.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.093 -1.077 . . . . 53.030000000000001 108.093 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -58.87 149.8 25.87 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.772 0.67 . . . . 73.400000000000006 110.468 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -21.18 64.17 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.975 -0.557 . . . . 53.409999999999997 112.032 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 9.72 68.5 Favored Glycine 0 C--O 1.244 0.766 0 C-N-CA 119.966 -1.111 . . . . 75.030000000000001 112.893 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 165.81 53.12 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 121.384 -0.436 . . . . 73.010000000000005 113.139 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.506 ' HB3' ' HZ1' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -98.58 118.52 35.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.771 -0.826 . . . . 73.200000000000003 108.771 179.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.523 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 22.8 m-85 -124.33 165.63 17.35 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.736 -0.665 . . . . 74.140000000000001 111.494 -170.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.77 117.94 34.39 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.954 -0.758 . . . . 64.109999999999999 108.954 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -125.03 147.66 48.85 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.911 -0.586 . . . . 74.310000000000002 111.829 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.417 HG21 ' HG2' ' A' ' 61' ' ' LYS . 7.6 p -137.75 135.33 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 45.100000000000001 108.905 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -121.78 137.64 54.69 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.092 -1.043 . . . . 73.239999999999995 110.504 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 41.7 t -118.74 131.34 71.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.037 -1.468 . . . . 71.409999999999997 107.037 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.405 ' C ' ' H ' ' A' ' 49' ' ' LYS . 41.0 p -115.16 158.27 22.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.635 0.606 . . . . 71.239999999999995 112.635 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' HA ' ' CG ' ' A' ' 96' ' ' LYS . 36.3 t70 68.73 -12.89 0.35 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.629 1.972 . . . . 64.430000000000007 113.445 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.4 mttm -94.72 135.92 23.46 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 108.458 -0.941 . . . . 72.200000000000003 108.458 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.93 156.88 11.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.877 2.385 . . . . 73.430000000000007 111.337 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 98' ' ' LEU . 55.9 t -46.49 -47.68 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.893 0.877 . . . . 73.219999999999999 113.263 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.675 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 14.1 t70 -63.35 -47.84 80.46 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.528 -0.469 . . . . 74.310000000000002 110.208 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -63.56 -41.43 98.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.34 0.656 . . . . 73.230000000000004 112.195 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -65.42 -39.78 92.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.132 0.492 . . . . 73.129999999999995 110.115 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.9 tp -66.3 -33.75 76.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.883 -0.599 . . . . 62.329999999999998 110.001 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 29.9 mmt180 -59.05 -34.36 71.84 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.853 -0.612 . . . . 64.510000000000005 110.78 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.03 -49.53 10.12 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.312 -0.858 . . . . 63.310000000000002 110.72 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -66.99 -33.06 74.75 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.317 1.228 . . . . 64.25 114.317 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.571 ' O ' ' HG2' ' A' ' 63' ' ' MET . 6.5 mmt -61.11 -58.19 20.84 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 119.752 -0.779 . . . . 75.239999999999995 112.806 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.16 -30.84 91.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.407 2.071 . . . . 73.140000000000001 111.131 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 18.1 tppt? -61.43 -44.49 97.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.092 -0.958 . . . . 65.129999999999995 110.369 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.4 mm -73.57 -39.41 53.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.313 -0.555 . . . . 70.0 109.583 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 59' ' ' MET . 25.9 mmt -55.38 -44.15 75.81 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.453 0.538 . . . . 70.0 112.453 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.01 -38.61 91.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.183 0.516 . . . . 74.439999999999998 110.652 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -70.83 -51.02 29.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.892 -0.595 . . . . 74.129999999999995 111.159 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p -74.85 -25.46 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-O 121.07 0.462 . . . . 72.150000000000006 111.229 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.75 -30.81 67.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.88 -0.6 . . . . 74.120000000000005 113.074 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.53 -3.63 1.88 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.271 -1.443 . . . . 52.420000000000002 113.855 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 m -89.56 27.07 1.56 Allowed 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 122.627 1.203 . . . . 75.319999999999993 109.387 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.08 177.29 7.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.068 -0.969 . . . . 74.150000000000006 109.231 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.82 -31.57 72.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.965 0.728 . . . . 70.239999999999995 112.965 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -87.6 -12.88 44.33 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.911 -0.716 . . . . 73.299999999999997 110.741 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.81 28.29 73.2 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.684 -0.77 . . . . 54.539999999999999 111.566 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.01 121.84 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.01 0.433 . . . . 73.140000000000001 109.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.95 63.74 0.61 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.431 -0.89 . . . . 74.120000000000005 112.144 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.93 -26.43 48.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.51 -0.552 . . . . 75.329999999999998 109.51 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.77 83.98 0.36 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.245 -0.889 . . . . 45.420000000000002 111.554 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.515 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 19.1 ptt? -96.19 125.41 40.69 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.926 0.393 . . . . 74.319999999999993 110.048 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.7 p -113.82 116.49 29.42 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.911 -0.586 . . . . 63.530000000000001 112.267 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.54 159.57 36.1 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 106.965 -1.495 . . . . 75.200000000000003 106.965 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.67 139.46 88.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.646 1.564 . . . . 71.530000000000001 112.616 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -103.94 153.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.193 -1.41 . . . . 72.310000000000002 107.193 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.4 m -133.75 145.45 49.83 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.303 -0.628 . . . . 73.530000000000001 109.303 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 51.4 p90 -138.12 139.96 39.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.403 -0.519 . . . . 71.239999999999995 110.309 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.69 134.87 34.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.878 -0.601 . . . . 63.520000000000003 110.175 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.48 150.02 30.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.952 -1.129 . . . . 70.5 107.952 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -119.48 108.05 40.17 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.17 -0.678 . . . . 73.109999999999999 109.17 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.4 142.09 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.088 1.858 . . . . 74.430000000000007 112.546 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.17 174.54 7.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.006 -0.543 . . . . 70.310000000000002 110.323 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -23.46 67.41 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.036 0.935 . . . . 61.240000000000002 110.622 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.46 -5.31 58.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.049 -0.978 . . . . 64.030000000000001 110.607 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.76 -10.25 65.7 Favored Glycine 0 CA--C 1.504 -0.636 0 CA-C-N 116.084 -0.507 . . . . 53.25 112.214 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 p -86.1 142.19 28.87 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.545 -0.539 . . . . 75.340000000000003 109.545 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.523 HD23 ' HH ' ' A' ' 167' ' ' TYR . 69.6 mt -75.84 145.21 40.79 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.024 -0.534 . . . . 74.439999999999998 110.61 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.64 150.25 32.7 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.657 -0.868 . . . . 74.510000000000005 108.657 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' CG ' ' HA ' ' A' ' 48' ' ' ASP 0.291 0.2 OUTLIER -83.03 75.31 9.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.651 1.215 . . . . 73.230000000000004 112.031 178.938 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -164.09 125.03 2.2 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.536 -2.024 . . . . 71.140000000000001 105.536 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD12 HG12 ' A' ' 51' ' ' VAL . 5.6 tt -140.22 135.31 32.23 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.057 -0.719 . . . . 71.120000000000005 109.057 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -124.16 115.34 20.95 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.562 -0.29 . . . . 73.109999999999999 110.237 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.7 t -91.17 134.45 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.542 -0.54 . . . . 61.310000000000002 109.542 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -117.75 122.16 42.73 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.646 -0.872 . . . . 72.109999999999999 108.646 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 75.8 t80 -102.93 111.14 23.33 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.817 -1.549 . . . . 74.299999999999997 106.817 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.523 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 34.1 ttp180 -81.56 113.21 19.43 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.714 -0.675 . . . . 71.519999999999996 110.247 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.503 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 68.7 mt -79.07 134.09 60.19 Favored Pre-proline 0 C--N 1.284 -2.253 0 CA-C-N 114.463 -1.244 . . . . 74.530000000000001 110.907 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 50.7 Cg_exo -53.4 153.75 16.77 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.328 2.685 . . . . 74.329999999999998 112.067 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -56.47 -36.28 68.91 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.012 1.116 . . . . 70.219999999999999 114.012 -174.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -62.4 -36.2 81.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.159 0.504 . . . . 75.209999999999994 111.004 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.5 -6.17 56.65 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.988 -0.551 . . . . 70.230000000000004 110.997 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.503 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 26.0 mm-40 -71.7 -30.2 65.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.829 0.347 . . . . 72.540000000000006 110.75 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.24 73.47 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.472 -0.785 . . . . 61.439999999999998 111.908 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.5 p -160.18 89.02 1.83 Allowed Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-O 120.661 0.267 . . . . 74.129999999999995 110.495 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.49 154.27 9.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.178 1.918 . . . . 52.409999999999997 110.935 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.96 158.11 58.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.341 2.027 . . . . 74.099999999999994 111.352 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.85 149.53 80.47 Favored Pre-proline 0 C--O 1.259 1.593 0 C-N-CA 120.874 -0.33 . . . . 73.409999999999997 110.205 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 24.9 Cg_exo -65.73 106.75 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.697 2.265 . . . . 60.140000000000001 111.38 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.5 t -83.16 -25.66 31.63 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.53 -0.545 . . . . 73.329999999999998 109.53 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.63 143.89 28.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.317 -0.994 . . . . 71.150000000000006 108.317 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.18 -24.04 60.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.019 0.748 . . . . 71.450000000000003 113.019 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.2 m -89.81 -19.11 25.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.002 0.429 . . . . 63.329999999999998 109.892 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 61.9 t -94.89 116.27 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 107.102 -1.444 . . . . 72.209999999999994 107.102 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -124.35 136.31 53.99 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.603 -0.726 . . . . 71.209999999999994 110.449 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.5 mm -91.68 111.19 23.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.612 -1.255 . . . . 71.030000000000001 107.612 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -124.73 143.38 50.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.806 -1.088 . . . . 70.310000000000002 109.142 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -105.23 132.58 51.25 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.624 -0.716 . . . . 75.310000000000002 109.339 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -123.2 123.1 40.03 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.291 -1.003 . . . . 72.319999999999993 108.291 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.6 158.03 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.5 -0.555 . . . . 73.299999999999997 109.5 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.36 19.2 50.57 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.626 -0.797 . . . . 71.420000000000002 112.128 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.26 145.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.058 0.456 . . . . 71.230000000000004 110.367 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 90.4 m -112.64 135.49 53.3 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 107.87 -1.159 . . . . 72.439999999999998 107.87 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.16 150.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 N-CA-C 107.839 -1.171 . . . . 75.219999999999999 107.839 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.35 121.12 43.43 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 104.664 -2.347 . . . . 75.430000000000007 104.664 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 24.8 m -115.93 132.75 56.56 Favored 'General case' 0 C--N 1.261 -3.246 0 C-N-CA 120.339 -0.545 . . . . 71.329999999999998 110.834 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 30' ' ' SER . 9.9 t -113.24 119.94 39.46 Favored 'General case' 0 N--CA 1.391 -3.421 0 CA-C-N 115.587 -0.733 . . . . 75.310000000000002 109.614 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -110.88 126.03 54.26 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.404 -1.332 . . . . 65.040000000000006 107.404 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 22.3 p90 -136.6 167.6 21.08 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.352 -0.84 . . . . 75.040000000000006 110.687 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -133.32 143.3 14.96 Favored Glycine 0 CA--C 1.485 -1.798 0 C-N-CA 120.484 -0.865 . . . . 52.329999999999998 111.559 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.81 -155.28 25.79 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.258 -1.137 . . . . 63.009999999999998 110.258 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -99.93 103.08 14.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.834 -0.802 . . . . 75.299999999999997 108.834 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.62 117.53 31.86 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.41 -0.359 . . . . 64.439999999999998 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -81.13 163.84 22.82 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.831 -1.174 . . . . 72.209999999999994 107.831 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.74 -35.23 42.5 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.004 0.522 . . . . 60.340000000000003 111.607 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.87 65.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.065 -0.516 . . . . 71.109999999999999 111.121 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.33 -30.89 69.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.119 -0.491 . . . . 73.439999999999998 110.433 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -59.72 -49.43 77.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.299 -0.63 . . . . 72.310000000000002 109.299 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.1 t -59.96 -42.96 91.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.032 -0.986 . . . . 63.509999999999998 109.341 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.16 85.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.46 -0.791 . . . . 44.340000000000003 111.179 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.499 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 29.3 m80 -66.94 -33.89 76.57 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 112.536 0.569 . . . . 71.019999999999996 112.536 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.23 -45.14 94.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.398 0.618 . . . . 62.030000000000001 109.627 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 m -66.58 -35.3 79.87 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.421 -0.809 . . . . 71.109999999999999 109.868 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.09 -29.01 61.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.752 -0.658 . . . . 74.329999999999998 111.373 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 82.6 mt -61.7 -36.71 81.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.944 -0.391 . . . . 71.140000000000001 109.944 173.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -57.42 -48.19 79.78 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.854 0.721 . . . . 72.219999999999999 110.802 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.6 t -75.72 -30.15 59.16 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.113 -0.494 . . . . 73.340000000000003 110.952 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.4 m -74.85 -34.17 62.25 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.358 0.599 . . . . 73.150000000000006 110.819 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.54 6.75 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.373 0.606 . . . . 72.129999999999995 110.36 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 131.53 34.34 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.826 -1.546 . . . . 72.040000000000006 106.826 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.89 -4.78 61.35 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.514 -0.635 . . . . 65.140000000000001 111.514 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.1 p -99.89 163.94 17.44 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 107.844 -1.169 . . . . 43.240000000000002 107.844 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 63.6 Cg_endo -73.88 0.82 7.79 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.992 1.794 . . . . 71.349999999999994 112.901 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.95 140.99 32.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.881 0.372 . . . . 73.540000000000006 111.557 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.0 p -118.13 153.48 33.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.212 -0.662 . . . . 74.299999999999997 109.212 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.426 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 38.8 p90 -135.3 137.81 42.85 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.139 -0.35 . . . . 75.109999999999999 110.171 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.617 ' NE2' HG11 ' A' ' 188' ' ' VAL 0.26 0.4 OUTLIER -97.92 116.63 30.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.739 1.385 . . . . 74.439999999999998 114.739 -176.455 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.16 65.82 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.773 -0.649 . . . . 75.549999999999997 112.623 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . 0.261 8.6 p-10 49.38 27.66 2.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.765 1.226 . . . . 74.519999999999996 113.22 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.481 ' O ' HD13 ' A' ' 187' ' ' LEU . 77.6 t -66.57 138.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 113.968 -1.469 . . . . 73.120000000000005 110.137 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.523 ' HH ' HD23 ' A' ' 94' ' ' LEU . 34.4 p90 -143.26 171.13 14.53 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.989 -0.55 . . . . 73.299999999999997 111.492 -176.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 4.2 m-85 -121.75 150.54 41.68 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.671 -0.695 . . . . 64.540000000000006 109.865 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 20.4 t -115.02 146.22 41.48 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.994 -1.113 . . . . 75.010000000000005 107.994 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.36 158.5 18.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.925 0.393 . . . . 74.150000000000006 110.907 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.419 0 N-CA-C 108.732 -1.747 . . . . 71.019999999999996 108.732 179.495 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 111.787 0.291 . . . . 73.150000000000006 111.787 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -116.6 136.06 53.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 110.579 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.431 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.2 m120 -126.52 146.94 49.93 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.729 -1.582 . . . . 72.329999999999998 106.729 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 133' ' ' THR . 33.9 tt0 -142.82 132.64 24.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.965 -0.694 . . . . 53.140000000000001 110.459 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 132' ' ' SER . 82.4 t -126.49 130.18 71.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.863 0.865 . . . . 65.150000000000006 109.287 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.5 m0 -109.36 121.3 44.87 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 109.449 -0.574 . . . . 63.439999999999998 109.449 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 166' ' ' VAL . 40.3 tp -100.78 135.48 42.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.865 -1.532 . . . . 73.310000000000002 106.865 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.617 HG11 ' NE2' ' A' ' 163' ' ' GLN . 6.1 p -106.72 135.44 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 114.036 1.124 . . . . 75.349999999999994 114.036 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -63.16 144.37 56.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.015 1.326 . . . . 71.409999999999997 114.421 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.452 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.241 -0.89 . . . . 74.209999999999994 109.045 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.3 p90 . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 106.426 -1.694 . . . . 55.140000000000001 106.426 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -121.11 109.62 15.24 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.929 -1.109 . . . . 75.140000000000001 112.392 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.45 125.68 45.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.103 -1.814 . . . . 75.230000000000004 106.103 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 22' ' ' SER . 2.9 pp -90.22 -29.26 18.31 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.677 -1.209 . . . . 74.209999999999994 111.366 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.49 ' N ' HD12 ' A' ' 21' ' ' LEU . 30.7 t -179.32 164.59 1.37 Allowed 'General case' 0 C--O 1.25 1.117 0 O-C-N 123.575 0.547 . . . . 74.420000000000002 110.124 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -131.19 165.76 22.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.852 -1.166 . . . . 63.439999999999998 107.852 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.68 -164.38 29.87 Favored Glycine 0 C--N 1.306 -1.139 0 C-N-CA 120.577 -0.82 . . . . 54.450000000000003 111.545 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.92 -138.75 10.44 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.597 -0.811 . . . . 73.510000000000005 112.263 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 5.2 ttpm? -118.09 170.73 8.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.107 -1.442 . . . . 71.239999999999995 107.107 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.96 159.67 33.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 118.569 0.622 . . . . 74.400000000000006 110.07 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 76.26 -52.78 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.754 1.622 . . . . 61.140000000000001 110.426 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.445 HG13 ' HG3' ' A' ' 150' ' ' GLN . 7.7 p -120.14 110.0 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-O 122.235 1.017 . . . . 74.129999999999995 109.811 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 133' ' ' THR . 45.0 m -122.16 154.11 37.87 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.446 -0.946 . . . . 51.130000000000003 108.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.489 ' HB3' HD13 ' A' ' 151' ' ' LEU . 8.9 p90 -118.06 156.52 28.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.91 1.078 . . . . 74.209999999999994 113.91 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.32 125.9 23.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.734 -1.95 . . . . 73.109999999999999 105.734 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 115.1 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.499 -1.667 . . . . 73.099999999999994 106.499 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -131.79 133.7 45.02 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.687 -0.688 . . . . 74.340000000000003 111.403 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.63 136.27 33.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.26 -1.385 . . . . 71.409999999999997 107.26 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.43 158.08 21.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.548 0.573 . . . . 71.140000000000001 112.548 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -86.54 -18.66 30.95 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.665 -0.698 . . . . 74.450000000000003 112.858 -174.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.81 46.62 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.494 -1.813 . . . . 71.400000000000006 112.544 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.35 149.22 46.81 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.804 -0.712 . . . . 42.130000000000003 113.874 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -88.88 119.45 29.4 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.656 -0.868 . . . . 74.430000000000007 108.656 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.54 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 27.7 m-85 -127.0 166.35 17.73 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 123.693 0.797 . . . . 74.409999999999997 111.083 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.56 116.82 30.5 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.092 -1.077 . . . . 60.100000000000001 108.092 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.8 t -135.29 150.76 50.08 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 115.414 -0.812 . . . . 74.140000000000001 112.516 -173.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 58' ' ' ALA . 9.2 p -141.64 142.28 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.121 -1.066 . . . . 74.209999999999994 108.121 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.3 133.05 48.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.658 -0.817 . . . . 74.319999999999993 112.572 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.48 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 52.7 t -112.08 141.87 26.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.656 -1.979 . . . . 74.209999999999994 105.656 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 49' ' ' LYS . 26.4 p -132.31 152.24 51.48 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.668 0.988 . . . . 63.130000000000003 113.668 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 67.6 -16.37 0.17 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 126.204 1.801 . . . . 74.230000000000004 112.141 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 47' ' ' THR . 48.6 mtpt -88.78 146.86 37.84 Favored Pre-proline 0 N--CA 1.422 -1.874 0 C-N-CA 124.175 0.99 . . . . 70.340000000000003 110.035 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.23 153.05 61.91 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.509 2.139 . . . . 60.100000000000001 111.675 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.451 HG13 HD12 ' A' ' 98' ' ' LEU . 32.2 t -49.89 -42.56 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 124.035 0.934 . . . . 71.120000000000005 112.316 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 13.0 t70 -61.63 -46.32 90.3 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.548 -0.461 . . . . 73.230000000000004 109.823 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -69.01 -42.13 76.83 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 111.48 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.15 -42.46 99.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.723 -0.672 . . . . 72.5 111.062 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.11 -31.97 72.79 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 116.336 -0.393 . . . . 72.549999999999997 111.156 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 5.2 mmp_? -55.95 -41.51 74.78 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.734 0.646 . . . . 75.099999999999994 110.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 44.4 mt-10 -84.41 -43.55 14.56 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.085 -0.507 . . . . 71.120000000000005 112.08 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.51 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . . . -68.97 -41.82 77.42 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.52 1.304 . . . . 43.450000000000003 114.52 -171.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.417 ' HB2' ' HE2' ' A' ' 59' ' ' MET . 43.4 ttm -57.27 -48.54 97.18 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.54 0.941 . . . . 71.530000000000001 113.54 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.68 -31.89 52.4 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.264 1.976 . . . . 75.109999999999999 112.245 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 91.0 mttt -72.12 -35.53 69.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.389 0.614 . . . . 55.329999999999998 111.058 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.05 -34.19 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 116.016 -0.538 . . . . 75.450000000000003 110.536 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 ttp -64.58 -43.31 94.26 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 124.062 0.945 . . . . 63.409999999999997 110.581 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 21.3 ptmt -69.48 -31.62 70.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.559 -0.291 . . . . 74.409999999999997 110.704 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -62.44 -60.48 3.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.46 -0.336 . . . . 74.209999999999994 111.796 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 76' ' ' MET . 14.6 p -83.86 -2.24 6.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-O 121.988 0.899 . . . . 72.129999999999995 109.859 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.01 -32.36 32.5 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.674 -0.774 . . . . 38.240000000000002 111.72 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 140.97 -2.56 2.14 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.689 -1.243 . . . . 51.219999999999999 113.52 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.5 m -92.06 34.32 1.02 Allowed 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.504 1.145 . . . . 64.519999999999996 109.156 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.466 ' OD1' HG13 ' A' ' 74' ' ' VAL . 7.2 p30 -96.8 168.93 10.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.769 -0.65 . . . . 74.239999999999995 109.759 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 23.2 t70 -71.79 -27.7 63.12 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.794 0.665 . . . . 71.140000000000001 112.794 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.91 -14.12 58.86 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.627 0.727 . . . . 70.329999999999998 109.334 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.63 78.6 Favored Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 110.847 -0.901 . . . . 75.430000000000007 110.847 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 14.5 p -93.11 153.08 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 108.127 -1.064 . . . . 74.120000000000005 108.127 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -133.48 0.41 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.736 -0.745 . . . . 54.240000000000002 112.416 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.724 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 55.7 ttp -76.61 -75.66 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.494 -0.482 . . . . 73.340000000000003 110.03 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.68 -52.01 0.68 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.541 0.977 . . . . 44.409999999999997 115.541 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.48 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 62.0 mtm -101.45 124.99 48.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 117.756 0.778 . . . . 71.040000000000006 111.356 -173.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.7 m -126.3 114.49 18.33 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.808 -0.441 . . . . 73.530000000000001 109.808 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 103' ' ' ARG . 24.9 m -148.78 167.75 12.47 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 108.125 -1.065 . . . . 73.030000000000001 108.125 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.49 146.33 84.76 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.894 1.729 . . . . 74.019999999999996 111.592 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.3 144.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.374 -0.973 . . . . 53.32 108.374 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 p -129.22 146.14 51.19 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 110.126 -0.324 . . . . 74.040000000000006 110.126 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.37 138.89 43.78 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.536 -0.465 . . . . 73.239999999999995 110.078 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.62 135.05 34.41 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.019 -0.734 . . . . 75.519999999999996 109.019 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.86 150.23 26.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 108.331 -0.988 . . . . 44.32 108.331 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 97' ' ' LYS . 6.1 m-85 -123.52 105.11 33.52 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 121.018 -0.273 . . . . 74.230000000000004 110.573 -175.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.17 159.03 17.79 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.473 2.116 . . . . 75.030000000000001 111.871 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -104.36 166.51 10.35 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.385 -0.968 . . . . 72.209999999999994 108.385 175.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.84 -17.53 50.48 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.96 1.096 . . . . 75.230000000000004 113.96 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -98.73 -1.26 40.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.235 -0.586 . . . . 64.230000000000004 112.163 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.18 1.0 55.87 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.632 1.013 . . . . 63.219999999999999 115.632 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.2 m -83.79 136.98 33.94 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.452 1.126 . . . . 74.319999999999993 109.528 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.4 mt -93.38 78.1 4.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.165 0.507 . . . . 73.319999999999993 110.513 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -149.36 114.49 5.46 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.867 -0.606 . . . . 74.409999999999997 110.911 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 tttp 178.19 -62.41 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.21 -1.033 . . . . 72.409999999999997 108.21 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 22.7 ttmm -154.31 149.34 26.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.518 -1.29 . . . . 73.140000000000001 107.518 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.451 HD12 HG13 ' A' ' 51' ' ' VAL . 5.9 tt -141.01 124.94 17.09 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.997 -1.853 . . . . 71.209999999999994 105.997 169.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 79.4 tttt -130.87 115.19 16.24 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 120.423 -0.511 . . . . 50.240000000000002 110.05 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' THR . 62.1 t -83.88 133.78 28.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.692 -0.685 . . . . 73.010000000000005 109.322 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -121.62 113.63 20.04 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.748 0.819 . . . . 73.430000000000007 109.156 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -103.74 115.97 31.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.319 -0.993 . . . . 75.010000000000005 108.319 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 29.4 ttt85 -76.11 136.35 39.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.336 -0.847 . . . . 73.439999999999998 110.416 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 77.8 mt -103.47 126.96 30.63 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 109.478 -0.564 . . . . 75.209999999999994 109.478 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.48 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 84.2 Cg_exo -46.83 151.25 2.2 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.491 2.794 . . . . 74.450000000000003 113.028 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.04 -42.58 65.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.443 1.275 . . . . 64.420000000000002 114.443 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.28 -30.96 72.0 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.353 0.597 . . . . 65.120000000000005 110.875 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.66 -2.88 55.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.912 -0.585 . . . . 65.200000000000003 110.839 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.09 -36.24 74.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.586 -0.524 . . . . 74.340000000000003 109.586 175.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.19 -31.7 78.18 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-N 115.464 -0.789 . . . . 61.020000000000003 112.026 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -160.34 97.3 1.46 Allowed Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 109.049 -0.723 . . . . 65.120000000000005 109.049 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.62 162.08 1.86 Allowed 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 123.274 2.649 . . . . 63.310000000000002 111.519 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.58 133.76 44.23 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.032 1.821 . . . . 74.140000000000001 110.093 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 71' ' ' ASP . . . -74.88 152.69 86.83 Favored Pre-proline 0 C--O 1.255 1.395 0 CA-C-N 116.515 -0.311 . . . . 70.319999999999993 111.48 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.552 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 17.2 Cg_exo -69.46 111.13 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.761 2.308 . . . . 64.230000000000004 112.146 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -85.25 -8.69 58.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.827 0.822 . . . . 74.409999999999997 108.795 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.95 148.42 42.21 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.241 -1.392 . . . . 72.150000000000006 107.241 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -88.62 -9.97 50.3 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.858 1.429 . . . . 64.219999999999999 114.858 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.489 ' CB ' ' HD3' ' A' ' 61' ' ' LYS . 17.7 m -81.53 -45.03 16.51 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.813 -0.81 . . . . 74.150000000000006 108.813 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 5.9 p -95.5 115.85 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 108.83 -0.804 . . . . 73.310000000000002 108.83 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -119.0 151.22 38.59 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.842 -0.799 . . . . 74.120000000000005 108.842 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.8 mm -92.56 110.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.427 -1.323 . . . . 73.349999999999994 107.427 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -127.14 146.48 50.38 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.387 -0.824 . . . . 73.400000000000006 108.9 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.06 144.13 34.18 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 109.023 -0.732 . . . . 70.209999999999994 109.023 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.474 ' NE ' ' HA ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -129.74 123.13 30.3 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.169 -1.413 . . . . 71.530000000000001 110.008 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.24 156.63 45.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.105 -2.554 . . . . 72.430000000000007 104.105 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.5 8.03 62.86 Favored Glycine 0 C--N 1.281 -2.52 0 C-N-CA 120.661 -0.78 . . . . 70.430000000000007 112.859 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.0 pt -121.61 145.66 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.353 -0.539 . . . . 62.100000000000001 110.275 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.0 m -120.88 137.44 54.57 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.039 -0.982 . . . . 74.239999999999995 109.126 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.36 160.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-N 115.767 -0.651 . . . . 73.239999999999995 110.021 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.499 ' OH ' ' HE2' ' A' ' 189' ' ' LYS . 39.3 m-85 -114.03 122.56 47.27 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.232 -2.136 . . . . 75.109999999999999 105.232 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -106.82 127.89 53.79 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.835 -0.346 . . . . 70.530000000000001 111.145 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.477 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 14.0 t -113.43 138.98 49.31 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.808 -0.812 . . . . 71.109999999999999 108.808 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.46 125.82 42.76 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.455 -0.793 . . . . 72.120000000000005 109.895 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -132.86 140.69 48.04 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.444 -0.798 . . . . 72.109999999999999 109.581 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 182' ' ' ARG . . . -102.8 145.99 16.53 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.842 -0.694 . . . . 63.009999999999998 112.852 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.71 -140.26 14.84 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.984 -1.103 . . . . 72.230000000000004 113.906 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -76.63 126.7 31.43 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.8 0.84 . . . . 72.349999999999994 112.006 -172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.409 ' HB2' ' ND2' ' A' ' 183' ' ' ASN . . . -123.81 136.82 54.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.794 -0.639 . . . . 70.120000000000005 110.303 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.467 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 38.8 ttmt -114.98 155.41 26.98 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.615 -1.994 . . . . 62.509999999999998 105.615 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.413 ' O ' HG22 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -53.67 -45.19 70.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 118.412 0.551 . . . . 70.140000000000001 110.001 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.75 70.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 42.43 111.399 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 28.2 t70 -74.73 -30.62 61.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 110.063 -0.347 . . . . 74.409999999999997 110.063 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -63.33 -44.85 93.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.827 -0.805 . . . . 53.520000000000003 108.827 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 141' ' ' GLU . 61.0 t -60.02 -51.24 75.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.058 -0.974 . . . . 71.439999999999998 109.579 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.11 86.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.586 -0.734 . . . . 64.420000000000002 111.562 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 150' ' ' GLN . 24.6 m80 -62.38 -33.45 74.76 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 113.445 0.906 . . . . 65.540000000000006 113.445 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.01 79.32 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.481 0.488 . . . . 73.329999999999998 111.409 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.5 m -78.09 -35.14 49.73 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.801 0.334 . . . . 64.450000000000003 111.015 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' HG3' HG13 ' A' ' 29' ' ' VAL . 7.1 tp60 -58.68 -36.37 74.09 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.211 0.529 . . . . 75.349999999999994 109.692 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 31' ' ' TYR . 46.1 tp -65.4 -39.12 91.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.528 -0.76 . . . . 73.239999999999995 110.127 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.513 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.0 mtm180 -63.3 -44.07 96.03 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 116.436 -0.347 . . . . 75.209999999999994 110.308 177.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.3 m -61.98 -34.78 76.78 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.521 0.677 . . . . 75.420000000000002 110.582 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.6 m -74.02 -33.97 63.95 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.552 0.691 . . . . 74.329999999999998 109.965 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 26.3 mt -83.7 6.98 19.05 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.938 0.895 . . . . 73.530000000000001 112.61 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 43.9 mt-10 -75.79 145.59 40.62 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.104 -1.038 . . . . 73.129999999999995 112.498 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.66 12.64 46.77 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.548 -1.021 . . . . 60.109999999999999 110.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.9 p -122.11 165.66 19.84 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 107.809 -1.182 . . . . 62.119999999999997 107.809 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -81.27 21.63 0.89 Allowed 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 121.886 1.724 . . . . 74.319999999999993 111.968 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 121.12 24.76 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.085 0.469 . . . . 52.210000000000001 111.217 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.0 m -105.32 157.68 17.15 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.45 -1.315 . . . . 73.549999999999997 107.45 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.33 157.64 46.17 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.635 -0.876 . . . . 71.430000000000007 108.635 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.6 pt20 -119.07 109.75 16.28 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.579 -0.849 . . . . 74.430000000000007 111.064 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.51 8.08 55.03 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.39 -0.909 . . . . 44.409999999999997 114.35 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.97 26.42 14.13 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.767 0.794 . . . . 75.200000000000003 109.621 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.7 138.86 22.05 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 115.64 -0.709 . . . . 65.140000000000001 110.32 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 24.8 p90 -148.2 167.9 23.88 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.884 -0.598 . . . . 73.140000000000001 112.249 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -115.71 153.72 30.84 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.501 -0.772 . . . . 74.209999999999994 110.259 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.65 136.77 54.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.591 -1.633 . . . . 74.030000000000001 106.591 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 184' ' ' GLU . . . -132.13 156.85 45.64 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.119 0.414 . . . . 60.119999999999997 112.119 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.1 0 N-CA-C 109.085 -1.606 . . . . 54.329999999999998 109.085 -179.726 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 . . . . . 0 CA--C 1.506 -0.712 0 CA-C-O 121.541 0.686 . . . . 62.329999999999998 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.424 ' HA ' ' HA2' ' A' ' 136' ' ' GLY . 14.6 ptt180 -152.13 157.65 41.84 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.521 -2.029 . . . . 74.010000000000005 105.521 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 139' ' ' ALA . 22.1 m-80 -134.72 142.97 46.93 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.882 -0.784 . . . . 52.310000000000002 108.882 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 9.3 mm-40 -111.49 132.5 54.45 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.384 -0.969 . . . . 73.230000000000004 108.384 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 88.5 t -127.06 121.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.074 -0.713 . . . . 75.140000000000001 109.074 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 33.1 m0 -107.0 124.94 50.34 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 119.606 -0.235 . . . . 74.319999999999993 110.799 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.64 138.75 33.74 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.375 -0.972 . . . . 52.229999999999997 108.375 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.11 129.64 53.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 120.04 -0.664 . . . . 74.409999999999997 109.366 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.499 ' HE2' ' OH ' ' A' ' 131' ' ' TYR . 19.2 ptpt -72.94 142.99 47.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 71.430000000000007 111.422 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 118.963 -0.541 . . . . 61.130000000000003 109.773 176.568 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.522 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.7 p90 . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 108.75 -0.833 . . . . 75.439999999999998 108.75 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -105.65 112.53 25.65 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.226 -0.59 . . . . 62.109999999999999 110.911 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.58 127.94 41.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.036 -1.468 . . . . 71.239999999999995 107.036 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD23 ' OE2' ' A' ' 33' ' ' GLU . 3.6 pp -95.77 -24.9 16.28 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.938 -1.105 . . . . 73.329999999999998 112.925 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.1 p -175.71 160.2 2.4 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 123.361 0.413 . . . . 73.349999999999994 111.611 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 73.9 p -131.21 154.12 48.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.283 -1.006 . . . . 73.120000000000005 108.283 174.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.59 -146.41 14.44 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 119.518 -1.325 . . . . 63.329999999999998 112.085 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.09 -118.02 5.11 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.705 -0.958 . . . . 50.329999999999998 110.705 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -117.44 169.28 9.64 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.741 -1.577 . . . . 73.030000000000001 106.741 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -87.16 157.05 19.45 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.13 -1.028 . . . . 74.519999999999996 111.911 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 82.0 -41.92 0.14 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.4 1.88 . . . . 74.040000000000006 110.053 -172.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.35 109.92 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.802 -1.184 . . . . 74.439999999999998 107.802 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 p -113.41 153.58 28.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.38 -0.6 . . . . 75.200000000000003 109.38 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.3 OUTLIER -112.88 150.87 31.15 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.587 -0.445 . . . . 71.5 111.319 178.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 36.3 tt0 -137.33 124.33 21.48 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.483 -1.673 . . . . 70.219999999999999 106.483 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' OE2' HD23 ' A' ' 21' ' ' LEU . 36.1 tt0 -100.5 117.6 34.99 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.138 -1.43 . . . . 62.530000000000001 107.138 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 28.8 ptt180 -138.4 144.71 40.34 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.096 -0.642 . . . . 72.450000000000003 110.837 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -81.96 136.61 35.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.493 -0.929 . . . . 62.200000000000003 108.493 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.47 133.81 51.17 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.65 0.241 . . . . 71.209999999999994 111.65 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' CD ' HH12 ' A' ' 103' ' ' ARG . 8.6 pt-20 -55.28 -45.11 76.18 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.945 -0.57 . . . . 70.319999999999993 112.072 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.54 10.29 50.88 Favored Glycine 0 C--N 1.311 -0.856 0 C-N-CA 119.673 -1.251 . . . . 54.420000000000002 114.682 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.62 165.22 52.49 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.357 -0.925 . . . . 75.150000000000006 112.182 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.16 131.64 35.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 75.010000000000005 110.881 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 60.3 m-85 -131.33 166.04 22.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.404 0.682 . . . . 73.329999999999998 110.951 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.45 116.21 29.23 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 107.837 -1.171 . . . . 73.140000000000001 107.837 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.5 t -124.41 144.58 49.97 Favored 'General case' 0 N--CA 1.402 -2.867 0 CA-C-N 115.419 -0.809 . . . . 70.319999999999993 112.044 -175.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.546 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.6 m -127.85 145.08 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.913 -1.04 . . . . 74.150000000000006 109.446 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -122.34 128.61 51.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.945 0.403 . . . . 62.340000000000003 111.158 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 54' ' ' ALA . 22.0 t -125.73 142.43 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.455 -1.313 . . . . 73.409999999999997 107.455 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 49' ' ' LYS . 17.5 p -134.32 166.81 21.97 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.097 0.159 . . . . 74.420000000000002 111.42 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.7 t70 71.88 -36.17 0.35 Allowed 'General case' 0 N--CA 1.514 2.769 0 C-N-CA 125.131 1.372 . . . . 72.129999999999995 112.12 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 47' ' ' THR . 25.0 mtpp -86.14 141.32 35.05 Favored Pre-proline 0 C--N 1.282 -2.36 0 C-N-CA 124.786 1.235 . . . . 75.409999999999997 109.743 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.67 155.89 40.33 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.316 2.01 . . . . 73.120000000000005 109.367 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.63 -36.18 41.39 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 113.635 0.976 . . . . 72.319999999999993 113.635 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 15.9 t70 -60.01 -47.74 84.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.739 -0.467 . . . . 74.040000000000006 109.739 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -69.7 -41.62 75.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.699 . . . . 74.400000000000006 111.3 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . . . -61.58 -42.35 98.72 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.914 -0.585 . . . . 71.5 110.334 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 tp -60.22 -35.23 74.96 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.13 0.972 . . . . 64.230000000000004 110.759 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 26.0 mmt180 -63.83 -35.23 79.93 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.463 0.649 . . . . 72.120000000000005 109.524 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 28.0 tt0 -82.95 -32.03 27.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 73.400000000000006 110.135 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.18 60.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.306 0.854 . . . . 72.200000000000003 113.306 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.546 ' HE1' ' HA ' ' A' ' 59' ' ' MET . 8.9 mmt -55.34 -56.16 31.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 112.796 0.665 . . . . 75.239999999999995 112.796 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.64 -31.26 69.88 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.7 2.267 . . . . 75.030000000000001 113.193 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.455 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 95.4 mttt -62.53 -49.36 75.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.027 0.441 . . . . 72.120000000000005 110.162 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.85 -38.0 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 120.635 -0.426 . . . . 71.420000000000002 110.836 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.3 mtt -61.01 -38.97 87.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.833 0.679 . . . . 74.409999999999997 112.833 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -72.56 -31.38 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.219 -0.592 . . . . 74.239999999999995 110.684 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.07 -55.32 22.97 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.317 -0.402 . . . . 73.230000000000004 110.783 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.79 -10.4 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.162 0.505 . . . . 53.240000000000002 111.209 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -21.98 73.65 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.606 -0.725 . . . . 73.450000000000003 111.483 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.88 -5.63 6.94 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.934 -1.127 . . . . 71.129999999999995 113.598 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -86.25 33.76 0.62 Allowed 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.565 1.174 . . . . 72.129999999999995 110.105 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -93.99 173.1 7.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.06 -0.973 . . . . 53.119999999999997 108.841 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.32 -34.45 78.16 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.373 0.508 . . . . 72.010000000000005 112.373 -173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.528 ' HZ2' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -83.78 -12.6 55.47 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.508 -0.477 . . . . 75.120000000000005 109.998 -177.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.87 27.85 72.64 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.713 0.633 . . . . 52.310000000000002 112.321 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 35.8 m -86.16 122.06 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.041 -0.664 . . . . 63.229999999999997 111.31 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.62 86.63 0.7 Allowed Glycine 0 N--CA 1.432 -1.58 0 CA-C-N 115.611 -0.722 . . . . 72.540000000000006 111.323 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -150.27 116.1 5.58 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.187 0.517 . . . . 63.119999999999997 110.19 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.83 124.59 7.1 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.644 -0.707 . . . . 73.409999999999997 112.069 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.8 ptp -105.82 126.46 52.2 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.962 -0.755 . . . . 73.209999999999994 108.962 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 p -120.38 115.87 24.36 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 61.119999999999997 111.302 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.524 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 10.8 m -154.03 -179.89 1.16 Allowed Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 125.801 1.64 . . . . 74.439999999999998 106.922 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 80' ' ' VAL . 84.5 Cg_exo -51.0 140.67 39.01 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.751 2.301 . . . . 73.209999999999994 115.414 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.91 138.16 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.787 -1.56 . . . . 72.040000000000006 106.787 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -133.87 145.25 49.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.674 -0.491 . . . . 62.549999999999997 109.674 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.404 ' CD1' HD11 ' A' ' 98' ' ' LEU . 52.2 p90 -145.28 138.31 26.32 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.902 -0.499 . . . . 73.019999999999996 111.169 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.417 ' O ' HD13 ' A' ' 98' ' ' LEU . . . -93.18 135.28 34.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.461 -0.94 . . . . 70.450000000000003 108.461 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.429 ' O ' HG21 ' A' ' 166' ' ' VAL . 33.4 m -121.15 149.16 24.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.719 -0.845 . . . . 73.540000000000006 108.719 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.56 105.51 51.85 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 116.118 -0.492 . . . . 75.420000000000002 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.28 159.05 20.09 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.898 1.732 . . . . 65.450000000000003 110.801 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -122.33 162.66 21.13 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.79 -0.818 . . . . 72.099999999999994 108.79 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.77 -13.7 59.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.557 0.694 . . . . 62.200000000000003 110.513 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.69 -6.67 58.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.845 -1.071 . . . . 75.409999999999997 110.099 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.28 10.27 83.88 Favored Glycine 0 C--O 1.218 -0.876 0 CA-C-N 115.911 -0.586 . . . . 72.510000000000005 113.192 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 m -105.24 134.76 47.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.874 0.337 . . . . 74.150000000000006 110.445 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.47 HD21 ' HH ' ' A' ' 167' ' ' TYR . 71.6 mt -88.42 75.57 8.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.784 -1.191 . . . . 75.439999999999998 107.784 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 58.9 tt0 -147.18 114.51 6.28 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.345 -0.843 . . . . 72.219999999999999 111.183 -174.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 6.1 mmpt? -178.87 -66.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.95 2.1 . . . . 72.109999999999999 106.356 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -147.28 150.64 35.21 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.435 -1.257 . . . . 64.420000000000002 107.885 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 85' ' ' ALA . 56.6 tp -127.71 124.35 37.63 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.206 -1.775 . . . . 73.239999999999995 106.206 168.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -114.31 113.78 25.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.237 -1.764 . . . . 72.439999999999998 106.237 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 43' ' ' THR . 97.0 t -99.85 123.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 109.438 -0.579 . . . . 52.240000000000002 109.438 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -110.25 120.69 43.25 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.101 -0.703 . . . . 74.340000000000003 109.101 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -104.16 124.54 49.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.621 -0.511 . . . . 72.530000000000001 109.621 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.413 HH12 ' CD ' ' A' ' 37' ' ' GLU . 19.0 mmm180 -74.57 132.67 41.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.339 -0.846 . . . . 74.329999999999998 109.019 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.6 mt -99.03 135.89 20.72 Favored Pre-proline 0 C--N 1.285 -2.204 0 N-CA-C 107.838 -1.171 . . . . 44.25 107.838 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.81 148.97 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.589 2.192 . . . . 73.420000000000002 112.312 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -47.6 -43.18 25.37 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.472 1.509 . . . . 74.349999999999994 112.288 -174.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.13 -36.15 83.37 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.67 0.619 . . . . 62.109999999999999 112.67 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -88.93 -6.37 57.32 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-N 116.559 -0.291 . . . . 74.540000000000006 111.605 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.09 -28.48 65.45 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.751 -0.204 . . . . 54.340000000000003 111.519 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.08 -38.1 92.56 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.868 -0.493 . . . . 72.439999999999998 111.868 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 p -158.67 87.77 2.26 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 123.466 0.706 . . . . 63.240000000000002 109.956 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 10.0 Cg_endo -86.63 144.71 7.74 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 122.577 2.185 . . . . 70.109999999999999 112.104 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 33.2 Cg_exo -60.79 142.84 98.86 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.767 2.312 . . . . 74.310000000000002 112.628 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.67 144.82 73.96 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.857 -0.61 . . . . 54.509999999999998 109.997 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.433 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 6.6 Cg_exo -80.36 126.51 6.2 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.514 2.143 . . . . 71.420000000000002 111.923 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.4 m -74.91 -23.91 58.43 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.657 -0.701 . . . . 73.129999999999995 111.606 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -99.64 135.73 40.61 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.111 -1.44 . . . . 72.019999999999996 107.111 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -77.01 -3.71 40.45 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.434 0.901 . . . . 72.420000000000002 113.434 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 44' ' ' VAL . 17.1 m -73.74 -26.44 60.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.775 -0.824 . . . . 74.219999999999999 108.775 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.3 t -113.98 124.12 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 106.593 -1.632 . . . . 60.409999999999997 106.593 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 115' ' ' PRO . 27.3 mtpp -129.66 145.91 51.48 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.81 -1.156 . . . . 71.239999999999995 110.568 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 26.7 mm -91.91 111.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.997 -1.483 . . . . 74.400000000000006 106.997 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -133.81 149.55 51.41 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.085 -0.961 . . . . 62.149999999999999 109.77 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.49 153.3 23.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.134 -0.691 . . . . 70.540000000000006 109.134 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -139.25 123.17 17.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.458 -0.897 . . . . 62.32 109.984 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -143.85 177.14 8.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.373 -0.83 . . . . 75.510000000000005 109.314 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.06 -1.42 84.82 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 121.134 -0.555 . . . . 37.68 113.736 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.46 162.47 32.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 117.398 0.599 . . . . 72.219999999999999 111.381 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.2 m -120.6 135.99 54.94 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.437 -0.801 . . . . 71.219999999999999 109.777 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.94 161.87 28.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 120.94 0.4 . . . . 71.239999999999995 110.413 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 160' ' ' ALA . 67.3 m-85 -113.99 123.47 49.79 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.703 -1.962 . . . . 73.030000000000001 105.703 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.4 t -111.91 147.55 35.6 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 120.444 -0.502 . . . . 70.409999999999997 109.905 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 8.9 t -129.23 132.98 47.33 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.112 -0.494 . . . . 64.409999999999997 109.848 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.46 ' HG2' ' HG2' ' A' ' 184' ' ' GLU . 74.2 mt-30 -110.46 131.64 54.87 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 121.258 0.552 . . . . 70.129999999999995 111.425 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.86 149.63 40.52 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.722 -1.127 . . . . 75.420000000000002 109.494 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -121.92 149.09 17.16 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.78 -0.724 . . . . 75.120000000000005 111.465 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.54 24.49 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.24 -1.144 . . . . 54.310000000000002 110.24 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -90.54 100.52 13.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.037 -0.727 . . . . 65.099999999999994 109.037 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.25 107.7 19.82 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.913 0.863 . . . . 72.0 112.672 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -100.77 169.68 8.85 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.513 -1.662 . . . . 62.409999999999997 106.513 171.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 1.6 mp0 -57.55 -42.16 82.42 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.173 0.511 . . . . 62.240000000000002 110.109 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.67 70.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.519 -0.764 . . . . 64.420000000000002 111.542 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.67 -36.85 70.77 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.653 -0.499 . . . . 74.109999999999999 109.653 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -60.47 -47.8 84.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.778 -0.646 . . . . 72.310000000000002 110.224 173.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -46.88 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.726 0.641 . . . . 65.430000000000007 110.604 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.65 87.86 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.062 0.458 . . . . 63.32 110.926 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -68.95 -33.3 73.49 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 116.325 -0.398 . . . . 74.010000000000005 111.688 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.46 -45.85 92.53 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.059 -0.349 . . . . 37.68 110.059 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.561 ' HA ' ' HE ' ' A' ' 152' ' ' ARG . 63.2 m -59.11 -46.98 86.91 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 122.818 0.447 . . . . 73.109999999999999 110.32 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.46 -39.41 93.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.827 -0.624 . . . . 72.409999999999997 110.998 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.94 -40.88 95.7 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.999 -0.371 . . . . 75.549999999999997 109.999 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' A' ' 149' ' ' THR . 88.5 mtm180 -62.22 -40.16 95.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.892 -0.594 . . . . 73.030000000000001 111.144 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.2 m -69.77 -36.03 75.42 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.428 0.632 . . . . 72.129999999999995 110.312 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.7 m -70.33 -33.7 71.8 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.373 0.606 . . . . 75.209999999999994 110.424 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 187' ' ' LEU . 93.4 mt -77.63 6.69 6.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.707 -0.679 . . . . 71.430000000000007 112.54 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.22 142.38 32.74 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.004 -0.739 . . . . 62.32 109.004 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.43 -10.29 65.02 Favored Glycine 0 C--N 1.307 -1.052 0 N-CA-C 110.095 -1.202 . . . . 71.219999999999999 110.095 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 160' ' ' ALA . 10.9 t -120.9 153.16 57.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.448 -1.686 . . . . 75.239999999999995 106.448 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.59 17.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.592 2.861 . . . . 44.329999999999998 115.199 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 131' ' ' TYR . . . -85.41 131.7 34.35 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.068 -0.395 . . . . 71.510000000000005 110.097 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 32.2 p -124.94 154.94 40.37 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.754 -0.832 . . . . 53.240000000000002 108.754 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -136.73 149.25 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 118.287 0.494 . . . . 72.219999999999999 110.956 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -116.77 141.63 47.97 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.727 0.64 . . . . 72.340000000000003 112.727 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.21 -2.28 15.01 Favored Glycine 0 C--N 1.318 -0.461 0 CA-C-N 115.021 -0.99 . . . . 64.310000000000002 113.35 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.3 t70 61.22 11.72 3.72 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.549 1.14 . . . . 73.420000000000002 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 86' ' ' VAL . 7.3 p -73.79 139.38 19.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.904 1.282 . . . . 71.530000000000001 111.385 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.47 ' HH ' HD21 ' A' ' 94' ' ' LEU . 15.4 p90 -144.61 168.74 19.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.387 -0.824 . . . . 73.400000000000006 110.713 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 16.0 m-85 -115.29 156.42 25.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.096 -0.502 . . . . 72.109999999999999 110.451 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 64.4 m -124.19 119.84 30.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.626 -1.62 . . . . 63.43 106.626 172.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.5 154.98 49.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.62 -0.264 . . . . 54.520000000000003 110.306 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.083 0 N-CA-C 108.931 -1.668 . . . . 40.439999999999998 108.931 179.612 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 120.949 0.404 . . . . 64.549999999999997 109.922 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -103.51 127.09 50.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.552 -1.647 . . . . 73.329999999999998 106.552 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.11 146.51 33.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.838 -0.801 . . . . 73.349999999999994 108.838 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 133' ' ' THR . 40.0 mt-10 -135.23 149.38 49.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.443 0.64 . . . . 62.130000000000003 111.323 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 77.7 t -125.02 118.58 53.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.927 -1.508 . . . . 71.230000000000004 106.927 172.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -102.91 120.65 40.99 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.139 -1.06 . . . . 74.230000000000004 108.139 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 155' ' ' LEU . 37.8 tp -106.05 129.95 54.06 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.303 -1.369 . . . . 64.099999999999994 107.303 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.89 125.1 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.565 -0.454 . . . . 63.119999999999997 110.705 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 161' ' ' THR . 13.8 pttp -71.06 145.95 49.6 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.005 -0.739 . . . . 74.510000000000005 109.005 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 108.787 -0.82 . . . . 37.68 108.787 174.671 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.2 p90 . . . . . 0 N--CA 1.431 -1.388 0 CA-C-O 121.819 0.819 . . . . 73.140000000000001 109.153 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -113.55 122.44 47.24 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.888 -1.051 . . . . 72.340000000000003 111.18 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.0 119.79 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 106.111 -1.811 . . . . 75.409999999999997 106.111 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -89.96 -25.78 20.73 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.123 -0.631 . . . . 73.209999999999994 111.062 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -176.84 153.85 1.09 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.511 0.507 . . . . 75.140000000000001 109.794 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.3 p -132.29 154.59 49.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.801 -0.814 . . . . 62.530000000000001 108.801 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.03 -148.82 20.1 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 119.24 -1.457 . . . . 71.510000000000005 113.313 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.2 -118.45 5.23 Favored Glycine 0 N--CA 1.427 -1.934 0 N-CA-C 110.268 -1.133 . . . . 74.040000000000006 110.268 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -99.41 169.96 8.97 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.876 -1.527 . . . . 72.409999999999997 106.876 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.3 162.86 14.11 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 75.319999999999993 109.236 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 72.72 -53.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.365 1.066 . . . . 71.430000000000007 110.12 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.63 111.75 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 107.999 -1.111 . . . . 73.200000000000003 107.999 172.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.2 p -133.69 155.82 49.03 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.594 -0.73 . . . . 61.229999999999997 110.477 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -112.01 161.8 16.07 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.233 0.539 . . . . 71.010000000000005 111.428 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' OE1' ' HD2' ' A' ' 34' ' ' ARG . 39.7 tt0 -133.81 124.86 27.27 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.159 -1.423 . . . . 73.329999999999998 107.159 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.07 114.9 26.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.84 -1.541 . . . . 75.430000000000007 106.84 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 13.7 ptm180 -134.22 143.47 47.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.32 0.581 . . . . 72.319999999999993 112.563 -172.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.78 135.78 35.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.194 -1.78 . . . . 72.140000000000001 106.194 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.4 t -68.99 146.74 52.47 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.356 0.598 . . . . 62.130000000000003 111.94 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.5 pm0 -67.84 0.5 3.32 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 126.162 1.785 . . . . 74.140000000000001 114.236 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 75.08 11.51 83.96 Favored Glycine 0 C--N 1.305 -1.147 0 C-N-CA 119.656 -1.259 . . . . 62.399999999999999 114.565 169.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.65 152.08 48.76 Favored Glycine 0 N--CA 1.408 -3.204 0 C-N-CA 120.349 -0.929 . . . . 72.310000000000002 113.39 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.446 ' O ' HD11 ' A' ' 104' ' ' ILE . 17.7 ptpt -102.96 118.93 37.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.041 -1.466 . . . . 70.329999999999998 107.041 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 59.3 m-85 -117.15 163.72 15.85 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.562 -0.745 . . . . 62.149999999999999 111.525 -168.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.03 116.91 32.34 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 108.093 -1.077 . . . . 75.239999999999995 108.093 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -124.21 146.41 48.73 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 113.033 0.753 . . . . 74.099999999999994 113.033 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.4 m -128.03 144.13 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 114.262 -1.336 . . . . 62.530000000000001 108.645 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.25 136.7 51.4 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 120.77 0.319 . . . . 73.319999999999993 111.016 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 54' ' ' ALA . 44.4 t -130.39 141.99 44.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 105.916 -1.883 . . . . 72.329999999999998 105.916 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 49' ' ' LYS . 34.1 p -130.49 159.76 36.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.651 0.612 . . . . 61.509999999999998 112.651 -171.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.3 -32.75 0.24 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.642 1.577 . . . . 72.239999999999995 112.541 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 47' ' ' THR . 52.6 mtpt -85.05 136.34 38.48 Favored Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 124.673 1.189 . . . . 72.409999999999997 109.336 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 156.15 16.81 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.268 2.645 . . . . 73.019999999999996 112.111 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.66 -41.44 12.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 113.293 0.849 . . . . 75.129999999999995 113.293 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -59.7 -47.66 84.76 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 120.644 -0.422 . . . . 73.129999999999995 110.975 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.64 -39.82 73.44 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.94 -0.573 . . . . 75.310000000000002 111.702 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . . . -67.47 -46.32 73.33 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.692 -0.686 . . . . 41.140000000000001 110.453 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.8 -45.74 85.01 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 122.423 0.289 . . . . 73.430000000000007 111.758 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 5.6 ppt_? -61.82 -28.24 69.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.813 0.672 . . . . 72.510000000000005 112.813 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 tt0 -85.64 -39.51 17.21 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.426 0.631 . . . . 71.010000000000005 111.154 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 44' ' ' VAL . . . -76.51 -32.17 58.14 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.95 0.722 . . . . 44.149999999999999 112.95 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.49 ' CE ' ' HA ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -53.59 -48.05 94.41 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 112.401 0.519 . . . . 73.510000000000005 112.401 -178.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' A' ' 57' ' ' GLU . 36.4 Cg_exo -56.48 -34.54 95.1 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.135 1.89 . . . . 71.230000000000004 111.515 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 58' ' ' ALA . 50.6 mtmt -69.03 -32.61 72.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.117 0.484 . . . . 71.230000000000004 110.791 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.49 -48.74 26.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.1 -0.5 . . . . 73.340000000000003 111.503 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . 0.276 3.2 ppp? -66.01 -29.23 69.57 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.696 0.998 . . . . 74.040000000000006 113.696 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.08 -29.45 69.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.24 0.543 . . . . 64.239999999999995 110.296 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.769 -0.65 . . . . 74.200000000000003 110.139 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 76' ' ' MET . 2.7 p -66.8 -27.23 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.013 0.435 . . . . 71.120000000000005 110.124 176.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.79 -20.77 62.39 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.842 -0.617 . . . . 54.5 113.686 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 131.67 -15.74 5.15 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.859 -1.162 . . . . 73.439999999999998 113.028 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -81.69 29.0 0.39 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.928 0.871 . . . . 74.430000000000007 110.502 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.403 ' HA ' ' OG ' ' A' ' 116' ' ' SER . 7.7 p30 -90.01 166.02 13.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.919 -0.582 . . . . 73.120000000000005 109.908 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.76 -35.03 79.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 112.928 0.714 . . . . 72.239999999999995 112.928 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 1.6 mptm? -82.71 -10.56 58.85 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.113 0.482 . . . . 73.420000000000002 111.526 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.88 33.88 76.02 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.56 -0.746 . . . . 75.209999999999994 112.541 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.521 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 24.7 m -80.65 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.712 -0.795 . . . . 72.439999999999998 108.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.31 167.34 51.96 Favored Glycine 0 N--CA 1.435 -1.372 0 O-C-N 123.776 0.672 . . . . 44.329999999999998 113.033 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 27.1 ttt -76.14 101.25 5.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.284 -0.458 . . . . 74.219999999999999 109.968 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.57 41.86 0.18 Allowed Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.217 -0.992 . . . . 73.120000000000005 112.978 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.3 ptm -124.91 123.5 40.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.947 -1.131 . . . . 73.209999999999994 107.947 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.3 m -125.67 117.36 23.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.034 0.753 . . . . 73.329999999999998 113.034 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -156.72 159.02 31.59 Favored Pre-proline 0 C--O 1.242 0.7 0 C-N-CA 125.494 1.518 . . . . 70.200000000000003 107.311 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.16 140.12 81.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.763 1.642 . . . . 54.149999999999999 112.131 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.98 150.61 5.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.949 -1.13 . . . . 65.239999999999995 107.949 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -138.65 144.64 39.77 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.866 -0.42 . . . . 71.439999999999998 109.866 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 46.5 p90 -135.2 144.83 47.16 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 122.083 -0.386 . . . . 74.329999999999998 110.653 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.517 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.64 34.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 108.523 -0.917 . . . . 61.32 108.523 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.23 150.25 25.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 N-CA-C 107.821 -1.177 . . . . 74.450000000000003 107.821 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 97' ' ' LYS . 2.7 m-85 -117.07 100.3 53.23 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.672 -0.862 . . . . 75.140000000000001 108.672 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.87 152.38 16.86 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 121.911 1.741 . . . . 75.010000000000005 112.677 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -100.14 158.37 15.9 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.327 -1.731 . . . . 71.420000000000002 106.327 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.25 -12.79 58.42 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.352 0.501 . . . . 70.230000000000004 112.352 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.39 -3.03 54.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.988 -0.551 . . . . 71.420000000000002 110.984 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.07 -4.01 82.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.936 -0.65 . . . . 38.659999999999997 112.984 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.0 m -83.01 131.42 35.18 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.765 0.317 . . . . 73.140000000000001 110.414 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.57 79.26 4.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.539 0.685 . . . . 64.209999999999994 110.534 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.577 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 52.0 tt0 -148.46 114.26 5.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.29 -0.868 . . . . 74.219999999999999 111.012 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 56.3 mtpt -176.82 -67.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.727 2.011 . . . . 72.129999999999995 107.048 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 64.9 mttm -145.67 158.63 43.83 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.883 -1.053 . . . . 73.150000000000006 108.518 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 85' ' ' ALA . 46.8 tp -139.14 124.74 19.45 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.964 -1.125 . . . . 71.209999999999994 107.964 171.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -123.68 114.04 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.158 -1.052 . . . . 71.540000000000006 108.158 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 58.2 t -97.15 130.14 46.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.178 -0.675 . . . . 62.049999999999997 109.178 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.45 131.65 56.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.149 -0.685 . . . . 71.310000000000002 109.149 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -102.98 114.67 29.16 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.022 -1.103 . . . . 73.019999999999996 108.022 175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.608 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 75.9 ttt180 -75.52 133.04 41.11 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.014 -1.448 . . . . 74.109999999999999 109.755 -176.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 40' ' ' LYS . 76.1 mt -106.44 137.54 19.46 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.565 -0.902 . . . . 70.150000000000006 108.565 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.77 149.43 77.55 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.259 1.972 . . . . 63.240000000000002 110.428 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -60.99 -33.82 73.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.831 1.049 . . . . 64.299999999999997 113.831 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -66.94 -23.91 66.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 65.310000000000002 111.119 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -92.66 -7.7 46.13 Favored 'General case' 0 C--O 1.192 -1.958 0 CA-C-N 116.66 -0.246 . . . . 73.319999999999993 110.895 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.643 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.52 -33.29 69.06 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.922 -0.711 . . . . 74.040000000000006 111.478 177.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.83 -29.61 74.59 Favored Glycine 0 C--N 1.334 0.464 0 O-C-N 123.559 0.537 . . . . 42.399999999999999 111.949 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.0 t -153.69 82.56 4.58 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 108.996 -0.742 . . . . 71.109999999999999 108.996 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.73 162.14 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.468 2.112 . . . . 54.329999999999998 111.902 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.3 Cg_exo -60.45 156.98 38.37 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 C-N-CA 121.581 1.52 . . . . 72.120000000000005 109.783 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.94 154.56 37.74 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.431 -0.581 . . . . 72.219999999999999 109.431 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.479 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 27.8 Cg_exo -62.98 104.99 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.781 2.321 . . . . 75.109999999999999 111.81 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 11.2 p -90.67 -28.35 18.42 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.871 -0.604 . . . . 71.340000000000003 112.177 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.7 156.03 18.38 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.813 -0.81 . . . . 73.109999999999999 108.813 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.47 -31.71 63.91 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.455 0.645 . . . . 70.25 110.366 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.8 m -99.28 5.14 46.67 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.525 -0.762 . . . . 43.25 112.013 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 59.6 t -119.7 122.6 69.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.071 -1.085 . . . . 61.119999999999997 108.071 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -128.22 143.4 51.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.366 -0.379 . . . . 72.25 110.502 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.2 mm -92.75 110.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.826 -1.176 . . . . 63.530000000000001 107.826 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -108.01 144.04 35.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.23 -0.895 . . . . 62.200000000000003 109.382 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.16 127.33 45.1 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.842 -0.617 . . . . 74.010000000000005 110.492 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.522 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 2.1 mmp_? -123.36 116.25 22.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 118.745 -1.182 . . . . 64.109999999999999 109.686 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -148.49 161.01 42.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.379 -0.828 . . . . 75.25 110.962 173.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.13 19.7 71.68 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.919 -0.658 . . . . 74.0 112.264 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -121.14 147.67 24.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.314 0.578 . . . . 75.230000000000004 111.009 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.9 m -117.47 128.21 54.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.446 -0.946 . . . . 74.519999999999996 108.446 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.448 HG21 ' CE3' ' A' ' 186' ' ' TRP . 30.2 m -124.72 166.06 20.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 116.13 -0.486 . . . . 75.540000000000006 110.001 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 55.4 m-85 -113.75 122.18 46.33 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 106.256 -1.757 . . . . 74.340000000000003 106.256 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 p -119.73 132.73 55.72 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.773 -0.771 . . . . 71.219999999999999 110.735 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.8 t -121.76 123.84 42.79 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 109.007 -0.738 . . . . 63.329999999999998 109.007 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -110.58 136.91 48.96 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.431 -0.951 . . . . 73.019999999999996 108.431 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 43.2 p90 -145.49 144.7 30.72 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.026 -0.533 . . . . 72.329999999999998 111.561 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -106.64 138.25 14.31 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.503 -1.039 . . . . 64.450000000000003 110.503 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.11 -175.06 28.52 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.868 -0.682 . . . . 51.210000000000001 111.484 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -87.59 111.13 20.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.784 -1.191 . . . . 75.319999999999993 107.784 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.28 130.8 53.24 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.531 0.567 . . . . 55.350000000000001 112.531 -174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.15 178.21 5.32 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.702 -1.222 . . . . 73.510000000000005 107.702 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.71 77.86 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.323 0.582 . . . . 64.310000000000002 109.869 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.48 71.31 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.355 -0.839 . . . . 73.420000000000002 111.063 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.37 -30.52 70.33 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.413 0.149 . . . . 74.299999999999997 111.199 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -69.7 -41.63 75.13 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 110.036 -0.357 . . . . 72.219999999999999 110.036 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.81 -48.0 83.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.396 -0.594 . . . . 72.450000000000003 109.396 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.98 87.88 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.36 -0.836 . . . . 64.239999999999995 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -66.37 -32.43 73.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 112.402 0.519 . . . . 61.229999999999997 112.402 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 -46.7 79.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.86 0.362 . . . . 72.230000000000004 111.037 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.4 t -72.58 -33.39 66.72 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.482 0.658 . . . . 74.540000000000006 110.235 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -64.44 -37.07 86.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.168 -0.678 . . . . 74.010000000000005 109.168 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.35 -39.45 93.91 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.859 -0.609 . . . . 62.340000000000003 110.058 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -63.28 -36.54 84.01 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.372 -0.603 . . . . 75.310000000000002 109.372 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 m -70.53 -32.71 70.27 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.261 -0.881 . . . . 73.25 110.031 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.6 m -76.79 -34.33 57.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.671 -0.695 . . . . 74.5 110.06 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -85.71 11.22 11.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.58 0.752 . . . . 73.129999999999995 111.095 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -73.68 135.21 43.7 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.624 -1.621 . . . . 55.399999999999999 106.624 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.49 58.83 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.521 -0.632 . . . . 61.439999999999998 111.521 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 160' ' ' ALA . 34.9 p -114.3 160.14 33.91 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 107.259 -1.385 . . . . 71.450000000000003 107.259 176.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.13 27.31 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 122.192 1.928 . . . . 61.140000000000001 112.163 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 158' ' ' THR . . . -67.16 101.1 0.85 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.359 0.599 . . . . 71.310000000000002 112.273 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.5 p -89.33 156.03 18.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.559 -0.904 . . . . 74.129999999999995 108.559 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.433 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 24.2 m-85 -138.74 150.4 46.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.2 pt20 -114.04 109.89 19.17 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.309 0.576 . . . . 73.340000000000003 110.438 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.27 41.95 Favored Glycine 0 N--CA 1.46 0.3 0 C-N-CA 120.808 -0.71 . . . . 62.439999999999998 111.901 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 59.31 25.55 14.22 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.936 1.294 . . . . 72.010000000000005 110.499 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.1 m -75.1 140.03 18.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 119.799 -0.761 . . . . 74.319999999999993 110.76 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -139.9 170.24 16.23 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.162 -0.926 . . . . 72.409999999999997 109.607 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 60.6 m-85 -115.43 148.09 39.79 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.721 -0.844 . . . . 73.540000000000006 108.721 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 63.1 m -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.522 -1.658 . . . . 75.329999999999998 106.522 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 184' ' ' GLU . . . -117.59 145.45 44.29 Favored 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 123.558 0.536 . . . . 72.219999999999999 111.253 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.04 0 N-CA-C 108.932 -1.667 . . . . 38.659999999999997 108.932 -179.454 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.432 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 97.0 mtt180 . . . . . 0 CA--C 1.503 -0.851 0 CA-C-O 120.47 0.176 . . . . 75.519999999999996 110.998 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.87 130.55 49.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 109.245 -0.65 . . . . 60.310000000000002 109.245 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.6 m-80 -127.47 139.34 52.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.241 -1.392 . . . . 63.329999999999998 107.241 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 170' ' ' ALA . 39.0 tt0 -132.09 133.93 44.9 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.829 -0.348 . . . . 73.310000000000002 111.051 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.49 125.71 69.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.466 0.706 . . . . 73.040000000000006 110.062 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.8 m0 -109.08 121.13 44.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.904 -0.776 . . . . 73.349999999999994 108.904 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.35 124.03 49.21 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 107.522 -1.288 . . . . 64.540000000000006 107.522 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.34 132.31 39.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.782 0.325 . . . . 75.129999999999995 111.262 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 21.0 ptmt -76.45 141.95 41.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.128 -0.487 . . . . 70.209999999999994 111.288 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.433 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.809 -0.632 . . . . 65.340000000000003 110.42 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 105.501 -2.037 . . . . 73.010000000000005 105.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.83 118.75 21.23 Favored 'General case' 0 C--N 1.284 -2.273 0 C-N-CA 119.633 -0.827 . . . . 73.230000000000004 109.105 -171.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t -89.7 126.29 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.883 -0.784 . . . . 70.329999999999998 108.883 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.78 -38.57 15.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.384 -0.969 . . . . 61.420000000000002 108.384 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.5 t 179.69 165.68 1.13 Allowed 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.932 -1.031 . . . . 62.229999999999997 108.291 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -131.64 165.13 24.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.958 -1.127 . . . . 63.240000000000002 107.958 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.99 -157.04 25.82 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 119.352 -1.404 . . . . 51.030000000000001 113.04 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.97 -138.51 14.6 Favored Glycine 0 N--CA 1.42 -2.397 0 N-CA-C 111.186 -0.766 . . . . 74.099999999999994 111.186 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.1 171.06 8.48 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.283 -1.006 . . . . 72.140000000000001 108.283 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.44 162.17 23.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.129 -1.028 . . . . 71.420000000000002 109.622 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 72.39 -54.27 0.69 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.345 1.058 . . . . 75.420000000000002 109.797 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.21 109.39 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-O 122.049 0.928 . . . . 44.219999999999999 109.125 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 m -129.67 146.36 51.46 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.003 -1.11 . . . . 71.349999999999994 108.003 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -113.83 160.49 18.67 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 112.795 0.665 . . . . 75.030000000000001 112.795 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.567 ' OE1' ' HD3' ' A' ' 34' ' ' ARG . 39.7 tt0 -136.56 125.71 24.61 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.468 -2.049 . . . . 73.030000000000001 105.468 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -98.91 118.04 34.77 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.883 -1.525 . . . . 43.009999999999998 106.883 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.567 ' HD3' ' OE1' ' A' ' 32' ' ' GLU . 27.0 mtm180 -131.68 145.76 51.82 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.931 -1.108 . . . . 72.129999999999995 111.717 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.34 136.86 34.92 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.303 -2.11 . . . . 63.100000000000001 105.303 168.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.0 t -58.25 148.45 27.19 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.349 0.406 . . . . 54.240000000000002 111.817 -175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -73.17 -3.35 26.03 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 115.753 -0.658 . . . . 37.560000000000002 111.641 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 74.01 9.07 79.62 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 120.979 -0.629 . . . . 45.140000000000001 114.021 171.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.37 162.5 54.23 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 121.052 -0.594 . . . . 54.530000000000001 113.527 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.04 118.65 37.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.315 -1.365 . . . . 63.310000000000002 107.315 178.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.1 m-85 -121.4 165.7 15.18 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.665 -0.698 . . . . 71.439999999999998 112.05 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.69 116.79 30.59 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 107.79 -1.189 . . . . 75.239999999999995 107.79 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -127.66 144.24 51.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.655 0.74 . . . . 73.439999999999998 112.24 -174.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 58' ' ' ALA . 6.5 p -127.61 133.63 67.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.298 -1.371 . . . . 73.540000000000006 107.298 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.71 123.58 45.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.072 -0.651 . . . . 73.439999999999998 111.382 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.425 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 31.6 t -118.16 123.19 71.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.261 -1.385 . . . . 52.5 107.261 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' LYS . 25.0 m -117.76 159.5 22.92 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.669 -0.241 . . . . 72.010000000000005 110.532 -175.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 75.58 -27.39 0.19 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.852 1.661 . . . . 72.010000000000005 112.035 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.0 mttm -85.19 145.05 42.08 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 109.274 -0.639 . . . . 74.209999999999994 109.274 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.57 156.84 34.69 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.927 2.418 . . . . 74.219999999999999 111.514 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.409 HG13 HD13 ' A' ' 98' ' ' LEU . 54.5 t -48.03 -44.74 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.36 0.664 . . . . 71.439999999999998 112.408 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -58.04 -44.41 87.38 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.95 0.405 . . . . 63.119999999999997 110.737 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.15 -48.79 26.98 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.505 -0.77 . . . . 62.32 111.063 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -59.7 -40.18 87.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 73.230000000000004 111.317 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 59' ' ' MET . 52.7 tp -65.61 -51.3 60.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 116.338 -0.392 . . . . 62.020000000000003 110.959 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 4.9 ppt_? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.318 0.858 . . . . 74.310000000000002 113.318 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 1.3 tm-20 -74.69 -45.82 41.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.384 -0.969 . . . . 74.530000000000001 108.384 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . . . -76.57 -33.16 58.5 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.525 1.13 . . . . 37.560000000000002 114.046 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.535 ' HE2' ' HA ' ' A' ' 59' ' ' MET . 8.9 mmt -50.98 -55.09 30.65 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 114.918 1.451 . . . . 71.129999999999995 114.918 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.42 -30.91 75.47 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.681 2.254 . . . . 64.200000000000003 112.163 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -67.35 -48.63 66.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 54.200000000000003 111.029 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.7 mm -66.48 -40.1 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 74.040000000000006 109.767 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -48.53 79.88 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 123.666 0.787 . . . . 71.340000000000003 111.13 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -27.58 65.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.952 -0.699 . . . . 74.010000000000005 112.382 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.95 -50.52 68.3 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.576 -0.283 . . . . 72.219999999999999 110.517 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -2.92 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.901 -0.591 . . . . 72.519999999999996 111.583 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.55 -21.59 36.88 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.809 -0.632 . . . . 72.230000000000004 111.929 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 136.69 -14.29 3.89 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.174 -1.012 . . . . 37.560000000000002 113.425 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 m -81.48 40.53 0.58 Allowed 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.89 1.329 . . . . 73.420000000000002 110.957 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.81 177.16 5.55 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.24 -0.891 . . . . 74.420000000000002 108.978 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.442 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . 17.0 t70 -69.33 -30.88 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.859 0.361 . . . . 74.109999999999999 111.961 -175.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -81.77 -12.63 58.48 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.36 -0.382 . . . . 71.219999999999999 110.289 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.31 20.8 75.5 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.805 -0.634 . . . . 73.340000000000003 112.18 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.484 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 33.4 m -86.33 125.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.622 -0.431 . . . . 74.299999999999997 110.738 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.64 -71.13 0.96 Allowed Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 111.542 -0.623 . . . . 74.299999999999997 111.542 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.5 mmt 66.43 -64.18 0.23 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.185 1.179 . . . . 72.120000000000005 114.185 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 60.7 5.9 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.621 -1.392 . . . . 70.319999999999993 109.621 -174.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -96.12 126.25 41.22 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.179 0.514 . . . . 64.299999999999997 110.946 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.8 t -123.45 116.6 23.5 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 122.361 1.077 . . . . 74.430000000000007 111.557 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.2 m -143.65 170.93 7.57 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 105.262 -2.125 . . . . 70.430000000000007 105.262 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.03 138.62 79.68 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.609 1.253 . . . . 72.349999999999994 113.547 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.9 p -111.88 147.22 15.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.696 -1.594 . . . . 71.400000000000006 106.696 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.0 p -132.61 144.95 50.71 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.438 -0.505 . . . . 51.43 110.22 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -131.68 141.32 49.55 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 120.199 -0.6 . . . . 71.129999999999995 110.716 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.75 135.02 34.48 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 115.54 -0.755 . . . . 74.239999999999995 109.414 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.69 150.21 32.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.696 -0.684 . . . . 62.350000000000001 109.457 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 97' ' ' LYS . 90.7 m-85 -119.48 101.88 48.42 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 110.143 -0.318 . . . . 73.010000000000005 110.143 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.95 142.55 15.69 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 122.447 2.098 . . . . 64.040000000000006 112.589 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.459 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 45.6 m-80 -96.66 162.63 13.36 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.034 -0.728 . . . . 60.219999999999999 109.034 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.1 -13.56 62.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.424 0.631 . . . . 73.510000000000005 110.232 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.51 -6.19 54.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.27 -0.877 . . . . 55.020000000000003 109.457 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -6.8 82.95 Favored Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 116.024 -0.535 . . . . 72.140000000000001 112.296 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 p -84.39 140.88 31.25 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.833 0.349 . . . . 71.209999999999994 110.48 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.47 79.11 2.46 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.302 0.573 . . . . 64.230000000000004 109.569 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 78.2 mt-30 -147.02 114.63 6.39 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.766 -0.652 . . . . 72.219999999999999 110.596 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 89.2 mttt -176.63 -63.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 126.274 1.83 . . . . 73.519999999999996 108.091 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 21.9 ttmm -161.04 153.83 20.92 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.691 -0.855 . . . . 62.030000000000001 108.691 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 5.8 tt -139.92 128.37 22.79 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.031 -1.47 . . . . 73.230000000000004 107.031 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -123.43 115.61 21.89 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.014 -0.735 . . . . 74.140000000000001 109.014 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 43' ' ' THR . 82.6 t -88.74 123.03 40.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.952 -0.388 . . . . 64.420000000000002 109.952 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -109.78 124.75 51.81 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.971 -0.751 . . . . 75.140000000000001 108.971 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 87.8 t80 -102.52 112.4 25.12 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.995 -1.113 . . . . 75.510000000000005 107.995 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.472 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 2.3 tmt_? -75.5 112.93 12.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.931 -1.507 . . . . 72.409999999999997 106.931 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.514 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 67.7 mt -85.68 137.92 35.88 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.156 -0.475 . . . . 74.319999999999993 109.9 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.29 143.36 34.08 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.63 2.22 . . . . 55.219999999999999 111.539 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.92 -33.39 62.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.363 1.246 . . . . 74.519999999999996 114.363 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -59.41 -31.23 69.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.893 0.378 . . . . 75.530000000000001 111.006 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.98 -2.78 49.71 Favored 'General case' 0 C--O 1.192 -1.942 0 CA-C-N 116.341 -0.39 . . . . 65.530000000000001 111.605 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.514 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 29.5 mm-40 -71.01 -28.62 64.55 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.199 -0.6 . . . . 72.129999999999995 110.608 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.04 -38.29 92.49 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.266 -0.734 . . . . 44.530000000000001 111.266 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.8 m -155.39 92.99 2.7 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 123.212 0.605 . . . . 65.200000000000003 109.52 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -83.96 145.04 11.1 Favored 'Trans proline' 0 C--O 1.251 1.158 0 C-N-CA 122.472 2.115 . . . . 62.140000000000001 111.832 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.1 130.6 29.44 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.886 1.724 . . . . 72.129999999999995 109.432 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 71' ' ' ASP . . . -61.18 139.67 94.42 Favored Pre-proline 0 C--O 1.257 1.479 0 CA-C-O 120.767 0.318 . . . . 72.129999999999995 110.68 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 61.2 Cg_endo -72.2 108.21 2.43 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.584 2.189 . . . . 74.510000000000005 111.199 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.8 t -89.91 82.47 6.18 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 116.02 -0.536 . . . . 70.439999999999998 110.428 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.49 ' HB3' HG11 ' A' ' 120' ' ' VAL . 13.0 t70 -178.49 164.37 1.65 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 104.492 -2.41 . . . . 64.420000000000002 104.492 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.47 -28.37 22.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 118.727 0.694 . . . . 74.519999999999996 112.269 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 p -91.28 -18.46 24.32 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.704 1.001 . . . . 71.519999999999996 113.704 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 117' ' ' ASP . 2.5 p -104.37 120.64 55.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.237 0.541 . . . . 54.299999999999997 109.879 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 154.24 46.98 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.332 -0.849 . . . . 72.209999999999994 110.519 -175.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.8 mm -91.75 112.32 25.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.806 -0.813 . . . . 75.310000000000002 108.806 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -126.15 147.73 49.56 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.27 -1.011 . . . . 74.150000000000006 108.27 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -121.24 151.2 40.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 120.948 0.404 . . . . 75.129999999999995 111.341 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -134.33 125.68 28.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.82 -0.627 . . . . 71.140000000000001 111.581 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.422 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -143.14 174.2 10.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.616 -1.253 . . . . 73.120000000000005 107.616 171.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.94 19.34 77.68 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 119.884 -1.15 . . . . 75.040000000000006 111.12 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.8 145.74 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-O 121.003 0.43 . . . . 75.420000000000002 109.912 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.1 m -115.73 131.67 56.87 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.543 -1.28 . . . . 63.310000000000002 107.543 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -123.96 154.23 30.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.073 0.463 . . . . 71.129999999999995 109.906 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 66.2 m-85 -114.03 122.04 45.71 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 105.998 -1.853 . . . . 75.049999999999997 105.998 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.6 p -112.59 143.01 44.49 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.854 0.359 . . . . 70.230000000000004 111.005 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.472 ' HB ' HD21 ' A' ' 151' ' ' LEU . 13.5 t -128.01 134.35 49.23 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 120.693 -0.403 . . . . 63.240000000000002 110.008 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.516 ' NE2' ' HG2' ' A' ' 184' ' ' GLU . 2.0 mp0 -110.84 142.18 43.2 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.552 -1.648 . . . . 72.120000000000005 106.552 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 143' ' ' ASP . 30.7 p90 -143.17 118.25 10.08 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 115.133 1.531 . . . . 75.450000000000003 115.133 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 47.74 -138.96 10.37 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.005 -1.452 . . . . 73.150000000000006 115.776 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 181' ' ' ARG . . . -124.78 -28.39 1.16 Allowed Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.103 -0.799 . . . . 53.109999999999999 111.103 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.6 119.43 38.06 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.002 0.43 . . . . 70.340000000000003 112.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.59 107.63 11.23 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.578 -0.737 . . . . 75.319999999999993 110.883 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.14 171.9 8.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.737 -1.209 . . . . 73.030000000000001 107.737 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.59 -39.02 75.87 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.135 0.493 . . . . 63.420000000000002 110.434 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.36 74.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.38 -0.827 . . . . 70.439999999999998 111.362 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 17.2 m-20 -65.92 -36.26 82.88 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 111.815 0.302 . . . . 74.430000000000007 111.815 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.37 -39.9 89.38 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.927 0.394 . . . . 72.439999999999998 110.709 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.424 HG21 ' HH ' ' A' ' 167' ' ' TYR . 48.5 t -71.99 -51.13 32.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.949 -0.569 . . . . 65.430000000000007 110.372 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -57.4 -46.52 83.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.714 -0.675 . . . . 72.319999999999993 111.667 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -65.03 -32.65 74.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.027 0.751 . . . . 74.120000000000005 113.027 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.92 86.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.342 -0.614 . . . . 74.340000000000003 109.342 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.8 m -65.59 -40.19 92.42 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.711 -0.677 . . . . 72.349999999999994 109.937 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 30.2 mm-40 -61.84 -37.02 82.92 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 111.938 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.472 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.0 mt -60.92 -35.03 75.64 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 120.865 -0.334 . . . . 54.32 111.752 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -59.81 -48.14 82.87 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.25 0.343 . . . . 75.140000000000001 111.276 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 156' ' ' GLU . 13.0 t -75.56 -30.61 59.75 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.201 0.524 . . . . 75.510000000000005 111.033 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.9 m -70.69 -35.35 72.75 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 120.963 0.411 . . . . 74.239999999999995 110.421 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.5 6.45 17.39 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.014 0.525 . . . . 73.209999999999994 112.283 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 153' ' ' THR . 56.5 mt-10 -68.93 138.3 54.5 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.008 -0.677 . . . . 75.129999999999995 110.082 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.09 56.6 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.756 -0.656 . . . . 74.150000000000006 111.595 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.5 p -125.37 165.33 26.97 Favored Pre-proline 0 N--CA 1.441 -0.922 0 N-CA-C 108.293 -1.002 . . . . 73.0 108.293 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -75.44 20.14 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.796 2.331 . . . . 71.209999999999994 112.451 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.73 120.73 17.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.309 0.576 . . . . 72.5 110.426 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 10.1 t -124.59 157.5 35.29 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.007 -1.849 . . . . 75.519999999999996 106.007 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -132.6 160.09 37.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 119.115 0.871 . . . . 72.230000000000004 108.893 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -128.77 132.86 47.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.125 0.417 . . . . 52.43 112.125 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.63 -0.45 27.14 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.508 -0.769 . . . . 63.140000000000001 114.12 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 60.62 10.77 2.74 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.033 0.933 . . . . 74.0 112.285 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.436 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.5 p -68.77 138.53 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.784 0.802 . . . . 74.299999999999997 111.488 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.424 ' HH ' HG21 ' A' ' 145' ' ' VAL . 36.4 p90 -135.95 161.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.8 -1.091 . . . . 71.230000000000004 108.897 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 88.4 m-85 -115.41 142.07 47.19 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.153 -0.476 . . . . 75.510000000000005 109.913 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.2 m -114.22 120.3 40.0 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.731 -1.211 . . . . 65.340000000000003 107.731 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 184' ' ' GLU . . . -116.3 143.07 46.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.154 0.502 . . . . 71.439999999999998 111.708 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.654 0 N-CA-C 107.279 -2.328 . . . . 54.520000000000003 107.279 -179.525 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.43 ' HA ' ' HA2' ' A' ' 137' ' ' GLY 0.258 19.7 ptt180 . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 116.185 1.92 . . . . 74.109999999999999 116.185 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -101.23 125.25 47.84 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 115.342 -2.543 . . . . 75.519999999999996 108.581 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -146.84 158.37 43.9 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.648 -1.614 . . . . 65.239999999999995 108.786 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.516 ' HG2' ' NE2' ' A' ' 134' ' ' GLN . 43.5 mt-10 -143.12 137.38 29.09 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.098 0.475 . . . . 72.129999999999995 110.537 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 84.7 t -124.22 118.5 53.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 105.913 -1.884 . . . . 75.340000000000003 105.913 171.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.549 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 49.2 m0 -106.32 124.42 49.57 Favored 'General case' 0 CA--C 1.495 -1.154 0 O-C-N 123.463 0.477 . . . . 75.340000000000003 111.413 -176.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 mt -97.35 125.2 41.81 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.676 -1.601 . . . . 70.420000000000002 106.676 167.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.7 124.75 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 120.536 -0.466 . . . . 74.010000000000005 109.993 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 161' ' ' THR . 15.5 pttp -70.19 145.1 51.69 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.643 -0.708 . . . . 73.040000000000006 109.644 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.76 0 C-N-CA 118.976 -1.089 . . . . 41.43 109.442 171.109 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 41.2 p90 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 109.375 -0.602 . . . . 71.200000000000003 109.375 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -122.91 110.0 14.86 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.943 -0.303 . . . . 60.43 110.546 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.3 116.42 30.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 106.906 -1.516 . . . . 74.200000000000003 106.906 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -91.93 -26.28 18.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.36 -0.536 . . . . 63.240000000000002 112.111 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -172.85 153.14 2.58 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.006 0.431 . . . . 64.530000000000001 110.779 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.6 p -133.03 134.58 44.6 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.867 -1.06 . . . . 71.430000000000007 110.231 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.94 132.55 7.81 Favored Glycine 0 C--N 1.304 -1.246 0 C-N-CA 120.265 -0.969 . . . . 62.5 112.752 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.46 -115.03 0.98 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.029 -0.605 . . . . 62.130000000000003 111.749 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.489 ' HZ1' ' HB2' ' A' ' 26' ' ' LYS . 4.7 ttmp? -91.71 117.55 29.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.518 -1.66 . . . . 64.329999999999998 106.518 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -67.75 134.31 50.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 115.27 1.582 . . . . 73.420000000000002 115.27 -170.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 158.17 -58.87 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 129.704 3.202 . . . . 72.439999999999998 103.737 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.2 p -129.22 129.96 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 106.901 -1.518 . . . . 74.329999999999998 106.901 170.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 m -95.27 154.64 17.09 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.893 -0.504 . . . . 75.209999999999994 110.087 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.47 163.37 14.98 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.983 -0.553 . . . . 74.340000000000003 110.885 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -132.96 124.53 27.96 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.628 -1.99 . . . . 74.5 105.628 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.4 115.27 30.13 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.552 -1.277 . . . . 71.150000000000006 107.552 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -131.3 139.79 49.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.216 -0.594 . . . . 63.0 110.933 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.39 133.65 35.44 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 104.924 -2.251 . . . . 73.510000000000005 104.924 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.27 138.92 58.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 123.674 0.609 . . . . 71.349999999999994 109.851 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.8 OUTLIER -60.69 -26.94 67.49 Favored 'General case' 0 N--CA 1.422 -1.85 0 O-C-N 124.435 1.085 . . . . 62.229999999999997 112.531 -178.193 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 84.31 10.24 80.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 118.465 -1.826 . . . . 73.239999999999995 112.247 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.22 157.27 53.4 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.822 -0.704 . . . . 61.210000000000001 111.395 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -88.32 123.43 32.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.409 -0.96 . . . . 72.120000000000005 108.409 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.0 m-85 -122.32 165.45 16.23 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.588 -0.733 . . . . 72.319999999999993 110.996 -172.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.25 115.35 28.18 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.384 -0.969 . . . . 73.239999999999995 108.384 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.9 t -120.32 142.67 48.91 Favored 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 115.124 -0.943 . . . . 62.299999999999997 111.643 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 13.8 m -128.89 127.14 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 107.147 -1.427 . . . . 71.010000000000005 107.147 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.59 119.68 31.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-O 121.887 0.851 . . . . 74.049999999999997 112.093 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.72 135.8 53.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.221 -1.354 . . . . 75.329999999999998 107.616 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 49' ' ' LYS . 33.3 p -125.78 167.5 15.09 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.582 -0.281 . . . . 65.049999999999997 110.736 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.7 t70 73.64 -26.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 124.039 0.935 . . . . 71.230000000000004 112.202 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 47' ' ' THR . 94.6 mttt -96.96 143.27 25.83 Favored Pre-proline 0 C--N 1.3 -1.565 0 CA-C-N 115.808 -0.633 . . . . 64.510000000000005 110.22 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.14 158.95 36.82 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.374 2.716 . . . . 65.310000000000002 111.789 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.2 t -45.66 -45.66 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.131 0.972 . . . . 64.239999999999995 112.756 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.58 -50.04 75.27 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.506 0.67 . . . . 53.43 110.52 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.99 -35.73 77.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.104 -0.953 . . . . 74.200000000000003 112.273 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.18 -45.26 63.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.462 -0.335 . . . . 73.140000000000001 110.624 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.08 -43.64 94.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.304 -0.407 . . . . 71.120000000000005 111.413 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -64.51 -26.74 68.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.159 0.429 . . . . 62.229999999999997 112.159 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 27.5 tt0 -84.07 -30.39 26.06 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.09 -0.707 . . . . 74.25 109.09 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.58 52.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.979 -1.01 . . . . 63.200000000000003 113.49 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.524 ' HE1' ' HA ' ' A' ' 59' ' ' MET . 3.4 mmt -51.08 -55.85 24.77 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 112.504 0.557 . . . . 74.530000000000001 112.504 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.11 -31.32 74.83 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.739 2.293 . . . . 73.439999999999998 113.202 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 93.1 mttt -64.19 -48.46 75.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.77 0.319 . . . . 75.450000000000003 110.362 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.8 -38.81 83.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.341 -0.39 . . . . 74.319999999999993 110.756 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.1 mmt -59.15 -43.23 92.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.253 -0.43 . . . . 74.120000000000005 112.038 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -76.22 -29.72 57.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.834 -0.747 . . . . 75.209999999999994 111.634 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.402 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 36.9 t80 -60.91 -56.3 22.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.165 -0.471 . . . . 75.349999999999994 110.743 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.4 m -77.45 -7.56 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.391 0.615 . . . . 74.340000000000003 110.739 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.85 -20.74 62.77 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.602 -0.726 . . . . 36.990000000000002 112.436 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.32 6.55 8.11 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.028 -1.082 . . . . 75.420000000000002 113.288 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -91.85 17.73 8.74 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.777 1.275 . . . . 71.150000000000006 109.573 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.07 173.47 10.46 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.562 -1.199 . . . . 73.239999999999995 109.438 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 24.1 t70 -67.09 -33.23 75.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.541 0.571 . . . . 73.530000000000001 112.541 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.15 -12.29 59.25 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.45 -0.5 . . . . 71.040000000000006 110.554 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.25 24.76 74.81 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 115.535 -0.757 . . . . 44.109999999999999 111.884 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.61 122.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 C-N-CA 120.004 -0.679 . . . . 45.340000000000003 111.287 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.42 97.84 1.36 Allowed Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 109.241 -1.543 . . . . 72.099999999999994 109.241 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtt -126.41 135.53 51.53 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.625 -0.509 . . . . 53.219999999999999 109.625 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.95 70.91 1.45 Allowed Glycine 0 C--N 1.292 -1.908 0 CA-C-N 115.296 -0.865 . . . . 43.009999999999998 111.922 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.0 ptm -96.68 122.44 39.62 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.283 -0.636 . . . . 64.530000000000001 109.283 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.8 m -127.44 133.98 49.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.758 -0.656 . . . . 74.019999999999996 110.478 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -166.43 148.29 5.84 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.044 -1.465 . . . . 62.32 107.044 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 27.8 Cg_exo -40.1 140.97 0.75 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.753 2.968 . . . . 75.439999999999998 115.133 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.26 152.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.262 -1.014 . . . . 63.32 108.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.9 m -139.3 152.32 47.13 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.202 -0.666 . . . . 62.509999999999998 109.202 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -145.14 144.99 31.19 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 122.1 -0.375 . . . . 65.340000000000003 110.578 172.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -92.39 137.97 31.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.648 -0.501 . . . . 54.439999999999998 109.648 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.18 150.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 N-CA-C 108.744 -0.836 . . . . 72.200000000000003 108.744 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 62.7 m-85 -117.09 112.34 40.01 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 107.02 -1.474 . . . . 73.340000000000003 107.02 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.22 133.66 18.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 120.948 1.099 . . . . 73.109999999999999 112.247 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.35 156.57 20.16 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 107.823 -1.177 . . . . 73.439999999999998 107.823 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.01 -13.33 62.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.186 0.517 . . . . 62.299999999999997 112.147 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.16 -6.14 58.97 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.998 -0.546 . . . . 72.049999999999997 110.278 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.54 -2.45 72.5 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.335 -0.393 . . . . 54.020000000000003 113.269 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -87.36 3.56 46.46 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.881 0.697 . . . . 74.349999999999994 112.881 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt 65.3 148.29 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.108 0.963 . . . . 70.510000000000005 112.889 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.406 ' OE1' ' HE2' ' A' ' 97' ' ' LYS . 34.8 tt0 -82.08 148.57 28.5 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.707 -0.679 . . . . 75.230000000000004 109.854 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -86.06 70.43 10.59 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.752 0.786 . . . . 74.310000000000002 111.31 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 22.0 ttmm -158.26 125.5 5.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 105.483 -2.043 . . . . 71.420000000000002 105.483 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.03 131.89 22.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.328 -0.949 . . . . 73.439999999999998 111.38 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.79 115.16 23.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.299 -0.864 . . . . 70.299999999999997 109.311 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 43' ' ' THR . 92.9 t -88.33 127.93 40.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 108.041 -1.096 . . . . 73.019999999999996 108.041 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -114.79 113.61 24.47 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.359 -0.978 . . . . 75.150000000000006 108.359 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -103.04 114.08 28.08 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.682 -1.229 . . . . 74.200000000000003 107.682 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.613 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 14.8 ptp180 -75.07 138.78 42.36 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.771 -1.104 . . . . 64.239999999999995 108.085 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -97.91 141.16 22.54 Favored Pre-proline 0 C--N 1.266 -3.046 0 CA-C-N 116.264 -0.425 . . . . 73.349999999999994 110.056 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.42 146.89 9.64 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.902 2.401 . . . . 64.219999999999999 111.731 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -52.27 -40.38 61.68 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.379 1.251 . . . . 73.450000000000003 114.379 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.37 -27.87 66.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.211 0.529 . . . . 62.350000000000001 111.313 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.24 -1.66 47.67 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 112.156 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.578 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -64.72 -41.21 96.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.881 0.372 . . . . 72.420000000000002 110.507 176.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.14 -23.42 68.73 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.679 -0.691 . . . . 64.209999999999994 112.35 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -149.77 87.91 5.01 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 120.782 0.325 . . . . 71.239999999999995 110.351 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -96.42 162.56 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.008 2.472 . . . . 73.310000000000002 111.713 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.2 135.49 27.18 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.409 2.073 . . . . 72.349999999999994 111.402 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 71' ' ' ASP . . . -71.98 150.29 92.59 Favored Pre-proline 0 C--O 1.256 1.42 0 CA-C-O 120.594 0.235 . . . . 64.219999999999999 111.441 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.85 117.07 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.829 2.352 . . . . 74.209999999999994 112.185 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -97.79 21.62 10.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.529 -0.915 . . . . 52.109999999999999 108.529 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.456 ' HB3' HG13 ' A' ' 120' ' ' VAL . 17.4 t70 -140.26 156.22 46.56 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.402 -1.333 . . . . 73.340000000000003 107.402 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -25.33 22.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.967 -0.693 . . . . 64.040000000000006 111.89 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -78.61 -34.06 46.97 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.355 -0.384 . . . . 74.129999999999995 110.932 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 117' ' ' ASP . 7.4 p -98.77 125.23 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.364 -0.606 . . . . 61.520000000000003 109.364 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -128.21 138.43 52.46 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.341 -0.845 . . . . 64.519999999999996 109.539 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 22.9 mm -93.64 110.81 23.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.173 -1.417 . . . . 73.230000000000004 107.173 173.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.27 145.19 51.12 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.32 -0.993 . . . . 64.530000000000001 108.32 -174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.13 144.22 40.62 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.982 0.42 . . . . 73.439999999999998 110.706 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.522 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -123.97 122.68 38.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.058 -1.83 . . . . 73.409999999999997 106.058 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.73 157.01 47.37 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.855 1.057 . . . . 75.409999999999997 113.855 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.66 17.2 79.22 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.159 -0.928 . . . . 55.140000000000001 113.449 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.31 165.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 C-N-CA 120.553 -0.459 . . . . 74.219999999999999 110.54 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.536 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 28.6 m -120.13 133.09 55.6 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 109.136 -0.69 . . . . 74.230000000000004 109.136 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.99 151.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.387 -0.968 . . . . 63.420000000000002 108.387 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 41.4 m-85 -113.64 121.46 44.23 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.413 -1.699 . . . . 74.340000000000003 106.413 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 t -111.46 125.15 53.58 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.878 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 151' ' ' LEU . 12.7 t -113.58 127.36 56.04 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 107.796 -1.187 . . . . 73.140000000000001 107.796 174.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -110.41 132.93 53.75 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 121.645 0.736 . . . . 74.299999999999997 110.938 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 182' ' ' ARG . 48.7 p90 -129.8 146.38 51.54 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 74.120000000000005 108.973 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -124.54 111.03 1.49 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 111.061 -0.816 . . . . 50.219999999999999 111.061 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 175.05 -126.53 1.18 Allowed Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.712 -0.756 . . . . 50.43 111.719 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -100.14 135.67 41.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.062 -0.718 . . . . 75.439999999999998 109.062 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.88 107.51 10.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 113.277 0.843 . . . . 72.209999999999994 113.277 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.662 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 58.0 pttt -104.18 170.63 7.79 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 71.409999999999997 106.324 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -39.52 73.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.497 0.665 . . . . 74.510000000000005 110.365 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.435 ' HB1' ' HE3' ' A' ' 140' ' ' LYS . . . -64.86 -28.65 69.7 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.138 -0.937 . . . . 74.109999999999999 111.869 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.662 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 13.8 m-20 -62.91 -35.52 80.33 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 120.212 -0.595 . . . . 74.310000000000002 110.787 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.421 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 98.9 m-85 -68.69 -39.3 80.62 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.588 -0.445 . . . . 73.230000000000004 110.553 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.07 -47.13 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.613 -0.514 . . . . 70.430000000000007 109.613 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -60.81 -46.63 89.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.888 -0.596 . . . . 73.540000000000006 110.657 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -65.83 -32.64 74.28 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 112.116 0.413 . . . . 74.200000000000003 112.116 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -64.57 -46.34 83.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 74.120000000000005 109.523 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.5 m -61.45 -44.17 97.58 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.088 -0.505 . . . . 72.540000000000006 110.128 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 15.2 mm100 -64.45 -35.39 80.75 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.224 -0.444 . . . . 64.430000000000007 110.701 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.446 HD13 ' HB ' ' A' ' 133' ' ' THR . 49.1 tp -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.153 -0.342 . . . . 55.350000000000001 110.445 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.452 ' HD2' ' OD1' ' A' ' 165' ' ' ASP . 70.2 mtp180 -63.27 -40.79 98.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.567 -0.288 . . . . 71.439999999999998 111.447 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.2 t -75.4 -29.78 59.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.807 0.813 . . . . 75.329999999999998 110.095 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.485 HG21 ' H ' ' A' ' 26' ' ' LYS . 59.6 m -71.62 -34.67 70.03 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.751 -0.659 . . . . 63.229999999999997 110.36 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.87 4.31 37.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 74.120000000000005 111.506 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.6 138.71 31.47 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.072 -1.455 . . . . 73.310000000000002 107.072 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.73 -10.16 62.43 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 111.169 -0.772 . . . . 64.299999999999997 111.169 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.8 t -119.72 145.5 39.46 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 106.607 -1.627 . . . . 75.340000000000003 106.607 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.58 29.13 0.17 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 123.607 2.871 . . . . 74.5 114.62 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.75 128.5 34.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.833 0.349 . . . . 73.019999999999996 110.312 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 8.9 t -107.44 152.39 24.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.915 -0.584 . . . . 64.099999999999994 109.571 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -141.84 159.76 41.58 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 122.745 0.418 . . . . 72.129999999999995 110.533 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.478 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.4 pt20 -129.4 137.09 50.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.713 -0.477 . . . . 71.030000000000001 109.713 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.8 -0.64 9.75 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.143 -0.551 . . . . 51.310000000000002 114.405 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 152' ' ' ARG . 37.5 t70 65.54 19.27 11.49 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.07 0.948 . . . . 72.439999999999998 109.197 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 163' ' ' GLN . 8.4 p -71.49 138.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 CA-C-N 116.023 -0.535 . . . . 75.209999999999994 110.551 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -150.28 173.4 14.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.589 -0.732 . . . . 75.049999999999997 111.381 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 46.3 m-85 -115.52 152.02 33.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.355 -0.839 . . . . 74.439999999999998 110.314 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.421 ' SG ' ' CE1' ' A' ' 144' ' ' TYR . 15.0 t -114.47 120.11 39.16 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.197 -1.408 . . . . 65.010000000000005 107.197 175.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.41 159.21 36.09 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 110.559 -0.163 . . . . 62.340000000000003 110.559 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.046 0 N-CA-C 109.792 -1.323 . . . . 45.140000000000001 109.792 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.416 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 99.3 mtt180 . . . . . 0 CA--C 1.511 -0.519 0 N-CA-C 114.586 1.328 . . . . 71.549999999999997 114.586 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 135' ' ' PHE . 36.7 ttm180 -100.48 129.55 46.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 118.147 -1.421 . . . . 64.549999999999997 110.337 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -140.36 153.46 46.4 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.031 -1.441 . . . . 74.040000000000006 108.095 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 40.3 mt-10 -116.51 151.75 35.49 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.961 -0.755 . . . . 63.0 108.961 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.02 118.2 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.102 -1.814 . . . . 71.409999999999997 106.102 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 20.6 m0 -102.96 121.25 42.16 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.998 -0.742 . . . . 75.340000000000003 108.998 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 166' ' ' VAL . 36.5 tp -98.13 134.3 41.39 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.996 -1.112 . . . . 75.450000000000003 107.996 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.43 125.16 44.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 O-C-N 123.171 0.295 . . . . 71.120000000000005 110.745 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -64.02 142.49 58.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 123.639 0.587 . . . . 70.209999999999994 110.991 176.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.34 0 CA-C-O 119.065 -0.493 . . . . 74.519999999999996 110.921 179.141 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 25.6 p90 . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 108.787 -0.82 . . . . 73.049999999999997 108.787 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.8 111.28 23.95 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.674 -0.41 . . . . 74.439999999999998 110.407 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.5 t -84.05 120.41 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.469 -0.937 . . . . 61.119999999999997 108.469 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.3 -35.8 15.05 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.504 -0.479 . . . . 75.25 110.935 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -164.25 149.88 10.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.346 0.593 . . . . 73.409999999999997 111.233 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.524 HG23 ' CB ' ' A' ' 32' ' ' GLU . 47.7 p -132.51 155.18 49.06 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.031 -1.47 . . . . 75.420000000000002 107.031 173.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.19 103.16 2.44 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 119.198 -1.477 . . . . 74.019999999999996 112.345 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.81 -135.11 3.92 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.546 -0.835 . . . . 71.400000000000006 111.424 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -96.45 139.26 32.82 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 105.916 -1.883 . . . . 71.230000000000004 105.916 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.7 173.18 2.95 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 114.127 1.158 . . . . 74.319999999999993 114.127 -171.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 83.15 -51.88 0.16 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.666 1.587 . . . . 73.430000000000007 111.023 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.03 110.8 28.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.771 -1.196 . . . . 74.519999999999996 107.771 175.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 p -94.98 154.52 17.14 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.917 -0.583 . . . . 74.430000000000007 111.257 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.15 158.95 42.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.383 0.611 . . . . 71.409999999999997 111.626 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' CB ' HG23 ' A' ' 23' ' ' THR . 12.9 pt-20 -134.89 132.2 38.23 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.482 -1.303 . . . . 75.25 107.482 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -96.77 114.32 25.94 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.292 -1.744 . . . . 74.230000000000004 106.292 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.28 1.2 ppt_? -142.14 145.2 33.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.287 1.217 . . . . 70.349999999999994 114.287 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -80.52 137.75 36.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.526 -1.287 . . . . 72.299999999999997 107.526 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.3 t -57.27 147.75 24.58 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.782 0.676 . . . . 73.400000000000006 111.186 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -63.89 -28.13 69.63 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 124.115 0.966 . . . . 61.530000000000001 112.59 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 77.31 9.75 86.64 Favored Glycine 0 C--N 1.317 -0.512 0 C-N-CA 120.432 -0.889 . . . . 61.229999999999997 113.556 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.68 160.57 54.09 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.682 -0.771 . . . . 74.510000000000005 112.212 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HB3' ' NZ ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -88.79 122.11 31.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.597 -0.52 . . . . 63.310000000000002 109.597 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.562 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 26.5 m-85 -126.9 166.17 17.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.467 -0.788 . . . . 72.030000000000001 111.699 -171.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.62 115.82 28.63 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.846 -0.798 . . . . 71.239999999999995 108.846 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -125.81 143.54 51.02 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-N 115.314 -0.857 . . . . 70.310000000000002 112.112 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.452 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 12.8 p -132.83 144.56 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 108.352 -0.981 . . . . 75.129999999999995 108.352 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.78 127.69 50.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.675 0.75 . . . . 74.430000000000007 111.032 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t -120.64 133.15 68.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.102 -1.444 . . . . 52.5 107.102 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.418 HG21 ' HG3' ' A' ' 97' ' ' LYS . 35.7 p -130.76 176.6 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.51 0.559 . . . . 73.549999999999997 112.51 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 69.34 4.07 4.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.903 1.281 . . . . 53.439999999999998 112.316 174.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -141.0 141.16 22.97 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 108.058 -1.09 . . . . 75.030000000000001 108.058 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.27 156.86 7.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.341 2.694 . . . . 73.129999999999995 112.364 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.45 HG13 HD11 ' A' ' 98' ' ' LEU . 71.4 t -47.67 -41.36 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.575 0.954 . . . . 45.140000000000001 113.575 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 9.9 m-20 -58.75 -50.09 75.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.413 0.625 . . . . 60.240000000000002 109.911 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.33 -40.7 81.51 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.996 -1.002 . . . . 73.109999999999999 110.871 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -61.13 -46.57 90.04 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.542 -0.753 . . . . 73.120000000000005 110.104 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.68 -31.7 70.95 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.899 -0.591 . . . . 70.25 110.906 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 36.7 mtm180 -61.25 -30.24 70.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.554 0.576 . . . . 73.319999999999993 112.554 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 37.1 mt-10 -85.61 -46.3 10.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.416 -0.513 . . . . 71.340000000000003 111.512 173.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -67.75 -36.27 80.22 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.971 1.1 . . . . 73.299999999999997 113.971 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.474 ' HB3' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.81 -52.72 72.33 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 119.483 -0.294 . . . . 54.310000000000002 110.463 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 71.9 Cg_exo -51.75 -37.15 64.46 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.702 2.268 . . . . 73.430000000000007 112.319 173.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 88.9 mttt -67.41 -42.49 83.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.28 0.474 . . . . 75.409999999999997 112.28 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.95 -41.04 77.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.612 -0.435 . . . . 44.020000000000003 111.834 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.9 ptm -69.91 -29.63 66.85 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.795 0.665 . . . . 61.200000000000003 112.795 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -70.37 -40.83 73.79 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.928 -0.767 . . . . 74.530000000000001 108.928 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.22 -56.87 16.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.839 -0.619 . . . . 73.540000000000006 111.529 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.413 HG12 ' CE2' ' A' ' 102' ' ' PHE . 11.8 m -78.35 -20.97 13.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 120.983 0.42 . . . . 74.299999999999997 111.284 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.05 70.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.674 -0.693 . . . . 74.549999999999997 112.89 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.69 -17.41 0.49 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.768 -1.205 . . . . 64.5 113.53 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -81.83 32.52 0.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 122.304 1.05 . . . . 74.120000000000005 110.752 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.68 168.94 9.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.782 -0.645 . . . . 62.109999999999999 109.836 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 114' ' ' ALA . 11.0 t70 -66.06 -33.99 77.05 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.04 0.756 . . . . 71.140000000000001 113.04 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -82.22 -11.22 58.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 73.430000000000007 109.728 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.91 34.87 77.97 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.329 -0.85 . . . . 51.25 112.128 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.44 121.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.969 -0.692 . . . . 65.400000000000006 110.263 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.11 116.0 5.47 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.561 -0.828 . . . . 74.349999999999994 112.285 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.6 mmt 61.8 28.39 17.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.049999999999997 109.565 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.98 -34.54 90.19 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.589 -1.187 . . . . 73.540000000000006 113.471 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -124.72 126.1 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 112.843 0.683 . . . . 72.239999999999995 112.843 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.0 m -125.21 117.09 23.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.993 -0.743 . . . . 73.140000000000001 108.993 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -170.22 143.32 1.95 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.296 -1.372 . . . . 75.450000000000003 107.296 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -41.4 139.84 1.73 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.994 3.129 . . . . 63.009999999999998 116.729 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.74 154.23 7.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.68 -1.6 . . . . 71.319999999999993 107.145 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 48.5 m -139.7 145.18 38.05 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.436 -0.579 . . . . 75.140000000000001 109.436 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 37.0 p90 -135.09 147.16 49.47 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.944 -0.472 . . . . 75.450000000000003 111.151 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.26 134.71 34.63 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.684 0.615 . . . . 74.010000000000005 109.533 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.7 152.9 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.825 -0.806 . . . . 71.0 108.825 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.559 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 40.6 m-85 -122.5 104.04 37.5 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.878 -0.786 . . . . 74.109999999999999 108.878 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.5 133.69 10.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.823 1.682 . . . . 55.109999999999999 113.002 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.46 166.05 15.81 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.329 -0.989 . . . . 61.439999999999998 108.329 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.76 -15.39 61.53 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 73.109999999999999 111.149 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -91.18 1.13 57.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 63.439999999999998 111.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.85 0.62 90.32 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.948 -0.644 . . . . 75.310000000000002 112.503 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 t -92.07 141.16 28.91 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.509 -1.293 . . . . 64.319999999999993 107.509 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.29 156.71 27.94 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 120.96 0.409 . . . . 75.239999999999995 110.639 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -79.22 158.25 27.66 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.272 -0.64 . . . . 61.219999999999999 109.272 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -75.82 40.03 0.18 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.85 0.86 . . . . 63.299999999999997 112.212 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.559 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 38.4 ttmt -141.68 125.83 17.4 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.325 -0.991 . . . . 60.420000000000002 108.325 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD11 HG13 ' A' ' 51' ' ' VAL . 60.3 tp -135.47 129.14 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 110.208 -0.293 . . . . 74.140000000000001 110.208 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.37 115.51 21.09 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.219 -0.66 . . . . 44.219999999999999 109.219 174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 43' ' ' THR . 59.0 t -96.61 134.9 32.55 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-N 115.229 -0.896 . . . . 74.140000000000001 109.871 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -120.84 120.02 34.35 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.941 0.896 . . . . 72.349999999999994 109.751 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 73.5 t80 -104.08 123.85 47.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.902 -0.407 . . . . 74.409999999999997 109.902 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.562 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 42.3 ttm-85 -75.35 134.2 41.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.343 -0.844 . . . . 70.549999999999997 110.187 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 108' ' ' PHE . 65.7 mt -104.79 133.09 20.34 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 116.532 -0.304 . . . . 72.239999999999995 111.21 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -60.81 161.2 22.41 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.549 2.833 . . . . 74.439999999999998 112.6 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -57.98 -37.11 73.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.147 1.166 . . . . 72.409999999999997 114.147 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.83 -30.45 71.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.327 0.584 . . . . 75.219999999999999 111.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.416 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 96.4 m-85 -99.65 -4.95 29.79 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.948 -0.569 . . . . 74.0 110.972 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.6 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.4 -37.87 71.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 119.586 -0.846 . . . . 74.530000000000001 109.735 174.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.1 94.26 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.183 -0.917 . . . . 75.019999999999996 111.918 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -154.11 93.33 2.95 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.182 -0.673 . . . . 63.340000000000003 109.182 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.3 146.41 24.93 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.307 2.004 . . . . 74.209999999999994 112.565 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.62 130.17 34.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.401 2.067 . . . . 74.209999999999994 109.801 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 71' ' ' ASP . . . -68.86 148.98 98.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.81 -0.632 . . . . 64.010000000000005 111.48 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 39.6 Cg_exo -60.59 113.14 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.709 2.273 . . . . 73.329999999999998 111.938 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -97.07 5.74 49.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.368 -0.975 . . . . 71.230000000000004 108.368 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.26 148.76 49.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.132 -1.803 . . . . 72.25 106.132 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -81.1 -25.06 37.28 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.717 0.636 . . . . 75.420000000000002 112.717 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.2 p -91.7 -16.42 26.98 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.78 0.659 . . . . 38.159999999999997 112.78 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 50.2 t -94.71 116.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.875 -1.157 . . . . 74.340000000000003 107.875 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -119.7 144.08 47.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 110.274 -0.269 . . . . 72.120000000000005 110.274 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.5 mm -92.85 111.98 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.964 -1.124 . . . . 74.109999999999999 107.964 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -125.57 143.35 51.05 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.909 -1.041 . . . . 73.230000000000004 109.346 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.05 143.11 40.56 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.038 -0.727 . . . . 62.020000000000003 109.038 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.506 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -135.99 127.31 28.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.235 -0.654 . . . . 73.409999999999997 109.235 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.19 171.02 14.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.668 -0.493 . . . . 75.019999999999996 109.668 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.23 7.05 62.52 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 121.009 -0.615 . . . . 42.130000000000003 112.176 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.96 145.27 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 120.095 -0.642 . . . . 73.25 110.878 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.545 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 59.5 m -109.22 135.69 49.92 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.145 -1.428 . . . . 75.109999999999999 107.145 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.42 157.31 32.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 108.849 -0.797 . . . . 71.310000000000002 108.849 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 40.2 m-85 -113.3 121.77 45.42 Favored 'General case' 0 N--CA 1.411 -2.381 0 N-CA-C 105.166 -2.161 . . . . 75.299999999999997 105.166 178.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 t -109.96 125.89 53.34 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.623 -0.51 . . . . 70.299999999999997 109.623 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.7 t -113.47 126.64 55.55 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.185 -1.043 . . . . 74.030000000000001 108.185 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -115.61 124.94 52.21 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.028 -1.101 . . . . 72.349999999999994 108.028 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.17 137.02 48.8 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 116.392 -0.367 . . . . 75.120000000000005 110.439 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.49 161.81 24.23 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 115.784 -0.643 . . . . 61.399999999999999 111.788 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.59 161.31 12.91 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.655 -1.378 . . . . 65.310000000000002 109.655 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -79.51 108.4 13.02 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.37 0.605 . . . . 73.329999999999998 109.886 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 143' ' ' ASP . . . -112.73 145.87 39.76 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.16 -0.927 . . . . 71.219999999999999 111.844 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.476 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 18.6 ptpt -95.43 176.94 5.99 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.739 -0.838 . . . . 74.099999999999994 108.739 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.32 -37.96 82.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.49 -0.559 . . . . 71.219999999999999 109.49 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.63 70.7 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.437 -0.801 . . . . 72.219999999999999 111.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 23.4 m-20 -64.4 -31.21 72.32 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 62.32 111.283 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -64.61 -46.68 81.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.68 0.276 . . . . 73.310000000000002 110.902 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.59 -46.08 95.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.457 0.646 . . . . 75.310000000000002 109.978 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.84 99.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 43.329999999999998 111.482 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -71.12 -32.52 69.11 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 112.281 0.475 . . . . 73.129999999999995 112.281 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.3 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.216 -0.661 . . . . 73.430000000000007 109.216 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.4 m -65.07 -40.97 95.44 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.355 -0.839 . . . . 71.420000000000002 110.835 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -73.73 -30.3 62.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.937 0.399 . . . . 75.420000000000002 110.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.11 -31.7 72.91 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 109.618 -0.512 . . . . 71.040000000000006 109.618 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HD2' ' OD2' ' A' ' 165' ' ' ASP . 79.9 mtp180 -63.81 -39.09 93.4 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.024 -0.534 . . . . 50.140000000000001 109.931 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 56.6 m -71.6 -30.98 66.43 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.654 0.74 . . . . 71.409999999999997 109.703 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 38.4 m -72.1 -34.87 68.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.581 -0.736 . . . . 74.450000000000003 109.091 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.08 6.66 41.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.364 -0.835 . . . . 74.340000000000003 111.137 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.13 128.14 33.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.334 -1.728 . . . . 74.140000000000001 106.334 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.32 13.47 41.83 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.268 -0.967 . . . . 64.439999999999998 111.811 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 70.9 p -117.2 163.12 24.58 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.893 -0.78 . . . . 44.0 108.893 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -86.33 12.83 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.643 2.229 . . . . 74.129999999999995 111.802 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.96 148.31 47.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.921 -0.582 . . . . 62.439999999999998 111.25 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 43.4 p -122.04 141.44 51.37 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.76 -0.83 . . . . 75.430000000000007 108.76 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -135.52 144.94 46.58 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.113 -0.367 . . . . 75.409999999999997 111.278 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.7 pt20 -106.32 110.97 23.36 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.184 0.809 . . . . 74.299999999999997 113.184 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.73 8.48 57.08 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.77 -0.729 . . . . 52.420000000000002 113.339 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.442 ' OD2' ' HD2' ' A' ' 152' ' ' ARG . 3.8 m-20 62.5 24.17 14.38 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.695 0.798 . . . . 74.25 111.263 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.57 140.24 18.09 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 119.52 -0.872 . . . . 75.129999999999995 109.283 -174.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 32.8 p90 -140.65 168.68 19.22 Favored 'General case' 0 N--CA 1.415 -2.209 0 C-N-CA 120.196 -0.602 . . . . 70.319999999999993 112.009 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 35.7 m-85 -115.32 147.26 40.66 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.423 -0.808 . . . . 73.239999999999995 109.87 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 83' ' ' SER . 41.4 t -114.44 137.38 51.91 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.75 32.79 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.921 0.391 . . . . 73.519999999999996 111.067 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.926 0 N-CA-C 108.924 -1.67 . . . . 63.049999999999997 108.924 178.341 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.497 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 122.051 0.929 . . . . 75.040000000000006 109.815 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -134.57 130.57 36.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.957 -2.238 . . . . 72.25 104.957 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -133.22 137.09 45.99 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 108.757 -0.831 . . . . 73.230000000000004 108.757 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 133' ' ' THR . 45.7 mt-10 -132.31 136.03 46.61 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.899 0.381 . . . . 45.219999999999999 111.5 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.436 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 74.4 t -124.98 124.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.806 -1.183 . . . . 71.120000000000005 107.806 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.512 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 35.1 m0 -109.42 121.3 44.89 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 120.872 -0.331 . . . . 74.519999999999996 110.244 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 67.3 mt -96.24 126.31 41.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.138 -1.06 . . . . 75.540000000000006 108.138 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.08 127.25 42.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.592 -0.521 . . . . 64.349999999999994 109.592 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -64.77 143.01 58.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.65 0.611 . . . . 75.510000000000005 112.65 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.7 0 CA-C-N 115.261 -0.881 . . . . 74.349999999999994 108.761 176.568 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.4 p90 . . . . . 0 N--CA 1.428 -1.54 0 N-CA-C 107.488 -1.301 . . . . 73.400000000000006 107.488 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 109.5 21.5 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.355 0.598 . . . . 74.099999999999994 109.497 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.7 t -93.71 119.63 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.077 -0.965 . . . . 75.129999999999995 109.122 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.456 ' H ' HD21 ' A' ' 21' ' ' LEU 0.257 0.4 OUTLIER -90.63 -38.17 13.3 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 113.05 0.759 . . . . 73.329999999999998 113.05 -178.887 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -158.98 149.44 19.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.247 -0.581 . . . . 72.340000000000003 111.258 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.3 p -134.0 161.38 34.98 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.28 1.032 . . . . 75.329999999999998 110.265 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.8 113.28 1.46 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.844 -0.693 . . . . 73.5 114.515 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.68 -95.19 0.32 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.84 -0.504 . . . . 61.240000000000002 111.84 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -97.99 164.4 12.37 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.277 -1.379 . . . . 75.099999999999994 107.277 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.62 153.71 27.83 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 118.752 -1.179 . . . . 74.120000000000005 111.483 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 72.21 -49.79 0.69 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.976 1.31 . . . . 70.430000000000007 111.556 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 110.61 32.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.996 0.903 . . . . 74.0 109.108 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 p -113.1 154.25 26.91 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.373 -0.83 . . . . 73.209999999999994 110.32 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' CD2' HG22 ' A' ' 154' ' ' THR . 0.2 OUTLIER -113.43 158.45 20.64 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 120.058 -0.657 . . . . 75.329999999999998 111.446 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 34.0 tt0 -143.37 124.99 14.88 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 106.187 -1.783 . . . . 70.430000000000007 106.187 175.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . 43.3 mt-10 -97.79 115.06 27.29 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.496 -1.668 . . . . 74.420000000000002 106.496 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -135.83 147.22 48.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.908 -0.717 . . . . 65.430000000000007 112.415 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.66 127.24 34.93 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.16 -2.163 . . . . 63.43 105.16 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.7 t -58.87 143.22 48.31 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.751 0.657 . . . . 63.350000000000001 111.339 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -37.32 -52.67 1.09 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.801 1.64 . . . . 71.319999999999993 112.982 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.19 9.03 54.53 Favored Glycine 0 C--N 1.286 -2.213 0 C-N-CA 119.77 -1.205 . . . . 73.230000000000004 110.94 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.8 163.09 54.42 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.396 -1.082 . . . . 61.009999999999998 110.396 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 104' ' ' ILE . 18.3 ptmt -100.91 128.82 46.78 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.358 -0.608 . . . . 73.430000000000007 109.358 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 53.2 m-85 -129.81 164.53 23.88 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.692 -0.686 . . . . 72.299999999999997 110.906 -171.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 116.36 30.84 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.223 -1.028 . . . . 72.409999999999997 108.223 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.0 t -128.81 146.63 50.87 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.35 0.595 . . . . 73.420000000000002 111.801 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' A' ' 58' ' ' ALA . 9.0 p -128.41 139.11 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.385 -0.969 . . . . 63.049999999999997 108.385 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -121.52 138.83 54.13 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.192 -1.003 . . . . 75.430000000000007 111.371 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.83 133.9 67.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.389 -1.708 . . . . 75.109999999999999 106.389 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.6 p -125.7 169.61 12.37 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.619 -0.433 . . . . 71.540000000000006 110.042 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 71.47 -2.11 2.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.032 0.933 . . . . 62.229999999999997 112.737 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.99 147.66 52.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 109.306 -0.627 . . . . 73.239999999999995 109.306 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.13 156.35 63.35 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 122.167 1.911 . . . . 71.140000000000001 111.015 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.483 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 54.7 t -49.82 -37.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.931 0.893 . . . . 71.230000000000004 113.23 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.25 -49.89 63.15 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.264 0.353 . . . . 65.549999999999997 110.991 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 41.6 mt-10 -76.04 -50.54 14.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.037 -0.529 . . . . 74.140000000000001 111.266 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.1 68.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.935 0.717 . . . . 73.329999999999998 112.935 -174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 tt -62.66 -50.2 72.13 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.842 -0.799 . . . . 64.209999999999994 108.842 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.321 6.6 ppt_? -72.43 -23.86 61.14 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 114.018 1.118 . . . . 65.040000000000006 114.018 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 12.4 mm-40 -66.58 -44.06 83.23 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 71.319999999999993 111.186 172.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . . . -75.75 -40.38 55.51 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.857 1.058 . . . . 72.409999999999997 113.857 -174.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . 0.253 24.7 mmt -47.07 -52.88 31.16 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 115.929 1.825 . . . . 62.439999999999998 115.929 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.44 -31.65 78.78 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.296 1.997 . . . . 71.310000000000002 112.176 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HD2' HG21 ' A' ' 44' ' ' VAL . 82.5 mttt -74.31 -34.99 63.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.772 -0.649 . . . . 75.439999999999998 109.892 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.7 mm -72.85 -39.71 59.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.287 0.565 . . . . 71.120000000000005 109.625 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.34 -37.89 89.03 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.633 -0.712 . . . . 75.230000000000004 112.853 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -67.57 -31.66 71.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.08 -0.648 . . . . 74.239999999999995 110.728 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.75 -58.2 7.61 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.385 -0.37 . . . . 74.409999999999997 111.335 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.58 -23.08 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 121.224 0.535 . . . . 75.329999999999998 111.285 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.56 72.91 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.903 -0.589 . . . . 74.340000000000003 113.196 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.44 -5.08 5.56 Favored Glycine 0 CA--C 1.505 -0.565 0 C-N-CA 119.821 -1.181 . . . . 62.530000000000001 113.263 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 116' ' ' SER . 15.2 m -86.33 32.92 0.62 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 122.631 1.205 . . . . 42.409999999999997 110.053 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -97.82 177.17 5.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.229 -0.896 . . . . 73.519999999999996 109.437 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 114' ' ' ALA . 12.6 t70 -63.97 -33.03 74.8 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.258 0.623 . . . . 63.130000000000003 111.823 -175.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 72' ' ' LYS . 6.9 mmpt? -86.8 -11.26 51.48 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.631 -0.428 . . . . 70.239999999999995 110.777 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.22 22.5 74.51 Favored Glycine 0 CA--C 1.498 -0.99 0 CA-C-N 115.6 -0.727 . . . . 44.240000000000002 112.066 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.99 122.09 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-O 121.153 0.501 . . . . 72.510000000000005 110.907 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.16 54.36 0.82 Allowed Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.957 -0.857 . . . . 73.340000000000003 110.957 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 51.6 ttm -83.8 110.09 18.06 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.089 0.471 . . . . 62.299999999999997 110.015 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.34 82.34 0.67 Allowed Glycine 0 C--N 1.303 -1.3 0 CA-C-N 115.121 -0.945 . . . . 74.219999999999999 111.512 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -96.79 134.92 39.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.216 -0.661 . . . . 74.140000000000001 109.216 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -124.12 129.86 51.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.258 0.551 . . . . 71.219999999999999 112.052 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.428 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 10.5 p -158.63 148.82 15.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 104.107 -2.553 . . . . 74.439999999999998 104.107 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 80' ' ' VAL . 47.0 Cg_exo -34.98 138.81 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.7 2.934 . . . . 71.140000000000001 115.036 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.54 151.29 6.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.52 -1.289 . . . . 61.240000000000002 107.52 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 34.5 m -141.96 145.08 34.09 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 120.706 -0.398 . . . . 62.439999999999998 110.409 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -140.44 141.47 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.787 -0.571 . . . . 75.040000000000006 110.811 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.05 134.95 35.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.855 -0.611 . . . . 72.239999999999995 110.063 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.6 m -126.93 150.67 33.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.327 -0.852 . . . . 73.319999999999993 109.668 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.611 ' CE2' ' HB ' ' A' ' 166' ' ' VAL . 91.5 m-85 -116.01 107.15 48.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 116.375 -0.375 . . . . 71.129999999999995 110.598 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.25 132.04 7.99 Favored 'Trans proline' 0 N--CA 1.428 -2.38 0 N-CA-C 108.139 -1.524 . . . . 65.040000000000006 108.139 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -93.49 167.71 11.52 Favored 'General case' 0 C--N 1.272 -2.773 0 C-N-CA 119.861 -0.736 . . . . 75.340000000000003 110.961 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.77 -17.55 56.43 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.883 0.739 . . . . 63.329999999999998 110.78 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.54 -6.8 57.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.249 1.02 . . . . 74.340000000000003 110.072 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.89 -10.14 71.57 Favored Glycine 0 C--O 1.229 -0.158 0 CA-C-N 116.048 -0.524 . . . . 73.5 112.389 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.4 m -96.06 134.35 39.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.769 0.318 . . . . 74.439999999999998 111.455 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 8.2 mp -78.77 100.09 6.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.453 0.644 . . . . 63.420000000000002 110.187 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -148.09 169.86 19.04 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.874 -1.057 . . . . 71.019999999999996 108.981 -176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.264 64.8 mttp 94.93 -73.87 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.097 1.759 . . . . 63.439999999999998 112.456 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 2.4 mppt? -131.04 146.57 52.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 119.005 -1.078 . . . . 73.400000000000006 112.215 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tt -143.28 129.44 19.75 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.512 -1.222 . . . . 72.510000000000005 108.049 173.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -119.89 115.47 23.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.456 -0.572 . . . . 74.319999999999993 109.456 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 43' ' ' THR . 91.1 t -92.43 125.8 45.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.796 -0.816 . . . . 75.140000000000001 108.796 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -109.18 123.82 49.84 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.618 0.574 . . . . 70.420000000000002 109.641 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -102.76 113.49 26.95 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.458 -1.682 . . . . 74.219999999999999 106.458 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.505 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 24.4 ttt85 -76.67 132.58 39.45 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.191 -0.913 . . . . 74.340000000000003 110.606 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.55 HD12 ' O ' ' A' ' 40' ' ' LYS . 74.4 mt -96.67 131.95 27.15 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.092 -1.448 . . . . 54.420000000000002 107.092 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.72 146.5 54.61 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.533 2.156 . . . . 74.129999999999995 111.816 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -47.57 -39.74 17.37 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.693 1.597 . . . . 74.510000000000005 111.867 -175.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -61.2 -32.9 72.67 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.001 0.52 . . . . 71.310000000000002 112.4 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.79 -2.65 34.55 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 112.205 0.446 . . . . 75.319999999999993 112.205 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.73 -28.24 67.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.574 0.953 . . . . 75.319999999999993 113.574 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.47 59.65 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.899 -1.143 . . . . 71.209999999999994 111.578 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -142.98 87.08 8.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-O 120.95 0.405 . . . . 73.299999999999997 110.295 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -97.47 162.42 0.93 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.302 2.668 . . . . 74.230000000000004 112.128 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.39 137.36 46.77 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 122.354 2.036 . . . . 70.340000000000003 111.626 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HB2' ' CB ' ' A' ' 71' ' ' ASP . . . -74.26 152.33 88.07 Favored Pre-proline 0 C--O 1.248 0.995 0 CA-C-N 116.439 -0.346 . . . . 75.140000000000001 110.787 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -81.4 121.72 3.91 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 122.103 1.869 . . . . 52.240000000000002 111.932 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 69' ' ' THR . 23.5 t -92.41 22.83 4.29 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.91 0.862 . . . . 72.099999999999994 109.66 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -137.17 151.27 48.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.779 -1.193 . . . . 74.310000000000002 107.779 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -88.26 -17.12 31.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.162 1.171 . . . . 63.130000000000003 114.162 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.6 m -80.92 -39.7 25.77 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.397 -0.594 . . . . 74.040000000000006 109.397 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.47 123.96 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.588 -0.733 . . . . 73.140000000000001 109.809 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.77 148.91 47.85 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.917 -0.583 . . . . 72.109999999999999 110.418 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.1 mm -92.39 111.48 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.802 -1.555 . . . . 70.129999999999995 106.802 174.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -115.79 145.8 42.5 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.68 -0.691 . . . . 74.430000000000007 111.05 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 9.6 pt-20 -121.13 124.74 45.49 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.121 -1.066 . . . . 61.130000000000003 108.121 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.45 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.8 mmt180 -136.15 122.64 20.78 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.075 -0.65 . . . . 74.5 111.483 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -143.05 164.73 29.31 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.563 -0.902 . . . . 73.049999999999997 108.563 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.02 14.63 54.45 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.65 -0.98 . . . . 61.439999999999998 110.65 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.1 pt -120.65 145.17 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 109.267 -0.642 . . . . 74.530000000000001 109.267 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.2 m -108.12 128.79 55.0 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.313 -0.995 . . . . 64.409999999999997 108.313 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.19 155.28 31.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.475 -0.935 . . . . 71.219999999999999 108.475 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 64.1 m-85 -113.89 122.13 46.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.987 -1.486 . . . . 75.5 106.987 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 m -102.49 127.94 49.32 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.734 -0.469 . . . . 64.030000000000001 109.734 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.7 t -120.03 121.9 39.92 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 108.582 -0.895 . . . . 61.109999999999999 108.582 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -109.67 126.78 54.03 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.194 -1.41 . . . . 75.329999999999998 107.194 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.9 p90 -129.61 152.63 48.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.672 -0.411 . . . . 74.150000000000006 112.019 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.79 106.98 2.6 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.23 -1.148 . . . . 72.109999999999999 110.23 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.68 173.75 36.75 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 111.131 -0.788 . . . . 64.230000000000004 111.131 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.2 128.48 33.81 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.146 -0.687 . . . . 64.340000000000003 109.146 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.64 125.75 54.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.385 0.883 . . . . 73.510000000000005 113.385 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -115.78 173.13 6.71 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.86 -1.533 . . . . 62.409999999999997 106.86 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.02 -43.92 70.5 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.478 0.581 . . . . 71.019999999999996 110.679 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.39 69.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.721 . . . . 72.510000000000005 111.42 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.0 -37.15 83.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.391 -0.596 . . . . 71.230000000000004 109.391 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -64.94 -38.92 92.56 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.706 -0.679 . . . . 63.240000000000002 111.023 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.66 -47.36 93.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.771 -0.825 . . . . 73.200000000000003 108.771 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.61 86.16 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.244 -0.889 . . . . 74.140000000000001 111.094 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -68.2 -35.07 77.43 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 113.141 0.793 . . . . 75.030000000000001 113.141 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.85 88.94 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.434 0.459 . . . . 42.039999999999999 110.835 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.2 t -73.14 -33.77 65.71 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 120.309 -0.556 . . . . 71.209999999999994 110.495 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.26 -32.17 73.66 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 120.807 0.337 . . . . 61.109999999999999 110.937 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 31' ' ' TYR . 33.7 tp -74.55 -31.53 62.13 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.119 -0.632 . . . . 71.109999999999999 109.778 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.63 -37.25 79.57 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 112.616 0.599 . . . . 74.439999999999998 112.616 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.2 t -70.23 -30.04 67.02 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 73.019999999999996 109.649 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 31' ' ' TYR . 63.8 m -71.95 -38.44 69.8 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 115.268 -0.878 . . . . 74.129999999999995 109.433 176.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.1 -2.17 51.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.874 -0.603 . . . . 44.009999999999998 111.358 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.44 130.4 41.22 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.339 -1.356 . . . . 71.409999999999997 107.339 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.58 -2.09 57.22 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.834 -0.621 . . . . 64.519999999999996 112.122 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.4 p -107.25 164.55 14.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 107.636 -1.246 . . . . 74.409999999999997 107.636 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.88 26.11 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.823 1.682 . . . . 52.210000000000001 112.301 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 138.03 58.15 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.347 0.594 . . . . 64.530000000000001 112.464 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.0 p -120.99 151.04 40.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.534 -1.284 . . . . 73.120000000000005 107.534 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.433 ' C ' ' HB3' ' A' ' 190' ' ' ALA . 32.8 m-85 -136.36 151.86 50.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.9 0.773 . . . . 75.340000000000003 109.354 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.435 ' O ' HG13 ' A' ' 166' ' ' VAL . 4.3 pp0? -124.68 122.97 39.01 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.182 0.438 . . . . 64.430000000000007 112.182 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.38 2.78 43.94 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.659 -0.701 . . . . 50.219999999999999 113.491 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.8 14.97 5.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.704 0.802 . . . . 73.109999999999999 112.256 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.611 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.9 p -59.37 138.46 20.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 CA-C-O 121.729 0.776 . . . . 73.239999999999995 111.543 -177.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.435 ' OH ' HD22 ' A' ' 94' ' ' LEU . 55.5 p90 -139.84 163.27 33.08 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.854 -1.066 . . . . 75.299999999999997 108.721 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.94 153.18 31.04 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.098 0.475 . . . . 63.140000000000001 110.384 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 83' ' ' SER . 31.3 t -113.21 118.72 35.47 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.396 -1.705 . . . . 55.020000000000003 106.396 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -122.09 133.5 54.77 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.084 -0.71 . . . . 60.119999999999997 109.084 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.154 0 N-CA-C 110.406 -1.077 . . . . 74.120000000000005 110.406 -178.008 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 114.261 1.208 . . . . 73.219999999999999 114.261 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -101.81 127.83 48.44 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 118.367 -1.333 . . . . 71.040000000000006 109.326 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 37.5 m-80 -144.03 156.18 44.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.231 -1.026 . . . . 63.420000000000002 108.231 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -138.94 145.92 40.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.569 0.224 . . . . 53.130000000000003 110.548 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.8 t -125.63 133.7 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.69 -0.855 . . . . 60.25 108.69 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.56 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 37.3 m0 -112.26 128.4 56.25 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.715 -0.476 . . . . 74.340000000000003 109.715 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 167' ' ' TYR . 85.3 mt -99.33 136.76 38.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.589 -1.263 . . . . 74.099999999999994 107.589 170.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.1 t -96.14 122.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.104 -0.638 . . . . 74.450000000000003 111.12 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.678 ' HA ' ' O ' ' A' ' 161' ' ' THR . 54.0 tttp -72.09 123.78 23.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.715 -0.675 . . . . 64.150000000000006 109.928 174.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.433 ' HB3' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 118.277 -0.868 . . . . 72.519999999999996 109.178 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 39.9 p90 . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 108.36 -0.978 . . . . 74.049999999999997 108.36 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -106.39 108.93 20.7 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.084 -0.646 . . . . 74.420000000000002 109.742 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.23 115.96 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 107.087 -1.449 . . . . 74.439999999999998 107.087 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.447 ' H ' HD22 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -90.27 -37.17 14.27 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 120.332 -0.547 . . . . 65.409999999999997 112.152 -175.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.492 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 32.2 t -162.25 156.05 21.13 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.106 -0.637 . . . . 71.430000000000007 110.393 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 p -132.0 162.95 29.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.253 -1.388 . . . . 72.510000000000005 107.253 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.86 -149.55 20.62 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 119.286 -1.435 . . . . 74.439999999999998 112.635 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.92 159.73 32.61 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.098 -0.801 . . . . 65.420000000000002 111.098 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 6.2 ttpm? -75.51 123.1 24.87 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.05 -1.093 . . . . 73.439999999999998 108.05 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.53 133.49 51.35 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 122.534 1.159 . . . . 53.210000000000001 113.814 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t70 148.32 -48.82 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 130.83 3.652 . . . . 73.450000000000003 101.8 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.424 ' HB ' ' CD2' ' A' ' 147' ' ' HIS . 3.8 p -127.8 109.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 112.611 -2.086 . . . . 75.510000000000005 106.718 169.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -117.08 151.12 37.48 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.84 -1.17 . . . . 73.129999999999995 107.84 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.481 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.3 p90 -113.57 158.48 20.73 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.899 -1.12 . . . . 75.409999999999997 112.684 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -134.47 125.21 26.94 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.589 -2.004 . . . . 73.120000000000005 105.589 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.492 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 38.2 mt-10 -98.22 114.59 26.89 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 106.832 -1.544 . . . . 73.430000000000007 106.832 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -134.79 140.91 46.25 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.559 -0.857 . . . . 75.420000000000002 111.449 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.07 133.59 35.5 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 104.415 -2.439 . . . . 72.299999999999997 104.415 169.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 128' ' ' ILE . 84.1 m -58.46 138.28 56.76 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.488 0.922 . . . . 65.450000000000003 113.488 -173.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 10.6 pt-20 -58.22 -31.56 67.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.664 -1.607 . . . . 74.239999999999995 113.169 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.73 10.25 57.95 Favored Glycine 0 CA--C 1.495 -1.208 0 C-N-CA 119.045 -1.55 . . . . 38.670000000000002 112.111 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.24 52.11 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.779 -0.724 . . . . 63.009999999999998 111.931 -176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.466 ' O ' HD13 ' A' ' 104' ' ' ILE . 16.7 ptpt -90.68 118.28 29.99 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.214 -0.661 . . . . 63.240000000000002 109.214 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 33.1 m-85 -119.14 164.33 15.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.022 -0.536 . . . . 72.439999999999998 111.165 -172.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 121' ' ' LYS . . . -99.47 116.22 31.11 Favored 'General case' 0 C--O 1.209 -1.037 0 N-CA-C 109.017 -0.734 . . . . 75.319999999999993 109.017 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.5 t -122.03 147.16 46.44 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.346 0.593 . . . . 63.310000000000002 111.97 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.578 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.0 m -131.85 132.32 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 124.669 1.188 . . . . 71.239999999999995 108.581 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.64 128.67 56.44 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.517 0.675 . . . . 75.319999999999993 111.927 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 12.2 t -123.99 139.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.065 -1.458 . . . . 73.329999999999998 107.065 178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.4 p -135.95 165.19 26.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.314 -0.554 . . . . 73.319999999999993 110.377 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.82 11.38 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.558 1.161 . . . . 73.430000000000007 110.654 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -133.99 137.56 28.65 Favored Pre-proline 0 N--CA 1.424 -1.747 0 N-CA-C 109.257 -0.646 . . . . 73.030000000000001 109.257 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.48 156.87 16.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.309 2.672 . . . . 73.230000000000004 111.597 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -47.75 -48.5 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.701 1.0 . . . . 62.509999999999998 113.701 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.37 -33.68 76.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.945 0.402 . . . . 63.409999999999997 110.932 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -75.98 -34.65 59.78 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.861 -0.609 . . . . 74.439999999999998 111.382 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -77.23 -44.47 29.86 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.332 -0.395 . . . . 71.140000000000001 110.889 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.8 tp -63.65 -37.78 88.64 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.115 -0.493 . . . . 71.099999999999994 111.872 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -59.26 -32.3 69.88 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 112.133 0.42 . . . . 72.450000000000003 112.133 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -84.68 -39.9 18.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.465 0.65 . . . . 75.510000000000005 110.923 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -75.85 -31.81 59.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.439 -0.8 . . . . 71.540000000000006 112.622 -177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.422 ' CE ' ' HA ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -55.53 -57.65 19.76 Favored Pre-proline 0 CA--C 1.574 1.885 0 CA-C-O 119.372 -0.347 . . . . 72.540000000000006 111.5 -178.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 19.1 Cg_endo -60.42 -31.31 92.44 Favored 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 122.535 2.157 . . . . 41.43 111.147 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 41.5 ttmt -65.98 -37.03 84.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.776 -1.102 . . . . 73.109999999999999 111.276 -177.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.37 -47.25 30.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.927 0.394 . . . . 74.099999999999994 110.667 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.479 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.1 ptm -63.54 -29.54 70.79 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 113.624 0.972 . . . . 75.109999999999999 113.624 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.4 -38.82 91.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 120.546 -0.462 . . . . 74.230000000000004 110.481 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.31 -58.41 7.79 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.236 -0.438 . . . . 74.109999999999999 110.985 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -69.41 -27.23 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 116.039 -0.528 . . . . 73.230000000000004 111.621 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.34 -18.23 73.14 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.921 -0.581 . . . . 38.670000000000002 113.358 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 134.37 -8.52 4.69 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.174 -1.488 . . . . 63.43 114.308 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 m -84.08 33.38 0.49 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-O 122.924 1.345 . . . . 75.030000000000001 110.014 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.6 163.55 12.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.107 -0.951 . . . . 74.530000000000001 108.694 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB3' ' HB1' ' A' ' 114' ' ' ALA . 29.8 t70 -66.28 -33.56 76.03 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.258 0.836 . . . . 74.530000000000001 113.258 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -80.14 -12.43 59.66 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.166 -0.614 . . . . 63.130000000000003 110.612 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.57 38.05 61.81 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.035 -0.602 . . . . 55.25 111.761 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 94.8 t -79.56 120.78 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.034 -1.099 . . . . 72.400000000000006 108.034 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.59 -23.19 8.48 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 121.244 -0.503 . . . . 38.670000000000002 112.34 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.5 mtp -66.03 -37.85 86.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.201 0.524 . . . . 73.040000000000006 109.746 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.92 -166.34 49.82 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.073 -0.967 . . . . 38.670000000000002 112.196 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -133.05 146.35 51.62 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.181 -0.674 . . . . 73.109999999999999 109.181 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.9 m -113.08 117.61 32.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.01 0.433 . . . . 71.049999999999997 109.97 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.664 HG11 ' O ' ' A' ' 103' ' ' ARG . 8.2 p -165.57 151.22 8.31 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 107.492 -1.299 . . . . 73.030000000000001 107.492 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.95 140.66 61.39 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.175 1.25 . . . . 73.319999999999993 111.214 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 9.9 p -93.45 150.03 4.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.607 -0.886 . . . . 64.409999999999997 108.607 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 p -128.77 145.84 51.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.482 0.182 . . . . 64.150000000000006 110.942 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -139.78 143.6 36.98 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.475 -0.49 . . . . 74.239999999999995 110.5 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -92.59 134.92 34.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.891 -0.595 . . . . 65.140000000000001 110.407 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.69 151.62 28.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.156 -0.929 . . . . 74.329999999999998 108.57 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.22 107.83 38.93 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 120.942 -0.303 . . . . 75.420000000000002 110.404 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.22 133.09 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.581 1.521 . . . . 74.430000000000007 111.867 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 95' ' ' GLN . 38.5 m-80 -99.84 171.07 8.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.384 -0.825 . . . . 65.239999999999995 108.927 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.41 -27.75 62.65 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.981 1.104 . . . . 74.430000000000007 113.981 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.83 -7.26 58.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 119.815 -0.754 . . . . 74.340000000000003 110.878 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.04 3.6 57.89 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 120.33 -0.938 . . . . 53.43 113.38 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m -91.14 138.59 31.48 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 122.611 -0.346 . . . . 71.409999999999997 110.259 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.29 107.73 17.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.608 -1.256 . . . . 75.340000000000003 107.608 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 15.5 mm-40 -141.37 170.06 16.44 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.495 -0.558 . . . . 65.5 109.495 -173.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 35.4 mmtp 87.76 -70.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.367 1.467 . . . . 73.430000000000007 113.875 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -136.54 154.43 50.71 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.49 -0.884 . . . . 73.129999999999995 111.822 -177.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.41 HD21 ' C ' ' A' ' 98' ' ' LEU . 6.4 tt -143.95 134.54 24.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.663 -1.153 . . . . 75.519999999999996 109.231 173.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.467 ' HZ2' ' HB2' ' A' ' 99' ' ' LYS . 10.0 mtmp? -131.37 115.94 16.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.649 -0.251 . . . . 60.229999999999997 110.532 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.578 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 66.7 t -93.08 121.62 43.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.697 0.623 . . . . 75.519999999999996 109.783 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -109.65 122.53 47.67 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.832 0.853 . . . . 72.450000000000003 109.473 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.11 113.53 27.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.193 -1.41 . . . . 75.109999999999999 107.193 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.664 ' O ' HG11 ' A' ' 80' ' ' VAL . 70.6 ttt180 -75.08 137.2 41.27 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.523 -1.217 . . . . 72.239999999999995 109.269 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 40' ' ' LYS . 73.0 mt -108.46 124.83 33.33 Favored Pre-proline 0 C--N 1.289 -2.053 0 O-C-N 122.388 -0.195 . . . . 74.310000000000002 111.314 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -55.59 161.37 7.81 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.161 2.574 . . . . 51.420000000000002 113.231 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -47.69 -49.56 27.42 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.87 1.668 . . . . 71.120000000000005 115.028 -171.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.54 -37.49 78.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.517 . . . . 75.239999999999995 112.397 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.416 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 98.1 m-85 -86.91 -10.33 53.57 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.24 -0.584 . . . . 72.420000000000002 112.031 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.645 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.56 -31.88 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.214 -0.994 . . . . 74.109999999999999 110.081 174.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.55 96.27 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 111.605 -0.598 . . . . 72.219999999999999 111.605 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.9 t -157.21 97.84 2.02 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 108.248 -1.019 . . . . 64.019999999999996 108.248 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -85.78 148.26 9.61 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 122.49 2.127 . . . . 74.030000000000001 112.782 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.77 142.31 69.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.275 1.983 . . . . 71.219999999999999 111.109 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 71' ' ' ASP . . . -73.19 144.17 84.28 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.578 -0.449 . . . . 63.119999999999997 110.257 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.02 118.4 4.4 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.364 2.042 . . . . 74.329999999999998 111.76 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.2 m -88.39 21.77 2.76 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.163 0.506 . . . . 65.319999999999993 111.13 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.431 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.4 t70 -135.21 150.3 50.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.486 -1.302 . . . . 72.409999999999997 107.486 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.43 -23.76 37.32 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.555 0.946 . . . . 73.420000000000002 113.555 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -90.02 -25.85 20.61 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.669 -0.413 . . . . 63.229999999999997 111.258 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.5 p -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.597 -0.52 . . . . 70.140000000000001 109.597 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 52.9 mtpt -128.41 152.83 47.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.346 -0.843 . . . . 72.209999999999994 110.234 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 31.0 mm -92.85 112.57 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.049 -0.723 . . . . 75.129999999999995 109.049 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -121.86 142.65 50.04 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.563 -0.744 . . . . 72.049999999999997 109.856 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -115.89 128.56 55.88 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.696 -0.683 . . . . 64.25 110.255 -178.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.39 133.0 43.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.352 0.596 . . . . 75.209999999999994 112.343 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -139.46 172.4 12.87 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.902 -1.518 . . . . 71.209999999999994 106.902 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.49 5.14 79.39 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 119.86 -1.162 . . . . 75.109999999999999 113.32 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.589 HG13 ' SG ' ' A' ' 36' ' ' CYS . 45.4 pt -121.47 145.9 27.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.109 0.454 . . . . 72.400000000000006 110.391 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.1 m -107.68 133.26 52.36 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.503 -0.925 . . . . 73.150000000000006 108.503 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.23 149.47 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 N-CA-C 108.804 -0.813 . . . . 74.120000000000005 108.804 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 36.7 m-85 -113.79 121.82 45.21 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 104.639 -2.356 . . . . 74.219999999999999 104.639 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 55.3 p -119.41 141.29 49.23 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 120.038 -0.665 . . . . 73.140000000000001 111.653 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 10.8 t -121.48 139.38 53.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 115.696 -0.684 . . . . 71.129999999999995 109.391 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -121.11 126.3 49.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.764 -0.828 . . . . 63.439999999999998 108.764 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 38.4 p90 -138.44 168.71 19.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.387 -0.598 . . . . 74.340000000000003 109.387 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.21 169.21 35.35 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.331 -0.938 . . . . 71.120000000000005 111.794 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.8 -116.79 3.86 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.636 -0.586 . . . . 73.019999999999996 111.636 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -98.65 103.0 14.91 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.424 -0.584 . . . . 74.420000000000002 109.424 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 126.83 46.95 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.882 0.848 . . . . 71.310000000000002 112.434 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.95 172.82 6.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.732 -1.122 . . . . 65.040000000000006 108.164 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -40.11 95.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.211 0.529 . . . . 73.209999999999994 112.229 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.56 -27.11 68.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.721 -0.672 . . . . 61.439999999999998 110.494 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.11 -31.93 73.3 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.873 -0.603 . . . . 63.32 110.475 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -63.48 -42.23 98.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.231 -0.44 . . . . 74.219999999999999 109.97 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.83 -45.02 88.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.86 -0.609 . . . . 72.340000000000003 109.717 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.83 -47.17 87.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 61.450000000000003 110.965 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.424 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 27.6 m80 -69.25 -35.25 75.92 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 112.734 0.642 . . . . 62.420000000000002 112.734 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.31 90.43 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.05 0.452 . . . . 74.530000000000001 110.077 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.2 m -64.94 -53.38 47.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.789 -0.642 . . . . 75.329999999999998 109.937 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -38.66 83.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.945 -0.571 . . . . 75.209999999999994 112.222 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.481 HD11 ' HB3' ' A' ' 31' ' ' TYR . 62.9 tp -63.62 -43.16 97.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.776 -0.453 . . . . 73.010000000000005 109.776 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 39.4 ttp180 -61.85 -40.6 95.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.652 -0.704 . . . . 73.439999999999998 109.137 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.421 ' HA ' ' OE2' ' A' ' 156' ' ' GLU . 47.0 m -66.32 -35.47 80.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.462 -0.79 . . . . 75.420000000000002 110.663 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -73.08 -33.99 65.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.465 0.65 . . . . 74.439999999999998 109.873 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.73 -1.83 29.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.549 -0.75 . . . . 74.140000000000001 112.188 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 42.8 mt-10 -75.85 141.63 42.39 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.861 -0.735 . . . . 73.409999999999997 110.512 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.16 -1.18 59.03 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.054 -0.819 . . . . 73.040000000000006 111.054 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 160' ' ' ALA . 27.7 p -114.45 166.84 10.71 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.924 -1.51 . . . . 65.310000000000002 106.924 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.13 20.29 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.648 2.232 . . . . 74.109999999999999 112.987 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 158' ' ' THR . . . -69.68 118.28 12.33 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 121.193 0.52 . . . . 71.140000000000001 111.736 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.3 p -103.7 158.49 16.34 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.295 -1.002 . . . . 74.409999999999997 108.295 175.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.5 ' C ' ' HB3' ' A' ' 190' ' ' ALA . 30.0 m-85 -137.8 147.19 44.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.761 -0.829 . . . . 72.420000000000002 108.761 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 26.1 pt20 -121.72 109.21 14.44 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.269 0.557 . . . . 63.439999999999998 110.686 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.39 8.53 55.73 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.13 -1.033 . . . . 72.319999999999993 111.785 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 55.64 30.84 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.495 1.118 . . . . 71.239999999999995 111.332 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.45 139.05 21.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.21 0.528 . . . . 64.140000000000001 110.945 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.92 163.22 33.37 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.526 -0.761 . . . . 74.200000000000003 110.309 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.511 ' CE2' ' HB1' ' A' ' 85' ' ' ALA . 34.5 m-85 -115.49 149.45 38.08 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.722 -0.672 . . . . 63.399999999999999 109.29 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.44 120.28 39.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.086 -1.45 . . . . 74.340000000000003 107.086 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -123.64 135.98 54.23 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.166 -0.47 . . . . 64.239999999999995 110.633 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.7 0 N-CA-C 108.931 -1.668 . . . . 61.5 108.931 -178.944 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 . . . . . 0 CA--C 1.511 -0.526 0 N-CA-C 112.159 0.429 . . . . 75.329999999999998 112.159 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.463 ' HD3' ' OE2' ' A' ' 184' ' ' GLU . 15.1 ttm180 -139.96 130.11 25.09 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.333 -0.547 . . . . 74.420000000000002 110.881 176.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.411 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.6 m120 -137.53 134.69 35.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 105.046 -2.205 . . . . 64.030000000000001 105.046 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.6 mt-10 -129.14 137.43 51.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 110.028 -0.36 . . . . 74.209999999999994 110.028 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.11 124.24 67.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 74.010000000000005 108.352 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.3 m0 -108.58 123.3 48.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.297 -0.41 . . . . 63.520000000000003 110.142 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.7 mt -103.14 118.68 37.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.742 -1.206 . . . . 75.219999999999999 107.742 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.28 126.46 46.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.418 -0.586 . . . . 65.430000000000007 109.418 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' THR . 63.5 pttt -66.9 142.13 57.4 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 116.125 -0.489 . . . . 65.340000000000003 110.934 -175.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.5 ' HB3' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.253 1.246 0 CA-C-O 118.177 -0.916 . . . . 74.409999999999997 109.585 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.0 p90 . . . . . 0 C--O 1.244 0.804 0 N-CA-C 108.697 -0.853 . . . . 70.310000000000002 108.697 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -106.42 120.15 41.15 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.911 0.708 . . . . 64.5 112.911 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.6 t -89.19 116.89 31.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.002 -1.851 . . . . 64.409999999999997 106.002 170.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.519 HD12 ' OE1' ' A' ' 33' ' ' GLU . 4.4 pp -99.86 -27.76 13.46 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.874 -0.73 . . . . 65.129999999999995 111.931 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -161.79 149.82 14.98 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.871 0.367 . . . . 72.409999999999997 110.806 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.7 p -132.79 157.37 45.16 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.227 -0.897 . . . . 62.130000000000003 109.562 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.16 -167.0 37.94 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.365 -0.922 . . . . 74.230000000000004 111.991 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.76 177.49 15.08 Favored Glycine 0 C--O 1.243 0.659 0 C-N-CA 120.745 -0.74 . . . . 36.859999999999999 112.718 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -87.1 126.25 34.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.457 -2.053 . . . . 75.420000000000002 105.457 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -64.24 132.69 51.03 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.103 0.954 . . . . 74.340000000000003 112.393 -167.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 129.41 -39.63 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.938 3.295 . . . . 71.519999999999996 103.105 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.612 HG23 ' CD2' ' A' ' 147' ' ' HIS . 21.6 t -123.0 110.23 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 112.983 -1.917 . . . . 75.010000000000005 106.844 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 133' ' ' THR . 52.4 m -119.56 131.87 55.61 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.362 -1.348 . . . . 74.230000000000004 107.362 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.61 160.57 16.55 Favored 'General case' 0 N--CA 1.423 -1.789 0 C-N-CA 120.302 -0.559 . . . . 73.329999999999998 111.108 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -134.98 125.44 26.61 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 106.648 -1.612 . . . . 64.450000000000003 106.648 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.519 ' OE1' HD12 ' A' ' 21' ' ' LEU . 45.5 tt0 -100.17 114.73 28.34 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.367 -1.716 . . . . 75.099999999999994 106.367 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -135.93 142.16 44.6 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.789 -1.096 . . . . 74.530000000000001 111.377 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.98 136.44 33.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.128 -1.064 . . . . 64.540000000000006 108.128 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.0 t -69.07 143.31 54.27 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 110.002 -0.37 . . . . 70.540000000000006 110.002 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.12 -20.49 64.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.576 -0.738 . . . . 73.099999999999994 112.412 -177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 89.84 10.4 64.92 Favored Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.044 -1.55 . . . . 64.329999999999998 110.938 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.92 165.56 53.83 Favored Glycine 0 N--CA 1.417 -2.633 0 CA-C-N 114.788 -0.706 . . . . 72.040000000000006 112.282 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.555 ' O ' HD11 ' A' ' 104' ' ' ILE . 13.4 ptpt -94.35 132.6 38.79 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.01 -1.107 . . . . 73.420000000000002 108.01 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 37.8 m-85 -131.58 163.71 27.44 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.02 0.2 . . . . 74.129999999999995 111.128 -172.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.32 117.17 33.16 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.857 -0.794 . . . . 73.319999999999993 108.857 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 6.6 t -127.75 149.52 50.2 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 115.883 -0.599 . . . . 60.409999999999997 112.19 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 100' ' ' VAL . 3.2 p -145.58 134.7 17.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 124.557 1.143 . . . . 73.310000000000002 108.026 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.8 pt-20 -122.31 128.91 51.62 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.325 -0.95 . . . . 73.310000000000002 111.43 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -112.42 139.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 106.547 -1.649 . . . . 64.140000000000001 106.547 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 49' ' ' LYS . 76.5 p -117.51 166.25 12.58 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 111.826 0.306 . . . . 73.530000000000001 111.826 -173.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 72.1 -33.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.117 1.367 . . . . 64.530000000000001 112.97 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.0 mttm -85.76 146.1 42.98 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 115.238 -0.892 . . . . 62.049999999999997 111.726 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.97 158.91 48.97 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.409 2.74 . . . . 71.430000000000007 110.439 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -45.65 -47.24 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.112 1.152 . . . . 72.099999999999994 114.112 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.46 -48.2 74.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.673 0.67 . . . . 71.299999999999997 111.816 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.18 -45.54 73.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.663 -0.698 . . . . 74.519999999999996 112.418 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.32 -37.63 83.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.09 -0.504 . . . . 72.219999999999999 111.143 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.91 -37.56 72.96 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.242 -0.435 . . . . 73.319999999999993 111.091 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.317 6.2 ppt_? -66.51 -23.94 66.32 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.058 1.133 . . . . 73.420000000000002 114.058 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 14.1 mm-40 -79.22 -43.84 23.01 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.18 0.514 . . . . 75.049999999999997 110.839 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . . . -75.94 -38.37 57.67 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 114.522 1.305 . . . . 73.439999999999998 114.522 -173.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.554 ' HE1' ' HA ' ' A' ' 59' ' ' MET . 8.0 mmt -55.58 -53.36 63.33 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 113.305 0.854 . . . . 55.399999999999999 113.305 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 59' ' ' MET . 10.4 Cg_endo -56.13 -31.73 84.29 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.005 1.803 . . . . 63.409999999999997 112.103 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 67.5 mttm -66.37 -39.94 89.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.901 0.381 . . . . 74.040000000000006 111.27 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -43.16 78.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 120.466 -0.493 . . . . 73.209999999999994 109.706 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.41 -35.02 78.45 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.262 0.838 . . . . 72.129999999999995 113.262 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -67.5 -40.86 85.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.357 -0.609 . . . . 74.099999999999994 109.357 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -60.97 -54.51 44.11 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.458 -0.792 . . . . 75.209999999999994 111.757 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.81 -5.81 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.169 0.433 . . . . 71.420000000000002 112.169 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.76 -36.64 10.15 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.949 -0.644 . . . . 71.519999999999996 112.254 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 148.26 2.22 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.542 -1.314 . . . . 45.240000000000002 113.618 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.3 m -85.77 11.92 10.08 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.495 1.14 . . . . 73.129999999999995 109.7 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.428 ' OD1' HG13 ' A' ' 74' ' ' VAL . 7.2 p30 -78.8 176.39 9.6 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.738 -1.119 . . . . 74.329999999999998 110.449 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.09 -33.16 73.08 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.06 0.457 . . . . 63.049999999999997 111.321 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -85.15 -13.86 48.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.45 0.643 . . . . 73.420000000000002 109.878 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.17 32.52 80.44 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.343 -0.844 . . . . 36.859999999999999 111.266 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.428 HG13 ' OD1' ' A' ' 70' ' ' ASN . 6.5 p -79.57 120.95 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 120.306 -0.558 . . . . 75.450000000000003 110.777 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.46 145.48 17.64 Favored Glycine 0 CA--C 1.481 -2.059 0 N-CA-C 109.447 -1.461 . . . . 74.150000000000006 109.447 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 53.7 ttp 59.3 79.81 0.21 Allowed 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.233 -1.395 . . . . 74.409999999999997 107.233 -171.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.88 -111.96 1.21 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.965 -1.112 . . . . 72.319999999999993 113.147 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.528 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 20.8 ptt? -132.91 128.44 36.54 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.271 -0.464 . . . . 71.129999999999995 111.689 -173.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 m -125.66 117.24 23.07 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 108.932 -0.766 . . . . 75.120000000000005 108.932 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.5 HG21 ' CD ' ' A' ' 81' ' ' PRO . 2.0 p -158.87 -178.52 0.91 Allowed Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 102.85 -3.018 . . . . 72.409999999999997 102.85 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 171' ' ' GLY . 92.8 Cg_exo -47.07 136.58 17.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 CA-C-N 123.085 2.137 . . . . 72.219999999999999 116.026 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.74 142.28 26.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 113.293 -1.776 . . . . 61.109999999999999 106.48 172.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.8 p -139.24 151.41 46.49 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.765 -0.374 . . . . 75.319999999999993 110.314 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.8 137.33 31.45 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 120.552 -0.459 . . . . 70.409999999999997 110.125 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.532 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.04 134.71 34.57 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 109.123 -0.695 . . . . 64.340000000000003 109.123 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.6 149.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.613 -1.254 . . . . 72.310000000000002 107.613 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -119.96 100.86 48.14 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 107.428 -1.323 . . . . 75.530000000000001 107.428 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.03 135.42 12.35 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.034 1.823 . . . . 62.119999999999997 113.444 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -78.27 159.16 28.62 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.855 -1.535 . . . . 71.319999999999993 106.855 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.28 -31.77 67.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.486 0.66 . . . . 75.439999999999998 112.492 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.14 -5.17 40.17 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.98 -1.009 . . . . 72.310000000000002 112.027 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.02 63.28 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.65 -0.786 . . . . 52.25 111.908 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -84.23 119.49 25.1 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.799 -0.815 . . . . 63.310000000000002 108.799 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.42 82.87 5.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.606 0.717 . . . . 74.5 109.35 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.628 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 16.8 tm0? -147.52 130.43 16.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.819 -1.082 . . . . 70.239999999999995 108.828 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 86.0 mttt 161.17 -63.62 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 C-N-CA 127.59 2.356 . . . . 75.099999999999994 108.92 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -160.55 158.16 28.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.849 -1.537 . . . . 73.450000000000003 106.849 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 tt -141.69 127.45 19.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 107.221 -1.4 . . . . 72.400000000000006 107.221 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.9 mttt -113.1 114.93 27.53 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.851 -0.426 . . . . 74.099999999999994 109.851 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.1 t -87.87 132.94 31.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 108.434 -0.951 . . . . 62.509999999999998 108.434 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -124.03 117.99 25.97 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.865 -1.161 . . . . 75.450000000000003 107.865 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -102.54 121.12 41.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.487 -1.301 . . . . 64.129999999999995 107.487 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 60.1 ttt180 -78.75 131.53 36.6 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 115.291 -0.868 . . . . 73.430000000000007 108.981 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.555 HD11 ' O ' ' A' ' 40' ' ' LYS . 68.3 mt -93.53 129.6 38.05 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.926 -0.579 . . . . 75.25 110.15 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.528 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 48.0 Cg_endo -68.61 162.32 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.135 2.557 . . . . 73.200000000000003 112.24 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -47.45 -41.62 20.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.024 1.329 . . . . 74.329999999999998 113.877 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.49 -46.9 87.49 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.344 0.498 . . . . 62.350000000000001 112.344 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.58 -4.76 59.25 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 111.472 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.217 -0.66 . . . . 65.010000000000005 109.217 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.68 -26.41 60.92 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.179 -0.919 . . . . 64.019999999999996 111.824 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.9 t -174.87 99.63 0.27 Allowed Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 122.884 0.474 . . . . 54.130000000000003 109.878 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.93 157.73 1.77 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.65 2.233 . . . . 65.219999999999999 111.968 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -71.7 158.16 53.96 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 121.756 1.638 . . . . 75.030000000000001 110.6 172.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.87 59.02 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 110.334 -0.247 . . . . 73.099999999999994 110.334 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.46 106.86 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.78 2.32 . . . . 74.530000000000001 111.593 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -106.3 87.61 2.59 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.757 0.789 . . . . 64.239999999999995 111.505 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.509 ' HB3' HG13 ' A' ' 120' ' ' VAL . 17.8 t70 -176.34 155.8 1.5 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 104.961 -2.236 . . . . 64.040000000000006 104.961 173.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -12.32 60.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 115.07 1.507 . . . . 72.030000000000001 115.07 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.3 p -127.57 6.77 6.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.851 1.426 . . . . 75.349999999999994 114.851 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.509 HG13 ' HB3' ' A' ' 117' ' ' ASP . 15.0 p -103.06 127.68 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.788 -0.819 . . . . 65.310000000000002 108.788 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 121' ' ' LYS . 9.0 mmpt? -126.15 145.17 50.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.25 -0.648 . . . . 74.400000000000006 109.25 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.8 mm -92.59 111.67 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.612 -1.255 . . . . 73.219999999999999 107.612 172.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -125.55 139.27 53.74 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.682 -0.69 . . . . 74.420000000000002 109.864 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.77 139.3 43.78 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.155 -0.93 . . . . 73.439999999999998 109.745 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.532 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 49.4 mtp180 -133.43 136.44 45.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.07 0.462 . . . . 74.439999999999998 111.761 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 157.13 46.75 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.182 -0.917 . . . . 61.340000000000003 111.519 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.02 18.63 46.12 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.096 -0.574 . . . . 72.319999999999993 113.158 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.0 pt -121.97 145.4 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.678 -0.809 . . . . 64.239999999999995 111.966 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.8 m -106.16 131.4 53.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 106.594 -1.632 . . . . 72.099999999999994 106.594 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.01 150.41 28.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.583 -0.895 . . . . 70.420000000000002 108.583 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 13.1 m-85 -115.19 121.73 43.88 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.207 -1.775 . . . . 72.420000000000002 106.207 -177.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 53.8 p -120.55 132.52 55.21 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 120.043 -0.663 . . . . 74.409999999999997 112.263 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 10.0 t -113.41 135.76 53.52 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.36 -0.607 . . . . 75.420000000000002 109.36 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -109.55 127.75 54.7 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.023 -1.103 . . . . 72.400000000000006 108.023 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -130.6 168.4 17.16 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.447 -0.946 . . . . 64.420000000000002 108.447 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.27 165.58 29.92 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.074 -1.06 . . . . 63.340000000000003 112.002 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.17 -133.8 7.9 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 110.968 -0.853 . . . . 71.5 110.968 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -100.71 101.32 12.17 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.169 -1.419 . . . . 73.140000000000001 107.169 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.33 107.93 17.57 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.931 0.872 . . . . 54.350000000000001 112.514 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -99.63 169.29 9.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.42 -1.326 . . . . 73.319999999999993 107.42 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.63 -29.09 69.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.842 0.83 . . . . 72.25 109.389 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.61 -30.92 70.63 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.738 -1.119 . . . . 73.25 111.093 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.17 -36.87 84.23 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 120.383 0.135 . . . . 71.519999999999996 111.28 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -66.61 -41.07 89.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.916 -0.314 . . . . 74.340000000000003 110.633 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.63 -45.35 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 109.959 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.68 90.94 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.049 -0.523 . . . . 72.430000000000007 111.366 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.612 ' CD2' HG23 ' A' ' 29' ' ' VAL . 76.5 m80 -69.14 -32.96 72.68 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.096 -0.642 . . . . 73.329999999999998 111.733 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -66.84 -47.04 73.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.506 -0.315 . . . . 62.399999999999999 110.863 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 t -63.12 -38.14 89.99 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.931 -0.308 . . . . 70.450000000000003 111.682 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.77 -35.13 78.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 112.419 0.526 . . . . 53.530000000000001 112.419 176.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.505 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.1 mt -57.6 -36.87 72.32 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 120.846 0.355 . . . . 75.239999999999995 111.2 175.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 51.2 mtm180 -65.14 -36.56 84.62 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.547 -0.751 . . . . 72.140000000000001 110.076 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 m -75.82 -43.3 46.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.615 -0.721 . . . . 74.430000000000007 110.068 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 151' ' ' LEU . 60.1 p -71.93 -33.59 68.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.753 -0.658 . . . . 75.109999999999999 112.723 -174.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.75 9.59 7.65 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.061 0.763 . . . . 74.420000000000002 113.061 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 45.5 mt-10 -88.02 145.94 25.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.298 -1.001 . . . . 70.150000000000006 108.298 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.96 -9.86 63.85 Favored Glycine 0 C--N 1.302 -1.338 0 C-N-CA 120.647 -0.787 . . . . 74.230000000000004 111.404 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 14.0 t -122.03 149.32 53.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 107.2 -1.408 . . . . 72.109999999999999 107.2 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.79 34.67 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 123.84 3.027 . . . . 60.229999999999997 114.377 -175.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.32 136.06 39.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.966 0.412 . . . . 72.319999999999993 110.547 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 25.2 m -124.45 154.14 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.04 -1.096 . . . . 60.030000000000001 108.04 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.403 ' C ' ' HB3' ' A' ' 190' ' ' ALA . 26.2 p90 -134.21 158.84 42.68 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.794 -0.447 . . . . 75.340000000000003 109.794 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -122.22 140.56 52.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.584 0.957 . . . . 75.150000000000006 113.584 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.78 30.17 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.066 -0.97 . . . . 60.109999999999999 113.968 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.9 t70 66.27 17.15 10.65 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 122.645 1.212 . . . . 72.239999999999995 108.439 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 83.0 t -72.52 139.88 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 125.83 1.652 . . . . 64.310000000000002 111.731 -176.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -146.23 167.47 23.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.497 -0.774 . . . . 71.219999999999999 109.898 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 10.7 m-85 -115.42 152.77 32.28 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.799 -0.815 . . . . 70.019999999999996 108.799 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.1 m -114.65 129.63 56.7 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 106.477 -1.675 . . . . 71.430000000000007 106.477 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.61 157.12 42.96 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.098 0.475 . . . . 71.349999999999994 111.91 -175.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . . . . . . 0 N--CA 1.429 -1.825 0 N-CA-C 108.553 -1.819 . . . . 64.109999999999999 108.553 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.697 0.284 . . . . 64.420000000000002 110.591 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.403 -0.592 . . . . 63.420000000000002 109.403 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -141.59 153.46 44.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.394 -1.706 . . . . 71.329999999999998 106.394 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 133' ' ' THR . 47.2 mt-10 -125.63 154.25 42.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.954 0.724 . . . . 61.310000000000002 112.954 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' SER . 51.9 t -125.45 118.9 53.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.742 -1.577 . . . . 74.150000000000006 106.742 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.9 m0 -103.73 121.15 42.4 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.027 -0.731 . . . . 72.340000000000003 109.027 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.0 tp -97.86 138.78 34.7 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.654 -1.61 . . . . 74.329999999999998 106.654 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.64 135.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.645 -0.422 . . . . 73.0 111.894 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.3 ptmm? -65.5 143.29 57.75 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.614 -0.721 . . . . 75.230000000000004 111.595 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.403 ' HB3' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.188 -1.042 . . . . 45.200000000000003 108.188 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.1 p90 . . . . . 0 N--CA 1.432 -1.368 0 N-CA-C 107.787 -1.19 . . . . 63.399999999999999 107.787 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 108.31 19.75 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.595 -0.729 . . . . 74.299999999999997 109.202 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.6 131.37 41.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 116.085 -0.507 . . . . 73.129999999999995 110.443 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 22' ' ' SER . 4.1 pp -90.85 -34.99 15.05 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.657 -0.817 . . . . 74.129999999999995 112.431 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.438 ' N ' HD12 ' A' ' 21' ' ' LEU . 32.6 t -177.65 164.76 2.05 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.789 -0.819 . . . . 74.530000000000001 108.789 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -131.26 156.34 45.58 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.972 -1.122 . . . . 70.400000000000006 107.972 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.0 -158.94 31.66 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.582 -1.294 . . . . 71.310000000000002 112.42 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.58 -116.59 3.16 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 121.192 -0.528 . . . . 62.130000000000003 111.794 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -108.19 171.29 7.49 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.695 0.798 . . . . 72.109999999999999 109.853 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.67 140.85 35.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 106.44 -1.689 . . . . 74.349999999999994 106.44 172.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 77.3 -53.92 0.55 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.69 1.196 . . . . 72.140000000000001 110.47 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG23 ' CD2' ' A' ' 147' ' ' HIS . 21.9 t -97.96 108.27 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.164 -1.421 . . . . 75.129999999999995 107.164 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 133' ' ' THR . 50.3 m -130.52 140.85 50.49 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.261 -1.014 . . . . 71.219999999999999 108.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 132' ' ' SER . 1.6 p90 -112.15 161.46 16.52 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.075 0.464 . . . . 70.510000000000005 112.151 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.534 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -133.13 126.19 31.17 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.456 -1.313 . . . . 74.409999999999997 107.456 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.33 112.82 26.07 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.031 -1.47 . . . . 54.509999999999998 107.031 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.534 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 13.4 ptt180 -144.04 159.23 42.97 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 119.853 -0.739 . . . . 73.230000000000004 110.327 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.19 136.9 33.78 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.958 -1.497 . . . . 43.200000000000003 106.958 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.43 151.59 43.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.097 0.475 . . . . 73.549999999999997 111.122 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.62 -21.09 65.41 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.364 -0.834 . . . . 72.400000000000006 112.898 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 74.49 9.49 81.91 Favored Glycine 0 CA--C 1.51 -0.235 0 C-N-CA 119.873 -1.156 . . . . 72.109999999999999 113.926 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.61 165.25 53.66 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.947 -0.644 . . . . 71.140000000000001 113.574 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -93.95 135.66 35.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.21 -0.663 . . . . 65.129999999999995 109.21 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 63.1 m-85 -136.59 165.92 24.75 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.688 0.618 . . . . 74.540000000000006 110.815 -172.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.73 118.95 35.41 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.236 -1.024 . . . . 72.340000000000003 108.236 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.7 t -128.49 154.12 46.44 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 113.174 0.805 . . . . 71.209999999999994 113.174 -172.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.08 132.94 66.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.989 1.315 . . . . 63.43 108.63 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.38 126.67 55.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.653 0.263 . . . . 55.109999999999999 110.503 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 45.1 t -127.33 127.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.942 -1.503 . . . . 74.439999999999998 106.942 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 49' ' ' LYS . 18.6 m -120.34 162.99 18.52 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.563 -0.532 . . . . 72.219999999999999 109.563 -173.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 75.58 -31.81 0.21 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.985 1.314 . . . . 73.109999999999999 112.362 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.1 mttm -85.4 146.6 44.98 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.795 -0.639 . . . . 74.420000000000002 110.663 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.5 156.86 39.32 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.853 2.369 . . . . 65.420000000000002 111.113 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 37.2 t -47.8 -48.08 11.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.908 1.077 . . . . 72.430000000000007 113.908 -177.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 33.2 t70 -59.51 -49.64 76.98 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.47 -0.492 . . . . 75.239999999999995 110.832 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -61.96 -48.19 81.47 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.662 0.616 . . . . 72.109999999999999 112.662 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -60.59 -38.65 85.36 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 123.612 0.57 . . . . 54.530000000000001 110.778 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 59' ' ' MET . 65.3 tp -66.48 -42.53 87.31 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.081 -0.509 . . . . 71.129999999999995 110.302 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.684 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 20.0 mmm180 -59.43 -45.31 91.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.861 0.363 . . . . 73.530000000000001 110.595 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -66.69 -37.43 84.72 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.336 -0.847 . . . . 74.209999999999994 111.34 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.57 59.97 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.274 0.842 . . . . 74.219999999999999 113.274 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.539 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 3.2 mmt -48.32 -57.69 10.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.254 1.205 . . . . 64.319999999999993 114.254 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.55 -32.12 88.82 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.749 2.299 . . . . 72.140000000000001 112.384 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.06 -47.48 68.2 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.329 -0.619 . . . . 74.540000000000006 109.329 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.88 -38.08 79.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.901 -0.59 . . . . 75.420000000000002 110.303 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.51 ' HE2' ' HA ' ' A' ' 63' ' ' MET . 9.7 mmt -66.36 -37.36 85.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 73.439999999999998 112.031 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -72.98 -33.71 66.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.699 -0.401 . . . . 73.140000000000001 110.807 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.71 -60.08 4.23 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 116.431 -0.35 . . . . 73.340000000000003 111.246 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 76' ' ' MET . 6.4 p -73.48 -25.27 20.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 120.864 0.364 . . . . 75.099999999999994 110.542 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.49 -25.05 66.56 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.261 -0.427 . . . . 45.039999999999999 113.249 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 -0.58 2.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.781 -1.2 . . . . 72.310000000000002 113.494 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -91.2 29.74 1.37 Allowed 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.609 1.195 . . . . 60.140000000000001 109.431 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.07 159.87 14.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.596 -0.891 . . . . 52.030000000000001 108.596 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.422 ' HB3' ' HB1' ' A' ' 114' ' ' ALA . 23.2 t70 -70.8 -28.04 64.34 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.081 0.4 . . . . 72.540000000000006 112.081 -172.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.84 -12.34 59.97 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.192 -0.67 . . . . 74.430000000000007 109.192 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.61 33.25 75.94 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.158 -0.928 . . . . 64.420000000000002 112.813 177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.58 126.93 40.25 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.78 -0.768 . . . . 72.140000000000001 111.331 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.86 92.45 1.54 Allowed Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.281 -1.127 . . . . 41.32 110.281 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 56.0 ttp 70.62 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.771 1.228 . . . . 71.099999999999994 110.535 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.52 -55.62 0.68 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.837 0.695 . . . . 74.129999999999995 114.837 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.403 ' SD ' HG21 ' A' ' 104' ' ' ILE . 21.6 ptt? -124.75 126.24 45.33 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.5 m -126.1 124.5 40.72 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.329999999999998 109.652 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -165.7 145.5 5.44 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 107.465 -1.309 . . . . 72.200000000000003 107.465 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -35.61 139.98 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.177 3.251 . . . . 64.400000000000006 115.767 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.27 150.06 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 113.485 -1.689 . . . . 74.099999999999994 106.5 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 m -138.61 145.08 40.11 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.467 -0.568 . . . . 72.219999999999999 109.467 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 42.9 p90 -136.53 143.69 43.86 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.463 -0.495 . . . . 64.150000000000006 111.358 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.425 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.87 34.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.678 -0.86 . . . . 75.439999999999998 108.678 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.98 150.95 30.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.188 -0.915 . . . . 73.120000000000005 109.291 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.557 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 1.9 m-85 -117.36 102.28 52.31 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 109.231 -0.655 . . . . 72.340000000000003 109.231 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -88.67 146.8 5.91 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.235 1.957 . . . . 75.319999999999993 112.693 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.54 152.66 18.23 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.988 -1.856 . . . . 72.109999999999999 105.988 171.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.268 11.3 pt-20 -64.53 -13.36 52.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 115.683 1.734 . . . . 70.439999999999998 115.683 -172.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.6 -6.25 59.25 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 121.609 0.718 . . . . 61.020000000000003 109.866 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.22 5.14 54.84 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 72.040000000000006 112.941 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 m -83.99 126.42 33.01 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.489 -0.56 . . . . 50.219999999999999 109.489 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 78.0 mt -94.04 78.58 4.08 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.923 0.392 . . . . 63.409999999999997 111.095 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.1 tt0 -149.25 115.29 5.73 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 111.949 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 95.1 mttt -176.75 -62.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.278 1.831 . . . . 73.510000000000005 108.648 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.557 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 38.5 ttmt -161.31 155.0 21.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.299 -1.0 . . . . 72.109999999999999 108.299 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.434 HD13 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -143.76 143.38 31.35 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.331 -0.618 . . . . 72.530000000000001 109.331 173.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -136.92 115.47 11.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.636 -0.505 . . . . 73.0 109.636 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 43' ' ' THR . 84.0 t -92.15 129.88 42.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 N-CA-C 109.785 -0.45 . . . . 43.329999999999998 109.785 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -112.72 128.15 56.33 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.941 -0.763 . . . . 75.109999999999999 108.941 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -103.26 123.62 47.1 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.969 -1.123 . . . . 75.030000000000001 107.969 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.453 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 68.4 mtt-85 -75.49 132.22 40.63 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.503 0.927 . . . . 74.140000000000001 113.503 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.403 HG21 ' SD ' ' A' ' 78' ' ' MET . 72.1 mt -102.11 122.77 45.78 Favored Pre-proline 0 N--CA 1.398 -3.041 0 N-CA-C 105.98 -1.859 . . . . 74.329999999999998 105.98 172.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.16 152.01 62.75 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.236 1.958 . . . . 62.310000000000002 110.733 175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -48.12 -37.33 15.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.564 0.746 . . . . 71.340000000000003 112.848 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.75 -31.87 70.04 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.502 0.721 . . . . 75.230000000000004 112.225 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -100.29 -8.45 23.42 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 112.498 0.555 . . . . 71.510000000000005 112.498 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -70.75 -29.24 65.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.641 1.349 . . . . 63.310000000000002 114.641 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.11 -38.59 94.1 Favored Glycine 0 C--O 1.241 0.587 0 C-N-CA 120.029 -1.082 . . . . 61.210000000000001 111.514 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -142.92 85.81 9.72 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 108.26 -1.015 . . . . 72.010000000000005 108.26 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -88.34 159.82 6.83 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.886 1.724 . . . . 74.209999999999994 112.824 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.28 130.27 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.478 2.119 . . . . 71.310000000000002 110.802 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 71' ' ' ASP . . . -70.03 138.73 87.5 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 109.287 -0.634 . . . . 60.520000000000003 109.287 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.27 111.3 3.16 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.155 1.904 . . . . 54.32 112.074 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -98.69 79.23 2.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.806 -0.813 . . . . 74.120000000000005 108.806 177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -173.89 150.26 1.63 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.792 -1.188 . . . . 72.349999999999994 107.792 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -76.27 -24.2 54.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.214 0.82 . . . . 73.209999999999994 113.214 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.4 m -92.6 -26.21 17.97 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.57 -0.452 . . . . 73.310000000000002 110.799 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.8 t -94.35 118.35 40.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.849 -0.426 . . . . 75.319999999999993 109.849 -175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -128.73 147.63 50.78 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.471 -0.937 . . . . 71.329999999999998 108.471 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 26.1 mm -92.71 112.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.24 -1.022 . . . . 74.409999999999997 108.24 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -122.06 149.7 43.16 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 109.769 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.74 152.52 24.24 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.814 -0.63 . . . . 62.039999999999999 109.821 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.504 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 65.0 ttt180 -151.57 123.25 7.96 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.821 -0.807 . . . . 71.340000000000003 108.821 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -138.39 166.92 23.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.545 -0.539 . . . . 72.230000000000004 109.545 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.44 61.01 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.431 -1.366 . . . . 73.230000000000004 113.282 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.6 pt -119.28 151.93 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.347 -0.941 . . . . 74.430000000000007 112.166 -175.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 92.9 m -105.78 123.35 47.81 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.943 -1.48 . . . . 73.430000000000007 107.788 178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.52 146.66 30.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 116.01 -0.541 . . . . 64.299999999999997 110.632 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 39.9 m-85 -114.47 121.92 45.0 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.707 -1.96 . . . . 73.219999999999999 105.707 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 31' ' ' TYR . 56.1 p -122.41 139.16 54.17 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 119.832 -0.747 . . . . 75.140000000000001 111.193 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.8 t -113.51 133.19 55.37 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 120.574 -0.451 . . . . 73.209999999999994 109.932 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -110.91 125.33 53.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.514 -1.291 . . . . 64.209999999999994 107.514 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.68 158.08 44.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.463 -0.199 . . . . 73.319999999999993 110.463 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -137.06 154.54 22.32 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 123.973 0.796 . . . . 74.310000000000002 111.372 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.09 -142.37 11.73 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 109.009 -1.637 . . . . 63.43 109.009 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -100.43 118.95 37.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 118.239 1.02 . . . . 63.200000000000003 108.964 174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.53 133.41 55.4 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.611 0.72 . . . . 63.299999999999997 112.177 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -112.64 177.37 4.66 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.419 -1.697 . . . . 73.319999999999993 106.419 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.55 78.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.346 0.594 . . . . 60.350000000000001 110.817 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.65 -29.29 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 74.329999999999998 111.77 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.24 -30.23 70.09 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 111.879 0.325 . . . . 64.040000000000006 111.879 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.88 -48.94 69.85 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.728 -0.841 . . . . 75.030000000000001 108.728 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.03 -41.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.841 -1.072 . . . . 64.340000000000003 110.185 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.71 88.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.841 -0.618 . . . . 74.319999999999993 110.521 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.405 ' CD2' HG23 ' A' ' 29' ' ' VAL . 62.8 m80 -66.63 -32.36 73.63 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 112.827 0.677 . . . . 75.349999999999994 112.827 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.68 -47.31 84.93 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.105 0.478 . . . . 64.530000000000001 109.921 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -65.03 -46.87 79.48 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.628 -0.715 . . . . 65.049999999999997 110.447 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.06 -40.82 86.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 111.318 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 187' ' ' LEU . 1.5 tt -62.72 -46.07 89.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.828 -1.175 . . . . 72.310000000000002 107.828 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -64.09 -39.47 94.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.068 -0.969 . . . . 74.030000000000001 110.451 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.9 m -68.55 -33.09 73.48 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.312 0.577 . . . . 72.400000000000006 110.257 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -73.02 -33.51 65.78 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.37 0.605 . . . . 74.340000000000003 109.702 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.1 9.2 7.06 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.998 -0.546 . . . . 71.340000000000003 111.486 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.96 134.08 35.64 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 71.219999999999999 106.91 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.89 57.28 Favored Glycine 0 C--N 1.307 -1.028 0 C-N-CA 121.211 -0.518 . . . . 61.509999999999998 112.551 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.3 t -125.41 146.24 53.72 Favored Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 106.879 -1.526 . . . . 72.430000000000007 106.879 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.83 34.79 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 123.744 2.963 . . . . 61.439999999999998 114.676 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 131' ' ' TYR . . . -74.87 139.64 43.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.446 -0.576 . . . . 64.329999999999998 109.446 177.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 19.6 p -114.91 158.66 21.68 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.145 -0.48 . . . . 72.340000000000003 110.364 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 190' ' ' ALA . 43.6 m-85 -136.23 152.36 50.66 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.615 -0.883 . . . . 72.409999999999997 108.615 -176.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -113.02 111.34 22.0 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.262 0.838 . . . . 70.019999999999996 113.262 178.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.53 4.71 46.81 Favored Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 115.658 -0.701 . . . . 61.100000000000001 112.495 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 17.8 t70 63.83 15.75 9.3 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.813 1.245 . . . . 74.540000000000006 109.565 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.14 151.56 7.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 CA-C-O 121.205 0.526 . . . . 72.439999999999998 110.516 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -146.1 170.64 16.28 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.599 -0.728 . . . . 71.030000000000001 111.215 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 97.6 m-85 -115.15 152.28 32.88 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.64 -0.504 . . . . 62.43 109.64 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.03 137.75 53.67 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.757 -1.201 . . . . 62.329999999999998 107.757 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.73 150.03 32.13 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 111.896 0.332 . . . . 73.099999999999994 111.896 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.748 0 N-CA-C 107.871 -2.092 . . . . 71.510000000000005 107.871 179.608 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 . . . . . 0 CA--C 1.498 -1.041 0 CA-C-O 120.729 0.299 . . . . 74.230000000000004 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -133.8 128.16 34.19 Favored 'General case' 0 CA--C 1.469 -2.143 0 CA-C-O 121.459 0.647 . . . . 70.299999999999997 111.231 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -144.86 134.59 23.51 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 103.743 -2.688 . . . . 75.519999999999996 103.743 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -115.71 137.22 52.3 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 119.261 -0.976 . . . . 73.540000000000006 110.334 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 89.8 t -124.99 121.06 60.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.636 -1.246 . . . . 54.229999999999997 107.636 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.516 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 6.8 m0 -119.31 120.96 38.51 Favored 'General case' 0 C--O 1.197 -1.682 0 CA-C-O 119.129 -0.462 . . . . 75.140000000000001 110.929 -174.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 151' ' ' LEU . 9.2 mp -96.95 138.83 33.88 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.822 -1.177 . . . . 73.219999999999999 107.822 171.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.16 131.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 120.323 -0.551 . . . . 74.219999999999999 110.681 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 161' ' ' THR . 4.5 tmtm? -73.46 130.74 40.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.519 -0.764 . . . . 60.130000000000003 109.997 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.252 1.199 0 CA-C-N 115.734 -0.666 . . . . 52.130000000000003 111.054 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 39.1 p90 . . . . . 0 N--CA 1.435 -1.205 0 N-CA-C 107.056 -1.461 . . . . 75.140000000000001 107.056 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -126.81 122.53 35.02 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.92 -1.112 . . . . 74.099999999999994 111.73 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.92 121.16 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 106.966 -1.494 . . . . 52.43 106.966 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.56 -33.41 15.91 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.59 -0.444 . . . . 65.040000000000006 111.044 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.407 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 46.8 t -162.26 149.86 14.14 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.401 0.619 . . . . 40.119999999999997 110.806 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.1 p -133.29 166.71 21.87 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 125.05 1.34 . . . . 74.450000000000003 108.255 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.01 76.76 0.4 Allowed Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 119.513 -1.327 . . . . 73.319999999999993 112.961 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.18 -160.34 22.45 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.226 -0.988 . . . . 74.019999999999996 111.659 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -89.96 170.58 10.25 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.781 -1.192 . . . . 73.200000000000003 107.781 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.22 148.27 51.07 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 119.652 -0.819 . . . . 63.530000000000001 109.91 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.0 t70 77.43 -62.23 0.39 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.425 1.49 . . . . 65.209999999999994 110.791 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.76 110.06 29.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.369 -0.974 . . . . 60.200000000000003 108.369 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -118.88 154.44 32.93 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.461 -0.94 . . . . 74.150000000000006 108.461 -176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' HB3' HD12 ' A' ' 151' ' ' LEU . 5.7 p90 -117.28 152.19 35.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.214 -1.394 . . . . 71.439999999999998 113.868 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -135.18 124.75 25.07 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.527 -2.027 . . . . 75.109999999999999 105.527 172.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 32.3 mt-10 -106.31 118.38 36.48 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.200000000000003 107.571 -177.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -139.04 148.34 43.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.512 0.93 . . . . 74.219999999999999 113.512 -175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.59 136.41 34.82 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.082 -1.451 . . . . 62.520000000000003 107.082 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.625 ' SG ' HG13 ' A' ' 128' ' ' ILE . 99.1 m -63.49 142.9 58.22 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.644 0.979 . . . . 70.340000000000003 113.644 -176.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -47.98 -48.25 32.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.827 1.251 . . . . 54.32 112.323 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.01 69.91 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 110.747 -0.941 . . . . 51.109999999999999 110.747 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.23 165.75 53.37 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 111.214 -0.754 . . . . 63.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 137.24 32.51 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.921 -0.311 . . . . 70.450000000000003 110.763 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 53.9 m-85 -135.34 164.22 28.23 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.766 0.827 . . . . 75.129999999999995 109.403 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.51 116.51 31.8 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.135 -0.691 . . . . 72.519999999999996 109.135 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -119.91 138.98 53.1 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 112.621 0.6 . . . . 74.129999999999995 112.621 -175.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.495 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 11.5 m -130.44 124.95 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.425 1.09 . . . . 60.420000000000002 110.393 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.55 139.06 45.01 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.086 -0.646 . . . . 72.120000000000005 112.281 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 39.4 t -126.38 141.33 46.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 N-CA-C 108.465 -0.939 . . . . 75.209999999999994 108.465 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -127.83 174.89 8.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 122.859 0.463 . . . . 71.349999999999994 110.13 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.51 -34.28 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.122 0.969 . . . . 73.329999999999998 113.202 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 3.5 mppt? -100.57 138.78 20.22 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 112.143 0.424 . . . . 62.450000000000003 112.143 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.73 159.76 4.59 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 124.589 3.526 . . . . 73.010000000000005 111.841 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 98' ' ' LEU . 52.6 t -46.14 -48.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.708 0.803 . . . . 72.510000000000005 113.043 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.99 -45.18 91.27 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.423 0.63 . . . . 70.409999999999997 110.744 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 23.1 mm-40 -75.06 -31.84 61.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.986 -1.006 . . . . 74.109999999999999 112.585 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -73.0 -44.84 60.57 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.512 0.673 . . . . 71.120000000000005 109.669 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.304 -0.862 . . . . 73.439999999999998 111.309 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 17.0 ptm180 -64.09 -26.6 68.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 116.564 -0.289 . . . . 71.409999999999997 111.645 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 51.9 mt-10 -84.72 -41.75 15.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.982 0.42 . . . . 72.109999999999999 111.181 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.09 69.42 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.271 0.841 . . . . 74.099999999999994 113.271 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.514 ' HE2' ' HA ' ' A' ' 59' ' ' MET . 6.6 mmt -56.07 -53.56 62.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.205 -0.426 . . . . 71.319999999999993 111.711 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 34.5 Cg_exo -55.87 -31.89 82.98 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.348 2.032 . . . . 74.349999999999994 112.129 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 43.0 mtmt -73.04 -31.02 64.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.626 -0.43 . . . . 73.150000000000006 111.589 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 66' ' ' VAL . 35.4 mm -74.34 -43.4 49.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.409 -0.96 . . . . 74.219999999999999 108.409 171.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.496 ' HE2' ' HA ' ' A' ' 63' ' ' MET . 19.3 mmt -56.26 -37.73 70.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.854 0.686 . . . . 74.439999999999998 112.854 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.4 -47.62 72.69 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.439 -0.504 . . . . 72.099999999999994 110.74 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.88 -58.03 6.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.134 -0.485 . . . . 75.230000000000004 111.767 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -68.88 -17.38 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 64.340000000000003 110.897 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.62 -19.78 65.3 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.88 -0.6 . . . . 37.460000000000001 112.82 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.72 -22.28 0.4 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.096 -1.526 . . . . 51.039999999999999 113.968 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -79.37 58.02 2.5 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.439 1.114 . . . . 73.010000000000005 111.338 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -99.88 160.28 14.43 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.325 -1.361 . . . . 74.349999999999994 107.325 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -69.2 -33.57 73.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.597 0.635 . . . . 70.209999999999994 110.278 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -80.41 -9.58 59.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.746 . . . . 73.519999999999996 110.327 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.78 62.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.642 -0.708 . . . . 60.310000000000002 112.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 m -82.97 159.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 108.11 -1.07 . . . . 73.310000000000002 108.11 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -170.89 12.28 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 119.082 -1.532 . . . . 62.450000000000003 113.733 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.0 mtp 70.69 101.96 0.06 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.379 1.472 . . . . 72.239999999999995 110.466 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 66' ' ' VAL . . . -54.44 122.1 22.97 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.817 -1.083 . . . . 37.460000000000001 114.385 -174.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -96.31 126.89 41.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.645 -0.872 . . . . 72.310000000000002 108.645 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 m -123.77 123.94 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.435 0.636 . . . . 72.340000000000003 111.838 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.14 176.72 2.28 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 104.202 -2.518 . . . . 70.010000000000005 104.202 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -62.53 139.08 74.15 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 CA-C-N 121.494 1.569 . . . . 37.460000000000001 112.293 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 8.8 p -110.47 148.88 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.806 -1.183 . . . . 54.219999999999999 107.806 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 47.0 p -125.72 145.36 50.22 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 121.164 -0.214 . . . . 62.520000000000003 110.658 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -139.75 148.12 41.82 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.617 -0.433 . . . . 72.310000000000002 110.621 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.09 135.36 34.04 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.634 0.584 . . . . 73.120000000000005 110.019 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.27 151.07 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.001 -1.0 . . . . 73.230000000000004 109.577 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 76.4 m-85 -118.12 110.45 39.69 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 110.253 -0.277 . . . . 75.430000000000007 110.253 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.78 137.03 9.78 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 121.5 1.467 . . . . 64.329999999999998 110.989 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -82.77 179.31 7.82 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.745 -0.835 . . . . 75.25 108.745 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.2 -36.32 77.4 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.763 0.792 . . . . 72.439999999999998 109.807 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.31 -5.42 52.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.284 -1.325 . . . . 71.409999999999997 112.777 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.55 -4.03 83.74 Favored Glycine 0 CA--C 1.501 -0.829 0 C-N-CA 120.378 -0.915 . . . . 75.329999999999998 112.718 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.1 p -74.64 146.92 42.02 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.001 -0.741 . . . . 72.409999999999997 109.001 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.495 HD21 ' HH ' ' A' ' 167' ' ' TYR . 95.9 mt -82.64 132.6 35.18 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.149 0.499 . . . . 73.519999999999996 110.879 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -87.35 150.95 23.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 75.439999999999998 109.923 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -74.63 77.37 2.01 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.934 1.087 . . . . 70.25 113.934 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.671 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -165.49 122.89 1.5 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 104.21 -2.515 . . . . 73.219999999999999 104.21 173.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.671 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 5.7 tt -143.88 145.26 32.18 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 121.078 -0.249 . . . . 70.120000000000005 110.571 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -142.1 130.24 22.09 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.404 -0.518 . . . . 73.239999999999995 110.726 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.8 t -91.85 139.28 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.228 -0.896 . . . . 71.129999999999995 109.944 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.265 -1.383 . . . . 75.150000000000006 107.265 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -102.2 114.31 28.36 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.495 -0.928 . . . . 73.209999999999994 108.495 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.441 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -75.54 113.14 12.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.105 -1.443 . . . . 71.319999999999993 107.105 -175.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -78.3 135.26 61.77 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 112.276 0.473 . . . . 61.140000000000001 112.276 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.23 157.83 13.3 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.416 2.744 . . . . 73.200000000000003 112.127 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -54.59 -45.94 73.69 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.155 1.168 . . . . 74.430000000000007 114.155 -171.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -59.85 -37.92 80.66 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.214 0.531 . . . . 71.299999999999997 111.785 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.44 -3.15 57.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.696 0.628 . . . . 73.319999999999993 112.696 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.51 -33.73 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.184 -1.006 . . . . 75.530000000000001 109.91 172.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 -34.75 55.78 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.024 -0.535 . . . . 61.310000000000002 112.187 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.6 t -142.72 89.09 8.27 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 108.283 -1.006 . . . . 51.240000000000002 108.283 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 73.5 Cg_endo -87.18 141.18 5.87 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.914 1.743 . . . . 73.129999999999995 110.977 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 12.5 Cg_exo -71.25 154.67 61.5 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 121.705 1.603 . . . . 64.530000000000001 110.448 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.38 143.12 55.24 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.376 -0.972 . . . . 72.120000000000005 108.376 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.82 110.71 2.84 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.045 1.83 . . . . 71.120000000000005 111.643 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.2 t -72.76 -22.17 60.9 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.575 -0.738 . . . . 75.239999999999995 110.548 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.58 144.23 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.635 -0.876 . . . . 65.430000000000007 108.635 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.92 -33.14 74.12 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.224 0.824 . . . . 71.150000000000006 113.224 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.1 p -90.36 -12.13 38.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.991 0.424 . . . . 72.209999999999994 111.944 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.31 123.21 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.454 -2.054 . . . . 74.439999999999998 105.454 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -128.39 138.28 52.27 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.249 -0.58 . . . . 75.230000000000004 110.57 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 25.3 mm -92.01 109.49 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.541 -1.652 . . . . 62.219999999999999 106.541 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -129.87 153.14 48.59 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.395 -0.821 . . . . 63.049999999999997 109.176 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.27 137.58 54.8 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 109.501 -0.555 . . . . 73.099999999999994 109.501 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.94 127.48 28.77 Favored 'General case' 0 N--CA 1.426 -1.659 0 C-N-CA 120.555 -0.458 . . . . 61.340000000000003 111.413 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.17 175.57 9.44 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.398 -0.964 . . . . 73.120000000000005 108.398 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.71 46.11 Favored Glycine 0 C--N 1.306 -1.083 0 C-N-CA 120.836 -0.697 . . . . 72.099999999999994 111.758 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.625 HG13 ' SG ' ' A' ' 36' ' ' CYS . 36.2 pt -132.99 146.51 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.088 0.47 . . . . 75.340000000000003 110.801 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.2 m -104.06 135.16 46.08 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.98 -1.489 . . . . 74.530000000000001 106.98 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 m -123.66 145.97 29.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.355 -0.609 . . . . 71.519999999999996 109.355 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -113.48 122.53 47.57 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 105.923 -1.88 . . . . 74.200000000000003 105.923 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.7 m -110.1 146.59 35.16 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 115.867 -0.606 . . . . 73.109999999999999 110.916 -173.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.9 t -133.62 124.89 27.61 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.327 -0.619 . . . . 74.239999999999995 109.327 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -111.23 126.36 54.79 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 109.505 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 37.3 p90 -137.24 167.43 21.59 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.974 -1.012 . . . . 72.019999999999996 109.314 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -120.62 123.21 5.5 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.09 -1.204 . . . . 37.460000000000001 110.09 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 167.03 170.84 32.43 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 111.345 -0.702 . . . . 62.299999999999997 111.345 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -93.11 100.26 12.69 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.664 -0.865 . . . . 63.210000000000001 108.664 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.69 132.2 43.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.32 0.859 . . . . 55.329999999999998 113.32 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.06 177.15 5.03 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.929 -1.508 . . . . 74.409999999999997 106.929 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.27 -36.49 73.34 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.729 0.3 . . . . 65.25 111.262 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.23 81.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.353 -0.385 . . . . 63.530000000000001 110.297 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.9 -42.51 99.8 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.773 -0.454 . . . . 61.539999999999999 109.773 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.752 ' HA ' ' NE2' ' A' ' 147' ' ' HIS . 63.9 m-85 -56.95 -43.96 82.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 123.365 0.416 . . . . 73.549999999999997 112.108 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.11 -49.29 77.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 123.753 0.658 . . . . 64.129999999999995 110.305 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.62 -48.27 77.85 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.778 -0.646 . . . . 74.319999999999993 112.062 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.752 ' NE2' ' HA ' ' A' ' 144' ' ' TYR . 3.2 p-80 -72.46 -32.0 65.89 Favored 'General case' 0 C--O 1.205 -1.271 0 N-CA-C 113.067 0.765 . . . . 64.540000000000006 113.067 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.31 80.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.147 0.498 . . . . 73.430000000000007 110.651 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.4 t -76.53 -32.02 57.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 120.127 -0.629 . . . . 71.209999999999994 109.758 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.96 -34.3 78.11 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 116.379 -0.373 . . . . 75.400000000000006 110.298 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' A' ' 31' ' ' TYR . 57.9 tp -62.61 -41.78 99.2 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.531 -0.544 . . . . 74.230000000000004 109.531 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -62.25 -36.99 83.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.447 0.642 . . . . 65.319999999999993 110.165 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 41.1 m -72.6 -30.18 64.14 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 115.153 -0.93 . . . . 74.040000000000006 110.105 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 156' ' ' GLU . 85.7 m -75.12 -33.35 61.57 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.473 0.709 . . . . 72.019999999999996 109.834 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.9 mt -72.8 13.25 0.4 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.295 1.438 . . . . 75.230000000000004 111.76 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 154' ' ' THR . 44.6 tt0 -51.11 124.24 11.08 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.481 1.112 . . . . 74.239999999999995 110.357 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.54 60.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.736 -0.745 . . . . 62.310000000000002 113.724 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 81.0 p -93.23 154.41 41.51 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 117.565 0.682 . . . . 75.200000000000003 109.742 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.86 25.7 0.69 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.676 2.251 . . . . 74.230000000000004 110.897 175.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.03 138.81 39.81 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.835 -0.62 . . . . 71.319999999999993 110.753 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.5 p -110.8 149.84 29.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.356 -0.609 . . . . 71.049999999999997 109.356 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -143.75 161.51 38.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.88 -0.785 . . . . 74.030000000000001 108.88 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.403 ' O ' HG11 ' A' ' 166' ' ' VAL . 27.8 pt20 -131.65 109.65 10.36 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.235 -0.586 . . . . 75.519999999999996 111.825 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.57 62.69 Favored Glycine 0 C--N 1.315 -0.628 0 C-N-CA 120.617 -0.802 . . . . 54.25 114.141 171.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 61.04 23.15 13.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.032 0.533 . . . . 65.109999999999999 111.185 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 163' ' ' GLN . 9.8 p -63.59 138.16 23.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 N-CA-C 109.274 -0.639 . . . . 42.43 109.274 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.495 ' HH ' HD21 ' A' ' 94' ' ' LEU . 40.6 p90 -147.2 174.61 11.45 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 121.447 0.641 . . . . 74.310000000000002 111.192 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -116.98 150.32 38.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.714 -1.13 . . . . 74.519999999999996 109.17 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 83' ' ' SER . 34.7 t -113.29 120.32 40.74 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.291 -1.003 . . . . 73.129999999999995 108.291 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 184' ' ' GLU . . . -120.62 131.79 54.8 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.446 0.466 . . . . 74.200000000000003 111.604 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.441 0 N-CA-C 108.098 -2.001 . . . . 74.219999999999999 108.098 179.511 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.492 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 2.6 tmm_? . . . . . 0 C--O 1.217 -0.623 0 N-CA-C 109.238 -0.653 . . . . 72.340000000000003 109.238 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -113.13 131.21 55.93 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.508 -0.477 . . . . 73.310000000000002 110.247 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -131.62 161.74 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.831 -0.803 . . . . 74.239999999999995 108.831 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 170' ' ' ALA . 43.4 tt0 -125.27 139.23 53.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.38 -1.341 . . . . 72.540000000000006 107.38 174.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.703 HG22 ' CD2' ' A' ' 147' ' ' HIS . 59.4 t -126.7 131.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.906 -0.775 . . . . 71.519999999999996 108.906 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 36.3 m0 -111.08 123.19 49.7 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 123.322 0.389 . . . . 74.030000000000001 110.444 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.5 128.08 43.1 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.413 -1.699 . . . . 44.549999999999997 106.413 169.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.016 -0.674 . . . . 74.409999999999997 111.75 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' THR . 52.2 tttp -63.69 127.63 32.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.563 -1.198 . . . . 71.329999999999998 111.753 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 108.825 -0.806 . . . . 64.430000000000007 108.825 173.407 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 43.8 p90 . . . . . 0 N--CA 1.426 -1.633 0 N-CA-C 104.872 -2.269 . . . . 71.099999999999994 104.872 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -106.05 109.03 20.84 Favored 'General case' 0 C--N 1.279 -2.488 0 C-N-CA 118.052 -1.459 . . . . 72.200000000000003 111.177 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 34' ' ' ARG . 48.1 t -91.28 115.54 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 103.299 -2.852 . . . . 75.040000000000006 103.299 169.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.98 -23.77 22.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.925 -1.51 . . . . 71.450000000000003 111.339 -171.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -174.83 168.0 3.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.427 -0.583 . . . . 72.140000000000001 109.427 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.407 HG21 ' HG3' ' A' ' 32' ' ' GLU . 72.8 p -133.74 145.7 50.08 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.089 -1.078 . . . . 63.329999999999998 108.089 170.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.2 -139.43 6.11 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 118.997 -1.573 . . . . 45.32 113.648 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.0 -112.57 4.47 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.947 -0.861 . . . . 44.310000000000002 110.947 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 8.6 mtpm? -113.52 170.32 8.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.03 -0.359 . . . . 72.200000000000003 110.03 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -83.97 157.53 21.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.027 -1.101 . . . . 55.210000000000001 108.027 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 75.88 -61.8 0.45 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.459 1.104 . . . . 70.310000000000002 110.444 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.77 110.14 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.153 -1.795 . . . . 63.420000000000002 106.153 171.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.0 p -122.57 155.05 37.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.544 -0.753 . . . . 63.340000000000003 109.065 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.498 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -114.98 153.21 31.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 113.155 0.798 . . . . 73.040000000000006 113.155 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.582 ' OE2' ' HD2' ' A' ' 34' ' ' ARG . 35.9 tt0 -135.35 123.35 22.74 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.216 -2.142 . . . . 61.299999999999997 105.216 173.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -109.95 125.2 52.6 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.105 0.955 . . . . 74.239999999999995 111.026 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.582 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 16.4 mtp180 -127.5 140.48 52.11 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.347 -1.297 . . . . 62.310000000000002 110.414 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.11 40.5 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.515 -1.291 . . . . 75.450000000000003 107.515 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.2 m -58.94 146.05 39.27 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.794 0.683 . . . . 63.329999999999998 111.604 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -87.41 -19.43 28.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.371 -0.377 . . . . 64.230000000000004 110.054 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 98.69 11.63 46.62 Favored Glycine 0 CA--C 1.489 -1.586 0 C-N-CA 119.423 -1.37 . . . . 55.409999999999997 111.824 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 160.0 53.61 Favored Glycine 0 N--CA 1.426 -2.006 0 C-N-CA 120.522 -0.847 . . . . 71.420000000000002 112.133 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.3 ptmt -95.9 128.93 43.21 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 109.748 -0.464 . . . . 64.340000000000003 109.748 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.8 m-85 -127.17 163.81 23.03 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.977 -0.556 . . . . 75.239999999999995 110.985 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.17 116.73 32.05 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.075 -1.083 . . . . 52.329999999999998 108.075 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.9 t -127.29 147.77 50.23 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 120.329 -0.548 . . . . 74.209999999999994 112.015 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.8 t -128.18 126.63 66.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.841 -1.072 . . . . 73.120000000000005 108.446 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 43.5 tt0 -113.16 123.94 51.39 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.018 0.437 . . . . 71.430000000000007 111.088 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 34.5 t -121.4 127.54 75.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.835 -1.543 . . . . 74.040000000000006 106.835 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 49' ' ' LYS . 72.7 p -116.09 166.19 12.29 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.551 -0.46 . . . . 61.310000000000002 110.566 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 73.3 -27.49 0.19 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.897 0.879 . . . . 72.120000000000005 113.007 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 47' ' ' THR . 63.8 mmtt -89.84 146.85 36.16 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 115.946 -0.57 . . . . 74.310000000000002 110.54 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.23 156.65 61.92 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.435 2.09 . . . . 52.0 109.926 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.87 -45.71 11.79 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 113.383 0.883 . . . . 71.109999999999999 113.383 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.75 -46.55 87.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.175 0.435 . . . . 73.129999999999995 112.175 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.32 -43.69 55.65 Favored 'General case' 0 N--CA 1.397 -3.118 0 CA-C-N 116.278 -0.419 . . . . 64.329999999999998 111.728 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -63.79 -37.76 88.56 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 120.893 0.377 . . . . 52.329999999999998 110.675 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.426 HD12 ' HE2' ' A' ' 59' ' ' MET . 47.2 tp -70.84 -37.97 73.17 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.398 -0.365 . . . . 73.239999999999995 111.181 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.272 6.7 ppt_? -65.27 -23.54 67.07 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 112.283 0.475 . . . . 72.420000000000002 112.283 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.4 mm-40 -81.99 -52.34 7.15 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.44 -0.8 . . . . 72.439999999999998 112.778 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.21 -40.53 64.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 114.643 1.349 . . . . 52.240000000000002 114.643 -172.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.431 ' HB2' ' HE2' ' A' ' 59' ' ' MET . 35.5 ttm -57.74 -49.31 94.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 114.957 1.466 . . . . 55.219999999999999 114.957 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 59' ' ' MET . 13.0 Cg_endo -57.17 -31.86 91.75 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.909 1.74 . . . . 75.239999999999995 111.639 175.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 93.3 mttt -67.59 -36.08 80.2 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.315 0.578 . . . . 73.340000000000003 110.096 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.58 -43.94 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 72.329999999999998 109.884 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.67 -43.51 98.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.845 0.683 . . . . 73.099999999999994 112.845 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -64.16 -37.68 88.35 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.059 0.457 . . . . 71.040000000000006 110.507 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.448 ' CE1' ' HA ' ' A' ' 115' ' ' PRO . 38.6 t80 -66.28 -59.93 3.26 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.711 -0.677 . . . . 74.019999999999996 110.443 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.93 -26.15 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-O 121.17 0.51 . . . . 75.299999999999997 111.397 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -27.91 73.34 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 116.021 -0.536 . . . . 72.329999999999998 112.731 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.4 -11.87 0.22 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.33 -1.414 . . . . 71.450000000000003 114.321 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 116' ' ' SER . 23.5 m -82.23 49.53 1.43 Allowed 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 121.934 0.873 . . . . 75.120000000000005 110.268 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -98.61 149.54 22.67 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.567 -1.642 . . . . 61.409999999999997 106.567 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.47 -32.1 71.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.092 0.472 . . . . 73.430000000000007 112.044 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -78.05 -7.47 56.96 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.042 0.449 . . . . 74.010000000000005 111.016 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.0 18.27 80.22 Favored Glycine 0 CA--C 1.509 -0.291 0 C-N-CA 121.164 -0.541 . . . . 64.329999999999998 112.118 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.94 165.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.245 -1.02 . . . . 53.020000000000003 108.245 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.95 -120.15 0.95 Allowed Glycine 0 N--CA 1.41 -3.084 0 C-N-CA 119.484 -1.341 . . . . 51.509999999999998 112.227 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 69.9 mtm 68.4 9.69 7.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.201 1.0 . . . . 54.119999999999997 111.165 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.73 92.26 1.1 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.807 -0.633 . . . . 72.439999999999998 113.961 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -95.79 125.48 40.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.602 -1.999 . . . . 73.420000000000002 105.602 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.1 p -117.1 116.96 28.34 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 115.605 1.706 . . . . 74.409999999999997 115.605 -166.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.58 155.35 45.37 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 105.206 -2.146 . . . . 72.329999999999998 105.206 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.85 140.5 85.31 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.225 1.95 . . . . 62.43 114.151 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -106.35 151.36 8.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.957 -1.497 . . . . 70.409999999999997 106.957 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.3 t -141.79 147.48 37.36 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.902 -0.777 . . . . 74.549999999999997 108.902 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.83 144.35 48.91 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 122.337 -0.227 . . . . 75.120000000000005 110.506 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 136.23 33.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.722 -0.672 . . . . 71.439999999999998 109.519 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.89 150.62 25.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.011 -1.107 . . . . 63.439999999999998 108.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.617 ' CD2' ' HE2' ' A' ' 97' ' ' LYS . 1.7 m-85 -119.84 103.54 45.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 108.746 -0.835 . . . . 75.299999999999997 108.746 -175.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 151.37 37.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.145 1.897 . . . . 75.420000000000002 114.545 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.709 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 92.2 m-20 -102.89 156.09 17.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.466 -1.243 . . . . 64.129999999999995 108.171 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.05 -17.2 62.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.597 0.713 . . . . 73.519999999999996 109.747 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.96 -5.47 46.38 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.917 -1.038 . . . . 72.209999999999994 110.8 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.96 0.71 87.25 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 121.104 -0.569 . . . . 61.310000000000002 111.988 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.5 p -92.59 152.1 19.78 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 109.228 -0.656 . . . . 71.120000000000005 109.228 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.71 85.63 2.16 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.04 0.447 . . . . 74.040000000000006 110.765 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.605 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 34.3 tt0 -148.87 113.75 5.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.174 -0.466 . . . . 61.439999999999998 111.277 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.709 ' HE3' ' OD1' ' A' ' 89' ' ' ASN . 91.3 mttt -173.14 -75.44 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.883 1.673 . . . . 64.310000000000002 107.752 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.617 ' HE2' ' CD2' ' A' ' 87' ' ' PHE . 4.0 mppt? -143.05 156.57 44.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.997 -1.001 . . . . 74.439999999999998 108.942 177.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 tt -143.84 134.84 25.44 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.8 -1.185 . . . . 54.140000000000001 107.8 172.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 45' ' ' GLU . 33.9 ttpt -140.83 116.54 10.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 120.601 -0.44 . . . . 72.099999999999994 110.943 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' THR . 53.7 t -87.18 132.58 32.2 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 115.679 -0.691 . . . . 71.140000000000001 109.731 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -115.8 122.06 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.453 0.701 . . . . 75.25 109.27 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 85.9 t80 -103.21 123.22 46.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.334 0.587 . . . . 72.430000000000007 110.087 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -75.12 113.42 12.44 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.375 -1.284 . . . . 72.329999999999998 110.12 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.5 mt -89.26 125.03 63.25 Favored Pre-proline 0 N--CA 1.42 -1.958 0 N-CA-C 107.254 -1.387 . . . . 65.409999999999997 107.254 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.26 148.24 42.04 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.705 2.27 . . . . 75.0 111.335 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.422 HD21 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -57.23 -36.22 70.64 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.078 0.399 . . . . 63.399999999999999 112.078 -173.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -62.93 -28.46 70.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.449 0.642 . . . . 74.239999999999995 111.364 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.14 -12.28 38.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 116.119 -0.492 . . . . 70.450000000000003 110.668 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.483 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 11.9 mm-40 -68.11 -29.42 68.33 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.591 0.589 . . . . 72.329999999999998 112.591 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.45 -39.19 97.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.15 -1.024 . . . . 62.409999999999997 111.403 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 m -153.46 87.73 3.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.36 -0.978 . . . . 72.109999999999999 108.36 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.67 151.21 11.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.278 1.985 . . . . 65.099999999999994 110.532 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.07 157.05 59.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.876 1.717 . . . . 73.299999999999997 110.805 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.49 147.22 71.44 Favored Pre-proline 0 N--CA 1.423 -1.808 0 N-CA-C 108.918 -0.771 . . . . 72.340000000000003 108.918 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.448 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 58.6 Cg_endo -73.18 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 121.917 1.744 . . . . 71.310000000000002 111.091 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 69' ' ' THR . 47.9 t -77.77 -28.68 50.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.34 -0.845 . . . . 75.200000000000003 111.655 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.29 152.1 25.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.281 -0.568 . . . . 65.319999999999993 110.401 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.11 -32.97 74.46 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.931 0.715 . . . . 75.209999999999994 112.931 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.471 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 20.1 m -93.44 -8.64 41.07 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.293 -0.563 . . . . 73.400000000000006 111.483 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 61.3 t -97.7 118.64 44.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.476 -1.305 . . . . 73.209999999999994 107.476 -176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -128.97 140.28 51.72 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.078 -0.712 . . . . 71.129999999999995 109.078 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.2 mm -92.08 112.0 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.271 -1.011 . . . . 72.310000000000002 108.271 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -123.44 148.41 46.18 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.553 -0.749 . . . . 72.510000000000005 109.963 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 1.7 mp0 -98.17 139.38 34.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.809 -1.182 . . . . 73.219999999999999 107.809 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -126.7 121.16 31.29 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.256 -0.978 . . . . 75.450000000000003 110.696 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.432 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -144.9 176.83 9.18 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.199 -0.909 . . . . 74.319999999999993 111.031 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.8 64.61 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.962 -0.637 . . . . 37.810000000000002 114.661 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.41 160.41 22.71 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 C-N-CA 119.386 -0.926 . . . . 70.030000000000001 112.065 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.2 m -112.88 142.97 44.93 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.027 -1.442 . . . . 73.329999999999998 107.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.78 145.39 29.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.525 -0.546 . . . . 73.400000000000006 109.525 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.589 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 56.3 m-85 -113.72 122.4 47.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.893 -2.262 . . . . 75.109999999999999 104.893 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.8 p -123.0 139.24 54.29 Favored 'General case' 0 C--N 1.263 -3.163 0 C-N-CA 120.092 -0.643 . . . . 62.530000000000001 110.983 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -113.21 127.41 56.17 Favored 'General case' 0 N--CA 1.402 -2.835 0 N-CA-C 108.138 -1.06 . . . . 65.209999999999994 108.138 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -110.43 125.32 53.13 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.734 -1.21 . . . . 73.310000000000002 107.734 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -147.0 153.72 40.39 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.167 0.508 . . . . 72.140000000000001 112.36 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.02 156.26 19.2 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.446 -0.797 . . . . 74.219999999999999 111.482 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.78 141.43 12.16 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.303 -1.119 . . . . 53.439999999999998 110.303 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -70.77 122.92 20.76 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.392 0.615 . . . . 73.540000000000006 111.198 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.95 133.5 53.33 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.589 -0.732 . . . . 51.119999999999997 109.629 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -80.95 170.21 16.55 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.718 -0.845 . . . . 62.329999999999998 108.718 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -53.29 -38.68 63.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.99 0.424 . . . . 52.399999999999999 111.185 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.06 77.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.589 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -66.8 -31.66 72.42 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 116.24 -0.436 . . . . 62.149999999999999 110.617 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -62.78 -40.95 98.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.784 -0.367 . . . . 72.540000000000006 110.522 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.57 -44.24 90.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.903 -0.59 . . . . 65.340000000000003 109.574 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -63.8 -47.22 81.76 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.572 -0.74 . . . . 74.409999999999997 111.275 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -66.02 -33.18 75.21 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.009 0.374 . . . . 74.319999999999993 112.009 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.7 94.49 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.299 -0.63 . . . . 61.119999999999997 109.299 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.2 m -64.24 -44.5 91.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.458 -0.792 . . . . 65.209999999999994 110.458 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 98.7 mt-30 -59.3 -49.22 78.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.818 0.447 . . . . 74.219999999999999 110.561 177.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.498 ' CD1' ' HB3' ' A' ' 31' ' ' TYR . 48.1 tp -58.02 -46.19 85.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.857 -0.61 . . . . 73.420000000000002 110.61 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -64.35 -34.54 78.38 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.857 -0.611 . . . . 73.450000000000003 110.216 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.5 m -73.18 -33.17 65.27 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.331 0.586 . . . . 73.040000000000006 109.837 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.405 HG21 ' HG3' ' A' ' 26' ' ' LYS . 42.0 m -72.38 -33.72 67.42 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.239 0.542 . . . . 74.019999999999996 109.779 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 158' ' ' THR . 87.8 mt -74.66 4.99 5.32 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.061 0.944 . . . . 73.019999999999996 113.197 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.1 142.5 43.64 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.654 -0.818 . . . . 74.340000000000003 111.1 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.23 62.18 Favored Glycine 0 C--N 1.297 -1.606 0 CA-C-N 115.456 -0.793 . . . . 63.340000000000003 111.15 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 155' ' ' LEU . 11.5 t -116.55 147.34 39.52 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 108.228 -1.027 . . . . 73.129999999999995 108.228 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -70.94 36.11 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.981 3.12 . . . . 62.219999999999999 113.666 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . . . -74.13 136.63 42.92 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.847 0.356 . . . . 63.329999999999998 111.02 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 69.3 p -111.82 162.91 14.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.341 -0.985 . . . . 74.319999999999993 108.341 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.8 m-85 -137.66 150.6 47.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.616 -0.883 . . . . 65.430000000000007 108.616 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.548 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -127.43 126.82 43.08 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.854 -0.738 . . . . 74.319999999999993 112.574 -177.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.84 -1.19 17.29 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.287 -0.869 . . . . 73.510000000000005 113.441 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 63.11 12.17 5.8 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 64.349999999999994 110.588 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.5 160.37 4.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.272 -0.876 . . . . 62.030000000000001 111.88 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.87 170.89 17.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.42 -0.809 . . . . 71.219999999999999 110.015 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 18.1 m-85 -115.58 153.31 31.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.252 0.548 . . . . 72.519999999999996 111.848 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 41.7 t -115.12 144.82 43.08 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.241 -1.763 . . . . 72.209999999999994 106.241 172.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.24 160.56 16.87 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 121.131 -0.228 . . . . 62.409999999999997 110.644 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.525 0 N-CA-C 110.3 -1.12 . . . . 52.039999999999999 110.3 -177.886 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.923 0.392 . . . . 64.049999999999997 111.676 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.2 134.39 29.43 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 116.325 -0.398 . . . . 73.510000000000005 111.155 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.28 143.4 46.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.85 0.46 . . . . 74.340000000000003 111.025 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -122.08 148.0 45.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.49 -0.323 . . . . 75.219999999999999 110.912 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.3 t -128.18 128.93 69.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.614 -1.254 . . . . 71.109999999999999 107.614 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 7.0 m0 -114.98 124.83 52.66 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 110.354 -0.239 . . . . 65.329999999999998 110.354 -178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.12 138.97 35.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.94 -1.133 . . . . 63.219999999999999 107.94 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 38.5 t -100.17 127.74 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 120.696 -0.401 . . . . 72.310000000000002 111.547 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.1 tmtt? -78.14 123.76 27.27 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.426 -0.806 . . . . 73.140000000000001 109.691 176.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.26 1.651 0 O-C-N 124.268 0.98 . . . . 64.310000000000002 110.183 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.1 p90 . . . . . 0 N--CA 1.433 -1.282 0 N-CA-C 106.331 -1.729 . . . . 75.030000000000001 106.331 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -119.32 120.22 36.29 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 119.148 -1.021 . . . . 75.25 112.073 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.411 HG21 ' HG2' ' A' ' 34' ' ' ARG . 44.5 t -78.16 114.52 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 102.803 -3.036 . . . . 74.319999999999993 102.803 168.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.62 -30.13 17.36 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.288 -1.365 . . . . 74.310000000000002 112.874 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -158.67 163.07 37.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.922 -0.77 . . . . 72.340000000000003 108.922 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.445 HG23 ' CB ' ' A' ' 32' ' ' GLU . 44.8 p -132.66 162.59 30.98 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.461 -0.57 . . . . 65.439999999999998 109.461 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.24 -145.4 10.15 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.775 -0.726 . . . . 73.340000000000003 111.831 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -156.7 16.71 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.917 -0.658 . . . . 44.439999999999998 111.905 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.01 171.87 7.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.398 0.679 . . . . 74.439999999999998 111.642 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.68 143.59 48.04 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.68 -1.6 . . . . 75.299999999999997 106.68 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 80.23 -50.58 0.35 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.305 1.042 . . . . 74.140000000000001 111.314 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.0 t -116.09 109.14 27.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.287 -0.634 . . . . 53.109999999999999 109.287 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -116.91 154.91 29.99 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.454 -0.794 . . . . 73.549999999999997 109.629 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 162.48 31.97 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.76 0.314 . . . . 75.329999999999998 111.821 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.445 ' CB ' HG23 ' A' ' 23' ' ' THR . 12.6 pt-20 -154.89 139.74 17.2 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.699 -1.593 . . . . 75.310000000000002 106.699 174.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.6 ' HB3' ' CD2' ' A' ' 131' ' ' TYR 0.283 0.2 OUTLIER -103.53 125.6 50.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.208 -0.997 . . . . 63.450000000000003 111.93 177.251 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.411 ' HG2' HG21 ' A' ' 20' ' ' VAL . 70.7 mtt180 -115.03 127.15 55.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.616 -1.174 . . . . 75.140000000000001 109.481 -176.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.64 132.49 34.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.895 -1.52 . . . . 74.450000000000003 106.895 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' A' ' 128' ' ' ILE . 74.6 m -74.71 157.79 34.68 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 120.129 -0.628 . . . . 75.209999999999994 111.622 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -84.7 -25.02 28.66 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.602 -0.726 . . . . 74.310000000000002 111.522 -174.556 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.13 11.02 56.81 Favored Glycine 0 CA--C 1.497 -1.072 0 C-N-CA 119.49 -1.338 . . . . 37.030000000000001 111.474 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.55 165.74 51.88 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 114.114 0.406 . . . . 71.420000000000002 114.114 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -101.02 122.59 43.8 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.818 -0.691 . . . . 71.129999999999995 109.378 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 44.7 m-85 -125.57 165.65 18.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.293 -0.867 . . . . 73.540000000000006 111.894 -170.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.22 116.7 30.99 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 108.78 -0.822 . . . . 73.120000000000005 108.78 -177.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 10.1 t -124.77 143.91 50.54 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-O 121.349 0.595 . . . . 74.219999999999999 111.352 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.517 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.3 m -128.4 139.98 50.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.054 -0.975 . . . . 74.120000000000005 108.791 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.13 136.83 51.7 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.077 -0.649 . . . . 72.140000000000001 112.074 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 29.6 t -131.06 142.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.058 -0.719 . . . . 75.200000000000003 109.058 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 p -135.26 178.15 7.26 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.531 0.332 . . . . 73.040000000000006 110.311 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.0 t70 73.6 -14.99 0.59 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.448 1.099 . . . . 61.43 113.159 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -131.21 147.26 65.53 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.313 -0.625 . . . . 70.239999999999995 109.313 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.28 156.29 5.71 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.652 2.902 . . . . 74.299999999999997 112.526 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 20.5 m -56.2 -36.33 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.518 0.562 . . . . 73.040000000000006 112.518 -174.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 10.4 m-20 -58.78 -49.82 76.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.164 0.507 . . . . 75.430000000000007 110.158 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.04 -36.32 79.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.318 -0.855 . . . . 75.239999999999995 110.191 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -60.38 -47.35 86.43 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.437 -0.801 . . . . 70.400000000000006 110.59 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 59' ' ' MET . 96.1 mt -55.87 -36.97 68.18 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 122.43 0.292 . . . . 74.310000000000002 111.479 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 1.7 mmp_? -59.37 -34.29 72.23 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.307 0.575 . . . . 71.439999999999998 110.456 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -83.98 -41.41 17.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.418 -0.81 . . . . 73.430000000000007 111.338 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.01 -33.09 67.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 114.393 1.257 . . . . 74.0 114.393 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 17.8 mmt -61.31 -57.2 27.22 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 120.317 -0.553 . . . . 74.099999999999994 111.713 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.95 -38.45 86.38 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.594 2.196 . . . . 71.340000000000003 113.008 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -69.15 -28.8 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.019 0.748 . . . . 75.340000000000003 113.019 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.5 mm -76.55 -45.11 33.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.342 -0.614 . . . . 51.109999999999999 109.342 170.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.2 mtp -62.25 -33.49 74.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.452 -0.795 . . . . 62.43 112.941 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -70.25 -40.25 74.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.872 0.368 . . . . 71.129999999999995 110.172 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -59.03 -52.09 67.25 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.137 -0.483 . . . . 75.349999999999994 110.801 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.87 -13.09 14.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.062 -0.517 . . . . 43.219999999999999 111.523 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.37 -16.78 70.52 Favored Glycine 0 CA--C 1.506 -0.486 0 CA-C-N 115.94 -0.573 . . . . 72.519999999999996 112.436 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . 134.4 -11.04 4.68 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 119.746 -1.216 . . . . 40.439999999999998 112.828 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 m -80.3 30.11 0.29 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 122.888 1.327 . . . . 73.230000000000004 110.369 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 68' ' ' GLY . 7.3 p30 -97.81 171.36 8.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.978 -1.01 . . . . 74.420000000000002 109.032 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . 26.5 t70 -67.97 -27.55 66.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 37.030000000000001 113.084 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.55 -13.2 55.0 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.446 -0.902 . . . . 72.140000000000001 109.595 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.31 22.49 74.67 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.608 -0.724 . . . . 54.439999999999998 111.308 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 m -81.97 122.17 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 121.246 0.546 . . . . 62.210000000000001 112.293 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.02 52.76 0.62 Allowed Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.11 -1.196 . . . . 72.120000000000005 110.11 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.7 mtt -82.91 -41.74 18.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.309 0.576 . . . . 73.140000000000001 110.519 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.04 129.03 3.39 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.306 -0.95 . . . . 73.129999999999995 111.593 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.43 ' SD ' ' HE2' ' A' ' 102' ' ' PHE . 23.6 ptp -132.78 126.03 31.45 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.806 -0.442 . . . . 73.209999999999994 109.806 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.4 p -124.83 115.79 21.23 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.023 0.749 . . . . 63.420000000000002 113.023 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 15.6 m -153.59 174.54 3.67 Favored Pre-proline 0 C--N 1.313 -1.003 0 C-N-CA 125.88 1.672 . . . . 75.319999999999993 106.498 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 171' ' ' GLY . 78.2 Cg_exo -56.72 140.36 90.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.157 1.905 . . . . 73.530000000000001 114.057 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 48.6 t -105.75 143.04 17.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.395 -1.706 . . . . 74.209999999999994 106.395 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.4 m -132.35 151.4 51.87 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.996 0.362 . . . . 75.319999999999993 110.332 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -145.07 146.46 31.86 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 122.036 -0.415 . . . . 74.510000000000005 111.162 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.42 135.33 34.13 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 116.029 -0.532 . . . . 72.209999999999994 109.943 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.7 m -137.81 150.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.43 -0.952 . . . . 72.230000000000004 108.43 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 39.5 m-85 -119.88 108.24 39.11 Favored Pre-proline 0 C--N 1.281 -2.378 0 N-CA-C 107.466 -1.309 . . . . 73.010000000000005 107.466 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.01 147.8 8.01 Favored 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 121.243 1.295 . . . . 60.409999999999997 113.69 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.37 154.62 18.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.71 -1.959 . . . . 72.340000000000003 105.71 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.5 -13.15 62.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 114.247 1.202 . . . . 73.049999999999997 114.247 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.66 -4.09 58.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.502 0.668 . . . . 74.420000000000002 109.763 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 -11.07 59.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.733 -0.667 . . . . 37.030000000000001 113.466 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.2 m -78.53 139.38 38.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.251 -0.58 . . . . 63.219999999999999 110.112 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.69 150.9 23.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.645 -0.422 . . . . 71.239999999999995 110.083 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.402 ' NE2' ' HB2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -79.77 150.1 30.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.736 -1.579 . . . . 74.349999999999994 106.736 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.0 38.92 0.54 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.712 0.805 . . . . 63.009999999999998 111.956 -171.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -127.8 122.55 33.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 104.207 -2.516 . . . . 62.210000000000001 104.207 176.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.526 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 3.1 tm? -131.36 145.49 51.86 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.009 0.433 . . . . 75.140000000000001 109.993 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' N ' HD13 ' A' ' 98' ' ' LEU . 87.9 tttt -148.19 116.13 6.41 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.248 -0.887 . . . . 63.039999999999999 110.724 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.517 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 93.7 t -95.1 126.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 122.94 0.496 . . . . 75.140000000000001 110.103 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.94 122.71 46.97 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.274 -1.01 . . . . 75.340000000000003 108.274 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 82.5 t80 -103.5 120.17 40.31 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.315 -0.994 . . . . 72.329999999999998 108.315 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -74.99 122.33 23.33 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.783 -0.644 . . . . 62.039999999999999 109.33 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.466 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 66.7 mt -91.75 125.92 55.65 Favored Pre-proline 0 N--CA 1.415 -2.201 0 N-CA-C 107.226 -1.398 . . . . 52.450000000000003 107.226 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -52.86 155.59 10.7 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 123.289 2.659 . . . . 64.519999999999996 113.558 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -47.29 -44.36 23.2 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.475 1.51 . . . . 75.349999999999994 112.052 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.86 -30.02 68.69 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.015 -0.539 . . . . 71.109999999999999 112.435 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -99.95 -2.69 34.0 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.719 -0.219 . . . . 74.019999999999996 111.584 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.466 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 25.3 mm-40 -70.49 -34.99 72.98 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.21 0.818 . . . . 71.519999999999996 113.21 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.49 -38.28 93.33 Favored Glycine 0 N--CA 1.466 0.64 0 C-N-CA 120.953 -0.642 . . . . 52.539999999999999 112.41 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.3 m -155.46 93.41 2.65 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.682 -0.859 . . . . 74.439999999999998 108.682 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -87.14 157.83 8.41 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.571 2.18 . . . . 74.549999999999997 111.971 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.62 151.93 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.223 1.948 . . . . 64.140000000000001 111.575 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.444 ' HB1' ' CB ' ' A' ' 71' ' ' ASP . . . -85.55 152.69 57.77 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-N 116.012 -0.54 . . . . 52.340000000000003 110.206 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.67 110.94 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.29 1.993 . . . . 52.100000000000001 112.561 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.7 m -80.87 -20.3 42.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.02 0.438 . . . . 75.239999999999995 110.958 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -107.88 140.57 40.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.926 -1.509 . . . . 71.230000000000004 106.926 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -76.18 -12.86 60.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.215 0.45 . . . . 64.409999999999997 112.215 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.3 m -70.88 -32.23 69.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.496 . . . . 73.540000000000006 109.988 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.18 130.07 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.661 -0.699 . . . . 64.109999999999999 109.176 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -127.86 133.14 49.34 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.925 -0.579 . . . . 74.150000000000006 110.275 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.7 mm -93.09 112.4 26.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.606 -0.887 . . . . 63.039999999999999 108.606 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.86 151.86 46.3 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.691 -0.855 . . . . 63.020000000000003 108.691 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.25 146.65 30.06 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.801 -0.444 . . . . 73.150000000000006 109.801 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -140.55 123.09 16.11 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.781 -0.368 . . . . 52.43 110.051 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.8 164.88 28.46 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.412 -0.958 . . . . 60.520000000000003 108.412 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.72 35.47 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.02 -1.086 . . . . 54.43 112.42 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.433 HG13 ' SG ' ' A' ' 36' ' ' CYS . 38.2 pt -135.51 145.72 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.899 0.856 . . . . 75.400000000000006 112.324 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.444 ' HB ' ' HG2' ' A' ' 189' ' ' LYS . 19.8 m -115.5 140.17 49.39 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 104.992 -2.225 . . . . 74.430000000000007 104.992 173.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.16 153.9 30.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.413 0 N-CA-C 109.246 -0.65 . . . . 74.409999999999997 109.246 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 33' ' ' GLU . 42.3 m-85 -113.11 121.49 44.71 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.144 -2.169 . . . . 71.5 105.144 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 16.6 p -112.58 134.28 54.19 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 121.581 0.705 . . . . 61.219999999999999 111.865 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.425 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 8.8 t -126.25 133.87 51.35 Favored 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 114.87 -1.059 . . . . 64.230000000000004 109.255 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 50.1 mt-30 -111.09 146.57 36.55 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.781 -0.368 . . . . 75.319999999999993 110.676 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -146.93 168.16 22.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.897 -0.592 . . . . 75.329999999999998 109.476 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.12 152.15 23.42 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.815 -0.914 . . . . 75.129999999999995 110.815 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 135.68 -138.58 10.05 Favored Glycine 0 C--N 1.313 -0.73 0 N-CA-C 110.921 -0.872 . . . . 73.129999999999995 110.921 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -100.56 106.67 18.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.782 -0.821 . . . . 75.150000000000006 108.782 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.85 114.64 27.31 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.48 0.919 . . . . 73.310000000000002 113.48 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -102.14 175.56 5.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.875 -1.528 . . . . 63.409999999999997 106.875 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.46 ' O ' HG21 ' A' ' 145' ' ' VAL . 2.1 mp0 -57.79 -44.18 86.09 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.252 -1.018 . . . . 51.409999999999997 108.252 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.33 67.36 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.191 -1.368 . . . . 70.530000000000001 112.16 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 147' ' ' HIS . 5.1 m-20 -65.72 -49.07 69.8 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 121.098 -0.241 . . . . 71.420000000000002 110.387 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.453 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 48.5 m-85 -57.96 -43.47 86.43 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.499 0.499 . . . . 74.109999999999999 110.099 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 141' ' ' GLU . 58.8 t -62.7 -51.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 120.997 0.427 . . . . 74.109999999999999 111.322 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.16 75.3 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.397 0.618 . . . . 62.020000000000003 110.41 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 7.7 t-160 -66.79 -47.89 70.7 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.457 -0.792 . . . . 62.420000000000002 108.902 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.24 92.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.589 -0.732 . . . . 75.200000000000003 110.368 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 89.0 m -64.56 -36.61 84.77 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.744 -0.662 . . . . 75.340000000000003 110.838 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -74.11 -28.62 61.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.691 -0.403 . . . . 70.349999999999994 110.161 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 81.4 mt -58.98 -34.58 71.98 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 109.938 -0.393 . . . . 54.350000000000001 109.938 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 149' ' ' THR . 30.6 mtp180 -61.33 -38.82 88.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.779 -0.646 . . . . 63.030000000000001 109.454 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -73.07 -37.41 66.8 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.147 -0.933 . . . . 74.310000000000002 110.365 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.2 m -77.41 -34.51 54.72 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.09 0.471 . . . . 74.540000000000006 110.829 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 158' ' ' THR . 95.4 mt -80.83 7.66 9.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.579 0.752 . . . . 63.420000000000002 111.136 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -82.34 130.37 35.08 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.92 -1.141 . . . . 75.230000000000004 107.92 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.56 58.3 Favored Glycine 0 C--N 1.307 -1.081 0 C-N-CA 120.649 -0.786 . . . . 74.5 112.528 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 155' ' ' LEU . 15.4 t -125.2 149.25 63.28 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 107.772 -1.196 . . . . 75.340000000000003 107.772 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -64.25 -2.77 5.24 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 123.489 2.793 . . . . 73.0 115.154 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . . . -62.98 142.54 58.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.723 0.297 . . . . 74.349999999999994 111.361 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 46.7 p -116.56 151.72 35.6 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.085 -0.507 . . . . 73.219999999999999 109.886 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -143.91 149.29 36.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.764 -0.458 . . . . 74.400000000000006 109.764 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -134.0 145.49 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.514 0.931 . . . . 75.439999999999998 113.514 -174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.84 -1.39 23.45 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.876 -1.056 . . . . 43.219999999999999 115.257 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 t70 61.16 7.99 1.84 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.024 0.93 . . . . 70.409999999999997 111.057 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.74 139.69 18.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 124.446 1.098 . . . . 62.109999999999999 110.165 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 144' ' ' TYR . 43.9 p90 -137.86 167.61 21.39 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.619 -0.719 . . . . 73.140000000000001 109.173 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.514 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 79.2 m-85 -115.69 152.78 32.53 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.308 -0.997 . . . . 64.340000000000003 108.308 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 83' ' ' SER . 59.7 m -113.62 132.34 55.78 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.616 -1.253 . . . . 73.319999999999993 107.616 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 82' ' ' VAL . . . -128.23 147.19 50.57 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.032 0.444 . . . . 70.400000000000006 111.034 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.912 0 N-CA-C 110.133 -1.187 . . . . 64.010000000000005 110.133 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 CA--C 1.515 -0.377 0 CA-C-O 122.019 0.914 . . . . 70.340000000000003 109.125 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -142.27 129.51 21.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.634 -1.166 . . . . 74.409999999999997 108.211 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 38.1 m-80 -141.14 148.58 40.28 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 105.257 -2.127 . . . . 72.409999999999997 105.257 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 37.4 tt0 -126.38 141.02 52.05 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.023 -0.671 . . . . 72.030000000000001 110.486 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 132' ' ' SER . 29.0 t -124.49 129.14 73.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.744 -1.206 . . . . 74.299999999999997 107.744 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 39.0 m0 -110.15 126.9 54.57 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 110.135 -0.32 . . . . 75.140000000000001 110.135 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.83 137.74 39.72 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.523 -1.658 . . . . 75.230000000000004 106.523 172.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.46 133.18 43.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 120.554 -0.459 . . . . 74.129999999999995 112.203 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -69.64 143.38 53.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.683 -0.69 . . . . 72.439999999999998 111.92 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.416 ' HB2' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.305 -1.338 0 CA-C-O 118.433 -0.794 . . . . 60.149999999999999 109.123 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 109.839 -0.43 . . . . 73.25 109.839 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -103.55 135.87 44.33 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.635 -0.876 . . . . 73.409999999999997 108.635 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.433 ' H ' HD21 ' A' ' 9' ' ' LEU . 1.6 pt? -119.24 115.6 24.54 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.183 0.516 . . . . 75.540000000000006 111.552 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -132.1 174.98 9.64 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.927 -0.768 . . . . 73.340000000000003 108.927 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.12 -177.84 21.97 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.789 -0.924 . . . . 65.040000000000006 110.789 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.4 p -91.15 -25.84 19.37 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.13 0.491 . . . . 61.310000000000002 111.001 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.92 97.42 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 122.152 0.977 . . . . 51.520000000000003 111.163 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.27 123.16 0.8 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.237 -2.505 . . . . 73.439999999999998 104.237 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.474 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 8.9 t -142.37 -52.85 0.41 Allowed 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 118.633 -1.227 . . . . 73.549999999999997 113.203 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -140.04 95.56 8.47 Favored Pre-proline 0 CA--C 1.503 -0.832 0 CA-C-N 117.993 0.361 . . . . 73.230000000000004 110.969 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.618 ' HD2' ' OE2' ' A' ' 37' ' ' GLU . 9.9 Cg_exo -72.38 119.87 6.4 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 121.548 1.499 . . . . 74.409999999999997 109.594 173.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.562 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.2 p90 -139.94 172.0 13.39 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.91 -1.144 . . . . 74.329999999999998 107.91 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 54.4 tt0 -106.0 109.24 21.12 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.057 -0.657 . . . . 71.510000000000005 109.646 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.8 p -93.31 131.92 38.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.247 -1.019 . . . . 71.510000000000005 108.247 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 33' ' ' GLU . 10.2 mt -89.25 -40.93 12.5 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.12 -1.067 . . . . 72.439999999999998 108.12 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 m -173.11 169.6 4.57 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.617 1.167 . . . . 74.239999999999995 108.313 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.77 165.59 24.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.562 -1.273 . . . . 75.329999999999998 107.562 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.31 89.87 0.17 Allowed Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 118.759 -1.686 . . . . 62.039999999999999 113.78 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.68 -134.11 4.25 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.757 -0.735 . . . . 54.329999999999998 111.912 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -115.27 173.81 6.32 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 123.821 0.848 . . . . 74.409999999999997 110.411 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -64.61 141.72 58.68 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.074 -1.084 . . . . 70.329999999999998 108.074 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 73.86 -62.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.673 1.189 . . . . 73.150000000000006 110.587 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.466 HG23 ' CD2' ' A' ' 147' ' ' HIS . 23.5 t -97.32 108.82 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.07 -1.085 . . . . 63.0 108.07 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.9 m -123.53 137.56 54.74 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.093 -1.077 . . . . 74.230000000000004 108.093 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -115.75 160.84 19.57 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.497 1.295 . . . . 71.129999999999995 114.497 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.5 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -147.0 125.85 12.7 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.126 -1.852 . . . . 73.329999999999998 106.682 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.49 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -104.66 122.1 44.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 119.169 -1.012 . . . . 74.310000000000002 108.676 175.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 31.7 ptt180 -141.37 153.86 45.32 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.123 -0.944 . . . . 75.099999999999994 111.445 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.05 136.33 36.65 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.093 -1.077 . . . . 54.119999999999997 108.093 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -61.58 149.24 39.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.315 1.228 . . . . 62.329999999999998 114.315 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.618 ' OE2' ' HD2' ' A' ' 17' ' ' PRO . 4.4 tp10 -51.32 -50.7 58.89 Favored 'General case' 0 C--N 1.367 1.367 0 C-N-CA 124.151 0.981 . . . . 75.219999999999999 110.786 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.52 9.31 53.32 Favored Glycine 0 C--N 1.294 -1.763 0 C-N-CA 120.099 -1.048 . . . . 63.350000000000001 110.924 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -71.82 165.38 53.85 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.062 -0.569 . . . . 71.340000000000003 112.28 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 18.4 ptpt -88.54 129.69 35.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.471 -0.566 . . . . 64.340000000000003 109.471 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 58.1 m-85 -128.69 164.21 23.44 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.372 0.669 . . . . 74.409999999999997 110.549 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.97 116.87 33.02 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 108.652 -0.87 . . . . 61.310000000000002 108.652 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.4 t -125.43 143.46 50.98 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 121.141 0.496 . . . . 75.439999999999998 112.213 -175.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 14.8 m -129.65 127.74 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.077 -0.965 . . . . 71.430000000000007 109.906 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.76 128.08 56.1 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.711 0.767 . . . . 65.299999999999997 111.42 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 40.2 t -112.6 140.55 31.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.892 -1.049 . . . . 75.329999999999998 109.239 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 49' ' ' LYS . 40.9 p -132.37 172.73 12.09 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.264 -0.643 . . . . 63.25 109.264 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.22 -40.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.597 1.159 . . . . 73.120000000000005 111.626 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 47' ' ' THR . 36.3 mtmm -93.24 127.86 45.17 Favored Pre-proline 0 C--N 1.288 -2.066 0 CA-C-N 114.965 -1.016 . . . . 61.25 110.219 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.3 158.95 11.2 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 124.394 3.396 . . . . 65.019999999999996 112.37 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG12 HD11 ' A' ' 98' ' ' LEU . 53.0 t -46.53 -39.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.61 0.764 . . . . 71.030000000000001 112.189 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.28 -50.41 71.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.971 0.415 . . . . 72.319999999999993 111.061 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 32.4 mm-40 -75.18 -44.1 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.784 -0.644 . . . . 61.350000000000001 111.919 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -56.68 -42.97 79.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.295 0.638 . . . . 71.540000000000006 111.977 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 59' ' ' MET . 64.6 tp -63.8 -51.84 62.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.719 0.295 . . . . 41.229999999999997 110.703 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -65.82 -24.86 67.0 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 113.162 0.801 . . . . 74.099999999999994 113.162 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' CD ' ' HZ3' ' A' ' 61' ' ' LYS . 3.8 tm-20 -83.87 -33.85 24.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.657 0.741 . . . . 74.150000000000006 109.837 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.538 ' HA ' ' NZ ' ' A' ' 61' ' ' LYS . . . -75.88 -33.03 59.94 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 112.885 0.698 . . . . 65.200000000000003 112.885 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.533 ' HA ' ' HE3' ' A' ' 59' ' ' MET . 12.4 mmt -50.79 -51.31 67.54 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 112.738 0.644 . . . . 74.430000000000007 112.738 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -52.29 -39.11 73.21 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.482 2.121 . . . . 64.329999999999998 111.619 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.538 ' NZ ' ' HA ' ' A' ' 58' ' ' ALA . 35.2 mtmm -69.71 -32.19 70.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.422 . . . . 72.510000000000005 111.878 -177.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -76.3 -45.1 35.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.001 0.429 . . . . 74.430000000000007 110.823 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ptm -69.7 -30.68 68.38 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 112.275 0.472 . . . . 74.299999999999997 112.275 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 61' ' ' LYS . 20.2 ptmt -67.95 -30.52 69.83 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.704 -0.398 . . . . 72.409999999999997 109.936 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -63.11 -55.95 20.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.044 -0.525 . . . . 73.129999999999995 111.103 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.89 -15.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.894 0.378 . . . . 74.439999999999998 111.781 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.015 -0.539 . . . . 53.329999999999998 113.071 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.58 -12.75 2.71 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.438 -1.363 . . . . 72.299999999999997 113.495 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 116' ' ' SER . 21.5 m -82.77 29.55 0.45 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.724 1.25 . . . . 71.120000000000005 110.314 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.12 161.05 13.91 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.973 -1.121 . . . . 37.789999999999999 107.973 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -67.4 -33.21 74.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.724 0.639 . . . . 63.25 112.724 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -78.16 -12.47 60.0 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.266 0.555 . . . . 70.030000000000001 110.461 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 36.12 70.18 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.806 -0.634 . . . . 74.329999999999998 112.256 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -80.54 122.51 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.409 -0.589 . . . . 74.439999999999998 109.409 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.92 1.99 61.55 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.193 -0.527 . . . . 63.340000000000003 111.93 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.2 tpt -73.14 98.33 2.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.193 0.52 . . . . 74.450000000000003 110.621 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.79 89.3 0.86 Allowed Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.71 -0.956 . . . . 64.239999999999995 110.71 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.73 125.38 40.27 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.525 0.678 . . . . 62.420000000000002 111.11 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 m -127.86 118.46 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.867 1.062 . . . . 72.030000000000001 113.867 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.44 -179.62 0.66 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 104.602 -2.37 . . . . 74.109999999999999 104.602 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.27 137.8 67.96 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 122.582 1.958 . . . . 73.340000000000003 111.4 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 44.6 t -102.75 141.68 18.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.272 -1.381 . . . . 53.340000000000003 107.272 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 168' ' ' TYR . 26.1 t -126.32 146.23 50.11 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.605 -0.438 . . . . 61.229999999999997 109.859 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 43.9 p90 -135.36 142.69 45.79 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 110.135 -0.32 . . . . 74.310000000000002 110.135 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.479 ' HB3' ' CE2' ' A' ' 168' ' ' TYR . . . -93.11 134.89 34.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 123.785 0.678 . . . . 64.109999999999999 110.411 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 m -126.58 150.14 32.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.787 -1.097 . . . . 64.150000000000006 108.294 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.575 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 46.0 m-85 -120.87 104.1 42.25 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 120.371 -0.531 . . . . 75.219999999999999 110.288 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.58 133.58 3.79 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.037 1.824 . . . . 72.5 112.103 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -86.48 162.33 18.14 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.15 -1.055 . . . . 72.0 108.15 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.49 -12.95 61.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.513 0.673 . . . . 73.049999999999997 111.211 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.36 -6.09 56.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.857 -0.611 . . . . 72.340000000000003 109.917 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.88 -10.32 74.1 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 115.97 -0.559 . . . . 75.329999999999998 112.791 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.9 m -91.97 137.95 31.94 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 110.151 -0.314 . . . . 74.239999999999995 110.151 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 mp -75.14 138.68 42.21 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.266 0.555 . . . . 50.130000000000003 111.545 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.2 129.38 34.46 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.535 -2.024 . . . . 63.039999999999999 105.535 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -71.73 81.73 0.87 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.165 0.983 . . . . 74.129999999999995 113.27 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.575 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 37.8 ttmt -160.46 125.61 3.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.998 -2.223 . . . . 71.400000000000006 104.998 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD11 HG12 ' A' ' 51' ' ' VAL . 6.0 tt -135.5 129.28 32.85 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 108.669 -0.863 . . . . 63.229999999999997 108.669 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -122.3 114.84 21.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.244 -0.65 . . . . 75.310000000000002 109.244 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.5 t -92.4 129.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.958 -0.565 . . . . 63.229999999999997 109.579 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -110.79 123.35 49.9 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.904 -0.776 . . . . 75.049999999999997 108.904 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -102.53 112.48 25.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.939 -1.134 . . . . 74.450000000000003 107.939 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 39.7 ttp180 -76.91 121.26 23.19 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-N 114.376 -1.284 . . . . 61.439999999999998 109.901 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.0 mt -88.45 133.04 37.26 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 115.211 -0.904 . . . . 74.140000000000001 109.934 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.13 154.67 32.55 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.919 2.412 . . . . 74.349999999999994 111.562 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 15' ' ' THR . 26.1 t-20 -53.42 -45.26 69.32 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.086 1.143 . . . . 73.140000000000001 114.086 -174.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.97 -31.55 71.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.225 0.536 . . . . 55.039999999999999 111.161 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.89 -5.85 49.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.18 -0.464 . . . . 73.150000000000006 111.323 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.599 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.68 -38.26 73.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.728 -0.842 . . . . 74.409999999999997 108.728 174.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.96 93.56 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.281 -0.872 . . . . 72.230000000000004 112.138 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.2 m -154.27 92.88 2.96 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 122.534 0.334 . . . . 50.119999999999997 111.049 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -90.11 149.4 4.67 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.364 2.043 . . . . 70.420000000000002 111.535 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -65.9 146.33 82.66 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.592 2.195 . . . . 73.140000000000001 111.407 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.22 147.01 85.19 Favored Pre-proline 0 C--O 1.255 1.36 0 C-N-CA 120.634 -0.426 . . . . 72.430000000000007 110.413 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.45 113.38 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.604 2.203 . . . . 64.530000000000001 111.547 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 69' ' ' THR . 26.5 t -91.23 -12.52 35.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.563 0.697 . . . . 72.140000000000001 109.718 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 120' ' ' VAL . 9.5 t70 -100.67 136.78 40.0 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.52 -1.289 . . . . 73.430000000000007 107.52 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 121' ' ' LYS . 13.9 pt-20 -72.45 -19.12 61.63 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.234 0.827 . . . . 73.230000000000004 113.234 -173.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.8 m -86.36 -25.6 25.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.531 -0.468 . . . . 75.239999999999995 111.169 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 117' ' ' ASP . 10.7 p -97.13 129.09 47.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 120.402 -0.519 . . . . 63.409999999999997 109.627 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 118' ' ' GLU . 75.7 mmtt -124.21 143.19 50.66 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.255 -0.429 . . . . 74.409999999999997 110.22 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 23.6 mm -92.74 111.1 23.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.703 -1.221 . . . . 64.450000000000003 107.703 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -125.22 142.39 51.52 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.557 -0.747 . . . . 75.25 109.387 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 11.2 pt-20 -100.41 135.71 41.43 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.079 -0.711 . . . . 73.120000000000005 109.079 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.533 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 32.3 tpt180 -125.58 122.15 35.66 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.032 -0.667 . . . . 74.430000000000007 110.767 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.56 177.61 8.36 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.143 -1.058 . . . . 74.219999999999999 108.143 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.28 -12.8 68.75 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.514 -0.85 . . . . 63.299999999999997 114.68 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.265 2.6 pp -121.13 157.73 24.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 118.553 -1.259 . . . . 70.319999999999993 113.593 -176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.6 m -109.57 133.61 52.89 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.922 -1.49 . . . . 50.420000000000002 108.751 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.441 HG12 HG22 ' A' ' 188' ' ' VAL . 32.0 m -124.0 157.06 31.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-O 121.155 0.502 . . . . 72.209999999999994 110.454 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 69.4 m-85 -113.21 121.87 45.77 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 103.618 -2.734 . . . . 61.219999999999999 103.618 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.7 m -119.46 132.24 55.76 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 120.656 -0.418 . . . . 63.350000000000001 110.353 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.9 t -112.8 128.13 56.35 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.936 -0.764 . . . . 74.150000000000006 108.936 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.04 125.34 53.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.522 -1.658 . . . . 71.209999999999994 106.522 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 26.1 p90 -141.71 154.89 45.6 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.858 -0.61 . . . . 73.310000000000002 110.491 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.86 14.75 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.79 -0.719 . . . . 51.340000000000003 113.109 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 144.17 -176.92 23.14 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.202 -1.559 . . . . 53.450000000000003 109.202 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -81.36 107.7 14.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.014 0.907 . . . . 75.099999999999994 109.288 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 175' ' ' PRO . . . -96.45 138.19 34.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.508 0.671 . . . . 70.310000000000002 112.483 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.495 ' HE3' ' OD1' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -109.98 176.66 4.98 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.562 -1.644 . . . . 74.510000000000005 106.562 172.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -36.19 80.36 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.261 0.467 . . . . 73.519999999999996 112.261 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.11 -32.56 73.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 73.430000000000007 111.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.495 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 5.4 m-20 -63.97 -34.42 77.95 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 116.365 -0.38 . . . . 64.510000000000005 111.52 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.17 -43.93 90.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.99 0.424 . . . . 74.129999999999995 110.022 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.447 HG22 ' HH ' ' A' ' 167' ' ' TYR . 41.1 t -66.17 -45.86 89.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.533 -0.758 . . . . 74.439999999999998 109.457 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.12 96.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 65.219999999999999 111.084 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.466 ' CD2' HG23 ' A' ' 29' ' ' VAL . 56.6 m80 -67.78 -33.88 75.69 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 120.729 -0.389 . . . . 73.400000000000006 111.97 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.71 82.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.505 -0.554 . . . . 70.010000000000005 109.505 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 56.3 m -60.37 -49.95 75.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.612 -0.722 . . . . 75.430000000000007 109.725 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.28 -29.73 66.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.969 -0.559 . . . . 73.340000000000003 112.16 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.46 ' HA ' HG21 ' A' ' 154' ' ' THR . 34.6 tp -65.69 -36.98 85.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.653 -0.499 . . . . 71.409999999999997 109.653 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.533 ' HG2' ' CE2' ' A' ' 162' ' ' TYR . 40.3 mtp180 -69.28 -37.22 77.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.917 -0.583 . . . . 74.420000000000002 110.218 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.1 m -69.02 -35.65 76.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.632 -0.713 . . . . 64.299999999999997 110.34 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 151' ' ' LEU . 14.7 t -78.18 -33.22 50.24 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 120.65 -0.42 . . . . 71.209999999999994 111.011 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.68 6.21 9.37 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.167 0.508 . . . . 71.310000000000002 111.495 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.49 132.02 44.92 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.329 -0.619 . . . . 73.420000000000002 109.329 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.34 11.74 50.84 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 121.139 -0.553 . . . . 51.119999999999997 111.993 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.7 p -123.38 165.48 22.58 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 108.386 -0.968 . . . . 74.430000000000007 108.386 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.63 12.67 1.58 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.573 2.182 . . . . 73.439999999999998 112.312 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.52 118.84 14.84 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.943 0.401 . . . . 74.219999999999999 111.041 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.7 p -121.18 164.65 16.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.701 -1.592 . . . . 75.340000000000003 106.701 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.533 ' CE2' ' HG2' ' A' ' 152' ' ' ARG . 12.2 m-85 -130.43 152.29 50.0 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.337 -0.945 . . . . 71.420000000000002 108.847 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 190' ' ' ALA 0.268 3.5 pp0? -102.53 115.08 29.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.295 0.569 . . . . 74.319999999999993 111.889 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.89 1.36 62.29 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.477 -0.783 . . . . 72.430000000000007 111.357 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.7 t70 59.96 20.62 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.609 1.564 . . . . 54.399999999999999 109.658 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.4 138.47 16.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 114.621 -1.172 . . . . 74.319999999999993 112.069 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.447 ' HH ' HG22 ' A' ' 145' ' ' VAL . 22.0 p90 -135.79 152.67 51.33 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.949 -1.023 . . . . 62.229999999999997 108.694 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 9.7 m-85 -115.15 140.75 48.81 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.231 -1.025 . . . . 74.430000000000007 108.231 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 83' ' ' SER . 61.9 m -114.22 119.54 37.38 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.85 -0.796 . . . . 74.310000000000002 108.85 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 82' ' ' VAL . . . -112.32 139.65 47.7 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.092 0.473 . . . . 73.219999999999999 111.818 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.74 164.6 37.8 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 107.248 -2.341 . . . . 45.109999999999999 107.248 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -80.51 -29.64 37.29 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 118.58 1.19 . . . . 73.299999999999997 110.427 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -143.47 162.93 39.68 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 106.992 -1.484 . . . . 63.439999999999998 106.992 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -72.59 108.58 2.57 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.898 1.732 . . . . 73.120000000000005 107.947 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.46 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 4.9 Cg_exo -76.84 130.61 11.57 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.164 1.909 . . . . 72.120000000000005 113.873 -173.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 51.5 ttm -97.0 -43.35 7.48 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.819 -1.178 . . . . 73.230000000000004 107.819 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.506 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 67.4 mttm -153.87 -72.42 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 113.4 0.889 . . . . 62.240000000000002 113.4 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 177' ' ' LYS . 1.5 Cg_endo -84.3 -31.28 0.51 Allowed 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.699 1.599 . . . . 65.510000000000005 114.985 -172.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -94.79 87.8 5.13 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.67 0.748 . . . . 75.120000000000005 111.951 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.68 61.03 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 108.659 -1.776 . . . . 63.549999999999997 108.659 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 80.4 mtt180 -96.13 -28.56 14.52 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.899 -0.651 . . . . 73.420000000000002 110.976 -176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -112.97 127.83 56.33 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.596 -1.261 . . . . 74.010000000000005 107.596 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.46 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 8.6 m120 -143.76 158.86 43.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.744 -0.465 . . . . 73.230000000000004 109.744 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.461 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 43.9 mt-10 -137.08 145.15 43.6 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.02 -0.733 . . . . 64.450000000000003 109.02 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 81.7 t -125.6 121.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.786 -1.191 . . . . 74.310000000000002 107.786 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.431 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 24.7 m0 -110.21 122.15 46.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 110.617 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 87.6 mt -102.41 138.57 39.16 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.776 -1.194 . . . . 71.319999999999993 107.776 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.441 HG22 HG12 ' A' ' 130' ' ' VAL . 27.9 t -103.47 130.59 53.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.477 -0.564 . . . . 73.439999999999998 109.477 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.9 ttpt -69.25 132.54 46.64 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.82 -0.807 . . . . 70.209999999999994 108.82 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.468 1.105 . . . . 61.030000000000001 112.054 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 . . . . . 0 C--O 1.24 0.573 0 N-CA-C 109.89 -0.411 . . . . 72.400000000000006 109.89 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.2 p -92.84 107.69 19.41 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.427 0.632 . . . . 74.219999999999999 111.047 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.5 mt -98.37 134.02 41.95 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.88 -0.785 . . . . 60.439999999999998 108.88 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -89.87 135.58 33.55 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.752 -0.379 . . . . 75.409999999999997 110.323 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.2 100.79 0.55 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.3 -1.12 . . . . 74.239999999999995 110.3 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -67.22 128.2 35.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 123.114 0.566 . . . . 44.240000000000002 111.057 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.1 m -94.3 85.52 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 122.004 0.907 . . . . 73.329999999999998 110.705 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -70.14 137.55 51.15 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.116 -0.947 . . . . 65.150000000000006 108.825 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.6 m 73.75 68.79 0.11 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 124.39 1.076 . . . . 71.340000000000003 109.839 -176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.641 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 71.9 t-105 -82.47 133.21 50.37 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 114.773 -1.103 . . . . 72.310000000000002 108.505 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.81 150.17 83.33 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 C-N-CA 122.535 2.157 . . . . 74.439999999999998 110.566 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.435 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 45.8 p90 -99.94 149.67 23.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.739 -0.784 . . . . 72.239999999999995 109.868 -176.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -105.58 109.16 21.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.253 -0.885 . . . . 73.150000000000006 110.038 -173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.13 128.22 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.724 -1.213 . . . . 75.109999999999999 107.724 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.258 0.5 OUTLIER -96.6 -32.45 12.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 113.747 1.017 . . . . 74.430000000000007 113.747 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 28.5 t -151.86 152.91 33.21 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.864 -0.735 . . . . 72.209999999999994 111.907 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 32' ' ' GLU . 27.2 p -133.81 152.91 52.01 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.171 -0.922 . . . . 72.109999999999999 110.578 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.04 -131.99 10.76 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 120.632 -0.794 . . . . 64.239999999999995 112.691 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -104.5 1.45 Allowed Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 121.116 -0.564 . . . . 65.049999999999997 112.077 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.13 171.67 7.66 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 122.827 0.451 . . . . 65.150000000000006 110.203 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.18 157.52 25.24 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.679 -1.23 . . . . 74.310000000000002 107.679 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t70 75.48 -49.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.436 1.494 . . . . 74.310000000000002 111.425 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.24 110.98 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.68 0.752 . . . . 73.0 110.03 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 p -110.8 135.9 50.66 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.731 -0.668 . . . . 73.409999999999997 109.495 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -112.1 162.25 15.62 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.129 0.49 . . . . 73.120000000000005 112.154 -175.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 22' ' ' SER . 13.1 pt-20 -153.0 129.83 10.94 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.554 -2.017 . . . . 71.230000000000004 105.554 170.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.49 141.61 47.47 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 118.898 -1.121 . . . . 74.430000000000007 109.518 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 157.11 46.26 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 119.535 -0.866 . . . . 72.209999999999994 109.261 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 133.89 35.41 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.466 -2.05 . . . . 52.420000000000002 105.466 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.6 m -58.38 141.65 50.68 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.87 1.063 . . . . 70.109999999999999 113.87 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.641 ' HB2' ' O ' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -70.3 -16.53 63.02 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.47 -1.695 . . . . 53.420000000000002 112.137 -175.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.94 12.03 66.77 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.414 -1.851 . . . . 64.430000000000007 111.664 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.03 145.98 42.25 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 120.343 -0.932 . . . . 51.420000000000002 111.72 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -96.32 117.99 31.94 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.842 -0.799 . . . . 62.43 108.842 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.9 m-85 -122.69 163.86 19.34 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.512 -0.767 . . . . 72.420000000000002 110.826 -172.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.21 116.49 31.51 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.312 -0.625 . . . . 74.209999999999994 109.312 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.7 t -122.17 145.94 47.72 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 112.477 0.547 . . . . 65.430000000000007 112.477 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 16.0 m -129.95 140.89 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 125.104 1.361 . . . . 73.430000000000007 107.776 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.3 pt-20 -128.01 135.77 50.36 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.16 -1.416 . . . . 74.109999999999999 112.22 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 41.2 t -118.41 140.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 106.386 -1.709 . . . . 74.310000000000002 106.386 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 49' ' ' LYS . 38.6 p -126.26 167.17 15.84 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.727 -0.389 . . . . 73.510000000000005 110.537 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t70 73.72 -36.97 0.36 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.436 1.094 . . . . 52.219999999999999 112.108 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 47' ' ' THR . 95.0 mttt -85.75 138.14 35.63 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.53 -0.759 . . . . 71.230000000000004 110.841 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.96 157.14 25.67 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.002 2.468 . . . . 74.310000000000002 110.748 174.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 t -47.63 -43.88 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 114.952 1.464 . . . . 72.030000000000001 114.952 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.95 -33.11 74.03 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.048 -0.661 . . . . 75.129999999999995 110.675 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -74.85 -44.06 51.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.526 0.679 . . . . 73.120000000000005 110.129 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -65.23 -43.56 91.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.369 -0.832 . . . . 63.43 111.468 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.03 -40.13 82.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 111.694 0.257 . . . . 71.319999999999993 111.694 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.91 -24.82 66.92 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 121.013 -0.275 . . . . 64.010000000000005 111.431 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 30.2 tt0 -84.47 -44.72 13.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.506 0.67 . . . . 73.540000000000006 110.26 175.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.5 -40.45 70.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 114.67 1.359 . . . . 62.130000000000003 114.67 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.436 ' HE1' ' HB2' ' A' ' 59' ' ' MET . 42.5 ttm -57.83 -46.02 99.76 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 113.078 0.77 . . . . 72.329999999999998 113.078 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.34 -40.75 52.7 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.385 2.057 . . . . 72.109999999999999 111.923 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 48.2 mtmt -69.14 -34.5 75.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.862 -0.608 . . . . 63.130000000000003 110.81 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -70.96 -48.88 53.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.886 -0.597 . . . . 72.540000000000006 111.059 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.5 ptm -68.96 -30.3 68.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.069 0.766 . . . . 74.549999999999997 113.069 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -72.33 -27.98 62.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.325 -0.95 . . . . 73.200000000000003 109.989 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.428 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 93.4 t80 -63.07 -57.94 8.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.335 -0.848 . . . . 74.040000000000006 109.886 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.3 m -73.17 -20.79 18.78 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 CA-C-N 116.149 -0.478 . . . . 75.040000000000006 110.928 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.77 -25.68 69.29 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.08 -0.509 . . . . 37.810000000000002 113.264 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.22 -10.22 2.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.149 -1.024 . . . . 75.329999999999998 113.039 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 m -89.56 27.6 1.46 Allowed 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.115 0.959 . . . . 74.439999999999998 110.254 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.31 169.21 10.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 110.003 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.85 -32.86 73.23 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.904 0.705 . . . . 73.109999999999999 112.904 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 113' ' ' PRO . 99.5 mttt -91.23 -7.69 50.56 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.764 -0.775 . . . . 64.329999999999998 112.577 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.69 73.65 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.929 -0.578 . . . . 62.450000000000003 112.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.5 m -82.23 158.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.42 -0.512 . . . . 74.040000000000006 110.243 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.27 173.69 41.1 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 120.891 -0.671 . . . . 63.020000000000003 111.735 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 52.6 ttp -75.17 95.95 3.2 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.064 0.459 . . . . 71.430000000000007 110.154 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.65 10.3 9.77 Favored Glycine 0 N--CA 1.426 -1.971 0 CA-C-N 115.386 -0.824 . . . . 45.409999999999997 112.341 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -118.79 123.45 44.82 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.207 -0.597 . . . . 65.349999999999994 110.865 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.9 p -127.53 117.54 22.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.748 0.647 . . . . 70.299999999999997 112.748 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -152.99 172.82 5.17 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.503 -1.665 . . . . 65.409999999999997 106.503 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.76 139.94 25.57 Favored 'Trans proline' 0 C--O 1.253 1.225 0 C-N-CA 121.01 1.14 . . . . 73.219999999999999 110.505 175.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.86 141.43 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.815 -0.809 . . . . 73.230000000000004 108.815 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 p -119.46 145.41 46.3 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 110.203 -0.295 . . . . 70.099999999999994 110.203 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -144.44 140.62 29.08 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 122.048 -0.408 . . . . 71.329999999999998 110.822 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -92.68 134.55 34.91 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-N 115.68 -0.691 . . . . 74.239999999999995 109.287 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.25 159.21 30.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 114.779 -1.101 . . . . 74.450000000000003 109.158 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 97' ' ' LYS . 78.4 m-85 -125.23 106.16 28.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 110.03 -0.359 . . . . 75.120000000000005 110.03 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.07 136.15 11.47 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.502 2.135 . . . . 72.230000000000004 114.07 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' A' ' 96' ' ' LYS . 49.9 m-80 -95.3 161.51 14.06 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.252 -1.388 . . . . 74.430000000000007 107.252 172.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.59 -13.35 58.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.698 0.761 . . . . 72.400000000000006 111.005 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.24 -6.32 54.58 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.832 -1.076 . . . . 61.100000000000001 110.338 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.53 -9.73 69.79 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.338 -0.458 . . . . 45.350000000000001 112.247 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 m -90.19 132.6 35.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 110.163 -0.31 . . . . 65.209999999999994 110.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.87 96.11 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.46 -0.941 . . . . 74.0 108.46 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -147.44 114.34 6.12 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.571 -0.899 . . . . 72.430000000000007 108.571 -178.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 74.1 mmtt -176.63 -70.1 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.565 1.946 . . . . 52.200000000000003 106.478 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 87' ' ' PHE . 27.4 mtpp -153.16 159.33 42.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.279 -1.782 . . . . 72.340000000000003 107.586 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 98' ' ' LEU . 5.7 tt -143.77 128.43 18.18 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.135 -0.691 . . . . 72.409999999999997 109.135 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.7 mttt -117.56 115.55 25.35 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.592 -0.276 . . . . 74.439999999999998 110.781 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.1 t -89.09 127.02 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.039 -1.097 . . . . 53.409999999999997 108.039 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.552 ' CD1' ' HE2' ' A' ' 168' ' ' TYR . 70.1 m95 -113.97 120.59 41.18 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.734 -0.839 . . . . 75.230000000000004 108.734 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -102.78 113.28 26.57 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 108.317 -0.994 . . . . 75.400000000000006 108.317 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.542 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 81.7 mtm180 -75.12 137.91 41.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.535 -1.211 . . . . 72.400000000000006 111.803 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.558 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 63.9 mt -113.24 130.4 23.66 Favored Pre-proline 0 C--N 1.286 -2.193 0 CA-C-N 115.396 -0.82 . . . . 73.129999999999995 109.862 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.19 163.99 36.6 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.62 2.88 . . . . 74.230000000000004 112.921 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -46.46 -35.52 5.7 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.996 1.718 . . . . 75.219999999999999 112.976 -176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -46.52 86.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.968 0.413 . . . . 42.219999999999999 110.581 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -99.17 -4.5 31.99 Favored 'General case' 0 C--O 1.197 -1.666 0 N-CA-C 112.652 0.612 . . . . 75.439999999999998 112.652 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.558 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 24.5 mm-40 -70.77 -32.17 69.2 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.31 -0.556 . . . . 73.420000000000002 110.805 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.88 -35.7 90.77 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.778 -0.646 . . . . 44.140000000000001 111.598 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.8 p -161.0 92.22 1.52 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 C-N-CA 123.08 0.552 . . . . 73.239999999999995 110.117 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.99 162.33 8.82 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.203 1.935 . . . . 61.329999999999998 112.123 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 29.5 Cg_endo -68.17 156.43 65.79 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.751 1.634 . . . . 72.209999999999994 109.903 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 155.07 45.93 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.629 -0.26 . . . . 74.140000000000001 110.51 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.572 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 34.0 Cg_exo -60.48 111.55 1.06 Allowed 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.589 2.192 . . . . 62.030000000000001 111.724 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -88.0 -41.31 13.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.454 -0.793 . . . . 44.119999999999997 110.602 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.424 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.0 t70 -92.43 156.0 17.49 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.626 -1.25 . . . . 75.430000000000007 107.626 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.37 -20.29 48.08 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 120.93 0.395 . . . . 70.409999999999997 111.036 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 m -74.53 -39.71 62.19 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.944 -0.571 . . . . 63.119999999999997 110.536 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.572 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 3.2 p -107.15 116.41 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.516 0.674 . . . . 64.409999999999997 111.507 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -120.82 148.29 44.22 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.835 -1.075 . . . . 75.120000000000005 108.796 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 22.6 mm -92.82 111.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.263 -1.014 . . . . 72.400000000000006 108.263 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.267 -0.878 . . . . 73.120000000000005 109.005 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.78 140.91 46.03 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.41 -0.589 . . . . 74.420000000000002 109.41 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -122.78 123.33 40.81 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 119.841 -0.744 . . . . 74.340000000000003 110.474 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.76 165.8 26.67 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.538 -1.21 . . . . 74.049999999999997 110.48 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.95 -1.15 69.79 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.688 -0.767 . . . . 63.200000000000003 114.681 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.89 166.42 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-N 117.774 0.787 . . . . 71.519999999999996 110.24 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 55.3 m -120.63 138.39 53.94 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.895 -0.593 . . . . 65.329999999999998 109.855 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.436 HG23 ' CE3' ' A' ' 186' ' ' TRP . 19.1 m -124.66 153.54 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 109.12 -0.696 . . . . 55.43 109.12 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 51.8 m-85 -113.03 121.6 45.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.145 -2.168 . . . . 74.129999999999995 105.145 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 p -117.91 130.02 55.98 Favored 'General case' 0 C--N 1.269 -2.896 0 C-N-CA 120.252 -0.579 . . . . 71.340000000000003 111.162 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.446 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 7.8 t -116.06 126.06 53.25 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.689 -0.687 . . . . 74.510000000000005 110.168 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -111.1 130.53 55.59 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.925 -1.509 . . . . 72.019999999999996 106.925 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.96 146.06 44.94 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.502 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -125.92 128.4 6.45 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.513 -0.767 . . . . 53.340000000000003 111.335 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.59 -138.13 4.95 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.21 -0.756 . . . . 64.310000000000002 111.21 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 178' ' ' PRO . 19.6 t80 -100.49 100.63 11.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.787 -1.561 . . . . 74.519999999999996 106.787 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 140.11 53.29 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.018 1.118 . . . . 62.210000000000001 114.018 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -115.68 176.86 4.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.583 -1.189 . . . . 74.310000000000002 108.318 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.71 -37.03 85.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.964 0.412 . . . . 73.120000000000005 111.356 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.07 67.2 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.236 0.541 . . . . 60.310000000000002 110.225 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.26 -30.53 71.18 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.834 -0.621 . . . . 72.239999999999995 110.642 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -61.03 -38.1 84.9 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.003 0.43 . . . . 75.439999999999998 110.565 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.63 -43.87 86.58 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 109.021 -0.733 . . . . 62.130000000000003 109.021 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -62.24 -47.79 82.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.202 -0.908 . . . . 63.219999999999999 110.266 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -66.83 -33.09 74.84 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 113.612 0.967 . . . . 72.120000000000005 113.612 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.5 80.89 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.432 0.634 . . . . 71.099999999999994 110.122 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.8 m -75.29 -44.61 44.76 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.494 -0.776 . . . . 73.530000000000001 109.641 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 53.2 mt-30 -63.85 -27.7 69.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.765 0.426 . . . . 74.329999999999998 111.486 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.432 ' HA ' HG21 ' A' ' 154' ' ' THR . 3.3 tm? -64.87 -37.05 86.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.328 -0.99 . . . . 74.409999999999997 108.328 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.33 -33.14 67.1 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.851 -0.613 . . . . 74.319999999999993 110.447 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -35.1 79.75 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.648 -0.706 . . . . 74.040000000000006 109.952 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 151' ' ' LEU . 8.9 t -77.86 -32.87 52.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.546 -0.462 . . . . 62.350000000000001 110.568 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.01 9.26 2.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.208 0.447 . . . . 74.140000000000001 112.208 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.43 24.51 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.664 -1.606 . . . . 65.109999999999999 106.664 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.38 47.74 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.263 -0.97 . . . . 64.549999999999997 111.374 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 55.8 p -118.82 158.17 48.31 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.84 -0.8 . . . . 74.420000000000002 108.84 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.95 20.3 1.18 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.179 1.919 . . . . 73.409999999999997 112.22 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.72 127.46 31.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.124 -0.489 . . . . 44.32 111.995 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.8 p -104.56 156.34 18.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.021 -1.103 . . . . 75.030000000000001 108.021 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.47 ' C ' ' HB3' ' A' ' 190' ' ' ALA . 31.4 m-85 -136.59 157.53 46.55 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.073 -0.651 . . . . 72.420000000000002 109.753 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -143.04 123.92 14.28 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.361 -0.536 . . . . 63.32 112.272 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.64 -0.27 28.19 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.535 -0.757 . . . . 64.349999999999994 114.417 175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 64.56 8.53 4.44 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.388 1.075 . . . . 74.099999999999994 111.765 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.504 ' HB ' ' CE1' ' A' ' 87' ' ' PHE . 7.3 p -66.17 139.42 21.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.701 0.763 . . . . 60.149999999999999 111.881 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -143.56 168.57 19.54 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.95 -1.023 . . . . 73.430000000000007 109.179 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.552 ' HE2' ' CD1' ' A' ' 101' ' ' TRP . 94.1 m-85 -114.93 147.6 39.78 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 120.951 0.405 . . . . 72.430000000000007 110.375 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 66.0 m -114.79 123.74 49.98 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.913 -1.884 . . . . 75.319999999999993 105.913 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 184' ' ' GLU . . . -128.98 131.41 47.45 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.498 0.666 . . . . 74.340000000000003 112.184 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.68 165.04 37.87 Favored Glycine 0 N--CA 1.422 -2.251 0 N-CA-C 108.779 -1.728 . . . . 65.439999999999998 108.779 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -66.34 -28.19 68.47 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 118.235 1.018 . . . . 64.109999999999999 108.53 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -156.15 141.83 12.72 Favored Pre-proline 0 N--CA 1.427 -1.623 0 CA-C-N 113.906 -1.497 . . . . 73.540000000000006 107.067 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -79.51 120.09 4.3 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.111 1.874 . . . . 70.109999999999999 108.488 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.4 127.54 15.87 Favored 'Trans proline' 0 N--CA 1.439 -1.706 0 C-N-CA 120.669 0.913 . . . . 72.25 113.356 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 55.9 mtm -96.75 -26.95 14.96 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.879 -1.897 . . . . 64.519999999999996 105.879 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -84.41 135.76 40.88 Favored Pre-proline 0 N--CA 1.418 -2.07 0 CA-C-N 113.037 -1.892 . . . . 74.209999999999994 107.899 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 138' ' ' TYR . 30.3 Cg_endo -58.59 -12.86 15.36 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 124.982 3.788 . . . . 71.340000000000003 118.094 -172.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -70.3 -81.8 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 119.076 0.853 . . . . 72.530000000000001 112.513 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 46.89 76.02 0.16 Allowed Glycine 0 N--CA 1.475 1.275 0 O-C-N 123.88 0.737 . . . . 73.200000000000003 113.979 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.572 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 71.9 ttt180 -75.45 -36.32 60.74 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.933 -0.707 . . . . 73.109999999999999 111.623 -176.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 182' ' ' ARG . 1.3 ppt_? -102.75 129.41 49.38 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.24 -0.984 . . . . 74.340000000000003 112.477 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -145.02 153.76 41.81 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.044 -0.525 . . . . 70.209999999999994 110.197 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 42.7 mt-10 -138.14 132.05 31.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.592 0.357 . . . . 72.239999999999995 110.288 173.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.446 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 96.5 t -128.95 118.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.271 -1.011 . . . . 74.120000000000005 108.271 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 11.3 m0 -107.65 121.03 43.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 108.918 -0.771 . . . . 72.219999999999999 108.918 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.58 134.82 42.97 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.678 -1.971 . . . . 72.530000000000001 105.678 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.04 124.79 45.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 120.619 -0.432 . . . . 53.240000000000002 112.068 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 161' ' ' THR . 82.8 tttt -75.45 133.27 41.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.103 -0.703 . . . . 72.549999999999997 109.103 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.47 ' HB3' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.255 1.353 0 CA-C-O 118.694 -0.669 . . . . 54.420000000000002 110.688 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 112.158 0.429 . . . . 63.340000000000003 112.158 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t 63.5 26.68 14.89 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 121.856 0.836 . . . . 61.420000000000002 109.704 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -102.02 94.08 5.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.843 -0.617 . . . . 52.409999999999997 110.199 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -123.24 110.18 14.9 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.111 -0.7 . . . . 75.310000000000002 109.111 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.91 -159.51 25.29 Favored Glycine 0 N--CA 1.424 -2.119 0 C-N-CA 120.084 -1.055 . . . . 73.030000000000001 112.52 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.4 t -81.65 103.86 11.65 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.004 0.43 . . . . 64.299999999999997 110.318 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.82 106.88 11.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.894 -0.594 . . . . 73.109999999999999 110.918 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 62.15 19.22 10.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.841 0.856 . . . . 75.329999999999998 111.478 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 p -96.77 98.54 10.23 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 115.489 -0.778 . . . . 73.140000000000001 111.81 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -128.05 83.81 65.04 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.507 -0.77 . . . . 73.409999999999997 111.347 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -100.19 148.89 0.44 Allowed 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 123.314 2.676 . . . . 65.209999999999994 112.404 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.514 ' CD1' ' HG3' ' A' ' 34' ' ' ARG . 37.3 p90 -102.12 149.4 24.32 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.301 -1.0 . . . . 74.030000000000001 108.301 175.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.03 0.443 . . . . 61.439999999999998 110.791 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.52 123.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.528 -0.916 . . . . 73.340000000000003 108.528 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.6 -28.95 18.11 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.051 -0.66 . . . . 74.049999999999997 109.901 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t 179.08 158.74 0.59 Allowed 'General case' 0 C--O 1.248 1.011 0 CA-C-N 115.303 -0.862 . . . . 54.229999999999997 109.483 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.9 p -131.43 156.53 45.44 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.038 -1.468 . . . . 71.530000000000001 107.038 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.49 88.79 0.59 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.894 -1.622 . . . . 73.439999999999998 113.581 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.32 -139.94 10.02 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 109.248 -1.541 . . . . 37.109999999999999 109.248 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -104.84 110.03 22.23 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 102.582 -3.118 . . . . 73.310000000000002 102.582 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.93 133.04 49.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.327 -0.949 . . . . 75.239999999999995 112.565 -167.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 153.25 -45.77 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 101.844 -3.391 . . . . 53.299999999999997 101.844 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.04 111.85 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 111.788 -2.46 . . . . 72.150000000000006 104.699 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -100.48 140.2 35.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.96 -0.385 . . . . 60.219999999999999 109.96 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.45 157.71 34.54 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.579 -0.848 . . . . 71.430000000000007 112.535 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -134.0 126.67 30.72 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.172 -1.418 . . . . 75.219999999999999 107.172 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.45 113.89 26.06 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 106.69 -1.596 . . . . 74.040000000000006 106.69 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.514 ' HG3' ' CD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -138.5 145.88 41.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.791 -1.163 . . . . 74.0 113.382 -177.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 128' ' ' ILE . . . -86.77 138.35 31.68 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.065 -1.425 . . . . 75.530000000000001 107.784 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' SG ' HG13 ' A' ' 128' ' ' ILE . 25.6 p -57.89 168.57 0.92 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.25 0.833 . . . . 71.519999999999996 113.25 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -82.85 -18.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.304 -0.862 . . . . 61.329999999999998 111.483 -174.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.38 9.42 59.1 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 119.971 -1.109 . . . . 65.530000000000001 112.969 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.85 165.07 45.32 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.649 -0.786 . . . . 75.409999999999997 113.137 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -99.14 131.86 44.87 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.922 -0.399 . . . . 70.420000000000002 109.922 175.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.671 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 40.9 m-85 -127.89 165.27 20.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.527 -0.761 . . . . 71.230000000000004 112.101 -169.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.0 116.99 31.34 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.675 -0.861 . . . . 55.030000000000001 108.675 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 4.2 t -126.87 143.29 51.31 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-N 115.135 -0.938 . . . . 74.420000000000002 112.517 -175.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.437 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.2 m -133.32 146.11 32.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.4 -1.273 . . . . 72.030000000000001 108.366 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -127.88 126.31 41.32 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.63 -0.428 . . . . 70.340000000000003 110.367 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.401 ' CG1' ' HD2' ' A' ' 49' ' ' LYS . 33.2 t -120.74 130.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.988 -1.486 . . . . 74.549999999999997 106.988 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 49' ' ' LYS . 73.5 p -117.97 167.94 10.98 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.317 -0.553 . . . . 71.230000000000004 111.416 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 72.8 -25.31 0.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.898 1.279 . . . . 70.019999999999996 112.947 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.6 mttm -86.28 146.45 42.42 Favored Pre-proline 0 C--N 1.29 -1.985 0 CA-C-N 115.58 -0.736 . . . . 61.299999999999997 110.264 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.69 157.27 43.16 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.472 2.115 . . . . 64.310000000000002 110.032 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.0 t -47.49 -42.52 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 113.146 0.795 . . . . 73.019999999999996 113.146 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.668 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t70 -61.62 -50.9 70.71 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 120.164 -0.614 . . . . 73.209999999999994 110.617 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.42 -51.71 68.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.827 -0.624 . . . . 75.530000000000001 111.497 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.4 -34.84 77.51 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.875 -0.602 . . . . 72.519999999999996 110.932 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.01 -34.16 71.06 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.644 -0.253 . . . . 71.340000000000003 110.615 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 24.3 mmm180 -67.87 -36.16 79.8 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.099 -0.704 . . . . 75.409999999999997 109.099 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.5 mm-40 -73.47 -53.31 10.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.273 -0.876 . . . . 71.109999999999999 112.587 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.89 -36.14 62.25 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.372 1.619 . . . . 75.230000000000004 115.372 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.6 tpp -55.18 -54.16 53.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 112.681 0.622 . . . . 74.209999999999994 112.681 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -57.55 -30.57 88.93 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.472 2.115 . . . . 74.25 112.583 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 53.4 mtpt -65.45 -34.11 77.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.255 0.55 . . . . 73.510000000000005 110.913 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.12 -38.54 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.006 0.432 . . . . 61.439999999999998 110.824 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.6 mtp -66.86 -30.13 70.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.976 0.732 . . . . 73.329999999999998 112.976 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -67.75 -45.22 75.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 65.319999999999993 109.62 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -62.21 -60.95 2.84 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.16 -0.473 . . . . 75.030000000000001 112.072 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 76' ' ' MET . 16.5 m -77.13 -3.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.544 0.688 . . . . 74.430000000000007 110.759 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.57 -11.37 59.46 Favored Glycine 0 N--CA 1.418 -2.539 0 CA-C-N 114.984 -1.007 . . . . 52.020000000000003 112.392 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.33 -28.81 0.63 Allowed Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.455 -1.355 . . . . 60.109999999999999 113.518 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -81.58 55.14 2.56 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.235 1.017 . . . . 64.040000000000006 111.253 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -98.38 149.39 22.71 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 106.061 -1.829 . . . . 62.200000000000003 106.061 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.97 -26.95 65.3 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.966 -0.693 . . . . 72.200000000000003 111.543 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HB2' HG21 ' A' ' 74' ' ' VAL . 57.3 mtpt -80.43 0.14 34.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.114 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 34.06 66.7 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 121.075 -0.583 . . . . 64.519999999999996 112.278 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 72' ' ' LYS . 48.5 t -80.1 143.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 107.776 -1.194 . . . . 51.140000000000001 107.776 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.84 -172.77 37.67 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.745 -0.741 . . . . 70.200000000000003 112.656 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -78.99 103.68 9.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.406 -0.961 . . . . 71.340000000000003 108.406 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -161.13 19.42 0.2 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.335 -0.936 . . . . 53.409999999999997 112.478 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.2 ptm -123.1 122.78 39.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.066 -1.053 . . . . 71.209999999999994 109.687 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.9 m -127.11 117.85 23.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.621 -0.718 . . . . 70.439999999999998 110.365 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 2.9 m -150.46 166.79 14.33 Favored Pre-proline 0 C--N 1.298 -1.665 0 C-N-CA 124.723 1.209 . . . . 75.140000000000001 107.822 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 172' ' ' TYR . 38.3 Cg_endo -66.23 140.92 60.78 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.291 1.327 . . . . 44.32 113.588 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.9 139.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.085 -1.416 . . . . 64.340000000000003 107.94 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 p -127.38 148.79 50.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.636 -0.505 . . . . 72.129999999999995 109.636 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 42.0 p90 -144.35 142.04 30.12 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.63 -0.428 . . . . 73.540000000000006 110.157 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -91.89 134.9 34.36 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 109.174 -0.676 . . . . 42.520000000000003 109.174 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.49 150.18 26.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-N 114.869 -1.06 . . . . 73.239999999999995 108.382 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -121.0 105.11 40.65 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.723 -0.473 . . . . 73.530000000000001 109.723 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 158.06 48.98 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.121 1.88 . . . . 75.030000000000001 112.984 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -118.09 160.7 21.07 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.578 -0.737 . . . . 71.349999999999994 110.453 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.63 -21.68 66.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.485 -0.78 . . . . 73.439999999999998 111.254 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.5 -6.92 57.97 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.552 0.691 . . . . 72.140000000000001 110.737 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.5 -0.48 85.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.761 -0.733 . . . . 74.150000000000006 113.272 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.6 m -96.9 136.31 37.63 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.565 -0.902 . . . . 73.129999999999995 108.565 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.4 mt -84.84 87.58 7.34 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.604 -0.438 . . . . 65.530000000000001 111.056 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -148.58 113.34 5.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.873 1.064 . . . . 64.109999999999999 113.873 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -168.77 -68.79 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.749 1.22 . . . . 62.009999999999998 108.013 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -148.87 153.93 38.75 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.837 -1.529 . . . . 73.310000000000002 108.743 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.16 127.44 16.74 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.634 -0.876 . . . . 74.430000000000007 108.634 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HE3' ' HE1' ' A' ' 101' ' ' TRP . 37.6 ttpt -130.01 115.58 17.33 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.081 0.467 . . . . 54.340000000000003 110.408 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' THR . 96.9 t -85.73 138.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.447 -0.797 . . . . 71.120000000000005 110.567 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.427 ' HE1' ' HE3' ' A' ' 99' ' ' LYS . 93.4 m95 -128.7 117.18 20.72 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.3 1.04 . . . . 74.329999999999998 108.278 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CE2' HG13 ' A' ' 66' ' ' VAL . 83.7 t80 -104.32 118.18 35.99 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.604 -0.517 . . . . 75.040000000000006 109.604 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.671 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 34.5 ttm180 -74.57 131.1 40.68 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.817 -0.808 . . . . 74.049999999999997 108.817 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.17 140.67 22.51 Favored Pre-proline 0 C--N 1.296 -1.754 0 N-CA-C 109.69 -0.485 . . . . 62.420000000000002 109.69 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.26 144.57 47.98 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.812 2.342 . . . . 72.299999999999997 111.523 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -55.01 -35.49 64.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.734 1.013 . . . . 55.329999999999998 113.734 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -61.34 -45.04 96.05 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.467 0.651 . . . . 75.319999999999993 109.987 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -78.82 -10.64 59.86 Favored 'General case' 0 C--O 1.196 -1.745 0 CA-C-N 115.456 -0.793 . . . . 73.349999999999994 111.141 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.592 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.0 -28.84 64.71 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.721 -0.392 . . . . 75.349999999999994 110.439 176.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.91 94.76 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.246 -0.742 . . . . 62.420000000000002 111.246 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 55.2 p -160.74 90.77 1.63 Allowed Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 109.454 -0.573 . . . . 61.299999999999997 109.454 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.29 146.61 36.05 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.346 2.031 . . . . 70.109999999999999 110.777 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 138.41 74.64 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.743 1.629 . . . . 73.430000000000007 110.109 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 140.34 96.31 Favored Pre-proline 0 C--O 1.256 1.414 0 CA-C-N 116.532 -0.304 . . . . 64.439999999999998 110.463 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.38 113.08 2.11 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.147 1.898 . . . . 74.430000000000007 110.703 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -90.69 29.89 1.25 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.603 -0.726 . . . . 65.239999999999995 109.988 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -138.53 145.98 41.36 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.379 -1.712 . . . . 62.210000000000001 106.379 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.71 -24.39 49.19 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.919 0.711 . . . . 64.420000000000002 112.919 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 61.1 p -102.95 -13.79 16.76 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.897 0.38 . . . . 71.409999999999997 111.851 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.42 116.38 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 105.399 -2.075 . . . . 75.140000000000001 105.399 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.71 146.4 50.23 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.238 -0.585 . . . . 50.240000000000002 111.212 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.0 mm -93.0 111.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.413 -0.958 . . . . 71.310000000000002 108.413 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -119.05 147.77 43.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.16 -0.927 . . . . 73.120000000000005 108.96 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.74 138.15 44.48 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.327 -0.397 . . . . 70.400000000000006 111.626 -174.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -131.15 122.36 26.5 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.185 0.517 . . . . 64.349999999999994 110.57 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -140.23 148.61 41.76 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.574 -0.739 . . . . 62.530000000000001 109.124 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.6 20.32 78.48 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.261 -0.971 . . . . 41.549999999999997 113.746 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.498 HG13 ' SG ' ' A' ' 36' ' ' CYS . 2.2 pp -119.16 151.91 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.34 -0.944 . . . . 70.530000000000001 109.073 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.4 m -121.49 133.54 55.05 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 115.549 -0.751 . . . . 62.119999999999997 111.809 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.17 155.8 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 108.324 -0.991 . . . . 64.150000000000006 108.324 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 160' ' ' ALA . 24.7 m-85 -113.57 122.25 46.68 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.794 -1.928 . . . . 75.319999999999993 105.794 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 59.4 p -117.17 147.34 42.55 Favored 'General case' 0 C--N 1.269 -2.92 0 C-N-CA 120.344 -0.542 . . . . 73.430000000000007 111.999 -173.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.464 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -126.01 130.57 51.44 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 115.231 -0.895 . . . . 64.530000000000001 108.954 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -113.81 126.37 55.13 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.978 0.894 . . . . 74.140000000000001 109.169 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -130.81 137.81 49.59 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 114.408 -1.269 . . . . 72.219999999999999 110.65 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.77 127.32 7.19 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.337 -0.705 . . . . 72.319999999999993 111.337 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 153.79 -143.13 9.78 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 109.029 -1.628 . . . . 37.109999999999999 109.029 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -99.83 110.57 22.94 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 117.412 0.606 . . . . 73.409999999999997 110.002 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.78 139.45 44.82 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.214 -0.662 . . . . 60.350000000000001 109.214 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -114.89 169.28 9.2 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.303 -2.11 . . . . 43.420000000000002 105.303 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.65 -39.8 58.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.207 0.527 . . . . 63.530000000000001 111.598 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.2 66.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.617 -0.72 . . . . 72.409999999999997 111.071 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.46 -30.29 63.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.147 -0.479 . . . . 74.340000000000003 111.01 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -59.0 -50.5 73.87 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.115 -0.698 . . . . 75.200000000000003 109.115 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.8 t -61.73 -42.09 93.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.85 -1.068 . . . . 72.239999999999995 109.459 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.39 -46.57 88.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.529 -0.76 . . . . 73.430000000000007 110.887 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.553 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 40.5 m80 -64.24 -39.81 94.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 112.489 0.551 . . . . 74.209999999999994 112.489 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -60.77 -43.22 98.31 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.242 0.544 . . . . 73.530000000000001 110.015 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.41 HG22 ' NH2' ' A' ' 152' ' ' ARG . 88.2 m -62.73 -47.12 84.94 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 123.822 0.849 . . . . 54.140000000000001 110.022 177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -58.79 -42.9 90.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.66 0.784 . . . . 73.019999999999996 109.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 77.5 mt -57.74 -40.89 80.73 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.431 -0.349 . . . . 74.439999999999998 111.744 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 20.8 mtm180 -65.2 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.34 0.591 . . . . 72.239999999999995 110.028 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 m -72.95 -36.91 67.26 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.267 -0.879 . . . . 74.540000000000006 109.709 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.5 m -77.77 -37.82 48.12 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 116.085 -0.507 . . . . 70.140000000000001 111.394 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.77 -5.11 41.56 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.344 0.593 . . . . 75.549999999999997 111.26 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.74 120.61 20.51 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.747 -1.205 . . . . 71.209999999999994 107.747 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.44 47.52 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.381 -0.914 . . . . 51.009999999999998 111.843 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.7 p -118.5 166.18 14.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.461 -0.941 . . . . 71.140000000000001 108.461 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 10.69 1.79 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.401 2.067 . . . . 63.219999999999999 112.759 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 131' ' ' TYR . . . -88.9 126.15 35.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.911 0.386 . . . . 51.530000000000001 111.9 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.4 p -100.98 151.97 21.14 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.458 -0.571 . . . . 74.0 109.458 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.81 148.0 33.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.183 0.447 . . . . 72.310000000000002 110.405 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -129.14 139.37 51.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.123 0.786 . . . . 75.349999999999994 113.123 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.68 -0.08 29.5 Favored Glycine 0 C--O 1.236 0.239 0 CA-C-N 115.444 -0.798 . . . . 70.310000000000002 114.33 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 61.92 10.71 3.71 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.198 0.999 . . . . 71.349999999999994 111.676 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.56 138.28 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.41 0.624 . . . . 74.430000000000007 110.292 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -145.62 169.91 17.5 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.545 -0.752 . . . . 73.450000000000003 110.027 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' A' ' 85' ' ' ALA . 85.5 m-85 -115.52 148.35 39.61 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 110.104 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.55 125.52 53.89 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.343 -1.725 . . . . 72.450000000000003 106.343 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -130.77 149.11 52.56 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 111.747 0.277 . . . . 70.340000000000003 111.747 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.44 160.31 32.98 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 111.027 -0.829 . . . . 60.240000000000002 111.027 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 81' ' ' PRO . 2.8 m-85 -91.73 -8.98 45.37 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.051 0.54 . . . . 63.539999999999999 110.99 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -139.63 134.44 16.21 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.392 -0.595 . . . . 73.109999999999999 109.392 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.64 113.42 3.3 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.983 1.789 . . . . 64.230000000000004 108.69 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.91 130.14 26.73 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.874 1.716 . . . . 73.549999999999997 112.443 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 27.9 ttt -93.56 -36.04 12.6 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.751 -1.203 . . . . 71.409999999999997 107.751 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -96.04 173.82 3.92 Favored Pre-proline 0 N--CA 1.429 -1.523 0 N-CA-C 107.005 -1.479 . . . . 71.420000000000002 107.005 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -70.64 -14.46 33.33 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 121.908 1.739 . . . . 61.340000000000003 112.2 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -64.91 105.88 1.12 Allowed 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.521 0.729 . . . . 74.420000000000002 112.932 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -108.24 105.93 2.26 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 107.955 -2.058 . . . . 74.340000000000003 107.955 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -89.58 -40.31 12.7 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.279 1.215 . . . . 73.420000000000002 114.279 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -128.97 127.41 41.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.325 -1.732 . . . . 71.409999999999997 106.325 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -145.17 156.2 43.73 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.116 -0.633 . . . . 74.120000000000005 109.865 -171.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.4 mt-10 -129.33 147.91 51.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.793 -0.447 . . . . 74.239999999999995 109.793 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 132' ' ' SER . 73.9 t -125.24 118.71 53.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.091 -1.448 . . . . 74.530000000000001 107.091 173.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.4 m0 -106.45 120.83 42.95 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.473 -0.936 . . . . 74.450000000000003 108.473 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 58.3 tp -98.29 128.65 44.83 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.519 -1.289 . . . . 63.039999999999999 107.519 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.08 135.27 27.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.119 0.485 . . . . 63.130000000000003 111.646 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 161' ' ' THR . 21.0 pttp -77.1 143.28 39.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.78 -0.645 . . . . 71.109999999999999 111.886 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.421 0 CA-C-O 118.062 -0.97 . . . . 73.439999999999998 109.007 176.07 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.741 0.305 . . . . 72.409999999999997 110.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 m -103.81 113.37 26.84 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 109.006 -0.739 . . . . 70.340000000000003 109.006 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' CB ' ' HB2' ' A' ' 12' ' ' SER . 5.5 mp -83.47 88.95 7.0 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.147 -0.479 . . . . 75.409999999999997 110.721 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -75.06 95.8 3.11 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.528 -0.916 . . . . 74.0 108.528 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.42 -4.17 5.51 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 111.179 -0.768 . . . . 73.140000000000001 111.179 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.423 ' HB2' ' CB ' ' A' ' 9' ' ' LEU . 20.8 t -70.76 134.32 47.31 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.115 -1.439 . . . . 74.540000000000006 107.115 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.1 t -110.46 94.77 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-O 121.349 0.595 . . . . 62.109999999999999 111.423 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -89.31 -37.18 15.1 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.076 -1.083 . . . . 74.430000000000007 108.076 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 m -88.08 82.83 7.08 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 106.189 -1.782 . . . . 72.030000000000001 106.189 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.4 t-105 -85.54 139.8 35.86 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.25 -0.886 . . . . 73.329999999999998 110.046 -172.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.0 149.85 33.26 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.909 2.406 . . . . 73.109999999999999 111.859 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.9 p90 -101.19 149.54 23.88 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.588 -0.893 . . . . 73.439999999999998 108.588 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.79 107.96 19.22 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.027 -0.731 . . . . 62.329999999999998 109.027 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.34 116.91 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.657 -1.156 . . . . 73.319999999999993 109.711 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -90.3 -29.17 18.29 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.294 0.479 . . . . 64.519999999999996 112.294 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -173.55 154.94 2.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.049 0.452 . . . . 37.170000000000002 109.818 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.15 157.03 45.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.316 -0.994 . . . . 74.209999999999994 108.316 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.69 -158.8 27.83 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.499 -1.334 . . . . 63.229999999999997 113.017 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.02 -119.78 4.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.415 -0.674 . . . . 60.420000000000002 111.415 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -116.44 171.28 7.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 110.134 -0.321 . . . . 74.239999999999995 110.134 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 43.9 mt-10 -85.0 156.89 20.94 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.231 -1.766 . . . . 72.129999999999995 106.231 166.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 14.6 t70 78.15 -45.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.524 0.73 . . . . 73.420000000000002 110.533 -171.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.34 108.93 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 108.715 -0.846 . . . . 62.329999999999998 108.715 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.4 m -124.38 134.04 53.24 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.62 -1.252 . . . . 72.430000000000007 107.62 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -113.31 161.67 16.96 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.358 0.873 . . . . 75.129999999999995 113.358 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -133.08 125.13 28.92 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.478 -1.675 . . . . 74.439999999999998 106.478 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.45 114.0 26.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 106.989 -1.486 . . . . 75.200000000000003 106.989 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -141.39 144.34 34.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.402 0.519 . . . . 75.530000000000001 112.402 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.49 136.23 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.288 -1.745 . . . . 72.340000000000003 106.288 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.415 ' SG ' HG13 ' A' ' 128' ' ' ILE . 83.0 m -63.91 153.87 35.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.13 0.789 . . . . 72.239999999999995 113.13 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.09 -34.77 61.78 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.165 -0.925 . . . . 72.450000000000003 111.016 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 91.9 10.98 60.8 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 118.454 -1.831 . . . . 74.209999999999994 112.095 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.23 164.14 52.33 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 111.052 -0.819 . . . . 37.170000000000002 111.052 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' O ' HD11 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -88.64 129.67 35.46 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.939 -0.763 . . . . 74.209999999999994 108.939 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 36.3 m-85 -126.89 165.4 19.43 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.582 -0.735 . . . . 72.310000000000002 110.027 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.34 116.37 30.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.7 -1.222 . . . . 75.030000000000001 107.7 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.8 t -131.86 146.85 52.36 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.566 0.698 . . . . 72.219999999999999 112.137 -175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.492 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 7.5 p -133.28 138.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 107.366 -1.346 . . . . 73.25 107.366 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -126.71 139.07 53.42 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.264 -0.574 . . . . 62.32 111.19 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 50.0 t -127.5 140.08 50.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.385 -1.339 . . . . 74.310000000000002 107.385 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.1 p -125.49 163.22 23.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.989 0.737 . . . . 72.129999999999995 112.989 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 68.44 6.03 5.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.123 1.369 . . . . 74.439999999999998 112.877 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -124.87 147.25 55.88 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 116.513 -0.312 . . . . 75.200000000000003 110.361 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 46.9 Cg_exo -58.95 156.58 32.84 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.693 2.262 . . . . 70.019999999999996 110.829 173.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 25.1 t -48.12 -43.3 11.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 113.111 0.782 . . . . 71.230000000000004 113.111 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -59.54 -41.74 90.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.931 0.396 . . . . 37.170000000000002 111.449 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.46 -46.45 48.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 72.540000000000006 110.809 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -63.81 -44.02 94.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.482 -0.781 . . . . 62.299999999999997 111.073 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.1 -42.05 85.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.857 -0.611 . . . . 74.329999999999998 111.649 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -64.43 -28.11 69.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.033 0.753 . . . . 74.450000000000003 113.033 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.2 -33.8 24.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.02 0.438 . . . . 72.25 111.613 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.83 -32.7 59.91 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.556 0.576 . . . . 52.0 112.556 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.537 ' HE2' ' HA ' ' A' ' 59' ' ' MET . 5.9 mmt -53.0 -56.84 19.58 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.32 1.23 . . . . 73.329999999999998 114.32 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.15 -31.65 84.19 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.197 1.931 . . . . 72.120000000000005 111.841 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 119' ' ' SER . 91.3 mttt -65.45 -41.02 93.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.145 -0.479 . . . . 63.149999999999999 110.751 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.15 -38.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.343 0.592 . . . . 73.439999999999998 110.008 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.27 -30.66 71.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.207 0.817 . . . . 50.350000000000001 113.207 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.02 -29.69 60.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.218 0.533 . . . . 72.519999999999996 109.925 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -64.57 -60.97 2.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.533 -0.758 . . . . 74.010000000000005 110.957 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 p -75.48 -17.96 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.437 0.637 . . . . 72.310000000000002 110.485 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.4 -28.39 73.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.976 -0.556 . . . . 37.170000000000002 113.139 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.64 3.33 6.04 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.189 -1.005 . . . . 73.099999999999994 112.852 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.4 m -95.23 22.41 6.82 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.811 0.815 . . . . 64.450000000000003 109.948 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.412 ' HA ' ' OG ' ' A' ' 116' ' ' SER . 7.9 p30 -88.07 172.73 9.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 74.420000000000002 110.827 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . 9.2 t70 -67.72 -34.32 76.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.89 -0.595 . . . . 51.020000000000003 112.518 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -78.75 -12.45 60.02 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.434 0.635 . . . . 65.030000000000001 109.683 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.69 25.07 75.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.446 -0.797 . . . . 74.400000000000006 112.645 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 34.1 m -90.41 146.79 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 120.066 -0.653 . . . . 74.400000000000006 109.888 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.99 -153.46 19.86 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.945 -0.862 . . . . 64.5 110.945 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.6 ttt -80.57 72.08 7.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.007 0.908 . . . . 74.140000000000001 110.204 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.96 3.05 41.17 Favored Glycine 0 N--CA 1.438 -1.202 0 CA-C-N 114.729 -1.123 . . . . 71.349999999999994 110.976 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.8 ptm -125.11 121.66 34.89 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.667 -0.864 . . . . 71.349999999999994 108.667 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -126.84 116.22 20.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.218 -0.446 . . . . 64.540000000000006 111.81 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -150.47 139.39 13.01 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 105.52 -2.03 . . . . 71.540000000000006 105.52 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.97 138.97 88.51 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 121.344 1.363 . . . . 71.120000000000005 110.427 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.85 139.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.963 -0.754 . . . . 72.230000000000004 108.963 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 m -118.98 145.05 46.14 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.864 -0.791 . . . . 74.349999999999994 108.864 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -132.42 137.0 47.14 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 119.949 -0.7 . . . . 72.120000000000005 109.658 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.94 135.14 34.42 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.499 -0.773 . . . . 52.310000000000002 109.008 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.77 149.71 25.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 54.520000000000003 107.798 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.643 ' CE2' ' HE3' ' A' ' 97' ' ' LYS . 67.5 m-85 -119.19 99.78 50.48 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 107.186 -1.413 . . . . 74.450000000000003 107.186 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.49 158.9 50.29 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.543 2.162 . . . . 63.43 114.542 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -103.53 160.15 14.98 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.673 -1.603 . . . . 74.230000000000004 106.673 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.2 -17.5 64.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.061 0.458 . . . . 73.109999999999999 111.795 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.54 -7.3 56.08 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.957 -0.565 . . . . 71.129999999999995 110.983 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.72 -6.06 84.01 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.696 -0.764 . . . . 72.299999999999997 112.295 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.1 m -83.94 136.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.11 0.481 . . . . 62.32 110.332 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 89.0 mt -93.59 98.63 11.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.728 0.775 . . . . 74.010000000000005 111.193 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 29.6 tt0 -148.13 170.43 17.84 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.795 -1.187 . . . . 73.109999999999999 107.795 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 105.09 -65.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 126.697 1.999 . . . . 73.310000000000002 112.255 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.643 ' HE3' ' CE2' ' A' ' 87' ' ' PHE . 33.7 ttpt -159.24 150.05 19.72 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.482 -0.326 . . . . 74.310000000000002 110.649 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 99' ' ' LYS . 5.0 tt -142.84 136.56 28.86 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.022 -1.103 . . . . 71.409999999999997 108.022 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.405 ' N ' HD23 ' A' ' 98' ' ' LEU . 68.2 mttm -122.02 115.67 22.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.469 -0.567 . . . . 75.129999999999995 109.469 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' THR . 87.7 t -88.41 128.05 40.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.899 -1.149 . . . . 65.430000000000007 107.899 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.11 123.86 46.62 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.293 -0.632 . . . . 73.450000000000003 109.293 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -102.99 112.61 25.53 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.471 -1.677 . . . . 64.219999999999999 106.471 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.84 113.06 14.11 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.957 -1.498 . . . . 71.439999999999998 106.957 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.532 HD11 ' O ' ' A' ' 40' ' ' LYS . 76.8 mt -73.36 138.7 78.21 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 115.926 -0.579 . . . . 60.039999999999999 110.555 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.7 161.32 45.83 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.504 2.136 . . . . 73.319999999999993 112.002 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -35.22 27.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.296 1.438 . . . . 74.239999999999995 111.081 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.04 -42.96 99.47 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.419 0.688 . . . . 72.519999999999996 111.992 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -99.76 -1.74 36.93 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 114.011 1.115 . . . . 73.439999999999998 114.011 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.614 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -62.97 -28.75 70.3 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.421 1.267 . . . . 63.119999999999997 114.421 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -39.38 32.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.89 -1.147 . . . . 52.539999999999999 111.942 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.9 m -149.0 94.4 4.03 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 109.251 -0.648 . . . . 74.310000000000002 109.251 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.63 158.1 12.26 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.417 2.078 . . . . 74.230000000000004 111.638 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.46 131.68 46.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.985 1.79 . . . . 55.329999999999998 109.943 175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 71' ' ' ASP . . . -66.23 140.27 96.77 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.319 -0.401 . . . . 73.239999999999995 110.358 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.61 101.5 1.04 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.438 2.092 . . . . 70.329999999999998 111.952 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 11.4 p -81.02 2.19 28.08 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.605 1.162 . . . . 72.430000000000007 111.886 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.472 ' HB3' HG11 ' A' ' 120' ' ' VAL . 13.1 t70 -113.27 152.69 29.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.415 -0.957 . . . . 74.510000000000005 108.415 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -13.16 45.5 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 115.372 1.619 . . . . 70.439999999999998 115.372 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 71.9 m -97.85 -28.84 13.66 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.152 -0.619 . . . . 73.450000000000003 111.898 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' ' 117' ' ' ASP . 6.8 p -94.68 128.04 46.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.844 -0.743 . . . . 63.130000000000003 109.478 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -124.49 153.29 42.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.996 -0.742 . . . . 64.329999999999998 108.996 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.9 mm -92.45 111.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 74.120000000000005 107.793 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -127.0 145.74 50.6 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.519 -0.764 . . . . 60.420000000000002 109.887 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.45 144.99 33.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.845 -0.798 . . . . 55.450000000000003 108.845 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.543 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.6 tpt180 -134.85 123.06 22.91 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.445 -0.902 . . . . 63.130000000000003 109.901 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.56 173.79 11.22 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.529 -0.545 . . . . 64.129999999999995 109.529 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.11 19.03 70.64 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.822 -0.626 . . . . 51.140000000000001 112.617 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.415 HG13 ' SG ' ' A' ' 36' ' ' CYS . 43.3 pt -128.37 145.53 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 121.17 0.51 . . . . 73.5 111.02 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.0 m -104.07 129.72 51.74 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 107.449 -1.315 . . . . 62.130000000000003 107.449 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.25 151.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.43 -0.581 . . . . 63.450000000000003 109.43 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 72.0 m-85 -114.04 121.48 43.97 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.308 -1.738 . . . . 64.439999999999998 106.308 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.5 m -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 109.869 -0.419 . . . . 70.450000000000003 109.869 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.0 t -118.32 131.38 56.33 Favored 'General case' 0 N--CA 1.411 -2.4 0 C-N-CA 120.391 -0.523 . . . . 73.530000000000001 110.067 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.522 ' HG2' ' HG3' ' A' ' 184' ' ' GLU . 51.4 mt-30 -110.84 128.36 55.75 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.089 -1.078 . . . . 74.0 108.089 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.2 p90 -114.68 135.68 53.89 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 115.309 -0.86 . . . . 74.549999999999997 110.563 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.14 101.57 2.61 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.408 -1.077 . . . . 55.149999999999999 110.408 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.06 167.82 27.28 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.231 -0.748 . . . . 61.520000000000003 111.231 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 54.3 p90 -75.44 139.72 42.46 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 110.124 -0.324 . . . . 72.319999999999993 110.124 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -116.04 123.76 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.549 0.69 . . . . 74.230000000000004 112.246 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.447 ' HG2' ' OE2' ' A' ' 141' ' ' GLU . 26.3 ttpp -115.68 170.53 8.38 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 104.721 -2.326 . . . . 75.200000000000003 104.721 172.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.447 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -51.54 -42.86 62.11 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.901 0.773 . . . . 73.430000000000007 113.058 -174.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.5 67.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.469 -0.332 . . . . 64.329999999999998 111.828 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -69.07 -37.11 78.33 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.968 -0.293 . . . . 70.140000000000001 111.112 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.69 -42.55 88.83 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.672 -0.492 . . . . 73.329999999999998 109.672 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.72 -40.7 84.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.424 -0.807 . . . . 74.409999999999997 109.794 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -61.93 -47.6 84.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 74.329999999999998 111.24 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -69.04 -33.52 73.72 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 112.228 0.455 . . . . 74.310000000000002 112.228 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.29 92.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.177 0.513 . . . . 73.519999999999996 109.969 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 76.5 m -62.91 -46.93 85.49 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.675 -0.693 . . . . 64.420000000000002 110.125 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 25.8 mt-30 -59.92 -38.36 82.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.107 -0.497 . . . . 55.140000000000001 110.359 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.25 -43.58 96.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.845 -0.616 . . . . 71.530000000000001 110.995 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -63.39 -39.18 93.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 65.140000000000001 109.61 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -71.78 -30.81 65.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.203 -0.908 . . . . 74.209999999999994 111.133 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.7 m -76.74 -34.69 58.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.282 0.563 . . . . 70.540000000000006 109.67 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.96 7.71 12.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.928 -0.578 . . . . 62.509999999999998 111.027 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -74.49 130.64 39.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.331 -0.618 . . . . 64.530000000000001 109.331 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.23 3.45 58.81 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.939 -0.648 . . . . 52.520000000000003 112.128 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 54.5 p -112.18 165.64 12.55 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.764 -0.828 . . . . 73.319999999999993 108.764 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.28 14.93 0.53 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.764 2.31 . . . . 71.439999999999998 112.872 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.67 109.83 3.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.084 0.469 . . . . 44.509999999999998 110.562 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.6 p -95.97 156.54 16.29 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.909 -1.145 . . . . 74.129999999999995 107.909 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.507 ' C ' ' HB1' ' A' ' 190' ' ' ALA . 19.9 m-85 -132.64 151.27 52.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.595 -0.842 . . . . 75.310000000000002 109.277 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -127.3 122.33 33.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.002 0.43 . . . . 74.409999999999997 111.32 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.09 0.73 37.03 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.334 -0.848 . . . . 74.299999999999997 113.352 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.63 18.47 10.56 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.561 1.172 . . . . 54.109999999999999 109.366 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.27 139.22 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 113.724 -1.58 . . . . 74.219999999999999 112.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.453 ' OH ' HD23 ' A' ' 94' ' ' LEU . 11.4 p90 -149.41 167.66 25.56 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.194 -0.912 . . . . 74.219999999999999 110.747 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 2.8 m-85 -116.0 153.47 31.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 123.586 0.754 . . . . 74.239999999999995 109.557 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.9 m -124.03 131.41 53.55 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.252 -1.388 . . . . 63.350000000000001 107.252 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 184' ' ' GLU . . . -129.77 148.11 51.61 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.544 0.572 . . . . 74.319999999999993 112.544 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.84 165.85 39.04 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 108.647 -1.781 . . . . 73.409999999999997 108.647 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -57.56 -37.61 73.4 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.448 1.124 . . . . 72.349999999999994 109.619 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -156.36 142.81 13.23 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 106.327 -1.731 . . . . 74.349999999999994 106.327 172.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.99 117.48 3.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.536 2.158 . . . . 55.140000000000001 109.518 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -54.07 127.33 25.29 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.483 2.122 . . . . 53.020000000000003 115.526 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.57 -35.41 11.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 103.518 -2.771 . . . . 74.299999999999997 103.518 167.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -109.83 126.71 28.49 Favored Pre-proline 0 N--CA 1.421 -1.911 0 N-CA-C 104.845 -2.28 . . . . 74.340000000000003 104.845 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 138' ' ' TYR . 35.1 Cg_endo -63.16 -14.74 43.69 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.813 2.342 . . . . 73.530000000000001 113.595 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.46 147.17 53.67 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.69 0.757 . . . . 71.140000000000001 112.794 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.88 134.69 3.09 Favored Glycine 0 C--N 1.3 -1.443 0 N-CA-C 107.215 -2.354 . . . . 65.209999999999994 107.215 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -96.9 -28.39 14.23 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 115.721 1.749 . . . . 75.239999999999995 115.721 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 0.7 OUTLIER -117.08 130.37 56.6 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 118.2 -1.4 . . . . 73.420000000000002 110.269 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 40.4 m-80 -144.16 148.02 34.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.854 -1.165 . . . . 74.150000000000006 107.854 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.522 ' HG3' ' HG2' ' A' ' 134' ' ' GLN . 2.5 mp0 -112.04 144.36 41.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.115 0.484 . . . . 71.109999999999999 110.873 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 57.8 t -125.52 118.84 53.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.366 -1.716 . . . . 73.140000000000001 106.366 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.517 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 27.9 m0 -106.52 120.77 42.81 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.131 -0.692 . . . . 74.329999999999998 109.131 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 tp -98.88 133.94 42.46 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.363 -1.347 . . . . 73.329999999999998 107.363 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.25 126.86 45.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.328 -0.549 . . . . 71.120000000000005 111.32 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.2 tttm -75.14 137.85 41.64 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.886 -0.597 . . . . 74.540000000000006 109.808 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.507 ' HB1' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.301 -1.528 0 CA-C-O 118.259 -0.877 . . . . 73.519999999999996 108.86 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 . . . . . 0 CA--C 1.501 -0.904 0 N-CA-C 109.67 -0.493 . . . . 71.109999999999999 109.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.3 p -149.04 88.62 1.61 Allowed 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.786 -0.643 . . . . 52.43 109.532 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.1 tp -153.72 -72.07 0.13 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.777 -1.194 . . . . 72.349999999999994 107.777 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 61.29 173.84 0.11 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.337 1.055 . . . . 75.549999999999997 113.467 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.97 -79.91 1.83 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.885 -0.598 . . . . 74.209999999999994 112.174 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.2 m -85.14 82.08 8.57 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.356 0.598 . . . . 73.120000000000005 111.931 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -120.28 95.46 3.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.27 -1.011 . . . . 75.439999999999998 108.27 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.2 111.58 24.38 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.333 -0.849 . . . . 71.519999999999996 112.44 -171.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 p -102.7 -69.45 0.79 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.561 -0.903 . . . . 75.120000000000005 108.561 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -138.9 81.16 22.7 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 112.27 0.47 . . . . 74.329999999999998 112.27 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -99.0 149.09 0.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.469 2.779 . . . . 62.450000000000003 111.954 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -102.46 148.66 25.23 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.47 -0.937 . . . . 74.209999999999994 108.47 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -106.63 115.44 30.21 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.371 -0.377 . . . . 73.510000000000005 111.397 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 121.05 41.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.739 0.781 . . . . 71.120000000000005 109.966 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.24 -24.16 15.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.608 -0.723 . . . . 71.310000000000002 111.754 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -165.93 148.5 7.33 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.868 0.366 . . . . 74.439999999999998 110.29 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.9 p -134.56 164.31 27.78 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.95 -1.023 . . . . 74.540000000000006 110.321 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.94 -136.34 12.86 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 119.964 -1.112 . . . . 64.549999999999997 113.809 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.31 -108.26 2.89 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.85 -1.3 . . . . 73.450000000000003 109.85 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -108.9 168.02 9.66 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.458 -1.312 . . . . 72.010000000000005 107.458 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.65 154.08 25.08 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 118.62 0.646 . . . . 65.25 111.223 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 72.58 -64.77 0.38 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.93 1.292 . . . . 74.349999999999994 110.321 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.9 t -92.6 109.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.756 -1.942 . . . . 73.129999999999995 105.756 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 m -133.4 154.31 50.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.907 -0.775 . . . . 52.329999999999998 108.907 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.32 160.56 18.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.513 0.673 . . . . 74.040000000000006 111.668 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.92 124.95 25.74 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.832 -1.914 . . . . 71.120000000000005 105.832 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.86 114.08 27.85 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.221 -1.77 . . . . 74.329999999999998 106.221 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.22 146.65 52.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.413 0.625 . . . . 72.329999999999998 111.652 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.82 136.14 33.51 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.745 -1.576 . . . . 71.430000000000007 106.745 172.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -60.44 162.57 6.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.53 0.937 . . . . 72.140000000000001 113.53 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -20.77 32.91 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.656 -0.702 . . . . 64.239999999999995 110.42 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.57 11.1 56.11 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 119.362 -1.399 . . . . 73.430000000000007 112.077 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.21 160.71 54.1 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 120.877 -0.678 . . . . 51.420000000000002 112.923 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 122' ' ' ILE . 17.1 ptpt -96.76 130.68 43.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.948 -0.76 . . . . 74.230000000000004 108.948 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 58.9 m-85 -130.66 164.43 25.02 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.056 -0.52 . . . . 74.420000000000002 110.509 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.34 120.09 38.14 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 107.762 -1.199 . . . . 62.109999999999999 107.762 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.634 ' OG1' ' HE2' ' A' ' 99' ' ' LYS . 9.4 t -135.19 150.49 50.14 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 119.911 -0.716 . . . . 61.32 112.038 -174.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.539 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 18.8 m -134.85 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.897 -1.047 . . . . 74.209999999999994 109.739 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -123.81 139.8 53.62 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.813 -0.439 . . . . 51.329999999999998 109.813 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.32 133.12 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.328 -1.36 . . . . 74.120000000000005 107.328 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 49' ' ' LYS . 36.2 m -133.14 157.1 46.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.336 -0.616 . . . . 73.120000000000005 109.336 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 79.6 -9.38 1.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.794 1.637 . . . . 64.209999999999994 109.359 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.5 mttm -111.22 131.53 22.18 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.16 -1.382 . . . . 70.230000000000004 109.049 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.24 158.48 35.03 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.053 2.502 . . . . 73.439999999999998 110.787 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG12 HD12 ' A' ' 98' ' ' LEU . 39.3 t -45.95 -37.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.06 0.944 . . . . 71.230000000000004 112.976 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.55 -51.11 69.82 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.216 0.532 . . . . 44.130000000000003 110.561 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -76.41 -37.44 57.08 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.176 -0.92 . . . . 62.340000000000003 112.237 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.82 91.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.006 -0.543 . . . . 71.510000000000005 112.01 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -48.18 77.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.339 -0.615 . . . . 73.310000000000002 109.339 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.69 -24.29 66.24 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.792 -0.64 . . . . 73.430000000000007 111.983 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 10.4 tp10 -84.5 -45.5 12.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.515 0.674 . . . . 73.439999999999998 110.291 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.433 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.74 -39.65 69.91 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.596 0.961 . . . . 72.420000000000002 113.596 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.451 ' SD ' ' HG3' ' A' ' 174' ' ' PRO . 35.5 ttm -57.73 -46.72 99.72 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 114.196 1.184 . . . . 75.319999999999993 114.196 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 83.6 Cg_exo -50.89 -37.4 55.68 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.391 2.06 . . . . 74.150000000000006 111.233 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.565 ' HD2' ' CB ' ' A' ' 119' ' ' SER . 43.5 mtmt -68.77 -37.01 79.03 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.683 -0.69 . . . . 75.019999999999996 110.792 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.0 mm -76.39 -47.63 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 112.18 0.437 . . . . 74.430000000000007 112.18 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.425 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 25.0 ptm -62.59 -29.58 70.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.663 0.986 . . . . 71.230000000000004 113.663 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.67 -36.27 82.13 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.196 -0.602 . . . . 72.140000000000001 110.107 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -56.69 -59.43 5.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 111.813 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.85 -17.0 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 62.329999999999998 110.264 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.86 -14.27 82.53 Favored Glycine 0 C--O 1.24 0.508 0 CA-C-N 115.92 -0.582 . . . . 72.049999999999997 113.275 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.19 4.11 2.35 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.684 -1.246 . . . . 60.210000000000001 114.552 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.0 m -91.35 23.51 3.35 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 123.077 1.418 . . . . 73.420000000000002 110.412 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.73 170.28 8.89 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.099 -0.955 . . . . 75.439999999999998 110.228 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.94 -27.46 62.81 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 111.844 0.313 . . . . 72.200000000000003 111.844 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -86.05 -12.41 50.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.56 0.695 . . . . 74.109999999999999 110.525 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 31.84 63.2 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 115.319 -0.855 . . . . 63.119999999999997 112.518 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.11 123.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.319 -0.552 . . . . 72.299999999999997 110.758 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.37 -40.36 1.14 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 110.902 -0.879 . . . . 73.340000000000003 110.902 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.5 mtt -107.03 81.21 1.52 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.904 -1.517 . . . . 71.540000000000006 106.904 173.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.1 -79.32 0.54 Allowed Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.795 -1.193 . . . . 72.409999999999997 114.495 -172.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 24.1 ptt? -127.8 125.2 39.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.118 0.485 . . . . 75.310000000000002 111.945 -173.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 p -125.25 115.92 21.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.693 -0.685 . . . . 44.109999999999999 111.182 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.428 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 28.6 m -142.26 175.86 2.71 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.767 -1.568 . . . . 61.530000000000001 106.767 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' CD ' ' HB ' ' A' ' 80' ' ' VAL . 39.8 Cg_exo -59.89 140.11 91.4 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 121.55 1.5 . . . . 71.120000000000005 113.268 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.95 153.19 8.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.085 -1.45 . . . . 75.209999999999994 107.085 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -140.01 145.23 37.53 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.888 -0.508 . . . . 65.239999999999995 109.881 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 53.5 p90 -136.61 143.11 43.38 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.149 -0.62 . . . . 72.019999999999996 111.147 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.633 ' HB1' ' CE1' ' A' ' 168' ' ' TYR . . . -92.66 135.6 33.95 Favored 'General case' 0 CA--C 1.478 -1.819 0 O-C-N 123.801 0.688 . . . . 70.230000000000004 109.774 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.83 149.73 33.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.156 -1.053 . . . . 64.329999999999998 108.156 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 99.3 m-85 -112.25 108.06 55.16 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.176 -0.675 . . . . 72.329999999999998 109.176 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -83.6 151.67 13.25 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.626 1.55 . . . . 54.240000000000002 112.358 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.03 168.56 10.01 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.007 . . . . 72.120000000000005 108.282 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.55 -19.76 65.86 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.069 0.461 . . . . 64.120000000000005 111.626 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -81.07 -6.91 59.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 53.009999999999998 110.08 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.36 73.37 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.883 -0.599 . . . . 74.030000000000001 111.838 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.0 m -74.46 140.48 44.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.067 -0.716 . . . . 74.310000000000002 109.067 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.7 139.65 33.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.023 0.44 . . . . 73.219999999999999 111.036 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.3 167.82 19.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 124.225 1.01 . . . . 73.239999999999995 111.891 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.6 pttt -70.35 21.87 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 126.224 1.81 . . . . 71.409999999999997 114.879 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.553 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 24.2 ttmm -139.66 134.72 32.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 119.449 1.022 . . . . 71.310000000000002 110.972 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.484 HD12 HG12 ' A' ' 51' ' ' VAL . 6.0 tt -143.07 130.57 21.17 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 107.998 -1.112 . . . . 61.020000000000003 107.998 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.634 ' HE2' ' OG1' ' A' ' 43' ' ' THR . 23.6 tptm -116.11 115.3 25.81 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.466 -0.938 . . . . 71.219999999999999 108.466 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.539 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 99.3 t -94.25 126.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.893 -0.41 . . . . 72.049999999999997 109.893 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -113.04 124.99 53.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.151 0.581 . . . . 71.510000000000005 109.564 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -103.12 113.66 27.31 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.639 -1.615 . . . . 65.140000000000001 106.639 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -77.29 131.3 38.08 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.461 -0.79 . . . . 75.040000000000006 110.494 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.418 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 73.3 mt -100.17 133.86 21.22 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-N 115.031 -0.986 . . . . 70.310000000000002 108.556 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 31.9 Cg_exo -58.32 151.53 59.8 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.788 2.325 . . . . 62.219999999999999 111.229 175.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.31 -34.25 60.55 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.881 0.872 . . . . 42.109999999999999 110.076 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -59.68 -34.33 72.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.903 -0.589 . . . . 73.310000000000002 111.873 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.53 -3.98 32.24 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 120.816 -0.354 . . . . 70.299999999999997 111.521 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 97.7 mt-30 -70.55 -27.89 64.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.89 0.33 . . . . 72.219999999999999 111.89 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.87 -38.16 95.71 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.438 -0.665 . . . . 62.549999999999997 111.438 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 t -158.28 90.68 2.19 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 108.724 -0.843 . . . . 72.439999999999998 108.724 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -85.85 154.86 10.07 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.026 1.817 . . . . 65.209999999999994 112.06 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.5 149.23 83.17 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.193 1.929 . . . . 70.439999999999998 110.742 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.9 130.29 49.05 Favored Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 116.299 -0.409 . . . . 72.120000000000005 111.112 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 74.0 Cg_endo -76.89 112.59 3.47 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.904 2.403 . . . . 74.420000000000002 111.653 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 79.87 2.93 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.54 -0.864 . . . . 73.109999999999999 110.87 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.474 ' HB3' HG11 ' A' ' 120' ' ' VAL . 14.9 t70 -169.66 149.0 3.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.298 -1.742 . . . . 74.310000000000002 106.298 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.94 -14.97 59.35 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.944 0.72 . . . . 72.319999999999993 112.944 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.565 ' CB ' ' HD2' ' A' ' 61' ' ' LYS . 36.9 m -95.4 -29.71 14.29 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.88 -0.328 . . . . 65.409999999999997 111.836 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 117' ' ' ASP . 3.9 p -106.25 116.46 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.54 0 CA-C-O 121.821 0.819 . . . . 74.120000000000005 110.575 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -130.74 155.24 46.98 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.144 -1.389 . . . . 74.420000000000002 110.19 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.0 mm -91.37 112.64 25.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.56 -0.904 . . . . 74.010000000000005 108.56 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -115.58 141.84 47.53 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.157 -0.682 . . . . 72.299999999999997 109.157 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -111.18 145.84 37.95 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.575 -0.739 . . . . 71.420000000000002 109.756 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -146.98 126.93 13.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.309 0.576 . . . . 62.350000000000001 110.805 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.76 169.96 16.28 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.106 -0.952 . . . . 75.040000000000006 110.346 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 16.38 78.7 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.373 -0.441 . . . . 63.399999999999999 113.53 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pp -121.23 162.6 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 119.542 -0.863 . . . . 75.510000000000005 109.245 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.7 m -120.29 136.99 54.49 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 115.485 -0.78 . . . . 64.510000000000005 109.29 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.5 m -124.84 146.35 30.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.314 -0.995 . . . . 65.530000000000001 108.314 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.557 ' OH ' ' HB2' ' A' ' 160' ' ' ALA . 19.9 m-85 -114.95 121.54 43.47 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 105.932 -1.877 . . . . 75.010000000000005 105.932 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 p -117.4 131.5 56.75 Favored 'General case' 0 C--N 1.274 -2.712 0 C-N-CA 120.213 -0.595 . . . . 63.130000000000003 111.798 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.9 t -113.29 119.14 36.68 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 108.187 -1.042 . . . . 72.219999999999999 108.187 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -111.15 126.69 55.11 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 109.183 -0.673 . . . . 72.219999999999999 109.183 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 36.3 p90 -142.3 153.48 43.92 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 115.179 -0.918 . . . . 72.329999999999998 110.901 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.69 145.25 18.24 Favored Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 110.039 -1.224 . . . . 75.319999999999993 110.039 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.67 168.16 11.93 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 109.41 -1.476 . . . . 70.120000000000005 109.41 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.414 ' CE1' ' HA ' ' A' ' 179' ' ' TYR . 87.1 t80 -68.38 101.54 1.24 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.287 0.565 . . . . 74.230000000000004 111.574 -175.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.33 130.85 53.3 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.618 -0.882 . . . . 72.310000000000002 108.618 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -89.74 176.91 6.66 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.754 -0.832 . . . . 75.030000000000001 108.754 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.41 -31.95 71.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.244 0.545 . . . . 71.200000000000003 109.911 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.09 -29.36 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.502 -0.772 . . . . 63.009999999999998 109.784 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -69.54 -29.81 67.48 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 116.037 -0.529 . . . . 62.329999999999998 111.268 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -59.26 -41.89 89.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.67 -0.412 . . . . 75.129999999999995 110.133 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.29 -49.1 84.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.451 -0.795 . . . . 73.109999999999999 110.102 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.04 -44.49 84.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.656 . . . . 37.729999999999997 111.79 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -63.53 -31.55 72.75 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 112.538 0.57 . . . . 73.25 112.538 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.63 85.3 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.352 -0.61 . . . . 73.019999999999996 109.352 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.427 HG21 ' NH2' ' A' ' 152' ' ' ARG . 22.1 m -66.83 -41.31 87.65 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 115.654 -0.703 . . . . 74.450000000000003 111.46 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.2 -37.48 85.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.428 . . . . 72.319999999999993 109.97 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.18 -41.99 98.86 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.723 -0.671 . . . . 72.230000000000004 110.224 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.525 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.8 mtm105 -62.22 -46.93 86.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.568 -0.287 . . . . 72.430000000000007 111.063 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.2 m -61.59 -34.37 75.5 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.877 0.736 . . . . 72.310000000000002 110.431 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 30.0 m -76.99 -35.43 57.16 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.86 -0.609 . . . . 75.200000000000003 110.164 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.1 mt -70.05 -31.4 69.0 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 113.354 0.872 . . . . 64.219999999999999 113.354 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 46.1 mt-10 -46.31 131.1 10.67 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.621 0.6 . . . . 72.109999999999999 112.621 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.64 12.64 43.5 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.516 -1.034 . . . . 52.229999999999997 110.516 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.9 t -102.56 149.72 36.98 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 109.06 -0.719 . . . . 64.120000000000005 109.06 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -75.18 -4.82 15.91 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.594 2.196 . . . . 74.319999999999993 111.173 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.557 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . . . -71.99 147.04 47.29 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.771 -0.65 . . . . 61.450000000000003 110.854 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 74.0 p -108.02 138.05 44.95 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.3 -0.63 . . . . 74.140000000000001 109.3 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -144.02 150.51 38.36 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 122.29 -0.256 . . . . 62.200000000000003 110.938 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.523 ' O ' HG12 ' A' ' 166' ' ' VAL . 29.0 pt20 -129.33 122.84 30.38 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.999 1.111 . . . . 71.340000000000003 113.999 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.71 12.79 62.5 Favored Glycine 0 C--N 1.309 -0.964 0 N-CA-C 115.207 0.843 . . . . 63.530000000000001 115.207 164.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.401 ' O ' ' HD1' ' A' ' 167' ' ' TYR . 25.4 t70 67.43 19.76 9.99 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.959 0.409 . . . . 61.140000000000001 110.641 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 163' ' ' GLN . 7.2 p -64.81 137.95 24.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 120.367 -0.533 . . . . 62.140000000000001 109.788 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' ASP . 26.9 p90 -151.12 170.83 18.46 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.701 0.762 . . . . 74.209999999999994 111.644 -173.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.633 ' CE1' ' HB1' ' A' ' 85' ' ' ALA . 97.2 m-85 -114.64 151.65 33.19 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.216 -1.356 . . . . 75.409999999999997 109.737 175.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.54 122.16 45.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.506 -1.294 . . . . 73.450000000000003 107.506 174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.18 142.41 44.69 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.153 0.283 . . . . 53.109999999999999 111.436 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.03 164.56 37.94 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.039 -1.224 . . . . 72.230000000000004 110.039 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -73.45 -39.29 65.08 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 118.034 0.917 . . . . 75.150000000000006 110.767 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -150.77 158.1 35.47 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 108.785 -0.82 . . . . 64.450000000000003 108.785 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.451 ' HG3' ' SD ' ' A' ' 59' ' ' MET . 17.8 Cg_endo -56.24 123.88 14.91 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.772 2.315 . . . . 73.409999999999997 111.467 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.55 129.82 31.04 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.727 1.618 . . . . 71.019999999999996 110.725 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.65 -21.23 18.34 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.802 0.81 . . . . 71.239999999999995 109.743 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -140.0 150.78 63.36 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 104.831 -2.285 . . . . 64.409999999999997 104.831 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.12 -14.45 2.65 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.546 2.831 . . . . 61.049999999999997 113.264 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.414 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 84.8 t80 -60.86 103.9 0.31 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 123.874 0.869 . . . . 65.540000000000006 112.436 176.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -128.73 126.52 5.33 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.166 -1.574 . . . . 71.549999999999997 109.166 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -83.78 -55.17 4.41 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 117.568 0.684 . . . . 73.25 110.069 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -109.13 132.94 53.64 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.739 -1.208 . . . . 73.329999999999998 107.739 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.7 m-80 -134.37 134.29 41.56 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.385 -0.969 . . . . 74.040000000000006 108.385 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -128.82 136.35 50.37 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.865 -0.42 . . . . 74.299999999999997 109.865 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.1 t -124.74 121.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.468 -0.938 . . . . 72.340000000000003 108.468 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.6 m0 -103.21 123.15 46.19 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 108.087 -1.079 . . . . 72.310000000000002 108.087 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 166' ' ' VAL . 1.7 tt -97.35 138.57 34.61 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.896 -1.52 . . . . 63.109999999999999 106.896 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.473 HG22 ' CE2' ' A' ' 168' ' ' TYR . 20.7 t -87.88 131.98 34.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 110.455 -0.202 . . . . 73.239999999999995 110.455 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.569 ' C ' ' HD2' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -70.39 143.38 51.9 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.204 -0.665 . . . . 74.310000000000002 109.204 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 118.551 -0.738 . . . . 65.439999999999998 109.333 176.504 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 . . . . . 0 CA--C 1.51 -0.562 0 N-CA-C 109.715 -0.476 . . . . 41.25 109.715 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 m -88.09 83.17 7.02 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.366 0.603 . . . . 55.439999999999998 111.896 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.4 mt -147.8 164.19 34.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.835 -1.075 . . . . 62.399999999999999 108.16 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -118.75 129.28 55.17 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.638 -0.875 . . . . 73.400000000000006 108.638 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.31 76.03 1.97 Allowed Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.75 -0.738 . . . . 72.450000000000003 113.215 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -76.83 153.42 34.87 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.432 -0.951 . . . . 44.109999999999999 108.432 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.68 89.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.696 0.76 . . . . 72.019999999999996 111.52 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.48 113.54 19.61 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.619 -0.882 . . . . 73.299999999999997 108.619 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 86.3 m 72.14 106.86 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 124.066 0.854 . . . . 64.420000000000002 110.572 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 37' ' ' GLU . 8.9 t-105 -93.75 99.85 3.98 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.104 -1.813 . . . . 73.510000000000005 106.104 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 15' ' ' THR . 64.8 Cg_endo -97.82 150.14 0.83 Allowed 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 123.093 2.529 . . . . 73.219999999999999 116.247 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -101.2 151.97 21.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.3 -2.111 . . . . 75.430000000000007 105.3 171.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -106.03 114.98 29.44 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.997 -1.081 . . . . 74.25 111.963 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.51 121.16 35.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.311 -1.737 . . . . 61.450000000000003 106.311 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.3 -26.42 20.01 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.389 -0.924 . . . . 72.239999999999995 110.758 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -175.99 165.31 2.92 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.681 -0.859 . . . . 74.150000000000006 108.681 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.4 p -132.57 150.02 52.22 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.771 -1.196 . . . . 73.239999999999995 107.771 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.39 113.61 2.11 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.101 -1.523 . . . . 73.030000000000001 113.406 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.25 -99.49 0.49 Allowed Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 110.857 -0.897 . . . . 41.119999999999997 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -98.87 169.1 9.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.302 -0.999 . . . . 74.420000000000002 108.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.48 157.38 23.62 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.504 -0.554 . . . . 74.010000000000005 109.504 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 72.74 -58.28 0.6 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.408 1.083 . . . . 64.120000000000005 110.875 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.86 111.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.823 0.82 . . . . 70.010000000000005 108.791 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.5 m -106.37 136.91 45.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.826 -0.625 . . . . 72.430000000000007 109.809 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.49 160.14 18.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.597 -0.841 . . . . 75.120000000000005 111.405 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.61 124.29 25.17 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.646 -1.613 . . . . 63.240000000000002 106.646 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.8 115.66 30.86 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.042 0.925 . . . . 73.310000000000002 110.835 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -128.81 138.58 52.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 114.458 -1.246 . . . . 74.209999999999994 110.871 -174.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.22 136.94 32.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.407 -0.815 . . . . 73.099999999999994 109.071 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.01 148.92 28.98 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.945 0.778 . . . . 75.109999999999999 109.718 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.457 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -77.62 -13.55 59.88 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 112.496 0.554 . . . . 74.219999999999999 112.496 -175.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.29 61.68 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.219 -1.467 . . . . 53.210000000000001 113.253 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 163.65 40.17 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.616 -1.278 . . . . 72.540000000000006 112.337 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.497 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.4 ptpt -96.03 133.9 39.71 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 75.109999999999999 108.375 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 37.0 m-85 -124.52 163.12 22.54 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.269 -0.423 . . . . 73.209999999999994 111.922 -171.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.53 116.63 32.12 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.575 -0.898 . . . . 72.450000000000003 108.575 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.4 t -123.29 149.64 44.56 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 121.23 0.538 . . . . 75.319999999999993 110.978 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.4 m -127.09 123.27 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.098 -0.955 . . . . 63.229999999999997 109.41 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -109.89 132.57 54.03 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.44 0.638 . . . . 71.140000000000001 112.504 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.41 136.9 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.569 -1.271 . . . . 74.019999999999996 107.569 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.531 ' C ' ' H ' ' A' ' 49' ' ' LYS . 31.0 m -138.75 164.83 28.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.712 -1.218 . . . . 73.329999999999998 107.712 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG21 ' A' ' 47' ' ' THR . 14.1 t70 76.16 -26.47 0.19 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.012 1.325 . . . . 74.549999999999997 110.309 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 47' ' ' THR . 54.0 mtmt -103.16 122.59 44.83 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 114.483 -1.235 . . . . 72.420000000000002 108.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.48 158.79 1.57 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 124.596 3.531 . . . . 73.109999999999999 114.416 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.66 -41.47 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.452 1.101 . . . . 64.120000000000005 112.055 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.672 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 24.5 t70 -58.81 -43.45 90.56 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.638 -0.256 . . . . 70.019999999999996 110.517 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -73.77 -47.67 37.33 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.335 0.654 . . . . 64.200000000000003 110.85 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.77 -41.56 77.85 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.442 -0.799 . . . . 74.219999999999999 111.698 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.1 tp -68.72 -35.71 77.49 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.342 -0.39 . . . . 74.510000000000005 110.443 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 17.6 mtp180 -56.89 -46.0 82.18 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.206 0.527 . . . . 74.299999999999997 111.624 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 49' ' ' LYS . 40.0 mt-10 -79.58 -35.33 39.84 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.429 -0.805 . . . . 74.430000000000007 112.292 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.29 -32.91 59.03 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.37 0.878 . . . . 72.319999999999993 113.37 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.521 ' HE2' ' HA ' ' A' ' 59' ' ' MET . 5.2 mmt -56.26 -57.91 19.86 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.121 0.786 . . . . 75.530000000000001 113.121 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.604 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 28.9 Cg_endo -63.9 -32.49 66.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 121.867 1.712 . . . . 64.219999999999999 110.552 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -58.35 -45.65 87.78 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.923 -1.035 . . . . 54.420000000000002 110.796 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.5 mm -75.63 -47.63 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.389 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.423 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.292 3.7 ppp? -62.85 -32.23 73.41 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.667 1.358 . . . . 75.040000000000006 114.667 -174.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 60' ' ' PRO 0.295 0.0 OUTLIER -77.65 -29.09 51.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.697 -1.201 . . . . 71.230000000000004 112.504 176.347 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' THR . 62.2 t80 -65.07 -52.23 56.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.343 0.592 . . . . 74.409999999999997 110.207 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -72.19 -15.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.556 -0.747 . . . . 73.099999999999994 111.853 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.4 -11.58 68.82 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.439 -0.801 . . . . 70.340000000000003 112.458 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.0 -23.32 1.44 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.486 -1.34 . . . . 44.439999999999998 113.577 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 58.0 m -82.0 70.01 8.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.65 1.214 . . . . 74.239999999999995 111.976 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -98.36 170.16 9.05 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.528 -2.027 . . . . 72.299999999999997 105.528 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 36.6 t70 -69.31 -33.52 73.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 119.809 -0.756 . . . . 64.329999999999998 111.723 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.2 1.91 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 72.239999999999995 110.792 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.86 28.57 72.96 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.638 -0.71 . . . . 64.209999999999994 113.656 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.16 120.73 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 109.3 -0.629 . . . . 74.510000000000005 109.3 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.76 -135.3 1.85 Allowed Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 111.0 -0.84 . . . . 54.439999999999998 111.0 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.8 ttp 178.0 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.271 0.558 . . . . 74.450000000000003 111.284 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.54 65.58 0.58 Allowed Glycine 0 CA--C 1.491 -1.414 0 N-CA-C 106.291 -2.724 . . . . 60.530000000000001 106.291 -169.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.401 ' HE3' ' HD2' ' A' ' 105' ' ' PRO . 11.4 ptm -97.01 121.94 39.45 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.266 -0.967 . . . . 72.549999999999997 111.448 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -128.26 134.93 49.05 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.712 -0.676 . . . . 64.530000000000001 111.589 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -157.11 172.29 6.33 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 104.991 -2.226 . . . . 71.25 104.991 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.18 139.52 72.09 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 121.431 1.42 . . . . 75.439999999999998 113.161 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.83 142.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.421 -1.326 . . . . 42.100000000000001 107.421 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.6 p -138.33 144.5 40.41 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.952 -0.299 . . . . 64.25 110.234 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 50.4 p90 -131.01 143.73 50.94 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.582 -0.447 . . . . 73.219999999999999 110.96 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.5 ' HB3' ' CE2' ' A' ' 168' ' ' TYR . . . -93.35 134.24 35.78 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.602 0.564 . . . . 74.329999999999998 110.6 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.26 150.79 32.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.438 -0.801 . . . . 75.239999999999995 109.799 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -114.75 112.69 45.1 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.951 -0.389 . . . . 74.040000000000006 109.951 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.59 158.83 2.93 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.869 1.713 . . . . 63.530000000000001 111.289 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -104.67 160.76 14.7 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.279 -1.749 . . . . 72.209999999999994 106.279 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.01 -24.73 64.73 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.49 0.662 . . . . 74.109999999999999 111.058 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.57 -5.89 47.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.01 -0.995 . . . . 73.329999999999998 110.804 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.91 -10.67 74.29 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.846 -0.502 . . . . 44.399999999999999 111.846 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 m -77.22 136.01 38.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 109.032 -0.729 . . . . 74.129999999999995 109.032 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.3 mt -84.72 136.85 33.55 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.069 0.461 . . . . 74.400000000000006 111.037 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -81.9 144.97 30.6 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.769 -1.567 . . . . 71.530000000000001 106.769 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -92.29 80.12 5.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.364 1.246 . . . . 70.510000000000005 114.364 -174.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.623 ' HE2' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -160.42 122.37 3.18 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.434 -2.802 . . . . 73.329999999999998 103.434 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.623 ' N ' ' HE2' ' A' ' 97' ' ' LYS . 5.2 tt -144.11 137.62 27.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.77 0.319 . . . . 62.350000000000001 110.515 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -129.09 123.88 33.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.205 -0.598 . . . . 65.340000000000003 110.553 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.547 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 86.2 t -86.94 129.78 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.629 -0.714 . . . . 73.219999999999999 109.145 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -107.16 127.87 53.9 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.622 -0.51 . . . . 74.219999999999999 109.622 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -104.04 117.71 34.94 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.812 -1.181 . . . . 74.510000000000005 107.812 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 59.4 ttt-85 -75.34 129.46 37.42 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.023 -1.473 . . . . 74.019999999999996 107.023 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.7 mt -89.87 134.28 32.31 Favored Pre-proline 0 C--N 1.271 -2.831 0 N-CA-C 109.868 -0.419 . . . . 73.439999999999998 109.868 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.536 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 74.7 Cg_exo -53.59 158.84 7.34 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.021 2.481 . . . . 74.510000000000005 112.972 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.429 HD21 ' HB2' ' A' ' 16' ' ' TRP . 2.1 t-20 -46.27 -54.32 9.08 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 126.137 1.775 . . . . 73.120000000000005 115.585 -172.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -72.29 -28.15 62.91 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.053 -0.659 . . . . 72.120000000000005 112.456 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.89 -12.56 55.28 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.623 -0.431 . . . . 73.340000000000003 111.458 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 49.9 mt-30 -70.9 -28.53 64.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.748 0.309 . . . . 62.409999999999997 111.482 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -38.24 92.38 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.975 -0.631 . . . . 60.439999999999998 111.64 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -157.41 98.9 1.93 Allowed Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 107.748 -1.204 . . . . 75.310000000000002 107.748 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.6 158.95 10.73 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.75 2.3 . . . . 75.200000000000003 112.586 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.5 156.2 66.4 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.434 2.089 . . . . 74.120000000000005 111.511 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 71' ' ' ASP . . . -72.74 142.46 83.47 Favored Pre-proline 0 N--CA 1.426 -1.665 0 CA-C-N 115.958 -0.565 . . . . 61.240000000000002 110.011 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.74 114.74 3.43 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.844 2.362 . . . . 63.020000000000003 112.088 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -61.14 -42.65 98.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.739 -0.664 . . . . 75.299999999999997 109.498 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -91.19 161.07 15.23 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 63.32 110.256 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -87.18 -28.4 22.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.507 -0.77 . . . . 63.009999999999998 109.03 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.3 p -79.07 -12.25 60.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.657 -0.701 . . . . 55.109999999999999 112.025 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.14 116.99 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 105.833 -1.914 . . . . 63.130000000000003 105.833 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -128.78 143.43 50.92 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 120.701 -0.4 . . . . 74.530000000000001 110.316 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.0 mm -92.45 112.76 26.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.462 -0.94 . . . . 75.430000000000007 108.462 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.82 153.11 38.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.862 -0.792 . . . . 71.430000000000007 108.862 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 4.5 mp0 -98.45 146.87 25.3 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.994 0.426 . . . . 74.519999999999996 110.24 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -134.54 120.99 20.35 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.637 -0.71 . . . . 75.129999999999995 109.697 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.28 156.15 43.65 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.651 -0.87 . . . . 70.319999999999993 108.651 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.22 19.39 78.48 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.194 -1.003 . . . . 50.149999999999999 114.096 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -120.08 145.25 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 C-N-CA 119.92 -0.712 . . . . 71.310000000000002 109.588 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.0 m -112.59 138.46 49.34 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 105.646 -1.983 . . . . 75.519999999999996 105.646 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.88 148.33 26.73 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 108.3 -1.0 . . . . 65.329999999999998 108.3 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -112.56 121.05 43.66 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 103.646 -2.724 . . . . 75.420000000000002 103.646 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.2 m -122.34 135.2 54.67 Favored 'General case' 0 C--N 1.263 -3.162 0 C-N-CA 120.587 -0.445 . . . . 65.5 109.926 -174.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.6 t -112.51 136.81 51.59 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 108.727 -0.842 . . . . 65.109999999999999 108.727 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 9.3 pt20 -117.25 130.03 56.3 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.527 -0.761 . . . . 65.230000000000004 109.404 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.83 168.37 19.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.405 -0.816 . . . . 71.230000000000004 109.515 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -126.38 136.35 9.48 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.922 -0.656 . . . . 64.420000000000002 112.022 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 152.01 -163.22 30.06 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.203 -1.159 . . . . 54.420000000000002 110.203 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -99.13 107.71 20.14 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.562 -0.903 . . . . 75.030000000000001 108.562 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.18 133.38 35.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.203 1.186 . . . . 64.230000000000004 114.203 -172.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HB3' ' OE1' ' A' ' 141' ' ' GLU . 25.4 mtpp -112.33 177.5 4.62 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.941 -1.503 . . . . 73.340000000000003 106.941 170.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -63.27 -34.46 77.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.075 0.464 . . . . 54.130000000000003 109.98 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.57 -30.0 71.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.525 -0.762 . . . . 54.219999999999999 111.254 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.2 -31.72 71.43 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.968 0.413 . . . . 54.229999999999997 110.789 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -73.03 -43.98 61.39 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.047 -0.524 . . . . 71.450000000000003 109.935 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.22 -48.36 87.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 O-C-N 123.42 0.45 . . . . 74.329999999999998 110.38 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.51 87.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.574 -0.739 . . . . 50.140000000000001 111.546 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.441 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 65.1 m80 -71.08 -34.8 71.52 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.463 -0.495 . . . . 63.539999999999999 112.068 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.584 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.446 0.165 . . . . 73.040000000000006 110.76 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.2 t -68.73 -32.72 72.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 74.120000000000005 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -66.75 -40.61 88.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.334 0.587 . . . . 72.140000000000001 109.762 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 65.8 mt -65.05 -33.75 76.78 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 116.149 -0.478 . . . . 72.120000000000005 111.363 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 50.3 mtt180 -56.09 -49.04 74.95 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.483 0.489 . . . . 71.209999999999994 110.847 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.547 ' HA ' ' OE1' ' A' ' 156' ' ' GLU . 11.0 t -73.7 -29.56 62.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.922 -0.581 . . . . 71.299999999999997 110.807 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 34.1 m -71.14 -34.57 71.15 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.428 0.632 . . . . 65.450000000000003 109.691 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.45 0.52 16.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.491 0.716 . . . . 75.129999999999995 111.643 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.547 ' OE1' ' HA ' ' A' ' 153' ' ' THR . 46.5 mt-10 -84.16 140.22 31.89 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.55 -0.537 . . . . 71.530000000000001 109.55 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 96.88 -10.09 66.08 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.08 -0.581 . . . . 71.409999999999997 111.957 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 160' ' ' ALA . 12.2 t -122.2 155.59 61.32 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.198 . . . . 73.040000000000006 107.764 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 36.56 0.1 Allowed 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 124.351 3.367 . . . . 60.530000000000001 114.287 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 158' ' ' THR . . . -101.03 119.04 38.16 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.123 0.487 . . . . 75.120000000000005 110.631 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.5 p -123.83 144.54 49.66 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.011 -0.737 . . . . 62.200000000000003 109.011 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -131.31 150.61 52.08 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.353 -0.24 . . . . 75.120000000000005 110.353 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -120.06 148.77 43.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.752 0.649 . . . . 72.109999999999999 112.752 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.25 1.95 37.93 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 115.112 0.805 . . . . 74.450000000000003 115.112 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.429 ' HB3' HH22 ' A' ' 152' ' ' ARG . 21.3 m-20 65.88 0.47 1.56 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.748 0.819 . . . . 61.329999999999998 112.04 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.63 139.27 20.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.648 0.737 . . . . 53.119999999999997 112.706 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -136.24 164.0 29.09 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.095 -1.076 . . . . 60.119999999999997 108.095 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 50.8 m-85 -115.63 151.38 35.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.411 -0.588 . . . . 75.25 109.411 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 83' ' ' SER . 60.4 m -113.94 123.7 50.38 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.928 -1.508 . . . . 75.400000000000006 106.928 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.72 149.21 31.95 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.859 0.362 . . . . 74.409999999999997 111.324 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -163.26 164.73 36.25 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 108.544 -1.823 . . . . 74.219999999999999 108.544 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -85.06 -39.3 18.13 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 117.837 0.818 . . . . 71.540000000000006 109.543 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -157.47 154.38 25.31 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 106.844 -1.539 . . . . 74.140000000000001 106.844 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -41.87 111.31 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.506 2.804 . . . . 61.340000000000003 112.716 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.43 130.83 37.85 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 123.866 3.044 . . . . 73.140000000000001 113.647 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.6 ' O ' ' HG3' ' A' ' 177' ' ' LYS . 26.0 ttt -87.87 -43.35 11.88 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 115.614 -0.721 . . . . 72.299999999999997 109.25 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 176' ' ' MET . 88.9 mttt 162.4 -67.48 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.192 0 C-N-CA 129.017 2.927 . . . . 74.030000000000001 108.835 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.14 -28.84 12.3 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 121.055 1.17 . . . . 71.099999999999994 109.388 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -84.57 123.87 30.8 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.682 -1.229 . . . . 71.540000000000006 107.682 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 101.7 43.84 2.05 Favored Glycine 0 C--N 1.3 -1.435 0 N-CA-C 109.867 -1.293 . . . . 37.859999999999999 109.867 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.6 ptp180 -96.88 -15.63 21.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.992 -0.604 . . . . 74.109999999999999 111.864 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -115.12 127.91 55.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.483 -2.414 . . . . 74.150000000000006 104.483 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 10.8 m120 -139.67 160.25 40.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.15 -0.62 . . . . 74.140000000000001 110.526 -171.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 133' ' ' THR . 49.6 mt-10 -132.45 145.9 51.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 123.753 0.658 . . . . 71.209999999999994 109.823 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 132' ' ' SER . 21.8 t -123.95 120.85 60.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 106.071 -1.826 . . . . 74.340000000000003 106.071 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 13.1 m0 -104.78 121.36 43.47 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.798 -0.361 . . . . 74.450000000000003 110.932 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 84.8 mt -99.1 131.18 45.32 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.03 -1.47 . . . . 54.340000000000003 107.03 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.35 135.21 38.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.506 -0.478 . . . . 63.520000000000003 110.563 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 161' ' ' THR . 19.9 pttp -72.0 143.24 49.26 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.563 -0.455 . . . . 73.420000000000002 110.854 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 115.062 -0.972 . . . . 74.349999999999994 110.505 178.26 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 . . . . . 0 CA--C 1.511 -0.552 0 N-CA-C 109.982 -0.377 . . . . 74.420000000000002 109.982 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.9 p -149.25 160.5 43.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.902 -0.777 . . . . 70.349999999999994 108.902 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.73 90.77 3.5 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 120.791 0.329 . . . . 63.450000000000003 110.976 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -124.55 162.94 22.97 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.459 -0.571 . . . . 74.230000000000004 109.459 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.03 13.64 68.63 Favored Glycine 0 C--N 1.31 -0.879 0 N-CA-C 110.452 -1.059 . . . . 39.079999999999998 110.452 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.8 p -76.82 160.97 28.83 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 123.398 0.679 . . . . 73.319999999999993 109.87 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.07 111.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.889 -0.782 . . . . 72.530000000000001 108.889 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.14 178.33 7.12 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.24 -0.436 . . . . 71.230000000000004 111.131 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.1 m -111.35 95.95 5.83 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 120.116 -0.634 . . . . 75.420000000000002 111.619 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -115.07 88.49 17.56 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 105.975 -1.861 . . . . 74.310000000000002 105.975 170.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -87.32 148.88 7.77 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.113 1.875 . . . . 71.349999999999994 114.216 -169.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.1 p90 -101.25 136.06 41.71 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 104.378 -2.453 . . . . 74.140000000000001 104.378 173.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 91.8 mt-30 -106.17 109.28 21.16 Favored 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 118.648 -1.221 . . . . 73.400000000000006 111.542 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.91 115.87 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 108.089 -1.078 . . . . 74.230000000000004 108.089 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -96.08 -36.55 10.96 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.074 -0.966 . . . . 62.310000000000002 111.883 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.461 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 42.6 t -157.12 150.41 23.98 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.296 0.569 . . . . 73.329999999999998 111.009 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.6 p -132.45 162.45 31.13 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.431 -1.692 . . . . 74.450000000000003 106.431 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.5 99.66 0.97 Allowed Glycine 0 C--N 1.304 -1.209 0 C-N-CA 118.297 -1.906 . . . . 61.43 114.243 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.07 -147.49 5.76 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.707 -0.957 . . . . 61.409999999999997 110.707 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -86.76 170.89 11.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.065 -0.717 . . . . 65.409999999999997 109.065 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.15 155.01 39.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.551 -0.907 . . . . 72.409999999999997 108.551 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 74.35 -52.81 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.791 0.836 . . . . 72.310000000000002 111.464 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.04 109.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 122.441 1.115 . . . . 73.030000000000001 110.376 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.8 m -111.53 128.66 56.09 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.662 -0.866 . . . . 74.439999999999998 108.662 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.04 155.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.558 -1.257 . . . . 73.340000000000003 111.301 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.532 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 35.2 tt0 -134.36 125.63 27.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.796 -1.557 . . . . 70.310000000000002 106.796 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.461 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 36.2 mt-10 -94.73 114.86 26.83 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.436 -1.69 . . . . 62.100000000000001 106.436 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.532 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 30.2 ptt180 -140.27 132.37 27.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.435 0.636 . . . . 75.519999999999996 112.54 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 129' ' ' THR . . . -80.98 137.34 36.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.093 -1.077 . . . . 53.030000000000001 108.093 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -58.87 149.8 25.87 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.772 0.67 . . . . 73.400000000000006 110.468 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -21.18 64.17 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.975 -0.557 . . . . 53.409999999999997 112.032 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 9.72 68.5 Favored Glycine 0 C--O 1.244 0.766 0 C-N-CA 119.966 -1.111 . . . . 75.030000000000001 112.893 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 165.81 53.12 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 121.384 -0.436 . . . . 73.010000000000005 113.139 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.506 ' HB3' ' HZ1' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -98.58 118.52 35.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.771 -0.826 . . . . 73.200000000000003 108.771 179.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.523 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 22.8 m-85 -124.33 165.63 17.35 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.736 -0.665 . . . . 74.140000000000001 111.494 -170.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.77 117.94 34.39 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.954 -0.758 . . . . 64.109999999999999 108.954 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -125.03 147.66 48.85 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.911 -0.586 . . . . 74.310000000000002 111.829 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.417 HG21 ' HG2' ' A' ' 61' ' ' LYS . 7.6 p -137.75 135.33 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 45.100000000000001 108.905 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -121.78 137.64 54.69 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.092 -1.043 . . . . 73.239999999999995 110.504 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 41.7 t -118.74 131.34 71.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.037 -1.468 . . . . 71.409999999999997 107.037 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.405 ' C ' ' H ' ' A' ' 49' ' ' LYS . 41.0 p -115.16 158.27 22.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.635 0.606 . . . . 71.239999999999995 112.635 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' HA ' ' CG ' ' A' ' 96' ' ' LYS . 36.3 t70 68.73 -12.89 0.35 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.629 1.972 . . . . 64.430000000000007 113.445 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.4 mttm -94.72 135.92 23.46 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 108.458 -0.941 . . . . 72.200000000000003 108.458 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.93 156.88 11.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.877 2.385 . . . . 73.430000000000007 111.337 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 98' ' ' LEU . 55.9 t -46.49 -47.68 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.893 0.877 . . . . 73.219999999999999 113.263 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.675 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 14.1 t70 -63.35 -47.84 80.46 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.528 -0.469 . . . . 74.310000000000002 110.208 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -63.56 -41.43 98.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.34 0.656 . . . . 73.230000000000004 112.195 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -65.42 -39.78 92.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.132 0.492 . . . . 73.129999999999995 110.115 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.9 tp -66.3 -33.75 76.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.883 -0.599 . . . . 62.329999999999998 110.001 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 29.9 mmt180 -59.05 -34.36 71.84 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.853 -0.612 . . . . 64.510000000000005 110.78 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.03 -49.53 10.12 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.312 -0.858 . . . . 63.310000000000002 110.72 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -66.99 -33.06 74.75 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.317 1.228 . . . . 64.25 114.317 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.571 ' O ' ' HG2' ' A' ' 63' ' ' MET . 6.5 mmt -61.11 -58.19 20.84 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 119.752 -0.779 . . . . 75.239999999999995 112.806 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.16 -30.84 91.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.407 2.071 . . . . 73.140000000000001 111.131 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 18.1 tppt? -61.43 -44.49 97.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.092 -0.958 . . . . 65.129999999999995 110.369 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.4 mm -73.57 -39.41 53.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.313 -0.555 . . . . 70.0 109.583 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 59' ' ' MET . 25.9 mmt -55.38 -44.15 75.81 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.453 0.538 . . . . 70.0 112.453 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.01 -38.61 91.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.183 0.516 . . . . 74.439999999999998 110.652 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -70.83 -51.02 29.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.892 -0.595 . . . . 74.129999999999995 111.159 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p -74.85 -25.46 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-O 121.07 0.462 . . . . 72.150000000000006 111.229 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.75 -30.81 67.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.88 -0.6 . . . . 74.120000000000005 113.074 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.53 -3.63 1.88 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.271 -1.443 . . . . 52.420000000000002 113.855 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 m -89.56 27.07 1.56 Allowed 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 122.627 1.203 . . . . 75.319999999999993 109.387 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.08 177.29 7.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.068 -0.969 . . . . 74.150000000000006 109.231 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.82 -31.57 72.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.965 0.728 . . . . 70.239999999999995 112.965 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -87.6 -12.88 44.33 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.911 -0.716 . . . . 73.299999999999997 110.741 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.81 28.29 73.2 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.684 -0.77 . . . . 54.539999999999999 111.566 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.01 121.84 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.01 0.433 . . . . 73.140000000000001 109.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.95 63.74 0.61 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.431 -0.89 . . . . 74.120000000000005 112.144 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.93 -26.43 48.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.51 -0.552 . . . . 75.329999999999998 109.51 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.77 83.98 0.36 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.245 -0.889 . . . . 45.420000000000002 111.554 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.515 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 19.1 ptt? -96.19 125.41 40.69 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.926 0.393 . . . . 74.319999999999993 110.048 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.7 p -113.82 116.49 29.42 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.911 -0.586 . . . . 63.530000000000001 112.267 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.54 159.57 36.1 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 106.965 -1.495 . . . . 75.200000000000003 106.965 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.67 139.46 88.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.646 1.564 . . . . 71.530000000000001 112.616 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -103.94 153.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.193 -1.41 . . . . 72.310000000000002 107.193 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.4 m -133.75 145.45 49.83 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.303 -0.628 . . . . 73.530000000000001 109.303 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 51.4 p90 -138.12 139.96 39.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.403 -0.519 . . . . 71.239999999999995 110.309 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.69 134.87 34.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.878 -0.601 . . . . 63.520000000000003 110.175 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.48 150.02 30.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.952 -1.129 . . . . 70.5 107.952 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -119.48 108.05 40.17 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.17 -0.678 . . . . 73.109999999999999 109.17 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.4 142.09 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.088 1.858 . . . . 74.430000000000007 112.546 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.17 174.54 7.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.006 -0.543 . . . . 70.310000000000002 110.323 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -23.46 67.41 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.036 0.935 . . . . 61.240000000000002 110.622 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.46 -5.31 58.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.049 -0.978 . . . . 64.030000000000001 110.607 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.76 -10.25 65.7 Favored Glycine 0 CA--C 1.504 -0.636 0 CA-C-N 116.084 -0.507 . . . . 53.25 112.214 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 p -86.1 142.19 28.87 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.545 -0.539 . . . . 75.340000000000003 109.545 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.523 HD23 ' HH ' ' A' ' 167' ' ' TYR . 69.6 mt -75.84 145.21 40.79 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.024 -0.534 . . . . 74.439999999999998 110.61 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.64 150.25 32.7 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.657 -0.868 . . . . 74.510000000000005 108.657 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' CG ' ' HA ' ' A' ' 48' ' ' ASP 0.291 0.2 OUTLIER -83.03 75.31 9.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.651 1.215 . . . . 73.230000000000004 112.031 178.938 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -164.09 125.03 2.2 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.536 -2.024 . . . . 71.140000000000001 105.536 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD12 HG12 ' A' ' 51' ' ' VAL . 5.6 tt -140.22 135.31 32.23 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.057 -0.719 . . . . 71.120000000000005 109.057 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -124.16 115.34 20.95 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.562 -0.29 . . . . 73.109999999999999 110.237 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.7 t -91.17 134.45 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.542 -0.54 . . . . 61.310000000000002 109.542 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -117.75 122.16 42.73 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.646 -0.872 . . . . 72.109999999999999 108.646 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 75.8 t80 -102.93 111.14 23.33 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.817 -1.549 . . . . 74.299999999999997 106.817 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.523 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 34.1 ttp180 -81.56 113.21 19.43 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.714 -0.675 . . . . 71.519999999999996 110.247 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.503 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 68.7 mt -79.07 134.09 60.19 Favored Pre-proline 0 C--N 1.284 -2.253 0 CA-C-N 114.463 -1.244 . . . . 74.530000000000001 110.907 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 50.7 Cg_exo -53.4 153.75 16.77 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.328 2.685 . . . . 74.329999999999998 112.067 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -56.47 -36.28 68.91 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.012 1.116 . . . . 70.219999999999999 114.012 -174.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -62.4 -36.2 81.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.159 0.504 . . . . 75.209999999999994 111.004 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.5 -6.17 56.65 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.988 -0.551 . . . . 70.230000000000004 110.997 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.503 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 26.0 mm-40 -71.7 -30.2 65.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.829 0.347 . . . . 72.540000000000006 110.75 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.24 73.47 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.472 -0.785 . . . . 61.439999999999998 111.908 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.5 p -160.18 89.02 1.83 Allowed Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-O 120.661 0.267 . . . . 74.129999999999995 110.495 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.49 154.27 9.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.178 1.918 . . . . 52.409999999999997 110.935 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.96 158.11 58.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.341 2.027 . . . . 74.099999999999994 111.352 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.85 149.53 80.47 Favored Pre-proline 0 C--O 1.259 1.593 0 C-N-CA 120.874 -0.33 . . . . 73.409999999999997 110.205 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 24.9 Cg_exo -65.73 106.75 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.697 2.265 . . . . 60.140000000000001 111.38 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.5 t -83.16 -25.66 31.63 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.53 -0.545 . . . . 73.329999999999998 109.53 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.63 143.89 28.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.317 -0.994 . . . . 71.150000000000006 108.317 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.18 -24.04 60.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.019 0.748 . . . . 71.450000000000003 113.019 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.2 m -89.81 -19.11 25.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.002 0.429 . . . . 63.329999999999998 109.892 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 61.9 t -94.89 116.27 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 107.102 -1.444 . . . . 72.209999999999994 107.102 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -124.35 136.31 53.99 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.603 -0.726 . . . . 71.209999999999994 110.449 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.5 mm -91.68 111.19 23.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.612 -1.255 . . . . 71.030000000000001 107.612 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -124.73 143.38 50.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.806 -1.088 . . . . 70.310000000000002 109.142 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -105.23 132.58 51.25 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.624 -0.716 . . . . 75.310000000000002 109.339 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -123.2 123.1 40.03 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.291 -1.003 . . . . 72.319999999999993 108.291 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.6 158.03 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.5 -0.555 . . . . 73.299999999999997 109.5 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.36 19.2 50.57 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.626 -0.797 . . . . 71.420000000000002 112.128 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.26 145.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.058 0.456 . . . . 71.230000000000004 110.367 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 90.4 m -112.64 135.49 53.3 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 107.87 -1.159 . . . . 72.439999999999998 107.87 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.16 150.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 N-CA-C 107.839 -1.171 . . . . 75.219999999999999 107.839 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.35 121.12 43.43 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 104.664 -2.347 . . . . 75.430000000000007 104.664 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 24.8 m -115.93 132.75 56.56 Favored 'General case' 0 C--N 1.261 -3.246 0 C-N-CA 120.339 -0.545 . . . . 71.329999999999998 110.834 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 30' ' ' SER . 9.9 t -113.24 119.94 39.46 Favored 'General case' 0 N--CA 1.391 -3.421 0 CA-C-N 115.587 -0.733 . . . . 75.310000000000002 109.614 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -110.88 126.03 54.26 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.404 -1.332 . . . . 65.040000000000006 107.404 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 22.3 p90 -136.6 167.6 21.08 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.352 -0.84 . . . . 75.040000000000006 110.687 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -133.32 143.3 14.96 Favored Glycine 0 CA--C 1.485 -1.798 0 C-N-CA 120.484 -0.865 . . . . 52.329999999999998 111.559 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.81 -155.28 25.79 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.258 -1.137 . . . . 63.009999999999998 110.258 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -99.93 103.08 14.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.834 -0.802 . . . . 75.299999999999997 108.834 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.62 117.53 31.86 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.41 -0.359 . . . . 64.439999999999998 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HA ' ' CE2' ' A' ' 179' ' ' TYR . 40.5 ttmt -81.13 163.84 22.82 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.831 -1.174 . . . . 72.209999999999994 107.831 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.74 -35.23 42.5 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.004 0.522 . . . . 60.340000000000003 111.607 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.87 65.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.065 -0.516 . . . . 71.109999999999999 111.121 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.33 -30.89 69.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.119 -0.491 . . . . 73.439999999999998 110.433 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -59.72 -49.43 77.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.299 -0.63 . . . . 72.310000000000002 109.299 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.1 t -59.96 -42.96 91.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.032 -0.986 . . . . 63.509999999999998 109.341 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.16 85.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.46 -0.791 . . . . 44.340000000000003 111.179 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.499 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 29.3 m80 -66.94 -33.89 76.57 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 112.536 0.569 . . . . 71.019999999999996 112.536 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.23 -45.14 94.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.398 0.618 . . . . 62.030000000000001 109.627 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 m -66.58 -35.3 79.87 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.421 -0.809 . . . . 71.109999999999999 109.868 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.09 -29.01 61.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.752 -0.658 . . . . 74.329999999999998 111.373 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 82.6 mt -61.7 -36.71 81.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.944 -0.391 . . . . 71.140000000000001 109.944 173.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -57.42 -48.19 79.78 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.854 0.721 . . . . 72.219999999999999 110.802 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.6 t -75.72 -30.15 59.16 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.113 -0.494 . . . . 73.340000000000003 110.952 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.4 m -74.85 -34.17 62.25 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.358 0.599 . . . . 73.150000000000006 110.819 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.54 6.75 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.373 0.606 . . . . 72.129999999999995 110.36 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 131.53 34.34 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.826 -1.546 . . . . 72.040000000000006 106.826 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.89 -4.78 61.35 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.514 -0.635 . . . . 65.140000000000001 111.514 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.1 p -99.89 163.94 17.44 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 107.844 -1.169 . . . . 43.240000000000002 107.844 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 63.6 Cg_endo -73.88 0.82 7.79 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.992 1.794 . . . . 71.349999999999994 112.901 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.95 140.99 32.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.881 0.372 . . . . 73.540000000000006 111.557 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.0 p -118.13 153.48 33.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.212 -0.662 . . . . 74.299999999999997 109.212 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.426 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 38.8 p90 -135.3 137.81 42.85 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.139 -0.35 . . . . 75.109999999999999 110.171 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.617 ' NE2' HG11 ' A' ' 188' ' ' VAL 0.26 0.4 OUTLIER -97.92 116.63 30.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.739 1.385 . . . . 74.439999999999998 114.739 -176.455 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.16 65.82 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.773 -0.649 . . . . 75.549999999999997 112.623 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . 0.261 8.6 p-10 49.38 27.66 2.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.765 1.226 . . . . 74.519999999999996 113.22 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.481 ' O ' HD13 ' A' ' 187' ' ' LEU . 77.6 t -66.57 138.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 113.968 -1.469 . . . . 73.120000000000005 110.137 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.523 ' HH ' HD23 ' A' ' 94' ' ' LEU . 34.4 p90 -143.26 171.13 14.53 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.989 -0.55 . . . . 73.299999999999997 111.492 -176.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 4.2 m-85 -121.75 150.54 41.68 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.671 -0.695 . . . . 64.540000000000006 109.865 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 20.4 t -115.02 146.22 41.48 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.994 -1.113 . . . . 75.010000000000005 107.994 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.36 158.5 18.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.925 0.393 . . . . 74.150000000000006 110.907 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.53 156.32 26.79 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 108.732 -1.747 . . . . 71.019999999999996 108.732 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -142.46 -38.59 0.36 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 114.051 1.13 . . . . 73.109999999999999 114.051 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 4.2 p-10 -154.26 154.9 30.35 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 108.912 -0.774 . . . . 70.329999999999998 108.912 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.29 105.59 1.63 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.233 1.955 . . . . 74.0 108.99 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 69.0 Cg_endo -74.54 149.37 38.91 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 122.197 1.932 . . . . 71.409999999999997 112.609 -173.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.6 ptm -80.67 -21.37 41.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.534 -1.284 . . . . 73.109999999999999 107.534 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -83.24 152.44 64.73 Favored Pre-proline 0 N--CA 1.431 -1.414 0 N-CA-C 104.7 -2.333 . . . . 74.420000000000002 104.7 172.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.57 -33.02 29.48 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.32 2.013 . . . . 62.350000000000001 114.107 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 140' ' ' LYS . 89.5 m-85 -152.4 172.43 16.51 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 122.949 0.5 . . . . 72.400000000000006 109.746 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.67 -179.71 49.12 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.168 -1.173 . . . . 45.240000000000002 110.168 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -86.28 -24.16 26.05 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 117.538 0.669 . . . . 73.150000000000006 111.787 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -116.6 136.06 53.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 110.579 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.431 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.2 m120 -126.52 146.94 49.93 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.729 -1.582 . . . . 72.329999999999998 106.729 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 133' ' ' THR . 33.9 tt0 -142.82 132.64 24.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.965 -0.694 . . . . 53.140000000000001 110.459 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 132' ' ' SER . 82.4 t -126.49 130.18 71.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.863 0.865 . . . . 65.150000000000006 109.287 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.5 m0 -109.36 121.3 44.87 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 109.449 -0.574 . . . . 63.439999999999998 109.449 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 166' ' ' VAL . 40.3 tp -100.78 135.48 42.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.865 -1.532 . . . . 73.310000000000002 106.865 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.617 HG11 ' NE2' ' A' ' 163' ' ' GLN . 6.1 p -106.72 135.44 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 114.036 1.124 . . . . 75.349999999999994 114.036 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -63.16 144.37 56.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.015 1.326 . . . . 71.409999999999997 114.421 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.452 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.241 -0.89 . . . . 74.209999999999994 109.045 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 109.043 -0.725 . . . . 73.120000000000005 109.043 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.1 t 73.29 112.16 0.06 Allowed 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.962 1.305 . . . . 63.119999999999997 111.291 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 99.1 mt -108.15 136.78 47.25 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.125 -1.065 . . . . 72.310000000000002 108.125 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -95.03 103.37 15.22 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 112.605 0.594 . . . . 62.5 112.605 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.97 65.17 3.52 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 108.486 -1.846 . . . . 64.239999999999995 108.486 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.5 p -61.51 109.67 1.24 Allowed 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 113.642 0.979 . . . . 73.310000000000002 113.642 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.08 78.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-O 122.415 1.102 . . . . 63.200000000000003 109.09 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -116.08 99.95 7.6 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.606 -1.179 . . . . 72.409999999999997 111.226 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.6 p -111.88 104.95 13.27 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.368 -0.833 . . . . 74.319999999999993 110.785 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.519 ' CZ2' ' HB3' ' A' ' 109' ' ' GLN . 3.2 p90 -73.36 120.0 78.76 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-O 120.908 0.385 . . . . 70.230000000000004 110.73 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -87.69 150.25 7.41 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.343 2.695 . . . . 64.150000000000006 114.536 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -101.3 154.42 18.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.426 -1.694 . . . . 55.140000000000001 106.426 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -121.11 109.62 15.24 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.929 -1.109 . . . . 75.140000000000001 112.392 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.45 125.68 45.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.103 -1.814 . . . . 75.230000000000004 106.103 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 22' ' ' SER . 2.9 pp -90.22 -29.26 18.31 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.677 -1.209 . . . . 74.209999999999994 111.366 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.49 ' N ' HD12 ' A' ' 21' ' ' LEU . 30.7 t -179.32 164.59 1.37 Allowed 'General case' 0 C--O 1.25 1.117 0 O-C-N 123.575 0.547 . . . . 74.420000000000002 110.124 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -131.19 165.76 22.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.852 -1.166 . . . . 63.439999999999998 107.852 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.68 -164.38 29.87 Favored Glycine 0 C--N 1.306 -1.139 0 C-N-CA 120.577 -0.82 . . . . 54.450000000000003 111.545 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.92 -138.75 10.44 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.597 -0.811 . . . . 73.510000000000005 112.263 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 5.2 ttpm? -118.09 170.73 8.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.107 -1.442 . . . . 71.239999999999995 107.107 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.96 159.67 33.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 118.569 0.622 . . . . 74.400000000000006 110.07 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 76.26 -52.78 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.754 1.622 . . . . 61.140000000000001 110.426 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.445 HG13 ' HG3' ' A' ' 150' ' ' GLN . 7.7 p -120.14 110.0 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-O 122.235 1.017 . . . . 74.129999999999995 109.811 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 133' ' ' THR . 45.0 m -122.16 154.11 37.87 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.446 -0.946 . . . . 51.130000000000003 108.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.489 ' HB3' HD13 ' A' ' 151' ' ' LEU . 8.9 p90 -118.06 156.52 28.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.91 1.078 . . . . 74.209999999999994 113.91 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.32 125.9 23.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.734 -1.95 . . . . 73.109999999999999 105.734 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 115.1 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.499 -1.667 . . . . 73.099999999999994 106.499 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -131.79 133.7 45.02 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.687 -0.688 . . . . 74.340000000000003 111.403 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.63 136.27 33.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.26 -1.385 . . . . 71.409999999999997 107.26 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.43 158.08 21.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.548 0.573 . . . . 71.140000000000001 112.548 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -86.54 -18.66 30.95 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.665 -0.698 . . . . 74.450000000000003 112.858 -174.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.81 46.62 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.494 -1.813 . . . . 71.400000000000006 112.544 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.35 149.22 46.81 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.804 -0.712 . . . . 42.130000000000003 113.874 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -88.88 119.45 29.4 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.656 -0.868 . . . . 74.430000000000007 108.656 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.54 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 27.7 m-85 -127.0 166.35 17.73 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 123.693 0.797 . . . . 74.409999999999997 111.083 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.56 116.82 30.5 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.092 -1.077 . . . . 60.100000000000001 108.092 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.8 t -135.29 150.76 50.08 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 115.414 -0.812 . . . . 74.140000000000001 112.516 -173.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 58' ' ' ALA . 9.2 p -141.64 142.28 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.121 -1.066 . . . . 74.209999999999994 108.121 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.3 133.05 48.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.658 -0.817 . . . . 74.319999999999993 112.572 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.48 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 52.7 t -112.08 141.87 26.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.656 -1.979 . . . . 74.209999999999994 105.656 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 49' ' ' LYS . 26.4 p -132.31 152.24 51.48 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.668 0.988 . . . . 63.130000000000003 113.668 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 67.6 -16.37 0.17 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 126.204 1.801 . . . . 74.230000000000004 112.141 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 47' ' ' THR . 48.6 mtpt -88.78 146.86 37.84 Favored Pre-proline 0 N--CA 1.422 -1.874 0 C-N-CA 124.175 0.99 . . . . 70.340000000000003 110.035 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.23 153.05 61.91 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.509 2.139 . . . . 60.100000000000001 111.675 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.451 HG13 HD12 ' A' ' 98' ' ' LEU . 32.2 t -49.89 -42.56 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 124.035 0.934 . . . . 71.120000000000005 112.316 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 13.0 t70 -61.63 -46.32 90.3 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.548 -0.461 . . . . 73.230000000000004 109.823 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -69.01 -42.13 76.83 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 111.48 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.15 -42.46 99.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.723 -0.672 . . . . 72.5 111.062 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.11 -31.97 72.79 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 116.336 -0.393 . . . . 72.549999999999997 111.156 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 5.2 mmp_? -55.95 -41.51 74.78 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.734 0.646 . . . . 75.099999999999994 110.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 44.4 mt-10 -84.41 -43.55 14.56 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.085 -0.507 . . . . 71.120000000000005 112.08 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.51 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . . . -68.97 -41.82 77.42 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.52 1.304 . . . . 43.450000000000003 114.52 -171.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.417 ' HB2' ' HE2' ' A' ' 59' ' ' MET . 43.4 ttm -57.27 -48.54 97.18 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.54 0.941 . . . . 71.530000000000001 113.54 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.68 -31.89 52.4 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.264 1.976 . . . . 75.109999999999999 112.245 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 91.0 mttt -72.12 -35.53 69.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.389 0.614 . . . . 55.329999999999998 111.058 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.05 -34.19 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 116.016 -0.538 . . . . 75.450000000000003 110.536 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 ttp -64.58 -43.31 94.26 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 124.062 0.945 . . . . 63.409999999999997 110.581 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 21.3 ptmt -69.48 -31.62 70.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.559 -0.291 . . . . 74.409999999999997 110.704 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -62.44 -60.48 3.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.46 -0.336 . . . . 74.209999999999994 111.796 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 76' ' ' MET . 14.6 p -83.86 -2.24 6.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-O 121.988 0.899 . . . . 72.129999999999995 109.859 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.01 -32.36 32.5 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.674 -0.774 . . . . 38.240000000000002 111.72 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 140.97 -2.56 2.14 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.689 -1.243 . . . . 51.219999999999999 113.52 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.5 m -92.06 34.32 1.02 Allowed 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.504 1.145 . . . . 64.519999999999996 109.156 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.466 ' OD1' HG13 ' A' ' 74' ' ' VAL . 7.2 p30 -96.8 168.93 10.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.769 -0.65 . . . . 74.239999999999995 109.759 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 23.2 t70 -71.79 -27.7 63.12 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.794 0.665 . . . . 71.140000000000001 112.794 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.91 -14.12 58.86 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.627 0.727 . . . . 70.329999999999998 109.334 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.63 78.6 Favored Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 110.847 -0.901 . . . . 75.430000000000007 110.847 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 14.5 p -93.11 153.08 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 108.127 -1.064 . . . . 74.120000000000005 108.127 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -133.48 0.41 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.736 -0.745 . . . . 54.240000000000002 112.416 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.724 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 55.7 ttp -76.61 -75.66 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.494 -0.482 . . . . 73.340000000000003 110.03 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.68 -52.01 0.68 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.541 0.977 . . . . 44.409999999999997 115.541 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.48 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 62.0 mtm -101.45 124.99 48.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 117.756 0.778 . . . . 71.040000000000006 111.356 -173.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.7 m -126.3 114.49 18.33 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.808 -0.441 . . . . 73.530000000000001 109.808 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 103' ' ' ARG . 24.9 m -148.78 167.75 12.47 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 108.125 -1.065 . . . . 73.030000000000001 108.125 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.49 146.33 84.76 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.894 1.729 . . . . 74.019999999999996 111.592 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.3 144.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.374 -0.973 . . . . 53.32 108.374 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 p -129.22 146.14 51.19 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 110.126 -0.324 . . . . 74.040000000000006 110.126 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.37 138.89 43.78 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.536 -0.465 . . . . 73.239999999999995 110.078 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.62 135.05 34.41 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.019 -0.734 . . . . 75.519999999999996 109.019 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.86 150.23 26.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 108.331 -0.988 . . . . 44.32 108.331 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 97' ' ' LYS . 6.1 m-85 -123.52 105.11 33.52 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 121.018 -0.273 . . . . 74.230000000000004 110.573 -175.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.17 159.03 17.79 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.473 2.116 . . . . 75.030000000000001 111.871 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -104.36 166.51 10.35 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.385 -0.968 . . . . 72.209999999999994 108.385 175.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.84 -17.53 50.48 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.96 1.096 . . . . 75.230000000000004 113.96 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -98.73 -1.26 40.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.235 -0.586 . . . . 64.230000000000004 112.163 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.18 1.0 55.87 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.632 1.013 . . . . 63.219999999999999 115.632 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.2 m -83.79 136.98 33.94 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.452 1.126 . . . . 74.319999999999993 109.528 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.4 mt -93.38 78.1 4.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.165 0.507 . . . . 73.319999999999993 110.513 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -149.36 114.49 5.46 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.867 -0.606 . . . . 74.409999999999997 110.911 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 tttp 178.19 -62.41 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.21 -1.033 . . . . 72.409999999999997 108.21 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 22.7 ttmm -154.31 149.34 26.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.518 -1.29 . . . . 73.140000000000001 107.518 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.451 HD12 HG13 ' A' ' 51' ' ' VAL . 5.9 tt -141.01 124.94 17.09 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.997 -1.853 . . . . 71.209999999999994 105.997 169.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 79.4 tttt -130.87 115.19 16.24 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 120.423 -0.511 . . . . 50.240000000000002 110.05 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' THR . 62.1 t -83.88 133.78 28.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.692 -0.685 . . . . 73.010000000000005 109.322 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -121.62 113.63 20.04 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.748 0.819 . . . . 73.430000000000007 109.156 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -103.74 115.97 31.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.319 -0.993 . . . . 75.010000000000005 108.319 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 29.4 ttt85 -76.11 136.35 39.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.336 -0.847 . . . . 73.439999999999998 110.416 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 77.8 mt -103.47 126.96 30.63 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 109.478 -0.564 . . . . 75.209999999999994 109.478 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.48 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 84.2 Cg_exo -46.83 151.25 2.2 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.491 2.794 . . . . 74.450000000000003 113.028 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.04 -42.58 65.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.443 1.275 . . . . 64.420000000000002 114.443 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.28 -30.96 72.0 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.353 0.597 . . . . 65.120000000000005 110.875 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.66 -2.88 55.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.912 -0.585 . . . . 65.200000000000003 110.839 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.09 -36.24 74.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.586 -0.524 . . . . 74.340000000000003 109.586 175.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.19 -31.7 78.18 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-N 115.464 -0.789 . . . . 61.020000000000003 112.026 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -160.34 97.3 1.46 Allowed Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 109.049 -0.723 . . . . 65.120000000000005 109.049 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.62 162.08 1.86 Allowed 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 123.274 2.649 . . . . 63.310000000000002 111.519 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.58 133.76 44.23 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.032 1.821 . . . . 74.140000000000001 110.093 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 71' ' ' ASP . . . -74.88 152.69 86.83 Favored Pre-proline 0 C--O 1.255 1.395 0 CA-C-N 116.515 -0.311 . . . . 70.319999999999993 111.48 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.552 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 17.2 Cg_exo -69.46 111.13 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.761 2.308 . . . . 64.230000000000004 112.146 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -85.25 -8.69 58.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.827 0.822 . . . . 74.409999999999997 108.795 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.95 148.42 42.21 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.241 -1.392 . . . . 72.150000000000006 107.241 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -88.62 -9.97 50.3 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.858 1.429 . . . . 64.219999999999999 114.858 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.489 ' CB ' ' HD3' ' A' ' 61' ' ' LYS . 17.7 m -81.53 -45.03 16.51 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.813 -0.81 . . . . 74.150000000000006 108.813 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 5.9 p -95.5 115.85 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 108.83 -0.804 . . . . 73.310000000000002 108.83 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -119.0 151.22 38.59 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.842 -0.799 . . . . 74.120000000000005 108.842 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.8 mm -92.56 110.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.427 -1.323 . . . . 73.349999999999994 107.427 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -127.14 146.48 50.38 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.387 -0.824 . . . . 73.400000000000006 108.9 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.06 144.13 34.18 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 109.023 -0.732 . . . . 70.209999999999994 109.023 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.474 ' NE ' ' HA ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -129.74 123.13 30.3 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.169 -1.413 . . . . 71.530000000000001 110.008 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.24 156.63 45.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.105 -2.554 . . . . 72.430000000000007 104.105 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.5 8.03 62.86 Favored Glycine 0 C--N 1.281 -2.52 0 C-N-CA 120.661 -0.78 . . . . 70.430000000000007 112.859 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.0 pt -121.61 145.66 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.353 -0.539 . . . . 62.100000000000001 110.275 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.0 m -120.88 137.44 54.57 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.039 -0.982 . . . . 74.239999999999995 109.126 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.36 160.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-N 115.767 -0.651 . . . . 73.239999999999995 110.021 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.499 ' OH ' ' HE2' ' A' ' 189' ' ' LYS . 39.3 m-85 -114.03 122.56 47.27 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.232 -2.136 . . . . 75.109999999999999 105.232 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -106.82 127.89 53.79 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.835 -0.346 . . . . 70.530000000000001 111.145 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.477 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 14.0 t -113.43 138.98 49.31 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.808 -0.812 . . . . 71.109999999999999 108.808 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.46 125.82 42.76 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.455 -0.793 . . . . 72.120000000000005 109.895 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -132.86 140.69 48.04 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.444 -0.798 . . . . 72.109999999999999 109.581 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 182' ' ' ARG . . . -102.8 145.99 16.53 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.842 -0.694 . . . . 63.009999999999998 112.852 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.71 -140.26 14.84 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.984 -1.103 . . . . 72.230000000000004 113.906 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 39.5 t80 -76.63 126.7 31.43 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.8 0.84 . . . . 72.349999999999994 112.006 -172.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.409 ' HB2' ' ND2' ' A' ' 183' ' ' ASN . . . -123.81 136.82 54.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.794 -0.639 . . . . 70.120000000000005 110.303 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.467 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 38.8 ttmt -114.98 155.41 26.98 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.615 -1.994 . . . . 62.509999999999998 105.615 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.413 ' O ' HG22 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -53.67 -45.19 70.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 118.412 0.551 . . . . 70.140000000000001 110.001 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.75 70.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 42.43 111.399 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 28.2 t70 -74.73 -30.62 61.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 110.063 -0.347 . . . . 74.409999999999997 110.063 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -63.33 -44.85 93.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.827 -0.805 . . . . 53.520000000000003 108.827 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 141' ' ' GLU . 61.0 t -60.02 -51.24 75.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.058 -0.974 . . . . 71.439999999999998 109.579 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.11 86.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.586 -0.734 . . . . 64.420000000000002 111.562 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 150' ' ' GLN . 24.6 m80 -62.38 -33.45 74.76 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 113.445 0.906 . . . . 65.540000000000006 113.445 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.01 79.32 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.481 0.488 . . . . 73.329999999999998 111.409 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.5 m -78.09 -35.14 49.73 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.801 0.334 . . . . 64.450000000000003 111.015 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' HG3' HG13 ' A' ' 29' ' ' VAL . 7.1 tp60 -58.68 -36.37 74.09 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.211 0.529 . . . . 75.349999999999994 109.692 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 31' ' ' TYR . 46.1 tp -65.4 -39.12 91.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.528 -0.76 . . . . 73.239999999999995 110.127 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.513 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.0 mtm180 -63.3 -44.07 96.03 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 116.436 -0.347 . . . . 75.209999999999994 110.308 177.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.3 m -61.98 -34.78 76.78 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.521 0.677 . . . . 75.420000000000002 110.582 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.6 m -74.02 -33.97 63.95 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.552 0.691 . . . . 74.329999999999998 109.965 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 26.3 mt -83.7 6.98 19.05 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.938 0.895 . . . . 73.530000000000001 112.61 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 43.9 mt-10 -75.79 145.59 40.62 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.104 -1.038 . . . . 73.129999999999995 112.498 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.66 12.64 46.77 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.548 -1.021 . . . . 60.109999999999999 110.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.9 p -122.11 165.66 19.84 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 107.809 -1.182 . . . . 62.119999999999997 107.809 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -81.27 21.63 0.89 Allowed 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 121.886 1.724 . . . . 74.319999999999993 111.968 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 121.12 24.76 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.085 0.469 . . . . 52.210000000000001 111.217 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.0 m -105.32 157.68 17.15 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.45 -1.315 . . . . 73.549999999999997 107.45 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.33 157.64 46.17 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.635 -0.876 . . . . 71.430000000000007 108.635 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.6 pt20 -119.07 109.75 16.28 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.579 -0.849 . . . . 74.430000000000007 111.064 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.51 8.08 55.03 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.39 -0.909 . . . . 44.409999999999997 114.35 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.97 26.42 14.13 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.767 0.794 . . . . 75.200000000000003 109.621 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.7 138.86 22.05 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 115.64 -0.709 . . . . 65.140000000000001 110.32 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 24.8 p90 -148.2 167.9 23.88 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.884 -0.598 . . . . 73.140000000000001 112.249 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -115.71 153.72 30.84 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.501 -0.772 . . . . 74.209999999999994 110.259 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.65 136.77 54.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.591 -1.633 . . . . 74.030000000000001 106.591 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 184' ' ' GLU . . . -132.13 156.85 45.64 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.119 0.414 . . . . 60.119999999999997 112.119 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.32 163.81 37.1 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 109.085 -1.606 . . . . 54.329999999999998 109.085 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.42 ' OH ' ' HD2' ' A' ' 181' ' ' ARG . 14.5 p90 -127.57 -32.79 2.37 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 114.235 1.198 . . . . 74.430000000000007 114.235 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -119.94 144.87 38.41 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.596 -0.89 . . . . 52.25 108.596 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.87 127.3 23.88 Favored 'Trans proline' 0 C--O 1.252 1.222 0 C-N-CA 121.96 1.773 . . . . 73.329999999999998 109.285 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.4 129.88 22.48 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 121.66 1.574 . . . . 71.129999999999995 111.9 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.36 -42.33 9.85 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 106.236 -1.765 . . . . 51.100000000000001 106.236 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -106.45 152.33 40.59 Favored Pre-proline 0 N--CA 1.419 -2.013 0 N-CA-C 107.379 -1.341 . . . . 72.319999999999993 107.379 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.77 -12.95 34.07 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.962 2.441 . . . . 65.219999999999999 112.755 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 138' ' ' TYR . 45.0 m-85 -68.37 -81.45 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.191 0.811 . . . . 75.120000000000005 113.191 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 105.12 176.76 24.43 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.873 -1.691 . . . . 74.209999999999994 108.873 -172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.42 ' HD2' ' OH ' ' A' ' 172' ' ' TYR . 79.6 mtt180 -97.38 -56.25 2.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.744 1.272 . . . . 62.329999999999998 109.322 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.424 ' HA ' ' HA2' ' A' ' 136' ' ' GLY . 14.6 ptt180 -152.13 157.65 41.84 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.521 -2.029 . . . . 74.010000000000005 105.521 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 139' ' ' ALA . 22.1 m-80 -134.72 142.97 46.93 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.882 -0.784 . . . . 52.310000000000002 108.882 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 9.3 mm-40 -111.49 132.5 54.45 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.384 -0.969 . . . . 73.230000000000004 108.384 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 88.5 t -127.06 121.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.074 -0.713 . . . . 75.140000000000001 109.074 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 33.1 m0 -107.0 124.94 50.34 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 119.606 -0.235 . . . . 74.319999999999993 110.799 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.64 138.75 33.74 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.375 -0.972 . . . . 52.229999999999997 108.375 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.11 129.64 53.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 120.04 -0.664 . . . . 74.409999999999997 109.366 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.499 ' HE2' ' OH ' ' A' ' 131' ' ' TYR . 19.2 ptpt -72.94 142.99 47.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 71.430000000000007 111.422 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 118.963 -0.541 . . . . 61.130000000000003 109.773 176.568 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 CA--C 1.505 -0.758 0 N-CA-C 110.175 -0.305 . . . . 75.219999999999999 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.0 m -104.53 100.97 10.65 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.994 -0.372 . . . . 72.200000000000003 109.994 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD22 ' H ' ' A' ' 9' ' ' LEU . 1.9 pt? -71.09 152.6 43.33 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.411 -0.359 . . . . 62.119999999999997 110.516 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' HD2' ' O ' ' A' ' 12' ' ' SER . 59.6 t80 -83.55 147.72 27.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.147 -1.057 . . . . 75.540000000000006 108.147 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.27 -60.26 9.28 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 115.091 0.797 . . . . 54.210000000000001 115.091 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.416 ' O ' ' HD2' ' A' ' 10' ' ' PHE . 32.7 p -105.54 157.24 17.52 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 117.212 0.506 . . . . 72.129999999999995 111.054 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.52 77.1 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.08 0 CA-C-O 122.616 1.198 . . . . 72.430000000000007 110.899 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -145.87 114.57 6.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.439 -1.255 . . . . 71.200000000000003 108.841 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -79.77 -31.09 40.86 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.447 -0.945 . . . . 74.400000000000006 108.447 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -155.39 123.98 2.98 Favored Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 105.842 -1.91 . . . . 75.430000000000007 105.842 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.26 134.59 25.16 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.598 1.532 . . . . 72.219999999999999 112.67 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.522 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.7 p90 -102.54 159.27 15.59 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.75 -0.833 . . . . 75.439999999999998 108.75 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -105.65 112.53 25.65 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.226 -0.59 . . . . 62.109999999999999 110.911 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.58 127.94 41.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.036 -1.468 . . . . 71.239999999999995 107.036 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD23 ' OE2' ' A' ' 33' ' ' GLU . 3.6 pp -95.77 -24.9 16.28 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.938 -1.105 . . . . 73.329999999999998 112.925 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.1 p -175.71 160.2 2.4 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 123.361 0.413 . . . . 73.349999999999994 111.611 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 73.9 p -131.21 154.12 48.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.283 -1.006 . . . . 73.120000000000005 108.283 174.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.59 -146.41 14.44 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 119.518 -1.325 . . . . 63.329999999999998 112.085 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.09 -118.02 5.11 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.705 -0.958 . . . . 50.329999999999998 110.705 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -117.44 169.28 9.64 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.741 -1.577 . . . . 73.030000000000001 106.741 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -87.16 157.05 19.45 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.13 -1.028 . . . . 74.519999999999996 111.911 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 82.0 -41.92 0.14 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.4 1.88 . . . . 74.040000000000006 110.053 -172.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.35 109.92 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.802 -1.184 . . . . 74.439999999999998 107.802 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 p -113.41 153.58 28.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.38 -0.6 . . . . 75.200000000000003 109.38 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.3 OUTLIER -112.88 150.87 31.15 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.587 -0.445 . . . . 71.5 111.319 178.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 36.3 tt0 -137.33 124.33 21.48 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.483 -1.673 . . . . 70.219999999999999 106.483 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' OE2' HD23 ' A' ' 21' ' ' LEU . 36.1 tt0 -100.5 117.6 34.99 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.138 -1.43 . . . . 62.530000000000001 107.138 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 28.8 ptt180 -138.4 144.71 40.34 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.096 -0.642 . . . . 72.450000000000003 110.837 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -81.96 136.61 35.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.493 -0.929 . . . . 62.200000000000003 108.493 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.47 133.81 51.17 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.65 0.241 . . . . 71.209999999999994 111.65 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' CD ' HH12 ' A' ' 103' ' ' ARG . 8.6 pt-20 -55.28 -45.11 76.18 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.945 -0.57 . . . . 70.319999999999993 112.072 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.54 10.29 50.88 Favored Glycine 0 C--N 1.311 -0.856 0 C-N-CA 119.673 -1.251 . . . . 54.420000000000002 114.682 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.62 165.22 52.49 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.357 -0.925 . . . . 75.150000000000006 112.182 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.16 131.64 35.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 75.010000000000005 110.881 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 60.3 m-85 -131.33 166.04 22.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.404 0.682 . . . . 73.329999999999998 110.951 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.45 116.21 29.23 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 107.837 -1.171 . . . . 73.140000000000001 107.837 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.5 t -124.41 144.58 49.97 Favored 'General case' 0 N--CA 1.402 -2.867 0 CA-C-N 115.419 -0.809 . . . . 70.319999999999993 112.044 -175.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.546 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.6 m -127.85 145.08 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.913 -1.04 . . . . 74.150000000000006 109.446 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -122.34 128.61 51.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.945 0.403 . . . . 62.340000000000003 111.158 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 54' ' ' ALA . 22.0 t -125.73 142.43 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.455 -1.313 . . . . 73.409999999999997 107.455 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 49' ' ' LYS . 17.5 p -134.32 166.81 21.97 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.097 0.159 . . . . 74.420000000000002 111.42 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.7 t70 71.88 -36.17 0.35 Allowed 'General case' 0 N--CA 1.514 2.769 0 C-N-CA 125.131 1.372 . . . . 72.129999999999995 112.12 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 47' ' ' THR . 25.0 mtpp -86.14 141.32 35.05 Favored Pre-proline 0 C--N 1.282 -2.36 0 C-N-CA 124.786 1.235 . . . . 75.409999999999997 109.743 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.67 155.89 40.33 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.316 2.01 . . . . 73.120000000000005 109.367 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.63 -36.18 41.39 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 113.635 0.976 . . . . 72.319999999999993 113.635 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 15.9 t70 -60.01 -47.74 84.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.739 -0.467 . . . . 74.040000000000006 109.739 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -69.7 -41.62 75.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.699 . . . . 74.400000000000006 111.3 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . . . -61.58 -42.35 98.72 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.914 -0.585 . . . . 71.5 110.334 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 tp -60.22 -35.23 74.96 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.13 0.972 . . . . 64.230000000000004 110.759 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 26.0 mmt180 -63.83 -35.23 79.93 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.463 0.649 . . . . 72.120000000000005 109.524 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 28.0 tt0 -82.95 -32.03 27.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 73.400000000000006 110.135 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.18 60.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.306 0.854 . . . . 72.200000000000003 113.306 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.546 ' HE1' ' HA ' ' A' ' 59' ' ' MET . 8.9 mmt -55.34 -56.16 31.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 112.796 0.665 . . . . 75.239999999999995 112.796 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.64 -31.26 69.88 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.7 2.267 . . . . 75.030000000000001 113.193 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.455 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 95.4 mttt -62.53 -49.36 75.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.027 0.441 . . . . 72.120000000000005 110.162 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.85 -38.0 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 120.635 -0.426 . . . . 71.420000000000002 110.836 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.3 mtt -61.01 -38.97 87.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.833 0.679 . . . . 74.409999999999997 112.833 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -72.56 -31.38 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.219 -0.592 . . . . 74.239999999999995 110.684 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.07 -55.32 22.97 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.317 -0.402 . . . . 73.230000000000004 110.783 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.79 -10.4 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.162 0.505 . . . . 53.240000000000002 111.209 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -21.98 73.65 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.606 -0.725 . . . . 73.450000000000003 111.483 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.88 -5.63 6.94 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.934 -1.127 . . . . 71.129999999999995 113.598 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -86.25 33.76 0.62 Allowed 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.565 1.174 . . . . 72.129999999999995 110.105 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -93.99 173.1 7.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.06 -0.973 . . . . 53.119999999999997 108.841 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.32 -34.45 78.16 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.373 0.508 . . . . 72.010000000000005 112.373 -173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.528 ' HZ2' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -83.78 -12.6 55.47 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.508 -0.477 . . . . 75.120000000000005 109.998 -177.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.87 27.85 72.64 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.713 0.633 . . . . 52.310000000000002 112.321 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 35.8 m -86.16 122.06 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.041 -0.664 . . . . 63.229999999999997 111.31 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.62 86.63 0.7 Allowed Glycine 0 N--CA 1.432 -1.58 0 CA-C-N 115.611 -0.722 . . . . 72.540000000000006 111.323 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -150.27 116.1 5.58 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.187 0.517 . . . . 63.119999999999997 110.19 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.83 124.59 7.1 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.644 -0.707 . . . . 73.409999999999997 112.069 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.8 ptp -105.82 126.46 52.2 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.962 -0.755 . . . . 73.209999999999994 108.962 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 p -120.38 115.87 24.36 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 61.119999999999997 111.302 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.524 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 10.8 m -154.03 -179.89 1.16 Allowed Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 125.801 1.64 . . . . 74.439999999999998 106.922 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 80' ' ' VAL . 84.5 Cg_exo -51.0 140.67 39.01 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.751 2.301 . . . . 73.209999999999994 115.414 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.91 138.16 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.787 -1.56 . . . . 72.040000000000006 106.787 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -133.87 145.25 49.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.674 -0.491 . . . . 62.549999999999997 109.674 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.404 ' CD1' HD11 ' A' ' 98' ' ' LEU . 52.2 p90 -145.28 138.31 26.32 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.902 -0.499 . . . . 73.019999999999996 111.169 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.417 ' O ' HD13 ' A' ' 98' ' ' LEU . . . -93.18 135.28 34.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.461 -0.94 . . . . 70.450000000000003 108.461 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.429 ' O ' HG21 ' A' ' 166' ' ' VAL . 33.4 m -121.15 149.16 24.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.719 -0.845 . . . . 73.540000000000006 108.719 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.56 105.51 51.85 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 116.118 -0.492 . . . . 75.420000000000002 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.28 159.05 20.09 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.898 1.732 . . . . 65.450000000000003 110.801 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -122.33 162.66 21.13 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.79 -0.818 . . . . 72.099999999999994 108.79 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.77 -13.7 59.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.557 0.694 . . . . 62.200000000000003 110.513 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.69 -6.67 58.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.845 -1.071 . . . . 75.409999999999997 110.099 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.28 10.27 83.88 Favored Glycine 0 C--O 1.218 -0.876 0 CA-C-N 115.911 -0.586 . . . . 72.510000000000005 113.192 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 m -105.24 134.76 47.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.874 0.337 . . . . 74.150000000000006 110.445 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.47 HD21 ' HH ' ' A' ' 167' ' ' TYR . 71.6 mt -88.42 75.57 8.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.784 -1.191 . . . . 75.439999999999998 107.784 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 58.9 tt0 -147.18 114.51 6.28 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.345 -0.843 . . . . 72.219999999999999 111.183 -174.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 6.1 mmpt? -178.87 -66.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.95 2.1 . . . . 72.109999999999999 106.356 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -147.28 150.64 35.21 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.435 -1.257 . . . . 64.420000000000002 107.885 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 85' ' ' ALA . 56.6 tp -127.71 124.35 37.63 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.206 -1.775 . . . . 73.239999999999995 106.206 168.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -114.31 113.78 25.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.237 -1.764 . . . . 72.439999999999998 106.237 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 43' ' ' THR . 97.0 t -99.85 123.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 109.438 -0.579 . . . . 52.240000000000002 109.438 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -110.25 120.69 43.25 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.101 -0.703 . . . . 74.340000000000003 109.101 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -104.16 124.54 49.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.621 -0.511 . . . . 72.530000000000001 109.621 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.413 HH12 ' CD ' ' A' ' 37' ' ' GLU . 19.0 mmm180 -74.57 132.67 41.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.339 -0.846 . . . . 74.329999999999998 109.019 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.6 mt -99.03 135.89 20.72 Favored Pre-proline 0 C--N 1.285 -2.204 0 N-CA-C 107.838 -1.171 . . . . 44.25 107.838 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.81 148.97 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.589 2.192 . . . . 73.420000000000002 112.312 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -47.6 -43.18 25.37 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.472 1.509 . . . . 74.349999999999994 112.288 -174.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.13 -36.15 83.37 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.67 0.619 . . . . 62.109999999999999 112.67 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -88.93 -6.37 57.32 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-N 116.559 -0.291 . . . . 74.540000000000006 111.605 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.09 -28.48 65.45 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.751 -0.204 . . . . 54.340000000000003 111.519 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.08 -38.1 92.56 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.868 -0.493 . . . . 72.439999999999998 111.868 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 p -158.67 87.77 2.26 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 123.466 0.706 . . . . 63.240000000000002 109.956 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 10.0 Cg_endo -86.63 144.71 7.74 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 122.577 2.185 . . . . 70.109999999999999 112.104 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 33.2 Cg_exo -60.79 142.84 98.86 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.767 2.312 . . . . 74.310000000000002 112.628 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.67 144.82 73.96 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.857 -0.61 . . . . 54.509999999999998 109.997 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.433 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 6.6 Cg_exo -80.36 126.51 6.2 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.514 2.143 . . . . 71.420000000000002 111.923 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.4 m -74.91 -23.91 58.43 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.657 -0.701 . . . . 73.129999999999995 111.606 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -99.64 135.73 40.61 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.111 -1.44 . . . . 72.019999999999996 107.111 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -77.01 -3.71 40.45 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.434 0.901 . . . . 72.420000000000002 113.434 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 44' ' ' VAL . 17.1 m -73.74 -26.44 60.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.775 -0.824 . . . . 74.219999999999999 108.775 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.3 t -113.98 124.12 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 106.593 -1.632 . . . . 60.409999999999997 106.593 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 115' ' ' PRO . 27.3 mtpp -129.66 145.91 51.48 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.81 -1.156 . . . . 71.239999999999995 110.568 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 26.7 mm -91.91 111.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.997 -1.483 . . . . 74.400000000000006 106.997 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -133.81 149.55 51.41 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.085 -0.961 . . . . 62.149999999999999 109.77 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.49 153.3 23.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.134 -0.691 . . . . 70.540000000000006 109.134 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -139.25 123.17 17.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.458 -0.897 . . . . 62.32 109.984 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -143.85 177.14 8.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.373 -0.83 . . . . 75.510000000000005 109.314 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.06 -1.42 84.82 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 121.134 -0.555 . . . . 37.68 113.736 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.46 162.47 32.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 117.398 0.599 . . . . 72.219999999999999 111.381 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.2 m -120.6 135.99 54.94 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.437 -0.801 . . . . 71.219999999999999 109.777 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.94 161.87 28.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 120.94 0.4 . . . . 71.239999999999995 110.413 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 160' ' ' ALA . 67.3 m-85 -113.99 123.47 49.79 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.703 -1.962 . . . . 73.030000000000001 105.703 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.4 t -111.91 147.55 35.6 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 120.444 -0.502 . . . . 70.409999999999997 109.905 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 8.9 t -129.23 132.98 47.33 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.112 -0.494 . . . . 64.409999999999997 109.848 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.46 ' HG2' ' HG2' ' A' ' 184' ' ' GLU . 74.2 mt-30 -110.46 131.64 54.87 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 121.258 0.552 . . . . 70.129999999999995 111.425 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.86 149.63 40.52 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.722 -1.127 . . . . 75.420000000000002 109.494 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -121.92 149.09 17.16 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.78 -0.724 . . . . 75.120000000000005 111.465 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.54 24.49 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.24 -1.144 . . . . 54.310000000000002 110.24 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -90.54 100.52 13.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.037 -0.727 . . . . 65.099999999999994 109.037 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.25 107.7 19.82 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.913 0.863 . . . . 72.0 112.672 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -100.77 169.68 8.85 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.513 -1.662 . . . . 62.409999999999997 106.513 171.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 1.6 mp0 -57.55 -42.16 82.42 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.173 0.511 . . . . 62.240000000000002 110.109 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.67 70.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.519 -0.764 . . . . 64.420000000000002 111.542 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.67 -36.85 70.77 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.653 -0.499 . . . . 74.109999999999999 109.653 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.422 ' HH ' ' HG2' ' A' ' 175' ' ' PRO . 68.4 m-85 -60.47 -47.8 84.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.778 -0.646 . . . . 72.310000000000002 110.224 173.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -46.88 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.726 0.641 . . . . 65.430000000000007 110.604 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.65 87.86 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.062 0.458 . . . . 63.32 110.926 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -68.95 -33.3 73.49 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 116.325 -0.398 . . . . 74.010000000000005 111.688 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.46 -45.85 92.53 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.059 -0.349 . . . . 37.68 110.059 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.561 ' HA ' ' HE ' ' A' ' 152' ' ' ARG . 63.2 m -59.11 -46.98 86.91 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 122.818 0.447 . . . . 73.109999999999999 110.32 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.46 -39.41 93.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.827 -0.624 . . . . 72.409999999999997 110.998 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.94 -40.88 95.7 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.999 -0.371 . . . . 75.549999999999997 109.999 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' A' ' 149' ' ' THR . 88.5 mtm180 -62.22 -40.16 95.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.892 -0.594 . . . . 73.030000000000001 111.144 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.2 m -69.77 -36.03 75.42 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.428 0.632 . . . . 72.129999999999995 110.312 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.7 m -70.33 -33.7 71.8 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.373 0.606 . . . . 75.209999999999994 110.424 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 187' ' ' LEU . 93.4 mt -77.63 6.69 6.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.707 -0.679 . . . . 71.430000000000007 112.54 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.22 142.38 32.74 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.004 -0.739 . . . . 62.32 109.004 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.43 -10.29 65.02 Favored Glycine 0 C--N 1.307 -1.052 0 N-CA-C 110.095 -1.202 . . . . 71.219999999999999 110.095 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 160' ' ' ALA . 10.9 t -120.9 153.16 57.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.448 -1.686 . . . . 75.239999999999995 106.448 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.59 17.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.592 2.861 . . . . 44.329999999999998 115.199 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 131' ' ' TYR . . . -85.41 131.7 34.35 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.068 -0.395 . . . . 71.510000000000005 110.097 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 32.2 p -124.94 154.94 40.37 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.754 -0.832 . . . . 53.240000000000002 108.754 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -136.73 149.25 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 118.287 0.494 . . . . 72.219999999999999 110.956 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -116.77 141.63 47.97 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.727 0.64 . . . . 72.340000000000003 112.727 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.21 -2.28 15.01 Favored Glycine 0 C--N 1.318 -0.461 0 CA-C-N 115.021 -0.99 . . . . 64.310000000000002 113.35 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.3 t70 61.22 11.72 3.72 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.549 1.14 . . . . 73.420000000000002 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 86' ' ' VAL . 7.3 p -73.79 139.38 19.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.904 1.282 . . . . 71.530000000000001 111.385 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.47 ' HH ' HD21 ' A' ' 94' ' ' LEU . 15.4 p90 -144.61 168.74 19.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.387 -0.824 . . . . 73.400000000000006 110.713 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 16.0 m-85 -115.29 156.42 25.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.096 -0.502 . . . . 72.109999999999999 110.451 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 64.4 m -124.19 119.84 30.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.626 -1.62 . . . . 63.43 106.626 172.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.5 154.98 49.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.62 -0.264 . . . . 54.520000000000003 110.306 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.69 141.84 9.22 Favored Glycine 0 CA--C 1.481 -2.083 0 N-CA-C 108.931 -1.668 . . . . 40.439999999999998 108.931 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 182' ' ' ARG . 13.3 m-30 -84.44 -12.79 53.71 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.757 0.789 . . . . 74.25 110.71 -177.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -137.57 128.62 16.06 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 105.27 -2.122 . . . . 63.350000000000001 105.27 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.22 110.8 0.33 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 123.227 2.618 . . . . 72.319999999999993 112.497 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 179' ' ' TYR . 5.6 Cg_exo -78.15 126.67 7.93 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 121.542 1.495 . . . . 74.239999999999995 113.131 -174.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 50.6 ttm -100.16 -43.69 6.23 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.215 -1.402 . . . . 71.540000000000006 107.215 170.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 163.85 -60.84 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 127.729 2.412 . . . . 73.310000000000002 106.853 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.83 -31.75 4.98 Favored 'Trans proline' 0 C--N 1.4 3.256 0 N-CA-C 109.336 -1.063 . . . . 73.209999999999994 109.336 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 175' ' ' PRO . 78.8 m-85 -84.72 142.4 29.88 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 104.555 -2.387 . . . . 65.430000000000007 104.555 172.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 106.55 64.8 0.62 Allowed Glycine 0 C--N 1.284 -2.357 0 N-CA-C 108.732 -1.747 . . . . 63.409999999999997 108.732 -170.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -87.73 -39.51 14.88 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.949 0.404 . . . . 64.549999999999997 109.922 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.463 ' HB2' ' HB2' ' A' ' 172' ' ' TYR . 3.3 mmp_? -103.51 127.09 50.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.552 -1.647 . . . . 73.329999999999998 106.552 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.11 146.51 33.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.838 -0.801 . . . . 73.349999999999994 108.838 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 133' ' ' THR . 40.0 mt-10 -135.23 149.38 49.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.443 0.64 . . . . 62.130000000000003 111.323 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 77.7 t -125.02 118.58 53.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.927 -1.508 . . . . 71.230000000000004 106.927 172.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -102.91 120.65 40.99 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.139 -1.06 . . . . 74.230000000000004 108.139 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 155' ' ' LEU . 37.8 tp -106.05 129.95 54.06 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.303 -1.369 . . . . 64.099999999999994 107.303 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.89 125.1 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.565 -0.454 . . . . 63.119999999999997 110.705 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 161' ' ' THR . 13.8 pttp -71.06 145.95 49.6 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.005 -0.739 . . . . 74.510000000000005 109.005 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 108.787 -0.82 . . . . 37.68 108.787 174.671 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.506 -0.737 0 N-CA-C 109.397 -0.594 . . . . 70.549999999999997 109.397 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 m -68.43 -38.58 81.31 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.983 0.42 . . . . 72.439999999999998 110.336 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp -81.27 177.37 9.04 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.656 -0.702 . . . . 74.430000000000007 111.956 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.74 107.62 16.34 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.216 -0.661 . . . . 73.400000000000006 109.216 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.02 -25.19 58.29 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.189 -0.765 . . . . 45.32 111.189 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 p -67.68 150.73 48.33 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.693 -0.484 . . . . 74.109999999999999 109.693 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 15' ' ' THR . 27.9 m -60.78 117.8 2.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 113.598 0.962 . . . . 74.400000000000006 113.598 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.61 -27.76 37.23 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.096 -1.816 . . . . 73.140000000000001 106.096 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 5.5 t -118.94 121.66 40.45 Favored 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 114.021 -1.445 . . . . 75.129999999999995 107.698 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -74.63 138.24 73.98 Favored Pre-proline 0 C--N 1.292 -1.897 0 CA-C-N 115.448 -0.796 . . . . 74.540000000000006 109.563 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.84 141.32 84.29 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.529 1.486 . . . . 74.099999999999994 109.068 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -100.45 127.09 46.89 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 118.774 -1.17 . . . . 73.140000000000001 109.153 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -113.55 122.44 47.24 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.888 -1.051 . . . . 72.340000000000003 111.18 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.0 119.79 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 106.111 -1.811 . . . . 75.409999999999997 106.111 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -89.96 -25.78 20.73 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.123 -0.631 . . . . 73.209999999999994 111.062 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -176.84 153.85 1.09 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.511 0.507 . . . . 75.140000000000001 109.794 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.3 p -132.29 154.59 49.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.801 -0.814 . . . . 62.530000000000001 108.801 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.03 -148.82 20.1 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 119.24 -1.457 . . . . 71.510000000000005 113.313 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.2 -118.45 5.23 Favored Glycine 0 N--CA 1.427 -1.934 0 N-CA-C 110.268 -1.133 . . . . 74.040000000000006 110.268 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -99.41 169.96 8.97 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.876 -1.527 . . . . 72.409999999999997 106.876 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.3 162.86 14.11 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 75.319999999999993 109.236 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 72.72 -53.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.365 1.066 . . . . 71.430000000000007 110.12 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.63 111.75 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 107.999 -1.111 . . . . 73.200000000000003 107.999 172.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.2 p -133.69 155.82 49.03 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.594 -0.73 . . . . 61.229999999999997 110.477 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -112.01 161.8 16.07 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.233 0.539 . . . . 71.010000000000005 111.428 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' OE1' ' HD2' ' A' ' 34' ' ' ARG . 39.7 tt0 -133.81 124.86 27.27 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.159 -1.423 . . . . 73.329999999999998 107.159 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.07 114.9 26.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.84 -1.541 . . . . 75.430000000000007 106.84 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 13.7 ptm180 -134.22 143.47 47.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.32 0.581 . . . . 72.319999999999993 112.563 -172.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.78 135.78 35.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.194 -1.78 . . . . 72.140000000000001 106.194 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.4 t -68.99 146.74 52.47 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.356 0.598 . . . . 62.130000000000003 111.94 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.5 pm0 -67.84 0.5 3.32 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 126.162 1.785 . . . . 74.140000000000001 114.236 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 75.08 11.51 83.96 Favored Glycine 0 C--N 1.305 -1.147 0 C-N-CA 119.656 -1.259 . . . . 62.399999999999999 114.565 169.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.65 152.08 48.76 Favored Glycine 0 N--CA 1.408 -3.204 0 C-N-CA 120.349 -0.929 . . . . 72.310000000000002 113.39 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.446 ' O ' HD11 ' A' ' 104' ' ' ILE . 17.7 ptpt -102.96 118.93 37.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.041 -1.466 . . . . 70.329999999999998 107.041 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 59.3 m-85 -117.15 163.72 15.85 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.562 -0.745 . . . . 62.149999999999999 111.525 -168.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.03 116.91 32.34 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 108.093 -1.077 . . . . 75.239999999999995 108.093 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -124.21 146.41 48.73 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 113.033 0.753 . . . . 74.099999999999994 113.033 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.4 m -128.03 144.13 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 114.262 -1.336 . . . . 62.530000000000001 108.645 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.25 136.7 51.4 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 120.77 0.319 . . . . 73.319999999999993 111.016 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 54' ' ' ALA . 44.4 t -130.39 141.99 44.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 105.916 -1.883 . . . . 72.329999999999998 105.916 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 49' ' ' LYS . 34.1 p -130.49 159.76 36.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.651 0.612 . . . . 61.509999999999998 112.651 -171.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.3 -32.75 0.24 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.642 1.577 . . . . 72.239999999999995 112.541 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 47' ' ' THR . 52.6 mtpt -85.05 136.34 38.48 Favored Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 124.673 1.189 . . . . 72.409999999999997 109.336 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 156.15 16.81 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.268 2.645 . . . . 73.019999999999996 112.111 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.66 -41.44 12.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 113.293 0.849 . . . . 75.129999999999995 113.293 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -59.7 -47.66 84.76 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 120.644 -0.422 . . . . 73.129999999999995 110.975 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.64 -39.82 73.44 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.94 -0.573 . . . . 75.310000000000002 111.702 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . . . -67.47 -46.32 73.33 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.692 -0.686 . . . . 41.140000000000001 110.453 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.8 -45.74 85.01 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 122.423 0.289 . . . . 73.430000000000007 111.758 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 5.6 ppt_? -61.82 -28.24 69.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.813 0.672 . . . . 72.510000000000005 112.813 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 tt0 -85.64 -39.51 17.21 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.426 0.631 . . . . 71.010000000000005 111.154 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 44' ' ' VAL . . . -76.51 -32.17 58.14 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.95 0.722 . . . . 44.149999999999999 112.95 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.49 ' CE ' ' HA ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -53.59 -48.05 94.41 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 112.401 0.519 . . . . 73.510000000000005 112.401 -178.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' A' ' 57' ' ' GLU . 36.4 Cg_exo -56.48 -34.54 95.1 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.135 1.89 . . . . 71.230000000000004 111.515 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 58' ' ' ALA . 50.6 mtmt -69.03 -32.61 72.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.117 0.484 . . . . 71.230000000000004 110.791 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.49 -48.74 26.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.1 -0.5 . . . . 73.340000000000003 111.503 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . 0.276 3.2 ppp? -66.01 -29.23 69.57 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.696 0.998 . . . . 74.040000000000006 113.696 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.08 -29.45 69.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.24 0.543 . . . . 64.239999999999995 110.296 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.769 -0.65 . . . . 74.200000000000003 110.139 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 76' ' ' MET . 2.7 p -66.8 -27.23 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.013 0.435 . . . . 71.120000000000005 110.124 176.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.79 -20.77 62.39 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.842 -0.617 . . . . 54.5 113.686 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 131.67 -15.74 5.15 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.859 -1.162 . . . . 73.439999999999998 113.028 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -81.69 29.0 0.39 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.928 0.871 . . . . 74.430000000000007 110.502 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.403 ' HA ' ' OG ' ' A' ' 116' ' ' SER . 7.7 p30 -90.01 166.02 13.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.919 -0.582 . . . . 73.120000000000005 109.908 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.76 -35.03 79.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 112.928 0.714 . . . . 72.239999999999995 112.928 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 1.6 mptm? -82.71 -10.56 58.85 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.113 0.482 . . . . 73.420000000000002 111.526 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.88 33.88 76.02 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.56 -0.746 . . . . 75.209999999999994 112.541 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.521 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 24.7 m -80.65 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.712 -0.795 . . . . 72.439999999999998 108.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.31 167.34 51.96 Favored Glycine 0 N--CA 1.435 -1.372 0 O-C-N 123.776 0.672 . . . . 44.329999999999998 113.033 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 27.1 ttt -76.14 101.25 5.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.284 -0.458 . . . . 74.219999999999999 109.968 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.57 41.86 0.18 Allowed Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.217 -0.992 . . . . 73.120000000000005 112.978 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.3 ptm -124.91 123.5 40.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.947 -1.131 . . . . 73.209999999999994 107.947 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.3 m -125.67 117.36 23.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.034 0.753 . . . . 73.329999999999998 113.034 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -156.72 159.02 31.59 Favored Pre-proline 0 C--O 1.242 0.7 0 C-N-CA 125.494 1.518 . . . . 70.200000000000003 107.311 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.16 140.12 81.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.763 1.642 . . . . 54.149999999999999 112.131 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.98 150.61 5.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.949 -1.13 . . . . 65.239999999999995 107.949 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -138.65 144.64 39.77 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.866 -0.42 . . . . 71.439999999999998 109.866 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 46.5 p90 -135.2 144.83 47.16 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 122.083 -0.386 . . . . 74.329999999999998 110.653 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.517 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.64 34.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 108.523 -0.917 . . . . 61.32 108.523 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.23 150.25 25.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 N-CA-C 107.821 -1.177 . . . . 74.450000000000003 107.821 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 97' ' ' LYS . 2.7 m-85 -117.07 100.3 53.23 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.672 -0.862 . . . . 75.140000000000001 108.672 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.87 152.38 16.86 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 121.911 1.741 . . . . 75.010000000000005 112.677 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -100.14 158.37 15.9 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.327 -1.731 . . . . 71.420000000000002 106.327 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.25 -12.79 58.42 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.352 0.501 . . . . 70.230000000000004 112.352 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.39 -3.03 54.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.988 -0.551 . . . . 71.420000000000002 110.984 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.07 -4.01 82.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.936 -0.65 . . . . 38.659999999999997 112.984 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.0 m -83.01 131.42 35.18 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.765 0.317 . . . . 73.140000000000001 110.414 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.57 79.26 4.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.539 0.685 . . . . 64.209999999999994 110.534 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.577 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 52.0 tt0 -148.46 114.26 5.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.29 -0.868 . . . . 74.219999999999999 111.012 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 56.3 mtpt -176.82 -67.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.727 2.011 . . . . 72.129999999999995 107.048 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 64.9 mttm -145.67 158.63 43.83 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.883 -1.053 . . . . 73.150000000000006 108.518 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 85' ' ' ALA . 46.8 tp -139.14 124.74 19.45 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.964 -1.125 . . . . 71.209999999999994 107.964 171.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -123.68 114.04 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.158 -1.052 . . . . 71.540000000000006 108.158 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 58.2 t -97.15 130.14 46.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.178 -0.675 . . . . 62.049999999999997 109.178 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.45 131.65 56.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.149 -0.685 . . . . 71.310000000000002 109.149 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -102.98 114.67 29.16 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.022 -1.103 . . . . 73.019999999999996 108.022 175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.608 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 75.9 ttt180 -75.52 133.04 41.11 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.014 -1.448 . . . . 74.109999999999999 109.755 -176.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 40' ' ' LYS . 76.1 mt -106.44 137.54 19.46 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.565 -0.902 . . . . 70.150000000000006 108.565 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.77 149.43 77.55 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.259 1.972 . . . . 63.240000000000002 110.428 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -60.99 -33.82 73.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.831 1.049 . . . . 64.299999999999997 113.831 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -66.94 -23.91 66.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 65.310000000000002 111.119 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -92.66 -7.7 46.13 Favored 'General case' 0 C--O 1.192 -1.958 0 CA-C-N 116.66 -0.246 . . . . 73.319999999999993 110.895 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.643 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.52 -33.29 69.06 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.922 -0.711 . . . . 74.040000000000006 111.478 177.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.83 -29.61 74.59 Favored Glycine 0 C--N 1.334 0.464 0 O-C-N 123.559 0.537 . . . . 42.399999999999999 111.949 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.0 t -153.69 82.56 4.58 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 108.996 -0.742 . . . . 71.109999999999999 108.996 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.73 162.14 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.468 2.112 . . . . 54.329999999999998 111.902 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.3 Cg_exo -60.45 156.98 38.37 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 C-N-CA 121.581 1.52 . . . . 72.120000000000005 109.783 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.94 154.56 37.74 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.431 -0.581 . . . . 72.219999999999999 109.431 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.479 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 27.8 Cg_exo -62.98 104.99 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.781 2.321 . . . . 75.109999999999999 111.81 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 11.2 p -90.67 -28.35 18.42 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.871 -0.604 . . . . 71.340000000000003 112.177 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.7 156.03 18.38 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.813 -0.81 . . . . 73.109999999999999 108.813 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.47 -31.71 63.91 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.455 0.645 . . . . 70.25 110.366 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.8 m -99.28 5.14 46.67 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.525 -0.762 . . . . 43.25 112.013 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 59.6 t -119.7 122.6 69.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.071 -1.085 . . . . 61.119999999999997 108.071 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -128.22 143.4 51.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.366 -0.379 . . . . 72.25 110.502 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.2 mm -92.75 110.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.826 -1.176 . . . . 63.530000000000001 107.826 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -108.01 144.04 35.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.23 -0.895 . . . . 62.200000000000003 109.382 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.16 127.33 45.1 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.842 -0.617 . . . . 74.010000000000005 110.492 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.522 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 2.1 mmp_? -123.36 116.25 22.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 118.745 -1.182 . . . . 64.109999999999999 109.686 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -148.49 161.01 42.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.379 -0.828 . . . . 75.25 110.962 173.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.13 19.7 71.68 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.919 -0.658 . . . . 74.0 112.264 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -121.14 147.67 24.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.314 0.578 . . . . 75.230000000000004 111.009 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.9 m -117.47 128.21 54.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.446 -0.946 . . . . 74.519999999999996 108.446 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.448 HG21 ' CE3' ' A' ' 186' ' ' TRP . 30.2 m -124.72 166.06 20.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 116.13 -0.486 . . . . 75.540000000000006 110.001 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 55.4 m-85 -113.75 122.18 46.33 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 106.256 -1.757 . . . . 74.340000000000003 106.256 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 p -119.73 132.73 55.72 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.773 -0.771 . . . . 71.219999999999999 110.735 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.8 t -121.76 123.84 42.79 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 109.007 -0.738 . . . . 63.329999999999998 109.007 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -110.58 136.91 48.96 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.431 -0.951 . . . . 73.019999999999996 108.431 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 43.2 p90 -145.49 144.7 30.72 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.026 -0.533 . . . . 72.329999999999998 111.561 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -106.64 138.25 14.31 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.503 -1.039 . . . . 64.450000000000003 110.503 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.11 -175.06 28.52 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.868 -0.682 . . . . 51.210000000000001 111.484 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -87.59 111.13 20.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.784 -1.191 . . . . 75.319999999999993 107.784 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.28 130.8 53.24 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.531 0.567 . . . . 55.350000000000001 112.531 -174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.15 178.21 5.32 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.702 -1.222 . . . . 73.510000000000005 107.702 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.71 77.86 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.323 0.582 . . . . 64.310000000000002 109.869 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.48 71.31 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.355 -0.839 . . . . 73.420000000000002 111.063 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.37 -30.52 70.33 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.413 0.149 . . . . 74.299999999999997 111.199 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -69.7 -41.63 75.13 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 110.036 -0.357 . . . . 72.219999999999999 110.036 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.81 -48.0 83.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.396 -0.594 . . . . 72.450000000000003 109.396 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.98 87.88 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.36 -0.836 . . . . 64.239999999999995 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -66.37 -32.43 73.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 112.402 0.519 . . . . 61.229999999999997 112.402 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 -46.7 79.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.86 0.362 . . . . 72.230000000000004 111.037 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.4 t -72.58 -33.39 66.72 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.482 0.658 . . . . 74.540000000000006 110.235 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -64.44 -37.07 86.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.168 -0.678 . . . . 74.010000000000005 109.168 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.35 -39.45 93.91 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.859 -0.609 . . . . 62.340000000000003 110.058 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -63.28 -36.54 84.01 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.372 -0.603 . . . . 75.310000000000002 109.372 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 m -70.53 -32.71 70.27 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.261 -0.881 . . . . 73.25 110.031 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.6 m -76.79 -34.33 57.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.671 -0.695 . . . . 74.5 110.06 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -85.71 11.22 11.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.58 0.752 . . . . 73.129999999999995 111.095 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -73.68 135.21 43.7 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.624 -1.621 . . . . 55.399999999999999 106.624 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.49 58.83 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.521 -0.632 . . . . 61.439999999999998 111.521 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 160' ' ' ALA . 34.9 p -114.3 160.14 33.91 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 107.259 -1.385 . . . . 71.450000000000003 107.259 176.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.13 27.31 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 122.192 1.928 . . . . 61.140000000000001 112.163 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 158' ' ' THR . . . -67.16 101.1 0.85 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.359 0.599 . . . . 71.310000000000002 112.273 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.5 p -89.33 156.03 18.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.559 -0.904 . . . . 74.129999999999995 108.559 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.433 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 24.2 m-85 -138.74 150.4 46.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.2 pt20 -114.04 109.89 19.17 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.309 0.576 . . . . 73.340000000000003 110.438 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.27 41.95 Favored Glycine 0 N--CA 1.46 0.3 0 C-N-CA 120.808 -0.71 . . . . 62.439999999999998 111.901 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 59.31 25.55 14.22 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.936 1.294 . . . . 72.010000000000005 110.499 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.1 m -75.1 140.03 18.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 119.799 -0.761 . . . . 74.319999999999993 110.76 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -139.9 170.24 16.23 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.162 -0.926 . . . . 72.409999999999997 109.607 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 60.6 m-85 -115.43 148.09 39.79 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.721 -0.844 . . . . 73.540000000000006 108.721 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 63.1 m -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.522 -1.658 . . . . 75.329999999999998 106.522 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 184' ' ' GLU . . . -117.59 145.45 44.29 Favored 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 123.558 0.536 . . . . 72.219999999999999 111.253 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.52 165.2 38.46 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 108.932 -1.667 . . . . 38.659999999999997 108.932 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -68.24 -31.35 70.78 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 118.042 0.921 . . . . 65.129999999999995 109.074 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -143.19 135.47 13.31 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 105.971 -1.863 . . . . 72.420000000000002 105.971 174.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.486 ' HG2' ' SD ' ' A' ' 59' ' ' MET . 50.3 Cg_exo -59.79 111.03 0.84 Allowed 'Trans proline' 0 CA--C 1.514 -0.477 0 C-N-CA 122.327 2.018 . . . . 75.319999999999993 109.522 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.68 128.37 22.05 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.839 1.692 . . . . 64.040000000000006 113.252 -172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 58.0 ttp -96.93 -31.69 12.43 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.203 -1.777 . . . . 73.439999999999998 106.203 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -107.53 144.67 29.71 Favored Pre-proline 0 N--CA 1.424 -1.768 0 CA-C-N 113.815 -1.538 . . . . 74.5 107.485 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.48 -13.72 26.74 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.437 2.758 . . . . 71.549999999999997 113.47 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.86 94.56 0.32 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.8 0.81 . . . . 63.549999999999997 111.916 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -156.21 124.59 1.49 Allowed Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 106.847 -2.501 . . . . 72.349999999999994 106.847 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.432 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 97.0 mtt180 -79.62 -54.57 5.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 117.26 0.53 . . . . 75.519999999999996 110.998 -172.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.87 130.55 49.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 109.245 -0.65 . . . . 60.310000000000002 109.245 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.6 m-80 -127.47 139.34 52.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.241 -1.392 . . . . 63.329999999999998 107.241 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 170' ' ' ALA . 39.0 tt0 -132.09 133.93 44.9 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.829 -0.348 . . . . 73.310000000000002 111.051 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.49 125.71 69.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.466 0.706 . . . . 73.040000000000006 110.062 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.8 m0 -109.08 121.13 44.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.904 -0.776 . . . . 73.349999999999994 108.904 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.35 124.03 49.21 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 107.522 -1.288 . . . . 64.540000000000006 107.522 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.34 132.31 39.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.782 0.325 . . . . 75.129999999999995 111.262 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 21.0 ptmt -76.45 141.95 41.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.128 -0.487 . . . . 70.209999999999994 111.288 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.433 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.809 -0.632 . . . . 65.340000000000003 110.42 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 CA--C 1.505 -0.764 0 N-CA-C 110.211 -0.292 . . . . 73.209999999999994 110.211 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.4 p -92.6 97.78 11.02 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 116.55 -0.295 . . . . 71.420000000000002 111.795 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.95 16.03 20.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.344 0.592 . . . . 73.409999999999997 109.924 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -142.35 150.68 41.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.441 -1.318 . . . . 62.329999999999998 107.441 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.69 -120.95 0.92 Allowed Glycine 0 C--N 1.301 -1.409 0 N-CA-C 110.92 -0.872 . . . . 72.150000000000006 110.92 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.2 p -90.85 95.09 9.95 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-O 121.513 0.673 . . . . 62.299999999999997 110.101 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.73 97.78 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 122.234 1.016 . . . . 75.549999999999997 112.358 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.81 -26.93 29.15 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.078 -0.964 . . . . 73.329999999999998 110.159 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.9 m -143.13 99.94 3.54 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.307 0.575 . . . . 64.340000000000003 111.84 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.615 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 49.2 t-105 -87.99 124.56 66.72 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 104.494 -2.41 . . . . 74.120000000000005 104.494 171.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.98 140.64 66.97 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.797 1.665 . . . . 63.450000000000003 114.083 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -101.87 149.99 23.64 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.501 -2.037 . . . . 73.010000000000005 105.501 174.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.83 118.75 21.23 Favored 'General case' 0 C--N 1.284 -2.273 0 C-N-CA 119.633 -0.827 . . . . 73.230000000000004 109.105 -171.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t -89.7 126.29 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.883 -0.784 . . . . 70.329999999999998 108.883 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.78 -38.57 15.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.384 -0.969 . . . . 61.420000000000002 108.384 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.5 t 179.69 165.68 1.13 Allowed 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.932 -1.031 . . . . 62.229999999999997 108.291 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -131.64 165.13 24.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.958 -1.127 . . . . 63.240000000000002 107.958 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.99 -157.04 25.82 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 119.352 -1.404 . . . . 51.030000000000001 113.04 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.97 -138.51 14.6 Favored Glycine 0 N--CA 1.42 -2.397 0 N-CA-C 111.186 -0.766 . . . . 74.099999999999994 111.186 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.1 171.06 8.48 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.283 -1.006 . . . . 72.140000000000001 108.283 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.44 162.17 23.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.129 -1.028 . . . . 71.420000000000002 109.622 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 72.39 -54.27 0.69 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.345 1.058 . . . . 75.420000000000002 109.797 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.21 109.39 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-O 122.049 0.928 . . . . 44.219999999999999 109.125 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 m -129.67 146.36 51.46 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.003 -1.11 . . . . 71.349999999999994 108.003 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -113.83 160.49 18.67 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 112.795 0.665 . . . . 75.030000000000001 112.795 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.567 ' OE1' ' HD3' ' A' ' 34' ' ' ARG . 39.7 tt0 -136.56 125.71 24.61 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.468 -2.049 . . . . 73.030000000000001 105.468 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -98.91 118.04 34.77 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.883 -1.525 . . . . 43.009999999999998 106.883 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.567 ' HD3' ' OE1' ' A' ' 32' ' ' GLU . 27.0 mtm180 -131.68 145.76 51.82 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.931 -1.108 . . . . 72.129999999999995 111.717 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.34 136.86 34.92 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.303 -2.11 . . . . 63.100000000000001 105.303 168.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.0 t -58.25 148.45 27.19 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.349 0.406 . . . . 54.240000000000002 111.817 -175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.615 ' O ' ' HB3' ' A' ' 16' ' ' TRP . 14.8 pt-20 -73.17 -3.35 26.03 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 115.753 -0.658 . . . . 37.560000000000002 111.641 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 74.01 9.07 79.62 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 120.979 -0.629 . . . . 45.140000000000001 114.021 171.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.37 162.5 54.23 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 121.052 -0.594 . . . . 54.530000000000001 113.527 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.04 118.65 37.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.315 -1.365 . . . . 63.310000000000002 107.315 178.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.1 m-85 -121.4 165.7 15.18 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.665 -0.698 . . . . 71.439999999999998 112.05 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.69 116.79 30.59 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 107.79 -1.189 . . . . 75.239999999999995 107.79 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -127.66 144.24 51.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.655 0.74 . . . . 73.439999999999998 112.24 -174.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 58' ' ' ALA . 6.5 p -127.61 133.63 67.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.298 -1.371 . . . . 73.540000000000006 107.298 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.71 123.58 45.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.072 -0.651 . . . . 73.439999999999998 111.382 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.425 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 31.6 t -118.16 123.19 71.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.261 -1.385 . . . . 52.5 107.261 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' LYS . 25.0 m -117.76 159.5 22.92 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.669 -0.241 . . . . 72.010000000000005 110.532 -175.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 75.58 -27.39 0.19 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.852 1.661 . . . . 72.010000000000005 112.035 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.0 mttm -85.19 145.05 42.08 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 109.274 -0.639 . . . . 74.209999999999994 109.274 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.57 156.84 34.69 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.927 2.418 . . . . 74.219999999999999 111.514 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.409 HG13 HD13 ' A' ' 98' ' ' LEU . 54.5 t -48.03 -44.74 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.36 0.664 . . . . 71.439999999999998 112.408 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -58.04 -44.41 87.38 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.95 0.405 . . . . 63.119999999999997 110.737 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.15 -48.79 26.98 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.505 -0.77 . . . . 62.32 111.063 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -59.7 -40.18 87.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 73.230000000000004 111.317 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 59' ' ' MET . 52.7 tp -65.61 -51.3 60.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 116.338 -0.392 . . . . 62.020000000000003 110.959 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 4.9 ppt_? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.318 0.858 . . . . 74.310000000000002 113.318 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 1.3 tm-20 -74.69 -45.82 41.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.384 -0.969 . . . . 74.530000000000001 108.384 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . . . -76.57 -33.16 58.5 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.525 1.13 . . . . 37.560000000000002 114.046 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.535 ' HE2' ' HA ' ' A' ' 59' ' ' MET . 8.9 mmt -50.98 -55.09 30.65 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 114.918 1.451 . . . . 71.129999999999995 114.918 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.42 -30.91 75.47 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.681 2.254 . . . . 64.200000000000003 112.163 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -67.35 -48.63 66.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 54.200000000000003 111.029 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.7 mm -66.48 -40.1 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 74.040000000000006 109.767 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -48.53 79.88 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 123.666 0.787 . . . . 71.340000000000003 111.13 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -27.58 65.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.952 -0.699 . . . . 74.010000000000005 112.382 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.95 -50.52 68.3 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.576 -0.283 . . . . 72.219999999999999 110.517 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -2.92 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.901 -0.591 . . . . 72.519999999999996 111.583 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.55 -21.59 36.88 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.809 -0.632 . . . . 72.230000000000004 111.929 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 136.69 -14.29 3.89 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.174 -1.012 . . . . 37.560000000000002 113.425 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 m -81.48 40.53 0.58 Allowed 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.89 1.329 . . . . 73.420000000000002 110.957 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.81 177.16 5.55 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.24 -0.891 . . . . 74.420000000000002 108.978 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.442 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . 17.0 t70 -69.33 -30.88 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.859 0.361 . . . . 74.109999999999999 111.961 -175.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -81.77 -12.63 58.48 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.36 -0.382 . . . . 71.219999999999999 110.289 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.31 20.8 75.5 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.805 -0.634 . . . . 73.340000000000003 112.18 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 33.4 m -86.33 125.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.622 -0.431 . . . . 74.299999999999997 110.738 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.64 -71.13 0.96 Allowed Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 111.542 -0.623 . . . . 74.299999999999997 111.542 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.5 mmt 66.43 -64.18 0.23 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.185 1.179 . . . . 72.120000000000005 114.185 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 60.7 5.9 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.621 -1.392 . . . . 70.319999999999993 109.621 -174.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -96.12 126.25 41.22 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.179 0.514 . . . . 64.299999999999997 110.946 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.8 t -123.45 116.6 23.5 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 122.361 1.077 . . . . 74.430000000000007 111.557 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.2 m -143.65 170.93 7.57 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 105.262 -2.125 . . . . 70.430000000000007 105.262 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.03 138.62 79.68 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.609 1.253 . . . . 72.349999999999994 113.547 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.9 p -111.88 147.22 15.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.696 -1.594 . . . . 71.400000000000006 106.696 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.0 p -132.61 144.95 50.71 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.438 -0.505 . . . . 51.43 110.22 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -131.68 141.32 49.55 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 120.199 -0.6 . . . . 71.129999999999995 110.716 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.75 135.02 34.48 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 115.54 -0.755 . . . . 74.239999999999995 109.414 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.69 150.21 32.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.696 -0.684 . . . . 62.350000000000001 109.457 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 97' ' ' LYS . 90.7 m-85 -119.48 101.88 48.42 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 110.143 -0.318 . . . . 73.010000000000005 110.143 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.95 142.55 15.69 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 122.447 2.098 . . . . 64.040000000000006 112.589 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.459 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 45.6 m-80 -96.66 162.63 13.36 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.034 -0.728 . . . . 60.219999999999999 109.034 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.1 -13.56 62.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.424 0.631 . . . . 73.510000000000005 110.232 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.51 -6.19 54.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.27 -0.877 . . . . 55.020000000000003 109.457 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -6.8 82.95 Favored Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 116.024 -0.535 . . . . 72.140000000000001 112.296 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 p -84.39 140.88 31.25 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.833 0.349 . . . . 71.209999999999994 110.48 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.47 79.11 2.46 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.302 0.573 . . . . 64.230000000000004 109.569 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 78.2 mt-30 -147.02 114.63 6.39 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.766 -0.652 . . . . 72.219999999999999 110.596 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 89.2 mttt -176.63 -63.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 126.274 1.83 . . . . 73.519999999999996 108.091 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 21.9 ttmm -161.04 153.83 20.92 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.691 -0.855 . . . . 62.030000000000001 108.691 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 5.8 tt -139.92 128.37 22.79 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.031 -1.47 . . . . 73.230000000000004 107.031 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -123.43 115.61 21.89 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.014 -0.735 . . . . 74.140000000000001 109.014 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 43' ' ' THR . 82.6 t -88.74 123.03 40.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.952 -0.388 . . . . 64.420000000000002 109.952 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -109.78 124.75 51.81 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.971 -0.751 . . . . 75.140000000000001 108.971 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 87.8 t80 -102.52 112.4 25.12 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.995 -1.113 . . . . 75.510000000000005 107.995 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.472 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 2.3 tmt_? -75.5 112.93 12.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.931 -1.507 . . . . 72.409999999999997 106.931 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.514 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 67.7 mt -85.68 137.92 35.88 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.156 -0.475 . . . . 74.319999999999993 109.9 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.29 143.36 34.08 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.63 2.22 . . . . 55.219999999999999 111.539 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.92 -33.39 62.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.363 1.246 . . . . 74.519999999999996 114.363 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -59.41 -31.23 69.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.893 0.378 . . . . 75.530000000000001 111.006 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.98 -2.78 49.71 Favored 'General case' 0 C--O 1.192 -1.942 0 CA-C-N 116.341 -0.39 . . . . 65.530000000000001 111.605 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.514 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 29.5 mm-40 -71.01 -28.62 64.55 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.199 -0.6 . . . . 72.129999999999995 110.608 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.04 -38.29 92.49 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.266 -0.734 . . . . 44.530000000000001 111.266 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.8 m -155.39 92.99 2.7 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 123.212 0.605 . . . . 65.200000000000003 109.52 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -83.96 145.04 11.1 Favored 'Trans proline' 0 C--O 1.251 1.158 0 C-N-CA 122.472 2.115 . . . . 62.140000000000001 111.832 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.1 130.6 29.44 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.886 1.724 . . . . 72.129999999999995 109.432 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 71' ' ' ASP . . . -61.18 139.67 94.42 Favored Pre-proline 0 C--O 1.257 1.479 0 CA-C-O 120.767 0.318 . . . . 72.129999999999995 110.68 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 61.2 Cg_endo -72.2 108.21 2.43 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.584 2.189 . . . . 74.510000000000005 111.199 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.8 t -89.91 82.47 6.18 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 116.02 -0.536 . . . . 70.439999999999998 110.428 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.49 ' HB3' HG11 ' A' ' 120' ' ' VAL . 13.0 t70 -178.49 164.37 1.65 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 104.492 -2.41 . . . . 64.420000000000002 104.492 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.47 -28.37 22.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 118.727 0.694 . . . . 74.519999999999996 112.269 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 p -91.28 -18.46 24.32 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.704 1.001 . . . . 71.519999999999996 113.704 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 117' ' ' ASP . 2.5 p -104.37 120.64 55.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.237 0.541 . . . . 54.299999999999997 109.879 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 154.24 46.98 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.332 -0.849 . . . . 72.209999999999994 110.519 -175.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.8 mm -91.75 112.32 25.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.806 -0.813 . . . . 75.310000000000002 108.806 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -126.15 147.73 49.56 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.27 -1.011 . . . . 74.150000000000006 108.27 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -121.24 151.2 40.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 120.948 0.404 . . . . 75.129999999999995 111.341 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -134.33 125.68 28.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.82 -0.627 . . . . 71.140000000000001 111.581 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.422 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -143.14 174.2 10.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.616 -1.253 . . . . 73.120000000000005 107.616 171.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.94 19.34 77.68 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 119.884 -1.15 . . . . 75.040000000000006 111.12 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.8 145.74 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-O 121.003 0.43 . . . . 75.420000000000002 109.912 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.1 m -115.73 131.67 56.87 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.543 -1.28 . . . . 63.310000000000002 107.543 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -123.96 154.23 30.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.073 0.463 . . . . 71.129999999999995 109.906 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 66.2 m-85 -114.03 122.04 45.71 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 105.998 -1.853 . . . . 75.049999999999997 105.998 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.6 p -112.59 143.01 44.49 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.854 0.359 . . . . 70.230000000000004 111.005 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.472 ' HB ' HD21 ' A' ' 151' ' ' LEU . 13.5 t -128.01 134.35 49.23 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 120.693 -0.403 . . . . 63.240000000000002 110.008 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.516 ' NE2' ' HG2' ' A' ' 184' ' ' GLU . 2.0 mp0 -110.84 142.18 43.2 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.552 -1.648 . . . . 72.120000000000005 106.552 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 143' ' ' ASP . 30.7 p90 -143.17 118.25 10.08 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 115.133 1.531 . . . . 75.450000000000003 115.133 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 47.74 -138.96 10.37 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.005 -1.452 . . . . 73.150000000000006 115.776 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 181' ' ' ARG . . . -124.78 -28.39 1.16 Allowed Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.103 -0.799 . . . . 53.109999999999999 111.103 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.6 119.43 38.06 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.002 0.43 . . . . 70.340000000000003 112.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.59 107.63 11.23 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.578 -0.737 . . . . 75.319999999999993 110.883 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.14 171.9 8.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.737 -1.209 . . . . 73.030000000000001 107.737 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.59 -39.02 75.87 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.135 0.493 . . . . 63.420000000000002 110.434 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.36 74.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.38 -0.827 . . . . 70.439999999999998 111.362 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 17.2 m-20 -65.92 -36.26 82.88 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 111.815 0.302 . . . . 74.430000000000007 111.815 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.37 -39.9 89.38 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.927 0.394 . . . . 72.439999999999998 110.709 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.424 HG21 ' HH ' ' A' ' 167' ' ' TYR . 48.5 t -71.99 -51.13 32.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.949 -0.569 . . . . 65.430000000000007 110.372 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -57.4 -46.52 83.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.714 -0.675 . . . . 72.319999999999993 111.667 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -65.03 -32.65 74.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.027 0.751 . . . . 74.120000000000005 113.027 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.92 86.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.342 -0.614 . . . . 74.340000000000003 109.342 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.8 m -65.59 -40.19 92.42 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.711 -0.677 . . . . 72.349999999999994 109.937 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 30.2 mm-40 -61.84 -37.02 82.92 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 111.938 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.472 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.0 mt -60.92 -35.03 75.64 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 120.865 -0.334 . . . . 54.32 111.752 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -59.81 -48.14 82.87 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.25 0.343 . . . . 75.140000000000001 111.276 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 156' ' ' GLU . 13.0 t -75.56 -30.61 59.75 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.201 0.524 . . . . 75.510000000000005 111.033 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.9 m -70.69 -35.35 72.75 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 120.963 0.411 . . . . 74.239999999999995 110.421 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.5 6.45 17.39 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.014 0.525 . . . . 73.209999999999994 112.283 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 153' ' ' THR . 56.5 mt-10 -68.93 138.3 54.5 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.008 -0.677 . . . . 75.129999999999995 110.082 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.09 56.6 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.756 -0.656 . . . . 74.150000000000006 111.595 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.5 p -125.37 165.33 26.97 Favored Pre-proline 0 N--CA 1.441 -0.922 0 N-CA-C 108.293 -1.002 . . . . 73.0 108.293 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -75.44 20.14 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.796 2.331 . . . . 71.209999999999994 112.451 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.73 120.73 17.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.309 0.576 . . . . 72.5 110.426 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 10.1 t -124.59 157.5 35.29 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.007 -1.849 . . . . 75.519999999999996 106.007 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -132.6 160.09 37.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 119.115 0.871 . . . . 72.230000000000004 108.893 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -128.77 132.86 47.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.125 0.417 . . . . 52.43 112.125 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.63 -0.45 27.14 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.508 -0.769 . . . . 63.140000000000001 114.12 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 60.62 10.77 2.74 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.033 0.933 . . . . 74.0 112.285 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.436 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.5 p -68.77 138.53 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.784 0.802 . . . . 74.299999999999997 111.488 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.424 ' HH ' HG21 ' A' ' 145' ' ' VAL . 36.4 p90 -135.95 161.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.8 -1.091 . . . . 71.230000000000004 108.897 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 88.4 m-85 -115.41 142.07 47.19 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.153 -0.476 . . . . 75.510000000000005 109.913 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.2 m -114.22 120.3 40.0 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.731 -1.211 . . . . 65.340000000000003 107.731 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 184' ' ' GLU . . . -116.3 143.07 46.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.154 0.502 . . . . 71.439999999999998 111.708 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -169.53 165.66 39.04 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 107.279 -2.328 . . . . 54.520000000000003 107.279 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -66.41 -38.76 88.2 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 118.85 1.325 . . . . 74.549999999999997 109.057 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -155.01 154.62 29.15 Favored Pre-proline 0 C--N 1.287 -2.111 0 N-CA-C 104.762 -2.31 . . . . 73.439999999999998 104.762 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.33 113.76 1.56 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.863 1.709 . . . . 72.299999999999997 108.333 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.26 127.67 26.97 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.569 1.513 . . . . 70.010000000000005 113.481 -170.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -94.82 -21.07 18.94 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.661 -1.154 . . . . 65.129999999999995 108.896 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -112.64 147.47 37.18 Favored Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 107.03 -1.47 . . . . 75.430000000000007 107.03 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.54 -31.0 93.51 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.643 2.229 . . . . 74.150000000000006 112.676 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -82.65 123.61 29.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.382 0.61 . . . . 75.209999999999994 111.0 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.55 82.06 0.09 OUTLIER Glycine 0 C--N 1.306 -1.114 0 N-CA-C 107.338 -2.305 . . . . 61.109999999999999 107.338 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.43 ' HA ' ' HA2' ' A' ' 137' ' ' GLY 0.258 19.7 ptt180 -65.34 -29.86 70.64 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 116.185 1.92 . . . . 74.109999999999999 116.185 -167.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -101.23 125.25 47.84 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 115.342 -2.543 . . . . 75.519999999999996 108.581 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -146.84 158.37 43.9 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.648 -1.614 . . . . 65.239999999999995 108.786 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.516 ' HG2' ' NE2' ' A' ' 134' ' ' GLN . 43.5 mt-10 -143.12 137.38 29.09 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.098 0.475 . . . . 72.129999999999995 110.537 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 84.7 t -124.22 118.5 53.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 105.913 -1.884 . . . . 75.340000000000003 105.913 171.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.549 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 49.2 m0 -106.32 124.42 49.57 Favored 'General case' 0 CA--C 1.495 -1.154 0 O-C-N 123.463 0.477 . . . . 75.340000000000003 111.413 -176.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 mt -97.35 125.2 41.81 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.676 -1.601 . . . . 70.420000000000002 106.676 167.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.7 124.75 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 120.536 -0.466 . . . . 74.010000000000005 109.993 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 161' ' ' THR . 15.5 pttp -70.19 145.1 51.69 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.643 -0.708 . . . . 73.040000000000006 109.644 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.76 0 C-N-CA 118.976 -1.089 . . . . 41.43 109.442 171.109 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.1 t30 . . . . . 0 C--O 1.235 0.335 0 N-CA-C 108.639 -0.875 . . . . 61.109999999999999 108.639 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.1 p -139.3 150.61 45.62 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.534 -0.913 . . . . 72.129999999999995 108.534 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.6 mt -84.54 120.58 26.5 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.725 -0.843 . . . . 72.230000000000004 108.725 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.75 151.66 19.92 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.149 0.5 . . . . 74.019999999999996 110.672 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.06 134.42 12.18 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 109.322 -1.511 . . . . 36.990000000000002 109.322 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.7 m -76.4 -27.06 56.17 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 117.102 0.451 . . . . 72.030000000000001 110.569 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t 53.97 76.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.214 1.005 . . . . 72.540000000000006 110.376 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.409 0.0 OUTLIER -91.63 78.65 5.52 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 122.754 1.264 . . . . 71.329999999999998 113.987 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.1 m -94.86 110.91 22.74 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 113.664 -1.607 . . . . 73.439999999999998 108.326 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 5.3 p90 -43.13 105.69 0.44 Allowed Pre-proline 0 CA--C 1.567 1.632 0 C-N-CA 126.151 1.78 . . . . 74.400000000000006 112.622 -177.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -95.09 121.07 0.29 Allowed 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 122.483 2.122 . . . . 73.200000000000003 112.862 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 41.2 p90 -111.66 141.02 45.78 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.375 -0.602 . . . . 71.200000000000003 109.375 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -122.91 110.0 14.86 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.943 -0.303 . . . . 60.43 110.546 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.3 116.42 30.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 106.906 -1.516 . . . . 74.200000000000003 106.906 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -91.93 -26.28 18.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.36 -0.536 . . . . 63.240000000000002 112.111 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -172.85 153.14 2.58 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.006 0.431 . . . . 64.530000000000001 110.779 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.6 p -133.03 134.58 44.6 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.867 -1.06 . . . . 71.430000000000007 110.231 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.94 132.55 7.81 Favored Glycine 0 C--N 1.304 -1.246 0 C-N-CA 120.265 -0.969 . . . . 62.5 112.752 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.46 -115.03 0.98 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.029 -0.605 . . . . 62.130000000000003 111.749 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.489 ' HZ1' ' HB2' ' A' ' 26' ' ' LYS . 4.7 ttmp? -91.71 117.55 29.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.518 -1.66 . . . . 64.329999999999998 106.518 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -67.75 134.31 50.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 115.27 1.582 . . . . 73.420000000000002 115.27 -170.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 158.17 -58.87 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 129.704 3.202 . . . . 72.439999999999998 103.737 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.2 p -129.22 129.96 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 106.901 -1.518 . . . . 74.329999999999998 106.901 170.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 m -95.27 154.64 17.09 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.893 -0.504 . . . . 75.209999999999994 110.087 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.47 163.37 14.98 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.983 -0.553 . . . . 74.340000000000003 110.885 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -132.96 124.53 27.96 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.628 -1.99 . . . . 74.5 105.628 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.4 115.27 30.13 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.552 -1.277 . . . . 71.150000000000006 107.552 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -131.3 139.79 49.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.216 -0.594 . . . . 63.0 110.933 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.39 133.65 35.44 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 104.924 -2.251 . . . . 73.510000000000005 104.924 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.27 138.92 58.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 123.674 0.609 . . . . 71.349999999999994 109.851 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.8 OUTLIER -60.69 -26.94 67.49 Favored 'General case' 0 N--CA 1.422 -1.85 0 O-C-N 124.435 1.085 . . . . 62.229999999999997 112.531 -178.193 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 84.31 10.24 80.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 118.465 -1.826 . . . . 73.239999999999995 112.247 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.22 157.27 53.4 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.822 -0.704 . . . . 61.210000000000001 111.395 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -88.32 123.43 32.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.409 -0.96 . . . . 72.120000000000005 108.409 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.0 m-85 -122.32 165.45 16.23 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.588 -0.733 . . . . 72.319999999999993 110.996 -172.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.25 115.35 28.18 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.384 -0.969 . . . . 73.239999999999995 108.384 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.9 t -120.32 142.67 48.91 Favored 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 115.124 -0.943 . . . . 62.299999999999997 111.643 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 13.8 m -128.89 127.14 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 107.147 -1.427 . . . . 71.010000000000005 107.147 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.59 119.68 31.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-O 121.887 0.851 . . . . 74.049999999999997 112.093 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.72 135.8 53.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.221 -1.354 . . . . 75.329999999999998 107.616 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 49' ' ' LYS . 33.3 p -125.78 167.5 15.09 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.582 -0.281 . . . . 65.049999999999997 110.736 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.7 t70 73.64 -26.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 124.039 0.935 . . . . 71.230000000000004 112.202 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 47' ' ' THR . 94.6 mttt -96.96 143.27 25.83 Favored Pre-proline 0 C--N 1.3 -1.565 0 CA-C-N 115.808 -0.633 . . . . 64.510000000000005 110.22 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.14 158.95 36.82 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.374 2.716 . . . . 65.310000000000002 111.789 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.2 t -45.66 -45.66 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.131 0.972 . . . . 64.239999999999995 112.756 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.58 -50.04 75.27 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.506 0.67 . . . . 53.43 110.52 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.99 -35.73 77.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.104 -0.953 . . . . 74.200000000000003 112.273 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.18 -45.26 63.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.462 -0.335 . . . . 73.140000000000001 110.624 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.08 -43.64 94.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.304 -0.407 . . . . 71.120000000000005 111.413 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -64.51 -26.74 68.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.159 0.429 . . . . 62.229999999999997 112.159 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 27.5 tt0 -84.07 -30.39 26.06 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.09 -0.707 . . . . 74.25 109.09 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.58 52.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.979 -1.01 . . . . 63.200000000000003 113.49 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.524 ' HE1' ' HA ' ' A' ' 59' ' ' MET . 3.4 mmt -51.08 -55.85 24.77 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 112.504 0.557 . . . . 74.530000000000001 112.504 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.11 -31.32 74.83 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.739 2.293 . . . . 73.439999999999998 113.202 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 93.1 mttt -64.19 -48.46 75.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.77 0.319 . . . . 75.450000000000003 110.362 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.8 -38.81 83.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.341 -0.39 . . . . 74.319999999999993 110.756 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.1 mmt -59.15 -43.23 92.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.253 -0.43 . . . . 74.120000000000005 112.038 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -76.22 -29.72 57.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.834 -0.747 . . . . 75.209999999999994 111.634 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.402 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 36.9 t80 -60.91 -56.3 22.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.165 -0.471 . . . . 75.349999999999994 110.743 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.4 m -77.45 -7.56 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.391 0.615 . . . . 74.340000000000003 110.739 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.85 -20.74 62.77 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.602 -0.726 . . . . 36.990000000000002 112.436 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.32 6.55 8.11 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.028 -1.082 . . . . 75.420000000000002 113.288 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -91.85 17.73 8.74 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.777 1.275 . . . . 71.150000000000006 109.573 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.07 173.47 10.46 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.562 -1.199 . . . . 73.239999999999995 109.438 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 24.1 t70 -67.09 -33.23 75.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.541 0.571 . . . . 73.530000000000001 112.541 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.15 -12.29 59.25 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.45 -0.5 . . . . 71.040000000000006 110.554 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.25 24.76 74.81 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 115.535 -0.757 . . . . 44.109999999999999 111.884 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.61 122.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 C-N-CA 120.004 -0.679 . . . . 45.340000000000003 111.287 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.42 97.84 1.36 Allowed Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 109.241 -1.543 . . . . 72.099999999999994 109.241 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtt -126.41 135.53 51.53 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.625 -0.509 . . . . 53.219999999999999 109.625 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.95 70.91 1.45 Allowed Glycine 0 C--N 1.292 -1.908 0 CA-C-N 115.296 -0.865 . . . . 43.009999999999998 111.922 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.0 ptm -96.68 122.44 39.62 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.283 -0.636 . . . . 64.530000000000001 109.283 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.8 m -127.44 133.98 49.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.758 -0.656 . . . . 74.019999999999996 110.478 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -166.43 148.29 5.84 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.044 -1.465 . . . . 62.32 107.044 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 27.8 Cg_exo -40.1 140.97 0.75 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.753 2.968 . . . . 75.439999999999998 115.133 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.26 152.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.262 -1.014 . . . . 63.32 108.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.9 m -139.3 152.32 47.13 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.202 -0.666 . . . . 62.509999999999998 109.202 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -145.14 144.99 31.19 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 122.1 -0.375 . . . . 65.340000000000003 110.578 172.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -92.39 137.97 31.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.648 -0.501 . . . . 54.439999999999998 109.648 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.18 150.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 N-CA-C 108.744 -0.836 . . . . 72.200000000000003 108.744 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 62.7 m-85 -117.09 112.34 40.01 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 107.02 -1.474 . . . . 73.340000000000003 107.02 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.22 133.66 18.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 120.948 1.099 . . . . 73.109999999999999 112.247 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.35 156.57 20.16 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 107.823 -1.177 . . . . 73.439999999999998 107.823 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.01 -13.33 62.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.186 0.517 . . . . 62.299999999999997 112.147 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.16 -6.14 58.97 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.998 -0.546 . . . . 72.049999999999997 110.278 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.54 -2.45 72.5 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.335 -0.393 . . . . 54.020000000000003 113.269 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -87.36 3.56 46.46 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.881 0.697 . . . . 74.349999999999994 112.881 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt 65.3 148.29 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.108 0.963 . . . . 70.510000000000005 112.889 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.406 ' OE1' ' HE2' ' A' ' 97' ' ' LYS . 34.8 tt0 -82.08 148.57 28.5 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.707 -0.679 . . . . 75.230000000000004 109.854 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -86.06 70.43 10.59 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.752 0.786 . . . . 74.310000000000002 111.31 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 22.0 ttmm -158.26 125.5 5.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 105.483 -2.043 . . . . 71.420000000000002 105.483 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.03 131.89 22.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.328 -0.949 . . . . 73.439999999999998 111.38 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.79 115.16 23.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.299 -0.864 . . . . 70.299999999999997 109.311 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 43' ' ' THR . 92.9 t -88.33 127.93 40.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 108.041 -1.096 . . . . 73.019999999999996 108.041 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -114.79 113.61 24.47 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.359 -0.978 . . . . 75.150000000000006 108.359 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -103.04 114.08 28.08 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.682 -1.229 . . . . 74.200000000000003 107.682 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.613 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 14.8 ptp180 -75.07 138.78 42.36 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.771 -1.104 . . . . 64.239999999999995 108.085 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -97.91 141.16 22.54 Favored Pre-proline 0 C--N 1.266 -3.046 0 CA-C-N 116.264 -0.425 . . . . 73.349999999999994 110.056 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.42 146.89 9.64 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.902 2.401 . . . . 64.219999999999999 111.731 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -52.27 -40.38 61.68 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.379 1.251 . . . . 73.450000000000003 114.379 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.37 -27.87 66.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.211 0.529 . . . . 62.350000000000001 111.313 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.24 -1.66 47.67 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 112.156 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.578 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -64.72 -41.21 96.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.881 0.372 . . . . 72.420000000000002 110.507 176.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.14 -23.42 68.73 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.679 -0.691 . . . . 64.209999999999994 112.35 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -149.77 87.91 5.01 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 120.782 0.325 . . . . 71.239999999999995 110.351 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -96.42 162.56 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.008 2.472 . . . . 73.310000000000002 111.713 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.2 135.49 27.18 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.409 2.073 . . . . 72.349999999999994 111.402 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 71' ' ' ASP . . . -71.98 150.29 92.59 Favored Pre-proline 0 C--O 1.256 1.42 0 CA-C-O 120.594 0.235 . . . . 64.219999999999999 111.441 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.85 117.07 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.829 2.352 . . . . 74.209999999999994 112.185 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -97.79 21.62 10.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.529 -0.915 . . . . 52.109999999999999 108.529 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.456 ' HB3' HG13 ' A' ' 120' ' ' VAL . 17.4 t70 -140.26 156.22 46.56 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.402 -1.333 . . . . 73.340000000000003 107.402 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -25.33 22.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.967 -0.693 . . . . 64.040000000000006 111.89 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -78.61 -34.06 46.97 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.355 -0.384 . . . . 74.129999999999995 110.932 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 117' ' ' ASP . 7.4 p -98.77 125.23 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.364 -0.606 . . . . 61.520000000000003 109.364 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -128.21 138.43 52.46 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.341 -0.845 . . . . 64.519999999999996 109.539 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 22.9 mm -93.64 110.81 23.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.173 -1.417 . . . . 73.230000000000004 107.173 173.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.27 145.19 51.12 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.32 -0.993 . . . . 64.530000000000001 108.32 -174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.13 144.22 40.62 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.982 0.42 . . . . 73.439999999999998 110.706 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.522 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -123.97 122.68 38.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.058 -1.83 . . . . 73.409999999999997 106.058 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.73 157.01 47.37 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.855 1.057 . . . . 75.409999999999997 113.855 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.66 17.2 79.22 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.159 -0.928 . . . . 55.140000000000001 113.449 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.31 165.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 C-N-CA 120.553 -0.459 . . . . 74.219999999999999 110.54 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.536 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 28.6 m -120.13 133.09 55.6 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 109.136 -0.69 . . . . 74.230000000000004 109.136 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.99 151.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.387 -0.968 . . . . 63.420000000000002 108.387 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 41.4 m-85 -113.64 121.46 44.23 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.413 -1.699 . . . . 74.340000000000003 106.413 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 t -111.46 125.15 53.58 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.878 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 151' ' ' LEU . 12.7 t -113.58 127.36 56.04 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 107.796 -1.187 . . . . 73.140000000000001 107.796 174.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -110.41 132.93 53.75 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 121.645 0.736 . . . . 74.299999999999997 110.938 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 182' ' ' ARG . 48.7 p90 -129.8 146.38 51.54 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 74.120000000000005 108.973 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -124.54 111.03 1.49 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 111.061 -0.816 . . . . 50.219999999999999 111.061 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 175.05 -126.53 1.18 Allowed Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.712 -0.756 . . . . 50.43 111.719 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -100.14 135.67 41.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.062 -0.718 . . . . 75.439999999999998 109.062 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.88 107.51 10.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 113.277 0.843 . . . . 72.209999999999994 113.277 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.662 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 58.0 pttt -104.18 170.63 7.79 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 71.409999999999997 106.324 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -39.52 73.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.497 0.665 . . . . 74.510000000000005 110.365 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' HB1' ' HE3' ' A' ' 140' ' ' LYS . . . -64.86 -28.65 69.7 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.138 -0.937 . . . . 74.109999999999999 111.869 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.662 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 13.8 m-20 -62.91 -35.52 80.33 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 120.212 -0.595 . . . . 74.310000000000002 110.787 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.421 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 98.9 m-85 -68.69 -39.3 80.62 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.588 -0.445 . . . . 73.230000000000004 110.553 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.07 -47.13 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.613 -0.514 . . . . 70.430000000000007 109.613 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -60.81 -46.63 89.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.888 -0.596 . . . . 73.540000000000006 110.657 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -65.83 -32.64 74.28 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 112.116 0.413 . . . . 74.200000000000003 112.116 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -64.57 -46.34 83.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 74.120000000000005 109.523 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.5 m -61.45 -44.17 97.58 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.088 -0.505 . . . . 72.540000000000006 110.128 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 15.2 mm100 -64.45 -35.39 80.75 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.224 -0.444 . . . . 64.430000000000007 110.701 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.446 HD13 ' HB ' ' A' ' 133' ' ' THR . 49.1 tp -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.153 -0.342 . . . . 55.350000000000001 110.445 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.452 ' HD2' ' OD1' ' A' ' 165' ' ' ASP . 70.2 mtp180 -63.27 -40.79 98.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.567 -0.288 . . . . 71.439999999999998 111.447 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.2 t -75.4 -29.78 59.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.807 0.813 . . . . 75.329999999999998 110.095 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.485 HG21 ' H ' ' A' ' 26' ' ' LYS . 59.6 m -71.62 -34.67 70.03 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.751 -0.659 . . . . 63.229999999999997 110.36 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.87 4.31 37.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 74.120000000000005 111.506 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.6 138.71 31.47 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.072 -1.455 . . . . 73.310000000000002 107.072 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.73 -10.16 62.43 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 111.169 -0.772 . . . . 64.299999999999997 111.169 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.8 t -119.72 145.5 39.46 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 106.607 -1.627 . . . . 75.340000000000003 106.607 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.58 29.13 0.17 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 123.607 2.871 . . . . 74.5 114.62 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.75 128.5 34.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.833 0.349 . . . . 73.019999999999996 110.312 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 8.9 t -107.44 152.39 24.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.915 -0.584 . . . . 64.099999999999994 109.571 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -141.84 159.76 41.58 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 122.745 0.418 . . . . 72.129999999999995 110.533 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.478 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.4 pt20 -129.4 137.09 50.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.713 -0.477 . . . . 71.030000000000001 109.713 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.8 -0.64 9.75 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.143 -0.551 . . . . 51.310000000000002 114.405 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 152' ' ' ARG . 37.5 t70 65.54 19.27 11.49 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.07 0.948 . . . . 72.439999999999998 109.197 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 163' ' ' GLN . 8.4 p -71.49 138.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 CA-C-N 116.023 -0.535 . . . . 75.209999999999994 110.551 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -150.28 173.4 14.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.589 -0.732 . . . . 75.049999999999997 111.381 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 46.3 m-85 -115.52 152.02 33.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.355 -0.839 . . . . 74.439999999999998 110.314 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.421 ' SG ' ' CE1' ' A' ' 144' ' ' TYR . 15.0 t -114.47 120.11 39.16 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.197 -1.408 . . . . 65.010000000000005 107.197 175.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.41 159.21 36.09 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 110.559 -0.163 . . . . 62.340000000000003 110.559 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -161.31 150.13 19.55 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.792 -1.323 . . . . 45.140000000000001 109.792 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 m-30 -80.66 -16.6 53.59 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.912 0.863 . . . . 75.010000000000005 109.992 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -155.5 136.61 9.16 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 105.281 -2.118 . . . . 73.439999999999998 105.281 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.2 108.1 0.23 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.337 2.025 . . . . 65.109999999999999 110.726 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.418 ' HG3' ' OH ' ' A' ' 144' ' ' TYR . 55.6 Cg_endo -67.98 137.84 42.35 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.604 2.202 . . . . 63.149999999999999 113.5 -172.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.593 ' O ' ' HG3' ' A' ' 177' ' ' LYS . 65.7 mtt -89.4 -42.87 11.27 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.106 -1.442 . . . . 63.210000000000001 107.106 174.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 176' ' ' MET . 51.8 mttp 161.86 -59.72 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 130.015 3.326 . . . . 73.420000000000002 109.031 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 177' ' ' LYS . 6.1 Cg_exo -82.65 -31.47 0.79 Allowed 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.722 1.615 . . . . 54.409999999999997 110.64 175.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -94.9 141.82 28.19 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 107.747 -1.205 . . . . 74.420000000000002 107.747 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 88.76 64.03 1.32 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 107.794 -2.122 . . . . 74.5 107.794 -171.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.416 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 99.3 mtt180 -73.83 -46.68 43.6 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 114.586 1.328 . . . . 71.549999999999997 114.586 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 135' ' ' PHE . 36.7 ttm180 -100.48 129.55 46.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 118.147 -1.421 . . . . 64.549999999999997 110.337 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -140.36 153.46 46.4 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.031 -1.441 . . . . 74.040000000000006 108.095 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 40.3 mt-10 -116.51 151.75 35.49 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.961 -0.755 . . . . 63.0 108.961 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.02 118.2 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.102 -1.814 . . . . 71.409999999999997 106.102 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 20.6 m0 -102.96 121.25 42.16 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.998 -0.742 . . . . 75.340000000000003 108.998 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 166' ' ' VAL . 36.5 tp -98.13 134.3 41.39 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.996 -1.112 . . . . 75.450000000000003 107.996 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.43 125.16 44.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 O-C-N 123.171 0.295 . . . . 71.120000000000005 110.745 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -64.02 142.49 58.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 123.639 0.587 . . . . 70.209999999999994 110.991 176.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.34 0 CA-C-O 119.065 -0.493 . . . . 74.519999999999996 110.921 179.141 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 t30 . . . . . 0 C--O 1.222 -0.373 0 N-CA-C 108.751 -0.833 . . . . 73.349999999999994 108.751 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -137.45 105.31 5.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 112.941 0.719 . . . . 75.140000000000001 112.941 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.2 106.92 12.39 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.025 -1.102 . . . . 72.519999999999996 108.025 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -69.56 128.0 34.96 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.613 -0.514 . . . . 71.230000000000004 109.613 -175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.8 60.61 4.75 Favored Glycine 0 CA--C 1.506 -0.528 0 CA-C-N 116.044 -0.526 . . . . 62.119999999999997 113.382 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 t -166.5 120.16 1.07 Allowed 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 105.871 -1.899 . . . . 73.219999999999999 105.871 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.63 93.17 2.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 113.082 0.771 . . . . 75.230000000000004 113.082 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -130.53 91.7 3.13 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.97 -1.493 . . . . 73.319999999999993 106.97 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 m -77.15 2.53 15.04 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.269 1.033 . . . . 64.519999999999996 111.462 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -115.31 84.54 11.71 Favored Pre-proline 0 N--CA 1.418 -2.048 0 N-CA-C 106.681 -1.6 . . . . 74.439999999999998 106.681 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -86.87 121.18 1.75 Allowed 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 121.786 1.657 . . . . 72.439999999999998 113.384 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 25.6 p90 -103.88 149.91 24.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.787 -0.82 . . . . 73.049999999999997 108.787 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.8 111.28 23.95 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.674 -0.41 . . . . 74.439999999999998 110.407 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.5 t -84.05 120.41 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.469 -0.937 . . . . 61.119999999999997 108.469 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.3 -35.8 15.05 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.504 -0.479 . . . . 75.25 110.935 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -164.25 149.88 10.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.346 0.593 . . . . 73.409999999999997 111.233 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.524 HG23 ' CB ' ' A' ' 32' ' ' GLU . 47.7 p -132.51 155.18 49.06 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.031 -1.47 . . . . 75.420000000000002 107.031 173.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.19 103.16 2.44 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 119.198 -1.477 . . . . 74.019999999999996 112.345 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.81 -135.11 3.92 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.546 -0.835 . . . . 71.400000000000006 111.424 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -96.45 139.26 32.82 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 105.916 -1.883 . . . . 71.230000000000004 105.916 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.7 173.18 2.95 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 114.127 1.158 . . . . 74.319999999999993 114.127 -171.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 83.15 -51.88 0.16 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.666 1.587 . . . . 73.430000000000007 111.023 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.03 110.8 28.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.771 -1.196 . . . . 74.519999999999996 107.771 175.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 p -94.98 154.52 17.14 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.917 -0.583 . . . . 74.430000000000007 111.257 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.15 158.95 42.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.383 0.611 . . . . 71.409999999999997 111.626 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' CB ' HG23 ' A' ' 23' ' ' THR . 12.9 pt-20 -134.89 132.2 38.23 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.482 -1.303 . . . . 75.25 107.482 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -96.77 114.32 25.94 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.292 -1.744 . . . . 74.230000000000004 106.292 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.28 1.2 ppt_? -142.14 145.2 33.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.287 1.217 . . . . 70.349999999999994 114.287 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -80.52 137.75 36.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.526 -1.287 . . . . 72.299999999999997 107.526 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.3 t -57.27 147.75 24.58 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.782 0.676 . . . . 73.400000000000006 111.186 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -63.89 -28.13 69.63 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 124.115 0.966 . . . . 61.530000000000001 112.59 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 77.31 9.75 86.64 Favored Glycine 0 C--N 1.317 -0.512 0 C-N-CA 120.432 -0.889 . . . . 61.229999999999997 113.556 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.68 160.57 54.09 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.682 -0.771 . . . . 74.510000000000005 112.212 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HB3' ' NZ ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -88.79 122.11 31.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.597 -0.52 . . . . 63.310000000000002 109.597 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.562 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 26.5 m-85 -126.9 166.17 17.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.467 -0.788 . . . . 72.030000000000001 111.699 -171.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.62 115.82 28.63 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.846 -0.798 . . . . 71.239999999999995 108.846 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -125.81 143.54 51.02 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-N 115.314 -0.857 . . . . 70.310000000000002 112.112 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.452 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 12.8 p -132.83 144.56 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 108.352 -0.981 . . . . 75.129999999999995 108.352 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.78 127.69 50.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.675 0.75 . . . . 74.430000000000007 111.032 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t -120.64 133.15 68.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.102 -1.444 . . . . 52.5 107.102 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.418 HG21 ' HG3' ' A' ' 97' ' ' LYS . 35.7 p -130.76 176.6 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.51 0.559 . . . . 73.549999999999997 112.51 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 69.34 4.07 4.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.903 1.281 . . . . 53.439999999999998 112.316 174.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -141.0 141.16 22.97 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 108.058 -1.09 . . . . 75.030000000000001 108.058 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.27 156.86 7.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.341 2.694 . . . . 73.129999999999995 112.364 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG13 HD11 ' A' ' 98' ' ' LEU . 71.4 t -47.67 -41.36 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.575 0.954 . . . . 45.140000000000001 113.575 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 9.9 m-20 -58.75 -50.09 75.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.413 0.625 . . . . 60.240000000000002 109.911 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.33 -40.7 81.51 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.996 -1.002 . . . . 73.109999999999999 110.871 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -61.13 -46.57 90.04 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.542 -0.753 . . . . 73.120000000000005 110.104 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.68 -31.7 70.95 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.899 -0.591 . . . . 70.25 110.906 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 36.7 mtm180 -61.25 -30.24 70.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.554 0.576 . . . . 73.319999999999993 112.554 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 37.1 mt-10 -85.61 -46.3 10.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.416 -0.513 . . . . 71.340000000000003 111.512 173.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -67.75 -36.27 80.22 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.971 1.1 . . . . 73.299999999999997 113.971 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.474 ' HB3' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.81 -52.72 72.33 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 119.483 -0.294 . . . . 54.310000000000002 110.463 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 71.9 Cg_exo -51.75 -37.15 64.46 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.702 2.268 . . . . 73.430000000000007 112.319 173.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 88.9 mttt -67.41 -42.49 83.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.28 0.474 . . . . 75.409999999999997 112.28 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.95 -41.04 77.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.612 -0.435 . . . . 44.020000000000003 111.834 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.9 ptm -69.91 -29.63 66.85 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.795 0.665 . . . . 61.200000000000003 112.795 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -70.37 -40.83 73.79 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.928 -0.767 . . . . 74.530000000000001 108.928 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.22 -56.87 16.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.839 -0.619 . . . . 73.540000000000006 111.529 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.413 HG12 ' CE2' ' A' ' 102' ' ' PHE . 11.8 m -78.35 -20.97 13.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 120.983 0.42 . . . . 74.299999999999997 111.284 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.05 70.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.674 -0.693 . . . . 74.549999999999997 112.89 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.69 -17.41 0.49 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.768 -1.205 . . . . 64.5 113.53 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -81.83 32.52 0.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 122.304 1.05 . . . . 74.120000000000005 110.752 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.68 168.94 9.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.782 -0.645 . . . . 62.109999999999999 109.836 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 114' ' ' ALA . 11.0 t70 -66.06 -33.99 77.05 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.04 0.756 . . . . 71.140000000000001 113.04 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -82.22 -11.22 58.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 73.430000000000007 109.728 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.91 34.87 77.97 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.329 -0.85 . . . . 51.25 112.128 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.44 121.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.969 -0.692 . . . . 65.400000000000006 110.263 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.11 116.0 5.47 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.561 -0.828 . . . . 74.349999999999994 112.285 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.6 mmt 61.8 28.39 17.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.049999999999997 109.565 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.98 -34.54 90.19 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.589 -1.187 . . . . 73.540000000000006 113.471 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -124.72 126.1 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 112.843 0.683 . . . . 72.239999999999995 112.843 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.0 m -125.21 117.09 23.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.993 -0.743 . . . . 73.140000000000001 108.993 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -170.22 143.32 1.95 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.296 -1.372 . . . . 75.450000000000003 107.296 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -41.4 139.84 1.73 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.994 3.129 . . . . 63.009999999999998 116.729 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 p -105.74 154.23 7.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.68 -1.6 . . . . 71.319999999999993 107.145 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 48.5 m -139.7 145.18 38.05 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.436 -0.579 . . . . 75.140000000000001 109.436 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 37.0 p90 -135.09 147.16 49.47 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.944 -0.472 . . . . 75.450000000000003 111.151 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.26 134.71 34.63 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.684 0.615 . . . . 74.010000000000005 109.533 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.7 152.9 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.825 -0.806 . . . . 71.0 108.825 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.559 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 40.6 m-85 -122.5 104.04 37.5 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.878 -0.786 . . . . 74.109999999999999 108.878 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.5 133.69 10.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.823 1.682 . . . . 55.109999999999999 113.002 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.46 166.05 15.81 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.329 -0.989 . . . . 61.439999999999998 108.329 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.76 -15.39 61.53 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 73.109999999999999 111.149 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -91.18 1.13 57.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 63.439999999999998 111.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.85 0.62 90.32 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.948 -0.644 . . . . 75.310000000000002 112.503 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 t -92.07 141.16 28.91 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.509 -1.293 . . . . 64.319999999999993 107.509 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.29 156.71 27.94 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 120.96 0.409 . . . . 75.239999999999995 110.639 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -79.22 158.25 27.66 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.272 -0.64 . . . . 61.219999999999999 109.272 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -75.82 40.03 0.18 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.85 0.86 . . . . 63.299999999999997 112.212 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.559 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 38.4 ttmt -141.68 125.83 17.4 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.325 -0.991 . . . . 60.420000000000002 108.325 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD11 HG13 ' A' ' 51' ' ' VAL . 60.3 tp -135.47 129.14 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 110.208 -0.293 . . . . 74.140000000000001 110.208 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.37 115.51 21.09 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.219 -0.66 . . . . 44.219999999999999 109.219 174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 43' ' ' THR . 59.0 t -96.61 134.9 32.55 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-N 115.229 -0.896 . . . . 74.140000000000001 109.871 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -120.84 120.02 34.35 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.941 0.896 . . . . 72.349999999999994 109.751 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 73.5 t80 -104.08 123.85 47.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.902 -0.407 . . . . 74.409999999999997 109.902 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.562 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 42.3 ttm-85 -75.35 134.2 41.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.343 -0.844 . . . . 70.549999999999997 110.187 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 108' ' ' PHE . 65.7 mt -104.79 133.09 20.34 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 116.532 -0.304 . . . . 72.239999999999995 111.21 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -60.81 161.2 22.41 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.549 2.833 . . . . 74.439999999999998 112.6 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -57.98 -37.11 73.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.147 1.166 . . . . 72.409999999999997 114.147 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.83 -30.45 71.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.327 0.584 . . . . 75.219999999999999 111.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.416 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 96.4 m-85 -99.65 -4.95 29.79 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.948 -0.569 . . . . 74.0 110.972 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.6 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.4 -37.87 71.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 119.586 -0.846 . . . . 74.530000000000001 109.735 174.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.1 94.26 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.183 -0.917 . . . . 75.019999999999996 111.918 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -154.11 93.33 2.95 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.182 -0.673 . . . . 63.340000000000003 109.182 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.3 146.41 24.93 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.307 2.004 . . . . 74.209999999999994 112.565 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.62 130.17 34.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.401 2.067 . . . . 74.209999999999994 109.801 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 71' ' ' ASP . . . -68.86 148.98 98.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.81 -0.632 . . . . 64.010000000000005 111.48 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 39.6 Cg_exo -60.59 113.14 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.709 2.273 . . . . 73.329999999999998 111.938 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -97.07 5.74 49.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.368 -0.975 . . . . 71.230000000000004 108.368 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.26 148.76 49.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.132 -1.803 . . . . 72.25 106.132 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -81.1 -25.06 37.28 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.717 0.636 . . . . 75.420000000000002 112.717 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.2 p -91.7 -16.42 26.98 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.78 0.659 . . . . 38.159999999999997 112.78 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 50.2 t -94.71 116.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.875 -1.157 . . . . 74.340000000000003 107.875 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -119.7 144.08 47.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 110.274 -0.269 . . . . 72.120000000000005 110.274 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.5 mm -92.85 111.98 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.964 -1.124 . . . . 74.109999999999999 107.964 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -125.57 143.35 51.05 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.909 -1.041 . . . . 73.230000000000004 109.346 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.05 143.11 40.56 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.038 -0.727 . . . . 62.020000000000003 109.038 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.506 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -135.99 127.31 28.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.235 -0.654 . . . . 73.409999999999997 109.235 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.19 171.02 14.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.668 -0.493 . . . . 75.019999999999996 109.668 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.23 7.05 62.52 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 121.009 -0.615 . . . . 42.130000000000003 112.176 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.96 145.27 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 120.095 -0.642 . . . . 73.25 110.878 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.545 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 59.5 m -109.22 135.69 49.92 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.145 -1.428 . . . . 75.109999999999999 107.145 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.42 157.31 32.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 108.849 -0.797 . . . . 71.310000000000002 108.849 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 40.2 m-85 -113.3 121.77 45.42 Favored 'General case' 0 N--CA 1.411 -2.381 0 N-CA-C 105.166 -2.161 . . . . 75.299999999999997 105.166 178.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 t -109.96 125.89 53.34 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.623 -0.51 . . . . 70.299999999999997 109.623 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.7 t -113.47 126.64 55.55 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.185 -1.043 . . . . 74.030000000000001 108.185 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -115.61 124.94 52.21 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.028 -1.101 . . . . 72.349999999999994 108.028 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.17 137.02 48.8 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 116.392 -0.367 . . . . 75.120000000000005 110.439 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.49 161.81 24.23 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 115.784 -0.643 . . . . 61.399999999999999 111.788 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.59 161.31 12.91 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.655 -1.378 . . . . 65.310000000000002 109.655 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 86.2 m-85 -79.51 108.4 13.02 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.37 0.605 . . . . 73.329999999999998 109.886 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 143' ' ' ASP . . . -112.73 145.87 39.76 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.16 -0.927 . . . . 71.219999999999999 111.844 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.476 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 18.6 ptpt -95.43 176.94 5.99 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.739 -0.838 . . . . 74.099999999999994 108.739 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.32 -37.96 82.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.49 -0.559 . . . . 71.219999999999999 109.49 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.63 70.7 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.437 -0.801 . . . . 72.219999999999999 111.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 23.4 m-20 -64.4 -31.21 72.32 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 62.32 111.283 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -64.61 -46.68 81.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.68 0.276 . . . . 73.310000000000002 110.902 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.59 -46.08 95.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.457 0.646 . . . . 75.310000000000002 109.978 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.84 99.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 43.329999999999998 111.482 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -71.12 -32.52 69.11 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 112.281 0.475 . . . . 73.129999999999995 112.281 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.3 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.216 -0.661 . . . . 73.430000000000007 109.216 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.4 m -65.07 -40.97 95.44 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.355 -0.839 . . . . 71.420000000000002 110.835 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -73.73 -30.3 62.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.937 0.399 . . . . 75.420000000000002 110.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.11 -31.7 72.91 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 109.618 -0.512 . . . . 71.040000000000006 109.618 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HD2' ' OD2' ' A' ' 165' ' ' ASP . 79.9 mtp180 -63.81 -39.09 93.4 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.024 -0.534 . . . . 50.140000000000001 109.931 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 56.6 m -71.6 -30.98 66.43 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.654 0.74 . . . . 71.409999999999997 109.703 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 38.4 m -72.1 -34.87 68.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.581 -0.736 . . . . 74.450000000000003 109.091 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.08 6.66 41.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.364 -0.835 . . . . 74.340000000000003 111.137 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.13 128.14 33.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.334 -1.728 . . . . 74.140000000000001 106.334 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.32 13.47 41.83 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.268 -0.967 . . . . 64.439999999999998 111.811 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 70.9 p -117.2 163.12 24.58 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.893 -0.78 . . . . 44.0 108.893 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -86.33 12.83 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.643 2.229 . . . . 74.129999999999995 111.802 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.96 148.31 47.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.921 -0.582 . . . . 62.439999999999998 111.25 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 43.4 p -122.04 141.44 51.37 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.76 -0.83 . . . . 75.430000000000007 108.76 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -135.52 144.94 46.58 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.113 -0.367 . . . . 75.409999999999997 111.278 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.7 pt20 -106.32 110.97 23.36 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.184 0.809 . . . . 74.299999999999997 113.184 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.73 8.48 57.08 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.77 -0.729 . . . . 52.420000000000002 113.339 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.442 ' OD2' ' HD2' ' A' ' 152' ' ' ARG . 3.8 m-20 62.5 24.17 14.38 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.695 0.798 . . . . 74.25 111.263 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.57 140.24 18.09 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 119.52 -0.872 . . . . 75.129999999999995 109.283 -174.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 32.8 p90 -140.65 168.68 19.22 Favored 'General case' 0 N--CA 1.415 -2.209 0 C-N-CA 120.196 -0.602 . . . . 70.319999999999993 112.009 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 35.7 m-85 -115.32 147.26 40.66 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.423 -0.808 . . . . 73.239999999999995 109.87 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 83' ' ' SER . 41.4 t -114.44 137.38 51.91 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.75 32.79 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.921 0.391 . . . . 73.519999999999996 111.067 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.2 164.64 36.74 Favored Glycine 0 C--O 1.201 -1.926 0 N-CA-C 108.924 -1.67 . . . . 63.049999999999997 108.924 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -132.22 -18.51 2.58 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.59 1.195 . . . . 74.319999999999993 112.16 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 2.8 p30 -156.19 139.83 11.27 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 106.837 -1.542 . . . . 72.109999999999999 106.837 172.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -91.91 102.97 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.366 2.044 . . . . 71.25 112.591 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 6.1 Cg_exo -83.63 149.22 12.75 Favored 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.828 2.352 . . . . 75.400000000000006 111.978 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.5 ttt -82.65 -31.31 28.8 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.219 -0.9 . . . . 74.329999999999998 110.249 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -107.5 -65.59 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 115.477 1.658 . . . . 74.409999999999997 115.477 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.66 -20.93 22.53 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 121.545 1.496 . . . . 64.400000000000006 114.853 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 60.54 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.856 0.862 . . . . 75.120000000000005 113.213 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 138' ' ' TYR . . . -130.66 124.28 4.17 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 119.859 -1.162 . . . . 40.439999999999998 112.722 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.497 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -96.39 -21.58 17.69 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.051 0.929 . . . . 75.040000000000006 109.815 174.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -134.57 130.57 36.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.957 -2.238 . . . . 72.25 104.957 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -133.22 137.09 45.99 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 108.757 -0.831 . . . . 73.230000000000004 108.757 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 133' ' ' THR . 45.7 mt-10 -132.31 136.03 46.61 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.899 0.381 . . . . 45.219999999999999 111.5 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.436 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 74.4 t -124.98 124.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.806 -1.183 . . . . 71.120000000000005 107.806 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.512 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 35.1 m0 -109.42 121.3 44.89 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 120.872 -0.331 . . . . 74.519999999999996 110.244 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 67.3 mt -96.24 126.31 41.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.138 -1.06 . . . . 75.540000000000006 108.138 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.08 127.25 42.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.592 -0.521 . . . . 64.349999999999994 109.592 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -64.77 143.01 58.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.65 0.611 . . . . 75.510000000000005 112.65 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.7 0 CA-C-N 115.261 -0.881 . . . . 74.349999999999994 108.761 176.568 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 . . . . . 0 C--O 1.236 0.343 0 N-CA-C 106.515 -1.661 . . . . 73.420000000000002 106.515 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.8 m 75.1 -5.19 2.22 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.558 1.318 . . . . 61.439999999999998 114.558 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.2 mt -75.49 144.31 42.1 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 119.752 -0.779 . . . . 75.239999999999995 109.728 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 69.38 21.54 6.89 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.851 0.86 . . . . 71.200000000000003 109.818 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.25 137.15 47.79 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.42 -0.809 . . . . 63.310000000000002 111.389 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.3 m -119.44 171.68 8.16 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 110.039 -0.356 . . . . 73.109999999999999 110.039 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.75 106.05 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 109.003 -0.739 . . . . 72.510000000000005 109.003 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.8 144.96 56.52 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.455 -0.793 . . . . 63.32 111.175 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -80.01 129.85 34.81 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 104.362 -2.458 . . . . 75.030000000000001 104.362 168.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 37' ' ' GLU . 4.3 t-105 -68.17 113.42 15.02 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 123.541 0.526 . . . . 73.120000000000005 109.688 -170.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -94.93 140.21 1.11 Allowed 'Trans proline' 0 N--CA 1.432 -2.13 0 C-N-CA 122.577 2.184 . . . . 75.409999999999997 113.885 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -111.54 155.15 23.73 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.488 -1.301 . . . . 73.400000000000006 107.488 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 109.5 21.5 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.355 0.598 . . . . 74.099999999999994 109.497 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.7 t -93.71 119.63 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.077 -0.965 . . . . 75.129999999999995 109.122 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.456 ' H ' HD21 ' A' ' 21' ' ' LEU 0.257 0.4 OUTLIER -90.63 -38.17 13.3 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 113.05 0.759 . . . . 73.329999999999998 113.05 -178.887 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -158.98 149.44 19.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.247 -0.581 . . . . 72.340000000000003 111.258 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.3 p -134.0 161.38 34.98 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.28 1.032 . . . . 75.329999999999998 110.265 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.8 113.28 1.46 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.844 -0.693 . . . . 73.5 114.515 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.68 -95.19 0.32 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.84 -0.504 . . . . 61.240000000000002 111.84 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -97.99 164.4 12.37 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.277 -1.379 . . . . 75.099999999999994 107.277 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.62 153.71 27.83 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 118.752 -1.179 . . . . 74.120000000000005 111.483 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 72.21 -49.79 0.69 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.976 1.31 . . . . 70.430000000000007 111.556 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 110.61 32.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.996 0.903 . . . . 74.0 109.108 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 p -113.1 154.25 26.91 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.373 -0.83 . . . . 73.209999999999994 110.32 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' CD2' HG22 ' A' ' 154' ' ' THR . 0.2 OUTLIER -113.43 158.45 20.64 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 120.058 -0.657 . . . . 75.329999999999998 111.446 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 34.0 tt0 -143.37 124.99 14.88 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 106.187 -1.783 . . . . 70.430000000000007 106.187 175.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . 43.3 mt-10 -97.79 115.06 27.29 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.496 -1.668 . . . . 74.420000000000002 106.496 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -135.83 147.22 48.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.908 -0.717 . . . . 65.430000000000007 112.415 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.66 127.24 34.93 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.16 -2.163 . . . . 63.43 105.16 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.7 t -58.87 143.22 48.31 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.751 0.657 . . . . 63.350000000000001 111.339 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 1.1 mp0 -37.32 -52.67 1.09 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.801 1.64 . . . . 71.319999999999993 112.982 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.19 9.03 54.53 Favored Glycine 0 C--N 1.286 -2.213 0 C-N-CA 119.77 -1.205 . . . . 73.230000000000004 110.94 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.8 163.09 54.42 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.396 -1.082 . . . . 61.009999999999998 110.396 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 104' ' ' ILE . 18.3 ptmt -100.91 128.82 46.78 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.358 -0.608 . . . . 73.430000000000007 109.358 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 53.2 m-85 -129.81 164.53 23.88 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.692 -0.686 . . . . 72.299999999999997 110.906 -171.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 116.36 30.84 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.223 -1.028 . . . . 72.409999999999997 108.223 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.0 t -128.81 146.63 50.87 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.35 0.595 . . . . 73.420000000000002 111.801 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' A' ' 58' ' ' ALA . 9.0 p -128.41 139.11 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.385 -0.969 . . . . 63.049999999999997 108.385 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -121.52 138.83 54.13 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.192 -1.003 . . . . 75.430000000000007 111.371 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.83 133.9 67.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.389 -1.708 . . . . 75.109999999999999 106.389 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.6 p -125.7 169.61 12.37 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.619 -0.433 . . . . 71.540000000000006 110.042 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 71.47 -2.11 2.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.032 0.933 . . . . 62.229999999999997 112.737 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.99 147.66 52.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 109.306 -0.627 . . . . 73.239999999999995 109.306 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.13 156.35 63.35 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 122.167 1.911 . . . . 71.140000000000001 111.015 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.483 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 54.7 t -49.82 -37.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.931 0.893 . . . . 71.230000000000004 113.23 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.25 -49.89 63.15 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.264 0.353 . . . . 65.549999999999997 110.991 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 41.6 mt-10 -76.04 -50.54 14.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.037 -0.529 . . . . 74.140000000000001 111.266 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.1 68.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.935 0.717 . . . . 73.329999999999998 112.935 -174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 tt -62.66 -50.2 72.13 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.842 -0.799 . . . . 64.209999999999994 108.842 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.321 6.6 ppt_? -72.43 -23.86 61.14 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 114.018 1.118 . . . . 65.040000000000006 114.018 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 12.4 mm-40 -66.58 -44.06 83.23 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 71.319999999999993 111.186 172.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . . . -75.75 -40.38 55.51 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.857 1.058 . . . . 72.409999999999997 113.857 -174.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . 0.253 24.7 mmt -47.07 -52.88 31.16 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 115.929 1.825 . . . . 62.439999999999998 115.929 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.44 -31.65 78.78 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.296 1.997 . . . . 71.310000000000002 112.176 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HD2' HG21 ' A' ' 44' ' ' VAL . 82.5 mttt -74.31 -34.99 63.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.772 -0.649 . . . . 75.439999999999998 109.892 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.7 mm -72.85 -39.71 59.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.287 0.565 . . . . 71.120000000000005 109.625 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.34 -37.89 89.03 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.633 -0.712 . . . . 75.230000000000004 112.853 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -67.57 -31.66 71.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.08 -0.648 . . . . 74.239999999999995 110.728 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.75 -58.2 7.61 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.385 -0.37 . . . . 74.409999999999997 111.335 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.58 -23.08 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 121.224 0.535 . . . . 75.329999999999998 111.285 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.56 72.91 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.903 -0.589 . . . . 74.340000000000003 113.196 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.44 -5.08 5.56 Favored Glycine 0 CA--C 1.505 -0.565 0 C-N-CA 119.821 -1.181 . . . . 62.530000000000001 113.263 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 116' ' ' SER . 15.2 m -86.33 32.92 0.62 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 122.631 1.205 . . . . 42.409999999999997 110.053 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -97.82 177.17 5.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.229 -0.896 . . . . 73.519999999999996 109.437 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 114' ' ' ALA . 12.6 t70 -63.97 -33.03 74.8 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.258 0.623 . . . . 63.130000000000003 111.823 -175.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 72' ' ' LYS . 6.9 mmpt? -86.8 -11.26 51.48 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.631 -0.428 . . . . 70.239999999999995 110.777 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.22 22.5 74.51 Favored Glycine 0 CA--C 1.498 -0.99 0 CA-C-N 115.6 -0.727 . . . . 44.240000000000002 112.066 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.99 122.09 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-O 121.153 0.501 . . . . 72.510000000000005 110.907 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.16 54.36 0.82 Allowed Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.957 -0.857 . . . . 73.340000000000003 110.957 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 51.6 ttm -83.8 110.09 18.06 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.089 0.471 . . . . 62.299999999999997 110.015 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.34 82.34 0.67 Allowed Glycine 0 C--N 1.303 -1.3 0 CA-C-N 115.121 -0.945 . . . . 74.219999999999999 111.512 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -96.79 134.92 39.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.216 -0.661 . . . . 74.140000000000001 109.216 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -124.12 129.86 51.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.258 0.551 . . . . 71.219999999999999 112.052 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.428 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 10.5 p -158.63 148.82 15.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 104.107 -2.553 . . . . 74.439999999999998 104.107 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 80' ' ' VAL . 47.0 Cg_exo -34.98 138.81 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.7 2.934 . . . . 71.140000000000001 115.036 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.54 151.29 6.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.52 -1.289 . . . . 61.240000000000002 107.52 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 34.5 m -141.96 145.08 34.09 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 120.706 -0.398 . . . . 62.439999999999998 110.409 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -140.44 141.47 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.787 -0.571 . . . . 75.040000000000006 110.811 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.05 134.95 35.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.855 -0.611 . . . . 72.239999999999995 110.063 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.6 m -126.93 150.67 33.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.327 -0.852 . . . . 73.319999999999993 109.668 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.611 ' CE2' ' HB ' ' A' ' 166' ' ' VAL . 91.5 m-85 -116.01 107.15 48.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 116.375 -0.375 . . . . 71.129999999999995 110.598 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.25 132.04 7.99 Favored 'Trans proline' 0 N--CA 1.428 -2.38 0 N-CA-C 108.139 -1.524 . . . . 65.040000000000006 108.139 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -93.49 167.71 11.52 Favored 'General case' 0 C--N 1.272 -2.773 0 C-N-CA 119.861 -0.736 . . . . 75.340000000000003 110.961 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.77 -17.55 56.43 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.883 0.739 . . . . 63.329999999999998 110.78 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.54 -6.8 57.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.249 1.02 . . . . 74.340000000000003 110.072 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.89 -10.14 71.57 Favored Glycine 0 C--O 1.229 -0.158 0 CA-C-N 116.048 -0.524 . . . . 73.5 112.389 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.4 m -96.06 134.35 39.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.769 0.318 . . . . 74.439999999999998 111.455 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 8.2 mp -78.77 100.09 6.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.453 0.644 . . . . 63.420000000000002 110.187 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -148.09 169.86 19.04 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.874 -1.057 . . . . 71.019999999999996 108.981 -176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.264 64.8 mttp 94.93 -73.87 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.097 1.759 . . . . 63.439999999999998 112.456 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 2.4 mppt? -131.04 146.57 52.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 119.005 -1.078 . . . . 73.400000000000006 112.215 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tt -143.28 129.44 19.75 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.512 -1.222 . . . . 72.510000000000005 108.049 173.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -119.89 115.47 23.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.456 -0.572 . . . . 74.319999999999993 109.456 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 43' ' ' THR . 91.1 t -92.43 125.8 45.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.796 -0.816 . . . . 75.140000000000001 108.796 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -109.18 123.82 49.84 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.618 0.574 . . . . 70.420000000000002 109.641 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -102.76 113.49 26.95 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.458 -1.682 . . . . 74.219999999999999 106.458 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.505 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 24.4 ttt85 -76.67 132.58 39.45 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.191 -0.913 . . . . 74.340000000000003 110.606 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.55 HD12 ' O ' ' A' ' 40' ' ' LYS . 74.4 mt -96.67 131.95 27.15 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.092 -1.448 . . . . 54.420000000000002 107.092 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.72 146.5 54.61 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.533 2.156 . . . . 74.129999999999995 111.816 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -47.57 -39.74 17.37 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.693 1.597 . . . . 74.510000000000005 111.867 -175.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -61.2 -32.9 72.67 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.001 0.52 . . . . 71.310000000000002 112.4 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.79 -2.65 34.55 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 112.205 0.446 . . . . 75.319999999999993 112.205 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.73 -28.24 67.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.574 0.953 . . . . 75.319999999999993 113.574 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.47 59.65 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.899 -1.143 . . . . 71.209999999999994 111.578 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -142.98 87.08 8.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-O 120.95 0.405 . . . . 73.299999999999997 110.295 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -97.47 162.42 0.93 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.302 2.668 . . . . 74.230000000000004 112.128 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.39 137.36 46.77 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 122.354 2.036 . . . . 70.340000000000003 111.626 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HB2' ' CB ' ' A' ' 71' ' ' ASP . . . -74.26 152.33 88.07 Favored Pre-proline 0 C--O 1.248 0.995 0 CA-C-N 116.439 -0.346 . . . . 75.140000000000001 110.787 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -81.4 121.72 3.91 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 122.103 1.869 . . . . 52.240000000000002 111.932 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 69' ' ' THR . 23.5 t -92.41 22.83 4.29 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.91 0.862 . . . . 72.099999999999994 109.66 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -137.17 151.27 48.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.779 -1.193 . . . . 74.310000000000002 107.779 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -88.26 -17.12 31.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.162 1.171 . . . . 63.130000000000003 114.162 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.6 m -80.92 -39.7 25.77 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.397 -0.594 . . . . 74.040000000000006 109.397 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.47 123.96 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.588 -0.733 . . . . 73.140000000000001 109.809 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.77 148.91 47.85 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.917 -0.583 . . . . 72.109999999999999 110.418 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.1 mm -92.39 111.48 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.802 -1.555 . . . . 70.129999999999995 106.802 174.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -115.79 145.8 42.5 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.68 -0.691 . . . . 74.430000000000007 111.05 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 9.6 pt-20 -121.13 124.74 45.49 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.121 -1.066 . . . . 61.130000000000003 108.121 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.45 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.8 mmt180 -136.15 122.64 20.78 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.075 -0.65 . . . . 74.5 111.483 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -143.05 164.73 29.31 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.563 -0.902 . . . . 73.049999999999997 108.563 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.02 14.63 54.45 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.65 -0.98 . . . . 61.439999999999998 110.65 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.1 pt -120.65 145.17 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 109.267 -0.642 . . . . 74.530000000000001 109.267 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.2 m -108.12 128.79 55.0 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.313 -0.995 . . . . 64.409999999999997 108.313 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.19 155.28 31.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.475 -0.935 . . . . 71.219999999999999 108.475 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 64.1 m-85 -113.89 122.13 46.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.987 -1.486 . . . . 75.5 106.987 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 m -102.49 127.94 49.32 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.734 -0.469 . . . . 64.030000000000001 109.734 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.7 t -120.03 121.9 39.92 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 108.582 -0.895 . . . . 61.109999999999999 108.582 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -109.67 126.78 54.03 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.194 -1.41 . . . . 75.329999999999998 107.194 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.9 p90 -129.61 152.63 48.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.672 -0.411 . . . . 74.150000000000006 112.019 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.79 106.98 2.6 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.23 -1.148 . . . . 72.109999999999999 110.23 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.68 173.75 36.75 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 111.131 -0.788 . . . . 64.230000000000004 111.131 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.2 128.48 33.81 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.146 -0.687 . . . . 64.340000000000003 109.146 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.64 125.75 54.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.385 0.883 . . . . 73.510000000000005 113.385 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -115.78 173.13 6.71 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.86 -1.533 . . . . 62.409999999999997 106.86 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.02 -43.92 70.5 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.478 0.581 . . . . 71.019999999999996 110.679 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.39 69.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.721 . . . . 72.510000000000005 111.42 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.0 -37.15 83.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.391 -0.596 . . . . 71.230000000000004 109.391 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -64.94 -38.92 92.56 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.706 -0.679 . . . . 63.240000000000002 111.023 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.66 -47.36 93.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.771 -0.825 . . . . 73.200000000000003 108.771 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.61 86.16 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.244 -0.889 . . . . 74.140000000000001 111.094 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -68.2 -35.07 77.43 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 113.141 0.793 . . . . 75.030000000000001 113.141 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.85 88.94 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.434 0.459 . . . . 42.039999999999999 110.835 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.2 t -73.14 -33.77 65.71 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 120.309 -0.556 . . . . 71.209999999999994 110.495 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.26 -32.17 73.66 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 120.807 0.337 . . . . 61.109999999999999 110.937 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 31' ' ' TYR . 33.7 tp -74.55 -31.53 62.13 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.119 -0.632 . . . . 71.109999999999999 109.778 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.63 -37.25 79.57 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 112.616 0.599 . . . . 74.439999999999998 112.616 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.2 t -70.23 -30.04 67.02 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 73.019999999999996 109.649 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 31' ' ' TYR . 63.8 m -71.95 -38.44 69.8 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 115.268 -0.878 . . . . 74.129999999999995 109.433 176.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.1 -2.17 51.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.874 -0.603 . . . . 44.009999999999998 111.358 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.44 130.4 41.22 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.339 -1.356 . . . . 71.409999999999997 107.339 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.58 -2.09 57.22 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.834 -0.621 . . . . 64.519999999999996 112.122 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.4 p -107.25 164.55 14.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 107.636 -1.246 . . . . 74.409999999999997 107.636 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.88 26.11 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.823 1.682 . . . . 52.210000000000001 112.301 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 138.03 58.15 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.347 0.594 . . . . 64.530000000000001 112.464 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.0 p -120.99 151.04 40.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.534 -1.284 . . . . 73.120000000000005 107.534 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.433 ' C ' ' HB3' ' A' ' 190' ' ' ALA . 32.8 m-85 -136.36 151.86 50.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.9 0.773 . . . . 75.340000000000003 109.354 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.435 ' O ' HG13 ' A' ' 166' ' ' VAL . 4.3 pp0? -124.68 122.97 39.01 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.182 0.438 . . . . 64.430000000000007 112.182 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.38 2.78 43.94 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.659 -0.701 . . . . 50.219999999999999 113.491 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.8 14.97 5.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.704 0.802 . . . . 73.109999999999999 112.256 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.611 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.9 p -59.37 138.46 20.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 CA-C-O 121.729 0.776 . . . . 73.239999999999995 111.543 -177.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.435 ' OH ' HD22 ' A' ' 94' ' ' LEU . 55.5 p90 -139.84 163.27 33.08 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.854 -1.066 . . . . 75.299999999999997 108.721 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.94 153.18 31.04 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.098 0.475 . . . . 63.140000000000001 110.384 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 83' ' ' SER . 31.3 t -113.21 118.72 35.47 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.396 -1.705 . . . . 55.020000000000003 106.396 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -122.09 133.5 54.77 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.084 -0.71 . . . . 60.119999999999997 109.084 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.11 165.53 38.84 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.406 -1.077 . . . . 74.120000000000005 110.406 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -77.55 -35.67 52.94 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.524 -0.917 . . . . 74.530000000000001 108.524 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -156.22 133.19 6.37 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.723 -1.126 . . . . 64.310000000000002 108.843 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.67 105.79 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.0 1.8 . . . . 74.109999999999999 107.814 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.469 ' HB3' ' HA3' ' A' ' 180' ' ' GLY . 93.2 Cg_endo -85.54 128.75 3.51 Favored 'Trans proline' 0 N--CA 1.429 -2.277 0 N-CA-C 116.385 1.648 . . . . 74.109999999999999 116.385 -166.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 ttt -97.43 -32.81 11.66 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.594 -1.632 . . . . 75.439999999999998 106.594 169.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -97.22 151.3 37.61 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 114.002 -1.454 . . . . 72.140000000000001 110.048 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.98 -13.58 32.12 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.871 3.047 . . . . 63.509999999999998 116.296 -172.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -76.8 1.84 16.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.298 1.222 . . . . 72.400000000000006 114.298 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 175' ' ' PRO . . . -87.5 67.53 3.26 Favored Glycine 0 C--N 1.314 -0.675 0 N-CA-C 108.482 -1.847 . . . . 38.479999999999997 108.482 171.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -86.69 -29.24 22.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 114.261 1.208 . . . . 73.219999999999999 114.261 -171.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -101.81 127.83 48.44 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 118.367 -1.333 . . . . 71.040000000000006 109.326 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 37.5 m-80 -144.03 156.18 44.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.231 -1.026 . . . . 63.420000000000002 108.231 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -138.94 145.92 40.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.569 0.224 . . . . 53.130000000000003 110.548 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.8 t -125.63 133.7 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.69 -0.855 . . . . 60.25 108.69 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.56 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 37.3 m0 -112.26 128.4 56.25 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.715 -0.476 . . . . 74.340000000000003 109.715 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 167' ' ' TYR . 85.3 mt -99.33 136.76 38.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.589 -1.263 . . . . 74.099999999999994 107.589 170.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.1 t -96.14 122.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.104 -0.638 . . . . 74.450000000000003 111.12 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.678 ' HA ' ' O ' ' A' ' 161' ' ' THR . 54.0 tttp -72.09 123.78 23.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.715 -0.675 . . . . 64.150000000000006 109.928 174.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.433 ' HB3' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 118.277 -0.868 . . . . 72.519999999999996 109.178 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.1 t30 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 109.466 -0.568 . . . . 75.120000000000005 109.466 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.7 p -97.35 123.54 41.21 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.8 0.333 . . . . 71.430000000000007 110.421 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.3 mt -117.85 83.35 1.98 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.734 0.302 . . . . 72.430000000000007 110.527 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -179.2 150.71 0.46 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.403 -0.962 . . . . 74.319999999999993 108.403 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.21 147.75 16.03 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.989 -0.844 . . . . 63.219999999999999 110.989 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.4 m -78.52 95.85 5.28 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.379 -0.6 . . . . 74.510000000000005 109.379 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.77 179.52 3.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.366 -0.834 . . . . 74.040000000000006 108.94 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -145.25 126.08 14.39 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.092 -1.077 . . . . 74.409999999999997 108.092 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 m -119.91 109.65 15.8 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.116 -1.809 . . . . 55.310000000000002 106.116 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.534 ' CZ2' ' HG3' ' A' ' 109' ' ' GLN . 2.7 p90 -132.67 111.95 13.72 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-O 121.335 0.588 . . . . 74.310000000000002 110.125 -172.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -94.53 146.51 1.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.464 2.11 . . . . 75.329999999999998 113.331 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 39.9 p90 -117.84 142.55 47.18 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.36 -0.978 . . . . 74.049999999999997 108.36 173.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -106.39 108.93 20.7 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.084 -0.646 . . . . 74.420000000000002 109.742 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.23 115.96 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 107.087 -1.449 . . . . 74.439999999999998 107.087 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.447 ' H ' HD22 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -90.27 -37.17 14.27 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 120.332 -0.547 . . . . 65.409999999999997 112.152 -175.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.492 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 32.2 t -162.25 156.05 21.13 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.106 -0.637 . . . . 71.430000000000007 110.393 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 p -132.0 162.95 29.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.253 -1.388 . . . . 72.510000000000005 107.253 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.86 -149.55 20.62 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 119.286 -1.435 . . . . 74.439999999999998 112.635 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.92 159.73 32.61 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.098 -0.801 . . . . 65.420000000000002 111.098 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 6.2 ttpm? -75.51 123.1 24.87 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.05 -1.093 . . . . 73.439999999999998 108.05 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.53 133.49 51.35 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 122.534 1.159 . . . . 53.210000000000001 113.814 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t70 148.32 -48.82 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 130.83 3.652 . . . . 73.450000000000003 101.8 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.424 ' HB ' ' CD2' ' A' ' 147' ' ' HIS . 3.8 p -127.8 109.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 112.611 -2.086 . . . . 75.510000000000005 106.718 169.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -117.08 151.12 37.48 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.84 -1.17 . . . . 73.129999999999995 107.84 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.481 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.3 p90 -113.57 158.48 20.73 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.899 -1.12 . . . . 75.409999999999997 112.684 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -134.47 125.21 26.94 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.589 -2.004 . . . . 73.120000000000005 105.589 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.492 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 38.2 mt-10 -98.22 114.59 26.89 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 106.832 -1.544 . . . . 73.430000000000007 106.832 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -134.79 140.91 46.25 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.559 -0.857 . . . . 75.420000000000002 111.449 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.07 133.59 35.5 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 104.415 -2.439 . . . . 72.299999999999997 104.415 169.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 128' ' ' ILE . 84.1 m -58.46 138.28 56.76 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.488 0.922 . . . . 65.450000000000003 113.488 -173.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 10.6 pt-20 -58.22 -31.56 67.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.664 -1.607 . . . . 74.239999999999995 113.169 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.73 10.25 57.95 Favored Glycine 0 CA--C 1.495 -1.208 0 C-N-CA 119.045 -1.55 . . . . 38.670000000000002 112.111 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.24 52.11 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.779 -0.724 . . . . 63.009999999999998 111.931 -176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.466 ' O ' HD13 ' A' ' 104' ' ' ILE . 16.7 ptpt -90.68 118.28 29.99 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.214 -0.661 . . . . 63.240000000000002 109.214 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 33.1 m-85 -119.14 164.33 15.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.022 -0.536 . . . . 72.439999999999998 111.165 -172.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 121' ' ' LYS . . . -99.47 116.22 31.11 Favored 'General case' 0 C--O 1.209 -1.037 0 N-CA-C 109.017 -0.734 . . . . 75.319999999999993 109.017 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.5 t -122.03 147.16 46.44 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.346 0.593 . . . . 63.310000000000002 111.97 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.0 m -131.85 132.32 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 124.669 1.188 . . . . 71.239999999999995 108.581 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.64 128.67 56.44 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.517 0.675 . . . . 75.319999999999993 111.927 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 12.2 t -123.99 139.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.065 -1.458 . . . . 73.329999999999998 107.065 178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.4 p -135.95 165.19 26.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.314 -0.554 . . . . 73.319999999999993 110.377 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.82 11.38 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.558 1.161 . . . . 73.430000000000007 110.654 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -133.99 137.56 28.65 Favored Pre-proline 0 N--CA 1.424 -1.747 0 N-CA-C 109.257 -0.646 . . . . 73.030000000000001 109.257 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.48 156.87 16.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.309 2.672 . . . . 73.230000000000004 111.597 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -47.75 -48.5 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.701 1.0 . . . . 62.509999999999998 113.701 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.37 -33.68 76.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.945 0.402 . . . . 63.409999999999997 110.932 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -75.98 -34.65 59.78 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.861 -0.609 . . . . 74.439999999999998 111.382 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -77.23 -44.47 29.86 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.332 -0.395 . . . . 71.140000000000001 110.889 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.8 tp -63.65 -37.78 88.64 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.115 -0.493 . . . . 71.099999999999994 111.872 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -59.26 -32.3 69.88 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 112.133 0.42 . . . . 72.450000000000003 112.133 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -84.68 -39.9 18.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.465 0.65 . . . . 75.510000000000005 110.923 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -75.85 -31.81 59.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.439 -0.8 . . . . 71.540000000000006 112.622 -177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.422 ' CE ' ' HA ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -55.53 -57.65 19.76 Favored Pre-proline 0 CA--C 1.574 1.885 0 CA-C-O 119.372 -0.347 . . . . 72.540000000000006 111.5 -178.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 19.1 Cg_endo -60.42 -31.31 92.44 Favored 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 122.535 2.157 . . . . 41.43 111.147 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 41.5 ttmt -65.98 -37.03 84.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.776 -1.102 . . . . 73.109999999999999 111.276 -177.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.37 -47.25 30.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.927 0.394 . . . . 74.099999999999994 110.667 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.479 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.1 ptm -63.54 -29.54 70.79 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 113.624 0.972 . . . . 75.109999999999999 113.624 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.4 -38.82 91.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 120.546 -0.462 . . . . 74.230000000000004 110.481 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.31 -58.41 7.79 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.236 -0.438 . . . . 74.109999999999999 110.985 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -69.41 -27.23 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 116.039 -0.528 . . . . 73.230000000000004 111.621 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.34 -18.23 73.14 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.921 -0.581 . . . . 38.670000000000002 113.358 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 134.37 -8.52 4.69 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.174 -1.488 . . . . 63.43 114.308 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 m -84.08 33.38 0.49 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-O 122.924 1.345 . . . . 75.030000000000001 110.014 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.6 163.55 12.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.107 -0.951 . . . . 74.530000000000001 108.694 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB3' ' HB1' ' A' ' 114' ' ' ALA . 29.8 t70 -66.28 -33.56 76.03 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.258 0.836 . . . . 74.530000000000001 113.258 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -80.14 -12.43 59.66 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.166 -0.614 . . . . 63.130000000000003 110.612 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.57 38.05 61.81 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.035 -0.602 . . . . 55.25 111.761 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 94.8 t -79.56 120.78 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.034 -1.099 . . . . 72.400000000000006 108.034 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.59 -23.19 8.48 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 121.244 -0.503 . . . . 38.670000000000002 112.34 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.5 mtp -66.03 -37.85 86.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.201 0.524 . . . . 73.040000000000006 109.746 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.92 -166.34 49.82 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.073 -0.967 . . . . 38.670000000000002 112.196 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -133.05 146.35 51.62 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.181 -0.674 . . . . 73.109999999999999 109.181 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.9 m -113.08 117.61 32.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.01 0.433 . . . . 71.049999999999997 109.97 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.664 HG11 ' O ' ' A' ' 103' ' ' ARG . 8.2 p -165.57 151.22 8.31 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 107.492 -1.299 . . . . 73.030000000000001 107.492 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.95 140.66 61.39 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.175 1.25 . . . . 73.319999999999993 111.214 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 9.9 p -93.45 150.03 4.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.607 -0.886 . . . . 64.409999999999997 108.607 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 p -128.77 145.84 51.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.482 0.182 . . . . 64.150000000000006 110.942 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -139.78 143.6 36.98 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.475 -0.49 . . . . 74.239999999999995 110.5 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -92.59 134.92 34.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.891 -0.595 . . . . 65.140000000000001 110.407 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.69 151.62 28.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.156 -0.929 . . . . 74.329999999999998 108.57 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.22 107.83 38.93 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 120.942 -0.303 . . . . 75.420000000000002 110.404 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.22 133.09 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.581 1.521 . . . . 74.430000000000007 111.867 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 95' ' ' GLN . 38.5 m-80 -99.84 171.07 8.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.384 -0.825 . . . . 65.239999999999995 108.927 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.41 -27.75 62.65 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.981 1.104 . . . . 74.430000000000007 113.981 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.83 -7.26 58.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 119.815 -0.754 . . . . 74.340000000000003 110.878 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.04 3.6 57.89 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 120.33 -0.938 . . . . 53.43 113.38 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m -91.14 138.59 31.48 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 122.611 -0.346 . . . . 71.409999999999997 110.259 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.29 107.73 17.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.608 -1.256 . . . . 75.340000000000003 107.608 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 15.5 mm-40 -141.37 170.06 16.44 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.495 -0.558 . . . . 65.5 109.495 -173.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 35.4 mmtp 87.76 -70.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.367 1.467 . . . . 73.430000000000007 113.875 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -136.54 154.43 50.71 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.49 -0.884 . . . . 73.129999999999995 111.822 -177.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.41 HD21 ' C ' ' A' ' 98' ' ' LEU . 6.4 tt -143.95 134.54 24.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.663 -1.153 . . . . 75.519999999999996 109.231 173.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.467 ' HZ2' ' HB2' ' A' ' 99' ' ' LYS . 10.0 mtmp? -131.37 115.94 16.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.649 -0.251 . . . . 60.229999999999997 110.532 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.578 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 66.7 t -93.08 121.62 43.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.697 0.623 . . . . 75.519999999999996 109.783 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -109.65 122.53 47.67 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.832 0.853 . . . . 72.450000000000003 109.473 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.11 113.53 27.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.193 -1.41 . . . . 75.109999999999999 107.193 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.664 ' O ' HG11 ' A' ' 80' ' ' VAL . 70.6 ttt180 -75.08 137.2 41.27 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.523 -1.217 . . . . 72.239999999999995 109.269 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 40' ' ' LYS . 73.0 mt -108.46 124.83 33.33 Favored Pre-proline 0 C--N 1.289 -2.053 0 O-C-N 122.388 -0.195 . . . . 74.310000000000002 111.314 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -55.59 161.37 7.81 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.161 2.574 . . . . 51.420000000000002 113.231 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -47.69 -49.56 27.42 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.87 1.668 . . . . 71.120000000000005 115.028 -171.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.54 -37.49 78.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.517 . . . . 75.239999999999995 112.397 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.416 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 98.1 m-85 -86.91 -10.33 53.57 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.24 -0.584 . . . . 72.420000000000002 112.031 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.645 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.56 -31.88 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.214 -0.994 . . . . 74.109999999999999 110.081 174.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.55 96.27 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 111.605 -0.598 . . . . 72.219999999999999 111.605 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.9 t -157.21 97.84 2.02 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 108.248 -1.019 . . . . 64.019999999999996 108.248 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -85.78 148.26 9.61 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 122.49 2.127 . . . . 74.030000000000001 112.782 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.77 142.31 69.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.275 1.983 . . . . 71.219999999999999 111.109 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 71' ' ' ASP . . . -73.19 144.17 84.28 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.578 -0.449 . . . . 63.119999999999997 110.257 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.02 118.4 4.4 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.364 2.042 . . . . 74.329999999999998 111.76 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.2 m -88.39 21.77 2.76 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.163 0.506 . . . . 65.319999999999993 111.13 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.431 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.4 t70 -135.21 150.3 50.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.486 -1.302 . . . . 72.409999999999997 107.486 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.43 -23.76 37.32 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.555 0.946 . . . . 73.420000000000002 113.555 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -90.02 -25.85 20.61 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.669 -0.413 . . . . 63.229999999999997 111.258 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.5 p -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.597 -0.52 . . . . 70.140000000000001 109.597 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 52.9 mtpt -128.41 152.83 47.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.346 -0.843 . . . . 72.209999999999994 110.234 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 31.0 mm -92.85 112.57 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.049 -0.723 . . . . 75.129999999999995 109.049 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -121.86 142.65 50.04 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.563 -0.744 . . . . 72.049999999999997 109.856 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -115.89 128.56 55.88 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.696 -0.683 . . . . 64.25 110.255 -178.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.39 133.0 43.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.352 0.596 . . . . 75.209999999999994 112.343 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -139.46 172.4 12.87 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.902 -1.518 . . . . 71.209999999999994 106.902 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.49 5.14 79.39 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 119.86 -1.162 . . . . 75.109999999999999 113.32 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.589 HG13 ' SG ' ' A' ' 36' ' ' CYS . 45.4 pt -121.47 145.9 27.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.109 0.454 . . . . 72.400000000000006 110.391 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.1 m -107.68 133.26 52.36 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.503 -0.925 . . . . 73.150000000000006 108.503 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.23 149.47 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 N-CA-C 108.804 -0.813 . . . . 74.120000000000005 108.804 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 36.7 m-85 -113.79 121.82 45.21 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 104.639 -2.356 . . . . 74.219999999999999 104.639 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 55.3 p -119.41 141.29 49.23 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 120.038 -0.665 . . . . 73.140000000000001 111.653 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 10.8 t -121.48 139.38 53.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 115.696 -0.684 . . . . 71.129999999999995 109.391 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -121.11 126.3 49.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.764 -0.828 . . . . 63.439999999999998 108.764 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 38.4 p90 -138.44 168.71 19.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.387 -0.598 . . . . 74.340000000000003 109.387 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.21 169.21 35.35 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.331 -0.938 . . . . 71.120000000000005 111.794 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.8 -116.79 3.86 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.636 -0.586 . . . . 73.019999999999996 111.636 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -98.65 103.0 14.91 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.424 -0.584 . . . . 74.420000000000002 109.424 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 126.83 46.95 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.882 0.848 . . . . 71.310000000000002 112.434 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.95 172.82 6.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.732 -1.122 . . . . 65.040000000000006 108.164 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -40.11 95.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.211 0.529 . . . . 73.209999999999994 112.229 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.56 -27.11 68.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.721 -0.672 . . . . 61.439999999999998 110.494 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.11 -31.93 73.3 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.873 -0.603 . . . . 63.32 110.475 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -63.48 -42.23 98.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.231 -0.44 . . . . 74.219999999999999 109.97 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.83 -45.02 88.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.86 -0.609 . . . . 72.340000000000003 109.717 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.83 -47.17 87.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 61.450000000000003 110.965 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.424 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 27.6 m80 -69.25 -35.25 75.92 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 112.734 0.642 . . . . 62.420000000000002 112.734 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.31 90.43 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.05 0.452 . . . . 74.530000000000001 110.077 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.2 m -64.94 -53.38 47.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.789 -0.642 . . . . 75.329999999999998 109.937 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -38.66 83.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.945 -0.571 . . . . 75.209999999999994 112.222 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.481 HD11 ' HB3' ' A' ' 31' ' ' TYR . 62.9 tp -63.62 -43.16 97.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.776 -0.453 . . . . 73.010000000000005 109.776 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 39.4 ttp180 -61.85 -40.6 95.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.652 -0.704 . . . . 73.439999999999998 109.137 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.421 ' HA ' ' OE2' ' A' ' 156' ' ' GLU . 47.0 m -66.32 -35.47 80.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.462 -0.79 . . . . 75.420000000000002 110.663 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -73.08 -33.99 65.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.465 0.65 . . . . 74.439999999999998 109.873 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.73 -1.83 29.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.549 -0.75 . . . . 74.140000000000001 112.188 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 42.8 mt-10 -75.85 141.63 42.39 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.861 -0.735 . . . . 73.409999999999997 110.512 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.16 -1.18 59.03 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.054 -0.819 . . . . 73.040000000000006 111.054 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 160' ' ' ALA . 27.7 p -114.45 166.84 10.71 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.924 -1.51 . . . . 65.310000000000002 106.924 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.13 20.29 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.648 2.232 . . . . 74.109999999999999 112.987 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 158' ' ' THR . . . -69.68 118.28 12.33 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 121.193 0.52 . . . . 71.140000000000001 111.736 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.3 p -103.7 158.49 16.34 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.295 -1.002 . . . . 74.409999999999997 108.295 175.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.5 ' C ' ' HB3' ' A' ' 190' ' ' ALA . 30.0 m-85 -137.8 147.19 44.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.761 -0.829 . . . . 72.420000000000002 108.761 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 26.1 pt20 -121.72 109.21 14.44 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.269 0.557 . . . . 63.439999999999998 110.686 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.39 8.53 55.73 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.13 -1.033 . . . . 72.319999999999993 111.785 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 55.64 30.84 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.495 1.118 . . . . 71.239999999999995 111.332 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.45 139.05 21.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.21 0.528 . . . . 64.140000000000001 110.945 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.92 163.22 33.37 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.526 -0.761 . . . . 74.200000000000003 110.309 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.511 ' CE2' ' HB1' ' A' ' 85' ' ' ALA . 34.5 m-85 -115.49 149.45 38.08 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.722 -0.672 . . . . 63.399999999999999 109.29 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.44 120.28 39.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.086 -1.45 . . . . 74.340000000000003 107.086 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -123.64 135.98 54.23 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.166 -0.47 . . . . 64.239999999999995 110.633 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.7 165.63 38.85 Favored Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 108.931 -1.668 . . . . 61.5 108.931 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.35 -30.24 65.94 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.222 -1.029 . . . . 61.149999999999999 108.222 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -151.45 145.15 17.63 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 106.502 -1.666 . . . . 74.310000000000002 106.502 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.46 108.79 2.29 Favored 'Trans proline' 0 C--O 1.249 1.032 0 N-CA-C 106.797 -2.04 . . . . 71.329999999999998 106.797 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.46 127.98 18.36 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 C-N-CA 121.268 1.312 . . . . 65.430000000000007 114.311 -168.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 57.2 ttp -96.88 -27.61 14.6 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.601 -1.629 . . . . 71.510000000000005 106.601 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 177' ' ' LYS . 0.1 OUTLIER -92.59 125.56 55.34 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 105.612 -1.996 . . . . 73.209999999999994 105.612 172.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.94 -19.77 56.81 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.698 2.265 . . . . 63.409999999999997 114.94 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -85.3 115.49 23.09 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.346 -0.942 . . . . 70.530000000000001 110.947 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -138.15 135.08 7.26 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 108.479 -1.848 . . . . 53.130000000000003 108.479 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -84.09 -20.54 32.42 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 117.869 0.835 . . . . 75.329999999999998 112.159 -175.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.463 ' HD3' ' OE2' ' A' ' 184' ' ' GLU . 15.1 ttm180 -139.96 130.11 25.09 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.333 -0.547 . . . . 74.420000000000002 110.881 176.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.411 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.6 m120 -137.53 134.69 35.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 105.046 -2.205 . . . . 64.030000000000001 105.046 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.6 mt-10 -129.14 137.43 51.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 110.028 -0.36 . . . . 74.209999999999994 110.028 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.11 124.24 67.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 74.010000000000005 108.352 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.3 m0 -108.58 123.3 48.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.297 -0.41 . . . . 63.520000000000003 110.142 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.7 mt -103.14 118.68 37.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.742 -1.206 . . . . 75.219999999999999 107.742 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.28 126.46 46.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.418 -0.586 . . . . 65.430000000000007 109.418 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' THR . 63.5 pttt -66.9 142.13 57.4 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 116.125 -0.489 . . . . 65.340000000000003 110.934 -175.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.5 ' HB3' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.253 1.246 0 CA-C-O 118.177 -0.916 . . . . 74.409999999999997 109.585 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 CA--C 1.504 -0.812 0 N-CA-C 109.421 -0.585 . . . . 65.430000000000007 109.421 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.1 t -170.98 106.53 0.26 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.878 0.371 . . . . 64.329999999999998 111.135 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -99.44 10.05 42.11 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.585 -0.894 . . . . 74.5 108.585 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -81.77 109.45 16.17 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 114.834 -1.075 . . . . 74.150000000000006 109.826 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.64 148.97 20.32 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 110.957 -0.857 . . . . 53.039999999999999 110.957 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.41 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 45.7 m -144.95 -171.87 3.73 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.879 -1.526 . . . . 65.310000000000002 106.879 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -56.02 -43.17 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.237 0.471 . . . . 73.340000000000003 111.289 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 12' ' ' SER . 19.0 mm-40 51.47 89.76 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 C-N-CA 124.884 1.273 . . . . 73.450000000000003 110.904 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.7 m 72.55 98.05 0.07 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.388 0.614 . . . . 63.350000000000001 110.226 -174.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -135.83 138.71 28.61 Favored Pre-proline 0 C--N 1.311 -1.098 0 N-CA-C 108.037 -1.097 . . . . 74.120000000000005 108.037 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.1 148.93 35.56 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.59 2.193 . . . . 43.210000000000001 111.743 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -101.6 144.5 30.27 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.697 -0.853 . . . . 70.310000000000002 108.697 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -106.42 120.15 41.15 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.911 0.708 . . . . 64.5 112.911 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.6 t -89.19 116.89 31.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.002 -1.851 . . . . 64.409999999999997 106.002 170.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.519 HD12 ' OE1' ' A' ' 33' ' ' GLU . 4.4 pp -99.86 -27.76 13.46 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.874 -0.73 . . . . 65.129999999999995 111.931 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -161.79 149.82 14.98 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.871 0.367 . . . . 72.409999999999997 110.806 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.7 p -132.79 157.37 45.16 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.227 -0.897 . . . . 62.130000000000003 109.562 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.16 -167.0 37.94 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.365 -0.922 . . . . 74.230000000000004 111.991 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.76 177.49 15.08 Favored Glycine 0 C--O 1.243 0.659 0 C-N-CA 120.745 -0.74 . . . . 36.859999999999999 112.718 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -87.1 126.25 34.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.457 -2.053 . . . . 75.420000000000002 105.457 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -64.24 132.69 51.03 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.103 0.954 . . . . 74.340000000000003 112.393 -167.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 129.41 -39.63 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.938 3.295 . . . . 71.519999999999996 103.105 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.612 HG23 ' CD2' ' A' ' 147' ' ' HIS . 21.6 t -123.0 110.23 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 112.983 -1.917 . . . . 75.010000000000005 106.844 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 133' ' ' THR . 52.4 m -119.56 131.87 55.61 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.362 -1.348 . . . . 74.230000000000004 107.362 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.61 160.57 16.55 Favored 'General case' 0 N--CA 1.423 -1.789 0 C-N-CA 120.302 -0.559 . . . . 73.329999999999998 111.108 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -134.98 125.44 26.61 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 106.648 -1.612 . . . . 64.450000000000003 106.648 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' OE1' HD12 ' A' ' 21' ' ' LEU . 45.5 tt0 -100.17 114.73 28.34 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.367 -1.716 . . . . 75.099999999999994 106.367 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -135.93 142.16 44.6 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.789 -1.096 . . . . 74.530000000000001 111.377 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.98 136.44 33.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.128 -1.064 . . . . 64.540000000000006 108.128 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.0 t -69.07 143.31 54.27 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 110.002 -0.37 . . . . 70.540000000000006 110.002 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.12 -20.49 64.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.576 -0.738 . . . . 73.099999999999994 112.412 -177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 89.84 10.4 64.92 Favored Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.044 -1.55 . . . . 64.329999999999998 110.938 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.92 165.56 53.83 Favored Glycine 0 N--CA 1.417 -2.633 0 CA-C-N 114.788 -0.706 . . . . 72.040000000000006 112.282 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.555 ' O ' HD11 ' A' ' 104' ' ' ILE . 13.4 ptpt -94.35 132.6 38.79 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.01 -1.107 . . . . 73.420000000000002 108.01 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 37.8 m-85 -131.58 163.71 27.44 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.02 0.2 . . . . 74.129999999999995 111.128 -172.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.32 117.17 33.16 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.857 -0.794 . . . . 73.319999999999993 108.857 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 6.6 t -127.75 149.52 50.2 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 115.883 -0.599 . . . . 60.409999999999997 112.19 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 100' ' ' VAL . 3.2 p -145.58 134.7 17.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 124.557 1.143 . . . . 73.310000000000002 108.026 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.8 pt-20 -122.31 128.91 51.62 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.325 -0.95 . . . . 73.310000000000002 111.43 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -112.42 139.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 106.547 -1.649 . . . . 64.140000000000001 106.547 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 49' ' ' LYS . 76.5 p -117.51 166.25 12.58 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 111.826 0.306 . . . . 73.530000000000001 111.826 -173.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 72.1 -33.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.117 1.367 . . . . 64.530000000000001 112.97 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.0 mttm -85.76 146.1 42.98 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 115.238 -0.892 . . . . 62.049999999999997 111.726 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.97 158.91 48.97 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.409 2.74 . . . . 71.430000000000007 110.439 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -45.65 -47.24 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.112 1.152 . . . . 72.099999999999994 114.112 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.46 -48.2 74.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.673 0.67 . . . . 71.299999999999997 111.816 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.18 -45.54 73.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.663 -0.698 . . . . 74.519999999999996 112.418 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.32 -37.63 83.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.09 -0.504 . . . . 72.219999999999999 111.143 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.91 -37.56 72.96 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.242 -0.435 . . . . 73.319999999999993 111.091 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.317 6.2 ppt_? -66.51 -23.94 66.32 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.058 1.133 . . . . 73.420000000000002 114.058 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 14.1 mm-40 -79.22 -43.84 23.01 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.18 0.514 . . . . 75.049999999999997 110.839 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . . . -75.94 -38.37 57.67 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 114.522 1.305 . . . . 73.439999999999998 114.522 -173.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.554 ' HE1' ' HA ' ' A' ' 59' ' ' MET . 8.0 mmt -55.58 -53.36 63.33 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 113.305 0.854 . . . . 55.399999999999999 113.305 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 59' ' ' MET . 10.4 Cg_endo -56.13 -31.73 84.29 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.005 1.803 . . . . 63.409999999999997 112.103 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 67.5 mttm -66.37 -39.94 89.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.901 0.381 . . . . 74.040000000000006 111.27 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -43.16 78.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 120.466 -0.493 . . . . 73.209999999999994 109.706 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.41 -35.02 78.45 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.262 0.838 . . . . 72.129999999999995 113.262 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -67.5 -40.86 85.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.357 -0.609 . . . . 74.099999999999994 109.357 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -60.97 -54.51 44.11 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.458 -0.792 . . . . 75.209999999999994 111.757 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.81 -5.81 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.169 0.433 . . . . 71.420000000000002 112.169 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.76 -36.64 10.15 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.949 -0.644 . . . . 71.519999999999996 112.254 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 148.26 2.22 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.542 -1.314 . . . . 45.240000000000002 113.618 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.3 m -85.77 11.92 10.08 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.495 1.14 . . . . 73.129999999999995 109.7 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.428 ' OD1' HG13 ' A' ' 74' ' ' VAL . 7.2 p30 -78.8 176.39 9.6 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.738 -1.119 . . . . 74.329999999999998 110.449 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.09 -33.16 73.08 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.06 0.457 . . . . 63.049999999999997 111.321 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -85.15 -13.86 48.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.45 0.643 . . . . 73.420000000000002 109.878 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.17 32.52 80.44 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.343 -0.844 . . . . 36.859999999999999 111.266 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.428 HG13 ' OD1' ' A' ' 70' ' ' ASN . 6.5 p -79.57 120.95 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 120.306 -0.558 . . . . 75.450000000000003 110.777 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.46 145.48 17.64 Favored Glycine 0 CA--C 1.481 -2.059 0 N-CA-C 109.447 -1.461 . . . . 74.150000000000006 109.447 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 53.7 ttp 59.3 79.81 0.21 Allowed 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.233 -1.395 . . . . 74.409999999999997 107.233 -171.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.88 -111.96 1.21 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.965 -1.112 . . . . 72.319999999999993 113.147 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.528 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 20.8 ptt? -132.91 128.44 36.54 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.271 -0.464 . . . . 71.129999999999995 111.689 -173.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 m -125.66 117.24 23.07 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 108.932 -0.766 . . . . 75.120000000000005 108.932 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.5 HG21 ' CD ' ' A' ' 81' ' ' PRO . 2.0 p -158.87 -178.52 0.91 Allowed Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 102.85 -3.018 . . . . 72.409999999999997 102.85 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 171' ' ' GLY . 92.8 Cg_exo -47.07 136.58 17.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 CA-C-N 123.085 2.137 . . . . 72.219999999999999 116.026 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.74 142.28 26.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 113.293 -1.776 . . . . 61.109999999999999 106.48 172.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.8 p -139.24 151.41 46.49 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.765 -0.374 . . . . 75.319999999999993 110.314 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.8 137.33 31.45 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 120.552 -0.459 . . . . 70.409999999999997 110.125 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.532 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.04 134.71 34.57 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 109.123 -0.695 . . . . 64.340000000000003 109.123 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.6 149.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.613 -1.254 . . . . 72.310000000000002 107.613 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -119.96 100.86 48.14 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 107.428 -1.323 . . . . 75.530000000000001 107.428 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.03 135.42 12.35 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.034 1.823 . . . . 62.119999999999997 113.444 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -78.27 159.16 28.62 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.855 -1.535 . . . . 71.319999999999993 106.855 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.28 -31.77 67.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.486 0.66 . . . . 75.439999999999998 112.492 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.14 -5.17 40.17 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.98 -1.009 . . . . 72.310000000000002 112.027 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.02 63.28 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.65 -0.786 . . . . 52.25 111.908 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -84.23 119.49 25.1 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.799 -0.815 . . . . 63.310000000000002 108.799 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.42 82.87 5.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.606 0.717 . . . . 74.5 109.35 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.628 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 16.8 tm0? -147.52 130.43 16.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.819 -1.082 . . . . 70.239999999999995 108.828 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 86.0 mttt 161.17 -63.62 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 C-N-CA 127.59 2.356 . . . . 75.099999999999994 108.92 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -160.55 158.16 28.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.849 -1.537 . . . . 73.450000000000003 106.849 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 tt -141.69 127.45 19.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 107.221 -1.4 . . . . 72.400000000000006 107.221 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.9 mttt -113.1 114.93 27.53 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.851 -0.426 . . . . 74.099999999999994 109.851 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.1 t -87.87 132.94 31.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 108.434 -0.951 . . . . 62.509999999999998 108.434 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -124.03 117.99 25.97 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.865 -1.161 . . . . 75.450000000000003 107.865 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -102.54 121.12 41.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.487 -1.301 . . . . 64.129999999999995 107.487 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 60.1 ttt180 -78.75 131.53 36.6 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 115.291 -0.868 . . . . 73.430000000000007 108.981 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.555 HD11 ' O ' ' A' ' 40' ' ' LYS . 68.3 mt -93.53 129.6 38.05 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.926 -0.579 . . . . 75.25 110.15 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.528 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 48.0 Cg_endo -68.61 162.32 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.135 2.557 . . . . 73.200000000000003 112.24 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -47.45 -41.62 20.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.024 1.329 . . . . 74.329999999999998 113.877 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.49 -46.9 87.49 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.344 0.498 . . . . 62.350000000000001 112.344 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.58 -4.76 59.25 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 111.472 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.217 -0.66 . . . . 65.010000000000005 109.217 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.68 -26.41 60.92 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.179 -0.919 . . . . 64.019999999999996 111.824 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.9 t -174.87 99.63 0.27 Allowed Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 122.884 0.474 . . . . 54.130000000000003 109.878 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.93 157.73 1.77 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.65 2.233 . . . . 65.219999999999999 111.968 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -71.7 158.16 53.96 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 121.756 1.638 . . . . 75.030000000000001 110.6 172.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.87 59.02 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 110.334 -0.247 . . . . 73.099999999999994 110.334 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.46 106.86 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.78 2.32 . . . . 74.530000000000001 111.593 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -106.3 87.61 2.59 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.757 0.789 . . . . 64.239999999999995 111.505 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.509 ' HB3' HG13 ' A' ' 120' ' ' VAL . 17.8 t70 -176.34 155.8 1.5 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 104.961 -2.236 . . . . 64.040000000000006 104.961 173.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -12.32 60.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 115.07 1.507 . . . . 72.030000000000001 115.07 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.3 p -127.57 6.77 6.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.851 1.426 . . . . 75.349999999999994 114.851 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.509 HG13 ' HB3' ' A' ' 117' ' ' ASP . 15.0 p -103.06 127.68 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.788 -0.819 . . . . 65.310000000000002 108.788 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 121' ' ' LYS . 9.0 mmpt? -126.15 145.17 50.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.25 -0.648 . . . . 74.400000000000006 109.25 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.8 mm -92.59 111.67 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.612 -1.255 . . . . 73.219999999999999 107.612 172.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -125.55 139.27 53.74 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.682 -0.69 . . . . 74.420000000000002 109.864 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.77 139.3 43.78 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.155 -0.93 . . . . 73.439999999999998 109.745 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.532 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 49.4 mtp180 -133.43 136.44 45.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.07 0.462 . . . . 74.439999999999998 111.761 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 157.13 46.75 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.182 -0.917 . . . . 61.340000000000003 111.519 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.02 18.63 46.12 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.096 -0.574 . . . . 72.319999999999993 113.158 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.0 pt -121.97 145.4 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.678 -0.809 . . . . 64.239999999999995 111.966 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.8 m -106.16 131.4 53.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 106.594 -1.632 . . . . 72.099999999999994 106.594 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.01 150.41 28.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.583 -0.895 . . . . 70.420000000000002 108.583 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 13.1 m-85 -115.19 121.73 43.88 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.207 -1.775 . . . . 72.420000000000002 106.207 -177.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 53.8 p -120.55 132.52 55.21 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 120.043 -0.663 . . . . 74.409999999999997 112.263 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 10.0 t -113.41 135.76 53.52 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.36 -0.607 . . . . 75.420000000000002 109.36 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -109.55 127.75 54.7 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.023 -1.103 . . . . 72.400000000000006 108.023 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -130.6 168.4 17.16 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.447 -0.946 . . . . 64.420000000000002 108.447 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.27 165.58 29.92 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.074 -1.06 . . . . 63.340000000000003 112.002 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.17 -133.8 7.9 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 110.968 -0.853 . . . . 71.5 110.968 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -100.71 101.32 12.17 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.169 -1.419 . . . . 73.140000000000001 107.169 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.33 107.93 17.57 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.931 0.872 . . . . 54.350000000000001 112.514 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -99.63 169.29 9.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.42 -1.326 . . . . 73.319999999999993 107.42 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.63 -29.09 69.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.842 0.83 . . . . 72.25 109.389 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.61 -30.92 70.63 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.738 -1.119 . . . . 73.25 111.093 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.17 -36.87 84.23 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 120.383 0.135 . . . . 71.519999999999996 111.28 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -66.61 -41.07 89.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.916 -0.314 . . . . 74.340000000000003 110.633 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.63 -45.35 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 109.959 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.68 90.94 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.049 -0.523 . . . . 72.430000000000007 111.366 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.612 ' CD2' HG23 ' A' ' 29' ' ' VAL . 76.5 m80 -69.14 -32.96 72.68 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.096 -0.642 . . . . 73.329999999999998 111.733 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -66.84 -47.04 73.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.506 -0.315 . . . . 62.399999999999999 110.863 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 t -63.12 -38.14 89.99 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.931 -0.308 . . . . 70.450000000000003 111.682 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.77 -35.13 78.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 112.419 0.526 . . . . 53.530000000000001 112.419 176.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.505 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.1 mt -57.6 -36.87 72.32 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 120.846 0.355 . . . . 75.239999999999995 111.2 175.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 51.2 mtm180 -65.14 -36.56 84.62 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.547 -0.751 . . . . 72.140000000000001 110.076 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 m -75.82 -43.3 46.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.615 -0.721 . . . . 74.430000000000007 110.068 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 151' ' ' LEU . 60.1 p -71.93 -33.59 68.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.753 -0.658 . . . . 75.109999999999999 112.723 -174.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.75 9.59 7.65 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.061 0.763 . . . . 74.420000000000002 113.061 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 45.5 mt-10 -88.02 145.94 25.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.298 -1.001 . . . . 70.150000000000006 108.298 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.96 -9.86 63.85 Favored Glycine 0 C--N 1.302 -1.338 0 C-N-CA 120.647 -0.787 . . . . 74.230000000000004 111.404 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 14.0 t -122.03 149.32 53.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 107.2 -1.408 . . . . 72.109999999999999 107.2 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.79 34.67 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 123.84 3.027 . . . . 60.229999999999997 114.377 -175.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.32 136.06 39.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.966 0.412 . . . . 72.319999999999993 110.547 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 25.2 m -124.45 154.14 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.04 -1.096 . . . . 60.030000000000001 108.04 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.403 ' C ' ' HB3' ' A' ' 190' ' ' ALA . 26.2 p90 -134.21 158.84 42.68 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.794 -0.447 . . . . 75.340000000000003 109.794 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -122.22 140.56 52.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.584 0.957 . . . . 75.150000000000006 113.584 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.78 30.17 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.066 -0.97 . . . . 60.109999999999999 113.968 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.9 t70 66.27 17.15 10.65 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 122.645 1.212 . . . . 72.239999999999995 108.439 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 83.0 t -72.52 139.88 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 125.83 1.652 . . . . 64.310000000000002 111.731 -176.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -146.23 167.47 23.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.497 -0.774 . . . . 71.219999999999999 109.898 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 10.7 m-85 -115.42 152.77 32.28 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.799 -0.815 . . . . 70.019999999999996 108.799 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.1 m -114.65 129.63 56.7 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 106.477 -1.675 . . . . 71.430000000000007 106.477 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.61 157.12 42.96 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.098 0.475 . . . . 71.349999999999994 111.91 -175.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . -155.66 164.19 32.02 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 108.553 -1.819 . . . . 64.109999999999999 108.553 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.498 ' CD1' ' HG3' ' A' ' 81' ' ' PRO . 70.2 m-85 -93.76 -15.72 24.9 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 117.779 0.79 . . . . 70.540000000000006 111.193 -176.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -157.81 144.62 13.18 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 105.293 -2.114 . . . . 74.530000000000001 105.293 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.85 106.01 0.72 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.008 1.805 . . . . 51.219999999999999 110.979 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.14 132.25 12.52 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.582 2.188 . . . . 44.43 112.243 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.9 tpt -81.46 -35.76 30.16 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.573 -0.899 . . . . 74.340000000000003 108.573 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -102.76 155.81 36.08 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 114.706 -1.134 . . . . 71.120000000000005 108.797 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.39 -14.92 28.15 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.876 2.384 . . . . 64.099999999999994 113.676 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -68.07 112.71 5.2 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.45 -0.5 . . . . 72.200000000000003 110.767 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -135.28 115.96 1.46 Allowed Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 110.351 -1.1 . . . . 51.229999999999997 110.351 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -69.62 -30.69 68.48 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 122.695 -0.297 . . . . 64.420000000000002 110.591 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.403 -0.592 . . . . 63.420000000000002 109.403 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -141.59 153.46 44.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.394 -1.706 . . . . 71.329999999999998 106.394 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 133' ' ' THR . 47.2 mt-10 -125.63 154.25 42.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.954 0.724 . . . . 61.310000000000002 112.954 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' SER . 51.9 t -125.45 118.9 53.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.742 -1.577 . . . . 74.150000000000006 106.742 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.9 m0 -103.73 121.15 42.4 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.027 -0.731 . . . . 72.340000000000003 109.027 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.0 tp -97.86 138.78 34.7 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.654 -1.61 . . . . 74.329999999999998 106.654 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.64 135.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.645 -0.422 . . . . 73.0 111.894 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.3 ptmm? -65.5 143.29 57.75 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.614 -0.721 . . . . 75.230000000000004 111.595 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.403 ' HB3' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.188 -1.042 . . . . 45.200000000000003 108.188 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.7 p30 . . . . . 0 CA--C 1.508 -0.668 0 N-CA-C 109.186 -0.672 . . . . 73.040000000000006 109.186 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.5 m 66.73 -20.44 0.11 Allowed 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.413 1.635 . . . . 71.310000000000002 115.413 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.1 mt 60.84 31.77 20.05 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.206 -1.405 . . . . 54.109999999999999 107.206 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -68.47 162.27 25.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.14 -1.391 . . . . 74.439999999999998 113.152 -171.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.28 69.51 0.38 Allowed Glycine 0 N--CA 1.412 -2.916 0 N-CA-C 108.897 -1.681 . . . . 74.129999999999995 108.897 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 m -66.0 107.92 2.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.918 -0.771 . . . . 73.439999999999998 108.918 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.1 t 59.69 77.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.598 1.189 . . . . 61.450000000000003 109.123 -172.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.568 ' HG2' ' H ' ' A' ' 15' ' ' THR . 35.6 tt0 -111.2 -169.11 1.4 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.564 -1.653 . . . . 73.25 106.642 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.568 ' H ' ' HG2' ' A' ' 14' ' ' GLU . 23.2 p -63.79 106.98 1.09 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.373 0.606 . . . . 72.239999999999995 111.915 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.512 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 76.1 t-105 -110.23 127.96 26.17 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.651 -1.24 . . . . 75.430000000000007 107.651 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.85 149.68 72.82 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.066 2.51 . . . . 74.329999999999998 112.619 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -100.7 127.45 47.11 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.787 -1.19 . . . . 63.399999999999999 107.787 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 108.31 19.75 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.595 -0.729 . . . . 74.299999999999997 109.202 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.6 131.37 41.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 116.085 -0.507 . . . . 73.129999999999995 110.443 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 22' ' ' SER . 4.1 pp -90.85 -34.99 15.05 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.657 -0.817 . . . . 74.129999999999995 112.431 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.438 ' N ' HD12 ' A' ' 21' ' ' LEU . 32.6 t -177.65 164.76 2.05 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.789 -0.819 . . . . 74.530000000000001 108.789 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -131.26 156.34 45.58 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.972 -1.122 . . . . 70.400000000000006 107.972 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.0 -158.94 31.66 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.582 -1.294 . . . . 71.310000000000002 112.42 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.58 -116.59 3.16 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 121.192 -0.528 . . . . 62.130000000000003 111.794 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -108.19 171.29 7.49 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.695 0.798 . . . . 72.109999999999999 109.853 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.67 140.85 35.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 106.44 -1.689 . . . . 74.349999999999994 106.44 172.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 77.3 -53.92 0.55 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.69 1.196 . . . . 72.140000000000001 110.47 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG23 ' CD2' ' A' ' 147' ' ' HIS . 21.9 t -97.96 108.27 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.164 -1.421 . . . . 75.129999999999995 107.164 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 133' ' ' THR . 50.3 m -130.52 140.85 50.49 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.261 -1.014 . . . . 71.219999999999999 108.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 132' ' ' SER . 1.6 p90 -112.15 161.46 16.52 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.075 0.464 . . . . 70.510000000000005 112.151 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.534 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -133.13 126.19 31.17 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.456 -1.313 . . . . 74.409999999999997 107.456 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.33 112.82 26.07 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.031 -1.47 . . . . 54.509999999999998 107.031 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.534 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 13.4 ptt180 -144.04 159.23 42.97 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 119.853 -0.739 . . . . 73.230000000000004 110.327 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.19 136.9 33.78 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.958 -1.497 . . . . 43.200000000000003 106.958 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.43 151.59 43.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.097 0.475 . . . . 73.549999999999997 111.122 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -67.62 -21.09 65.41 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.364 -0.834 . . . . 72.400000000000006 112.898 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 74.49 9.49 81.91 Favored Glycine 0 CA--C 1.51 -0.235 0 C-N-CA 119.873 -1.156 . . . . 72.109999999999999 113.926 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.61 165.25 53.66 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.947 -0.644 . . . . 71.140000000000001 113.574 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -93.95 135.66 35.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.21 -0.663 . . . . 65.129999999999995 109.21 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 63.1 m-85 -136.59 165.92 24.75 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.688 0.618 . . . . 74.540000000000006 110.815 -172.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.73 118.95 35.41 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.236 -1.024 . . . . 72.340000000000003 108.236 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.7 t -128.49 154.12 46.44 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 113.174 0.805 . . . . 71.209999999999994 113.174 -172.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.08 132.94 66.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.989 1.315 . . . . 63.43 108.63 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.38 126.67 55.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.653 0.263 . . . . 55.109999999999999 110.503 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 45.1 t -127.33 127.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.942 -1.503 . . . . 74.439999999999998 106.942 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 49' ' ' LYS . 18.6 m -120.34 162.99 18.52 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.563 -0.532 . . . . 72.219999999999999 109.563 -173.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 75.58 -31.81 0.21 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.985 1.314 . . . . 73.109999999999999 112.362 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.1 mttm -85.4 146.6 44.98 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.795 -0.639 . . . . 74.420000000000002 110.663 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.5 156.86 39.32 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.853 2.369 . . . . 65.420000000000002 111.113 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 37.2 t -47.8 -48.08 11.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.908 1.077 . . . . 72.430000000000007 113.908 -177.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 33.2 t70 -59.51 -49.64 76.98 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.47 -0.492 . . . . 75.239999999999995 110.832 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -61.96 -48.19 81.47 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.662 0.616 . . . . 72.109999999999999 112.662 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -60.59 -38.65 85.36 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 123.612 0.57 . . . . 54.530000000000001 110.778 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 59' ' ' MET . 65.3 tp -66.48 -42.53 87.31 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.081 -0.509 . . . . 71.129999999999995 110.302 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.684 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 20.0 mmm180 -59.43 -45.31 91.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.861 0.363 . . . . 73.530000000000001 110.595 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -66.69 -37.43 84.72 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.336 -0.847 . . . . 74.209999999999994 111.34 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.57 59.97 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.274 0.842 . . . . 74.219999999999999 113.274 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.539 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 3.2 mmt -48.32 -57.69 10.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.254 1.205 . . . . 64.319999999999993 114.254 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.55 -32.12 88.82 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.749 2.299 . . . . 72.140000000000001 112.384 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.06 -47.48 68.2 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.329 -0.619 . . . . 74.540000000000006 109.329 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.88 -38.08 79.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.901 -0.59 . . . . 75.420000000000002 110.303 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.51 ' HE2' ' HA ' ' A' ' 63' ' ' MET . 9.7 mmt -66.36 -37.36 85.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 73.439999999999998 112.031 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -72.98 -33.71 66.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.699 -0.401 . . . . 73.140000000000001 110.807 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.71 -60.08 4.23 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 116.431 -0.35 . . . . 73.340000000000003 111.246 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 76' ' ' MET . 6.4 p -73.48 -25.27 20.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 120.864 0.364 . . . . 75.099999999999994 110.542 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.49 -25.05 66.56 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.261 -0.427 . . . . 45.039999999999999 113.249 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 -0.58 2.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.781 -1.2 . . . . 72.310000000000002 113.494 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -91.2 29.74 1.37 Allowed 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.609 1.195 . . . . 60.140000000000001 109.431 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.07 159.87 14.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.596 -0.891 . . . . 52.030000000000001 108.596 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.422 ' HB3' ' HB1' ' A' ' 114' ' ' ALA . 23.2 t70 -70.8 -28.04 64.34 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.081 0.4 . . . . 72.540000000000006 112.081 -172.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.84 -12.34 59.97 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.192 -0.67 . . . . 74.430000000000007 109.192 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.61 33.25 75.94 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.158 -0.928 . . . . 64.420000000000002 112.813 177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.58 126.93 40.25 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.78 -0.768 . . . . 72.140000000000001 111.331 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.86 92.45 1.54 Allowed Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.281 -1.127 . . . . 41.32 110.281 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 56.0 ttp 70.62 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.771 1.228 . . . . 71.099999999999994 110.535 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.52 -55.62 0.68 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.837 0.695 . . . . 74.129999999999995 114.837 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.403 ' SD ' HG21 ' A' ' 104' ' ' ILE . 21.6 ptt? -124.75 126.24 45.33 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.5 m -126.1 124.5 40.72 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.329999999999998 109.652 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -165.7 145.5 5.44 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 107.465 -1.309 . . . . 72.200000000000003 107.465 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -35.61 139.98 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.177 3.251 . . . . 64.400000000000006 115.767 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.27 150.06 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 113.485 -1.689 . . . . 74.099999999999994 106.5 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 m -138.61 145.08 40.11 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.467 -0.568 . . . . 72.219999999999999 109.467 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 42.9 p90 -136.53 143.69 43.86 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.463 -0.495 . . . . 64.150000000000006 111.358 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.425 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.87 34.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.678 -0.86 . . . . 75.439999999999998 108.678 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.98 150.95 30.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.188 -0.915 . . . . 73.120000000000005 109.291 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.557 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 1.9 m-85 -117.36 102.28 52.31 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 109.231 -0.655 . . . . 72.340000000000003 109.231 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -88.67 146.8 5.91 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.235 1.957 . . . . 75.319999999999993 112.693 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.54 152.66 18.23 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.988 -1.856 . . . . 72.109999999999999 105.988 171.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.268 11.3 pt-20 -64.53 -13.36 52.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 115.683 1.734 . . . . 70.439999999999998 115.683 -172.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.6 -6.25 59.25 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 121.609 0.718 . . . . 61.020000000000003 109.866 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.22 5.14 54.84 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 72.040000000000006 112.941 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 m -83.99 126.42 33.01 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.489 -0.56 . . . . 50.219999999999999 109.489 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 78.0 mt -94.04 78.58 4.08 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.923 0.392 . . . . 63.409999999999997 111.095 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.1 tt0 -149.25 115.29 5.73 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 111.949 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 95.1 mttt -176.75 -62.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.278 1.831 . . . . 73.510000000000005 108.648 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.557 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 38.5 ttmt -161.31 155.0 21.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.299 -1.0 . . . . 72.109999999999999 108.299 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.434 HD13 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -143.76 143.38 31.35 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.331 -0.618 . . . . 72.530000000000001 109.331 173.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -136.92 115.47 11.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.636 -0.505 . . . . 73.0 109.636 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 43' ' ' THR . 84.0 t -92.15 129.88 42.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 N-CA-C 109.785 -0.45 . . . . 43.329999999999998 109.785 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -112.72 128.15 56.33 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.941 -0.763 . . . . 75.109999999999999 108.941 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -103.26 123.62 47.1 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.969 -1.123 . . . . 75.030000000000001 107.969 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.453 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 68.4 mtt-85 -75.49 132.22 40.63 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.503 0.927 . . . . 74.140000000000001 113.503 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.403 HG21 ' SD ' ' A' ' 78' ' ' MET . 72.1 mt -102.11 122.77 45.78 Favored Pre-proline 0 N--CA 1.398 -3.041 0 N-CA-C 105.98 -1.859 . . . . 74.329999999999998 105.98 172.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.16 152.01 62.75 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.236 1.958 . . . . 62.310000000000002 110.733 175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -48.12 -37.33 15.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.564 0.746 . . . . 71.340000000000003 112.848 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.75 -31.87 70.04 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.502 0.721 . . . . 75.230000000000004 112.225 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -100.29 -8.45 23.42 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 112.498 0.555 . . . . 71.510000000000005 112.498 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -70.75 -29.24 65.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.641 1.349 . . . . 63.310000000000002 114.641 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.11 -38.59 94.1 Favored Glycine 0 C--O 1.241 0.587 0 C-N-CA 120.029 -1.082 . . . . 61.210000000000001 111.514 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -142.92 85.81 9.72 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 108.26 -1.015 . . . . 72.010000000000005 108.26 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -88.34 159.82 6.83 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.886 1.724 . . . . 74.209999999999994 112.824 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.28 130.27 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.478 2.119 . . . . 71.310000000000002 110.802 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 71' ' ' ASP . . . -70.03 138.73 87.5 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 109.287 -0.634 . . . . 60.520000000000003 109.287 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.27 111.3 3.16 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.155 1.904 . . . . 54.32 112.074 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -98.69 79.23 2.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.806 -0.813 . . . . 74.120000000000005 108.806 177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -173.89 150.26 1.63 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.792 -1.188 . . . . 72.349999999999994 107.792 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -76.27 -24.2 54.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.214 0.82 . . . . 73.209999999999994 113.214 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.4 m -92.6 -26.21 17.97 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.57 -0.452 . . . . 73.310000000000002 110.799 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.8 t -94.35 118.35 40.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.849 -0.426 . . . . 75.319999999999993 109.849 -175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -128.73 147.63 50.78 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.471 -0.937 . . . . 71.329999999999998 108.471 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 26.1 mm -92.71 112.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.24 -1.022 . . . . 74.409999999999997 108.24 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -122.06 149.7 43.16 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 109.769 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.74 152.52 24.24 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.814 -0.63 . . . . 62.039999999999999 109.821 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.504 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 65.0 ttt180 -151.57 123.25 7.96 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.821 -0.807 . . . . 71.340000000000003 108.821 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -138.39 166.92 23.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.545 -0.539 . . . . 72.230000000000004 109.545 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.44 61.01 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.431 -1.366 . . . . 73.230000000000004 113.282 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.6 pt -119.28 151.93 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.347 -0.941 . . . . 74.430000000000007 112.166 -175.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 92.9 m -105.78 123.35 47.81 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.943 -1.48 . . . . 73.430000000000007 107.788 178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.52 146.66 30.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 116.01 -0.541 . . . . 64.299999999999997 110.632 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 39.9 m-85 -114.47 121.92 45.0 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.707 -1.96 . . . . 73.219999999999999 105.707 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 31' ' ' TYR . 56.1 p -122.41 139.16 54.17 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 119.832 -0.747 . . . . 75.140000000000001 111.193 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.8 t -113.51 133.19 55.37 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 120.574 -0.451 . . . . 73.209999999999994 109.932 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -110.91 125.33 53.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.514 -1.291 . . . . 64.209999999999994 107.514 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.68 158.08 44.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.463 -0.199 . . . . 73.319999999999993 110.463 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -137.06 154.54 22.32 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 123.973 0.796 . . . . 74.310000000000002 111.372 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.09 -142.37 11.73 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 109.009 -1.637 . . . . 63.43 109.009 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 179' ' ' TYR . 75.0 t80 -100.43 118.95 37.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 118.239 1.02 . . . . 63.200000000000003 108.964 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.53 133.41 55.4 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.611 0.72 . . . . 63.299999999999997 112.177 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -112.64 177.37 4.66 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.419 -1.697 . . . . 73.319999999999993 106.419 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.55 78.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.346 0.594 . . . . 60.350000000000001 110.817 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.65 -29.29 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 74.329999999999998 111.77 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.24 -30.23 70.09 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 111.879 0.325 . . . . 64.040000000000006 111.879 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.88 -48.94 69.85 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.728 -0.841 . . . . 75.030000000000001 108.728 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.03 -41.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.841 -1.072 . . . . 64.340000000000003 110.185 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.71 88.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.841 -0.618 . . . . 74.319999999999993 110.521 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.405 ' CD2' HG23 ' A' ' 29' ' ' VAL . 62.8 m80 -66.63 -32.36 73.63 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 112.827 0.677 . . . . 75.349999999999994 112.827 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.68 -47.31 84.93 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.105 0.478 . . . . 64.530000000000001 109.921 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -65.03 -46.87 79.48 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.628 -0.715 . . . . 65.049999999999997 110.447 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.06 -40.82 86.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 111.318 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 187' ' ' LEU . 1.5 tt -62.72 -46.07 89.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.828 -1.175 . . . . 72.310000000000002 107.828 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -64.09 -39.47 94.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.068 -0.969 . . . . 74.030000000000001 110.451 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.9 m -68.55 -33.09 73.48 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.312 0.577 . . . . 72.400000000000006 110.257 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -73.02 -33.51 65.78 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.37 0.605 . . . . 74.340000000000003 109.702 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.1 9.2 7.06 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.998 -0.546 . . . . 71.340000000000003 111.486 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.96 134.08 35.64 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 71.219999999999999 106.91 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.89 57.28 Favored Glycine 0 C--N 1.307 -1.028 0 C-N-CA 121.211 -0.518 . . . . 61.509999999999998 112.551 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.3 t -125.41 146.24 53.72 Favored Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 106.879 -1.526 . . . . 72.430000000000007 106.879 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.83 34.79 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 123.744 2.963 . . . . 61.439999999999998 114.676 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 131' ' ' TYR . . . -74.87 139.64 43.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.446 -0.576 . . . . 64.329999999999998 109.446 177.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 19.6 p -114.91 158.66 21.68 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.145 -0.48 . . . . 72.340000000000003 110.364 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 190' ' ' ALA . 43.6 m-85 -136.23 152.36 50.66 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.615 -0.883 . . . . 72.409999999999997 108.615 -176.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -113.02 111.34 22.0 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.262 0.838 . . . . 70.019999999999996 113.262 178.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.53 4.71 46.81 Favored Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 115.658 -0.701 . . . . 61.100000000000001 112.495 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 17.8 t70 63.83 15.75 9.3 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.813 1.245 . . . . 74.540000000000006 109.565 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.14 151.56 7.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 CA-C-O 121.205 0.526 . . . . 72.439999999999998 110.516 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -146.1 170.64 16.28 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.599 -0.728 . . . . 71.030000000000001 111.215 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 97.6 m-85 -115.15 152.28 32.88 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.64 -0.504 . . . . 62.43 109.64 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.03 137.75 53.67 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.757 -1.201 . . . . 62.329999999999998 107.757 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.73 150.03 32.13 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 111.896 0.332 . . . . 73.099999999999994 111.896 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.9 164.23 33.11 Favored Glycine 0 C--O 1.22 -0.748 0 N-CA-C 107.871 -2.092 . . . . 71.510000000000005 107.871 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -138.99 -39.48 0.49 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 115.228 1.566 . . . . 73.319999999999993 115.228 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.81 134.54 25.98 Favored Pre-proline 0 C--N 1.306 -1.283 0 C-N-CA 120.312 -0.555 . . . . 75.450000000000003 111.319 -175.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.46 104.05 0.88 Allowed 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.295 1.996 . . . . 74.099999999999994 107.865 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -97.36 149.7 0.91 Allowed 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.333 2.022 . . . . 72.140000000000001 115.694 -168.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 85.6 mtp -81.56 -33.83 31.44 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.068 -1.827 . . . . 71.549999999999997 106.068 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -132.81 109.92 13.16 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 106.029 -1.841 . . . . 74.109999999999999 106.029 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.68 -34.33 51.49 Favored 'Trans proline' 0 CA--C 1.511 -0.657 0 C-N-CA 121.431 1.421 . . . . 61.119999999999997 113.362 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 138' ' ' TYR . 52.5 t80 46.27 -89.4 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.405 1.082 . . . . 74.329999999999998 110.633 -172.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 116.51 54.58 0.33 Allowed Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.31 -0.948 . . . . 54.229999999999997 114.848 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -70.85 -26.36 63.23 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 117.952 0.876 . . . . 74.230000000000004 111.73 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -133.8 128.16 34.19 Favored 'General case' 0 CA--C 1.469 -2.143 0 CA-C-O 121.459 0.647 . . . . 70.299999999999997 111.231 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -144.86 134.59 23.51 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 103.743 -2.688 . . . . 75.519999999999996 103.743 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -115.71 137.22 52.3 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 119.261 -0.976 . . . . 73.540000000000006 110.334 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 89.8 t -124.99 121.06 60.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.636 -1.246 . . . . 54.229999999999997 107.636 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.516 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 6.8 m0 -119.31 120.96 38.51 Favored 'General case' 0 C--O 1.197 -1.682 0 CA-C-O 119.129 -0.462 . . . . 75.140000000000001 110.929 -174.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 151' ' ' LEU . 9.2 mp -96.95 138.83 33.88 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.822 -1.177 . . . . 73.219999999999999 107.822 171.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.16 131.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 120.323 -0.551 . . . . 74.219999999999999 110.681 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 161' ' ' THR . 4.5 tmtm? -73.46 130.74 40.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.519 -0.764 . . . . 60.130000000000003 109.997 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.252 1.199 0 CA-C-N 115.734 -0.666 . . . . 52.130000000000003 111.054 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.224 -1.028 . . . . 74.450000000000003 108.224 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.7 p -165.22 136.36 3.98 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.751 0.31 . . . . 62.310000000000002 111.783 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.87 93.61 3.88 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.611 -0.885 . . . . 73.439999999999998 108.611 171.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -87.49 135.49 33.32 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.63 -0.714 . . . . 71.409999999999997 110.09 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.99 165.36 22.16 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 109.299 -1.52 . . . . 55.329999999999998 109.299 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.8 t -82.65 97.79 8.7 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.901 -0.777 . . . . 72.310000000000002 108.901 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -95.53 -36.48 6.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.397 -0.964 . . . . 64.340000000000003 108.397 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.96 163.62 13.64 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.082 -1.822 . . . . 61.509999999999998 106.082 -178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.8 m 77.21 126.1 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.323 1.449 . . . . 70.129999999999995 112.475 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -82.1 111.73 29.76 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.157 -0.929 . . . . 55.539999999999999 109.453 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -96.33 121.63 0.23 Allowed 'Trans proline' 0 N--CA 1.44 -1.664 0 C-N-CA 121.835 1.69 . . . . 60.520000000000003 113.502 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -110.07 144.71 38.27 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.056 -1.461 . . . . 75.140000000000001 107.056 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -126.81 122.53 35.02 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.92 -1.112 . . . . 74.099999999999994 111.73 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.92 121.16 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 106.966 -1.494 . . . . 52.43 106.966 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.56 -33.41 15.91 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.59 -0.444 . . . . 65.040000000000006 111.044 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.407 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 46.8 t -162.26 149.86 14.14 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.401 0.619 . . . . 40.119999999999997 110.806 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.1 p -133.29 166.71 21.87 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 125.05 1.34 . . . . 74.450000000000003 108.255 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.01 76.76 0.4 Allowed Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 119.513 -1.327 . . . . 73.319999999999993 112.961 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.18 -160.34 22.45 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.226 -0.988 . . . . 74.019999999999996 111.659 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -89.96 170.58 10.25 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.781 -1.192 . . . . 73.200000000000003 107.781 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.22 148.27 51.07 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 119.652 -0.819 . . . . 63.530000000000001 109.91 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.0 t70 77.43 -62.23 0.39 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.425 1.49 . . . . 65.209999999999994 110.791 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.76 110.06 29.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.369 -0.974 . . . . 60.200000000000003 108.369 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -118.88 154.44 32.93 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.461 -0.94 . . . . 74.150000000000006 108.461 -176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' HB3' HD12 ' A' ' 151' ' ' LEU . 5.7 p90 -117.28 152.19 35.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.214 -1.394 . . . . 71.439999999999998 113.868 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -135.18 124.75 25.07 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.527 -2.027 . . . . 75.109999999999999 105.527 172.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 32.3 mt-10 -106.31 118.38 36.48 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.200000000000003 107.571 -177.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -139.04 148.34 43.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.512 0.93 . . . . 74.219999999999999 113.512 -175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.59 136.41 34.82 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.082 -1.451 . . . . 62.520000000000003 107.082 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.625 ' SG ' HG13 ' A' ' 128' ' ' ILE . 99.1 m -63.49 142.9 58.22 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.644 0.979 . . . . 70.340000000000003 113.644 -176.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -47.98 -48.25 32.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.827 1.251 . . . . 54.32 112.323 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.01 69.91 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 110.747 -0.941 . . . . 51.109999999999999 110.747 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.23 165.75 53.37 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 111.214 -0.754 . . . . 63.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 137.24 32.51 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.921 -0.311 . . . . 70.450000000000003 110.763 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 53.9 m-85 -135.34 164.22 28.23 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.766 0.827 . . . . 75.129999999999995 109.403 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.51 116.51 31.8 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.135 -0.691 . . . . 72.519999999999996 109.135 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -119.91 138.98 53.1 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 112.621 0.6 . . . . 74.129999999999995 112.621 -175.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.495 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 11.5 m -130.44 124.95 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.425 1.09 . . . . 60.420000000000002 110.393 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.55 139.06 45.01 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.086 -0.646 . . . . 72.120000000000005 112.281 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 39.4 t -126.38 141.33 46.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 N-CA-C 108.465 -0.939 . . . . 75.209999999999994 108.465 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -127.83 174.89 8.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 122.859 0.463 . . . . 71.349999999999994 110.13 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.51 -34.28 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.122 0.969 . . . . 73.329999999999998 113.202 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 3.5 mppt? -100.57 138.78 20.22 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 112.143 0.424 . . . . 62.450000000000003 112.143 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.73 159.76 4.59 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 124.589 3.526 . . . . 73.010000000000005 111.841 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 98' ' ' LEU . 52.6 t -46.14 -48.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.708 0.803 . . . . 72.510000000000005 113.043 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.99 -45.18 91.27 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.423 0.63 . . . . 70.409999999999997 110.744 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 23.1 mm-40 -75.06 -31.84 61.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.986 -1.006 . . . . 74.109999999999999 112.585 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -73.0 -44.84 60.57 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.512 0.673 . . . . 71.120000000000005 109.669 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.304 -0.862 . . . . 73.439999999999998 111.309 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 17.0 ptm180 -64.09 -26.6 68.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 116.564 -0.289 . . . . 71.409999999999997 111.645 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 51.9 mt-10 -84.72 -41.75 15.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.982 0.42 . . . . 72.109999999999999 111.181 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.09 69.42 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.271 0.841 . . . . 74.099999999999994 113.271 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.514 ' HE2' ' HA ' ' A' ' 59' ' ' MET . 6.6 mmt -56.07 -53.56 62.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.205 -0.426 . . . . 71.319999999999993 111.711 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 34.5 Cg_exo -55.87 -31.89 82.98 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.348 2.032 . . . . 74.349999999999994 112.129 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 43.0 mtmt -73.04 -31.02 64.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.626 -0.43 . . . . 73.150000000000006 111.589 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 66' ' ' VAL . 35.4 mm -74.34 -43.4 49.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.409 -0.96 . . . . 74.219999999999999 108.409 171.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.496 ' HE2' ' HA ' ' A' ' 63' ' ' MET . 19.3 mmt -56.26 -37.73 70.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.854 0.686 . . . . 74.439999999999998 112.854 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.4 -47.62 72.69 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.439 -0.504 . . . . 72.099999999999994 110.74 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.88 -58.03 6.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.134 -0.485 . . . . 75.230000000000004 111.767 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -68.88 -17.38 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 64.340000000000003 110.897 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.62 -19.78 65.3 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.88 -0.6 . . . . 37.460000000000001 112.82 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.72 -22.28 0.4 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.096 -1.526 . . . . 51.039999999999999 113.968 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -79.37 58.02 2.5 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.439 1.114 . . . . 73.010000000000005 111.338 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -99.88 160.28 14.43 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.325 -1.361 . . . . 74.349999999999994 107.325 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -69.2 -33.57 73.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.597 0.635 . . . . 70.209999999999994 110.278 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -80.41 -9.58 59.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.746 . . . . 73.519999999999996 110.327 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.78 62.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.642 -0.708 . . . . 60.310000000000002 112.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 m -82.97 159.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 108.11 -1.07 . . . . 73.310000000000002 108.11 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -170.89 12.28 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 119.082 -1.532 . . . . 62.450000000000003 113.733 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.0 mtp 70.69 101.96 0.06 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.379 1.472 . . . . 72.239999999999995 110.466 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 66' ' ' VAL . . . -54.44 122.1 22.97 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.817 -1.083 . . . . 37.460000000000001 114.385 -174.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -96.31 126.89 41.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.645 -0.872 . . . . 72.310000000000002 108.645 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 m -123.77 123.94 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.435 0.636 . . . . 72.340000000000003 111.838 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.14 176.72 2.28 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 104.202 -2.518 . . . . 70.010000000000005 104.202 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -62.53 139.08 74.15 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 CA-C-N 121.494 1.569 . . . . 37.460000000000001 112.293 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 8.8 p -110.47 148.88 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.806 -1.183 . . . . 54.219999999999999 107.806 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 47.0 p -125.72 145.36 50.22 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 121.164 -0.214 . . . . 62.520000000000003 110.658 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -139.75 148.12 41.82 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.617 -0.433 . . . . 72.310000000000002 110.621 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.09 135.36 34.04 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.634 0.584 . . . . 73.120000000000005 110.019 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.27 151.07 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.001 -1.0 . . . . 73.230000000000004 109.577 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 76.4 m-85 -118.12 110.45 39.69 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 110.253 -0.277 . . . . 75.430000000000007 110.253 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.78 137.03 9.78 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 121.5 1.467 . . . . 64.329999999999998 110.989 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -82.77 179.31 7.82 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.745 -0.835 . . . . 75.25 108.745 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.2 -36.32 77.4 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.763 0.792 . . . . 72.439999999999998 109.807 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.31 -5.42 52.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.284 -1.325 . . . . 71.409999999999997 112.777 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.55 -4.03 83.74 Favored Glycine 0 CA--C 1.501 -0.829 0 C-N-CA 120.378 -0.915 . . . . 75.329999999999998 112.718 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.1 p -74.64 146.92 42.02 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.001 -0.741 . . . . 72.409999999999997 109.001 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.495 HD21 ' HH ' ' A' ' 167' ' ' TYR . 95.9 mt -82.64 132.6 35.18 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.149 0.499 . . . . 73.519999999999996 110.879 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -87.35 150.95 23.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 75.439999999999998 109.923 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -74.63 77.37 2.01 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.934 1.087 . . . . 70.25 113.934 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.671 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -165.49 122.89 1.5 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 104.21 -2.515 . . . . 73.219999999999999 104.21 173.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.671 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 5.7 tt -143.88 145.26 32.18 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 121.078 -0.249 . . . . 70.120000000000005 110.571 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -142.1 130.24 22.09 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.404 -0.518 . . . . 73.239999999999995 110.726 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.8 t -91.85 139.28 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.228 -0.896 . . . . 71.129999999999995 109.944 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.265 -1.383 . . . . 75.150000000000006 107.265 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -102.2 114.31 28.36 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.495 -0.928 . . . . 73.209999999999994 108.495 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.441 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -75.54 113.14 12.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.105 -1.443 . . . . 71.319999999999993 107.105 -175.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -78.3 135.26 61.77 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 112.276 0.473 . . . . 61.140000000000001 112.276 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.23 157.83 13.3 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.416 2.744 . . . . 73.200000000000003 112.127 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -54.59 -45.94 73.69 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.155 1.168 . . . . 74.430000000000007 114.155 -171.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -59.85 -37.92 80.66 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.214 0.531 . . . . 71.299999999999997 111.785 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.44 -3.15 57.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.696 0.628 . . . . 73.319999999999993 112.696 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.51 -33.73 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.184 -1.006 . . . . 75.530000000000001 109.91 172.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 -34.75 55.78 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.024 -0.535 . . . . 61.310000000000002 112.187 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.6 t -142.72 89.09 8.27 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 108.283 -1.006 . . . . 51.240000000000002 108.283 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 73.5 Cg_endo -87.18 141.18 5.87 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.914 1.743 . . . . 73.129999999999995 110.977 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 12.5 Cg_exo -71.25 154.67 61.5 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 121.705 1.603 . . . . 64.530000000000001 110.448 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.38 143.12 55.24 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.376 -0.972 . . . . 72.120000000000005 108.376 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.82 110.71 2.84 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.045 1.83 . . . . 71.120000000000005 111.643 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.2 t -72.76 -22.17 60.9 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.575 -0.738 . . . . 75.239999999999995 110.548 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.58 144.23 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.635 -0.876 . . . . 65.430000000000007 108.635 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.92 -33.14 74.12 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.224 0.824 . . . . 71.150000000000006 113.224 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.1 p -90.36 -12.13 38.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.991 0.424 . . . . 72.209999999999994 111.944 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.31 123.21 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.454 -2.054 . . . . 74.439999999999998 105.454 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -128.39 138.28 52.27 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.249 -0.58 . . . . 75.230000000000004 110.57 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 25.3 mm -92.01 109.49 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.541 -1.652 . . . . 62.219999999999999 106.541 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -129.87 153.14 48.59 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.395 -0.821 . . . . 63.049999999999997 109.176 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.27 137.58 54.8 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 109.501 -0.555 . . . . 73.099999999999994 109.501 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.94 127.48 28.77 Favored 'General case' 0 N--CA 1.426 -1.659 0 C-N-CA 120.555 -0.458 . . . . 61.340000000000003 111.413 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.17 175.57 9.44 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.398 -0.964 . . . . 73.120000000000005 108.398 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.71 46.11 Favored Glycine 0 C--N 1.306 -1.083 0 C-N-CA 120.836 -0.697 . . . . 72.099999999999994 111.758 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.625 HG13 ' SG ' ' A' ' 36' ' ' CYS . 36.2 pt -132.99 146.51 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.088 0.47 . . . . 75.340000000000003 110.801 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.2 m -104.06 135.16 46.08 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.98 -1.489 . . . . 74.530000000000001 106.98 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 m -123.66 145.97 29.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.355 -0.609 . . . . 71.519999999999996 109.355 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -113.48 122.53 47.57 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 105.923 -1.88 . . . . 74.200000000000003 105.923 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.7 m -110.1 146.59 35.16 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 115.867 -0.606 . . . . 73.109999999999999 110.916 -173.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.9 t -133.62 124.89 27.61 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.327 -0.619 . . . . 74.239999999999995 109.327 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -111.23 126.36 54.79 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 109.505 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 37.3 p90 -137.24 167.43 21.59 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.974 -1.012 . . . . 72.019999999999996 109.314 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -120.62 123.21 5.5 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.09 -1.204 . . . . 37.460000000000001 110.09 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 167.03 170.84 32.43 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 111.345 -0.702 . . . . 62.299999999999997 111.345 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.453 ' HD1' ' O ' ' A' ' 177' ' ' LYS . 77.8 m-85 -93.11 100.26 12.69 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.664 -0.865 . . . . 63.210000000000001 108.664 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.69 132.2 43.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.32 0.859 . . . . 55.329999999999998 113.32 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.06 177.15 5.03 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.929 -1.508 . . . . 74.409999999999997 106.929 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.27 -36.49 73.34 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.729 0.3 . . . . 65.25 111.262 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.23 81.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.353 -0.385 . . . . 63.530000000000001 110.297 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.9 -42.51 99.8 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.773 -0.454 . . . . 61.539999999999999 109.773 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.752 ' HA ' ' NE2' ' A' ' 147' ' ' HIS . 63.9 m-85 -56.95 -43.96 82.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 123.365 0.416 . . . . 73.549999999999997 112.108 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.11 -49.29 77.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 123.753 0.658 . . . . 64.129999999999995 110.305 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.62 -48.27 77.85 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.778 -0.646 . . . . 74.319999999999993 112.062 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.752 ' NE2' ' HA ' ' A' ' 144' ' ' TYR . 3.2 p-80 -72.46 -32.0 65.89 Favored 'General case' 0 C--O 1.205 -1.271 0 N-CA-C 113.067 0.765 . . . . 64.540000000000006 113.067 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.31 80.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.147 0.498 . . . . 73.430000000000007 110.651 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.4 t -76.53 -32.02 57.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 120.127 -0.629 . . . . 71.209999999999994 109.758 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.96 -34.3 78.11 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 116.379 -0.373 . . . . 75.400000000000006 110.298 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' A' ' 31' ' ' TYR . 57.9 tp -62.61 -41.78 99.2 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.531 -0.544 . . . . 74.230000000000004 109.531 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -62.25 -36.99 83.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.447 0.642 . . . . 65.319999999999993 110.165 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 41.1 m -72.6 -30.18 64.14 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 115.153 -0.93 . . . . 74.040000000000006 110.105 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 156' ' ' GLU . 85.7 m -75.12 -33.35 61.57 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.473 0.709 . . . . 72.019999999999996 109.834 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.9 mt -72.8 13.25 0.4 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.295 1.438 . . . . 75.230000000000004 111.76 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 154' ' ' THR . 44.6 tt0 -51.11 124.24 11.08 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.481 1.112 . . . . 74.239999999999995 110.357 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.54 60.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.736 -0.745 . . . . 62.310000000000002 113.724 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 81.0 p -93.23 154.41 41.51 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 117.565 0.682 . . . . 75.200000000000003 109.742 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.86 25.7 0.69 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.676 2.251 . . . . 74.230000000000004 110.897 175.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.03 138.81 39.81 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.835 -0.62 . . . . 71.319999999999993 110.753 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.5 p -110.8 149.84 29.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.356 -0.609 . . . . 71.049999999999997 109.356 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -143.75 161.51 38.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.88 -0.785 . . . . 74.030000000000001 108.88 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.403 ' O ' HG11 ' A' ' 166' ' ' VAL . 27.8 pt20 -131.65 109.65 10.36 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.235 -0.586 . . . . 75.519999999999996 111.825 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.57 62.69 Favored Glycine 0 C--N 1.315 -0.628 0 C-N-CA 120.617 -0.802 . . . . 54.25 114.141 171.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 61.04 23.15 13.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.032 0.533 . . . . 65.109999999999999 111.185 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 163' ' ' GLN . 9.8 p -63.59 138.16 23.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 N-CA-C 109.274 -0.639 . . . . 42.43 109.274 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.495 ' HH ' HD21 ' A' ' 94' ' ' LEU . 40.6 p90 -147.2 174.61 11.45 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 121.447 0.641 . . . . 74.310000000000002 111.192 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -116.98 150.32 38.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.714 -1.13 . . . . 74.519999999999996 109.17 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 83' ' ' SER . 34.7 t -113.29 120.32 40.74 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.291 -1.003 . . . . 73.129999999999995 108.291 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 184' ' ' GLU . . . -120.62 131.79 54.8 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.446 0.466 . . . . 74.200000000000003 111.604 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.49 164.91 38.18 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.098 -2.001 . . . . 74.219999999999999 108.098 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -64.73 -42.7 95.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.737 1.268 . . . . 72.120000000000005 109.377 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -155.31 150.4 20.8 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 106.703 -1.591 . . . . 75.299999999999997 106.703 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -48.0 117.24 2.36 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.293 2.662 . . . . 71.409999999999997 112.372 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.97 129.81 19.13 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.101 1.868 . . . . 72.519999999999996 112.775 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.6 ttt -93.7 -42.31 9.23 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.789 -1.56 . . . . 62.240000000000002 106.789 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.464 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -172.51 -66.12 0.0 OUTLIER Pre-proline 0 C--O 1.208 -1.122 0 CA-C-N 114.85 -1.068 . . . . 70.310000000000002 110.284 173.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 177' ' ' LYS . 82.8 Cg_endo -76.01 -30.16 6.03 Favored 'Trans proline' 0 C--N 1.375 1.964 0 CA-C-N 120.523 1.223 . . . . 70.450000000000003 115.002 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -101.54 109.07 20.81 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.389 -0.524 . . . . 73.450000000000003 111.05 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 120.22 51.35 0.27 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.909 -0.876 . . . . 51.140000000000001 110.909 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.492 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 2.6 tmm_? -75.34 -31.05 60.44 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 109.238 -0.653 . . . . 72.340000000000003 109.238 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -113.13 131.21 55.93 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.508 -0.477 . . . . 73.310000000000002 110.247 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -131.62 161.74 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.831 -0.803 . . . . 74.239999999999995 108.831 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 170' ' ' ALA . 43.4 tt0 -125.27 139.23 53.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.38 -1.341 . . . . 72.540000000000006 107.38 174.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.703 HG22 ' CD2' ' A' ' 147' ' ' HIS . 59.4 t -126.7 131.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.906 -0.775 . . . . 71.519999999999996 108.906 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 36.3 m0 -111.08 123.19 49.7 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 123.322 0.389 . . . . 74.030000000000001 110.444 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.5 128.08 43.1 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.413 -1.699 . . . . 44.549999999999997 106.413 169.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.016 -0.674 . . . . 74.409999999999997 111.75 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' THR . 52.2 tttp -63.69 127.63 32.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.563 -1.198 . . . . 71.329999999999998 111.753 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 108.825 -0.806 . . . . 64.430000000000007 108.825 173.407 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 108.579 -0.896 . . . . 71.409999999999997 108.579 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.9 p -149.73 170.72 18.07 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 116.522 -0.308 . . . . 74.430000000000007 111.616 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 63.33 67.34 0.66 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.805 1.242 . . . . 74.140000000000001 112.821 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -140.03 138.39 35.39 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.884 -1.154 . . . . 75.400000000000006 107.884 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.62 20.2 58.69 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 109.921 -1.272 . . . . 60.439999999999998 109.921 -175.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 m -73.26 104.93 4.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.418 -0.956 . . . . 72.109999999999999 108.418 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.75 125.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 CA-C-N 115.912 -0.585 . . . . 73.219999999999999 109.425 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -134.6 148.81 50.5 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.727 -0.67 . . . . 53.130000000000003 109.198 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.3 t -104.34 86.39 2.52 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-O 122.022 0.915 . . . . 74.209999999999994 109.515 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.51 ' CZ2' ' HB3' ' A' ' 109' ' ' GLN . 35.0 p90 -79.46 126.12 81.61 Favored Pre-proline 0 N--CA 1.425 -1.708 0 CA-C-N 115.044 -0.98 . . . . 74.439999999999998 109.958 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.79 148.62 22.65 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.713 2.276 . . . . 70.25 114.595 -173.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 43.8 p90 -102.29 148.94 24.84 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 104.872 -2.269 . . . . 71.099999999999994 104.872 171.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -106.05 109.03 20.84 Favored 'General case' 0 C--N 1.279 -2.488 0 C-N-CA 118.052 -1.459 . . . . 72.200000000000003 111.177 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 34' ' ' ARG . 48.1 t -91.28 115.54 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 103.299 -2.852 . . . . 75.040000000000006 103.299 169.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.98 -23.77 22.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.925 -1.51 . . . . 71.450000000000003 111.339 -171.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -174.83 168.0 3.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.427 -0.583 . . . . 72.140000000000001 109.427 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.407 HG21 ' HG3' ' A' ' 32' ' ' GLU . 72.8 p -133.74 145.7 50.08 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.089 -1.078 . . . . 63.329999999999998 108.089 170.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.2 -139.43 6.11 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 118.997 -1.573 . . . . 45.32 113.648 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.0 -112.57 4.47 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.947 -0.861 . . . . 44.310000000000002 110.947 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 8.6 mtpm? -113.52 170.32 8.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.03 -0.359 . . . . 72.200000000000003 110.03 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -83.97 157.53 21.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.027 -1.101 . . . . 55.210000000000001 108.027 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 75.88 -61.8 0.45 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.459 1.104 . . . . 70.310000000000002 110.444 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.77 110.14 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.153 -1.795 . . . . 63.420000000000002 106.153 171.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.0 p -122.57 155.05 37.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.544 -0.753 . . . . 63.340000000000003 109.065 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.498 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -114.98 153.21 31.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 113.155 0.798 . . . . 73.040000000000006 113.155 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.582 ' OE2' ' HD2' ' A' ' 34' ' ' ARG . 35.9 tt0 -135.35 123.35 22.74 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.216 -2.142 . . . . 61.299999999999997 105.216 173.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -109.95 125.2 52.6 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.105 0.955 . . . . 74.239999999999995 111.026 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.582 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 16.4 mtp180 -127.5 140.48 52.11 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.347 -1.297 . . . . 62.310000000000002 110.414 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.11 40.5 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.515 -1.291 . . . . 75.450000000000003 107.515 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.2 m -58.94 146.05 39.27 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.794 0.683 . . . . 63.329999999999998 111.604 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -87.41 -19.43 28.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.371 -0.377 . . . . 64.230000000000004 110.054 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 98.69 11.63 46.62 Favored Glycine 0 CA--C 1.489 -1.586 0 C-N-CA 119.423 -1.37 . . . . 55.409999999999997 111.824 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 160.0 53.61 Favored Glycine 0 N--CA 1.426 -2.006 0 C-N-CA 120.522 -0.847 . . . . 71.420000000000002 112.133 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.3 ptmt -95.9 128.93 43.21 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 109.748 -0.464 . . . . 64.340000000000003 109.748 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.8 m-85 -127.17 163.81 23.03 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.977 -0.556 . . . . 75.239999999999995 110.985 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.17 116.73 32.05 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.075 -1.083 . . . . 52.329999999999998 108.075 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.9 t -127.29 147.77 50.23 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 120.329 -0.548 . . . . 74.209999999999994 112.015 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.8 t -128.18 126.63 66.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.841 -1.072 . . . . 73.120000000000005 108.446 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 43.5 tt0 -113.16 123.94 51.39 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.018 0.437 . . . . 71.430000000000007 111.088 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 34.5 t -121.4 127.54 75.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.835 -1.543 . . . . 74.040000000000006 106.835 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 49' ' ' LYS . 72.7 p -116.09 166.19 12.29 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.551 -0.46 . . . . 61.310000000000002 110.566 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 73.3 -27.49 0.19 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.897 0.879 . . . . 72.120000000000005 113.007 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 47' ' ' THR . 63.8 mmtt -89.84 146.85 36.16 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 115.946 -0.57 . . . . 74.310000000000002 110.54 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.23 156.65 61.92 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.435 2.09 . . . . 52.0 109.926 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.87 -45.71 11.79 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 113.383 0.883 . . . . 71.109999999999999 113.383 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.75 -46.55 87.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.175 0.435 . . . . 73.129999999999995 112.175 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.32 -43.69 55.65 Favored 'General case' 0 N--CA 1.397 -3.118 0 CA-C-N 116.278 -0.419 . . . . 64.329999999999998 111.728 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -63.79 -37.76 88.56 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 120.893 0.377 . . . . 52.329999999999998 110.675 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.426 HD12 ' HE2' ' A' ' 59' ' ' MET . 47.2 tp -70.84 -37.97 73.17 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.398 -0.365 . . . . 73.239999999999995 111.181 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.272 6.7 ppt_? -65.27 -23.54 67.07 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 112.283 0.475 . . . . 72.420000000000002 112.283 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.4 mm-40 -81.99 -52.34 7.15 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.44 -0.8 . . . . 72.439999999999998 112.778 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.21 -40.53 64.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 114.643 1.349 . . . . 52.240000000000002 114.643 -172.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.431 ' HB2' ' HE2' ' A' ' 59' ' ' MET . 35.5 ttm -57.74 -49.31 94.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 114.957 1.466 . . . . 55.219999999999999 114.957 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 59' ' ' MET . 13.0 Cg_endo -57.17 -31.86 91.75 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.909 1.74 . . . . 75.239999999999995 111.639 175.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 93.3 mttt -67.59 -36.08 80.2 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.315 0.578 . . . . 73.340000000000003 110.096 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.58 -43.94 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 72.329999999999998 109.884 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.67 -43.51 98.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.845 0.683 . . . . 73.099999999999994 112.845 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -64.16 -37.68 88.35 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.059 0.457 . . . . 71.040000000000006 110.507 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.448 ' CE1' ' HA ' ' A' ' 115' ' ' PRO . 38.6 t80 -66.28 -59.93 3.26 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.711 -0.677 . . . . 74.019999999999996 110.443 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.93 -26.15 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-O 121.17 0.51 . . . . 75.299999999999997 111.397 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -27.91 73.34 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 116.021 -0.536 . . . . 72.329999999999998 112.731 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.4 -11.87 0.22 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.33 -1.414 . . . . 71.450000000000003 114.321 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 116' ' ' SER . 23.5 m -82.23 49.53 1.43 Allowed 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 121.934 0.873 . . . . 75.120000000000005 110.268 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -98.61 149.54 22.67 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.567 -1.642 . . . . 61.409999999999997 106.567 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.47 -32.1 71.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.092 0.472 . . . . 73.430000000000007 112.044 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -78.05 -7.47 56.96 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.042 0.449 . . . . 74.010000000000005 111.016 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.0 18.27 80.22 Favored Glycine 0 CA--C 1.509 -0.291 0 C-N-CA 121.164 -0.541 . . . . 64.329999999999998 112.118 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.94 165.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.245 -1.02 . . . . 53.020000000000003 108.245 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.95 -120.15 0.95 Allowed Glycine 0 N--CA 1.41 -3.084 0 C-N-CA 119.484 -1.341 . . . . 51.509999999999998 112.227 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 69.9 mtm 68.4 9.69 7.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.201 1.0 . . . . 54.119999999999997 111.165 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.73 92.26 1.1 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.807 -0.633 . . . . 72.439999999999998 113.961 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -95.79 125.48 40.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.602 -1.999 . . . . 73.420000000000002 105.602 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.1 p -117.1 116.96 28.34 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 115.605 1.706 . . . . 74.409999999999997 115.605 -166.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.58 155.35 45.37 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 105.206 -2.146 . . . . 72.329999999999998 105.206 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.85 140.5 85.31 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.225 1.95 . . . . 62.43 114.151 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -106.35 151.36 8.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.957 -1.497 . . . . 70.409999999999997 106.957 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.3 t -141.79 147.48 37.36 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.902 -0.777 . . . . 74.549999999999997 108.902 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.83 144.35 48.91 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 122.337 -0.227 . . . . 75.120000000000005 110.506 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 136.23 33.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.722 -0.672 . . . . 71.439999999999998 109.519 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.89 150.62 25.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.011 -1.107 . . . . 63.439999999999998 108.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.617 ' CD2' ' HE2' ' A' ' 97' ' ' LYS . 1.7 m-85 -119.84 103.54 45.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 108.746 -0.835 . . . . 75.299999999999997 108.746 -175.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 151.37 37.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.145 1.897 . . . . 75.420000000000002 114.545 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.709 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 92.2 m-20 -102.89 156.09 17.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.466 -1.243 . . . . 64.129999999999995 108.171 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.05 -17.2 62.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.597 0.713 . . . . 73.519999999999996 109.747 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.96 -5.47 46.38 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.917 -1.038 . . . . 72.209999999999994 110.8 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.96 0.71 87.25 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 121.104 -0.569 . . . . 61.310000000000002 111.988 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.5 p -92.59 152.1 19.78 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 109.228 -0.656 . . . . 71.120000000000005 109.228 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.71 85.63 2.16 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.04 0.447 . . . . 74.040000000000006 110.765 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.605 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 34.3 tt0 -148.87 113.75 5.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.174 -0.466 . . . . 61.439999999999998 111.277 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.709 ' HE3' ' OD1' ' A' ' 89' ' ' ASN . 91.3 mttt -173.14 -75.44 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.883 1.673 . . . . 64.310000000000002 107.752 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.617 ' HE2' ' CD2' ' A' ' 87' ' ' PHE . 4.0 mppt? -143.05 156.57 44.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.997 -1.001 . . . . 74.439999999999998 108.942 177.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 tt -143.84 134.84 25.44 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.8 -1.185 . . . . 54.140000000000001 107.8 172.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 45' ' ' GLU . 33.9 ttpt -140.83 116.54 10.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 120.601 -0.44 . . . . 72.099999999999994 110.943 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' THR . 53.7 t -87.18 132.58 32.2 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 115.679 -0.691 . . . . 71.140000000000001 109.731 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -115.8 122.06 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.453 0.701 . . . . 75.25 109.27 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 85.9 t80 -103.21 123.22 46.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.334 0.587 . . . . 72.430000000000007 110.087 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -75.12 113.42 12.44 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.375 -1.284 . . . . 72.329999999999998 110.12 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.5 mt -89.26 125.03 63.25 Favored Pre-proline 0 N--CA 1.42 -1.958 0 N-CA-C 107.254 -1.387 . . . . 65.409999999999997 107.254 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.26 148.24 42.04 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.705 2.27 . . . . 75.0 111.335 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.422 HD21 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -57.23 -36.22 70.64 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.078 0.399 . . . . 63.399999999999999 112.078 -173.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -62.93 -28.46 70.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.449 0.642 . . . . 74.239999999999995 111.364 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.14 -12.28 38.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 116.119 -0.492 . . . . 70.450000000000003 110.668 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.51 ' HB3' ' CZ2' ' A' ' 16' ' ' TRP . 11.9 mm-40 -68.11 -29.42 68.33 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.591 0.589 . . . . 72.329999999999998 112.591 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.45 -39.19 97.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.15 -1.024 . . . . 62.409999999999997 111.403 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 m -153.46 87.73 3.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.36 -0.978 . . . . 72.109999999999999 108.36 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.67 151.21 11.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.278 1.985 . . . . 65.099999999999994 110.532 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.07 157.05 59.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.876 1.717 . . . . 73.299999999999997 110.805 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.49 147.22 71.44 Favored Pre-proline 0 N--CA 1.423 -1.808 0 N-CA-C 108.918 -0.771 . . . . 72.340000000000003 108.918 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.448 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 58.6 Cg_endo -73.18 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 121.917 1.744 . . . . 71.310000000000002 111.091 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 69' ' ' THR . 47.9 t -77.77 -28.68 50.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.34 -0.845 . . . . 75.200000000000003 111.655 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.29 152.1 25.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.281 -0.568 . . . . 65.319999999999993 110.401 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.11 -32.97 74.46 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.931 0.715 . . . . 75.209999999999994 112.931 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.471 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 20.1 m -93.44 -8.64 41.07 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.293 -0.563 . . . . 73.400000000000006 111.483 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 61.3 t -97.7 118.64 44.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.476 -1.305 . . . . 73.209999999999994 107.476 -176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -128.97 140.28 51.72 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.078 -0.712 . . . . 71.129999999999995 109.078 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.2 mm -92.08 112.0 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.271 -1.011 . . . . 72.310000000000002 108.271 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -123.44 148.41 46.18 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.553 -0.749 . . . . 72.510000000000005 109.963 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 1.7 mp0 -98.17 139.38 34.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.809 -1.182 . . . . 73.219999999999999 107.809 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -126.7 121.16 31.29 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.256 -0.978 . . . . 75.450000000000003 110.696 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.432 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -144.9 176.83 9.18 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.199 -0.909 . . . . 74.319999999999993 111.031 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.8 64.61 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.962 -0.637 . . . . 37.810000000000002 114.661 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.41 160.41 22.71 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 C-N-CA 119.386 -0.926 . . . . 70.030000000000001 112.065 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.2 m -112.88 142.97 44.93 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.027 -1.442 . . . . 73.329999999999998 107.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.78 145.39 29.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.525 -0.546 . . . . 73.400000000000006 109.525 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.589 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 56.3 m-85 -113.72 122.4 47.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.893 -2.262 . . . . 75.109999999999999 104.893 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.8 p -123.0 139.24 54.29 Favored 'General case' 0 C--N 1.263 -3.163 0 C-N-CA 120.092 -0.643 . . . . 62.530000000000001 110.983 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -113.21 127.41 56.17 Favored 'General case' 0 N--CA 1.402 -2.835 0 N-CA-C 108.138 -1.06 . . . . 65.209999999999994 108.138 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -110.43 125.32 53.13 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.734 -1.21 . . . . 73.310000000000002 107.734 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -147.0 153.72 40.39 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.167 0.508 . . . . 72.140000000000001 112.36 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.02 156.26 19.2 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.446 -0.797 . . . . 74.219999999999999 111.482 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.78 141.43 12.16 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.303 -1.119 . . . . 53.439999999999998 110.303 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -70.77 122.92 20.76 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.392 0.615 . . . . 73.540000000000006 111.198 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.95 133.5 53.33 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.589 -0.732 . . . . 51.119999999999997 109.629 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.618 ' HA ' ' CE2' ' A' ' 179' ' ' TYR . 39.0 ttpt -80.95 170.21 16.55 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.718 -0.845 . . . . 62.329999999999998 108.718 -177.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -53.29 -38.68 63.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.99 0.424 . . . . 52.399999999999999 111.185 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.06 77.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.589 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -66.8 -31.66 72.42 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 116.24 -0.436 . . . . 62.149999999999999 110.617 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -62.78 -40.95 98.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.784 -0.367 . . . . 72.540000000000006 110.522 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.57 -44.24 90.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.903 -0.59 . . . . 65.340000000000003 109.574 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -63.8 -47.22 81.76 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.572 -0.74 . . . . 74.409999999999997 111.275 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -66.02 -33.18 75.21 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.009 0.374 . . . . 74.319999999999993 112.009 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.7 94.49 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.299 -0.63 . . . . 61.119999999999997 109.299 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.2 m -64.24 -44.5 91.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.458 -0.792 . . . . 65.209999999999994 110.458 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 98.7 mt-30 -59.3 -49.22 78.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.818 0.447 . . . . 74.219999999999999 110.561 177.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.498 ' CD1' ' HB3' ' A' ' 31' ' ' TYR . 48.1 tp -58.02 -46.19 85.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.857 -0.61 . . . . 73.420000000000002 110.61 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -64.35 -34.54 78.38 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.857 -0.611 . . . . 73.450000000000003 110.216 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.5 m -73.18 -33.17 65.27 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.331 0.586 . . . . 73.040000000000006 109.837 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.405 HG21 ' HG3' ' A' ' 26' ' ' LYS . 42.0 m -72.38 -33.72 67.42 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.239 0.542 . . . . 74.019999999999996 109.779 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 158' ' ' THR . 87.8 mt -74.66 4.99 5.32 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.061 0.944 . . . . 73.019999999999996 113.197 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.1 142.5 43.64 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.654 -0.818 . . . . 74.340000000000003 111.1 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.23 62.18 Favored Glycine 0 C--N 1.297 -1.606 0 CA-C-N 115.456 -0.793 . . . . 63.340000000000003 111.15 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 155' ' ' LEU . 11.5 t -116.55 147.34 39.52 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 108.228 -1.027 . . . . 73.129999999999995 108.228 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -70.94 36.11 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.981 3.12 . . . . 62.219999999999999 113.666 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . . . -74.13 136.63 42.92 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.847 0.356 . . . . 63.329999999999998 111.02 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 69.3 p -111.82 162.91 14.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.341 -0.985 . . . . 74.319999999999993 108.341 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.8 m-85 -137.66 150.6 47.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.616 -0.883 . . . . 65.430000000000007 108.616 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.548 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -127.43 126.82 43.08 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.854 -0.738 . . . . 74.319999999999993 112.574 -177.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.84 -1.19 17.29 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.287 -0.869 . . . . 73.510000000000005 113.441 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 63.11 12.17 5.8 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 64.349999999999994 110.588 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.5 160.37 4.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.272 -0.876 . . . . 62.030000000000001 111.88 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.87 170.89 17.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.42 -0.809 . . . . 71.219999999999999 110.015 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 18.1 m-85 -115.58 153.31 31.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.252 0.548 . . . . 72.519999999999996 111.848 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 41.7 t -115.12 144.82 43.08 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.241 -1.763 . . . . 72.209999999999994 106.241 172.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.24 160.56 16.87 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 121.131 -0.228 . . . . 62.409999999999997 110.644 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.57 165.32 37.34 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.3 -1.12 . . . . 52.039999999999999 110.3 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -141.22 -53.23 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 112.847 0.684 . . . . 75.030000000000001 112.847 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -156.21 158.32 31.51 Favored Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 106.632 -1.618 . . . . 75.219999999999999 106.632 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.89 106.74 0.19 Allowed 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.18 1.92 . . . . 61.420000000000002 108.924 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -82.29 149.22 15.04 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 C-N-CA 122.309 2.006 . . . . 72.140000000000001 114.255 -169.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 65.0 mtt -64.27 -39.73 94.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.357 -0.838 . . . . 72.140000000000001 109.681 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -87.63 139.81 31.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 104.165 -2.531 . . . . 74.340000000000003 104.165 173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -38.11 -33.39 0.27 Allowed 'Trans proline' 0 N--CA 1.506 2.265 0 C-N-CA 124.393 3.395 . . . . 65.329999999999998 116.381 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 140' ' ' LYS . 97.1 m-85 -134.61 9.96 3.68 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.987 0.422 . . . . 64.010000000000005 111.603 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.96 -174.17 37.11 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.407 -0.902 . . . . 74.299999999999997 112.032 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -97.09 -14.68 21.4 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.923 0.392 . . . . 64.049999999999997 111.676 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.2 134.39 29.43 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 116.325 -0.398 . . . . 73.510000000000005 111.155 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.28 143.4 46.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.85 0.46 . . . . 74.340000000000003 111.025 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -122.08 148.0 45.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.49 -0.323 . . . . 75.219999999999999 110.912 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.3 t -128.18 128.93 69.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.614 -1.254 . . . . 71.109999999999999 107.614 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 7.0 m0 -114.98 124.83 52.66 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 110.354 -0.239 . . . . 65.329999999999998 110.354 -178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.12 138.97 35.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.94 -1.133 . . . . 63.219999999999999 107.94 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 38.5 t -100.17 127.74 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 120.696 -0.401 . . . . 72.310000000000002 111.547 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.1 tmtt? -78.14 123.76 27.27 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.426 -0.806 . . . . 73.140000000000001 109.691 176.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.26 1.651 0 O-C-N 124.268 0.98 . . . . 64.310000000000002 110.183 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 CA--C 1.504 -0.803 0 N-CA-C 108.989 -0.745 . . . . 74.319999999999993 108.989 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t -95.54 102.99 14.84 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.76 -1.2 . . . . 74.010000000000005 107.76 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.337 1.1 pp -73.68 72.61 1.48 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 122.779 1.276 . . . . 71.329999999999998 114.203 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -83.85 145.66 28.51 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 114.695 -1.139 . . . . 74.209999999999994 108.356 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.58 -34.72 2.82 Favored Glycine 0 CA--C 1.479 -2.171 0 N-CA-C 110.045 -1.222 . . . . 72.310000000000002 110.045 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -79.48 86.89 5.12 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.52 -0.918 . . . . 65.319999999999993 108.52 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.57 169.1 6.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 109.129 -0.693 . . . . 75.25 109.129 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HA ' ' N ' ' A' ' 110' ' ' GLY . 1.1 mp0 -62.27 -40.58 96.7 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 123.581 0.55 . . . . 70.420000000000002 111.202 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.8 m -100.04 88.62 3.79 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 114.908 1.447 . . . . 75.209999999999994 114.908 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -103.6 105.11 45.81 Favored Pre-proline 0 N--CA 1.422 -1.854 0 N-CA-C 106.266 -1.753 . . . . 73.120000000000005 106.266 162.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.68 145.17 22.83 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.061 1.841 . . . . 74.120000000000005 115.053 -170.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -103.8 146.28 28.87 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.331 -1.729 . . . . 75.030000000000001 106.331 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -119.32 120.22 36.29 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 119.148 -1.021 . . . . 75.25 112.073 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.411 HG21 ' HG2' ' A' ' 34' ' ' ARG . 44.5 t -78.16 114.52 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 102.803 -3.036 . . . . 74.319999999999993 102.803 168.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.62 -30.13 17.36 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.288 -1.365 . . . . 74.310000000000002 112.874 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -158.67 163.07 37.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.922 -0.77 . . . . 72.340000000000003 108.922 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.445 HG23 ' CB ' ' A' ' 32' ' ' GLU . 44.8 p -132.66 162.59 30.98 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.461 -0.57 . . . . 65.439999999999998 109.461 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.24 -145.4 10.15 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.775 -0.726 . . . . 73.340000000000003 111.831 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -156.7 16.71 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.917 -0.658 . . . . 44.439999999999998 111.905 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.01 171.87 7.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.398 0.679 . . . . 74.439999999999998 111.642 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.68 143.59 48.04 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.68 -1.6 . . . . 75.299999999999997 106.68 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 80.23 -50.58 0.35 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.305 1.042 . . . . 74.140000000000001 111.314 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.0 t -116.09 109.14 27.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.287 -0.634 . . . . 53.109999999999999 109.287 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -116.91 154.91 29.99 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.454 -0.794 . . . . 73.549999999999997 109.629 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 162.48 31.97 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.76 0.314 . . . . 75.329999999999998 111.821 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.445 ' CB ' HG23 ' A' ' 23' ' ' THR . 12.6 pt-20 -154.89 139.74 17.2 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.699 -1.593 . . . . 75.310000000000002 106.699 174.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.6 ' HB3' ' CD2' ' A' ' 131' ' ' TYR 0.283 0.2 OUTLIER -103.53 125.6 50.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.208 -0.997 . . . . 63.450000000000003 111.93 177.251 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' HG2' HG21 ' A' ' 20' ' ' VAL . 70.7 mtt180 -115.03 127.15 55.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.616 -1.174 . . . . 75.140000000000001 109.481 -176.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.64 132.49 34.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.895 -1.52 . . . . 74.450000000000003 106.895 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' A' ' 128' ' ' ILE . 74.6 m -74.71 157.79 34.68 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 120.129 -0.628 . . . . 75.209999999999994 111.622 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -84.7 -25.02 28.66 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.602 -0.726 . . . . 74.310000000000002 111.522 -174.556 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.13 11.02 56.81 Favored Glycine 0 CA--C 1.497 -1.072 0 C-N-CA 119.49 -1.338 . . . . 37.030000000000001 111.474 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.55 165.74 51.88 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 114.114 0.406 . . . . 71.420000000000002 114.114 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -101.02 122.59 43.8 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.818 -0.691 . . . . 71.129999999999995 109.378 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 44.7 m-85 -125.57 165.65 18.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.293 -0.867 . . . . 73.540000000000006 111.894 -170.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.22 116.7 30.99 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 108.78 -0.822 . . . . 73.120000000000005 108.78 -177.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 10.1 t -124.77 143.91 50.54 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-O 121.349 0.595 . . . . 74.219999999999999 111.352 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.517 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.3 m -128.4 139.98 50.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.054 -0.975 . . . . 74.120000000000005 108.791 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.13 136.83 51.7 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.077 -0.649 . . . . 72.140000000000001 112.074 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 54' ' ' ALA . 29.6 t -131.06 142.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.058 -0.719 . . . . 75.200000000000003 109.058 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 p -135.26 178.15 7.26 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.531 0.332 . . . . 73.040000000000006 110.311 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.0 t70 73.6 -14.99 0.59 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.448 1.099 . . . . 61.43 113.159 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -131.21 147.26 65.53 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.313 -0.625 . . . . 70.239999999999995 109.313 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.28 156.29 5.71 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.652 2.902 . . . . 74.299999999999997 112.526 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 20.5 m -56.2 -36.33 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.518 0.562 . . . . 73.040000000000006 112.518 -174.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 10.4 m-20 -58.78 -49.82 76.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.164 0.507 . . . . 75.430000000000007 110.158 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.04 -36.32 79.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.318 -0.855 . . . . 75.239999999999995 110.191 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . . . -60.38 -47.35 86.43 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.437 -0.801 . . . . 70.400000000000006 110.59 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 59' ' ' MET . 96.1 mt -55.87 -36.97 68.18 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 122.43 0.292 . . . . 74.310000000000002 111.479 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 1.7 mmp_? -59.37 -34.29 72.23 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.307 0.575 . . . . 71.439999999999998 110.456 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -83.98 -41.41 17.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.418 -0.81 . . . . 73.430000000000007 111.338 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.01 -33.09 67.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 114.393 1.257 . . . . 74.0 114.393 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 17.8 mmt -61.31 -57.2 27.22 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 120.317 -0.553 . . . . 74.099999999999994 111.713 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.95 -38.45 86.38 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.594 2.196 . . . . 71.340000000000003 113.008 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -69.15 -28.8 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.019 0.748 . . . . 75.340000000000003 113.019 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.5 mm -76.55 -45.11 33.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.342 -0.614 . . . . 51.109999999999999 109.342 170.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.2 mtp -62.25 -33.49 74.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.452 -0.795 . . . . 62.43 112.941 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -70.25 -40.25 74.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.872 0.368 . . . . 71.129999999999995 110.172 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -59.03 -52.09 67.25 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.137 -0.483 . . . . 75.349999999999994 110.801 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.87 -13.09 14.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.062 -0.517 . . . . 43.219999999999999 111.523 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.37 -16.78 70.52 Favored Glycine 0 CA--C 1.506 -0.486 0 CA-C-N 115.94 -0.573 . . . . 72.519999999999996 112.436 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . 134.4 -11.04 4.68 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 119.746 -1.216 . . . . 40.439999999999998 112.828 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 m -80.3 30.11 0.29 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 122.888 1.327 . . . . 73.230000000000004 110.369 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 68' ' ' GLY . 7.3 p30 -97.81 171.36 8.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.978 -1.01 . . . . 74.420000000000002 109.032 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . 26.5 t70 -67.97 -27.55 66.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 37.030000000000001 113.084 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.55 -13.2 55.0 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.446 -0.902 . . . . 72.140000000000001 109.595 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.31 22.49 74.67 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.608 -0.724 . . . . 54.439999999999998 111.308 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 m -81.97 122.17 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 121.246 0.546 . . . . 62.210000000000001 112.293 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.02 52.76 0.62 Allowed Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.11 -1.196 . . . . 72.120000000000005 110.11 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.7 mtt -82.91 -41.74 18.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.309 0.576 . . . . 73.140000000000001 110.519 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.04 129.03 3.39 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.306 -0.95 . . . . 73.129999999999995 111.593 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.43 ' SD ' ' HE2' ' A' ' 102' ' ' PHE . 23.6 ptp -132.78 126.03 31.45 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.806 -0.442 . . . . 73.209999999999994 109.806 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.4 p -124.83 115.79 21.23 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.023 0.749 . . . . 63.420000000000002 113.023 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 15.6 m -153.59 174.54 3.67 Favored Pre-proline 0 C--N 1.313 -1.003 0 C-N-CA 125.88 1.672 . . . . 75.319999999999993 106.498 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 171' ' ' GLY . 78.2 Cg_exo -56.72 140.36 90.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.157 1.905 . . . . 73.530000000000001 114.057 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 48.6 t -105.75 143.04 17.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.395 -1.706 . . . . 74.209999999999994 106.395 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.4 m -132.35 151.4 51.87 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.996 0.362 . . . . 75.319999999999993 110.332 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -145.07 146.46 31.86 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 122.036 -0.415 . . . . 74.510000000000005 111.162 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.42 135.33 34.13 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 116.029 -0.532 . . . . 72.209999999999994 109.943 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.7 m -137.81 150.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.43 -0.952 . . . . 72.230000000000004 108.43 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 39.5 m-85 -119.88 108.24 39.11 Favored Pre-proline 0 C--N 1.281 -2.378 0 N-CA-C 107.466 -1.309 . . . . 73.010000000000005 107.466 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.01 147.8 8.01 Favored 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 121.243 1.295 . . . . 60.409999999999997 113.69 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.37 154.62 18.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.71 -1.959 . . . . 72.340000000000003 105.71 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.5 -13.15 62.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 114.247 1.202 . . . . 73.049999999999997 114.247 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.66 -4.09 58.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.502 0.668 . . . . 74.420000000000002 109.763 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 -11.07 59.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.733 -0.667 . . . . 37.030000000000001 113.466 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.2 m -78.53 139.38 38.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.251 -0.58 . . . . 63.219999999999999 110.112 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.69 150.9 23.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.645 -0.422 . . . . 71.239999999999995 110.083 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.402 ' NE2' ' HB2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -79.77 150.1 30.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.736 -1.579 . . . . 74.349999999999994 106.736 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.0 38.92 0.54 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.712 0.805 . . . . 63.009999999999998 111.956 -171.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -127.8 122.55 33.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 104.207 -2.516 . . . . 62.210000000000001 104.207 176.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.526 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 3.1 tm? -131.36 145.49 51.86 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.009 0.433 . . . . 75.140000000000001 109.993 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' N ' HD13 ' A' ' 98' ' ' LEU . 87.9 tttt -148.19 116.13 6.41 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.248 -0.887 . . . . 63.039999999999999 110.724 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.517 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 93.7 t -95.1 126.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 122.94 0.496 . . . . 75.140000000000001 110.103 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.94 122.71 46.97 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.274 -1.01 . . . . 75.340000000000003 108.274 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 82.5 t80 -103.5 120.17 40.31 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.315 -0.994 . . . . 72.329999999999998 108.315 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -74.99 122.33 23.33 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.783 -0.644 . . . . 62.039999999999999 109.33 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.466 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 66.7 mt -91.75 125.92 55.65 Favored Pre-proline 0 N--CA 1.415 -2.201 0 N-CA-C 107.226 -1.398 . . . . 52.450000000000003 107.226 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -52.86 155.59 10.7 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 123.289 2.659 . . . . 64.519999999999996 113.558 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -47.29 -44.36 23.2 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.475 1.51 . . . . 75.349999999999994 112.052 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.86 -30.02 68.69 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.015 -0.539 . . . . 71.109999999999999 112.435 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -99.95 -2.69 34.0 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.719 -0.219 . . . . 74.019999999999996 111.584 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.466 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 25.3 mm-40 -70.49 -34.99 72.98 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.21 0.818 . . . . 71.519999999999996 113.21 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.456 ' N ' ' HA ' ' A' ' 14' ' ' GLU . . . -59.49 -38.28 93.33 Favored Glycine 0 N--CA 1.466 0.64 0 C-N-CA 120.953 -0.642 . . . . 52.539999999999999 112.41 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.3 m -155.46 93.41 2.65 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.682 -0.859 . . . . 74.439999999999998 108.682 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -87.14 157.83 8.41 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.571 2.18 . . . . 74.549999999999997 111.971 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.62 151.93 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.223 1.948 . . . . 64.140000000000001 111.575 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.444 ' HB1' ' CB ' ' A' ' 71' ' ' ASP . . . -85.55 152.69 57.77 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-N 116.012 -0.54 . . . . 52.340000000000003 110.206 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.67 110.94 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.29 1.993 . . . . 52.100000000000001 112.561 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.7 m -80.87 -20.3 42.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.02 0.438 . . . . 75.239999999999995 110.958 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -107.88 140.57 40.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.926 -1.509 . . . . 71.230000000000004 106.926 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -76.18 -12.86 60.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.215 0.45 . . . . 64.409999999999997 112.215 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.3 m -70.88 -32.23 69.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.496 . . . . 73.540000000000006 109.988 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.18 130.07 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.661 -0.699 . . . . 64.109999999999999 109.176 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -127.86 133.14 49.34 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.925 -0.579 . . . . 74.150000000000006 110.275 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.7 mm -93.09 112.4 26.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.606 -0.887 . . . . 63.039999999999999 108.606 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.86 151.86 46.3 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.691 -0.855 . . . . 63.020000000000003 108.691 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.25 146.65 30.06 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.801 -0.444 . . . . 73.150000000000006 109.801 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -140.55 123.09 16.11 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.781 -0.368 . . . . 52.43 110.051 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.8 164.88 28.46 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.412 -0.958 . . . . 60.520000000000003 108.412 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.72 35.47 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.02 -1.086 . . . . 54.43 112.42 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.433 HG13 ' SG ' ' A' ' 36' ' ' CYS . 38.2 pt -135.51 145.72 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.899 0.856 . . . . 75.400000000000006 112.324 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.444 ' HB ' ' HG2' ' A' ' 189' ' ' LYS . 19.8 m -115.5 140.17 49.39 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 104.992 -2.225 . . . . 74.430000000000007 104.992 173.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.16 153.9 30.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.413 0 N-CA-C 109.246 -0.65 . . . . 74.409999999999997 109.246 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 33' ' ' GLU . 42.3 m-85 -113.11 121.49 44.71 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.144 -2.169 . . . . 71.5 105.144 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 16.6 p -112.58 134.28 54.19 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 121.581 0.705 . . . . 61.219999999999999 111.865 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.425 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 8.8 t -126.25 133.87 51.35 Favored 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 114.87 -1.059 . . . . 64.230000000000004 109.255 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 50.1 mt-30 -111.09 146.57 36.55 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.781 -0.368 . . . . 75.319999999999993 110.676 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -146.93 168.16 22.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.897 -0.592 . . . . 75.329999999999998 109.476 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.12 152.15 23.42 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.815 -0.914 . . . . 75.129999999999995 110.815 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 135.68 -138.58 10.05 Favored Glycine 0 C--N 1.313 -0.73 0 N-CA-C 110.921 -0.872 . . . . 73.129999999999995 110.921 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -100.56 106.67 18.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.782 -0.821 . . . . 75.150000000000006 108.782 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.85 114.64 27.31 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.48 0.919 . . . . 73.310000000000002 113.48 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -102.14 175.56 5.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.875 -1.528 . . . . 63.409999999999997 106.875 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.46 ' O ' HG21 ' A' ' 145' ' ' VAL . 2.1 mp0 -57.79 -44.18 86.09 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.252 -1.018 . . . . 51.409999999999997 108.252 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.33 67.36 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.191 -1.368 . . . . 70.530000000000001 112.16 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 147' ' ' HIS . 5.1 m-20 -65.72 -49.07 69.8 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 121.098 -0.241 . . . . 71.420000000000002 110.387 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.453 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 48.5 m-85 -57.96 -43.47 86.43 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.499 0.499 . . . . 74.109999999999999 110.099 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 141' ' ' GLU . 58.8 t -62.7 -51.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 120.997 0.427 . . . . 74.109999999999999 111.322 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.16 75.3 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.397 0.618 . . . . 62.020000000000003 110.41 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 7.7 t-160 -66.79 -47.89 70.7 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.457 -0.792 . . . . 62.420000000000002 108.902 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.24 92.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.589 -0.732 . . . . 75.200000000000003 110.368 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 89.0 m -64.56 -36.61 84.77 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.744 -0.662 . . . . 75.340000000000003 110.838 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -74.11 -28.62 61.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.691 -0.403 . . . . 70.349999999999994 110.161 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 81.4 mt -58.98 -34.58 71.98 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 109.938 -0.393 . . . . 54.350000000000001 109.938 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 149' ' ' THR . 30.6 mtp180 -61.33 -38.82 88.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.779 -0.646 . . . . 63.030000000000001 109.454 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -73.07 -37.41 66.8 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.147 -0.933 . . . . 74.310000000000002 110.365 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.2 m -77.41 -34.51 54.72 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.09 0.471 . . . . 74.540000000000006 110.829 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 158' ' ' THR . 95.4 mt -80.83 7.66 9.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.579 0.752 . . . . 63.420000000000002 111.136 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -82.34 130.37 35.08 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.92 -1.141 . . . . 75.230000000000004 107.92 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.56 58.3 Favored Glycine 0 C--N 1.307 -1.081 0 C-N-CA 120.649 -0.786 . . . . 74.5 112.528 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 155' ' ' LEU . 15.4 t -125.2 149.25 63.28 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 107.772 -1.196 . . . . 75.340000000000003 107.772 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -64.25 -2.77 5.24 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 123.489 2.793 . . . . 73.0 115.154 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . . . -62.98 142.54 58.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.723 0.297 . . . . 74.349999999999994 111.361 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 46.7 p -116.56 151.72 35.6 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.085 -0.507 . . . . 73.219999999999999 109.886 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -143.91 149.29 36.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.764 -0.458 . . . . 74.400000000000006 109.764 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -134.0 145.49 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.514 0.931 . . . . 75.439999999999998 113.514 -174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.84 -1.39 23.45 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.876 -1.056 . . . . 43.219999999999999 115.257 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 t70 61.16 7.99 1.84 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.024 0.93 . . . . 70.409999999999997 111.057 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.74 139.69 18.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 124.446 1.098 . . . . 62.109999999999999 110.165 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 144' ' ' TYR . 43.9 p90 -137.86 167.61 21.39 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.619 -0.719 . . . . 73.140000000000001 109.173 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.514 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 79.2 m-85 -115.69 152.78 32.53 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.308 -0.997 . . . . 64.340000000000003 108.308 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 83' ' ' SER . 59.7 m -113.62 132.34 55.78 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.616 -1.253 . . . . 73.319999999999993 107.616 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 82' ' ' VAL . . . -128.23 147.19 50.57 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.032 0.444 . . . . 70.400000000000006 111.034 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . -142.49 141.28 10.59 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 110.133 -1.187 . . . . 64.010000000000005 110.133 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -103.99 -14.1 16.07 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.148 0.499 . . . . 75.030000000000001 110.405 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -128.21 136.01 28.4 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 107.398 -1.334 . . . . 73.420000000000002 107.398 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.33 112.79 3.1 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 121.879 1.719 . . . . 75.010000000000005 109.533 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.36 130.92 3.44 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 122.054 1.836 . . . . 73.510000000000005 114.087 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 28.1 ttt -94.47 -39.51 10.38 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.201 -1.407 . . . . 64.450000000000003 107.201 172.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.78 144.65 29.32 Favored Pre-proline 0 N--CA 1.436 -1.175 0 CA-C-N 115.044 -0.98 . . . . 62.240000000000002 108.493 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.85 -13.36 22.16 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 124.13 3.22 . . . . 54.539999999999999 115.212 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -51.06 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.443 1.275 . . . . 74.230000000000004 114.443 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 75.76 113.8 0.11 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.891 -0.671 . . . . 54.25 111.846 -176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -77.42 -15.59 59.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.019 0.914 . . . . 70.340000000000003 109.125 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -142.27 129.51 21.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.634 -1.166 . . . . 74.409999999999997 108.211 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 38.1 m-80 -141.14 148.58 40.28 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 105.257 -2.127 . . . . 72.409999999999997 105.257 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 37.4 tt0 -126.38 141.02 52.05 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.023 -0.671 . . . . 72.030000000000001 110.486 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 132' ' ' SER . 29.0 t -124.49 129.14 73.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.744 -1.206 . . . . 74.299999999999997 107.744 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 39.0 m0 -110.15 126.9 54.57 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 110.135 -0.32 . . . . 75.140000000000001 110.135 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.83 137.74 39.72 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.523 -1.658 . . . . 75.230000000000004 106.523 172.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.46 133.18 43.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 120.554 -0.459 . . . . 74.129999999999995 112.203 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -69.64 143.38 53.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.683 -0.69 . . . . 72.439999999999998 111.92 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.416 ' HB2' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.305 -1.338 0 CA-C-O 118.433 -0.794 . . . . 60.149999999999999 109.123 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.583 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.2 p90 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 54.4 tt0 -106.0 109.24 21.12 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.057 -0.657 . . . . 71.51 109.646 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.8 p -93.31 131.92 38.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.247 -1.019 . . . . 62.42 108.247 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 33' ' ' GLU . 10.2 mt -89.25 -40.93 12.5 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.12 -1.067 . . . . 71.24 108.12 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 m -173.11 169.6 4.57 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.617 1.167 . . . . 74.24 108.313 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.77 165.59 24.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.562 -1.273 . . . . 75.33 107.562 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.31 89.87 0.17 Allowed Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 118.759 -1.686 . . . . 62.04 113.78 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.68 -134.11 4.25 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.757 -0.735 . . . . 54.33 111.912 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -115.27 173.81 6.32 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 123.821 0.848 . . . . 74.41 110.411 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -64.61 141.72 58.68 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.074 -1.084 . . . . 70.33 108.074 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 73.86 -62.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.673 1.189 . . . . 73.15 110.587 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.477 HG22 ' CD2' ' A' ' 147' ' ' HIS . 23.5 t -97.32 108.82 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.07 -1.085 . . . . 62.41 108.07 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.9 m -123.53 137.56 54.74 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.093 -1.077 . . . . 74.23 108.093 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -115.75 160.84 19.57 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.497 1.295 . . . . 61.13 114.497 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.515 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -147.0 125.85 12.7 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.126 -1.852 . . . . 73.33 106.682 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -104.66 122.1 44.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 119.169 -1.012 . . . . 74.31 108.676 175.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 31.7 ptt180 -141.37 153.86 45.32 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.123 -0.944 . . . . 75.1 111.445 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.05 136.33 36.65 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.093 -1.077 . . . . 54.12 108.093 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -61.58 149.24 39.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.315 1.228 . . . . 62.33 114.315 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 39' ' ' GLY . 4.4 tp10 -51.32 -50.7 58.89 Favored 'General case' 0 C--N 1.367 1.367 0 C-N-CA 124.151 0.981 . . . . 75.22 110.786 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.52 9.31 53.32 Favored Glycine 0 C--N 1.294 -1.763 0 C-N-CA 120.099 -1.048 . . . . 63.35 110.924 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -71.82 165.38 53.85 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.062 -0.569 . . . . 71.34 112.28 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 18.4 ptpt -88.54 129.69 35.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.471 -0.566 . . . . 52.1 109.471 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 58.1 m-85 -128.69 164.21 23.44 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.372 0.669 . . . . 74.41 110.549 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.97 116.87 33.02 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 108.652 -0.87 . . . . 61.31 108.652 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.4 t -125.43 143.46 50.98 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 121.141 0.496 . . . . 75.44 112.213 -175.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 14.8 m -129.65 127.74 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.077 -0.965 . . . . 71.43 109.906 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.76 128.08 56.1 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.711 0.767 . . . . 65.3 111.42 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 40.2 t -112.6 140.55 31.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.892 -1.049 . . . . 64.31 109.239 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 49' ' ' LYS . 40.9 p -132.37 172.73 12.09 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.264 -0.643 . . . . 63.25 109.264 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.22 -40.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.597 1.159 . . . . 72.32 111.626 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 36.3 mtmm -93.24 127.86 45.17 Favored Pre-proline 0 C--N 1.288 -2.066 0 CA-C-N 114.965 -1.016 . . . . 61.25 110.219 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 51.8 Cg_exo -55.3 158.95 11.2 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 124.394 3.396 . . . . 65.02 112.37 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 98' ' ' LEU . 53.0 t -46.53 -39.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.61 0.764 . . . . 71.03 112.189 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.28 -50.41 71.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.971 0.415 . . . . 72.32 111.061 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 32.4 mm-40 -75.18 -44.1 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.784 -0.644 . . . . 61.35 111.919 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -56.68 -42.97 79.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.295 0.638 . . . . 71.54 111.977 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 59' ' ' MET . 64.6 tp -63.8 -51.84 62.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.719 0.295 . . . . 41.23 110.703 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -65.82 -24.86 67.0 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 113.162 0.801 . . . . 74.1 113.162 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 49' ' ' LYS . 3.8 tm-20 -83.87 -33.85 24.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.657 0.741 . . . . 74.15 109.837 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.556 ' HA ' ' NZ ' ' A' ' 61' ' ' LYS . . . -75.88 -33.03 59.94 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 112.885 0.698 . . . . 65.2 112.885 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 12.4 mmt -50.79 -51.31 67.54 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 112.738 0.644 . . . . 74.43 112.738 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 89.3 Cg_exo -52.29 -39.11 73.21 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.482 2.121 . . . . 64.33 111.619 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.556 ' NZ ' ' HA ' ' A' ' 58' ' ' ALA . 35.2 mtmm -69.71 -32.19 70.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.422 . . . . 72.51 111.878 -177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 102' ' ' PHE . 31.8 mm -76.3 -45.1 35.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.001 0.429 . . . . 73.11 110.823 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.446 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.3 ptm -69.7 -30.68 68.38 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 112.275 0.472 . . . . 74.3 112.275 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 61' ' ' LYS . 20.2 ptmt -67.95 -30.52 69.83 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.704 -0.398 . . . . 72.41 109.936 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -63.11 -55.95 20.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.044 -0.525 . . . . 73.13 111.103 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.89 -15.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.894 0.378 . . . . 74.44 111.781 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.015 -0.539 . . . . 53.33 113.071 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.58 -12.75 2.71 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.438 -1.363 . . . . 72.3 113.495 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 116' ' ' SER . 21.5 m -82.77 29.55 0.45 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.724 1.25 . . . . 71.12 110.314 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.12 161.05 13.91 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.973 -1.121 . . . . 32.13 107.973 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 15.8 t70 -67.4 -33.21 74.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.724 0.639 . . . . 63.25 112.724 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -78.16 -12.47 60.0 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.266 0.555 . . . . 70.03 110.461 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 36.12 70.18 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.806 -0.634 . . . . 74.33 112.256 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -80.54 122.51 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.409 -0.589 . . . . 74.44 109.409 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.92 1.99 61.55 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.193 -0.527 . . . . 63.34 111.93 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.2 tpt -73.14 98.33 2.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.193 0.52 . . . . 74.45 110.621 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.79 89.3 0.86 Allowed Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.71 -0.956 . . . . 64.24 110.71 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.73 125.38 40.27 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.525 0.678 . . . . 62.42 111.11 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 m -127.86 118.46 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.867 1.062 . . . . 72.03 113.867 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.44 -179.62 0.66 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 104.602 -2.37 . . . . 74.11 104.602 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.27 137.8 67.96 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 122.582 1.958 . . . . 73.34 111.4 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 44.6 t -102.75 141.68 18.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.272 -1.381 . . . . 53.34 107.272 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 168' ' ' TYR . 26.1 t -126.32 146.23 50.11 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.605 -0.438 . . . . 61.23 109.859 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 43.9 p90 -135.36 142.69 45.79 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 110.135 -0.32 . . . . 61.13 110.135 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.11 134.89 34.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 123.785 0.678 . . . . 64.11 110.411 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 m -126.58 150.14 32.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.787 -1.097 . . . . 64.15 108.294 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.604 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 46.0 m-85 -120.87 104.1 42.25 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 120.371 -0.531 . . . . 62.2 110.288 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.58 133.58 3.79 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.037 1.824 . . . . 72.5 112.103 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -86.48 162.33 18.14 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.15 -1.055 . . . . 72.0 108.15 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.49 -12.95 61.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.513 0.673 . . . . 73.05 111.211 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.36 -6.09 56.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.857 -0.611 . . . . 72.34 109.917 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.88 -10.32 74.1 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 115.97 -0.559 . . . . 75.33 112.791 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.9 m -91.97 137.95 31.94 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 110.151 -0.314 . . . . 73.11 110.151 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 mp -75.14 138.68 42.21 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.266 0.555 . . . . 42.53 111.545 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.2 129.38 34.46 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.535 -2.024 . . . . 63.04 105.535 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -71.73 81.73 0.87 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.165 0.983 . . . . 74.13 113.27 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.604 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 37.8 ttmt -160.46 125.61 3.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.998 -2.223 . . . . 71.4 104.998 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 51' ' ' VAL . 6.0 tt -135.5 129.28 32.85 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 108.669 -0.863 . . . . 61.42 108.669 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -122.3 114.84 21.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.244 -0.65 . . . . 75.31 109.244 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.5 t -92.4 129.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.958 -0.565 . . . . 63.23 109.579 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -110.79 123.35 49.9 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.904 -0.776 . . . . 61.42 108.904 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HB2' HD12 ' A' ' 62' ' ' ILE . 86.4 t80 -102.53 112.48 25.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.939 -1.134 . . . . 65.24 107.939 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 39.7 ttp180 -76.91 121.26 23.19 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-N 114.376 -1.284 . . . . 61.44 109.901 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.0 mt -88.45 133.04 37.26 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 115.211 -0.904 . . . . 74.14 109.934 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.13 154.67 32.55 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.919 2.412 . . . . 74.35 111.562 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -53.42 -45.26 69.32 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.086 1.143 . . . . 73.14 114.086 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.97 -31.55 71.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.225 0.536 . . . . 55.04 111.161 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.89 -5.85 49.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.18 -0.464 . . . . 73.15 111.323 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -70.68 -38.26 73.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.728 -0.842 . . . . 74.41 108.728 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.96 93.56 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.281 -0.872 . . . . 72.23 112.138 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.2 m -154.27 92.88 2.96 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 122.534 0.334 . . . . 50.12 111.049 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 84.8 Cg_endo -90.11 149.4 4.67 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.364 2.043 . . . . 70.42 111.535 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 27.3 Cg_exo -65.9 146.33 82.66 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.592 2.195 . . . . 73.14 111.407 175.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -74.22 147.01 85.19 Favored Pre-proline 0 C--O 1.255 1.36 0 C-N-CA 120.634 -0.426 . . . . 72.43 110.413 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.45 113.38 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.604 2.203 . . . . 64.53 111.547 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 69' ' ' THR . 26.5 t -91.23 -12.52 35.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.563 0.697 . . . . 72.14 109.718 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.565 ' HB3' HG12 ' A' ' 120' ' ' VAL . 9.5 t70 -100.67 136.78 40.0 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.52 -1.289 . . . . 73.43 107.52 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.434 ' O ' ' HE2' ' A' ' 121' ' ' LYS . 13.9 pt-20 -72.45 -19.12 61.63 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.234 0.827 . . . . 73.23 113.234 -173.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.8 m -86.36 -25.6 25.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.531 -0.468 . . . . 75.24 111.169 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 117' ' ' ASP . 10.7 p -97.13 129.09 47.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 120.402 -0.519 . . . . 62.2 109.627 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 118' ' ' GLU . 75.7 mmtt -124.21 143.19 50.66 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.255 -0.429 . . . . 74.41 110.22 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 23.6 mm -92.74 111.1 23.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.703 -1.221 . . . . 55.43 107.703 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -125.22 142.39 51.52 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.557 -0.747 . . . . 75.25 109.387 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 11.2 pt-20 -100.41 135.71 41.43 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.079 -0.711 . . . . 71.23 109.079 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.517 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 32.3 tpt180 -125.58 122.15 35.66 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.032 -0.667 . . . . 74.43 110.767 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.56 177.61 8.36 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.143 -1.058 . . . . 74.22 108.143 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.28 -12.8 68.75 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.514 -0.85 . . . . 63.3 114.68 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.265 2.6 pp -121.13 157.73 24.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 118.553 -1.259 . . . . 64.23 113.593 -176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.6 m -109.57 133.61 52.89 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.922 -1.49 . . . . 50.42 108.751 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 188' ' ' VAL . 32.0 m -124.0 157.06 31.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-O 121.155 0.502 . . . . 65.2 110.454 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 69.4 m-85 -113.21 121.87 45.77 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 103.618 -2.734 . . . . 61.22 103.618 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.7 m -119.46 132.24 55.76 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 120.656 -0.418 . . . . 63.35 110.353 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.9 t -112.8 128.13 56.35 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.936 -0.764 . . . . 70.53 108.936 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.04 125.34 53.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.522 -1.658 . . . . 64.4 106.522 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 26.1 p90 -141.71 154.89 45.6 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.858 -0.61 . . . . 73.31 110.491 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.86 14.75 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.79 -0.719 . . . . 51.34 113.109 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 144.17 -176.92 23.14 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.202 -1.559 . . . . 53.45 109.202 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -81.36 107.7 14.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.014 0.907 . . . . 71.23 109.288 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -96.45 138.19 34.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.508 0.671 . . . . 70.31 112.483 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.505 ' HE3' ' OD1' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -109.98 176.66 4.98 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.562 -1.644 . . . . 53.32 106.562 172.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -36.19 80.36 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.261 0.467 . . . . 73.52 112.261 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.11 -32.56 73.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 73.43 111.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.505 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 5.4 m-20 -63.97 -34.42 77.95 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 116.365 -0.38 . . . . 64.51 111.52 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.17 -43.93 90.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.99 0.424 . . . . 74.13 110.022 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.1 t -66.17 -45.86 89.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.533 -0.758 . . . . 73.24 109.457 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.12 96.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 60.34 111.084 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.477 ' CD2' HG22 ' A' ' 29' ' ' VAL . 56.6 m80 -67.78 -33.88 75.69 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 120.729 -0.389 . . . . 73.4 111.97 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.71 82.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.505 -0.554 . . . . 70.01 109.505 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 56.3 m -60.37 -49.95 75.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.612 -0.722 . . . . 65.21 109.725 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.28 -29.73 66.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.969 -0.559 . . . . 73.34 112.16 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HA ' HG22 ' A' ' 154' ' ' THR . 34.6 tp -65.69 -36.98 85.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.653 -0.499 . . . . 71.41 109.653 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.538 ' HG2' ' CE2' ' A' ' 162' ' ' TYR . 40.3 mtp180 -69.28 -37.22 77.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.917 -0.583 . . . . 71.41 110.218 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.1 m -69.02 -35.65 76.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.632 -0.713 . . . . 64.24 110.34 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 151' ' ' LEU . 14.7 t -78.18 -33.22 50.24 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 120.65 -0.42 . . . . 65.13 111.011 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.68 6.21 9.37 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.167 0.508 . . . . 71.31 111.495 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.49 132.02 44.92 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.329 -0.619 . . . . 55.12 109.329 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.34 11.74 50.84 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 121.139 -0.553 . . . . 51.12 111.993 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.7 p -123.38 165.48 22.58 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 108.386 -0.968 . . . . 73.23 108.386 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.63 12.67 1.58 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.573 2.182 . . . . 73.44 112.312 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.52 118.84 14.84 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.943 0.401 . . . . 74.22 111.041 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.7 p -121.18 164.65 16.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.701 -1.592 . . . . 73.44 106.701 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.538 ' CE2' ' HG2' ' A' ' 152' ' ' ARG . 12.2 m-85 -130.43 152.29 50.0 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.337 -0.945 . . . . 71.42 108.847 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.431 ' HG3' ' HA ' ' A' ' 190' ' ' ALA 0.268 3.5 pp0? -102.53 115.08 29.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.295 0.569 . . . . 74.32 111.889 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.89 1.36 62.29 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.477 -0.783 . . . . 72.43 111.357 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.7 t70 59.96 20.62 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.609 1.564 . . . . 54.4 109.658 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.4 138.47 16.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 114.621 -1.172 . . . . 74.32 112.069 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.445 ' HB3' HD23 ' A' ' 187' ' ' LEU . 22.0 p90 -135.79 152.67 51.33 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.949 -1.023 . . . . 62.23 108.694 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 9.7 m-85 -115.15 140.75 48.81 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.231 -1.025 . . . . 71.34 108.231 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' SER . 61.9 m -114.22 119.54 37.38 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.85 -0.796 . . . . 74.31 108.85 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -112.32 139.65 47.7 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.092 0.473 . . . . 73.22 111.818 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.109 0 N-CA-C 107.248 -2.341 . . . . 45.11 107.248 179.724 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 80.4 mtt180 . . . . . 0 N--CA 1.442 -0.853 0 CA-C-O 120.618 0.247 . . . . 73.23 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -112.97 127.83 56.33 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.596 -1.261 . . . . 74.01 107.596 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 11.4 m-80 -143.76 158.86 43.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.744 -0.465 . . . . 73.23 109.744 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 43.9 mt-10 -137.08 145.15 43.6 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.02 -0.733 . . . . 64.45 109.02 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 81.7 t -125.6 121.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.786 -1.191 . . . . 74.31 107.786 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 24.7 m0 -110.21 122.15 46.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.617 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 167' ' ' TYR . 87.6 mt -102.41 138.57 39.16 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.776 -1.194 . . . . 71.32 107.776 171.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 130' ' ' VAL . 27.9 t -103.47 130.59 53.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.477 -0.564 . . . . 73.44 109.477 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.9 ttpt -69.25 132.54 46.64 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.82 -0.807 . . . . 70.21 108.82 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.431 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.468 1.105 . . . . 61.03 112.054 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 45.8 p90 . . . . . 0 N--CA 1.437 -1.105 0 CA-C-O 121.305 0.574 . . . . 72.24 109.868 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -105.58 109.16 21.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.253 -0.885 . . . . 73.15 110.038 -173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.13 128.22 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.724 -1.213 . . . . 74.42 107.724 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 21' ' ' LEU 0.258 0.5 OUTLIER -96.6 -32.45 12.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 113.747 1.017 . . . . 74.43 113.747 -178.998 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 28.5 t -151.86 152.91 33.21 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.864 -0.735 . . . . 62.52 111.907 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 32' ' ' GLU . 27.2 p -133.81 152.91 52.01 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.171 -0.922 . . . . 70.43 110.578 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.04 -131.99 10.76 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 120.632 -0.794 . . . . 64.24 112.691 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -104.5 1.45 Allowed Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 121.116 -0.564 . . . . 65.05 112.077 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.13 171.67 7.66 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 122.827 0.451 . . . . 65.15 110.203 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.18 157.52 25.24 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.679 -1.23 . . . . 74.31 107.679 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t70 75.48 -49.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.436 1.494 . . . . 74.31 111.425 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.24 110.98 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.68 0.752 . . . . 73.0 110.03 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 p -110.8 135.9 50.66 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.731 -0.668 . . . . 73.41 109.495 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -112.1 162.25 15.62 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.129 0.49 . . . . 73.12 112.154 -175.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 22' ' ' SER . 13.1 pt-20 -153.0 129.83 10.94 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.554 -2.017 . . . . 71.23 105.554 170.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HG2' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -114.49 141.61 47.47 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 118.898 -1.121 . . . . 74.43 109.518 177.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 157.11 46.26 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 119.535 -0.866 . . . . 71.0 109.261 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 133.89 35.41 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.466 -2.05 . . . . 52.41 105.466 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.6 m -58.38 141.65 50.68 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.87 1.063 . . . . 70.11 113.87 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -70.3 -16.53 63.02 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.47 -1.695 . . . . 53.42 112.137 -175.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 87.94 12.03 66.77 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.414 -1.851 . . . . 64.43 111.664 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.03 145.98 42.25 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 120.343 -0.932 . . . . 51.42 111.72 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -96.32 117.99 31.94 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.842 -0.799 . . . . 62.43 108.842 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.9 m-85 -122.69 163.86 19.34 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.512 -0.767 . . . . 72.42 110.826 -172.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.21 116.49 31.51 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.312 -0.625 . . . . 74.21 109.312 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.7 t -122.17 145.94 47.72 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 112.477 0.547 . . . . 65.43 112.477 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.579 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 16.0 m -129.95 140.89 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 125.104 1.361 . . . . 73.43 107.776 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.59 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.3 pt-20 -128.01 135.77 50.36 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.16 -1.416 . . . . 74.11 112.22 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 41.2 t -118.41 140.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 106.386 -1.709 . . . . 74.31 106.386 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 49' ' ' LYS . 38.6 p -126.26 167.17 15.84 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.727 -0.389 . . . . 73.51 110.537 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t70 73.72 -36.97 0.36 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.436 1.094 . . . . 52.22 112.108 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 47' ' ' THR . 95.0 mttt -85.75 138.14 35.63 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.53 -0.759 . . . . 71.23 110.841 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.96 157.14 25.67 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.002 2.468 . . . . 74.31 110.748 174.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 98' ' ' LEU . 31.8 t -47.63 -43.88 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 114.952 1.464 . . . . 62.12 114.952 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.95 -33.11 74.03 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.048 -0.661 . . . . 75.13 110.675 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -74.85 -44.06 51.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.526 0.679 . . . . 73.12 110.129 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -65.23 -43.56 91.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.369 -0.832 . . . . 63.32 111.468 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.03 -40.13 82.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 111.694 0.257 . . . . 71.32 111.694 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.91 -24.82 66.92 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 121.013 -0.275 . . . . 64.01 111.431 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 30.2 tt0 -84.47 -44.72 13.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.506 0.67 . . . . 73.54 110.26 175.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.49 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.5 -40.45 70.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 114.67 1.359 . . . . 62.13 114.67 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 ttm -57.83 -46.02 99.76 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 113.078 0.77 . . . . 72.33 113.078 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 76.3 Cg_exo -50.34 -40.75 52.7 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.385 2.057 . . . . 71.24 111.923 171.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 48.2 mtmt -69.14 -34.5 75.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.862 -0.608 . . . . 63.13 110.81 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -70.96 -48.88 53.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.886 -0.597 . . . . 53.01 111.059 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.49 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.5 ptm -68.96 -30.3 68.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.069 0.766 . . . . 74.55 113.069 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -72.33 -27.98 62.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.325 -0.95 . . . . 61.23 109.989 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 93.4 t80 -63.07 -57.94 8.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.335 -0.848 . . . . 74.04 109.886 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.3 m -73.17 -20.79 18.78 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 CA-C-N 116.149 -0.478 . . . . 75.04 110.928 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.77 -25.68 69.29 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.08 -0.509 . . . . 24.33 113.264 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 143.22 -10.22 2.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.149 -1.024 . . . . 75.33 113.039 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 m -89.56 27.6 1.46 Allowed 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.115 0.959 . . . . 74.44 110.254 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.31 169.21 10.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.788 -0.642 . . . . 62.12 110.003 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.85 -32.86 73.23 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.904 0.705 . . . . 73.11 112.904 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 113' ' ' PRO . 99.5 mttt -91.23 -7.69 50.56 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.764 -0.775 . . . . 64.33 112.577 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.69 73.65 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.929 -0.578 . . . . 62.45 112.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 32.5 m -82.23 158.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.42 -0.512 . . . . 74.04 110.243 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.27 173.69 41.1 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 120.891 -0.671 . . . . 63.02 111.735 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 52.6 ttp -75.17 95.95 3.2 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.064 0.459 . . . . 71.43 110.154 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.65 10.3 9.77 Favored Glycine 0 N--CA 1.426 -1.971 0 CA-C-N 115.386 -0.824 . . . . 45.41 112.341 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -118.79 123.45 44.82 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.207 -0.597 . . . . 65.35 110.865 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.9 p -127.53 117.54 22.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.748 0.647 . . . . 70.3 112.748 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -152.99 172.82 5.17 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.503 -1.665 . . . . 65.41 106.503 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.76 139.94 25.57 Favored 'Trans proline' 0 C--O 1.253 1.225 0 C-N-CA 121.01 1.14 . . . . 73.22 110.505 175.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.86 141.43 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.815 -0.809 . . . . 73.23 108.815 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 p -119.46 145.41 46.3 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 110.203 -0.295 . . . . 70.1 110.203 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -144.44 140.62 29.08 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 122.048 -0.408 . . . . 71.33 110.822 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.68 134.55 34.91 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-N 115.68 -0.691 . . . . 70.04 109.287 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.25 159.21 30.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 114.779 -1.101 . . . . 74.45 109.158 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 97' ' ' LYS . 78.4 m-85 -125.23 106.16 28.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 110.03 -0.359 . . . . 75.12 110.03 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.07 136.15 11.47 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.502 2.135 . . . . 72.23 114.07 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 96' ' ' LYS . 49.9 m-80 -95.3 161.51 14.06 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.252 -1.388 . . . . 74.43 107.252 172.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.59 -13.35 58.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.698 0.761 . . . . 72.4 111.005 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.24 -6.32 54.58 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.832 -1.076 . . . . 54.13 110.338 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.53 -9.73 69.79 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.338 -0.458 . . . . 45.35 112.247 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 m -90.19 132.6 35.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 110.163 -0.31 . . . . 65.21 110.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.87 96.11 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.46 -0.941 . . . . 74.0 108.46 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -147.44 114.34 6.12 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.571 -0.899 . . . . 72.43 108.571 -178.389 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 87' ' ' PHE . 74.1 mmtt -176.63 -70.1 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.565 1.946 . . . . 52.2 106.478 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 87' ' ' PHE . 27.4 mtpp -153.16 159.33 42.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.279 -1.782 . . . . 72.34 107.586 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 51' ' ' VAL . 5.7 tt -143.77 128.43 18.18 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.135 -0.691 . . . . 71.11 109.135 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.7 mttt -117.56 115.55 25.35 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.592 -0.276 . . . . 73.04 110.781 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.1 t -89.09 127.02 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.039 -1.097 . . . . 53.41 108.039 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.552 ' CD1' ' HE2' ' A' ' 168' ' ' TYR . 70.1 m95 -113.97 120.59 41.18 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.734 -0.839 . . . . 75.23 108.734 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -102.78 113.28 26.57 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 108.317 -0.994 . . . . 75.4 108.317 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 81.7 mtm180 -75.12 137.91 41.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.535 -1.211 . . . . 72.4 111.803 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.568 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 63.9 mt -113.24 130.4 23.66 Favored Pre-proline 0 C--N 1.286 -2.193 0 CA-C-N 115.396 -0.82 . . . . 65.33 109.862 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.19 163.99 36.6 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.62 2.88 . . . . 74.23 112.921 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -46.46 -35.52 5.7 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.996 1.718 . . . . 75.22 112.976 -176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -46.52 86.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.968 0.413 . . . . 41.45 110.581 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -99.17 -4.5 31.99 Favored 'General case' 0 C--O 1.197 -1.666 0 N-CA-C 112.652 0.612 . . . . 75.44 112.652 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.568 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 24.5 mm-40 -70.77 -32.17 69.2 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.31 -0.556 . . . . 73.42 110.805 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.88 -35.7 90.77 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.778 -0.646 . . . . 44.14 111.598 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.8 p -161.0 92.22 1.52 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 C-N-CA 123.08 0.552 . . . . 73.24 110.117 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.99 162.33 8.82 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.203 1.935 . . . . 61.33 112.123 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.435 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 29.5 Cg_endo -68.17 156.43 65.79 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.751 1.634 . . . . 72.21 109.903 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 155.07 45.93 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.629 -0.26 . . . . 74.14 110.51 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.563 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 34.0 Cg_exo -60.48 111.55 1.06 Allowed 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.589 2.192 . . . . 62.03 111.724 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -88.0 -41.31 13.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.454 -0.793 . . . . 44.12 110.602 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.526 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.0 t70 -92.43 156.0 17.49 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.626 -1.25 . . . . 75.43 107.626 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.37 -20.29 48.08 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 120.93 0.395 . . . . 70.41 111.036 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 m -74.53 -39.71 62.19 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.944 -0.571 . . . . 63.12 110.536 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 3.2 p -107.15 116.41 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.516 0.674 . . . . 64.41 111.507 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -120.82 148.29 44.22 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.835 -1.075 . . . . 75.12 108.796 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.48 ' H ' ' HG3' ' A' ' 115' ' ' PRO . 22.6 mm -92.82 111.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.263 -1.014 . . . . 72.4 108.263 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.267 -0.878 . . . . 73.12 109.005 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.78 140.91 46.03 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.41 -0.589 . . . . 74.42 109.41 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -122.78 123.33 40.81 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 119.841 -0.744 . . . . 74.34 110.474 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -143.76 165.8 26.67 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.538 -1.21 . . . . 74.05 110.48 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.95 -1.15 69.79 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.688 -0.767 . . . . 63.2 114.681 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.89 166.42 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-N 117.774 0.787 . . . . 61.14 110.24 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 55.3 m -120.63 138.39 53.94 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.895 -0.593 . . . . 65.33 109.855 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.444 HG21 ' CE3' ' A' ' 186' ' ' TRP . 19.1 m -124.66 153.54 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 109.12 -0.696 . . . . 55.43 109.12 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 51.8 m-85 -113.03 121.6 45.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.145 -2.168 . . . . 74.13 105.145 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 p -117.91 130.02 55.98 Favored 'General case' 0 C--N 1.269 -2.896 0 C-N-CA 120.252 -0.579 . . . . 71.34 111.162 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.499 ' HB ' HD23 ' A' ' 151' ' ' LEU . 7.8 t -116.06 126.06 53.25 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.689 -0.687 . . . . 74.51 110.168 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -111.1 130.53 55.59 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.925 -1.509 . . . . 65.1 106.925 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.96 146.06 44.94 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.502 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -125.92 128.4 6.45 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.513 -0.767 . . . . 53.34 111.335 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.59 -138.13 4.95 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.21 -0.756 . . . . 64.31 111.21 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -100.49 100.63 11.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.787 -1.561 . . . . 74.52 106.787 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 140.11 53.29 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.018 1.118 . . . . 62.21 114.018 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -115.68 176.86 4.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.583 -1.189 . . . . 74.31 108.318 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.71 -37.03 85.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.964 0.412 . . . . 73.12 111.356 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.07 67.2 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.236 0.541 . . . . 55.3 110.225 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.26 -30.53 71.18 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.834 -0.621 . . . . 72.24 110.642 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -61.03 -38.1 84.9 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.003 0.43 . . . . 74.52 110.565 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.63 -43.87 86.58 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 109.021 -0.733 . . . . 62.13 109.021 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -62.24 -47.79 82.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.202 -0.908 . . . . 63.22 110.266 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -66.83 -33.09 74.84 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 113.612 0.967 . . . . 72.12 113.612 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.5 80.89 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.432 0.634 . . . . 71.1 110.122 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.8 m -75.29 -44.61 44.76 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.494 -0.776 . . . . 45.31 109.641 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 53.2 mt-30 -63.85 -27.7 69.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.765 0.426 . . . . 74.33 111.486 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 133' ' ' THR . 3.3 tm? -64.87 -37.05 86.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.328 -0.99 . . . . 74.41 108.328 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.33 -33.14 67.1 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.851 -0.613 . . . . 74.32 110.447 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -35.1 79.75 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.648 -0.706 . . . . 74.04 109.952 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 151' ' ' LEU . 8.9 t -77.86 -32.87 52.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.546 -0.462 . . . . 51.54 110.568 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.01 9.26 2.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.208 0.447 . . . . 71.32 112.208 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.43 24.51 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.664 -1.606 . . . . 65.11 106.664 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.38 47.74 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.263 -0.97 . . . . 64.55 111.374 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 55.8 p -118.82 158.17 48.31 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.84 -0.8 . . . . 62.24 108.84 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.95 20.3 1.18 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.179 1.919 . . . . 73.41 112.22 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.72 127.46 31.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.124 -0.489 . . . . 44.32 111.995 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.8 p -104.56 156.34 18.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.021 -1.103 . . . . 75.03 108.021 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.447 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 31.4 m-85 -136.59 157.53 46.55 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.073 -0.651 . . . . 72.42 109.753 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -143.04 123.92 14.28 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.361 -0.536 . . . . 63.32 112.272 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.64 -0.27 28.19 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.535 -0.757 . . . . 64.35 114.417 175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 64.56 8.53 4.44 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.388 1.075 . . . . 72.42 111.765 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 87' ' ' PHE . 7.3 p -66.17 139.42 21.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.701 0.763 . . . . 60.15 111.881 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.411 ' HB3' HD22 ' A' ' 187' ' ' LEU . 47.5 p90 -143.56 168.57 19.54 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.95 -1.023 . . . . 73.43 109.179 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 94.1 m-85 -114.93 147.6 39.78 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 120.951 0.405 . . . . 71.13 110.375 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 66.0 m -114.79 123.74 49.98 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.913 -1.884 . . . . 75.32 105.913 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.98 131.41 47.45 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.498 0.666 . . . . 74.34 112.184 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.251 0 N-CA-C 108.779 -1.728 . . . . 65.44 108.779 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.593 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 71.9 ttt180 . . . . . 0 C--O 1.216 -0.708 0 N-CA-C 111.623 0.231 . . . . 73.11 111.623 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.631 ' O ' ' HD2' ' A' ' 182' ' ' ARG . 1.3 ppt_? -102.75 129.41 49.38 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.24 -0.984 . . . . 74.34 112.477 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -145.02 153.76 41.81 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.044 -0.525 . . . . 70.21 110.197 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 42.7 mt-10 -138.14 132.05 31.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.592 0.357 . . . . 72.24 110.288 173.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.458 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 96.5 t -128.95 118.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.271 -1.011 . . . . 74.12 108.271 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 11.3 m0 -107.65 121.03 43.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 108.918 -0.771 . . . . 72.22 108.918 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 167' ' ' TYR . 0.8 OUTLIER -100.58 134.82 42.97 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.678 -1.971 . . . . 72.53 105.678 178.013 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.04 124.79 45.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 120.619 -0.432 . . . . 53.0 112.068 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 161' ' ' THR . 82.8 tttt -75.45 133.27 41.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.103 -0.703 . . . . 72.55 109.103 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.255 1.353 0 CA-C-O 118.694 -0.669 . . . . 54.42 110.688 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.521 ' CD1' ' HG3' ' A' ' 34' ' ' ARG . 37.3 p90 . . . . . 0 N--CA 1.426 -1.64 0 N-CA-C 108.301 -1.0 . . . . 74.01 108.301 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.03 0.443 . . . . 61.44 110.791 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.52 123.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.528 -0.916 . . . . 65.01 108.528 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.6 -28.95 18.11 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.051 -0.66 . . . . 73.51 109.901 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t 179.08 158.74 0.59 Allowed 'General case' 0 C--O 1.248 1.011 0 CA-C-N 115.303 -0.862 . . . . 54.23 109.483 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.9 p -131.43 156.53 45.44 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.038 -1.468 . . . . 64.21 107.038 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.49 88.79 0.59 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.894 -1.622 . . . . 73.44 113.581 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.32 -139.94 10.02 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 109.248 -1.541 . . . . 22.15 109.248 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -104.84 110.03 22.23 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 102.582 -3.118 . . . . 71.4 102.582 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.93 133.04 49.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.327 -0.949 . . . . 74.0 112.565 -167.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 153.25 -45.77 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 101.844 -3.391 . . . . 53.3 101.844 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.04 111.85 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 111.788 -2.46 . . . . 72.15 104.699 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -100.48 140.2 35.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.96 -0.385 . . . . 60.22 109.96 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.45 157.71 34.54 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.579 -0.848 . . . . 64.41 112.535 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -134.0 126.67 30.72 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.172 -1.418 . . . . 75.22 107.172 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.45 113.89 26.06 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 106.69 -1.596 . . . . 74.04 106.69 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.521 ' HG3' ' CD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -138.5 145.88 41.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.791 -1.163 . . . . 74.0 113.382 -177.329 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 128' ' ' ILE . . . -86.77 138.35 31.68 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.065 -1.425 . . . . 75.53 107.784 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' SG ' HG13 ' A' ' 128' ' ' ILE . 25.6 p -57.89 168.57 0.92 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.25 0.833 . . . . 50.22 113.25 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -82.85 -18.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.304 -0.862 . . . . 61.33 111.483 -174.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.38 9.42 59.1 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 119.971 -1.109 . . . . 65.53 112.969 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.85 165.07 45.32 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.649 -0.786 . . . . 75.41 113.137 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 46.3 pttt -99.14 131.86 44.87 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.922 -0.399 . . . . 70.42 109.922 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.685 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 40.9 m-85 -127.89 165.27 20.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.527 -0.761 . . . . 71.23 112.101 -169.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.0 116.99 31.34 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.675 -0.861 . . . . 55.03 108.675 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 4.2 t -126.87 143.29 51.31 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-N 115.135 -0.938 . . . . 74.42 112.517 -175.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.2 m -133.32 146.11 32.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.4 -1.273 . . . . 72.03 108.366 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -127.88 126.31 41.32 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.63 -0.428 . . . . 70.34 110.367 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 33.2 t -120.74 130.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.988 -1.486 . . . . 74.55 106.988 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 49' ' ' LYS . 73.5 p -117.97 167.94 10.98 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.317 -0.553 . . . . 71.23 111.416 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 72.8 -25.31 0.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.898 1.279 . . . . 70.02 112.947 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 68.6 mttm -86.28 146.45 42.42 Favored Pre-proline 0 C--N 1.29 -1.985 0 CA-C-N 115.58 -0.736 . . . . 61.3 110.264 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.69 157.27 43.16 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.472 2.115 . . . . 64.31 110.032 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 98' ' ' LEU . 54.0 t -47.49 -42.52 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 113.146 0.795 . . . . 71.33 113.146 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t70 -61.62 -50.9 70.71 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 120.164 -0.614 . . . . 73.21 110.617 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 25.5 mm-40 -58.42 -51.71 68.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.827 -0.624 . . . . 75.53 111.497 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -62.4 -34.84 77.51 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.875 -0.602 . . . . 60.13 110.932 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.01 -34.16 71.06 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.644 -0.253 . . . . 71.34 110.615 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 24.3 mmm180 -67.87 -36.16 79.8 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.099 -0.704 . . . . 75.41 109.099 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.5 mm-40 -73.47 -53.31 10.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.273 -0.876 . . . . 71.11 112.587 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.89 -36.14 62.25 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.372 1.619 . . . . 75.23 115.372 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.6 tpp -55.18 -54.16 53.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 112.681 0.622 . . . . 74.21 112.681 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 63' ' ' MET . 14.0 Cg_endo -57.55 -30.57 88.93 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.472 2.115 . . . . 74.25 112.583 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 53.4 mtpt -65.45 -34.11 77.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.255 0.55 . . . . 73.51 110.913 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.12 -38.54 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.006 0.432 . . . . 61.44 110.824 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 87.6 mtp -66.86 -30.13 70.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.976 0.732 . . . . 73.33 112.976 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -67.75 -45.22 75.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 65.32 109.62 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -62.21 -60.95 2.84 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.16 -0.473 . . . . 70.33 112.072 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 76' ' ' MET . 16.5 m -77.13 -3.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.544 0.688 . . . . 74.43 110.759 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.57 -11.37 59.46 Favored Glycine 0 N--CA 1.418 -2.539 0 CA-C-N 114.984 -1.007 . . . . 52.02 112.392 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.33 -28.81 0.63 Allowed Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.455 -1.355 . . . . 60.11 113.518 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -81.58 55.14 2.56 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.235 1.017 . . . . 64.04 111.253 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.42 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 34.9 m-80 -98.38 149.39 22.71 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 106.061 -1.829 . . . . 62.2 106.061 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.97 -26.95 65.3 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.966 -0.693 . . . . 70.35 111.543 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HB2' HG23 ' A' ' 74' ' ' VAL . 57.3 mtpt -80.43 0.14 34.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.114 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 34.06 66.7 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 121.075 -0.583 . . . . 64.52 112.278 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 72' ' ' LYS . 48.5 t -80.1 143.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 107.776 -1.194 . . . . 51.14 107.776 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.84 -172.77 37.67 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.745 -0.741 . . . . 70.2 112.656 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -78.99 103.68 9.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.406 -0.961 . . . . 71.34 108.406 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -161.13 19.42 0.2 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.335 -0.936 . . . . 53.41 112.478 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.2 ptm -123.1 122.78 39.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.066 -1.053 . . . . 71.21 109.687 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.9 m -127.11 117.85 23.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.621 -0.718 . . . . 70.44 110.365 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.506 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 2.9 m -150.46 166.79 14.33 Favored Pre-proline 0 C--N 1.298 -1.665 0 C-N-CA 124.723 1.209 . . . . 75.14 107.822 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 38.3 Cg_endo -66.23 140.92 60.78 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.291 1.327 . . . . 44.32 113.588 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.9 139.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.085 -1.416 . . . . 64.34 107.94 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 p -127.38 148.79 50.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.636 -0.505 . . . . 72.13 109.636 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -144.35 142.04 30.12 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.63 -0.428 . . . . 73.54 110.157 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -91.89 134.9 34.36 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 109.174 -0.676 . . . . 33.32 109.174 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.49 150.18 26.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-N 114.869 -1.06 . . . . 73.24 108.382 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 1.9 m-85 -121.0 105.11 40.65 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.723 -0.473 . . . . 73.53 109.723 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 158.06 48.98 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.121 1.88 . . . . 75.03 112.984 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -118.09 160.7 21.07 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.578 -0.737 . . . . 71.35 110.453 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.63 -21.68 66.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.485 -0.78 . . . . 73.44 111.254 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.5 -6.92 57.97 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.552 0.691 . . . . 72.14 110.737 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.5 -0.48 85.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.761 -0.733 . . . . 74.15 113.272 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.6 m -96.9 136.31 37.63 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.565 -0.902 . . . . 73.13 108.565 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.4 mt -84.84 87.58 7.34 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.604 -0.438 . . . . 65.53 111.056 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -148.58 113.34 5.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.873 1.064 . . . . 64.11 113.873 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 87' ' ' PHE . 62.5 mttp -168.77 -68.79 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.749 1.22 . . . . 54.41 108.013 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HG2' HG22 ' A' ' 47' ' ' THR . 55.7 mtpt -148.87 153.93 38.75 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.837 -1.529 . . . . 73.31 108.743 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -144.16 127.44 16.74 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.634 -0.876 . . . . 74.43 108.634 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HE3' ' HE1' ' A' ' 101' ' ' TRP . 37.6 ttpt -130.01 115.58 17.33 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.081 0.467 . . . . 54.34 110.408 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' THR . 96.9 t -85.73 138.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.447 -0.797 . . . . 71.12 110.567 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.475 ' HE1' ' HE3' ' A' ' 99' ' ' LYS . 93.4 m95 -128.7 117.18 20.72 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.3 1.04 . . . . 72.25 108.278 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' HG11 ' A' ' 66' ' ' VAL . 83.7 t80 -104.32 118.18 35.99 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.604 -0.517 . . . . 72.51 109.604 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.685 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 34.5 ttm180 -74.57 131.1 40.68 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.817 -0.808 . . . . 74.05 108.817 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.17 140.67 22.51 Favored Pre-proline 0 C--N 1.296 -1.754 0 N-CA-C 109.69 -0.485 . . . . 62.42 109.69 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.47 ' HD3' HG21 ' A' ' 80' ' ' VAL . 8.2 Cg_endo -53.26 144.57 47.98 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.812 2.342 . . . . 72.3 111.523 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -55.01 -35.49 64.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.734 1.013 . . . . 55.33 113.734 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -61.34 -45.04 96.05 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.467 0.651 . . . . 75.32 109.987 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -78.82 -10.64 59.86 Favored 'General case' 0 C--O 1.196 -1.745 0 CA-C-N 115.456 -0.793 . . . . 73.35 111.141 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.405 HE22 ' HE1' ' A' ' 41' ' ' PHE . 21.3 mm-40 -71.0 -28.84 64.71 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.721 -0.392 . . . . 75.35 110.439 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.91 94.76 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.246 -0.742 . . . . 62.42 111.246 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 55.2 p -160.74 90.77 1.63 Allowed Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 109.454 -0.573 . . . . 53.45 109.454 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.29 146.61 36.05 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.346 2.031 . . . . 70.11 110.777 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 138.41 74.64 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.743 1.629 . . . . 73.43 110.109 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 140.34 96.31 Favored Pre-proline 0 C--O 1.256 1.414 0 CA-C-N 116.532 -0.304 . . . . 64.44 110.463 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.38 113.08 2.11 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.147 1.898 . . . . 74.43 110.703 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -90.69 29.89 1.25 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.603 -0.726 . . . . 65.24 109.988 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -138.53 145.98 41.36 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.379 -1.712 . . . . 62.21 106.379 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.71 -24.39 49.19 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.919 0.711 . . . . 64.42 112.919 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 61.1 p -102.95 -13.79 16.76 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.897 0.38 . . . . 71.41 111.851 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.42 116.38 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 105.399 -2.075 . . . . 75.14 105.399 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.71 146.4 50.23 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.238 -0.585 . . . . 50.24 111.212 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.0 mm -93.0 111.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.413 -0.958 . . . . 71.31 108.413 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -119.05 147.77 43.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.16 -0.927 . . . . 73.12 108.96 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -107.74 138.15 44.48 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.327 -0.397 . . . . 70.4 111.626 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -131.15 122.36 26.5 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.185 0.517 . . . . 64.35 110.57 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.408 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -140.23 148.61 41.76 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.574 -0.739 . . . . 62.53 109.124 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.6 20.32 78.48 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.261 -0.971 . . . . 41.55 113.746 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.509 HG13 ' SG ' ' A' ' 36' ' ' CYS . 2.2 pp -119.16 151.91 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.34 -0.944 . . . . 70.53 109.073 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' HD3' ' A' ' 189' ' ' LYS . 46.4 m -121.49 133.54 55.05 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 115.549 -0.751 . . . . 61.32 111.809 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.17 155.8 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 108.324 -0.991 . . . . 53.34 108.324 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -113.57 122.25 46.68 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.794 -1.928 . . . . 75.32 105.794 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 59.4 p -117.17 147.34 42.55 Favored 'General case' 0 C--N 1.269 -2.92 0 C-N-CA 120.344 -0.542 . . . . 73.43 111.999 -173.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.527 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -126.01 130.57 51.44 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 115.231 -0.895 . . . . 64.53 108.954 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -113.81 126.37 55.13 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.978 0.894 . . . . 74.14 109.169 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -130.81 137.81 49.59 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 114.408 -1.269 . . . . 72.22 110.65 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.77 127.32 7.19 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.337 -0.705 . . . . 72.32 111.337 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 153.79 -143.13 9.78 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 109.029 -1.628 . . . . 33.43 109.029 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -99.83 110.57 22.94 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 117.412 0.606 . . . . 73.41 110.002 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.78 139.45 44.82 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.214 -0.662 . . . . 54.2 109.214 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.43 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 22.1 ttmm -114.89 169.28 9.2 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.303 -2.11 . . . . 43.14 105.303 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.65 -39.8 58.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.207 0.527 . . . . 63.53 111.598 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.2 66.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.617 -0.72 . . . . 72.41 111.071 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 31.8 t70 -73.46 -30.29 63.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.147 -0.479 . . . . 74.34 111.01 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -59.0 -50.5 73.87 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.115 -0.698 . . . . 73.42 109.115 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.8 t -61.73 -42.09 93.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.85 -1.068 . . . . 72.24 109.459 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.39 -46.57 88.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.529 -0.76 . . . . 73.43 110.887 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.559 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 40.5 m80 -64.24 -39.81 94.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 112.489 0.551 . . . . 60.21 112.489 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -60.77 -43.22 98.31 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.242 0.544 . . . . 73.53 110.015 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.401 HG23 ' NH2' ' A' ' 152' ' ' ARG . 88.2 m -62.73 -47.12 84.94 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 123.822 0.849 . . . . 44.24 110.022 177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -58.79 -42.9 90.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.66 0.784 . . . . 73.02 109.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 77.5 mt -57.74 -40.89 80.73 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.431 -0.349 . . . . 62.24 111.744 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 20.8 mtm180 -65.2 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.34 0.591 . . . . 72.24 110.028 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 m -72.95 -36.91 67.26 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.267 -0.879 . . . . 71.41 109.709 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.5 m -77.77 -37.82 48.12 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 116.085 -0.507 . . . . 63.01 111.394 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.77 -5.11 41.56 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.344 0.593 . . . . 75.55 111.26 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.74 120.61 20.51 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.747 -1.205 . . . . 71.21 107.747 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.44 47.52 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.381 -0.914 . . . . 51.01 111.843 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.7 p -118.5 166.18 14.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.461 -0.941 . . . . 71.14 108.461 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 10.69 1.79 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.401 2.067 . . . . 63.22 112.759 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.9 126.15 35.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.911 0.386 . . . . 51.53 111.9 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.4 p -100.98 151.97 21.14 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.458 -0.571 . . . . 53.44 109.458 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.81 148.0 33.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.183 0.447 . . . . 72.31 110.405 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -129.14 139.37 51.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.123 0.786 . . . . 75.35 113.123 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.68 -0.08 29.5 Favored Glycine 0 C--O 1.236 0.239 0 CA-C-N 115.444 -0.798 . . . . 70.31 114.33 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 61.92 10.71 3.71 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.198 0.999 . . . . 71.35 111.676 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.56 138.28 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.41 0.624 . . . . 74.43 110.292 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -145.62 169.91 17.5 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.545 -0.752 . . . . 73.45 110.027 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 85.5 m-85 -115.52 148.35 39.61 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.056 -0.52 . . . . 74.44 110.104 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.55 125.52 53.89 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.343 -1.725 . . . . 63.23 106.343 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -130.77 149.11 52.56 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 111.747 0.277 . . . . 70.34 111.747 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.164 0 N-CA-C 111.027 -0.829 . . . . 60.24 111.027 -178.465 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 . . . . . 0 C--O 1.236 0.392 0 N-CA-C 114.279 1.215 . . . . 71.22 114.279 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -128.97 127.41 41.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.325 -1.732 . . . . 71.41 106.325 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -145.17 156.2 43.73 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.116 -0.633 . . . . 74.12 109.865 -171.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.4 mt-10 -129.33 147.91 51.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.793 -0.447 . . . . 74.24 109.793 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 132' ' ' SER . 73.9 t -125.24 118.71 53.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.091 -1.448 . . . . 61.11 107.091 173.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.4 m0 -106.45 120.83 42.95 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.473 -0.936 . . . . 74.45 108.473 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 58.3 tp -98.29 128.65 44.83 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.519 -1.289 . . . . 63.04 107.519 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.08 135.27 27.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.119 0.485 . . . . 63.13 111.646 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' THR . 21.0 pttp -77.1 143.28 39.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.78 -0.645 . . . . 71.11 111.886 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.421 0 CA-C-O 118.062 -0.97 . . . . 73.44 109.007 176.07 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.9 p90 . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 108.588 -0.893 . . . . 73.44 108.588 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.79 107.96 19.22 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.027 -0.731 . . . . 62.33 109.027 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.34 116.91 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.657 -1.156 . . . . 64.03 109.711 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -90.3 -29.17 18.29 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.294 0.479 . . . . 64.52 112.294 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -173.55 154.94 2.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.049 0.452 . . . . 22.33 109.818 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.15 157.03 45.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.316 -0.994 . . . . 73.43 108.316 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.69 -158.8 27.83 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.499 -1.334 . . . . 63.23 113.017 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.02 -119.78 4.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.415 -0.674 . . . . 60.42 111.415 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -116.44 171.28 7.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 110.134 -0.321 . . . . 74.24 110.134 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 43.9 mt-10 -85.0 156.89 20.94 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.231 -1.766 . . . . 72.13 106.231 166.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 14.6 t70 78.15 -45.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.524 0.73 . . . . 73.42 110.533 -171.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.34 108.93 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 108.715 -0.846 . . . . 62.33 108.715 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.4 m -124.38 134.04 53.24 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.62 -1.252 . . . . 72.43 107.62 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -113.31 161.67 16.96 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.358 0.873 . . . . 75.13 113.358 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -133.08 125.13 28.92 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.478 -1.675 . . . . 64.04 106.478 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.45 114.0 26.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 106.989 -1.486 . . . . 75.2 106.989 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -141.39 144.34 34.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.402 0.519 . . . . 75.53 112.402 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.49 136.23 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.288 -1.745 . . . . 72.34 106.288 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.422 ' SG ' HG13 ' A' ' 128' ' ' ILE . 83.0 m -63.91 153.87 35.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.13 0.789 . . . . 72.24 113.13 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -75.09 -34.77 61.78 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.165 -0.925 . . . . 72.45 111.016 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 91.9 10.98 60.8 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 118.454 -1.831 . . . . 74.21 112.095 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.23 164.14 52.33 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 111.052 -0.819 . . . . 22.03 111.052 -176.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -88.64 129.67 35.46 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.939 -0.763 . . . . 74.21 108.939 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 36.3 m-85 -126.89 165.4 19.43 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.582 -0.735 . . . . 72.31 110.027 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.412 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.34 116.37 30.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.7 -1.222 . . . . 75.03 107.7 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.8 t -131.86 146.85 52.36 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.566 0.698 . . . . 72.22 112.137 -175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG21 ' HD2' ' A' ' 61' ' ' LYS . 7.5 p -133.28 138.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 107.366 -1.346 . . . . 73.25 107.366 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 16.5 pt-20 -126.71 139.07 53.42 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.264 -0.574 . . . . 62.32 111.19 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 50.0 t -127.5 140.08 50.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.385 -1.339 . . . . 62.32 107.385 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.1 p -125.49 163.22 23.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.989 0.737 . . . . 72.13 112.989 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 68.44 6.03 5.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.123 1.369 . . . . 74.44 112.877 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 88.4 mttt -124.87 147.25 55.88 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 116.513 -0.312 . . . . 75.2 110.361 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 46.9 Cg_exo -58.95 156.58 32.84 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.693 2.262 . . . . 64.32 110.829 173.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 25.1 t -48.12 -43.3 11.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 113.111 0.782 . . . . 71.23 113.111 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -59.54 -41.74 90.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.931 0.396 . . . . 34.12 111.449 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 8.3 mm-40 -73.46 -46.45 48.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 64.04 110.809 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.81 -44.02 94.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.482 -0.781 . . . . 62.3 111.073 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.1 -42.05 85.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.857 -0.611 . . . . 71.11 111.649 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -64.43 -28.11 69.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.033 0.753 . . . . 74.45 113.033 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.2 -33.8 24.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.02 0.438 . . . . 72.25 111.613 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.83 -32.7 59.91 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.556 0.576 . . . . 51.54 112.556 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.538 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 5.9 mmt -53.0 -56.84 19.58 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.32 1.23 . . . . 73.33 114.32 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.15 -31.65 84.19 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.197 1.931 . . . . 72.12 111.841 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.594 ' HD3' ' HB2' ' A' ' 119' ' ' SER . 91.3 mttt -65.45 -41.02 93.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.145 -0.479 . . . . 63.15 110.751 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.15 -38.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.343 0.592 . . . . 73.44 110.008 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.27 -30.66 71.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.207 0.817 . . . . 43.1 113.207 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.02 -29.69 60.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.218 0.533 . . . . 61.43 109.925 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -64.57 -60.97 2.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.533 -0.758 . . . . 74.01 110.957 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 p -75.48 -17.96 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.437 0.637 . . . . 64.23 110.485 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.4 -28.39 73.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.976 -0.556 . . . . 30.31 113.139 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.684 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.64 3.33 6.04 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.189 -1.005 . . . . 73.1 112.852 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.4 m -95.23 22.41 6.82 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.811 0.815 . . . . 51.15 109.948 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.41 ' HA ' ' OG ' ' A' ' 116' ' ' SER . 7.9 p30 -88.07 172.73 9.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 74.42 110.827 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 9.2 t70 -67.72 -34.32 76.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.89 -0.595 . . . . 51.02 112.518 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -78.75 -12.45 60.02 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.434 0.635 . . . . 65.03 109.683 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.69 25.07 75.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.446 -0.797 . . . . 74.4 112.645 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.684 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 34.1 m -90.41 146.79 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 120.066 -0.653 . . . . 74.4 109.888 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.99 -153.46 19.86 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.945 -0.862 . . . . 64.5 110.945 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.6 ttt -80.57 72.08 7.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.007 0.908 . . . . 74.14 110.204 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.96 3.05 41.17 Favored Glycine 0 N--CA 1.438 -1.202 0 CA-C-N 114.729 -1.123 . . . . 71.35 110.976 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.8 ptm -125.11 121.66 34.89 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.667 -0.864 . . . . 71.35 108.667 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -126.84 116.22 20.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.218 -0.446 . . . . 64.54 111.81 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 103' ' ' ARG . 57.4 t -150.47 139.39 13.01 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 105.52 -2.03 . . . . 71.54 105.52 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.97 138.97 88.51 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 121.344 1.363 . . . . 71.12 110.427 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.85 139.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.963 -0.754 . . . . 71.31 108.963 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 m -118.98 145.05 46.14 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.864 -0.791 . . . . 74.35 108.864 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -132.42 137.0 47.14 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 119.949 -0.7 . . . . 72.12 109.658 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.94 135.14 34.42 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.499 -0.773 . . . . 52.31 109.008 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.77 149.71 25.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 54.52 107.798 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.651 ' CE2' ' HE3' ' A' ' 97' ' ' LYS . 67.5 m-85 -119.19 99.78 50.48 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 107.186 -1.413 . . . . 74.45 107.186 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.49 158.9 50.29 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.543 2.162 . . . . 63.43 114.542 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -103.53 160.15 14.98 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.673 -1.603 . . . . 74.23 106.673 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.2 -17.5 64.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.061 0.458 . . . . 73.11 111.795 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.54 -7.3 56.08 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.957 -0.565 . . . . 53.12 110.983 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.72 -6.06 84.01 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.696 -0.764 . . . . 72.3 112.295 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.1 m -83.94 136.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.11 0.481 . . . . 62.32 110.332 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 89.0 mt -93.59 98.63 11.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.728 0.775 . . . . 74.01 111.193 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 29.6 tt0 -148.13 170.43 17.84 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.795 -1.187 . . . . 73.11 107.795 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 105.09 -65.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 126.697 1.999 . . . . 73.31 112.255 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HE3' ' CE2' ' A' ' 87' ' ' PHE . 33.7 ttpt -159.24 150.05 19.72 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.482 -0.326 . . . . 74.31 110.649 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.472 HD12 HG13 ' A' ' 51' ' ' VAL . 5.0 tt -142.84 136.56 28.86 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.022 -1.103 . . . . 71.41 108.022 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 68.2 mttm -122.02 115.67 22.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.469 -0.567 . . . . 75.13 109.469 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 43' ' ' THR . 87.7 t -88.41 128.05 40.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.899 -1.149 . . . . 63.03 107.899 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.11 123.86 46.62 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.293 -0.632 . . . . 73.45 109.293 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -102.99 112.61 25.53 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.471 -1.677 . . . . 64.22 106.471 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 80' ' ' VAL . 1.1 tmt_? -76.84 113.06 14.11 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.957 -1.498 . . . . 70.23 106.957 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 40' ' ' LYS . 76.8 mt -73.36 138.7 78.21 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 115.926 -0.579 . . . . 60.04 110.555 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.7 161.32 45.83 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.504 2.136 . . . . 73.32 112.002 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -50.4 -35.22 27.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.296 1.438 . . . . 74.24 111.081 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.04 -42.96 99.47 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.419 0.688 . . . . 72.52 111.992 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -99.76 -1.74 36.93 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 114.011 1.115 . . . . 73.44 114.011 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.714 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -62.97 -28.75 70.3 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.421 1.267 . . . . 63.12 114.421 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -39.38 32.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.89 -1.147 . . . . 52.54 111.942 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.9 m -149.0 94.4 4.03 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 109.251 -0.648 . . . . 74.31 109.251 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.63 158.1 12.26 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.417 2.078 . . . . 74.23 111.638 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.46 131.68 46.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.985 1.79 . . . . 55.33 109.943 175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -66.23 140.27 96.77 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.319 -0.401 . . . . 73.24 110.358 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.61 101.5 1.04 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.438 2.092 . . . . 70.33 111.952 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 11.4 p -81.02 2.19 28.08 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.605 1.162 . . . . 72.43 111.886 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.542 ' HB3' HG12 ' A' ' 120' ' ' VAL . 13.1 t70 -113.27 152.69 29.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.415 -0.957 . . . . 74.51 108.415 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -13.16 45.5 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 115.372 1.619 . . . . 70.44 115.372 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.594 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 71.9 m -97.85 -28.84 13.66 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.152 -0.619 . . . . 73.45 111.898 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 117' ' ' ASP . 6.8 p -94.68 128.04 46.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.844 -0.743 . . . . 63.13 109.478 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -124.49 153.29 42.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.996 -0.742 . . . . 64.33 108.996 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.9 mm -92.45 111.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 72.33 107.793 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -127.0 145.74 50.6 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.519 -0.764 . . . . 53.04 109.887 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.45 144.99 33.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.845 -0.798 . . . . 55.45 108.845 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.6 tpt180 -134.85 123.06 22.91 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.445 -0.902 . . . . 63.13 109.901 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.56 173.79 11.22 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.529 -0.545 . . . . 64.13 109.529 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.11 19.03 70.64 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.822 -0.626 . . . . 51.14 112.617 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.422 HG13 ' SG ' ' A' ' 36' ' ' CYS . 43.3 pt -128.37 145.53 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 121.17 0.51 . . . . 73.5 111.02 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 60.0 m -104.07 129.72 51.74 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 107.449 -1.315 . . . . 62.13 107.449 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.25 151.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.43 -0.581 . . . . 62.5 109.43 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 72.0 m-85 -114.04 121.48 43.97 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.308 -1.738 . . . . 64.44 106.308 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.5 m -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 109.869 -0.419 . . . . 70.45 109.869 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.0 t -118.32 131.38 56.33 Favored 'General case' 0 N--CA 1.411 -2.4 0 C-N-CA 120.391 -0.523 . . . . 71.35 110.067 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.654 ' HG2' ' HG3' ' A' ' 184' ' ' GLU . 51.4 mt-30 -110.84 128.36 55.75 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.089 -1.078 . . . . 74.0 108.089 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.2 p90 -114.68 135.68 53.89 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 115.309 -0.86 . . . . 74.55 110.563 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.14 101.57 2.61 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.408 -1.077 . . . . 55.15 110.408 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.06 167.82 27.28 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.231 -0.748 . . . . 61.52 111.231 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -75.44 139.72 42.46 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 110.124 -0.324 . . . . 72.32 110.124 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -116.04 123.76 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.549 0.69 . . . . 34.22 112.246 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.449 ' HG2' ' OE2' ' A' ' 141' ' ' GLU . 26.3 ttpp -115.68 170.53 8.38 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 104.721 -2.326 . . . . 75.2 104.721 172.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -51.54 -42.86 62.11 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.901 0.773 . . . . 73.43 113.058 -174.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.5 67.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.469 -0.332 . . . . 64.33 111.828 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -69.07 -37.11 78.33 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.968 -0.293 . . . . 70.14 111.112 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.69 -42.55 88.83 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.672 -0.492 . . . . 73.33 109.672 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.72 -40.7 84.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.424 -0.807 . . . . 74.41 109.794 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -61.93 -47.6 84.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 74.33 111.24 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -69.04 -33.52 73.72 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 112.228 0.455 . . . . 74.31 112.228 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.29 92.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.177 0.513 . . . . 73.52 109.969 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 76.5 m -62.91 -46.93 85.49 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.675 -0.693 . . . . 64.42 110.125 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 25.8 mt-30 -59.92 -38.36 82.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.107 -0.497 . . . . 55.14 110.359 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.25 -43.58 96.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.845 -0.616 . . . . 71.53 110.995 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -63.39 -39.18 93.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 65.14 109.61 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -71.78 -30.81 65.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.203 -0.908 . . . . 74.21 111.133 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.7 m -76.74 -34.69 58.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.282 0.563 . . . . 52.25 109.67 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.96 7.71 12.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.928 -0.578 . . . . 62.51 111.027 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -74.49 130.64 39.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.331 -0.618 . . . . 64.53 109.331 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.23 3.45 58.81 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.939 -0.648 . . . . 52.52 112.128 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 54.5 p -112.18 165.64 12.55 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.764 -0.828 . . . . 73.32 108.764 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.28 14.93 0.53 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.764 2.31 . . . . 71.44 112.872 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.67 109.83 3.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.084 0.469 . . . . 44.51 110.562 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.6 p -95.97 156.54 16.29 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.909 -1.145 . . . . 74.13 107.909 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.505 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 19.9 m-85 -132.64 151.27 52.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.595 -0.842 . . . . 74.14 109.277 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -127.3 122.33 33.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.002 0.43 . . . . 74.41 111.32 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.09 0.73 37.03 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.334 -0.848 . . . . 74.3 113.352 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.63 18.47 10.56 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.561 1.172 . . . . 53.44 109.366 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.27 139.22 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 113.724 -1.58 . . . . 74.22 112.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.445 ' OH ' HD21 ' A' ' 94' ' ' LEU . 11.4 p90 -149.41 167.66 25.56 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.194 -0.912 . . . . 65.33 110.747 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 2.8 m-85 -116.0 153.47 31.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 123.586 0.754 . . . . 71.11 109.557 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.9 m -124.03 131.41 53.55 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.252 -1.388 . . . . 63.35 107.252 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.77 148.11 51.61 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.544 0.572 . . . . 74.32 112.544 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.688 0 N-CA-C 108.647 -1.781 . . . . 73.41 108.647 179.51 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 C--O 1.222 -0.37 0 N-CA-C 115.721 1.749 . . . . 75.24 115.721 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 182' ' ' ARG . 0.7 OUTLIER -117.08 130.37 56.6 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 118.2 -1.4 . . . . 73.42 110.269 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 40.4 m-80 -144.16 148.02 34.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.854 -1.165 . . . . 74.15 107.854 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.654 ' HG3' ' HG2' ' A' ' 134' ' ' GLN . 2.5 mp0 -112.04 144.36 41.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.115 0.484 . . . . 71.11 110.873 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 57.8 t -125.52 118.84 53.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.366 -1.716 . . . . 73.14 106.366 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.495 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 27.9 m0 -106.52 120.77 42.81 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.131 -0.692 . . . . 74.33 109.131 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 tp -98.88 133.94 42.46 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.363 -1.347 . . . . 62.22 107.363 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.25 126.86 45.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.328 -0.549 . . . . 71.12 111.32 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.2 tttm -75.14 137.85 41.64 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.886 -0.597 . . . . 74.54 109.808 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.301 -1.528 0 CA-C-O 118.259 -0.877 . . . . 73.52 108.86 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.7 p90 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 108.47 -0.937 . . . . 74.21 108.47 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -106.63 115.44 30.21 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.371 -0.377 . . . . 73.34 111.397 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 121.05 41.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.739 0.781 . . . . 71.12 109.966 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.24 -24.16 15.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.608 -0.723 . . . . 71.31 111.754 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -165.93 148.5 7.33 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.868 0.366 . . . . 74.44 110.29 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.9 p -134.56 164.31 27.78 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.95 -1.023 . . . . 74.54 110.321 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.94 -136.34 12.86 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 119.964 -1.112 . . . . 64.55 113.809 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.31 -108.26 2.89 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.85 -1.3 . . . . 73.45 109.85 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -108.9 168.02 9.66 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.458 -1.312 . . . . 72.01 107.458 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.65 154.08 25.08 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 118.62 0.646 . . . . 65.25 111.223 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 72.58 -64.77 0.38 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.93 1.292 . . . . 74.35 110.321 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.9 t -92.6 109.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.756 -1.942 . . . . 73.13 105.756 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 m -133.4 154.31 50.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.907 -0.775 . . . . 52.33 108.907 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.32 160.56 18.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.513 0.673 . . . . 74.04 111.668 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.92 124.95 25.74 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.832 -1.914 . . . . 71.12 105.832 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.86 114.08 27.85 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.221 -1.77 . . . . 74.33 106.221 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.22 146.65 52.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.413 0.625 . . . . 72.33 111.652 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.82 136.14 33.51 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.745 -1.576 . . . . 71.43 106.745 172.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -60.44 162.57 6.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.53 0.937 . . . . 55.02 113.53 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -83.69 -20.77 32.91 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.656 -0.702 . . . . 64.24 110.42 -177.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 95.57 11.1 56.11 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 119.362 -1.399 . . . . 73.43 112.077 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.21 160.71 54.1 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 120.877 -0.678 . . . . 51.42 112.923 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 17.1 ptpt -96.76 130.68 43.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.948 -0.76 . . . . 74.23 108.948 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.468 ' HD1' ' H ' ' A' ' 104' ' ' ILE . 58.9 m-85 -130.66 164.43 25.02 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.509 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.34 120.09 38.14 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 107.762 -1.199 . . . . 62.11 107.762 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.638 ' OG1' ' HE2' ' A' ' 99' ' ' LYS . 9.4 t -135.19 150.49 50.14 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 119.911 -0.716 . . . . 61.32 112.038 -174.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 18.8 m -134.85 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.897 -1.047 . . . . 74.21 109.739 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HB2' ' CD ' ' A' ' 99' ' ' LYS . 34.9 tt0 -123.81 139.8 53.62 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.813 -0.439 . . . . 51.33 109.813 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 58' ' ' ALA . 52.8 t -127.32 133.12 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.328 -1.36 . . . . 74.12 107.328 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 36.2 m -133.14 157.1 46.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.336 -0.616 . . . . 73.12 109.336 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 79.6 -9.38 1.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.794 1.637 . . . . 64.21 109.359 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.5 mttm -111.22 131.53 22.18 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.16 -1.382 . . . . 63.34 109.049 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.24 158.48 35.03 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.053 2.502 . . . . 73.44 110.787 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 98' ' ' LEU . 39.3 t -45.95 -37.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.06 0.944 . . . . 71.23 112.976 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.55 -51.11 69.82 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.216 0.532 . . . . 44.13 110.561 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -76.41 -37.44 57.08 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.176 -0.92 . . . . 62.34 112.237 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.82 91.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.006 -0.543 . . . . 71.51 112.01 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -48.18 77.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.339 -0.615 . . . . 61.21 109.339 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.69 -24.29 66.24 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.792 -0.64 . . . . 73.43 111.983 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 10.4 tp10 -84.5 -45.5 12.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.515 0.674 . . . . 73.44 110.291 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.74 -39.65 69.91 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.596 0.961 . . . . 72.42 113.596 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.5 ttm -57.73 -46.72 99.72 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 114.196 1.184 . . . . 75.32 114.196 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 83.6 Cg_exo -50.89 -37.4 55.68 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.391 2.06 . . . . 74.15 111.233 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HD2' ' CB ' ' A' ' 119' ' ' SER . 43.5 mtmt -68.77 -37.01 79.03 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.683 -0.69 . . . . 75.02 110.792 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.0 mm -76.39 -47.63 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 112.18 0.437 . . . . 74.43 112.18 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 25.0 ptm -62.59 -29.58 70.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.663 0.986 . . . . 71.23 113.663 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.67 -36.27 82.13 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.196 -0.602 . . . . 64.41 110.107 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -56.69 -59.43 5.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.243 -0.435 . . . . 74.33 111.813 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.85 -17.0 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 62.33 110.264 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.86 -14.27 82.53 Favored Glycine 0 C--O 1.24 0.508 0 CA-C-N 115.92 -0.582 . . . . 72.05 113.275 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.19 4.11 2.35 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.684 -1.246 . . . . 60.21 114.552 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.0 m -91.35 23.51 3.35 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 123.077 1.418 . . . . 64.24 110.412 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 114' ' ' ALA . 7.8 p30 -98.73 170.28 8.89 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.099 -0.955 . . . . 75.44 110.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.94 -27.46 62.81 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 111.844 0.313 . . . . 72.2 111.844 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -86.05 -12.41 50.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.56 0.695 . . . . 74.11 110.525 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 31.84 63.2 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 115.319 -0.855 . . . . 63.12 112.518 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.11 123.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.319 -0.552 . . . . 72.3 110.758 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.37 -40.36 1.14 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 110.902 -0.879 . . . . 73.34 110.902 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.5 mtt -107.03 81.21 1.52 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.904 -1.517 . . . . 71.54 106.904 173.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.1 -79.32 0.54 Allowed Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.795 -1.193 . . . . 72.41 114.495 -172.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.484 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 24.1 ptt? -127.8 125.2 39.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.118 0.485 . . . . 75.31 111.945 -173.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 p -125.25 115.92 21.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.693 -0.685 . . . . 44.11 111.182 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.449 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 28.6 m -142.26 175.86 2.71 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.767 -1.568 . . . . 61.53 106.767 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 80' ' ' VAL . 39.8 Cg_exo -59.89 140.11 91.4 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 121.55 1.5 . . . . 71.12 113.268 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.95 153.19 8.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.085 -1.45 . . . . 75.21 107.085 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -140.01 145.23 37.53 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.888 -0.508 . . . . 50.43 109.881 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -136.61 143.11 43.38 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.149 -0.62 . . . . 60.15 111.147 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -92.66 135.6 33.95 Favored 'General case' 0 CA--C 1.478 -1.819 0 O-C-N 123.801 0.688 . . . . 70.23 109.774 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.83 149.73 33.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.156 -1.053 . . . . 64.33 108.156 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.589 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 99.3 m-85 -112.25 108.06 55.16 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.176 -0.675 . . . . 72.33 109.176 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -83.6 151.67 13.25 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.626 1.55 . . . . 54.24 112.358 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.03 168.56 10.01 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.007 . . . . 72.12 108.282 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.55 -19.76 65.86 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.069 0.461 . . . . 64.12 111.626 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -81.07 -6.91 59.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 53.01 110.08 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.36 73.37 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.883 -0.599 . . . . 74.03 111.838 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.0 m -74.46 140.48 44.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.067 -0.716 . . . . 74.31 109.067 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.7 139.65 33.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.023 0.44 . . . . 73.22 111.036 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.3 167.82 19.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 124.225 1.01 . . . . 73.24 111.891 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.6 pttt -70.35 21.87 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 126.224 1.81 . . . . 71.41 114.879 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.589 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 24.2 ttmm -139.66 134.72 32.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 119.449 1.022 . . . . 64.22 110.972 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.655 HD12 HG13 ' A' ' 51' ' ' VAL . 6.0 tt -143.07 130.57 21.17 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 107.998 -1.112 . . . . 53.12 107.998 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.638 ' HE2' ' OG1' ' A' ' 43' ' ' THR . 23.6 tptm -116.11 115.3 25.81 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.466 -0.938 . . . . 71.22 108.466 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.54 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 99.3 t -94.25 126.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.893 -0.41 . . . . 72.05 109.893 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -113.04 124.99 53.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.151 0.581 . . . . 61.53 109.564 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -103.12 113.66 27.31 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.639 -1.615 . . . . 65.14 106.639 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -77.29 131.3 38.08 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.461 -0.79 . . . . 75.04 110.494 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 73.3 mt -100.17 133.86 21.22 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-N 115.031 -0.986 . . . . 44.11 108.556 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 31.9 Cg_exo -58.32 151.53 59.8 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.788 2.325 . . . . 62.22 111.229 175.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.31 -34.25 60.55 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.881 0.872 . . . . 42.11 110.076 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -59.68 -34.33 72.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.903 -0.589 . . . . 73.31 111.873 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.53 -3.98 32.24 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 120.816 -0.354 . . . . 70.3 111.521 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 97.7 mt-30 -70.55 -27.89 64.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.89 0.33 . . . . 72.22 111.89 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.87 -38.16 95.71 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.438 -0.665 . . . . 62.55 111.438 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 t -158.28 90.68 2.19 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 108.724 -0.843 . . . . 72.44 108.724 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -85.85 154.86 10.07 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.026 1.817 . . . . 65.21 112.06 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.5 149.23 83.17 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.193 1.929 . . . . 60.21 110.742 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' ASN . . . -86.9 130.29 49.05 Favored Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 116.299 -0.409 . . . . 72.12 111.112 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.44 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 74.0 Cg_endo -76.89 112.59 3.47 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.904 2.403 . . . . 74.42 111.653 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 79.87 2.93 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.54 -0.864 . . . . 73.11 110.87 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.632 ' HB3' HG12 ' A' ' 120' ' ' VAL . 14.9 t70 -169.66 149.0 3.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.298 -1.742 . . . . 74.31 106.298 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.94 -14.97 59.35 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.944 0.72 . . . . 72.32 112.944 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.573 ' CB ' ' HD2' ' A' ' 61' ' ' LYS . 36.9 m -95.4 -29.71 14.29 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.88 -0.328 . . . . 65.41 111.836 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.632 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.9 p -106.25 116.46 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.54 0 CA-C-O 121.821 0.819 . . . . 74.12 110.575 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -130.74 155.24 46.98 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.144 -1.389 . . . . 74.42 110.19 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.0 mm -91.37 112.64 25.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.56 -0.904 . . . . 74.01 108.56 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -115.58 141.84 47.53 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.157 -0.682 . . . . 72.3 109.157 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -111.18 145.84 37.95 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.575 -0.739 . . . . 71.42 109.756 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -146.98 126.93 13.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.309 0.576 . . . . 62.35 110.805 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -133.76 169.96 16.28 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.106 -0.952 . . . . 75.04 110.346 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 16.38 78.7 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.373 -0.441 . . . . 63.4 113.53 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pp -121.23 162.6 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 119.542 -0.863 . . . . 75.51 109.245 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.416 ' H ' ' HG2' ' A' ' 189' ' ' LYS . 41.7 m -120.29 136.99 54.49 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 115.485 -0.78 . . . . 54.55 109.29 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.418 HG21 ' CE3' ' A' ' 186' ' ' TRP . 15.5 m -124.84 146.35 30.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.314 -0.995 . . . . 60.24 108.314 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.557 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 19.9 m-85 -114.95 121.54 43.47 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 105.932 -1.877 . . . . 75.01 105.932 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 p -117.4 131.5 56.75 Favored 'General case' 0 C--N 1.274 -2.712 0 C-N-CA 120.213 -0.595 . . . . 63.13 111.798 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.488 ' HB ' HD13 ' A' ' 151' ' ' LEU . 8.9 t -113.29 119.14 36.68 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 108.187 -1.042 . . . . 72.22 108.187 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -111.15 126.69 55.11 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 109.183 -0.673 . . . . 72.22 109.183 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 36.3 p90 -142.3 153.48 43.92 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 115.179 -0.918 . . . . 72.33 110.901 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.69 145.25 18.24 Favored Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 110.039 -1.224 . . . . 75.32 110.039 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.67 168.16 11.93 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 109.41 -1.476 . . . . 70.12 109.41 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -68.38 101.54 1.24 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.287 0.565 . . . . 74.23 111.574 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.33 130.85 53.3 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.618 -0.882 . . . . 72.31 108.618 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -89.74 176.91 6.66 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.754 -0.832 . . . . 75.03 108.754 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.41 -31.95 71.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.244 0.545 . . . . 71.2 109.911 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.09 -29.36 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.502 -0.772 . . . . 63.01 109.784 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -69.54 -29.81 67.48 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 116.037 -0.529 . . . . 62.33 111.268 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -59.26 -41.89 89.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.67 -0.412 . . . . 75.11 110.133 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.29 -49.1 84.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.451 -0.795 . . . . 73.11 110.102 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.04 -44.49 84.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.656 . . . . 33.32 111.79 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -63.53 -31.55 72.75 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 112.538 0.57 . . . . 73.25 112.538 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.63 85.3 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.352 -0.61 . . . . 73.02 109.352 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.429 HG23 ' NH2' ' A' ' 152' ' ' ARG . 22.1 m -66.83 -41.31 87.65 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 115.654 -0.703 . . . . 74.4 111.46 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.2 -37.48 85.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.428 . . . . 72.32 109.97 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.488 HD13 ' HB ' ' A' ' 133' ' ' THR . 52.5 tp -62.18 -41.99 98.86 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.723 -0.671 . . . . 72.23 110.224 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.537 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.8 mtm105 -62.22 -46.93 86.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.568 -0.287 . . . . 72.43 111.063 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.2 m -61.59 -34.37 75.5 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.877 0.736 . . . . 72.31 110.431 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 30.0 m -76.99 -35.43 57.16 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.86 -0.609 . . . . 75.2 110.164 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.1 mt -70.05 -31.4 69.0 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 113.354 0.872 . . . . 64.22 113.354 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 46.1 mt-10 -46.31 131.1 10.67 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.621 0.6 . . . . 72.11 112.621 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.64 12.64 43.5 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.516 -1.034 . . . . 52.23 110.516 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.9 t -102.56 149.72 36.98 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 109.06 -0.719 . . . . 61.21 109.06 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -75.18 -4.82 15.91 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.594 2.196 . . . . 74.32 111.173 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.557 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -71.99 147.04 47.29 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.771 -0.65 . . . . 61.45 110.854 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 74.0 p -108.02 138.05 44.95 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.3 -0.63 . . . . 60.12 109.3 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -144.02 150.51 38.36 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 122.29 -0.256 . . . . 62.2 110.938 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.514 ' O ' HG12 ' A' ' 166' ' ' VAL . 29.0 pt20 -129.33 122.84 30.38 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.999 1.111 . . . . 71.34 113.999 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.71 12.79 62.5 Favored Glycine 0 C--N 1.309 -0.964 0 N-CA-C 115.207 0.843 . . . . 63.53 115.207 164.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.401 ' O ' ' HD1' ' A' ' 167' ' ' TYR . 25.4 t70 67.43 19.76 9.99 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.959 0.409 . . . . 41.04 110.641 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 163' ' ' GLN . 7.2 p -64.81 137.95 24.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 120.367 -0.533 . . . . 62.14 109.788 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' ASP . 26.9 p90 -151.12 170.83 18.46 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.701 0.762 . . . . 74.21 111.644 -173.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 97.2 m-85 -114.64 151.65 33.19 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.216 -1.356 . . . . 75.41 109.737 175.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.54 122.16 45.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.506 -1.294 . . . . 73.45 107.506 174.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -112.18 142.41 44.69 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.153 0.283 . . . . 53.11 111.436 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.987 0 N-CA-C 110.039 -1.224 . . . . 72.23 110.039 179.79 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 CA--C 1.511 -0.548 0 CA-C-O 120.964 0.411 . . . . 73.25 110.069 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -109.13 132.94 53.64 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.739 -1.208 . . . . 73.33 107.739 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.442 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 14.1 m120 -134.37 134.29 41.56 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.385 -0.969 . . . . 71.4 108.385 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 7.7 mp0 -128.82 136.35 50.37 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.865 -0.42 . . . . 74.3 109.865 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.1 t -124.74 121.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.468 -0.938 . . . . 70.4 108.468 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.6 m0 -103.21 123.15 46.19 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 108.087 -1.079 . . . . 72.31 108.087 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 166' ' ' VAL . 1.7 tt -97.35 138.57 34.61 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.896 -1.52 . . . . 63.11 106.896 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.483 HG22 ' CE2' ' A' ' 168' ' ' TYR . 20.7 t -87.88 131.98 34.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 110.455 -0.202 . . . . 73.24 110.455 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.578 ' HD2' ' C ' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -70.39 143.38 51.9 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 118.551 -0.738 . . . . 65.44 109.333 176.504 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.402 ' CD1' ' HD2' ' A' ' 34' ' ' ARG . 8.6 p90 . . . . . 0 N--CA 1.431 -1.379 0 N-CA-C 105.3 -2.111 . . . . 75.43 105.3 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -106.03 114.98 29.44 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.997 -1.081 . . . . 74.25 111.963 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.51 121.16 35.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.311 -1.737 . . . . 61.45 106.311 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.3 -26.42 20.01 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.389 -0.924 . . . . 72.24 110.758 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -175.99 165.31 2.92 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.681 -0.859 . . . . 74.15 108.681 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.4 HG22 ' HG3' ' A' ' 32' ' ' GLU . 36.4 p -132.57 150.02 52.22 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.771 -1.196 . . . . 70.15 107.771 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.39 113.61 2.11 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.101 -1.523 . . . . 73.03 113.406 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.25 -99.49 0.49 Allowed Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 110.857 -0.897 . . . . 41.12 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -98.87 169.1 9.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.302 -0.999 . . . . 74.42 108.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.48 157.38 23.62 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.504 -0.554 . . . . 74.01 109.504 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 72.74 -58.28 0.6 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.408 1.083 . . . . 64.12 110.875 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.86 111.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.823 0.82 . . . . 70.01 108.791 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.5 m -106.37 136.91 45.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.826 -0.625 . . . . 72.12 109.809 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.49 160.14 18.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.597 -0.841 . . . . 75.12 111.405 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 34.7 tt0 -134.61 124.29 25.17 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.646 -1.613 . . . . 63.24 106.646 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.8 115.66 30.86 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.042 0.925 . . . . 73.31 110.835 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 22.1 ptt180 -128.81 138.58 52.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 114.458 -1.246 . . . . 74.21 110.871 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.22 136.94 32.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.071 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.01 148.92 28.98 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.945 0.778 . . . . 75.11 109.718 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -77.62 -13.55 59.88 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 112.496 0.554 . . . . 74.22 112.496 -175.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.29 61.68 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.219 -1.467 . . . . 53.21 113.253 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 163.65 40.17 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.616 -1.278 . . . . 72.54 112.337 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.537 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.4 ptpt -96.03 133.9 39.71 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 75.11 108.375 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 37.0 m-85 -124.52 163.12 22.54 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.269 -0.423 . . . . 73.21 111.922 -171.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -99.53 116.63 32.12 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.575 -0.898 . . . . 72.45 108.575 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.4 t -123.29 149.64 44.56 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 121.23 0.538 . . . . 72.15 110.978 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.4 m -127.09 123.27 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.098 -0.955 . . . . 63.23 109.41 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -109.89 132.57 54.03 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.44 0.638 . . . . 71.14 112.504 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 54' ' ' ALA . 42.1 t -129.41 136.9 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.569 -1.271 . . . . 74.02 107.569 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 49' ' ' LYS . 31.0 m -138.75 164.83 28.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.712 -1.218 . . . . 73.33 107.712 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 47' ' ' THR . 14.1 t70 76.16 -26.47 0.19 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.012 1.325 . . . . 74.55 110.309 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 47' ' ' THR . 54.0 mtmt -103.16 122.59 44.83 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 114.483 -1.235 . . . . 72.42 108.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.48 158.79 1.57 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 124.596 3.531 . . . . 73.11 114.416 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.409 HG13 HD12 ' A' ' 98' ' ' LEU . 53.6 t -46.66 -41.47 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.452 1.101 . . . . 61.42 112.055 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.688 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 24.5 t70 -58.81 -43.45 90.56 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.638 -0.256 . . . . 70.02 110.517 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -73.77 -47.67 37.33 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.335 0.654 . . . . 64.2 110.85 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -56.77 -41.56 77.85 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.442 -0.799 . . . . 74.22 111.698 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 59' ' ' MET . 45.1 tp -68.72 -35.71 77.49 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.342 -0.39 . . . . 74.51 110.443 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 17.6 mtp180 -56.89 -46.0 82.18 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.206 0.527 . . . . 74.3 111.624 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.58 -35.33 39.84 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.429 -0.805 . . . . 74.43 112.292 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.29 -32.91 59.03 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.37 0.878 . . . . 72.32 113.37 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.447 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 5.2 mmt -56.26 -57.91 19.86 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.121 0.786 . . . . 74.4 113.121 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.612 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 28.9 Cg_endo -63.9 -32.49 66.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 121.867 1.712 . . . . 64.22 110.552 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -58.35 -45.65 87.78 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.923 -1.035 . . . . 54.42 110.796 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.5 mm -75.63 -47.63 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.219 -0.446 . . . . 73.42 111.389 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.505 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.292 3.7 ppp? -62.85 -32.23 73.41 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.667 1.358 . . . . 75.04 114.667 -174.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 60' ' ' PRO 0.295 0.0 OUTLIER -77.65 -29.09 51.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.697 -1.201 . . . . 71.23 112.504 176.347 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' THR . 62.2 t80 -65.07 -52.23 56.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.343 0.592 . . . . 74.41 110.207 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -72.19 -15.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.556 -0.747 . . . . 73.1 111.853 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.4 -11.58 68.82 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.439 -0.801 . . . . 70.34 112.458 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.0 -23.32 1.44 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.486 -1.34 . . . . 44.44 113.577 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 58.0 m -82.0 70.01 8.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.65 1.214 . . . . 74.24 111.976 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -98.36 170.16 9.05 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.528 -2.027 . . . . 72.3 105.528 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 36.6 t70 -69.31 -33.52 73.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 119.809 -0.756 . . . . 64.33 111.723 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.2 1.91 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 72.24 110.792 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.86 28.57 72.96 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.638 -0.71 . . . . 64.21 113.656 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.16 120.73 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 109.3 -0.629 . . . . 72.43 109.3 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.76 -135.3 1.85 Allowed Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 111.0 -0.84 . . . . 54.44 111.0 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.8 ttp 178.0 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.271 0.558 . . . . 54.03 111.284 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.54 65.58 0.58 Allowed Glycine 0 CA--C 1.491 -1.414 0 N-CA-C 106.291 -2.724 . . . . 60.53 106.291 -169.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.469 ' H ' ' HG2' ' A' ' 78' ' ' MET . 11.4 ptm -97.01 121.94 39.45 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.266 -0.967 . . . . 72.55 111.448 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -128.26 134.93 49.05 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.712 -0.676 . . . . 64.53 111.589 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m -157.11 172.29 6.33 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 104.991 -2.226 . . . . 71.25 104.991 171.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 86.3 Cg_exo -54.18 139.52 72.09 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 121.431 1.42 . . . . 75.44 113.161 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.83 142.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.421 -1.326 . . . . 41.13 107.421 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.6 p -138.33 144.5 40.41 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.952 -0.299 . . . . 62.33 110.234 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 50.4 p90 -131.01 143.73 50.94 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.582 -0.447 . . . . 73.22 110.96 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.35 134.24 35.78 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.602 0.564 . . . . 74.33 110.6 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.26 150.79 32.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.438 -0.801 . . . . 74.12 109.799 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 95' ' ' GLN . 78.9 m-85 -114.75 112.69 45.1 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.951 -0.389 . . . . 74.04 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.59 158.83 2.93 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.869 1.713 . . . . 63.53 111.289 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -104.67 160.76 14.7 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.279 -1.749 . . . . 72.21 106.279 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.01 -24.73 64.73 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.49 0.662 . . . . 74.11 111.058 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.57 -5.89 47.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.01 -0.995 . . . . 73.33 110.804 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.91 -10.67 74.29 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.846 -0.502 . . . . 44.4 111.846 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 m -77.22 136.01 38.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 109.032 -0.729 . . . . 74.13 109.032 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.3 mt -84.72 136.85 33.55 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.069 0.461 . . . . 72.25 111.037 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 53.1 tt0 -81.9 144.97 30.6 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.769 -1.567 . . . . 71.53 106.769 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -92.29 80.12 5.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.364 1.246 . . . . 70.51 114.364 -174.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.645 ' HE2' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -160.42 122.37 3.18 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.434 -2.802 . . . . 52.44 103.434 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.645 ' N ' ' HE2' ' A' ' 97' ' ' LYS . 5.2 tt -144.11 137.62 27.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.77 0.319 . . . . 62.35 110.515 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -129.09 123.88 33.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.205 -0.598 . . . . 65.34 110.553 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.553 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 86.2 t -86.94 129.78 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.629 -0.714 . . . . 71.51 109.145 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -107.16 127.87 53.9 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.622 -0.51 . . . . 74.22 109.622 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -104.04 117.71 34.94 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.812 -1.181 . . . . 74.51 107.812 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 59.4 ttt-85 -75.34 129.46 37.42 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.023 -1.473 . . . . 74.02 107.023 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.4 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 79.7 mt -89.87 134.28 32.31 Favored Pre-proline 0 C--N 1.271 -2.831 0 N-CA-C 109.868 -0.419 . . . . 73.44 109.868 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 74.7 Cg_exo -53.59 158.84 7.34 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.021 2.481 . . . . 74.51 112.972 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -46.27 -54.32 9.08 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 126.137 1.775 . . . . 73.12 115.585 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -72.29 -28.15 62.91 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.053 -0.659 . . . . 72.12 112.456 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.89 -12.56 55.28 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.623 -0.431 . . . . 73.34 111.458 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 49.9 mt-30 -70.9 -28.53 64.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.748 0.309 . . . . 62.41 111.482 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -38.24 92.38 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.975 -0.631 . . . . 60.44 111.64 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -157.41 98.9 1.93 Allowed Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.6 158.95 10.73 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.75 2.3 . . . . 75.2 112.586 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.5 156.2 66.4 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.434 2.089 . . . . 74.12 111.511 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -72.74 142.46 83.47 Favored Pre-proline 0 N--CA 1.426 -1.665 0 CA-C-N 115.958 -0.565 . . . . 61.24 110.011 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.74 114.74 3.43 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.844 2.362 . . . . 63.02 112.088 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -61.14 -42.65 98.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.739 -0.664 . . . . 75.3 109.498 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.539 ' HB2' HG23 ' A' ' 120' ' ' VAL . 9.0 m-20 -91.19 161.07 15.23 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 63.32 110.256 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -87.18 -28.4 22.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.507 -0.77 . . . . 63.01 109.03 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.3 p -79.07 -12.25 60.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.657 -0.701 . . . . 55.11 112.025 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 117' ' ' ASP . 59.3 t -100.14 116.99 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 105.833 -1.914 . . . . 63.13 105.833 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -128.78 143.43 50.92 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 120.701 -0.4 . . . . 74.53 110.316 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.0 mm -92.45 112.76 26.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.462 -0.94 . . . . 75.43 108.462 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.82 153.11 38.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.862 -0.792 . . . . 71.43 108.862 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 4.5 mp0 -98.45 146.87 25.3 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.994 0.426 . . . . 74.52 110.24 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 125' ' ' ARG . 32.6 mmt180 -134.54 120.99 20.35 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.637 -0.71 . . . . 75.13 109.697 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.28 156.15 43.65 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.651 -0.87 . . . . 70.32 108.651 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.22 19.39 78.48 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.194 -1.003 . . . . 50.15 114.096 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -120.08 145.25 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 C-N-CA 119.92 -0.712 . . . . 71.31 109.588 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.0 m -112.59 138.46 49.34 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 105.646 -1.983 . . . . 52.23 105.646 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.88 148.33 26.73 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 108.3 -1.0 . . . . 52.44 108.3 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -112.56 121.05 43.66 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 103.646 -2.724 . . . . 75.42 103.646 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.2 m -122.34 135.2 54.67 Favored 'General case' 0 C--N 1.263 -3.162 0 C-N-CA 120.587 -0.445 . . . . 60.45 109.926 -174.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.6 t -112.51 136.81 51.59 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 108.727 -0.842 . . . . 53.32 108.727 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 9.3 pt20 -117.25 130.03 56.3 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.527 -0.761 . . . . 65.23 109.404 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.83 168.37 19.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.405 -0.816 . . . . 71.23 109.515 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -126.38 136.35 9.48 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.922 -0.656 . . . . 64.42 112.022 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 152.01 -163.22 30.06 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.203 -1.159 . . . . 54.42 110.203 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -99.13 107.71 20.14 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.562 -0.903 . . . . 74.23 108.562 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.18 133.38 35.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.203 1.186 . . . . 64.23 114.203 -172.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HB3' ' OE1' ' A' ' 141' ' ' GLU . 25.4 mtpp -112.33 177.5 4.62 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.941 -1.503 . . . . 73.34 106.941 170.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -63.27 -34.46 77.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.075 0.464 . . . . 54.13 109.98 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.57 -30.0 71.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.525 -0.762 . . . . 54.03 111.254 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.2 -31.72 71.43 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.968 0.413 . . . . 54.23 110.789 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' A' ' 185' ' ' VAL . 90.8 m-85 -73.03 -43.98 61.39 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.047 -0.524 . . . . 61.54 109.935 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.22 -48.36 87.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 O-C-N 123.42 0.45 . . . . 74.33 110.38 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.51 87.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.574 -0.739 . . . . 50.14 111.546 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.444 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 65.1 m80 -71.08 -34.8 71.52 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.463 -0.495 . . . . 63.54 112.068 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.446 0.165 . . . . 73.04 110.76 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.2 t -68.73 -32.72 72.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 74.12 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -66.75 -40.61 88.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.334 0.587 . . . . 72.14 109.762 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.46 HD21 ' HB ' ' A' ' 133' ' ' THR . 65.8 mt -65.05 -33.75 76.78 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 116.149 -0.478 . . . . 72.12 111.363 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 50.3 mtt180 -56.09 -49.04 74.95 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.483 0.489 . . . . 71.21 110.847 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.588 ' HA ' ' OE1' ' A' ' 156' ' ' GLU . 11.0 t -73.7 -29.56 62.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.922 -0.581 . . . . 61.33 110.807 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 34.1 m -71.14 -34.57 71.15 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.428 0.632 . . . . 63.3 109.691 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.45 0.52 16.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.491 0.716 . . . . 75.13 111.643 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.588 ' OE1' ' HA ' ' A' ' 153' ' ' THR . 46.5 mt-10 -84.16 140.22 31.89 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.55 -0.537 . . . . 71.53 109.55 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 96.88 -10.09 66.08 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.08 -0.581 . . . . 71.41 111.957 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 12.2 t -122.2 155.59 61.32 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.198 . . . . 63.01 107.764 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 36.56 0.1 Allowed 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 124.351 3.367 . . . . 44.13 114.287 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -101.03 119.04 38.16 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.123 0.487 . . . . 75.12 110.631 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.5 p -123.83 144.54 49.66 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.011 -0.737 . . . . 61.01 109.011 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -131.31 150.61 52.08 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.353 -0.24 . . . . 72.25 110.353 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -120.06 148.77 43.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.752 0.649 . . . . 72.11 112.752 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.25 1.95 37.93 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 115.112 0.805 . . . . 74.45 115.112 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB3' HH22 ' A' ' 152' ' ' ARG . 21.3 m-20 65.88 0.47 1.56 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.748 0.819 . . . . 61.33 112.04 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.63 139.27 20.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.648 0.737 . . . . 53.12 112.706 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -136.24 164.0 29.09 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.095 -1.076 . . . . 60.12 108.095 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 50.8 m-85 -115.63 151.38 35.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.411 -0.588 . . . . 75.25 109.411 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 83' ' ' SER . 60.4 m -113.94 123.7 50.38 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.928 -1.508 . . . . 63.1 106.928 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -111.72 149.21 31.95 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.859 0.362 . . . . 74.41 111.324 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.06 0 N-CA-C 108.544 -1.823 . . . . 74.22 108.544 -178.4 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.6 ptp180 . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 121.19 0.519 . . . . 74.11 111.864 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -115.12 127.91 55.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.483 -2.414 . . . . 74.15 104.483 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 15.9 m-80 -139.67 160.25 40.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.15 -0.62 . . . . 74.14 110.526 -171.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 133' ' ' THR . 49.6 mt-10 -132.45 145.9 51.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 123.753 0.658 . . . . 71.21 109.823 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 132' ' ' SER . 21.8 t -123.95 120.85 60.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 106.071 -1.826 . . . . 74.34 106.071 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 13.1 m0 -104.78 121.36 43.47 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.798 -0.361 . . . . 72.51 110.932 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 84.8 mt -99.1 131.18 45.32 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.03 -1.47 . . . . 54.34 107.03 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.35 135.21 38.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.506 -0.478 . . . . 63.52 110.563 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 161' ' ' THR . 19.9 pttp -72.0 143.24 49.26 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.563 -0.455 . . . . 73.42 110.854 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 115.062 -0.972 . . . . 74.35 110.505 178.26 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.1 p90 . . . . . 0 N--CA 1.423 -1.815 0 N-CA-C 104.378 -2.453 . . . . 72.41 104.378 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 91.8 mt-30 -106.17 109.28 21.16 Favored 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 118.648 -1.221 . . . . 73.4 111.542 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.91 115.87 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 108.089 -1.078 . . . . 74.23 108.089 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -96.08 -36.55 10.96 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.074 -0.966 . . . . 62.31 111.883 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.471 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 42.6 t -157.12 150.41 23.98 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.296 0.569 . . . . 73.33 111.009 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.6 p -132.45 162.45 31.13 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.431 -1.692 . . . . 43.12 106.431 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.5 99.66 0.97 Allowed Glycine 0 C--N 1.304 -1.209 0 C-N-CA 118.297 -1.906 . . . . 61.43 114.243 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.07 -147.49 5.76 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.707 -0.957 . . . . 61.41 110.707 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -86.76 170.89 11.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.065 -0.717 . . . . 65.41 109.065 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.15 155.01 39.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.551 -0.907 . . . . 72.41 108.551 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 74.35 -52.81 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.791 0.836 . . . . 72.31 111.464 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.04 109.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 122.441 1.115 . . . . 72.34 110.376 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.8 m -111.53 128.66 56.09 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.662 -0.866 . . . . 74.44 108.662 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.04 155.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.558 -1.257 . . . . 62.43 111.301 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 35.2 tt0 -134.36 125.63 27.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.796 -1.557 . . . . 70.31 106.796 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 36.2 mt-10 -94.73 114.86 26.83 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.436 -1.69 . . . . 62.1 106.436 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.548 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 30.2 ptt180 -140.27 132.37 27.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.435 0.636 . . . . 75.52 112.54 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 129' ' ' THR . . . -80.98 137.34 36.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.093 -1.077 . . . . 53.03 108.093 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -58.87 149.8 25.87 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.772 0.67 . . . . 73.4 110.468 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -68.99 -21.18 64.17 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.975 -0.557 . . . . 53.41 112.032 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 9.72 68.5 Favored Glycine 0 C--O 1.244 0.766 0 C-N-CA 119.966 -1.111 . . . . 75.03 112.893 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 165.81 53.12 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 121.384 -0.436 . . . . 73.01 113.139 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -98.58 118.52 35.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.771 -0.826 . . . . 73.2 108.771 179.399 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.531 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 22.8 m-85 -124.33 165.63 17.35 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.736 -0.665 . . . . 72.41 111.494 -170.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.77 117.94 34.39 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.954 -0.758 . . . . 60.4 108.954 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -125.03 147.66 48.85 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.911 -0.586 . . . . 54.42 111.829 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.482 HG21 ' HG2' ' A' ' 61' ' ' LYS . 7.6 p -137.75 135.33 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 41.01 108.905 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -121.78 137.64 54.69 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.092 -1.043 . . . . 73.24 110.504 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 41.7 t -118.74 131.34 71.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.037 -1.468 . . . . 71.41 107.037 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -115.16 158.27 22.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.635 0.606 . . . . 45.14 112.635 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.455 ' HA ' ' CG ' ' A' ' 96' ' ' LYS . 36.3 t70 68.73 -12.89 0.35 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.629 1.972 . . . . 64.43 113.445 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.92 23.46 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 108.458 -0.941 . . . . 72.2 108.458 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.93 156.88 11.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.877 2.385 . . . . 73.43 111.337 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 98' ' ' LEU . 55.9 t -46.49 -47.68 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.893 0.877 . . . . 73.22 113.263 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 14.1 t70 -63.35 -47.84 80.46 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.528 -0.469 . . . . 74.31 110.208 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -63.56 -41.43 98.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.34 0.656 . . . . 73.23 112.195 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -65.42 -39.78 92.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.132 0.492 . . . . 54.11 110.115 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.9 tp -66.3 -33.75 76.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.883 -0.599 . . . . 62.33 110.001 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.684 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 29.9 mmt180 -59.05 -34.36 71.84 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.853 -0.612 . . . . 64.51 110.78 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.03 -49.53 10.12 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.312 -0.858 . . . . 63.31 110.72 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -66.99 -33.06 74.75 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.317 1.228 . . . . 64.25 114.317 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.581 ' O ' ' HG2' ' A' ' 63' ' ' MET . 6.5 mmt -61.11 -58.19 20.84 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 119.752 -0.779 . . . . 75.24 112.806 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.16 -30.84 91.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.407 2.071 . . . . 73.14 111.131 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HG2' HG21 ' A' ' 44' ' ' VAL . 18.1 tppt? -61.43 -44.49 97.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.092 -0.958 . . . . 65.13 110.369 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 38.4 mm -73.57 -39.41 53.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.313 -0.555 . . . . 65.32 109.583 175.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 59' ' ' MET . 25.9 mmt -55.38 -44.15 75.81 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.453 0.538 . . . . 70.0 112.453 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.01 -38.61 91.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.183 0.516 . . . . 74.44 110.652 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -70.83 -51.02 29.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.892 -0.595 . . . . 74.13 111.159 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 62' ' ' ILE . 14.6 p -74.85 -25.46 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-O 121.07 0.462 . . . . 72.15 111.229 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.75 -30.81 67.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.88 -0.6 . . . . 74.12 113.074 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.53 -3.63 1.88 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.271 -1.443 . . . . 52.42 113.855 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 m -89.56 27.07 1.56 Allowed 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 122.627 1.203 . . . . 72.45 109.387 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.08 177.29 7.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.068 -0.969 . . . . 74.15 109.231 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.82 -31.57 72.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.965 0.728 . . . . 70.24 112.965 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -87.6 -12.88 44.33 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.911 -0.716 . . . . 73.3 110.741 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.81 28.29 73.2 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.684 -0.77 . . . . 54.54 111.566 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.01 121.84 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.01 0.433 . . . . 73.14 109.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.95 63.74 0.61 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.431 -0.89 . . . . 74.12 112.144 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.93 -26.43 48.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.51 -0.552 . . . . 75.33 109.51 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.77 83.98 0.36 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.245 -0.889 . . . . 45.42 111.554 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 19.1 ptt? -96.19 125.41 40.69 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.926 0.393 . . . . 74.32 110.048 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.7 p -113.82 116.49 29.42 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.911 -0.586 . . . . 50.12 112.267 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.54 159.57 36.1 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 106.965 -1.495 . . . . 75.2 106.965 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.67 139.46 88.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.646 1.564 . . . . 71.53 112.616 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -103.94 153.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.193 -1.41 . . . . 72.31 107.193 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.4 m -133.75 145.45 49.83 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.303 -0.628 . . . . 73.53 109.303 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 51.4 p90 -138.12 139.96 39.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.403 -0.519 . . . . 64.34 110.309 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.69 134.87 34.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.878 -0.601 . . . . 63.52 110.175 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.48 150.02 30.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.952 -1.129 . . . . 70.5 107.952 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -119.48 108.05 40.17 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.17 -0.678 . . . . 73.11 109.17 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.4 142.09 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.088 1.858 . . . . 74.43 112.546 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.17 174.54 7.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.006 -0.543 . . . . 63.12 110.323 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -23.46 67.41 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.036 0.935 . . . . 61.24 110.622 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.46 -5.31 58.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.049 -0.978 . . . . 64.03 110.607 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.76 -10.25 65.7 Favored Glycine 0 CA--C 1.504 -0.636 0 CA-C-N 116.084 -0.507 . . . . 53.25 112.214 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 p -86.1 142.19 28.87 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.545 -0.539 . . . . 72.13 109.545 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 69.6 mt -75.84 145.21 40.79 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.024 -0.534 . . . . 74.44 110.61 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.64 150.25 32.7 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.657 -0.868 . . . . 74.51 108.657 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.527 ' H ' ' HD3' ' A' ' 96' ' ' LYS 0.291 0.2 OUTLIER -83.03 75.31 9.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.651 1.215 . . . . 73.23 112.031 178.938 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -164.09 125.03 2.2 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.536 -2.024 . . . . 71.14 105.536 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.515 HD12 HG13 ' A' ' 51' ' ' VAL . 5.6 tt -140.22 135.31 32.23 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.057 -0.719 . . . . 63.03 109.057 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -124.16 115.34 20.95 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.562 -0.29 . . . . 62.44 110.237 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.7 t -91.17 134.45 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.542 -0.54 . . . . 61.31 109.542 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -117.75 122.16 42.73 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.646 -0.872 . . . . 54.11 108.646 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 75.8 t80 -102.93 111.14 23.33 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.817 -1.549 . . . . 74.3 106.817 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.531 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 34.1 ttp180 -81.56 113.21 19.43 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.714 -0.675 . . . . 71.52 110.247 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.514 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 68.7 mt -79.07 134.09 60.19 Favored Pre-proline 0 C--N 1.284 -2.253 0 CA-C-N 114.463 -1.244 . . . . 73.42 110.907 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.521 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 50.7 Cg_exo -53.4 153.75 16.77 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.328 2.685 . . . . 74.33 112.067 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -56.47 -36.28 68.91 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.012 1.116 . . . . 64.54 114.012 -174.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -62.4 -36.2 81.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.159 0.504 . . . . 75.21 111.004 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.5 -6.17 56.65 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.988 -0.551 . . . . 70.23 110.997 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.514 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 26.0 mm-40 -71.7 -30.2 65.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.829 0.347 . . . . 72.54 110.75 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.24 73.47 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.472 -0.785 . . . . 61.44 111.908 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.5 p -160.18 89.02 1.83 Allowed Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-O 120.661 0.267 . . . . 73.24 110.495 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.49 154.27 9.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.178 1.918 . . . . 52.41 110.935 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.96 158.11 58.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.341 2.027 . . . . 74.1 111.352 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.85 149.53 80.47 Favored Pre-proline 0 C--O 1.259 1.593 0 C-N-CA 120.874 -0.33 . . . . 73.41 110.205 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 24.9 Cg_exo -65.73 106.75 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.697 2.265 . . . . 60.14 111.38 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.5 t -83.16 -25.66 31.63 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.53 -0.545 . . . . 73.33 109.53 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.63 143.89 28.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.317 -0.994 . . . . 71.15 108.317 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.18 -24.04 60.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.019 0.748 . . . . 71.45 113.019 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.2 m -89.81 -19.11 25.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.002 0.429 . . . . 63.33 109.892 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 61.9 t -94.89 116.27 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 107.102 -1.444 . . . . 72.21 107.102 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -124.35 136.31 53.99 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.603 -0.726 . . . . 71.21 110.449 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.5 mm -91.68 111.19 23.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.612 -1.255 . . . . 70.22 107.612 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -124.73 143.38 50.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.806 -1.088 . . . . 70.31 109.142 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -105.23 132.58 51.25 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.624 -0.716 . . . . 75.31 109.339 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -123.2 123.1 40.03 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.291 -1.003 . . . . 72.32 108.291 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.6 158.03 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.5 -0.555 . . . . 61.02 109.5 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.36 19.2 50.57 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.626 -0.797 . . . . 71.42 112.128 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.26 145.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.058 0.456 . . . . 71.03 110.367 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 90.4 m -112.64 135.49 53.3 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 107.87 -1.159 . . . . 72.44 107.87 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.16 150.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 N-CA-C 107.839 -1.171 . . . . 73.14 107.839 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.35 121.12 43.43 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 104.664 -2.347 . . . . 75.43 104.664 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 24.8 m -115.93 132.75 56.56 Favored 'General case' 0 C--N 1.261 -3.246 0 C-N-CA 120.339 -0.545 . . . . 71.33 110.834 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' SER . 9.9 t -113.24 119.94 39.46 Favored 'General case' 0 N--CA 1.391 -3.421 0 CA-C-N 115.587 -0.733 . . . . 71.32 109.614 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -110.88 126.03 54.26 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.404 -1.332 . . . . 65.04 107.404 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 22.3 p90 -136.6 167.6 21.08 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.352 -0.84 . . . . 75.04 110.687 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -133.32 143.3 14.96 Favored Glycine 0 CA--C 1.485 -1.798 0 C-N-CA 120.484 -0.865 . . . . 52.33 111.559 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.81 -155.28 25.79 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.258 -1.137 . . . . 63.01 110.258 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -99.93 103.08 14.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.834 -0.802 . . . . 75.3 108.834 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.62 117.53 31.86 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.41 -0.359 . . . . 64.44 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -81.13 163.84 22.82 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.831 -1.174 . . . . 72.21 107.831 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.74 -35.23 42.5 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.004 0.522 . . . . 60.34 111.607 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.87 65.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.065 -0.516 . . . . 71.11 111.121 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.33 -30.89 69.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.119 -0.491 . . . . 73.44 110.433 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -59.72 -49.43 77.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.299 -0.63 . . . . 72.31 109.299 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.1 t -59.96 -42.96 91.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.032 -0.986 . . . . 52.52 109.341 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.16 85.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.46 -0.791 . . . . 33.42 111.179 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.511 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 29.3 m80 -66.94 -33.89 76.57 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 112.536 0.569 . . . . 71.02 112.536 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.23 -45.14 94.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.398 0.618 . . . . 62.03 109.627 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 m -66.58 -35.3 79.87 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.421 -0.809 . . . . 71.11 109.868 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.09 -29.01 61.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.752 -0.658 . . . . 74.33 111.373 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 82.6 mt -61.7 -36.71 81.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.944 -0.391 . . . . 71.14 109.944 173.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -57.42 -48.19 79.78 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.854 0.721 . . . . 72.22 110.802 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.6 t -75.72 -30.15 59.16 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.113 -0.494 . . . . 73.34 110.952 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.4 m -74.85 -34.17 62.25 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.358 0.599 . . . . 73.15 110.819 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.54 6.75 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.373 0.606 . . . . 72.13 110.36 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 131.53 34.34 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.826 -1.546 . . . . 72.04 106.826 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.89 -4.78 61.35 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.514 -0.635 . . . . 65.14 111.514 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.1 p -99.89 163.94 17.44 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 107.844 -1.169 . . . . 43.24 107.844 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 63.6 Cg_endo -73.88 0.82 7.79 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.992 1.794 . . . . 71.35 112.901 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.95 140.99 32.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.881 0.372 . . . . 73.54 111.557 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.0 p -118.13 153.48 33.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.212 -0.662 . . . . 64.25 109.212 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.434 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 38.8 p90 -135.3 137.81 42.85 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.139 -0.35 . . . . 75.11 110.171 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.498 ' OE1' HG13 ' A' ' 188' ' ' VAL 0.26 0.0 OUTLIER -97.92 116.63 30.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.739 1.385 . . . . 74.44 114.739 -176.455 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.16 65.82 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.773 -0.649 . . . . 75.55 112.623 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . 0.261 8.6 p-10 49.38 27.66 2.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.765 1.226 . . . . 74.52 113.22 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 187' ' ' LEU . 77.6 t -66.57 138.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 113.968 -1.469 . . . . 73.12 110.137 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -143.26 171.13 14.53 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.989 -0.55 . . . . 61.43 111.492 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 4.2 m-85 -121.75 150.54 41.68 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.671 -0.695 . . . . 64.54 109.865 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 20.4 t -115.02 146.22 41.48 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.994 -1.113 . . . . 75.01 107.994 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.36 158.5 18.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.925 0.393 . . . . 74.15 110.907 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.419 0 N-CA-C 108.732 -1.747 . . . . 71.02 108.732 179.495 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 111.787 0.291 . . . . 73.15 111.787 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -116.6 136.06 53.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.085 0.469 . . . . 74.12 110.579 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.2 m120 -126.52 146.94 49.93 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.729 -1.582 . . . . 72.33 106.729 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 133' ' ' THR . 33.9 tt0 -142.82 132.64 24.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.965 -0.694 . . . . 53.14 110.459 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 132' ' ' SER . 82.4 t -126.49 130.18 71.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.863 0.865 . . . . 61.14 109.287 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.5 m0 -109.36 121.3 44.87 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 109.449 -0.574 . . . . 63.44 109.449 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 166' ' ' VAL . 40.3 tp -100.78 135.48 42.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.865 -1.532 . . . . 73.31 106.865 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.498 HG13 ' OE1' ' A' ' 163' ' ' GLN . 6.1 p -106.72 135.44 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 114.036 1.124 . . . . 75.35 114.036 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -63.16 144.37 56.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.015 1.326 . . . . 71.41 114.421 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.241 -0.89 . . . . 64.05 109.045 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.3 p90 . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 106.426 -1.694 . . . . 55.14 106.426 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -121.11 109.62 15.24 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.929 -1.109 . . . . 75.14 112.392 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.45 125.68 45.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.103 -1.814 . . . . 75.23 106.103 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 22' ' ' SER . 2.9 pp -90.22 -29.26 18.31 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.677 -1.209 . . . . 74.21 111.366 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.491 ' N ' HD12 ' A' ' 21' ' ' LEU . 30.7 t -179.32 164.59 1.37 Allowed 'General case' 0 C--O 1.25 1.117 0 O-C-N 123.575 0.547 . . . . 74.42 110.124 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -131.19 165.76 22.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.852 -1.166 . . . . 63.44 107.852 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.68 -164.38 29.87 Favored Glycine 0 C--N 1.306 -1.139 0 C-N-CA 120.577 -0.82 . . . . 54.45 111.545 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.92 -138.75 10.44 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.597 -0.811 . . . . 73.51 112.263 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -118.09 170.73 8.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.107 -1.442 . . . . 71.24 107.107 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.96 159.67 33.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 118.569 0.622 . . . . 74.4 110.07 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 76.26 -52.78 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.754 1.622 . . . . 61.14 110.426 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG11 ' HG3' ' A' ' 150' ' ' GLN . 7.7 p -120.14 110.0 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-O 122.235 1.017 . . . . 74.13 109.811 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 133' ' ' THR . 45.0 m -122.16 154.11 37.87 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.446 -0.946 . . . . 51.13 108.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.735 ' HB3' HD11 ' A' ' 151' ' ' LEU . 8.9 p90 -118.06 156.52 28.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.91 1.078 . . . . 72.23 113.91 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.32 125.9 23.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.734 -1.95 . . . . 73.11 105.734 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 115.1 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.499 -1.667 . . . . 73.1 106.499 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -131.79 133.7 45.02 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.687 -0.688 . . . . 74.34 111.403 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.63 136.27 33.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.26 -1.385 . . . . 53.04 107.26 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.43 158.08 21.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.548 0.573 . . . . 71.14 112.548 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -86.54 -18.66 30.95 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.665 -0.698 . . . . 74.45 112.858 -174.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.81 46.62 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.494 -1.813 . . . . 71.4 112.544 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.35 149.22 46.81 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.804 -0.712 . . . . 42.13 113.874 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 104' ' ' ILE . 19.5 ptmt -88.88 119.45 29.4 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.656 -0.868 . . . . 63.24 108.656 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.552 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 27.7 m-85 -127.0 166.35 17.73 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 123.693 0.797 . . . . 74.41 111.083 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -97.56 116.82 30.5 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.092 -1.077 . . . . 60.1 108.092 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.8 t -135.29 150.76 50.08 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 115.414 -0.812 . . . . 74.14 112.516 -173.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 9.2 p -141.64 142.28 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.121 -1.066 . . . . 74.21 108.121 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.3 133.05 48.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.658 -0.817 . . . . 74.32 112.572 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.58 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 52.7 t -112.08 141.87 26.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.656 -1.979 . . . . 72.52 105.656 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' LYS . 26.4 p -132.31 152.24 51.48 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.668 0.988 . . . . 52.25 113.668 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 67.6 -16.37 0.17 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 126.204 1.801 . . . . 74.23 112.141 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' THR . 48.6 mtpt -88.78 146.86 37.84 Favored Pre-proline 0 N--CA 1.422 -1.874 0 C-N-CA 124.175 0.99 . . . . 70.34 110.035 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 31.2 Cg_exo -60.23 153.05 61.91 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.509 2.139 . . . . 60.1 111.675 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 98' ' ' LEU . 32.2 t -49.89 -42.56 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 124.035 0.934 . . . . 53.23 112.316 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.698 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 13.0 t70 -61.63 -46.32 90.3 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.548 -0.461 . . . . 73.23 109.823 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -69.01 -42.13 76.83 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.199 -0.455 . . . . 74.33 111.48 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.15 -42.46 99.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.723 -0.672 . . . . 72.5 111.062 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.11 -31.97 72.79 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 116.336 -0.393 . . . . 72.55 111.156 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 5.2 mmp_? -55.95 -41.51 74.78 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.734 0.646 . . . . 75.1 110.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 44.4 mt-10 -84.41 -43.55 14.56 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.085 -0.507 . . . . 71.12 112.08 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.423 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -68.97 -41.82 77.42 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.52 1.304 . . . . 43.45 114.52 -171.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.4 ttm -57.27 -48.54 97.18 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.54 0.941 . . . . 71.53 113.54 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.68 -31.89 52.4 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.264 1.976 . . . . 75.11 112.245 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 91.0 mttt -72.12 -35.53 69.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.389 0.614 . . . . 55.33 111.058 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.05 -34.19 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 116.016 -0.538 . . . . 75.45 110.536 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 ttp -64.58 -43.31 94.26 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 124.062 0.945 . . . . 63.41 110.581 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 21.3 ptmt -69.48 -31.62 70.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.559 -0.291 . . . . 74.41 110.704 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -62.44 -60.48 3.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.46 -0.336 . . . . 74.21 111.796 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 76' ' ' MET . 14.6 p -83.86 -2.24 6.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-O 121.988 0.899 . . . . 72.13 109.859 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.01 -32.36 32.5 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.674 -0.774 . . . . 35.42 111.72 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 140.97 -2.56 2.14 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.689 -1.243 . . . . 51.22 113.52 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.5 m -92.06 34.32 1.02 Allowed 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.504 1.145 . . . . 64.52 109.156 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.48 ' OD1' HG12 ' A' ' 74' ' ' VAL . 7.2 p30 -96.8 168.93 10.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.769 -0.65 . . . . 74.24 109.759 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 23.2 t70 -71.79 -27.7 63.12 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.794 0.665 . . . . 71.14 112.794 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.91 -14.12 58.86 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.627 0.727 . . . . 70.33 109.334 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.63 78.6 Favored Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 110.847 -0.901 . . . . 75.43 110.847 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 14.5 p -93.11 153.08 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 108.127 -1.064 . . . . 74.12 108.127 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -133.48 0.41 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.736 -0.745 . . . . 54.24 112.416 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.728 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 55.7 ttp -76.61 -75.66 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.494 -0.482 . . . . 73.34 110.03 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.68 -52.01 0.68 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.541 0.977 . . . . 44.41 115.541 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 62.0 mtm -101.45 124.99 48.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 117.756 0.778 . . . . 71.04 111.356 -173.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.7 m -126.3 114.49 18.33 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.808 -0.441 . . . . 73.53 109.808 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 103' ' ' ARG . 24.9 m -148.78 167.75 12.47 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 108.125 -1.065 . . . . 73.03 108.125 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.49 146.33 84.76 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.894 1.729 . . . . 74.02 111.592 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.3 144.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.374 -0.973 . . . . 53.32 108.374 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 p -129.22 146.14 51.19 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 110.126 -0.324 . . . . 74.04 110.126 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.37 138.89 43.78 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.536 -0.465 . . . . 70.12 110.078 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.62 135.05 34.41 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.019 -0.734 . . . . 75.52 109.019 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.86 150.23 26.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 108.331 -0.988 . . . . 43.24 108.331 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 6.1 m-85 -123.52 105.11 33.52 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 121.018 -0.273 . . . . 74.23 110.573 -175.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.17 159.03 17.79 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.473 2.116 . . . . 75.03 111.871 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -104.36 166.51 10.35 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.385 -0.968 . . . . 72.21 108.385 175.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.84 -17.53 50.48 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.96 1.096 . . . . 75.23 113.96 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -98.73 -1.26 40.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.235 -0.586 . . . . 64.23 112.163 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.18 1.0 55.87 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.632 1.013 . . . . 63.22 115.632 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.2 m -83.79 136.98 33.94 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.452 1.126 . . . . 74.32 109.528 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.4 mt -93.38 78.1 4.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.165 0.507 . . . . 73.32 110.513 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -149.36 114.49 5.46 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.867 -0.606 . . . . 74.41 110.911 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 87' ' ' PHE . 56.2 tttp 178.19 -62.41 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.21 -1.033 . . . . 72.41 108.21 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 22.7 ttmm -154.31 149.34 26.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.518 -1.29 . . . . 73.14 107.518 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.592 HD12 HG13 ' A' ' 51' ' ' VAL . 5.9 tt -141.01 124.94 17.09 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.997 -1.853 . . . . 71.21 105.997 169.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 79.4 tttt -130.87 115.19 16.24 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 120.423 -0.511 . . . . 50.24 110.05 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' THR . 62.1 t -83.88 133.78 28.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.692 -0.685 . . . . 64.22 109.322 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -121.62 113.63 20.04 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.748 0.819 . . . . 73.43 109.156 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 89.6 t80 -103.74 115.97 31.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.319 -0.993 . . . . 75.01 108.319 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.552 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 29.4 ttt85 -76.11 136.35 39.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.336 -0.847 . . . . 73.44 110.416 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.436 HD11 HD12 ' A' ' 122' ' ' ILE . 77.8 mt -103.47 126.96 30.63 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 109.478 -0.564 . . . . 75.21 109.478 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 84.2 Cg_exo -46.83 151.25 2.2 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.491 2.794 . . . . 74.45 113.028 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.04 -42.58 65.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.443 1.275 . . . . 64.42 114.443 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.28 -30.96 72.0 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.353 0.597 . . . . 65.12 110.875 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.66 -2.88 55.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.912 -0.585 . . . . 63.23 110.839 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.525 HE22 ' HE1' ' A' ' 41' ' ' PHE . 19.4 mm-40 -70.09 -36.24 74.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.586 -0.524 . . . . 74.34 109.586 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.19 -31.7 78.18 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-N 115.464 -0.789 . . . . 61.02 112.026 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -160.34 97.3 1.46 Allowed Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 109.049 -0.723 . . . . 61.22 109.049 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.62 162.08 1.86 Allowed 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 123.274 2.649 . . . . 63.31 111.519 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.58 133.76 44.23 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.032 1.821 . . . . 74.14 110.093 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -74.88 152.69 86.83 Favored Pre-proline 0 C--O 1.255 1.395 0 CA-C-N 116.515 -0.311 . . . . 70.32 111.48 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 17.2 Cg_exo -69.46 111.13 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.761 2.308 . . . . 64.23 112.146 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -85.25 -8.69 58.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.827 0.822 . . . . 74.41 108.795 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.95 148.42 42.21 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.241 -1.392 . . . . 72.15 107.241 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -88.62 -9.97 50.3 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.858 1.429 . . . . 63.23 114.858 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.501 ' CB ' ' HD3' ' A' ' 61' ' ' LYS . 17.7 m -81.53 -45.03 16.51 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.813 -0.81 . . . . 74.15 108.813 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 5.9 p -95.5 115.85 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 108.83 -0.804 . . . . 73.31 108.83 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -119.0 151.22 38.59 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.842 -0.799 . . . . 74.12 108.842 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.8 mm -92.56 110.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.427 -1.323 . . . . 73.35 107.427 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -127.14 146.48 50.38 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.387 -0.824 . . . . 73.4 108.9 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.06 144.13 34.18 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 109.023 -0.732 . . . . 70.04 109.023 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.555 ' HA ' ' HE ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -129.74 123.13 30.3 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.169 -1.413 . . . . 71.53 110.008 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.24 156.63 45.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.105 -2.554 . . . . 72.43 104.105 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.5 8.03 62.86 Favored Glycine 0 C--N 1.281 -2.52 0 C-N-CA 120.661 -0.78 . . . . 70.43 112.859 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.0 pt -121.61 145.66 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.353 -0.539 . . . . 62.1 110.275 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.0 m -120.88 137.44 54.57 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.039 -0.982 . . . . 74.24 109.126 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.36 160.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-N 115.767 -0.651 . . . . 73.24 110.021 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.515 ' OH ' ' HE2' ' A' ' 189' ' ' LYS . 39.3 m-85 -114.03 122.56 47.27 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.232 -2.136 . . . . 75.11 105.232 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -106.82 127.89 53.79 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.835 -0.346 . . . . 70.53 111.145 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.553 ' HB ' HD13 ' A' ' 151' ' ' LEU . 14.0 t -113.43 138.98 49.31 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.808 -0.812 . . . . 63.23 108.808 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.46 125.82 42.76 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.455 -0.793 . . . . 72.12 109.895 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -132.86 140.69 48.04 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.444 -0.798 . . . . 72.11 109.581 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 182' ' ' ARG . . . -102.8 145.99 16.53 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.842 -0.694 . . . . 63.01 112.852 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.71 -140.26 14.84 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.984 -1.103 . . . . 72.23 113.906 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -76.63 126.7 31.43 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.8 0.84 . . . . 72.35 112.006 -172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.81 136.82 54.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.794 -0.639 . . . . 70.12 110.303 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.569 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 38.8 ttmt -114.98 155.41 26.98 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.615 -1.994 . . . . 62.51 105.615 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -53.67 -45.19 70.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 118.412 0.551 . . . . 70.14 110.001 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.75 70.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 42.43 111.399 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.569 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 28.2 t70 -74.73 -30.62 61.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 110.063 -0.347 . . . . 62.12 110.063 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -63.33 -44.85 93.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.827 -0.805 . . . . 53.12 108.827 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 141' ' ' GLU . 61.0 t -60.02 -51.24 75.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.058 -0.974 . . . . 71.43 109.579 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.11 86.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.586 -0.734 . . . . 64.42 111.562 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 150' ' ' GLN . 24.6 m80 -62.38 -33.45 74.76 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 113.445 0.906 . . . . 65.54 113.445 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.01 79.32 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.481 0.488 . . . . 73.33 111.409 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.5 m -78.09 -35.14 49.73 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.801 0.334 . . . . 64.45 111.015 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.517 ' HG3' HG11 ' A' ' 29' ' ' VAL . 7.1 tp60 -58.68 -36.37 74.09 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.211 0.529 . . . . 75.35 109.692 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 31' ' ' TYR . 46.1 tp -65.4 -39.12 91.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.528 -0.76 . . . . 73.24 110.127 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.0 mtm180 -63.3 -44.07 96.03 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 116.436 -0.347 . . . . 75.21 110.308 177.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.3 m -61.98 -34.78 76.78 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.521 0.677 . . . . 72.23 110.582 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.6 m -74.02 -33.97 63.95 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.552 0.691 . . . . 74.33 109.965 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 26.3 mt -83.7 6.98 19.05 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.938 0.895 . . . . 73.53 112.61 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 43.9 mt-10 -75.79 145.59 40.62 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.104 -1.038 . . . . 71.43 112.498 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.66 12.64 46.77 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.548 -1.021 . . . . 60.11 110.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 p -122.11 165.66 19.84 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 107.809 -1.182 . . . . 62.12 107.809 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 96.3 Cg_endo -81.27 21.63 0.89 Allowed 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 121.886 1.724 . . . . 74.32 111.968 174.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 121.12 24.76 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.085 0.469 . . . . 52.21 111.217 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.0 m -105.32 157.68 17.15 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.45 -1.315 . . . . 73.55 107.45 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.33 157.64 46.17 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.635 -0.876 . . . . 71.43 108.635 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.6 pt20 -119.07 109.75 16.28 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.579 -0.849 . . . . 74.43 111.064 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.51 8.08 55.03 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.39 -0.909 . . . . 44.41 114.35 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.97 26.42 14.13 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.767 0.794 . . . . 75.2 109.621 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.7 138.86 22.05 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 115.64 -0.709 . . . . 63.43 110.32 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 24.8 p90 -148.2 167.9 23.88 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.884 -0.598 . . . . 61.2 112.249 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 8.3 m-85 -115.71 153.72 30.84 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.501 -0.772 . . . . 74.21 110.259 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.65 136.77 54.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.591 -1.633 . . . . 65.24 106.591 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -132.13 156.85 45.64 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.119 0.414 . . . . 60.12 112.119 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.1 0 N-CA-C 109.085 -1.606 . . . . 54.33 109.085 -179.726 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 . . . . . 0 CA--C 1.506 -0.712 0 CA-C-O 121.541 0.686 . . . . 62.33 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.512 ' HA ' ' HA2' ' A' ' 136' ' ' GLY . 14.6 ptt180 -152.13 157.65 41.84 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.521 -2.029 . . . . 73.41 105.521 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -134.72 142.97 46.93 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.882 -0.784 . . . . 52.31 108.882 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 9.3 mm-40 -111.49 132.5 54.45 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.384 -0.969 . . . . 73.23 108.384 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.494 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 88.5 t -127.06 121.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.074 -0.713 . . . . 75.14 109.074 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.599 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 33.1 m0 -107.0 124.94 50.34 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 119.606 -0.235 . . . . 74.32 110.799 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 167' ' ' TYR . 82.6 mt -96.64 138.75 33.74 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.375 -0.972 . . . . 52.23 108.375 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.11 129.64 53.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 120.04 -0.664 . . . . 74.41 109.366 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.515 ' HE2' ' OH ' ' A' ' 131' ' ' TYR . 19.2 ptpt -72.94 142.99 47.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 71.43 111.422 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 118.963 -0.541 . . . . 61.13 109.773 176.568 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.546 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.7 p90 . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 108.75 -0.833 . . . . 75.11 108.75 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -105.65 112.53 25.65 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.226 -0.59 . . . . 62.11 110.911 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.58 127.94 41.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.036 -1.468 . . . . 71.24 107.036 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.53 HD21 ' OE2' ' A' ' 33' ' ' GLU . 3.6 pp -95.77 -24.9 16.28 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.938 -1.105 . . . . 73.33 112.925 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.1 p -175.71 160.2 2.4 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 123.361 0.413 . . . . 73.35 111.611 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 73.9 p -131.21 154.12 48.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.283 -1.006 . . . . 63.22 108.283 174.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.59 -146.41 14.44 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 119.518 -1.325 . . . . 63.33 112.085 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.09 -118.02 5.11 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.705 -0.958 . . . . 50.33 110.705 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -117.44 169.28 9.64 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.741 -1.577 . . . . 73.03 106.741 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -87.16 157.05 19.45 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.13 -1.028 . . . . 74.52 111.911 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 82.0 -41.92 0.14 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.4 1.88 . . . . 74.04 110.053 -172.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.35 109.92 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.802 -1.184 . . . . 74.44 107.802 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 p -113.41 153.58 28.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.38 -0.6 . . . . 72.01 109.38 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.3 OUTLIER -112.88 150.87 31.15 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.587 -0.445 . . . . 71.5 111.319 178.246 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 36.3 tt0 -137.33 124.33 21.48 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.483 -1.673 . . . . 70.22 106.483 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' OE2' HD21 ' A' ' 21' ' ' LEU . 36.1 tt0 -100.5 117.6 34.99 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.138 -1.43 . . . . 62.53 107.138 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.531 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 28.8 ptt180 -138.4 144.71 40.34 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.096 -0.642 . . . . 72.45 110.837 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -81.96 136.61 35.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.493 -0.929 . . . . 62.2 108.493 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.47 133.81 51.17 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.65 0.241 . . . . 71.21 111.65 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' CD ' HH12 ' A' ' 103' ' ' ARG . 8.6 pt-20 -55.28 -45.11 76.18 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.945 -0.57 . . . . 70.32 112.072 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.54 10.29 50.88 Favored Glycine 0 C--N 1.311 -0.856 0 C-N-CA 119.673 -1.251 . . . . 54.42 114.682 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.62 165.22 52.49 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.357 -0.925 . . . . 75.15 112.182 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.16 131.64 35.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 75.01 110.881 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 60.3 m-85 -131.33 166.04 22.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.404 0.682 . . . . 73.33 110.951 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.45 116.21 29.23 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 107.837 -1.171 . . . . 73.14 107.837 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.5 t -124.41 144.58 49.97 Favored 'General case' 0 N--CA 1.402 -2.867 0 CA-C-N 115.419 -0.809 . . . . 70.32 112.044 -175.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.6 m -127.85 145.08 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.913 -1.04 . . . . 74.15 109.446 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -122.34 128.61 51.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.945 0.403 . . . . 62.34 111.158 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.637 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 22.0 t -125.73 142.43 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.455 -1.313 . . . . 73.41 107.455 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 49' ' ' LYS . 17.5 p -134.32 166.81 21.97 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.097 0.159 . . . . 74.42 111.42 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.7 t70 71.88 -36.17 0.35 Allowed 'General case' 0 N--CA 1.514 2.769 0 C-N-CA 125.131 1.372 . . . . 72.13 112.12 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 47' ' ' THR . 25.0 mtpp -86.14 141.32 35.05 Favored Pre-proline 0 C--N 1.282 -2.36 0 C-N-CA 124.786 1.235 . . . . 75.41 109.743 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.67 155.89 40.33 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.316 2.01 . . . . 73.12 109.367 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.63 -36.18 41.39 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 113.635 0.976 . . . . 72.32 113.635 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 15.9 t70 -60.01 -47.74 84.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.739 -0.467 . . . . 74.04 109.739 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -69.7 -41.62 75.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.699 . . . . 74.4 111.3 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -61.58 -42.35 98.72 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.914 -0.585 . . . . 71.5 110.334 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 tp -60.22 -35.23 74.96 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.13 0.972 . . . . 63.21 110.759 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 26.0 mmt180 -63.83 -35.23 79.93 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.463 0.649 . . . . 72.12 109.524 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 28.0 tt0 -82.95 -32.03 27.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 73.4 110.135 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.18 60.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.306 0.854 . . . . 63.53 113.306 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 8.9 mmt -55.34 -56.16 31.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 112.796 0.665 . . . . 74.32 112.796 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.64 -31.26 69.88 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.7 2.267 . . . . 75.03 113.193 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 95.4 mttt -62.53 -49.36 75.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.027 0.441 . . . . 72.12 110.162 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.85 -38.0 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 120.635 -0.426 . . . . 71.42 110.836 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.3 mtt -61.01 -38.97 87.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.833 0.679 . . . . 74.41 112.833 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -72.56 -31.38 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.219 -0.592 . . . . 74.24 110.684 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.07 -55.32 22.97 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.317 -0.402 . . . . 73.23 110.783 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.79 -10.4 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.162 0.505 . . . . 53.24 111.209 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -21.98 73.65 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.606 -0.725 . . . . 73.45 111.483 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.88 -5.63 6.94 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.934 -1.127 . . . . 71.13 113.598 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -86.25 33.76 0.62 Allowed 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.565 1.174 . . . . 72.13 110.105 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -93.99 173.1 7.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.06 -0.973 . . . . 53.12 108.841 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.32 -34.45 78.16 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.373 0.508 . . . . 71.32 112.373 -173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.523 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -83.78 -12.6 55.47 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.508 -0.477 . . . . 75.12 109.998 -177.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.87 27.85 72.64 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.713 0.633 . . . . 52.31 112.321 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 35.8 m -86.16 122.06 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.041 -0.664 . . . . 63.23 111.31 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.62 86.63 0.7 Allowed Glycine 0 N--CA 1.432 -1.58 0 CA-C-N 115.611 -0.722 . . . . 72.54 111.323 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -150.27 116.1 5.58 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.187 0.517 . . . . 61.54 110.19 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.83 124.59 7.1 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.644 -0.707 . . . . 73.41 112.069 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.8 ptp -105.82 126.46 52.2 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.962 -0.755 . . . . 73.21 108.962 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 p -120.38 115.87 24.36 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 55.4 111.302 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.608 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 10.8 m -154.03 -179.89 1.16 Allowed Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 125.801 1.64 . . . . 74.44 106.922 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 84.5 Cg_exo -51.0 140.67 39.01 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.751 2.301 . . . . 73.21 115.414 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.91 138.16 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.787 -1.56 . . . . 72.04 106.787 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -133.87 145.25 49.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.674 -0.491 . . . . 53.12 109.674 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 98' ' ' LEU . 52.2 p90 -145.28 138.31 26.32 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.902 -0.499 . . . . 73.02 111.169 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -93.18 135.28 34.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.461 -0.94 . . . . 70.45 108.461 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 166' ' ' VAL . 33.4 m -121.15 149.16 24.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.719 -0.845 . . . . 71.43 108.719 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.56 105.51 51.85 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 116.118 -0.492 . . . . 75.42 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.28 159.05 20.09 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.898 1.732 . . . . 65.45 110.801 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.414 HD21 ' HG2' ' A' ' 96' ' ' LYS . 50.8 m-80 -122.33 162.66 21.13 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.79 -0.818 . . . . 72.1 108.79 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.77 -13.7 59.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.557 0.694 . . . . 62.2 110.513 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.69 -6.67 58.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.845 -1.071 . . . . 75.41 110.099 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.28 10.27 83.88 Favored Glycine 0 C--O 1.218 -0.876 0 CA-C-N 115.911 -0.586 . . . . 72.51 113.192 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 m -105.24 134.76 47.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.874 0.337 . . . . 74.15 110.445 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.6 mt -88.42 75.57 8.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.784 -1.191 . . . . 75.44 107.784 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 58.9 tt0 -147.18 114.51 6.28 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.345 -0.843 . . . . 72.22 111.183 -174.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' A' ' 96' ' ' LYS . 6.1 mmpt? -178.87 -66.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.95 2.1 . . . . 72.11 106.356 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -147.28 150.64 35.21 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.435 -1.257 . . . . 64.42 107.885 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 84' ' ' PHE . 56.6 tp -127.71 124.35 37.63 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.206 -1.775 . . . . 73.24 106.206 168.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -114.31 113.78 25.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.237 -1.764 . . . . 72.44 106.237 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' THR . 97.0 t -99.85 123.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 109.438 -0.579 . . . . 52.24 109.438 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -110.25 120.69 43.25 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -104.16 124.54 49.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.621 -0.511 . . . . 72.32 109.621 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.412 HH12 ' CD ' ' A' ' 37' ' ' GLU . 19.0 mmm180 -74.57 132.67 41.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.339 -0.846 . . . . 74.33 109.019 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.6 mt -99.03 135.89 20.72 Favored Pre-proline 0 C--N 1.285 -2.204 0 N-CA-C 107.838 -1.171 . . . . 44.25 107.838 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.81 148.97 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.589 2.192 . . . . 73.42 112.312 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -47.6 -43.18 25.37 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.472 1.509 . . . . 74.35 112.288 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.13 -36.15 83.37 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.67 0.619 . . . . 62.11 112.67 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -88.93 -6.37 57.32 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-N 116.559 -0.291 . . . . 72.32 111.605 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.425 HE22 ' HE1' ' A' ' 41' ' ' PHE . 23.4 mm-40 -70.09 -28.48 65.45 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.751 -0.204 . . . . 54.34 111.519 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.08 -38.1 92.56 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.868 -0.493 . . . . 72.44 111.868 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 p -158.67 87.77 2.26 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 123.466 0.706 . . . . 63.24 109.956 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 10.0 Cg_endo -86.63 144.71 7.74 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 122.577 2.185 . . . . 70.11 112.104 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 33.2 Cg_exo -60.79 142.84 98.86 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.767 2.312 . . . . 74.31 112.628 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . . . -76.67 144.82 73.96 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.857 -0.61 . . . . 54.51 109.997 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -80.36 126.51 6.2 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.514 2.143 . . . . 71.42 111.923 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.4 m -74.91 -23.91 58.43 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.657 -0.701 . . . . 73.13 111.606 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -99.64 135.73 40.61 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.111 -1.44 . . . . 72.02 107.111 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -77.01 -3.71 40.45 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.434 0.901 . . . . 72.42 113.434 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.525 ' O ' HG12 ' A' ' 44' ' ' VAL . 17.1 m -73.74 -26.44 60.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.775 -0.824 . . . . 64.45 108.775 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 61' ' ' LYS . 25.3 t -113.98 124.12 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 106.593 -1.632 . . . . 60.41 106.593 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.429 ' HA ' ' HG2' ' A' ' 115' ' ' PRO . 27.3 mtpp -129.66 145.91 51.48 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.81 -1.156 . . . . 71.11 110.568 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 26.7 mm -91.91 111.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.997 -1.483 . . . . 74.4 106.997 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -133.81 149.55 51.41 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.085 -0.961 . . . . 62.15 109.77 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.49 153.3 23.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.134 -0.691 . . . . 70.54 109.134 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 67.4 ttt180 -139.25 123.17 17.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.458 -0.897 . . . . 62.32 109.984 174.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -143.85 177.14 8.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.373 -0.83 . . . . 75.51 109.314 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.06 -1.42 84.82 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 121.134 -0.555 . . . . 35.31 113.736 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.46 162.47 32.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 117.398 0.599 . . . . 72.21 111.381 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.2 m -120.6 135.99 54.94 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.437 -0.801 . . . . 71.22 109.777 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.94 161.87 28.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 120.94 0.4 . . . . 71.24 110.413 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 67.3 m-85 -113.99 123.47 49.79 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.703 -1.962 . . . . 73.03 105.703 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 25.4 t -111.91 147.55 35.6 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 120.444 -0.502 . . . . 44.5 109.905 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 8.9 t -129.23 132.98 47.33 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.112 -0.494 . . . . 64.41 109.848 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 184' ' ' GLU . 74.2 mt-30 -110.46 131.64 54.87 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 121.258 0.552 . . . . 70.13 111.425 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.86 149.63 40.52 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.722 -1.127 . . . . 74.02 109.494 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -121.92 149.09 17.16 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.78 -0.724 . . . . 75.12 111.465 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.54 24.49 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.24 -1.144 . . . . 54.31 110.24 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -90.54 100.52 13.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.037 -0.727 . . . . 54.23 109.037 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.25 107.7 19.82 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.913 0.863 . . . . 72.0 112.672 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -100.77 169.68 8.85 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.513 -1.662 . . . . 62.41 106.513 171.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 1.6 mp0 -57.55 -42.16 82.42 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.173 0.511 . . . . 62.24 110.109 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.67 70.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.519 -0.764 . . . . 64.42 111.542 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.67 -36.85 70.77 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.653 -0.499 . . . . 74.11 109.653 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -60.47 -47.8 84.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.778 -0.646 . . . . 72.31 110.224 173.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -46.88 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.726 0.641 . . . . 65.43 110.604 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.65 87.86 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.062 0.458 . . . . 63.32 110.926 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -68.95 -33.3 73.49 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 116.325 -0.398 . . . . 74.01 111.688 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.46 -45.85 92.53 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.059 -0.349 . . . . 34.53 110.059 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.648 ' HA ' ' HE ' ' A' ' 152' ' ' ARG . 63.2 m -59.11 -46.98 86.91 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 122.818 0.447 . . . . 64.11 110.32 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.46 -39.41 93.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.827 -0.624 . . . . 72.41 110.998 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 31' ' ' TYR . 60.2 tp -64.94 -40.88 95.7 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.999 -0.371 . . . . 75.55 109.999 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.648 ' HE ' ' HA ' ' A' ' 149' ' ' THR . 88.5 mtm180 -62.22 -40.16 95.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.892 -0.594 . . . . 73.03 111.144 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.2 m -69.77 -36.03 75.42 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.428 0.632 . . . . 72.13 110.312 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.7 m -70.33 -33.7 71.8 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.373 0.606 . . . . 73.34 110.424 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.488 HD12 HD23 ' A' ' 187' ' ' LEU . 93.4 mt -77.63 6.69 6.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.707 -0.679 . . . . 71.43 112.54 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.22 142.38 32.74 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.004 -0.739 . . . . 62.32 109.004 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.43 -10.29 65.02 Favored Glycine 0 C--N 1.307 -1.052 0 N-CA-C 110.095 -1.202 . . . . 71.22 110.095 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 10.9 t -120.9 153.16 57.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.448 -1.686 . . . . 75.24 106.448 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.59 17.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.592 2.861 . . . . 44.33 115.199 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.41 131.7 34.35 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.068 -0.395 . . . . 71.51 110.097 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 32.2 p -124.94 154.94 40.37 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.754 -0.832 . . . . 52.05 108.754 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -136.73 149.25 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 118.287 0.494 . . . . 72.22 110.956 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -116.77 141.63 47.97 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.727 0.64 . . . . 72.34 112.727 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.21 -2.28 15.01 Favored Glycine 0 C--N 1.318 -0.461 0 CA-C-N 115.021 -0.99 . . . . 64.31 113.35 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.3 t70 61.22 11.72 3.72 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.549 1.14 . . . . 73.42 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 86' ' ' VAL . 7.3 p -73.79 139.38 19.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.904 1.282 . . . . 71.13 111.385 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.61 168.74 19.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.387 -0.824 . . . . 73.4 110.713 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 16.0 m-85 -115.29 156.42 25.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.096 -0.502 . . . . 72.11 110.451 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 64.4 m -124.19 119.84 30.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.626 -1.62 . . . . 63.43 106.626 172.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.5 154.98 49.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.62 -0.264 . . . . 31.14 110.306 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.083 0 N-CA-C 108.931 -1.668 . . . . 40.44 108.931 179.612 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 120.949 0.404 . . . . 64.55 109.922 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.426 ' HA ' ' NE ' ' A' ' 182' ' ' ARG . 3.3 mmp_? -103.51 127.09 50.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.552 -1.647 . . . . 73.33 106.552 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.11 146.51 33.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.838 -0.801 . . . . 73.35 108.838 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.607 ' HG2' ' HG2' ' A' ' 134' ' ' GLN . 40.0 mt-10 -135.23 149.38 49.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.443 0.64 . . . . 62.13 111.323 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.461 ' HB ' HG22 ' A' ' 133' ' ' THR . 77.7 t -125.02 118.58 53.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.927 -1.508 . . . . 71.23 106.927 172.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 18.0 m0 -102.91 120.65 40.99 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.139 -1.06 . . . . 74.23 108.139 -178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.488 HD23 HD12 ' A' ' 155' ' ' LEU . 37.8 tp -106.05 129.95 54.06 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.303 -1.369 . . . . 64.1 107.303 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.89 125.1 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.565 -0.454 . . . . 63.12 110.705 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 161' ' ' THR . 13.8 pttp -71.06 145.95 49.6 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.005 -0.739 . . . . 64.14 109.005 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 108.787 -0.82 . . . . 37.68 108.787 174.671 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.2 p90 . . . . . 0 N--CA 1.431 -1.388 0 CA-C-O 121.819 0.819 . . . . 73.14 109.153 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -113.55 122.44 47.24 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.888 -1.051 . . . . 72.34 111.18 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.0 119.79 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 106.111 -1.811 . . . . 75.41 106.111 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -89.96 -25.78 20.73 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.123 -0.631 . . . . 71.43 111.062 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -176.84 153.85 1.09 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.511 0.507 . . . . 75.14 109.794 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.3 p -132.29 154.59 49.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.801 -0.814 . . . . 62.53 108.801 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.03 -148.82 20.1 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 119.24 -1.457 . . . . 71.51 113.313 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.2 -118.45 5.23 Favored Glycine 0 N--CA 1.427 -1.934 0 N-CA-C 110.268 -1.133 . . . . 74.04 110.268 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -99.41 169.96 8.97 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.876 -1.527 . . . . 72.41 106.876 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.3 162.86 14.11 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 75.32 109.236 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 72.72 -53.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.365 1.066 . . . . 71.43 110.12 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.63 111.75 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 107.999 -1.111 . . . . 73.2 107.999 172.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.2 p -133.69 155.82 49.03 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.594 -0.73 . . . . 61.23 110.477 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -112.01 161.8 16.07 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.233 0.539 . . . . 71.01 111.428 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' OE1' ' HD2' ' A' ' 34' ' ' ARG . 39.7 tt0 -133.81 124.86 27.27 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.159 -1.423 . . . . 73.33 107.159 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.07 114.9 26.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.84 -1.541 . . . . 75.43 106.84 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.456 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 13.7 ptm180 -134.22 143.47 47.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.32 0.581 . . . . 72.32 112.563 -172.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.78 135.78 35.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.194 -1.78 . . . . 72.14 106.194 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.4 t -68.99 146.74 52.47 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.356 0.598 . . . . 62.13 111.94 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.5 pm0 -67.84 0.5 3.32 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 126.162 1.785 . . . . 74.14 114.236 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 75.08 11.51 83.96 Favored Glycine 0 C--N 1.305 -1.147 0 C-N-CA 119.656 -1.259 . . . . 62.4 114.565 169.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.65 152.08 48.76 Favored Glycine 0 N--CA 1.408 -3.204 0 C-N-CA 120.349 -0.929 . . . . 72.31 113.39 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 104' ' ' ILE . 17.7 ptpt -102.96 118.93 37.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.041 -1.466 . . . . 70.33 107.041 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 59.3 m-85 -117.15 163.72 15.85 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.562 -0.745 . . . . 62.15 111.525 -168.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.03 116.91 32.34 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 108.093 -1.077 . . . . 75.24 108.093 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -124.21 146.41 48.73 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 113.033 0.753 . . . . 74.1 113.033 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.4 m -128.03 144.13 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 114.262 -1.336 . . . . 62.53 108.645 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.25 136.7 51.4 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 120.77 0.319 . . . . 73.32 111.016 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.557 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 44.4 t -130.39 141.99 44.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 105.916 -1.883 . . . . 64.41 105.916 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.468 ' C ' ' H ' ' A' ' 49' ' ' LYS . 34.1 p -130.49 159.76 36.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.651 0.612 . . . . 61.51 112.651 -171.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.3 -32.75 0.24 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.642 1.577 . . . . 72.24 112.541 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 47' ' ' THR . 52.6 mtpt -85.05 136.34 38.48 Favored Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 124.673 1.189 . . . . 72.41 109.336 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 53.0 Cg_exo -55.05 156.15 16.81 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.268 2.645 . . . . 73.02 112.111 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.66 -41.44 12.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 113.293 0.849 . . . . 75.13 113.293 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -59.7 -47.66 84.76 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 120.644 -0.422 . . . . 73.13 110.975 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.64 -39.82 73.44 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.94 -0.573 . . . . 75.31 111.702 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -67.47 -46.32 73.33 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.692 -0.686 . . . . 41.14 110.453 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.8 -45.74 85.01 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 122.423 0.289 . . . . 72.53 111.758 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 5.6 ppt_? -61.82 -28.24 69.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.813 0.672 . . . . 72.51 112.813 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 tt0 -85.64 -39.51 17.21 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.426 0.631 . . . . 71.01 111.154 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -76.51 -32.17 58.14 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.95 0.722 . . . . 44.15 112.95 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.515 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -53.59 -48.05 94.41 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 112.401 0.519 . . . . 73.51 112.401 -178.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 63' ' ' MET . 36.4 Cg_exo -56.48 -34.54 95.1 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.135 1.89 . . . . 71.23 111.515 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 58' ' ' ALA . 50.6 mtmt -69.03 -32.61 72.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.117 0.484 . . . . 71.23 110.791 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 102' ' ' PHE . 29.7 mm -76.49 -48.74 26.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.1 -0.5 . . . . 73.34 111.503 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.411 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.276 3.2 ppp? -66.01 -29.23 69.57 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.696 0.998 . . . . 63.04 113.696 -176.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.08 -29.45 69.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.24 0.543 . . . . 64.24 110.296 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.769 -0.65 . . . . 72.43 110.139 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 76' ' ' MET . 2.7 p -66.8 -27.23 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.013 0.435 . . . . 71.12 110.124 176.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.79 -20.77 62.39 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.842 -0.617 . . . . 54.5 113.686 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 131.67 -15.74 5.15 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.859 -1.162 . . . . 73.44 113.028 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -81.69 29.0 0.39 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.928 0.871 . . . . 72.25 110.502 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.01 166.02 13.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.919 -0.582 . . . . 73.12 109.908 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.76 -35.03 79.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 112.928 0.714 . . . . 71.23 112.928 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.594 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 1.6 mptm? -82.71 -10.56 58.85 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.113 0.482 . . . . 73.42 111.526 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.88 33.88 76.02 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.56 -0.746 . . . . 75.21 112.541 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 24.7 m -80.65 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.712 -0.795 . . . . 72.44 108.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.31 167.34 51.96 Favored Glycine 0 N--CA 1.435 -1.372 0 O-C-N 123.776 0.672 . . . . 44.33 113.033 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 27.1 ttt -76.14 101.25 5.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.284 -0.458 . . . . 62.43 109.968 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.57 41.86 0.18 Allowed Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.217 -0.992 . . . . 73.12 112.978 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.414 ' HG2' HG23 ' A' ' 66' ' ' VAL . 15.3 ptm -124.91 123.5 40.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.947 -1.131 . . . . 73.21 107.947 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.3 m -125.67 117.36 23.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.034 0.753 . . . . 73.33 113.034 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -156.72 159.02 31.59 Favored Pre-proline 0 C--O 1.242 0.7 0 C-N-CA 125.494 1.518 . . . . 64.22 107.311 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.16 140.12 81.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.763 1.642 . . . . 54.15 112.131 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.98 150.61 5.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.949 -1.13 . . . . 65.24 107.949 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -138.65 144.64 39.77 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.866 -0.42 . . . . 71.44 109.866 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 46.5 p90 -135.2 144.83 47.16 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 122.083 -0.386 . . . . 74.33 110.653 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.64 34.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 108.523 -0.917 . . . . 61.32 108.523 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.23 150.25 25.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 N-CA-C 107.821 -1.177 . . . . 72.43 107.821 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.435 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 2.7 m-85 -117.07 100.3 53.23 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.672 -0.862 . . . . 75.14 108.672 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.87 152.38 16.86 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 121.911 1.741 . . . . 75.01 112.677 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -100.14 158.37 15.9 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.327 -1.731 . . . . 71.32 106.327 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.25 -12.79 58.42 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.352 0.501 . . . . 70.23 112.352 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.39 -3.03 54.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.988 -0.551 . . . . 71.42 110.984 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.07 -4.01 82.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.936 -0.65 . . . . 32.51 112.984 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.0 m -83.01 131.42 35.18 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.765 0.317 . . . . 45.32 110.414 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.57 79.26 4.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.539 0.685 . . . . 52.44 110.534 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 52.0 tt0 -148.46 114.26 5.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.29 -0.868 . . . . 74.22 111.012 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 56.3 mtpt -176.82 -67.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.727 2.011 . . . . 72.13 107.048 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 64.9 mttm -145.67 158.63 43.83 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.883 -1.053 . . . . 73.15 108.518 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 84' ' ' PHE . 46.8 tp -139.14 124.74 19.45 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.964 -1.125 . . . . 71.21 107.964 171.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -123.68 114.04 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.158 -1.052 . . . . 71.54 108.158 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.508 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 58.2 t -97.15 130.14 46.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.178 -0.675 . . . . 52.44 109.178 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.45 131.65 56.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.149 -0.685 . . . . 71.31 109.149 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.421 ' HB2' HD12 ' A' ' 62' ' ' ILE . 67.8 t80 -102.98 114.67 29.16 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.022 -1.103 . . . . 73.02 108.022 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.632 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 75.9 ttt180 -75.52 133.04 41.11 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.014 -1.448 . . . . 74.11 109.755 -176.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 40' ' ' LYS . 76.1 mt -106.44 137.54 19.46 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.565 -0.902 . . . . 70.15 108.565 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.77 149.43 77.55 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.259 1.972 . . . . 63.24 110.428 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -60.99 -33.82 73.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.831 1.049 . . . . 64.3 113.831 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -66.94 -23.91 66.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 64.03 111.119 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -92.66 -7.7 46.13 Favored 'General case' 0 C--O 1.192 -1.958 0 CA-C-N 116.66 -0.246 . . . . 73.32 110.895 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -71.52 -33.29 69.06 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.922 -0.711 . . . . 74.04 111.478 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.83 -29.61 74.59 Favored Glycine 0 C--N 1.334 0.464 0 O-C-N 123.559 0.537 . . . . 42.4 111.949 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.0 t -153.69 82.56 4.58 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 108.996 -0.742 . . . . 71.11 108.996 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.73 162.14 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.468 2.112 . . . . 54.33 111.902 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.594 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.3 Cg_exo -60.45 156.98 38.37 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 C-N-CA 121.581 1.52 . . . . 72.12 109.783 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.94 154.56 37.74 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.431 -0.581 . . . . 72.22 109.431 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 27.8 Cg_exo -62.98 104.99 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.781 2.321 . . . . 75.11 111.81 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.2 p -90.67 -28.35 18.42 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.871 -0.604 . . . . 71.34 112.177 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.7 156.03 18.38 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.813 -0.81 . . . . 73.11 108.813 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.47 -31.71 63.91 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.455 0.645 . . . . 70.25 110.366 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.8 m -99.28 5.14 46.67 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.525 -0.762 . . . . 43.25 112.013 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 59.6 t -119.7 122.6 69.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.071 -1.085 . . . . 61.12 108.071 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -128.22 143.4 51.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.366 -0.379 . . . . 72.25 110.502 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.2 mm -92.75 110.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.826 -1.176 . . . . 63.53 107.826 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -108.01 144.04 35.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.23 -0.895 . . . . 62.2 109.382 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.16 127.33 45.1 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.842 -0.617 . . . . 64.52 110.492 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 125' ' ' ARG . 2.1 mmp_? -123.36 116.25 22.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 118.745 -1.182 . . . . 64.11 109.686 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.586 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -148.49 161.01 42.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.379 -0.828 . . . . 75.25 110.962 173.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.13 19.7 71.68 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.919 -0.658 . . . . 74.0 112.264 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -121.14 147.67 24.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.314 0.578 . . . . 75.23 111.009 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.9 m -117.47 128.21 54.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.446 -0.946 . . . . 62.25 108.446 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.458 HG21 ' CE3' ' A' ' 186' ' ' TRP . 30.2 m -124.72 166.06 20.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 116.13 -0.486 . . . . 75.54 110.001 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 55.4 m-85 -113.75 122.18 46.33 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 106.256 -1.757 . . . . 74.34 106.256 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 p -119.73 132.73 55.72 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.773 -0.771 . . . . 71.22 110.735 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.8 t -121.76 123.84 42.79 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 109.007 -0.738 . . . . 51.33 109.007 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -110.58 136.91 48.96 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.431 -0.951 . . . . 73.02 108.431 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 43.2 p90 -145.49 144.7 30.72 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.026 -0.533 . . . . 72.33 111.561 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -106.64 138.25 14.31 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.503 -1.039 . . . . 64.45 110.503 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.11 -175.06 28.52 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.868 -0.682 . . . . 51.21 111.484 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -87.59 111.13 20.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.784 -1.191 . . . . 75.32 107.784 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.28 130.8 53.24 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.531 0.567 . . . . 55.35 112.531 -174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.15 178.21 5.32 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.702 -1.222 . . . . 73.51 107.702 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.71 77.86 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.323 0.582 . . . . 64.31 109.869 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.48 71.31 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.355 -0.839 . . . . 73.42 111.063 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.37 -30.52 70.33 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.413 0.149 . . . . 73.13 111.199 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -69.7 -41.63 75.13 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 110.036 -0.357 . . . . 72.22 110.036 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.81 -48.0 83.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.396 -0.594 . . . . 72.45 109.396 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.98 87.88 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.36 -0.836 . . . . 64.24 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -66.37 -32.43 73.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 112.402 0.519 . . . . 55.54 112.402 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 -46.7 79.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.86 0.362 . . . . 72.23 111.037 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.4 t -72.58 -33.39 66.72 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.482 0.658 . . . . 74.54 110.235 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -64.44 -37.07 86.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.168 -0.678 . . . . 74.01 109.168 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.35 -39.45 93.91 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.859 -0.609 . . . . 62.34 110.058 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -63.28 -36.54 84.01 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.372 -0.603 . . . . 75.31 109.372 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 m -70.53 -32.71 70.27 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.261 -0.881 . . . . 73.25 110.031 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.6 m -76.79 -34.33 57.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.671 -0.695 . . . . 74.11 110.06 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -85.71 11.22 11.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.58 0.752 . . . . 65.11 111.095 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -73.68 135.21 43.7 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.624 -1.621 . . . . 51.5 106.624 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.49 58.83 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.521 -0.632 . . . . 61.44 111.521 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 34.9 p -114.3 160.14 33.91 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 107.259 -1.385 . . . . 71.45 107.259 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.13 27.31 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 122.192 1.928 . . . . 53.52 112.163 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.16 101.1 0.85 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.359 0.599 . . . . 71.31 112.273 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.5 p -89.33 156.03 18.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.559 -0.904 . . . . 70.13 108.559 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.408 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 24.2 m-85 -138.74 150.4 46.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 4.5 pt20 -114.04 109.89 19.17 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.309 0.576 . . . . 73.34 110.438 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.27 41.95 Favored Glycine 0 N--CA 1.46 0.3 0 C-N-CA 120.808 -0.71 . . . . 62.44 111.901 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 59.31 25.55 14.22 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.936 1.294 . . . . 72.01 110.499 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.1 m -75.1 140.03 18.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 119.799 -0.761 . . . . 74.32 110.76 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -139.9 170.24 16.23 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.162 -0.926 . . . . 64.02 109.607 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.579 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 60.6 m-85 -115.43 148.09 39.79 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.721 -0.844 . . . . 73.54 108.721 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 63.1 m -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.522 -1.658 . . . . 75.33 106.522 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -117.59 145.45 44.29 Favored 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 123.558 0.536 . . . . 72.22 111.253 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.04 0 N-CA-C 108.932 -1.667 . . . . 34.22 108.932 -179.454 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.444 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 97.0 mtt180 . . . . . 0 CA--C 1.503 -0.851 0 CA-C-O 120.47 0.176 . . . . 75.52 110.998 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.87 130.55 49.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 109.245 -0.65 . . . . 60.31 109.245 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.434 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.6 m-80 -127.47 139.34 52.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.241 -1.392 . . . . 61.54 107.241 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 39.0 tt0 -132.09 133.93 44.9 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.829 -0.348 . . . . 73.31 111.051 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.49 125.71 69.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.466 0.706 . . . . 73.04 110.062 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.8 m0 -109.08 121.13 44.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.904 -0.776 . . . . 73.35 108.904 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.35 124.03 49.21 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 107.522 -1.288 . . . . 64.54 107.522 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.34 132.31 39.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.782 0.325 . . . . 74.12 111.262 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 21.0 ptmt -76.45 141.95 41.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.128 -0.487 . . . . 70.21 111.288 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.408 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.809 -0.632 . . . . 65.34 110.42 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 105.501 -2.037 . . . . 73.01 105.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.83 118.75 21.23 Favored 'General case' 0 C--N 1.284 -2.273 0 C-N-CA 119.633 -0.827 . . . . 73.23 109.105 -171.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t -89.7 126.29 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.883 -0.784 . . . . 61.54 108.883 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.78 -38.57 15.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.384 -0.969 . . . . 61.42 108.384 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.5 t 179.69 165.68 1.13 Allowed 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.932 -1.031 . . . . 62.23 108.291 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 32' ' ' GLU . 68.2 p -131.64 165.13 24.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.958 -1.127 . . . . 63.24 107.958 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.99 -157.04 25.82 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 119.352 -1.404 . . . . 51.03 113.04 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.97 -138.51 14.6 Favored Glycine 0 N--CA 1.42 -2.397 0 N-CA-C 111.186 -0.766 . . . . 74.1 111.186 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.1 171.06 8.48 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.283 -1.006 . . . . 72.14 108.283 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.44 162.17 23.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.129 -1.028 . . . . 71.42 109.622 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 72.39 -54.27 0.69 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.345 1.058 . . . . 75.42 109.797 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 150' ' ' GLN . 6.2 p -110.21 109.39 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-O 122.049 0.928 . . . . 44.22 109.125 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 m -129.67 146.36 51.46 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.003 -1.11 . . . . 71.35 108.003 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' HB3' HD22 ' A' ' 151' ' ' LEU . 6.0 p90 -113.83 160.49 18.67 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 112.795 0.665 . . . . 72.2 112.795 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.573 ' OE1' ' HD3' ' A' ' 34' ' ' ARG . 39.7 tt0 -136.56 125.71 24.61 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.468 -2.049 . . . . 73.03 105.468 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -98.91 118.04 34.77 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.883 -1.525 . . . . 42.15 106.883 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HD3' ' OE1' ' A' ' 32' ' ' GLU . 27.0 mtm180 -131.68 145.76 51.82 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.931 -1.108 . . . . 72.13 111.717 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.34 136.86 34.92 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.303 -2.11 . . . . 61.45 105.303 168.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.0 t -58.25 148.45 27.19 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.349 0.406 . . . . 54.24 111.817 -175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -73.17 -3.35 26.03 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 115.753 -0.658 . . . . 25.3 111.641 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 74.01 9.07 79.62 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 120.979 -0.629 . . . . 45.14 114.021 171.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.37 162.5 54.23 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 121.052 -0.594 . . . . 54.53 113.527 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.64 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.04 118.65 37.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.315 -1.365 . . . . 63.31 107.315 178.476 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.1 m-85 -121.4 165.7 15.18 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.665 -0.698 . . . . 70.14 112.05 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -97.69 116.79 30.59 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -127.66 144.24 51.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.655 0.74 . . . . 73.44 112.24 -174.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 6.5 p -127.61 133.63 67.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.298 -1.371 . . . . 73.54 107.298 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.71 123.58 45.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.072 -0.651 . . . . 73.44 111.382 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.449 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 31.6 t -118.16 123.19 71.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.261 -1.385 . . . . 52.5 107.261 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 25.0 m -117.76 159.5 22.92 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.669 -0.241 . . . . 72.01 110.532 -175.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 75.58 -27.39 0.19 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.852 1.661 . . . . 72.01 112.035 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -85.19 145.05 42.08 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 109.274 -0.639 . . . . 74.21 109.274 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.57 156.84 34.69 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.927 2.418 . . . . 74.22 111.514 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG13 HD12 ' A' ' 98' ' ' LEU . 54.5 t -48.03 -44.74 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.36 0.664 . . . . 60.34 112.408 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -58.04 -44.41 87.38 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.95 0.405 . . . . 63.12 110.737 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.15 -48.79 26.98 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.505 -0.77 . . . . 62.32 111.063 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -59.7 -40.18 87.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 73.23 111.317 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 59' ' ' MET . 52.7 tp -65.61 -51.3 60.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 116.338 -0.392 . . . . 62.02 110.959 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 4.9 ppt_? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.318 0.858 . . . . 64.44 113.318 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 1.3 tm-20 -74.69 -45.82 41.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.384 -0.969 . . . . 74.53 108.384 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -76.57 -33.16 58.5 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.525 1.13 . . . . 32.33 114.046 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 8.9 mmt -50.98 -55.09 30.65 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 114.918 1.451 . . . . 71.13 114.918 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.42 -30.91 75.47 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.681 2.254 . . . . 62.23 112.163 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -67.35 -48.63 66.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 54.2 111.029 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.7 mm -66.48 -40.1 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 74.04 109.767 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -48.53 79.88 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 123.666 0.787 . . . . 71.34 111.13 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -27.58 65.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.952 -0.699 . . . . 72.4 112.382 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.95 -50.52 68.3 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.576 -0.283 . . . . 52.42 110.517 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -2.92 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.901 -0.591 . . . . 72.52 111.583 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.55 -21.59 36.88 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.809 -0.632 . . . . 72.23 111.929 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 136.69 -14.29 3.89 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.174 -1.012 . . . . 25.03 113.425 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 m -81.48 40.53 0.58 Allowed 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.89 1.329 . . . . 73.42 110.957 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.81 177.16 5.55 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.24 -0.891 . . . . 74.42 108.978 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.45 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 17.0 t70 -69.33 -30.88 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.859 0.361 . . . . 74.11 111.961 -175.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -81.77 -12.63 58.48 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.36 -0.382 . . . . 71.22 110.289 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.31 20.8 75.5 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.805 -0.634 . . . . 73.34 112.18 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.494 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 33.4 m -86.33 125.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.622 -0.431 . . . . 74.3 110.738 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.64 -71.13 0.96 Allowed Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 111.542 -0.623 . . . . 74.3 111.542 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.5 mmt 66.43 -64.18 0.23 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.185 1.179 . . . . 72.12 114.185 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 60.7 5.9 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.621 -1.392 . . . . 70.32 109.621 -174.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -96.12 126.25 41.22 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.179 0.514 . . . . 64.3 110.946 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.8 t -123.45 116.6 23.5 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 122.361 1.077 . . . . 74.3 111.557 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.2 m -143.65 170.93 7.57 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 105.262 -2.125 . . . . 65.43 105.262 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.03 138.62 79.68 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.609 1.253 . . . . 72.35 113.547 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.9 p -111.88 147.22 15.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.696 -1.594 . . . . 71.4 106.696 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.0 p -132.61 144.95 50.71 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.438 -0.505 . . . . 51.43 110.22 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -131.68 141.32 49.55 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 120.199 -0.6 . . . . 71.13 110.716 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.594 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.75 135.02 34.48 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 115.54 -0.755 . . . . 54.43 109.414 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.69 150.21 32.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.696 -0.684 . . . . 62.35 109.457 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 90.7 m-85 -119.48 101.88 48.42 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 110.143 -0.318 . . . . 73.01 110.143 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.95 142.55 15.69 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 122.447 2.098 . . . . 64.04 112.589 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.473 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 45.6 m-80 -96.66 162.63 13.36 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.034 -0.728 . . . . 60.22 109.034 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.1 -13.56 62.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.424 0.631 . . . . 73.51 110.232 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.51 -6.19 54.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.27 -0.877 . . . . 54.31 109.457 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -6.8 82.95 Favored Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 116.024 -0.535 . . . . 72.14 112.296 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 p -84.39 140.88 31.25 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.833 0.349 . . . . 71.21 110.48 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.47 79.11 2.46 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.302 0.573 . . . . 64.23 109.569 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 78.2 mt-30 -147.02 114.63 6.39 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.766 -0.652 . . . . 72.22 110.596 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 89.2 mttt -176.63 -63.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 126.274 1.83 . . . . 73.52 108.091 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 21.9 ttmm -161.04 153.83 20.92 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.691 -0.855 . . . . 62.03 108.691 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 5.8 tt -139.92 128.37 22.79 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.031 -1.47 . . . . 73.23 107.031 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -123.43 115.61 21.89 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.014 -0.735 . . . . 74.14 109.014 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 43' ' ' THR . 82.6 t -88.74 123.03 40.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.952 -0.388 . . . . 52.41 109.952 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -109.78 124.75 51.81 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.971 -0.751 . . . . 75.14 108.971 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 87.8 t80 -102.52 112.4 25.12 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.995 -1.113 . . . . 74.52 107.995 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.492 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 2.3 tmt_? -75.5 112.93 12.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.931 -1.507 . . . . 72.41 106.931 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.521 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 67.7 mt -85.68 137.92 35.88 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.156 -0.475 . . . . 74.32 109.9 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.29 143.36 34.08 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.63 2.22 . . . . 55.22 111.539 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.92 -33.39 62.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.363 1.246 . . . . 74.52 114.363 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -59.41 -31.23 69.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.893 0.378 . . . . 75.53 111.006 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.98 -2.78 49.71 Favored 'General case' 0 C--O 1.192 -1.942 0 CA-C-N 116.341 -0.39 . . . . 65.53 111.605 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.521 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 29.5 mm-40 -71.01 -28.62 64.55 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.199 -0.6 . . . . 72.13 110.608 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.04 -38.29 92.49 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.266 -0.734 . . . . 44.53 111.266 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.8 m -155.39 92.99 2.7 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 123.212 0.605 . . . . 65.2 109.52 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 77.4 Cg_endo -83.96 145.04 11.1 Favored 'Trans proline' 0 C--O 1.251 1.158 0 C-N-CA 122.472 2.115 . . . . 62.14 111.832 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 29.5 Cg_exo -63.1 130.6 29.44 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.886 1.724 . . . . 72.13 109.432 174.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -61.18 139.67 94.42 Favored Pre-proline 0 C--O 1.257 1.479 0 CA-C-O 120.767 0.318 . . . . 72.13 110.68 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 61.2 Cg_endo -72.2 108.21 2.43 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.584 2.189 . . . . 74.51 111.199 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.8 t -89.91 82.47 6.18 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 116.02 -0.536 . . . . 51.43 110.428 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.629 ' HB3' HG12 ' A' ' 120' ' ' VAL . 13.0 t70 -178.49 164.37 1.65 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 104.492 -2.41 . . . . 64.42 104.492 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.47 -28.37 22.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 118.727 0.694 . . . . 74.52 112.269 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 p -91.28 -18.46 24.32 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.704 1.001 . . . . 71.52 113.704 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 117' ' ' ASP . 2.5 p -104.37 120.64 55.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.237 0.541 . . . . 54.3 109.879 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 154.24 46.98 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.332 -0.849 . . . . 72.21 110.519 -175.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.8 mm -91.75 112.32 25.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.806 -0.813 . . . . 75.31 108.806 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -126.15 147.73 49.56 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.27 -1.011 . . . . 74.15 108.27 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 40' ' ' LYS . 14.7 pt-20 -121.24 151.2 40.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 120.948 0.404 . . . . 75.13 111.341 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -134.33 125.68 28.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.82 -0.627 . . . . 71.14 111.581 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.493 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -143.14 174.2 10.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 171.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.94 19.34 77.68 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 119.884 -1.15 . . . . 75.04 111.12 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.8 145.74 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-O 121.003 0.43 . . . . 75.42 109.912 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.1 m -115.73 131.67 56.87 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.543 -1.28 . . . . 54.2 107.543 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -123.96 154.23 30.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.073 0.463 . . . . 71.13 109.906 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 66.2 m-85 -114.03 122.04 45.71 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 105.998 -1.853 . . . . 75.05 105.998 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.6 p -112.59 143.01 44.49 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.854 0.359 . . . . 70.23 111.005 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.509 ' HB ' HD21 ' A' ' 151' ' ' LEU . 13.5 t -128.01 134.35 49.23 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 120.693 -0.403 . . . . 63.24 110.008 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -110.84 142.18 43.2 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.552 -1.648 . . . . 72.12 106.552 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 143' ' ' ASP . 30.7 p90 -143.17 118.25 10.08 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 115.133 1.531 . . . . 73.42 115.133 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 47.74 -138.96 10.37 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.005 -1.452 . . . . 73.15 115.776 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 181' ' ' ARG . . . -124.78 -28.39 1.16 Allowed Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.103 -0.799 . . . . 53.11 111.103 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.6 119.43 38.06 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.002 0.43 . . . . 70.34 112.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.436 ' HB2' HD22 ' A' ' 183' ' ' ASN . . . -124.59 107.63 11.23 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.578 -0.737 . . . . 75.32 110.883 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.14 171.9 8.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.737 -1.209 . . . . 73.03 107.737 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.59 -39.02 75.87 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.135 0.493 . . . . 63.15 110.434 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.36 74.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.38 -0.827 . . . . 70.44 111.362 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 17.2 m-20 -65.92 -36.26 82.88 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 111.815 0.302 . . . . 74.43 111.815 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.37 -39.9 89.38 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.927 0.394 . . . . 72.44 110.709 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.99 -51.13 32.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.949 -0.569 . . . . 65.43 110.372 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -57.4 -46.52 83.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.714 -0.675 . . . . 72.32 111.667 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -65.03 -32.65 74.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.027 0.751 . . . . 74.12 113.027 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.92 86.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.342 -0.614 . . . . 74.34 109.342 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.8 m -65.59 -40.19 92.42 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.711 -0.677 . . . . 72.35 109.937 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 30.2 mm-40 -61.84 -37.02 82.92 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 116.186 -0.461 . . . . 74.34 111.938 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.509 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.0 mt -60.92 -35.03 75.64 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 120.865 -0.334 . . . . 54.32 111.752 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -59.81 -48.14 82.87 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.25 0.343 . . . . 75.14 111.276 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 156' ' ' GLU . 13.0 t -75.56 -30.61 59.75 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.201 0.524 . . . . 65.15 111.033 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.9 m -70.69 -35.35 72.75 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 120.963 0.411 . . . . 74.24 110.421 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.5 6.45 17.39 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.014 0.525 . . . . 73.21 112.283 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 153' ' ' THR . 56.5 mt-10 -68.93 138.3 54.5 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.008 -0.677 . . . . 75.13 110.082 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.09 56.6 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.756 -0.656 . . . . 74.15 111.595 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.5 p -125.37 165.33 26.97 Favored Pre-proline 0 N--CA 1.441 -0.922 0 N-CA-C 108.293 -1.002 . . . . 55.11 108.293 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -75.44 20.14 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.796 2.331 . . . . 71.21 112.451 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.73 120.73 17.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.309 0.576 . . . . 55.42 110.426 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 10.1 t -124.59 157.5 35.29 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.007 -1.849 . . . . 61.03 106.007 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -132.6 160.09 37.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 119.115 0.871 . . . . 72.23 108.893 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -128.77 132.86 47.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.125 0.417 . . . . 52.43 112.125 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.63 -0.45 27.14 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.508 -0.769 . . . . 63.14 114.12 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 60.62 10.77 2.74 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.033 0.933 . . . . 72.45 112.285 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.5 p -68.77 138.53 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.784 0.802 . . . . 74.3 111.488 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.414 ' HB3' HD23 ' A' ' 187' ' ' LEU . 36.4 p90 -135.95 161.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.8 -1.091 . . . . 71.23 108.897 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 88.4 m-85 -115.41 142.07 47.19 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.153 -0.476 . . . . 74.43 109.913 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.2 m -114.22 120.3 40.0 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.731 -1.211 . . . . 65.34 107.731 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -116.3 143.07 46.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.154 0.502 . . . . 71.44 111.708 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.654 0 N-CA-C 107.279 -2.328 . . . . 54.52 107.279 -179.525 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HA ' ' HA2' ' A' ' 137' ' ' GLY 0.258 19.7 ptt180 . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 116.185 1.92 . . . . 74.11 116.185 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -101.23 125.25 47.84 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 115.342 -2.543 . . . . 75.52 108.581 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.436 HD22 ' HB2' ' A' ' 139' ' ' ALA . 19.8 p30 -146.84 158.37 43.9 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.648 -1.614 . . . . 62.03 108.786 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 43.5 mt-10 -143.12 137.38 29.09 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.098 0.475 . . . . 72.13 110.537 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 84.7 t -124.22 118.5 53.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 105.913 -1.884 . . . . 74.43 105.913 171.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.526 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 49.2 m0 -106.32 124.42 49.57 Favored 'General case' 0 CA--C 1.495 -1.154 0 O-C-N 123.463 0.477 . . . . 75.34 111.413 -176.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 167' ' ' TYR . 62.4 mt -97.35 125.2 41.81 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.676 -1.601 . . . . 70.42 106.676 167.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.7 124.75 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 120.536 -0.466 . . . . 74.01 109.993 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 161' ' ' THR . 15.5 pttp -70.19 145.1 51.69 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.643 -0.708 . . . . 73.04 109.644 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.296 -1.76 0 C-N-CA 118.976 -1.089 . . . . 41.43 109.442 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 41.2 p90 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 109.375 -0.602 . . . . 61.43 109.375 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -122.91 110.0 14.86 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.943 -0.303 . . . . 60.43 110.546 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.3 116.42 30.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 106.906 -1.516 . . . . 74.2 106.906 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -91.93 -26.28 18.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.36 -0.536 . . . . 63.24 112.111 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -172.85 153.14 2.58 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.006 0.431 . . . . 64.53 110.779 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.6 p -133.03 134.58 44.6 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.867 -1.06 . . . . 71.43 110.231 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.94 132.55 7.81 Favored Glycine 0 C--N 1.304 -1.246 0 C-N-CA 120.265 -0.969 . . . . 62.5 112.752 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.46 -115.03 0.98 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.029 -0.605 . . . . 62.13 111.749 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.582 ' H ' HG23 ' A' ' 154' ' ' THR . 4.7 ttmp? -91.71 117.55 29.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.518 -1.66 . . . . 64.33 106.518 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -67.75 134.31 50.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 115.27 1.582 . . . . 73.42 115.27 -170.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 158.17 -58.87 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 129.704 3.202 . . . . 72.44 103.737 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.2 p -129.22 129.96 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 106.901 -1.518 . . . . 74.33 106.901 170.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 m -95.27 154.64 17.09 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.893 -0.504 . . . . 75.21 110.087 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CD2' HG22 ' A' ' 154' ' ' THR . 0.1 OUTLIER -113.47 163.37 14.98 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.983 -0.553 . . . . 74.34 110.885 178.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -132.96 124.53 27.96 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.628 -1.99 . . . . 74.5 105.628 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.4 115.27 30.13 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.552 -1.277 . . . . 71.15 107.552 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -131.3 139.79 49.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.216 -0.594 . . . . 63.0 110.933 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.39 133.65 35.44 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 104.924 -2.251 . . . . 73.51 104.924 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.27 138.92 58.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 123.674 0.609 . . . . 61.14 109.851 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.8 OUTLIER -60.69 -26.94 67.49 Favored 'General case' 0 N--CA 1.422 -1.85 0 O-C-N 124.435 1.085 . . . . 62.23 112.531 -178.193 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 84.31 10.24 80.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 118.465 -1.826 . . . . 73.24 112.247 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.22 157.27 53.4 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.822 -0.704 . . . . 61.21 111.395 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 14.4 ptpt -88.32 123.43 32.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.409 -0.96 . . . . 71.43 108.409 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.89 ' HE1' HE22 ' A' ' 109' ' ' GLN . 28.0 m-85 -122.32 165.45 16.23 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.588 -0.733 . . . . 65.05 110.996 -172.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.25 115.35 28.18 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.384 -0.969 . . . . 73.24 108.384 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.9 t -120.32 142.67 48.91 Favored 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 115.124 -0.943 . . . . 62.3 111.643 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 13.8 m -128.89 127.14 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 107.147 -1.427 . . . . 71.01 107.147 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.59 119.68 31.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-O 121.887 0.851 . . . . 74.05 112.093 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 39.9 t -114.72 135.8 53.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.221 -1.354 . . . . 75.33 107.616 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 49' ' ' LYS . 33.3 p -125.78 167.5 15.09 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.582 -0.281 . . . . 65.05 110.736 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.7 t70 73.64 -26.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 124.039 0.935 . . . . 71.23 112.202 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 47' ' ' THR . 94.6 mttt -96.96 143.27 25.83 Favored Pre-proline 0 C--N 1.3 -1.565 0 CA-C-N 115.808 -0.633 . . . . 64.51 110.22 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.14 158.95 36.82 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.374 2.716 . . . . 62.2 111.789 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG13 HD12 ' A' ' 98' ' ' LEU . 74.2 t -45.66 -45.66 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.131 0.972 . . . . 64.24 112.756 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.58 -50.04 75.27 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.506 0.67 . . . . 53.43 110.52 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.99 -35.73 77.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.104 -0.953 . . . . 72.21 112.273 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.463 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -71.18 -45.26 63.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.462 -0.335 . . . . 73.14 110.624 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.08 -43.64 94.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.304 -0.407 . . . . 71.12 111.413 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -64.51 -26.74 68.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.159 0.429 . . . . 62.23 112.159 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.5 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 27.5 tt0 -84.07 -30.39 26.06 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.09 -0.707 . . . . 74.25 109.09 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.58 52.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.979 -1.01 . . . . 61.0 113.49 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mmt -51.08 -55.85 24.77 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 112.504 0.557 . . . . 74.53 112.504 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.11 -31.32 74.83 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.739 2.293 . . . . 72.43 113.202 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.5 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 93.1 mttt -64.19 -48.46 75.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.77 0.319 . . . . 75.45 110.362 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.8 -38.81 83.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.341 -0.39 . . . . 74.32 110.756 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.1 mmt -59.15 -43.23 92.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.253 -0.43 . . . . 62.14 112.038 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -76.22 -29.72 57.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.834 -0.747 . . . . 75.21 111.634 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 36.9 t80 -60.91 -56.3 22.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.165 -0.471 . . . . 75.35 110.743 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.4 m -77.45 -7.56 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.391 0.615 . . . . 74.34 110.739 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.85 -20.74 62.77 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.602 -0.726 . . . . 14.2 112.436 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.32 6.55 8.11 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.028 -1.082 . . . . 75.42 113.288 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -91.85 17.73 8.74 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.777 1.275 . . . . 54.45 109.573 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.07 173.47 10.46 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.562 -1.199 . . . . 73.24 109.438 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 24.1 t70 -67.09 -33.23 75.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.541 0.571 . . . . 73.53 112.541 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.15 -12.29 59.25 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.45 -0.5 . . . . 71.04 110.554 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.25 24.76 74.81 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 115.535 -0.757 . . . . 44.11 111.884 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.61 122.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 C-N-CA 120.004 -0.679 . . . . 45.34 111.287 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.42 97.84 1.36 Allowed Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 109.241 -1.543 . . . . 72.1 109.241 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtt -126.41 135.53 51.53 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.625 -0.509 . . . . 53.22 109.625 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.95 70.91 1.45 Allowed Glycine 0 C--N 1.292 -1.908 0 CA-C-N 115.296 -0.865 . . . . 43.01 111.922 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' A' ' 78' ' ' MET . 18.0 ptm -96.68 122.44 39.62 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.283 -0.636 . . . . 64.53 109.283 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.8 m -127.44 133.98 49.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.758 -0.656 . . . . 74.02 110.478 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -166.43 148.29 5.84 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.044 -1.465 . . . . 62.14 107.044 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 27.8 Cg_exo -40.1 140.97 0.75 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.753 2.968 . . . . 75.44 115.133 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.26 152.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.262 -1.014 . . . . 63.32 108.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.9 m -139.3 152.32 47.13 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.202 -0.666 . . . . 62.51 109.202 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CB ' ' HA ' ' A' ' 100' ' ' VAL . 54.5 p90 -145.14 144.99 31.19 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 122.1 -0.375 . . . . 60.11 110.578 172.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.39 137.97 31.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.648 -0.501 . . . . 54.44 109.648 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.18 150.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 N-CA-C 108.744 -0.836 . . . . 72.2 108.744 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.58 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 62.7 m-85 -117.09 112.34 40.01 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 107.02 -1.474 . . . . 73.34 107.02 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.22 133.66 18.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 120.948 1.099 . . . . 73.11 112.247 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.35 156.57 20.16 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 107.823 -1.177 . . . . 73.44 107.823 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.01 -13.33 62.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.186 0.517 . . . . 62.3 112.147 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.16 -6.14 58.97 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.998 -0.546 . . . . 72.05 110.278 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.54 -2.45 72.5 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.335 -0.393 . . . . 54.02 113.269 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -87.36 3.56 46.46 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.881 0.697 . . . . 74.35 112.881 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt 65.3 148.29 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.108 0.963 . . . . 70.51 112.889 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 34.8 tt0 -82.08 148.57 28.5 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.707 -0.679 . . . . 75.23 109.854 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -86.06 70.43 10.59 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.752 0.786 . . . . 74.31 111.31 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 22.0 ttmm -158.26 125.5 5.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 105.483 -2.043 . . . . 71.42 105.483 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.459 HD12 HG13 ' A' ' 51' ' ' VAL . 6.1 tt -143.03 131.89 22.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.328 -0.949 . . . . 73.44 111.38 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.79 115.16 23.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.299 -0.864 . . . . 70.3 109.311 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 43' ' ' THR . 92.9 t -88.33 127.93 40.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 108.041 -1.096 . . . . 44.25 108.041 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -114.79 113.61 24.47 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.359 -0.978 . . . . 75.15 108.359 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -103.04 114.08 28.08 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.682 -1.229 . . . . 74.2 107.682 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.641 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 14.8 ptp180 -75.07 138.78 42.36 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.771 -1.104 . . . . 64.24 108.085 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -97.91 141.16 22.54 Favored Pre-proline 0 C--N 1.266 -3.046 0 CA-C-N 116.264 -0.425 . . . . 72.34 110.056 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.42 146.89 9.64 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.902 2.401 . . . . 64.22 111.731 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -52.27 -40.38 61.68 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.379 1.251 . . . . 73.45 114.379 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.37 -27.87 66.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.211 0.529 . . . . 62.35 111.313 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.24 -1.66 47.67 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.203 -0.453 . . . . 61.54 112.156 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.89 HE22 ' HE1' ' A' ' 41' ' ' PHE . 21.3 mm-40 -64.72 -41.21 96.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.881 0.372 . . . . 72.42 110.507 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.14 -23.42 68.73 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.679 -0.691 . . . . 64.21 112.35 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -149.77 87.91 5.01 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 120.782 0.325 . . . . 54.0 110.351 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -96.42 162.56 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.008 2.472 . . . . 73.31 111.713 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.2 135.49 27.18 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.409 2.073 . . . . 72.35 111.402 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -71.98 150.29 92.59 Favored Pre-proline 0 C--O 1.256 1.42 0 CA-C-O 120.594 0.235 . . . . 64.22 111.441 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 2.8 Cg_exo -75.85 117.07 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.829 2.352 . . . . 74.21 112.185 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -97.79 21.62 10.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.529 -0.915 . . . . 52.11 108.529 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.575 ' HB3' HG12 ' A' ' 120' ' ' VAL . 17.4 t70 -140.26 156.22 46.56 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.402 -1.333 . . . . 73.34 107.402 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -25.33 22.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.967 -0.693 . . . . 54.43 111.89 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -78.61 -34.06 46.97 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.355 -0.384 . . . . 63.34 110.932 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 117' ' ' ASP . 7.4 p -98.77 125.23 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.364 -0.606 . . . . 61.52 109.364 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -128.21 138.43 52.46 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.341 -0.845 . . . . 52.41 109.539 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 22.9 mm -93.64 110.81 23.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.173 -1.417 . . . . 73.23 107.173 173.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.27 145.19 51.12 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.32 -0.993 . . . . 64.53 108.32 -174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.13 144.22 40.62 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.982 0.42 . . . . 73.44 110.706 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.523 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -123.97 122.68 38.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.058 -1.83 . . . . 73.41 106.058 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.73 157.01 47.37 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.855 1.057 . . . . 73.43 113.855 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.66 17.2 79.22 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.159 -0.928 . . . . 55.14 113.449 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.31 165.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 C-N-CA 120.553 -0.459 . . . . 51.2 110.54 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.54 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 28.6 m -120.13 133.09 55.6 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 109.136 -0.69 . . . . 63.41 109.136 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.99 151.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.387 -0.968 . . . . 63.42 108.387 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 41.4 m-85 -113.64 121.46 44.23 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.413 -1.699 . . . . 74.34 106.413 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 t -111.46 125.15 53.58 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.878 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.556 ' HB ' HD13 ' A' ' 151' ' ' LEU . 12.7 t -113.58 127.36 56.04 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 107.796 -1.187 . . . . 73.14 107.796 174.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -110.41 132.93 53.75 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 121.645 0.736 . . . . 74.3 110.938 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 182' ' ' ARG . 48.7 p90 -129.8 146.38 51.54 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 74.12 108.973 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -124.54 111.03 1.49 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 111.061 -0.816 . . . . 50.22 111.061 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 175.05 -126.53 1.18 Allowed Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.712 -0.756 . . . . 50.43 111.719 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -100.14 135.67 41.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.062 -0.718 . . . . 73.14 109.062 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.88 107.51 10.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 113.277 0.843 . . . . 72.21 113.277 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.675 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 58.0 pttt -104.18 170.63 7.79 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 71.41 106.324 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -39.52 73.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.497 0.665 . . . . 74.51 110.365 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.467 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . . . -64.86 -28.65 69.7 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.138 -0.937 . . . . 74.11 111.869 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.675 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 13.8 m-20 -62.91 -35.52 80.33 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 120.212 -0.595 . . . . 74.31 110.787 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -68.69 -39.3 80.62 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.588 -0.445 . . . . 61.34 110.553 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.07 -47.13 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.613 -0.514 . . . . 70.43 109.613 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -60.81 -46.63 89.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.888 -0.596 . . . . 73.22 110.657 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -65.83 -32.64 74.28 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 112.116 0.413 . . . . 74.2 112.116 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -64.57 -46.34 83.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 74.12 109.523 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.5 m -61.45 -44.17 97.58 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.088 -0.505 . . . . 64.14 110.128 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 15.2 mm100 -64.45 -35.39 80.75 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.224 -0.444 . . . . 64.43 110.701 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.556 HD13 ' HB ' ' A' ' 133' ' ' THR . 49.1 tp -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.153 -0.342 . . . . 54.33 110.445 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.466 ' HD2' ' OD1' ' A' ' 165' ' ' ASP . 70.2 mtp180 -63.27 -40.79 98.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.567 -0.288 . . . . 71.44 111.447 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.2 t -75.4 -29.78 59.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.807 0.813 . . . . 64.43 110.095 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 26' ' ' LYS . 59.6 m -71.62 -34.67 70.03 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.751 -0.659 . . . . 63.23 110.36 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.409 HD12 HD23 ' A' ' 187' ' ' LEU . 82.2 mt -85.87 4.31 37.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 74.12 111.506 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.6 138.71 31.47 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.072 -1.455 . . . . 73.31 107.072 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.73 -10.16 62.43 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 111.169 -0.772 . . . . 64.3 111.169 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.8 t -119.72 145.5 39.46 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 106.607 -1.627 . . . . 75.34 106.607 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.58 29.13 0.17 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 123.607 2.871 . . . . 74.5 114.62 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.75 128.5 34.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.833 0.349 . . . . 73.02 110.312 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 8.9 t -107.44 152.39 24.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.915 -0.584 . . . . 53.34 109.571 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -141.84 159.76 41.58 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 122.745 0.418 . . . . 71.55 110.533 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.489 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.4 pt20 -129.4 137.09 50.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.713 -0.477 . . . . 71.03 109.713 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.8 -0.64 9.75 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.143 -0.551 . . . . 51.31 114.405 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 152' ' ' ARG . 37.5 t70 65.54 19.27 11.49 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.07 0.948 . . . . 72.44 109.197 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 163' ' ' GLN . 8.4 p -71.49 138.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 CA-C-N 116.023 -0.535 . . . . 72.42 110.551 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -150.28 173.4 14.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.589 -0.732 . . . . 61.42 111.381 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 46.3 m-85 -115.52 152.02 33.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.355 -0.839 . . . . 65.43 110.314 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.0 t -114.47 120.11 39.16 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.197 -1.408 . . . . 65.01 107.197 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.41 159.21 36.09 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 110.559 -0.163 . . . . 53.4 110.559 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.046 0 N-CA-C 109.792 -1.323 . . . . 45.14 109.792 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.419 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 99.3 mtt180 . . . . . 0 CA--C 1.511 -0.519 0 N-CA-C 114.586 1.328 . . . . 71.55 114.586 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 135' ' ' PHE . 36.7 ttm180 -100.48 129.55 46.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 118.147 -1.421 . . . . 64.55 110.337 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -140.36 153.46 46.4 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.031 -1.441 . . . . 74.04 108.095 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 40.3 mt-10 -116.51 151.75 35.49 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.961 -0.755 . . . . 63.0 108.961 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.02 118.2 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.102 -1.814 . . . . 71.41 106.102 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.6 m0 -102.96 121.25 42.16 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.998 -0.742 . . . . 75.34 108.998 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 166' ' ' VAL . 36.5 tp -98.13 134.3 41.39 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.996 -1.112 . . . . 73.02 107.996 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.43 125.16 44.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 O-C-N 123.171 0.295 . . . . 71.12 110.745 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -64.02 142.49 58.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 123.639 0.587 . . . . 63.34 110.991 176.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.34 0 CA-C-O 119.065 -0.493 . . . . 63.01 110.921 179.141 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.487 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 25.6 p90 . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.8 111.28 23.95 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.674 -0.41 . . . . 74.44 110.407 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.5 t -84.05 120.41 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.469 -0.937 . . . . 61.12 108.469 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -90.3 -35.8 15.05 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.504 -0.479 . . . . 75.25 110.935 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -164.25 149.88 10.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.346 0.593 . . . . 73.41 111.233 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.524 HG22 ' CB ' ' A' ' 32' ' ' GLU . 47.7 p -132.51 155.18 49.06 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.031 -1.47 . . . . 75.42 107.031 173.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.19 103.16 2.44 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 119.198 -1.477 . . . . 74.02 112.345 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.81 -135.11 3.92 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.546 -0.835 . . . . 71.4 111.424 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -96.45 139.26 32.82 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 105.916 -1.883 . . . . 71.23 105.916 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.7 173.18 2.95 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 114.127 1.158 . . . . 74.32 114.127 -171.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 83.15 -51.88 0.16 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.666 1.587 . . . . 73.43 111.023 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.03 110.8 28.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.771 -1.196 . . . . 74.52 107.771 175.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 p -94.98 154.52 17.14 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.917 -0.583 . . . . 74.43 111.257 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.15 158.95 42.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.383 0.611 . . . . 71.41 111.626 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' CB ' HG22 ' A' ' 23' ' ' THR . 12.9 pt-20 -134.89 132.2 38.23 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.482 -1.303 . . . . 75.25 107.482 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -96.77 114.32 25.94 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.292 -1.744 . . . . 74.23 106.292 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.28 1.2 ppt_? -142.14 145.2 33.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.287 1.217 . . . . 70.35 114.287 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -80.52 137.75 36.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.526 -1.287 . . . . 72.3 107.526 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.3 t -57.27 147.75 24.58 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.782 0.676 . . . . 73.4 111.186 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -63.89 -28.13 69.63 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 124.115 0.966 . . . . 61.53 112.59 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 77.31 9.75 86.64 Favored Glycine 0 C--N 1.317 -0.512 0 C-N-CA 120.432 -0.889 . . . . 61.23 113.556 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.68 160.57 54.09 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.682 -0.771 . . . . 74.51 112.212 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -88.79 122.11 31.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.597 -0.52 . . . . 63.31 109.597 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 26.5 m-85 -126.9 166.17 17.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.467 -0.788 . . . . 72.03 111.699 -171.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.62 115.82 28.63 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.846 -0.798 . . . . 71.24 108.846 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -125.81 143.54 51.02 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-N 115.314 -0.857 . . . . 63.22 112.112 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.485 HG21 ' HD2' ' A' ' 61' ' ' LYS . 12.8 p -132.83 144.56 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 108.352 -0.981 . . . . 75.13 108.352 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.78 127.69 50.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.675 0.75 . . . . 74.43 111.032 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 46.7 t -120.64 133.15 68.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.102 -1.444 . . . . 42.24 107.102 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 97' ' ' LYS . 35.7 p -130.76 176.6 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.51 0.559 . . . . 73.55 112.51 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 69.34 4.07 4.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.903 1.281 . . . . 53.44 112.316 174.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -141.0 141.16 22.97 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 108.058 -1.09 . . . . 75.03 108.058 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.27 156.86 7.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.341 2.694 . . . . 73.13 112.364 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.574 HG13 HD13 ' A' ' 98' ' ' LEU . 71.4 t -47.67 -41.36 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.575 0.954 . . . . 44.43 113.575 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 9.9 m-20 -58.75 -50.09 75.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.413 0.625 . . . . 60.24 109.911 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.33 -40.7 81.51 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.996 -1.002 . . . . 73.11 110.871 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -61.13 -46.57 90.04 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.542 -0.753 . . . . 71.54 110.104 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.68 -31.7 70.95 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.899 -0.591 . . . . 70.25 110.906 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 36.7 mtm180 -61.25 -30.24 70.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.554 0.576 . . . . 73.32 112.554 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 37.1 mt-10 -85.61 -46.3 10.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.416 -0.513 . . . . 71.34 111.512 173.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.27 80.22 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.971 1.1 . . . . 73.3 113.971 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.56 ' HB3' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.81 -52.72 72.33 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 119.483 -0.294 . . . . 54.31 110.463 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 71.9 Cg_exo -51.75 -37.15 64.46 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.702 2.268 . . . . 72.3 112.319 173.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 88.9 mttt -67.41 -42.49 83.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.28 0.474 . . . . 75.41 112.28 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.95 -41.04 77.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.612 -0.435 . . . . 43.01 111.834 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.526 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.9 ptm -69.91 -29.63 66.85 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.795 0.665 . . . . 54.15 112.795 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -70.37 -40.83 73.79 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.928 -0.767 . . . . 74.53 108.928 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.22 -56.87 16.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.839 -0.619 . . . . 73.31 111.529 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 102' ' ' PHE . 11.8 m -78.35 -20.97 13.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 120.983 0.42 . . . . 74.3 111.284 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.05 70.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.674 -0.693 . . . . 74.55 112.89 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.69 -17.41 0.49 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.768 -1.205 . . . . 64.5 113.53 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -81.83 32.52 0.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 122.304 1.05 . . . . 74.12 110.752 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.68 168.94 9.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.782 -0.645 . . . . 62.11 109.836 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.419 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 11.0 t70 -66.06 -33.99 77.05 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.04 0.756 . . . . 71.14 113.04 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -82.22 -11.22 58.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 73.43 109.728 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.91 34.87 77.97 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.329 -0.85 . . . . 51.25 112.128 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.44 121.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.969 -0.692 . . . . 65.4 110.263 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.11 116.0 5.47 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.561 -0.828 . . . . 74.35 112.285 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.6 mmt 61.8 28.39 17.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.05 109.565 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.98 -34.54 90.19 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.589 -1.187 . . . . 73.54 113.471 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.401 ' HB2' ' CD ' ' A' ' 105' ' ' PRO . 1.2 pmm? -124.72 126.1 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 112.843 0.683 . . . . 72.24 112.843 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.0 m -125.21 117.09 23.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.993 -0.743 . . . . 72.31 108.993 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -170.22 143.32 1.95 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.296 -1.372 . . . . 75.45 107.296 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -41.4 139.84 1.73 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.994 3.129 . . . . 62.23 116.729 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 102' ' ' PHE . 10.7 p -105.74 154.23 7.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.68 -1.6 . . . . 71.32 107.145 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 48.5 m -139.7 145.18 38.05 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.436 -0.579 . . . . 75.14 109.436 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 98' ' ' LEU . 37.0 p90 -135.09 147.16 49.47 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.944 -0.472 . . . . 75.45 111.151 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.26 134.71 34.63 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.684 0.615 . . . . 74.01 109.533 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.425 ' HB ' HD12 ' A' ' 94' ' ' LEU . 32.7 m -129.7 152.9 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.825 -0.806 . . . . 71.0 108.825 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 40.6 m-85 -122.5 104.04 37.5 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.878 -0.786 . . . . 74.11 108.878 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.5 133.69 10.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.823 1.682 . . . . 55.11 113.002 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -86.46 166.05 15.81 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.329 -0.989 . . . . 61.44 108.329 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.76 -15.39 61.53 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 73.11 111.149 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -91.18 1.13 57.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 63.44 111.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.85 0.62 90.32 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.948 -0.644 . . . . 75.31 112.503 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 t -92.07 141.16 28.91 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.509 -1.293 . . . . 64.32 107.509 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 86' ' ' VAL . 3.0 mm? -79.29 156.71 27.94 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 120.96 0.409 . . . . 71.33 110.639 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -79.22 158.25 27.66 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.272 -0.64 . . . . 61.22 109.272 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -75.82 40.03 0.18 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.85 0.86 . . . . 63.3 112.212 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 38.4 ttmt -141.68 125.83 17.4 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.325 -0.991 . . . . 60.42 108.325 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.574 HD13 HG13 ' A' ' 51' ' ' VAL . 60.3 tp -135.47 129.14 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 110.208 -0.293 . . . . 64.44 110.208 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.37 115.51 21.09 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.219 -0.66 . . . . 44.22 109.219 174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 43' ' ' THR . 59.0 t -96.61 134.9 32.55 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-N 115.229 -0.896 . . . . 74.14 109.871 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -120.84 120.02 34.35 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.941 0.896 . . . . 72.35 109.751 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 73.5 t80 -104.08 123.85 47.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.902 -0.407 . . . . 74.41 109.902 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.582 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 42.3 ttm-85 -75.35 134.2 41.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.343 -0.844 . . . . 70.55 110.187 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CG2' ' HB2' ' A' ' 108' ' ' PHE . 65.7 mt -104.79 133.09 20.34 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 116.532 -0.304 . . . . 72.24 111.21 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' ILE . 47.5 Cg_exo -60.81 161.2 22.41 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.549 2.833 . . . . 74.44 112.6 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -57.98 -37.11 73.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.147 1.166 . . . . 72.41 114.147 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.83 -30.45 71.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.327 0.584 . . . . 75.22 111.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.453 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 96.4 m-85 -99.65 -4.95 29.79 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.948 -0.569 . . . . 71.21 110.972 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -71.4 -37.87 71.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 119.586 -0.846 . . . . 74.53 109.735 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.1 94.26 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.183 -0.917 . . . . 75.02 111.918 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -154.11 93.33 2.95 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.182 -0.673 . . . . 61.3 109.182 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 71.7 Cg_endo -77.3 146.41 24.93 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.307 2.004 . . . . 74.21 112.565 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 32.3 Cg_exo -59.62 130.17 34.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.401 2.067 . . . . 74.21 109.801 175.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -68.86 148.98 98.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.81 -0.632 . . . . 64.01 111.48 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 39.6 Cg_exo -60.59 113.14 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.709 2.273 . . . . 73.33 111.938 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -97.07 5.74 49.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.368 -0.975 . . . . 71.23 108.368 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.26 148.76 49.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.132 -1.803 . . . . 72.25 106.132 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -81.1 -25.06 37.28 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.717 0.636 . . . . 75.42 112.717 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.402 ' OG ' ' HD3' ' A' ' 61' ' ' LYS . 47.2 p -91.7 -16.42 26.98 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.78 0.659 . . . . 25.04 112.78 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 50.2 t -94.71 116.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.875 -1.157 . . . . 74.34 107.875 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -119.7 144.08 47.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 110.274 -0.269 . . . . 72.12 110.274 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.5 mm -92.85 111.98 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.964 -1.124 . . . . 74.11 107.964 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -125.57 143.35 51.05 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.909 -1.041 . . . . 62.1 109.346 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.05 143.11 40.56 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.038 -0.727 . . . . 62.02 109.038 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -135.99 127.31 28.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.235 -0.654 . . . . 73.41 109.235 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.19 171.02 14.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.668 -0.493 . . . . 75.02 109.668 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.23 7.05 62.52 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 121.009 -0.615 . . . . 42.13 112.176 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.96 145.27 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 120.095 -0.642 . . . . 73.25 110.878 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 59.5 m -109.22 135.69 49.92 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.42 157.31 32.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 108.849 -0.797 . . . . 71.31 108.849 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 40.2 m-85 -113.3 121.77 45.42 Favored 'General case' 0 N--CA 1.411 -2.381 0 N-CA-C 105.166 -2.161 . . . . 75.3 105.166 178.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 t -109.96 125.89 53.34 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.623 -0.51 . . . . 63.23 109.623 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.7 t -113.47 126.64 55.55 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.185 -1.043 . . . . 74.03 108.185 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -115.61 124.94 52.21 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.028 -1.101 . . . . 72.35 108.028 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.17 137.02 48.8 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 116.392 -0.367 . . . . 75.12 110.439 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.49 161.81 24.23 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 115.784 -0.643 . . . . 61.4 111.788 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.59 161.31 12.91 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.655 -1.378 . . . . 65.31 109.655 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -79.51 108.4 13.02 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.37 0.605 . . . . 73.33 109.886 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -112.73 145.87 39.76 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.16 -0.927 . . . . 71.22 111.844 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.491 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 18.6 ptpt -95.43 176.94 5.99 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.739 -0.838 . . . . 74.1 108.739 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 1.3 mp0 -60.32 -37.96 82.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.49 -0.559 . . . . 71.22 109.49 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.63 70.7 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.437 -0.801 . . . . 54.43 111.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.491 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 23.4 m-20 -64.4 -31.21 72.32 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 62.32 111.283 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -64.61 -46.68 81.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.68 0.276 . . . . 73.31 110.902 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.59 -46.08 95.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.457 0.646 . . . . 54.51 109.978 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.84 99.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 43.33 111.482 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -71.12 -32.52 69.11 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 112.281 0.475 . . . . 73.13 112.281 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.3 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.216 -0.661 . . . . 70.31 109.216 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.4 m -65.07 -40.97 95.44 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.355 -0.839 . . . . 71.42 110.835 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -73.73 -30.3 62.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.937 0.399 . . . . 75.42 110.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.11 -31.7 72.91 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 109.618 -0.512 . . . . 71.04 109.618 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 165' ' ' ASP . 79.9 mtp180 -63.81 -39.09 93.4 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.024 -0.534 . . . . 50.14 109.931 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 56.6 m -71.6 -30.98 66.43 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.654 0.74 . . . . 71.41 109.703 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 38.4 m -72.1 -34.87 68.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.581 -0.736 . . . . 74.45 109.091 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.08 6.66 41.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.364 -0.835 . . . . 74.34 111.137 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.13 128.14 33.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.334 -1.728 . . . . 74.14 106.334 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.32 13.47 41.83 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.268 -0.967 . . . . 64.44 111.811 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 70.9 p -117.2 163.12 24.58 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.893 -0.78 . . . . 41.01 108.893 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -86.33 12.83 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.643 2.229 . . . . 74.13 111.802 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.96 148.31 47.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.921 -0.582 . . . . 62.44 111.25 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 43.4 p -122.04 141.44 51.37 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.76 -0.83 . . . . 74.12 108.76 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -135.52 144.94 46.58 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.113 -0.367 . . . . 75.41 111.278 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.7 pt20 -106.32 110.97 23.36 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.184 0.809 . . . . 74.2 113.184 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.73 8.48 57.08 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.77 -0.729 . . . . 52.42 113.339 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.455 ' OD2' ' HD2' ' A' ' 152' ' ' ARG . 3.8 m-20 62.5 24.17 14.38 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.695 0.798 . . . . 74.25 111.263 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.57 140.24 18.09 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 119.52 -0.872 . . . . 71.42 109.283 -174.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 32.8 p90 -140.65 168.68 19.22 Favored 'General case' 0 N--CA 1.415 -2.209 0 C-N-CA 120.196 -0.602 . . . . 61.33 112.009 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 35.7 m-85 -115.32 147.26 40.66 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.423 -0.808 . . . . 73.24 109.87 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 83' ' ' SER . 41.4 t -114.44 137.38 51.91 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.75 32.79 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.921 0.391 . . . . 54.12 111.067 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.926 0 N-CA-C 108.924 -1.67 . . . . 63.05 108.924 178.341 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 122.051 0.929 . . . . 75.04 109.815 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -134.57 130.57 36.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.957 -2.238 . . . . 72.25 104.957 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -133.22 137.09 45.99 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 108.757 -0.831 . . . . 73.23 108.757 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 133' ' ' THR . 45.7 mt-10 -132.31 136.03 46.61 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.899 0.381 . . . . 45.22 111.5 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.45 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 74.4 t -124.98 124.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.806 -1.183 . . . . 71.12 107.806 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.499 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 35.1 m0 -109.42 121.3 44.89 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 120.872 -0.331 . . . . 74.52 110.244 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 67.3 mt -96.24 126.31 41.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.138 -1.06 . . . . 75.54 108.138 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.08 127.25 42.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.592 -0.521 . . . . 64.35 109.592 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -64.77 143.01 58.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.65 0.611 . . . . 75.51 112.65 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.7 0 CA-C-N 115.261 -0.881 . . . . 38.16 108.761 176.568 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.4 p90 . . . . . 0 N--CA 1.428 -1.54 0 N-CA-C 107.488 -1.301 . . . . 73.4 107.488 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 109.5 21.5 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.355 0.598 . . . . 74.1 109.497 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.7 t -93.71 119.63 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.077 -0.965 . . . . 75.13 109.122 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 21' ' ' LEU 0.257 0.4 OUTLIER -90.63 -38.17 13.3 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 113.05 0.759 . . . . 73.33 113.05 -178.887 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -158.98 149.44 19.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.247 -0.581 . . . . 72.34 111.258 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.3 p -134.0 161.38 34.98 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.28 1.032 . . . . 73.41 110.265 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.8 113.28 1.46 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.844 -0.693 . . . . 73.5 114.515 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.68 -95.19 0.32 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.84 -0.504 . . . . 61.24 111.84 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -97.99 164.4 12.37 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.277 -1.379 . . . . 75.1 107.277 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.62 153.71 27.83 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 118.752 -1.179 . . . . 74.12 111.483 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 72.21 -49.79 0.69 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.976 1.31 . . . . 70.43 111.556 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 110.61 32.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.996 0.903 . . . . 74.0 109.108 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 p -113.1 154.25 26.91 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.373 -0.83 . . . . 73.21 110.32 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -113.43 158.45 20.64 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 120.058 -0.657 . . . . 75.33 111.446 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 34.0 tt0 -143.37 124.99 14.88 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 106.187 -1.783 . . . . 70.43 106.187 175.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . 43.3 mt-10 -97.79 115.06 27.29 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.496 -1.668 . . . . 74.42 106.496 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -135.83 147.22 48.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.908 -0.717 . . . . 65.43 112.415 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.66 127.24 34.93 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.16 -2.163 . . . . 63.43 105.16 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.7 t -58.87 143.22 48.31 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.751 0.657 . . . . 30.45 111.339 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -37.32 -52.67 1.09 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.801 1.64 . . . . 71.32 112.982 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.19 9.03 54.53 Favored Glycine 0 C--N 1.286 -2.213 0 C-N-CA 119.77 -1.205 . . . . 73.23 110.94 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.8 163.09 54.42 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.396 -1.082 . . . . 61.01 110.396 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 104' ' ' ILE . 18.3 ptmt -100.91 128.82 46.78 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.358 -0.608 . . . . 54.01 109.358 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 53.2 m-85 -129.81 164.53 23.88 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.692 -0.686 . . . . 72.3 110.906 -171.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 116.36 30.84 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.223 -1.028 . . . . 72.41 108.223 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.0 t -128.81 146.63 50.87 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.35 0.595 . . . . 60.35 111.801 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.562 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 9.0 p -128.41 139.11 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.385 -0.969 . . . . 63.05 108.385 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -121.52 138.83 54.13 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.192 -1.003 . . . . 75.43 111.371 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.83 133.9 67.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.389 -1.708 . . . . 51.02 106.389 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.6 p -125.7 169.61 12.37 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.619 -0.433 . . . . 71.54 110.042 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 71.47 -2.11 2.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.032 0.933 . . . . 62.23 112.737 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.99 147.66 52.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 109.306 -0.627 . . . . 73.24 109.306 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 32.9 Cg_endo -65.13 156.35 63.35 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 122.167 1.911 . . . . 71.14 111.015 174.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 54.7 t -49.82 -37.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.931 0.893 . . . . 71.23 113.23 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.25 -49.89 63.15 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.264 0.353 . . . . 65.55 110.991 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 41.6 mt-10 -76.04 -50.54 14.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.037 -0.529 . . . . 74.14 111.266 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.1 68.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.935 0.717 . . . . 73.33 112.935 -174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 tt -62.66 -50.2 72.13 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.842 -0.799 . . . . 64.21 108.842 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.321 6.6 ppt_? -72.43 -23.86 61.14 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 114.018 1.118 . . . . 65.04 114.018 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 12.4 mm-40 -66.58 -44.06 83.23 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 71.32 111.186 172.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.562 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.75 -40.38 55.51 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.857 1.058 . . . . 72.41 113.857 -174.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . 0.253 24.7 mmt -47.07 -52.88 31.16 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 115.929 1.825 . . . . 62.44 115.929 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.44 -31.65 78.78 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.296 1.997 . . . . 71.31 112.176 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD2' HG21 ' A' ' 44' ' ' VAL . 82.5 mttt -74.31 -34.99 63.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.772 -0.649 . . . . 75.44 109.892 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.7 mm -72.85 -39.71 59.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.287 0.565 . . . . 71.12 109.625 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.34 -37.89 89.03 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.633 -0.712 . . . . 75.23 112.853 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -67.57 -31.66 71.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.08 -0.648 . . . . 74.24 110.728 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.75 -58.2 7.61 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.385 -0.37 . . . . 74.41 111.335 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.58 -23.08 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 121.224 0.535 . . . . 75.33 111.285 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.56 72.91 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.903 -0.589 . . . . 74.34 113.196 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.44 -5.08 5.56 Favored Glycine 0 CA--C 1.505 -0.565 0 C-N-CA 119.821 -1.181 . . . . 62.53 113.263 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 116' ' ' SER . 15.2 m -86.33 32.92 0.62 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 122.631 1.205 . . . . 42.41 110.053 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -97.82 177.17 5.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.229 -0.896 . . . . 73.52 109.437 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.438 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 12.6 t70 -63.97 -33.03 74.8 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.258 0.623 . . . . 63.13 111.823 -175.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.691 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 6.9 mmpt? -86.8 -11.26 51.48 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.631 -0.428 . . . . 70.24 110.777 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.22 22.5 74.51 Favored Glycine 0 CA--C 1.498 -0.99 0 CA-C-N 115.6 -0.727 . . . . 44.24 112.066 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.99 122.09 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-O 121.153 0.501 . . . . 72.51 110.907 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.16 54.36 0.82 Allowed Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.957 -0.857 . . . . 73.34 110.957 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 51.6 ttm -83.8 110.09 18.06 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.089 0.471 . . . . 62.3 110.015 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.34 82.34 0.67 Allowed Glycine 0 C--N 1.303 -1.3 0 CA-C-N 115.121 -0.945 . . . . 74.22 111.512 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -96.79 134.92 39.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.216 -0.661 . . . . 74.14 109.216 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -124.12 129.86 51.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.258 0.551 . . . . 42.31 112.052 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.438 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 10.5 p -158.63 148.82 15.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 104.107 -2.553 . . . . 74.44 104.107 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 80' ' ' VAL . 47.0 Cg_exo -34.98 138.81 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.7 2.934 . . . . 71.14 115.036 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.54 151.29 6.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.52 -1.289 . . . . 61.24 107.52 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 34.5 m -141.96 145.08 34.09 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 120.706 -0.398 . . . . 62.44 110.409 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -140.44 141.47 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.787 -0.571 . . . . 75.04 110.811 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.05 134.95 35.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.855 -0.611 . . . . 72.24 110.063 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.6 m -126.93 150.67 33.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.327 -0.852 . . . . 65.04 109.668 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 166' ' ' VAL . 91.5 m-85 -116.01 107.15 48.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 116.375 -0.375 . . . . 71.13 110.598 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.25 132.04 7.99 Favored 'Trans proline' 0 N--CA 1.428 -2.38 0 N-CA-C 108.139 -1.524 . . . . 65.04 108.139 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -93.49 167.71 11.52 Favored 'General case' 0 C--N 1.272 -2.773 0 C-N-CA 119.861 -0.736 . . . . 75.34 110.961 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.77 -17.55 56.43 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.883 0.739 . . . . 63.33 110.78 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.54 -6.8 57.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.249 1.02 . . . . 74.34 110.072 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.89 -10.14 71.57 Favored Glycine 0 C--O 1.229 -0.158 0 CA-C-N 116.048 -0.524 . . . . 73.5 112.389 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.4 m -96.06 134.35 39.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.769 0.318 . . . . 74.44 111.455 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 8.2 mp -78.77 100.09 6.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.453 0.644 . . . . 63.42 110.187 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 53.0 tt0 -148.09 169.86 19.04 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.874 -1.057 . . . . 71.02 108.981 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HB3' ' HD3' ' A' ' 97' ' ' LYS 0.264 64.8 mttp 94.93 -73.87 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.097 1.759 . . . . 63.44 112.456 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 2.4 mppt? -131.04 146.57 52.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 119.005 -1.078 . . . . 73.4 112.215 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 51' ' ' VAL . 5.8 tt -143.28 129.44 19.75 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.512 -1.222 . . . . 72.51 108.049 173.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -119.89 115.47 23.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.456 -0.572 . . . . 74.32 109.456 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 43' ' ' THR . 91.1 t -92.43 125.8 45.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.796 -0.816 . . . . 73.52 108.796 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -109.18 123.82 49.84 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.618 0.574 . . . . 70.42 109.641 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -102.76 113.49 26.95 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.458 -1.682 . . . . 74.22 106.458 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.522 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 24.4 ttt85 -76.67 132.58 39.45 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.191 -0.913 . . . . 74.34 110.606 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 40' ' ' LYS . 74.4 mt -96.67 131.95 27.15 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.092 -1.448 . . . . 54.42 107.092 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.72 146.5 54.61 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.533 2.156 . . . . 74.13 111.816 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -47.57 -39.74 17.37 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.693 1.597 . . . . 74.51 111.867 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -61.2 -32.9 72.67 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.001 0.52 . . . . 71.31 112.4 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.79 -2.65 34.55 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 112.205 0.446 . . . . 75.32 112.205 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.73 -28.24 67.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.574 0.953 . . . . 74.13 113.574 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.47 59.65 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.899 -1.143 . . . . 71.21 111.578 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -142.98 87.08 8.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-O 120.95 0.405 . . . . 73.3 110.295 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -97.47 162.42 0.93 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.302 2.668 . . . . 74.23 112.128 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.39 137.36 46.77 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 122.354 2.036 . . . . 54.43 111.626 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -74.26 152.33 88.07 Favored Pre-proline 0 C--O 1.248 0.995 0 CA-C-N 116.439 -0.346 . . . . 75.14 110.787 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -81.4 121.72 3.91 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 122.103 1.869 . . . . 52.24 111.932 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 69' ' ' THR . 23.5 t -92.41 22.83 4.29 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.91 0.862 . . . . 72.1 109.66 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.403 ' HB3' HG12 ' A' ' 120' ' ' VAL . 14.5 t70 -137.17 151.27 48.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.779 -1.193 . . . . 74.31 107.779 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -88.26 -17.12 31.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.162 1.171 . . . . 63.13 114.162 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.6 m -80.92 -39.7 25.77 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.397 -0.594 . . . . 70.53 109.397 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 117' ' ' ASP . 7.1 p -97.47 123.96 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.588 -0.733 . . . . 73.14 109.809 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.77 148.91 47.85 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.917 -0.583 . . . . 72.11 110.418 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.1 mm -92.39 111.48 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.802 -1.555 . . . . 70.13 106.802 174.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -115.79 145.8 42.5 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.68 -0.691 . . . . 74.43 111.05 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 9.6 pt-20 -121.13 124.74 45.49 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.121 -1.066 . . . . 61.13 108.121 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.451 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.8 mmt180 -136.15 122.64 20.78 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.075 -0.65 . . . . 74.5 111.483 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -143.05 164.73 29.31 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.563 -0.902 . . . . 73.05 108.563 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.02 14.63 54.45 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.65 -0.98 . . . . 61.44 110.65 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.1 pt -120.65 145.17 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 109.267 -0.642 . . . . 74.53 109.267 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.2 m -108.12 128.79 55.0 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.313 -0.995 . . . . 64.41 108.313 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.19 155.28 31.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.475 -0.935 . . . . 71.22 108.475 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 64.1 m-85 -113.89 122.13 46.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.987 -1.486 . . . . 75.5 106.987 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 m -102.49 127.94 49.32 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.734 -0.469 . . . . 51.15 109.734 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 151' ' ' LEU . 13.7 t -120.03 121.9 39.92 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 108.582 -0.895 . . . . 61.11 108.582 171.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -109.67 126.78 54.03 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.194 -1.41 . . . . 75.33 107.194 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.9 p90 -129.61 152.63 48.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.672 -0.411 . . . . 74.15 112.019 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.79 106.98 2.6 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.23 -1.148 . . . . 72.11 110.23 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.68 173.75 36.75 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 111.131 -0.788 . . . . 64.23 111.131 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.2 128.48 33.81 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.146 -0.687 . . . . 64.34 109.146 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.64 125.75 54.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.385 0.883 . . . . 73.51 113.385 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -115.78 173.13 6.71 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.86 -1.533 . . . . 61.44 106.86 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.02 -43.92 70.5 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.478 0.581 . . . . 71.02 110.679 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.39 69.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.721 . . . . 72.51 111.42 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.0 -37.15 83.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.391 -0.596 . . . . 71.23 109.391 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.443 ' HD1' HG22 ' A' ' 185' ' ' VAL . 82.0 m-85 -64.94 -38.92 92.56 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.706 -0.679 . . . . 62.52 111.023 176.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.66 -47.36 93.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.771 -0.825 . . . . 73.2 108.771 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.61 86.16 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.244 -0.889 . . . . 74.14 111.094 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -68.2 -35.07 77.43 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 113.141 0.793 . . . . 75.03 113.141 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.85 88.94 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.434 0.459 . . . . 41.01 110.835 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.2 t -73.14 -33.77 65.71 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 120.309 -0.556 . . . . 71.21 110.495 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.26 -32.17 73.66 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 120.807 0.337 . . . . 54.32 110.937 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 31' ' ' TYR . 33.7 tp -74.55 -31.53 62.13 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.119 -0.632 . . . . 71.11 109.778 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.63 -37.25 79.57 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 112.616 0.599 . . . . 74.44 112.616 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.2 t -70.23 -30.04 67.02 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 73.02 109.649 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 31' ' ' TYR . 63.8 m -71.95 -38.44 69.8 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 115.268 -0.878 . . . . 70.12 109.433 176.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.1 -2.17 51.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.874 -0.603 . . . . 44.01 111.358 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.44 130.4 41.22 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.339 -1.356 . . . . 71.41 107.339 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.58 -2.09 57.22 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.834 -0.621 . . . . 64.52 112.122 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 43.4 p -107.25 164.55 14.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 107.636 -1.246 . . . . 73.44 107.636 175.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 89.2 Cg_endo -81.88 26.11 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.823 1.682 . . . . 52.21 112.301 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 138.03 58.15 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.347 0.594 . . . . 64.53 112.464 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.0 p -120.99 151.04 40.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.534 -1.284 . . . . 73.12 107.534 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.422 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 32.8 m-85 -136.36 151.86 50.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.9 0.773 . . . . 75.34 109.354 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.443 ' O ' HG12 ' A' ' 166' ' ' VAL . 4.3 pp0? -124.68 122.97 39.01 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.182 0.438 . . . . 64.43 112.182 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.38 2.78 43.94 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.659 -0.701 . . . . 50.22 113.491 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.8 14.97 5.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.704 0.802 . . . . 73.11 112.256 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.617 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.9 p -59.37 138.46 20.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 CA-C-O 121.729 0.776 . . . . 73.24 111.543 -177.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.484 ' HB3' HD23 ' A' ' 187' ' ' LEU . 55.5 p90 -139.84 163.27 33.08 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.854 -1.066 . . . . 65.11 108.721 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.94 153.18 31.04 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.098 0.475 . . . . 63.14 110.384 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 83' ' ' SER . 31.3 t -113.21 118.72 35.47 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.396 -1.705 . . . . 55.02 106.396 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -122.09 133.5 54.77 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.084 -0.71 . . . . 60.12 109.084 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.154 0 N-CA-C 110.406 -1.077 . . . . 74.12 110.406 -178.008 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 114.261 1.208 . . . . 73.22 114.261 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -101.81 127.83 48.44 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 118.367 -1.333 . . . . 63.04 109.326 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 37.5 m-80 -144.03 156.18 44.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.231 -1.026 . . . . 63.42 108.231 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 35.8 tt0 -138.94 145.92 40.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.569 0.224 . . . . 53.03 110.548 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.443 HG22 ' HD1' ' A' ' 144' ' ' TYR . 19.8 t -125.63 133.7 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.69 -0.855 . . . . 60.25 108.69 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.539 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 37.3 m0 -112.26 128.4 56.25 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.715 -0.476 . . . . 74.34 109.715 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 167' ' ' TYR . 85.3 mt -99.33 136.76 38.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.589 -1.263 . . . . 74.1 107.589 170.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.1 t -96.14 122.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.104 -0.638 . . . . 74.45 111.12 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 161' ' ' THR . 54.0 tttp -72.09 123.78 23.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.715 -0.675 . . . . 64.15 109.928 174.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.422 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 118.277 -0.868 . . . . 72.52 109.178 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 39.9 p90 . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 108.36 -0.978 . . . . 74.05 108.36 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -106.39 108.93 20.7 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.084 -0.646 . . . . 74.42 109.742 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.23 115.96 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 107.087 -1.449 . . . . 74.44 107.087 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -90.27 -37.17 14.27 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 120.332 -0.547 . . . . 65.41 112.152 -175.194 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.503 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 32.2 t -162.25 156.05 21.13 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.106 -0.637 . . . . 71.43 110.393 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 p -132.0 162.95 29.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.253 -1.388 . . . . 72.51 107.253 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.86 -149.55 20.62 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 119.286 -1.435 . . . . 74.44 112.635 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.92 159.73 32.61 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.098 -0.801 . . . . 65.42 111.098 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -75.51 123.1 24.87 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.05 -1.093 . . . . 73.44 108.05 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.53 133.49 51.35 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 122.534 1.159 . . . . 53.21 113.814 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t70 148.32 -48.82 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 130.83 3.652 . . . . 73.45 101.8 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 147' ' ' HIS . 3.8 p -127.8 109.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 112.611 -2.086 . . . . 75.51 106.718 169.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -117.08 151.12 37.48 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.84 -1.17 . . . . 73.13 107.84 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.589 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.3 p90 -113.57 158.48 20.73 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.899 -1.12 . . . . 75.41 112.684 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -134.47 125.21 26.94 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.589 -2.004 . . . . 73.12 105.589 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.503 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 38.2 mt-10 -98.22 114.59 26.89 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 106.832 -1.544 . . . . 73.43 106.832 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -134.79 140.91 46.25 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.559 -0.857 . . . . 75.42 111.449 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.07 133.59 35.5 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 104.415 -2.439 . . . . 72.3 104.415 169.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.593 ' SG ' HG13 ' A' ' 128' ' ' ILE . 84.1 m -58.46 138.28 56.76 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.488 0.922 . . . . 65.45 113.488 -173.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 10.6 pt-20 -58.22 -31.56 67.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.664 -1.607 . . . . 74.24 113.169 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.73 10.25 57.95 Favored Glycine 0 CA--C 1.495 -1.208 0 C-N-CA 119.045 -1.55 . . . . 30.53 112.111 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.24 52.11 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.779 -0.724 . . . . 63.01 111.931 -176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 16.7 ptpt -90.68 118.28 29.99 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.214 -0.661 . . . . 63.24 109.214 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 33.1 m-85 -119.14 164.33 15.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.022 -0.536 . . . . 72.44 111.165 -172.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 121' ' ' LYS . . . -99.47 116.22 31.11 Favored 'General case' 0 C--O 1.209 -1.037 0 N-CA-C 109.017 -0.734 . . . . 75.32 109.017 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.5 t -122.03 147.16 46.44 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.346 0.593 . . . . 55.45 111.97 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.0 m -131.85 132.32 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 124.669 1.188 . . . . 71.24 108.581 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.64 128.67 56.44 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.517 0.675 . . . . 75.32 111.927 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 12.2 t -123.99 139.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.065 -1.458 . . . . 61.21 107.065 178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.4 p -135.95 165.19 26.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.314 -0.554 . . . . 73.32 110.377 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.82 11.38 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.558 1.161 . . . . 73.43 110.654 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -133.99 137.56 28.65 Favored Pre-proline 0 N--CA 1.424 -1.747 0 N-CA-C 109.257 -0.646 . . . . 73.03 109.257 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.48 156.87 16.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.309 2.672 . . . . 73.23 111.597 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.46 HG13 HD12 ' A' ' 98' ' ' LEU . 55.1 t -47.75 -48.5 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.701 1.0 . . . . 62.51 113.701 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.37 -33.68 76.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.945 0.402 . . . . 63.41 110.932 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -75.98 -34.65 59.78 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.861 -0.609 . . . . 74.44 111.382 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -77.23 -44.47 29.86 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.332 -0.395 . . . . 71.14 110.889 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.8 tp -63.65 -37.78 88.64 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.115 -0.493 . . . . 63.41 111.872 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -59.26 -32.3 69.88 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 112.133 0.42 . . . . 72.45 112.133 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -84.68 -39.9 18.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.465 0.65 . . . . 75.51 110.923 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -75.85 -31.81 59.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.439 -0.8 . . . . 64.41 112.622 -177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.454 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -55.53 -57.65 19.76 Favored Pre-proline 0 CA--C 1.574 1.885 0 CA-C-O 119.372 -0.347 . . . . 72.54 111.5 -178.491 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 19.1 Cg_endo -60.42 -31.31 92.44 Favored 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 122.535 2.157 . . . . 41.43 111.147 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 41.5 ttmt -65.98 -37.03 84.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.776 -1.102 . . . . 73.11 111.276 -177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.37 -47.25 30.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.927 0.394 . . . . 71.1 110.667 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.1 ptm -63.54 -29.54 70.79 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 113.624 0.972 . . . . 75.11 113.624 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.4 -38.82 91.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 120.546 -0.462 . . . . 74.23 110.481 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.31 -58.41 7.79 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.985 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -69.41 -27.23 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 116.039 -0.528 . . . . 73.23 111.621 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.34 -18.23 73.14 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.921 -0.581 . . . . 22.04 113.358 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 134.37 -8.52 4.69 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.174 -1.488 . . . . 63.43 114.308 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 m -84.08 33.38 0.49 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-O 122.924 1.345 . . . . 75.03 110.014 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.6 163.55 12.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.107 -0.951 . . . . 74.53 108.694 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 29.8 t70 -66.28 -33.56 76.03 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.258 0.836 . . . . 74.53 113.258 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 113' ' ' PRO . 31.9 mmmt -80.14 -12.43 59.66 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.166 -0.614 . . . . 54.22 110.612 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.57 38.05 61.81 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.035 -0.602 . . . . 55.25 111.761 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 77' ' ' GLY . 94.8 t -79.56 120.78 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.034 -1.099 . . . . 61.13 108.034 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.59 -23.19 8.48 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 121.244 -0.503 . . . . 33.43 112.34 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.5 mtp -66.03 -37.85 86.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.201 0.524 . . . . 73.04 109.746 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 74' ' ' VAL . . . 69.92 -166.34 49.82 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.073 -0.967 . . . . 23.11 112.196 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.41 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 1.3 pmm? -133.05 146.35 51.62 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.181 -0.674 . . . . 73.11 109.181 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.9 m -113.08 117.61 32.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.01 0.433 . . . . 71.05 109.97 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 103' ' ' ARG . 8.2 p -165.57 151.22 8.31 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 107.492 -1.299 . . . . 73.03 107.492 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.95 140.66 61.39 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.175 1.25 . . . . 73.32 111.214 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 9.9 p -93.45 150.03 4.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.607 -0.886 . . . . 64.14 108.607 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 p -128.77 145.84 51.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.482 0.182 . . . . 64.15 110.942 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -139.78 143.6 36.98 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.475 -0.49 . . . . 73.12 110.5 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.59 134.92 34.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.891 -0.595 . . . . 65.14 110.407 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.69 151.62 28.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.156 -0.929 . . . . 74.33 108.57 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 97' ' ' LYS . 99.0 m-85 -120.22 107.83 38.93 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 120.942 -0.303 . . . . 73.44 110.404 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.22 133.09 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.581 1.521 . . . . 74.43 111.867 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 95' ' ' GLN . 38.5 m-80 -99.84 171.07 8.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.384 -0.825 . . . . 65.24 108.927 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.41 -27.75 62.65 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.981 1.104 . . . . 74.43 113.981 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.83 -7.26 58.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 119.815 -0.754 . . . . 72.42 110.878 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.04 3.6 57.89 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 120.33 -0.938 . . . . 53.43 113.38 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m -91.14 138.59 31.48 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 122.611 -0.346 . . . . 71.41 110.259 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.29 107.73 17.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.608 -1.256 . . . . 65.14 107.608 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 15.5 mm-40 -141.37 170.06 16.44 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.495 -0.558 . . . . 65.5 109.495 -173.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 35.4 mmtp 87.76 -70.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.367 1.467 . . . . 73.43 113.875 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HD3' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -136.54 154.43 50.71 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.49 -0.884 . . . . 73.13 111.822 -177.021 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 54' ' ' ALA . 6.4 tt -143.95 134.54 24.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.663 -1.153 . . . . 75.52 109.231 173.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -131.37 115.94 16.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.649 -0.251 . . . . 60.23 110.532 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.588 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 66.7 t -93.08 121.62 43.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.697 0.623 . . . . 75.52 109.783 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -109.65 122.53 47.67 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.832 0.853 . . . . 72.42 109.473 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.11 113.53 27.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.193 -1.41 . . . . 50.2 107.193 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.663 ' O ' HG11 ' A' ' 80' ' ' VAL . 70.6 ttt180 -75.08 137.2 41.27 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.523 -1.217 . . . . 72.24 109.269 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.0 mt -108.46 124.83 33.33 Favored Pre-proline 0 C--N 1.289 -2.053 0 O-C-N 122.388 -0.195 . . . . 74.31 111.314 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 78' ' ' MET . 83.9 Cg_exo -55.59 161.37 7.81 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.161 2.574 . . . . 51.42 113.231 172.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -47.69 -49.56 27.42 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.87 1.668 . . . . 32.54 115.028 -171.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.54 -37.49 78.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.517 . . . . 75.24 112.397 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.447 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 98.1 m-85 -86.91 -10.33 53.57 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.24 -0.584 . . . . 72.42 112.031 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -71.56 -31.88 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.214 -0.994 . . . . 74.11 110.081 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.55 96.27 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 111.605 -0.598 . . . . 72.22 111.605 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.9 t -157.21 97.84 2.02 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 108.248 -1.019 . . . . 64.02 108.248 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 63.1 Cg_endo -85.78 148.26 9.61 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 122.49 2.127 . . . . 74.03 112.782 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 24.0 Cg_exo -65.77 142.31 69.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.275 1.983 . . . . 71.22 111.109 174.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -73.19 144.17 84.28 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.578 -0.449 . . . . 63.12 110.257 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -78.02 118.4 4.4 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.364 2.042 . . . . 74.33 111.76 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.2 m -88.39 21.77 2.76 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.163 0.506 . . . . 65.32 111.13 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.521 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.4 t70 -135.21 150.3 50.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.486 -1.302 . . . . 72.41 107.486 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.43 -23.76 37.32 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.555 0.946 . . . . 73.42 113.555 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -90.02 -25.85 20.61 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.669 -0.413 . . . . 45.44 111.258 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.5 p -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.597 -0.52 . . . . 70.14 109.597 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 52.9 mtpt -128.41 152.83 47.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.346 -0.843 . . . . 72.21 110.234 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 31.0 mm -92.85 112.57 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.049 -0.723 . . . . 75.13 109.049 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -121.86 142.65 50.04 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.563 -0.744 . . . . 72.05 109.856 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -115.89 128.56 55.88 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.696 -0.683 . . . . 64.25 110.255 -178.404 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.39 133.0 43.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.352 0.596 . . . . 75.21 112.343 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -139.46 172.4 12.87 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.902 -1.518 . . . . 71.21 106.902 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.49 5.14 79.39 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 119.86 -1.162 . . . . 75.11 113.32 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.593 HG13 ' SG ' ' A' ' 36' ' ' CYS . 45.4 pt -121.47 145.9 27.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.109 0.454 . . . . 72.4 110.391 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.1 m -107.68 133.26 52.36 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.503 -0.925 . . . . 73.15 108.503 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.23 149.47 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 N-CA-C 108.804 -0.813 . . . . 74.12 108.804 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 36.7 m-85 -113.79 121.82 45.21 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 104.639 -2.356 . . . . 74.22 104.639 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 55.3 p -119.41 141.29 49.23 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 120.038 -0.665 . . . . 73.14 111.653 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 10.8 t -121.48 139.38 53.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 115.696 -0.684 . . . . 71.13 109.391 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -121.11 126.3 49.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.764 -0.828 . . . . 63.44 108.764 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 38.4 p90 -138.44 168.71 19.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.387 -0.598 . . . . 72.44 109.387 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.21 169.21 35.35 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.331 -0.938 . . . . 71.12 111.794 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.8 -116.79 3.86 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.636 -0.586 . . . . 73.02 111.636 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -98.65 103.0 14.91 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.424 -0.584 . . . . 74.42 109.424 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 126.83 46.95 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.882 0.848 . . . . 71.31 112.434 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.95 172.82 6.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.732 -1.122 . . . . 65.04 108.164 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -40.11 95.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.211 0.529 . . . . 73.21 112.229 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.56 -27.11 68.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.721 -0.672 . . . . 61.44 110.494 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.11 -31.93 73.3 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.873 -0.603 . . . . 63.32 110.475 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -63.48 -42.23 98.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.231 -0.44 . . . . 74.22 109.97 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.83 -45.02 88.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.86 -0.609 . . . . 72.34 109.717 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.83 -47.17 87.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 61.45 110.965 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.436 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 27.6 m80 -69.25 -35.25 75.92 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 112.734 0.642 . . . . 62.42 112.734 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.31 90.43 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.05 0.452 . . . . 74.25 110.077 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.2 m -64.94 -53.38 47.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.789 -0.642 . . . . 73.44 109.937 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -38.66 83.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.945 -0.571 . . . . 75.21 112.222 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 31' ' ' TYR . 62.9 tp -63.62 -43.16 97.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.776 -0.453 . . . . 73.01 109.776 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 39.4 ttp180 -61.85 -40.6 95.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.652 -0.704 . . . . 73.44 109.137 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.427 ' HA ' ' OE2' ' A' ' 156' ' ' GLU . 47.0 m -66.32 -35.47 80.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.462 -0.79 . . . . 71.33 110.663 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -73.08 -33.99 65.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.465 0.65 . . . . 64.33 109.873 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.73 -1.83 29.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.549 -0.75 . . . . 74.14 112.188 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 42.8 mt-10 -75.85 141.63 42.39 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.861 -0.735 . . . . 73.41 110.512 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.16 -1.18 59.03 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.054 -0.819 . . . . 73.04 111.054 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 27.7 p -114.45 166.84 10.71 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.924 -1.51 . . . . 63.34 106.924 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.13 20.29 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.648 2.232 . . . . 74.11 112.987 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.68 118.28 12.33 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 121.193 0.52 . . . . 71.14 111.736 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.3 p -103.7 158.49 16.34 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.295 -1.002 . . . . 74.41 108.295 175.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.484 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 30.0 m-85 -137.8 147.19 44.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.761 -0.829 . . . . 72.42 108.761 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 4.2 pt20 -121.72 109.21 14.44 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.269 0.557 . . . . 63.44 110.686 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.39 8.53 55.73 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.13 -1.033 . . . . 72.32 111.785 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 55.64 30.84 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.495 1.118 . . . . 71.24 111.332 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.45 139.05 21.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.21 0.528 . . . . 64.14 110.945 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.92 163.22 33.37 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.526 -0.761 . . . . 74.2 110.309 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 34.5 m-85 -115.49 149.45 38.08 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.722 -0.672 . . . . 63.4 109.29 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.44 120.28 39.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.086 -1.45 . . . . 74.34 107.086 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -123.64 135.98 54.23 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.166 -0.47 . . . . 64.24 110.633 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.7 0 N-CA-C 108.931 -1.668 . . . . 61.5 108.931 -178.944 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 . . . . . 0 CA--C 1.511 -0.526 0 N-CA-C 112.159 0.429 . . . . 75.33 112.159 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.476 ' HD3' ' OE2' ' A' ' 184' ' ' GLU . 15.1 ttm180 -139.96 130.11 25.09 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.333 -0.547 . . . . 74.42 110.881 176.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.6 m120 -137.53 134.69 35.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 105.046 -2.205 . . . . 64.03 105.046 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.6 mt-10 -129.14 137.43 51.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 110.028 -0.36 . . . . 74.21 110.028 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.11 124.24 67.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 74.01 108.352 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.3 m0 -108.58 123.3 48.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.297 -0.41 . . . . 63.52 110.142 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.7 mt -103.14 118.68 37.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.742 -1.206 . . . . 75.22 107.742 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.28 126.46 46.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.418 -0.586 . . . . 65.43 109.418 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 161' ' ' THR . 63.5 pttt -66.9 142.13 57.4 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 116.125 -0.489 . . . . 65.34 110.934 -175.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.253 1.246 0 CA-C-O 118.177 -0.916 . . . . 74.41 109.585 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.0 p90 . . . . . 0 C--O 1.244 0.804 0 N-CA-C 108.697 -0.853 . . . . 70.1 108.697 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -106.42 120.15 41.15 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.911 0.708 . . . . 64.5 112.911 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.501 HG13 ' HG3' ' A' ' 32' ' ' GLU . 91.6 t -89.19 116.89 31.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.002 -1.851 . . . . 64.41 106.002 170.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' OE1' ' A' ' 33' ' ' GLU . 4.4 pp -99.86 -27.76 13.46 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.874 -0.73 . . . . 65.13 111.931 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -161.79 149.82 14.98 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.871 0.367 . . . . 72.41 110.806 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.7 p -132.79 157.37 45.16 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.227 -0.897 . . . . 62.13 109.562 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.16 -167.0 37.94 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.365 -0.922 . . . . 74.23 111.991 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.76 177.49 15.08 Favored Glycine 0 C--O 1.243 0.659 0 C-N-CA 120.745 -0.74 . . . . 34.11 112.718 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -87.1 126.25 34.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.457 -2.053 . . . . 75.42 105.457 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -64.24 132.69 51.03 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.103 0.954 . . . . 74.34 112.393 -167.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 129.41 -39.63 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.938 3.295 . . . . 71.52 103.105 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.627 HG22 ' CD2' ' A' ' 147' ' ' HIS . 21.6 t -123.0 110.23 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 112.983 -1.917 . . . . 75.01 106.844 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' THR . 52.4 m -119.56 131.87 55.61 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.362 -1.348 . . . . 74.23 107.362 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.61 160.57 16.55 Favored 'General case' 0 N--CA 1.423 -1.789 0 C-N-CA 120.302 -0.559 . . . . 73.33 111.108 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.501 ' HG3' HG13 ' A' ' 20' ' ' VAL . 43.9 tt0 -134.98 125.44 26.61 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 106.648 -1.612 . . . . 64.45 106.648 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.521 ' OE1' HD11 ' A' ' 21' ' ' LEU . 45.5 tt0 -100.17 114.73 28.34 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.367 -1.716 . . . . 75.1 106.367 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -135.93 142.16 44.6 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.789 -1.096 . . . . 73.23 111.377 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.98 136.44 33.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.128 -1.064 . . . . 64.54 108.128 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.0 t -69.07 143.31 54.27 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 110.002 -0.37 . . . . 65.32 110.002 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.12 -20.49 64.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.576 -0.738 . . . . 73.1 112.412 -177.296 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 89.84 10.4 64.92 Favored Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.044 -1.55 . . . . 64.33 110.938 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -71.92 165.56 53.83 Favored Glycine 0 N--CA 1.417 -2.633 0 CA-C-N 114.788 -0.706 . . . . 72.04 112.282 -175.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.546 ' O ' HD12 ' A' ' 104' ' ' ILE . 13.4 ptpt -94.35 132.6 38.79 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.01 -1.107 . . . . 73.42 108.01 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 37.8 m-85 -131.58 163.71 27.44 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.02 0.2 . . . . 74.13 111.128 -172.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.32 117.17 33.16 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.857 -0.794 . . . . 73.32 108.857 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 6.6 t -127.75 149.52 50.2 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 115.883 -0.599 . . . . 60.41 112.19 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 100' ' ' VAL . 3.2 p -145.58 134.7 17.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 124.557 1.143 . . . . 70.4 108.026 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.552 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.8 pt-20 -122.31 128.91 51.62 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.325 -0.95 . . . . 73.31 111.43 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.421 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 47.4 t -112.42 139.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 106.547 -1.649 . . . . 55.13 106.547 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 49' ' ' LYS . 76.5 p -117.51 166.25 12.58 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 111.826 0.306 . . . . 61.21 111.826 -173.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 72.1 -33.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.117 1.367 . . . . 64.53 112.97 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.0 mttm -85.76 146.1 42.98 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 115.238 -0.892 . . . . 62.05 111.726 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.97 158.91 48.97 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.409 2.74 . . . . 71.43 110.439 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -45.65 -47.24 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.112 1.152 . . . . 54.23 114.112 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.46 -48.2 74.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.673 0.67 . . . . 71.3 111.816 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.18 -45.54 73.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.663 -0.698 . . . . 74.52 112.418 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -67.32 -37.63 83.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.09 -0.504 . . . . 72.22 111.143 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.91 -37.56 72.96 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.242 -0.435 . . . . 73.32 111.091 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.317 6.2 ppt_? -66.51 -23.94 66.32 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.058 1.133 . . . . 73.42 114.058 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 14.1 mm-40 -79.22 -43.84 23.01 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.18 0.514 . . . . 75.05 110.839 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.94 -38.37 57.67 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 114.522 1.305 . . . . 73.44 114.522 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 8.0 mmt -55.58 -53.36 63.33 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 113.305 0.854 . . . . 55.4 113.305 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 59' ' ' MET . 10.4 Cg_endo -56.13 -31.73 84.29 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.005 1.803 . . . . 63.41 112.103 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 67.5 mttm -66.37 -39.94 89.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.901 0.381 . . . . 74.04 111.27 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -43.16 78.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 120.466 -0.493 . . . . 62.33 109.706 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.41 -35.02 78.45 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.262 0.838 . . . . 72.13 113.262 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -67.5 -40.86 85.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.357 -0.609 . . . . 74.1 109.357 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -60.97 -54.51 44.11 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.458 -0.792 . . . . 75.21 111.757 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.81 -5.81 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.169 0.433 . . . . 71.42 112.169 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.76 -36.64 10.15 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.949 -0.644 . . . . 71.52 112.254 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 148.26 2.22 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.542 -1.314 . . . . 45.24 113.618 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.3 m -85.77 11.92 10.08 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.495 1.14 . . . . 73.13 109.7 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' OD1' HG12 ' A' ' 74' ' ' VAL . 7.2 p30 -78.8 176.39 9.6 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.738 -1.119 . . . . 74.33 110.449 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.09 -33.16 73.08 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.06 0.457 . . . . 52.11 111.321 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -85.15 -13.86 48.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.45 0.643 . . . . 73.42 109.878 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.17 32.52 80.44 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.343 -0.844 . . . . 33.21 111.266 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.44 HG12 ' OD1' ' A' ' 70' ' ' ASN . 6.5 p -79.57 120.95 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 120.306 -0.558 . . . . 75.45 110.777 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.46 145.48 17.64 Favored Glycine 0 CA--C 1.481 -2.059 0 N-CA-C 109.447 -1.461 . . . . 74.15 109.447 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 53.7 ttp 59.3 79.81 0.21 Allowed 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.233 -1.395 . . . . 74.41 107.233 -171.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.88 -111.96 1.21 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.965 -1.112 . . . . 72.32 113.147 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.547 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 20.8 ptt? -132.91 128.44 36.54 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.271 -0.464 . . . . 71.13 111.689 -173.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 m -125.66 117.24 23.07 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 108.932 -0.766 . . . . 73.32 108.932 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.558 HG22 ' HD2' ' A' ' 81' ' ' PRO . 2.0 p -158.87 -178.52 0.91 Allowed Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 102.85 -3.018 . . . . 72.41 102.85 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 80' ' ' VAL . 92.8 Cg_exo -47.07 136.58 17.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 CA-C-N 123.085 2.137 . . . . 72.22 116.026 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.74 142.28 26.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 113.293 -1.776 . . . . 61.11 106.48 172.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.8 p -139.24 151.41 46.49 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.765 -0.374 . . . . 75.32 110.314 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.8 137.33 31.45 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 120.552 -0.459 . . . . 54.02 110.125 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.544 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.04 134.71 34.57 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 109.123 -0.695 . . . . 64.34 109.123 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 166' ' ' VAL . 33.8 m -122.6 149.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.613 -1.254 . . . . 72.31 107.613 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -119.96 100.86 48.14 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 107.428 -1.323 . . . . 74.0 107.428 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.03 135.42 12.35 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.034 1.823 . . . . 62.12 113.444 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -78.27 159.16 28.62 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.855 -1.535 . . . . 71.32 106.855 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.28 -31.77 67.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.486 0.66 . . . . 75.44 112.492 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.14 -5.17 40.17 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.98 -1.009 . . . . 72.31 112.027 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.02 63.28 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.65 -0.786 . . . . 52.25 111.908 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -84.23 119.49 25.1 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.799 -0.815 . . . . 62.1 108.799 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.42 82.87 5.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.606 0.717 . . . . 74.5 109.35 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 16.8 tm0? -147.52 130.43 16.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.819 -1.082 . . . . 70.24 108.828 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 86.0 mttt 161.17 -63.62 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 C-N-CA 127.59 2.356 . . . . 75.1 108.92 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -160.55 158.16 28.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.849 -1.537 . . . . 73.45 106.849 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 tt -141.69 127.45 19.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 107.221 -1.4 . . . . 72.4 107.221 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.552 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.9 mttt -113.1 114.93 27.53 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.851 -0.426 . . . . 74.1 109.851 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.1 t -87.87 132.94 31.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 108.434 -0.951 . . . . 62.51 108.434 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -124.03 117.99 25.97 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.865 -1.161 . . . . 73.22 107.865 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -102.54 121.12 41.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.487 -1.301 . . . . 45.54 107.487 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.508 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 60.1 ttt180 -78.75 131.53 36.6 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 115.291 -0.868 . . . . 71.22 108.981 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 40' ' ' LYS . 68.3 mt -93.53 129.6 38.05 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.926 -0.579 . . . . 75.25 110.15 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 48.0 Cg_endo -68.61 162.32 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.135 2.557 . . . . 73.2 112.24 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -47.45 -41.62 20.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.024 1.329 . . . . 74.33 113.877 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.49 -46.9 87.49 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.344 0.498 . . . . 62.35 112.344 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.58 -4.76 59.25 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.151 -0.477 . . . . 73.43 111.472 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.217 -0.66 . . . . 65.01 109.217 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.68 -26.41 60.92 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.179 -0.919 . . . . 64.02 111.824 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.9 t -174.87 99.63 0.27 Allowed Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 122.884 0.474 . . . . 54.13 109.878 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.93 157.73 1.77 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.65 2.233 . . . . 65.22 111.968 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -71.7 158.16 53.96 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 121.756 1.638 . . . . 75.03 110.6 172.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.87 59.02 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 110.334 -0.247 . . . . 73.1 110.334 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HB2' HG13 ' A' ' 120' ' ' VAL . 45.7 Cg_endo -68.46 106.86 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.78 2.32 . . . . 74.53 111.593 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -106.3 87.61 2.59 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.757 0.789 . . . . 61.11 111.505 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.817 ' HB3' HG12 ' A' ' 120' ' ' VAL . 17.8 t70 -176.34 155.8 1.5 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 104.961 -2.236 . . . . 64.04 104.961 173.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -12.32 60.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 115.07 1.507 . . . . 72.03 115.07 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.3 p -127.57 6.77 6.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.851 1.426 . . . . 73.42 114.851 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 117' ' ' ASP . 15.0 p -103.06 127.68 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.788 -0.819 . . . . 52.53 108.788 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.522 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 9.0 mmpt? -126.15 145.17 50.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.25 -0.648 . . . . 74.4 109.25 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.8 mm -92.59 111.67 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.612 -1.255 . . . . 73.22 107.612 172.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -125.55 139.27 53.74 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.682 -0.69 . . . . 74.42 109.864 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.77 139.3 43.78 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.155 -0.93 . . . . 73.44 109.745 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.521 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 49.4 mtp180 -133.43 136.44 45.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.07 0.462 . . . . 73.01 111.761 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 157.13 46.75 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.182 -0.917 . . . . 61.34 111.519 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.02 18.63 46.12 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.096 -0.574 . . . . 72.32 113.158 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.0 pt -121.97 145.4 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.678 -0.809 . . . . 63.34 111.966 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.8 m -106.16 131.4 53.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 106.594 -1.632 . . . . 72.1 106.594 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.01 150.41 28.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.583 -0.895 . . . . 70.42 108.583 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 13.1 m-85 -115.19 121.73 43.88 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.207 -1.775 . . . . 72.42 106.207 -177.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 53.8 p -120.55 132.52 55.21 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 120.043 -0.663 . . . . 74.41 112.263 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.553 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -113.41 135.76 53.52 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.36 -0.607 . . . . 75.42 109.36 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -109.55 127.75 54.7 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.023 -1.103 . . . . 53.23 108.023 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -130.6 168.4 17.16 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.447 -0.946 . . . . 64.21 108.447 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.27 165.58 29.92 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.074 -1.06 . . . . 63.34 112.002 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.17 -133.8 7.9 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 110.968 -0.853 . . . . 71.5 110.968 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -100.71 101.32 12.17 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.169 -1.419 . . . . 63.54 107.169 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.33 107.93 17.57 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.931 0.872 . . . . 15.24 112.514 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -99.63 169.29 9.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.42 -1.326 . . . . 73.32 107.42 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.63 -29.09 69.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.842 0.83 . . . . 72.25 109.389 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.61 -30.92 70.63 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.738 -1.119 . . . . 73.25 111.093 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.17 -36.87 84.23 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 120.383 0.135 . . . . 71.52 111.28 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -66.61 -41.07 89.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.916 -0.314 . . . . 74.34 110.633 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.63 -45.35 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 72.31 109.959 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.68 90.94 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.049 -0.523 . . . . 72.43 111.366 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.627 ' CD2' HG22 ' A' ' 29' ' ' VAL . 76.5 m80 -69.14 -32.96 72.68 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.096 -0.642 . . . . 73.33 111.733 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -66.84 -47.04 73.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.506 -0.315 . . . . 62.4 110.863 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 t -63.12 -38.14 89.99 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.931 -0.308 . . . . 70.45 111.682 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.77 -35.13 78.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 112.419 0.526 . . . . 53.53 112.419 176.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.1 mt -57.6 -36.87 72.32 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 120.846 0.355 . . . . 75.24 111.2 175.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 51.2 mtm180 -65.14 -36.56 84.62 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.547 -0.751 . . . . 72.14 110.076 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 m -75.82 -43.3 46.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.615 -0.721 . . . . 74.43 110.068 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 151' ' ' LEU . 60.1 p -71.93 -33.59 68.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.753 -0.658 . . . . 75.11 112.723 -174.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.75 9.59 7.65 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.061 0.763 . . . . 74.42 113.061 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 45.5 mt-10 -88.02 145.94 25.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.298 -1.001 . . . . 70.15 108.298 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.96 -9.86 63.85 Favored Glycine 0 C--N 1.302 -1.338 0 C-N-CA 120.647 -0.787 . . . . 74.23 111.404 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 14.0 t -122.03 149.32 53.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 107.2 -1.408 . . . . 63.41 107.2 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.79 34.67 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 123.84 3.027 . . . . 60.23 114.377 -175.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.32 136.06 39.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.966 0.412 . . . . 52.21 110.547 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 25.2 m -124.45 154.14 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.04 -1.096 . . . . 50.14 108.04 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.412 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 26.2 p90 -134.21 158.84 42.68 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.794 -0.447 . . . . 75.34 109.794 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -122.22 140.56 52.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.584 0.957 . . . . 75.15 113.584 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.78 30.17 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.066 -0.97 . . . . 60.11 113.968 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.9 t70 66.27 17.15 10.65 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 122.645 1.212 . . . . 72.24 108.439 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 86' ' ' VAL . 83.0 t -72.52 139.88 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 125.83 1.652 . . . . 64.31 111.731 -176.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -146.23 167.47 23.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.497 -0.774 . . . . 65.0 109.898 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.612 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 10.7 m-85 -115.42 152.77 32.28 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.799 -0.815 . . . . 70.02 108.799 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.1 m -114.65 129.63 56.7 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 106.477 -1.675 . . . . 71.43 106.477 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.61 157.12 42.96 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.098 0.475 . . . . 71.35 111.91 -175.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . . . . . . 0 N--CA 1.429 -1.825 0 N-CA-C 108.553 -1.819 . . . . 64.11 108.553 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.697 0.284 . . . . 64.42 110.591 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.403 -0.592 . . . . 63.42 109.403 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -141.59 153.46 44.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.394 -1.706 . . . . 71.33 106.394 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 133' ' ' THR . 47.2 mt-10 -125.63 154.25 42.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.954 0.724 . . . . 61.31 112.954 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 132' ' ' SER . 51.9 t -125.45 118.9 53.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.742 -1.577 . . . . 74.15 106.742 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.9 m0 -103.73 121.15 42.4 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.027 -0.731 . . . . 65.24 109.027 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.0 tp -97.86 138.78 34.7 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.654 -1.61 . . . . 70.1 106.654 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.64 135.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.645 -0.422 . . . . 73.0 111.894 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.3 ptmm? -65.5 143.29 57.75 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.614 -0.721 . . . . 75.23 111.595 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.412 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.188 -1.042 . . . . 45.2 108.188 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.1 p90 . . . . . 0 N--CA 1.432 -1.368 0 N-CA-C 107.787 -1.19 . . . . 63.4 107.787 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 108.31 19.75 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.595 -0.729 . . . . 74.3 109.202 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.6 131.37 41.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 116.085 -0.507 . . . . 73.13 110.443 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 22' ' ' SER . 4.1 pp -90.85 -34.99 15.05 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.657 -0.817 . . . . 74.13 112.431 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.445 ' N ' HD12 ' A' ' 21' ' ' LEU . 32.6 t -177.65 164.76 2.05 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.789 -0.819 . . . . 74.53 108.789 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -131.26 156.34 45.58 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.972 -1.122 . . . . 70.4 107.972 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.0 -158.94 31.66 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.582 -1.294 . . . . 71.31 112.42 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.58 -116.59 3.16 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 121.192 -0.528 . . . . 62.13 111.794 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -108.19 171.29 7.49 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.695 0.798 . . . . 72.11 109.853 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.67 140.85 35.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 106.44 -1.689 . . . . 74.35 106.44 172.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 77.3 -53.92 0.55 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.69 1.196 . . . . 72.14 110.47 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 147' ' ' HIS . 21.9 t -97.96 108.27 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.164 -1.421 . . . . 75.13 107.164 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 133' ' ' THR . 50.3 m -130.52 140.85 50.49 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.261 -1.014 . . . . 71.22 108.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' SER . 1.6 p90 -112.15 161.46 16.52 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.075 0.464 . . . . 70.51 112.151 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.541 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -133.13 126.19 31.17 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.456 -1.313 . . . . 74.41 107.456 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.33 112.82 26.07 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.031 -1.47 . . . . 54.51 107.031 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 13.4 ptt180 -144.04 159.23 42.97 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 119.853 -0.739 . . . . 73.23 110.327 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.19 136.9 33.78 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.958 -1.497 . . . . 43.2 106.958 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.43 151.59 43.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.097 0.475 . . . . 73.55 111.122 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -67.62 -21.09 65.41 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.364 -0.834 . . . . 72.4 112.898 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 74.49 9.49 81.91 Favored Glycine 0 CA--C 1.51 -0.235 0 C-N-CA 119.873 -1.156 . . . . 72.11 113.926 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.61 165.25 53.66 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.947 -0.644 . . . . 71.14 113.574 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -93.95 135.66 35.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.21 -0.663 . . . . 65.13 109.21 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 63.1 m-85 -136.59 165.92 24.75 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.688 0.618 . . . . 74.14 110.815 -172.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.73 118.95 35.41 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.236 -1.024 . . . . 72.34 108.236 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.7 t -128.49 154.12 46.44 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 113.174 0.805 . . . . 71.21 113.174 -172.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 119' ' ' SER . 97.1 t -129.08 132.94 66.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.989 1.315 . . . . 63.43 108.63 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.38 126.67 55.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.653 0.263 . . . . 55.11 110.503 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 45.1 t -127.33 127.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.942 -1.503 . . . . 65.33 106.942 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -120.34 162.99 18.52 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.563 -0.532 . . . . 72.22 109.563 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 75.58 -31.81 0.21 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.985 1.314 . . . . 73.11 112.362 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -85.4 146.6 44.98 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.795 -0.639 . . . . 54.32 110.663 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.5 156.86 39.32 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.853 2.369 . . . . 54.3 111.113 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.52 HG13 HD12 ' A' ' 98' ' ' LEU . 37.2 t -47.8 -48.08 11.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.908 1.077 . . . . 72.43 113.908 -177.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 33.2 t70 -59.51 -49.64 76.98 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.47 -0.492 . . . . 75.24 110.832 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -61.96 -48.19 81.47 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.662 0.616 . . . . 72.11 112.662 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -60.59 -38.65 85.36 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 123.612 0.57 . . . . 54.53 110.778 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' O ' ' HG2' ' A' ' 59' ' ' MET . 65.3 tp -66.48 -42.53 87.31 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.081 -0.509 . . . . 71.13 110.302 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 20.0 mmm180 -59.43 -45.31 91.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.861 0.363 . . . . 73.53 110.595 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -66.69 -37.43 84.72 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.336 -0.847 . . . . 74.21 111.34 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.57 59.97 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.274 0.842 . . . . 74.22 113.274 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 3.2 mmt -48.32 -57.69 10.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.254 1.205 . . . . 54.0 114.254 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.55 -32.12 88.82 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.749 2.299 . . . . 63.53 112.384 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.06 -47.48 68.2 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.329 -0.619 . . . . 72.31 109.329 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.88 -38.08 79.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.901 -0.59 . . . . 75.42 110.303 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 59' ' ' MET . 9.7 mmt -66.36 -37.36 85.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 73.44 112.031 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -72.98 -33.71 66.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.699 -0.401 . . . . 71.05 110.807 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.71 -60.08 4.23 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 116.431 -0.35 . . . . 61.2 111.246 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 76' ' ' MET . 6.4 p -73.48 -25.27 20.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 120.864 0.364 . . . . 74.54 110.542 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.49 -25.05 66.56 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.261 -0.427 . . . . 45.04 113.249 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 -0.58 2.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.781 -1.2 . . . . 72.31 113.494 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -91.2 29.74 1.37 Allowed 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.609 1.195 . . . . 50.22 109.431 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.07 159.87 14.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.596 -0.891 . . . . 52.03 108.596 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 23.2 t70 -70.8 -28.04 64.34 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.081 0.4 . . . . 72.32 112.081 -172.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.84 -12.34 59.97 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.192 -0.67 . . . . 74.43 109.192 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.61 33.25 75.94 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.158 -0.928 . . . . 64.42 112.813 177.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.58 126.93 40.25 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.78 -0.768 . . . . 72.14 111.331 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.86 92.45 1.54 Allowed Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.281 -1.127 . . . . 41.32 110.281 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 56.0 ttp 70.62 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.771 1.228 . . . . 71.1 110.535 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.52 -55.62 0.68 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.837 0.695 . . . . 74.13 114.837 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.412 ' SD ' HG23 ' A' ' 104' ' ' ILE . 21.6 ptt? -124.75 126.24 45.33 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.5 m -126.1 124.5 40.72 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.33 109.652 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -165.7 145.5 5.44 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 107.465 -1.309 . . . . 72.2 107.465 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -35.61 139.98 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.177 3.251 . . . . 64.4 115.767 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.27 150.06 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 113.485 -1.689 . . . . 74.1 106.5 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 m -138.61 145.08 40.11 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.467 -0.568 . . . . 72.22 109.467 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 42.9 p90 -136.53 143.69 43.86 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.463 -0.495 . . . . 64.15 111.358 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.87 34.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.678 -0.86 . . . . 75.44 108.678 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.98 150.95 30.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.188 -0.915 . . . . 63.31 109.291 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.537 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 1.9 m-85 -117.36 102.28 52.31 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 109.231 -0.655 . . . . 64.44 109.231 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -88.67 146.8 5.91 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.235 1.957 . . . . 75.32 112.693 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.54 152.66 18.23 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.988 -1.856 . . . . 63.14 105.988 171.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.268 11.3 pt-20 -64.53 -13.36 52.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 115.683 1.734 . . . . 70.44 115.683 -172.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.6 -6.25 59.25 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 121.609 0.718 . . . . 61.02 109.866 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.22 5.14 54.84 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 72.04 112.941 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 m -83.99 126.42 33.01 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.489 -0.56 . . . . 50.22 109.489 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 78.0 mt -94.04 78.58 4.08 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.923 0.392 . . . . 63.41 111.095 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.1 tt0 -149.25 115.29 5.73 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.949 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 95.1 mttt -176.75 -62.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.278 1.831 . . . . 73.51 108.648 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.537 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 38.5 ttmt -161.31 155.0 21.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.299 -1.0 . . . . 53.12 108.299 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.52 HD12 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -143.76 143.38 31.35 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.331 -0.618 . . . . 72.53 109.331 173.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -136.92 115.47 11.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.636 -0.505 . . . . 73.0 109.636 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' THR . 84.0 t -92.15 129.88 42.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 N-CA-C 109.785 -0.45 . . . . 43.33 109.785 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.422 ' HE3' ' HB2' ' A' ' 41' ' ' PHE . 89.8 m95 -112.72 128.15 56.33 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.941 -0.763 . . . . 75.11 108.941 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -103.26 123.62 47.1 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.969 -1.123 . . . . 75.03 107.969 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.451 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 68.4 mtt-85 -75.49 132.22 40.63 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.503 0.927 . . . . 73.33 113.503 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.412 HG23 ' SD ' ' A' ' 78' ' ' MET . 72.1 mt -102.11 122.77 45.78 Favored Pre-proline 0 N--CA 1.398 -3.041 0 N-CA-C 105.98 -1.859 . . . . 74.33 105.98 172.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.16 152.01 62.75 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.236 1.958 . . . . 62.31 110.733 175.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -48.12 -37.33 15.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.564 0.746 . . . . 62.34 112.848 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.75 -31.87 70.04 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.502 0.721 . . . . 75.23 112.225 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -100.29 -8.45 23.42 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 112.498 0.555 . . . . 64.43 112.498 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -70.75 -29.24 65.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.641 1.349 . . . . 63.31 114.641 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.11 -38.59 94.1 Favored Glycine 0 C--O 1.241 0.587 0 C-N-CA 120.029 -1.082 . . . . 61.21 111.514 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -142.92 85.81 9.72 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 108.26 -1.015 . . . . 72.01 108.26 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -88.34 159.82 6.83 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.886 1.724 . . . . 73.23 112.824 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.28 130.27 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.478 2.119 . . . . 71.31 110.802 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -70.03 138.73 87.5 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 109.287 -0.634 . . . . 60.52 109.287 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 73.1 Cg_endo -77.27 111.3 3.16 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.155 1.904 . . . . 51.13 112.074 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -98.69 79.23 2.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.806 -0.813 . . . . 74.12 108.806 177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -173.89 150.26 1.63 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.792 -1.188 . . . . 72.35 107.792 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -76.27 -24.2 54.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.214 0.82 . . . . 73.21 113.214 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 44' ' ' VAL . 60.4 m -92.6 -26.21 17.97 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.57 -0.452 . . . . 73.31 110.799 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 26.8 t -94.35 118.35 40.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.849 -0.426 . . . . 75.32 109.849 -175.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -128.73 147.63 50.78 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.471 -0.937 . . . . 71.33 108.471 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.1 mm -92.71 112.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.24 -1.022 . . . . 53.44 108.24 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -122.06 149.7 43.16 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.942 -0.572 . . . . 74.44 109.769 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.74 152.52 24.24 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.814 -0.63 . . . . 62.04 109.821 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.503 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 65.0 ttt180 -151.57 123.25 7.96 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.821 -0.807 . . . . 71.34 108.821 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -138.39 166.92 23.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.545 -0.539 . . . . 72.23 109.545 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.44 61.01 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.431 -1.366 . . . . 73.23 113.282 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.6 pt -119.28 151.93 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.347 -0.941 . . . . 74.43 112.166 -175.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 92.9 m -105.78 123.35 47.81 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.943 -1.48 . . . . 73.43 107.788 178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.52 146.66 30.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 116.01 -0.541 . . . . 64.3 110.632 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 39.9 m-85 -114.47 121.92 45.0 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.707 -1.96 . . . . 73.22 105.707 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 31' ' ' TYR . 56.1 p -122.41 139.16 54.17 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 119.832 -0.747 . . . . 43.44 111.193 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.8 t -113.51 133.19 55.37 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 120.574 -0.451 . . . . 40.14 109.932 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -110.91 125.33 53.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.514 -1.291 . . . . 64.21 107.514 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.68 158.08 44.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.463 -0.199 . . . . 65.41 110.463 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -137.06 154.54 22.32 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 123.973 0.796 . . . . 74.31 111.372 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.09 -142.37 11.73 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 109.009 -1.637 . . . . 63.43 109.009 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -100.43 118.95 37.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 118.239 1.02 . . . . 63.2 108.964 174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.53 133.41 55.4 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.611 0.72 . . . . 63.3 112.177 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -112.64 177.37 4.66 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.419 -1.697 . . . . 73.32 106.419 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.55 78.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.346 0.594 . . . . 60.35 110.817 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.65 -29.29 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 74.33 111.77 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.24 -30.23 70.09 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 111.879 0.325 . . . . 64.04 111.879 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.88 -48.94 69.85 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.728 -0.841 . . . . 75.03 108.728 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.03 -41.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.841 -1.072 . . . . 54.4 110.185 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.71 88.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.841 -0.618 . . . . 63.12 110.521 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.428 ' CD2' HG22 ' A' ' 29' ' ' VAL . 62.8 m80 -66.63 -32.36 73.63 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 112.827 0.677 . . . . 75.35 112.827 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.68 -47.31 84.93 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.105 0.478 . . . . 64.53 109.921 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -65.03 -46.87 79.48 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.628 -0.715 . . . . 65.05 110.447 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.06 -40.82 86.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.118 -0.492 . . . . 74.43 111.318 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 187' ' ' LEU . 1.5 tt -62.72 -46.07 89.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.828 -1.175 . . . . 72.31 107.828 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -64.09 -39.47 94.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.068 -0.969 . . . . 74.03 110.451 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.9 m -68.55 -33.09 73.48 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.312 0.577 . . . . 72.4 110.257 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -73.02 -33.51 65.78 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.37 0.605 . . . . 74.34 109.702 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 158' ' ' THR . 98.6 mt -81.1 9.2 7.06 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.998 -0.546 . . . . 71.34 111.486 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.96 134.08 35.64 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 71.22 106.91 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.89 57.28 Favored Glycine 0 C--N 1.307 -1.028 0 C-N-CA 121.211 -0.518 . . . . 61.51 112.551 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 155' ' ' LEU . 15.3 t -125.41 146.24 53.72 Favored Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 106.879 -1.526 . . . . 72.43 106.879 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.83 34.79 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 123.744 2.963 . . . . 60.15 114.676 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.64 43.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.446 -0.576 . . . . 64.33 109.446 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 19.6 p -114.91 158.66 21.68 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.364 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -136.23 152.36 50.66 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.615 -0.883 . . . . 64.42 108.615 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -113.02 111.34 22.0 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.262 0.838 . . . . 70.02 113.262 178.164 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.53 4.71 46.81 Favored Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 115.658 -0.701 . . . . 61.1 112.495 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 17.8 t70 63.83 15.75 9.3 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.813 1.245 . . . . 74.54 109.565 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.14 151.56 7.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 CA-C-O 121.205 0.526 . . . . 72.44 110.516 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -146.1 170.64 16.28 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.599 -0.728 . . . . 70.14 111.215 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.494 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 97.6 m-85 -115.15 152.28 32.88 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.64 -0.504 . . . . 55.21 109.64 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.03 137.75 53.67 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.757 -1.201 . . . . 62.33 107.757 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.73 150.03 32.13 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 111.896 0.332 . . . . 73.1 111.896 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.748 0 N-CA-C 107.871 -2.092 . . . . 71.51 107.871 179.608 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 . . . . . 0 CA--C 1.498 -1.041 0 CA-C-O 120.729 0.299 . . . . 65.21 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -133.8 128.16 34.19 Favored 'General case' 0 CA--C 1.469 -2.143 0 CA-C-O 121.459 0.647 . . . . 70.3 111.231 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -144.86 134.59 23.51 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 103.743 -2.688 . . . . 75.52 103.743 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 186' ' ' TRP . 2.7 mp0 -115.71 137.22 52.3 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 119.261 -0.976 . . . . 73.54 110.334 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 89.8 t -124.99 121.06 60.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.636 -1.246 . . . . 54.23 107.636 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.502 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 6.8 m0 -119.31 120.96 38.51 Favored 'General case' 0 C--O 1.197 -1.682 0 CA-C-O 119.129 -0.462 . . . . 72.43 110.929 -174.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 151' ' ' LEU . 9.2 mp -96.95 138.83 33.88 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.822 -1.177 . . . . 73.22 107.822 171.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.16 131.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 120.323 -0.551 . . . . 74.22 110.681 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 161' ' ' THR . 4.5 tmtm? -73.46 130.74 40.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.519 -0.764 . . . . 60.13 109.997 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.252 1.199 0 CA-C-N 115.734 -0.666 . . . . 52.13 111.054 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 39.1 p90 . . . . . 0 N--CA 1.435 -1.205 0 N-CA-C 107.056 -1.461 . . . . 70.42 107.056 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -126.81 122.53 35.02 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.92 -1.112 . . . . 74.1 111.73 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.92 121.16 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 106.966 -1.494 . . . . 52.43 106.966 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.56 -33.41 15.91 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.59 -0.444 . . . . 65.04 111.044 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 46.8 t -162.26 149.86 14.14 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.401 0.619 . . . . 40.12 110.806 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.1 p -133.29 166.71 21.87 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 125.05 1.34 . . . . 73.41 108.255 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.01 76.76 0.4 Allowed Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 119.513 -1.327 . . . . 73.32 112.961 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.18 -160.34 22.45 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.226 -0.988 . . . . 74.02 111.659 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -89.96 170.58 10.25 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.781 -1.192 . . . . 73.2 107.781 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.22 148.27 51.07 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 119.652 -0.819 . . . . 63.53 109.91 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.0 t70 77.43 -62.23 0.39 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.425 1.49 . . . . 62.42 110.791 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.76 110.06 29.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.369 -0.974 . . . . 60.2 108.369 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -118.88 154.44 32.93 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.461 -0.94 . . . . 55.44 108.461 -176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.594 ' HB3' HD11 ' A' ' 151' ' ' LEU . 5.7 p90 -117.28 152.19 35.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.214 -1.394 . . . . 71.44 113.868 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -135.18 124.75 25.07 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.527 -2.027 . . . . 75.11 105.527 172.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.412 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 32.3 mt-10 -106.31 118.38 36.48 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.2 107.571 -177.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -139.04 148.34 43.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.512 0.93 . . . . 74.22 113.512 -175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.59 136.41 34.82 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.082 -1.451 . . . . 62.52 107.082 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.632 ' SG ' HG13 ' A' ' 128' ' ' ILE . 99.1 m -63.49 142.9 58.22 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.644 0.979 . . . . 70.34 113.644 -176.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -47.98 -48.25 32.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.827 1.251 . . . . 54.32 112.323 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.01 69.91 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 110.747 -0.941 . . . . 51.11 110.747 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.23 165.75 53.37 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 111.214 -0.754 . . . . 63.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 137.24 32.51 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.921 -0.311 . . . . 70.45 110.763 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.541 ' HE1' HE22 ' A' ' 109' ' ' GLN . 53.9 m-85 -135.34 164.22 28.23 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.766 0.827 . . . . 75.13 109.403 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.51 116.51 31.8 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.135 -0.691 . . . . 72.52 109.135 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -119.91 138.98 53.1 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 112.621 0.6 . . . . 74.13 112.621 -175.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.498 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 11.5 m -130.44 124.95 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.425 1.09 . . . . 60.42 110.393 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.55 139.06 45.01 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.086 -0.646 . . . . 64.12 112.281 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 39.4 t -126.38 141.33 46.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 N-CA-C 108.465 -0.939 . . . . 64.31 108.465 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -127.83 174.89 8.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 122.859 0.463 . . . . 71.35 110.13 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.51 -34.28 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.122 0.969 . . . . 73.33 113.202 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 3.5 mppt? -100.57 138.78 20.22 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 112.143 0.424 . . . . 62.45 112.143 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.73 159.76 4.59 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 124.589 3.526 . . . . 73.01 111.841 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.613 HG13 HD12 ' A' ' 98' ' ' LEU . 52.6 t -46.14 -48.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.708 0.803 . . . . 72.51 113.043 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.99 -45.18 91.27 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.423 0.63 . . . . 70.41 110.744 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 23.1 mm-40 -75.06 -31.84 61.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.986 -1.006 . . . . 74.11 112.585 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -73.0 -44.84 60.57 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.512 0.673 . . . . 71.12 109.669 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.304 -0.862 . . . . 62.3 111.309 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 17.0 ptm180 -64.09 -26.6 68.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 116.564 -0.289 . . . . 71.41 111.645 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 51.9 mt-10 -84.72 -41.75 15.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.982 0.42 . . . . 72.11 111.181 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.09 69.42 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.271 0.841 . . . . 74.1 113.271 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.484 ' HB2' ' HD3' ' A' ' 60' ' ' PRO . 6.6 mmt -56.07 -53.56 62.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.205 -0.426 . . . . 71.32 111.711 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 34.5 Cg_exo -55.87 -31.89 82.98 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.348 2.032 . . . . 74.35 112.129 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 43.0 mtmt -73.04 -31.02 64.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.626 -0.43 . . . . 54.55 111.589 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 66' ' ' VAL . 35.4 mm -74.34 -43.4 49.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.409 -0.96 . . . . 74.22 108.409 171.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 59' ' ' MET . 19.3 mmt -56.26 -37.73 70.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.854 0.686 . . . . 74.01 112.854 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.4 -47.62 72.69 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.439 -0.504 . . . . 72.1 110.74 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.88 -58.03 6.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.134 -0.485 . . . . 74.52 111.767 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -68.88 -17.38 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 64.34 110.897 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.62 -19.78 65.3 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.88 -0.6 . . . . 32.34 112.82 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.72 -22.28 0.4 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.096 -1.526 . . . . 51.04 113.968 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -79.37 58.02 2.5 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.439 1.114 . . . . 73.01 111.338 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -99.88 160.28 14.43 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.325 -1.361 . . . . 74.35 107.325 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -69.2 -33.57 73.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.597 0.635 . . . . 70.21 110.278 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -80.41 -9.58 59.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.746 . . . . 73.52 110.327 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.78 62.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.642 -0.708 . . . . 60.31 112.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 m -82.97 159.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 108.11 -1.07 . . . . 73.31 108.11 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -170.89 12.28 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 119.082 -1.532 . . . . 62.45 113.733 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.0 mtp 70.69 101.96 0.06 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.379 1.472 . . . . 72.24 110.466 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 66' ' ' VAL . . . -54.44 122.1 22.97 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.817 -1.083 . . . . 33.44 114.385 -174.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -96.31 126.89 41.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.645 -0.872 . . . . 72.31 108.645 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 m -123.77 123.94 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.435 0.636 . . . . 72.34 111.838 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.14 176.72 2.28 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 104.202 -2.518 . . . . 70.01 104.202 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -62.53 139.08 74.15 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 CA-C-N 121.494 1.569 . . . . 33.52 112.293 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 8.8 p -110.47 148.88 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.806 -1.183 . . . . 54.22 107.806 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 47.0 p -125.72 145.36 50.22 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 121.164 -0.214 . . . . 62.52 110.658 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -139.75 148.12 41.82 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.617 -0.433 . . . . 71.41 110.621 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.09 135.36 34.04 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.634 0.584 . . . . 73.12 110.019 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.27 151.07 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.001 -1.0 . . . . 73.23 109.577 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 76.4 m-85 -118.12 110.45 39.69 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 110.253 -0.277 . . . . 75.43 110.253 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.78 137.03 9.78 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 121.5 1.467 . . . . 64.33 110.989 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -82.77 179.31 7.82 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.745 -0.835 . . . . 75.25 108.745 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.2 -36.32 77.4 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.763 0.792 . . . . 72.44 109.807 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.31 -5.42 52.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.284 -1.325 . . . . 71.41 112.777 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.55 -4.03 83.74 Favored Glycine 0 CA--C 1.501 -0.829 0 C-N-CA 120.378 -0.915 . . . . 75.33 112.718 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.1 p -74.64 146.92 42.02 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.001 -0.741 . . . . 72.41 109.001 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.64 132.6 35.18 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.149 0.499 . . . . 73.52 110.879 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -87.35 150.95 23.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 75.44 109.923 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -74.63 77.37 2.01 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.934 1.087 . . . . 70.25 113.934 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.68 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -165.49 122.89 1.5 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 104.21 -2.515 . . . . 73.22 104.21 173.116 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.68 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 5.7 tt -143.88 145.26 32.18 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 121.078 -0.249 . . . . 70.12 110.571 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -142.1 130.24 22.09 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.404 -0.518 . . . . 73.24 110.726 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.8 t -91.85 139.28 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.228 -0.896 . . . . 52.1 109.944 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.265 -1.383 . . . . 75.15 107.265 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HA ' HG23 ' A' ' 82' ' ' VAL . 88.5 t80 -102.2 114.31 28.36 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.495 -0.928 . . . . 73.21 108.495 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -75.54 113.14 12.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.105 -1.443 . . . . 71.32 107.105 -175.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -78.3 135.26 61.77 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 112.276 0.473 . . . . 61.14 112.276 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.23 157.83 13.3 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.416 2.744 . . . . 73.2 112.127 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -54.59 -45.94 73.69 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.155 1.168 . . . . 62.52 114.155 -171.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -59.85 -37.92 80.66 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.214 0.531 . . . . 71.3 111.785 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.44 -3.15 57.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.696 0.628 . . . . 71.44 112.696 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.541 HE22 ' HE1' ' A' ' 41' ' ' PHE . 20.4 mm-40 -71.51 -33.73 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.184 -1.006 . . . . 75.53 109.91 172.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 -34.75 55.78 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.024 -0.535 . . . . 61.31 112.187 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.6 t -142.72 89.09 8.27 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 108.283 -1.006 . . . . 50.35 108.283 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 73.5 Cg_endo -87.18 141.18 5.87 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.914 1.743 . . . . 73.13 110.977 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 12.5 Cg_exo -71.25 154.67 61.5 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 121.705 1.603 . . . . 64.53 110.448 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.38 143.12 55.24 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.376 -0.972 . . . . 72.12 108.376 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.82 110.71 2.84 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.045 1.83 . . . . 71.12 111.643 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.2 t -72.76 -22.17 60.9 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.575 -0.738 . . . . 44.1 110.548 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.58 144.23 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.635 -0.876 . . . . 65.43 108.635 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.92 -33.14 74.12 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.224 0.824 . . . . 71.15 113.224 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.1 p -90.36 -12.13 38.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.991 0.424 . . . . 72.21 111.944 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.31 123.21 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.454 -2.054 . . . . 74.44 105.454 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -128.39 138.28 52.27 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.249 -0.58 . . . . 75.23 110.57 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 25.3 mm -92.01 109.49 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.541 -1.652 . . . . 62.22 106.541 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -129.87 153.14 48.59 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.395 -0.821 . . . . 63.05 109.176 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.27 137.58 54.8 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 109.501 -0.555 . . . . 73.1 109.501 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.94 127.48 28.77 Favored 'General case' 0 N--CA 1.426 -1.659 0 C-N-CA 120.555 -0.458 . . . . 61.34 111.413 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.17 175.57 9.44 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.398 -0.964 . . . . 73.12 108.398 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.71 46.11 Favored Glycine 0 C--N 1.306 -1.083 0 C-N-CA 120.836 -0.697 . . . . 72.1 111.758 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.632 HG13 ' SG ' ' A' ' 36' ' ' CYS . 36.2 pt -132.99 146.51 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.088 0.47 . . . . 75.34 110.801 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.2 m -104.06 135.16 46.08 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.98 -1.489 . . . . 61.31 106.98 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 m -123.66 145.97 29.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.355 -0.609 . . . . 71.52 109.355 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -113.48 122.53 47.57 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 105.923 -1.88 . . . . 61.53 105.923 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.7 m -110.1 146.59 35.16 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 115.867 -0.606 . . . . 73.11 110.916 -173.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.499 HG22 ' HB ' ' A' ' 185' ' ' VAL . 9.9 t -133.62 124.89 27.61 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.327 -0.619 . . . . 71.34 109.327 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -111.23 126.36 54.79 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 121.424 0.63 . . . . 74.15 109.505 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 37.3 p90 -137.24 167.43 21.59 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.974 -1.012 . . . . 72.02 109.314 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -120.62 123.21 5.5 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.09 -1.204 . . . . 22.31 110.09 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 167.03 170.84 32.43 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 111.345 -0.702 . . . . 62.3 111.345 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -93.11 100.26 12.69 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.664 -0.865 . . . . 63.21 108.664 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.69 132.2 43.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.32 0.859 . . . . 55.33 113.32 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.06 177.15 5.03 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.27 -36.49 73.34 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.729 0.3 . . . . 65.25 111.262 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.23 81.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.353 -0.385 . . . . 63.53 110.297 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.9 -42.51 99.8 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.773 -0.454 . . . . 61.54 109.773 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.759 ' HA ' ' NE2' ' A' ' 147' ' ' HIS . 63.9 m-85 -56.95 -43.96 82.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 123.365 0.416 . . . . 73.44 112.108 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.11 -49.29 77.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 123.753 0.658 . . . . 64.13 110.305 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.62 -48.27 77.85 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.778 -0.646 . . . . 74.32 112.062 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.759 ' NE2' ' HA ' ' A' ' 144' ' ' TYR . 3.2 p-80 -72.46 -32.0 65.89 Favored 'General case' 0 C--O 1.205 -1.271 0 N-CA-C 113.067 0.765 . . . . 60.3 113.067 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.31 80.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.147 0.498 . . . . 64.44 110.651 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.4 t -76.53 -32.02 57.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 120.127 -0.629 . . . . 71.21 109.758 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.96 -34.3 78.11 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 116.379 -0.373 . . . . 75.4 110.298 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 31' ' ' TYR . 57.9 tp -62.61 -41.78 99.2 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.531 -0.544 . . . . 74.23 109.531 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -62.25 -36.99 83.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.447 0.642 . . . . 65.32 110.165 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 41.1 m -72.6 -30.18 64.14 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 115.153 -0.93 . . . . 53.21 110.105 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.7 m -75.12 -33.35 61.57 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.473 0.709 . . . . 72.02 109.834 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.9 mt -72.8 13.25 0.4 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.295 1.438 . . . . 75.23 111.76 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 153' ' ' THR . 44.6 tt0 -51.11 124.24 11.08 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.481 1.112 . . . . 73.31 110.357 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.54 60.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.736 -0.745 . . . . 62.31 113.724 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 81.0 p -93.23 154.41 41.51 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 117.565 0.682 . . . . 65.14 109.742 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.86 25.7 0.69 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.676 2.251 . . . . 64.33 110.897 175.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.03 138.81 39.81 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.835 -0.62 . . . . 71.32 110.753 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.5 p -110.8 149.84 29.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.356 -0.609 . . . . 71.05 109.356 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -143.75 161.51 38.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.88 -0.785 . . . . 72.43 108.88 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.414 ' O ' HG12 ' A' ' 166' ' ' VAL . 27.8 pt20 -131.65 109.65 10.36 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.235 -0.586 . . . . 75.52 111.825 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.57 62.69 Favored Glycine 0 C--N 1.315 -0.628 0 C-N-CA 120.617 -0.802 . . . . 54.25 114.141 171.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 61.04 23.15 13.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.032 0.533 . . . . 65.11 111.185 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 163' ' ' GLN . 9.8 p -63.59 138.16 23.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 N-CA-C 109.274 -0.639 . . . . 42.43 109.274 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.405 ' HB3' HD23 ' A' ' 187' ' ' LEU . 40.6 p90 -147.2 174.61 11.45 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 121.447 0.641 . . . . 74.31 111.192 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -116.98 150.32 38.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.714 -1.13 . . . . 74.52 109.17 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 83' ' ' SER . 34.7 t -113.29 120.32 40.74 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.291 -1.003 . . . . 73.13 108.291 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 82' ' ' VAL . . . -120.62 131.79 54.8 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.446 0.466 . . . . 74.2 111.604 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.441 0 N-CA-C 108.098 -2.001 . . . . 74.22 108.098 179.511 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.49 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 2.6 tmm_? . . . . . 0 C--O 1.217 -0.623 0 N-CA-C 109.238 -0.653 . . . . 72.34 109.238 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -113.13 131.21 55.93 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.508 -0.477 . . . . 73.31 110.247 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -131.62 161.74 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.831 -0.803 . . . . 74.24 108.831 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 133' ' ' THR . 43.4 tt0 -125.27 139.23 53.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.38 -1.341 . . . . 72.54 107.38 174.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.719 HG21 ' CD2' ' A' ' 147' ' ' HIS . 59.4 t -126.7 131.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.906 -0.775 . . . . 71.52 108.906 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 36.3 m0 -111.08 123.19 49.7 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 123.322 0.389 . . . . 74.03 110.444 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 167' ' ' TYR . 91.0 mt -96.5 128.08 43.1 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.413 -1.699 . . . . 44.55 106.413 169.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.016 -0.674 . . . . 74.41 111.75 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 161' ' ' THR . 52.2 tttp -63.69 127.63 32.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.563 -1.198 . . . . 71.33 111.753 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 108.825 -0.806 . . . . 64.11 108.825 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 43.8 p90 . . . . . 0 N--CA 1.426 -1.633 0 N-CA-C 104.872 -2.269 . . . . 54.2 104.872 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 6.2 tp-100 -106.05 109.03 20.84 Favored 'General case' 0 C--N 1.279 -2.488 0 C-N-CA 118.052 -1.459 . . . . 63.53 111.177 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.485 HG22 ' HG2' ' A' ' 34' ' ' ARG . 48.1 t -91.28 115.54 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 103.299 -2.852 . . . . 75.04 103.299 169.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.98 -23.77 22.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.925 -1.51 . . . . 54.4 111.339 -171.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -174.83 168.0 3.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.427 -0.583 . . . . 63.02 109.427 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 32' ' ' GLU . 72.8 p -133.74 145.7 50.08 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.089 -1.078 . . . . 63.33 108.089 170.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.2 -139.43 6.11 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 118.997 -1.573 . . . . 45.32 113.648 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.0 -112.57 4.47 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.947 -0.861 . . . . 44.31 110.947 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HG3' HG23 ' A' ' 154' ' ' THR . 8.6 mtpm? -113.52 170.32 8.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.03 -0.359 . . . . 72.2 110.03 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -83.97 157.53 21.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.027 -1.101 . . . . 55.21 108.027 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 75.88 -61.8 0.45 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.459 1.104 . . . . 70.31 110.444 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.77 110.14 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.153 -1.795 . . . . 40.44 106.153 171.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.0 p -122.57 155.05 37.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.544 -0.753 . . . . 63.23 109.065 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.521 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -114.98 153.21 31.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 113.155 0.798 . . . . 73.04 113.155 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.589 ' OE2' ' HD2' ' A' ' 34' ' ' ARG . 35.9 tt0 -135.35 123.35 22.74 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.216 -2.142 . . . . 61.3 105.216 173.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -109.95 125.2 52.6 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.105 0.955 . . . . 74.24 111.026 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.589 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 16.4 mtp180 -127.5 140.48 52.11 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.347 -1.297 . . . . 62.31 110.414 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.11 40.5 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.515 -1.291 . . . . 75.45 107.515 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.2 m -58.94 146.05 39.27 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.794 0.683 . . . . 61.12 111.604 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -87.41 -19.43 28.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.371 -0.377 . . . . 64.23 110.054 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 98.69 11.63 46.62 Favored Glycine 0 CA--C 1.489 -1.586 0 C-N-CA 119.423 -1.37 . . . . 55.41 111.824 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 160.0 53.61 Favored Glycine 0 N--CA 1.426 -2.006 0 C-N-CA 120.522 -0.847 . . . . 71.42 112.133 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.569 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.3 ptmt -95.9 128.93 43.21 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 109.748 -0.464 . . . . 64.34 109.748 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.8 m-85 -127.17 163.81 23.03 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.977 -0.556 . . . . 75.24 110.985 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.17 116.73 32.05 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.075 -1.083 . . . . 52.33 108.075 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.9 t -127.29 147.77 50.23 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 120.329 -0.548 . . . . 74.21 112.015 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 119' ' ' SER . 95.8 t -128.18 126.63 66.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.841 -1.072 . . . . 73.12 108.446 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 43.5 tt0 -113.16 123.94 51.39 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.018 0.437 . . . . 71.43 111.088 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 34.5 t -121.4 127.54 75.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.835 -1.543 . . . . 74.04 106.835 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 72.7 p -116.09 166.19 12.29 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.551 -0.46 . . . . 61.31 110.566 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 73.3 -27.49 0.19 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.897 0.879 . . . . 72.12 113.007 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 47' ' ' THR . 63.8 mmtt -89.84 146.85 36.16 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 115.946 -0.57 . . . . 70.4 110.54 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.23 156.65 61.92 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.435 2.09 . . . . 52.0 109.926 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 98' ' ' LEU . 54.4 t -47.87 -45.71 11.79 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 113.383 0.883 . . . . 71.11 113.383 -177.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.75 -46.55 87.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.175 0.435 . . . . 73.13 112.175 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . 33.8 tt0 -74.32 -43.69 55.65 Favored 'General case' 0 N--CA 1.397 -3.118 0 CA-C-N 116.278 -0.419 . . . . 64.33 111.728 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.79 -37.76 88.56 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 120.893 0.377 . . . . 52.33 110.675 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.84 -37.97 73.17 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.398 -0.365 . . . . 73.24 111.181 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 53' ' ' GLU 0.272 6.7 ppt_? -65.27 -23.54 67.07 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 112.283 0.475 . . . . 72.42 112.283 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.4 mm-40 -81.99 -52.34 7.15 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.44 -0.8 . . . . 72.44 112.778 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.21 -40.53 64.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 114.643 1.349 . . . . 52.24 114.643 -172.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 35.5 ttm -57.74 -49.31 94.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 114.957 1.466 . . . . 55.22 114.957 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 59' ' ' MET . 13.0 Cg_endo -57.17 -31.86 91.75 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.909 1.74 . . . . 74.41 111.639 175.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 93.3 mttt -67.59 -36.08 80.2 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.315 0.578 . . . . 73.34 110.096 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.58 -43.94 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 72.33 109.884 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.67 -43.51 98.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.845 0.683 . . . . 73.1 112.845 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -64.16 -37.68 88.35 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.059 0.457 . . . . 71.04 110.507 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 115' ' ' PRO . 38.6 t80 -66.28 -59.93 3.26 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.711 -0.677 . . . . 74.02 110.443 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.93 -26.15 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-O 121.17 0.51 . . . . 75.3 111.397 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -27.91 73.34 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 116.021 -0.536 . . . . 72.33 112.731 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.4 -11.87 0.22 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.33 -1.414 . . . . 71.45 114.321 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 116' ' ' SER . 23.5 m -82.23 49.53 1.43 Allowed 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 121.934 0.873 . . . . 75.12 110.268 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 113' ' ' PRO . 35.1 m-80 -98.61 149.54 22.67 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.567 -1.642 . . . . 61.41 106.567 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.47 -32.1 71.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.092 0.472 . . . . 73.43 112.044 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -78.05 -7.47 56.96 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.042 0.449 . . . . 74.01 111.016 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.0 18.27 80.22 Favored Glycine 0 CA--C 1.509 -0.291 0 C-N-CA 121.164 -0.541 . . . . 64.33 112.118 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.94 165.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.245 -1.02 . . . . 53.02 108.245 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.95 -120.15 0.95 Allowed Glycine 0 N--CA 1.41 -3.084 0 C-N-CA 119.484 -1.341 . . . . 51.51 112.227 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 69.9 mtm 68.4 9.69 7.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.201 1.0 . . . . 54.12 111.165 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.73 92.26 1.1 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.807 -0.633 . . . . 72.44 113.961 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -95.79 125.48 40.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.602 -1.999 . . . . 73.42 105.602 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.1 p -117.1 116.96 28.34 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 115.605 1.706 . . . . 44.35 115.605 -166.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.58 155.35 45.37 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 105.206 -2.146 . . . . 72.33 105.206 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.85 140.5 85.31 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.225 1.95 . . . . 62.43 114.151 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -106.35 151.36 8.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.957 -1.497 . . . . 70.41 106.957 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.3 t -141.79 147.48 37.36 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.902 -0.777 . . . . 74.55 108.902 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.83 144.35 48.91 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 122.337 -0.227 . . . . 75.12 110.506 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 136.23 33.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.722 -0.672 . . . . 71.44 109.519 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.89 150.62 25.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.011 -1.107 . . . . 63.44 108.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.627 ' CD2' ' HE2' ' A' ' 97' ' ' LYS . 1.7 m-85 -119.84 103.54 45.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 108.746 -0.835 . . . . 75.3 108.746 -175.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 151.37 37.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.145 1.897 . . . . 75.42 114.545 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.715 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 92.2 m-20 -102.89 156.09 17.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.466 -1.243 . . . . 64.13 108.171 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.05 -17.2 62.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.597 0.713 . . . . 73.52 109.747 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.96 -5.47 46.38 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.917 -1.038 . . . . 72.21 110.8 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.96 0.71 87.25 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 121.104 -0.569 . . . . 61.31 111.988 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.5 p -92.59 152.1 19.78 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 109.228 -0.656 . . . . 71.12 109.228 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.71 85.63 2.16 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.04 0.447 . . . . 74.04 110.765 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.61 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 34.3 tt0 -148.87 113.75 5.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.174 -0.466 . . . . 61.44 111.277 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.715 ' HE3' ' OD1' ' A' ' 89' ' ' ASN . 91.3 mttt -173.14 -75.44 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.883 1.673 . . . . 64.31 107.752 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.627 ' HE2' ' CD2' ' A' ' 87' ' ' PHE . 4.0 mppt? -143.05 156.57 44.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.997 -1.001 . . . . 74.44 108.942 177.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 51' ' ' VAL . 6.3 tt -143.84 134.84 25.44 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.8 -1.185 . . . . 54.14 107.8 172.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.47 ' HD3' ' HB2' ' A' ' 45' ' ' GLU . 33.9 ttpt -140.83 116.54 10.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 120.601 -0.44 . . . . 72.1 110.943 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 43' ' ' THR . 53.7 t -87.18 132.58 32.2 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 115.679 -0.691 . . . . 71.14 109.731 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -115.8 122.06 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.453 0.701 . . . . 74.31 109.27 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 85.9 t80 -103.21 123.22 46.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.334 0.587 . . . . 72.43 110.087 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -75.12 113.42 12.44 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.375 -1.284 . . . . 72.33 110.12 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.5 mt -89.26 125.03 63.25 Favored Pre-proline 0 N--CA 1.42 -1.958 0 N-CA-C 107.254 -1.387 . . . . 65.41 107.254 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.26 148.24 42.04 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.705 2.27 . . . . 61.13 111.335 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.43 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -57.23 -36.22 70.64 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.078 0.399 . . . . 63.4 112.078 -173.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -62.93 -28.46 70.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.449 0.642 . . . . 74.24 111.364 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.14 -12.28 38.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 116.119 -0.492 . . . . 64.44 110.668 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.478 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 11.9 mm-40 -68.11 -29.42 68.33 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.591 0.589 . . . . 72.33 112.591 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.45 -39.19 97.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.15 -1.024 . . . . 62.41 111.403 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 m -153.46 87.73 3.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.36 -0.978 . . . . 54.52 108.36 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.67 151.21 11.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.278 1.985 . . . . 65.1 110.532 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -65.07 157.05 59.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.876 1.717 . . . . 73.3 110.805 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.49 147.22 71.44 Favored Pre-proline 0 N--CA 1.423 -1.808 0 N-CA-C 108.918 -0.771 . . . . 72.12 108.918 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 58.6 Cg_endo -73.18 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 121.917 1.744 . . . . 71.31 111.091 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 69' ' ' THR . 47.9 t -77.77 -28.68 50.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.34 -0.845 . . . . 75.2 111.655 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.29 152.1 25.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.281 -0.568 . . . . 65.32 110.401 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.11 -32.97 74.46 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.931 0.715 . . . . 63.32 112.931 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.56 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 20.1 m -93.44 -8.64 41.07 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.293 -0.563 . . . . 73.4 111.483 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 61.3 t -97.7 118.64 44.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.476 -1.305 . . . . 73.21 107.476 -176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -128.97 140.28 51.72 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.078 -0.712 . . . . 71.13 109.078 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.2 mm -92.08 112.0 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.271 -1.011 . . . . 72.31 108.271 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -123.44 148.41 46.18 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.553 -0.749 . . . . 72.51 109.963 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 1.7 mp0 -98.17 139.38 34.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.809 -1.182 . . . . 73.22 107.809 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -126.7 121.16 31.29 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.256 -0.978 . . . . 75.45 110.696 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.529 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -144.9 176.83 9.18 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.199 -0.909 . . . . 74.32 111.031 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.8 64.61 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.962 -0.637 . . . . 24.55 114.661 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.41 160.41 22.71 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 C-N-CA 119.386 -0.926 . . . . 70.03 112.065 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.2 m -112.88 142.97 44.93 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.027 -1.442 . . . . 73.33 107.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.78 145.39 29.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.525 -0.546 . . . . 64.02 109.525 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 56.3 m-85 -113.72 122.4 47.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.893 -2.262 . . . . 75.11 104.893 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 42.8 p -123.0 139.24 54.29 Favored 'General case' 0 C--N 1.263 -3.163 0 C-N-CA 120.092 -0.643 . . . . 62.53 110.983 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -113.21 127.41 56.17 Favored 'General case' 0 N--CA 1.402 -2.835 0 N-CA-C 108.138 -1.06 . . . . 65.21 108.138 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -110.43 125.32 53.13 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.734 -1.21 . . . . 73.31 107.734 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -147.0 153.72 40.39 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.167 0.508 . . . . 72.14 112.36 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.02 156.26 19.2 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.446 -0.797 . . . . 74.22 111.482 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.78 141.43 12.16 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.303 -1.119 . . . . 53.44 110.303 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -70.77 122.92 20.76 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.392 0.615 . . . . 73.44 111.198 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -110.95 133.5 53.33 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.589 -0.732 . . . . 51.12 109.629 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -80.95 170.21 16.55 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.718 -0.845 . . . . 62.33 108.718 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -53.29 -38.68 63.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.99 0.424 . . . . 52.4 111.185 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.06 77.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.589 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.418 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 11.8 m-20 -66.8 -31.66 72.42 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 116.24 -0.436 . . . . 62.15 110.617 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -62.78 -40.95 98.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.784 -0.367 . . . . 72.54 110.522 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.57 -44.24 90.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.903 -0.59 . . . . 52.22 109.574 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -63.8 -47.22 81.76 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.572 -0.74 . . . . 73.31 111.275 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -66.02 -33.18 75.21 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.009 0.374 . . . . 72.54 112.009 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.7 94.49 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.299 -0.63 . . . . 61.12 109.299 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.2 m -64.24 -44.5 91.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.458 -0.792 . . . . 65.21 110.458 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 98.7 mt-30 -59.3 -49.22 78.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.818 0.447 . . . . 74.22 110.561 177.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 31' ' ' TYR . 48.1 tp -58.02 -46.19 85.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.857 -0.61 . . . . 52.11 110.61 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -64.35 -34.54 78.38 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.857 -0.611 . . . . 73.45 110.216 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.5 m -73.18 -33.17 65.27 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.331 0.586 . . . . 73.04 109.837 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 26' ' ' LYS . 42.0 m -72.38 -33.72 67.42 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.239 0.542 . . . . 74.02 109.779 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 158' ' ' THR . 87.8 mt -74.66 4.99 5.32 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.061 0.944 . . . . 73.02 113.197 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.1 142.5 43.64 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.654 -0.818 . . . . 74.34 111.1 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.23 62.18 Favored Glycine 0 C--N 1.297 -1.606 0 CA-C-N 115.456 -0.793 . . . . 63.34 111.15 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 155' ' ' LEU . 11.5 t -116.55 147.34 39.52 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 108.228 -1.027 . . . . 73.13 108.228 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -70.94 36.11 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.981 3.12 . . . . 62.22 113.666 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.13 136.63 42.92 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.847 0.356 . . . . 63.33 111.02 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 69.3 p -111.82 162.91 14.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.341 -0.985 . . . . 71.44 108.341 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.8 m-85 -137.66 150.6 47.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.616 -0.883 . . . . 65.43 108.616 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -127.43 126.82 43.08 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.854 -0.738 . . . . 74.32 112.574 -177.218 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.84 -1.19 17.29 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.287 -0.869 . . . . 73.51 113.441 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 63.11 12.17 5.8 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 64.35 110.588 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.5 160.37 4.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.272 -0.876 . . . . 62.03 111.88 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.87 170.89 17.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.42 -0.809 . . . . 71.22 110.015 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 18.1 m-85 -115.58 153.31 31.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.252 0.548 . . . . 72.52 111.848 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 41.7 t -115.12 144.82 43.08 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.241 -1.763 . . . . 72.21 106.241 172.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.24 160.56 16.87 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 121.131 -0.228 . . . . 60.33 110.644 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.525 0 N-CA-C 110.3 -1.12 . . . . 52.04 110.3 -177.886 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.923 0.392 . . . . 64.05 111.676 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.2 134.39 29.43 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 116.325 -0.398 . . . . 73.51 111.155 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.28 143.4 46.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.85 0.46 . . . . 74.34 111.025 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -122.08 148.0 45.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.49 -0.323 . . . . 75.22 110.912 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 132' ' ' SER . 57.3 t -128.18 128.93 69.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.614 -1.254 . . . . 64.3 107.614 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 7.0 m0 -114.98 124.83 52.66 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 110.354 -0.239 . . . . 62.31 110.354 -178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.12 138.97 35.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.94 -1.133 . . . . 63.22 107.94 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 38.5 t -100.17 127.74 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 120.696 -0.401 . . . . 72.31 111.547 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.1 tmtt? -78.14 123.76 27.27 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.426 -0.806 . . . . 73.14 109.691 176.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.26 1.651 0 O-C-N 124.268 0.98 . . . . 64.31 110.183 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.1 p90 . . . . . 0 N--CA 1.433 -1.282 0 N-CA-C 106.331 -1.729 . . . . 75.03 106.331 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -119.32 120.22 36.29 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 119.148 -1.021 . . . . 75.25 112.073 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 34' ' ' ARG . 44.5 t -78.16 114.52 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 102.803 -3.036 . . . . 74.32 102.803 168.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.62 -30.13 17.36 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.288 -1.365 . . . . 65.42 112.874 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -158.67 163.07 37.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.922 -0.77 . . . . 72.34 108.922 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 32' ' ' GLU . 44.8 p -132.66 162.59 30.98 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.461 -0.57 . . . . 65.44 109.461 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.24 -145.4 10.15 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.775 -0.726 . . . . 73.34 111.831 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -156.7 16.71 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.917 -0.658 . . . . 44.44 111.905 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.01 171.87 7.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.398 0.679 . . . . 74.44 111.642 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.68 143.59 48.04 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.68 -1.6 . . . . 75.3 106.68 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 80.23 -50.58 0.35 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.305 1.042 . . . . 74.14 111.314 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.0 t -116.09 109.14 27.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.287 -0.634 . . . . 53.11 109.287 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -116.91 154.91 29.99 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.454 -0.794 . . . . 73.55 109.629 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 162.48 31.97 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.76 0.314 . . . . 75.03 111.821 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HB3' HG22 ' A' ' 23' ' ' THR . 12.6 pt-20 -154.89 139.74 17.2 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.699 -1.593 . . . . 75.31 106.699 174.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB3' ' CD2' ' A' ' 131' ' ' TYR 0.283 0.2 OUTLIER -103.53 125.6 50.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.208 -0.997 . . . . 63.45 111.93 177.251 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.446 ' HG2' HG22 ' A' ' 20' ' ' VAL . 70.7 mtt180 -115.03 127.15 55.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.616 -1.174 . . . . 75.14 109.481 -176.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.64 132.49 34.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.895 -1.52 . . . . 74.45 106.895 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.442 ' SG ' HG13 ' A' ' 128' ' ' ILE . 74.6 m -74.71 157.79 34.68 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 120.129 -0.628 . . . . 75.21 111.622 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -84.7 -25.02 28.66 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.602 -0.726 . . . . 74.31 111.522 -174.556 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 95.13 11.02 56.81 Favored Glycine 0 CA--C 1.497 -1.072 0 C-N-CA 119.49 -1.338 . . . . 30.45 111.474 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.488 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.55 165.74 51.88 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 114.114 0.406 . . . . 71.42 114.114 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -101.02 122.59 43.8 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.818 -0.691 . . . . 71.13 109.378 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 44.7 m-85 -125.57 165.65 18.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.293 -0.867 . . . . 73.54 111.894 -170.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.49 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.22 116.7 30.99 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 108.78 -0.822 . . . . 73.12 108.78 -177.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 10.1 t -124.77 143.91 50.54 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-O 121.349 0.595 . . . . 72.25 111.352 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.3 m -128.4 139.98 50.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.054 -0.975 . . . . 74.12 108.791 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.13 136.83 51.7 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.077 -0.649 . . . . 72.14 112.074 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.529 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 29.6 t -131.06 142.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.058 -0.719 . . . . 72.14 109.058 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 p -135.26 178.15 7.26 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.531 0.332 . . . . 73.04 110.311 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.0 t70 73.6 -14.99 0.59 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.448 1.099 . . . . 61.43 113.159 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -131.21 147.26 65.53 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.313 -0.625 . . . . 70.24 109.313 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.28 156.29 5.71 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.652 2.902 . . . . 74.3 112.526 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 20.5 m -56.2 -36.33 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.518 0.562 . . . . 73.04 112.518 -174.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 10.4 m-20 -58.78 -49.82 76.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.164 0.507 . . . . 75.43 110.158 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.04 -36.32 79.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.318 -0.855 . . . . 75.24 110.191 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -60.38 -47.35 86.43 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.437 -0.801 . . . . 70.4 110.59 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 59' ' ' MET . 96.1 mt -55.87 -36.97 68.18 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 122.43 0.292 . . . . 73.24 111.479 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 1.7 mmp_? -59.37 -34.29 72.23 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.307 0.575 . . . . 71.44 110.456 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -83.98 -41.41 17.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.418 -0.81 . . . . 73.43 111.338 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.01 -33.09 67.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 114.393 1.257 . . . . 74.0 114.393 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 17.8 mmt -61.31 -57.2 27.22 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 120.317 -0.553 . . . . 74.1 111.713 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.95 -38.45 86.38 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.594 2.196 . . . . 70.23 113.008 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG3' HG11 ' A' ' 44' ' ' VAL . 16.4 ptpt -69.15 -28.8 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.019 0.748 . . . . 75.34 113.019 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.5 mm -76.55 -45.11 33.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.342 -0.614 . . . . 51.11 109.342 170.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.2 mtp -62.25 -33.49 74.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.452 -0.795 . . . . 62.43 112.941 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -70.25 -40.25 74.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.872 0.368 . . . . 71.13 110.172 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -59.03 -52.09 67.25 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.801 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.87 -13.09 14.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.062 -0.517 . . . . 43.22 111.523 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.37 -16.78 70.52 Favored Glycine 0 CA--C 1.506 -0.486 0 CA-C-N 115.94 -0.573 . . . . 72.52 112.436 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . 134.4 -11.04 4.68 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 119.746 -1.216 . . . . 40.44 112.828 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 m -80.3 30.11 0.29 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 122.888 1.327 . . . . 54.11 110.369 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 68' ' ' GLY . 7.3 p30 -97.81 171.36 8.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.978 -1.01 . . . . 74.42 109.032 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 26.5 t70 -67.97 -27.55 66.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 21.52 113.084 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.55 -13.2 55.0 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.446 -0.902 . . . . 72.14 109.595 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.31 22.49 74.67 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.608 -0.724 . . . . 54.44 111.308 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 m -81.97 122.17 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 121.246 0.546 . . . . 62.21 112.293 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.02 52.76 0.62 Allowed Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.11 -1.196 . . . . 72.12 110.11 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.7 mtt -82.91 -41.74 18.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.309 0.576 . . . . 73.14 110.519 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.04 129.03 3.39 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.306 -0.95 . . . . 73.13 111.593 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.474 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 23.6 ptp -132.78 126.03 31.45 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.806 -0.442 . . . . 73.21 109.806 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.4 p -124.83 115.79 21.23 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.023 0.749 . . . . 63.42 113.023 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 15.6 m -153.59 174.54 3.67 Favored Pre-proline 0 C--N 1.313 -1.003 0 C-N-CA 125.88 1.672 . . . . 75.32 106.498 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 78.2 Cg_exo -56.72 140.36 90.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.157 1.905 . . . . 73.53 114.057 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 48.6 t -105.75 143.04 17.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.395 -1.706 . . . . 74.21 106.395 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.4 m -132.35 151.4 51.87 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.996 0.362 . . . . 71.43 110.332 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' CD2' HD21 ' A' ' 98' ' ' LEU . 52.5 p90 -145.07 146.46 31.86 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 122.036 -0.415 . . . . 74.44 111.162 174.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.42 135.33 34.13 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 116.029 -0.532 . . . . 72.21 109.943 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG12 HG11 ' A' ' 51' ' ' VAL . 30.7 m -137.81 150.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.43 -0.952 . . . . 72.23 108.43 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 39.5 m-85 -119.88 108.24 39.11 Favored Pre-proline 0 C--N 1.281 -2.378 0 N-CA-C 107.466 -1.309 . . . . 73.01 107.466 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.01 147.8 8.01 Favored 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 121.243 1.295 . . . . 60.41 113.69 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.37 154.62 18.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.71 -1.959 . . . . 71.41 105.71 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.5 -13.15 62.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 114.247 1.202 . . . . 73.05 114.247 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.66 -4.09 58.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.502 0.668 . . . . 74.42 109.763 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 -11.07 59.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.733 -0.667 . . . . 21.22 113.466 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.2 m -78.53 139.38 38.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.251 -0.58 . . . . 53.13 110.112 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.69 150.9 23.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.645 -0.422 . . . . 65.42 110.083 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -79.77 150.1 30.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.736 -1.579 . . . . 74.35 106.736 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.0 38.92 0.54 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.712 0.805 . . . . 63.01 111.956 -171.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.529 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -127.8 122.55 33.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 104.207 -2.516 . . . . 62.21 104.207 176.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.529 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 3.1 tm? -131.36 145.49 51.86 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.009 0.433 . . . . 64.11 109.993 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' N ' HD13 ' A' ' 98' ' ' LEU . 87.9 tttt -148.19 116.13 6.41 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.248 -0.887 . . . . 63.04 110.724 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.519 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 93.7 t -95.1 126.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 122.94 0.496 . . . . 71.03 110.103 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.94 122.71 46.97 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 82.5 t80 -103.5 120.17 40.31 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.315 -0.994 . . . . 63.15 108.315 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -74.99 122.33 23.33 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.783 -0.644 . . . . 62.04 109.33 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.497 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 66.7 mt -91.75 125.92 55.65 Favored Pre-proline 0 N--CA 1.415 -2.201 0 N-CA-C 107.226 -1.398 . . . . 52.45 107.226 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 78' ' ' MET . 64.9 Cg_exo -52.86 155.59 10.7 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 123.289 2.659 . . . . 64.52 113.558 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -47.29 -44.36 23.2 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.475 1.51 . . . . 75.35 112.052 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.86 -30.02 68.69 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.015 -0.539 . . . . 71.11 112.435 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -99.95 -2.69 34.0 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.719 -0.219 . . . . 74.02 111.584 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.475 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 25.3 mm-40 -70.49 -34.99 72.98 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.21 0.818 . . . . 71.52 113.21 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.49 -38.28 93.33 Favored Glycine 0 N--CA 1.466 0.64 0 C-N-CA 120.953 -0.642 . . . . 52.54 112.41 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.3 m -155.46 93.41 2.65 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.682 -0.859 . . . . 74.44 108.682 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -87.14 157.83 8.41 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.571 2.18 . . . . 65.4 111.971 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.62 151.93 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.223 1.948 . . . . 64.14 111.575 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -85.55 152.69 57.77 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-N 116.012 -0.54 . . . . 52.34 110.206 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.67 110.94 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.29 1.993 . . . . 52.1 112.561 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.7 m -80.87 -20.3 42.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.02 0.438 . . . . 75.24 110.958 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -107.88 140.57 40.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.926 -1.509 . . . . 71.23 106.926 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -76.18 -12.86 60.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.215 0.45 . . . . 64.41 112.215 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HD3' ' A' ' 61' ' ' LYS . 18.3 m -70.88 -32.23 69.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.496 . . . . 73.54 109.988 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 44' ' ' VAL . 8.4 p -105.18 130.07 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.661 -0.699 . . . . 64.11 109.176 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -127.86 133.14 49.34 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.925 -0.579 . . . . 74.15 110.275 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.7 mm -93.09 112.4 26.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.606 -0.887 . . . . 63.04 108.606 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.86 151.86 46.3 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.691 -0.855 . . . . 63.02 108.691 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.25 146.65 30.06 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.801 -0.444 . . . . 73.15 109.801 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -140.55 123.09 16.11 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.781 -0.368 . . . . 52.43 110.051 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.415 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 12.9 pt-20 -138.8 164.88 28.46 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.412 -0.958 . . . . 60.52 108.412 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.72 35.47 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.02 -1.086 . . . . 54.43 112.42 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.442 HG13 ' SG ' ' A' ' 36' ' ' CYS . 38.2 pt -135.51 145.72 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.899 0.856 . . . . 75.4 112.324 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 189' ' ' LYS . 19.8 m -115.5 140.17 49.39 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 104.992 -2.225 . . . . 74.43 104.992 173.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.16 153.9 30.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.413 0 N-CA-C 109.246 -0.65 . . . . 74.41 109.246 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.609 ' CD2' ' HB3' ' A' ' 33' ' ' GLU . 42.3 m-85 -113.11 121.49 44.71 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.144 -2.169 . . . . 52.3 105.144 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 16.6 p -112.58 134.28 54.19 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 121.581 0.705 . . . . 61.22 111.865 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.44 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 8.8 t -126.25 133.87 51.35 Favored 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 114.87 -1.059 . . . . 64.23 109.255 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 50.1 mt-30 -111.09 146.57 36.55 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.781 -0.368 . . . . 75.32 110.676 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 183' ' ' ASN . 11.0 p90 -146.93 168.16 22.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.897 -0.592 . . . . 75.33 109.476 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.12 152.15 23.42 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.815 -0.914 . . . . 75.13 110.815 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 135.68 -138.58 10.05 Favored Glycine 0 C--N 1.313 -0.73 0 N-CA-C 110.921 -0.872 . . . . 73.13 110.921 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -100.56 106.67 18.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.782 -0.821 . . . . 75.15 108.782 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.85 114.64 27.31 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.48 0.919 . . . . 72.41 113.48 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -102.14 175.56 5.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.875 -1.528 . . . . 63.41 106.875 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.1 mp0 -57.79 -44.18 86.09 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.252 -1.018 . . . . 50.41 108.252 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.33 67.36 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.191 -1.368 . . . . 35.24 112.16 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 147' ' ' HIS . 5.1 m-20 -65.72 -49.07 69.8 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 121.098 -0.241 . . . . 71.42 110.387 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 48.5 m-85 -57.96 -43.47 86.43 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.499 0.499 . . . . 74.11 110.099 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 141' ' ' GLU . 58.8 t -62.7 -51.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 120.997 0.427 . . . . 74.11 111.322 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.16 75.3 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.397 0.618 . . . . 62.02 110.41 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.567 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 7.7 t-160 -66.79 -47.89 70.7 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.457 -0.792 . . . . 62.42 108.902 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.24 92.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.589 -0.732 . . . . 70.44 110.368 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 89.0 m -64.56 -36.61 84.77 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.744 -0.662 . . . . 75.14 110.838 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -74.11 -28.62 61.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.691 -0.403 . . . . 70.35 110.161 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 81.4 mt -58.98 -34.58 71.98 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 109.938 -0.393 . . . . 54.35 109.938 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 149' ' ' THR . 30.6 mtp180 -61.33 -38.82 88.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.779 -0.646 . . . . 62.43 109.454 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -73.07 -37.41 66.8 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.147 -0.933 . . . . 74.31 110.365 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.2 m -77.41 -34.51 54.72 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.09 0.471 . . . . 74.54 110.829 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 158' ' ' THR . 95.4 mt -80.83 7.66 9.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.579 0.752 . . . . 63.42 111.136 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -82.34 130.37 35.08 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.92 -1.141 . . . . 75.23 107.92 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.56 58.3 Favored Glycine 0 C--N 1.307 -1.081 0 C-N-CA 120.649 -0.786 . . . . 74.5 112.528 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 155' ' ' LEU . 15.4 t -125.2 149.25 63.28 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 107.772 -1.196 . . . . 71.34 107.772 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -64.25 -2.77 5.24 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 123.489 2.793 . . . . 73.0 115.154 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -62.98 142.54 58.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.723 0.297 . . . . 74.35 111.361 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 46.7 p -116.56 151.72 35.6 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.085 -0.507 . . . . 73.22 109.886 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -143.91 149.29 36.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.764 -0.458 . . . . 74.4 109.764 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 5.2 pp0? -134.0 145.49 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.514 0.931 . . . . 75.44 113.514 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.84 -1.39 23.45 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.876 -1.056 . . . . 43.22 115.257 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 t70 61.16 7.99 1.84 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.024 0.93 . . . . 70.41 111.057 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.74 139.69 18.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 124.446 1.098 . . . . 55.43 110.165 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 144' ' ' TYR . 43.9 p90 -137.86 167.61 21.39 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.619 -0.719 . . . . 73.14 109.173 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 79.2 m-85 -115.69 152.78 32.53 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.308 -0.997 . . . . 64.34 108.308 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 83' ' ' SER . 59.7 m -113.62 132.34 55.78 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.616 -1.253 . . . . 73.32 107.616 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -128.23 147.19 50.57 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.032 0.444 . . . . 70.4 111.034 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.912 0 N-CA-C 110.133 -1.187 . . . . 64.01 110.133 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 CA--C 1.515 -0.377 0 CA-C-O 122.019 0.914 . . . . 70.34 109.125 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -142.27 129.51 21.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.634 -1.166 . . . . 74.41 108.211 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 38.1 m-80 -141.14 148.58 40.28 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 105.257 -2.127 . . . . 72.41 105.257 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 37.4 tt0 -126.38 141.02 52.05 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.023 -0.671 . . . . 72.03 110.486 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 132' ' ' SER . 29.0 t -124.49 129.14 73.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.744 -1.206 . . . . 74.3 107.744 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 39.0 m0 -110.15 126.9 54.57 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 110.135 -0.32 . . . . 75.14 110.135 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.83 137.74 39.72 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 172.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.46 133.18 43.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 120.554 -0.459 . . . . 74.13 112.203 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -69.64 143.38 53.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.683 -0.69 . . . . 72.44 111.92 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.305 -1.338 0 CA-C-O 118.433 -0.794 . . . . 60.15 109.123 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 109.839 -0.43 . . . . 73.25 109.839 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -103.55 135.87 44.33 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.635 -0.876 . . . . 71.14 108.635 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 9' ' ' LEU . 1.6 pt? -119.24 115.6 24.54 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.183 0.516 . . . . 75.54 111.552 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -132.1 174.98 9.64 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.927 -0.768 . . . . 73.34 108.927 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.12 -177.84 21.97 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.789 -0.924 . . . . 65.04 110.789 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.4 p -91.15 -25.84 19.37 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.13 0.491 . . . . 61.31 111.001 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.92 97.42 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 122.152 0.977 . . . . 51.52 111.163 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.27 123.16 0.8 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.237 -2.505 . . . . 73.44 104.237 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.575 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 8.9 t -142.37 -52.85 0.41 Allowed 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 118.633 -1.227 . . . . 73.55 113.203 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.824 ' HE1' HE21 ' A' ' 109' ' ' GLN . 17.9 m-90 -140.04 95.56 8.47 Favored Pre-proline 0 CA--C 1.503 -0.832 0 CA-C-N 117.993 0.361 . . . . 73.23 110.969 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.636 ' HD2' ' OE2' ' A' ' 37' ' ' GLU . 9.9 Cg_exo -72.38 119.87 6.4 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 121.548 1.499 . . . . 74.41 109.594 173.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.583 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.2 p90 -139.94 172.0 13.39 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 54.4 tt0 -106.0 109.24 21.12 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.057 -0.657 . . . . 71.51 109.646 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.8 p -93.31 131.92 38.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.247 -1.019 . . . . 62.42 108.247 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 33' ' ' GLU . 10.2 mt -89.25 -40.93 12.5 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.12 -1.067 . . . . 71.24 108.12 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 m -173.11 169.6 4.57 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.617 1.167 . . . . 74.24 108.313 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.77 165.59 24.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.562 -1.273 . . . . 75.33 107.562 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.31 89.87 0.17 Allowed Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 118.759 -1.686 . . . . 62.04 113.78 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.68 -134.11 4.25 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.757 -0.735 . . . . 54.33 111.912 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -115.27 173.81 6.32 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 123.821 0.848 . . . . 74.41 110.411 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -64.61 141.72 58.68 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.074 -1.084 . . . . 70.33 108.074 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 73.86 -62.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.673 1.189 . . . . 73.15 110.587 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG22 ' CD2' ' A' ' 147' ' ' HIS . 23.5 t -97.32 108.82 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.07 -1.085 . . . . 62.41 108.07 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.9 m -123.53 137.56 54.74 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.093 -1.077 . . . . 74.23 108.093 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -115.75 160.84 19.57 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.497 1.295 . . . . 61.13 114.497 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -147.0 125.85 12.7 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.126 -1.852 . . . . 73.33 106.682 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -104.66 122.1 44.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 119.169 -1.012 . . . . 74.31 108.676 175.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 31.7 ptt180 -141.37 153.86 45.32 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.123 -0.944 . . . . 75.1 111.445 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.05 136.33 36.65 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.093 -1.077 . . . . 54.12 108.093 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -61.58 149.24 39.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.315 1.228 . . . . 62.33 114.315 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.636 ' OE2' ' HD2' ' A' ' 17' ' ' PRO . 4.4 tp10 -51.32 -50.7 58.89 Favored 'General case' 0 C--N 1.367 1.367 0 C-N-CA 124.151 0.981 . . . . 75.22 110.786 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.52 9.31 53.32 Favored Glycine 0 C--N 1.294 -1.763 0 C-N-CA 120.099 -1.048 . . . . 63.35 110.924 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -71.82 165.38 53.85 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.062 -0.569 . . . . 71.34 112.28 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 18.4 ptpt -88.54 129.69 35.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.471 -0.566 . . . . 52.1 109.471 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 58.1 m-85 -128.69 164.21 23.44 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.372 0.669 . . . . 74.41 110.549 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.97 116.87 33.02 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 108.652 -0.87 . . . . 61.31 108.652 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.4 t -125.43 143.46 50.98 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 121.141 0.496 . . . . 75.44 112.213 -175.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 14.8 m -129.65 127.74 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.077 -0.965 . . . . 71.43 109.906 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.76 128.08 56.1 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.711 0.767 . . . . 65.3 111.42 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 40.2 t -112.6 140.55 31.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.892 -1.049 . . . . 64.31 109.239 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 49' ' ' LYS . 40.9 p -132.37 172.73 12.09 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.264 -0.643 . . . . 63.25 109.264 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.22 -40.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.597 1.159 . . . . 72.32 111.626 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 36.3 mtmm -93.24 127.86 45.17 Favored Pre-proline 0 C--N 1.288 -2.066 0 CA-C-N 114.965 -1.016 . . . . 61.25 110.219 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 51.8 Cg_exo -55.3 158.95 11.2 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 124.394 3.396 . . . . 65.02 112.37 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 98' ' ' LEU . 53.0 t -46.53 -39.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.61 0.764 . . . . 71.03 112.189 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.28 -50.41 71.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.971 0.415 . . . . 72.32 111.061 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 32.4 mm-40 -75.18 -44.1 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.784 -0.644 . . . . 61.35 111.919 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -56.68 -42.97 79.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.295 0.638 . . . . 71.54 111.977 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 59' ' ' MET . 64.6 tp -63.8 -51.84 62.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.719 0.295 . . . . 41.23 110.703 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -65.82 -24.86 67.0 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 113.162 0.801 . . . . 74.1 113.162 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 49' ' ' LYS . 3.8 tm-20 -83.87 -33.85 24.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.657 0.741 . . . . 74.15 109.837 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.556 ' HA ' ' NZ ' ' A' ' 61' ' ' LYS . . . -75.88 -33.03 59.94 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 112.885 0.698 . . . . 65.2 112.885 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 12.4 mmt -50.79 -51.31 67.54 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 112.738 0.644 . . . . 74.43 112.738 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 89.3 Cg_exo -52.29 -39.11 73.21 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.482 2.121 . . . . 64.33 111.619 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.556 ' NZ ' ' HA ' ' A' ' 58' ' ' ALA . 35.2 mtmm -69.71 -32.19 70.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.422 . . . . 72.51 111.878 -177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 102' ' ' PHE . 31.8 mm -76.3 -45.1 35.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.001 0.429 . . . . 73.11 110.823 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.446 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.3 ptm -69.7 -30.68 68.38 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 112.275 0.472 . . . . 74.3 112.275 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 61' ' ' LYS . 20.2 ptmt -67.95 -30.52 69.83 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.704 -0.398 . . . . 72.41 109.936 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -63.11 -55.95 20.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.044 -0.525 . . . . 73.13 111.103 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.89 -15.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.894 0.378 . . . . 74.44 111.781 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.015 -0.539 . . . . 53.33 113.071 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.58 -12.75 2.71 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.438 -1.363 . . . . 72.3 113.495 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 116' ' ' SER . 21.5 m -82.77 29.55 0.45 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.724 1.25 . . . . 71.12 110.314 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.12 161.05 13.91 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.973 -1.121 . . . . 32.13 107.973 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 15.8 t70 -67.4 -33.21 74.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.724 0.639 . . . . 63.25 112.724 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -78.16 -12.47 60.0 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.266 0.555 . . . . 70.03 110.461 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 36.12 70.18 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.806 -0.634 . . . . 74.33 112.256 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -80.54 122.51 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.409 -0.589 . . . . 74.44 109.409 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.92 1.99 61.55 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.193 -0.527 . . . . 63.34 111.93 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.2 tpt -73.14 98.33 2.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.193 0.52 . . . . 74.45 110.621 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.79 89.3 0.86 Allowed Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.71 -0.956 . . . . 64.24 110.71 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.73 125.38 40.27 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.525 0.678 . . . . 62.42 111.11 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 m -127.86 118.46 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.867 1.062 . . . . 72.03 113.867 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.44 -179.62 0.66 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 104.602 -2.37 . . . . 74.11 104.602 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.27 137.8 67.96 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 122.582 1.958 . . . . 73.34 111.4 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 44.6 t -102.75 141.68 18.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.272 -1.381 . . . . 53.34 107.272 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 168' ' ' TYR . 26.1 t -126.32 146.23 50.11 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.605 -0.438 . . . . 61.23 109.859 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 43.9 p90 -135.36 142.69 45.79 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 110.135 -0.32 . . . . 61.13 110.135 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.11 134.89 34.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 123.785 0.678 . . . . 64.11 110.411 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 m -126.58 150.14 32.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.787 -1.097 . . . . 64.15 108.294 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.604 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 46.0 m-85 -120.87 104.1 42.25 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 120.371 -0.531 . . . . 62.2 110.288 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.58 133.58 3.79 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.037 1.824 . . . . 72.5 112.103 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -86.48 162.33 18.14 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.15 -1.055 . . . . 72.0 108.15 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.49 -12.95 61.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.513 0.673 . . . . 73.05 111.211 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.36 -6.09 56.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.857 -0.611 . . . . 72.34 109.917 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.88 -10.32 74.1 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 115.97 -0.559 . . . . 75.33 112.791 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.9 m -91.97 137.95 31.94 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 110.151 -0.314 . . . . 73.11 110.151 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 mp -75.14 138.68 42.21 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.266 0.555 . . . . 42.53 111.545 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.2 129.38 34.46 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.535 -2.024 . . . . 63.04 105.535 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -71.73 81.73 0.87 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.165 0.983 . . . . 74.13 113.27 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.604 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 37.8 ttmt -160.46 125.61 3.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.998 -2.223 . . . . 71.4 104.998 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 51' ' ' VAL . 6.0 tt -135.5 129.28 32.85 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 108.669 -0.863 . . . . 61.42 108.669 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -122.3 114.84 21.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.244 -0.65 . . . . 75.31 109.244 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.5 t -92.4 129.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.958 -0.565 . . . . 63.23 109.579 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -110.79 123.35 49.9 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.904 -0.776 . . . . 61.42 108.904 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HB2' HD12 ' A' ' 62' ' ' ILE . 86.4 t80 -102.53 112.48 25.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.939 -1.134 . . . . 65.24 107.939 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 39.7 ttp180 -76.91 121.26 23.19 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-N 114.376 -1.284 . . . . 61.44 109.901 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.0 mt -88.45 133.04 37.26 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 115.211 -0.904 . . . . 74.14 109.934 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.13 154.67 32.55 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.919 2.412 . . . . 74.35 111.562 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.575 ' HB2' ' HA ' ' A' ' 15' ' ' THR . 26.1 t-20 -53.42 -45.26 69.32 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.086 1.143 . . . . 73.14 114.086 -174.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.97 -31.55 71.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.225 0.536 . . . . 55.04 111.161 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.89 -5.85 49.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.18 -0.464 . . . . 73.15 111.323 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.824 HE21 ' HE1' ' A' ' 16' ' ' TRP . 20.2 mm-40 -70.68 -38.26 73.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.728 -0.842 . . . . 74.41 108.728 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.96 93.56 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.281 -0.872 . . . . 72.23 112.138 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.2 m -154.27 92.88 2.96 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 122.534 0.334 . . . . 50.12 111.049 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 84.8 Cg_endo -90.11 149.4 4.67 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.364 2.043 . . . . 70.42 111.535 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 27.3 Cg_exo -65.9 146.33 82.66 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.592 2.195 . . . . 73.14 111.407 175.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -74.22 147.01 85.19 Favored Pre-proline 0 C--O 1.255 1.36 0 C-N-CA 120.634 -0.426 . . . . 72.43 110.413 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.45 113.38 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.604 2.203 . . . . 64.53 111.547 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 69' ' ' THR . 26.5 t -91.23 -12.52 35.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.563 0.697 . . . . 72.14 109.718 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.565 ' HB3' HG12 ' A' ' 120' ' ' VAL . 9.5 t70 -100.67 136.78 40.0 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.52 -1.289 . . . . 73.43 107.52 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.434 ' O ' ' HE2' ' A' ' 121' ' ' LYS . 13.9 pt-20 -72.45 -19.12 61.63 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.234 0.827 . . . . 73.23 113.234 -173.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.8 m -86.36 -25.6 25.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.531 -0.468 . . . . 75.24 111.169 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 117' ' ' ASP . 10.7 p -97.13 129.09 47.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 120.402 -0.519 . . . . 62.2 109.627 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 118' ' ' GLU . 75.7 mmtt -124.21 143.19 50.66 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.255 -0.429 . . . . 74.41 110.22 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 23.6 mm -92.74 111.1 23.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.703 -1.221 . . . . 55.43 107.703 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -125.22 142.39 51.52 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.557 -0.747 . . . . 75.25 109.387 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 11.2 pt-20 -100.41 135.71 41.43 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.079 -0.711 . . . . 71.23 109.079 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.517 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 32.3 tpt180 -125.58 122.15 35.66 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.032 -0.667 . . . . 74.43 110.767 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.56 177.61 8.36 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.143 -1.058 . . . . 74.22 108.143 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.28 -12.8 68.75 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.514 -0.85 . . . . 63.3 114.68 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.265 2.6 pp -121.13 157.73 24.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 118.553 -1.259 . . . . 64.23 113.593 -176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.6 m -109.57 133.61 52.89 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.922 -1.49 . . . . 50.42 108.751 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 188' ' ' VAL . 32.0 m -124.0 157.06 31.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-O 121.155 0.502 . . . . 65.2 110.454 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 69.4 m-85 -113.21 121.87 45.77 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 103.618 -2.734 . . . . 61.22 103.618 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.7 m -119.46 132.24 55.76 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 120.656 -0.418 . . . . 63.35 110.353 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.9 t -112.8 128.13 56.35 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.936 -0.764 . . . . 70.53 108.936 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.04 125.34 53.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.522 -1.658 . . . . 64.4 106.522 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 26.1 p90 -141.71 154.89 45.6 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.858 -0.61 . . . . 73.31 110.491 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.86 14.75 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.79 -0.719 . . . . 51.34 113.109 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 144.17 -176.92 23.14 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.202 -1.559 . . . . 53.45 109.202 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -81.36 107.7 14.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.014 0.907 . . . . 71.23 109.288 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 175' ' ' PRO . . . -96.45 138.19 34.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.508 0.671 . . . . 70.31 112.483 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' HE3' ' OD1' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -109.98 176.66 4.98 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.562 -1.644 . . . . 53.32 106.562 172.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -36.19 80.36 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.261 0.467 . . . . 73.52 112.261 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.11 -32.56 73.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 73.43 111.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.505 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 5.4 m-20 -63.97 -34.42 77.95 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 116.365 -0.38 . . . . 64.51 111.52 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.17 -43.93 90.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.99 0.424 . . . . 74.13 110.022 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.1 t -66.17 -45.86 89.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.533 -0.758 . . . . 73.24 109.457 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.12 96.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 60.34 111.084 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.477 ' CD2' HG22 ' A' ' 29' ' ' VAL . 56.6 m80 -67.78 -33.88 75.69 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 120.729 -0.389 . . . . 73.4 111.97 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.71 82.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.505 -0.554 . . . . 70.01 109.505 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 56.3 m -60.37 -49.95 75.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.612 -0.722 . . . . 65.21 109.725 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.28 -29.73 66.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.969 -0.559 . . . . 73.34 112.16 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HA ' HG22 ' A' ' 154' ' ' THR . 34.6 tp -65.69 -36.98 85.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.653 -0.499 . . . . 71.41 109.653 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.538 ' HG2' ' CE2' ' A' ' 162' ' ' TYR . 40.3 mtp180 -69.28 -37.22 77.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.917 -0.583 . . . . 71.41 110.218 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.1 m -69.02 -35.65 76.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.632 -0.713 . . . . 64.24 110.34 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 151' ' ' LEU . 14.7 t -78.18 -33.22 50.24 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 120.65 -0.42 . . . . 65.13 111.011 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.68 6.21 9.37 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.167 0.508 . . . . 71.31 111.495 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.49 132.02 44.92 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.329 -0.619 . . . . 55.12 109.329 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.34 11.74 50.84 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 121.139 -0.553 . . . . 51.12 111.993 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.7 p -123.38 165.48 22.58 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 108.386 -0.968 . . . . 73.23 108.386 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.63 12.67 1.58 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.573 2.182 . . . . 73.44 112.312 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.52 118.84 14.84 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.943 0.401 . . . . 74.22 111.041 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.7 p -121.18 164.65 16.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.701 -1.592 . . . . 73.44 106.701 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.538 ' CE2' ' HG2' ' A' ' 152' ' ' ARG . 12.2 m-85 -130.43 152.29 50.0 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.337 -0.945 . . . . 71.42 108.847 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.431 ' HG3' ' HA ' ' A' ' 190' ' ' ALA 0.268 3.5 pp0? -102.53 115.08 29.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.295 0.569 . . . . 74.32 111.889 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.89 1.36 62.29 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.477 -0.783 . . . . 72.43 111.357 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.7 t70 59.96 20.62 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.609 1.564 . . . . 54.4 109.658 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.4 138.47 16.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 114.621 -1.172 . . . . 74.32 112.069 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.445 ' HB3' HD23 ' A' ' 187' ' ' LEU . 22.0 p90 -135.79 152.67 51.33 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.949 -1.023 . . . . 62.23 108.694 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 9.7 m-85 -115.15 140.75 48.81 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.231 -1.025 . . . . 71.34 108.231 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' SER . 61.9 m -114.22 119.54 37.38 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.85 -0.796 . . . . 74.31 108.85 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -112.32 139.65 47.7 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.092 0.473 . . . . 73.22 111.818 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.74 164.6 37.8 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 107.248 -2.341 . . . . 45.11 107.248 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -80.51 -29.64 37.29 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 118.58 1.19 . . . . 65.33 110.427 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -143.47 162.93 39.68 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 106.992 -1.484 . . . . 63.44 106.992 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -72.59 108.58 2.57 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.898 1.732 . . . . 71.21 107.947 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 4.9 Cg_exo -76.84 130.61 11.57 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.164 1.909 . . . . 72.12 113.873 -173.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 51.5 ttm -97.0 -43.35 7.48 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.819 -1.178 . . . . 72.2 107.819 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 67.4 mttm -153.87 -72.42 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 113.4 0.889 . . . . 62.24 113.4 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 177' ' ' LYS . 1.5 Cg_endo -84.3 -31.28 0.51 Allowed 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.699 1.599 . . . . 65.51 114.985 -172.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -94.79 87.8 5.13 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.67 0.748 . . . . 75.12 111.951 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 175' ' ' PRO . . . 155.68 61.03 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 108.659 -1.776 . . . . 63.55 108.659 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 80.4 mtt180 -96.13 -28.56 14.52 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.899 -0.651 . . . . 73.23 110.976 -176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -112.97 127.83 56.33 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.596 -1.261 . . . . 74.01 107.596 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 11.4 m-80 -143.76 158.86 43.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.744 -0.465 . . . . 73.23 109.744 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 43.9 mt-10 -137.08 145.15 43.6 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.02 -0.733 . . . . 64.45 109.02 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 81.7 t -125.6 121.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.786 -1.191 . . . . 74.31 107.786 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 24.7 m0 -110.21 122.15 46.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.617 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 167' ' ' TYR . 87.6 mt -102.41 138.57 39.16 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.776 -1.194 . . . . 71.32 107.776 171.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 130' ' ' VAL . 27.9 t -103.47 130.59 53.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.477 -0.564 . . . . 73.44 109.477 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.9 ttpt -69.25 132.54 46.64 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.82 -0.807 . . . . 70.21 108.82 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.431 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.468 1.105 . . . . 61.03 112.054 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.516 ' N ' HD21 ' A' ' 7' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.573 0 N-CA-C 109.89 -0.411 . . . . 72.4 109.89 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.2 p -92.84 107.69 19.41 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.427 0.632 . . . . 74.22 111.047 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.5 mt -98.37 134.02 41.95 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.88 -0.785 . . . . 55.42 108.88 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -89.87 135.58 33.55 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.752 -0.379 . . . . 75.41 110.323 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.2 100.79 0.55 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.3 -1.12 . . . . 74.24 110.3 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -67.22 128.2 35.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 123.114 0.566 . . . . 42.11 111.057 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.1 m -94.3 85.52 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 122.004 0.907 . . . . 73.33 110.705 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -70.14 137.55 51.15 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.116 -0.947 . . . . 65.15 108.825 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.6 m 73.75 68.79 0.11 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 124.39 1.076 . . . . 71.34 109.839 -176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.657 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 71.9 t-105 -82.47 133.21 50.37 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 114.773 -1.103 . . . . 72.31 108.505 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.81 150.17 83.33 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 C-N-CA 122.535 2.157 . . . . 74.44 110.566 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 45.8 p90 -99.94 149.67 23.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.739 -0.784 . . . . 72.24 109.868 -176.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -105.58 109.16 21.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.253 -0.885 . . . . 73.15 110.038 -173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.13 128.22 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.724 -1.213 . . . . 74.42 107.724 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 21' ' ' LEU 0.258 0.5 OUTLIER -96.6 -32.45 12.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 113.747 1.017 . . . . 74.43 113.747 -178.998 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 28.5 t -151.86 152.91 33.21 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.864 -0.735 . . . . 62.52 111.907 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 32' ' ' GLU . 27.2 p -133.81 152.91 52.01 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.171 -0.922 . . . . 70.43 110.578 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.04 -131.99 10.76 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 120.632 -0.794 . . . . 64.24 112.691 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -104.5 1.45 Allowed Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 121.116 -0.564 . . . . 65.05 112.077 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.13 171.67 7.66 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 122.827 0.451 . . . . 65.15 110.203 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.18 157.52 25.24 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.679 -1.23 . . . . 74.31 107.679 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t70 75.48 -49.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.436 1.494 . . . . 74.31 111.425 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.24 110.98 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.68 0.752 . . . . 73.0 110.03 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 p -110.8 135.9 50.66 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.731 -0.668 . . . . 73.41 109.495 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -112.1 162.25 15.62 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.129 0.49 . . . . 73.12 112.154 -175.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 22' ' ' SER . 13.1 pt-20 -153.0 129.83 10.94 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.554 -2.017 . . . . 71.23 105.554 170.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HG2' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -114.49 141.61 47.47 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 118.898 -1.121 . . . . 74.43 109.518 177.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 157.11 46.26 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 119.535 -0.866 . . . . 71.0 109.261 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 133.89 35.41 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.466 -2.05 . . . . 52.41 105.466 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.6 m -58.38 141.65 50.68 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.87 1.063 . . . . 70.11 113.87 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -70.3 -16.53 63.02 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.47 -1.695 . . . . 53.42 112.137 -175.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 87.94 12.03 66.77 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.414 -1.851 . . . . 64.43 111.664 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.03 145.98 42.25 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 120.343 -0.932 . . . . 51.42 111.72 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -96.32 117.99 31.94 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.842 -0.799 . . . . 62.43 108.842 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.9 m-85 -122.69 163.86 19.34 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.512 -0.767 . . . . 72.42 110.826 -172.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.21 116.49 31.51 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.312 -0.625 . . . . 74.21 109.312 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.7 t -122.17 145.94 47.72 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 112.477 0.547 . . . . 65.43 112.477 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.579 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 16.0 m -129.95 140.89 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 125.104 1.361 . . . . 73.43 107.776 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.59 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.3 pt-20 -128.01 135.77 50.36 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.16 -1.416 . . . . 74.11 112.22 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 41.2 t -118.41 140.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 106.386 -1.709 . . . . 74.31 106.386 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 49' ' ' LYS . 38.6 p -126.26 167.17 15.84 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.727 -0.389 . . . . 73.51 110.537 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t70 73.72 -36.97 0.36 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.436 1.094 . . . . 52.22 112.108 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 47' ' ' THR . 95.0 mttt -85.75 138.14 35.63 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.53 -0.759 . . . . 71.23 110.841 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.96 157.14 25.67 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.002 2.468 . . . . 74.31 110.748 174.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 98' ' ' LEU . 31.8 t -47.63 -43.88 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 114.952 1.464 . . . . 62.12 114.952 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.95 -33.11 74.03 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.048 -0.661 . . . . 75.13 110.675 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -74.85 -44.06 51.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.526 0.679 . . . . 73.12 110.129 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -65.23 -43.56 91.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.369 -0.832 . . . . 63.32 111.468 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.03 -40.13 82.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 111.694 0.257 . . . . 71.32 111.694 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.91 -24.82 66.92 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 121.013 -0.275 . . . . 64.01 111.431 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 30.2 tt0 -84.47 -44.72 13.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.506 0.67 . . . . 73.54 110.26 175.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.49 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.5 -40.45 70.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 114.67 1.359 . . . . 62.13 114.67 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 ttm -57.83 -46.02 99.76 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 113.078 0.77 . . . . 72.33 113.078 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 76.3 Cg_exo -50.34 -40.75 52.7 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.385 2.057 . . . . 71.24 111.923 171.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 48.2 mtmt -69.14 -34.5 75.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.862 -0.608 . . . . 63.13 110.81 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -70.96 -48.88 53.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.886 -0.597 . . . . 53.01 111.059 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.49 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.5 ptm -68.96 -30.3 68.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.069 0.766 . . . . 74.55 113.069 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -72.33 -27.98 62.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.325 -0.95 . . . . 61.23 109.989 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 93.4 t80 -63.07 -57.94 8.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.335 -0.848 . . . . 74.04 109.886 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.3 m -73.17 -20.79 18.78 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 CA-C-N 116.149 -0.478 . . . . 75.04 110.928 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.77 -25.68 69.29 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.08 -0.509 . . . . 24.33 113.264 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 143.22 -10.22 2.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.149 -1.024 . . . . 75.33 113.039 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 m -89.56 27.6 1.46 Allowed 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.115 0.959 . . . . 74.44 110.254 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.31 169.21 10.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.788 -0.642 . . . . 62.12 110.003 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.85 -32.86 73.23 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.904 0.705 . . . . 73.11 112.904 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 113' ' ' PRO . 99.5 mttt -91.23 -7.69 50.56 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.764 -0.775 . . . . 64.33 112.577 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.69 73.65 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.929 -0.578 . . . . 62.45 112.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 32.5 m -82.23 158.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.42 -0.512 . . . . 74.04 110.243 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.27 173.69 41.1 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 120.891 -0.671 . . . . 63.02 111.735 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 52.6 ttp -75.17 95.95 3.2 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.064 0.459 . . . . 71.43 110.154 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.65 10.3 9.77 Favored Glycine 0 N--CA 1.426 -1.971 0 CA-C-N 115.386 -0.824 . . . . 45.41 112.341 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -118.79 123.45 44.82 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.207 -0.597 . . . . 65.35 110.865 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.9 p -127.53 117.54 22.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.748 0.647 . . . . 70.3 112.748 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -152.99 172.82 5.17 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.503 -1.665 . . . . 65.41 106.503 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.76 139.94 25.57 Favored 'Trans proline' 0 C--O 1.253 1.225 0 C-N-CA 121.01 1.14 . . . . 73.22 110.505 175.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.86 141.43 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.815 -0.809 . . . . 73.23 108.815 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 p -119.46 145.41 46.3 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 110.203 -0.295 . . . . 70.1 110.203 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -144.44 140.62 29.08 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 122.048 -0.408 . . . . 71.33 110.822 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.68 134.55 34.91 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-N 115.68 -0.691 . . . . 70.04 109.287 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.25 159.21 30.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 114.779 -1.101 . . . . 74.45 109.158 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 97' ' ' LYS . 78.4 m-85 -125.23 106.16 28.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 110.03 -0.359 . . . . 75.12 110.03 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.07 136.15 11.47 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.502 2.135 . . . . 72.23 114.07 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 96' ' ' LYS . 49.9 m-80 -95.3 161.51 14.06 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.252 -1.388 . . . . 74.43 107.252 172.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.59 -13.35 58.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.698 0.761 . . . . 72.4 111.005 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.24 -6.32 54.58 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.832 -1.076 . . . . 54.13 110.338 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.53 -9.73 69.79 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.338 -0.458 . . . . 45.35 112.247 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 m -90.19 132.6 35.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 110.163 -0.31 . . . . 65.21 110.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.87 96.11 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.46 -0.941 . . . . 74.0 108.46 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -147.44 114.34 6.12 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.571 -0.899 . . . . 72.43 108.571 -178.389 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 87' ' ' PHE . 74.1 mmtt -176.63 -70.1 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.565 1.946 . . . . 52.2 106.478 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 87' ' ' PHE . 27.4 mtpp -153.16 159.33 42.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.279 -1.782 . . . . 72.34 107.586 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 51' ' ' VAL . 5.7 tt -143.77 128.43 18.18 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.135 -0.691 . . . . 71.11 109.135 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.7 mttt -117.56 115.55 25.35 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.592 -0.276 . . . . 73.04 110.781 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.1 t -89.09 127.02 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.039 -1.097 . . . . 53.41 108.039 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.552 ' CD1' ' HE2' ' A' ' 168' ' ' TYR . 70.1 m95 -113.97 120.59 41.18 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.734 -0.839 . . . . 75.23 108.734 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -102.78 113.28 26.57 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 108.317 -0.994 . . . . 75.4 108.317 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 81.7 mtm180 -75.12 137.91 41.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.535 -1.211 . . . . 72.4 111.803 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.568 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 63.9 mt -113.24 130.4 23.66 Favored Pre-proline 0 C--N 1.286 -2.193 0 CA-C-N 115.396 -0.82 . . . . 65.33 109.862 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.19 163.99 36.6 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.62 2.88 . . . . 74.23 112.921 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -46.46 -35.52 5.7 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.996 1.718 . . . . 75.22 112.976 -176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -46.52 86.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.968 0.413 . . . . 41.45 110.581 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -99.17 -4.5 31.99 Favored 'General case' 0 C--O 1.197 -1.666 0 N-CA-C 112.652 0.612 . . . . 75.44 112.652 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.568 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 24.5 mm-40 -70.77 -32.17 69.2 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.31 -0.556 . . . . 73.42 110.805 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.88 -35.7 90.77 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.778 -0.646 . . . . 44.14 111.598 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.8 p -161.0 92.22 1.52 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 C-N-CA 123.08 0.552 . . . . 73.24 110.117 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.99 162.33 8.82 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.203 1.935 . . . . 61.33 112.123 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.435 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 29.5 Cg_endo -68.17 156.43 65.79 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.751 1.634 . . . . 72.21 109.903 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 155.07 45.93 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.629 -0.26 . . . . 74.14 110.51 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.563 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 34.0 Cg_exo -60.48 111.55 1.06 Allowed 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.589 2.192 . . . . 62.03 111.724 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -88.0 -41.31 13.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.454 -0.793 . . . . 44.12 110.602 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.526 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.0 t70 -92.43 156.0 17.49 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.626 -1.25 . . . . 75.43 107.626 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.37 -20.29 48.08 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 120.93 0.395 . . . . 70.41 111.036 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 m -74.53 -39.71 62.19 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.944 -0.571 . . . . 63.12 110.536 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 3.2 p -107.15 116.41 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.516 0.674 . . . . 64.41 111.507 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -120.82 148.29 44.22 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.835 -1.075 . . . . 75.12 108.796 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.48 ' H ' ' HG3' ' A' ' 115' ' ' PRO . 22.6 mm -92.82 111.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.263 -1.014 . . . . 72.4 108.263 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.267 -0.878 . . . . 73.12 109.005 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.78 140.91 46.03 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.41 -0.589 . . . . 74.42 109.41 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -122.78 123.33 40.81 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 119.841 -0.744 . . . . 74.34 110.474 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -143.76 165.8 26.67 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.538 -1.21 . . . . 74.05 110.48 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.95 -1.15 69.79 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.688 -0.767 . . . . 63.2 114.681 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.89 166.42 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-N 117.774 0.787 . . . . 61.14 110.24 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 55.3 m -120.63 138.39 53.94 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.895 -0.593 . . . . 65.33 109.855 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.444 HG21 ' CE3' ' A' ' 186' ' ' TRP . 19.1 m -124.66 153.54 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 109.12 -0.696 . . . . 55.43 109.12 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 51.8 m-85 -113.03 121.6 45.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.145 -2.168 . . . . 74.13 105.145 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 p -117.91 130.02 55.98 Favored 'General case' 0 C--N 1.269 -2.896 0 C-N-CA 120.252 -0.579 . . . . 71.34 111.162 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.499 ' HB ' HD23 ' A' ' 151' ' ' LEU . 7.8 t -116.06 126.06 53.25 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.689 -0.687 . . . . 74.51 110.168 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -111.1 130.53 55.59 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.925 -1.509 . . . . 65.1 106.925 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.96 146.06 44.94 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.502 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -125.92 128.4 6.45 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.513 -0.767 . . . . 53.34 111.335 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.59 -138.13 4.95 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.21 -0.756 . . . . 64.31 111.21 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 178' ' ' PRO . 19.6 t80 -100.49 100.63 11.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.787 -1.561 . . . . 74.52 106.787 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 140.11 53.29 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.018 1.118 . . . . 62.21 114.018 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -115.68 176.86 4.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.583 -1.189 . . . . 74.31 108.318 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.71 -37.03 85.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.964 0.412 . . . . 73.12 111.356 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.07 67.2 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.236 0.541 . . . . 55.3 110.225 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.26 -30.53 71.18 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.834 -0.621 . . . . 72.24 110.642 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -61.03 -38.1 84.9 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.003 0.43 . . . . 74.52 110.565 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.63 -43.87 86.58 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 109.021 -0.733 . . . . 62.13 109.021 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -62.24 -47.79 82.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.202 -0.908 . . . . 63.22 110.266 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -66.83 -33.09 74.84 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 113.612 0.967 . . . . 72.12 113.612 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.5 80.89 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.432 0.634 . . . . 71.1 110.122 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.8 m -75.29 -44.61 44.76 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.494 -0.776 . . . . 45.31 109.641 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 53.2 mt-30 -63.85 -27.7 69.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.765 0.426 . . . . 74.33 111.486 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 133' ' ' THR . 3.3 tm? -64.87 -37.05 86.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.328 -0.99 . . . . 74.41 108.328 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.33 -33.14 67.1 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.851 -0.613 . . . . 74.32 110.447 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -35.1 79.75 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.648 -0.706 . . . . 74.04 109.952 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 151' ' ' LEU . 8.9 t -77.86 -32.87 52.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.546 -0.462 . . . . 51.54 110.568 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.01 9.26 2.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.208 0.447 . . . . 71.32 112.208 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.43 24.51 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.664 -1.606 . . . . 65.11 106.664 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.38 47.74 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.263 -0.97 . . . . 64.55 111.374 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 55.8 p -118.82 158.17 48.31 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.84 -0.8 . . . . 62.24 108.84 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.95 20.3 1.18 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.179 1.919 . . . . 73.41 112.22 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.72 127.46 31.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.124 -0.489 . . . . 44.32 111.995 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.8 p -104.56 156.34 18.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.021 -1.103 . . . . 75.03 108.021 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.447 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 31.4 m-85 -136.59 157.53 46.55 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.073 -0.651 . . . . 72.42 109.753 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -143.04 123.92 14.28 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.361 -0.536 . . . . 63.32 112.272 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.64 -0.27 28.19 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.535 -0.757 . . . . 64.35 114.417 175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 64.56 8.53 4.44 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.388 1.075 . . . . 72.42 111.765 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 87' ' ' PHE . 7.3 p -66.17 139.42 21.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.701 0.763 . . . . 60.15 111.881 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.411 ' HB3' HD22 ' A' ' 187' ' ' LEU . 47.5 p90 -143.56 168.57 19.54 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.95 -1.023 . . . . 73.43 109.179 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 94.1 m-85 -114.93 147.6 39.78 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 120.951 0.405 . . . . 71.13 110.375 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 66.0 m -114.79 123.74 49.98 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.913 -1.884 . . . . 75.32 105.913 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.98 131.41 47.45 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.498 0.666 . . . . 74.34 112.184 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.68 165.04 37.87 Favored Glycine 0 N--CA 1.422 -2.251 0 N-CA-C 108.779 -1.728 . . . . 65.44 108.779 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -66.34 -28.19 68.47 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 118.235 1.018 . . . . 64.11 108.53 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -156.15 141.83 12.72 Favored Pre-proline 0 N--CA 1.427 -1.623 0 CA-C-N 113.906 -1.497 . . . . 73.54 107.067 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -79.51 120.09 4.3 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.111 1.874 . . . . 70.11 108.488 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.4 127.54 15.87 Favored 'Trans proline' 0 N--CA 1.439 -1.706 0 C-N-CA 120.669 0.913 . . . . 72.25 113.356 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 55.9 mtm -96.75 -26.95 14.96 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.879 -1.897 . . . . 64.52 105.879 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -84.41 135.76 40.88 Favored Pre-proline 0 N--CA 1.418 -2.07 0 CA-C-N 113.037 -1.892 . . . . 74.21 107.899 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 138' ' ' TYR . 30.3 Cg_endo -58.59 -12.86 15.36 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 124.982 3.788 . . . . 71.34 118.094 -172.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -70.3 -81.8 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 119.076 0.853 . . . . 72.53 112.513 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 46.89 76.02 0.16 Allowed Glycine 0 N--CA 1.475 1.275 0 O-C-N 123.88 0.737 . . . . 73.2 113.979 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.593 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 71.9 ttt180 -75.45 -36.32 60.74 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.933 -0.707 . . . . 73.11 111.623 -176.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.631 ' O ' ' HD2' ' A' ' 182' ' ' ARG . 1.3 ppt_? -102.75 129.41 49.38 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.24 -0.984 . . . . 74.34 112.477 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -145.02 153.76 41.81 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.044 -0.525 . . . . 70.21 110.197 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 42.7 mt-10 -138.14 132.05 31.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.592 0.357 . . . . 72.24 110.288 173.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.458 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 96.5 t -128.95 118.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.271 -1.011 . . . . 74.12 108.271 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 11.3 m0 -107.65 121.03 43.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 108.918 -0.771 . . . . 72.22 108.918 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 167' ' ' TYR . 0.8 OUTLIER -100.58 134.82 42.97 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.678 -1.971 . . . . 72.53 105.678 178.013 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.04 124.79 45.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 120.619 -0.432 . . . . 53.0 112.068 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 161' ' ' THR . 82.8 tttt -75.45 133.27 41.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.103 -0.703 . . . . 72.55 109.103 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.255 1.353 0 CA-C-O 118.694 -0.669 . . . . 54.42 110.688 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 112.158 0.429 . . . . 63.34 112.158 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t 63.5 26.68 14.89 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 121.856 0.836 . . . . 61.42 109.704 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -102.02 94.08 5.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.843 -0.617 . . . . 52.41 110.199 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -123.24 110.18 14.9 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.111 -0.7 . . . . 75.31 109.111 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.91 -159.51 25.29 Favored Glycine 0 N--CA 1.424 -2.119 0 C-N-CA 120.084 -1.055 . . . . 73.03 112.52 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.4 t -81.65 103.86 11.65 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.004 0.43 . . . . 64.3 110.318 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.82 106.88 11.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.894 -0.594 . . . . 71.41 110.918 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 62.15 19.22 10.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.841 0.856 . . . . 75.33 111.478 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 p -96.77 98.54 10.23 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 115.489 -0.778 . . . . 73.14 111.81 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -128.05 83.81 65.04 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.507 -0.77 . . . . 71.21 111.347 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -100.19 148.89 0.44 Allowed 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 123.314 2.676 . . . . 43.03 112.404 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.521 ' CD1' ' HG3' ' A' ' 34' ' ' ARG . 37.3 p90 -102.12 149.4 24.32 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.301 -1.0 . . . . 74.01 108.301 175.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.03 0.443 . . . . 61.44 110.791 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.52 123.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.528 -0.916 . . . . 65.01 108.528 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.6 -28.95 18.11 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.051 -0.66 . . . . 73.51 109.901 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t 179.08 158.74 0.59 Allowed 'General case' 0 C--O 1.248 1.011 0 CA-C-N 115.303 -0.862 . . . . 54.23 109.483 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.9 p -131.43 156.53 45.44 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.038 -1.468 . . . . 64.21 107.038 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.49 88.79 0.59 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.894 -1.622 . . . . 73.44 113.581 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.32 -139.94 10.02 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 109.248 -1.541 . . . . 22.15 109.248 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -104.84 110.03 22.23 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 102.582 -3.118 . . . . 71.4 102.582 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.93 133.04 49.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.327 -0.949 . . . . 74.0 112.565 -167.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 153.25 -45.77 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 101.844 -3.391 . . . . 53.3 101.844 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.04 111.85 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 111.788 -2.46 . . . . 72.15 104.699 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -100.48 140.2 35.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.96 -0.385 . . . . 60.22 109.96 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.45 157.71 34.54 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.579 -0.848 . . . . 64.41 112.535 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -134.0 126.67 30.72 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.172 -1.418 . . . . 75.22 107.172 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.45 113.89 26.06 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 106.69 -1.596 . . . . 74.04 106.69 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.521 ' HG3' ' CD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -138.5 145.88 41.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.791 -1.163 . . . . 74.0 113.382 -177.329 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 128' ' ' ILE . . . -86.77 138.35 31.68 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.065 -1.425 . . . . 75.53 107.784 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' SG ' HG13 ' A' ' 128' ' ' ILE . 25.6 p -57.89 168.57 0.92 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.25 0.833 . . . . 50.22 113.25 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -82.85 -18.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.304 -0.862 . . . . 61.33 111.483 -174.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.38 9.42 59.1 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 119.971 -1.109 . . . . 65.53 112.969 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.85 165.07 45.32 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.649 -0.786 . . . . 75.41 113.137 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 46.3 pttt -99.14 131.86 44.87 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.922 -0.399 . . . . 70.42 109.922 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.685 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 40.9 m-85 -127.89 165.27 20.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.527 -0.761 . . . . 71.23 112.101 -169.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.0 116.99 31.34 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.675 -0.861 . . . . 55.03 108.675 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 4.2 t -126.87 143.29 51.31 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-N 115.135 -0.938 . . . . 74.42 112.517 -175.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.2 m -133.32 146.11 32.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.4 -1.273 . . . . 72.03 108.366 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -127.88 126.31 41.32 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.63 -0.428 . . . . 70.34 110.367 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 33.2 t -120.74 130.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.988 -1.486 . . . . 74.55 106.988 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 49' ' ' LYS . 73.5 p -117.97 167.94 10.98 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.317 -0.553 . . . . 71.23 111.416 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 72.8 -25.31 0.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.898 1.279 . . . . 70.02 112.947 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 68.6 mttm -86.28 146.45 42.42 Favored Pre-proline 0 C--N 1.29 -1.985 0 CA-C-N 115.58 -0.736 . . . . 61.3 110.264 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.69 157.27 43.16 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.472 2.115 . . . . 64.31 110.032 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 98' ' ' LEU . 54.0 t -47.49 -42.52 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 113.146 0.795 . . . . 71.33 113.146 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t70 -61.62 -50.9 70.71 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 120.164 -0.614 . . . . 73.21 110.617 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 25.5 mm-40 -58.42 -51.71 68.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.827 -0.624 . . . . 75.53 111.497 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -62.4 -34.84 77.51 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.875 -0.602 . . . . 60.13 110.932 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.01 -34.16 71.06 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.644 -0.253 . . . . 71.34 110.615 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 24.3 mmm180 -67.87 -36.16 79.8 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.099 -0.704 . . . . 75.41 109.099 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.5 mm-40 -73.47 -53.31 10.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.273 -0.876 . . . . 71.11 112.587 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.89 -36.14 62.25 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.372 1.619 . . . . 75.23 115.372 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.6 tpp -55.18 -54.16 53.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 112.681 0.622 . . . . 74.21 112.681 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 63' ' ' MET . 14.0 Cg_endo -57.55 -30.57 88.93 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.472 2.115 . . . . 74.25 112.583 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 53.4 mtpt -65.45 -34.11 77.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.255 0.55 . . . . 73.51 110.913 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.12 -38.54 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.006 0.432 . . . . 61.44 110.824 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 87.6 mtp -66.86 -30.13 70.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.976 0.732 . . . . 73.33 112.976 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -67.75 -45.22 75.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 65.32 109.62 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -62.21 -60.95 2.84 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.16 -0.473 . . . . 70.33 112.072 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 76' ' ' MET . 16.5 m -77.13 -3.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.544 0.688 . . . . 74.43 110.759 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.57 -11.37 59.46 Favored Glycine 0 N--CA 1.418 -2.539 0 CA-C-N 114.984 -1.007 . . . . 52.02 112.392 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.33 -28.81 0.63 Allowed Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.455 -1.355 . . . . 60.11 113.518 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -81.58 55.14 2.56 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.235 1.017 . . . . 64.04 111.253 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.42 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 34.9 m-80 -98.38 149.39 22.71 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 106.061 -1.829 . . . . 62.2 106.061 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.97 -26.95 65.3 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.966 -0.693 . . . . 70.35 111.543 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HB2' HG23 ' A' ' 74' ' ' VAL . 57.3 mtpt -80.43 0.14 34.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.114 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 34.06 66.7 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 121.075 -0.583 . . . . 64.52 112.278 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 72' ' ' LYS . 48.5 t -80.1 143.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 107.776 -1.194 . . . . 51.14 107.776 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.84 -172.77 37.67 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.745 -0.741 . . . . 70.2 112.656 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -78.99 103.68 9.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.406 -0.961 . . . . 71.34 108.406 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -161.13 19.42 0.2 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.335 -0.936 . . . . 53.41 112.478 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.2 ptm -123.1 122.78 39.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.066 -1.053 . . . . 71.21 109.687 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.9 m -127.11 117.85 23.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.621 -0.718 . . . . 70.44 110.365 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.506 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 2.9 m -150.46 166.79 14.33 Favored Pre-proline 0 C--N 1.298 -1.665 0 C-N-CA 124.723 1.209 . . . . 75.14 107.822 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 38.3 Cg_endo -66.23 140.92 60.78 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.291 1.327 . . . . 44.32 113.588 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.9 139.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.085 -1.416 . . . . 64.34 107.94 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 p -127.38 148.79 50.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.636 -0.505 . . . . 72.13 109.636 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -144.35 142.04 30.12 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.63 -0.428 . . . . 73.54 110.157 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -91.89 134.9 34.36 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 109.174 -0.676 . . . . 33.32 109.174 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.49 150.18 26.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-N 114.869 -1.06 . . . . 73.24 108.382 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 1.9 m-85 -121.0 105.11 40.65 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.723 -0.473 . . . . 73.53 109.723 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 158.06 48.98 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.121 1.88 . . . . 75.03 112.984 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -118.09 160.7 21.07 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.578 -0.737 . . . . 71.35 110.453 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.63 -21.68 66.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.485 -0.78 . . . . 73.44 111.254 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.5 -6.92 57.97 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.552 0.691 . . . . 72.14 110.737 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.5 -0.48 85.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.761 -0.733 . . . . 74.15 113.272 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.6 m -96.9 136.31 37.63 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.565 -0.902 . . . . 73.13 108.565 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.4 mt -84.84 87.58 7.34 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.604 -0.438 . . . . 65.53 111.056 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -148.58 113.34 5.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.873 1.064 . . . . 64.11 113.873 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 87' ' ' PHE . 62.5 mttp -168.77 -68.79 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.749 1.22 . . . . 54.41 108.013 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HG2' HG22 ' A' ' 47' ' ' THR . 55.7 mtpt -148.87 153.93 38.75 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.837 -1.529 . . . . 73.31 108.743 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -144.16 127.44 16.74 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.634 -0.876 . . . . 74.43 108.634 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HE3' ' HE1' ' A' ' 101' ' ' TRP . 37.6 ttpt -130.01 115.58 17.33 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.081 0.467 . . . . 54.34 110.408 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' THR . 96.9 t -85.73 138.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.447 -0.797 . . . . 71.12 110.567 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.475 ' HE1' ' HE3' ' A' ' 99' ' ' LYS . 93.4 m95 -128.7 117.18 20.72 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.3 1.04 . . . . 72.25 108.278 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' HG11 ' A' ' 66' ' ' VAL . 83.7 t80 -104.32 118.18 35.99 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.604 -0.517 . . . . 72.51 109.604 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.685 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 34.5 ttm180 -74.57 131.1 40.68 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.817 -0.808 . . . . 74.05 108.817 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.17 140.67 22.51 Favored Pre-proline 0 C--N 1.296 -1.754 0 N-CA-C 109.69 -0.485 . . . . 62.42 109.69 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.47 ' HD3' HG21 ' A' ' 80' ' ' VAL . 8.2 Cg_endo -53.26 144.57 47.98 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.812 2.342 . . . . 72.3 111.523 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -55.01 -35.49 64.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.734 1.013 . . . . 55.33 113.734 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -61.34 -45.04 96.05 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.467 0.651 . . . . 75.32 109.987 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -78.82 -10.64 59.86 Favored 'General case' 0 C--O 1.196 -1.745 0 CA-C-N 115.456 -0.793 . . . . 73.35 111.141 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.405 HE22 ' HE1' ' A' ' 41' ' ' PHE . 21.3 mm-40 -71.0 -28.84 64.71 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.721 -0.392 . . . . 75.35 110.439 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.91 94.76 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.246 -0.742 . . . . 62.42 111.246 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 55.2 p -160.74 90.77 1.63 Allowed Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 109.454 -0.573 . . . . 53.45 109.454 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.29 146.61 36.05 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.346 2.031 . . . . 70.11 110.777 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 138.41 74.64 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.743 1.629 . . . . 73.43 110.109 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 140.34 96.31 Favored Pre-proline 0 C--O 1.256 1.414 0 CA-C-N 116.532 -0.304 . . . . 64.44 110.463 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.38 113.08 2.11 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.147 1.898 . . . . 74.43 110.703 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -90.69 29.89 1.25 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.603 -0.726 . . . . 65.24 109.988 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -138.53 145.98 41.36 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.379 -1.712 . . . . 62.21 106.379 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.71 -24.39 49.19 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.919 0.711 . . . . 64.42 112.919 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 61.1 p -102.95 -13.79 16.76 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.897 0.38 . . . . 71.41 111.851 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.42 116.38 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 105.399 -2.075 . . . . 75.14 105.399 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.71 146.4 50.23 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.238 -0.585 . . . . 50.24 111.212 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.0 mm -93.0 111.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.413 -0.958 . . . . 71.31 108.413 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -119.05 147.77 43.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.16 -0.927 . . . . 73.12 108.96 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -107.74 138.15 44.48 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.327 -0.397 . . . . 70.4 111.626 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -131.15 122.36 26.5 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.185 0.517 . . . . 64.35 110.57 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.408 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -140.23 148.61 41.76 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.574 -0.739 . . . . 62.53 109.124 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.6 20.32 78.48 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.261 -0.971 . . . . 41.55 113.746 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.509 HG13 ' SG ' ' A' ' 36' ' ' CYS . 2.2 pp -119.16 151.91 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.34 -0.944 . . . . 70.53 109.073 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' HD3' ' A' ' 189' ' ' LYS . 46.4 m -121.49 133.54 55.05 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 115.549 -0.751 . . . . 61.32 111.809 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.17 155.8 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 108.324 -0.991 . . . . 53.34 108.324 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -113.57 122.25 46.68 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.794 -1.928 . . . . 75.32 105.794 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 59.4 p -117.17 147.34 42.55 Favored 'General case' 0 C--N 1.269 -2.92 0 C-N-CA 120.344 -0.542 . . . . 73.43 111.999 -173.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.527 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -126.01 130.57 51.44 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 115.231 -0.895 . . . . 64.53 108.954 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -113.81 126.37 55.13 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.978 0.894 . . . . 74.14 109.169 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -130.81 137.81 49.59 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 114.408 -1.269 . . . . 72.22 110.65 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.77 127.32 7.19 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.337 -0.705 . . . . 72.32 111.337 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 153.79 -143.13 9.78 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 109.029 -1.628 . . . . 33.43 109.029 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -99.83 110.57 22.94 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 117.412 0.606 . . . . 73.41 110.002 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.78 139.45 44.82 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.214 -0.662 . . . . 54.2 109.214 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.43 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 22.1 ttmm -114.89 169.28 9.2 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.303 -2.11 . . . . 43.14 105.303 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.65 -39.8 58.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.207 0.527 . . . . 63.53 111.598 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.2 66.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.617 -0.72 . . . . 72.41 111.071 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 31.8 t70 -73.46 -30.29 63.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.147 -0.479 . . . . 74.34 111.01 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -59.0 -50.5 73.87 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.115 -0.698 . . . . 73.42 109.115 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.8 t -61.73 -42.09 93.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.85 -1.068 . . . . 72.24 109.459 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.39 -46.57 88.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.529 -0.76 . . . . 73.43 110.887 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.559 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 40.5 m80 -64.24 -39.81 94.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 112.489 0.551 . . . . 60.21 112.489 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -60.77 -43.22 98.31 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.242 0.544 . . . . 73.53 110.015 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.401 HG23 ' NH2' ' A' ' 152' ' ' ARG . 88.2 m -62.73 -47.12 84.94 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 123.822 0.849 . . . . 44.24 110.022 177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -58.79 -42.9 90.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.66 0.784 . . . . 73.02 109.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 77.5 mt -57.74 -40.89 80.73 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.431 -0.349 . . . . 62.24 111.744 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 20.8 mtm180 -65.2 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.34 0.591 . . . . 72.24 110.028 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 m -72.95 -36.91 67.26 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.267 -0.879 . . . . 71.41 109.709 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.5 m -77.77 -37.82 48.12 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 116.085 -0.507 . . . . 63.01 111.394 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.77 -5.11 41.56 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.344 0.593 . . . . 75.55 111.26 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.74 120.61 20.51 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.747 -1.205 . . . . 71.21 107.747 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.44 47.52 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.381 -0.914 . . . . 51.01 111.843 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.7 p -118.5 166.18 14.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.461 -0.941 . . . . 71.14 108.461 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 10.69 1.79 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.401 2.067 . . . . 63.22 112.759 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.9 126.15 35.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.911 0.386 . . . . 51.53 111.9 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.4 p -100.98 151.97 21.14 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.458 -0.571 . . . . 53.44 109.458 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.81 148.0 33.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.183 0.447 . . . . 72.31 110.405 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -129.14 139.37 51.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.123 0.786 . . . . 75.35 113.123 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.68 -0.08 29.5 Favored Glycine 0 C--O 1.236 0.239 0 CA-C-N 115.444 -0.798 . . . . 70.31 114.33 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 61.92 10.71 3.71 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.198 0.999 . . . . 71.35 111.676 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.56 138.28 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.41 0.624 . . . . 74.43 110.292 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -145.62 169.91 17.5 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.545 -0.752 . . . . 73.45 110.027 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 85.5 m-85 -115.52 148.35 39.61 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.056 -0.52 . . . . 74.44 110.104 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.55 125.52 53.89 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.343 -1.725 . . . . 63.23 106.343 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -130.77 149.11 52.56 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 111.747 0.277 . . . . 70.34 111.747 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.44 160.31 32.98 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 111.027 -0.829 . . . . 60.24 111.027 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 81' ' ' PRO . 2.8 m-85 -91.73 -8.98 45.37 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.051 0.54 . . . . 62.44 110.99 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -139.63 134.44 16.21 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.392 -0.595 . . . . 73.11 109.392 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.64 113.42 3.3 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.983 1.789 . . . . 64.23 108.69 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.91 130.14 26.73 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.874 1.716 . . . . 42.25 112.443 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 27.9 ttt -93.56 -36.04 12.6 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.751 -1.203 . . . . 71.41 107.751 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -96.04 173.82 3.92 Favored Pre-proline 0 N--CA 1.429 -1.523 0 N-CA-C 107.005 -1.479 . . . . 71.42 107.005 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -70.64 -14.46 33.33 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 121.908 1.739 . . . . 61.34 112.2 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -64.91 105.88 1.12 Allowed 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.521 0.729 . . . . 74.42 112.932 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -108.24 105.93 2.26 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 107.955 -2.058 . . . . 74.34 107.955 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -89.58 -40.31 12.7 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.279 1.215 . . . . 71.22 114.279 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -128.97 127.41 41.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.325 -1.732 . . . . 71.41 106.325 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -145.17 156.2 43.73 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.116 -0.633 . . . . 74.12 109.865 -171.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.4 mt-10 -129.33 147.91 51.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.793 -0.447 . . . . 74.24 109.793 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 132' ' ' SER . 73.9 t -125.24 118.71 53.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.091 -1.448 . . . . 61.11 107.091 173.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.4 m0 -106.45 120.83 42.95 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.473 -0.936 . . . . 74.45 108.473 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 58.3 tp -98.29 128.65 44.83 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.519 -1.289 . . . . 63.04 107.519 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.08 135.27 27.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.119 0.485 . . . . 63.13 111.646 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' THR . 21.0 pttp -77.1 143.28 39.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.78 -0.645 . . . . 71.11 111.886 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.421 0 CA-C-O 118.062 -0.97 . . . . 73.44 109.007 176.07 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.741 0.305 . . . . 72.41 110.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 m -103.81 113.37 26.84 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 109.006 -0.739 . . . . 70.34 109.006 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 12' ' ' SER . 5.5 mp -83.47 88.95 7.0 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.147 -0.479 . . . . 71.42 110.721 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -75.06 95.8 3.11 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.528 -0.916 . . . . 74.0 108.528 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.42 -4.17 5.51 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 111.179 -0.768 . . . . 73.14 111.179 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.447 ' HB2' ' CB ' ' A' ' 9' ' ' LEU . 20.8 t -70.76 134.32 47.31 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.115 -1.439 . . . . 70.51 107.115 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.1 t -110.46 94.77 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-O 121.349 0.595 . . . . 62.11 111.423 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HB2' ' HA2' ' A' ' 110' ' ' GLY . 1.1 mp0 -89.31 -37.18 15.1 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.076 -1.083 . . . . 74.43 108.076 173.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 m -88.08 82.83 7.08 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 106.189 -1.782 . . . . 72.03 106.189 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.4 t-105 -85.54 139.8 35.86 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.25 -0.886 . . . . 73.33 110.046 -172.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.0 149.85 33.26 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.909 2.406 . . . . 73.11 111.859 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.9 p90 -101.19 149.54 23.88 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.588 -0.893 . . . . 73.44 108.588 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.79 107.96 19.22 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.027 -0.731 . . . . 62.33 109.027 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.34 116.91 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.657 -1.156 . . . . 64.03 109.711 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -90.3 -29.17 18.29 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.294 0.479 . . . . 64.52 112.294 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -173.55 154.94 2.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.049 0.452 . . . . 22.33 109.818 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.15 157.03 45.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.316 -0.994 . . . . 73.43 108.316 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.69 -158.8 27.83 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.499 -1.334 . . . . 63.23 113.017 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.02 -119.78 4.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.415 -0.674 . . . . 60.42 111.415 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -116.44 171.28 7.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 110.134 -0.321 . . . . 74.24 110.134 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 43.9 mt-10 -85.0 156.89 20.94 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.231 -1.766 . . . . 72.13 106.231 166.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 14.6 t70 78.15 -45.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.524 0.73 . . . . 73.42 110.533 -171.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.34 108.93 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 108.715 -0.846 . . . . 62.33 108.715 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.4 m -124.38 134.04 53.24 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.62 -1.252 . . . . 72.43 107.62 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -113.31 161.67 16.96 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.358 0.873 . . . . 75.13 113.358 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -133.08 125.13 28.92 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.478 -1.675 . . . . 64.04 106.478 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.45 114.0 26.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 106.989 -1.486 . . . . 75.2 106.989 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -141.39 144.34 34.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.402 0.519 . . . . 75.53 112.402 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.49 136.23 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.288 -1.745 . . . . 72.34 106.288 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.422 ' SG ' HG13 ' A' ' 128' ' ' ILE . 83.0 m -63.91 153.87 35.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.13 0.789 . . . . 72.24 113.13 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -75.09 -34.77 61.78 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.165 -0.925 . . . . 72.45 111.016 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 91.9 10.98 60.8 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 118.454 -1.831 . . . . 74.21 112.095 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.23 164.14 52.33 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 111.052 -0.819 . . . . 22.03 111.052 -176.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -88.64 129.67 35.46 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.939 -0.763 . . . . 74.21 108.939 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 36.3 m-85 -126.89 165.4 19.43 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.582 -0.735 . . . . 72.31 110.027 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.412 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.34 116.37 30.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.7 -1.222 . . . . 75.03 107.7 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.8 t -131.86 146.85 52.36 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.566 0.698 . . . . 72.22 112.137 -175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG21 ' HD2' ' A' ' 61' ' ' LYS . 7.5 p -133.28 138.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 107.366 -1.346 . . . . 73.25 107.366 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 16.5 pt-20 -126.71 139.07 53.42 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.264 -0.574 . . . . 62.32 111.19 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 50.0 t -127.5 140.08 50.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.385 -1.339 . . . . 62.32 107.385 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.1 p -125.49 163.22 23.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.989 0.737 . . . . 72.13 112.989 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 68.44 6.03 5.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.123 1.369 . . . . 74.44 112.877 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 88.4 mttt -124.87 147.25 55.88 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 116.513 -0.312 . . . . 75.2 110.361 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 46.9 Cg_exo -58.95 156.58 32.84 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.693 2.262 . . . . 64.32 110.829 173.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 25.1 t -48.12 -43.3 11.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 113.111 0.782 . . . . 71.23 113.111 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -59.54 -41.74 90.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.931 0.396 . . . . 34.12 111.449 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 8.3 mm-40 -73.46 -46.45 48.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 64.04 110.809 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.81 -44.02 94.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.482 -0.781 . . . . 62.3 111.073 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.1 -42.05 85.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.857 -0.611 . . . . 71.11 111.649 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -64.43 -28.11 69.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.033 0.753 . . . . 74.45 113.033 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.2 -33.8 24.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.02 0.438 . . . . 72.25 111.613 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.83 -32.7 59.91 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.556 0.576 . . . . 51.54 112.556 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.538 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 5.9 mmt -53.0 -56.84 19.58 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.32 1.23 . . . . 73.33 114.32 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.15 -31.65 84.19 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.197 1.931 . . . . 72.12 111.841 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.594 ' HD3' ' HB2' ' A' ' 119' ' ' SER . 91.3 mttt -65.45 -41.02 93.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.145 -0.479 . . . . 63.15 110.751 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.15 -38.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.343 0.592 . . . . 73.44 110.008 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.27 -30.66 71.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.207 0.817 . . . . 43.1 113.207 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.02 -29.69 60.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.218 0.533 . . . . 61.43 109.925 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -64.57 -60.97 2.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.533 -0.758 . . . . 74.01 110.957 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 p -75.48 -17.96 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.437 0.637 . . . . 64.23 110.485 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.4 -28.39 73.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.976 -0.556 . . . . 30.31 113.139 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.684 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.64 3.33 6.04 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.189 -1.005 . . . . 73.1 112.852 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.4 m -95.23 22.41 6.82 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.811 0.815 . . . . 51.15 109.948 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.41 ' HA ' ' OG ' ' A' ' 116' ' ' SER . 7.9 p30 -88.07 172.73 9.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 74.42 110.827 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 9.2 t70 -67.72 -34.32 76.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.89 -0.595 . . . . 51.02 112.518 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -78.75 -12.45 60.02 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.434 0.635 . . . . 65.03 109.683 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.69 25.07 75.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.446 -0.797 . . . . 74.4 112.645 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.684 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 34.1 m -90.41 146.79 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 120.066 -0.653 . . . . 74.4 109.888 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.99 -153.46 19.86 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.945 -0.862 . . . . 64.5 110.945 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.6 ttt -80.57 72.08 7.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.007 0.908 . . . . 74.14 110.204 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.96 3.05 41.17 Favored Glycine 0 N--CA 1.438 -1.202 0 CA-C-N 114.729 -1.123 . . . . 71.35 110.976 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.8 ptm -125.11 121.66 34.89 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.667 -0.864 . . . . 71.35 108.667 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -126.84 116.22 20.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.218 -0.446 . . . . 64.54 111.81 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 103' ' ' ARG . 57.4 t -150.47 139.39 13.01 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 105.52 -2.03 . . . . 71.54 105.52 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.97 138.97 88.51 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 121.344 1.363 . . . . 71.12 110.427 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.85 139.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.963 -0.754 . . . . 71.31 108.963 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 m -118.98 145.05 46.14 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.864 -0.791 . . . . 74.35 108.864 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -132.42 137.0 47.14 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 119.949 -0.7 . . . . 72.12 109.658 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.94 135.14 34.42 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.499 -0.773 . . . . 52.31 109.008 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.77 149.71 25.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 54.52 107.798 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.651 ' CE2' ' HE3' ' A' ' 97' ' ' LYS . 67.5 m-85 -119.19 99.78 50.48 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 107.186 -1.413 . . . . 74.45 107.186 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.49 158.9 50.29 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.543 2.162 . . . . 63.43 114.542 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -103.53 160.15 14.98 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.673 -1.603 . . . . 74.23 106.673 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.2 -17.5 64.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.061 0.458 . . . . 73.11 111.795 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.54 -7.3 56.08 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.957 -0.565 . . . . 53.12 110.983 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.72 -6.06 84.01 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.696 -0.764 . . . . 72.3 112.295 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.1 m -83.94 136.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.11 0.481 . . . . 62.32 110.332 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 89.0 mt -93.59 98.63 11.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.728 0.775 . . . . 74.01 111.193 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 29.6 tt0 -148.13 170.43 17.84 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.795 -1.187 . . . . 73.11 107.795 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 105.09 -65.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 126.697 1.999 . . . . 73.31 112.255 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HE3' ' CE2' ' A' ' 87' ' ' PHE . 33.7 ttpt -159.24 150.05 19.72 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.482 -0.326 . . . . 74.31 110.649 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.472 HD12 HG13 ' A' ' 51' ' ' VAL . 5.0 tt -142.84 136.56 28.86 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.022 -1.103 . . . . 71.41 108.022 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 68.2 mttm -122.02 115.67 22.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.469 -0.567 . . . . 75.13 109.469 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 43' ' ' THR . 87.7 t -88.41 128.05 40.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.899 -1.149 . . . . 63.03 107.899 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.11 123.86 46.62 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.293 -0.632 . . . . 73.45 109.293 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -102.99 112.61 25.53 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.471 -1.677 . . . . 64.22 106.471 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 80' ' ' VAL . 1.1 tmt_? -76.84 113.06 14.11 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.957 -1.498 . . . . 70.23 106.957 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 40' ' ' LYS . 76.8 mt -73.36 138.7 78.21 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 115.926 -0.579 . . . . 60.04 110.555 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.7 161.32 45.83 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.504 2.136 . . . . 73.32 112.002 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -50.4 -35.22 27.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.296 1.438 . . . . 74.24 111.081 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.04 -42.96 99.47 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.419 0.688 . . . . 72.52 111.992 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -99.76 -1.74 36.93 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 114.011 1.115 . . . . 73.44 114.011 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.714 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -62.97 -28.75 70.3 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.421 1.267 . . . . 63.12 114.421 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 14' ' ' GLU . . . -76.1 -39.38 32.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.89 -1.147 . . . . 52.54 111.942 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.9 m -149.0 94.4 4.03 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 109.251 -0.648 . . . . 74.31 109.251 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.63 158.1 12.26 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.417 2.078 . . . . 74.23 111.638 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.46 131.68 46.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.985 1.79 . . . . 55.33 109.943 175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -66.23 140.27 96.77 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.319 -0.401 . . . . 73.24 110.358 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.61 101.5 1.04 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.438 2.092 . . . . 70.33 111.952 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 11.4 p -81.02 2.19 28.08 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.605 1.162 . . . . 72.43 111.886 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.542 ' HB3' HG12 ' A' ' 120' ' ' VAL . 13.1 t70 -113.27 152.69 29.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.415 -0.957 . . . . 74.51 108.415 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -13.16 45.5 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 115.372 1.619 . . . . 70.44 115.372 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.594 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 71.9 m -97.85 -28.84 13.66 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.152 -0.619 . . . . 73.45 111.898 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 117' ' ' ASP . 6.8 p -94.68 128.04 46.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.844 -0.743 . . . . 63.13 109.478 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -124.49 153.29 42.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.996 -0.742 . . . . 64.33 108.996 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.9 mm -92.45 111.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 72.33 107.793 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -127.0 145.74 50.6 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.519 -0.764 . . . . 53.04 109.887 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.45 144.99 33.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.845 -0.798 . . . . 55.45 108.845 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.6 tpt180 -134.85 123.06 22.91 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.445 -0.902 . . . . 63.13 109.901 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.56 173.79 11.22 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.529 -0.545 . . . . 64.13 109.529 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.11 19.03 70.64 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.822 -0.626 . . . . 51.14 112.617 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.422 HG13 ' SG ' ' A' ' 36' ' ' CYS . 43.3 pt -128.37 145.53 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 121.17 0.51 . . . . 73.5 111.02 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 60.0 m -104.07 129.72 51.74 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 107.449 -1.315 . . . . 62.13 107.449 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.25 151.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.43 -0.581 . . . . 62.5 109.43 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 72.0 m-85 -114.04 121.48 43.97 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.308 -1.738 . . . . 64.44 106.308 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.5 m -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 109.869 -0.419 . . . . 70.45 109.869 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.0 t -118.32 131.38 56.33 Favored 'General case' 0 N--CA 1.411 -2.4 0 C-N-CA 120.391 -0.523 . . . . 71.35 110.067 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.654 ' HG2' ' HG3' ' A' ' 184' ' ' GLU . 51.4 mt-30 -110.84 128.36 55.75 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.089 -1.078 . . . . 74.0 108.089 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.2 p90 -114.68 135.68 53.89 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 115.309 -0.86 . . . . 74.55 110.563 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.14 101.57 2.61 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.408 -1.077 . . . . 55.15 110.408 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.06 167.82 27.28 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.231 -0.748 . . . . 61.52 111.231 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 54.3 p90 -75.44 139.72 42.46 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 110.124 -0.324 . . . . 72.32 110.124 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -116.04 123.76 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.549 0.69 . . . . 34.22 112.246 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.449 ' HG2' ' OE2' ' A' ' 141' ' ' GLU . 26.3 ttpp -115.68 170.53 8.38 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 104.721 -2.326 . . . . 75.2 104.721 172.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -51.54 -42.86 62.11 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.901 0.773 . . . . 73.43 113.058 -174.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.5 67.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.469 -0.332 . . . . 64.33 111.828 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -69.07 -37.11 78.33 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.968 -0.293 . . . . 70.14 111.112 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.69 -42.55 88.83 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.672 -0.492 . . . . 73.33 109.672 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.72 -40.7 84.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.424 -0.807 . . . . 74.41 109.794 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -61.93 -47.6 84.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 74.33 111.24 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -69.04 -33.52 73.72 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 112.228 0.455 . . . . 74.31 112.228 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.29 92.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.177 0.513 . . . . 73.52 109.969 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 76.5 m -62.91 -46.93 85.49 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.675 -0.693 . . . . 64.42 110.125 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 25.8 mt-30 -59.92 -38.36 82.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.107 -0.497 . . . . 55.14 110.359 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.25 -43.58 96.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.845 -0.616 . . . . 71.53 110.995 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -63.39 -39.18 93.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 65.14 109.61 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -71.78 -30.81 65.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.203 -0.908 . . . . 74.21 111.133 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.7 m -76.74 -34.69 58.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.282 0.563 . . . . 52.25 109.67 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.96 7.71 12.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.928 -0.578 . . . . 62.51 111.027 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -74.49 130.64 39.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.331 -0.618 . . . . 64.53 109.331 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.23 3.45 58.81 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.939 -0.648 . . . . 52.52 112.128 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 54.5 p -112.18 165.64 12.55 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.764 -0.828 . . . . 73.32 108.764 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.28 14.93 0.53 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.764 2.31 . . . . 71.44 112.872 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.67 109.83 3.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.084 0.469 . . . . 44.51 110.562 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.6 p -95.97 156.54 16.29 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.909 -1.145 . . . . 74.13 107.909 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.505 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 19.9 m-85 -132.64 151.27 52.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.595 -0.842 . . . . 74.14 109.277 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -127.3 122.33 33.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.002 0.43 . . . . 74.41 111.32 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.09 0.73 37.03 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.334 -0.848 . . . . 74.3 113.352 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.63 18.47 10.56 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.561 1.172 . . . . 53.44 109.366 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.27 139.22 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 113.724 -1.58 . . . . 74.22 112.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.445 ' OH ' HD21 ' A' ' 94' ' ' LEU . 11.4 p90 -149.41 167.66 25.56 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.194 -0.912 . . . . 65.33 110.747 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 2.8 m-85 -116.0 153.47 31.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 123.586 0.754 . . . . 71.11 109.557 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.9 m -124.03 131.41 53.55 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.252 -1.388 . . . . 63.35 107.252 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.77 148.11 51.61 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.544 0.572 . . . . 74.32 112.544 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.84 165.85 39.04 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 108.647 -1.781 . . . . 73.41 108.647 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -57.56 -37.61 73.4 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.448 1.124 . . . . 71.0 109.619 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -156.36 142.81 13.23 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 106.327 -1.731 . . . . 74.35 106.327 172.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.99 117.48 3.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.536 2.158 . . . . 55.14 109.518 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -54.07 127.33 25.29 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.483 2.122 . . . . 53.02 115.526 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.57 -35.41 11.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 103.518 -2.771 . . . . 52.41 103.518 167.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -109.83 126.71 28.49 Favored Pre-proline 0 N--CA 1.421 -1.911 0 N-CA-C 104.845 -2.28 . . . . 74.34 104.845 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 138' ' ' TYR . 35.1 Cg_endo -63.16 -14.74 43.69 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.813 2.342 . . . . 51.2 113.595 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.46 147.17 53.67 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.69 0.757 . . . . 71.14 112.794 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.88 134.69 3.09 Favored Glycine 0 C--N 1.3 -1.443 0 N-CA-C 107.215 -2.354 . . . . 65.21 107.215 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -96.9 -28.39 14.23 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 115.721 1.749 . . . . 75.24 115.721 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 182' ' ' ARG . 0.7 OUTLIER -117.08 130.37 56.6 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 118.2 -1.4 . . . . 73.42 110.269 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 40.4 m-80 -144.16 148.02 34.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.854 -1.165 . . . . 74.15 107.854 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.654 ' HG3' ' HG2' ' A' ' 134' ' ' GLN . 2.5 mp0 -112.04 144.36 41.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.115 0.484 . . . . 71.11 110.873 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 57.8 t -125.52 118.84 53.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.366 -1.716 . . . . 73.14 106.366 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.495 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 27.9 m0 -106.52 120.77 42.81 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.131 -0.692 . . . . 74.33 109.131 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 tp -98.88 133.94 42.46 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.363 -1.347 . . . . 62.22 107.363 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.25 126.86 45.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.328 -0.549 . . . . 71.12 111.32 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.2 tttm -75.14 137.85 41.64 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.886 -0.597 . . . . 74.54 109.808 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.301 -1.528 0 CA-C-O 118.259 -0.877 . . . . 73.52 108.86 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 . . . . . 0 CA--C 1.501 -0.904 0 N-CA-C 109.67 -0.493 . . . . 71.11 109.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.3 p -149.04 88.62 1.61 Allowed 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.786 -0.643 . . . . 52.43 109.532 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.1 tp -153.72 -72.07 0.13 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.777 -1.194 . . . . 72.35 107.777 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 61.29 173.84 0.11 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.337 1.055 . . . . 75.55 113.467 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.97 -79.91 1.83 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.885 -0.598 . . . . 74.21 112.174 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.2 m -85.14 82.08 8.57 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.356 0.598 . . . . 73.12 111.931 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -120.28 95.46 3.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.27 -1.011 . . . . 75.44 108.27 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.2 111.58 24.38 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.333 -0.849 . . . . 71.52 112.44 -171.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 p -102.7 -69.45 0.79 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.561 -0.903 . . . . 75.12 108.561 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -138.9 81.16 22.7 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 112.27 0.47 . . . . 74.33 112.27 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -99.0 149.09 0.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.469 2.779 . . . . 62.45 111.954 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -102.46 148.66 25.23 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.47 -0.937 . . . . 74.21 108.47 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -106.63 115.44 30.21 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.371 -0.377 . . . . 73.34 111.397 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 121.05 41.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.739 0.781 . . . . 71.12 109.966 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.24 -24.16 15.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.608 -0.723 . . . . 71.31 111.754 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -165.93 148.5 7.33 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.868 0.366 . . . . 74.44 110.29 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.9 p -134.56 164.31 27.78 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.95 -1.023 . . . . 74.54 110.321 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.94 -136.34 12.86 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 119.964 -1.112 . . . . 64.55 113.809 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.31 -108.26 2.89 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.85 -1.3 . . . . 73.45 109.85 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -108.9 168.02 9.66 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.458 -1.312 . . . . 72.01 107.458 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.65 154.08 25.08 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 118.62 0.646 . . . . 65.25 111.223 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 72.58 -64.77 0.38 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.93 1.292 . . . . 74.35 110.321 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.9 t -92.6 109.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.756 -1.942 . . . . 73.13 105.756 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 m -133.4 154.31 50.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.907 -0.775 . . . . 52.33 108.907 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.32 160.56 18.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.513 0.673 . . . . 74.04 111.668 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.92 124.95 25.74 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.832 -1.914 . . . . 71.12 105.832 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.86 114.08 27.85 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.221 -1.77 . . . . 74.33 106.221 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.22 146.65 52.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.413 0.625 . . . . 72.33 111.652 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.82 136.14 33.51 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.745 -1.576 . . . . 71.43 106.745 172.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -60.44 162.57 6.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.53 0.937 . . . . 55.02 113.53 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -83.69 -20.77 32.91 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.656 -0.702 . . . . 64.24 110.42 -177.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 95.57 11.1 56.11 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 119.362 -1.399 . . . . 73.43 112.077 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.21 160.71 54.1 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 120.877 -0.678 . . . . 51.42 112.923 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 17.1 ptpt -96.76 130.68 43.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.948 -0.76 . . . . 74.23 108.948 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.468 ' HD1' ' H ' ' A' ' 104' ' ' ILE . 58.9 m-85 -130.66 164.43 25.02 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.509 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.34 120.09 38.14 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 107.762 -1.199 . . . . 62.11 107.762 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.638 ' OG1' ' HE2' ' A' ' 99' ' ' LYS . 9.4 t -135.19 150.49 50.14 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 119.911 -0.716 . . . . 61.32 112.038 -174.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 18.8 m -134.85 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.897 -1.047 . . . . 74.21 109.739 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HB2' ' CD ' ' A' ' 99' ' ' LYS . 34.9 tt0 -123.81 139.8 53.62 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.813 -0.439 . . . . 51.33 109.813 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 58' ' ' ALA . 52.8 t -127.32 133.12 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.328 -1.36 . . . . 74.12 107.328 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 36.2 m -133.14 157.1 46.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.336 -0.616 . . . . 73.12 109.336 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 79.6 -9.38 1.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.794 1.637 . . . . 64.21 109.359 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.5 mttm -111.22 131.53 22.18 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.16 -1.382 . . . . 63.34 109.049 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.24 158.48 35.03 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.053 2.502 . . . . 73.44 110.787 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 98' ' ' LEU . 39.3 t -45.95 -37.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.06 0.944 . . . . 71.23 112.976 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.55 -51.11 69.82 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.216 0.532 . . . . 44.13 110.561 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -76.41 -37.44 57.08 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.176 -0.92 . . . . 62.34 112.237 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.82 91.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.006 -0.543 . . . . 71.51 112.01 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -48.18 77.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.339 -0.615 . . . . 61.21 109.339 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.69 -24.29 66.24 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.792 -0.64 . . . . 73.43 111.983 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 10.4 tp10 -84.5 -45.5 12.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.515 0.674 . . . . 73.44 110.291 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.74 -39.65 69.91 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.596 0.961 . . . . 72.42 113.596 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.433 ' SD ' ' HG3' ' A' ' 174' ' ' PRO . 35.5 ttm -57.73 -46.72 99.72 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 114.196 1.184 . . . . 75.32 114.196 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 83.6 Cg_exo -50.89 -37.4 55.68 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.391 2.06 . . . . 74.15 111.233 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HD2' ' CB ' ' A' ' 119' ' ' SER . 43.5 mtmt -68.77 -37.01 79.03 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.683 -0.69 . . . . 75.02 110.792 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.0 mm -76.39 -47.63 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 112.18 0.437 . . . . 74.43 112.18 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 25.0 ptm -62.59 -29.58 70.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.663 0.986 . . . . 71.23 113.663 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.67 -36.27 82.13 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.196 -0.602 . . . . 64.41 110.107 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -56.69 -59.43 5.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.243 -0.435 . . . . 74.33 111.813 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.85 -17.0 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 62.33 110.264 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.86 -14.27 82.53 Favored Glycine 0 C--O 1.24 0.508 0 CA-C-N 115.92 -0.582 . . . . 72.05 113.275 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.19 4.11 2.35 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.684 -1.246 . . . . 60.21 114.552 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.0 m -91.35 23.51 3.35 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 123.077 1.418 . . . . 64.24 110.412 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 114' ' ' ALA . 7.8 p30 -98.73 170.28 8.89 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.099 -0.955 . . . . 75.44 110.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.94 -27.46 62.81 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 111.844 0.313 . . . . 72.2 111.844 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -86.05 -12.41 50.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.56 0.695 . . . . 74.11 110.525 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 31.84 63.2 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 115.319 -0.855 . . . . 63.12 112.518 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.11 123.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.319 -0.552 . . . . 72.3 110.758 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.37 -40.36 1.14 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 110.902 -0.879 . . . . 73.34 110.902 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.5 mtt -107.03 81.21 1.52 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.904 -1.517 . . . . 71.54 106.904 173.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.1 -79.32 0.54 Allowed Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.795 -1.193 . . . . 72.41 114.495 -172.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.484 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 24.1 ptt? -127.8 125.2 39.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.118 0.485 . . . . 75.31 111.945 -173.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 p -125.25 115.92 21.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.693 -0.685 . . . . 44.11 111.182 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.449 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 28.6 m -142.26 175.86 2.71 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.767 -1.568 . . . . 61.53 106.767 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 80' ' ' VAL . 39.8 Cg_exo -59.89 140.11 91.4 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 121.55 1.5 . . . . 71.12 113.268 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.95 153.19 8.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.085 -1.45 . . . . 75.21 107.085 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -140.01 145.23 37.53 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.888 -0.508 . . . . 50.43 109.881 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -136.61 143.11 43.38 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.149 -0.62 . . . . 60.15 111.147 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -92.66 135.6 33.95 Favored 'General case' 0 CA--C 1.478 -1.819 0 O-C-N 123.801 0.688 . . . . 70.23 109.774 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.83 149.73 33.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.156 -1.053 . . . . 64.33 108.156 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.589 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 99.3 m-85 -112.25 108.06 55.16 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.176 -0.675 . . . . 72.33 109.176 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -83.6 151.67 13.25 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.626 1.55 . . . . 54.24 112.358 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.03 168.56 10.01 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.007 . . . . 72.12 108.282 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.55 -19.76 65.86 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.069 0.461 . . . . 64.12 111.626 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -81.07 -6.91 59.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 53.01 110.08 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.36 73.37 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.883 -0.599 . . . . 74.03 111.838 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.0 m -74.46 140.48 44.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.067 -0.716 . . . . 74.31 109.067 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.7 139.65 33.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.023 0.44 . . . . 73.22 111.036 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.3 167.82 19.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 124.225 1.01 . . . . 73.24 111.891 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.6 pttt -70.35 21.87 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 126.224 1.81 . . . . 71.41 114.879 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.589 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 24.2 ttmm -139.66 134.72 32.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 119.449 1.022 . . . . 64.22 110.972 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.655 HD12 HG13 ' A' ' 51' ' ' VAL . 6.0 tt -143.07 130.57 21.17 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 107.998 -1.112 . . . . 53.12 107.998 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.638 ' HE2' ' OG1' ' A' ' 43' ' ' THR . 23.6 tptm -116.11 115.3 25.81 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.466 -0.938 . . . . 71.22 108.466 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.54 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 99.3 t -94.25 126.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.893 -0.41 . . . . 72.05 109.893 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -113.04 124.99 53.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.151 0.581 . . . . 61.53 109.564 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -103.12 113.66 27.31 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.639 -1.615 . . . . 65.14 106.639 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -77.29 131.3 38.08 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.461 -0.79 . . . . 75.04 110.494 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 73.3 mt -100.17 133.86 21.22 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-N 115.031 -0.986 . . . . 44.11 108.556 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 31.9 Cg_exo -58.32 151.53 59.8 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.788 2.325 . . . . 62.22 111.229 175.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.31 -34.25 60.55 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.881 0.872 . . . . 42.11 110.076 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -59.68 -34.33 72.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.903 -0.589 . . . . 73.31 111.873 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.53 -3.98 32.24 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 120.816 -0.354 . . . . 70.3 111.521 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 97.7 mt-30 -70.55 -27.89 64.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.89 0.33 . . . . 72.22 111.89 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.87 -38.16 95.71 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.438 -0.665 . . . . 62.55 111.438 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 t -158.28 90.68 2.19 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 108.724 -0.843 . . . . 72.44 108.724 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -85.85 154.86 10.07 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.026 1.817 . . . . 65.21 112.06 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.5 149.23 83.17 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.193 1.929 . . . . 60.21 110.742 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' ASN . . . -86.9 130.29 49.05 Favored Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 116.299 -0.409 . . . . 72.12 111.112 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.44 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 74.0 Cg_endo -76.89 112.59 3.47 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.904 2.403 . . . . 74.42 111.653 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 79.87 2.93 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.54 -0.864 . . . . 73.11 110.87 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.632 ' HB3' HG12 ' A' ' 120' ' ' VAL . 14.9 t70 -169.66 149.0 3.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.298 -1.742 . . . . 74.31 106.298 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.94 -14.97 59.35 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.944 0.72 . . . . 72.32 112.944 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.573 ' CB ' ' HD2' ' A' ' 61' ' ' LYS . 36.9 m -95.4 -29.71 14.29 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.88 -0.328 . . . . 65.41 111.836 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.632 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.9 p -106.25 116.46 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.54 0 CA-C-O 121.821 0.819 . . . . 74.12 110.575 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -130.74 155.24 46.98 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.144 -1.389 . . . . 74.42 110.19 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.0 mm -91.37 112.64 25.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.56 -0.904 . . . . 74.01 108.56 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -115.58 141.84 47.53 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.157 -0.682 . . . . 72.3 109.157 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -111.18 145.84 37.95 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.575 -0.739 . . . . 71.42 109.756 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -146.98 126.93 13.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.309 0.576 . . . . 62.35 110.805 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -133.76 169.96 16.28 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.106 -0.952 . . . . 75.04 110.346 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 16.38 78.7 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.373 -0.441 . . . . 63.4 113.53 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pp -121.23 162.6 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 119.542 -0.863 . . . . 75.51 109.245 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.416 ' H ' ' HG2' ' A' ' 189' ' ' LYS . 41.7 m -120.29 136.99 54.49 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 115.485 -0.78 . . . . 54.55 109.29 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.418 HG21 ' CE3' ' A' ' 186' ' ' TRP . 15.5 m -124.84 146.35 30.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.314 -0.995 . . . . 60.24 108.314 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.557 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 19.9 m-85 -114.95 121.54 43.47 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 105.932 -1.877 . . . . 75.01 105.932 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 p -117.4 131.5 56.75 Favored 'General case' 0 C--N 1.274 -2.712 0 C-N-CA 120.213 -0.595 . . . . 63.13 111.798 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.488 ' HB ' HD13 ' A' ' 151' ' ' LEU . 8.9 t -113.29 119.14 36.68 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 108.187 -1.042 . . . . 72.22 108.187 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -111.15 126.69 55.11 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 109.183 -0.673 . . . . 72.22 109.183 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 36.3 p90 -142.3 153.48 43.92 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 115.179 -0.918 . . . . 72.33 110.901 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.69 145.25 18.24 Favored Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 110.039 -1.224 . . . . 75.32 110.039 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.67 168.16 11.93 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 109.41 -1.476 . . . . 70.12 109.41 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.406 ' CE1' ' HA ' ' A' ' 179' ' ' TYR . 87.1 t80 -68.38 101.54 1.24 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.287 0.565 . . . . 74.23 111.574 -175.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.33 130.85 53.3 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.618 -0.882 . . . . 72.31 108.618 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -89.74 176.91 6.66 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.754 -0.832 . . . . 75.03 108.754 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.41 -31.95 71.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.244 0.545 . . . . 71.2 109.911 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.09 -29.36 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.502 -0.772 . . . . 63.01 109.784 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -69.54 -29.81 67.48 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 116.037 -0.529 . . . . 62.33 111.268 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -59.26 -41.89 89.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.67 -0.412 . . . . 75.11 110.133 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.29 -49.1 84.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.451 -0.795 . . . . 73.11 110.102 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.04 -44.49 84.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.656 . . . . 33.32 111.79 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -63.53 -31.55 72.75 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 112.538 0.57 . . . . 73.25 112.538 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.63 85.3 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.352 -0.61 . . . . 73.02 109.352 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.429 HG23 ' NH2' ' A' ' 152' ' ' ARG . 22.1 m -66.83 -41.31 87.65 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 115.654 -0.703 . . . . 74.4 111.46 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.2 -37.48 85.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.428 . . . . 72.32 109.97 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.488 HD13 ' HB ' ' A' ' 133' ' ' THR . 52.5 tp -62.18 -41.99 98.86 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.723 -0.671 . . . . 72.23 110.224 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.537 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.8 mtm105 -62.22 -46.93 86.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.568 -0.287 . . . . 72.43 111.063 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.2 m -61.59 -34.37 75.5 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.877 0.736 . . . . 72.31 110.431 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 30.0 m -76.99 -35.43 57.16 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.86 -0.609 . . . . 75.2 110.164 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.1 mt -70.05 -31.4 69.0 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 113.354 0.872 . . . . 64.22 113.354 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 46.1 mt-10 -46.31 131.1 10.67 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.621 0.6 . . . . 72.11 112.621 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.64 12.64 43.5 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.516 -1.034 . . . . 52.23 110.516 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.9 t -102.56 149.72 36.98 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 109.06 -0.719 . . . . 61.21 109.06 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -75.18 -4.82 15.91 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.594 2.196 . . . . 74.32 111.173 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.557 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -71.99 147.04 47.29 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.771 -0.65 . . . . 61.45 110.854 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 74.0 p -108.02 138.05 44.95 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.3 -0.63 . . . . 60.12 109.3 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -144.02 150.51 38.36 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 122.29 -0.256 . . . . 62.2 110.938 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.514 ' O ' HG12 ' A' ' 166' ' ' VAL . 29.0 pt20 -129.33 122.84 30.38 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.999 1.111 . . . . 71.34 113.999 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.71 12.79 62.5 Favored Glycine 0 C--N 1.309 -0.964 0 N-CA-C 115.207 0.843 . . . . 63.53 115.207 164.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.401 ' O ' ' HD1' ' A' ' 167' ' ' TYR . 25.4 t70 67.43 19.76 9.99 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.959 0.409 . . . . 41.04 110.641 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 163' ' ' GLN . 7.2 p -64.81 137.95 24.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 120.367 -0.533 . . . . 62.14 109.788 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' ASP . 26.9 p90 -151.12 170.83 18.46 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.701 0.762 . . . . 74.21 111.644 -173.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 97.2 m-85 -114.64 151.65 33.19 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.216 -1.356 . . . . 75.41 109.737 175.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.54 122.16 45.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.506 -1.294 . . . . 73.45 107.506 174.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -112.18 142.41 44.69 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.153 0.283 . . . . 53.11 111.436 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.03 164.56 37.94 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.039 -1.224 . . . . 72.23 110.039 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -73.45 -39.29 65.08 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 118.034 0.917 . . . . 75.15 110.767 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -150.77 158.1 35.47 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 108.785 -0.82 . . . . 64.45 108.785 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.433 ' HG3' ' SD ' ' A' ' 59' ' ' MET . 17.8 Cg_endo -56.24 123.88 14.91 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.772 2.315 . . . . 73.41 111.467 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.55 129.82 31.04 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.727 1.618 . . . . 71.02 110.725 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.65 -21.23 18.34 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.802 0.81 . . . . 71.24 109.743 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -140.0 150.78 63.36 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 104.831 -2.285 . . . . 64.41 104.831 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.12 -14.45 2.65 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.546 2.831 . . . . 61.05 113.264 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.406 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 84.8 t80 -60.86 103.9 0.31 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 123.874 0.869 . . . . 63.21 112.436 176.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -128.73 126.52 5.33 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.166 -1.574 . . . . 71.55 109.166 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -83.78 -55.17 4.41 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 117.568 0.684 . . . . 73.25 110.069 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -109.13 132.94 53.64 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.739 -1.208 . . . . 73.33 107.739 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.442 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.7 m-80 -134.37 134.29 41.56 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.385 -0.969 . . . . 71.4 108.385 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 7.7 mp0 -128.82 136.35 50.37 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.865 -0.42 . . . . 74.3 109.865 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.1 t -124.74 121.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.468 -0.938 . . . . 70.4 108.468 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.6 m0 -103.21 123.15 46.19 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 108.087 -1.079 . . . . 72.31 108.087 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 166' ' ' VAL . 1.7 tt -97.35 138.57 34.61 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.896 -1.52 . . . . 63.11 106.896 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.483 HG22 ' CE2' ' A' ' 168' ' ' TYR . 20.7 t -87.88 131.98 34.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 110.455 -0.202 . . . . 73.24 110.455 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.578 ' HD2' ' C ' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -70.39 143.38 51.9 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 118.551 -0.738 . . . . 65.44 109.333 176.504 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 CA--C 1.51 -0.562 0 N-CA-C 109.715 -0.476 . . . . 34.13 109.715 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 m -88.09 83.17 7.02 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.366 0.603 . . . . 55.44 111.896 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.4 mt -147.8 164.19 34.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.835 -1.075 . . . . 62.4 108.16 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -118.75 129.28 55.17 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.638 -0.875 . . . . 73.4 108.638 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.31 76.03 1.97 Allowed Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.75 -0.738 . . . . 72.45 113.215 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -76.83 153.42 34.87 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.432 -0.951 . . . . 44.11 108.432 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.68 89.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.696 0.76 . . . . 72.02 111.52 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.48 113.54 19.61 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.619 -0.882 . . . . 73.3 108.619 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.504 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 86.3 m 72.14 106.86 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 124.066 0.854 . . . . 64.42 110.572 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CD1' ' HB2' ' A' ' 37' ' ' GLU . 8.9 t-105 -93.75 99.85 3.98 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.104 -1.813 . . . . 73.51 106.104 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 15' ' ' THR . 64.8 Cg_endo -97.82 150.14 0.83 Allowed 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 123.093 2.529 . . . . 73.22 116.247 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.402 ' CD1' ' HD2' ' A' ' 34' ' ' ARG . 8.6 p90 -101.2 151.97 21.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.3 -2.111 . . . . 75.43 105.3 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -106.03 114.98 29.44 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.997 -1.081 . . . . 74.25 111.963 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.51 121.16 35.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.311 -1.737 . . . . 61.45 106.311 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.3 -26.42 20.01 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.389 -0.924 . . . . 72.24 110.758 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -175.99 165.31 2.92 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.681 -0.859 . . . . 74.15 108.681 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.4 HG22 ' HG3' ' A' ' 32' ' ' GLU . 36.4 p -132.57 150.02 52.22 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.771 -1.196 . . . . 70.15 107.771 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.39 113.61 2.11 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.101 -1.523 . . . . 73.03 113.406 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.25 -99.49 0.49 Allowed Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 110.857 -0.897 . . . . 41.12 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -98.87 169.1 9.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.302 -0.999 . . . . 74.42 108.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.48 157.38 23.62 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.504 -0.554 . . . . 74.01 109.504 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 72.74 -58.28 0.6 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.408 1.083 . . . . 64.12 110.875 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.86 111.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.823 0.82 . . . . 70.01 108.791 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.5 m -106.37 136.91 45.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.826 -0.625 . . . . 72.12 109.809 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.49 160.14 18.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.597 -0.841 . . . . 75.12 111.405 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 34.7 tt0 -134.61 124.29 25.17 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.646 -1.613 . . . . 63.24 106.646 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.8 115.66 30.86 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.042 0.925 . . . . 73.31 110.835 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 22.1 ptt180 -128.81 138.58 52.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 114.458 -1.246 . . . . 74.21 110.871 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.22 136.94 32.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.071 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.01 148.92 28.98 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.945 0.778 . . . . 75.11 109.718 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -77.62 -13.55 59.88 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 112.496 0.554 . . . . 74.22 112.496 -175.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.29 61.68 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.219 -1.467 . . . . 53.21 113.253 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 163.65 40.17 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.616 -1.278 . . . . 72.54 112.337 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.4 ptpt -96.03 133.9 39.71 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 75.11 108.375 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 37.0 m-85 -124.52 163.12 22.54 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.269 -0.423 . . . . 73.21 111.922 -171.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -99.53 116.63 32.12 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.575 -0.898 . . . . 72.45 108.575 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.4 t -123.29 149.64 44.56 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 121.23 0.538 . . . . 72.15 110.978 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.4 m -127.09 123.27 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.098 -0.955 . . . . 63.23 109.41 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -109.89 132.57 54.03 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.44 0.638 . . . . 71.14 112.504 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 54' ' ' ALA . 42.1 t -129.41 136.9 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.569 -1.271 . . . . 74.02 107.569 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 49' ' ' LYS . 31.0 m -138.75 164.83 28.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.712 -1.218 . . . . 73.33 107.712 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 47' ' ' THR . 14.1 t70 76.16 -26.47 0.19 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.012 1.325 . . . . 74.55 110.309 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 47' ' ' THR . 54.0 mtmt -103.16 122.59 44.83 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 114.483 -1.235 . . . . 72.42 108.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.48 158.79 1.57 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 124.596 3.531 . . . . 73.11 114.416 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.409 HG13 HD12 ' A' ' 98' ' ' LEU . 53.6 t -46.66 -41.47 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.452 1.101 . . . . 61.42 112.055 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.688 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 24.5 t70 -58.81 -43.45 90.56 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.638 -0.256 . . . . 70.02 110.517 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -73.77 -47.67 37.33 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.335 0.654 . . . . 64.2 110.85 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -56.77 -41.56 77.85 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.442 -0.799 . . . . 74.22 111.698 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 59' ' ' MET . 45.1 tp -68.72 -35.71 77.49 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.342 -0.39 . . . . 74.51 110.443 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 17.6 mtp180 -56.89 -46.0 82.18 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.206 0.527 . . . . 74.3 111.624 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.58 -35.33 39.84 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.429 -0.805 . . . . 74.43 112.292 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.29 -32.91 59.03 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.37 0.878 . . . . 72.32 113.37 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.447 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 5.2 mmt -56.26 -57.91 19.86 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.121 0.786 . . . . 74.4 113.121 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.612 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 28.9 Cg_endo -63.9 -32.49 66.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 121.867 1.712 . . . . 64.22 110.552 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -58.35 -45.65 87.78 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.923 -1.035 . . . . 54.42 110.796 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.5 mm -75.63 -47.63 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.219 -0.446 . . . . 73.42 111.389 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.505 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.292 3.7 ppp? -62.85 -32.23 73.41 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.667 1.358 . . . . 75.04 114.667 -174.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 60' ' ' PRO 0.295 0.0 OUTLIER -77.65 -29.09 51.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.697 -1.201 . . . . 71.23 112.504 176.347 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' THR . 62.2 t80 -65.07 -52.23 56.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.343 0.592 . . . . 74.41 110.207 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -72.19 -15.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.556 -0.747 . . . . 73.1 111.853 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.4 -11.58 68.82 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.439 -0.801 . . . . 70.34 112.458 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.0 -23.32 1.44 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.486 -1.34 . . . . 44.44 113.577 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 58.0 m -82.0 70.01 8.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.65 1.214 . . . . 74.24 111.976 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -98.36 170.16 9.05 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.528 -2.027 . . . . 72.3 105.528 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 36.6 t70 -69.31 -33.52 73.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 119.809 -0.756 . . . . 64.33 111.723 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.2 1.91 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 72.24 110.792 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.86 28.57 72.96 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.638 -0.71 . . . . 64.21 113.656 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.16 120.73 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 109.3 -0.629 . . . . 72.43 109.3 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.76 -135.3 1.85 Allowed Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 111.0 -0.84 . . . . 54.44 111.0 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.8 ttp 178.0 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.271 0.558 . . . . 54.03 111.284 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.54 65.58 0.58 Allowed Glycine 0 CA--C 1.491 -1.414 0 N-CA-C 106.291 -2.724 . . . . 60.53 106.291 -169.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.469 ' H ' ' HG2' ' A' ' 78' ' ' MET . 11.4 ptm -97.01 121.94 39.45 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.266 -0.967 . . . . 72.55 111.448 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -128.26 134.93 49.05 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.712 -0.676 . . . . 64.53 111.589 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m -157.11 172.29 6.33 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 104.991 -2.226 . . . . 71.25 104.991 171.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 86.3 Cg_exo -54.18 139.52 72.09 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 121.431 1.42 . . . . 75.44 113.161 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.83 142.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.421 -1.326 . . . . 41.13 107.421 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.6 p -138.33 144.5 40.41 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.952 -0.299 . . . . 62.33 110.234 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 50.4 p90 -131.01 143.73 50.94 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.582 -0.447 . . . . 73.22 110.96 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.35 134.24 35.78 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.602 0.564 . . . . 74.33 110.6 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.26 150.79 32.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.438 -0.801 . . . . 74.12 109.799 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 95' ' ' GLN . 78.9 m-85 -114.75 112.69 45.1 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.951 -0.389 . . . . 74.04 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.59 158.83 2.93 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.869 1.713 . . . . 63.53 111.289 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -104.67 160.76 14.7 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.279 -1.749 . . . . 72.21 106.279 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.01 -24.73 64.73 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.49 0.662 . . . . 74.11 111.058 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.57 -5.89 47.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.01 -0.995 . . . . 73.33 110.804 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.91 -10.67 74.29 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.846 -0.502 . . . . 44.4 111.846 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 m -77.22 136.01 38.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 109.032 -0.729 . . . . 74.13 109.032 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.3 mt -84.72 136.85 33.55 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.069 0.461 . . . . 72.25 111.037 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 53.1 tt0 -81.9 144.97 30.6 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.769 -1.567 . . . . 71.53 106.769 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -92.29 80.12 5.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.364 1.246 . . . . 70.51 114.364 -174.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.645 ' HE2' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -160.42 122.37 3.18 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.434 -2.802 . . . . 52.44 103.434 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.645 ' N ' ' HE2' ' A' ' 97' ' ' LYS . 5.2 tt -144.11 137.62 27.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.77 0.319 . . . . 62.35 110.515 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -129.09 123.88 33.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.205 -0.598 . . . . 65.34 110.553 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.553 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 86.2 t -86.94 129.78 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.629 -0.714 . . . . 71.51 109.145 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -107.16 127.87 53.9 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.622 -0.51 . . . . 74.22 109.622 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -104.04 117.71 34.94 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.812 -1.181 . . . . 74.51 107.812 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 59.4 ttt-85 -75.34 129.46 37.42 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.023 -1.473 . . . . 74.02 107.023 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 79.7 mt -89.87 134.28 32.31 Favored Pre-proline 0 C--N 1.271 -2.831 0 N-CA-C 109.868 -0.419 . . . . 73.44 109.868 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 74.7 Cg_exo -53.59 158.84 7.34 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.021 2.481 . . . . 74.51 112.972 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.451 HD22 ' HB2' ' A' ' 16' ' ' TRP . 2.1 t-20 -46.27 -54.32 9.08 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 126.137 1.775 . . . . 73.12 115.585 -172.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -72.29 -28.15 62.91 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.053 -0.659 . . . . 72.12 112.456 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.89 -12.56 55.28 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.623 -0.431 . . . . 73.34 111.458 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 49.9 mt-30 -70.9 -28.53 64.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.748 0.309 . . . . 62.41 111.482 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -38.24 92.38 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.975 -0.631 . . . . 60.44 111.64 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -157.41 98.9 1.93 Allowed Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.6 158.95 10.73 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.75 2.3 . . . . 75.2 112.586 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.5 156.2 66.4 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.434 2.089 . . . . 74.12 111.511 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -72.74 142.46 83.47 Favored Pre-proline 0 N--CA 1.426 -1.665 0 CA-C-N 115.958 -0.565 . . . . 61.24 110.011 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.74 114.74 3.43 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.844 2.362 . . . . 63.02 112.088 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -61.14 -42.65 98.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.739 -0.664 . . . . 75.3 109.498 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.539 ' HB2' HG23 ' A' ' 120' ' ' VAL . 9.0 m-20 -91.19 161.07 15.23 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 63.32 110.256 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -87.18 -28.4 22.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.507 -0.77 . . . . 63.01 109.03 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.3 p -79.07 -12.25 60.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.657 -0.701 . . . . 55.11 112.025 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 117' ' ' ASP . 59.3 t -100.14 116.99 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 105.833 -1.914 . . . . 63.13 105.833 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -128.78 143.43 50.92 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 120.701 -0.4 . . . . 74.53 110.316 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.0 mm -92.45 112.76 26.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.462 -0.94 . . . . 75.43 108.462 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.82 153.11 38.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.862 -0.792 . . . . 71.43 108.862 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 4.5 mp0 -98.45 146.87 25.3 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.994 0.426 . . . . 74.52 110.24 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 125' ' ' ARG . 32.6 mmt180 -134.54 120.99 20.35 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.637 -0.71 . . . . 75.13 109.697 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.28 156.15 43.65 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.651 -0.87 . . . . 70.32 108.651 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.22 19.39 78.48 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.194 -1.003 . . . . 50.15 114.096 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -120.08 145.25 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 C-N-CA 119.92 -0.712 . . . . 71.31 109.588 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.0 m -112.59 138.46 49.34 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 105.646 -1.983 . . . . 52.23 105.646 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.88 148.33 26.73 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 108.3 -1.0 . . . . 52.44 108.3 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -112.56 121.05 43.66 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 103.646 -2.724 . . . . 75.42 103.646 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.2 m -122.34 135.2 54.67 Favored 'General case' 0 C--N 1.263 -3.162 0 C-N-CA 120.587 -0.445 . . . . 60.45 109.926 -174.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.6 t -112.51 136.81 51.59 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 108.727 -0.842 . . . . 53.32 108.727 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 9.3 pt20 -117.25 130.03 56.3 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.527 -0.761 . . . . 65.23 109.404 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.83 168.37 19.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.405 -0.816 . . . . 71.23 109.515 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -126.38 136.35 9.48 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.922 -0.656 . . . . 64.42 112.022 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 152.01 -163.22 30.06 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.203 -1.159 . . . . 54.42 110.203 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -99.13 107.71 20.14 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.562 -0.903 . . . . 74.23 108.562 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.18 133.38 35.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.203 1.186 . . . . 64.23 114.203 -172.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HB3' ' OE1' ' A' ' 141' ' ' GLU . 25.4 mtpp -112.33 177.5 4.62 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.941 -1.503 . . . . 73.34 106.941 170.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -63.27 -34.46 77.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.075 0.464 . . . . 54.13 109.98 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.57 -30.0 71.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.525 -0.762 . . . . 54.03 111.254 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.2 -31.72 71.43 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.968 0.413 . . . . 54.23 110.789 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' A' ' 185' ' ' VAL . 90.8 m-85 -73.03 -43.98 61.39 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.047 -0.524 . . . . 61.54 109.935 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.22 -48.36 87.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 O-C-N 123.42 0.45 . . . . 74.33 110.38 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.51 87.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.574 -0.739 . . . . 50.14 111.546 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.444 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 65.1 m80 -71.08 -34.8 71.52 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.463 -0.495 . . . . 63.54 112.068 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.446 0.165 . . . . 73.04 110.76 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.2 t -68.73 -32.72 72.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 74.12 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -66.75 -40.61 88.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.334 0.587 . . . . 72.14 109.762 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.46 HD21 ' HB ' ' A' ' 133' ' ' THR . 65.8 mt -65.05 -33.75 76.78 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 116.149 -0.478 . . . . 72.12 111.363 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 50.3 mtt180 -56.09 -49.04 74.95 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.483 0.489 . . . . 71.21 110.847 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.588 ' HA ' ' OE1' ' A' ' 156' ' ' GLU . 11.0 t -73.7 -29.56 62.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.922 -0.581 . . . . 61.33 110.807 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 34.1 m -71.14 -34.57 71.15 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.428 0.632 . . . . 63.3 109.691 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.45 0.52 16.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.491 0.716 . . . . 75.13 111.643 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.588 ' OE1' ' HA ' ' A' ' 153' ' ' THR . 46.5 mt-10 -84.16 140.22 31.89 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.55 -0.537 . . . . 71.53 109.55 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 96.88 -10.09 66.08 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.08 -0.581 . . . . 71.41 111.957 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 12.2 t -122.2 155.59 61.32 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.198 . . . . 63.01 107.764 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 36.56 0.1 Allowed 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 124.351 3.367 . . . . 44.13 114.287 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -101.03 119.04 38.16 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.123 0.487 . . . . 75.12 110.631 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.5 p -123.83 144.54 49.66 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.011 -0.737 . . . . 61.01 109.011 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -131.31 150.61 52.08 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.353 -0.24 . . . . 72.25 110.353 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -120.06 148.77 43.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.752 0.649 . . . . 72.11 112.752 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.25 1.95 37.93 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 115.112 0.805 . . . . 74.45 115.112 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB3' HH22 ' A' ' 152' ' ' ARG . 21.3 m-20 65.88 0.47 1.56 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.748 0.819 . . . . 61.33 112.04 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.63 139.27 20.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.648 0.737 . . . . 53.12 112.706 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -136.24 164.0 29.09 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.095 -1.076 . . . . 60.12 108.095 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 50.8 m-85 -115.63 151.38 35.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.411 -0.588 . . . . 75.25 109.411 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 83' ' ' SER . 60.4 m -113.94 123.7 50.38 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.928 -1.508 . . . . 63.1 106.928 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -111.72 149.21 31.95 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.859 0.362 . . . . 74.41 111.324 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -163.26 164.73 36.25 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 108.544 -1.823 . . . . 74.22 108.544 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -85.06 -39.3 18.13 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 117.837 0.818 . . . . 64.22 109.543 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -157.47 154.38 25.31 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 106.844 -1.539 . . . . 74.14 106.844 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -41.87 111.31 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.506 2.804 . . . . 61.34 112.716 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.43 130.83 37.85 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 123.866 3.044 . . . . 73.14 113.647 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.596 ' O ' ' HG3' ' A' ' 177' ' ' LYS . 26.0 ttt -87.87 -43.35 11.88 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 115.614 -0.721 . . . . 72.3 109.25 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 176' ' ' MET . 88.9 mttt 162.4 -67.48 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.192 0 C-N-CA 129.017 2.927 . . . . 74.03 108.835 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.14 -28.84 12.3 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 121.055 1.17 . . . . 71.1 109.388 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -84.57 123.87 30.8 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.682 -1.229 . . . . 71.54 107.682 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 101.7 43.84 2.05 Favored Glycine 0 C--N 1.3 -1.435 0 N-CA-C 109.867 -1.293 . . . . 25.52 109.867 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.6 ptp180 -96.88 -15.63 21.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.992 -0.604 . . . . 74.11 111.864 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -115.12 127.91 55.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.483 -2.414 . . . . 74.15 104.483 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 15.9 m-80 -139.67 160.25 40.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.15 -0.62 . . . . 74.14 110.526 -171.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 133' ' ' THR . 49.6 mt-10 -132.45 145.9 51.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 123.753 0.658 . . . . 71.21 109.823 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 132' ' ' SER . 21.8 t -123.95 120.85 60.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 106.071 -1.826 . . . . 74.34 106.071 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 13.1 m0 -104.78 121.36 43.47 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.798 -0.361 . . . . 72.51 110.932 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 84.8 mt -99.1 131.18 45.32 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.03 -1.47 . . . . 54.34 107.03 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.35 135.21 38.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.506 -0.478 . . . . 63.52 110.563 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 161' ' ' THR . 19.9 pttp -72.0 143.24 49.26 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.563 -0.455 . . . . 73.42 110.854 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 115.062 -0.972 . . . . 74.35 110.505 178.26 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 . . . . . 0 CA--C 1.511 -0.552 0 N-CA-C 109.982 -0.377 . . . . 73.13 109.982 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.9 p -149.25 160.5 43.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.902 -0.777 . . . . 70.35 108.902 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.73 90.77 3.5 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 120.791 0.329 . . . . 63.45 110.976 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -124.55 162.94 22.97 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.459 -0.571 . . . . 74.23 109.459 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.03 13.64 68.63 Favored Glycine 0 C--N 1.31 -0.879 0 N-CA-C 110.452 -1.059 . . . . 24.12 110.452 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.8 p -76.82 160.97 28.83 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 123.398 0.679 . . . . 73.32 109.87 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.07 111.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.889 -0.782 . . . . 72.53 108.889 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.14 178.33 7.12 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.24 -0.436 . . . . 71.23 111.131 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.1 m -111.35 95.95 5.83 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 120.116 -0.634 . . . . 75.42 111.619 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -115.07 88.49 17.56 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 105.975 -1.861 . . . . 74.31 105.975 170.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -87.32 148.88 7.77 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.113 1.875 . . . . 71.35 114.216 -169.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.1 p90 -101.25 136.06 41.71 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 104.378 -2.453 . . . . 72.41 104.378 173.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 91.8 mt-30 -106.17 109.28 21.16 Favored 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 118.648 -1.221 . . . . 73.4 111.542 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.91 115.87 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 108.089 -1.078 . . . . 74.23 108.089 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -96.08 -36.55 10.96 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.074 -0.966 . . . . 62.31 111.883 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.471 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 42.6 t -157.12 150.41 23.98 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.296 0.569 . . . . 73.33 111.009 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.6 p -132.45 162.45 31.13 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.431 -1.692 . . . . 43.12 106.431 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.5 99.66 0.97 Allowed Glycine 0 C--N 1.304 -1.209 0 C-N-CA 118.297 -1.906 . . . . 61.43 114.243 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.07 -147.49 5.76 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.707 -0.957 . . . . 61.41 110.707 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -86.76 170.89 11.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.065 -0.717 . . . . 65.41 109.065 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.15 155.01 39.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.551 -0.907 . . . . 72.41 108.551 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 74.35 -52.81 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.791 0.836 . . . . 72.31 111.464 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.04 109.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 122.441 1.115 . . . . 72.34 110.376 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.8 m -111.53 128.66 56.09 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.662 -0.866 . . . . 74.44 108.662 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.04 155.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.558 -1.257 . . . . 62.43 111.301 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 35.2 tt0 -134.36 125.63 27.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.796 -1.557 . . . . 70.31 106.796 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 36.2 mt-10 -94.73 114.86 26.83 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.436 -1.69 . . . . 62.1 106.436 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.548 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 30.2 ptt180 -140.27 132.37 27.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.435 0.636 . . . . 75.52 112.54 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 129' ' ' THR . . . -80.98 137.34 36.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.093 -1.077 . . . . 53.03 108.093 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -58.87 149.8 25.87 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.772 0.67 . . . . 73.4 110.468 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -68.99 -21.18 64.17 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.975 -0.557 . . . . 53.41 112.032 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 9.72 68.5 Favored Glycine 0 C--O 1.244 0.766 0 C-N-CA 119.966 -1.111 . . . . 75.03 112.893 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 165.81 53.12 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 121.384 -0.436 . . . . 73.01 113.139 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -98.58 118.52 35.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.771 -0.826 . . . . 73.2 108.771 179.399 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.531 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 22.8 m-85 -124.33 165.63 17.35 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.736 -0.665 . . . . 72.41 111.494 -170.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.77 117.94 34.39 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.954 -0.758 . . . . 60.4 108.954 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -125.03 147.66 48.85 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.911 -0.586 . . . . 54.42 111.829 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.482 HG21 ' HG2' ' A' ' 61' ' ' LYS . 7.6 p -137.75 135.33 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 41.01 108.905 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -121.78 137.64 54.69 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.092 -1.043 . . . . 73.24 110.504 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 41.7 t -118.74 131.34 71.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.037 -1.468 . . . . 71.41 107.037 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -115.16 158.27 22.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.635 0.606 . . . . 45.14 112.635 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.455 ' HA ' ' CG ' ' A' ' 96' ' ' LYS . 36.3 t70 68.73 -12.89 0.35 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.629 1.972 . . . . 64.43 113.445 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.92 23.46 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 108.458 -0.941 . . . . 72.2 108.458 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.93 156.88 11.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.877 2.385 . . . . 73.43 111.337 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 98' ' ' LEU . 55.9 t -46.49 -47.68 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.893 0.877 . . . . 73.22 113.263 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 14.1 t70 -63.35 -47.84 80.46 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.528 -0.469 . . . . 74.31 110.208 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -63.56 -41.43 98.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.34 0.656 . . . . 73.23 112.195 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -65.42 -39.78 92.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.132 0.492 . . . . 54.11 110.115 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.9 tp -66.3 -33.75 76.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.883 -0.599 . . . . 62.33 110.001 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.684 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 29.9 mmt180 -59.05 -34.36 71.84 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.853 -0.612 . . . . 64.51 110.78 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.03 -49.53 10.12 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.312 -0.858 . . . . 63.31 110.72 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -66.99 -33.06 74.75 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.317 1.228 . . . . 64.25 114.317 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.581 ' O ' ' HG2' ' A' ' 63' ' ' MET . 6.5 mmt -61.11 -58.19 20.84 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 119.752 -0.779 . . . . 75.24 112.806 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.16 -30.84 91.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.407 2.071 . . . . 73.14 111.131 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HG2' HG21 ' A' ' 44' ' ' VAL . 18.1 tppt? -61.43 -44.49 97.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.092 -0.958 . . . . 65.13 110.369 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 38.4 mm -73.57 -39.41 53.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.313 -0.555 . . . . 65.32 109.583 175.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 59' ' ' MET . 25.9 mmt -55.38 -44.15 75.81 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.453 0.538 . . . . 70.0 112.453 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.01 -38.61 91.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.183 0.516 . . . . 74.44 110.652 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -70.83 -51.02 29.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.892 -0.595 . . . . 74.13 111.159 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 62' ' ' ILE . 14.6 p -74.85 -25.46 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-O 121.07 0.462 . . . . 72.15 111.229 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.75 -30.81 67.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.88 -0.6 . . . . 74.12 113.074 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.53 -3.63 1.88 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.271 -1.443 . . . . 52.42 113.855 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 m -89.56 27.07 1.56 Allowed 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 122.627 1.203 . . . . 72.45 109.387 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.08 177.29 7.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.068 -0.969 . . . . 74.15 109.231 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.82 -31.57 72.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.965 0.728 . . . . 70.24 112.965 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -87.6 -12.88 44.33 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.911 -0.716 . . . . 73.3 110.741 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.81 28.29 73.2 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.684 -0.77 . . . . 54.54 111.566 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.01 121.84 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.01 0.433 . . . . 73.14 109.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.95 63.74 0.61 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.431 -0.89 . . . . 74.12 112.144 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.93 -26.43 48.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.51 -0.552 . . . . 75.33 109.51 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.77 83.98 0.36 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.245 -0.889 . . . . 45.42 111.554 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 19.1 ptt? -96.19 125.41 40.69 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.926 0.393 . . . . 74.32 110.048 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.7 p -113.82 116.49 29.42 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.911 -0.586 . . . . 50.12 112.267 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.54 159.57 36.1 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 106.965 -1.495 . . . . 75.2 106.965 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.67 139.46 88.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.646 1.564 . . . . 71.53 112.616 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -103.94 153.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.193 -1.41 . . . . 72.31 107.193 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.4 m -133.75 145.45 49.83 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.303 -0.628 . . . . 73.53 109.303 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 51.4 p90 -138.12 139.96 39.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.403 -0.519 . . . . 64.34 110.309 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.69 134.87 34.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.878 -0.601 . . . . 63.52 110.175 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.48 150.02 30.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.952 -1.129 . . . . 70.5 107.952 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -119.48 108.05 40.17 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.17 -0.678 . . . . 73.11 109.17 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.4 142.09 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.088 1.858 . . . . 74.43 112.546 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.17 174.54 7.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.006 -0.543 . . . . 63.12 110.323 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -23.46 67.41 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.036 0.935 . . . . 61.24 110.622 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.46 -5.31 58.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.049 -0.978 . . . . 64.03 110.607 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.76 -10.25 65.7 Favored Glycine 0 CA--C 1.504 -0.636 0 CA-C-N 116.084 -0.507 . . . . 53.25 112.214 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 p -86.1 142.19 28.87 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.545 -0.539 . . . . 72.13 109.545 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 69.6 mt -75.84 145.21 40.79 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.024 -0.534 . . . . 74.44 110.61 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.64 150.25 32.7 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.657 -0.868 . . . . 74.51 108.657 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.527 ' H ' ' HD3' ' A' ' 96' ' ' LYS 0.291 0.2 OUTLIER -83.03 75.31 9.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.651 1.215 . . . . 73.23 112.031 178.938 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -164.09 125.03 2.2 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.536 -2.024 . . . . 71.14 105.536 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.515 HD12 HG13 ' A' ' 51' ' ' VAL . 5.6 tt -140.22 135.31 32.23 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.057 -0.719 . . . . 63.03 109.057 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -124.16 115.34 20.95 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.562 -0.29 . . . . 62.44 110.237 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.7 t -91.17 134.45 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.542 -0.54 . . . . 61.31 109.542 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -117.75 122.16 42.73 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.646 -0.872 . . . . 54.11 108.646 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 75.8 t80 -102.93 111.14 23.33 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.817 -1.549 . . . . 74.3 106.817 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.531 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 34.1 ttp180 -81.56 113.21 19.43 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.714 -0.675 . . . . 71.52 110.247 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.514 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 68.7 mt -79.07 134.09 60.19 Favored Pre-proline 0 C--N 1.284 -2.253 0 CA-C-N 114.463 -1.244 . . . . 73.42 110.907 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.521 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 50.7 Cg_exo -53.4 153.75 16.77 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.328 2.685 . . . . 74.33 112.067 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -56.47 -36.28 68.91 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.012 1.116 . . . . 64.54 114.012 -174.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -62.4 -36.2 81.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.159 0.504 . . . . 75.21 111.004 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.5 -6.17 56.65 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.988 -0.551 . . . . 70.23 110.997 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.514 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 26.0 mm-40 -71.7 -30.2 65.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.829 0.347 . . . . 72.54 110.75 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.24 73.47 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.472 -0.785 . . . . 61.44 111.908 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.5 p -160.18 89.02 1.83 Allowed Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-O 120.661 0.267 . . . . 73.24 110.495 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.49 154.27 9.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.178 1.918 . . . . 52.41 110.935 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.96 158.11 58.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.341 2.027 . . . . 74.1 111.352 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.85 149.53 80.47 Favored Pre-proline 0 C--O 1.259 1.593 0 C-N-CA 120.874 -0.33 . . . . 73.41 110.205 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 24.9 Cg_exo -65.73 106.75 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.697 2.265 . . . . 60.14 111.38 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.5 t -83.16 -25.66 31.63 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.53 -0.545 . . . . 73.33 109.53 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.63 143.89 28.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.317 -0.994 . . . . 71.15 108.317 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.18 -24.04 60.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.019 0.748 . . . . 71.45 113.019 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.2 m -89.81 -19.11 25.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.002 0.429 . . . . 63.33 109.892 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 61.9 t -94.89 116.27 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 107.102 -1.444 . . . . 72.21 107.102 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -124.35 136.31 53.99 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.603 -0.726 . . . . 71.21 110.449 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.5 mm -91.68 111.19 23.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.612 -1.255 . . . . 70.22 107.612 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -124.73 143.38 50.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.806 -1.088 . . . . 70.31 109.142 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -105.23 132.58 51.25 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.624 -0.716 . . . . 75.31 109.339 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -123.2 123.1 40.03 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.291 -1.003 . . . . 72.32 108.291 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.6 158.03 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.5 -0.555 . . . . 61.02 109.5 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.36 19.2 50.57 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.626 -0.797 . . . . 71.42 112.128 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.26 145.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.058 0.456 . . . . 71.03 110.367 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 90.4 m -112.64 135.49 53.3 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 107.87 -1.159 . . . . 72.44 107.87 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.16 150.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 N-CA-C 107.839 -1.171 . . . . 73.14 107.839 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.35 121.12 43.43 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 104.664 -2.347 . . . . 75.43 104.664 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 24.8 m -115.93 132.75 56.56 Favored 'General case' 0 C--N 1.261 -3.246 0 C-N-CA 120.339 -0.545 . . . . 71.33 110.834 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' SER . 9.9 t -113.24 119.94 39.46 Favored 'General case' 0 N--CA 1.391 -3.421 0 CA-C-N 115.587 -0.733 . . . . 71.32 109.614 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -110.88 126.03 54.26 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.404 -1.332 . . . . 65.04 107.404 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 22.3 p90 -136.6 167.6 21.08 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.352 -0.84 . . . . 75.04 110.687 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -133.32 143.3 14.96 Favored Glycine 0 CA--C 1.485 -1.798 0 C-N-CA 120.484 -0.865 . . . . 52.33 111.559 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.81 -155.28 25.79 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.258 -1.137 . . . . 63.01 110.258 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -99.93 103.08 14.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.834 -0.802 . . . . 75.3 108.834 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.62 117.53 31.86 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.41 -0.359 . . . . 64.44 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HA ' ' CE2' ' A' ' 179' ' ' TYR . 40.5 ttmt -81.13 163.84 22.82 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.831 -1.174 . . . . 72.21 107.831 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.74 -35.23 42.5 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.004 0.522 . . . . 60.34 111.607 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.87 65.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.065 -0.516 . . . . 71.11 111.121 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.33 -30.89 69.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.119 -0.491 . . . . 73.44 110.433 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -59.72 -49.43 77.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.299 -0.63 . . . . 72.31 109.299 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.1 t -59.96 -42.96 91.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.032 -0.986 . . . . 52.52 109.341 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.16 85.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.46 -0.791 . . . . 33.42 111.179 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.511 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 29.3 m80 -66.94 -33.89 76.57 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 112.536 0.569 . . . . 71.02 112.536 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.23 -45.14 94.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.398 0.618 . . . . 62.03 109.627 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 m -66.58 -35.3 79.87 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.421 -0.809 . . . . 71.11 109.868 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.09 -29.01 61.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.752 -0.658 . . . . 74.33 111.373 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 82.6 mt -61.7 -36.71 81.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.944 -0.391 . . . . 71.14 109.944 173.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -57.42 -48.19 79.78 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.854 0.721 . . . . 72.22 110.802 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.6 t -75.72 -30.15 59.16 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.113 -0.494 . . . . 73.34 110.952 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.4 m -74.85 -34.17 62.25 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.358 0.599 . . . . 73.15 110.819 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.54 6.75 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.373 0.606 . . . . 72.13 110.36 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 131.53 34.34 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.826 -1.546 . . . . 72.04 106.826 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.89 -4.78 61.35 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.514 -0.635 . . . . 65.14 111.514 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.1 p -99.89 163.94 17.44 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 107.844 -1.169 . . . . 43.24 107.844 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 63.6 Cg_endo -73.88 0.82 7.79 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.992 1.794 . . . . 71.35 112.901 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.95 140.99 32.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.881 0.372 . . . . 73.54 111.557 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.0 p -118.13 153.48 33.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.212 -0.662 . . . . 64.25 109.212 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.434 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 38.8 p90 -135.3 137.81 42.85 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.139 -0.35 . . . . 75.11 110.171 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.498 ' OE1' HG13 ' A' ' 188' ' ' VAL 0.26 0.0 OUTLIER -97.92 116.63 30.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.739 1.385 . . . . 74.44 114.739 -176.455 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.16 65.82 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.773 -0.649 . . . . 75.55 112.623 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . 0.261 8.6 p-10 49.38 27.66 2.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.765 1.226 . . . . 74.52 113.22 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 187' ' ' LEU . 77.6 t -66.57 138.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 113.968 -1.469 . . . . 73.12 110.137 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -143.26 171.13 14.53 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.989 -0.55 . . . . 61.43 111.492 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 4.2 m-85 -121.75 150.54 41.68 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.671 -0.695 . . . . 64.54 109.865 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 20.4 t -115.02 146.22 41.48 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.994 -1.113 . . . . 75.01 107.994 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.36 158.5 18.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.925 0.393 . . . . 74.15 110.907 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.53 156.32 26.79 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 108.732 -1.747 . . . . 71.02 108.732 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -142.46 -38.59 0.36 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 114.051 1.13 . . . . 72.24 114.051 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.459 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 4.2 p-10 -154.26 154.9 30.35 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 108.912 -0.774 . . . . 70.33 108.912 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.29 105.59 1.63 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.233 1.955 . . . . 74.0 108.99 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 69.0 Cg_endo -74.54 149.37 38.91 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 122.197 1.932 . . . . 71.41 112.609 -173.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.6 ptm -80.67 -21.37 41.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.534 -1.284 . . . . 73.11 107.534 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -83.24 152.44 64.73 Favored Pre-proline 0 N--CA 1.431 -1.414 0 N-CA-C 104.7 -2.333 . . . . 74.42 104.7 172.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.57 -33.02 29.48 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.32 2.013 . . . . 62.35 114.107 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 140' ' ' LYS . 89.5 m-85 -152.4 172.43 16.51 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 122.949 0.5 . . . . 72.4 109.746 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.67 -179.71 49.12 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.168 -1.173 . . . . 45.24 110.168 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -86.28 -24.16 26.05 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 117.538 0.669 . . . . 73.15 111.787 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -116.6 136.06 53.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.085 0.469 . . . . 74.12 110.579 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.2 m120 -126.52 146.94 49.93 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.729 -1.582 . . . . 72.33 106.729 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 133' ' ' THR . 33.9 tt0 -142.82 132.64 24.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.965 -0.694 . . . . 53.14 110.459 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 132' ' ' SER . 82.4 t -126.49 130.18 71.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.863 0.865 . . . . 61.14 109.287 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.5 m0 -109.36 121.3 44.87 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 109.449 -0.574 . . . . 63.44 109.449 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 166' ' ' VAL . 40.3 tp -100.78 135.48 42.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.865 -1.532 . . . . 73.31 106.865 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.498 HG13 ' OE1' ' A' ' 163' ' ' GLN . 6.1 p -106.72 135.44 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 114.036 1.124 . . . . 75.35 114.036 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -63.16 144.37 56.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.015 1.326 . . . . 71.41 114.421 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.241 -0.89 . . . . 64.05 109.045 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 109.043 -0.725 . . . . 73.12 109.043 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.1 t 73.29 112.16 0.06 Allowed 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.962 1.305 . . . . 63.12 111.291 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 99.1 mt -108.15 136.78 47.25 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.125 -1.065 . . . . 70.43 108.125 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -95.03 103.37 15.22 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 112.605 0.594 . . . . 62.5 112.605 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.97 65.17 3.52 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 108.486 -1.846 . . . . 64.24 108.486 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.5 p -61.51 109.67 1.24 Allowed 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 113.642 0.979 . . . . 64.04 113.642 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.08 78.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-O 122.415 1.102 . . . . 63.2 109.09 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -116.08 99.95 7.6 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.606 -1.179 . . . . 72.41 111.226 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.6 p -111.88 104.95 13.27 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.368 -0.833 . . . . 74.32 110.785 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 109' ' ' GLN . 3.2 p90 -73.36 120.0 78.76 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-O 120.908 0.385 . . . . 70.23 110.73 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -87.69 150.25 7.41 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.343 2.695 . . . . 61.55 114.536 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -101.3 154.42 18.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.426 -1.694 . . . . 55.14 106.426 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -121.11 109.62 15.24 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.929 -1.109 . . . . 75.14 112.392 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.45 125.68 45.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.103 -1.814 . . . . 75.23 106.103 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 22' ' ' SER . 2.9 pp -90.22 -29.26 18.31 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.677 -1.209 . . . . 74.21 111.366 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.491 ' N ' HD12 ' A' ' 21' ' ' LEU . 30.7 t -179.32 164.59 1.37 Allowed 'General case' 0 C--O 1.25 1.117 0 O-C-N 123.575 0.547 . . . . 74.42 110.124 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -131.19 165.76 22.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.852 -1.166 . . . . 63.44 107.852 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.68 -164.38 29.87 Favored Glycine 0 C--N 1.306 -1.139 0 C-N-CA 120.577 -0.82 . . . . 54.45 111.545 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.92 -138.75 10.44 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.597 -0.811 . . . . 73.51 112.263 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -118.09 170.73 8.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.107 -1.442 . . . . 71.24 107.107 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.96 159.67 33.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 118.569 0.622 . . . . 74.4 110.07 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 76.26 -52.78 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.754 1.622 . . . . 61.14 110.426 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG11 ' HG3' ' A' ' 150' ' ' GLN . 7.7 p -120.14 110.0 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-O 122.235 1.017 . . . . 74.13 109.811 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 133' ' ' THR . 45.0 m -122.16 154.11 37.87 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.446 -0.946 . . . . 51.13 108.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.735 ' HB3' HD11 ' A' ' 151' ' ' LEU . 8.9 p90 -118.06 156.52 28.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.91 1.078 . . . . 72.23 113.91 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.32 125.9 23.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.734 -1.95 . . . . 73.11 105.734 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 115.1 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.499 -1.667 . . . . 73.1 106.499 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -131.79 133.7 45.02 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.687 -0.688 . . . . 74.34 111.403 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.63 136.27 33.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.26 -1.385 . . . . 53.04 107.26 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.43 158.08 21.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.548 0.573 . . . . 71.14 112.548 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -86.54 -18.66 30.95 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.665 -0.698 . . . . 74.45 112.858 -174.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.81 46.62 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.494 -1.813 . . . . 71.4 112.544 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.35 149.22 46.81 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.804 -0.712 . . . . 42.13 113.874 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 104' ' ' ILE . 19.5 ptmt -88.88 119.45 29.4 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.656 -0.868 . . . . 63.24 108.656 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.552 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 27.7 m-85 -127.0 166.35 17.73 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 123.693 0.797 . . . . 74.41 111.083 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -97.56 116.82 30.5 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.092 -1.077 . . . . 60.1 108.092 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.8 t -135.29 150.76 50.08 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 115.414 -0.812 . . . . 74.14 112.516 -173.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 9.2 p -141.64 142.28 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.121 -1.066 . . . . 74.21 108.121 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.3 133.05 48.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.658 -0.817 . . . . 74.32 112.572 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.58 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 52.7 t -112.08 141.87 26.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.656 -1.979 . . . . 72.52 105.656 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' LYS . 26.4 p -132.31 152.24 51.48 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.668 0.988 . . . . 52.25 113.668 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 67.6 -16.37 0.17 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 126.204 1.801 . . . . 74.23 112.141 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' THR . 48.6 mtpt -88.78 146.86 37.84 Favored Pre-proline 0 N--CA 1.422 -1.874 0 C-N-CA 124.175 0.99 . . . . 70.34 110.035 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 31.2 Cg_exo -60.23 153.05 61.91 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.509 2.139 . . . . 60.1 111.675 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 98' ' ' LEU . 32.2 t -49.89 -42.56 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 124.035 0.934 . . . . 53.23 112.316 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.698 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 13.0 t70 -61.63 -46.32 90.3 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.548 -0.461 . . . . 73.23 109.823 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -69.01 -42.13 76.83 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.199 -0.455 . . . . 74.33 111.48 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.15 -42.46 99.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.723 -0.672 . . . . 72.5 111.062 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.11 -31.97 72.79 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 116.336 -0.393 . . . . 72.55 111.156 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 5.2 mmp_? -55.95 -41.51 74.78 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.734 0.646 . . . . 75.1 110.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 44.4 mt-10 -84.41 -43.55 14.56 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.085 -0.507 . . . . 71.12 112.08 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.423 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -68.97 -41.82 77.42 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.52 1.304 . . . . 43.45 114.52 -171.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.4 ttm -57.27 -48.54 97.18 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.54 0.941 . . . . 71.53 113.54 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.68 -31.89 52.4 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.264 1.976 . . . . 75.11 112.245 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 91.0 mttt -72.12 -35.53 69.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.389 0.614 . . . . 55.33 111.058 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.05 -34.19 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 116.016 -0.538 . . . . 75.45 110.536 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 ttp -64.58 -43.31 94.26 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 124.062 0.945 . . . . 63.41 110.581 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 21.3 ptmt -69.48 -31.62 70.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.559 -0.291 . . . . 74.41 110.704 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -62.44 -60.48 3.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.46 -0.336 . . . . 74.21 111.796 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 76' ' ' MET . 14.6 p -83.86 -2.24 6.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-O 121.988 0.899 . . . . 72.13 109.859 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.01 -32.36 32.5 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.674 -0.774 . . . . 35.42 111.72 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 140.97 -2.56 2.14 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.689 -1.243 . . . . 51.22 113.52 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.5 m -92.06 34.32 1.02 Allowed 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.504 1.145 . . . . 64.52 109.156 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.48 ' OD1' HG12 ' A' ' 74' ' ' VAL . 7.2 p30 -96.8 168.93 10.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.769 -0.65 . . . . 74.24 109.759 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 23.2 t70 -71.79 -27.7 63.12 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.794 0.665 . . . . 71.14 112.794 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.91 -14.12 58.86 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.627 0.727 . . . . 70.33 109.334 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.63 78.6 Favored Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 110.847 -0.901 . . . . 75.43 110.847 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 14.5 p -93.11 153.08 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 108.127 -1.064 . . . . 74.12 108.127 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -133.48 0.41 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.736 -0.745 . . . . 54.24 112.416 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.728 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 55.7 ttp -76.61 -75.66 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.494 -0.482 . . . . 73.34 110.03 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.68 -52.01 0.68 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.541 0.977 . . . . 44.41 115.541 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 62.0 mtm -101.45 124.99 48.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 117.756 0.778 . . . . 71.04 111.356 -173.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.7 m -126.3 114.49 18.33 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.808 -0.441 . . . . 73.53 109.808 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 103' ' ' ARG . 24.9 m -148.78 167.75 12.47 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 108.125 -1.065 . . . . 73.03 108.125 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.49 146.33 84.76 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.894 1.729 . . . . 74.02 111.592 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.3 144.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.374 -0.973 . . . . 53.32 108.374 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 p -129.22 146.14 51.19 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 110.126 -0.324 . . . . 74.04 110.126 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.37 138.89 43.78 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.536 -0.465 . . . . 70.12 110.078 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.62 135.05 34.41 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.019 -0.734 . . . . 75.52 109.019 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.86 150.23 26.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 108.331 -0.988 . . . . 43.24 108.331 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 6.1 m-85 -123.52 105.11 33.52 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 121.018 -0.273 . . . . 74.23 110.573 -175.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.17 159.03 17.79 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.473 2.116 . . . . 75.03 111.871 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -104.36 166.51 10.35 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.385 -0.968 . . . . 72.21 108.385 175.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.84 -17.53 50.48 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.96 1.096 . . . . 75.23 113.96 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -98.73 -1.26 40.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.235 -0.586 . . . . 64.23 112.163 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.18 1.0 55.87 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.632 1.013 . . . . 63.22 115.632 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.2 m -83.79 136.98 33.94 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.452 1.126 . . . . 74.32 109.528 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.4 mt -93.38 78.1 4.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.165 0.507 . . . . 73.32 110.513 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -149.36 114.49 5.46 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.867 -0.606 . . . . 74.41 110.911 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 87' ' ' PHE . 56.2 tttp 178.19 -62.41 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.21 -1.033 . . . . 72.41 108.21 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.489 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 22.7 ttmm -154.31 149.34 26.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.518 -1.29 . . . . 73.14 107.518 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.592 HD12 HG13 ' A' ' 51' ' ' VAL . 5.9 tt -141.01 124.94 17.09 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.997 -1.853 . . . . 71.21 105.997 169.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 79.4 tttt -130.87 115.19 16.24 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 120.423 -0.511 . . . . 50.24 110.05 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' THR . 62.1 t -83.88 133.78 28.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.692 -0.685 . . . . 64.22 109.322 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -121.62 113.63 20.04 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.748 0.819 . . . . 73.43 109.156 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 89.6 t80 -103.74 115.97 31.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.319 -0.993 . . . . 75.01 108.319 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.552 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 29.4 ttt85 -76.11 136.35 39.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.336 -0.847 . . . . 73.44 110.416 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.436 HD11 HD12 ' A' ' 122' ' ' ILE . 77.8 mt -103.47 126.96 30.63 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 109.478 -0.564 . . . . 75.21 109.478 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 84.2 Cg_exo -46.83 151.25 2.2 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.491 2.794 . . . . 74.45 113.028 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.04 -42.58 65.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.443 1.275 . . . . 64.42 114.443 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.28 -30.96 72.0 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.353 0.597 . . . . 65.12 110.875 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.66 -2.88 55.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.912 -0.585 . . . . 63.23 110.839 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 16' ' ' TRP . 19.4 mm-40 -70.09 -36.24 74.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.586 -0.524 . . . . 74.34 109.586 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.19 -31.7 78.18 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-N 115.464 -0.789 . . . . 61.02 112.026 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -160.34 97.3 1.46 Allowed Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 109.049 -0.723 . . . . 61.22 109.049 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.62 162.08 1.86 Allowed 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 123.274 2.649 . . . . 63.31 111.519 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.58 133.76 44.23 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.032 1.821 . . . . 74.14 110.093 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -74.88 152.69 86.83 Favored Pre-proline 0 C--O 1.255 1.395 0 CA-C-N 116.515 -0.311 . . . . 70.32 111.48 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 17.2 Cg_exo -69.46 111.13 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.761 2.308 . . . . 64.23 112.146 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -85.25 -8.69 58.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.827 0.822 . . . . 74.41 108.795 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.95 148.42 42.21 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.241 -1.392 . . . . 72.15 107.241 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -88.62 -9.97 50.3 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.858 1.429 . . . . 63.23 114.858 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.501 ' CB ' ' HD3' ' A' ' 61' ' ' LYS . 17.7 m -81.53 -45.03 16.51 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.813 -0.81 . . . . 74.15 108.813 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 5.9 p -95.5 115.85 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 108.83 -0.804 . . . . 73.31 108.83 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -119.0 151.22 38.59 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.842 -0.799 . . . . 74.12 108.842 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.8 mm -92.56 110.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.427 -1.323 . . . . 73.35 107.427 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -127.14 146.48 50.38 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.387 -0.824 . . . . 73.4 108.9 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.06 144.13 34.18 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 109.023 -0.732 . . . . 70.04 109.023 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.555 ' HA ' ' HE ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -129.74 123.13 30.3 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.169 -1.413 . . . . 71.53 110.008 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.24 156.63 45.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.105 -2.554 . . . . 72.43 104.105 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.5 8.03 62.86 Favored Glycine 0 C--N 1.281 -2.52 0 C-N-CA 120.661 -0.78 . . . . 70.43 112.859 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.0 pt -121.61 145.66 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.353 -0.539 . . . . 62.1 110.275 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.0 m -120.88 137.44 54.57 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.039 -0.982 . . . . 74.24 109.126 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.36 160.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-N 115.767 -0.651 . . . . 73.24 110.021 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.515 ' OH ' ' HE2' ' A' ' 189' ' ' LYS . 39.3 m-85 -114.03 122.56 47.27 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.232 -2.136 . . . . 75.11 105.232 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -106.82 127.89 53.79 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.835 -0.346 . . . . 70.53 111.145 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.553 ' HB ' HD13 ' A' ' 151' ' ' LEU . 14.0 t -113.43 138.98 49.31 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.808 -0.812 . . . . 63.23 108.808 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.46 125.82 42.76 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.455 -0.793 . . . . 72.12 109.895 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -132.86 140.69 48.04 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.444 -0.798 . . . . 72.11 109.581 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 182' ' ' ARG . . . -102.8 145.99 16.53 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.842 -0.694 . . . . 63.01 112.852 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.71 -140.26 14.84 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.984 -1.103 . . . . 72.23 113.906 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 39.5 t80 -76.63 126.7 31.43 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.8 0.84 . . . . 72.35 112.006 -172.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.81 136.82 54.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.794 -0.639 . . . . 70.12 110.303 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.569 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 38.8 ttmt -114.98 155.41 26.98 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.615 -1.994 . . . . 62.51 105.615 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -53.67 -45.19 70.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 118.412 0.551 . . . . 70.14 110.001 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.75 70.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 42.43 111.399 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.569 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 28.2 t70 -74.73 -30.62 61.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 110.063 -0.347 . . . . 62.12 110.063 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -63.33 -44.85 93.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.827 -0.805 . . . . 53.12 108.827 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 141' ' ' GLU . 61.0 t -60.02 -51.24 75.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.058 -0.974 . . . . 71.43 109.579 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.11 86.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.586 -0.734 . . . . 64.42 111.562 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 150' ' ' GLN . 24.6 m80 -62.38 -33.45 74.76 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 113.445 0.906 . . . . 65.54 113.445 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.01 79.32 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.481 0.488 . . . . 73.33 111.409 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.5 m -78.09 -35.14 49.73 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.801 0.334 . . . . 64.45 111.015 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.517 ' HG3' HG11 ' A' ' 29' ' ' VAL . 7.1 tp60 -58.68 -36.37 74.09 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.211 0.529 . . . . 75.35 109.692 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 31' ' ' TYR . 46.1 tp -65.4 -39.12 91.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.528 -0.76 . . . . 73.24 110.127 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.0 mtm180 -63.3 -44.07 96.03 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 116.436 -0.347 . . . . 75.21 110.308 177.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.3 m -61.98 -34.78 76.78 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.521 0.677 . . . . 72.23 110.582 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.6 m -74.02 -33.97 63.95 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.552 0.691 . . . . 74.33 109.965 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 26.3 mt -83.7 6.98 19.05 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.938 0.895 . . . . 73.53 112.61 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 43.9 mt-10 -75.79 145.59 40.62 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.104 -1.038 . . . . 71.43 112.498 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.66 12.64 46.77 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.548 -1.021 . . . . 60.11 110.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 p -122.11 165.66 19.84 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 107.809 -1.182 . . . . 62.12 107.809 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 96.3 Cg_endo -81.27 21.63 0.89 Allowed 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 121.886 1.724 . . . . 74.32 111.968 174.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 121.12 24.76 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.085 0.469 . . . . 52.21 111.217 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.0 m -105.32 157.68 17.15 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.45 -1.315 . . . . 73.55 107.45 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.33 157.64 46.17 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.635 -0.876 . . . . 71.43 108.635 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.6 pt20 -119.07 109.75 16.28 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.579 -0.849 . . . . 74.43 111.064 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.51 8.08 55.03 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.39 -0.909 . . . . 44.41 114.35 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.97 26.42 14.13 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.767 0.794 . . . . 75.2 109.621 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.7 138.86 22.05 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 115.64 -0.709 . . . . 63.43 110.32 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 24.8 p90 -148.2 167.9 23.88 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.884 -0.598 . . . . 61.2 112.249 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 8.3 m-85 -115.71 153.72 30.84 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.501 -0.772 . . . . 74.21 110.259 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.65 136.77 54.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.591 -1.633 . . . . 65.24 106.591 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -132.13 156.85 45.64 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.119 0.414 . . . . 60.12 112.119 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.32 163.81 37.1 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 109.085 -1.606 . . . . 54.33 109.085 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.432 ' OH ' ' HD2' ' A' ' 181' ' ' ARG . 14.5 p90 -127.57 -32.79 2.37 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 114.235 1.198 . . . . 74.43 114.235 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -119.94 144.87 38.41 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.596 -0.89 . . . . 52.25 108.596 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.87 127.3 23.88 Favored 'Trans proline' 0 C--O 1.252 1.222 0 C-N-CA 121.96 1.773 . . . . 73.33 109.285 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.4 129.88 22.48 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 121.66 1.574 . . . . 71.13 111.9 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.36 -42.33 9.85 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 106.236 -1.765 . . . . 51.1 106.236 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -106.45 152.33 40.59 Favored Pre-proline 0 N--CA 1.419 -2.013 0 N-CA-C 107.379 -1.341 . . . . 72.32 107.379 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.77 -12.95 34.07 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.962 2.441 . . . . 65.22 112.755 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 138' ' ' TYR . 45.0 m-85 -68.37 -81.45 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.191 0.811 . . . . 72.02 113.191 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 105.12 176.76 24.43 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.873 -1.691 . . . . 74.21 108.873 -172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.432 ' HD2' ' OH ' ' A' ' 172' ' ' TYR . 79.6 mtt180 -97.38 -56.25 2.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.744 1.272 . . . . 62.33 109.322 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.512 ' HA ' ' HA2' ' A' ' 136' ' ' GLY . 14.6 ptt180 -152.13 157.65 41.84 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.521 -2.029 . . . . 73.41 105.521 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -134.72 142.97 46.93 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.882 -0.784 . . . . 52.31 108.882 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 9.3 mm-40 -111.49 132.5 54.45 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.384 -0.969 . . . . 73.23 108.384 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.494 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 88.5 t -127.06 121.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.074 -0.713 . . . . 75.14 109.074 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.599 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 33.1 m0 -107.0 124.94 50.34 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 119.606 -0.235 . . . . 74.32 110.799 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 167' ' ' TYR . 82.6 mt -96.64 138.75 33.74 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.375 -0.972 . . . . 52.23 108.375 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.11 129.64 53.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 120.04 -0.664 . . . . 74.41 109.366 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.515 ' HE2' ' OH ' ' A' ' 131' ' ' TYR . 19.2 ptpt -72.94 142.99 47.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 71.43 111.422 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 118.963 -0.541 . . . . 61.13 109.773 176.568 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.499 ' N ' HD21 ' A' ' 7' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.505 -0.758 0 N-CA-C 110.175 -0.305 . . . . 75.22 110.175 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.0 m -104.53 100.97 10.65 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.994 -0.372 . . . . 72.2 109.994 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 9' ' ' LEU . 1.9 pt? -71.09 152.6 43.33 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.411 -0.359 . . . . 62.12 110.516 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.418 ' HD2' ' O ' ' A' ' 12' ' ' SER . 59.6 t80 -83.55 147.72 27.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.147 -1.057 . . . . 75.54 108.147 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.27 -60.26 9.28 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 115.091 0.797 . . . . 54.21 115.091 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' HD2' ' A' ' 10' ' ' PHE . 32.7 p -105.54 157.24 17.52 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 117.212 0.506 . . . . 72.13 111.054 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.52 77.1 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.08 0 CA-C-O 122.616 1.198 . . . . 64.35 110.899 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -145.87 114.57 6.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.439 -1.255 . . . . 71.2 108.841 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -79.77 -31.09 40.86 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.447 -0.945 . . . . 54.32 108.447 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -155.39 123.98 2.98 Favored Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 105.842 -1.91 . . . . 75.11 105.842 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.26 134.59 25.16 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.598 1.532 . . . . 72.22 112.67 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.546 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.7 p90 -102.54 159.27 15.59 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.75 -0.833 . . . . 75.11 108.75 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -105.65 112.53 25.65 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.226 -0.59 . . . . 62.11 110.911 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.58 127.94 41.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.036 -1.468 . . . . 71.24 107.036 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.53 HD21 ' OE2' ' A' ' 33' ' ' GLU . 3.6 pp -95.77 -24.9 16.28 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.938 -1.105 . . . . 73.33 112.925 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.1 p -175.71 160.2 2.4 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 123.361 0.413 . . . . 73.35 111.611 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 73.9 p -131.21 154.12 48.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.283 -1.006 . . . . 63.22 108.283 174.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.59 -146.41 14.44 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 119.518 -1.325 . . . . 63.33 112.085 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.09 -118.02 5.11 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.705 -0.958 . . . . 50.33 110.705 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -117.44 169.28 9.64 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.741 -1.577 . . . . 73.03 106.741 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -87.16 157.05 19.45 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.13 -1.028 . . . . 74.52 111.911 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 82.0 -41.92 0.14 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.4 1.88 . . . . 74.04 110.053 -172.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.35 109.92 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.802 -1.184 . . . . 74.44 107.802 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 p -113.41 153.58 28.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.38 -0.6 . . . . 72.01 109.38 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.3 OUTLIER -112.88 150.87 31.15 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.587 -0.445 . . . . 71.5 111.319 178.246 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 36.3 tt0 -137.33 124.33 21.48 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.483 -1.673 . . . . 70.22 106.483 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' OE2' HD21 ' A' ' 21' ' ' LEU . 36.1 tt0 -100.5 117.6 34.99 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.138 -1.43 . . . . 62.53 107.138 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.531 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 28.8 ptt180 -138.4 144.71 40.34 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.096 -0.642 . . . . 72.45 110.837 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -81.96 136.61 35.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.493 -0.929 . . . . 62.2 108.493 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.47 133.81 51.17 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.65 0.241 . . . . 71.21 111.65 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' CD ' HH12 ' A' ' 103' ' ' ARG . 8.6 pt-20 -55.28 -45.11 76.18 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.945 -0.57 . . . . 70.32 112.072 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.54 10.29 50.88 Favored Glycine 0 C--N 1.311 -0.856 0 C-N-CA 119.673 -1.251 . . . . 54.42 114.682 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.62 165.22 52.49 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.357 -0.925 . . . . 75.15 112.182 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.16 131.64 35.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 75.01 110.881 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 60.3 m-85 -131.33 166.04 22.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.404 0.682 . . . . 73.33 110.951 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.45 116.21 29.23 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 107.837 -1.171 . . . . 73.14 107.837 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.5 t -124.41 144.58 49.97 Favored 'General case' 0 N--CA 1.402 -2.867 0 CA-C-N 115.419 -0.809 . . . . 70.32 112.044 -175.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.6 m -127.85 145.08 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.913 -1.04 . . . . 74.15 109.446 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -122.34 128.61 51.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.945 0.403 . . . . 62.34 111.158 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.637 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 22.0 t -125.73 142.43 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.455 -1.313 . . . . 73.41 107.455 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 49' ' ' LYS . 17.5 p -134.32 166.81 21.97 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.097 0.159 . . . . 74.42 111.42 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.7 t70 71.88 -36.17 0.35 Allowed 'General case' 0 N--CA 1.514 2.769 0 C-N-CA 125.131 1.372 . . . . 72.13 112.12 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 47' ' ' THR . 25.0 mtpp -86.14 141.32 35.05 Favored Pre-proline 0 C--N 1.282 -2.36 0 C-N-CA 124.786 1.235 . . . . 75.41 109.743 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.67 155.89 40.33 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.316 2.01 . . . . 73.12 109.367 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.63 -36.18 41.39 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 113.635 0.976 . . . . 72.32 113.635 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 15.9 t70 -60.01 -47.74 84.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.739 -0.467 . . . . 74.04 109.739 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -69.7 -41.62 75.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.699 . . . . 74.4 111.3 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -61.58 -42.35 98.72 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.914 -0.585 . . . . 71.5 110.334 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 tp -60.22 -35.23 74.96 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.13 0.972 . . . . 63.21 110.759 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 26.0 mmt180 -63.83 -35.23 79.93 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.463 0.649 . . . . 72.12 109.524 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 28.0 tt0 -82.95 -32.03 27.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 73.4 110.135 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.18 60.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.306 0.854 . . . . 63.53 113.306 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 8.9 mmt -55.34 -56.16 31.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 112.796 0.665 . . . . 74.32 112.796 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.64 -31.26 69.88 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.7 2.267 . . . . 75.03 113.193 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 95.4 mttt -62.53 -49.36 75.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.027 0.441 . . . . 72.12 110.162 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.85 -38.0 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 120.635 -0.426 . . . . 71.42 110.836 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.3 mtt -61.01 -38.97 87.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.833 0.679 . . . . 74.41 112.833 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -72.56 -31.38 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.219 -0.592 . . . . 74.24 110.684 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.07 -55.32 22.97 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.317 -0.402 . . . . 73.23 110.783 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.79 -10.4 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.162 0.505 . . . . 53.24 111.209 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -21.98 73.65 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.606 -0.725 . . . . 73.45 111.483 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.88 -5.63 6.94 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.934 -1.127 . . . . 71.13 113.598 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -86.25 33.76 0.62 Allowed 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.565 1.174 . . . . 72.13 110.105 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -93.99 173.1 7.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.06 -0.973 . . . . 53.12 108.841 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.32 -34.45 78.16 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.373 0.508 . . . . 71.32 112.373 -173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.523 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -83.78 -12.6 55.47 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.508 -0.477 . . . . 75.12 109.998 -177.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.87 27.85 72.64 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.713 0.633 . . . . 52.31 112.321 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 35.8 m -86.16 122.06 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.041 -0.664 . . . . 63.23 111.31 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.62 86.63 0.7 Allowed Glycine 0 N--CA 1.432 -1.58 0 CA-C-N 115.611 -0.722 . . . . 72.54 111.323 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -150.27 116.1 5.58 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.187 0.517 . . . . 61.54 110.19 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.83 124.59 7.1 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.644 -0.707 . . . . 73.41 112.069 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.8 ptp -105.82 126.46 52.2 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.962 -0.755 . . . . 73.21 108.962 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 p -120.38 115.87 24.36 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 55.4 111.302 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.608 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 10.8 m -154.03 -179.89 1.16 Allowed Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 125.801 1.64 . . . . 74.44 106.922 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 84.5 Cg_exo -51.0 140.67 39.01 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.751 2.301 . . . . 73.21 115.414 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.91 138.16 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.787 -1.56 . . . . 72.04 106.787 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -133.87 145.25 49.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.674 -0.491 . . . . 53.12 109.674 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 98' ' ' LEU . 52.2 p90 -145.28 138.31 26.32 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.902 -0.499 . . . . 73.02 111.169 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -93.18 135.28 34.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.461 -0.94 . . . . 70.45 108.461 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 166' ' ' VAL . 33.4 m -121.15 149.16 24.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.719 -0.845 . . . . 71.43 108.719 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.56 105.51 51.85 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 116.118 -0.492 . . . . 75.42 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.28 159.05 20.09 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.898 1.732 . . . . 65.45 110.801 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.414 HD21 ' HG2' ' A' ' 96' ' ' LYS . 50.8 m-80 -122.33 162.66 21.13 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.79 -0.818 . . . . 72.1 108.79 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.77 -13.7 59.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.557 0.694 . . . . 62.2 110.513 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.69 -6.67 58.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.845 -1.071 . . . . 75.41 110.099 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.28 10.27 83.88 Favored Glycine 0 C--O 1.218 -0.876 0 CA-C-N 115.911 -0.586 . . . . 72.51 113.192 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 m -105.24 134.76 47.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.874 0.337 . . . . 74.15 110.445 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.6 mt -88.42 75.57 8.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.784 -1.191 . . . . 75.44 107.784 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 58.9 tt0 -147.18 114.51 6.28 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.345 -0.843 . . . . 72.22 111.183 -174.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' A' ' 96' ' ' LYS . 6.1 mmpt? -178.87 -66.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.95 2.1 . . . . 72.11 106.356 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -147.28 150.64 35.21 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.435 -1.257 . . . . 64.42 107.885 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 84' ' ' PHE . 56.6 tp -127.71 124.35 37.63 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.206 -1.775 . . . . 73.24 106.206 168.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -114.31 113.78 25.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.237 -1.764 . . . . 72.44 106.237 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' THR . 97.0 t -99.85 123.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 109.438 -0.579 . . . . 52.24 109.438 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -110.25 120.69 43.25 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -104.16 124.54 49.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.621 -0.511 . . . . 72.32 109.621 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.412 HH12 ' CD ' ' A' ' 37' ' ' GLU . 19.0 mmm180 -74.57 132.67 41.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.339 -0.846 . . . . 74.33 109.019 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.6 mt -99.03 135.89 20.72 Favored Pre-proline 0 C--N 1.285 -2.204 0 N-CA-C 107.838 -1.171 . . . . 44.25 107.838 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.81 148.97 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.589 2.192 . . . . 73.42 112.312 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -47.6 -43.18 25.37 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.472 1.509 . . . . 74.35 112.288 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.13 -36.15 83.37 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.67 0.619 . . . . 62.11 112.67 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -88.93 -6.37 57.32 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-N 116.559 -0.291 . . . . 72.32 111.605 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.425 HE22 ' HE1' ' A' ' 41' ' ' PHE . 23.4 mm-40 -70.09 -28.48 65.45 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.751 -0.204 . . . . 54.34 111.519 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.08 -38.1 92.56 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.868 -0.493 . . . . 72.44 111.868 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 p -158.67 87.77 2.26 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 123.466 0.706 . . . . 63.24 109.956 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 10.0 Cg_endo -86.63 144.71 7.74 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 122.577 2.185 . . . . 70.11 112.104 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 33.2 Cg_exo -60.79 142.84 98.86 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.767 2.312 . . . . 74.31 112.628 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . . . -76.67 144.82 73.96 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.857 -0.61 . . . . 54.51 109.997 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -80.36 126.51 6.2 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.514 2.143 . . . . 71.42 111.923 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.4 m -74.91 -23.91 58.43 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.657 -0.701 . . . . 73.13 111.606 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -99.64 135.73 40.61 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.111 -1.44 . . . . 72.02 107.111 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -77.01 -3.71 40.45 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.434 0.901 . . . . 72.42 113.434 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.525 ' O ' HG12 ' A' ' 44' ' ' VAL . 17.1 m -73.74 -26.44 60.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.775 -0.824 . . . . 64.45 108.775 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 61' ' ' LYS . 25.3 t -113.98 124.12 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 106.593 -1.632 . . . . 60.41 106.593 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.429 ' HA ' ' HG2' ' A' ' 115' ' ' PRO . 27.3 mtpp -129.66 145.91 51.48 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.81 -1.156 . . . . 71.11 110.568 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 26.7 mm -91.91 111.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.997 -1.483 . . . . 74.4 106.997 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -133.81 149.55 51.41 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.085 -0.961 . . . . 62.15 109.77 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.49 153.3 23.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.134 -0.691 . . . . 70.54 109.134 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 67.4 ttt180 -139.25 123.17 17.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.458 -0.897 . . . . 62.32 109.984 174.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -143.85 177.14 8.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.373 -0.83 . . . . 75.51 109.314 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.06 -1.42 84.82 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 121.134 -0.555 . . . . 35.31 113.736 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.46 162.47 32.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 117.398 0.599 . . . . 72.21 111.381 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.2 m -120.6 135.99 54.94 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.437 -0.801 . . . . 71.22 109.777 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.94 161.87 28.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 120.94 0.4 . . . . 71.24 110.413 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 67.3 m-85 -113.99 123.47 49.79 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.703 -1.962 . . . . 73.03 105.703 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 25.4 t -111.91 147.55 35.6 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 120.444 -0.502 . . . . 44.5 109.905 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 8.9 t -129.23 132.98 47.33 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.112 -0.494 . . . . 64.41 109.848 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 184' ' ' GLU . 74.2 mt-30 -110.46 131.64 54.87 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 121.258 0.552 . . . . 70.13 111.425 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.86 149.63 40.52 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.722 -1.127 . . . . 74.02 109.494 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -121.92 149.09 17.16 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.78 -0.724 . . . . 75.12 111.465 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.54 24.49 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.24 -1.144 . . . . 54.31 110.24 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -90.54 100.52 13.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.037 -0.727 . . . . 54.23 109.037 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.25 107.7 19.82 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.913 0.863 . . . . 72.0 112.672 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -100.77 169.68 8.85 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.513 -1.662 . . . . 62.41 106.513 171.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 1.6 mp0 -57.55 -42.16 82.42 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.173 0.511 . . . . 62.24 110.109 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.67 70.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.519 -0.764 . . . . 64.42 111.542 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.67 -36.85 70.77 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.653 -0.499 . . . . 74.11 109.653 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -60.47 -47.8 84.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.778 -0.646 . . . . 72.31 110.224 173.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -46.88 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.726 0.641 . . . . 65.43 110.604 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.65 87.86 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.062 0.458 . . . . 63.32 110.926 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -68.95 -33.3 73.49 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 116.325 -0.398 . . . . 74.01 111.688 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.46 -45.85 92.53 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.059 -0.349 . . . . 34.53 110.059 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.648 ' HA ' ' HE ' ' A' ' 152' ' ' ARG . 63.2 m -59.11 -46.98 86.91 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 122.818 0.447 . . . . 64.11 110.32 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.46 -39.41 93.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.827 -0.624 . . . . 72.41 110.998 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 31' ' ' TYR . 60.2 tp -64.94 -40.88 95.7 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.999 -0.371 . . . . 75.55 109.999 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.648 ' HE ' ' HA ' ' A' ' 149' ' ' THR . 88.5 mtm180 -62.22 -40.16 95.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.892 -0.594 . . . . 73.03 111.144 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.2 m -69.77 -36.03 75.42 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.428 0.632 . . . . 72.13 110.312 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.7 m -70.33 -33.7 71.8 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.373 0.606 . . . . 73.34 110.424 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.488 HD12 HD23 ' A' ' 187' ' ' LEU . 93.4 mt -77.63 6.69 6.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.707 -0.679 . . . . 71.43 112.54 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.22 142.38 32.74 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.004 -0.739 . . . . 62.32 109.004 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.43 -10.29 65.02 Favored Glycine 0 C--N 1.307 -1.052 0 N-CA-C 110.095 -1.202 . . . . 71.22 110.095 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 10.9 t -120.9 153.16 57.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.448 -1.686 . . . . 75.24 106.448 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.59 17.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.592 2.861 . . . . 44.33 115.199 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.41 131.7 34.35 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.068 -0.395 . . . . 71.51 110.097 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 32.2 p -124.94 154.94 40.37 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.754 -0.832 . . . . 52.05 108.754 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -136.73 149.25 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 118.287 0.494 . . . . 72.22 110.956 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -116.77 141.63 47.97 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.727 0.64 . . . . 72.34 112.727 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.21 -2.28 15.01 Favored Glycine 0 C--N 1.318 -0.461 0 CA-C-N 115.021 -0.99 . . . . 64.31 113.35 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.3 t70 61.22 11.72 3.72 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.549 1.14 . . . . 73.42 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 86' ' ' VAL . 7.3 p -73.79 139.38 19.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.904 1.282 . . . . 71.13 111.385 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.61 168.74 19.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.387 -0.824 . . . . 73.4 110.713 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 16.0 m-85 -115.29 156.42 25.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.096 -0.502 . . . . 72.11 110.451 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 64.4 m -124.19 119.84 30.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.626 -1.62 . . . . 63.43 106.626 172.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.5 154.98 49.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.62 -0.264 . . . . 31.14 110.306 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.69 141.84 9.22 Favored Glycine 0 CA--C 1.481 -2.083 0 N-CA-C 108.931 -1.668 . . . . 40.44 108.931 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 182' ' ' ARG . 13.3 m-30 -84.44 -12.79 53.71 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.757 0.789 . . . . 74.25 110.71 -177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -137.57 128.62 16.06 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 105.27 -2.122 . . . . 63.35 105.27 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 83.0 Cg_exo -47.22 110.8 0.33 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 123.227 2.618 . . . . 72.32 112.497 -176.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 179' ' ' TYR . 5.6 Cg_exo -78.15 126.67 7.93 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 121.542 1.495 . . . . 74.24 113.131 -174.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 50.6 ttm -100.16 -43.69 6.23 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.215 -1.402 . . . . 63.0 107.215 170.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.444 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 86.9 tttt 163.85 -60.84 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 127.729 2.412 . . . . 73.31 106.853 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 177' ' ' LYS . 60.1 Cg_endo -75.83 -31.75 4.98 Favored 'Trans proline' 0 C--N 1.4 3.256 0 N-CA-C 109.336 -1.063 . . . . 73.21 109.336 172.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 175' ' ' PRO . 78.8 m-85 -84.72 142.4 29.88 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 104.555 -2.387 . . . . 62.32 104.555 172.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 106.55 64.8 0.62 Allowed Glycine 0 C--N 1.284 -2.357 0 N-CA-C 108.732 -1.747 . . . . 63.41 108.732 -170.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -87.73 -39.51 14.88 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.949 0.404 . . . . 64.55 109.922 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.535 ' HB2' ' HB2' ' A' ' 172' ' ' TYR . 3.3 mmp_? -103.51 127.09 50.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.552 -1.647 . . . . 73.33 106.552 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.11 146.51 33.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.838 -0.801 . . . . 73.35 108.838 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.607 ' HG2' ' HG2' ' A' ' 134' ' ' GLN . 40.0 mt-10 -135.23 149.38 49.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.443 0.64 . . . . 62.13 111.323 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.461 ' HB ' HG22 ' A' ' 133' ' ' THR . 77.7 t -125.02 118.58 53.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.927 -1.508 . . . . 71.23 106.927 172.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 18.0 m0 -102.91 120.65 40.99 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.139 -1.06 . . . . 74.23 108.139 -178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.488 HD23 HD12 ' A' ' 155' ' ' LEU . 37.8 tp -106.05 129.95 54.06 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.303 -1.369 . . . . 64.1 107.303 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.89 125.1 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.565 -0.454 . . . . 63.12 110.705 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 161' ' ' THR . 13.8 pttp -71.06 145.95 49.6 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.005 -0.739 . . . . 64.14 109.005 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 108.787 -0.82 . . . . 37.68 108.787 174.671 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.594 ' N ' HD21 ' A' ' 7' ' ' ASN . 0.6 OUTLIER . . . . . 0 CA--C 1.506 -0.737 0 N-CA-C 109.397 -0.594 . . . . 70.55 109.397 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 m -68.43 -38.58 81.31 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.983 0.42 . . . . 72.44 110.336 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp -81.27 177.37 9.04 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.656 -0.702 . . . . 74.43 111.956 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.74 107.62 16.34 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.216 -0.661 . . . . 73.4 109.216 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.02 -25.19 58.29 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.189 -0.765 . . . . 45.32 111.189 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 p -67.68 150.73 48.33 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.693 -0.484 . . . . 74.11 109.693 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 15' ' ' THR . 27.9 m -60.78 117.8 2.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 113.598 0.962 . . . . 74.4 113.598 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.61 -27.76 37.23 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.096 -1.816 . . . . 73.14 106.096 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.544 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 5.5 t -118.94 121.66 40.45 Favored 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 114.021 -1.445 . . . . 75.13 107.698 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -74.63 138.24 73.98 Favored Pre-proline 0 C--N 1.292 -1.897 0 CA-C-N 115.448 -0.796 . . . . 74.54 109.563 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.84 141.32 84.29 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.529 1.486 . . . . 74.1 109.068 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -100.45 127.09 46.89 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 118.774 -1.17 . . . . 73.14 109.153 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -113.55 122.44 47.24 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.888 -1.051 . . . . 72.34 111.18 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.0 119.79 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 106.111 -1.811 . . . . 75.41 106.111 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -89.96 -25.78 20.73 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.123 -0.631 . . . . 71.43 111.062 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -176.84 153.85 1.09 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.511 0.507 . . . . 75.14 109.794 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.3 p -132.29 154.59 49.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.801 -0.814 . . . . 62.53 108.801 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.03 -148.82 20.1 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 119.24 -1.457 . . . . 71.51 113.313 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.2 -118.45 5.23 Favored Glycine 0 N--CA 1.427 -1.934 0 N-CA-C 110.268 -1.133 . . . . 74.04 110.268 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -99.41 169.96 8.97 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.876 -1.527 . . . . 72.41 106.876 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.3 162.86 14.11 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 75.32 109.236 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 72.72 -53.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.365 1.066 . . . . 71.43 110.12 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.63 111.75 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 107.999 -1.111 . . . . 73.2 107.999 172.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.2 p -133.69 155.82 49.03 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.594 -0.73 . . . . 61.23 110.477 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -112.01 161.8 16.07 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.233 0.539 . . . . 71.01 111.428 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' OE1' ' HD2' ' A' ' 34' ' ' ARG . 39.7 tt0 -133.81 124.86 27.27 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.159 -1.423 . . . . 73.33 107.159 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.07 114.9 26.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.84 -1.541 . . . . 75.43 106.84 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.456 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 13.7 ptm180 -134.22 143.47 47.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.32 0.581 . . . . 72.32 112.563 -172.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.78 135.78 35.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.194 -1.78 . . . . 72.14 106.194 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.4 t -68.99 146.74 52.47 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.356 0.598 . . . . 62.13 111.94 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.5 pm0 -67.84 0.5 3.32 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 126.162 1.785 . . . . 74.14 114.236 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 75.08 11.51 83.96 Favored Glycine 0 C--N 1.305 -1.147 0 C-N-CA 119.656 -1.259 . . . . 62.4 114.565 169.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.65 152.08 48.76 Favored Glycine 0 N--CA 1.408 -3.204 0 C-N-CA 120.349 -0.929 . . . . 72.31 113.39 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 104' ' ' ILE . 17.7 ptpt -102.96 118.93 37.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.041 -1.466 . . . . 70.33 107.041 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 59.3 m-85 -117.15 163.72 15.85 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.562 -0.745 . . . . 62.15 111.525 -168.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.03 116.91 32.34 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 108.093 -1.077 . . . . 75.24 108.093 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -124.21 146.41 48.73 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 113.033 0.753 . . . . 74.1 113.033 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.4 m -128.03 144.13 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 114.262 -1.336 . . . . 62.53 108.645 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.25 136.7 51.4 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 120.77 0.319 . . . . 73.32 111.016 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.557 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 44.4 t -130.39 141.99 44.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 105.916 -1.883 . . . . 64.41 105.916 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.468 ' C ' ' H ' ' A' ' 49' ' ' LYS . 34.1 p -130.49 159.76 36.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.651 0.612 . . . . 61.51 112.651 -171.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.3 -32.75 0.24 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.642 1.577 . . . . 72.24 112.541 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 47' ' ' THR . 52.6 mtpt -85.05 136.34 38.48 Favored Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 124.673 1.189 . . . . 72.41 109.336 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 53.0 Cg_exo -55.05 156.15 16.81 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.268 2.645 . . . . 73.02 112.111 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.66 -41.44 12.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 113.293 0.849 . . . . 75.13 113.293 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -59.7 -47.66 84.76 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 120.644 -0.422 . . . . 73.13 110.975 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.64 -39.82 73.44 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.94 -0.573 . . . . 75.31 111.702 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -67.47 -46.32 73.33 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.692 -0.686 . . . . 41.14 110.453 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.8 -45.74 85.01 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 122.423 0.289 . . . . 72.53 111.758 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 5.6 ppt_? -61.82 -28.24 69.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.813 0.672 . . . . 72.51 112.813 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 tt0 -85.64 -39.51 17.21 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.426 0.631 . . . . 71.01 111.154 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -76.51 -32.17 58.14 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.95 0.722 . . . . 44.15 112.95 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.515 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -53.59 -48.05 94.41 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 112.401 0.519 . . . . 73.51 112.401 -178.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 63' ' ' MET . 36.4 Cg_exo -56.48 -34.54 95.1 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.135 1.89 . . . . 71.23 111.515 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 58' ' ' ALA . 50.6 mtmt -69.03 -32.61 72.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.117 0.484 . . . . 71.23 110.791 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 102' ' ' PHE . 29.7 mm -76.49 -48.74 26.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.1 -0.5 . . . . 73.34 111.503 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.411 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.276 3.2 ppp? -66.01 -29.23 69.57 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.696 0.998 . . . . 63.04 113.696 -176.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.08 -29.45 69.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.24 0.543 . . . . 64.24 110.296 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.769 -0.65 . . . . 72.43 110.139 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 76' ' ' MET . 2.7 p -66.8 -27.23 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.013 0.435 . . . . 71.12 110.124 176.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.79 -20.77 62.39 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.842 -0.617 . . . . 54.5 113.686 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 131.67 -15.74 5.15 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.859 -1.162 . . . . 73.44 113.028 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -81.69 29.0 0.39 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.928 0.871 . . . . 72.25 110.502 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.01 166.02 13.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.919 -0.582 . . . . 73.12 109.908 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.76 -35.03 79.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 112.928 0.714 . . . . 71.23 112.928 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.594 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 1.6 mptm? -82.71 -10.56 58.85 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.113 0.482 . . . . 73.42 111.526 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.88 33.88 76.02 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.56 -0.746 . . . . 75.21 112.541 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 24.7 m -80.65 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.712 -0.795 . . . . 72.44 108.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.31 167.34 51.96 Favored Glycine 0 N--CA 1.435 -1.372 0 O-C-N 123.776 0.672 . . . . 44.33 113.033 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 27.1 ttt -76.14 101.25 5.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.284 -0.458 . . . . 62.43 109.968 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.57 41.86 0.18 Allowed Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.217 -0.992 . . . . 73.12 112.978 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.414 ' HG2' HG23 ' A' ' 66' ' ' VAL . 15.3 ptm -124.91 123.5 40.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.947 -1.131 . . . . 73.21 107.947 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.3 m -125.67 117.36 23.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.034 0.753 . . . . 73.33 113.034 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -156.72 159.02 31.59 Favored Pre-proline 0 C--O 1.242 0.7 0 C-N-CA 125.494 1.518 . . . . 64.22 107.311 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.16 140.12 81.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.763 1.642 . . . . 54.15 112.131 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.98 150.61 5.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.949 -1.13 . . . . 65.24 107.949 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -138.65 144.64 39.77 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.866 -0.42 . . . . 71.44 109.866 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 46.5 p90 -135.2 144.83 47.16 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 122.083 -0.386 . . . . 74.33 110.653 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.64 34.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 108.523 -0.917 . . . . 61.32 108.523 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.23 150.25 25.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 N-CA-C 107.821 -1.177 . . . . 72.43 107.821 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.435 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 2.7 m-85 -117.07 100.3 53.23 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.672 -0.862 . . . . 75.14 108.672 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.87 152.38 16.86 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 121.911 1.741 . . . . 75.01 112.677 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -100.14 158.37 15.9 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.327 -1.731 . . . . 71.32 106.327 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.25 -12.79 58.42 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.352 0.501 . . . . 70.23 112.352 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.39 -3.03 54.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.988 -0.551 . . . . 71.42 110.984 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.07 -4.01 82.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.936 -0.65 . . . . 32.51 112.984 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.0 m -83.01 131.42 35.18 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.765 0.317 . . . . 45.32 110.414 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.57 79.26 4.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.539 0.685 . . . . 52.44 110.534 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 52.0 tt0 -148.46 114.26 5.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.29 -0.868 . . . . 74.22 111.012 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 56.3 mtpt -176.82 -67.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.727 2.011 . . . . 72.13 107.048 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 64.9 mttm -145.67 158.63 43.83 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.883 -1.053 . . . . 73.15 108.518 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 84' ' ' PHE . 46.8 tp -139.14 124.74 19.45 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.964 -1.125 . . . . 71.21 107.964 171.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -123.68 114.04 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.158 -1.052 . . . . 71.54 108.158 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.508 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 58.2 t -97.15 130.14 46.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.178 -0.675 . . . . 52.44 109.178 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.45 131.65 56.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.149 -0.685 . . . . 71.31 109.149 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.421 ' HB2' HD12 ' A' ' 62' ' ' ILE . 67.8 t80 -102.98 114.67 29.16 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.022 -1.103 . . . . 73.02 108.022 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.632 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 75.9 ttt180 -75.52 133.04 41.11 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.014 -1.448 . . . . 74.11 109.755 -176.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 40' ' ' LYS . 76.1 mt -106.44 137.54 19.46 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.565 -0.902 . . . . 70.15 108.565 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.77 149.43 77.55 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.259 1.972 . . . . 63.24 110.428 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -60.99 -33.82 73.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.831 1.049 . . . . 64.3 113.831 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -66.94 -23.91 66.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 64.03 111.119 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -92.66 -7.7 46.13 Favored 'General case' 0 C--O 1.192 -1.958 0 CA-C-N 116.66 -0.246 . . . . 73.32 110.895 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -71.52 -33.29 69.06 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.922 -0.711 . . . . 74.04 111.478 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.83 -29.61 74.59 Favored Glycine 0 C--N 1.334 0.464 0 O-C-N 123.559 0.537 . . . . 42.4 111.949 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.0 t -153.69 82.56 4.58 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 108.996 -0.742 . . . . 71.11 108.996 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.73 162.14 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.468 2.112 . . . . 54.33 111.902 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.594 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.3 Cg_exo -60.45 156.98 38.37 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 C-N-CA 121.581 1.52 . . . . 72.12 109.783 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.94 154.56 37.74 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.431 -0.581 . . . . 72.22 109.431 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 27.8 Cg_exo -62.98 104.99 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.781 2.321 . . . . 75.11 111.81 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.2 p -90.67 -28.35 18.42 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.871 -0.604 . . . . 71.34 112.177 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.7 156.03 18.38 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.813 -0.81 . . . . 73.11 108.813 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.47 -31.71 63.91 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.455 0.645 . . . . 70.25 110.366 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.8 m -99.28 5.14 46.67 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.525 -0.762 . . . . 43.25 112.013 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 59.6 t -119.7 122.6 69.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.071 -1.085 . . . . 61.12 108.071 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -128.22 143.4 51.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.366 -0.379 . . . . 72.25 110.502 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.2 mm -92.75 110.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.826 -1.176 . . . . 63.53 107.826 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -108.01 144.04 35.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.23 -0.895 . . . . 62.2 109.382 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.16 127.33 45.1 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.842 -0.617 . . . . 64.52 110.492 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 125' ' ' ARG . 2.1 mmp_? -123.36 116.25 22.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 118.745 -1.182 . . . . 64.11 109.686 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.586 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -148.49 161.01 42.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.379 -0.828 . . . . 75.25 110.962 173.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.13 19.7 71.68 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.919 -0.658 . . . . 74.0 112.264 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -121.14 147.67 24.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.314 0.578 . . . . 75.23 111.009 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.9 m -117.47 128.21 54.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.446 -0.946 . . . . 62.25 108.446 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.458 HG21 ' CE3' ' A' ' 186' ' ' TRP . 30.2 m -124.72 166.06 20.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 116.13 -0.486 . . . . 75.54 110.001 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 55.4 m-85 -113.75 122.18 46.33 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 106.256 -1.757 . . . . 74.34 106.256 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 p -119.73 132.73 55.72 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.773 -0.771 . . . . 71.22 110.735 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.8 t -121.76 123.84 42.79 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 109.007 -0.738 . . . . 51.33 109.007 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -110.58 136.91 48.96 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.431 -0.951 . . . . 73.02 108.431 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 43.2 p90 -145.49 144.7 30.72 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.026 -0.533 . . . . 72.33 111.561 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -106.64 138.25 14.31 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.503 -1.039 . . . . 64.45 110.503 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.11 -175.06 28.52 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.868 -0.682 . . . . 51.21 111.484 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -87.59 111.13 20.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.784 -1.191 . . . . 75.32 107.784 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.28 130.8 53.24 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.531 0.567 . . . . 55.35 112.531 -174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.15 178.21 5.32 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.702 -1.222 . . . . 73.51 107.702 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.71 77.86 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.323 0.582 . . . . 64.31 109.869 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.48 71.31 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.355 -0.839 . . . . 73.42 111.063 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.37 -30.52 70.33 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.413 0.149 . . . . 73.13 111.199 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -69.7 -41.63 75.13 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 110.036 -0.357 . . . . 72.22 110.036 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.81 -48.0 83.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.396 -0.594 . . . . 72.45 109.396 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.98 87.88 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.36 -0.836 . . . . 64.24 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -66.37 -32.43 73.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 112.402 0.519 . . . . 55.54 112.402 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 -46.7 79.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.86 0.362 . . . . 72.23 111.037 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.4 t -72.58 -33.39 66.72 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.482 0.658 . . . . 74.54 110.235 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -64.44 -37.07 86.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.168 -0.678 . . . . 74.01 109.168 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.35 -39.45 93.91 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.859 -0.609 . . . . 62.34 110.058 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -63.28 -36.54 84.01 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.372 -0.603 . . . . 75.31 109.372 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 m -70.53 -32.71 70.27 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.261 -0.881 . . . . 73.25 110.031 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.6 m -76.79 -34.33 57.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.671 -0.695 . . . . 74.11 110.06 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -85.71 11.22 11.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.58 0.752 . . . . 65.11 111.095 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -73.68 135.21 43.7 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.624 -1.621 . . . . 51.5 106.624 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.49 58.83 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.521 -0.632 . . . . 61.44 111.521 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 34.9 p -114.3 160.14 33.91 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 107.259 -1.385 . . . . 71.45 107.259 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.13 27.31 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 122.192 1.928 . . . . 53.52 112.163 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.16 101.1 0.85 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.359 0.599 . . . . 71.31 112.273 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.5 p -89.33 156.03 18.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.559 -0.904 . . . . 70.13 108.559 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.408 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 24.2 m-85 -138.74 150.4 46.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 4.5 pt20 -114.04 109.89 19.17 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.309 0.576 . . . . 73.34 110.438 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.27 41.95 Favored Glycine 0 N--CA 1.46 0.3 0 C-N-CA 120.808 -0.71 . . . . 62.44 111.901 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 59.31 25.55 14.22 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.936 1.294 . . . . 72.01 110.499 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.1 m -75.1 140.03 18.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 119.799 -0.761 . . . . 74.32 110.76 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -139.9 170.24 16.23 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.162 -0.926 . . . . 64.02 109.607 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.579 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 60.6 m-85 -115.43 148.09 39.79 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.721 -0.844 . . . . 73.54 108.721 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 63.1 m -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.522 -1.658 . . . . 75.33 106.522 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -117.59 145.45 44.29 Favored 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 123.558 0.536 . . . . 72.22 111.253 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.52 165.2 38.46 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 108.932 -1.667 . . . . 34.22 108.932 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -68.24 -31.35 70.78 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 118.042 0.921 . . . . 65.13 109.074 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -143.19 135.47 13.31 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 105.971 -1.863 . . . . 72.42 105.971 174.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.48 ' HG2' ' SD ' ' A' ' 59' ' ' MET . 50.3 Cg_exo -59.79 111.03 0.84 Allowed 'Trans proline' 0 CA--C 1.514 -0.477 0 C-N-CA 122.327 2.018 . . . . 75.32 109.522 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 174' ' ' PRO . 23.6 Cg_exo -63.68 128.37 22.05 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.839 1.692 . . . . 64.04 113.252 -172.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 58.0 ttp -96.93 -31.69 12.43 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.203 -1.777 . . . . 73.44 106.203 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -107.53 144.67 29.71 Favored Pre-proline 0 N--CA 1.424 -1.768 0 CA-C-N 113.815 -1.538 . . . . 74.5 107.485 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.48 -13.72 26.74 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.437 2.758 . . . . 71.55 113.47 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.86 94.56 0.32 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.8 0.81 . . . . 63.55 111.916 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -156.21 124.59 1.49 Allowed Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 106.847 -2.501 . . . . 72.35 106.847 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.444 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 97.0 mtt180 -79.62 -54.57 5.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 117.26 0.53 . . . . 75.52 110.998 -172.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.87 130.55 49.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 109.245 -0.65 . . . . 60.31 109.245 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.434 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.6 m-80 -127.47 139.34 52.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.241 -1.392 . . . . 61.54 107.241 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 39.0 tt0 -132.09 133.93 44.9 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.829 -0.348 . . . . 73.31 111.051 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.49 125.71 69.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.466 0.706 . . . . 73.04 110.062 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.8 m0 -109.08 121.13 44.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.904 -0.776 . . . . 73.35 108.904 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.35 124.03 49.21 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 107.522 -1.288 . . . . 64.54 107.522 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.34 132.31 39.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.782 0.325 . . . . 74.12 111.262 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 21.0 ptmt -76.45 141.95 41.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.128 -0.487 . . . . 70.21 111.288 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.408 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.809 -0.632 . . . . 65.34 110.42 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 CA--C 1.505 -0.764 0 N-CA-C 110.211 -0.292 . . . . 73.21 110.211 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.4 p -92.6 97.78 11.02 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 116.55 -0.295 . . . . 71.42 111.795 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.95 16.03 20.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.344 0.592 . . . . 73.41 109.924 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -142.35 150.68 41.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.441 -1.318 . . . . 62.33 107.441 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.69 -120.95 0.92 Allowed Glycine 0 C--N 1.301 -1.409 0 N-CA-C 110.92 -0.872 . . . . 72.15 110.92 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.2 p -90.85 95.09 9.95 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-O 121.513 0.673 . . . . 62.3 110.101 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.73 97.78 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 122.234 1.016 . . . . 75.55 112.358 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.81 -26.93 29.15 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.078 -0.964 . . . . 73.33 110.159 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.9 m -143.13 99.94 3.54 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.307 0.575 . . . . 64.34 111.84 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.617 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 49.2 t-105 -87.99 124.56 66.72 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 104.494 -2.41 . . . . 74.12 104.494 171.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.98 140.64 66.97 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.797 1.665 . . . . 63.45 114.083 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -101.87 149.99 23.64 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.501 -2.037 . . . . 73.01 105.501 174.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.83 118.75 21.23 Favored 'General case' 0 C--N 1.284 -2.273 0 C-N-CA 119.633 -0.827 . . . . 73.23 109.105 -171.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t -89.7 126.29 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.883 -0.784 . . . . 61.54 108.883 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.78 -38.57 15.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.384 -0.969 . . . . 61.42 108.384 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.5 t 179.69 165.68 1.13 Allowed 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.932 -1.031 . . . . 62.23 108.291 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 32' ' ' GLU . 68.2 p -131.64 165.13 24.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.958 -1.127 . . . . 63.24 107.958 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.99 -157.04 25.82 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 119.352 -1.404 . . . . 51.03 113.04 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.97 -138.51 14.6 Favored Glycine 0 N--CA 1.42 -2.397 0 N-CA-C 111.186 -0.766 . . . . 74.1 111.186 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.1 171.06 8.48 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.283 -1.006 . . . . 72.14 108.283 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.44 162.17 23.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.129 -1.028 . . . . 71.42 109.622 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 72.39 -54.27 0.69 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.345 1.058 . . . . 75.42 109.797 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 150' ' ' GLN . 6.2 p -110.21 109.39 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-O 122.049 0.928 . . . . 44.22 109.125 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 m -129.67 146.36 51.46 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.003 -1.11 . . . . 71.35 108.003 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' HB3' HD22 ' A' ' 151' ' ' LEU . 6.0 p90 -113.83 160.49 18.67 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 112.795 0.665 . . . . 72.2 112.795 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.573 ' OE1' ' HD3' ' A' ' 34' ' ' ARG . 39.7 tt0 -136.56 125.71 24.61 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.468 -2.049 . . . . 73.03 105.468 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -98.91 118.04 34.77 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.883 -1.525 . . . . 42.15 106.883 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HD3' ' OE1' ' A' ' 32' ' ' GLU . 27.0 mtm180 -131.68 145.76 51.82 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.931 -1.108 . . . . 72.13 111.717 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.34 136.86 34.92 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.303 -2.11 . . . . 61.45 105.303 168.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.0 t -58.25 148.45 27.19 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.349 0.406 . . . . 54.24 111.817 -175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.617 ' O ' ' HB3' ' A' ' 16' ' ' TRP . 14.8 pt-20 -73.17 -3.35 26.03 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 115.753 -0.658 . . . . 25.3 111.641 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 74.01 9.07 79.62 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 120.979 -0.629 . . . . 45.14 114.021 171.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.37 162.5 54.23 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 121.052 -0.594 . . . . 54.53 113.527 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.64 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.04 118.65 37.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.315 -1.365 . . . . 63.31 107.315 178.476 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.1 m-85 -121.4 165.7 15.18 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.665 -0.698 . . . . 70.14 112.05 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -97.69 116.79 30.59 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -127.66 144.24 51.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.655 0.74 . . . . 73.44 112.24 -174.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 6.5 p -127.61 133.63 67.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.298 -1.371 . . . . 73.54 107.298 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.71 123.58 45.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.072 -0.651 . . . . 73.44 111.382 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 31.6 t -118.16 123.19 71.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.261 -1.385 . . . . 52.5 107.261 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 25.0 m -117.76 159.5 22.92 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.669 -0.241 . . . . 72.01 110.532 -175.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 75.58 -27.39 0.19 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.852 1.661 . . . . 72.01 112.035 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -85.19 145.05 42.08 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 109.274 -0.639 . . . . 74.21 109.274 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.57 156.84 34.69 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.927 2.418 . . . . 74.22 111.514 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG13 HD12 ' A' ' 98' ' ' LEU . 54.5 t -48.03 -44.74 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.36 0.664 . . . . 60.34 112.408 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -58.04 -44.41 87.38 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.95 0.405 . . . . 63.12 110.737 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.15 -48.79 26.98 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.505 -0.77 . . . . 62.32 111.063 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -59.7 -40.18 87.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 73.23 111.317 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 59' ' ' MET . 52.7 tp -65.61 -51.3 60.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 116.338 -0.392 . . . . 62.02 110.959 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 4.9 ppt_? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.318 0.858 . . . . 64.44 113.318 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 1.3 tm-20 -74.69 -45.82 41.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.384 -0.969 . . . . 74.53 108.384 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -76.57 -33.16 58.5 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.525 1.13 . . . . 32.33 114.046 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 8.9 mmt -50.98 -55.09 30.65 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 114.918 1.451 . . . . 71.13 114.918 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.42 -30.91 75.47 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.681 2.254 . . . . 62.23 112.163 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -67.35 -48.63 66.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 54.2 111.029 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.7 mm -66.48 -40.1 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 74.04 109.767 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -48.53 79.88 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 123.666 0.787 . . . . 71.34 111.13 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -27.58 65.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.952 -0.699 . . . . 72.4 112.382 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.95 -50.52 68.3 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.576 -0.283 . . . . 52.42 110.517 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -2.92 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.901 -0.591 . . . . 72.52 111.583 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.55 -21.59 36.88 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.809 -0.632 . . . . 72.23 111.929 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 136.69 -14.29 3.89 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.174 -1.012 . . . . 25.03 113.425 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 m -81.48 40.53 0.58 Allowed 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.89 1.329 . . . . 73.42 110.957 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.81 177.16 5.55 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.24 -0.891 . . . . 74.42 108.978 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.45 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 17.0 t70 -69.33 -30.88 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.859 0.361 . . . . 74.11 111.961 -175.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -81.77 -12.63 58.48 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.36 -0.382 . . . . 71.22 110.289 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.31 20.8 75.5 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.805 -0.634 . . . . 73.34 112.18 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.494 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 33.4 m -86.33 125.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.622 -0.431 . . . . 74.3 110.738 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.64 -71.13 0.96 Allowed Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 111.542 -0.623 . . . . 74.3 111.542 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.5 mmt 66.43 -64.18 0.23 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.185 1.179 . . . . 72.12 114.185 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 60.7 5.9 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.621 -1.392 . . . . 70.32 109.621 -174.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -96.12 126.25 41.22 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.179 0.514 . . . . 64.3 110.946 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.8 t -123.45 116.6 23.5 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 122.361 1.077 . . . . 74.3 111.557 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.2 m -143.65 170.93 7.57 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 105.262 -2.125 . . . . 65.43 105.262 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.03 138.62 79.68 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.609 1.253 . . . . 72.35 113.547 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.9 p -111.88 147.22 15.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.696 -1.594 . . . . 71.4 106.696 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.0 p -132.61 144.95 50.71 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.438 -0.505 . . . . 51.43 110.22 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -131.68 141.32 49.55 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 120.199 -0.6 . . . . 71.13 110.716 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.594 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.75 135.02 34.48 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 115.54 -0.755 . . . . 54.43 109.414 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.69 150.21 32.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.696 -0.684 . . . . 62.35 109.457 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 90.7 m-85 -119.48 101.88 48.42 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 110.143 -0.318 . . . . 73.01 110.143 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.95 142.55 15.69 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 122.447 2.098 . . . . 64.04 112.589 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.473 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 45.6 m-80 -96.66 162.63 13.36 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.034 -0.728 . . . . 60.22 109.034 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.1 -13.56 62.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.424 0.631 . . . . 73.51 110.232 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.51 -6.19 54.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.27 -0.877 . . . . 54.31 109.457 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -6.8 82.95 Favored Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 116.024 -0.535 . . . . 72.14 112.296 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 p -84.39 140.88 31.25 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.833 0.349 . . . . 71.21 110.48 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.47 79.11 2.46 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.302 0.573 . . . . 64.23 109.569 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 78.2 mt-30 -147.02 114.63 6.39 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.766 -0.652 . . . . 72.22 110.596 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 89.2 mttt -176.63 -63.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 126.274 1.83 . . . . 73.52 108.091 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 21.9 ttmm -161.04 153.83 20.92 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.691 -0.855 . . . . 62.03 108.691 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 5.8 tt -139.92 128.37 22.79 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.031 -1.47 . . . . 73.23 107.031 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -123.43 115.61 21.89 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.014 -0.735 . . . . 74.14 109.014 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 43' ' ' THR . 82.6 t -88.74 123.03 40.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.952 -0.388 . . . . 52.41 109.952 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -109.78 124.75 51.81 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.971 -0.751 . . . . 75.14 108.971 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 87.8 t80 -102.52 112.4 25.12 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.995 -1.113 . . . . 74.52 107.995 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.492 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 2.3 tmt_? -75.5 112.93 12.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.931 -1.507 . . . . 72.41 106.931 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.521 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 67.7 mt -85.68 137.92 35.88 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.156 -0.475 . . . . 74.32 109.9 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.29 143.36 34.08 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.63 2.22 . . . . 55.22 111.539 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.92 -33.39 62.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.363 1.246 . . . . 74.52 114.363 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -59.41 -31.23 69.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.893 0.378 . . . . 75.53 111.006 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.98 -2.78 49.71 Favored 'General case' 0 C--O 1.192 -1.942 0 CA-C-N 116.341 -0.39 . . . . 65.53 111.605 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.521 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 29.5 mm-40 -71.01 -28.62 64.55 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.199 -0.6 . . . . 72.13 110.608 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.04 -38.29 92.49 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.266 -0.734 . . . . 44.53 111.266 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.8 m -155.39 92.99 2.7 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 123.212 0.605 . . . . 65.2 109.52 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 77.4 Cg_endo -83.96 145.04 11.1 Favored 'Trans proline' 0 C--O 1.251 1.158 0 C-N-CA 122.472 2.115 . . . . 62.14 111.832 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 29.5 Cg_exo -63.1 130.6 29.44 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.886 1.724 . . . . 72.13 109.432 174.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -61.18 139.67 94.42 Favored Pre-proline 0 C--O 1.257 1.479 0 CA-C-O 120.767 0.318 . . . . 72.13 110.68 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 61.2 Cg_endo -72.2 108.21 2.43 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.584 2.189 . . . . 74.51 111.199 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.8 t -89.91 82.47 6.18 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 116.02 -0.536 . . . . 51.43 110.428 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.629 ' HB3' HG12 ' A' ' 120' ' ' VAL . 13.0 t70 -178.49 164.37 1.65 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 104.492 -2.41 . . . . 64.42 104.492 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.47 -28.37 22.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 118.727 0.694 . . . . 74.52 112.269 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 p -91.28 -18.46 24.32 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.704 1.001 . . . . 71.52 113.704 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 117' ' ' ASP . 2.5 p -104.37 120.64 55.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.237 0.541 . . . . 54.3 109.879 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 154.24 46.98 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.332 -0.849 . . . . 72.21 110.519 -175.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.8 mm -91.75 112.32 25.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.806 -0.813 . . . . 75.31 108.806 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -126.15 147.73 49.56 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.27 -1.011 . . . . 74.15 108.27 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 40' ' ' LYS . 14.7 pt-20 -121.24 151.2 40.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 120.948 0.404 . . . . 75.13 111.341 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -134.33 125.68 28.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.82 -0.627 . . . . 71.14 111.581 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.493 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -143.14 174.2 10.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 171.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.94 19.34 77.68 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 119.884 -1.15 . . . . 75.04 111.12 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.8 145.74 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-O 121.003 0.43 . . . . 75.42 109.912 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.1 m -115.73 131.67 56.87 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.543 -1.28 . . . . 54.2 107.543 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -123.96 154.23 30.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.073 0.463 . . . . 71.13 109.906 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 66.2 m-85 -114.03 122.04 45.71 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 105.998 -1.853 . . . . 75.05 105.998 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.6 p -112.59 143.01 44.49 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.854 0.359 . . . . 70.23 111.005 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.509 ' HB ' HD21 ' A' ' 151' ' ' LEU . 13.5 t -128.01 134.35 49.23 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 120.693 -0.403 . . . . 63.24 110.008 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -110.84 142.18 43.2 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.552 -1.648 . . . . 72.12 106.552 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 143' ' ' ASP . 30.7 p90 -143.17 118.25 10.08 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 115.133 1.531 . . . . 73.42 115.133 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 47.74 -138.96 10.37 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.005 -1.452 . . . . 73.15 115.776 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 181' ' ' ARG . . . -124.78 -28.39 1.16 Allowed Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.103 -0.799 . . . . 53.11 111.103 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.6 119.43 38.06 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.002 0.43 . . . . 70.34 112.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.436 ' HB2' HD22 ' A' ' 183' ' ' ASN . . . -124.59 107.63 11.23 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.578 -0.737 . . . . 75.32 110.883 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.14 171.9 8.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.737 -1.209 . . . . 73.03 107.737 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.59 -39.02 75.87 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.135 0.493 . . . . 63.15 110.434 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.36 74.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.38 -0.827 . . . . 70.44 111.362 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 17.2 m-20 -65.92 -36.26 82.88 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 111.815 0.302 . . . . 74.43 111.815 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.37 -39.9 89.38 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.927 0.394 . . . . 72.44 110.709 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.99 -51.13 32.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.949 -0.569 . . . . 65.43 110.372 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -57.4 -46.52 83.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.714 -0.675 . . . . 72.32 111.667 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -65.03 -32.65 74.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.027 0.751 . . . . 74.12 113.027 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.92 86.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.342 -0.614 . . . . 74.34 109.342 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.8 m -65.59 -40.19 92.42 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.711 -0.677 . . . . 72.35 109.937 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 30.2 mm-40 -61.84 -37.02 82.92 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 116.186 -0.461 . . . . 74.34 111.938 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.509 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.0 mt -60.92 -35.03 75.64 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 120.865 -0.334 . . . . 54.32 111.752 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -59.81 -48.14 82.87 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.25 0.343 . . . . 75.14 111.276 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 156' ' ' GLU . 13.0 t -75.56 -30.61 59.75 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.201 0.524 . . . . 65.15 111.033 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.9 m -70.69 -35.35 72.75 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 120.963 0.411 . . . . 74.24 110.421 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.5 6.45 17.39 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.014 0.525 . . . . 73.21 112.283 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 153' ' ' THR . 56.5 mt-10 -68.93 138.3 54.5 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.008 -0.677 . . . . 75.13 110.082 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.09 56.6 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.756 -0.656 . . . . 74.15 111.595 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.5 p -125.37 165.33 26.97 Favored Pre-proline 0 N--CA 1.441 -0.922 0 N-CA-C 108.293 -1.002 . . . . 55.11 108.293 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -75.44 20.14 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.796 2.331 . . . . 71.21 112.451 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.73 120.73 17.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.309 0.576 . . . . 55.42 110.426 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 10.1 t -124.59 157.5 35.29 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.007 -1.849 . . . . 61.03 106.007 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -132.6 160.09 37.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 119.115 0.871 . . . . 72.23 108.893 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -128.77 132.86 47.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.125 0.417 . . . . 52.43 112.125 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.63 -0.45 27.14 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.508 -0.769 . . . . 63.14 114.12 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 60.62 10.77 2.74 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.033 0.933 . . . . 72.45 112.285 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.5 p -68.77 138.53 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.784 0.802 . . . . 74.3 111.488 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.414 ' HB3' HD23 ' A' ' 187' ' ' LEU . 36.4 p90 -135.95 161.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.8 -1.091 . . . . 71.23 108.897 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 88.4 m-85 -115.41 142.07 47.19 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.153 -0.476 . . . . 74.43 109.913 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.2 m -114.22 120.3 40.0 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.731 -1.211 . . . . 65.34 107.731 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -116.3 143.07 46.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.154 0.502 . . . . 71.44 111.708 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -169.53 165.66 39.04 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 107.279 -2.328 . . . . 54.52 107.279 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -66.41 -38.76 88.2 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 118.85 1.325 . . . . 73.53 109.057 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -155.01 154.62 29.15 Favored Pre-proline 0 C--N 1.287 -2.111 0 N-CA-C 104.762 -2.31 . . . . 73.44 104.762 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.33 113.76 1.56 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.863 1.709 . . . . 72.3 108.333 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.26 127.67 26.97 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.569 1.513 . . . . 70.01 113.481 -170.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -94.82 -21.07 18.94 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.661 -1.154 . . . . 65.13 108.896 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -112.64 147.47 37.18 Favored Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 107.03 -1.47 . . . . 75.43 107.03 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.54 -31.0 93.51 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.643 2.229 . . . . 74.15 112.676 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -82.65 123.61 29.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.382 0.61 . . . . 75.21 111.0 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.55 82.06 0.09 OUTLIER Glycine 0 C--N 1.306 -1.114 0 N-CA-C 107.338 -2.305 . . . . 61.11 107.338 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HA ' ' HA2' ' A' ' 137' ' ' GLY 0.258 19.7 ptt180 -65.34 -29.86 70.64 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 116.185 1.92 . . . . 74.11 116.185 -167.195 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -101.23 125.25 47.84 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 115.342 -2.543 . . . . 75.52 108.581 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.436 HD22 ' HB2' ' A' ' 139' ' ' ALA . 19.8 p30 -146.84 158.37 43.9 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.648 -1.614 . . . . 62.03 108.786 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 43.5 mt-10 -143.12 137.38 29.09 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.098 0.475 . . . . 72.13 110.537 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 84.7 t -124.22 118.5 53.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 105.913 -1.884 . . . . 74.43 105.913 171.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.526 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 49.2 m0 -106.32 124.42 49.57 Favored 'General case' 0 CA--C 1.495 -1.154 0 O-C-N 123.463 0.477 . . . . 75.34 111.413 -176.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 167' ' ' TYR . 62.4 mt -97.35 125.2 41.81 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.676 -1.601 . . . . 70.42 106.676 167.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.7 124.75 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 120.536 -0.466 . . . . 74.01 109.993 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 161' ' ' THR . 15.5 pttp -70.19 145.1 51.69 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.643 -0.708 . . . . 73.04 109.644 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.296 -1.76 0 C-N-CA 118.976 -1.089 . . . . 41.43 109.442 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.1 t30 . . . . . 0 C--O 1.235 0.335 0 N-CA-C 108.639 -0.875 . . . . 61.11 108.639 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.1 p -139.3 150.61 45.62 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.534 -0.913 . . . . 72.13 108.534 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.6 mt -84.54 120.58 26.5 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.725 -0.843 . . . . 72.23 108.725 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.75 151.66 19.92 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.149 0.5 . . . . 74.02 110.672 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.06 134.42 12.18 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 109.322 -1.511 . . . . 22.13 109.322 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.7 m -76.4 -27.06 56.17 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 117.102 0.451 . . . . 72.03 110.569 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t 53.97 76.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.214 1.005 . . . . 72.54 110.376 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.409 0.0 OUTLIER -91.63 78.65 5.52 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 122.754 1.264 . . . . 71.33 113.987 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.1 m -94.86 110.91 22.74 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 113.664 -1.607 . . . . 70.42 108.326 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 5.3 p90 -43.13 105.69 0.44 Allowed Pre-proline 0 CA--C 1.567 1.632 0 C-N-CA 126.151 1.78 . . . . 74.4 112.622 -177.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -95.09 121.07 0.29 Allowed 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 122.483 2.122 . . . . 73.2 112.862 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 41.2 p90 -111.66 141.02 45.78 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.375 -0.602 . . . . 61.43 109.375 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -122.91 110.0 14.86 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.943 -0.303 . . . . 60.43 110.546 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.3 116.42 30.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 106.906 -1.516 . . . . 74.2 106.906 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -91.93 -26.28 18.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.36 -0.536 . . . . 63.24 112.111 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -172.85 153.14 2.58 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.006 0.431 . . . . 64.53 110.779 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.6 p -133.03 134.58 44.6 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.867 -1.06 . . . . 71.43 110.231 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.94 132.55 7.81 Favored Glycine 0 C--N 1.304 -1.246 0 C-N-CA 120.265 -0.969 . . . . 62.5 112.752 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.46 -115.03 0.98 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.029 -0.605 . . . . 62.13 111.749 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.582 ' H ' HG23 ' A' ' 154' ' ' THR . 4.7 ttmp? -91.71 117.55 29.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.518 -1.66 . . . . 64.33 106.518 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -67.75 134.31 50.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 115.27 1.582 . . . . 73.42 115.27 -170.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 158.17 -58.87 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 129.704 3.202 . . . . 72.44 103.737 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.2 p -129.22 129.96 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 106.901 -1.518 . . . . 74.33 106.901 170.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 m -95.27 154.64 17.09 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.893 -0.504 . . . . 75.21 110.087 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CD2' HG22 ' A' ' 154' ' ' THR . 0.1 OUTLIER -113.47 163.37 14.98 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.983 -0.553 . . . . 74.34 110.885 178.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -132.96 124.53 27.96 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.628 -1.99 . . . . 74.5 105.628 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.4 115.27 30.13 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.552 -1.277 . . . . 71.15 107.552 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -131.3 139.79 49.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.216 -0.594 . . . . 63.0 110.933 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.39 133.65 35.44 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 104.924 -2.251 . . . . 73.51 104.924 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.27 138.92 58.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 123.674 0.609 . . . . 61.14 109.851 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.8 OUTLIER -60.69 -26.94 67.49 Favored 'General case' 0 N--CA 1.422 -1.85 0 O-C-N 124.435 1.085 . . . . 62.23 112.531 -178.193 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 84.31 10.24 80.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 118.465 -1.826 . . . . 73.24 112.247 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.22 157.27 53.4 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.822 -0.704 . . . . 61.21 111.395 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 14.4 ptpt -88.32 123.43 32.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.409 -0.96 . . . . 71.43 108.409 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.89 ' HE1' HE22 ' A' ' 109' ' ' GLN . 28.0 m-85 -122.32 165.45 16.23 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.588 -0.733 . . . . 65.05 110.996 -172.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.25 115.35 28.18 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.384 -0.969 . . . . 73.24 108.384 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.9 t -120.32 142.67 48.91 Favored 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 115.124 -0.943 . . . . 62.3 111.643 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 13.8 m -128.89 127.14 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 107.147 -1.427 . . . . 71.01 107.147 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.59 119.68 31.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-O 121.887 0.851 . . . . 74.05 112.093 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 39.9 t -114.72 135.8 53.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.221 -1.354 . . . . 75.33 107.616 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 49' ' ' LYS . 33.3 p -125.78 167.5 15.09 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.582 -0.281 . . . . 65.05 110.736 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.7 t70 73.64 -26.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 124.039 0.935 . . . . 71.23 112.202 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 47' ' ' THR . 94.6 mttt -96.96 143.27 25.83 Favored Pre-proline 0 C--N 1.3 -1.565 0 CA-C-N 115.808 -0.633 . . . . 64.51 110.22 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.14 158.95 36.82 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.374 2.716 . . . . 62.2 111.789 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG13 HD12 ' A' ' 98' ' ' LEU . 74.2 t -45.66 -45.66 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.131 0.972 . . . . 64.24 112.756 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.58 -50.04 75.27 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.506 0.67 . . . . 53.43 110.52 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.99 -35.73 77.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.104 -0.953 . . . . 72.21 112.273 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.463 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -71.18 -45.26 63.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.462 -0.335 . . . . 73.14 110.624 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.08 -43.64 94.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.304 -0.407 . . . . 71.12 111.413 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -64.51 -26.74 68.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.159 0.429 . . . . 62.23 112.159 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.5 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 27.5 tt0 -84.07 -30.39 26.06 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.09 -0.707 . . . . 74.25 109.09 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.58 52.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.979 -1.01 . . . . 61.0 113.49 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mmt -51.08 -55.85 24.77 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 112.504 0.557 . . . . 74.53 112.504 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.11 -31.32 74.83 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.739 2.293 . . . . 72.43 113.202 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.5 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 93.1 mttt -64.19 -48.46 75.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.77 0.319 . . . . 75.45 110.362 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.8 -38.81 83.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.341 -0.39 . . . . 74.32 110.756 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.1 mmt -59.15 -43.23 92.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.253 -0.43 . . . . 62.14 112.038 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -76.22 -29.72 57.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.834 -0.747 . . . . 75.21 111.634 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 36.9 t80 -60.91 -56.3 22.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.165 -0.471 . . . . 75.35 110.743 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.4 m -77.45 -7.56 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.391 0.615 . . . . 74.34 110.739 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.85 -20.74 62.77 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.602 -0.726 . . . . 14.2 112.436 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.32 6.55 8.11 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.028 -1.082 . . . . 75.42 113.288 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -91.85 17.73 8.74 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.777 1.275 . . . . 54.45 109.573 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.07 173.47 10.46 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.562 -1.199 . . . . 73.24 109.438 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 24.1 t70 -67.09 -33.23 75.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.541 0.571 . . . . 73.53 112.541 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.15 -12.29 59.25 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.45 -0.5 . . . . 71.04 110.554 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.25 24.76 74.81 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 115.535 -0.757 . . . . 44.11 111.884 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.61 122.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 C-N-CA 120.004 -0.679 . . . . 45.34 111.287 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.42 97.84 1.36 Allowed Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 109.241 -1.543 . . . . 72.1 109.241 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtt -126.41 135.53 51.53 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.625 -0.509 . . . . 53.22 109.625 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.95 70.91 1.45 Allowed Glycine 0 C--N 1.292 -1.908 0 CA-C-N 115.296 -0.865 . . . . 43.01 111.922 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' A' ' 78' ' ' MET . 18.0 ptm -96.68 122.44 39.62 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.283 -0.636 . . . . 64.53 109.283 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.8 m -127.44 133.98 49.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.758 -0.656 . . . . 74.02 110.478 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -166.43 148.29 5.84 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.044 -1.465 . . . . 62.14 107.044 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 27.8 Cg_exo -40.1 140.97 0.75 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.753 2.968 . . . . 75.44 115.133 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.26 152.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.262 -1.014 . . . . 63.32 108.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.9 m -139.3 152.32 47.13 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.202 -0.666 . . . . 62.51 109.202 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CB ' ' HA ' ' A' ' 100' ' ' VAL . 54.5 p90 -145.14 144.99 31.19 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 122.1 -0.375 . . . . 60.11 110.578 172.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.39 137.97 31.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.648 -0.501 . . . . 54.44 109.648 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.18 150.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 N-CA-C 108.744 -0.836 . . . . 72.2 108.744 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.58 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 62.7 m-85 -117.09 112.34 40.01 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 107.02 -1.474 . . . . 73.34 107.02 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.22 133.66 18.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 120.948 1.099 . . . . 73.11 112.247 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.35 156.57 20.16 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 107.823 -1.177 . . . . 73.44 107.823 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.01 -13.33 62.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.186 0.517 . . . . 62.3 112.147 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.16 -6.14 58.97 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.998 -0.546 . . . . 72.05 110.278 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.54 -2.45 72.5 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.335 -0.393 . . . . 54.02 113.269 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -87.36 3.56 46.46 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.881 0.697 . . . . 74.35 112.881 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt 65.3 148.29 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.108 0.963 . . . . 70.51 112.889 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 34.8 tt0 -82.08 148.57 28.5 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.707 -0.679 . . . . 75.23 109.854 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -86.06 70.43 10.59 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.752 0.786 . . . . 74.31 111.31 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 22.0 ttmm -158.26 125.5 5.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 105.483 -2.043 . . . . 71.42 105.483 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.459 HD12 HG13 ' A' ' 51' ' ' VAL . 6.1 tt -143.03 131.89 22.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.328 -0.949 . . . . 73.44 111.38 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.79 115.16 23.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.299 -0.864 . . . . 70.3 109.311 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 43' ' ' THR . 92.9 t -88.33 127.93 40.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 108.041 -1.096 . . . . 44.25 108.041 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -114.79 113.61 24.47 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.359 -0.978 . . . . 75.15 108.359 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -103.04 114.08 28.08 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.682 -1.229 . . . . 74.2 107.682 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.641 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 14.8 ptp180 -75.07 138.78 42.36 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.771 -1.104 . . . . 64.24 108.085 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -97.91 141.16 22.54 Favored Pre-proline 0 C--N 1.266 -3.046 0 CA-C-N 116.264 -0.425 . . . . 72.34 110.056 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.42 146.89 9.64 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.902 2.401 . . . . 64.22 111.731 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -52.27 -40.38 61.68 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.379 1.251 . . . . 73.45 114.379 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.37 -27.87 66.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.211 0.529 . . . . 62.35 111.313 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.24 -1.66 47.67 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.203 -0.453 . . . . 61.54 112.156 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.89 HE22 ' HE1' ' A' ' 41' ' ' PHE . 21.3 mm-40 -64.72 -41.21 96.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.881 0.372 . . . . 72.42 110.507 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.14 -23.42 68.73 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.679 -0.691 . . . . 64.21 112.35 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -149.77 87.91 5.01 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 120.782 0.325 . . . . 54.0 110.351 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -96.42 162.56 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.008 2.472 . . . . 73.31 111.713 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.2 135.49 27.18 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.409 2.073 . . . . 72.35 111.402 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -71.98 150.29 92.59 Favored Pre-proline 0 C--O 1.256 1.42 0 CA-C-O 120.594 0.235 . . . . 64.22 111.441 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 2.8 Cg_exo -75.85 117.07 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.829 2.352 . . . . 74.21 112.185 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -97.79 21.62 10.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.529 -0.915 . . . . 52.11 108.529 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.575 ' HB3' HG12 ' A' ' 120' ' ' VAL . 17.4 t70 -140.26 156.22 46.56 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.402 -1.333 . . . . 73.34 107.402 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -25.33 22.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.967 -0.693 . . . . 54.43 111.89 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -78.61 -34.06 46.97 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.355 -0.384 . . . . 63.34 110.932 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 117' ' ' ASP . 7.4 p -98.77 125.23 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.364 -0.606 . . . . 61.52 109.364 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -128.21 138.43 52.46 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.341 -0.845 . . . . 52.41 109.539 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 22.9 mm -93.64 110.81 23.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.173 -1.417 . . . . 73.23 107.173 173.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.27 145.19 51.12 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.32 -0.993 . . . . 64.53 108.32 -174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.13 144.22 40.62 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.982 0.42 . . . . 73.44 110.706 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.523 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -123.97 122.68 38.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.058 -1.83 . . . . 73.41 106.058 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.73 157.01 47.37 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.855 1.057 . . . . 73.43 113.855 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.66 17.2 79.22 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.159 -0.928 . . . . 55.14 113.449 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.31 165.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 C-N-CA 120.553 -0.459 . . . . 51.2 110.54 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.54 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 28.6 m -120.13 133.09 55.6 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 109.136 -0.69 . . . . 63.41 109.136 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.99 151.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.387 -0.968 . . . . 63.42 108.387 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 41.4 m-85 -113.64 121.46 44.23 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.413 -1.699 . . . . 74.34 106.413 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 t -111.46 125.15 53.58 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.878 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.556 ' HB ' HD13 ' A' ' 151' ' ' LEU . 12.7 t -113.58 127.36 56.04 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 107.796 -1.187 . . . . 73.14 107.796 174.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -110.41 132.93 53.75 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 121.645 0.736 . . . . 74.3 110.938 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 182' ' ' ARG . 48.7 p90 -129.8 146.38 51.54 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 74.12 108.973 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -124.54 111.03 1.49 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 111.061 -0.816 . . . . 50.22 111.061 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 175.05 -126.53 1.18 Allowed Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.712 -0.756 . . . . 50.43 111.719 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -100.14 135.67 41.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.062 -0.718 . . . . 73.14 109.062 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.88 107.51 10.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 113.277 0.843 . . . . 72.21 113.277 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.675 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 58.0 pttt -104.18 170.63 7.79 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 71.41 106.324 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -39.52 73.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.497 0.665 . . . . 74.51 110.365 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.467 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . . . -64.86 -28.65 69.7 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.138 -0.937 . . . . 74.11 111.869 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.675 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 13.8 m-20 -62.91 -35.52 80.33 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 120.212 -0.595 . . . . 74.31 110.787 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.438 ' OH ' ' HG3' ' A' ' 175' ' ' PRO . 98.9 m-85 -68.69 -39.3 80.62 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.588 -0.445 . . . . 61.34 110.553 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.07 -47.13 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.613 -0.514 . . . . 70.43 109.613 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -60.81 -46.63 89.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.888 -0.596 . . . . 73.22 110.657 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -65.83 -32.64 74.28 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 112.116 0.413 . . . . 74.2 112.116 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -64.57 -46.34 83.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 74.12 109.523 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.5 m -61.45 -44.17 97.58 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.088 -0.505 . . . . 64.14 110.128 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 15.2 mm100 -64.45 -35.39 80.75 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.224 -0.444 . . . . 64.43 110.701 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.556 HD13 ' HB ' ' A' ' 133' ' ' THR . 49.1 tp -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.153 -0.342 . . . . 54.33 110.445 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.466 ' HD2' ' OD1' ' A' ' 165' ' ' ASP . 70.2 mtp180 -63.27 -40.79 98.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.567 -0.288 . . . . 71.44 111.447 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.2 t -75.4 -29.78 59.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.807 0.813 . . . . 64.43 110.095 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 26' ' ' LYS . 59.6 m -71.62 -34.67 70.03 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.751 -0.659 . . . . 63.23 110.36 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.409 HD12 HD23 ' A' ' 187' ' ' LEU . 82.2 mt -85.87 4.31 37.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 74.12 111.506 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.6 138.71 31.47 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.072 -1.455 . . . . 73.31 107.072 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.73 -10.16 62.43 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 111.169 -0.772 . . . . 64.3 111.169 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.8 t -119.72 145.5 39.46 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 106.607 -1.627 . . . . 75.34 106.607 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.58 29.13 0.17 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 123.607 2.871 . . . . 74.5 114.62 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.75 128.5 34.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.833 0.349 . . . . 73.02 110.312 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 8.9 t -107.44 152.39 24.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.915 -0.584 . . . . 53.34 109.571 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -141.84 159.76 41.58 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 122.745 0.418 . . . . 71.55 110.533 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.489 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.4 pt20 -129.4 137.09 50.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.713 -0.477 . . . . 71.03 109.713 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.8 -0.64 9.75 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.143 -0.551 . . . . 51.31 114.405 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 152' ' ' ARG . 37.5 t70 65.54 19.27 11.49 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.07 0.948 . . . . 72.44 109.197 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 163' ' ' GLN . 8.4 p -71.49 138.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 CA-C-N 116.023 -0.535 . . . . 72.42 110.551 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -150.28 173.4 14.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.589 -0.732 . . . . 61.42 111.381 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 46.3 m-85 -115.52 152.02 33.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.355 -0.839 . . . . 65.43 110.314 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.0 t -114.47 120.11 39.16 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.197 -1.408 . . . . 65.01 107.197 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.41 159.21 36.09 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 110.559 -0.163 . . . . 53.4 110.559 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -161.31 150.13 19.55 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.792 -1.323 . . . . 45.14 109.792 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 m-30 -80.66 -16.6 53.59 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.912 0.863 . . . . 75.01 109.992 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -155.5 136.61 9.16 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 105.281 -2.118 . . . . 73.44 105.281 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.2 108.1 0.23 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.337 2.025 . . . . 65.11 110.726 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.438 ' HG3' ' OH ' ' A' ' 144' ' ' TYR . 55.6 Cg_endo -67.98 137.84 42.35 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.604 2.202 . . . . 63.15 113.5 -172.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.592 ' O ' ' HG3' ' A' ' 177' ' ' LYS . 65.7 mtt -89.4 -42.87 11.27 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.106 -1.442 . . . . 63.21 107.106 174.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 176' ' ' MET . 51.8 mttp 161.86 -59.72 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 130.015 3.326 . . . . 73.42 109.031 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 177' ' ' LYS . 6.1 Cg_exo -82.65 -31.47 0.79 Allowed 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.722 1.615 . . . . 54.41 110.64 175.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -94.9 141.82 28.19 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 107.747 -1.205 . . . . 74.42 107.747 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 88.76 64.03 1.32 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 107.794 -2.122 . . . . 74.5 107.794 -171.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.419 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 99.3 mtt180 -73.83 -46.68 43.6 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 114.586 1.328 . . . . 71.55 114.586 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 135' ' ' PHE . 36.7 ttm180 -100.48 129.55 46.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 118.147 -1.421 . . . . 64.55 110.337 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -140.36 153.46 46.4 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.031 -1.441 . . . . 74.04 108.095 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 40.3 mt-10 -116.51 151.75 35.49 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.961 -0.755 . . . . 63.0 108.961 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.02 118.2 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.102 -1.814 . . . . 71.41 106.102 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.6 m0 -102.96 121.25 42.16 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.998 -0.742 . . . . 75.34 108.998 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 166' ' ' VAL . 36.5 tp -98.13 134.3 41.39 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.996 -1.112 . . . . 73.02 107.996 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.43 125.16 44.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 O-C-N 123.171 0.295 . . . . 71.12 110.745 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -64.02 142.49 58.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 123.639 0.587 . . . . 63.34 110.991 176.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.34 0 CA-C-O 119.065 -0.493 . . . . 63.01 110.921 179.141 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 t30 . . . . . 0 C--O 1.222 -0.373 0 N-CA-C 108.751 -0.833 . . . . 73.35 108.751 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -137.45 105.31 5.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 112.941 0.719 . . . . 61.2 112.941 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.2 106.92 12.39 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.025 -1.102 . . . . 64.34 108.025 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 54.8 t80 -69.56 128.0 34.96 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.613 -0.514 . . . . 64.05 109.613 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.8 60.61 4.75 Favored Glycine 0 CA--C 1.506 -0.528 0 CA-C-N 116.044 -0.526 . . . . 62.12 113.382 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . 35.0 t -166.5 120.16 1.07 Allowed 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 105.871 -1.899 . . . . 73.22 105.871 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.63 93.17 2.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 113.082 0.771 . . . . 71.33 113.082 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -130.53 91.7 3.13 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.97 -1.493 . . . . 73.32 106.97 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 m -77.15 2.53 15.04 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.269 1.033 . . . . 64.52 111.462 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -115.31 84.54 11.71 Favored Pre-proline 0 N--CA 1.418 -2.048 0 N-CA-C 106.681 -1.6 . . . . 74.44 106.681 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -86.87 121.18 1.75 Allowed 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 121.786 1.657 . . . . 72.44 113.384 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.487 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 25.6 p90 -103.88 149.91 24.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.8 111.28 23.95 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.674 -0.41 . . . . 74.44 110.407 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.5 t -84.05 120.41 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.469 -0.937 . . . . 61.12 108.469 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -90.3 -35.8 15.05 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.504 -0.479 . . . . 75.25 110.935 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -164.25 149.88 10.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.346 0.593 . . . . 73.41 111.233 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.524 HG22 ' CB ' ' A' ' 32' ' ' GLU . 47.7 p -132.51 155.18 49.06 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.031 -1.47 . . . . 75.42 107.031 173.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.19 103.16 2.44 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 119.198 -1.477 . . . . 74.02 112.345 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.81 -135.11 3.92 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.546 -0.835 . . . . 71.4 111.424 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -96.45 139.26 32.82 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 105.916 -1.883 . . . . 71.23 105.916 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.7 173.18 2.95 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 114.127 1.158 . . . . 74.32 114.127 -171.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 83.15 -51.88 0.16 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.666 1.587 . . . . 73.43 111.023 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.03 110.8 28.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.771 -1.196 . . . . 74.52 107.771 175.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 p -94.98 154.52 17.14 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.917 -0.583 . . . . 74.43 111.257 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.15 158.95 42.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.383 0.611 . . . . 71.41 111.626 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' CB ' HG22 ' A' ' 23' ' ' THR . 12.9 pt-20 -134.89 132.2 38.23 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.482 -1.303 . . . . 75.25 107.482 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -96.77 114.32 25.94 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.292 -1.744 . . . . 74.23 106.292 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.28 1.2 ppt_? -142.14 145.2 33.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.287 1.217 . . . . 70.35 114.287 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -80.52 137.75 36.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.526 -1.287 . . . . 72.3 107.526 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.3 t -57.27 147.75 24.58 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.782 0.676 . . . . 73.4 111.186 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -63.89 -28.13 69.63 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 124.115 0.966 . . . . 61.53 112.59 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 77.31 9.75 86.64 Favored Glycine 0 C--N 1.317 -0.512 0 C-N-CA 120.432 -0.889 . . . . 61.23 113.556 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.68 160.57 54.09 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.682 -0.771 . . . . 74.51 112.212 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -88.79 122.11 31.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.597 -0.52 . . . . 63.31 109.597 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 26.5 m-85 -126.9 166.17 17.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.467 -0.788 . . . . 72.03 111.699 -171.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.62 115.82 28.63 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.846 -0.798 . . . . 71.24 108.846 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -125.81 143.54 51.02 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-N 115.314 -0.857 . . . . 63.22 112.112 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.485 HG21 ' HD2' ' A' ' 61' ' ' LYS . 12.8 p -132.83 144.56 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 108.352 -0.981 . . . . 75.13 108.352 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.78 127.69 50.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.675 0.75 . . . . 74.43 111.032 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 46.7 t -120.64 133.15 68.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.102 -1.444 . . . . 42.24 107.102 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 97' ' ' LYS . 35.7 p -130.76 176.6 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.51 0.559 . . . . 73.55 112.51 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 69.34 4.07 4.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.903 1.281 . . . . 53.44 112.316 174.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -141.0 141.16 22.97 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 108.058 -1.09 . . . . 75.03 108.058 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.27 156.86 7.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.341 2.694 . . . . 73.13 112.364 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.574 HG13 HD13 ' A' ' 98' ' ' LEU . 71.4 t -47.67 -41.36 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.575 0.954 . . . . 44.43 113.575 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 9.9 m-20 -58.75 -50.09 75.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.413 0.625 . . . . 60.24 109.911 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.33 -40.7 81.51 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.996 -1.002 . . . . 73.11 110.871 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -61.13 -46.57 90.04 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.542 -0.753 . . . . 71.54 110.104 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.68 -31.7 70.95 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.899 -0.591 . . . . 70.25 110.906 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 36.7 mtm180 -61.25 -30.24 70.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.554 0.576 . . . . 73.32 112.554 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 37.1 mt-10 -85.61 -46.3 10.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.416 -0.513 . . . . 71.34 111.512 173.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.27 80.22 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.971 1.1 . . . . 73.3 113.971 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.56 ' HB3' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.81 -52.72 72.33 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 119.483 -0.294 . . . . 54.31 110.463 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 71.9 Cg_exo -51.75 -37.15 64.46 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.702 2.268 . . . . 72.3 112.319 173.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 88.9 mttt -67.41 -42.49 83.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.28 0.474 . . . . 75.41 112.28 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.95 -41.04 77.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.612 -0.435 . . . . 43.01 111.834 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.526 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.9 ptm -69.91 -29.63 66.85 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.795 0.665 . . . . 54.15 112.795 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -70.37 -40.83 73.79 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.928 -0.767 . . . . 74.53 108.928 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.22 -56.87 16.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.839 -0.619 . . . . 73.31 111.529 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 102' ' ' PHE . 11.8 m -78.35 -20.97 13.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 120.983 0.42 . . . . 74.3 111.284 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.05 70.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.674 -0.693 . . . . 74.55 112.89 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.69 -17.41 0.49 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.768 -1.205 . . . . 64.5 113.53 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -81.83 32.52 0.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 122.304 1.05 . . . . 74.12 110.752 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.68 168.94 9.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.782 -0.645 . . . . 62.11 109.836 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.419 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 11.0 t70 -66.06 -33.99 77.05 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.04 0.756 . . . . 71.14 113.04 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -82.22 -11.22 58.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 73.43 109.728 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.91 34.87 77.97 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.329 -0.85 . . . . 51.25 112.128 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.44 121.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.969 -0.692 . . . . 65.4 110.263 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.11 116.0 5.47 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.561 -0.828 . . . . 74.35 112.285 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.6 mmt 61.8 28.39 17.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.05 109.565 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.98 -34.54 90.19 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.589 -1.187 . . . . 73.54 113.471 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.401 ' HB2' ' CD ' ' A' ' 105' ' ' PRO . 1.2 pmm? -124.72 126.1 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 112.843 0.683 . . . . 72.24 112.843 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.0 m -125.21 117.09 23.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.993 -0.743 . . . . 72.31 108.993 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -170.22 143.32 1.95 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.296 -1.372 . . . . 75.45 107.296 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -41.4 139.84 1.73 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.994 3.129 . . . . 62.23 116.729 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 102' ' ' PHE . 10.7 p -105.74 154.23 7.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.68 -1.6 . . . . 71.32 107.145 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 48.5 m -139.7 145.18 38.05 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.436 -0.579 . . . . 75.14 109.436 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 98' ' ' LEU . 37.0 p90 -135.09 147.16 49.47 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.944 -0.472 . . . . 75.45 111.151 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.26 134.71 34.63 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.684 0.615 . . . . 74.01 109.533 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.425 ' HB ' HD12 ' A' ' 94' ' ' LEU . 32.7 m -129.7 152.9 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.825 -0.806 . . . . 71.0 108.825 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 40.6 m-85 -122.5 104.04 37.5 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.878 -0.786 . . . . 74.11 108.878 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.5 133.69 10.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.823 1.682 . . . . 55.11 113.002 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -86.46 166.05 15.81 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.329 -0.989 . . . . 61.44 108.329 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.76 -15.39 61.53 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 73.11 111.149 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -91.18 1.13 57.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 63.44 111.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.85 0.62 90.32 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.948 -0.644 . . . . 75.31 112.503 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 t -92.07 141.16 28.91 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.509 -1.293 . . . . 64.32 107.509 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 86' ' ' VAL . 3.0 mm? -79.29 156.71 27.94 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 120.96 0.409 . . . . 71.33 110.639 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -79.22 158.25 27.66 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.272 -0.64 . . . . 61.22 109.272 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -75.82 40.03 0.18 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.85 0.86 . . . . 63.3 112.212 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 38.4 ttmt -141.68 125.83 17.4 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.325 -0.991 . . . . 60.42 108.325 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.574 HD13 HG13 ' A' ' 51' ' ' VAL . 60.3 tp -135.47 129.14 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 110.208 -0.293 . . . . 64.44 110.208 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.37 115.51 21.09 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.219 -0.66 . . . . 44.22 109.219 174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 43' ' ' THR . 59.0 t -96.61 134.9 32.55 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-N 115.229 -0.896 . . . . 74.14 109.871 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -120.84 120.02 34.35 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.941 0.896 . . . . 72.35 109.751 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 73.5 t80 -104.08 123.85 47.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.902 -0.407 . . . . 74.41 109.902 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.582 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 42.3 ttm-85 -75.35 134.2 41.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.343 -0.844 . . . . 70.55 110.187 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CG2' ' HB2' ' A' ' 108' ' ' PHE . 65.7 mt -104.79 133.09 20.34 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 116.532 -0.304 . . . . 72.24 111.21 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' ILE . 47.5 Cg_exo -60.81 161.2 22.41 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.549 2.833 . . . . 74.44 112.6 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -57.98 -37.11 73.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.147 1.166 . . . . 72.41 114.147 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.83 -30.45 71.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.327 0.584 . . . . 75.22 111.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.453 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 96.4 m-85 -99.65 -4.95 29.79 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.948 -0.569 . . . . 71.21 110.972 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -71.4 -37.87 71.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 119.586 -0.846 . . . . 74.53 109.735 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.1 94.26 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.183 -0.917 . . . . 75.02 111.918 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -154.11 93.33 2.95 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.182 -0.673 . . . . 61.3 109.182 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 71.7 Cg_endo -77.3 146.41 24.93 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.307 2.004 . . . . 74.21 112.565 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 32.3 Cg_exo -59.62 130.17 34.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.401 2.067 . . . . 74.21 109.801 175.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -68.86 148.98 98.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.81 -0.632 . . . . 64.01 111.48 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 39.6 Cg_exo -60.59 113.14 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.709 2.273 . . . . 73.33 111.938 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -97.07 5.74 49.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.368 -0.975 . . . . 71.23 108.368 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.26 148.76 49.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.132 -1.803 . . . . 72.25 106.132 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -81.1 -25.06 37.28 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.717 0.636 . . . . 75.42 112.717 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.402 ' OG ' ' HD3' ' A' ' 61' ' ' LYS . 47.2 p -91.7 -16.42 26.98 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.78 0.659 . . . . 25.04 112.78 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 50.2 t -94.71 116.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.875 -1.157 . . . . 74.34 107.875 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -119.7 144.08 47.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 110.274 -0.269 . . . . 72.12 110.274 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.5 mm -92.85 111.98 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.964 -1.124 . . . . 74.11 107.964 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -125.57 143.35 51.05 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.909 -1.041 . . . . 62.1 109.346 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.05 143.11 40.56 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.038 -0.727 . . . . 62.02 109.038 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -135.99 127.31 28.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.235 -0.654 . . . . 73.41 109.235 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.19 171.02 14.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.668 -0.493 . . . . 75.02 109.668 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.23 7.05 62.52 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 121.009 -0.615 . . . . 42.13 112.176 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.96 145.27 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 120.095 -0.642 . . . . 73.25 110.878 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 59.5 m -109.22 135.69 49.92 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.42 157.31 32.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 108.849 -0.797 . . . . 71.31 108.849 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 40.2 m-85 -113.3 121.77 45.42 Favored 'General case' 0 N--CA 1.411 -2.381 0 N-CA-C 105.166 -2.161 . . . . 75.3 105.166 178.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 t -109.96 125.89 53.34 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.623 -0.51 . . . . 63.23 109.623 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.7 t -113.47 126.64 55.55 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.185 -1.043 . . . . 74.03 108.185 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -115.61 124.94 52.21 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.028 -1.101 . . . . 72.35 108.028 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.17 137.02 48.8 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 116.392 -0.367 . . . . 75.12 110.439 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.49 161.81 24.23 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 115.784 -0.643 . . . . 61.4 111.788 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.59 161.31 12.91 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.655 -1.378 . . . . 65.31 109.655 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 86.2 m-85 -79.51 108.4 13.02 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.37 0.605 . . . . 73.33 109.886 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -112.73 145.87 39.76 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.16 -0.927 . . . . 71.22 111.844 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.491 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 18.6 ptpt -95.43 176.94 5.99 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.739 -0.838 . . . . 74.1 108.739 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 1.3 mp0 -60.32 -37.96 82.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.49 -0.559 . . . . 71.22 109.49 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.63 70.7 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.437 -0.801 . . . . 54.43 111.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.491 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 23.4 m-20 -64.4 -31.21 72.32 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 62.32 111.283 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -64.61 -46.68 81.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.68 0.276 . . . . 73.31 110.902 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.59 -46.08 95.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.457 0.646 . . . . 54.51 109.978 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.84 99.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 43.33 111.482 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -71.12 -32.52 69.11 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 112.281 0.475 . . . . 73.13 112.281 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.3 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.216 -0.661 . . . . 70.31 109.216 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.4 m -65.07 -40.97 95.44 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.355 -0.839 . . . . 71.42 110.835 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -73.73 -30.3 62.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.937 0.399 . . . . 75.42 110.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.11 -31.7 72.91 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 109.618 -0.512 . . . . 71.04 109.618 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 165' ' ' ASP . 79.9 mtp180 -63.81 -39.09 93.4 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.024 -0.534 . . . . 50.14 109.931 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 56.6 m -71.6 -30.98 66.43 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.654 0.74 . . . . 71.41 109.703 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 38.4 m -72.1 -34.87 68.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.581 -0.736 . . . . 74.45 109.091 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.08 6.66 41.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.364 -0.835 . . . . 74.34 111.137 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.13 128.14 33.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.334 -1.728 . . . . 74.14 106.334 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.32 13.47 41.83 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.268 -0.967 . . . . 64.44 111.811 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 70.9 p -117.2 163.12 24.58 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.893 -0.78 . . . . 41.01 108.893 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -86.33 12.83 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.643 2.229 . . . . 74.13 111.802 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.96 148.31 47.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.921 -0.582 . . . . 62.44 111.25 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 43.4 p -122.04 141.44 51.37 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.76 -0.83 . . . . 74.12 108.76 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -135.52 144.94 46.58 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.113 -0.367 . . . . 75.41 111.278 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.7 pt20 -106.32 110.97 23.36 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.184 0.809 . . . . 74.2 113.184 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.73 8.48 57.08 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.77 -0.729 . . . . 52.42 113.339 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.455 ' OD2' ' HD2' ' A' ' 152' ' ' ARG . 3.8 m-20 62.5 24.17 14.38 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.695 0.798 . . . . 74.25 111.263 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.57 140.24 18.09 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 119.52 -0.872 . . . . 71.42 109.283 -174.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 32.8 p90 -140.65 168.68 19.22 Favored 'General case' 0 N--CA 1.415 -2.209 0 C-N-CA 120.196 -0.602 . . . . 61.33 112.009 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 35.7 m-85 -115.32 147.26 40.66 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.423 -0.808 . . . . 73.24 109.87 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 83' ' ' SER . 41.4 t -114.44 137.38 51.91 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.75 32.79 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.921 0.391 . . . . 54.12 111.067 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.2 164.64 36.74 Favored Glycine 0 C--O 1.201 -1.926 0 N-CA-C 108.924 -1.67 . . . . 63.05 108.924 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -132.22 -18.51 2.58 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.59 1.195 . . . . 72.11 112.16 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.554 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 2.8 p30 -156.19 139.83 11.27 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 106.837 -1.542 . . . . 72.11 106.837 172.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 57.6 Cg_endo -91.91 102.97 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.366 2.044 . . . . 71.25 112.591 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 6.1 Cg_exo -83.63 149.22 12.75 Favored 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.828 2.352 . . . . 75.4 111.978 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.5 ttt -82.65 -31.31 28.8 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.219 -0.9 . . . . 74.33 110.249 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -107.5 -65.59 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 115.477 1.658 . . . . 74.41 115.477 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.66 -20.93 22.53 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 121.545 1.496 . . . . 64.4 114.853 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 60.54 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.856 0.862 . . . . 75.12 113.213 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 138' ' ' TYR . . . -130.66 124.28 4.17 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 119.859 -1.162 . . . . 40.44 112.722 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.579 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -96.39 -21.58 17.69 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.051 0.929 . . . . 75.04 109.815 174.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -134.57 130.57 36.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.957 -2.238 . . . . 72.25 104.957 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -133.22 137.09 45.99 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 108.757 -0.831 . . . . 73.23 108.757 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 133' ' ' THR . 45.7 mt-10 -132.31 136.03 46.61 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.899 0.381 . . . . 45.22 111.5 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.45 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 74.4 t -124.98 124.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.806 -1.183 . . . . 71.12 107.806 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.499 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 35.1 m0 -109.42 121.3 44.89 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 120.872 -0.331 . . . . 74.52 110.244 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 67.3 mt -96.24 126.31 41.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.138 -1.06 . . . . 75.54 108.138 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.08 127.25 42.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.592 -0.521 . . . . 64.35 109.592 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -64.77 143.01 58.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.65 0.611 . . . . 75.51 112.65 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.7 0 CA-C-N 115.261 -0.881 . . . . 38.16 108.761 176.568 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 . . . . . 0 C--O 1.236 0.343 0 N-CA-C 106.515 -1.661 . . . . 73.42 106.515 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.8 m 75.1 -5.19 2.22 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.558 1.318 . . . . 61.44 114.558 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.2 mt -75.49 144.31 42.1 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 119.752 -0.779 . . . . 75.24 109.728 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 69.38 21.54 6.89 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.851 0.86 . . . . 71.2 109.818 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.25 137.15 47.79 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.42 -0.809 . . . . 63.31 111.389 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.3 m -119.44 171.68 8.16 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 110.039 -0.356 . . . . 73.11 110.039 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.75 106.05 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 109.003 -0.739 . . . . 72.51 109.003 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.8 144.96 56.52 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.455 -0.793 . . . . 63.32 111.175 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -80.01 129.85 34.81 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 104.362 -2.458 . . . . 75.03 104.362 168.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 37' ' ' GLU . 4.3 t-105 -68.17 113.42 15.02 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 123.541 0.526 . . . . 73.12 109.688 -170.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -94.93 140.21 1.11 Allowed 'Trans proline' 0 N--CA 1.432 -2.13 0 C-N-CA 122.577 2.184 . . . . 75.41 113.885 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -111.54 155.15 23.73 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.488 -1.301 . . . . 73.4 107.488 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 109.5 21.5 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.355 0.598 . . . . 74.1 109.497 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.7 t -93.71 119.63 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.077 -0.965 . . . . 75.13 109.122 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 21' ' ' LEU 0.257 0.4 OUTLIER -90.63 -38.17 13.3 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 113.05 0.759 . . . . 73.33 113.05 -178.887 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -158.98 149.44 19.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.247 -0.581 . . . . 72.34 111.258 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.3 p -134.0 161.38 34.98 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.28 1.032 . . . . 73.41 110.265 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.8 113.28 1.46 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.844 -0.693 . . . . 73.5 114.515 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.68 -95.19 0.32 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.84 -0.504 . . . . 61.24 111.84 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -97.99 164.4 12.37 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.277 -1.379 . . . . 75.1 107.277 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.62 153.71 27.83 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 118.752 -1.179 . . . . 74.12 111.483 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 72.21 -49.79 0.69 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.976 1.31 . . . . 70.43 111.556 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 110.61 32.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.996 0.903 . . . . 74.0 109.108 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 p -113.1 154.25 26.91 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.373 -0.83 . . . . 73.21 110.32 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -113.43 158.45 20.64 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 120.058 -0.657 . . . . 75.33 111.446 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 34.0 tt0 -143.37 124.99 14.88 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 106.187 -1.783 . . . . 70.43 106.187 175.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . 43.3 mt-10 -97.79 115.06 27.29 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.496 -1.668 . . . . 74.42 106.496 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -135.83 147.22 48.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.908 -0.717 . . . . 65.43 112.415 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.66 127.24 34.93 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.16 -2.163 . . . . 63.43 105.16 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.7 t -58.87 143.22 48.31 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.751 0.657 . . . . 30.45 111.339 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 1.1 mp0 -37.32 -52.67 1.09 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.801 1.64 . . . . 71.32 112.982 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.19 9.03 54.53 Favored Glycine 0 C--N 1.286 -2.213 0 C-N-CA 119.77 -1.205 . . . . 73.23 110.94 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.8 163.09 54.42 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.396 -1.082 . . . . 61.01 110.396 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 104' ' ' ILE . 18.3 ptmt -100.91 128.82 46.78 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.358 -0.608 . . . . 54.01 109.358 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 53.2 m-85 -129.81 164.53 23.88 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.692 -0.686 . . . . 72.3 110.906 -171.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 116.36 30.84 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.223 -1.028 . . . . 72.41 108.223 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.0 t -128.81 146.63 50.87 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.35 0.595 . . . . 60.35 111.801 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.562 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 9.0 p -128.41 139.11 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.385 -0.969 . . . . 63.05 108.385 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -121.52 138.83 54.13 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.192 -1.003 . . . . 75.43 111.371 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.83 133.9 67.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.389 -1.708 . . . . 51.02 106.389 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.6 p -125.7 169.61 12.37 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.619 -0.433 . . . . 71.54 110.042 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 71.47 -2.11 2.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.032 0.933 . . . . 62.23 112.737 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.99 147.66 52.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 109.306 -0.627 . . . . 73.24 109.306 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 32.9 Cg_endo -65.13 156.35 63.35 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 122.167 1.911 . . . . 71.14 111.015 174.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 54.7 t -49.82 -37.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.931 0.893 . . . . 71.23 113.23 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.25 -49.89 63.15 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.264 0.353 . . . . 65.55 110.991 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 41.6 mt-10 -76.04 -50.54 14.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.037 -0.529 . . . . 74.14 111.266 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.1 68.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.935 0.717 . . . . 73.33 112.935 -174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 tt -62.66 -50.2 72.13 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.842 -0.799 . . . . 64.21 108.842 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.321 6.6 ppt_? -72.43 -23.86 61.14 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 114.018 1.118 . . . . 65.04 114.018 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 12.4 mm-40 -66.58 -44.06 83.23 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 71.32 111.186 172.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.562 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.75 -40.38 55.51 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.857 1.058 . . . . 72.41 113.857 -174.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . 0.253 24.7 mmt -47.07 -52.88 31.16 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 115.929 1.825 . . . . 62.44 115.929 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.44 -31.65 78.78 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.296 1.997 . . . . 71.31 112.176 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD2' HG21 ' A' ' 44' ' ' VAL . 82.5 mttt -74.31 -34.99 63.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.772 -0.649 . . . . 75.44 109.892 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.7 mm -72.85 -39.71 59.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.287 0.565 . . . . 71.12 109.625 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.34 -37.89 89.03 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.633 -0.712 . . . . 75.23 112.853 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -67.57 -31.66 71.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.08 -0.648 . . . . 74.24 110.728 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.75 -58.2 7.61 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.385 -0.37 . . . . 74.41 111.335 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.58 -23.08 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 121.224 0.535 . . . . 75.33 111.285 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.56 72.91 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.903 -0.589 . . . . 74.34 113.196 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.44 -5.08 5.56 Favored Glycine 0 CA--C 1.505 -0.565 0 C-N-CA 119.821 -1.181 . . . . 62.53 113.263 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 116' ' ' SER . 15.2 m -86.33 32.92 0.62 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 122.631 1.205 . . . . 42.41 110.053 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -97.82 177.17 5.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.229 -0.896 . . . . 73.52 109.437 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.438 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 12.6 t70 -63.97 -33.03 74.8 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.258 0.623 . . . . 63.13 111.823 -175.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.691 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 6.9 mmpt? -86.8 -11.26 51.48 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.631 -0.428 . . . . 70.24 110.777 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.22 22.5 74.51 Favored Glycine 0 CA--C 1.498 -0.99 0 CA-C-N 115.6 -0.727 . . . . 44.24 112.066 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.99 122.09 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-O 121.153 0.501 . . . . 72.51 110.907 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.16 54.36 0.82 Allowed Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.957 -0.857 . . . . 73.34 110.957 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 51.6 ttm -83.8 110.09 18.06 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.089 0.471 . . . . 62.3 110.015 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.34 82.34 0.67 Allowed Glycine 0 C--N 1.303 -1.3 0 CA-C-N 115.121 -0.945 . . . . 74.22 111.512 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -96.79 134.92 39.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.216 -0.661 . . . . 74.14 109.216 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -124.12 129.86 51.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.258 0.551 . . . . 42.31 112.052 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.438 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 10.5 p -158.63 148.82 15.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 104.107 -2.553 . . . . 74.44 104.107 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 80' ' ' VAL . 47.0 Cg_exo -34.98 138.81 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.7 2.934 . . . . 71.14 115.036 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.54 151.29 6.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.52 -1.289 . . . . 61.24 107.52 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 34.5 m -141.96 145.08 34.09 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 120.706 -0.398 . . . . 62.44 110.409 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -140.44 141.47 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.787 -0.571 . . . . 75.04 110.811 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.05 134.95 35.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.855 -0.611 . . . . 72.24 110.063 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.6 m -126.93 150.67 33.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.327 -0.852 . . . . 65.04 109.668 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 166' ' ' VAL . 91.5 m-85 -116.01 107.15 48.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 116.375 -0.375 . . . . 71.13 110.598 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.25 132.04 7.99 Favored 'Trans proline' 0 N--CA 1.428 -2.38 0 N-CA-C 108.139 -1.524 . . . . 65.04 108.139 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -93.49 167.71 11.52 Favored 'General case' 0 C--N 1.272 -2.773 0 C-N-CA 119.861 -0.736 . . . . 75.34 110.961 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.77 -17.55 56.43 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.883 0.739 . . . . 63.33 110.78 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.54 -6.8 57.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.249 1.02 . . . . 74.34 110.072 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.89 -10.14 71.57 Favored Glycine 0 C--O 1.229 -0.158 0 CA-C-N 116.048 -0.524 . . . . 73.5 112.389 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.4 m -96.06 134.35 39.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.769 0.318 . . . . 74.44 111.455 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 8.2 mp -78.77 100.09 6.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.453 0.644 . . . . 63.42 110.187 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 53.0 tt0 -148.09 169.86 19.04 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.874 -1.057 . . . . 71.02 108.981 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HB3' ' HD3' ' A' ' 97' ' ' LYS 0.264 64.8 mttp 94.93 -73.87 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.097 1.759 . . . . 63.44 112.456 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 2.4 mppt? -131.04 146.57 52.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 119.005 -1.078 . . . . 73.4 112.215 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 51' ' ' VAL . 5.8 tt -143.28 129.44 19.75 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.512 -1.222 . . . . 72.51 108.049 173.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -119.89 115.47 23.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.456 -0.572 . . . . 74.32 109.456 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 43' ' ' THR . 91.1 t -92.43 125.8 45.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.796 -0.816 . . . . 73.52 108.796 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -109.18 123.82 49.84 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.618 0.574 . . . . 70.42 109.641 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -102.76 113.49 26.95 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.458 -1.682 . . . . 74.22 106.458 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.522 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 24.4 ttt85 -76.67 132.58 39.45 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.191 -0.913 . . . . 74.34 110.606 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 40' ' ' LYS . 74.4 mt -96.67 131.95 27.15 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.092 -1.448 . . . . 54.42 107.092 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.72 146.5 54.61 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.533 2.156 . . . . 74.13 111.816 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.42 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -47.57 -39.74 17.37 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.693 1.597 . . . . 74.51 111.867 -175.289 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -61.2 -32.9 72.67 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.001 0.52 . . . . 71.31 112.4 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.79 -2.65 34.55 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 112.205 0.446 . . . . 75.32 112.205 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.73 -28.24 67.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.574 0.953 . . . . 74.13 113.574 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.47 59.65 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.899 -1.143 . . . . 71.21 111.578 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -142.98 87.08 8.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-O 120.95 0.405 . . . . 73.3 110.295 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -97.47 162.42 0.93 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.302 2.668 . . . . 74.23 112.128 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.39 137.36 46.77 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 122.354 2.036 . . . . 54.43 111.626 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -74.26 152.33 88.07 Favored Pre-proline 0 C--O 1.248 0.995 0 CA-C-N 116.439 -0.346 . . . . 75.14 110.787 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -81.4 121.72 3.91 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 122.103 1.869 . . . . 52.24 111.932 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 69' ' ' THR . 23.5 t -92.41 22.83 4.29 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.91 0.862 . . . . 72.1 109.66 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.403 ' HB3' HG12 ' A' ' 120' ' ' VAL . 14.5 t70 -137.17 151.27 48.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.779 -1.193 . . . . 74.31 107.779 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -88.26 -17.12 31.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.162 1.171 . . . . 63.13 114.162 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.6 m -80.92 -39.7 25.77 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.397 -0.594 . . . . 70.53 109.397 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 117' ' ' ASP . 7.1 p -97.47 123.96 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.588 -0.733 . . . . 73.14 109.809 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.77 148.91 47.85 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.917 -0.583 . . . . 72.11 110.418 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.1 mm -92.39 111.48 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.802 -1.555 . . . . 70.13 106.802 174.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -115.79 145.8 42.5 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.68 -0.691 . . . . 74.43 111.05 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 9.6 pt-20 -121.13 124.74 45.49 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.121 -1.066 . . . . 61.13 108.121 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.451 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.8 mmt180 -136.15 122.64 20.78 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.075 -0.65 . . . . 74.5 111.483 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -143.05 164.73 29.31 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.563 -0.902 . . . . 73.05 108.563 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.02 14.63 54.45 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.65 -0.98 . . . . 61.44 110.65 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.1 pt -120.65 145.17 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 109.267 -0.642 . . . . 74.53 109.267 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.2 m -108.12 128.79 55.0 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.313 -0.995 . . . . 64.41 108.313 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.19 155.28 31.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.475 -0.935 . . . . 71.22 108.475 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 64.1 m-85 -113.89 122.13 46.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.987 -1.486 . . . . 75.5 106.987 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 m -102.49 127.94 49.32 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.734 -0.469 . . . . 51.15 109.734 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 151' ' ' LEU . 13.7 t -120.03 121.9 39.92 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 108.582 -0.895 . . . . 61.11 108.582 171.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -109.67 126.78 54.03 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.194 -1.41 . . . . 75.33 107.194 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.9 p90 -129.61 152.63 48.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.672 -0.411 . . . . 74.15 112.019 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.79 106.98 2.6 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.23 -1.148 . . . . 72.11 110.23 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.68 173.75 36.75 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 111.131 -0.788 . . . . 64.23 111.131 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.2 128.48 33.81 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.146 -0.687 . . . . 64.34 109.146 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.64 125.75 54.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.385 0.883 . . . . 73.51 113.385 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -115.78 173.13 6.71 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.86 -1.533 . . . . 61.44 106.86 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.02 -43.92 70.5 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.478 0.581 . . . . 71.02 110.679 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.39 69.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.721 . . . . 72.51 111.42 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.0 -37.15 83.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.391 -0.596 . . . . 71.23 109.391 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.443 ' HD1' HG22 ' A' ' 185' ' ' VAL . 82.0 m-85 -64.94 -38.92 92.56 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.706 -0.679 . . . . 62.52 111.023 176.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.66 -47.36 93.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.771 -0.825 . . . . 73.2 108.771 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.61 86.16 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.244 -0.889 . . . . 74.14 111.094 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -68.2 -35.07 77.43 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 113.141 0.793 . . . . 75.03 113.141 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.85 88.94 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.434 0.459 . . . . 41.01 110.835 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.2 t -73.14 -33.77 65.71 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 120.309 -0.556 . . . . 71.21 110.495 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.26 -32.17 73.66 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 120.807 0.337 . . . . 54.32 110.937 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 31' ' ' TYR . 33.7 tp -74.55 -31.53 62.13 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.119 -0.632 . . . . 71.11 109.778 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.63 -37.25 79.57 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 112.616 0.599 . . . . 74.44 112.616 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.2 t -70.23 -30.04 67.02 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 73.02 109.649 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 31' ' ' TYR . 63.8 m -71.95 -38.44 69.8 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 115.268 -0.878 . . . . 70.12 109.433 176.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.1 -2.17 51.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.874 -0.603 . . . . 44.01 111.358 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.44 130.4 41.22 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.339 -1.356 . . . . 71.41 107.339 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.58 -2.09 57.22 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.834 -0.621 . . . . 64.52 112.122 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 43.4 p -107.25 164.55 14.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 107.636 -1.246 . . . . 73.44 107.636 175.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 89.2 Cg_endo -81.88 26.11 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.823 1.682 . . . . 52.21 112.301 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 138.03 58.15 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.347 0.594 . . . . 64.53 112.464 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.0 p -120.99 151.04 40.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.534 -1.284 . . . . 73.12 107.534 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.422 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 32.8 m-85 -136.36 151.86 50.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.9 0.773 . . . . 75.34 109.354 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.443 ' O ' HG12 ' A' ' 166' ' ' VAL . 4.3 pp0? -124.68 122.97 39.01 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.182 0.438 . . . . 64.43 112.182 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.38 2.78 43.94 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.659 -0.701 . . . . 50.22 113.491 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.8 14.97 5.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.704 0.802 . . . . 73.11 112.256 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.617 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.9 p -59.37 138.46 20.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 CA-C-O 121.729 0.776 . . . . 73.24 111.543 -177.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.484 ' HB3' HD23 ' A' ' 187' ' ' LEU . 55.5 p90 -139.84 163.27 33.08 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.854 -1.066 . . . . 65.11 108.721 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.94 153.18 31.04 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.098 0.475 . . . . 63.14 110.384 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 83' ' ' SER . 31.3 t -113.21 118.72 35.47 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.396 -1.705 . . . . 55.02 106.396 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -122.09 133.5 54.77 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.084 -0.71 . . . . 60.12 109.084 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.11 165.53 38.84 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.406 -1.077 . . . . 74.12 110.406 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -77.55 -35.67 52.94 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.524 -0.917 . . . . 74.53 108.524 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -156.22 133.19 6.37 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.723 -1.126 . . . . 64.31 108.843 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.67 105.79 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.0 1.8 . . . . 74.11 107.814 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.568 ' HB3' ' HA3' ' A' ' 180' ' ' GLY . 93.2 Cg_endo -85.54 128.75 3.51 Favored 'Trans proline' 0 N--CA 1.429 -2.277 0 N-CA-C 116.385 1.648 . . . . 74.11 116.385 -166.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 ttt -97.43 -32.81 11.66 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.594 -1.632 . . . . 72.33 106.594 169.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -97.22 151.3 37.61 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 114.002 -1.454 . . . . 72.14 110.048 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.98 -13.58 32.12 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.871 3.047 . . . . 63.51 116.296 -172.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -76.8 1.84 16.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.298 1.222 . . . . 72.4 114.298 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 175' ' ' PRO . . . -87.5 67.53 3.26 Favored Glycine 0 C--N 1.314 -0.675 0 N-CA-C 108.482 -1.847 . . . . 33.0 108.482 171.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -86.69 -29.24 22.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 114.261 1.208 . . . . 73.22 114.261 -171.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -101.81 127.83 48.44 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 118.367 -1.333 . . . . 63.04 109.326 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 37.5 m-80 -144.03 156.18 44.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.231 -1.026 . . . . 63.42 108.231 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 35.8 tt0 -138.94 145.92 40.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.569 0.224 . . . . 53.03 110.548 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.443 HG22 ' HD1' ' A' ' 144' ' ' TYR . 19.8 t -125.63 133.7 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.69 -0.855 . . . . 60.25 108.69 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.539 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 37.3 m0 -112.26 128.4 56.25 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.715 -0.476 . . . . 74.34 109.715 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 167' ' ' TYR . 85.3 mt -99.33 136.76 38.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.589 -1.263 . . . . 74.1 107.589 170.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.1 t -96.14 122.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.104 -0.638 . . . . 74.45 111.12 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 161' ' ' THR . 54.0 tttp -72.09 123.78 23.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.715 -0.675 . . . . 64.15 109.928 174.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.422 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 118.277 -0.868 . . . . 72.52 109.178 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.1 t30 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 109.466 -0.568 . . . . 71.33 109.466 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.7 p -97.35 123.54 41.21 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.8 0.333 . . . . 71.43 110.421 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.3 mt -117.85 83.35 1.98 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.734 0.302 . . . . 72.43 110.527 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -179.2 150.71 0.46 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.403 -0.962 . . . . 74.32 108.403 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.21 147.75 16.03 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.989 -0.844 . . . . 63.22 110.989 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.4 m -78.52 95.85 5.28 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.379 -0.6 . . . . 74.51 109.379 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.77 179.52 3.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.366 -0.834 . . . . 74.04 108.94 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -145.25 126.08 14.39 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.092 -1.077 . . . . 74.41 108.092 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 m -119.91 109.65 15.8 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.116 -1.809 . . . . 55.31 106.116 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.537 ' CZ2' ' HG3' ' A' ' 109' ' ' GLN . 2.7 p90 -132.67 111.95 13.72 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-O 121.335 0.588 . . . . 74.31 110.125 -172.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -94.53 146.51 1.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.464 2.11 . . . . 75.33 113.331 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 39.9 p90 -117.84 142.55 47.18 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.36 -0.978 . . . . 74.05 108.36 173.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -106.39 108.93 20.7 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.084 -0.646 . . . . 74.42 109.742 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.23 115.96 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 107.087 -1.449 . . . . 74.44 107.087 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -90.27 -37.17 14.27 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 120.332 -0.547 . . . . 65.41 112.152 -175.194 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.503 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 32.2 t -162.25 156.05 21.13 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.106 -0.637 . . . . 71.43 110.393 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 p -132.0 162.95 29.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.253 -1.388 . . . . 72.51 107.253 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.86 -149.55 20.62 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 119.286 -1.435 . . . . 74.44 112.635 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.92 159.73 32.61 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.098 -0.801 . . . . 65.42 111.098 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -75.51 123.1 24.87 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.05 -1.093 . . . . 73.44 108.05 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.53 133.49 51.35 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 122.534 1.159 . . . . 53.21 113.814 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t70 148.32 -48.82 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 130.83 3.652 . . . . 73.45 101.8 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 147' ' ' HIS . 3.8 p -127.8 109.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 112.611 -2.086 . . . . 75.51 106.718 169.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -117.08 151.12 37.48 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.84 -1.17 . . . . 73.13 107.84 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.589 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.3 p90 -113.57 158.48 20.73 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.899 -1.12 . . . . 75.41 112.684 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -134.47 125.21 26.94 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.589 -2.004 . . . . 73.12 105.589 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.503 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 38.2 mt-10 -98.22 114.59 26.89 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 106.832 -1.544 . . . . 73.43 106.832 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -134.79 140.91 46.25 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.559 -0.857 . . . . 75.42 111.449 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.07 133.59 35.5 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 104.415 -2.439 . . . . 72.3 104.415 169.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.593 ' SG ' HG13 ' A' ' 128' ' ' ILE . 84.1 m -58.46 138.28 56.76 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.488 0.922 . . . . 65.45 113.488 -173.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 10.6 pt-20 -58.22 -31.56 67.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.664 -1.607 . . . . 74.24 113.169 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.73 10.25 57.95 Favored Glycine 0 CA--C 1.495 -1.208 0 C-N-CA 119.045 -1.55 . . . . 30.53 112.111 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.24 52.11 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.779 -0.724 . . . . 63.01 111.931 -176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 16.7 ptpt -90.68 118.28 29.99 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.214 -0.661 . . . . 63.24 109.214 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 33.1 m-85 -119.14 164.33 15.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.022 -0.536 . . . . 72.44 111.165 -172.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 121' ' ' LYS . . . -99.47 116.22 31.11 Favored 'General case' 0 C--O 1.209 -1.037 0 N-CA-C 109.017 -0.734 . . . . 75.32 109.017 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.5 t -122.03 147.16 46.44 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.346 0.593 . . . . 55.45 111.97 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.0 m -131.85 132.32 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 124.669 1.188 . . . . 71.24 108.581 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.64 128.67 56.44 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.517 0.675 . . . . 75.32 111.927 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 12.2 t -123.99 139.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.065 -1.458 . . . . 61.21 107.065 178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.4 p -135.95 165.19 26.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.314 -0.554 . . . . 73.32 110.377 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.82 11.38 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.558 1.161 . . . . 73.43 110.654 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -133.99 137.56 28.65 Favored Pre-proline 0 N--CA 1.424 -1.747 0 N-CA-C 109.257 -0.646 . . . . 73.03 109.257 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.48 156.87 16.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.309 2.672 . . . . 73.23 111.597 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.46 HG13 HD12 ' A' ' 98' ' ' LEU . 55.1 t -47.75 -48.5 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.701 1.0 . . . . 62.51 113.701 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.37 -33.68 76.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.945 0.402 . . . . 63.41 110.932 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -75.98 -34.65 59.78 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.861 -0.609 . . . . 74.44 111.382 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -77.23 -44.47 29.86 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.332 -0.395 . . . . 71.14 110.889 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.8 tp -63.65 -37.78 88.64 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.115 -0.493 . . . . 63.41 111.872 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -59.26 -32.3 69.88 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 112.133 0.42 . . . . 72.45 112.133 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -84.68 -39.9 18.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.465 0.65 . . . . 75.51 110.923 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -75.85 -31.81 59.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.439 -0.8 . . . . 64.41 112.622 -177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.454 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -55.53 -57.65 19.76 Favored Pre-proline 0 CA--C 1.574 1.885 0 CA-C-O 119.372 -0.347 . . . . 72.54 111.5 -178.491 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 19.1 Cg_endo -60.42 -31.31 92.44 Favored 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 122.535 2.157 . . . . 41.43 111.147 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 41.5 ttmt -65.98 -37.03 84.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.776 -1.102 . . . . 73.11 111.276 -177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.37 -47.25 30.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.927 0.394 . . . . 71.1 110.667 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.1 ptm -63.54 -29.54 70.79 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 113.624 0.972 . . . . 75.11 113.624 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.4 -38.82 91.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 120.546 -0.462 . . . . 74.23 110.481 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.31 -58.41 7.79 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.985 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -69.41 -27.23 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 116.039 -0.528 . . . . 73.23 111.621 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.34 -18.23 73.14 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.921 -0.581 . . . . 22.04 113.358 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 134.37 -8.52 4.69 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.174 -1.488 . . . . 63.43 114.308 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 m -84.08 33.38 0.49 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-O 122.924 1.345 . . . . 75.03 110.014 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.6 163.55 12.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.107 -0.951 . . . . 74.53 108.694 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 29.8 t70 -66.28 -33.56 76.03 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.258 0.836 . . . . 74.53 113.258 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 113' ' ' PRO . 31.9 mmmt -80.14 -12.43 59.66 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.166 -0.614 . . . . 54.22 110.612 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.57 38.05 61.81 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.035 -0.602 . . . . 55.25 111.761 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 77' ' ' GLY . 94.8 t -79.56 120.78 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.034 -1.099 . . . . 61.13 108.034 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.59 -23.19 8.48 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 121.244 -0.503 . . . . 33.43 112.34 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.5 mtp -66.03 -37.85 86.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.201 0.524 . . . . 73.04 109.746 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 74' ' ' VAL . . . 69.92 -166.34 49.82 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.073 -0.967 . . . . 23.11 112.196 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.41 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 1.3 pmm? -133.05 146.35 51.62 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.181 -0.674 . . . . 73.11 109.181 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.9 m -113.08 117.61 32.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.01 0.433 . . . . 71.05 109.97 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 103' ' ' ARG . 8.2 p -165.57 151.22 8.31 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 107.492 -1.299 . . . . 73.03 107.492 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.95 140.66 61.39 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.175 1.25 . . . . 73.32 111.214 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 9.9 p -93.45 150.03 4.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.607 -0.886 . . . . 64.14 108.607 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 p -128.77 145.84 51.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.482 0.182 . . . . 64.15 110.942 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -139.78 143.6 36.98 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.475 -0.49 . . . . 73.12 110.5 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.59 134.92 34.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.891 -0.595 . . . . 65.14 110.407 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.69 151.62 28.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.156 -0.929 . . . . 74.33 108.57 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 97' ' ' LYS . 99.0 m-85 -120.22 107.83 38.93 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 120.942 -0.303 . . . . 73.44 110.404 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.22 133.09 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.581 1.521 . . . . 74.43 111.867 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 95' ' ' GLN . 38.5 m-80 -99.84 171.07 8.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.384 -0.825 . . . . 65.24 108.927 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.41 -27.75 62.65 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.981 1.104 . . . . 74.43 113.981 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.83 -7.26 58.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 119.815 -0.754 . . . . 72.42 110.878 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.04 3.6 57.89 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 120.33 -0.938 . . . . 53.43 113.38 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m -91.14 138.59 31.48 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 122.611 -0.346 . . . . 71.41 110.259 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.29 107.73 17.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.608 -1.256 . . . . 65.14 107.608 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 15.5 mm-40 -141.37 170.06 16.44 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.495 -0.558 . . . . 65.5 109.495 -173.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 35.4 mmtp 87.76 -70.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.367 1.467 . . . . 73.43 113.875 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HD3' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -136.54 154.43 50.71 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.49 -0.884 . . . . 73.13 111.822 -177.021 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 54' ' ' ALA . 6.4 tt -143.95 134.54 24.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.663 -1.153 . . . . 75.52 109.231 173.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -131.37 115.94 16.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.649 -0.251 . . . . 60.23 110.532 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.588 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 66.7 t -93.08 121.62 43.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.697 0.623 . . . . 75.52 109.783 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -109.65 122.53 47.67 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.832 0.853 . . . . 72.42 109.473 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.11 113.53 27.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.193 -1.41 . . . . 50.2 107.193 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.663 ' O ' HG11 ' A' ' 80' ' ' VAL . 70.6 ttt180 -75.08 137.2 41.27 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.523 -1.217 . . . . 72.24 109.269 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.0 mt -108.46 124.83 33.33 Favored Pre-proline 0 C--N 1.289 -2.053 0 O-C-N 122.388 -0.195 . . . . 74.31 111.314 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 78' ' ' MET . 83.9 Cg_exo -55.59 161.37 7.81 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.161 2.574 . . . . 51.42 113.231 172.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -47.69 -49.56 27.42 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.87 1.668 . . . . 32.54 115.028 -171.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.54 -37.49 78.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.517 . . . . 75.24 112.397 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.447 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 98.1 m-85 -86.91 -10.33 53.57 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.24 -0.584 . . . . 72.42 112.031 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.537 ' HG3' ' CZ2' ' A' ' 16' ' ' TRP . 13.7 mm-40 -71.56 -31.88 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.214 -0.994 . . . . 74.11 110.081 174.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.55 96.27 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 111.605 -0.598 . . . . 72.22 111.605 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.9 t -157.21 97.84 2.02 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 108.248 -1.019 . . . . 64.02 108.248 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 63.1 Cg_endo -85.78 148.26 9.61 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 122.49 2.127 . . . . 74.03 112.782 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 24.0 Cg_exo -65.77 142.31 69.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.275 1.983 . . . . 71.22 111.109 174.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -73.19 144.17 84.28 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.578 -0.449 . . . . 63.12 110.257 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -78.02 118.4 4.4 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.364 2.042 . . . . 74.33 111.76 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.2 m -88.39 21.77 2.76 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.163 0.506 . . . . 65.32 111.13 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.521 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.4 t70 -135.21 150.3 50.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.486 -1.302 . . . . 72.41 107.486 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.43 -23.76 37.32 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.555 0.946 . . . . 73.42 113.555 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -90.02 -25.85 20.61 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.669 -0.413 . . . . 45.44 111.258 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.5 p -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.597 -0.52 . . . . 70.14 109.597 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 52.9 mtpt -128.41 152.83 47.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.346 -0.843 . . . . 72.21 110.234 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 31.0 mm -92.85 112.57 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.049 -0.723 . . . . 75.13 109.049 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -121.86 142.65 50.04 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.563 -0.744 . . . . 72.05 109.856 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -115.89 128.56 55.88 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.696 -0.683 . . . . 64.25 110.255 -178.404 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.39 133.0 43.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.352 0.596 . . . . 75.21 112.343 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -139.46 172.4 12.87 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.902 -1.518 . . . . 71.21 106.902 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.49 5.14 79.39 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 119.86 -1.162 . . . . 75.11 113.32 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.593 HG13 ' SG ' ' A' ' 36' ' ' CYS . 45.4 pt -121.47 145.9 27.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.109 0.454 . . . . 72.4 110.391 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.1 m -107.68 133.26 52.36 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.503 -0.925 . . . . 73.15 108.503 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.23 149.47 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 N-CA-C 108.804 -0.813 . . . . 74.12 108.804 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 36.7 m-85 -113.79 121.82 45.21 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 104.639 -2.356 . . . . 74.22 104.639 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 55.3 p -119.41 141.29 49.23 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 120.038 -0.665 . . . . 73.14 111.653 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 10.8 t -121.48 139.38 53.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 115.696 -0.684 . . . . 71.13 109.391 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -121.11 126.3 49.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.764 -0.828 . . . . 63.44 108.764 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 38.4 p90 -138.44 168.71 19.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.387 -0.598 . . . . 72.44 109.387 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.21 169.21 35.35 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.331 -0.938 . . . . 71.12 111.794 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.8 -116.79 3.86 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.636 -0.586 . . . . 73.02 111.636 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -98.65 103.0 14.91 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.424 -0.584 . . . . 74.42 109.424 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 126.83 46.95 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.882 0.848 . . . . 71.31 112.434 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.95 172.82 6.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.732 -1.122 . . . . 65.04 108.164 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -40.11 95.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.211 0.529 . . . . 73.21 112.229 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.56 -27.11 68.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.721 -0.672 . . . . 61.44 110.494 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.11 -31.93 73.3 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.873 -0.603 . . . . 63.32 110.475 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -63.48 -42.23 98.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.231 -0.44 . . . . 74.22 109.97 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.83 -45.02 88.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.86 -0.609 . . . . 72.34 109.717 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.83 -47.17 87.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 61.45 110.965 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.436 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 27.6 m80 -69.25 -35.25 75.92 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 112.734 0.642 . . . . 62.42 112.734 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.31 90.43 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.05 0.452 . . . . 74.25 110.077 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.2 m -64.94 -53.38 47.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.789 -0.642 . . . . 73.44 109.937 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -38.66 83.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.945 -0.571 . . . . 75.21 112.222 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 31' ' ' TYR . 62.9 tp -63.62 -43.16 97.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.776 -0.453 . . . . 73.01 109.776 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 39.4 ttp180 -61.85 -40.6 95.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.652 -0.704 . . . . 73.44 109.137 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.427 ' HA ' ' OE2' ' A' ' 156' ' ' GLU . 47.0 m -66.32 -35.47 80.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.462 -0.79 . . . . 71.33 110.663 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -73.08 -33.99 65.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.465 0.65 . . . . 64.33 109.873 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.73 -1.83 29.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.549 -0.75 . . . . 74.14 112.188 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 42.8 mt-10 -75.85 141.63 42.39 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.861 -0.735 . . . . 73.41 110.512 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.16 -1.18 59.03 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.054 -0.819 . . . . 73.04 111.054 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 27.7 p -114.45 166.84 10.71 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.924 -1.51 . . . . 63.34 106.924 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.13 20.29 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.648 2.232 . . . . 74.11 112.987 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.68 118.28 12.33 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 121.193 0.52 . . . . 71.14 111.736 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.3 p -103.7 158.49 16.34 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.295 -1.002 . . . . 74.41 108.295 175.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.484 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 30.0 m-85 -137.8 147.19 44.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.761 -0.829 . . . . 72.42 108.761 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 4.2 pt20 -121.72 109.21 14.44 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.269 0.557 . . . . 63.44 110.686 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.39 8.53 55.73 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.13 -1.033 . . . . 72.32 111.785 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 55.64 30.84 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.495 1.118 . . . . 71.24 111.332 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.45 139.05 21.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.21 0.528 . . . . 64.14 110.945 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.92 163.22 33.37 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.526 -0.761 . . . . 74.2 110.309 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 34.5 m-85 -115.49 149.45 38.08 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.722 -0.672 . . . . 63.4 109.29 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.44 120.28 39.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.086 -1.45 . . . . 74.34 107.086 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -123.64 135.98 54.23 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.166 -0.47 . . . . 64.24 110.633 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.7 165.63 38.85 Favored Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 108.931 -1.668 . . . . 61.5 108.931 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.35 -30.24 65.94 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.222 -1.029 . . . . 61.15 108.222 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -151.45 145.15 17.63 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 106.502 -1.666 . . . . 74.31 106.502 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.46 108.79 2.29 Favored 'Trans proline' 0 C--O 1.249 1.032 0 N-CA-C 106.797 -2.04 . . . . 71.33 106.797 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.46 127.98 18.36 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 C-N-CA 121.268 1.312 . . . . 65.43 114.311 -168.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 57.2 ttp -96.88 -27.61 14.6 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.601 -1.629 . . . . 71.51 106.601 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 177' ' ' LYS . 0.1 OUTLIER -92.59 125.56 55.34 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 105.612 -1.996 . . . . 73.21 105.612 172.541 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.94 -19.77 56.81 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.698 2.265 . . . . 63.41 114.94 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -85.3 115.49 23.09 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.346 -0.942 . . . . 70.53 110.947 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -138.15 135.08 7.26 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 108.479 -1.848 . . . . 53.13 108.479 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -84.09 -20.54 32.42 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 117.869 0.835 . . . . 75.33 112.159 -175.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.476 ' HD3' ' OE2' ' A' ' 184' ' ' GLU . 15.1 ttm180 -139.96 130.11 25.09 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.333 -0.547 . . . . 74.42 110.881 176.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.6 m120 -137.53 134.69 35.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 105.046 -2.205 . . . . 64.03 105.046 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.6 mt-10 -129.14 137.43 51.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 110.028 -0.36 . . . . 74.21 110.028 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.11 124.24 67.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 74.01 108.352 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.3 m0 -108.58 123.3 48.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.297 -0.41 . . . . 63.52 110.142 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.7 mt -103.14 118.68 37.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.742 -1.206 . . . . 75.22 107.742 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.28 126.46 46.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.418 -0.586 . . . . 65.43 109.418 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 161' ' ' THR . 63.5 pttt -66.9 142.13 57.4 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 116.125 -0.489 . . . . 65.34 110.934 -175.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.253 1.246 0 CA-C-O 118.177 -0.916 . . . . 74.41 109.585 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 CA--C 1.504 -0.812 0 N-CA-C 109.421 -0.585 . . . . 65.43 109.421 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.1 t -170.98 106.53 0.26 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.878 0.371 . . . . 64.33 111.135 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -99.44 10.05 42.11 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.585 -0.894 . . . . 74.5 108.585 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -81.77 109.45 16.17 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 114.834 -1.075 . . . . 74.15 109.826 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.64 148.97 20.32 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 110.957 -0.857 . . . . 53.04 110.957 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.416 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 45.7 m -144.95 -171.87 3.73 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.879 -1.526 . . . . 65.31 106.879 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -56.02 -43.17 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.237 0.471 . . . . 73.34 111.289 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' OE2' ' HB2' ' A' ' 12' ' ' SER . 19.0 mm-40 51.47 89.76 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 C-N-CA 124.884 1.273 . . . . 73.45 110.904 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.7 m 72.55 98.05 0.07 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.388 0.614 . . . . 63.35 110.226 -174.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.405 ' CD2' ' HD2' ' A' ' 17' ' ' PRO . 77.4 t-105 -135.83 138.71 28.61 Favored Pre-proline 0 C--N 1.311 -1.098 0 N-CA-C 108.037 -1.097 . . . . 71.45 108.037 -178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HD2' ' CD2' ' A' ' 16' ' ' TRP . 66.0 Cg_endo -75.1 148.93 35.56 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.59 2.193 . . . . 43.21 111.743 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -101.6 144.5 30.27 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.697 -0.853 . . . . 70.1 108.697 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -106.42 120.15 41.15 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.911 0.708 . . . . 64.5 112.911 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.501 HG13 ' HG3' ' A' ' 32' ' ' GLU . 91.6 t -89.19 116.89 31.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.002 -1.851 . . . . 64.41 106.002 170.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' OE1' ' A' ' 33' ' ' GLU . 4.4 pp -99.86 -27.76 13.46 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.874 -0.73 . . . . 65.13 111.931 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -161.79 149.82 14.98 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.871 0.367 . . . . 72.41 110.806 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.7 p -132.79 157.37 45.16 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.227 -0.897 . . . . 62.13 109.562 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.16 -167.0 37.94 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.365 -0.922 . . . . 74.23 111.991 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.76 177.49 15.08 Favored Glycine 0 C--O 1.243 0.659 0 C-N-CA 120.745 -0.74 . . . . 34.11 112.718 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -87.1 126.25 34.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.457 -2.053 . . . . 75.42 105.457 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -64.24 132.69 51.03 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.103 0.954 . . . . 74.34 112.393 -167.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 129.41 -39.63 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.938 3.295 . . . . 71.52 103.105 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.627 HG22 ' CD2' ' A' ' 147' ' ' HIS . 21.6 t -123.0 110.23 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 112.983 -1.917 . . . . 75.01 106.844 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' THR . 52.4 m -119.56 131.87 55.61 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.362 -1.348 . . . . 74.23 107.362 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.61 160.57 16.55 Favored 'General case' 0 N--CA 1.423 -1.789 0 C-N-CA 120.302 -0.559 . . . . 73.33 111.108 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.501 ' HG3' HG13 ' A' ' 20' ' ' VAL . 43.9 tt0 -134.98 125.44 26.61 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 106.648 -1.612 . . . . 64.45 106.648 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' OE1' HD11 ' A' ' 21' ' ' LEU . 45.5 tt0 -100.17 114.73 28.34 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.367 -1.716 . . . . 75.1 106.367 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -135.93 142.16 44.6 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.789 -1.096 . . . . 73.23 111.377 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.98 136.44 33.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.128 -1.064 . . . . 64.54 108.128 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.0 t -69.07 143.31 54.27 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 110.002 -0.37 . . . . 65.32 110.002 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.12 -20.49 64.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.576 -0.738 . . . . 73.1 112.412 -177.296 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 89.84 10.4 64.92 Favored Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.044 -1.55 . . . . 64.33 110.938 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -71.92 165.56 53.83 Favored Glycine 0 N--CA 1.417 -2.633 0 CA-C-N 114.788 -0.706 . . . . 72.04 112.282 -175.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.546 ' O ' HD12 ' A' ' 104' ' ' ILE . 13.4 ptpt -94.35 132.6 38.79 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.01 -1.107 . . . . 73.42 108.01 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 37.8 m-85 -131.58 163.71 27.44 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.02 0.2 . . . . 74.13 111.128 -172.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.32 117.17 33.16 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.857 -0.794 . . . . 73.32 108.857 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 6.6 t -127.75 149.52 50.2 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 115.883 -0.599 . . . . 60.41 112.19 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 100' ' ' VAL . 3.2 p -145.58 134.7 17.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 124.557 1.143 . . . . 70.4 108.026 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.552 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.8 pt-20 -122.31 128.91 51.62 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.325 -0.95 . . . . 73.31 111.43 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.421 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 47.4 t -112.42 139.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 106.547 -1.649 . . . . 55.13 106.547 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 49' ' ' LYS . 76.5 p -117.51 166.25 12.58 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 111.826 0.306 . . . . 61.21 111.826 -173.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 72.1 -33.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.117 1.367 . . . . 64.53 112.97 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.0 mttm -85.76 146.1 42.98 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 115.238 -0.892 . . . . 62.05 111.726 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.97 158.91 48.97 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.409 2.74 . . . . 71.43 110.439 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -45.65 -47.24 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.112 1.152 . . . . 54.23 114.112 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.46 -48.2 74.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.673 0.67 . . . . 71.3 111.816 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.18 -45.54 73.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.663 -0.698 . . . . 74.52 112.418 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -67.32 -37.63 83.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.09 -0.504 . . . . 72.22 111.143 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.91 -37.56 72.96 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.242 -0.435 . . . . 73.32 111.091 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.317 6.2 ppt_? -66.51 -23.94 66.32 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.058 1.133 . . . . 73.42 114.058 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 14.1 mm-40 -79.22 -43.84 23.01 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.18 0.514 . . . . 75.05 110.839 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.94 -38.37 57.67 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 114.522 1.305 . . . . 73.44 114.522 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 8.0 mmt -55.58 -53.36 63.33 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 113.305 0.854 . . . . 55.4 113.305 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 59' ' ' MET . 10.4 Cg_endo -56.13 -31.73 84.29 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.005 1.803 . . . . 63.41 112.103 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 67.5 mttm -66.37 -39.94 89.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.901 0.381 . . . . 74.04 111.27 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -43.16 78.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 120.466 -0.493 . . . . 62.33 109.706 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.41 -35.02 78.45 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.262 0.838 . . . . 72.13 113.262 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -67.5 -40.86 85.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.357 -0.609 . . . . 74.1 109.357 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -60.97 -54.51 44.11 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.458 -0.792 . . . . 75.21 111.757 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.81 -5.81 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.169 0.433 . . . . 71.42 112.169 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.76 -36.64 10.15 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.949 -0.644 . . . . 71.52 112.254 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 148.26 2.22 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.542 -1.314 . . . . 45.24 113.618 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.3 m -85.77 11.92 10.08 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.495 1.14 . . . . 73.13 109.7 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' OD1' HG12 ' A' ' 74' ' ' VAL . 7.2 p30 -78.8 176.39 9.6 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.738 -1.119 . . . . 74.33 110.449 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.09 -33.16 73.08 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.06 0.457 . . . . 52.11 111.321 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -85.15 -13.86 48.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.45 0.643 . . . . 73.42 109.878 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.17 32.52 80.44 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.343 -0.844 . . . . 33.21 111.266 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.44 HG12 ' OD1' ' A' ' 70' ' ' ASN . 6.5 p -79.57 120.95 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 120.306 -0.558 . . . . 75.45 110.777 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.46 145.48 17.64 Favored Glycine 0 CA--C 1.481 -2.059 0 N-CA-C 109.447 -1.461 . . . . 74.15 109.447 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 53.7 ttp 59.3 79.81 0.21 Allowed 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.233 -1.395 . . . . 74.41 107.233 -171.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.88 -111.96 1.21 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.965 -1.112 . . . . 72.32 113.147 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.547 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 20.8 ptt? -132.91 128.44 36.54 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.271 -0.464 . . . . 71.13 111.689 -173.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 m -125.66 117.24 23.07 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 108.932 -0.766 . . . . 73.32 108.932 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.558 HG22 ' HD2' ' A' ' 81' ' ' PRO . 2.0 p -158.87 -178.52 0.91 Allowed Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 102.85 -3.018 . . . . 72.41 102.85 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 80' ' ' VAL . 92.8 Cg_exo -47.07 136.58 17.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 CA-C-N 123.085 2.137 . . . . 72.22 116.026 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.74 142.28 26.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 113.293 -1.776 . . . . 61.11 106.48 172.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.8 p -139.24 151.41 46.49 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.765 -0.374 . . . . 75.32 110.314 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.8 137.33 31.45 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 120.552 -0.459 . . . . 54.02 110.125 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.04 134.71 34.57 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 109.123 -0.695 . . . . 64.34 109.123 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 166' ' ' VAL . 33.8 m -122.6 149.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.613 -1.254 . . . . 72.31 107.613 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -119.96 100.86 48.14 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 107.428 -1.323 . . . . 74.0 107.428 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.03 135.42 12.35 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.034 1.823 . . . . 62.12 113.444 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -78.27 159.16 28.62 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.855 -1.535 . . . . 71.32 106.855 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.28 -31.77 67.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.486 0.66 . . . . 75.44 112.492 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.14 -5.17 40.17 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.98 -1.009 . . . . 72.31 112.027 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.02 63.28 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.65 -0.786 . . . . 52.25 111.908 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -84.23 119.49 25.1 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.799 -0.815 . . . . 62.1 108.799 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.42 82.87 5.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.606 0.717 . . . . 74.5 109.35 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 16.8 tm0? -147.52 130.43 16.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.819 -1.082 . . . . 70.24 108.828 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 86.0 mttt 161.17 -63.62 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 C-N-CA 127.59 2.356 . . . . 75.1 108.92 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -160.55 158.16 28.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.849 -1.537 . . . . 73.45 106.849 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 tt -141.69 127.45 19.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 107.221 -1.4 . . . . 72.4 107.221 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.552 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.9 mttt -113.1 114.93 27.53 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.851 -0.426 . . . . 74.1 109.851 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.1 t -87.87 132.94 31.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 108.434 -0.951 . . . . 62.51 108.434 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -124.03 117.99 25.97 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.865 -1.161 . . . . 73.22 107.865 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -102.54 121.12 41.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.487 -1.301 . . . . 45.54 107.487 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.508 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 60.1 ttt180 -78.75 131.53 36.6 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 115.291 -0.868 . . . . 71.22 108.981 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 40' ' ' LYS . 68.3 mt -93.53 129.6 38.05 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.926 -0.579 . . . . 75.25 110.15 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 48.0 Cg_endo -68.61 162.32 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.135 2.557 . . . . 73.2 112.24 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -47.45 -41.62 20.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.024 1.329 . . . . 74.33 113.877 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.49 -46.9 87.49 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.344 0.498 . . . . 62.35 112.344 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.58 -4.76 59.25 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.151 -0.477 . . . . 73.43 111.472 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.217 -0.66 . . . . 65.01 109.217 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.68 -26.41 60.92 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.179 -0.919 . . . . 64.02 111.824 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.9 t -174.87 99.63 0.27 Allowed Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 122.884 0.474 . . . . 54.13 109.878 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.93 157.73 1.77 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.65 2.233 . . . . 65.22 111.968 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -71.7 158.16 53.96 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 121.756 1.638 . . . . 75.03 110.6 172.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.87 59.02 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 110.334 -0.247 . . . . 73.1 110.334 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HB2' HG13 ' A' ' 120' ' ' VAL . 45.7 Cg_endo -68.46 106.86 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.78 2.32 . . . . 74.53 111.593 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -106.3 87.61 2.59 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.757 0.789 . . . . 61.11 111.505 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.817 ' HB3' HG12 ' A' ' 120' ' ' VAL . 17.8 t70 -176.34 155.8 1.5 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 104.961 -2.236 . . . . 64.04 104.961 173.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -12.32 60.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 115.07 1.507 . . . . 72.03 115.07 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.3 p -127.57 6.77 6.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.851 1.426 . . . . 73.42 114.851 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 117' ' ' ASP . 15.0 p -103.06 127.68 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.788 -0.819 . . . . 52.53 108.788 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.522 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 9.0 mmpt? -126.15 145.17 50.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.25 -0.648 . . . . 74.4 109.25 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.8 mm -92.59 111.67 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.612 -1.255 . . . . 73.22 107.612 172.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -125.55 139.27 53.74 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.682 -0.69 . . . . 74.42 109.864 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.77 139.3 43.78 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.155 -0.93 . . . . 73.44 109.745 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.521 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 49.4 mtp180 -133.43 136.44 45.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.07 0.462 . . . . 73.01 111.761 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 157.13 46.75 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.182 -0.917 . . . . 61.34 111.519 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.02 18.63 46.12 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.096 -0.574 . . . . 72.32 113.158 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.0 pt -121.97 145.4 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.678 -0.809 . . . . 63.34 111.966 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.8 m -106.16 131.4 53.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 106.594 -1.632 . . . . 72.1 106.594 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.01 150.41 28.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.583 -0.895 . . . . 70.42 108.583 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 13.1 m-85 -115.19 121.73 43.88 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.207 -1.775 . . . . 72.42 106.207 -177.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 53.8 p -120.55 132.52 55.21 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 120.043 -0.663 . . . . 74.41 112.263 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.553 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -113.41 135.76 53.52 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.36 -0.607 . . . . 75.42 109.36 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -109.55 127.75 54.7 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.023 -1.103 . . . . 53.23 108.023 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -130.6 168.4 17.16 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.447 -0.946 . . . . 64.21 108.447 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.27 165.58 29.92 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.074 -1.06 . . . . 63.34 112.002 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.17 -133.8 7.9 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 110.968 -0.853 . . . . 71.5 110.968 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -100.71 101.32 12.17 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.169 -1.419 . . . . 63.54 107.169 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.33 107.93 17.57 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.931 0.872 . . . . 15.24 112.514 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -99.63 169.29 9.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.42 -1.326 . . . . 73.32 107.42 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.63 -29.09 69.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.842 0.83 . . . . 72.25 109.389 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.61 -30.92 70.63 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.738 -1.119 . . . . 73.25 111.093 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.17 -36.87 84.23 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 120.383 0.135 . . . . 71.52 111.28 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -66.61 -41.07 89.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.916 -0.314 . . . . 74.34 110.633 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.63 -45.35 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 72.31 109.959 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.68 90.94 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.049 -0.523 . . . . 72.43 111.366 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.627 ' CD2' HG22 ' A' ' 29' ' ' VAL . 76.5 m80 -69.14 -32.96 72.68 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.096 -0.642 . . . . 73.33 111.733 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -66.84 -47.04 73.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.506 -0.315 . . . . 62.4 110.863 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 t -63.12 -38.14 89.99 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.931 -0.308 . . . . 70.45 111.682 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.77 -35.13 78.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 112.419 0.526 . . . . 53.53 112.419 176.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.1 mt -57.6 -36.87 72.32 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 120.846 0.355 . . . . 75.24 111.2 175.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 51.2 mtm180 -65.14 -36.56 84.62 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.547 -0.751 . . . . 72.14 110.076 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 m -75.82 -43.3 46.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.615 -0.721 . . . . 74.43 110.068 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 151' ' ' LEU . 60.1 p -71.93 -33.59 68.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.753 -0.658 . . . . 75.11 112.723 -174.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.75 9.59 7.65 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.061 0.763 . . . . 74.42 113.061 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 45.5 mt-10 -88.02 145.94 25.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.298 -1.001 . . . . 70.15 108.298 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.96 -9.86 63.85 Favored Glycine 0 C--N 1.302 -1.338 0 C-N-CA 120.647 -0.787 . . . . 74.23 111.404 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 14.0 t -122.03 149.32 53.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 107.2 -1.408 . . . . 63.41 107.2 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.79 34.67 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 123.84 3.027 . . . . 60.23 114.377 -175.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.32 136.06 39.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.966 0.412 . . . . 52.21 110.547 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 25.2 m -124.45 154.14 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.04 -1.096 . . . . 50.14 108.04 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.412 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 26.2 p90 -134.21 158.84 42.68 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.794 -0.447 . . . . 75.34 109.794 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -122.22 140.56 52.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.584 0.957 . . . . 75.15 113.584 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.78 30.17 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.066 -0.97 . . . . 60.11 113.968 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.9 t70 66.27 17.15 10.65 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 122.645 1.212 . . . . 72.24 108.439 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 86' ' ' VAL . 83.0 t -72.52 139.88 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 125.83 1.652 . . . . 64.31 111.731 -176.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -146.23 167.47 23.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.497 -0.774 . . . . 65.0 109.898 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.612 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 10.7 m-85 -115.42 152.77 32.28 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.799 -0.815 . . . . 70.02 108.799 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.1 m -114.65 129.63 56.7 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 106.477 -1.675 . . . . 71.43 106.477 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.61 157.12 42.96 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.098 0.475 . . . . 71.35 111.91 -175.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . -155.66 164.19 32.02 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 108.553 -1.819 . . . . 64.11 108.553 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.499 ' CD1' ' HG3' ' A' ' 81' ' ' PRO . 70.2 m-85 -93.76 -15.72 24.9 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 117.779 0.79 . . . . 70.54 111.193 -176.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -157.81 144.62 13.18 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 105.293 -2.114 . . . . 62.45 105.293 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 25.0 Cg_exo -64.85 106.01 0.72 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.008 1.805 . . . . 51.22 110.979 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 174' ' ' PRO . 5.0 Cg_exo -77.14 132.25 12.52 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.582 2.188 . . . . 44.43 112.243 -174.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.9 tpt -81.46 -35.76 30.16 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.573 -0.899 . . . . 74.34 108.573 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -102.76 155.81 36.08 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 114.706 -1.134 . . . . 71.12 108.797 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.39 -14.92 28.15 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.876 2.384 . . . . 64.1 113.676 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -68.07 112.71 5.2 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.45 -0.5 . . . . 64.12 110.767 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -135.28 115.96 1.46 Allowed Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 110.351 -1.1 . . . . 51.23 110.351 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -69.62 -30.69 68.48 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 122.695 -0.297 . . . . 64.42 110.591 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.403 -0.592 . . . . 63.42 109.403 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -141.59 153.46 44.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.394 -1.706 . . . . 71.33 106.394 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 133' ' ' THR . 47.2 mt-10 -125.63 154.25 42.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.954 0.724 . . . . 61.31 112.954 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 132' ' ' SER . 51.9 t -125.45 118.9 53.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.742 -1.577 . . . . 74.15 106.742 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.9 m0 -103.73 121.15 42.4 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.027 -0.731 . . . . 65.24 109.027 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.0 tp -97.86 138.78 34.7 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.654 -1.61 . . . . 70.1 106.654 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.64 135.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.645 -0.422 . . . . 73.0 111.894 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.3 ptmm? -65.5 143.29 57.75 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.614 -0.721 . . . . 75.23 111.595 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.412 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.188 -1.042 . . . . 45.2 108.188 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.7 p30 . . . . . 0 CA--C 1.508 -0.668 0 N-CA-C 109.186 -0.672 . . . . 73.04 109.186 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.5 m 66.73 -20.44 0.11 Allowed 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.413 1.635 . . . . 71.31 115.413 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.1 mt 60.84 31.77 20.05 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.206 -1.405 . . . . 54.11 107.206 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -68.47 162.27 25.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.14 -1.391 . . . . 74.44 113.152 -171.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.28 69.51 0.38 Allowed Glycine 0 N--CA 1.412 -2.916 0 N-CA-C 108.897 -1.681 . . . . 74.13 108.897 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 m -66.0 107.92 2.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.918 -0.771 . . . . 73.44 108.918 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.1 t 59.69 77.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.598 1.189 . . . . 61.45 109.123 -172.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.614 ' HG2' ' H ' ' A' ' 15' ' ' THR . 35.6 tt0 -111.2 -169.11 1.4 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.564 -1.653 . . . . 73.25 106.642 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.614 ' H ' ' HG2' ' A' ' 14' ' ' GLU . 23.2 p -63.79 106.98 1.09 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.373 0.606 . . . . 72.24 111.915 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.518 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 76.1 t-105 -110.23 127.96 26.17 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.651 -1.24 . . . . 75.43 107.651 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.85 149.68 72.82 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.066 2.51 . . . . 74.33 112.619 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -100.7 127.45 47.11 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.787 -1.19 . . . . 63.4 107.787 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 108.31 19.75 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.595 -0.729 . . . . 74.3 109.202 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.6 131.37 41.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 116.085 -0.507 . . . . 73.13 110.443 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 22' ' ' SER . 4.1 pp -90.85 -34.99 15.05 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.657 -0.817 . . . . 74.13 112.431 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.445 ' N ' HD12 ' A' ' 21' ' ' LEU . 32.6 t -177.65 164.76 2.05 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.789 -0.819 . . . . 74.53 108.789 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -131.26 156.34 45.58 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.972 -1.122 . . . . 70.4 107.972 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.0 -158.94 31.66 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.582 -1.294 . . . . 71.31 112.42 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.58 -116.59 3.16 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 121.192 -0.528 . . . . 62.13 111.794 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -108.19 171.29 7.49 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.695 0.798 . . . . 72.11 109.853 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.67 140.85 35.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 106.44 -1.689 . . . . 74.35 106.44 172.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 77.3 -53.92 0.55 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.69 1.196 . . . . 72.14 110.47 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 147' ' ' HIS . 21.9 t -97.96 108.27 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.164 -1.421 . . . . 75.13 107.164 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 133' ' ' THR . 50.3 m -130.52 140.85 50.49 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.261 -1.014 . . . . 71.22 108.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' SER . 1.6 p90 -112.15 161.46 16.52 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.075 0.464 . . . . 70.51 112.151 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.541 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -133.13 126.19 31.17 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.456 -1.313 . . . . 74.41 107.456 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.33 112.82 26.07 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.031 -1.47 . . . . 54.51 107.031 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 13.4 ptt180 -144.04 159.23 42.97 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 119.853 -0.739 . . . . 73.23 110.327 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.19 136.9 33.78 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.958 -1.497 . . . . 43.2 106.958 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.43 151.59 43.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.097 0.475 . . . . 73.55 111.122 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -67.62 -21.09 65.41 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.364 -0.834 . . . . 72.4 112.898 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 74.49 9.49 81.91 Favored Glycine 0 CA--C 1.51 -0.235 0 C-N-CA 119.873 -1.156 . . . . 72.11 113.926 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.61 165.25 53.66 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.947 -0.644 . . . . 71.14 113.574 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -93.95 135.66 35.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.21 -0.663 . . . . 65.13 109.21 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 63.1 m-85 -136.59 165.92 24.75 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.688 0.618 . . . . 74.14 110.815 -172.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.73 118.95 35.41 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.236 -1.024 . . . . 72.34 108.236 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.7 t -128.49 154.12 46.44 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 113.174 0.805 . . . . 71.21 113.174 -172.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 119' ' ' SER . 97.1 t -129.08 132.94 66.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.989 1.315 . . . . 63.43 108.63 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.38 126.67 55.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.653 0.263 . . . . 55.11 110.503 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 45.1 t -127.33 127.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.942 -1.503 . . . . 65.33 106.942 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -120.34 162.99 18.52 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.563 -0.532 . . . . 72.22 109.563 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 75.58 -31.81 0.21 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.985 1.314 . . . . 73.11 112.362 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -85.4 146.6 44.98 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.795 -0.639 . . . . 54.32 110.663 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.5 156.86 39.32 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.853 2.369 . . . . 54.3 111.113 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.52 HG13 HD12 ' A' ' 98' ' ' LEU . 37.2 t -47.8 -48.08 11.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.908 1.077 . . . . 72.43 113.908 -177.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 33.2 t70 -59.51 -49.64 76.98 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.47 -0.492 . . . . 75.24 110.832 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -61.96 -48.19 81.47 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.662 0.616 . . . . 72.11 112.662 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -60.59 -38.65 85.36 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 123.612 0.57 . . . . 54.53 110.778 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' O ' ' HG2' ' A' ' 59' ' ' MET . 65.3 tp -66.48 -42.53 87.31 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.081 -0.509 . . . . 71.13 110.302 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 20.0 mmm180 -59.43 -45.31 91.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.861 0.363 . . . . 73.53 110.595 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -66.69 -37.43 84.72 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.336 -0.847 . . . . 74.21 111.34 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.57 59.97 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.274 0.842 . . . . 74.22 113.274 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 3.2 mmt -48.32 -57.69 10.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.254 1.205 . . . . 54.0 114.254 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.55 -32.12 88.82 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.749 2.299 . . . . 63.53 112.384 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.06 -47.48 68.2 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.329 -0.619 . . . . 72.31 109.329 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.88 -38.08 79.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.901 -0.59 . . . . 75.42 110.303 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 59' ' ' MET . 9.7 mmt -66.36 -37.36 85.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 73.44 112.031 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -72.98 -33.71 66.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.699 -0.401 . . . . 71.05 110.807 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.71 -60.08 4.23 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 116.431 -0.35 . . . . 61.2 111.246 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 76' ' ' MET . 6.4 p -73.48 -25.27 20.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 120.864 0.364 . . . . 74.54 110.542 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.49 -25.05 66.56 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.261 -0.427 . . . . 45.04 113.249 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 -0.58 2.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.781 -1.2 . . . . 72.31 113.494 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -91.2 29.74 1.37 Allowed 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.609 1.195 . . . . 50.22 109.431 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.07 159.87 14.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.596 -0.891 . . . . 52.03 108.596 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 23.2 t70 -70.8 -28.04 64.34 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.081 0.4 . . . . 72.32 112.081 -172.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.84 -12.34 59.97 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.192 -0.67 . . . . 74.43 109.192 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.61 33.25 75.94 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.158 -0.928 . . . . 64.42 112.813 177.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.58 126.93 40.25 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.78 -0.768 . . . . 72.14 111.331 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.86 92.45 1.54 Allowed Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.281 -1.127 . . . . 41.32 110.281 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 56.0 ttp 70.62 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.771 1.228 . . . . 71.1 110.535 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.52 -55.62 0.68 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.837 0.695 . . . . 74.13 114.837 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.412 ' SD ' HG23 ' A' ' 104' ' ' ILE . 21.6 ptt? -124.75 126.24 45.33 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.5 m -126.1 124.5 40.72 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.33 109.652 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -165.7 145.5 5.44 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 107.465 -1.309 . . . . 72.2 107.465 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -35.61 139.98 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.177 3.251 . . . . 64.4 115.767 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.27 150.06 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 113.485 -1.689 . . . . 74.1 106.5 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 m -138.61 145.08 40.11 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.467 -0.568 . . . . 72.22 109.467 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 42.9 p90 -136.53 143.69 43.86 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.463 -0.495 . . . . 64.15 111.358 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.87 34.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.678 -0.86 . . . . 75.44 108.678 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.98 150.95 30.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.188 -0.915 . . . . 63.31 109.291 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.537 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 1.9 m-85 -117.36 102.28 52.31 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 109.231 -0.655 . . . . 64.44 109.231 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -88.67 146.8 5.91 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.235 1.957 . . . . 75.32 112.693 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.54 152.66 18.23 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.988 -1.856 . . . . 63.14 105.988 171.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.268 11.3 pt-20 -64.53 -13.36 52.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 115.683 1.734 . . . . 70.44 115.683 -172.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.6 -6.25 59.25 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 121.609 0.718 . . . . 61.02 109.866 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.22 5.14 54.84 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 72.04 112.941 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 m -83.99 126.42 33.01 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.489 -0.56 . . . . 50.22 109.489 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 78.0 mt -94.04 78.58 4.08 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.923 0.392 . . . . 63.41 111.095 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.1 tt0 -149.25 115.29 5.73 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.949 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 95.1 mttt -176.75 -62.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.278 1.831 . . . . 73.51 108.648 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.537 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 38.5 ttmt -161.31 155.0 21.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.299 -1.0 . . . . 53.12 108.299 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.52 HD12 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -143.76 143.38 31.35 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.331 -0.618 . . . . 72.53 109.331 173.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -136.92 115.47 11.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.636 -0.505 . . . . 73.0 109.636 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' THR . 84.0 t -92.15 129.88 42.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 N-CA-C 109.785 -0.45 . . . . 43.33 109.785 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.422 ' HE3' ' HB2' ' A' ' 41' ' ' PHE . 89.8 m95 -112.72 128.15 56.33 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.941 -0.763 . . . . 75.11 108.941 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -103.26 123.62 47.1 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.969 -1.123 . . . . 75.03 107.969 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.451 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 68.4 mtt-85 -75.49 132.22 40.63 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.503 0.927 . . . . 73.33 113.503 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.412 HG23 ' SD ' ' A' ' 78' ' ' MET . 72.1 mt -102.11 122.77 45.78 Favored Pre-proline 0 N--CA 1.398 -3.041 0 N-CA-C 105.98 -1.859 . . . . 74.33 105.98 172.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.16 152.01 62.75 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.236 1.958 . . . . 62.31 110.733 175.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -48.12 -37.33 15.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.564 0.746 . . . . 62.34 112.848 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.75 -31.87 70.04 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.502 0.721 . . . . 75.23 112.225 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -100.29 -8.45 23.42 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 112.498 0.555 . . . . 64.43 112.498 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -70.75 -29.24 65.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.641 1.349 . . . . 63.31 114.641 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.11 -38.59 94.1 Favored Glycine 0 C--O 1.241 0.587 0 C-N-CA 120.029 -1.082 . . . . 61.21 111.514 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -142.92 85.81 9.72 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 108.26 -1.015 . . . . 72.01 108.26 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -88.34 159.82 6.83 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.886 1.724 . . . . 73.23 112.824 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.28 130.27 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.478 2.119 . . . . 71.31 110.802 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -70.03 138.73 87.5 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 109.287 -0.634 . . . . 60.52 109.287 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 73.1 Cg_endo -77.27 111.3 3.16 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.155 1.904 . . . . 51.13 112.074 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -98.69 79.23 2.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.806 -0.813 . . . . 74.12 108.806 177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -173.89 150.26 1.63 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.792 -1.188 . . . . 72.35 107.792 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -76.27 -24.2 54.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.214 0.82 . . . . 73.21 113.214 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 44' ' ' VAL . 60.4 m -92.6 -26.21 17.97 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.57 -0.452 . . . . 73.31 110.799 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 26.8 t -94.35 118.35 40.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.849 -0.426 . . . . 75.32 109.849 -175.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -128.73 147.63 50.78 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.471 -0.937 . . . . 71.33 108.471 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.1 mm -92.71 112.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.24 -1.022 . . . . 53.44 108.24 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -122.06 149.7 43.16 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.942 -0.572 . . . . 74.44 109.769 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.74 152.52 24.24 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.814 -0.63 . . . . 62.04 109.821 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.503 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 65.0 ttt180 -151.57 123.25 7.96 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.821 -0.807 . . . . 71.34 108.821 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -138.39 166.92 23.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.545 -0.539 . . . . 72.23 109.545 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.44 61.01 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.431 -1.366 . . . . 73.23 113.282 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.6 pt -119.28 151.93 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.347 -0.941 . . . . 74.43 112.166 -175.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 92.9 m -105.78 123.35 47.81 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.943 -1.48 . . . . 73.43 107.788 178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.52 146.66 30.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 116.01 -0.541 . . . . 64.3 110.632 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 39.9 m-85 -114.47 121.92 45.0 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.707 -1.96 . . . . 73.22 105.707 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 31' ' ' TYR . 56.1 p -122.41 139.16 54.17 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 119.832 -0.747 . . . . 43.44 111.193 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.8 t -113.51 133.19 55.37 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 120.574 -0.451 . . . . 40.14 109.932 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -110.91 125.33 53.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.514 -1.291 . . . . 64.21 107.514 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.68 158.08 44.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.463 -0.199 . . . . 65.41 110.463 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -137.06 154.54 22.32 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 123.973 0.796 . . . . 74.31 111.372 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.09 -142.37 11.73 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 109.009 -1.637 . . . . 63.43 109.009 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 179' ' ' TYR . 75.0 t80 -100.43 118.95 37.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 118.239 1.02 . . . . 63.2 108.964 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.53 133.41 55.4 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.611 0.72 . . . . 63.3 112.177 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -112.64 177.37 4.66 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.419 -1.697 . . . . 73.32 106.419 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.55 78.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.346 0.594 . . . . 60.35 110.817 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.65 -29.29 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 74.33 111.77 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.24 -30.23 70.09 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 111.879 0.325 . . . . 64.04 111.879 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.88 -48.94 69.85 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.728 -0.841 . . . . 75.03 108.728 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.03 -41.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.841 -1.072 . . . . 54.4 110.185 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.71 88.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.841 -0.618 . . . . 63.12 110.521 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.428 ' CD2' HG22 ' A' ' 29' ' ' VAL . 62.8 m80 -66.63 -32.36 73.63 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 112.827 0.677 . . . . 75.35 112.827 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.68 -47.31 84.93 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.105 0.478 . . . . 64.53 109.921 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -65.03 -46.87 79.48 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.628 -0.715 . . . . 65.05 110.447 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.06 -40.82 86.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.118 -0.492 . . . . 74.43 111.318 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 187' ' ' LEU . 1.5 tt -62.72 -46.07 89.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.828 -1.175 . . . . 72.31 107.828 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -64.09 -39.47 94.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.068 -0.969 . . . . 74.03 110.451 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.9 m -68.55 -33.09 73.48 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.312 0.577 . . . . 72.4 110.257 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -73.02 -33.51 65.78 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.37 0.605 . . . . 74.34 109.702 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 158' ' ' THR . 98.6 mt -81.1 9.2 7.06 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.998 -0.546 . . . . 71.34 111.486 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.96 134.08 35.64 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 71.22 106.91 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.89 57.28 Favored Glycine 0 C--N 1.307 -1.028 0 C-N-CA 121.211 -0.518 . . . . 61.51 112.551 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 155' ' ' LEU . 15.3 t -125.41 146.24 53.72 Favored Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 106.879 -1.526 . . . . 72.43 106.879 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.83 34.79 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 123.744 2.963 . . . . 60.15 114.676 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.64 43.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.446 -0.576 . . . . 64.33 109.446 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 19.6 p -114.91 158.66 21.68 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.364 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -136.23 152.36 50.66 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.615 -0.883 . . . . 64.42 108.615 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -113.02 111.34 22.0 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.262 0.838 . . . . 70.02 113.262 178.164 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.53 4.71 46.81 Favored Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 115.658 -0.701 . . . . 61.1 112.495 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 17.8 t70 63.83 15.75 9.3 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.813 1.245 . . . . 74.54 109.565 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.14 151.56 7.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 CA-C-O 121.205 0.526 . . . . 72.44 110.516 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -146.1 170.64 16.28 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.599 -0.728 . . . . 70.14 111.215 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.494 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 97.6 m-85 -115.15 152.28 32.88 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.64 -0.504 . . . . 55.21 109.64 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.03 137.75 53.67 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.757 -1.201 . . . . 62.33 107.757 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.73 150.03 32.13 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 111.896 0.332 . . . . 73.1 111.896 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.9 164.23 33.11 Favored Glycine 0 C--O 1.22 -0.748 0 N-CA-C 107.871 -2.092 . . . . 71.51 107.871 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -138.99 -39.48 0.49 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 115.228 1.566 . . . . 71.41 115.228 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.81 134.54 25.98 Favored Pre-proline 0 C--N 1.306 -1.283 0 C-N-CA 120.312 -0.555 . . . . 75.45 111.319 -175.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.46 104.05 0.88 Allowed 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.295 1.996 . . . . 74.1 107.865 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -97.36 149.7 0.91 Allowed 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.333 2.022 . . . . 72.14 115.694 -168.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 85.6 mtp -81.56 -33.83 31.44 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.068 -1.827 . . . . 71.55 106.068 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -132.81 109.92 13.16 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 106.029 -1.841 . . . . 73.25 106.029 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.68 -34.33 51.49 Favored 'Trans proline' 0 CA--C 1.511 -0.657 0 C-N-CA 121.431 1.421 . . . . 61.12 113.362 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 138' ' ' TYR . 52.5 t80 46.27 -89.4 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.405 1.082 . . . . 74.33 110.633 -172.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 116.51 54.58 0.33 Allowed Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.31 -0.948 . . . . 54.23 114.848 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -70.85 -26.36 63.23 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 117.952 0.876 . . . . 65.21 111.73 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -133.8 128.16 34.19 Favored 'General case' 0 CA--C 1.469 -2.143 0 CA-C-O 121.459 0.647 . . . . 70.3 111.231 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -144.86 134.59 23.51 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 103.743 -2.688 . . . . 75.52 103.743 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 186' ' ' TRP . 2.7 mp0 -115.71 137.22 52.3 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 119.261 -0.976 . . . . 73.54 110.334 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 89.8 t -124.99 121.06 60.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.636 -1.246 . . . . 54.23 107.636 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.502 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 6.8 m0 -119.31 120.96 38.51 Favored 'General case' 0 C--O 1.197 -1.682 0 CA-C-O 119.129 -0.462 . . . . 72.43 110.929 -174.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 151' ' ' LEU . 9.2 mp -96.95 138.83 33.88 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.822 -1.177 . . . . 73.22 107.822 171.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.16 131.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 120.323 -0.551 . . . . 74.22 110.681 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 161' ' ' THR . 4.5 tmtm? -73.46 130.74 40.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.519 -0.764 . . . . 60.13 109.997 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.252 1.199 0 CA-C-N 115.734 -0.666 . . . . 52.13 111.054 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.224 -1.028 . . . . 74.45 108.224 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.7 p -165.22 136.36 3.98 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.751 0.31 . . . . 62.31 111.783 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.87 93.61 3.88 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.611 -0.885 . . . . 73.44 108.611 171.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -87.49 135.49 33.32 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.63 -0.714 . . . . 71.41 110.09 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.99 165.36 22.16 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 109.299 -1.52 . . . . 55.33 109.299 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.8 t -82.65 97.79 8.7 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.901 -0.777 . . . . 72.31 108.901 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -95.53 -36.48 6.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.397 -0.964 . . . . 64.34 108.397 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.96 163.62 13.64 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.082 -1.822 . . . . 61.51 106.082 -178.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.8 m 77.21 126.1 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.323 1.449 . . . . 70.13 112.475 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -82.1 111.73 29.76 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.157 -0.929 . . . . 54.32 109.453 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -96.33 121.63 0.23 Allowed 'Trans proline' 0 N--CA 1.44 -1.664 0 C-N-CA 121.835 1.69 . . . . 60.52 113.502 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -110.07 144.71 38.27 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.056 -1.461 . . . . 70.42 107.056 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -126.81 122.53 35.02 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.92 -1.112 . . . . 74.1 111.73 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.92 121.16 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 106.966 -1.494 . . . . 52.43 106.966 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.56 -33.41 15.91 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.59 -0.444 . . . . 65.04 111.044 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 46.8 t -162.26 149.86 14.14 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.401 0.619 . . . . 40.12 110.806 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.1 p -133.29 166.71 21.87 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 125.05 1.34 . . . . 73.41 108.255 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.01 76.76 0.4 Allowed Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 119.513 -1.327 . . . . 73.32 112.961 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.18 -160.34 22.45 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.226 -0.988 . . . . 74.02 111.659 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -89.96 170.58 10.25 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.781 -1.192 . . . . 73.2 107.781 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.22 148.27 51.07 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 119.652 -0.819 . . . . 63.53 109.91 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.0 t70 77.43 -62.23 0.39 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.425 1.49 . . . . 62.42 110.791 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.76 110.06 29.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.369 -0.974 . . . . 60.2 108.369 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -118.88 154.44 32.93 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.461 -0.94 . . . . 55.44 108.461 -176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.594 ' HB3' HD11 ' A' ' 151' ' ' LEU . 5.7 p90 -117.28 152.19 35.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.214 -1.394 . . . . 71.44 113.868 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -135.18 124.75 25.07 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.527 -2.027 . . . . 75.11 105.527 172.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.412 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 32.3 mt-10 -106.31 118.38 36.48 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.2 107.571 -177.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -139.04 148.34 43.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.512 0.93 . . . . 74.22 113.512 -175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.59 136.41 34.82 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.082 -1.451 . . . . 62.52 107.082 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.632 ' SG ' HG13 ' A' ' 128' ' ' ILE . 99.1 m -63.49 142.9 58.22 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.644 0.979 . . . . 70.34 113.644 -176.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -47.98 -48.25 32.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.827 1.251 . . . . 54.32 112.323 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.01 69.91 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 110.747 -0.941 . . . . 51.11 110.747 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.23 165.75 53.37 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 111.214 -0.754 . . . . 63.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 137.24 32.51 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.921 -0.311 . . . . 70.45 110.763 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.541 ' HE1' HE22 ' A' ' 109' ' ' GLN . 53.9 m-85 -135.34 164.22 28.23 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.766 0.827 . . . . 75.13 109.403 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.51 116.51 31.8 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.135 -0.691 . . . . 72.52 109.135 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -119.91 138.98 53.1 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 112.621 0.6 . . . . 74.13 112.621 -175.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.498 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 11.5 m -130.44 124.95 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.425 1.09 . . . . 60.42 110.393 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.55 139.06 45.01 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.086 -0.646 . . . . 64.12 112.281 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 39.4 t -126.38 141.33 46.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 N-CA-C 108.465 -0.939 . . . . 64.31 108.465 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -127.83 174.89 8.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 122.859 0.463 . . . . 71.35 110.13 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.51 -34.28 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.122 0.969 . . . . 73.33 113.202 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 3.5 mppt? -100.57 138.78 20.22 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 112.143 0.424 . . . . 62.45 112.143 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.73 159.76 4.59 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 124.589 3.526 . . . . 73.01 111.841 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.613 HG13 HD12 ' A' ' 98' ' ' LEU . 52.6 t -46.14 -48.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.708 0.803 . . . . 72.51 113.043 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.99 -45.18 91.27 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.423 0.63 . . . . 70.41 110.744 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 23.1 mm-40 -75.06 -31.84 61.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.986 -1.006 . . . . 74.11 112.585 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -73.0 -44.84 60.57 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.512 0.673 . . . . 71.12 109.669 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.304 -0.862 . . . . 62.3 111.309 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 17.0 ptm180 -64.09 -26.6 68.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 116.564 -0.289 . . . . 71.41 111.645 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 51.9 mt-10 -84.72 -41.75 15.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.982 0.42 . . . . 72.11 111.181 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.09 69.42 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.271 0.841 . . . . 74.1 113.271 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.484 ' HB2' ' HD3' ' A' ' 60' ' ' PRO . 6.6 mmt -56.07 -53.56 62.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.205 -0.426 . . . . 71.32 111.711 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 34.5 Cg_exo -55.87 -31.89 82.98 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.348 2.032 . . . . 74.35 112.129 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 43.0 mtmt -73.04 -31.02 64.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.626 -0.43 . . . . 54.55 111.589 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 66' ' ' VAL . 35.4 mm -74.34 -43.4 49.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.409 -0.96 . . . . 74.22 108.409 171.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 59' ' ' MET . 19.3 mmt -56.26 -37.73 70.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.854 0.686 . . . . 74.01 112.854 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.4 -47.62 72.69 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.439 -0.504 . . . . 72.1 110.74 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.88 -58.03 6.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.134 -0.485 . . . . 74.52 111.767 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -68.88 -17.38 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 64.34 110.897 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.62 -19.78 65.3 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.88 -0.6 . . . . 32.34 112.82 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.72 -22.28 0.4 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.096 -1.526 . . . . 51.04 113.968 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -79.37 58.02 2.5 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.439 1.114 . . . . 73.01 111.338 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -99.88 160.28 14.43 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.325 -1.361 . . . . 74.35 107.325 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -69.2 -33.57 73.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.597 0.635 . . . . 70.21 110.278 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -80.41 -9.58 59.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.746 . . . . 73.52 110.327 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.78 62.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.642 -0.708 . . . . 60.31 112.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 m -82.97 159.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 108.11 -1.07 . . . . 73.31 108.11 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -170.89 12.28 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 119.082 -1.532 . . . . 62.45 113.733 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.0 mtp 70.69 101.96 0.06 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.379 1.472 . . . . 72.24 110.466 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 66' ' ' VAL . . . -54.44 122.1 22.97 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.817 -1.083 . . . . 33.44 114.385 -174.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -96.31 126.89 41.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.645 -0.872 . . . . 72.31 108.645 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 m -123.77 123.94 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.435 0.636 . . . . 72.34 111.838 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.14 176.72 2.28 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 104.202 -2.518 . . . . 70.01 104.202 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -62.53 139.08 74.15 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 CA-C-N 121.494 1.569 . . . . 33.52 112.293 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 8.8 p -110.47 148.88 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.806 -1.183 . . . . 54.22 107.806 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 47.0 p -125.72 145.36 50.22 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 121.164 -0.214 . . . . 62.52 110.658 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -139.75 148.12 41.82 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.617 -0.433 . . . . 71.41 110.621 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.09 135.36 34.04 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.634 0.584 . . . . 73.12 110.019 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.27 151.07 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.001 -1.0 . . . . 73.23 109.577 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 76.4 m-85 -118.12 110.45 39.69 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 110.253 -0.277 . . . . 75.43 110.253 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.78 137.03 9.78 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 121.5 1.467 . . . . 64.33 110.989 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -82.77 179.31 7.82 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.745 -0.835 . . . . 75.25 108.745 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.2 -36.32 77.4 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.763 0.792 . . . . 72.44 109.807 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.31 -5.42 52.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.284 -1.325 . . . . 71.41 112.777 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.55 -4.03 83.74 Favored Glycine 0 CA--C 1.501 -0.829 0 C-N-CA 120.378 -0.915 . . . . 75.33 112.718 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.1 p -74.64 146.92 42.02 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.001 -0.741 . . . . 72.41 109.001 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.64 132.6 35.18 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.149 0.499 . . . . 73.52 110.879 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -87.35 150.95 23.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 75.44 109.923 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -74.63 77.37 2.01 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.934 1.087 . . . . 70.25 113.934 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.68 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -165.49 122.89 1.5 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 104.21 -2.515 . . . . 73.22 104.21 173.116 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.68 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 5.7 tt -143.88 145.26 32.18 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 121.078 -0.249 . . . . 70.12 110.571 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -142.1 130.24 22.09 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.404 -0.518 . . . . 73.24 110.726 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.8 t -91.85 139.28 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.228 -0.896 . . . . 52.1 109.944 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.265 -1.383 . . . . 75.15 107.265 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HA ' HG23 ' A' ' 82' ' ' VAL . 88.5 t80 -102.2 114.31 28.36 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.495 -0.928 . . . . 73.21 108.495 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -75.54 113.14 12.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.105 -1.443 . . . . 71.32 107.105 -175.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -78.3 135.26 61.77 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 112.276 0.473 . . . . 61.14 112.276 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.23 157.83 13.3 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.416 2.744 . . . . 73.2 112.127 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -54.59 -45.94 73.69 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.155 1.168 . . . . 62.52 114.155 -171.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -59.85 -37.92 80.66 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.214 0.531 . . . . 71.3 111.785 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.44 -3.15 57.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.696 0.628 . . . . 71.44 112.696 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.541 HE22 ' HE1' ' A' ' 41' ' ' PHE . 20.4 mm-40 -71.51 -33.73 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.184 -1.006 . . . . 75.53 109.91 172.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 -34.75 55.78 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.024 -0.535 . . . . 61.31 112.187 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.6 t -142.72 89.09 8.27 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 108.283 -1.006 . . . . 50.35 108.283 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 73.5 Cg_endo -87.18 141.18 5.87 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.914 1.743 . . . . 73.13 110.977 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 12.5 Cg_exo -71.25 154.67 61.5 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 121.705 1.603 . . . . 64.53 110.448 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.38 143.12 55.24 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.376 -0.972 . . . . 72.12 108.376 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.82 110.71 2.84 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.045 1.83 . . . . 71.12 111.643 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.2 t -72.76 -22.17 60.9 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.575 -0.738 . . . . 44.1 110.548 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.58 144.23 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.635 -0.876 . . . . 65.43 108.635 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.92 -33.14 74.12 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.224 0.824 . . . . 71.15 113.224 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.1 p -90.36 -12.13 38.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.991 0.424 . . . . 72.21 111.944 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.31 123.21 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.454 -2.054 . . . . 74.44 105.454 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -128.39 138.28 52.27 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.249 -0.58 . . . . 75.23 110.57 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 25.3 mm -92.01 109.49 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.541 -1.652 . . . . 62.22 106.541 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -129.87 153.14 48.59 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.395 -0.821 . . . . 63.05 109.176 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.27 137.58 54.8 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 109.501 -0.555 . . . . 73.1 109.501 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.94 127.48 28.77 Favored 'General case' 0 N--CA 1.426 -1.659 0 C-N-CA 120.555 -0.458 . . . . 61.34 111.413 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.17 175.57 9.44 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.398 -0.964 . . . . 73.12 108.398 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.71 46.11 Favored Glycine 0 C--N 1.306 -1.083 0 C-N-CA 120.836 -0.697 . . . . 72.1 111.758 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.632 HG13 ' SG ' ' A' ' 36' ' ' CYS . 36.2 pt -132.99 146.51 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.088 0.47 . . . . 75.34 110.801 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.2 m -104.06 135.16 46.08 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.98 -1.489 . . . . 61.31 106.98 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 m -123.66 145.97 29.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.355 -0.609 . . . . 71.52 109.355 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -113.48 122.53 47.57 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 105.923 -1.88 . . . . 61.53 105.923 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.7 m -110.1 146.59 35.16 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 115.867 -0.606 . . . . 73.11 110.916 -173.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.499 HG22 ' HB ' ' A' ' 185' ' ' VAL . 9.9 t -133.62 124.89 27.61 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.327 -0.619 . . . . 71.34 109.327 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -111.23 126.36 54.79 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 121.424 0.63 . . . . 74.15 109.505 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 37.3 p90 -137.24 167.43 21.59 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.974 -1.012 . . . . 72.02 109.314 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -120.62 123.21 5.5 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.09 -1.204 . . . . 22.31 110.09 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 167.03 170.84 32.43 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 111.345 -0.702 . . . . 62.3 111.345 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 177' ' ' LYS . 77.8 m-85 -93.11 100.26 12.69 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.664 -0.865 . . . . 63.21 108.664 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.69 132.2 43.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.32 0.859 . . . . 55.33 113.32 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.06 177.15 5.03 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.27 -36.49 73.34 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.729 0.3 . . . . 65.25 111.262 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.23 81.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.353 -0.385 . . . . 63.53 110.297 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.9 -42.51 99.8 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.773 -0.454 . . . . 61.54 109.773 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.759 ' HA ' ' NE2' ' A' ' 147' ' ' HIS . 63.9 m-85 -56.95 -43.96 82.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 123.365 0.416 . . . . 73.44 112.108 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.11 -49.29 77.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 123.753 0.658 . . . . 64.13 110.305 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.62 -48.27 77.85 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.778 -0.646 . . . . 74.32 112.062 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.759 ' NE2' ' HA ' ' A' ' 144' ' ' TYR . 3.2 p-80 -72.46 -32.0 65.89 Favored 'General case' 0 C--O 1.205 -1.271 0 N-CA-C 113.067 0.765 . . . . 60.3 113.067 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.31 80.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.147 0.498 . . . . 64.44 110.651 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.4 t -76.53 -32.02 57.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 120.127 -0.629 . . . . 71.21 109.758 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.96 -34.3 78.11 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 116.379 -0.373 . . . . 75.4 110.298 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 31' ' ' TYR . 57.9 tp -62.61 -41.78 99.2 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.531 -0.544 . . . . 74.23 109.531 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -62.25 -36.99 83.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.447 0.642 . . . . 65.32 110.165 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 41.1 m -72.6 -30.18 64.14 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 115.153 -0.93 . . . . 53.21 110.105 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.7 m -75.12 -33.35 61.57 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.473 0.709 . . . . 72.02 109.834 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.9 mt -72.8 13.25 0.4 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.295 1.438 . . . . 75.23 111.76 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 153' ' ' THR . 44.6 tt0 -51.11 124.24 11.08 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.481 1.112 . . . . 73.31 110.357 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.54 60.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.736 -0.745 . . . . 62.31 113.724 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 81.0 p -93.23 154.41 41.51 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 117.565 0.682 . . . . 65.14 109.742 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.86 25.7 0.69 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.676 2.251 . . . . 64.33 110.897 175.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.03 138.81 39.81 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.835 -0.62 . . . . 71.32 110.753 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.5 p -110.8 149.84 29.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.356 -0.609 . . . . 71.05 109.356 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -143.75 161.51 38.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.88 -0.785 . . . . 72.43 108.88 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.414 ' O ' HG12 ' A' ' 166' ' ' VAL . 27.8 pt20 -131.65 109.65 10.36 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.235 -0.586 . . . . 75.52 111.825 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.57 62.69 Favored Glycine 0 C--N 1.315 -0.628 0 C-N-CA 120.617 -0.802 . . . . 54.25 114.141 171.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 61.04 23.15 13.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.032 0.533 . . . . 65.11 111.185 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 163' ' ' GLN . 9.8 p -63.59 138.16 23.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 N-CA-C 109.274 -0.639 . . . . 42.43 109.274 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.405 ' HB3' HD23 ' A' ' 187' ' ' LEU . 40.6 p90 -147.2 174.61 11.45 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 121.447 0.641 . . . . 74.31 111.192 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -116.98 150.32 38.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.714 -1.13 . . . . 74.52 109.17 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 83' ' ' SER . 34.7 t -113.29 120.32 40.74 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.291 -1.003 . . . . 73.13 108.291 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 82' ' ' VAL . . . -120.62 131.79 54.8 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.446 0.466 . . . . 74.2 111.604 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.49 164.91 38.18 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.098 -2.001 . . . . 74.22 108.098 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -64.73 -42.7 95.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.737 1.268 . . . . 72.12 109.377 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -155.31 150.4 20.8 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 106.703 -1.591 . . . . 75.3 106.703 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -48.0 117.24 2.36 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.293 2.662 . . . . 71.41 112.372 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.97 129.81 19.13 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.101 1.868 . . . . 72.52 112.775 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.6 ttt -93.7 -42.31 9.23 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.789 -1.56 . . . . 62.24 106.789 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -172.51 -66.12 0.0 OUTLIER Pre-proline 0 C--O 1.208 -1.122 0 CA-C-N 114.85 -1.068 . . . . 70.31 110.284 173.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 177' ' ' LYS . 82.8 Cg_endo -76.01 -30.16 6.03 Favored 'Trans proline' 0 C--N 1.375 1.964 0 CA-C-N 120.523 1.223 . . . . 70.45 115.002 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -101.54 109.07 20.81 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.389 -0.524 . . . . 73.45 111.05 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 120.22 51.35 0.27 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.909 -0.876 . . . . 51.14 110.909 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.49 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 2.6 tmm_? -75.34 -31.05 60.44 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 109.238 -0.653 . . . . 72.34 109.238 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -113.13 131.21 55.93 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.508 -0.477 . . . . 73.31 110.247 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -131.62 161.74 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.831 -0.803 . . . . 74.24 108.831 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 133' ' ' THR . 43.4 tt0 -125.27 139.23 53.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.38 -1.341 . . . . 72.54 107.38 174.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.719 HG21 ' CD2' ' A' ' 147' ' ' HIS . 59.4 t -126.7 131.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.906 -0.775 . . . . 71.52 108.906 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 36.3 m0 -111.08 123.19 49.7 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 123.322 0.389 . . . . 74.03 110.444 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 167' ' ' TYR . 91.0 mt -96.5 128.08 43.1 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.413 -1.699 . . . . 44.55 106.413 169.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.016 -0.674 . . . . 74.41 111.75 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 161' ' ' THR . 52.2 tttp -63.69 127.63 32.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.563 -1.198 . . . . 71.33 111.753 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 108.825 -0.806 . . . . 64.11 108.825 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 108.579 -0.896 . . . . 71.41 108.579 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.9 p -149.73 170.72 18.07 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 116.522 -0.308 . . . . 65.41 111.616 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 63.33 67.34 0.66 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.805 1.242 . . . . 74.14 112.821 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -140.03 138.39 35.39 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.884 -1.154 . . . . 74.05 107.884 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.62 20.2 58.69 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 109.921 -1.272 . . . . 60.44 109.921 -175.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 m -73.26 104.93 4.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.418 -0.956 . . . . 72.11 108.418 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.75 125.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 CA-C-N 115.912 -0.585 . . . . 73.22 109.425 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -134.6 148.81 50.5 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.727 -0.67 . . . . 53.13 109.198 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HA ' HD21 ' A' ' 106' ' ' ASN . 6.3 t -104.34 86.39 2.52 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-O 122.022 0.915 . . . . 74.21 109.515 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.521 ' CZ2' ' HB3' ' A' ' 109' ' ' GLN . 35.0 p90 -79.46 126.12 81.61 Favored Pre-proline 0 N--CA 1.425 -1.708 0 CA-C-N 115.044 -0.98 . . . . 74.44 109.958 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.79 148.62 22.65 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.713 2.276 . . . . 51.34 114.595 -173.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 43.8 p90 -102.29 148.94 24.84 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 104.872 -2.269 . . . . 54.2 104.872 171.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 6.2 tp-100 -106.05 109.03 20.84 Favored 'General case' 0 C--N 1.279 -2.488 0 C-N-CA 118.052 -1.459 . . . . 63.53 111.177 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.485 HG22 ' HG2' ' A' ' 34' ' ' ARG . 48.1 t -91.28 115.54 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 103.299 -2.852 . . . . 75.04 103.299 169.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.98 -23.77 22.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.925 -1.51 . . . . 54.4 111.339 -171.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -174.83 168.0 3.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.427 -0.583 . . . . 63.02 109.427 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 32' ' ' GLU . 72.8 p -133.74 145.7 50.08 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.089 -1.078 . . . . 63.33 108.089 170.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.2 -139.43 6.11 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 118.997 -1.573 . . . . 45.32 113.648 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.0 -112.57 4.47 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.947 -0.861 . . . . 44.31 110.947 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HG3' HG23 ' A' ' 154' ' ' THR . 8.6 mtpm? -113.52 170.32 8.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.03 -0.359 . . . . 72.2 110.03 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -83.97 157.53 21.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.027 -1.101 . . . . 55.21 108.027 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 75.88 -61.8 0.45 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.459 1.104 . . . . 70.31 110.444 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.77 110.14 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.153 -1.795 . . . . 40.44 106.153 171.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.0 p -122.57 155.05 37.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.544 -0.753 . . . . 63.23 109.065 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -114.98 153.21 31.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 113.155 0.798 . . . . 73.04 113.155 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.589 ' OE2' ' HD2' ' A' ' 34' ' ' ARG . 35.9 tt0 -135.35 123.35 22.74 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.216 -2.142 . . . . 61.3 105.216 173.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -109.95 125.2 52.6 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.105 0.955 . . . . 74.24 111.026 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.589 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 16.4 mtp180 -127.5 140.48 52.11 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.347 -1.297 . . . . 62.31 110.414 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.11 40.5 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.515 -1.291 . . . . 75.45 107.515 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.2 m -58.94 146.05 39.27 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.794 0.683 . . . . 61.12 111.604 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -87.41 -19.43 28.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.371 -0.377 . . . . 64.23 110.054 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 98.69 11.63 46.62 Favored Glycine 0 CA--C 1.489 -1.586 0 C-N-CA 119.423 -1.37 . . . . 55.41 111.824 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 160.0 53.61 Favored Glycine 0 N--CA 1.426 -2.006 0 C-N-CA 120.522 -0.847 . . . . 71.42 112.133 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.569 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.3 ptmt -95.9 128.93 43.21 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 109.748 -0.464 . . . . 64.34 109.748 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.8 m-85 -127.17 163.81 23.03 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.977 -0.556 . . . . 75.24 110.985 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.17 116.73 32.05 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.075 -1.083 . . . . 52.33 108.075 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.9 t -127.29 147.77 50.23 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 120.329 -0.548 . . . . 74.21 112.015 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 119' ' ' SER . 95.8 t -128.18 126.63 66.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.841 -1.072 . . . . 73.12 108.446 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 43.5 tt0 -113.16 123.94 51.39 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.018 0.437 . . . . 71.43 111.088 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 34.5 t -121.4 127.54 75.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.835 -1.543 . . . . 74.04 106.835 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 72.7 p -116.09 166.19 12.29 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.551 -0.46 . . . . 61.31 110.566 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 73.3 -27.49 0.19 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.897 0.879 . . . . 72.12 113.007 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 47' ' ' THR . 63.8 mmtt -89.84 146.85 36.16 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 115.946 -0.57 . . . . 70.4 110.54 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.23 156.65 61.92 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.435 2.09 . . . . 52.0 109.926 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 98' ' ' LEU . 54.4 t -47.87 -45.71 11.79 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 113.383 0.883 . . . . 71.11 113.383 -177.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.75 -46.55 87.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.175 0.435 . . . . 73.13 112.175 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . 33.8 tt0 -74.32 -43.69 55.65 Favored 'General case' 0 N--CA 1.397 -3.118 0 CA-C-N 116.278 -0.419 . . . . 64.33 111.728 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.79 -37.76 88.56 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 120.893 0.377 . . . . 52.33 110.675 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.84 -37.97 73.17 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.398 -0.365 . . . . 73.24 111.181 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 53' ' ' GLU 0.272 6.7 ppt_? -65.27 -23.54 67.07 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 112.283 0.475 . . . . 72.42 112.283 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.4 mm-40 -81.99 -52.34 7.15 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.44 -0.8 . . . . 72.44 112.778 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.21 -40.53 64.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 114.643 1.349 . . . . 52.24 114.643 -172.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 35.5 ttm -57.74 -49.31 94.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 114.957 1.466 . . . . 55.22 114.957 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 59' ' ' MET . 13.0 Cg_endo -57.17 -31.86 91.75 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.909 1.74 . . . . 74.41 111.639 175.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 93.3 mttt -67.59 -36.08 80.2 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.315 0.578 . . . . 73.34 110.096 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.58 -43.94 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 72.33 109.884 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.67 -43.51 98.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.845 0.683 . . . . 73.1 112.845 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -64.16 -37.68 88.35 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.059 0.457 . . . . 71.04 110.507 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 115' ' ' PRO . 38.6 t80 -66.28 -59.93 3.26 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.711 -0.677 . . . . 74.02 110.443 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.93 -26.15 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-O 121.17 0.51 . . . . 75.3 111.397 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -27.91 73.34 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 116.021 -0.536 . . . . 72.33 112.731 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.4 -11.87 0.22 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.33 -1.414 . . . . 71.45 114.321 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 116' ' ' SER . 23.5 m -82.23 49.53 1.43 Allowed 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 121.934 0.873 . . . . 75.12 110.268 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 113' ' ' PRO . 35.1 m-80 -98.61 149.54 22.67 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.567 -1.642 . . . . 61.41 106.567 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.47 -32.1 71.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.092 0.472 . . . . 73.43 112.044 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -78.05 -7.47 56.96 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.042 0.449 . . . . 74.01 111.016 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.0 18.27 80.22 Favored Glycine 0 CA--C 1.509 -0.291 0 C-N-CA 121.164 -0.541 . . . . 64.33 112.118 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.94 165.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.245 -1.02 . . . . 53.02 108.245 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.95 -120.15 0.95 Allowed Glycine 0 N--CA 1.41 -3.084 0 C-N-CA 119.484 -1.341 . . . . 51.51 112.227 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 69.9 mtm 68.4 9.69 7.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.201 1.0 . . . . 54.12 111.165 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.73 92.26 1.1 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.807 -0.633 . . . . 72.44 113.961 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -95.79 125.48 40.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.602 -1.999 . . . . 73.42 105.602 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.1 p -117.1 116.96 28.34 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 115.605 1.706 . . . . 44.35 115.605 -166.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.58 155.35 45.37 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 105.206 -2.146 . . . . 72.33 105.206 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.85 140.5 85.31 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.225 1.95 . . . . 62.43 114.151 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -106.35 151.36 8.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.957 -1.497 . . . . 70.41 106.957 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.3 t -141.79 147.48 37.36 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.902 -0.777 . . . . 74.55 108.902 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.83 144.35 48.91 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 122.337 -0.227 . . . . 75.12 110.506 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 136.23 33.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.722 -0.672 . . . . 71.44 109.519 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.89 150.62 25.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.011 -1.107 . . . . 63.44 108.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.627 ' CD2' ' HE2' ' A' ' 97' ' ' LYS . 1.7 m-85 -119.84 103.54 45.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 108.746 -0.835 . . . . 75.3 108.746 -175.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 151.37 37.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.145 1.897 . . . . 75.42 114.545 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.715 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 92.2 m-20 -102.89 156.09 17.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.466 -1.243 . . . . 64.13 108.171 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.05 -17.2 62.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.597 0.713 . . . . 73.52 109.747 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.96 -5.47 46.38 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.917 -1.038 . . . . 72.21 110.8 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.96 0.71 87.25 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 121.104 -0.569 . . . . 61.31 111.988 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.5 p -92.59 152.1 19.78 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 109.228 -0.656 . . . . 71.12 109.228 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.71 85.63 2.16 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.04 0.447 . . . . 74.04 110.765 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.61 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 34.3 tt0 -148.87 113.75 5.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.174 -0.466 . . . . 61.44 111.277 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.715 ' HE3' ' OD1' ' A' ' 89' ' ' ASN . 91.3 mttt -173.14 -75.44 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.883 1.673 . . . . 64.31 107.752 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.627 ' HE2' ' CD2' ' A' ' 87' ' ' PHE . 4.0 mppt? -143.05 156.57 44.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.997 -1.001 . . . . 74.44 108.942 177.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 51' ' ' VAL . 6.3 tt -143.84 134.84 25.44 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.8 -1.185 . . . . 54.14 107.8 172.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.47 ' HD3' ' HB2' ' A' ' 45' ' ' GLU . 33.9 ttpt -140.83 116.54 10.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 120.601 -0.44 . . . . 72.1 110.943 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 43' ' ' THR . 53.7 t -87.18 132.58 32.2 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 115.679 -0.691 . . . . 71.14 109.731 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -115.8 122.06 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.453 0.701 . . . . 74.31 109.27 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 85.9 t80 -103.21 123.22 46.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.334 0.587 . . . . 72.43 110.087 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -75.12 113.42 12.44 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.375 -1.284 . . . . 72.33 110.12 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.5 mt -89.26 125.03 63.25 Favored Pre-proline 0 N--CA 1.42 -1.958 0 N-CA-C 107.254 -1.387 . . . . 65.41 107.254 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.26 148.24 42.04 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.705 2.27 . . . . 61.13 111.335 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 15' ' ' THR . 0.2 OUTLIER -57.23 -36.22 70.64 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.078 0.399 . . . . 63.4 112.078 -173.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -62.93 -28.46 70.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.449 0.642 . . . . 74.24 111.364 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.14 -12.28 38.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 116.119 -0.492 . . . . 64.44 110.668 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.521 ' HB3' ' CZ2' ' A' ' 16' ' ' TRP . 11.9 mm-40 -68.11 -29.42 68.33 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.591 0.589 . . . . 72.33 112.591 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.45 -39.19 97.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.15 -1.024 . . . . 62.41 111.403 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 m -153.46 87.73 3.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.36 -0.978 . . . . 54.52 108.36 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.67 151.21 11.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.278 1.985 . . . . 65.1 110.532 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -65.07 157.05 59.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.876 1.717 . . . . 73.3 110.805 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.49 147.22 71.44 Favored Pre-proline 0 N--CA 1.423 -1.808 0 N-CA-C 108.918 -0.771 . . . . 72.12 108.918 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 58.6 Cg_endo -73.18 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 121.917 1.744 . . . . 71.31 111.091 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 69' ' ' THR . 47.9 t -77.77 -28.68 50.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.34 -0.845 . . . . 75.2 111.655 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.29 152.1 25.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.281 -0.568 . . . . 65.32 110.401 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.11 -32.97 74.46 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.931 0.715 . . . . 63.32 112.931 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.56 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 20.1 m -93.44 -8.64 41.07 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.293 -0.563 . . . . 73.4 111.483 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 61.3 t -97.7 118.64 44.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.476 -1.305 . . . . 73.21 107.476 -176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -128.97 140.28 51.72 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.078 -0.712 . . . . 71.13 109.078 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.2 mm -92.08 112.0 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.271 -1.011 . . . . 72.31 108.271 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -123.44 148.41 46.18 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.553 -0.749 . . . . 72.51 109.963 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 1.7 mp0 -98.17 139.38 34.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.809 -1.182 . . . . 73.22 107.809 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -126.7 121.16 31.29 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.256 -0.978 . . . . 75.45 110.696 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.529 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -144.9 176.83 9.18 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.199 -0.909 . . . . 74.32 111.031 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.8 64.61 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.962 -0.637 . . . . 24.55 114.661 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.41 160.41 22.71 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 C-N-CA 119.386 -0.926 . . . . 70.03 112.065 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.2 m -112.88 142.97 44.93 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.027 -1.442 . . . . 73.33 107.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.78 145.39 29.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.525 -0.546 . . . . 64.02 109.525 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 56.3 m-85 -113.72 122.4 47.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.893 -2.262 . . . . 75.11 104.893 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 42.8 p -123.0 139.24 54.29 Favored 'General case' 0 C--N 1.263 -3.163 0 C-N-CA 120.092 -0.643 . . . . 62.53 110.983 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -113.21 127.41 56.17 Favored 'General case' 0 N--CA 1.402 -2.835 0 N-CA-C 108.138 -1.06 . . . . 65.21 108.138 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -110.43 125.32 53.13 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.734 -1.21 . . . . 73.31 107.734 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -147.0 153.72 40.39 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.167 0.508 . . . . 72.14 112.36 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.02 156.26 19.2 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.446 -0.797 . . . . 74.22 111.482 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.78 141.43 12.16 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.303 -1.119 . . . . 53.44 110.303 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -70.77 122.92 20.76 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.392 0.615 . . . . 73.44 111.198 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -110.95 133.5 53.33 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.589 -0.732 . . . . 51.12 109.629 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.622 ' HA ' ' CE2' ' A' ' 179' ' ' TYR . 39.0 ttpt -80.95 170.21 16.55 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.718 -0.845 . . . . 62.33 108.718 -177.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -53.29 -38.68 63.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.99 0.424 . . . . 52.4 111.185 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.06 77.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.589 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.418 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 11.8 m-20 -66.8 -31.66 72.42 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 116.24 -0.436 . . . . 62.15 110.617 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -62.78 -40.95 98.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.784 -0.367 . . . . 72.54 110.522 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.57 -44.24 90.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.903 -0.59 . . . . 52.22 109.574 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -63.8 -47.22 81.76 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.572 -0.74 . . . . 73.31 111.275 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -66.02 -33.18 75.21 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.009 0.374 . . . . 72.54 112.009 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.7 94.49 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.299 -0.63 . . . . 61.12 109.299 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.2 m -64.24 -44.5 91.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.458 -0.792 . . . . 65.21 110.458 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 98.7 mt-30 -59.3 -49.22 78.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.818 0.447 . . . . 74.22 110.561 177.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 31' ' ' TYR . 48.1 tp -58.02 -46.19 85.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.857 -0.61 . . . . 52.11 110.61 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -64.35 -34.54 78.38 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.857 -0.611 . . . . 73.45 110.216 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.5 m -73.18 -33.17 65.27 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.331 0.586 . . . . 73.04 109.837 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 26' ' ' LYS . 42.0 m -72.38 -33.72 67.42 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.239 0.542 . . . . 74.02 109.779 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 158' ' ' THR . 87.8 mt -74.66 4.99 5.32 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.061 0.944 . . . . 73.02 113.197 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.1 142.5 43.64 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.654 -0.818 . . . . 74.34 111.1 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.23 62.18 Favored Glycine 0 C--N 1.297 -1.606 0 CA-C-N 115.456 -0.793 . . . . 63.34 111.15 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 155' ' ' LEU . 11.5 t -116.55 147.34 39.52 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 108.228 -1.027 . . . . 73.13 108.228 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -70.94 36.11 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.981 3.12 . . . . 62.22 113.666 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.13 136.63 42.92 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.847 0.356 . . . . 63.33 111.02 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 69.3 p -111.82 162.91 14.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.341 -0.985 . . . . 71.44 108.341 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.8 m-85 -137.66 150.6 47.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.616 -0.883 . . . . 65.43 108.616 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -127.43 126.82 43.08 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.854 -0.738 . . . . 74.32 112.574 -177.218 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.84 -1.19 17.29 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.287 -0.869 . . . . 73.51 113.441 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 63.11 12.17 5.8 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 64.35 110.588 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.5 160.37 4.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.272 -0.876 . . . . 62.03 111.88 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.87 170.89 17.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.42 -0.809 . . . . 71.22 110.015 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 18.1 m-85 -115.58 153.31 31.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.252 0.548 . . . . 72.52 111.848 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 41.7 t -115.12 144.82 43.08 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.241 -1.763 . . . . 72.21 106.241 172.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.24 160.56 16.87 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 121.131 -0.228 . . . . 60.33 110.644 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.57 165.32 37.34 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.3 -1.12 . . . . 52.04 110.3 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -141.22 -53.23 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 112.847 0.684 . . . . 74.1 112.847 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -156.21 158.32 31.51 Favored Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 106.632 -1.618 . . . . 75.22 106.632 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.89 106.74 0.19 Allowed 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.18 1.92 . . . . 61.42 108.924 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -82.29 149.22 15.04 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 C-N-CA 122.309 2.006 . . . . 72.14 114.255 -169.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 65.0 mtt -64.27 -39.73 94.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.357 -0.838 . . . . 72.14 109.681 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.47 ' HA ' ' HE3' ' A' ' 177' ' ' LYS . 1.6 tpmt? -87.63 139.81 31.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 104.165 -2.531 . . . . 72.32 104.165 173.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.451 ' HD2' ' HE2' ' A' ' 177' ' ' LYS . 80.3 Cg_exo -38.11 -33.39 0.27 Allowed 'Trans proline' 0 N--CA 1.506 2.265 0 C-N-CA 124.393 3.395 . . . . 65.33 116.381 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.622 ' CE2' ' HA ' ' A' ' 140' ' ' LYS . 97.1 m-85 -134.61 9.96 3.68 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.987 0.422 . . . . 64.01 111.603 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.96 -174.17 37.11 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.407 -0.902 . . . . 74.3 112.032 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -97.09 -14.68 21.4 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.923 0.392 . . . . 64.05 111.676 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.2 134.39 29.43 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 116.325 -0.398 . . . . 73.51 111.155 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.28 143.4 46.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.85 0.46 . . . . 74.34 111.025 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -122.08 148.0 45.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.49 -0.323 . . . . 75.22 110.912 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 132' ' ' SER . 57.3 t -128.18 128.93 69.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.614 -1.254 . . . . 64.3 107.614 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 7.0 m0 -114.98 124.83 52.66 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 110.354 -0.239 . . . . 62.31 110.354 -178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.12 138.97 35.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.94 -1.133 . . . . 63.22 107.94 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 38.5 t -100.17 127.74 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 120.696 -0.401 . . . . 72.31 111.547 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.1 tmtt? -78.14 123.76 27.27 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.426 -0.806 . . . . 73.14 109.691 176.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.26 1.651 0 O-C-N 124.268 0.98 . . . . 64.31 110.183 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 CA--C 1.504 -0.803 0 N-CA-C 108.989 -0.745 . . . . 74.32 108.989 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t -95.54 102.99 14.84 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.76 -1.2 . . . . 74.01 107.76 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.337 1.1 pp -73.68 72.61 1.48 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 122.779 1.276 . . . . 71.33 114.203 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -83.85 145.66 28.51 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 114.695 -1.139 . . . . 73.23 108.356 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.58 -34.72 2.82 Favored Glycine 0 CA--C 1.479 -2.171 0 N-CA-C 110.045 -1.222 . . . . 72.31 110.045 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -79.48 86.89 5.12 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.52 -0.918 . . . . 65.32 108.52 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.57 169.1 6.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 109.129 -0.693 . . . . 44.24 109.129 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HA ' ' N ' ' A' ' 110' ' ' GLY . 1.1 mp0 -62.27 -40.58 96.7 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 123.581 0.55 . . . . 70.42 111.202 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.8 m -100.04 88.62 3.79 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 114.908 1.447 . . . . 75.21 114.908 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -103.6 105.11 45.81 Favored Pre-proline 0 N--CA 1.422 -1.854 0 N-CA-C 106.266 -1.753 . . . . 73.12 106.266 162.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.68 145.17 22.83 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.061 1.841 . . . . 74.12 115.053 -170.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -103.8 146.28 28.87 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.331 -1.729 . . . . 75.03 106.331 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -119.32 120.22 36.29 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 119.148 -1.021 . . . . 75.25 112.073 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 34' ' ' ARG . 44.5 t -78.16 114.52 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 102.803 -3.036 . . . . 74.32 102.803 168.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.62 -30.13 17.36 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.288 -1.365 . . . . 65.42 112.874 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -158.67 163.07 37.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.922 -0.77 . . . . 72.34 108.922 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 32' ' ' GLU . 44.8 p -132.66 162.59 30.98 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.461 -0.57 . . . . 65.44 109.461 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.24 -145.4 10.15 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.775 -0.726 . . . . 73.34 111.831 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -156.7 16.71 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.917 -0.658 . . . . 44.44 111.905 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.01 171.87 7.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.398 0.679 . . . . 74.44 111.642 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.68 143.59 48.04 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.68 -1.6 . . . . 75.3 106.68 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 80.23 -50.58 0.35 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.305 1.042 . . . . 74.14 111.314 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.0 t -116.09 109.14 27.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.287 -0.634 . . . . 53.11 109.287 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -116.91 154.91 29.99 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.454 -0.794 . . . . 73.55 109.629 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 162.48 31.97 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.76 0.314 . . . . 75.03 111.821 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HB3' HG22 ' A' ' 23' ' ' THR . 12.6 pt-20 -154.89 139.74 17.2 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.699 -1.593 . . . . 75.31 106.699 174.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB3' ' CD2' ' A' ' 131' ' ' TYR 0.283 0.2 OUTLIER -103.53 125.6 50.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.208 -0.997 . . . . 63.45 111.93 177.251 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.446 ' HG2' HG22 ' A' ' 20' ' ' VAL . 70.7 mtt180 -115.03 127.15 55.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.616 -1.174 . . . . 75.14 109.481 -176.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.64 132.49 34.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.895 -1.52 . . . . 74.45 106.895 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.442 ' SG ' HG13 ' A' ' 128' ' ' ILE . 74.6 m -74.71 157.79 34.68 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 120.129 -0.628 . . . . 75.21 111.622 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -84.7 -25.02 28.66 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.602 -0.726 . . . . 74.31 111.522 -174.556 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 95.13 11.02 56.81 Favored Glycine 0 CA--C 1.497 -1.072 0 C-N-CA 119.49 -1.338 . . . . 30.45 111.474 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.488 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.55 165.74 51.88 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 114.114 0.406 . . . . 71.42 114.114 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -101.02 122.59 43.8 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.818 -0.691 . . . . 71.13 109.378 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 44.7 m-85 -125.57 165.65 18.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.293 -0.867 . . . . 73.54 111.894 -170.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.49 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.22 116.7 30.99 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 108.78 -0.822 . . . . 73.12 108.78 -177.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 10.1 t -124.77 143.91 50.54 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-O 121.349 0.595 . . . . 72.25 111.352 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.3 m -128.4 139.98 50.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.054 -0.975 . . . . 74.12 108.791 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.13 136.83 51.7 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.077 -0.649 . . . . 72.14 112.074 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.529 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 29.6 t -131.06 142.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.058 -0.719 . . . . 72.14 109.058 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 p -135.26 178.15 7.26 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.531 0.332 . . . . 73.04 110.311 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.0 t70 73.6 -14.99 0.59 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.448 1.099 . . . . 61.43 113.159 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -131.21 147.26 65.53 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.313 -0.625 . . . . 70.24 109.313 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.28 156.29 5.71 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.652 2.902 . . . . 74.3 112.526 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 20.5 m -56.2 -36.33 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.518 0.562 . . . . 73.04 112.518 -174.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 10.4 m-20 -58.78 -49.82 76.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.164 0.507 . . . . 75.43 110.158 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.04 -36.32 79.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.318 -0.855 . . . . 75.24 110.191 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -60.38 -47.35 86.43 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.437 -0.801 . . . . 70.4 110.59 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 59' ' ' MET . 96.1 mt -55.87 -36.97 68.18 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 122.43 0.292 . . . . 73.24 111.479 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 1.7 mmp_? -59.37 -34.29 72.23 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.307 0.575 . . . . 71.44 110.456 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -83.98 -41.41 17.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.418 -0.81 . . . . 73.43 111.338 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.01 -33.09 67.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 114.393 1.257 . . . . 74.0 114.393 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 17.8 mmt -61.31 -57.2 27.22 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 120.317 -0.553 . . . . 74.1 111.713 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.95 -38.45 86.38 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.594 2.196 . . . . 70.23 113.008 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG3' HG11 ' A' ' 44' ' ' VAL . 16.4 ptpt -69.15 -28.8 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.019 0.748 . . . . 75.34 113.019 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.5 mm -76.55 -45.11 33.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.342 -0.614 . . . . 51.11 109.342 170.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.2 mtp -62.25 -33.49 74.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.452 -0.795 . . . . 62.43 112.941 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -70.25 -40.25 74.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.872 0.368 . . . . 71.13 110.172 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -59.03 -52.09 67.25 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.801 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.87 -13.09 14.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.062 -0.517 . . . . 43.22 111.523 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.37 -16.78 70.52 Favored Glycine 0 CA--C 1.506 -0.486 0 CA-C-N 115.94 -0.573 . . . . 72.52 112.436 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . 134.4 -11.04 4.68 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 119.746 -1.216 . . . . 40.44 112.828 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 m -80.3 30.11 0.29 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 122.888 1.327 . . . . 54.11 110.369 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 68' ' ' GLY . 7.3 p30 -97.81 171.36 8.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.978 -1.01 . . . . 74.42 109.032 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 26.5 t70 -67.97 -27.55 66.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 21.52 113.084 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.55 -13.2 55.0 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.446 -0.902 . . . . 72.14 109.595 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.31 22.49 74.67 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.608 -0.724 . . . . 54.44 111.308 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 m -81.97 122.17 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 121.246 0.546 . . . . 62.21 112.293 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.02 52.76 0.62 Allowed Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.11 -1.196 . . . . 72.12 110.11 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.7 mtt -82.91 -41.74 18.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.309 0.576 . . . . 73.14 110.519 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.04 129.03 3.39 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.306 -0.95 . . . . 73.13 111.593 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.474 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 23.6 ptp -132.78 126.03 31.45 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.806 -0.442 . . . . 73.21 109.806 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.4 p -124.83 115.79 21.23 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.023 0.749 . . . . 63.42 113.023 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 15.6 m -153.59 174.54 3.67 Favored Pre-proline 0 C--N 1.313 -1.003 0 C-N-CA 125.88 1.672 . . . . 75.32 106.498 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 78.2 Cg_exo -56.72 140.36 90.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.157 1.905 . . . . 73.53 114.057 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 48.6 t -105.75 143.04 17.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.395 -1.706 . . . . 74.21 106.395 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.4 m -132.35 151.4 51.87 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.996 0.362 . . . . 71.43 110.332 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' CD2' HD21 ' A' ' 98' ' ' LEU . 52.5 p90 -145.07 146.46 31.86 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 122.036 -0.415 . . . . 74.44 111.162 174.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.42 135.33 34.13 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 116.029 -0.532 . . . . 72.21 109.943 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG12 HG11 ' A' ' 51' ' ' VAL . 30.7 m -137.81 150.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.43 -0.952 . . . . 72.23 108.43 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 39.5 m-85 -119.88 108.24 39.11 Favored Pre-proline 0 C--N 1.281 -2.378 0 N-CA-C 107.466 -1.309 . . . . 73.01 107.466 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.01 147.8 8.01 Favored 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 121.243 1.295 . . . . 60.41 113.69 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.37 154.62 18.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.71 -1.959 . . . . 71.41 105.71 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.5 -13.15 62.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 114.247 1.202 . . . . 73.05 114.247 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.66 -4.09 58.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.502 0.668 . . . . 74.42 109.763 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 -11.07 59.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.733 -0.667 . . . . 21.22 113.466 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.2 m -78.53 139.38 38.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.251 -0.58 . . . . 53.13 110.112 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.69 150.9 23.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.645 -0.422 . . . . 65.42 110.083 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -79.77 150.1 30.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.736 -1.579 . . . . 74.35 106.736 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.0 38.92 0.54 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.712 0.805 . . . . 63.01 111.956 -171.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.529 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -127.8 122.55 33.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 104.207 -2.516 . . . . 62.21 104.207 176.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.529 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 3.1 tm? -131.36 145.49 51.86 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.009 0.433 . . . . 64.11 109.993 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' N ' HD13 ' A' ' 98' ' ' LEU . 87.9 tttt -148.19 116.13 6.41 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.248 -0.887 . . . . 63.04 110.724 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.519 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 93.7 t -95.1 126.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 122.94 0.496 . . . . 71.03 110.103 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.94 122.71 46.97 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 82.5 t80 -103.5 120.17 40.31 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.315 -0.994 . . . . 63.15 108.315 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -74.99 122.33 23.33 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.783 -0.644 . . . . 62.04 109.33 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.497 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 66.7 mt -91.75 125.92 55.65 Favored Pre-proline 0 N--CA 1.415 -2.201 0 N-CA-C 107.226 -1.398 . . . . 52.45 107.226 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 78' ' ' MET . 64.9 Cg_exo -52.86 155.59 10.7 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 123.289 2.659 . . . . 64.52 113.558 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -47.29 -44.36 23.2 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.475 1.51 . . . . 75.35 112.052 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.86 -30.02 68.69 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.015 -0.539 . . . . 71.11 112.435 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -99.95 -2.69 34.0 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.719 -0.219 . . . . 74.02 111.584 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.475 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 25.3 mm-40 -70.49 -34.99 72.98 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.21 0.818 . . . . 71.52 113.21 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.47 ' N ' ' HA ' ' A' ' 14' ' ' GLU . . . -59.49 -38.28 93.33 Favored Glycine 0 N--CA 1.466 0.64 0 C-N-CA 120.953 -0.642 . . . . 52.54 112.41 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.3 m -155.46 93.41 2.65 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.682 -0.859 . . . . 74.44 108.682 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -87.14 157.83 8.41 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.571 2.18 . . . . 65.4 111.971 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.62 151.93 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.223 1.948 . . . . 64.14 111.575 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -85.55 152.69 57.77 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-N 116.012 -0.54 . . . . 52.34 110.206 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.67 110.94 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.29 1.993 . . . . 52.1 112.561 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.7 m -80.87 -20.3 42.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.02 0.438 . . . . 75.24 110.958 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -107.88 140.57 40.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.926 -1.509 . . . . 71.23 106.926 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -76.18 -12.86 60.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.215 0.45 . . . . 64.41 112.215 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HD3' ' A' ' 61' ' ' LYS . 18.3 m -70.88 -32.23 69.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.496 . . . . 73.54 109.988 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 44' ' ' VAL . 8.4 p -105.18 130.07 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.661 -0.699 . . . . 64.11 109.176 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -127.86 133.14 49.34 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.925 -0.579 . . . . 74.15 110.275 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.7 mm -93.09 112.4 26.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.606 -0.887 . . . . 63.04 108.606 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.86 151.86 46.3 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.691 -0.855 . . . . 63.02 108.691 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.25 146.65 30.06 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.801 -0.444 . . . . 73.15 109.801 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -140.55 123.09 16.11 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.781 -0.368 . . . . 52.43 110.051 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.415 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 12.9 pt-20 -138.8 164.88 28.46 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.412 -0.958 . . . . 60.52 108.412 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.72 35.47 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.02 -1.086 . . . . 54.43 112.42 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.442 HG13 ' SG ' ' A' ' 36' ' ' CYS . 38.2 pt -135.51 145.72 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.899 0.856 . . . . 75.4 112.324 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 189' ' ' LYS . 19.8 m -115.5 140.17 49.39 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 104.992 -2.225 . . . . 74.43 104.992 173.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.16 153.9 30.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.413 0 N-CA-C 109.246 -0.65 . . . . 74.41 109.246 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.609 ' CD2' ' HB3' ' A' ' 33' ' ' GLU . 42.3 m-85 -113.11 121.49 44.71 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.144 -2.169 . . . . 52.3 105.144 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 16.6 p -112.58 134.28 54.19 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 121.581 0.705 . . . . 61.22 111.865 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.44 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 8.8 t -126.25 133.87 51.35 Favored 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 114.87 -1.059 . . . . 64.23 109.255 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 50.1 mt-30 -111.09 146.57 36.55 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.781 -0.368 . . . . 75.32 110.676 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 183' ' ' ASN . 11.0 p90 -146.93 168.16 22.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.897 -0.592 . . . . 75.33 109.476 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.12 152.15 23.42 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.815 -0.914 . . . . 75.13 110.815 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 135.68 -138.58 10.05 Favored Glycine 0 C--N 1.313 -0.73 0 N-CA-C 110.921 -0.872 . . . . 73.13 110.921 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -100.56 106.67 18.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.782 -0.821 . . . . 75.15 108.782 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.85 114.64 27.31 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.48 0.919 . . . . 72.41 113.48 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -102.14 175.56 5.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.875 -1.528 . . . . 63.41 106.875 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.1 mp0 -57.79 -44.18 86.09 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.252 -1.018 . . . . 50.41 108.252 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.33 67.36 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.191 -1.368 . . . . 35.24 112.16 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 147' ' ' HIS . 5.1 m-20 -65.72 -49.07 69.8 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 121.098 -0.241 . . . . 71.42 110.387 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 48.5 m-85 -57.96 -43.47 86.43 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.499 0.499 . . . . 74.11 110.099 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 141' ' ' GLU . 58.8 t -62.7 -51.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 120.997 0.427 . . . . 74.11 111.322 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.16 75.3 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.397 0.618 . . . . 62.02 110.41 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.567 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 7.7 t-160 -66.79 -47.89 70.7 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.457 -0.792 . . . . 62.42 108.902 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.24 92.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.589 -0.732 . . . . 70.44 110.368 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 89.0 m -64.56 -36.61 84.77 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.744 -0.662 . . . . 75.14 110.838 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -74.11 -28.62 61.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.691 -0.403 . . . . 70.35 110.161 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 81.4 mt -58.98 -34.58 71.98 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 109.938 -0.393 . . . . 54.35 109.938 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 149' ' ' THR . 30.6 mtp180 -61.33 -38.82 88.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.779 -0.646 . . . . 62.43 109.454 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -73.07 -37.41 66.8 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.147 -0.933 . . . . 74.31 110.365 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.2 m -77.41 -34.51 54.72 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.09 0.471 . . . . 74.54 110.829 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 158' ' ' THR . 95.4 mt -80.83 7.66 9.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.579 0.752 . . . . 63.42 111.136 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -82.34 130.37 35.08 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.92 -1.141 . . . . 75.23 107.92 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.56 58.3 Favored Glycine 0 C--N 1.307 -1.081 0 C-N-CA 120.649 -0.786 . . . . 74.5 112.528 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 155' ' ' LEU . 15.4 t -125.2 149.25 63.28 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 107.772 -1.196 . . . . 71.34 107.772 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -64.25 -2.77 5.24 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 123.489 2.793 . . . . 73.0 115.154 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -62.98 142.54 58.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.723 0.297 . . . . 74.35 111.361 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 46.7 p -116.56 151.72 35.6 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.085 -0.507 . . . . 73.22 109.886 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -143.91 149.29 36.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.764 -0.458 . . . . 74.4 109.764 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 5.2 pp0? -134.0 145.49 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.514 0.931 . . . . 75.44 113.514 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.84 -1.39 23.45 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.876 -1.056 . . . . 43.22 115.257 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 t70 61.16 7.99 1.84 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.024 0.93 . . . . 70.41 111.057 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.74 139.69 18.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 124.446 1.098 . . . . 55.43 110.165 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 144' ' ' TYR . 43.9 p90 -137.86 167.61 21.39 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.619 -0.719 . . . . 73.14 109.173 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 79.2 m-85 -115.69 152.78 32.53 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.308 -0.997 . . . . 64.34 108.308 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 83' ' ' SER . 59.7 m -113.62 132.34 55.78 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.616 -1.253 . . . . 73.32 107.616 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -128.23 147.19 50.57 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.032 0.444 . . . . 70.4 111.034 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . -142.49 141.28 10.59 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 110.133 -1.187 . . . . 64.01 110.133 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -103.99 -14.1 16.07 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.148 0.499 . . . . 75.03 110.405 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -128.21 136.01 28.4 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 107.398 -1.334 . . . . 65.35 107.398 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.33 112.79 3.1 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 121.879 1.719 . . . . 75.01 109.533 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.36 130.92 3.44 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 122.054 1.836 . . . . 73.51 114.087 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 28.1 ttt -94.47 -39.51 10.38 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.201 -1.407 . . . . 64.45 107.201 172.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.78 144.65 29.32 Favored Pre-proline 0 N--CA 1.436 -1.175 0 CA-C-N 115.044 -0.98 . . . . 62.14 108.493 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.85 -13.36 22.16 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 124.13 3.22 . . . . 54.54 115.212 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -51.06 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.443 1.275 . . . . 74.23 114.443 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 75.76 113.8 0.11 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.891 -0.671 . . . . 54.25 111.846 -176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -77.42 -15.59 59.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.019 0.914 . . . . 70.34 109.125 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -142.27 129.51 21.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.634 -1.166 . . . . 74.41 108.211 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 38.1 m-80 -141.14 148.58 40.28 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 105.257 -2.127 . . . . 72.41 105.257 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 37.4 tt0 -126.38 141.02 52.05 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.023 -0.671 . . . . 72.03 110.486 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 132' ' ' SER . 29.0 t -124.49 129.14 73.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.744 -1.206 . . . . 74.3 107.744 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 39.0 m0 -110.15 126.9 54.57 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 110.135 -0.32 . . . . 75.14 110.135 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.83 137.74 39.72 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 172.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.46 133.18 43.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 120.554 -0.459 . . . . 74.13 112.203 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -69.64 143.38 53.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.683 -0.69 . . . . 72.44 111.92 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.305 -1.338 0 CA-C-O 118.433 -0.794 . . . . 60.15 109.123 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.583 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.2 p90 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 54.4 tt0 -106.0 109.24 21.12 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.057 -0.657 . . . . 71.51 109.646 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.8 p -93.31 131.92 38.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.247 -1.019 . . . . 62.42 108.247 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 33' ' ' GLU . 10.2 mt -89.25 -40.93 12.5 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.12 -1.067 . . . . 71.24 108.12 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 m -173.11 169.6 4.57 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.617 1.167 . . . . 74.24 108.313 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.77 165.59 24.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.562 -1.273 . . . . 75.33 107.562 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.31 89.87 0.17 Allowed Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 118.759 -1.686 . . . . 62.04 113.78 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.68 -134.11 4.25 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.757 -0.735 . . . . 54.33 111.912 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -115.27 173.81 6.32 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 123.821 0.848 . . . . 74.41 110.411 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -64.61 141.72 58.68 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.074 -1.084 . . . . 70.33 108.074 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 73.86 -62.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.673 1.189 . . . . 73.15 110.587 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.477 HG22 ' CD2' ' A' ' 147' ' ' HIS . 23.5 t -97.32 108.82 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.07 -1.085 . . . . 62.41 108.07 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.9 m -123.53 137.56 54.74 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.093 -1.077 . . . . 74.23 108.093 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -115.75 160.84 19.57 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.497 1.295 . . . . 61.13 114.497 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.515 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -147.0 125.85 12.7 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.126 -1.852 . . . . 73.33 106.682 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -104.66 122.1 44.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 119.169 -1.012 . . . . 74.31 108.676 175.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 31.7 ptt180 -141.37 153.86 45.32 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.123 -0.944 . . . . 75.1 111.445 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.05 136.33 36.65 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.093 -1.077 . . . . 54.12 108.093 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -61.58 149.24 39.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.315 1.228 . . . . 62.33 114.315 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 39' ' ' GLY . 4.4 tp10 -51.32 -50.7 58.89 Favored 'General case' 0 C--N 1.367 1.367 0 C-N-CA 124.151 0.981 . . . . 75.22 110.786 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.52 9.31 53.32 Favored Glycine 0 C--N 1.294 -1.763 0 C-N-CA 120.099 -1.048 . . . . 63.35 110.924 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -71.82 165.38 53.85 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.062 -0.569 . . . . 71.34 112.28 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 18.4 ptpt -88.54 129.69 35.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.471 -0.566 . . . . 52.1 109.471 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 58.1 m-85 -128.69 164.21 23.44 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.372 0.669 . . . . 74.41 110.549 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.97 116.87 33.02 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 108.652 -0.87 . . . . 61.31 108.652 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.4 t -125.43 143.46 50.98 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 121.141 0.496 . . . . 75.44 112.213 -175.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 14.8 m -129.65 127.74 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.077 -0.965 . . . . 71.43 109.906 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.76 128.08 56.1 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.711 0.767 . . . . 65.3 111.42 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 40.2 t -112.6 140.55 31.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.892 -1.049 . . . . 64.31 109.239 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 49' ' ' LYS . 40.9 p -132.37 172.73 12.09 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.264 -0.643 . . . . 63.25 109.264 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.22 -40.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.597 1.159 . . . . 72.32 111.626 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 36.3 mtmm -93.24 127.86 45.17 Favored Pre-proline 0 C--N 1.288 -2.066 0 CA-C-N 114.965 -1.016 . . . . 61.25 110.219 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 51.8 Cg_exo -55.3 158.95 11.2 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 124.394 3.396 . . . . 65.02 112.37 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 98' ' ' LEU . 53.0 t -46.53 -39.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.61 0.764 . . . . 71.03 112.189 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.28 -50.41 71.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.971 0.415 . . . . 72.32 111.061 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 32.4 mm-40 -75.18 -44.1 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.784 -0.644 . . . . 61.35 111.919 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -56.68 -42.97 79.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.295 0.638 . . . . 71.54 111.977 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 59' ' ' MET . 64.6 tp -63.8 -51.84 62.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.719 0.295 . . . . 41.23 110.703 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -65.82 -24.86 67.0 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 113.162 0.801 . . . . 74.1 113.162 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 49' ' ' LYS . 3.8 tm-20 -83.87 -33.85 24.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.657 0.741 . . . . 74.15 109.837 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.556 ' HA ' ' NZ ' ' A' ' 61' ' ' LYS . . . -75.88 -33.03 59.94 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 112.885 0.698 . . . . 65.2 112.885 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 12.4 mmt -50.79 -51.31 67.54 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 112.738 0.644 . . . . 74.43 112.738 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 89.3 Cg_exo -52.29 -39.11 73.21 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.482 2.121 . . . . 64.33 111.619 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.556 ' NZ ' ' HA ' ' A' ' 58' ' ' ALA . 35.2 mtmm -69.71 -32.19 70.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.422 . . . . 72.51 111.878 -177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 102' ' ' PHE . 31.8 mm -76.3 -45.1 35.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.001 0.429 . . . . 73.11 110.823 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.446 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.3 ptm -69.7 -30.68 68.38 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 112.275 0.472 . . . . 74.3 112.275 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 61' ' ' LYS . 20.2 ptmt -67.95 -30.52 69.83 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.704 -0.398 . . . . 72.41 109.936 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -63.11 -55.95 20.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.044 -0.525 . . . . 73.13 111.103 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.89 -15.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.894 0.378 . . . . 74.44 111.781 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.015 -0.539 . . . . 53.33 113.071 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.58 -12.75 2.71 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.438 -1.363 . . . . 72.3 113.495 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 116' ' ' SER . 21.5 m -82.77 29.55 0.45 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.724 1.25 . . . . 71.12 110.314 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.12 161.05 13.91 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.973 -1.121 . . . . 32.13 107.973 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 15.8 t70 -67.4 -33.21 74.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.724 0.639 . . . . 63.25 112.724 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -78.16 -12.47 60.0 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.266 0.555 . . . . 70.03 110.461 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 36.12 70.18 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.806 -0.634 . . . . 74.33 112.256 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -80.54 122.51 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.409 -0.589 . . . . 74.44 109.409 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.92 1.99 61.55 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.193 -0.527 . . . . 63.34 111.93 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.2 tpt -73.14 98.33 2.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.193 0.52 . . . . 74.45 110.621 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.79 89.3 0.86 Allowed Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.71 -0.956 . . . . 64.24 110.71 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.73 125.38 40.27 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.525 0.678 . . . . 62.42 111.11 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 m -127.86 118.46 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.867 1.062 . . . . 72.03 113.867 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.44 -179.62 0.66 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 104.602 -2.37 . . . . 74.11 104.602 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.27 137.8 67.96 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 122.582 1.958 . . . . 73.34 111.4 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 44.6 t -102.75 141.68 18.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.272 -1.381 . . . . 53.34 107.272 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 168' ' ' TYR . 26.1 t -126.32 146.23 50.11 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.605 -0.438 . . . . 61.23 109.859 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 43.9 p90 -135.36 142.69 45.79 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 110.135 -0.32 . . . . 61.13 110.135 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.11 134.89 34.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 123.785 0.678 . . . . 64.11 110.411 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 m -126.58 150.14 32.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.787 -1.097 . . . . 64.15 108.294 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.604 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 46.0 m-85 -120.87 104.1 42.25 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 120.371 -0.531 . . . . 62.2 110.288 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.58 133.58 3.79 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.037 1.824 . . . . 72.5 112.103 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -86.48 162.33 18.14 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.15 -1.055 . . . . 72.0 108.15 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.49 -12.95 61.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.513 0.673 . . . . 73.05 111.211 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.36 -6.09 56.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.857 -0.611 . . . . 72.34 109.917 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.88 -10.32 74.1 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 115.97 -0.559 . . . . 75.33 112.791 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.9 m -91.97 137.95 31.94 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 110.151 -0.314 . . . . 73.11 110.151 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 mp -75.14 138.68 42.21 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.266 0.555 . . . . 42.53 111.545 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.2 129.38 34.46 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.535 -2.024 . . . . 63.04 105.535 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -71.73 81.73 0.87 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.165 0.983 . . . . 74.13 113.27 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.604 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 37.8 ttmt -160.46 125.61 3.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.998 -2.223 . . . . 71.4 104.998 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 51' ' ' VAL . 6.0 tt -135.5 129.28 32.85 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 108.669 -0.863 . . . . 61.42 108.669 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -122.3 114.84 21.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.244 -0.65 . . . . 75.31 109.244 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.5 t -92.4 129.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.958 -0.565 . . . . 63.23 109.579 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -110.79 123.35 49.9 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.904 -0.776 . . . . 61.42 108.904 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HB2' HD12 ' A' ' 62' ' ' ILE . 86.4 t80 -102.53 112.48 25.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.939 -1.134 . . . . 65.24 107.939 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 39.7 ttp180 -76.91 121.26 23.19 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-N 114.376 -1.284 . . . . 61.44 109.901 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.0 mt -88.45 133.04 37.26 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 115.211 -0.904 . . . . 74.14 109.934 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.13 154.67 32.55 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.919 2.412 . . . . 74.35 111.562 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -53.42 -45.26 69.32 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.086 1.143 . . . . 73.14 114.086 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.97 -31.55 71.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.225 0.536 . . . . 55.04 111.161 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.89 -5.85 49.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.18 -0.464 . . . . 73.15 111.323 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.706 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.68 -38.26 73.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.728 -0.842 . . . . 74.41 108.728 174.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.96 93.56 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.281 -0.872 . . . . 72.23 112.138 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.2 m -154.27 92.88 2.96 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 122.534 0.334 . . . . 50.12 111.049 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 84.8 Cg_endo -90.11 149.4 4.67 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.364 2.043 . . . . 70.42 111.535 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 27.3 Cg_exo -65.9 146.33 82.66 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.592 2.195 . . . . 73.14 111.407 175.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -74.22 147.01 85.19 Favored Pre-proline 0 C--O 1.255 1.36 0 C-N-CA 120.634 -0.426 . . . . 72.43 110.413 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.45 113.38 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.604 2.203 . . . . 64.53 111.547 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 69' ' ' THR . 26.5 t -91.23 -12.52 35.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.563 0.697 . . . . 72.14 109.718 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.565 ' HB3' HG12 ' A' ' 120' ' ' VAL . 9.5 t70 -100.67 136.78 40.0 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.52 -1.289 . . . . 73.43 107.52 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.434 ' O ' ' HE2' ' A' ' 121' ' ' LYS . 13.9 pt-20 -72.45 -19.12 61.63 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.234 0.827 . . . . 73.23 113.234 -173.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.8 m -86.36 -25.6 25.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.531 -0.468 . . . . 75.24 111.169 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 117' ' ' ASP . 10.7 p -97.13 129.09 47.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 120.402 -0.519 . . . . 62.2 109.627 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 118' ' ' GLU . 75.7 mmtt -124.21 143.19 50.66 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.255 -0.429 . . . . 74.41 110.22 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 23.6 mm -92.74 111.1 23.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.703 -1.221 . . . . 55.43 107.703 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -125.22 142.39 51.52 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.557 -0.747 . . . . 75.25 109.387 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 11.2 pt-20 -100.41 135.71 41.43 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.079 -0.711 . . . . 71.23 109.079 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.517 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 32.3 tpt180 -125.58 122.15 35.66 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.032 -0.667 . . . . 74.43 110.767 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.56 177.61 8.36 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.143 -1.058 . . . . 74.22 108.143 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.28 -12.8 68.75 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.514 -0.85 . . . . 63.3 114.68 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.265 2.6 pp -121.13 157.73 24.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 118.553 -1.259 . . . . 64.23 113.593 -176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.6 m -109.57 133.61 52.89 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.922 -1.49 . . . . 50.42 108.751 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 188' ' ' VAL . 32.0 m -124.0 157.06 31.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-O 121.155 0.502 . . . . 65.2 110.454 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 69.4 m-85 -113.21 121.87 45.77 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 103.618 -2.734 . . . . 61.22 103.618 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.7 m -119.46 132.24 55.76 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 120.656 -0.418 . . . . 63.35 110.353 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.9 t -112.8 128.13 56.35 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.936 -0.764 . . . . 70.53 108.936 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.04 125.34 53.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.522 -1.658 . . . . 64.4 106.522 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 26.1 p90 -141.71 154.89 45.6 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.858 -0.61 . . . . 73.31 110.491 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.86 14.75 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.79 -0.719 . . . . 51.34 113.109 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 144.17 -176.92 23.14 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.202 -1.559 . . . . 53.45 109.202 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -81.36 107.7 14.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.014 0.907 . . . . 71.23 109.288 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -96.45 138.19 34.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.508 0.671 . . . . 70.31 112.483 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.505 ' HE3' ' OD1' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -109.98 176.66 4.98 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.562 -1.644 . . . . 53.32 106.562 172.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -36.19 80.36 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.261 0.467 . . . . 73.52 112.261 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.11 -32.56 73.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 73.43 111.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.505 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 5.4 m-20 -63.97 -34.42 77.95 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 116.365 -0.38 . . . . 64.51 111.52 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.17 -43.93 90.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.99 0.424 . . . . 74.13 110.022 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.1 t -66.17 -45.86 89.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.533 -0.758 . . . . 73.24 109.457 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.12 96.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 60.34 111.084 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.477 ' CD2' HG22 ' A' ' 29' ' ' VAL . 56.6 m80 -67.78 -33.88 75.69 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 120.729 -0.389 . . . . 73.4 111.97 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.71 82.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.505 -0.554 . . . . 70.01 109.505 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 56.3 m -60.37 -49.95 75.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.612 -0.722 . . . . 65.21 109.725 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.28 -29.73 66.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.969 -0.559 . . . . 73.34 112.16 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HA ' HG22 ' A' ' 154' ' ' THR . 34.6 tp -65.69 -36.98 85.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.653 -0.499 . . . . 71.41 109.653 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.538 ' HG2' ' CE2' ' A' ' 162' ' ' TYR . 40.3 mtp180 -69.28 -37.22 77.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.917 -0.583 . . . . 71.41 110.218 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.1 m -69.02 -35.65 76.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.632 -0.713 . . . . 64.24 110.34 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 151' ' ' LEU . 14.7 t -78.18 -33.22 50.24 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 120.65 -0.42 . . . . 65.13 111.011 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.68 6.21 9.37 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.167 0.508 . . . . 71.31 111.495 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.49 132.02 44.92 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.329 -0.619 . . . . 55.12 109.329 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.34 11.74 50.84 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 121.139 -0.553 . . . . 51.12 111.993 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.7 p -123.38 165.48 22.58 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 108.386 -0.968 . . . . 73.23 108.386 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.63 12.67 1.58 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.573 2.182 . . . . 73.44 112.312 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.52 118.84 14.84 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.943 0.401 . . . . 74.22 111.041 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.7 p -121.18 164.65 16.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.701 -1.592 . . . . 73.44 106.701 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.538 ' CE2' ' HG2' ' A' ' 152' ' ' ARG . 12.2 m-85 -130.43 152.29 50.0 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.337 -0.945 . . . . 71.42 108.847 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.431 ' HG3' ' HA ' ' A' ' 190' ' ' ALA 0.268 3.5 pp0? -102.53 115.08 29.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.295 0.569 . . . . 74.32 111.889 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.89 1.36 62.29 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.477 -0.783 . . . . 72.43 111.357 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.7 t70 59.96 20.62 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.609 1.564 . . . . 54.4 109.658 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.4 138.47 16.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 114.621 -1.172 . . . . 74.32 112.069 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.445 ' HB3' HD23 ' A' ' 187' ' ' LEU . 22.0 p90 -135.79 152.67 51.33 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.949 -1.023 . . . . 62.23 108.694 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 9.7 m-85 -115.15 140.75 48.81 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.231 -1.025 . . . . 71.34 108.231 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' SER . 61.9 m -114.22 119.54 37.38 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.85 -0.796 . . . . 74.31 108.85 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -112.32 139.65 47.7 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.092 0.473 . . . . 73.22 111.818 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.109 0 N-CA-C 107.248 -2.341 . . . . 45.11 107.248 179.724 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 80.4 mtt180 . . . . . 0 N--CA 1.442 -0.853 0 CA-C-O 120.618 0.247 . . . . 73.23 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -112.97 127.83 56.33 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.596 -1.261 . . . . 74.01 107.596 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 8.6 m120 -143.76 158.86 43.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.744 -0.465 . . . . 73.23 109.744 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 43.9 mt-10 -137.08 145.15 43.6 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.02 -0.733 . . . . 64.45 109.02 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 81.7 t -125.6 121.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.786 -1.191 . . . . 74.31 107.786 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 24.7 m0 -110.21 122.15 46.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.617 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 167' ' ' TYR . 87.6 mt -102.41 138.57 39.16 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.776 -1.194 . . . . 71.32 107.776 171.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 130' ' ' VAL . 27.9 t -103.47 130.59 53.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.477 -0.564 . . . . 73.44 109.477 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.9 ttpt -69.25 132.54 46.64 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.82 -0.807 . . . . 70.21 108.82 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.431 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.468 1.105 . . . . 61.03 112.054 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 45.8 p90 . . . . . 0 N--CA 1.437 -1.105 0 CA-C-O 121.305 0.574 . . . . 72.24 109.868 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -105.58 109.16 21.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.253 -0.885 . . . . 73.15 110.038 -173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.13 128.22 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.724 -1.213 . . . . 74.42 107.724 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 21' ' ' LEU 0.258 0.5 OUTLIER -96.6 -32.45 12.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 113.747 1.017 . . . . 74.43 113.747 -178.998 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 28.5 t -151.86 152.91 33.21 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.864 -0.735 . . . . 62.52 111.907 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 32' ' ' GLU . 27.2 p -133.81 152.91 52.01 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.171 -0.922 . . . . 70.43 110.578 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.04 -131.99 10.76 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 120.632 -0.794 . . . . 64.24 112.691 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -104.5 1.45 Allowed Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 121.116 -0.564 . . . . 65.05 112.077 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.13 171.67 7.66 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 122.827 0.451 . . . . 65.15 110.203 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.18 157.52 25.24 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.679 -1.23 . . . . 74.31 107.679 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t70 75.48 -49.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.436 1.494 . . . . 74.31 111.425 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.24 110.98 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.68 0.752 . . . . 73.0 110.03 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 p -110.8 135.9 50.66 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.731 -0.668 . . . . 73.41 109.495 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -112.1 162.25 15.62 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.129 0.49 . . . . 73.12 112.154 -175.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 22' ' ' SER . 13.1 pt-20 -153.0 129.83 10.94 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.554 -2.017 . . . . 71.23 105.554 170.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HG2' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -114.49 141.61 47.47 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 118.898 -1.121 . . . . 74.43 109.518 177.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 157.11 46.26 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 119.535 -0.866 . . . . 71.0 109.261 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 133.89 35.41 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.466 -2.05 . . . . 52.41 105.466 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.6 m -58.38 141.65 50.68 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.87 1.063 . . . . 70.11 113.87 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -70.3 -16.53 63.02 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.47 -1.695 . . . . 53.42 112.137 -175.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 87.94 12.03 66.77 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.414 -1.851 . . . . 64.43 111.664 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.03 145.98 42.25 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 120.343 -0.932 . . . . 51.42 111.72 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -96.32 117.99 31.94 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.842 -0.799 . . . . 62.43 108.842 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.9 m-85 -122.69 163.86 19.34 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.512 -0.767 . . . . 72.42 110.826 -172.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.21 116.49 31.51 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.312 -0.625 . . . . 74.21 109.312 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.7 t -122.17 145.94 47.72 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 112.477 0.547 . . . . 65.43 112.477 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.579 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 16.0 m -129.95 140.89 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 125.104 1.361 . . . . 73.43 107.776 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.59 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.3 pt-20 -128.01 135.77 50.36 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.16 -1.416 . . . . 74.11 112.22 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 41.2 t -118.41 140.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 106.386 -1.709 . . . . 74.31 106.386 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 49' ' ' LYS . 38.6 p -126.26 167.17 15.84 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.727 -0.389 . . . . 73.51 110.537 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t70 73.72 -36.97 0.36 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.436 1.094 . . . . 52.22 112.108 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 47' ' ' THR . 95.0 mttt -85.75 138.14 35.63 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.53 -0.759 . . . . 71.23 110.841 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.96 157.14 25.67 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.002 2.468 . . . . 74.31 110.748 174.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 98' ' ' LEU . 31.8 t -47.63 -43.88 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 114.952 1.464 . . . . 62.12 114.952 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.95 -33.11 74.03 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.048 -0.661 . . . . 75.13 110.675 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -74.85 -44.06 51.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.526 0.679 . . . . 73.12 110.129 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -65.23 -43.56 91.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.369 -0.832 . . . . 63.32 111.468 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.03 -40.13 82.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 111.694 0.257 . . . . 71.32 111.694 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.91 -24.82 66.92 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 121.013 -0.275 . . . . 64.01 111.431 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 30.2 tt0 -84.47 -44.72 13.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.506 0.67 . . . . 73.54 110.26 175.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.49 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.5 -40.45 70.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 114.67 1.359 . . . . 62.13 114.67 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 ttm -57.83 -46.02 99.76 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 113.078 0.77 . . . . 72.33 113.078 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 76.3 Cg_exo -50.34 -40.75 52.7 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.385 2.057 . . . . 71.24 111.923 171.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 48.2 mtmt -69.14 -34.5 75.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.862 -0.608 . . . . 63.13 110.81 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -70.96 -48.88 53.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.886 -0.597 . . . . 53.01 111.059 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.49 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.5 ptm -68.96 -30.3 68.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.069 0.766 . . . . 74.55 113.069 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -72.33 -27.98 62.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.325 -0.95 . . . . 61.23 109.989 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 93.4 t80 -63.07 -57.94 8.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.335 -0.848 . . . . 74.04 109.886 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.3 m -73.17 -20.79 18.78 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 CA-C-N 116.149 -0.478 . . . . 75.04 110.928 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.77 -25.68 69.29 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.08 -0.509 . . . . 24.33 113.264 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 143.22 -10.22 2.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.149 -1.024 . . . . 75.33 113.039 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 m -89.56 27.6 1.46 Allowed 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.115 0.959 . . . . 74.44 110.254 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.31 169.21 10.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.788 -0.642 . . . . 62.12 110.003 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.85 -32.86 73.23 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.904 0.705 . . . . 73.11 112.904 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 113' ' ' PRO . 99.5 mttt -91.23 -7.69 50.56 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.764 -0.775 . . . . 64.33 112.577 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.69 73.65 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.929 -0.578 . . . . 62.45 112.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 32.5 m -82.23 158.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.42 -0.512 . . . . 74.04 110.243 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.27 173.69 41.1 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 120.891 -0.671 . . . . 63.02 111.735 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 52.6 ttp -75.17 95.95 3.2 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.064 0.459 . . . . 71.43 110.154 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.65 10.3 9.77 Favored Glycine 0 N--CA 1.426 -1.971 0 CA-C-N 115.386 -0.824 . . . . 45.41 112.341 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -118.79 123.45 44.82 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.207 -0.597 . . . . 65.35 110.865 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.9 p -127.53 117.54 22.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.748 0.647 . . . . 70.3 112.748 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -152.99 172.82 5.17 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.503 -1.665 . . . . 65.41 106.503 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.76 139.94 25.57 Favored 'Trans proline' 0 C--O 1.253 1.225 0 C-N-CA 121.01 1.14 . . . . 73.22 110.505 175.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.86 141.43 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.815 -0.809 . . . . 73.23 108.815 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 p -119.46 145.41 46.3 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 110.203 -0.295 . . . . 70.1 110.203 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -144.44 140.62 29.08 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 122.048 -0.408 . . . . 71.33 110.822 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.68 134.55 34.91 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-N 115.68 -0.691 . . . . 70.04 109.287 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.25 159.21 30.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 114.779 -1.101 . . . . 74.45 109.158 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 97' ' ' LYS . 78.4 m-85 -125.23 106.16 28.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 110.03 -0.359 . . . . 75.12 110.03 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.07 136.15 11.47 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.502 2.135 . . . . 72.23 114.07 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 96' ' ' LYS . 49.9 m-80 -95.3 161.51 14.06 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.252 -1.388 . . . . 74.43 107.252 172.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.59 -13.35 58.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.698 0.761 . . . . 72.4 111.005 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.24 -6.32 54.58 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.832 -1.076 . . . . 54.13 110.338 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.53 -9.73 69.79 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.338 -0.458 . . . . 45.35 112.247 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 m -90.19 132.6 35.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 110.163 -0.31 . . . . 65.21 110.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.87 96.11 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.46 -0.941 . . . . 74.0 108.46 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -147.44 114.34 6.12 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.571 -0.899 . . . . 72.43 108.571 -178.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 87' ' ' PHE . 74.1 mmtt -176.63 -70.1 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.565 1.946 . . . . 52.2 106.478 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 87' ' ' PHE . 27.4 mtpp -153.16 159.33 42.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.279 -1.782 . . . . 72.34 107.586 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 51' ' ' VAL . 5.7 tt -143.77 128.43 18.18 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.135 -0.691 . . . . 71.11 109.135 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.7 mttt -117.56 115.55 25.35 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.592 -0.276 . . . . 73.04 110.781 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.1 t -89.09 127.02 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.039 -1.097 . . . . 53.41 108.039 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.552 ' CD1' ' HE2' ' A' ' 168' ' ' TYR . 70.1 m95 -113.97 120.59 41.18 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.734 -0.839 . . . . 75.23 108.734 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -102.78 113.28 26.57 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 108.317 -0.994 . . . . 75.4 108.317 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 81.7 mtm180 -75.12 137.91 41.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.535 -1.211 . . . . 72.4 111.803 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.568 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 63.9 mt -113.24 130.4 23.66 Favored Pre-proline 0 C--N 1.286 -2.193 0 CA-C-N 115.396 -0.82 . . . . 65.33 109.862 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.19 163.99 36.6 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.62 2.88 . . . . 74.23 112.921 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -46.46 -35.52 5.7 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.996 1.718 . . . . 75.22 112.976 -176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -46.52 86.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.968 0.413 . . . . 41.45 110.581 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -99.17 -4.5 31.99 Favored 'General case' 0 C--O 1.197 -1.666 0 N-CA-C 112.652 0.612 . . . . 75.44 112.652 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.568 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 24.5 mm-40 -70.77 -32.17 69.2 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.31 -0.556 . . . . 73.42 110.805 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.88 -35.7 90.77 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.778 -0.646 . . . . 44.14 111.598 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.8 p -161.0 92.22 1.52 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 C-N-CA 123.08 0.552 . . . . 73.24 110.117 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.99 162.33 8.82 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.203 1.935 . . . . 61.33 112.123 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.435 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 29.5 Cg_endo -68.17 156.43 65.79 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.751 1.634 . . . . 72.21 109.903 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 155.07 45.93 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.629 -0.26 . . . . 74.14 110.51 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.563 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 34.0 Cg_exo -60.48 111.55 1.06 Allowed 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.589 2.192 . . . . 62.03 111.724 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -88.0 -41.31 13.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.454 -0.793 . . . . 44.12 110.602 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.526 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.0 t70 -92.43 156.0 17.49 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.626 -1.25 . . . . 75.43 107.626 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.37 -20.29 48.08 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 120.93 0.395 . . . . 70.41 111.036 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 m -74.53 -39.71 62.19 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.944 -0.571 . . . . 63.12 110.536 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 3.2 p -107.15 116.41 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.516 0.674 . . . . 64.41 111.507 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -120.82 148.29 44.22 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.835 -1.075 . . . . 75.12 108.796 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.48 ' H ' ' HG3' ' A' ' 115' ' ' PRO . 22.6 mm -92.82 111.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.263 -1.014 . . . . 72.4 108.263 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.267 -0.878 . . . . 73.12 109.005 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.78 140.91 46.03 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.41 -0.589 . . . . 74.42 109.41 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -122.78 123.33 40.81 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 119.841 -0.744 . . . . 74.34 110.474 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -143.76 165.8 26.67 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.538 -1.21 . . . . 74.05 110.48 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.95 -1.15 69.79 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.688 -0.767 . . . . 63.2 114.681 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.89 166.42 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-N 117.774 0.787 . . . . 61.14 110.24 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 55.3 m -120.63 138.39 53.94 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.895 -0.593 . . . . 65.33 109.855 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.444 HG21 ' CE3' ' A' ' 186' ' ' TRP . 19.1 m -124.66 153.54 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 109.12 -0.696 . . . . 55.43 109.12 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 51.8 m-85 -113.03 121.6 45.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.145 -2.168 . . . . 74.13 105.145 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 p -117.91 130.02 55.98 Favored 'General case' 0 C--N 1.269 -2.896 0 C-N-CA 120.252 -0.579 . . . . 71.34 111.162 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.499 ' HB ' HD23 ' A' ' 151' ' ' LEU . 7.8 t -116.06 126.06 53.25 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.689 -0.687 . . . . 74.51 110.168 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -111.1 130.53 55.59 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.925 -1.509 . . . . 65.1 106.925 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.96 146.06 44.94 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.502 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -125.92 128.4 6.45 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.513 -0.767 . . . . 53.34 111.335 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.59 -138.13 4.95 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.21 -0.756 . . . . 64.31 111.21 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -100.49 100.63 11.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.787 -1.561 . . . . 74.52 106.787 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 140.11 53.29 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.018 1.118 . . . . 62.21 114.018 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -115.68 176.86 4.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.583 -1.189 . . . . 74.31 108.318 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.71 -37.03 85.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.964 0.412 . . . . 73.12 111.356 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.07 67.2 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.236 0.541 . . . . 55.3 110.225 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.26 -30.53 71.18 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.834 -0.621 . . . . 72.24 110.642 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -61.03 -38.1 84.9 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.003 0.43 . . . . 74.52 110.565 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.63 -43.87 86.58 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 109.021 -0.733 . . . . 62.13 109.021 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -62.24 -47.79 82.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.202 -0.908 . . . . 63.22 110.266 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -66.83 -33.09 74.84 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 113.612 0.967 . . . . 72.12 113.612 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.5 80.89 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.432 0.634 . . . . 71.1 110.122 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.8 m -75.29 -44.61 44.76 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.494 -0.776 . . . . 45.31 109.641 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 53.2 mt-30 -63.85 -27.7 69.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.765 0.426 . . . . 74.33 111.486 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 133' ' ' THR . 3.3 tm? -64.87 -37.05 86.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.328 -0.99 . . . . 74.41 108.328 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.33 -33.14 67.1 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.851 -0.613 . . . . 74.32 110.447 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -35.1 79.75 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.648 -0.706 . . . . 74.04 109.952 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 151' ' ' LEU . 8.9 t -77.86 -32.87 52.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.546 -0.462 . . . . 51.54 110.568 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.01 9.26 2.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.208 0.447 . . . . 71.32 112.208 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.43 24.51 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.664 -1.606 . . . . 65.11 106.664 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.38 47.74 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.263 -0.97 . . . . 64.55 111.374 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 55.8 p -118.82 158.17 48.31 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.84 -0.8 . . . . 62.24 108.84 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.95 20.3 1.18 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.179 1.919 . . . . 73.41 112.22 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.72 127.46 31.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.124 -0.489 . . . . 44.32 111.995 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.8 p -104.56 156.34 18.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.021 -1.103 . . . . 75.03 108.021 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.447 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 31.4 m-85 -136.59 157.53 46.55 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.073 -0.651 . . . . 72.42 109.753 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -143.04 123.92 14.28 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.361 -0.536 . . . . 63.32 112.272 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.64 -0.27 28.19 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.535 -0.757 . . . . 64.35 114.417 175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 64.56 8.53 4.44 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.388 1.075 . . . . 72.42 111.765 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 87' ' ' PHE . 7.3 p -66.17 139.42 21.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.701 0.763 . . . . 60.15 111.881 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.411 ' HB3' HD22 ' A' ' 187' ' ' LEU . 47.5 p90 -143.56 168.57 19.54 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.95 -1.023 . . . . 73.43 109.179 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 94.1 m-85 -114.93 147.6 39.78 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 120.951 0.405 . . . . 71.13 110.375 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 66.0 m -114.79 123.74 49.98 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.913 -1.884 . . . . 75.32 105.913 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.98 131.41 47.45 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.498 0.666 . . . . 74.34 112.184 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.251 0 N-CA-C 108.779 -1.728 . . . . 65.44 108.779 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.593 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 71.9 ttt180 . . . . . 0 C--O 1.216 -0.708 0 N-CA-C 111.623 0.231 . . . . 73.11 111.623 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.631 ' O ' ' HD2' ' A' ' 182' ' ' ARG . 1.3 ppt_? -102.75 129.41 49.38 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.24 -0.984 . . . . 74.34 112.477 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -145.02 153.76 41.81 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.044 -0.525 . . . . 70.21 110.197 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 42.7 mt-10 -138.14 132.05 31.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.592 0.357 . . . . 72.24 110.288 173.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.458 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 96.5 t -128.95 118.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.271 -1.011 . . . . 74.12 108.271 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 11.3 m0 -107.65 121.03 43.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 108.918 -0.771 . . . . 72.22 108.918 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 167' ' ' TYR . 0.8 OUTLIER -100.58 134.82 42.97 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.678 -1.971 . . . . 72.53 105.678 178.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.04 124.79 45.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 120.619 -0.432 . . . . 53.0 112.068 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 161' ' ' THR . 82.8 tttt -75.45 133.27 41.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.103 -0.703 . . . . 72.55 109.103 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.255 1.353 0 CA-C-O 118.694 -0.669 . . . . 54.42 110.688 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.521 ' CD1' ' HG3' ' A' ' 34' ' ' ARG . 37.3 p90 . . . . . 0 N--CA 1.426 -1.64 0 N-CA-C 108.301 -1.0 . . . . 74.01 108.301 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.03 0.443 . . . . 61.44 110.791 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.52 123.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.528 -0.916 . . . . 65.01 108.528 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.6 -28.95 18.11 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.051 -0.66 . . . . 73.51 109.901 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t 179.08 158.74 0.59 Allowed 'General case' 0 C--O 1.248 1.011 0 CA-C-N 115.303 -0.862 . . . . 54.23 109.483 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.9 p -131.43 156.53 45.44 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.038 -1.468 . . . . 64.21 107.038 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.49 88.79 0.59 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.894 -1.622 . . . . 73.44 113.581 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.32 -139.94 10.02 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 109.248 -1.541 . . . . 22.15 109.248 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -104.84 110.03 22.23 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 102.582 -3.118 . . . . 71.4 102.582 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.93 133.04 49.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.327 -0.949 . . . . 74.0 112.565 -167.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 153.25 -45.77 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 101.844 -3.391 . . . . 53.3 101.844 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.04 111.85 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 111.788 -2.46 . . . . 72.15 104.699 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -100.48 140.2 35.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.96 -0.385 . . . . 60.22 109.96 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.45 157.71 34.54 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.579 -0.848 . . . . 64.41 112.535 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -134.0 126.67 30.72 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.172 -1.418 . . . . 75.22 107.172 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.45 113.89 26.06 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 106.69 -1.596 . . . . 74.04 106.69 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.521 ' HG3' ' CD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -138.5 145.88 41.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.791 -1.163 . . . . 74.0 113.382 -177.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 128' ' ' ILE . . . -86.77 138.35 31.68 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.065 -1.425 . . . . 75.53 107.784 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' SG ' HG13 ' A' ' 128' ' ' ILE . 25.6 p -57.89 168.57 0.92 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.25 0.833 . . . . 50.22 113.25 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -82.85 -18.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.304 -0.862 . . . . 61.33 111.483 -174.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.38 9.42 59.1 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 119.971 -1.109 . . . . 65.53 112.969 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.85 165.07 45.32 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.649 -0.786 . . . . 75.41 113.137 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 46.3 pttt -99.14 131.86 44.87 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.922 -0.399 . . . . 70.42 109.922 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.685 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 40.9 m-85 -127.89 165.27 20.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.527 -0.761 . . . . 71.23 112.101 -169.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.0 116.99 31.34 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.675 -0.861 . . . . 55.03 108.675 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 4.2 t -126.87 143.29 51.31 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-N 115.135 -0.938 . . . . 74.42 112.517 -175.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.2 m -133.32 146.11 32.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.4 -1.273 . . . . 72.03 108.366 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -127.88 126.31 41.32 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.63 -0.428 . . . . 70.34 110.367 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 33.2 t -120.74 130.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.988 -1.486 . . . . 74.55 106.988 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 49' ' ' LYS . 73.5 p -117.97 167.94 10.98 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.317 -0.553 . . . . 71.23 111.416 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 72.8 -25.31 0.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.898 1.279 . . . . 70.02 112.947 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 68.6 mttm -86.28 146.45 42.42 Favored Pre-proline 0 C--N 1.29 -1.985 0 CA-C-N 115.58 -0.736 . . . . 61.3 110.264 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.69 157.27 43.16 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.472 2.115 . . . . 64.31 110.032 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 98' ' ' LEU . 54.0 t -47.49 -42.52 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 113.146 0.795 . . . . 71.33 113.146 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t70 -61.62 -50.9 70.71 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 120.164 -0.614 . . . . 73.21 110.617 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 25.5 mm-40 -58.42 -51.71 68.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.827 -0.624 . . . . 75.53 111.497 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -62.4 -34.84 77.51 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.875 -0.602 . . . . 60.13 110.932 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.01 -34.16 71.06 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.644 -0.253 . . . . 71.34 110.615 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 24.3 mmm180 -67.87 -36.16 79.8 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.099 -0.704 . . . . 75.41 109.099 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.5 mm-40 -73.47 -53.31 10.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.273 -0.876 . . . . 71.11 112.587 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.89 -36.14 62.25 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.372 1.619 . . . . 75.23 115.372 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.6 tpp -55.18 -54.16 53.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 112.681 0.622 . . . . 74.21 112.681 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 63' ' ' MET . 14.0 Cg_endo -57.55 -30.57 88.93 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.472 2.115 . . . . 74.25 112.583 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 53.4 mtpt -65.45 -34.11 77.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.255 0.55 . . . . 73.51 110.913 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.12 -38.54 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.006 0.432 . . . . 61.44 110.824 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 87.6 mtp -66.86 -30.13 70.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.976 0.732 . . . . 73.33 112.976 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -67.75 -45.22 75.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 65.32 109.62 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -62.21 -60.95 2.84 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.16 -0.473 . . . . 70.33 112.072 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 76' ' ' MET . 16.5 m -77.13 -3.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.544 0.688 . . . . 74.43 110.759 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.57 -11.37 59.46 Favored Glycine 0 N--CA 1.418 -2.539 0 CA-C-N 114.984 -1.007 . . . . 52.02 112.392 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.33 -28.81 0.63 Allowed Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.455 -1.355 . . . . 60.11 113.518 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -81.58 55.14 2.56 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.235 1.017 . . . . 64.04 111.253 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.42 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 34.9 m-80 -98.38 149.39 22.71 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 106.061 -1.829 . . . . 62.2 106.061 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.97 -26.95 65.3 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.966 -0.693 . . . . 70.35 111.543 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HB2' HG23 ' A' ' 74' ' ' VAL . 57.3 mtpt -80.43 0.14 34.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.114 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 34.06 66.7 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 121.075 -0.583 . . . . 64.52 112.278 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 72' ' ' LYS . 48.5 t -80.1 143.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 107.776 -1.194 . . . . 51.14 107.776 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.84 -172.77 37.67 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.745 -0.741 . . . . 70.2 112.656 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -78.99 103.68 9.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.406 -0.961 . . . . 71.34 108.406 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -161.13 19.42 0.2 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.335 -0.936 . . . . 53.41 112.478 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.2 ptm -123.1 122.78 39.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.066 -1.053 . . . . 71.21 109.687 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.9 m -127.11 117.85 23.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.621 -0.718 . . . . 70.44 110.365 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.506 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 2.9 m -150.46 166.79 14.33 Favored Pre-proline 0 C--N 1.298 -1.665 0 C-N-CA 124.723 1.209 . . . . 75.14 107.822 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 38.3 Cg_endo -66.23 140.92 60.78 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.291 1.327 . . . . 44.32 113.588 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.9 139.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.085 -1.416 . . . . 64.34 107.94 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 p -127.38 148.79 50.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.636 -0.505 . . . . 72.13 109.636 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -144.35 142.04 30.12 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.63 -0.428 . . . . 73.54 110.157 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -91.89 134.9 34.36 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 109.174 -0.676 . . . . 33.32 109.174 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.49 150.18 26.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-N 114.869 -1.06 . . . . 73.24 108.382 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 1.9 m-85 -121.0 105.11 40.65 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.723 -0.473 . . . . 73.53 109.723 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 158.06 48.98 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.121 1.88 . . . . 75.03 112.984 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -118.09 160.7 21.07 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.578 -0.737 . . . . 71.35 110.453 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.63 -21.68 66.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.485 -0.78 . . . . 73.44 111.254 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.5 -6.92 57.97 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.552 0.691 . . . . 72.14 110.737 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.5 -0.48 85.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.761 -0.733 . . . . 74.15 113.272 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.6 m -96.9 136.31 37.63 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.565 -0.902 . . . . 73.13 108.565 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.4 mt -84.84 87.58 7.34 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.604 -0.438 . . . . 65.53 111.056 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -148.58 113.34 5.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.873 1.064 . . . . 64.11 113.873 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 87' ' ' PHE . 62.5 mttp -168.77 -68.79 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.749 1.22 . . . . 54.41 108.013 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HG2' HG22 ' A' ' 47' ' ' THR . 55.7 mtpt -148.87 153.93 38.75 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.837 -1.529 . . . . 73.31 108.743 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -144.16 127.44 16.74 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.634 -0.876 . . . . 74.43 108.634 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HE3' ' HE1' ' A' ' 101' ' ' TRP . 37.6 ttpt -130.01 115.58 17.33 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.081 0.467 . . . . 54.34 110.408 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' THR . 96.9 t -85.73 138.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.447 -0.797 . . . . 71.12 110.567 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.475 ' HE1' ' HE3' ' A' ' 99' ' ' LYS . 93.4 m95 -128.7 117.18 20.72 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.3 1.04 . . . . 72.25 108.278 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' HG11 ' A' ' 66' ' ' VAL . 83.7 t80 -104.32 118.18 35.99 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.604 -0.517 . . . . 72.51 109.604 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.685 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 34.5 ttm180 -74.57 131.1 40.68 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.817 -0.808 . . . . 74.05 108.817 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.17 140.67 22.51 Favored Pre-proline 0 C--N 1.296 -1.754 0 N-CA-C 109.69 -0.485 . . . . 62.42 109.69 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.47 ' HD3' HG21 ' A' ' 80' ' ' VAL . 8.2 Cg_endo -53.26 144.57 47.98 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.812 2.342 . . . . 72.3 111.523 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -55.01 -35.49 64.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.734 1.013 . . . . 55.33 113.734 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -61.34 -45.04 96.05 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.467 0.651 . . . . 75.32 109.987 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -78.82 -10.64 59.86 Favored 'General case' 0 C--O 1.196 -1.745 0 CA-C-N 115.456 -0.793 . . . . 73.35 111.141 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.69 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.0 -28.84 64.71 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.721 -0.392 . . . . 75.35 110.439 176.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.91 94.76 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.246 -0.742 . . . . 62.42 111.246 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 55.2 p -160.74 90.77 1.63 Allowed Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 109.454 -0.573 . . . . 53.45 109.454 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.29 146.61 36.05 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.346 2.031 . . . . 70.11 110.777 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 138.41 74.64 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.743 1.629 . . . . 73.43 110.109 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 140.34 96.31 Favored Pre-proline 0 C--O 1.256 1.414 0 CA-C-N 116.532 -0.304 . . . . 64.44 110.463 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.38 113.08 2.11 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.147 1.898 . . . . 74.43 110.703 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -90.69 29.89 1.25 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.603 -0.726 . . . . 65.24 109.988 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -138.53 145.98 41.36 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.379 -1.712 . . . . 62.21 106.379 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.71 -24.39 49.19 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.919 0.711 . . . . 64.42 112.919 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 61.1 p -102.95 -13.79 16.76 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.897 0.38 . . . . 71.41 111.851 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.42 116.38 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 105.399 -2.075 . . . . 75.14 105.399 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.71 146.4 50.23 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.238 -0.585 . . . . 50.24 111.212 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.0 mm -93.0 111.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.413 -0.958 . . . . 71.31 108.413 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -119.05 147.77 43.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.16 -0.927 . . . . 73.12 108.96 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -107.74 138.15 44.48 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.327 -0.397 . . . . 70.4 111.626 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -131.15 122.36 26.5 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.185 0.517 . . . . 64.35 110.57 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.408 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -140.23 148.61 41.76 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.574 -0.739 . . . . 62.53 109.124 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.6 20.32 78.48 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.261 -0.971 . . . . 41.55 113.746 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.509 HG13 ' SG ' ' A' ' 36' ' ' CYS . 2.2 pp -119.16 151.91 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.34 -0.944 . . . . 70.53 109.073 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' HD3' ' A' ' 189' ' ' LYS . 46.4 m -121.49 133.54 55.05 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 115.549 -0.751 . . . . 61.32 111.809 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.17 155.8 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 108.324 -0.991 . . . . 53.34 108.324 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -113.57 122.25 46.68 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.794 -1.928 . . . . 75.32 105.794 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 59.4 p -117.17 147.34 42.55 Favored 'General case' 0 C--N 1.269 -2.92 0 C-N-CA 120.344 -0.542 . . . . 73.43 111.999 -173.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.527 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -126.01 130.57 51.44 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 115.231 -0.895 . . . . 64.53 108.954 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -113.81 126.37 55.13 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.978 0.894 . . . . 74.14 109.169 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -130.81 137.81 49.59 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 114.408 -1.269 . . . . 72.22 110.65 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.77 127.32 7.19 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.337 -0.705 . . . . 72.32 111.337 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 153.79 -143.13 9.78 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 109.029 -1.628 . . . . 33.43 109.029 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -99.83 110.57 22.94 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 117.412 0.606 . . . . 73.41 110.002 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.78 139.45 44.82 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.214 -0.662 . . . . 54.2 109.214 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.43 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 22.1 ttmm -114.89 169.28 9.2 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.303 -2.11 . . . . 43.14 105.303 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.65 -39.8 58.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.207 0.527 . . . . 63.53 111.598 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.2 66.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.617 -0.72 . . . . 72.41 111.071 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 31.8 t70 -73.46 -30.29 63.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.147 -0.479 . . . . 74.34 111.01 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -59.0 -50.5 73.87 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.115 -0.698 . . . . 73.42 109.115 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.8 t -61.73 -42.09 93.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.85 -1.068 . . . . 72.24 109.459 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.39 -46.57 88.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.529 -0.76 . . . . 73.43 110.887 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.559 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 40.5 m80 -64.24 -39.81 94.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 112.489 0.551 . . . . 60.21 112.489 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -60.77 -43.22 98.31 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.242 0.544 . . . . 73.53 110.015 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.401 HG23 ' NH2' ' A' ' 152' ' ' ARG . 88.2 m -62.73 -47.12 84.94 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 123.822 0.849 . . . . 44.24 110.022 177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -58.79 -42.9 90.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.66 0.784 . . . . 73.02 109.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 77.5 mt -57.74 -40.89 80.73 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.431 -0.349 . . . . 62.24 111.744 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 20.8 mtm180 -65.2 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.34 0.591 . . . . 72.24 110.028 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 m -72.95 -36.91 67.26 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.267 -0.879 . . . . 71.41 109.709 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.5 m -77.77 -37.82 48.12 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 116.085 -0.507 . . . . 63.01 111.394 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.77 -5.11 41.56 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.344 0.593 . . . . 75.55 111.26 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.74 120.61 20.51 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.747 -1.205 . . . . 71.21 107.747 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.44 47.52 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.381 -0.914 . . . . 51.01 111.843 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.7 p -118.5 166.18 14.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.461 -0.941 . . . . 71.14 108.461 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 10.69 1.79 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.401 2.067 . . . . 63.22 112.759 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.9 126.15 35.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.911 0.386 . . . . 51.53 111.9 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.4 p -100.98 151.97 21.14 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.458 -0.571 . . . . 53.44 109.458 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.81 148.0 33.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.183 0.447 . . . . 72.31 110.405 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -129.14 139.37 51.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.123 0.786 . . . . 75.35 113.123 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.68 -0.08 29.5 Favored Glycine 0 C--O 1.236 0.239 0 CA-C-N 115.444 -0.798 . . . . 70.31 114.33 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 61.92 10.71 3.71 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.198 0.999 . . . . 71.35 111.676 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.56 138.28 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.41 0.624 . . . . 74.43 110.292 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -145.62 169.91 17.5 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.545 -0.752 . . . . 73.45 110.027 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 85.5 m-85 -115.52 148.35 39.61 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.056 -0.52 . . . . 74.44 110.104 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.55 125.52 53.89 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.343 -1.725 . . . . 63.23 106.343 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -130.77 149.11 52.56 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 111.747 0.277 . . . . 70.34 111.747 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.164 0 N-CA-C 111.027 -0.829 . . . . 60.24 111.027 -178.465 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 . . . . . 0 C--O 1.236 0.392 0 N-CA-C 114.279 1.215 . . . . 71.22 114.279 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -128.97 127.41 41.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.325 -1.732 . . . . 71.41 106.325 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -145.17 156.2 43.73 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.116 -0.633 . . . . 74.12 109.865 -171.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.4 mt-10 -129.33 147.91 51.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.793 -0.447 . . . . 74.24 109.793 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 132' ' ' SER . 73.9 t -125.24 118.71 53.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.091 -1.448 . . . . 61.11 107.091 173.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.4 m0 -106.45 120.83 42.95 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.473 -0.936 . . . . 74.45 108.473 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 58.3 tp -98.29 128.65 44.83 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.519 -1.289 . . . . 63.04 107.519 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.08 135.27 27.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.119 0.485 . . . . 63.13 111.646 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' THR . 21.0 pttp -77.1 143.28 39.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.78 -0.645 . . . . 71.11 111.886 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.421 0 CA-C-O 118.062 -0.97 . . . . 73.44 109.007 176.07 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.9 p90 . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 108.588 -0.893 . . . . 73.44 108.588 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.79 107.96 19.22 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.027 -0.731 . . . . 62.33 109.027 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.34 116.91 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.657 -1.156 . . . . 64.03 109.711 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -90.3 -29.17 18.29 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.294 0.479 . . . . 64.52 112.294 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -173.55 154.94 2.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.049 0.452 . . . . 22.33 109.818 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.15 157.03 45.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.316 -0.994 . . . . 73.43 108.316 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.69 -158.8 27.83 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.499 -1.334 . . . . 63.23 113.017 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.02 -119.78 4.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.415 -0.674 . . . . 60.42 111.415 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -116.44 171.28 7.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 110.134 -0.321 . . . . 74.24 110.134 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 43.9 mt-10 -85.0 156.89 20.94 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.231 -1.766 . . . . 72.13 106.231 166.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 14.6 t70 78.15 -45.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.524 0.73 . . . . 73.42 110.533 -171.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.34 108.93 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 108.715 -0.846 . . . . 62.33 108.715 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.4 m -124.38 134.04 53.24 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.62 -1.252 . . . . 72.43 107.62 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -113.31 161.67 16.96 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.358 0.873 . . . . 75.13 113.358 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -133.08 125.13 28.92 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.478 -1.675 . . . . 64.04 106.478 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.45 114.0 26.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 106.989 -1.486 . . . . 75.2 106.989 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -141.39 144.34 34.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.402 0.519 . . . . 75.53 112.402 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.49 136.23 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.288 -1.745 . . . . 72.34 106.288 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.422 ' SG ' HG13 ' A' ' 128' ' ' ILE . 83.0 m -63.91 153.87 35.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.13 0.789 . . . . 72.24 113.13 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -75.09 -34.77 61.78 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.165 -0.925 . . . . 72.45 111.016 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 91.9 10.98 60.8 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 118.454 -1.831 . . . . 74.21 112.095 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.23 164.14 52.33 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 111.052 -0.819 . . . . 22.03 111.052 -176.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -88.64 129.67 35.46 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.939 -0.763 . . . . 74.21 108.939 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 36.3 m-85 -126.89 165.4 19.43 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.582 -0.735 . . . . 72.31 110.027 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.412 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.34 116.37 30.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.7 -1.222 . . . . 75.03 107.7 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.8 t -131.86 146.85 52.36 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.566 0.698 . . . . 72.22 112.137 -175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG21 ' HD2' ' A' ' 61' ' ' LYS . 7.5 p -133.28 138.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 107.366 -1.346 . . . . 73.25 107.366 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 16.5 pt-20 -126.71 139.07 53.42 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.264 -0.574 . . . . 62.32 111.19 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 50.0 t -127.5 140.08 50.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.385 -1.339 . . . . 62.32 107.385 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.1 p -125.49 163.22 23.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.989 0.737 . . . . 72.13 112.989 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 68.44 6.03 5.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.123 1.369 . . . . 74.44 112.877 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 88.4 mttt -124.87 147.25 55.88 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 116.513 -0.312 . . . . 75.2 110.361 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 46.9 Cg_exo -58.95 156.58 32.84 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.693 2.262 . . . . 64.32 110.829 173.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 25.1 t -48.12 -43.3 11.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 113.111 0.782 . . . . 71.23 113.111 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -59.54 -41.74 90.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.931 0.396 . . . . 34.12 111.449 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 8.3 mm-40 -73.46 -46.45 48.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 64.04 110.809 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.81 -44.02 94.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.482 -0.781 . . . . 62.3 111.073 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.1 -42.05 85.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.857 -0.611 . . . . 71.11 111.649 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -64.43 -28.11 69.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.033 0.753 . . . . 74.45 113.033 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.2 -33.8 24.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.02 0.438 . . . . 72.25 111.613 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.83 -32.7 59.91 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.556 0.576 . . . . 51.54 112.556 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.538 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 5.9 mmt -53.0 -56.84 19.58 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.32 1.23 . . . . 73.33 114.32 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.15 -31.65 84.19 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.197 1.931 . . . . 72.12 111.841 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.594 ' HD3' ' HB2' ' A' ' 119' ' ' SER . 91.3 mttt -65.45 -41.02 93.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.145 -0.479 . . . . 63.15 110.751 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.15 -38.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.343 0.592 . . . . 73.44 110.008 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.27 -30.66 71.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.207 0.817 . . . . 43.1 113.207 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.02 -29.69 60.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.218 0.533 . . . . 61.43 109.925 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -64.57 -60.97 2.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.533 -0.758 . . . . 74.01 110.957 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 p -75.48 -17.96 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.437 0.637 . . . . 64.23 110.485 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.4 -28.39 73.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.976 -0.556 . . . . 30.31 113.139 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.684 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.64 3.33 6.04 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.189 -1.005 . . . . 73.1 112.852 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.4 m -95.23 22.41 6.82 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.811 0.815 . . . . 51.15 109.948 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.41 ' HA ' ' OG ' ' A' ' 116' ' ' SER . 7.9 p30 -88.07 172.73 9.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 74.42 110.827 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 9.2 t70 -67.72 -34.32 76.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.89 -0.595 . . . . 51.02 112.518 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -78.75 -12.45 60.02 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.434 0.635 . . . . 65.03 109.683 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.69 25.07 75.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.446 -0.797 . . . . 74.4 112.645 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.684 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 34.1 m -90.41 146.79 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 120.066 -0.653 . . . . 74.4 109.888 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.99 -153.46 19.86 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.945 -0.862 . . . . 64.5 110.945 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.6 ttt -80.57 72.08 7.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.007 0.908 . . . . 74.14 110.204 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.96 3.05 41.17 Favored Glycine 0 N--CA 1.438 -1.202 0 CA-C-N 114.729 -1.123 . . . . 71.35 110.976 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.8 ptm -125.11 121.66 34.89 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.667 -0.864 . . . . 71.35 108.667 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -126.84 116.22 20.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.218 -0.446 . . . . 64.54 111.81 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 103' ' ' ARG . 57.4 t -150.47 139.39 13.01 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 105.52 -2.03 . . . . 71.54 105.52 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.97 138.97 88.51 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 121.344 1.363 . . . . 71.12 110.427 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.85 139.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.963 -0.754 . . . . 71.31 108.963 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 m -118.98 145.05 46.14 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.864 -0.791 . . . . 74.35 108.864 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -132.42 137.0 47.14 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 119.949 -0.7 . . . . 72.12 109.658 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.94 135.14 34.42 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.499 -0.773 . . . . 52.31 109.008 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.77 149.71 25.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 54.52 107.798 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.651 ' CE2' ' HE3' ' A' ' 97' ' ' LYS . 67.5 m-85 -119.19 99.78 50.48 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 107.186 -1.413 . . . . 74.45 107.186 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.49 158.9 50.29 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.543 2.162 . . . . 63.43 114.542 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -103.53 160.15 14.98 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.673 -1.603 . . . . 74.23 106.673 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.2 -17.5 64.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.061 0.458 . . . . 73.11 111.795 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.54 -7.3 56.08 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.957 -0.565 . . . . 53.12 110.983 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.72 -6.06 84.01 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.696 -0.764 . . . . 72.3 112.295 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.1 m -83.94 136.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.11 0.481 . . . . 62.32 110.332 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 89.0 mt -93.59 98.63 11.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.728 0.775 . . . . 74.01 111.193 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 29.6 tt0 -148.13 170.43 17.84 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.795 -1.187 . . . . 73.11 107.795 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 105.09 -65.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 126.697 1.999 . . . . 73.31 112.255 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HE3' ' CE2' ' A' ' 87' ' ' PHE . 33.7 ttpt -159.24 150.05 19.72 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.482 -0.326 . . . . 74.31 110.649 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.472 HD12 HG13 ' A' ' 51' ' ' VAL . 5.0 tt -142.84 136.56 28.86 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.022 -1.103 . . . . 71.41 108.022 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 68.2 mttm -122.02 115.67 22.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.469 -0.567 . . . . 75.13 109.469 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 43' ' ' THR . 87.7 t -88.41 128.05 40.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.899 -1.149 . . . . 63.03 107.899 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.11 123.86 46.62 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.293 -0.632 . . . . 73.45 109.293 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -102.99 112.61 25.53 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.471 -1.677 . . . . 64.22 106.471 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 80' ' ' VAL . 1.1 tmt_? -76.84 113.06 14.11 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.957 -1.498 . . . . 70.23 106.957 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 40' ' ' LYS . 76.8 mt -73.36 138.7 78.21 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 115.926 -0.579 . . . . 60.04 110.555 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.7 161.32 45.83 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.504 2.136 . . . . 73.32 112.002 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.428 ' C ' HD22 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -50.4 -35.22 27.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.296 1.438 . . . . 74.24 111.081 -176.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.04 -42.96 99.47 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.419 0.688 . . . . 72.52 111.992 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -99.76 -1.74 36.93 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 114.011 1.115 . . . . 73.44 114.011 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.714 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -62.97 -28.75 70.3 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.421 1.267 . . . . 63.12 114.421 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -39.38 32.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.89 -1.147 . . . . 52.54 111.942 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.9 m -149.0 94.4 4.03 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 109.251 -0.648 . . . . 74.31 109.251 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.63 158.1 12.26 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.417 2.078 . . . . 74.23 111.638 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.46 131.68 46.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.985 1.79 . . . . 55.33 109.943 175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -66.23 140.27 96.77 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.319 -0.401 . . . . 73.24 110.358 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.61 101.5 1.04 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.438 2.092 . . . . 70.33 111.952 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 11.4 p -81.02 2.19 28.08 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.605 1.162 . . . . 72.43 111.886 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.542 ' HB3' HG12 ' A' ' 120' ' ' VAL . 13.1 t70 -113.27 152.69 29.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.415 -0.957 . . . . 74.51 108.415 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -13.16 45.5 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 115.372 1.619 . . . . 70.44 115.372 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.594 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 71.9 m -97.85 -28.84 13.66 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.152 -0.619 . . . . 73.45 111.898 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 117' ' ' ASP . 6.8 p -94.68 128.04 46.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.844 -0.743 . . . . 63.13 109.478 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -124.49 153.29 42.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.996 -0.742 . . . . 64.33 108.996 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.9 mm -92.45 111.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 72.33 107.793 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -127.0 145.74 50.6 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.519 -0.764 . . . . 53.04 109.887 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.45 144.99 33.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.845 -0.798 . . . . 55.45 108.845 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.6 tpt180 -134.85 123.06 22.91 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.445 -0.902 . . . . 63.13 109.901 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.56 173.79 11.22 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.529 -0.545 . . . . 64.13 109.529 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.11 19.03 70.64 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.822 -0.626 . . . . 51.14 112.617 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.422 HG13 ' SG ' ' A' ' 36' ' ' CYS . 43.3 pt -128.37 145.53 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 121.17 0.51 . . . . 73.5 111.02 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 60.0 m -104.07 129.72 51.74 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 107.449 -1.315 . . . . 62.13 107.449 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.25 151.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.43 -0.581 . . . . 62.5 109.43 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 72.0 m-85 -114.04 121.48 43.97 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.308 -1.738 . . . . 64.44 106.308 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.5 m -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 109.869 -0.419 . . . . 70.45 109.869 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.0 t -118.32 131.38 56.33 Favored 'General case' 0 N--CA 1.411 -2.4 0 C-N-CA 120.391 -0.523 . . . . 71.35 110.067 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.654 ' HG2' ' HG3' ' A' ' 184' ' ' GLU . 51.4 mt-30 -110.84 128.36 55.75 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.089 -1.078 . . . . 74.0 108.089 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.2 p90 -114.68 135.68 53.89 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 115.309 -0.86 . . . . 74.55 110.563 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.14 101.57 2.61 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.408 -1.077 . . . . 55.15 110.408 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.06 167.82 27.28 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.231 -0.748 . . . . 61.52 111.231 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -75.44 139.72 42.46 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 110.124 -0.324 . . . . 72.32 110.124 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -116.04 123.76 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.549 0.69 . . . . 34.22 112.246 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.449 ' HG2' ' OE2' ' A' ' 141' ' ' GLU . 26.3 ttpp -115.68 170.53 8.38 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 104.721 -2.326 . . . . 75.2 104.721 172.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -51.54 -42.86 62.11 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.901 0.773 . . . . 73.43 113.058 -174.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.5 67.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.469 -0.332 . . . . 64.33 111.828 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -69.07 -37.11 78.33 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.968 -0.293 . . . . 70.14 111.112 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.69 -42.55 88.83 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.672 -0.492 . . . . 73.33 109.672 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.72 -40.7 84.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.424 -0.807 . . . . 74.41 109.794 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -61.93 -47.6 84.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 74.33 111.24 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -69.04 -33.52 73.72 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 112.228 0.455 . . . . 74.31 112.228 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.29 92.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.177 0.513 . . . . 73.52 109.969 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 76.5 m -62.91 -46.93 85.49 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.675 -0.693 . . . . 64.42 110.125 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 25.8 mt-30 -59.92 -38.36 82.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.107 -0.497 . . . . 55.14 110.359 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.25 -43.58 96.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.845 -0.616 . . . . 71.53 110.995 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -63.39 -39.18 93.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 65.14 109.61 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -71.78 -30.81 65.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.203 -0.908 . . . . 74.21 111.133 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.7 m -76.74 -34.69 58.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.282 0.563 . . . . 52.25 109.67 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.96 7.71 12.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.928 -0.578 . . . . 62.51 111.027 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -74.49 130.64 39.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.331 -0.618 . . . . 64.53 109.331 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.23 3.45 58.81 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.939 -0.648 . . . . 52.52 112.128 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 54.5 p -112.18 165.64 12.55 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.764 -0.828 . . . . 73.32 108.764 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.28 14.93 0.53 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.764 2.31 . . . . 71.44 112.872 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.67 109.83 3.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.084 0.469 . . . . 44.51 110.562 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.6 p -95.97 156.54 16.29 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.909 -1.145 . . . . 74.13 107.909 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.505 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 19.9 m-85 -132.64 151.27 52.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.595 -0.842 . . . . 74.14 109.277 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -127.3 122.33 33.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.002 0.43 . . . . 74.41 111.32 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.09 0.73 37.03 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.334 -0.848 . . . . 74.3 113.352 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.63 18.47 10.56 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.561 1.172 . . . . 53.44 109.366 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.27 139.22 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 113.724 -1.58 . . . . 74.22 112.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.445 ' OH ' HD21 ' A' ' 94' ' ' LEU . 11.4 p90 -149.41 167.66 25.56 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.194 -0.912 . . . . 65.33 110.747 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 2.8 m-85 -116.0 153.47 31.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 123.586 0.754 . . . . 71.11 109.557 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.9 m -124.03 131.41 53.55 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.252 -1.388 . . . . 63.35 107.252 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.77 148.11 51.61 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.544 0.572 . . . . 74.32 112.544 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.688 0 N-CA-C 108.647 -1.781 . . . . 73.41 108.647 179.51 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 C--O 1.222 -0.37 0 N-CA-C 115.721 1.749 . . . . 75.24 115.721 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 182' ' ' ARG . 0.7 OUTLIER -117.08 130.37 56.6 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 118.2 -1.4 . . . . 73.42 110.269 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 40.4 m-80 -144.16 148.02 34.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.854 -1.165 . . . . 74.15 107.854 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.654 ' HG3' ' HG2' ' A' ' 134' ' ' GLN . 2.5 mp0 -112.04 144.36 41.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.115 0.484 . . . . 71.11 110.873 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 57.8 t -125.52 118.84 53.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.366 -1.716 . . . . 73.14 106.366 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.495 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 27.9 m0 -106.52 120.77 42.81 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.131 -0.692 . . . . 74.33 109.131 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 tp -98.88 133.94 42.46 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.363 -1.347 . . . . 62.22 107.363 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.25 126.86 45.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.328 -0.549 . . . . 71.12 111.32 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.2 tttm -75.14 137.85 41.64 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.886 -0.597 . . . . 74.54 109.808 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.301 -1.528 0 CA-C-O 118.259 -0.877 . . . . 73.52 108.86 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.7 p90 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 108.47 -0.937 . . . . 74.21 108.47 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -106.63 115.44 30.21 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.371 -0.377 . . . . 73.34 111.397 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 121.05 41.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.739 0.781 . . . . 71.12 109.966 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.24 -24.16 15.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.608 -0.723 . . . . 71.31 111.754 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -165.93 148.5 7.33 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.868 0.366 . . . . 74.44 110.29 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.9 p -134.56 164.31 27.78 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.95 -1.023 . . . . 74.54 110.321 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.94 -136.34 12.86 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 119.964 -1.112 . . . . 64.55 113.809 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.31 -108.26 2.89 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.85 -1.3 . . . . 73.45 109.85 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -108.9 168.02 9.66 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.458 -1.312 . . . . 72.01 107.458 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.65 154.08 25.08 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 118.62 0.646 . . . . 65.25 111.223 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 72.58 -64.77 0.38 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.93 1.292 . . . . 74.35 110.321 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.9 t -92.6 109.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.756 -1.942 . . . . 73.13 105.756 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 m -133.4 154.31 50.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.907 -0.775 . . . . 52.33 108.907 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.32 160.56 18.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.513 0.673 . . . . 74.04 111.668 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.92 124.95 25.74 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.832 -1.914 . . . . 71.12 105.832 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.86 114.08 27.85 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.221 -1.77 . . . . 74.33 106.221 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.22 146.65 52.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.413 0.625 . . . . 72.33 111.652 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.82 136.14 33.51 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.745 -1.576 . . . . 71.43 106.745 172.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -60.44 162.57 6.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.53 0.937 . . . . 55.02 113.53 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -83.69 -20.77 32.91 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.656 -0.702 . . . . 64.24 110.42 -177.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 95.57 11.1 56.11 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 119.362 -1.399 . . . . 73.43 112.077 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.21 160.71 54.1 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 120.877 -0.678 . . . . 51.42 112.923 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 17.1 ptpt -96.76 130.68 43.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.948 -0.76 . . . . 74.23 108.948 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.468 ' HD1' ' H ' ' A' ' 104' ' ' ILE . 58.9 m-85 -130.66 164.43 25.02 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.509 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.34 120.09 38.14 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 107.762 -1.199 . . . . 62.11 107.762 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.638 ' OG1' ' HE2' ' A' ' 99' ' ' LYS . 9.4 t -135.19 150.49 50.14 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 119.911 -0.716 . . . . 61.32 112.038 -174.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 18.8 m -134.85 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.897 -1.047 . . . . 74.21 109.739 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HB2' ' CD ' ' A' ' 99' ' ' LYS . 34.9 tt0 -123.81 139.8 53.62 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.813 -0.439 . . . . 51.33 109.813 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 58' ' ' ALA . 52.8 t -127.32 133.12 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.328 -1.36 . . . . 74.12 107.328 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 36.2 m -133.14 157.1 46.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.336 -0.616 . . . . 73.12 109.336 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 79.6 -9.38 1.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.794 1.637 . . . . 64.21 109.359 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.5 mttm -111.22 131.53 22.18 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.16 -1.382 . . . . 63.34 109.049 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.24 158.48 35.03 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.053 2.502 . . . . 73.44 110.787 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 98' ' ' LEU . 39.3 t -45.95 -37.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.06 0.944 . . . . 71.23 112.976 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.55 -51.11 69.82 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.216 0.532 . . . . 44.13 110.561 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -76.41 -37.44 57.08 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.176 -0.92 . . . . 62.34 112.237 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.82 91.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.006 -0.543 . . . . 71.51 112.01 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -48.18 77.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.339 -0.615 . . . . 61.21 109.339 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.69 -24.29 66.24 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.792 -0.64 . . . . 73.43 111.983 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 10.4 tp10 -84.5 -45.5 12.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.515 0.674 . . . . 73.44 110.291 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.74 -39.65 69.91 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.596 0.961 . . . . 72.42 113.596 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.5 ttm -57.73 -46.72 99.72 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 114.196 1.184 . . . . 75.32 114.196 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 83.6 Cg_exo -50.89 -37.4 55.68 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.391 2.06 . . . . 74.15 111.233 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HD2' ' CB ' ' A' ' 119' ' ' SER . 43.5 mtmt -68.77 -37.01 79.03 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.683 -0.69 . . . . 75.02 110.792 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.0 mm -76.39 -47.63 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 112.18 0.437 . . . . 74.43 112.18 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 25.0 ptm -62.59 -29.58 70.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.663 0.986 . . . . 71.23 113.663 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.67 -36.27 82.13 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.196 -0.602 . . . . 64.41 110.107 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -56.69 -59.43 5.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.243 -0.435 . . . . 74.33 111.813 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.85 -17.0 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 62.33 110.264 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.86 -14.27 82.53 Favored Glycine 0 C--O 1.24 0.508 0 CA-C-N 115.92 -0.582 . . . . 72.05 113.275 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.19 4.11 2.35 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.684 -1.246 . . . . 60.21 114.552 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.0 m -91.35 23.51 3.35 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 123.077 1.418 . . . . 64.24 110.412 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 114' ' ' ALA . 7.8 p30 -98.73 170.28 8.89 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.099 -0.955 . . . . 75.44 110.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.94 -27.46 62.81 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 111.844 0.313 . . . . 72.2 111.844 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -86.05 -12.41 50.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.56 0.695 . . . . 74.11 110.525 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 31.84 63.2 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 115.319 -0.855 . . . . 63.12 112.518 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.11 123.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.319 -0.552 . . . . 72.3 110.758 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.37 -40.36 1.14 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 110.902 -0.879 . . . . 73.34 110.902 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.5 mtt -107.03 81.21 1.52 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.904 -1.517 . . . . 71.54 106.904 173.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.1 -79.32 0.54 Allowed Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.795 -1.193 . . . . 72.41 114.495 -172.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.484 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 24.1 ptt? -127.8 125.2 39.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.118 0.485 . . . . 75.31 111.945 -173.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 p -125.25 115.92 21.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.693 -0.685 . . . . 44.11 111.182 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.449 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 28.6 m -142.26 175.86 2.71 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.767 -1.568 . . . . 61.53 106.767 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 80' ' ' VAL . 39.8 Cg_exo -59.89 140.11 91.4 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 121.55 1.5 . . . . 71.12 113.268 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.95 153.19 8.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.085 -1.45 . . . . 75.21 107.085 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -140.01 145.23 37.53 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.888 -0.508 . . . . 50.43 109.881 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -136.61 143.11 43.38 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.149 -0.62 . . . . 60.15 111.147 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -92.66 135.6 33.95 Favored 'General case' 0 CA--C 1.478 -1.819 0 O-C-N 123.801 0.688 . . . . 70.23 109.774 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.83 149.73 33.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.156 -1.053 . . . . 64.33 108.156 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.589 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 99.3 m-85 -112.25 108.06 55.16 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.176 -0.675 . . . . 72.33 109.176 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -83.6 151.67 13.25 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.626 1.55 . . . . 54.24 112.358 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.03 168.56 10.01 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.007 . . . . 72.12 108.282 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.55 -19.76 65.86 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.069 0.461 . . . . 64.12 111.626 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -81.07 -6.91 59.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 53.01 110.08 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.36 73.37 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.883 -0.599 . . . . 74.03 111.838 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.0 m -74.46 140.48 44.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.067 -0.716 . . . . 74.31 109.067 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.7 139.65 33.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.023 0.44 . . . . 73.22 111.036 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.3 167.82 19.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 124.225 1.01 . . . . 73.24 111.891 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.6 pttt -70.35 21.87 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 126.224 1.81 . . . . 71.41 114.879 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.589 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 24.2 ttmm -139.66 134.72 32.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 119.449 1.022 . . . . 64.22 110.972 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.655 HD12 HG13 ' A' ' 51' ' ' VAL . 6.0 tt -143.07 130.57 21.17 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 107.998 -1.112 . . . . 53.12 107.998 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.638 ' HE2' ' OG1' ' A' ' 43' ' ' THR . 23.6 tptm -116.11 115.3 25.81 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.466 -0.938 . . . . 71.22 108.466 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.54 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 99.3 t -94.25 126.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.893 -0.41 . . . . 72.05 109.893 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -113.04 124.99 53.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.151 0.581 . . . . 61.53 109.564 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -103.12 113.66 27.31 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.639 -1.615 . . . . 65.14 106.639 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -77.29 131.3 38.08 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.461 -0.79 . . . . 75.04 110.494 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 73.3 mt -100.17 133.86 21.22 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-N 115.031 -0.986 . . . . 44.11 108.556 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 31.9 Cg_exo -58.32 151.53 59.8 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.788 2.325 . . . . 62.22 111.229 175.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.31 -34.25 60.55 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.881 0.872 . . . . 42.11 110.076 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -59.68 -34.33 72.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.903 -0.589 . . . . 73.31 111.873 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.53 -3.98 32.24 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 120.816 -0.354 . . . . 70.3 111.521 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 97.7 mt-30 -70.55 -27.89 64.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.89 0.33 . . . . 72.22 111.89 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.87 -38.16 95.71 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.438 -0.665 . . . . 62.55 111.438 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 t -158.28 90.68 2.19 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 108.724 -0.843 . . . . 72.44 108.724 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -85.85 154.86 10.07 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.026 1.817 . . . . 65.21 112.06 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.5 149.23 83.17 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.193 1.929 . . . . 60.21 110.742 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' ASN . . . -86.9 130.29 49.05 Favored Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 116.299 -0.409 . . . . 72.12 111.112 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.44 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 74.0 Cg_endo -76.89 112.59 3.47 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.904 2.403 . . . . 74.42 111.653 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 79.87 2.93 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.54 -0.864 . . . . 73.11 110.87 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.632 ' HB3' HG12 ' A' ' 120' ' ' VAL . 14.9 t70 -169.66 149.0 3.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.298 -1.742 . . . . 74.31 106.298 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.94 -14.97 59.35 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.944 0.72 . . . . 72.32 112.944 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.573 ' CB ' ' HD2' ' A' ' 61' ' ' LYS . 36.9 m -95.4 -29.71 14.29 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.88 -0.328 . . . . 65.41 111.836 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.632 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.9 p -106.25 116.46 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.54 0 CA-C-O 121.821 0.819 . . . . 74.12 110.575 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -130.74 155.24 46.98 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.144 -1.389 . . . . 74.42 110.19 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.0 mm -91.37 112.64 25.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.56 -0.904 . . . . 74.01 108.56 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -115.58 141.84 47.53 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.157 -0.682 . . . . 72.3 109.157 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -111.18 145.84 37.95 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.575 -0.739 . . . . 71.42 109.756 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -146.98 126.93 13.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.309 0.576 . . . . 62.35 110.805 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -133.76 169.96 16.28 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.106 -0.952 . . . . 75.04 110.346 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 16.38 78.7 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.373 -0.441 . . . . 63.4 113.53 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pp -121.23 162.6 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 119.542 -0.863 . . . . 75.51 109.245 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.416 ' H ' ' HG2' ' A' ' 189' ' ' LYS . 41.7 m -120.29 136.99 54.49 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 115.485 -0.78 . . . . 54.55 109.29 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.418 HG21 ' CE3' ' A' ' 186' ' ' TRP . 15.5 m -124.84 146.35 30.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.314 -0.995 . . . . 60.24 108.314 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.557 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 19.9 m-85 -114.95 121.54 43.47 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 105.932 -1.877 . . . . 75.01 105.932 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 p -117.4 131.5 56.75 Favored 'General case' 0 C--N 1.274 -2.712 0 C-N-CA 120.213 -0.595 . . . . 63.13 111.798 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.488 ' HB ' HD13 ' A' ' 151' ' ' LEU . 8.9 t -113.29 119.14 36.68 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 108.187 -1.042 . . . . 72.22 108.187 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -111.15 126.69 55.11 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 109.183 -0.673 . . . . 72.22 109.183 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 36.3 p90 -142.3 153.48 43.92 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 115.179 -0.918 . . . . 72.33 110.901 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.69 145.25 18.24 Favored Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 110.039 -1.224 . . . . 75.32 110.039 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.67 168.16 11.93 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 109.41 -1.476 . . . . 70.12 109.41 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -68.38 101.54 1.24 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.287 0.565 . . . . 74.23 111.574 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.33 130.85 53.3 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.618 -0.882 . . . . 72.31 108.618 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -89.74 176.91 6.66 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.754 -0.832 . . . . 75.03 108.754 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.41 -31.95 71.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.244 0.545 . . . . 71.2 109.911 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.09 -29.36 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.502 -0.772 . . . . 63.01 109.784 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -69.54 -29.81 67.48 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 116.037 -0.529 . . . . 62.33 111.268 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -59.26 -41.89 89.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.67 -0.412 . . . . 75.11 110.133 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.29 -49.1 84.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.451 -0.795 . . . . 73.11 110.102 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.04 -44.49 84.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.656 . . . . 33.32 111.79 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -63.53 -31.55 72.75 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 112.538 0.57 . . . . 73.25 112.538 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.63 85.3 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.352 -0.61 . . . . 73.02 109.352 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.429 HG23 ' NH2' ' A' ' 152' ' ' ARG . 22.1 m -66.83 -41.31 87.65 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 115.654 -0.703 . . . . 74.4 111.46 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.2 -37.48 85.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.428 . . . . 72.32 109.97 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.488 HD13 ' HB ' ' A' ' 133' ' ' THR . 52.5 tp -62.18 -41.99 98.86 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.723 -0.671 . . . . 72.23 110.224 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.537 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.8 mtm105 -62.22 -46.93 86.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.568 -0.287 . . . . 72.43 111.063 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.2 m -61.59 -34.37 75.5 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.877 0.736 . . . . 72.31 110.431 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 30.0 m -76.99 -35.43 57.16 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.86 -0.609 . . . . 75.2 110.164 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.1 mt -70.05 -31.4 69.0 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 113.354 0.872 . . . . 64.22 113.354 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 46.1 mt-10 -46.31 131.1 10.67 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.621 0.6 . . . . 72.11 112.621 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.64 12.64 43.5 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.516 -1.034 . . . . 52.23 110.516 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.9 t -102.56 149.72 36.98 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 109.06 -0.719 . . . . 61.21 109.06 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -75.18 -4.82 15.91 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.594 2.196 . . . . 74.32 111.173 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.557 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -71.99 147.04 47.29 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.771 -0.65 . . . . 61.45 110.854 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 74.0 p -108.02 138.05 44.95 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.3 -0.63 . . . . 60.12 109.3 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -144.02 150.51 38.36 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 122.29 -0.256 . . . . 62.2 110.938 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.514 ' O ' HG12 ' A' ' 166' ' ' VAL . 29.0 pt20 -129.33 122.84 30.38 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.999 1.111 . . . . 71.34 113.999 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.71 12.79 62.5 Favored Glycine 0 C--N 1.309 -0.964 0 N-CA-C 115.207 0.843 . . . . 63.53 115.207 164.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.401 ' O ' ' HD1' ' A' ' 167' ' ' TYR . 25.4 t70 67.43 19.76 9.99 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.959 0.409 . . . . 41.04 110.641 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 163' ' ' GLN . 7.2 p -64.81 137.95 24.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 120.367 -0.533 . . . . 62.14 109.788 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' ASP . 26.9 p90 -151.12 170.83 18.46 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.701 0.762 . . . . 74.21 111.644 -173.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 97.2 m-85 -114.64 151.65 33.19 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.216 -1.356 . . . . 75.41 109.737 175.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.54 122.16 45.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.506 -1.294 . . . . 73.45 107.506 174.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -112.18 142.41 44.69 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.153 0.283 . . . . 53.11 111.436 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.987 0 N-CA-C 110.039 -1.224 . . . . 72.23 110.039 179.79 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 CA--C 1.511 -0.548 0 CA-C-O 120.964 0.411 . . . . 73.25 110.069 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -109.13 132.94 53.64 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.739 -1.208 . . . . 73.33 107.739 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.442 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.7 m-80 -134.37 134.29 41.56 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.385 -0.969 . . . . 71.4 108.385 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 7.7 mp0 -128.82 136.35 50.37 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.865 -0.42 . . . . 74.3 109.865 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.1 t -124.74 121.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.468 -0.938 . . . . 70.4 108.468 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.6 m0 -103.21 123.15 46.19 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 108.087 -1.079 . . . . 72.31 108.087 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 166' ' ' VAL . 1.7 tt -97.35 138.57 34.61 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.896 -1.52 . . . . 63.11 106.896 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.483 HG22 ' CE2' ' A' ' 168' ' ' TYR . 20.7 t -87.88 131.98 34.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 110.455 -0.202 . . . . 73.24 110.455 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.578 ' HD2' ' C ' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -70.39 143.38 51.9 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 118.551 -0.738 . . . . 65.44 109.333 176.504 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.402 ' CD1' ' HD2' ' A' ' 34' ' ' ARG . 8.6 p90 . . . . . 0 N--CA 1.431 -1.379 0 N-CA-C 105.3 -2.111 . . . . 75.43 105.3 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -106.03 114.98 29.44 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.997 -1.081 . . . . 74.25 111.963 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.51 121.16 35.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.311 -1.737 . . . . 61.45 106.311 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.3 -26.42 20.01 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.389 -0.924 . . . . 72.24 110.758 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -175.99 165.31 2.92 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.681 -0.859 . . . . 74.15 108.681 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.4 HG22 ' HG3' ' A' ' 32' ' ' GLU . 36.4 p -132.57 150.02 52.22 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.771 -1.196 . . . . 70.15 107.771 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.39 113.61 2.11 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.101 -1.523 . . . . 73.03 113.406 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.25 -99.49 0.49 Allowed Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 110.857 -0.897 . . . . 41.12 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -98.87 169.1 9.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.302 -0.999 . . . . 74.42 108.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.48 157.38 23.62 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.504 -0.554 . . . . 74.01 109.504 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 72.74 -58.28 0.6 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.408 1.083 . . . . 64.12 110.875 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.86 111.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.823 0.82 . . . . 70.01 108.791 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.5 m -106.37 136.91 45.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.826 -0.625 . . . . 72.12 109.809 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.49 160.14 18.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.597 -0.841 . . . . 75.12 111.405 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 34.7 tt0 -134.61 124.29 25.17 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.646 -1.613 . . . . 63.24 106.646 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.8 115.66 30.86 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.042 0.925 . . . . 73.31 110.835 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 22.1 ptt180 -128.81 138.58 52.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 114.458 -1.246 . . . . 74.21 110.871 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.22 136.94 32.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.071 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.01 148.92 28.98 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.945 0.778 . . . . 75.11 109.718 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -77.62 -13.55 59.88 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 112.496 0.554 . . . . 74.22 112.496 -175.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.29 61.68 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.219 -1.467 . . . . 53.21 113.253 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 163.65 40.17 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.616 -1.278 . . . . 72.54 112.337 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.537 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.4 ptpt -96.03 133.9 39.71 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 75.11 108.375 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 37.0 m-85 -124.52 163.12 22.54 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.269 -0.423 . . . . 73.21 111.922 -171.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -99.53 116.63 32.12 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.575 -0.898 . . . . 72.45 108.575 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.4 t -123.29 149.64 44.56 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 121.23 0.538 . . . . 72.15 110.978 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.4 m -127.09 123.27 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.098 -0.955 . . . . 63.23 109.41 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -109.89 132.57 54.03 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.44 0.638 . . . . 71.14 112.504 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 54' ' ' ALA . 42.1 t -129.41 136.9 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.569 -1.271 . . . . 74.02 107.569 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 49' ' ' LYS . 31.0 m -138.75 164.83 28.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.712 -1.218 . . . . 73.33 107.712 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 47' ' ' THR . 14.1 t70 76.16 -26.47 0.19 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.012 1.325 . . . . 74.55 110.309 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 47' ' ' THR . 54.0 mtmt -103.16 122.59 44.83 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 114.483 -1.235 . . . . 72.42 108.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.48 158.79 1.57 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 124.596 3.531 . . . . 73.11 114.416 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.409 HG13 HD12 ' A' ' 98' ' ' LEU . 53.6 t -46.66 -41.47 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.452 1.101 . . . . 61.42 112.055 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.688 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 24.5 t70 -58.81 -43.45 90.56 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.638 -0.256 . . . . 70.02 110.517 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -73.77 -47.67 37.33 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.335 0.654 . . . . 64.2 110.85 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -56.77 -41.56 77.85 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.442 -0.799 . . . . 74.22 111.698 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 59' ' ' MET . 45.1 tp -68.72 -35.71 77.49 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.342 -0.39 . . . . 74.51 110.443 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 17.6 mtp180 -56.89 -46.0 82.18 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.206 0.527 . . . . 74.3 111.624 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.58 -35.33 39.84 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.429 -0.805 . . . . 74.43 112.292 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.29 -32.91 59.03 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.37 0.878 . . . . 72.32 113.37 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.447 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 5.2 mmt -56.26 -57.91 19.86 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.121 0.786 . . . . 74.4 113.121 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.612 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 28.9 Cg_endo -63.9 -32.49 66.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 121.867 1.712 . . . . 64.22 110.552 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -58.35 -45.65 87.78 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.923 -1.035 . . . . 54.42 110.796 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.5 mm -75.63 -47.63 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.219 -0.446 . . . . 73.42 111.389 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.505 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.292 3.7 ppp? -62.85 -32.23 73.41 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.667 1.358 . . . . 75.04 114.667 -174.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 60' ' ' PRO 0.295 0.0 OUTLIER -77.65 -29.09 51.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.697 -1.201 . . . . 71.23 112.504 176.347 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' THR . 62.2 t80 -65.07 -52.23 56.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.343 0.592 . . . . 74.41 110.207 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -72.19 -15.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.556 -0.747 . . . . 73.1 111.853 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.4 -11.58 68.82 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.439 -0.801 . . . . 70.34 112.458 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.0 -23.32 1.44 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.486 -1.34 . . . . 44.44 113.577 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 58.0 m -82.0 70.01 8.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.65 1.214 . . . . 74.24 111.976 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -98.36 170.16 9.05 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.528 -2.027 . . . . 72.3 105.528 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 36.6 t70 -69.31 -33.52 73.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 119.809 -0.756 . . . . 64.33 111.723 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.2 1.91 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 72.24 110.792 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.86 28.57 72.96 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.638 -0.71 . . . . 64.21 113.656 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.16 120.73 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 109.3 -0.629 . . . . 72.43 109.3 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.76 -135.3 1.85 Allowed Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 111.0 -0.84 . . . . 54.44 111.0 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.8 ttp 178.0 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.271 0.558 . . . . 54.03 111.284 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.54 65.58 0.58 Allowed Glycine 0 CA--C 1.491 -1.414 0 N-CA-C 106.291 -2.724 . . . . 60.53 106.291 -169.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.469 ' H ' ' HG2' ' A' ' 78' ' ' MET . 11.4 ptm -97.01 121.94 39.45 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.266 -0.967 . . . . 72.55 111.448 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -128.26 134.93 49.05 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.712 -0.676 . . . . 64.53 111.589 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m -157.11 172.29 6.33 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 104.991 -2.226 . . . . 71.25 104.991 171.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 86.3 Cg_exo -54.18 139.52 72.09 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 121.431 1.42 . . . . 75.44 113.161 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.83 142.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.421 -1.326 . . . . 41.13 107.421 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.6 p -138.33 144.5 40.41 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.952 -0.299 . . . . 62.33 110.234 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 50.4 p90 -131.01 143.73 50.94 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.582 -0.447 . . . . 73.22 110.96 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.35 134.24 35.78 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.602 0.564 . . . . 74.33 110.6 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.26 150.79 32.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.438 -0.801 . . . . 74.12 109.799 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 95' ' ' GLN . 78.9 m-85 -114.75 112.69 45.1 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.951 -0.389 . . . . 74.04 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.59 158.83 2.93 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.869 1.713 . . . . 63.53 111.289 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -104.67 160.76 14.7 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.279 -1.749 . . . . 72.21 106.279 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.01 -24.73 64.73 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.49 0.662 . . . . 74.11 111.058 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.57 -5.89 47.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.01 -0.995 . . . . 73.33 110.804 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.91 -10.67 74.29 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.846 -0.502 . . . . 44.4 111.846 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 m -77.22 136.01 38.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 109.032 -0.729 . . . . 74.13 109.032 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.3 mt -84.72 136.85 33.55 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.069 0.461 . . . . 72.25 111.037 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 53.1 tt0 -81.9 144.97 30.6 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.769 -1.567 . . . . 71.53 106.769 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -92.29 80.12 5.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.364 1.246 . . . . 70.51 114.364 -174.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.645 ' HE2' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -160.42 122.37 3.18 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.434 -2.802 . . . . 52.44 103.434 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.645 ' N ' ' HE2' ' A' ' 97' ' ' LYS . 5.2 tt -144.11 137.62 27.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.77 0.319 . . . . 62.35 110.515 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -129.09 123.88 33.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.205 -0.598 . . . . 65.34 110.553 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.553 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 86.2 t -86.94 129.78 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.629 -0.714 . . . . 71.51 109.145 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -107.16 127.87 53.9 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.622 -0.51 . . . . 74.22 109.622 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -104.04 117.71 34.94 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.812 -1.181 . . . . 74.51 107.812 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 59.4 ttt-85 -75.34 129.46 37.42 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.023 -1.473 . . . . 74.02 107.023 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.4 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 79.7 mt -89.87 134.28 32.31 Favored Pre-proline 0 C--N 1.271 -2.831 0 N-CA-C 109.868 -0.419 . . . . 73.44 109.868 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 74.7 Cg_exo -53.59 158.84 7.34 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.021 2.481 . . . . 74.51 112.972 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -46.27 -54.32 9.08 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 126.137 1.775 . . . . 73.12 115.585 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -72.29 -28.15 62.91 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.053 -0.659 . . . . 72.12 112.456 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.89 -12.56 55.28 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.623 -0.431 . . . . 73.34 111.458 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 49.9 mt-30 -70.9 -28.53 64.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.748 0.309 . . . . 62.41 111.482 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -38.24 92.38 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.975 -0.631 . . . . 60.44 111.64 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -157.41 98.9 1.93 Allowed Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.6 158.95 10.73 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.75 2.3 . . . . 75.2 112.586 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.5 156.2 66.4 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.434 2.089 . . . . 74.12 111.511 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -72.74 142.46 83.47 Favored Pre-proline 0 N--CA 1.426 -1.665 0 CA-C-N 115.958 -0.565 . . . . 61.24 110.011 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.74 114.74 3.43 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.844 2.362 . . . . 63.02 112.088 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -61.14 -42.65 98.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.739 -0.664 . . . . 75.3 109.498 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.539 ' HB2' HG23 ' A' ' 120' ' ' VAL . 9.0 m-20 -91.19 161.07 15.23 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 63.32 110.256 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -87.18 -28.4 22.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.507 -0.77 . . . . 63.01 109.03 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.3 p -79.07 -12.25 60.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.657 -0.701 . . . . 55.11 112.025 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 117' ' ' ASP . 59.3 t -100.14 116.99 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 105.833 -1.914 . . . . 63.13 105.833 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -128.78 143.43 50.92 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 120.701 -0.4 . . . . 74.53 110.316 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.0 mm -92.45 112.76 26.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.462 -0.94 . . . . 75.43 108.462 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.82 153.11 38.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.862 -0.792 . . . . 71.43 108.862 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 4.5 mp0 -98.45 146.87 25.3 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.994 0.426 . . . . 74.52 110.24 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 125' ' ' ARG . 32.6 mmt180 -134.54 120.99 20.35 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.637 -0.71 . . . . 75.13 109.697 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.28 156.15 43.65 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.651 -0.87 . . . . 70.32 108.651 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.22 19.39 78.48 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.194 -1.003 . . . . 50.15 114.096 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -120.08 145.25 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 C-N-CA 119.92 -0.712 . . . . 71.31 109.588 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.0 m -112.59 138.46 49.34 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 105.646 -1.983 . . . . 52.23 105.646 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.88 148.33 26.73 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 108.3 -1.0 . . . . 52.44 108.3 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -112.56 121.05 43.66 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 103.646 -2.724 . . . . 75.42 103.646 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.2 m -122.34 135.2 54.67 Favored 'General case' 0 C--N 1.263 -3.162 0 C-N-CA 120.587 -0.445 . . . . 60.45 109.926 -174.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.6 t -112.51 136.81 51.59 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 108.727 -0.842 . . . . 53.32 108.727 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 9.3 pt20 -117.25 130.03 56.3 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.527 -0.761 . . . . 65.23 109.404 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.83 168.37 19.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.405 -0.816 . . . . 71.23 109.515 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -126.38 136.35 9.48 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.922 -0.656 . . . . 64.42 112.022 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 152.01 -163.22 30.06 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.203 -1.159 . . . . 54.42 110.203 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -99.13 107.71 20.14 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.562 -0.903 . . . . 74.23 108.562 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.18 133.38 35.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.203 1.186 . . . . 64.23 114.203 -172.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HB3' ' OE1' ' A' ' 141' ' ' GLU . 25.4 mtpp -112.33 177.5 4.62 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.941 -1.503 . . . . 73.34 106.941 170.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -63.27 -34.46 77.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.075 0.464 . . . . 54.13 109.98 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.57 -30.0 71.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.525 -0.762 . . . . 54.03 111.254 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.2 -31.72 71.43 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.968 0.413 . . . . 54.23 110.789 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' A' ' 185' ' ' VAL . 90.8 m-85 -73.03 -43.98 61.39 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.047 -0.524 . . . . 61.54 109.935 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.22 -48.36 87.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 O-C-N 123.42 0.45 . . . . 74.33 110.38 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.51 87.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.574 -0.739 . . . . 50.14 111.546 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.444 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 65.1 m80 -71.08 -34.8 71.52 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.463 -0.495 . . . . 63.54 112.068 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.446 0.165 . . . . 73.04 110.76 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.2 t -68.73 -32.72 72.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 74.12 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -66.75 -40.61 88.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.334 0.587 . . . . 72.14 109.762 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.46 HD21 ' HB ' ' A' ' 133' ' ' THR . 65.8 mt -65.05 -33.75 76.78 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 116.149 -0.478 . . . . 72.12 111.363 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 50.3 mtt180 -56.09 -49.04 74.95 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.483 0.489 . . . . 71.21 110.847 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.588 ' HA ' ' OE1' ' A' ' 156' ' ' GLU . 11.0 t -73.7 -29.56 62.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.922 -0.581 . . . . 61.33 110.807 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 34.1 m -71.14 -34.57 71.15 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.428 0.632 . . . . 63.3 109.691 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.45 0.52 16.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.491 0.716 . . . . 75.13 111.643 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.588 ' OE1' ' HA ' ' A' ' 153' ' ' THR . 46.5 mt-10 -84.16 140.22 31.89 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.55 -0.537 . . . . 71.53 109.55 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 96.88 -10.09 66.08 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.08 -0.581 . . . . 71.41 111.957 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 12.2 t -122.2 155.59 61.32 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.198 . . . . 63.01 107.764 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 36.56 0.1 Allowed 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 124.351 3.367 . . . . 44.13 114.287 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -101.03 119.04 38.16 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.123 0.487 . . . . 75.12 110.631 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.5 p -123.83 144.54 49.66 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.011 -0.737 . . . . 61.01 109.011 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -131.31 150.61 52.08 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.353 -0.24 . . . . 72.25 110.353 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -120.06 148.77 43.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.752 0.649 . . . . 72.11 112.752 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.25 1.95 37.93 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 115.112 0.805 . . . . 74.45 115.112 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB3' HH22 ' A' ' 152' ' ' ARG . 21.3 m-20 65.88 0.47 1.56 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.748 0.819 . . . . 61.33 112.04 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.63 139.27 20.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.648 0.737 . . . . 53.12 112.706 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -136.24 164.0 29.09 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.095 -1.076 . . . . 60.12 108.095 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 50.8 m-85 -115.63 151.38 35.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.411 -0.588 . . . . 75.25 109.411 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 83' ' ' SER . 60.4 m -113.94 123.7 50.38 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.928 -1.508 . . . . 63.1 106.928 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -111.72 149.21 31.95 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.859 0.362 . . . . 74.41 111.324 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.06 0 N-CA-C 108.544 -1.823 . . . . 74.22 108.544 -178.4 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.6 ptp180 . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 121.19 0.519 . . . . 74.11 111.864 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -115.12 127.91 55.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.483 -2.414 . . . . 74.15 104.483 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 10.8 m120 -139.67 160.25 40.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.15 -0.62 . . . . 74.14 110.526 -171.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 133' ' ' THR . 49.6 mt-10 -132.45 145.9 51.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 123.753 0.658 . . . . 71.21 109.823 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 132' ' ' SER . 21.8 t -123.95 120.85 60.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 106.071 -1.826 . . . . 74.34 106.071 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 13.1 m0 -104.78 121.36 43.47 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.798 -0.361 . . . . 72.51 110.932 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 84.8 mt -99.1 131.18 45.32 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.03 -1.47 . . . . 54.34 107.03 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.35 135.21 38.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.506 -0.478 . . . . 63.52 110.563 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 161' ' ' THR . 19.9 pttp -72.0 143.24 49.26 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.563 -0.455 . . . . 73.42 110.854 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 115.062 -0.972 . . . . 74.35 110.505 178.26 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.1 p90 . . . . . 0 N--CA 1.423 -1.815 0 N-CA-C 104.378 -2.453 . . . . 72.41 104.378 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 91.8 mt-30 -106.17 109.28 21.16 Favored 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 118.648 -1.221 . . . . 73.4 111.542 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.91 115.87 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 108.089 -1.078 . . . . 74.23 108.089 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -96.08 -36.55 10.96 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.074 -0.966 . . . . 62.31 111.883 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.471 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 42.6 t -157.12 150.41 23.98 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.296 0.569 . . . . 73.33 111.009 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.6 p -132.45 162.45 31.13 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.431 -1.692 . . . . 43.12 106.431 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.5 99.66 0.97 Allowed Glycine 0 C--N 1.304 -1.209 0 C-N-CA 118.297 -1.906 . . . . 61.43 114.243 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.07 -147.49 5.76 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.707 -0.957 . . . . 61.41 110.707 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -86.76 170.89 11.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.065 -0.717 . . . . 65.41 109.065 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.15 155.01 39.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.551 -0.907 . . . . 72.41 108.551 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 74.35 -52.81 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.791 0.836 . . . . 72.31 111.464 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.04 109.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 122.441 1.115 . . . . 72.34 110.376 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.8 m -111.53 128.66 56.09 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.662 -0.866 . . . . 74.44 108.662 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.04 155.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.558 -1.257 . . . . 62.43 111.301 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 35.2 tt0 -134.36 125.63 27.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.796 -1.557 . . . . 70.31 106.796 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 36.2 mt-10 -94.73 114.86 26.83 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.436 -1.69 . . . . 62.1 106.436 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.548 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 30.2 ptt180 -140.27 132.37 27.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.435 0.636 . . . . 75.52 112.54 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 129' ' ' THR . . . -80.98 137.34 36.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.093 -1.077 . . . . 53.03 108.093 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -58.87 149.8 25.87 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.772 0.67 . . . . 73.4 110.468 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -68.99 -21.18 64.17 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.975 -0.557 . . . . 53.41 112.032 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 9.72 68.5 Favored Glycine 0 C--O 1.244 0.766 0 C-N-CA 119.966 -1.111 . . . . 75.03 112.893 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 165.81 53.12 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 121.384 -0.436 . . . . 73.01 113.139 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -98.58 118.52 35.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.771 -0.826 . . . . 73.2 108.771 179.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.531 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 22.8 m-85 -124.33 165.63 17.35 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.736 -0.665 . . . . 72.41 111.494 -170.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.77 117.94 34.39 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.954 -0.758 . . . . 60.4 108.954 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -125.03 147.66 48.85 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.911 -0.586 . . . . 54.42 111.829 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.482 HG21 ' HG2' ' A' ' 61' ' ' LYS . 7.6 p -137.75 135.33 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 41.01 108.905 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -121.78 137.64 54.69 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.092 -1.043 . . . . 73.24 110.504 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 41.7 t -118.74 131.34 71.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.037 -1.468 . . . . 71.41 107.037 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -115.16 158.27 22.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.635 0.606 . . . . 45.14 112.635 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.455 ' HA ' ' CG ' ' A' ' 96' ' ' LYS . 36.3 t70 68.73 -12.89 0.35 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.629 1.972 . . . . 64.43 113.445 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.92 23.46 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 108.458 -0.941 . . . . 72.2 108.458 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.93 156.88 11.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.877 2.385 . . . . 73.43 111.337 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 98' ' ' LEU . 55.9 t -46.49 -47.68 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.893 0.877 . . . . 73.22 113.263 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 14.1 t70 -63.35 -47.84 80.46 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.528 -0.469 . . . . 74.31 110.208 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -63.56 -41.43 98.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.34 0.656 . . . . 73.23 112.195 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -65.42 -39.78 92.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.132 0.492 . . . . 54.11 110.115 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.9 tp -66.3 -33.75 76.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.883 -0.599 . . . . 62.33 110.001 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.684 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 29.9 mmt180 -59.05 -34.36 71.84 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.853 -0.612 . . . . 64.51 110.78 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.03 -49.53 10.12 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.312 -0.858 . . . . 63.31 110.72 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -66.99 -33.06 74.75 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.317 1.228 . . . . 64.25 114.317 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.581 ' O ' ' HG2' ' A' ' 63' ' ' MET . 6.5 mmt -61.11 -58.19 20.84 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 119.752 -0.779 . . . . 75.24 112.806 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.16 -30.84 91.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.407 2.071 . . . . 73.14 111.131 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HG2' HG21 ' A' ' 44' ' ' VAL . 18.1 tppt? -61.43 -44.49 97.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.092 -0.958 . . . . 65.13 110.369 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 38.4 mm -73.57 -39.41 53.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.313 -0.555 . . . . 65.32 109.583 175.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 59' ' ' MET . 25.9 mmt -55.38 -44.15 75.81 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.453 0.538 . . . . 70.0 112.453 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.01 -38.61 91.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.183 0.516 . . . . 74.44 110.652 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -70.83 -51.02 29.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.892 -0.595 . . . . 74.13 111.159 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 62' ' ' ILE . 14.6 p -74.85 -25.46 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-O 121.07 0.462 . . . . 72.15 111.229 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.75 -30.81 67.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.88 -0.6 . . . . 74.12 113.074 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.53 -3.63 1.88 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.271 -1.443 . . . . 52.42 113.855 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 m -89.56 27.07 1.56 Allowed 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 122.627 1.203 . . . . 72.45 109.387 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.08 177.29 7.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.068 -0.969 . . . . 74.15 109.231 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.82 -31.57 72.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.965 0.728 . . . . 70.24 112.965 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -87.6 -12.88 44.33 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.911 -0.716 . . . . 73.3 110.741 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.81 28.29 73.2 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.684 -0.77 . . . . 54.54 111.566 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.01 121.84 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.01 0.433 . . . . 73.14 109.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.95 63.74 0.61 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.431 -0.89 . . . . 74.12 112.144 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.93 -26.43 48.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.51 -0.552 . . . . 75.33 109.51 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.77 83.98 0.36 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.245 -0.889 . . . . 45.42 111.554 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 19.1 ptt? -96.19 125.41 40.69 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.926 0.393 . . . . 74.32 110.048 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.7 p -113.82 116.49 29.42 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.911 -0.586 . . . . 50.12 112.267 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.54 159.57 36.1 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 106.965 -1.495 . . . . 75.2 106.965 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.67 139.46 88.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.646 1.564 . . . . 71.53 112.616 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -103.94 153.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.193 -1.41 . . . . 72.31 107.193 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.4 m -133.75 145.45 49.83 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.303 -0.628 . . . . 73.53 109.303 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 51.4 p90 -138.12 139.96 39.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.403 -0.519 . . . . 64.34 110.309 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.69 134.87 34.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.878 -0.601 . . . . 63.52 110.175 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.48 150.02 30.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.952 -1.129 . . . . 70.5 107.952 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -119.48 108.05 40.17 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.17 -0.678 . . . . 73.11 109.17 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.4 142.09 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.088 1.858 . . . . 74.43 112.546 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.17 174.54 7.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.006 -0.543 . . . . 63.12 110.323 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -23.46 67.41 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.036 0.935 . . . . 61.24 110.622 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.46 -5.31 58.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.049 -0.978 . . . . 64.03 110.607 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.76 -10.25 65.7 Favored Glycine 0 CA--C 1.504 -0.636 0 CA-C-N 116.084 -0.507 . . . . 53.25 112.214 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 p -86.1 142.19 28.87 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.545 -0.539 . . . . 72.13 109.545 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 69.6 mt -75.84 145.21 40.79 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.024 -0.534 . . . . 74.44 110.61 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.64 150.25 32.7 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.657 -0.868 . . . . 74.51 108.657 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.527 ' H ' ' HD3' ' A' ' 96' ' ' LYS 0.291 0.2 OUTLIER -83.03 75.31 9.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.651 1.215 . . . . 73.23 112.031 178.938 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -164.09 125.03 2.2 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.536 -2.024 . . . . 71.14 105.536 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.515 HD12 HG13 ' A' ' 51' ' ' VAL . 5.6 tt -140.22 135.31 32.23 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.057 -0.719 . . . . 63.03 109.057 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -124.16 115.34 20.95 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.562 -0.29 . . . . 62.44 110.237 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.7 t -91.17 134.45 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.542 -0.54 . . . . 61.31 109.542 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -117.75 122.16 42.73 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.646 -0.872 . . . . 54.11 108.646 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 75.8 t80 -102.93 111.14 23.33 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.817 -1.549 . . . . 74.3 106.817 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.531 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 34.1 ttp180 -81.56 113.21 19.43 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.714 -0.675 . . . . 71.52 110.247 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.514 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 68.7 mt -79.07 134.09 60.19 Favored Pre-proline 0 C--N 1.284 -2.253 0 CA-C-N 114.463 -1.244 . . . . 73.42 110.907 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.521 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 50.7 Cg_exo -53.4 153.75 16.77 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.328 2.685 . . . . 74.33 112.067 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -56.47 -36.28 68.91 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.012 1.116 . . . . 64.54 114.012 -174.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -62.4 -36.2 81.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.159 0.504 . . . . 75.21 111.004 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.5 -6.17 56.65 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.988 -0.551 . . . . 70.23 110.997 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.514 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 26.0 mm-40 -71.7 -30.2 65.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.829 0.347 . . . . 72.54 110.75 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.24 73.47 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.472 -0.785 . . . . 61.44 111.908 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.5 p -160.18 89.02 1.83 Allowed Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-O 120.661 0.267 . . . . 73.24 110.495 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.49 154.27 9.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.178 1.918 . . . . 52.41 110.935 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.96 158.11 58.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.341 2.027 . . . . 74.1 111.352 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.85 149.53 80.47 Favored Pre-proline 0 C--O 1.259 1.593 0 C-N-CA 120.874 -0.33 . . . . 73.41 110.205 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 24.9 Cg_exo -65.73 106.75 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.697 2.265 . . . . 60.14 111.38 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.5 t -83.16 -25.66 31.63 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.53 -0.545 . . . . 73.33 109.53 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.63 143.89 28.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.317 -0.994 . . . . 71.15 108.317 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.18 -24.04 60.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.019 0.748 . . . . 71.45 113.019 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.2 m -89.81 -19.11 25.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.002 0.429 . . . . 63.33 109.892 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 61.9 t -94.89 116.27 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 107.102 -1.444 . . . . 72.21 107.102 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -124.35 136.31 53.99 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.603 -0.726 . . . . 71.21 110.449 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.5 mm -91.68 111.19 23.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.612 -1.255 . . . . 70.22 107.612 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -124.73 143.38 50.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.806 -1.088 . . . . 70.31 109.142 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -105.23 132.58 51.25 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.624 -0.716 . . . . 75.31 109.339 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -123.2 123.1 40.03 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.291 -1.003 . . . . 72.32 108.291 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.6 158.03 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.5 -0.555 . . . . 61.02 109.5 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.36 19.2 50.57 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.626 -0.797 . . . . 71.42 112.128 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.26 145.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.058 0.456 . . . . 71.03 110.367 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 90.4 m -112.64 135.49 53.3 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 107.87 -1.159 . . . . 72.44 107.87 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.16 150.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 N-CA-C 107.839 -1.171 . . . . 73.14 107.839 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.35 121.12 43.43 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 104.664 -2.347 . . . . 75.43 104.664 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 24.8 m -115.93 132.75 56.56 Favored 'General case' 0 C--N 1.261 -3.246 0 C-N-CA 120.339 -0.545 . . . . 71.33 110.834 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' SER . 9.9 t -113.24 119.94 39.46 Favored 'General case' 0 N--CA 1.391 -3.421 0 CA-C-N 115.587 -0.733 . . . . 71.32 109.614 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -110.88 126.03 54.26 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.404 -1.332 . . . . 65.04 107.404 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 22.3 p90 -136.6 167.6 21.08 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.352 -0.84 . . . . 75.04 110.687 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -133.32 143.3 14.96 Favored Glycine 0 CA--C 1.485 -1.798 0 C-N-CA 120.484 -0.865 . . . . 52.33 111.559 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.81 -155.28 25.79 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.258 -1.137 . . . . 63.01 110.258 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -99.93 103.08 14.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.834 -0.802 . . . . 75.3 108.834 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.62 117.53 31.86 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.41 -0.359 . . . . 64.44 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -81.13 163.84 22.82 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.831 -1.174 . . . . 72.21 107.831 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.74 -35.23 42.5 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.004 0.522 . . . . 60.34 111.607 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.87 65.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.065 -0.516 . . . . 71.11 111.121 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.33 -30.89 69.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.119 -0.491 . . . . 73.44 110.433 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -59.72 -49.43 77.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.299 -0.63 . . . . 72.31 109.299 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.1 t -59.96 -42.96 91.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.032 -0.986 . . . . 52.52 109.341 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.16 85.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.46 -0.791 . . . . 33.42 111.179 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.511 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 29.3 m80 -66.94 -33.89 76.57 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 112.536 0.569 . . . . 71.02 112.536 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.23 -45.14 94.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.398 0.618 . . . . 62.03 109.627 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 m -66.58 -35.3 79.87 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.421 -0.809 . . . . 71.11 109.868 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.09 -29.01 61.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.752 -0.658 . . . . 74.33 111.373 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 82.6 mt -61.7 -36.71 81.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.944 -0.391 . . . . 71.14 109.944 173.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -57.42 -48.19 79.78 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.854 0.721 . . . . 72.22 110.802 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.6 t -75.72 -30.15 59.16 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.113 -0.494 . . . . 73.34 110.952 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.4 m -74.85 -34.17 62.25 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.358 0.599 . . . . 73.15 110.819 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.54 6.75 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.373 0.606 . . . . 72.13 110.36 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 131.53 34.34 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.826 -1.546 . . . . 72.04 106.826 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.89 -4.78 61.35 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.514 -0.635 . . . . 65.14 111.514 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.1 p -99.89 163.94 17.44 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 107.844 -1.169 . . . . 43.24 107.844 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 63.6 Cg_endo -73.88 0.82 7.79 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.992 1.794 . . . . 71.35 112.901 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.95 140.99 32.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.881 0.372 . . . . 73.54 111.557 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.0 p -118.13 153.48 33.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.212 -0.662 . . . . 64.25 109.212 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.434 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 38.8 p90 -135.3 137.81 42.85 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.139 -0.35 . . . . 75.11 110.171 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.634 ' NE2' HG13 ' A' ' 188' ' ' VAL 0.26 0.4 OUTLIER -97.92 116.63 30.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.739 1.385 . . . . 74.44 114.739 -176.455 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.16 65.82 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.773 -0.649 . . . . 75.55 112.623 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . 0.261 8.6 p-10 49.38 27.66 2.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.765 1.226 . . . . 74.52 113.22 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 187' ' ' LEU . 77.6 t -66.57 138.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 113.968 -1.469 . . . . 73.12 110.137 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -143.26 171.13 14.53 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.989 -0.55 . . . . 61.43 111.492 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 4.2 m-85 -121.75 150.54 41.68 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.671 -0.695 . . . . 64.54 109.865 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 20.4 t -115.02 146.22 41.48 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.994 -1.113 . . . . 75.01 107.994 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.36 158.5 18.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.925 0.393 . . . . 74.15 110.907 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.419 0 N-CA-C 108.732 -1.747 . . . . 71.02 108.732 179.495 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 111.787 0.291 . . . . 73.15 111.787 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -116.6 136.06 53.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.085 0.469 . . . . 74.12 110.579 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.2 m120 -126.52 146.94 49.93 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.729 -1.582 . . . . 72.33 106.729 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 133' ' ' THR . 33.9 tt0 -142.82 132.64 24.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.965 -0.694 . . . . 53.14 110.459 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 132' ' ' SER . 82.4 t -126.49 130.18 71.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.863 0.865 . . . . 61.14 109.287 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.5 m0 -109.36 121.3 44.87 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 109.449 -0.574 . . . . 63.44 109.449 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 166' ' ' VAL . 40.3 tp -100.78 135.48 42.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.865 -1.532 . . . . 73.31 106.865 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.634 HG13 ' NE2' ' A' ' 163' ' ' GLN . 6.1 p -106.72 135.44 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 114.036 1.124 . . . . 75.35 114.036 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -63.16 144.37 56.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.015 1.326 . . . . 71.41 114.421 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.241 -0.89 . . . . 64.05 109.045 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.3 p90 . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 106.426 -1.694 . . . . 55.14 106.426 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -121.11 109.62 15.24 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.929 -1.109 . . . . 75.14 112.392 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.45 125.68 45.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.103 -1.814 . . . . 75.23 106.103 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 22' ' ' SER . 2.9 pp -90.22 -29.26 18.31 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.677 -1.209 . . . . 74.21 111.366 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.491 ' N ' HD12 ' A' ' 21' ' ' LEU . 30.7 t -179.32 164.59 1.37 Allowed 'General case' 0 C--O 1.25 1.117 0 O-C-N 123.575 0.547 . . . . 74.42 110.124 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -131.19 165.76 22.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.852 -1.166 . . . . 63.44 107.852 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.68 -164.38 29.87 Favored Glycine 0 C--N 1.306 -1.139 0 C-N-CA 120.577 -0.82 . . . . 54.45 111.545 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.92 -138.75 10.44 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.597 -0.811 . . . . 73.51 112.263 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -118.09 170.73 8.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.107 -1.442 . . . . 71.24 107.107 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.96 159.67 33.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 118.569 0.622 . . . . 74.4 110.07 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 76.26 -52.78 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.754 1.622 . . . . 61.14 110.426 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG11 ' HG3' ' A' ' 150' ' ' GLN . 7.7 p -120.14 110.0 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-O 122.235 1.017 . . . . 74.13 109.811 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 133' ' ' THR . 45.0 m -122.16 154.11 37.87 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.446 -0.946 . . . . 51.13 108.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.735 ' HB3' HD11 ' A' ' 151' ' ' LEU . 8.9 p90 -118.06 156.52 28.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.91 1.078 . . . . 72.23 113.91 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.32 125.9 23.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.734 -1.95 . . . . 73.11 105.734 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 115.1 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.499 -1.667 . . . . 73.1 106.499 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -131.79 133.7 45.02 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.687 -0.688 . . . . 74.34 111.403 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.63 136.27 33.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.26 -1.385 . . . . 53.04 107.26 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.43 158.08 21.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.548 0.573 . . . . 71.14 112.548 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -86.54 -18.66 30.95 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.665 -0.698 . . . . 74.45 112.858 -174.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.81 46.62 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.494 -1.813 . . . . 71.4 112.544 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.35 149.22 46.81 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.804 -0.712 . . . . 42.13 113.874 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 104' ' ' ILE . 19.5 ptmt -88.88 119.45 29.4 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.656 -0.868 . . . . 63.24 108.656 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.552 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 27.7 m-85 -127.0 166.35 17.73 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 123.693 0.797 . . . . 74.41 111.083 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -97.56 116.82 30.5 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.092 -1.077 . . . . 60.1 108.092 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.8 t -135.29 150.76 50.08 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 115.414 -0.812 . . . . 74.14 112.516 -173.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 9.2 p -141.64 142.28 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.121 -1.066 . . . . 74.21 108.121 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.3 133.05 48.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.658 -0.817 . . . . 74.32 112.572 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.58 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 52.7 t -112.08 141.87 26.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.656 -1.979 . . . . 72.52 105.656 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' LYS . 26.4 p -132.31 152.24 51.48 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.668 0.988 . . . . 52.25 113.668 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 67.6 -16.37 0.17 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 126.204 1.801 . . . . 74.23 112.141 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' THR . 48.6 mtpt -88.78 146.86 37.84 Favored Pre-proline 0 N--CA 1.422 -1.874 0 C-N-CA 124.175 0.99 . . . . 70.34 110.035 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 31.2 Cg_exo -60.23 153.05 61.91 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.509 2.139 . . . . 60.1 111.675 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 98' ' ' LEU . 32.2 t -49.89 -42.56 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 124.035 0.934 . . . . 53.23 112.316 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.698 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 13.0 t70 -61.63 -46.32 90.3 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.548 -0.461 . . . . 73.23 109.823 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -69.01 -42.13 76.83 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.199 -0.455 . . . . 74.33 111.48 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.15 -42.46 99.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.723 -0.672 . . . . 72.5 111.062 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.11 -31.97 72.79 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 116.336 -0.393 . . . . 72.55 111.156 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 5.2 mmp_? -55.95 -41.51 74.78 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.734 0.646 . . . . 75.1 110.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 44.4 mt-10 -84.41 -43.55 14.56 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.085 -0.507 . . . . 71.12 112.08 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.423 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -68.97 -41.82 77.42 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.52 1.304 . . . . 43.45 114.52 -171.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.4 ttm -57.27 -48.54 97.18 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.54 0.941 . . . . 71.53 113.54 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.68 -31.89 52.4 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.264 1.976 . . . . 75.11 112.245 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 91.0 mttt -72.12 -35.53 69.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.389 0.614 . . . . 55.33 111.058 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.05 -34.19 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 116.016 -0.538 . . . . 75.45 110.536 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 ttp -64.58 -43.31 94.26 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 124.062 0.945 . . . . 63.41 110.581 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 21.3 ptmt -69.48 -31.62 70.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.559 -0.291 . . . . 74.41 110.704 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -62.44 -60.48 3.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.46 -0.336 . . . . 74.21 111.796 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 76' ' ' MET . 14.6 p -83.86 -2.24 6.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-O 121.988 0.899 . . . . 72.13 109.859 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.01 -32.36 32.5 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.674 -0.774 . . . . 35.42 111.72 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 140.97 -2.56 2.14 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.689 -1.243 . . . . 51.22 113.52 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.5 m -92.06 34.32 1.02 Allowed 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.504 1.145 . . . . 64.52 109.156 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.48 ' OD1' HG12 ' A' ' 74' ' ' VAL . 7.2 p30 -96.8 168.93 10.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.769 -0.65 . . . . 74.24 109.759 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 23.2 t70 -71.79 -27.7 63.12 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.794 0.665 . . . . 71.14 112.794 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.91 -14.12 58.86 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.627 0.727 . . . . 70.33 109.334 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.63 78.6 Favored Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 110.847 -0.901 . . . . 75.43 110.847 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 14.5 p -93.11 153.08 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 108.127 -1.064 . . . . 74.12 108.127 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -133.48 0.41 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.736 -0.745 . . . . 54.24 112.416 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.728 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 55.7 ttp -76.61 -75.66 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.494 -0.482 . . . . 73.34 110.03 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.68 -52.01 0.68 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.541 0.977 . . . . 44.41 115.541 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 62.0 mtm -101.45 124.99 48.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 117.756 0.778 . . . . 71.04 111.356 -173.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.7 m -126.3 114.49 18.33 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.808 -0.441 . . . . 73.53 109.808 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 103' ' ' ARG . 24.9 m -148.78 167.75 12.47 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 108.125 -1.065 . . . . 73.03 108.125 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.49 146.33 84.76 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.894 1.729 . . . . 74.02 111.592 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.3 144.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.374 -0.973 . . . . 53.32 108.374 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 p -129.22 146.14 51.19 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 110.126 -0.324 . . . . 74.04 110.126 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.37 138.89 43.78 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.536 -0.465 . . . . 70.12 110.078 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.62 135.05 34.41 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.019 -0.734 . . . . 75.52 109.019 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.86 150.23 26.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 108.331 -0.988 . . . . 43.24 108.331 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 6.1 m-85 -123.52 105.11 33.52 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 121.018 -0.273 . . . . 74.23 110.573 -175.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.17 159.03 17.79 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.473 2.116 . . . . 75.03 111.871 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -104.36 166.51 10.35 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.385 -0.968 . . . . 72.21 108.385 175.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.84 -17.53 50.48 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.96 1.096 . . . . 75.23 113.96 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -98.73 -1.26 40.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.235 -0.586 . . . . 64.23 112.163 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.18 1.0 55.87 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.632 1.013 . . . . 63.22 115.632 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.2 m -83.79 136.98 33.94 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.452 1.126 . . . . 74.32 109.528 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.4 mt -93.38 78.1 4.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.165 0.507 . . . . 73.32 110.513 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -149.36 114.49 5.46 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.867 -0.606 . . . . 74.41 110.911 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 87' ' ' PHE . 56.2 tttp 178.19 -62.41 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.21 -1.033 . . . . 72.41 108.21 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 22.7 ttmm -154.31 149.34 26.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.518 -1.29 . . . . 73.14 107.518 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.592 HD12 HG13 ' A' ' 51' ' ' VAL . 5.9 tt -141.01 124.94 17.09 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.997 -1.853 . . . . 71.21 105.997 169.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 79.4 tttt -130.87 115.19 16.24 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 120.423 -0.511 . . . . 50.24 110.05 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' THR . 62.1 t -83.88 133.78 28.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.692 -0.685 . . . . 64.22 109.322 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -121.62 113.63 20.04 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.748 0.819 . . . . 73.43 109.156 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 89.6 t80 -103.74 115.97 31.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.319 -0.993 . . . . 75.01 108.319 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.552 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 29.4 ttt85 -76.11 136.35 39.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.336 -0.847 . . . . 73.44 110.416 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.436 HD11 HD12 ' A' ' 122' ' ' ILE . 77.8 mt -103.47 126.96 30.63 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 109.478 -0.564 . . . . 75.21 109.478 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 84.2 Cg_exo -46.83 151.25 2.2 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.491 2.794 . . . . 74.45 113.028 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.04 -42.58 65.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.443 1.275 . . . . 64.42 114.443 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.28 -30.96 72.0 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.353 0.597 . . . . 65.12 110.875 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.66 -2.88 55.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.912 -0.585 . . . . 63.23 110.839 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.671 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.09 -36.24 74.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.586 -0.524 . . . . 74.34 109.586 175.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.19 -31.7 78.18 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-N 115.464 -0.789 . . . . 61.02 112.026 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -160.34 97.3 1.46 Allowed Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 109.049 -0.723 . . . . 61.22 109.049 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.62 162.08 1.86 Allowed 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 123.274 2.649 . . . . 63.31 111.519 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.58 133.76 44.23 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.032 1.821 . . . . 74.14 110.093 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -74.88 152.69 86.83 Favored Pre-proline 0 C--O 1.255 1.395 0 CA-C-N 116.515 -0.311 . . . . 70.32 111.48 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 17.2 Cg_exo -69.46 111.13 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.761 2.308 . . . . 64.23 112.146 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -85.25 -8.69 58.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.827 0.822 . . . . 74.41 108.795 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.95 148.42 42.21 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.241 -1.392 . . . . 72.15 107.241 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -88.62 -9.97 50.3 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.858 1.429 . . . . 63.23 114.858 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.501 ' CB ' ' HD3' ' A' ' 61' ' ' LYS . 17.7 m -81.53 -45.03 16.51 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.813 -0.81 . . . . 74.15 108.813 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 5.9 p -95.5 115.85 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 108.83 -0.804 . . . . 73.31 108.83 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -119.0 151.22 38.59 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.842 -0.799 . . . . 74.12 108.842 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.8 mm -92.56 110.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.427 -1.323 . . . . 73.35 107.427 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -127.14 146.48 50.38 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.387 -0.824 . . . . 73.4 108.9 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.06 144.13 34.18 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 109.023 -0.732 . . . . 70.04 109.023 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.555 ' HA ' ' HE ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -129.74 123.13 30.3 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.169 -1.413 . . . . 71.53 110.008 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.24 156.63 45.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.105 -2.554 . . . . 72.43 104.105 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.5 8.03 62.86 Favored Glycine 0 C--N 1.281 -2.52 0 C-N-CA 120.661 -0.78 . . . . 70.43 112.859 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.0 pt -121.61 145.66 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.353 -0.539 . . . . 62.1 110.275 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.0 m -120.88 137.44 54.57 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.039 -0.982 . . . . 74.24 109.126 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.36 160.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-N 115.767 -0.651 . . . . 73.24 110.021 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.515 ' OH ' ' HE2' ' A' ' 189' ' ' LYS . 39.3 m-85 -114.03 122.56 47.27 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.232 -2.136 . . . . 75.11 105.232 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -106.82 127.89 53.79 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.835 -0.346 . . . . 70.53 111.145 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.553 ' HB ' HD13 ' A' ' 151' ' ' LEU . 14.0 t -113.43 138.98 49.31 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.808 -0.812 . . . . 63.23 108.808 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.46 125.82 42.76 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.455 -0.793 . . . . 72.12 109.895 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -132.86 140.69 48.04 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.444 -0.798 . . . . 72.11 109.581 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 182' ' ' ARG . . . -102.8 145.99 16.53 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.842 -0.694 . . . . 63.01 112.852 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.71 -140.26 14.84 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.984 -1.103 . . . . 72.23 113.906 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -76.63 126.7 31.43 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.8 0.84 . . . . 72.35 112.006 -172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.81 136.82 54.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.794 -0.639 . . . . 70.12 110.303 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.569 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 38.8 ttmt -114.98 155.41 26.98 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.615 -1.994 . . . . 62.51 105.615 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -53.67 -45.19 70.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 118.412 0.551 . . . . 70.14 110.001 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.75 70.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 42.43 111.399 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.569 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 28.2 t70 -74.73 -30.62 61.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 110.063 -0.347 . . . . 62.12 110.063 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -63.33 -44.85 93.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.827 -0.805 . . . . 53.12 108.827 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 141' ' ' GLU . 61.0 t -60.02 -51.24 75.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.058 -0.974 . . . . 71.43 109.579 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.11 86.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.586 -0.734 . . . . 64.42 111.562 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 150' ' ' GLN . 24.6 m80 -62.38 -33.45 74.76 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 113.445 0.906 . . . . 65.54 113.445 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.01 79.32 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.481 0.488 . . . . 73.33 111.409 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.5 m -78.09 -35.14 49.73 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.801 0.334 . . . . 64.45 111.015 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.517 ' HG3' HG11 ' A' ' 29' ' ' VAL . 7.1 tp60 -58.68 -36.37 74.09 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.211 0.529 . . . . 75.35 109.692 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 31' ' ' TYR . 46.1 tp -65.4 -39.12 91.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.528 -0.76 . . . . 73.24 110.127 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.0 mtm180 -63.3 -44.07 96.03 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 116.436 -0.347 . . . . 75.21 110.308 177.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.3 m -61.98 -34.78 76.78 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.521 0.677 . . . . 72.23 110.582 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.6 m -74.02 -33.97 63.95 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.552 0.691 . . . . 74.33 109.965 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 26.3 mt -83.7 6.98 19.05 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.938 0.895 . . . . 73.53 112.61 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 43.9 mt-10 -75.79 145.59 40.62 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.104 -1.038 . . . . 71.43 112.498 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.66 12.64 46.77 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.548 -1.021 . . . . 60.11 110.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 p -122.11 165.66 19.84 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 107.809 -1.182 . . . . 62.12 107.809 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 96.3 Cg_endo -81.27 21.63 0.89 Allowed 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 121.886 1.724 . . . . 74.32 111.968 174.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 121.12 24.76 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.085 0.469 . . . . 52.21 111.217 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.0 m -105.32 157.68 17.15 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.45 -1.315 . . . . 73.55 107.45 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.33 157.64 46.17 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.635 -0.876 . . . . 71.43 108.635 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.6 pt20 -119.07 109.75 16.28 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.579 -0.849 . . . . 74.43 111.064 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.51 8.08 55.03 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.39 -0.909 . . . . 44.41 114.35 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.97 26.42 14.13 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.767 0.794 . . . . 75.2 109.621 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.7 138.86 22.05 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 115.64 -0.709 . . . . 63.43 110.32 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 24.8 p90 -148.2 167.9 23.88 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.884 -0.598 . . . . 61.2 112.249 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 8.3 m-85 -115.71 153.72 30.84 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.501 -0.772 . . . . 74.21 110.259 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.65 136.77 54.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.591 -1.633 . . . . 65.24 106.591 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -132.13 156.85 45.64 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.119 0.414 . . . . 60.12 112.119 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.1 0 N-CA-C 109.085 -1.606 . . . . 54.33 109.085 -179.726 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 . . . . . 0 CA--C 1.506 -0.712 0 CA-C-O 121.541 0.686 . . . . 62.33 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.512 ' HA ' ' HA2' ' A' ' 136' ' ' GLY . 14.6 ptt180 -152.13 157.65 41.84 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.521 -2.029 . . . . 73.41 105.521 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -134.72 142.97 46.93 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.882 -0.784 . . . . 52.31 108.882 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 9.3 mm-40 -111.49 132.5 54.45 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.384 -0.969 . . . . 73.23 108.384 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.494 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 88.5 t -127.06 121.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.074 -0.713 . . . . 75.14 109.074 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.599 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 33.1 m0 -107.0 124.94 50.34 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 119.606 -0.235 . . . . 74.32 110.799 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 167' ' ' TYR . 82.6 mt -96.64 138.75 33.74 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.375 -0.972 . . . . 52.23 108.375 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.11 129.64 53.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 120.04 -0.664 . . . . 74.41 109.366 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.515 ' HE2' ' OH ' ' A' ' 131' ' ' TYR . 19.2 ptpt -72.94 142.99 47.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 71.43 111.422 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 118.963 -0.541 . . . . 61.13 109.773 176.568 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.546 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.7 p90 . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 108.75 -0.833 . . . . 75.11 108.75 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -105.65 112.53 25.65 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.226 -0.59 . . . . 62.11 110.911 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.58 127.94 41.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.036 -1.468 . . . . 71.24 107.036 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.53 HD21 ' OE2' ' A' ' 33' ' ' GLU . 3.6 pp -95.77 -24.9 16.28 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.938 -1.105 . . . . 73.33 112.925 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.1 p -175.71 160.2 2.4 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 123.361 0.413 . . . . 73.35 111.611 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 73.9 p -131.21 154.12 48.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.283 -1.006 . . . . 63.22 108.283 174.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.59 -146.41 14.44 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 119.518 -1.325 . . . . 63.33 112.085 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.09 -118.02 5.11 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.705 -0.958 . . . . 50.33 110.705 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -117.44 169.28 9.64 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.741 -1.577 . . . . 73.03 106.741 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -87.16 157.05 19.45 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.13 -1.028 . . . . 74.52 111.911 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 82.0 -41.92 0.14 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.4 1.88 . . . . 74.04 110.053 -172.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.35 109.92 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.802 -1.184 . . . . 74.44 107.802 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 p -113.41 153.58 28.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.38 -0.6 . . . . 72.01 109.38 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.3 OUTLIER -112.88 150.87 31.15 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.587 -0.445 . . . . 71.5 111.319 178.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 36.3 tt0 -137.33 124.33 21.48 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.483 -1.673 . . . . 70.22 106.483 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' OE2' HD21 ' A' ' 21' ' ' LEU . 36.1 tt0 -100.5 117.6 34.99 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.138 -1.43 . . . . 62.53 107.138 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.531 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 28.8 ptt180 -138.4 144.71 40.34 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.096 -0.642 . . . . 72.45 110.837 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -81.96 136.61 35.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.493 -0.929 . . . . 62.2 108.493 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.47 133.81 51.17 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.65 0.241 . . . . 71.21 111.65 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' CD ' HH12 ' A' ' 103' ' ' ARG . 8.6 pt-20 -55.28 -45.11 76.18 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.945 -0.57 . . . . 70.32 112.072 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.54 10.29 50.88 Favored Glycine 0 C--N 1.311 -0.856 0 C-N-CA 119.673 -1.251 . . . . 54.42 114.682 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.62 165.22 52.49 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.357 -0.925 . . . . 75.15 112.182 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.16 131.64 35.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 75.01 110.881 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 60.3 m-85 -131.33 166.04 22.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.404 0.682 . . . . 73.33 110.951 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.45 116.21 29.23 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 107.837 -1.171 . . . . 73.14 107.837 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.5 t -124.41 144.58 49.97 Favored 'General case' 0 N--CA 1.402 -2.867 0 CA-C-N 115.419 -0.809 . . . . 70.32 112.044 -175.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.6 m -127.85 145.08 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.913 -1.04 . . . . 74.15 109.446 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -122.34 128.61 51.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.945 0.403 . . . . 62.34 111.158 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.637 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 22.0 t -125.73 142.43 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.455 -1.313 . . . . 73.41 107.455 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 49' ' ' LYS . 17.5 p -134.32 166.81 21.97 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.097 0.159 . . . . 74.42 111.42 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.7 t70 71.88 -36.17 0.35 Allowed 'General case' 0 N--CA 1.514 2.769 0 C-N-CA 125.131 1.372 . . . . 72.13 112.12 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 47' ' ' THR . 25.0 mtpp -86.14 141.32 35.05 Favored Pre-proline 0 C--N 1.282 -2.36 0 C-N-CA 124.786 1.235 . . . . 75.41 109.743 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.67 155.89 40.33 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.316 2.01 . . . . 73.12 109.367 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.63 -36.18 41.39 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 113.635 0.976 . . . . 72.32 113.635 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 15.9 t70 -60.01 -47.74 84.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.739 -0.467 . . . . 74.04 109.739 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -69.7 -41.62 75.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.699 . . . . 74.4 111.3 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -61.58 -42.35 98.72 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.914 -0.585 . . . . 71.5 110.334 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 tp -60.22 -35.23 74.96 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.13 0.972 . . . . 63.21 110.759 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 26.0 mmt180 -63.83 -35.23 79.93 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.463 0.649 . . . . 72.12 109.524 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 28.0 tt0 -82.95 -32.03 27.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 73.4 110.135 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.18 60.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.306 0.854 . . . . 63.53 113.306 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 8.9 mmt -55.34 -56.16 31.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 112.796 0.665 . . . . 74.32 112.796 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.64 -31.26 69.88 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.7 2.267 . . . . 75.03 113.193 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 95.4 mttt -62.53 -49.36 75.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.027 0.441 . . . . 72.12 110.162 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.85 -38.0 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 120.635 -0.426 . . . . 71.42 110.836 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.3 mtt -61.01 -38.97 87.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.833 0.679 . . . . 74.41 112.833 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -72.56 -31.38 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.219 -0.592 . . . . 74.24 110.684 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.07 -55.32 22.97 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.317 -0.402 . . . . 73.23 110.783 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.79 -10.4 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.162 0.505 . . . . 53.24 111.209 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -21.98 73.65 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.606 -0.725 . . . . 73.45 111.483 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.88 -5.63 6.94 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.934 -1.127 . . . . 71.13 113.598 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -86.25 33.76 0.62 Allowed 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.565 1.174 . . . . 72.13 110.105 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -93.99 173.1 7.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.06 -0.973 . . . . 53.12 108.841 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.32 -34.45 78.16 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.373 0.508 . . . . 71.32 112.373 -173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.523 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -83.78 -12.6 55.47 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.508 -0.477 . . . . 75.12 109.998 -177.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.87 27.85 72.64 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.713 0.633 . . . . 52.31 112.321 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 35.8 m -86.16 122.06 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.041 -0.664 . . . . 63.23 111.31 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.62 86.63 0.7 Allowed Glycine 0 N--CA 1.432 -1.58 0 CA-C-N 115.611 -0.722 . . . . 72.54 111.323 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -150.27 116.1 5.58 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.187 0.517 . . . . 61.54 110.19 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.83 124.59 7.1 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.644 -0.707 . . . . 73.41 112.069 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.8 ptp -105.82 126.46 52.2 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.962 -0.755 . . . . 73.21 108.962 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 p -120.38 115.87 24.36 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 55.4 111.302 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.608 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 10.8 m -154.03 -179.89 1.16 Allowed Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 125.801 1.64 . . . . 74.44 106.922 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 84.5 Cg_exo -51.0 140.67 39.01 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.751 2.301 . . . . 73.21 115.414 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.91 138.16 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.787 -1.56 . . . . 72.04 106.787 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -133.87 145.25 49.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.674 -0.491 . . . . 53.12 109.674 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 98' ' ' LEU . 52.2 p90 -145.28 138.31 26.32 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.902 -0.499 . . . . 73.02 111.169 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -93.18 135.28 34.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.461 -0.94 . . . . 70.45 108.461 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 166' ' ' VAL . 33.4 m -121.15 149.16 24.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.719 -0.845 . . . . 71.43 108.719 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.56 105.51 51.85 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 116.118 -0.492 . . . . 75.42 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.28 159.05 20.09 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.898 1.732 . . . . 65.45 110.801 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.414 HD21 ' HG2' ' A' ' 96' ' ' LYS . 50.8 m-80 -122.33 162.66 21.13 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.79 -0.818 . . . . 72.1 108.79 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.77 -13.7 59.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.557 0.694 . . . . 62.2 110.513 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.69 -6.67 58.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.845 -1.071 . . . . 75.41 110.099 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.28 10.27 83.88 Favored Glycine 0 C--O 1.218 -0.876 0 CA-C-N 115.911 -0.586 . . . . 72.51 113.192 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 m -105.24 134.76 47.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.874 0.337 . . . . 74.15 110.445 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.6 mt -88.42 75.57 8.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.784 -1.191 . . . . 75.44 107.784 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 58.9 tt0 -147.18 114.51 6.28 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.345 -0.843 . . . . 72.22 111.183 -174.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' A' ' 96' ' ' LYS . 6.1 mmpt? -178.87 -66.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.95 2.1 . . . . 72.11 106.356 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -147.28 150.64 35.21 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.435 -1.257 . . . . 64.42 107.885 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 84' ' ' PHE . 56.6 tp -127.71 124.35 37.63 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.206 -1.775 . . . . 73.24 106.206 168.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -114.31 113.78 25.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.237 -1.764 . . . . 72.44 106.237 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' THR . 97.0 t -99.85 123.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 109.438 -0.579 . . . . 52.24 109.438 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -110.25 120.69 43.25 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -104.16 124.54 49.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.621 -0.511 . . . . 72.32 109.621 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.412 HH12 ' CD ' ' A' ' 37' ' ' GLU . 19.0 mmm180 -74.57 132.67 41.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.339 -0.846 . . . . 74.33 109.019 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.6 mt -99.03 135.89 20.72 Favored Pre-proline 0 C--N 1.285 -2.204 0 N-CA-C 107.838 -1.171 . . . . 44.25 107.838 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.81 148.97 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.589 2.192 . . . . 73.42 112.312 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.455 ' C ' HD22 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -47.6 -43.18 25.37 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.472 1.509 . . . . 74.35 112.288 -174.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.13 -36.15 83.37 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.67 0.619 . . . . 62.11 112.67 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -88.93 -6.37 57.32 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-N 116.559 -0.291 . . . . 72.32 111.605 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.629 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.09 -28.48 65.45 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.751 -0.204 . . . . 54.34 111.519 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.08 -38.1 92.56 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.868 -0.493 . . . . 72.44 111.868 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 p -158.67 87.77 2.26 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 123.466 0.706 . . . . 63.24 109.956 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 10.0 Cg_endo -86.63 144.71 7.74 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 122.577 2.185 . . . . 70.11 112.104 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 33.2 Cg_exo -60.79 142.84 98.86 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.767 2.312 . . . . 74.31 112.628 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . . . -76.67 144.82 73.96 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.857 -0.61 . . . . 54.51 109.997 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -80.36 126.51 6.2 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.514 2.143 . . . . 71.42 111.923 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.4 m -74.91 -23.91 58.43 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.657 -0.701 . . . . 73.13 111.606 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -99.64 135.73 40.61 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.111 -1.44 . . . . 72.02 107.111 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -77.01 -3.71 40.45 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.434 0.901 . . . . 72.42 113.434 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.525 ' O ' HG12 ' A' ' 44' ' ' VAL . 17.1 m -73.74 -26.44 60.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.775 -0.824 . . . . 64.45 108.775 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 61' ' ' LYS . 25.3 t -113.98 124.12 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 106.593 -1.632 . . . . 60.41 106.593 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.429 ' HA ' ' HG2' ' A' ' 115' ' ' PRO . 27.3 mtpp -129.66 145.91 51.48 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.81 -1.156 . . . . 71.11 110.568 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 26.7 mm -91.91 111.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.997 -1.483 . . . . 74.4 106.997 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -133.81 149.55 51.41 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.085 -0.961 . . . . 62.15 109.77 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.49 153.3 23.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.134 -0.691 . . . . 70.54 109.134 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 67.4 ttt180 -139.25 123.17 17.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.458 -0.897 . . . . 62.32 109.984 174.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -143.85 177.14 8.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.373 -0.83 . . . . 75.51 109.314 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.06 -1.42 84.82 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 121.134 -0.555 . . . . 35.31 113.736 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.46 162.47 32.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 117.398 0.599 . . . . 72.21 111.381 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.2 m -120.6 135.99 54.94 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.437 -0.801 . . . . 71.22 109.777 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.94 161.87 28.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 120.94 0.4 . . . . 71.24 110.413 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 67.3 m-85 -113.99 123.47 49.79 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.703 -1.962 . . . . 73.03 105.703 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 25.4 t -111.91 147.55 35.6 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 120.444 -0.502 . . . . 44.5 109.905 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 8.9 t -129.23 132.98 47.33 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.112 -0.494 . . . . 64.41 109.848 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 184' ' ' GLU . 74.2 mt-30 -110.46 131.64 54.87 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 121.258 0.552 . . . . 70.13 111.425 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.86 149.63 40.52 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.722 -1.127 . . . . 74.02 109.494 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -121.92 149.09 17.16 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.78 -0.724 . . . . 75.12 111.465 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.54 24.49 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.24 -1.144 . . . . 54.31 110.24 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -90.54 100.52 13.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.037 -0.727 . . . . 54.23 109.037 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.25 107.7 19.82 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.913 0.863 . . . . 72.0 112.672 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -100.77 169.68 8.85 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.513 -1.662 . . . . 62.41 106.513 171.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 1.6 mp0 -57.55 -42.16 82.42 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.173 0.511 . . . . 62.24 110.109 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.67 70.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.519 -0.764 . . . . 64.42 111.542 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.67 -36.85 70.77 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.653 -0.499 . . . . 74.11 109.653 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -60.47 -47.8 84.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.778 -0.646 . . . . 72.31 110.224 173.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -46.88 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.726 0.641 . . . . 65.43 110.604 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.65 87.86 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.062 0.458 . . . . 63.32 110.926 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -68.95 -33.3 73.49 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 116.325 -0.398 . . . . 74.01 111.688 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.46 -45.85 92.53 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.059 -0.349 . . . . 34.53 110.059 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.648 ' HA ' ' HE ' ' A' ' 152' ' ' ARG . 63.2 m -59.11 -46.98 86.91 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 122.818 0.447 . . . . 64.11 110.32 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.46 -39.41 93.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.827 -0.624 . . . . 72.41 110.998 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 31' ' ' TYR . 60.2 tp -64.94 -40.88 95.7 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.999 -0.371 . . . . 75.55 109.999 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.648 ' HE ' ' HA ' ' A' ' 149' ' ' THR . 88.5 mtm180 -62.22 -40.16 95.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.892 -0.594 . . . . 73.03 111.144 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.2 m -69.77 -36.03 75.42 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.428 0.632 . . . . 72.13 110.312 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.7 m -70.33 -33.7 71.8 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.373 0.606 . . . . 73.34 110.424 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.488 HD12 HD23 ' A' ' 187' ' ' LEU . 93.4 mt -77.63 6.69 6.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.707 -0.679 . . . . 71.43 112.54 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.22 142.38 32.74 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.004 -0.739 . . . . 62.32 109.004 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.43 -10.29 65.02 Favored Glycine 0 C--N 1.307 -1.052 0 N-CA-C 110.095 -1.202 . . . . 71.22 110.095 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 10.9 t -120.9 153.16 57.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.448 -1.686 . . . . 75.24 106.448 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.59 17.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.592 2.861 . . . . 44.33 115.199 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.41 131.7 34.35 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.068 -0.395 . . . . 71.51 110.097 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 32.2 p -124.94 154.94 40.37 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.754 -0.832 . . . . 52.05 108.754 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -136.73 149.25 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 118.287 0.494 . . . . 72.22 110.956 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -116.77 141.63 47.97 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.727 0.64 . . . . 72.34 112.727 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.21 -2.28 15.01 Favored Glycine 0 C--N 1.318 -0.461 0 CA-C-N 115.021 -0.99 . . . . 64.31 113.35 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.3 t70 61.22 11.72 3.72 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.549 1.14 . . . . 73.42 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 86' ' ' VAL . 7.3 p -73.79 139.38 19.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.904 1.282 . . . . 71.13 111.385 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.61 168.74 19.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.387 -0.824 . . . . 73.4 110.713 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 16.0 m-85 -115.29 156.42 25.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.096 -0.502 . . . . 72.11 110.451 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 64.4 m -124.19 119.84 30.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.626 -1.62 . . . . 63.43 106.626 172.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.5 154.98 49.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.62 -0.264 . . . . 31.14 110.306 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.083 0 N-CA-C 108.931 -1.668 . . . . 40.44 108.931 179.612 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 120.949 0.404 . . . . 64.55 109.922 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.426 ' HA ' ' NE ' ' A' ' 182' ' ' ARG . 3.3 mmp_? -103.51 127.09 50.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.552 -1.647 . . . . 73.33 106.552 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.11 146.51 33.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.838 -0.801 . . . . 73.35 108.838 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.607 ' HG2' ' HG2' ' A' ' 134' ' ' GLN . 40.0 mt-10 -135.23 149.38 49.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.443 0.64 . . . . 62.13 111.323 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.461 ' HB ' HG22 ' A' ' 133' ' ' THR . 77.7 t -125.02 118.58 53.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.927 -1.508 . . . . 71.23 106.927 172.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 18.0 m0 -102.91 120.65 40.99 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.139 -1.06 . . . . 74.23 108.139 -178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.488 HD23 HD12 ' A' ' 155' ' ' LEU . 37.8 tp -106.05 129.95 54.06 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.303 -1.369 . . . . 64.1 107.303 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.89 125.1 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.565 -0.454 . . . . 63.12 110.705 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 161' ' ' THR . 13.8 pttp -71.06 145.95 49.6 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.005 -0.739 . . . . 64.14 109.005 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 108.787 -0.82 . . . . 37.68 108.787 174.671 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.2 p90 . . . . . 0 N--CA 1.431 -1.388 0 CA-C-O 121.819 0.819 . . . . 73.14 109.153 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -113.55 122.44 47.24 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.888 -1.051 . . . . 72.34 111.18 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.0 119.79 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 106.111 -1.811 . . . . 75.41 106.111 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -89.96 -25.78 20.73 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.123 -0.631 . . . . 71.43 111.062 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -176.84 153.85 1.09 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.511 0.507 . . . . 75.14 109.794 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.3 p -132.29 154.59 49.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.801 -0.814 . . . . 62.53 108.801 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.03 -148.82 20.1 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 119.24 -1.457 . . . . 71.51 113.313 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.2 -118.45 5.23 Favored Glycine 0 N--CA 1.427 -1.934 0 N-CA-C 110.268 -1.133 . . . . 74.04 110.268 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -99.41 169.96 8.97 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.876 -1.527 . . . . 72.41 106.876 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.3 162.86 14.11 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 75.32 109.236 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 72.72 -53.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.365 1.066 . . . . 71.43 110.12 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.63 111.75 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 107.999 -1.111 . . . . 73.2 107.999 172.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.2 p -133.69 155.82 49.03 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.594 -0.73 . . . . 61.23 110.477 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -112.01 161.8 16.07 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.233 0.539 . . . . 71.01 111.428 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' OE1' ' HD2' ' A' ' 34' ' ' ARG . 39.7 tt0 -133.81 124.86 27.27 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.159 -1.423 . . . . 73.33 107.159 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.07 114.9 26.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.84 -1.541 . . . . 75.43 106.84 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.456 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 13.7 ptm180 -134.22 143.47 47.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.32 0.581 . . . . 72.32 112.563 -172.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.78 135.78 35.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.194 -1.78 . . . . 72.14 106.194 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.4 t -68.99 146.74 52.47 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.356 0.598 . . . . 62.13 111.94 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.5 pm0 -67.84 0.5 3.32 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 126.162 1.785 . . . . 74.14 114.236 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 75.08 11.51 83.96 Favored Glycine 0 C--N 1.305 -1.147 0 C-N-CA 119.656 -1.259 . . . . 62.4 114.565 169.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.65 152.08 48.76 Favored Glycine 0 N--CA 1.408 -3.204 0 C-N-CA 120.349 -0.929 . . . . 72.31 113.39 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 104' ' ' ILE . 17.7 ptpt -102.96 118.93 37.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.041 -1.466 . . . . 70.33 107.041 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 59.3 m-85 -117.15 163.72 15.85 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.562 -0.745 . . . . 62.15 111.525 -168.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.03 116.91 32.34 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 108.093 -1.077 . . . . 75.24 108.093 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -124.21 146.41 48.73 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 113.033 0.753 . . . . 74.1 113.033 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.4 m -128.03 144.13 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 114.262 -1.336 . . . . 62.53 108.645 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.25 136.7 51.4 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 120.77 0.319 . . . . 73.32 111.016 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.557 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 44.4 t -130.39 141.99 44.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 105.916 -1.883 . . . . 64.41 105.916 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.468 ' C ' ' H ' ' A' ' 49' ' ' LYS . 34.1 p -130.49 159.76 36.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.651 0.612 . . . . 61.51 112.651 -171.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.3 -32.75 0.24 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.642 1.577 . . . . 72.24 112.541 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 47' ' ' THR . 52.6 mtpt -85.05 136.34 38.48 Favored Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 124.673 1.189 . . . . 72.41 109.336 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 53.0 Cg_exo -55.05 156.15 16.81 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.268 2.645 . . . . 73.02 112.111 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.66 -41.44 12.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 113.293 0.849 . . . . 75.13 113.293 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -59.7 -47.66 84.76 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 120.644 -0.422 . . . . 73.13 110.975 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.64 -39.82 73.44 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.94 -0.573 . . . . 75.31 111.702 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -67.47 -46.32 73.33 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.692 -0.686 . . . . 41.14 110.453 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.8 -45.74 85.01 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 122.423 0.289 . . . . 72.53 111.758 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 5.6 ppt_? -61.82 -28.24 69.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.813 0.672 . . . . 72.51 112.813 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 tt0 -85.64 -39.51 17.21 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.426 0.631 . . . . 71.01 111.154 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -76.51 -32.17 58.14 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.95 0.722 . . . . 44.15 112.95 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.515 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -53.59 -48.05 94.41 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 112.401 0.519 . . . . 73.51 112.401 -178.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 63' ' ' MET . 36.4 Cg_exo -56.48 -34.54 95.1 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.135 1.89 . . . . 71.23 111.515 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 58' ' ' ALA . 50.6 mtmt -69.03 -32.61 72.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.117 0.484 . . . . 71.23 110.791 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 102' ' ' PHE . 29.7 mm -76.49 -48.74 26.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.1 -0.5 . . . . 73.34 111.503 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.411 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.276 3.2 ppp? -66.01 -29.23 69.57 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.696 0.998 . . . . 63.04 113.696 -176.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.08 -29.45 69.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.24 0.543 . . . . 64.24 110.296 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.769 -0.65 . . . . 72.43 110.139 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 76' ' ' MET . 2.7 p -66.8 -27.23 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.013 0.435 . . . . 71.12 110.124 176.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.79 -20.77 62.39 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.842 -0.617 . . . . 54.5 113.686 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 131.67 -15.74 5.15 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.859 -1.162 . . . . 73.44 113.028 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -81.69 29.0 0.39 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.928 0.871 . . . . 72.25 110.502 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.01 166.02 13.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.919 -0.582 . . . . 73.12 109.908 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.76 -35.03 79.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 112.928 0.714 . . . . 71.23 112.928 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.594 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 1.6 mptm? -82.71 -10.56 58.85 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.113 0.482 . . . . 73.42 111.526 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.88 33.88 76.02 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.56 -0.746 . . . . 75.21 112.541 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 24.7 m -80.65 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.712 -0.795 . . . . 72.44 108.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.31 167.34 51.96 Favored Glycine 0 N--CA 1.435 -1.372 0 O-C-N 123.776 0.672 . . . . 44.33 113.033 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 27.1 ttt -76.14 101.25 5.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.284 -0.458 . . . . 62.43 109.968 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.57 41.86 0.18 Allowed Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.217 -0.992 . . . . 73.12 112.978 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.414 ' HG2' HG23 ' A' ' 66' ' ' VAL . 15.3 ptm -124.91 123.5 40.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.947 -1.131 . . . . 73.21 107.947 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.3 m -125.67 117.36 23.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.034 0.753 . . . . 73.33 113.034 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -156.72 159.02 31.59 Favored Pre-proline 0 C--O 1.242 0.7 0 C-N-CA 125.494 1.518 . . . . 64.22 107.311 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.16 140.12 81.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.763 1.642 . . . . 54.15 112.131 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.98 150.61 5.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.949 -1.13 . . . . 65.24 107.949 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -138.65 144.64 39.77 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.866 -0.42 . . . . 71.44 109.866 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 46.5 p90 -135.2 144.83 47.16 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 122.083 -0.386 . . . . 74.33 110.653 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.64 34.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 108.523 -0.917 . . . . 61.32 108.523 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.23 150.25 25.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 N-CA-C 107.821 -1.177 . . . . 72.43 107.821 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.435 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 2.7 m-85 -117.07 100.3 53.23 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.672 -0.862 . . . . 75.14 108.672 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.87 152.38 16.86 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 121.911 1.741 . . . . 75.01 112.677 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -100.14 158.37 15.9 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.327 -1.731 . . . . 71.32 106.327 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.25 -12.79 58.42 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.352 0.501 . . . . 70.23 112.352 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.39 -3.03 54.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.988 -0.551 . . . . 71.42 110.984 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.07 -4.01 82.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.936 -0.65 . . . . 32.51 112.984 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.0 m -83.01 131.42 35.18 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.765 0.317 . . . . 45.32 110.414 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.57 79.26 4.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.539 0.685 . . . . 52.44 110.534 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 52.0 tt0 -148.46 114.26 5.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.29 -0.868 . . . . 74.22 111.012 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 56.3 mtpt -176.82 -67.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.727 2.011 . . . . 72.13 107.048 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 64.9 mttm -145.67 158.63 43.83 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.883 -1.053 . . . . 73.15 108.518 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 84' ' ' PHE . 46.8 tp -139.14 124.74 19.45 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.964 -1.125 . . . . 71.21 107.964 171.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -123.68 114.04 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.158 -1.052 . . . . 71.54 108.158 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.508 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 58.2 t -97.15 130.14 46.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.178 -0.675 . . . . 52.44 109.178 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.45 131.65 56.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.149 -0.685 . . . . 71.31 109.149 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.421 ' HB2' HD12 ' A' ' 62' ' ' ILE . 67.8 t80 -102.98 114.67 29.16 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.022 -1.103 . . . . 73.02 108.022 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.632 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 75.9 ttt180 -75.52 133.04 41.11 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.014 -1.448 . . . . 74.11 109.755 -176.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 40' ' ' LYS . 76.1 mt -106.44 137.54 19.46 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.565 -0.902 . . . . 70.15 108.565 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.77 149.43 77.55 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.259 1.972 . . . . 63.24 110.428 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -60.99 -33.82 73.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.831 1.049 . . . . 64.3 113.831 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -66.94 -23.91 66.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 64.03 111.119 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -92.66 -7.7 46.13 Favored 'General case' 0 C--O 1.192 -1.958 0 CA-C-N 116.66 -0.246 . . . . 73.32 110.895 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.749 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.52 -33.29 69.06 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.922 -0.711 . . . . 74.04 111.478 177.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.83 -29.61 74.59 Favored Glycine 0 C--N 1.334 0.464 0 O-C-N 123.559 0.537 . . . . 42.4 111.949 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.0 t -153.69 82.56 4.58 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 108.996 -0.742 . . . . 71.11 108.996 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.73 162.14 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.468 2.112 . . . . 54.33 111.902 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.594 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.3 Cg_exo -60.45 156.98 38.37 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 C-N-CA 121.581 1.52 . . . . 72.12 109.783 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.94 154.56 37.74 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.431 -0.581 . . . . 72.22 109.431 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 27.8 Cg_exo -62.98 104.99 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.781 2.321 . . . . 75.11 111.81 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.2 p -90.67 -28.35 18.42 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.871 -0.604 . . . . 71.34 112.177 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.7 156.03 18.38 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.813 -0.81 . . . . 73.11 108.813 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.47 -31.71 63.91 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.455 0.645 . . . . 70.25 110.366 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.8 m -99.28 5.14 46.67 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.525 -0.762 . . . . 43.25 112.013 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 59.6 t -119.7 122.6 69.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.071 -1.085 . . . . 61.12 108.071 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -128.22 143.4 51.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.366 -0.379 . . . . 72.25 110.502 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.2 mm -92.75 110.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.826 -1.176 . . . . 63.53 107.826 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -108.01 144.04 35.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.23 -0.895 . . . . 62.2 109.382 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.16 127.33 45.1 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.842 -0.617 . . . . 64.52 110.492 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 125' ' ' ARG . 2.1 mmp_? -123.36 116.25 22.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 118.745 -1.182 . . . . 64.11 109.686 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.586 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -148.49 161.01 42.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.379 -0.828 . . . . 75.25 110.962 173.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.13 19.7 71.68 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.919 -0.658 . . . . 74.0 112.264 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -121.14 147.67 24.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.314 0.578 . . . . 75.23 111.009 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.9 m -117.47 128.21 54.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.446 -0.946 . . . . 62.25 108.446 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.458 HG21 ' CE3' ' A' ' 186' ' ' TRP . 30.2 m -124.72 166.06 20.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 116.13 -0.486 . . . . 75.54 110.001 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 55.4 m-85 -113.75 122.18 46.33 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 106.256 -1.757 . . . . 74.34 106.256 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 p -119.73 132.73 55.72 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.773 -0.771 . . . . 71.22 110.735 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.8 t -121.76 123.84 42.79 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 109.007 -0.738 . . . . 51.33 109.007 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -110.58 136.91 48.96 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.431 -0.951 . . . . 73.02 108.431 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 43.2 p90 -145.49 144.7 30.72 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.026 -0.533 . . . . 72.33 111.561 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -106.64 138.25 14.31 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.503 -1.039 . . . . 64.45 110.503 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.11 -175.06 28.52 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.868 -0.682 . . . . 51.21 111.484 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -87.59 111.13 20.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.784 -1.191 . . . . 75.32 107.784 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.28 130.8 53.24 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.531 0.567 . . . . 55.35 112.531 -174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.15 178.21 5.32 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.702 -1.222 . . . . 73.51 107.702 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.71 77.86 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.323 0.582 . . . . 64.31 109.869 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.48 71.31 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.355 -0.839 . . . . 73.42 111.063 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.37 -30.52 70.33 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.413 0.149 . . . . 73.13 111.199 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -69.7 -41.63 75.13 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 110.036 -0.357 . . . . 72.22 110.036 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.81 -48.0 83.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.396 -0.594 . . . . 72.45 109.396 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.98 87.88 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.36 -0.836 . . . . 64.24 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -66.37 -32.43 73.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 112.402 0.519 . . . . 55.54 112.402 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 -46.7 79.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.86 0.362 . . . . 72.23 111.037 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.4 t -72.58 -33.39 66.72 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.482 0.658 . . . . 74.54 110.235 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -64.44 -37.07 86.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.168 -0.678 . . . . 74.01 109.168 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.35 -39.45 93.91 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.859 -0.609 . . . . 62.34 110.058 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -63.28 -36.54 84.01 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.372 -0.603 . . . . 75.31 109.372 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 m -70.53 -32.71 70.27 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.261 -0.881 . . . . 73.25 110.031 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.6 m -76.79 -34.33 57.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.671 -0.695 . . . . 74.11 110.06 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -85.71 11.22 11.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.58 0.752 . . . . 65.11 111.095 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -73.68 135.21 43.7 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.624 -1.621 . . . . 51.5 106.624 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.49 58.83 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.521 -0.632 . . . . 61.44 111.521 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 34.9 p -114.3 160.14 33.91 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 107.259 -1.385 . . . . 71.45 107.259 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.13 27.31 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 122.192 1.928 . . . . 53.52 112.163 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.16 101.1 0.85 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.359 0.599 . . . . 71.31 112.273 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.5 p -89.33 156.03 18.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.559 -0.904 . . . . 70.13 108.559 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.408 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 24.2 m-85 -138.74 150.4 46.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.2 pt20 -114.04 109.89 19.17 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.309 0.576 . . . . 73.34 110.438 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.27 41.95 Favored Glycine 0 N--CA 1.46 0.3 0 C-N-CA 120.808 -0.71 . . . . 62.44 111.901 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 59.31 25.55 14.22 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.936 1.294 . . . . 72.01 110.499 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.1 m -75.1 140.03 18.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 119.799 -0.761 . . . . 74.32 110.76 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -139.9 170.24 16.23 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.162 -0.926 . . . . 64.02 109.607 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.579 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 60.6 m-85 -115.43 148.09 39.79 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.721 -0.844 . . . . 73.54 108.721 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 63.1 m -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.522 -1.658 . . . . 75.33 106.522 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -117.59 145.45 44.29 Favored 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 123.558 0.536 . . . . 72.22 111.253 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.04 0 N-CA-C 108.932 -1.667 . . . . 34.22 108.932 -179.454 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.444 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 97.0 mtt180 . . . . . 0 CA--C 1.503 -0.851 0 CA-C-O 120.47 0.176 . . . . 75.52 110.998 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.87 130.55 49.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 109.245 -0.65 . . . . 60.31 109.245 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.434 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.6 m-80 -127.47 139.34 52.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.241 -1.392 . . . . 61.54 107.241 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 39.0 tt0 -132.09 133.93 44.9 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.829 -0.348 . . . . 73.31 111.051 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.49 125.71 69.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.466 0.706 . . . . 73.04 110.062 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.8 m0 -109.08 121.13 44.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.904 -0.776 . . . . 73.35 108.904 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.35 124.03 49.21 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 107.522 -1.288 . . . . 64.54 107.522 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.405 HG13 HE21 ' A' ' 163' ' ' GLN . 7.1 p -95.34 132.31 39.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.782 0.325 . . . . 74.12 111.262 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 21.0 ptmt -76.45 141.95 41.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.128 -0.487 . . . . 70.21 111.288 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.408 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.809 -0.632 . . . . 65.34 110.42 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 105.501 -2.037 . . . . 73.01 105.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.83 118.75 21.23 Favored 'General case' 0 C--N 1.284 -2.273 0 C-N-CA 119.633 -0.827 . . . . 73.23 109.105 -171.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t -89.7 126.29 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.883 -0.784 . . . . 61.54 108.883 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.78 -38.57 15.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.384 -0.969 . . . . 61.42 108.384 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.5 t 179.69 165.68 1.13 Allowed 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.932 -1.031 . . . . 62.23 108.291 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 32' ' ' GLU . 68.2 p -131.64 165.13 24.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.958 -1.127 . . . . 63.24 107.958 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.99 -157.04 25.82 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 119.352 -1.404 . . . . 51.03 113.04 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.97 -138.51 14.6 Favored Glycine 0 N--CA 1.42 -2.397 0 N-CA-C 111.186 -0.766 . . . . 74.1 111.186 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.1 171.06 8.48 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.283 -1.006 . . . . 72.14 108.283 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.44 162.17 23.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.129 -1.028 . . . . 71.42 109.622 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 72.39 -54.27 0.69 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.345 1.058 . . . . 75.42 109.797 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 150' ' ' GLN . 6.2 p -110.21 109.39 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-O 122.049 0.928 . . . . 44.22 109.125 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 m -129.67 146.36 51.46 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.003 -1.11 . . . . 71.35 108.003 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' HB3' HD22 ' A' ' 151' ' ' LEU . 6.0 p90 -113.83 160.49 18.67 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 112.795 0.665 . . . . 72.2 112.795 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.573 ' OE1' ' HD3' ' A' ' 34' ' ' ARG . 39.7 tt0 -136.56 125.71 24.61 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.468 -2.049 . . . . 73.03 105.468 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -98.91 118.04 34.77 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.883 -1.525 . . . . 42.15 106.883 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HD3' ' OE1' ' A' ' 32' ' ' GLU . 27.0 mtm180 -131.68 145.76 51.82 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.931 -1.108 . . . . 72.13 111.717 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.34 136.86 34.92 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.303 -2.11 . . . . 61.45 105.303 168.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.0 t -58.25 148.45 27.19 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.349 0.406 . . . . 54.24 111.817 -175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -73.17 -3.35 26.03 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 115.753 -0.658 . . . . 25.3 111.641 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 74.01 9.07 79.62 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 120.979 -0.629 . . . . 45.14 114.021 171.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.37 162.5 54.23 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 121.052 -0.594 . . . . 54.53 113.527 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.64 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.04 118.65 37.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.315 -1.365 . . . . 63.31 107.315 178.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.1 m-85 -121.4 165.7 15.18 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.665 -0.698 . . . . 70.14 112.05 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -97.69 116.79 30.59 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -127.66 144.24 51.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.655 0.74 . . . . 73.44 112.24 -174.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 6.5 p -127.61 133.63 67.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.298 -1.371 . . . . 73.54 107.298 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.71 123.58 45.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.072 -0.651 . . . . 73.44 111.382 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.449 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 31.6 t -118.16 123.19 71.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.261 -1.385 . . . . 52.5 107.261 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 25.0 m -117.76 159.5 22.92 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.669 -0.241 . . . . 72.01 110.532 -175.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 75.58 -27.39 0.19 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.852 1.661 . . . . 72.01 112.035 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -85.19 145.05 42.08 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 109.274 -0.639 . . . . 74.21 109.274 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.57 156.84 34.69 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.927 2.418 . . . . 74.22 111.514 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG13 HD12 ' A' ' 98' ' ' LEU . 54.5 t -48.03 -44.74 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.36 0.664 . . . . 60.34 112.408 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -58.04 -44.41 87.38 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.95 0.405 . . . . 63.12 110.737 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.15 -48.79 26.98 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.505 -0.77 . . . . 62.32 111.063 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -59.7 -40.18 87.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 73.23 111.317 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 59' ' ' MET . 52.7 tp -65.61 -51.3 60.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 116.338 -0.392 . . . . 62.02 110.959 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 4.9 ppt_? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.318 0.858 . . . . 64.44 113.318 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 1.3 tm-20 -74.69 -45.82 41.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.384 -0.969 . . . . 74.53 108.384 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -76.57 -33.16 58.5 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.525 1.13 . . . . 32.33 114.046 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 8.9 mmt -50.98 -55.09 30.65 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 114.918 1.451 . . . . 71.13 114.918 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.42 -30.91 75.47 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.681 2.254 . . . . 62.23 112.163 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -67.35 -48.63 66.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 54.2 111.029 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.7 mm -66.48 -40.1 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 74.04 109.767 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -48.53 79.88 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 123.666 0.787 . . . . 71.34 111.13 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -27.58 65.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.952 -0.699 . . . . 72.4 112.382 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.95 -50.52 68.3 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.576 -0.283 . . . . 52.42 110.517 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -2.92 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.901 -0.591 . . . . 72.52 111.583 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.55 -21.59 36.88 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.809 -0.632 . . . . 72.23 111.929 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 136.69 -14.29 3.89 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.174 -1.012 . . . . 25.03 113.425 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 m -81.48 40.53 0.58 Allowed 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.89 1.329 . . . . 73.42 110.957 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.81 177.16 5.55 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.24 -0.891 . . . . 74.42 108.978 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.45 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 17.0 t70 -69.33 -30.88 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.859 0.361 . . . . 74.11 111.961 -175.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -81.77 -12.63 58.48 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.36 -0.382 . . . . 71.22 110.289 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.31 20.8 75.5 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.805 -0.634 . . . . 73.34 112.18 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.494 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 33.4 m -86.33 125.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.622 -0.431 . . . . 74.3 110.738 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.64 -71.13 0.96 Allowed Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 111.542 -0.623 . . . . 74.3 111.542 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.5 mmt 66.43 -64.18 0.23 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.185 1.179 . . . . 72.12 114.185 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 60.7 5.9 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.621 -1.392 . . . . 70.32 109.621 -174.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -96.12 126.25 41.22 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.179 0.514 . . . . 64.3 110.946 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.8 t -123.45 116.6 23.5 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 122.361 1.077 . . . . 74.3 111.557 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.2 m -143.65 170.93 7.57 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 105.262 -2.125 . . . . 65.43 105.262 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.03 138.62 79.68 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.609 1.253 . . . . 72.35 113.547 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.9 p -111.88 147.22 15.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.696 -1.594 . . . . 71.4 106.696 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.0 p -132.61 144.95 50.71 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.438 -0.505 . . . . 51.43 110.22 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -131.68 141.32 49.55 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 120.199 -0.6 . . . . 71.13 110.716 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.594 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.75 135.02 34.48 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 115.54 -0.755 . . . . 54.43 109.414 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.69 150.21 32.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.696 -0.684 . . . . 62.35 109.457 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 90.7 m-85 -119.48 101.88 48.42 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 110.143 -0.318 . . . . 73.01 110.143 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.95 142.55 15.69 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 122.447 2.098 . . . . 64.04 112.589 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.473 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 45.6 m-80 -96.66 162.63 13.36 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.034 -0.728 . . . . 60.22 109.034 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.1 -13.56 62.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.424 0.631 . . . . 73.51 110.232 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.51 -6.19 54.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.27 -0.877 . . . . 54.31 109.457 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -6.8 82.95 Favored Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 116.024 -0.535 . . . . 72.14 112.296 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 p -84.39 140.88 31.25 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.833 0.349 . . . . 71.21 110.48 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.47 79.11 2.46 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.302 0.573 . . . . 64.23 109.569 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 78.2 mt-30 -147.02 114.63 6.39 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.766 -0.652 . . . . 72.22 110.596 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 89.2 mttt -176.63 -63.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 126.274 1.83 . . . . 73.52 108.091 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 21.9 ttmm -161.04 153.83 20.92 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.691 -0.855 . . . . 62.03 108.691 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 5.8 tt -139.92 128.37 22.79 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.031 -1.47 . . . . 73.23 107.031 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -123.43 115.61 21.89 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.014 -0.735 . . . . 74.14 109.014 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 43' ' ' THR . 82.6 t -88.74 123.03 40.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.952 -0.388 . . . . 52.41 109.952 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -109.78 124.75 51.81 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.971 -0.751 . . . . 75.14 108.971 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 87.8 t80 -102.52 112.4 25.12 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.995 -1.113 . . . . 74.52 107.995 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.492 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 2.3 tmt_? -75.5 112.93 12.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.931 -1.507 . . . . 72.41 106.931 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.521 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 67.7 mt -85.68 137.92 35.88 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.156 -0.475 . . . . 74.32 109.9 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.29 143.36 34.08 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.63 2.22 . . . . 55.22 111.539 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.92 -33.39 62.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.363 1.246 . . . . 74.52 114.363 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -59.41 -31.23 69.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.893 0.378 . . . . 75.53 111.006 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.98 -2.78 49.71 Favored 'General case' 0 C--O 1.192 -1.942 0 CA-C-N 116.341 -0.39 . . . . 65.53 111.605 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.521 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 29.5 mm-40 -71.01 -28.62 64.55 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.199 -0.6 . . . . 72.13 110.608 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.04 -38.29 92.49 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.266 -0.734 . . . . 44.53 111.266 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.8 m -155.39 92.99 2.7 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 123.212 0.605 . . . . 65.2 109.52 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 77.4 Cg_endo -83.96 145.04 11.1 Favored 'Trans proline' 0 C--O 1.251 1.158 0 C-N-CA 122.472 2.115 . . . . 62.14 111.832 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 29.5 Cg_exo -63.1 130.6 29.44 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.886 1.724 . . . . 72.13 109.432 174.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -61.18 139.67 94.42 Favored Pre-proline 0 C--O 1.257 1.479 0 CA-C-O 120.767 0.318 . . . . 72.13 110.68 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 61.2 Cg_endo -72.2 108.21 2.43 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.584 2.189 . . . . 74.51 111.199 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.8 t -89.91 82.47 6.18 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 116.02 -0.536 . . . . 51.43 110.428 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.629 ' HB3' HG12 ' A' ' 120' ' ' VAL . 13.0 t70 -178.49 164.37 1.65 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 104.492 -2.41 . . . . 64.42 104.492 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.47 -28.37 22.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 118.727 0.694 . . . . 74.52 112.269 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 p -91.28 -18.46 24.32 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.704 1.001 . . . . 71.52 113.704 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 117' ' ' ASP . 2.5 p -104.37 120.64 55.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.237 0.541 . . . . 54.3 109.879 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 154.24 46.98 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.332 -0.849 . . . . 72.21 110.519 -175.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.8 mm -91.75 112.32 25.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.806 -0.813 . . . . 75.31 108.806 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -126.15 147.73 49.56 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.27 -1.011 . . . . 74.15 108.27 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 40' ' ' LYS . 14.7 pt-20 -121.24 151.2 40.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 120.948 0.404 . . . . 75.13 111.341 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -134.33 125.68 28.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.82 -0.627 . . . . 71.14 111.581 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.493 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -143.14 174.2 10.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 171.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.94 19.34 77.68 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 119.884 -1.15 . . . . 75.04 111.12 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.8 145.74 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-O 121.003 0.43 . . . . 75.42 109.912 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.1 m -115.73 131.67 56.87 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.543 -1.28 . . . . 54.2 107.543 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -123.96 154.23 30.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.073 0.463 . . . . 71.13 109.906 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 66.2 m-85 -114.03 122.04 45.71 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 105.998 -1.853 . . . . 75.05 105.998 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.6 p -112.59 143.01 44.49 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.854 0.359 . . . . 70.23 111.005 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.509 ' HB ' HD21 ' A' ' 151' ' ' LEU . 13.5 t -128.01 134.35 49.23 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 120.693 -0.403 . . . . 63.24 110.008 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.521 ' NE2' ' HG2' ' A' ' 184' ' ' GLU . 2.0 mp0 -110.84 142.18 43.2 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.552 -1.648 . . . . 72.12 106.552 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 143' ' ' ASP . 30.7 p90 -143.17 118.25 10.08 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 115.133 1.531 . . . . 73.42 115.133 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 47.74 -138.96 10.37 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.005 -1.452 . . . . 73.15 115.776 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 181' ' ' ARG . . . -124.78 -28.39 1.16 Allowed Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.103 -0.799 . . . . 53.11 111.103 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.6 119.43 38.06 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.002 0.43 . . . . 70.34 112.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.436 ' HB2' HD22 ' A' ' 183' ' ' ASN . . . -124.59 107.63 11.23 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.578 -0.737 . . . . 75.32 110.883 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.14 171.9 8.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.737 -1.209 . . . . 73.03 107.737 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.59 -39.02 75.87 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.135 0.493 . . . . 63.15 110.434 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.36 74.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.38 -0.827 . . . . 70.44 111.362 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 17.2 m-20 -65.92 -36.26 82.88 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 111.815 0.302 . . . . 74.43 111.815 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.37 -39.9 89.38 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.927 0.394 . . . . 72.44 110.709 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.99 -51.13 32.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.949 -0.569 . . . . 65.43 110.372 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -57.4 -46.52 83.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.714 -0.675 . . . . 72.32 111.667 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -65.03 -32.65 74.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.027 0.751 . . . . 74.12 113.027 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.92 86.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.342 -0.614 . . . . 74.34 109.342 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.8 m -65.59 -40.19 92.42 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.711 -0.677 . . . . 72.35 109.937 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 30.2 mm-40 -61.84 -37.02 82.92 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 116.186 -0.461 . . . . 74.34 111.938 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.509 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.0 mt -60.92 -35.03 75.64 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 120.865 -0.334 . . . . 54.32 111.752 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -59.81 -48.14 82.87 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.25 0.343 . . . . 75.14 111.276 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 156' ' ' GLU . 13.0 t -75.56 -30.61 59.75 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.201 0.524 . . . . 65.15 111.033 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.9 m -70.69 -35.35 72.75 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 120.963 0.411 . . . . 74.24 110.421 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.5 6.45 17.39 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.014 0.525 . . . . 73.21 112.283 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 153' ' ' THR . 56.5 mt-10 -68.93 138.3 54.5 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.008 -0.677 . . . . 75.13 110.082 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.09 56.6 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.756 -0.656 . . . . 74.15 111.595 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.5 p -125.37 165.33 26.97 Favored Pre-proline 0 N--CA 1.441 -0.922 0 N-CA-C 108.293 -1.002 . . . . 55.11 108.293 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -75.44 20.14 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.796 2.331 . . . . 71.21 112.451 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.73 120.73 17.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.309 0.576 . . . . 55.42 110.426 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 10.1 t -124.59 157.5 35.29 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.007 -1.849 . . . . 61.03 106.007 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -132.6 160.09 37.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 119.115 0.871 . . . . 72.23 108.893 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -128.77 132.86 47.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.125 0.417 . . . . 52.43 112.125 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.63 -0.45 27.14 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.508 -0.769 . . . . 63.14 114.12 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 60.62 10.77 2.74 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.033 0.933 . . . . 72.45 112.285 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.5 p -68.77 138.53 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.784 0.802 . . . . 74.3 111.488 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.414 ' HB3' HD23 ' A' ' 187' ' ' LEU . 36.4 p90 -135.95 161.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.8 -1.091 . . . . 71.23 108.897 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 88.4 m-85 -115.41 142.07 47.19 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.153 -0.476 . . . . 74.43 109.913 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.2 m -114.22 120.3 40.0 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.731 -1.211 . . . . 65.34 107.731 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -116.3 143.07 46.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.154 0.502 . . . . 71.44 111.708 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.654 0 N-CA-C 107.279 -2.328 . . . . 54.52 107.279 -179.525 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HA ' ' HA2' ' A' ' 137' ' ' GLY 0.258 19.7 ptt180 . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 116.185 1.92 . . . . 74.11 116.185 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -101.23 125.25 47.84 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 115.342 -2.543 . . . . 75.52 108.581 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.436 HD22 ' HB2' ' A' ' 139' ' ' ALA . 19.8 p30 -146.84 158.37 43.9 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.648 -1.614 . . . . 62.03 108.786 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 43.5 mt-10 -143.12 137.38 29.09 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.098 0.475 . . . . 72.13 110.537 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 84.7 t -124.22 118.5 53.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 105.913 -1.884 . . . . 74.43 105.913 171.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.526 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 49.2 m0 -106.32 124.42 49.57 Favored 'General case' 0 CA--C 1.495 -1.154 0 O-C-N 123.463 0.477 . . . . 75.34 111.413 -176.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 167' ' ' TYR . 62.4 mt -97.35 125.2 41.81 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.676 -1.601 . . . . 70.42 106.676 167.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.7 124.75 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 120.536 -0.466 . . . . 74.01 109.993 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 161' ' ' THR . 15.5 pttp -70.19 145.1 51.69 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.643 -0.708 . . . . 73.04 109.644 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.296 -1.76 0 C-N-CA 118.976 -1.089 . . . . 41.43 109.442 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 41.2 p90 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 109.375 -0.602 . . . . 61.43 109.375 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -122.91 110.0 14.86 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.943 -0.303 . . . . 60.43 110.546 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.3 116.42 30.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 106.906 -1.516 . . . . 74.2 106.906 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -91.93 -26.28 18.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.36 -0.536 . . . . 63.24 112.111 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -172.85 153.14 2.58 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.006 0.431 . . . . 64.53 110.779 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.6 p -133.03 134.58 44.6 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.867 -1.06 . . . . 71.43 110.231 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.94 132.55 7.81 Favored Glycine 0 C--N 1.304 -1.246 0 C-N-CA 120.265 -0.969 . . . . 62.5 112.752 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.46 -115.03 0.98 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.029 -0.605 . . . . 62.13 111.749 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.582 ' H ' HG23 ' A' ' 154' ' ' THR . 4.7 ttmp? -91.71 117.55 29.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.518 -1.66 . . . . 64.33 106.518 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -67.75 134.31 50.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 115.27 1.582 . . . . 73.42 115.27 -170.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 158.17 -58.87 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 129.704 3.202 . . . . 72.44 103.737 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.2 p -129.22 129.96 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 106.901 -1.518 . . . . 74.33 106.901 170.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 m -95.27 154.64 17.09 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.893 -0.504 . . . . 75.21 110.087 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CD2' HG22 ' A' ' 154' ' ' THR . 0.1 OUTLIER -113.47 163.37 14.98 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.983 -0.553 . . . . 74.34 110.885 178.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -132.96 124.53 27.96 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.628 -1.99 . . . . 74.5 105.628 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.4 115.27 30.13 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.552 -1.277 . . . . 71.15 107.552 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -131.3 139.79 49.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.216 -0.594 . . . . 63.0 110.933 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.39 133.65 35.44 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 104.924 -2.251 . . . . 73.51 104.924 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.27 138.92 58.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 123.674 0.609 . . . . 61.14 109.851 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.8 OUTLIER -60.69 -26.94 67.49 Favored 'General case' 0 N--CA 1.422 -1.85 0 O-C-N 124.435 1.085 . . . . 62.23 112.531 -178.193 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 84.31 10.24 80.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 118.465 -1.826 . . . . 73.24 112.247 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.22 157.27 53.4 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.822 -0.704 . . . . 61.21 111.395 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 14.4 ptpt -88.32 123.43 32.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.409 -0.96 . . . . 71.43 108.409 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.641 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.0 m-85 -122.32 165.45 16.23 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.588 -0.733 . . . . 65.05 110.996 -172.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.25 115.35 28.18 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.384 -0.969 . . . . 73.24 108.384 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.9 t -120.32 142.67 48.91 Favored 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 115.124 -0.943 . . . . 62.3 111.643 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 13.8 m -128.89 127.14 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 107.147 -1.427 . . . . 71.01 107.147 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.59 119.68 31.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-O 121.887 0.851 . . . . 74.05 112.093 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 39.9 t -114.72 135.8 53.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.221 -1.354 . . . . 75.33 107.616 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 49' ' ' LYS . 33.3 p -125.78 167.5 15.09 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.582 -0.281 . . . . 65.05 110.736 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.7 t70 73.64 -26.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 124.039 0.935 . . . . 71.23 112.202 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 47' ' ' THR . 94.6 mttt -96.96 143.27 25.83 Favored Pre-proline 0 C--N 1.3 -1.565 0 CA-C-N 115.808 -0.633 . . . . 64.51 110.22 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.14 158.95 36.82 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.374 2.716 . . . . 62.2 111.789 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG13 HD12 ' A' ' 98' ' ' LEU . 74.2 t -45.66 -45.66 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.131 0.972 . . . . 64.24 112.756 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.58 -50.04 75.27 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.506 0.67 . . . . 53.43 110.52 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.99 -35.73 77.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.104 -0.953 . . . . 72.21 112.273 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.463 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -71.18 -45.26 63.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.462 -0.335 . . . . 73.14 110.624 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.08 -43.64 94.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.304 -0.407 . . . . 71.12 111.413 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -64.51 -26.74 68.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.159 0.429 . . . . 62.23 112.159 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.5 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 27.5 tt0 -84.07 -30.39 26.06 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.09 -0.707 . . . . 74.25 109.09 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.58 52.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.979 -1.01 . . . . 61.0 113.49 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mmt -51.08 -55.85 24.77 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 112.504 0.557 . . . . 74.53 112.504 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.11 -31.32 74.83 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.739 2.293 . . . . 72.43 113.202 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.5 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 93.1 mttt -64.19 -48.46 75.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.77 0.319 . . . . 75.45 110.362 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.8 -38.81 83.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.341 -0.39 . . . . 74.32 110.756 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.1 mmt -59.15 -43.23 92.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.253 -0.43 . . . . 62.14 112.038 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -76.22 -29.72 57.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.834 -0.747 . . . . 75.21 111.634 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 36.9 t80 -60.91 -56.3 22.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.165 -0.471 . . . . 75.35 110.743 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.4 m -77.45 -7.56 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.391 0.615 . . . . 74.34 110.739 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.85 -20.74 62.77 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.602 -0.726 . . . . 14.2 112.436 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.32 6.55 8.11 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.028 -1.082 . . . . 75.42 113.288 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -91.85 17.73 8.74 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.777 1.275 . . . . 54.45 109.573 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.07 173.47 10.46 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.562 -1.199 . . . . 73.24 109.438 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 24.1 t70 -67.09 -33.23 75.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.541 0.571 . . . . 73.53 112.541 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.15 -12.29 59.25 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.45 -0.5 . . . . 71.04 110.554 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.25 24.76 74.81 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 115.535 -0.757 . . . . 44.11 111.884 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.61 122.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 C-N-CA 120.004 -0.679 . . . . 45.34 111.287 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.42 97.84 1.36 Allowed Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 109.241 -1.543 . . . . 72.1 109.241 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtt -126.41 135.53 51.53 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.625 -0.509 . . . . 53.22 109.625 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.95 70.91 1.45 Allowed Glycine 0 C--N 1.292 -1.908 0 CA-C-N 115.296 -0.865 . . . . 43.01 111.922 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' A' ' 78' ' ' MET . 18.0 ptm -96.68 122.44 39.62 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.283 -0.636 . . . . 64.53 109.283 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.8 m -127.44 133.98 49.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.758 -0.656 . . . . 74.02 110.478 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -166.43 148.29 5.84 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.044 -1.465 . . . . 62.14 107.044 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 27.8 Cg_exo -40.1 140.97 0.75 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.753 2.968 . . . . 75.44 115.133 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.26 152.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.262 -1.014 . . . . 63.32 108.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.9 m -139.3 152.32 47.13 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.202 -0.666 . . . . 62.51 109.202 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CB ' ' HA ' ' A' ' 100' ' ' VAL . 54.5 p90 -145.14 144.99 31.19 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 122.1 -0.375 . . . . 60.11 110.578 172.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.39 137.97 31.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.648 -0.501 . . . . 54.44 109.648 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.18 150.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 N-CA-C 108.744 -0.836 . . . . 72.2 108.744 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.58 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 62.7 m-85 -117.09 112.34 40.01 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 107.02 -1.474 . . . . 73.34 107.02 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.22 133.66 18.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 120.948 1.099 . . . . 73.11 112.247 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.35 156.57 20.16 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 107.823 -1.177 . . . . 73.44 107.823 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.01 -13.33 62.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.186 0.517 . . . . 62.3 112.147 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.16 -6.14 58.97 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.998 -0.546 . . . . 72.05 110.278 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.54 -2.45 72.5 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.335 -0.393 . . . . 54.02 113.269 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -87.36 3.56 46.46 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.881 0.697 . . . . 74.35 112.881 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt 65.3 148.29 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.108 0.963 . . . . 70.51 112.889 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 34.8 tt0 -82.08 148.57 28.5 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.707 -0.679 . . . . 75.23 109.854 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -86.06 70.43 10.59 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.752 0.786 . . . . 74.31 111.31 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 22.0 ttmm -158.26 125.5 5.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 105.483 -2.043 . . . . 71.42 105.483 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.459 HD12 HG13 ' A' ' 51' ' ' VAL . 6.1 tt -143.03 131.89 22.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.328 -0.949 . . . . 73.44 111.38 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.79 115.16 23.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.299 -0.864 . . . . 70.3 109.311 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 43' ' ' THR . 92.9 t -88.33 127.93 40.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 108.041 -1.096 . . . . 44.25 108.041 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -114.79 113.61 24.47 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.359 -0.978 . . . . 75.15 108.359 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -103.04 114.08 28.08 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.682 -1.229 . . . . 74.2 107.682 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.641 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 14.8 ptp180 -75.07 138.78 42.36 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.771 -1.104 . . . . 64.24 108.085 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -97.91 141.16 22.54 Favored Pre-proline 0 C--N 1.266 -3.046 0 CA-C-N 116.264 -0.425 . . . . 72.34 110.056 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.42 146.89 9.64 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.902 2.401 . . . . 64.22 111.731 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -52.27 -40.38 61.68 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.379 1.251 . . . . 73.45 114.379 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.37 -27.87 66.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.211 0.529 . . . . 62.35 111.313 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.24 -1.66 47.67 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.203 -0.453 . . . . 61.54 112.156 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.647 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -64.72 -41.21 96.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.881 0.372 . . . . 72.42 110.507 176.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.14 -23.42 68.73 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.679 -0.691 . . . . 64.21 112.35 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -149.77 87.91 5.01 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 120.782 0.325 . . . . 54.0 110.351 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -96.42 162.56 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.008 2.472 . . . . 73.31 111.713 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.2 135.49 27.18 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.409 2.073 . . . . 72.35 111.402 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -71.98 150.29 92.59 Favored Pre-proline 0 C--O 1.256 1.42 0 CA-C-O 120.594 0.235 . . . . 64.22 111.441 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 2.8 Cg_exo -75.85 117.07 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.829 2.352 . . . . 74.21 112.185 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -97.79 21.62 10.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.529 -0.915 . . . . 52.11 108.529 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.575 ' HB3' HG12 ' A' ' 120' ' ' VAL . 17.4 t70 -140.26 156.22 46.56 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.402 -1.333 . . . . 73.34 107.402 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -25.33 22.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.967 -0.693 . . . . 54.43 111.89 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -78.61 -34.06 46.97 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.355 -0.384 . . . . 63.34 110.932 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 117' ' ' ASP . 7.4 p -98.77 125.23 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.364 -0.606 . . . . 61.52 109.364 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -128.21 138.43 52.46 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.341 -0.845 . . . . 52.41 109.539 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 22.9 mm -93.64 110.81 23.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.173 -1.417 . . . . 73.23 107.173 173.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.27 145.19 51.12 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.32 -0.993 . . . . 64.53 108.32 -174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.13 144.22 40.62 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.982 0.42 . . . . 73.44 110.706 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.523 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -123.97 122.68 38.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.058 -1.83 . . . . 73.41 106.058 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.73 157.01 47.37 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.855 1.057 . . . . 73.43 113.855 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.66 17.2 79.22 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.159 -0.928 . . . . 55.14 113.449 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.31 165.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 C-N-CA 120.553 -0.459 . . . . 51.2 110.54 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.54 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 28.6 m -120.13 133.09 55.6 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 109.136 -0.69 . . . . 63.41 109.136 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.99 151.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.387 -0.968 . . . . 63.42 108.387 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 41.4 m-85 -113.64 121.46 44.23 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.413 -1.699 . . . . 74.34 106.413 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 t -111.46 125.15 53.58 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.878 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.556 ' HB ' HD13 ' A' ' 151' ' ' LEU . 12.7 t -113.58 127.36 56.04 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 107.796 -1.187 . . . . 73.14 107.796 174.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -110.41 132.93 53.75 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 121.645 0.736 . . . . 74.3 110.938 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 182' ' ' ARG . 48.7 p90 -129.8 146.38 51.54 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 74.12 108.973 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -124.54 111.03 1.49 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 111.061 -0.816 . . . . 50.22 111.061 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 175.05 -126.53 1.18 Allowed Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.712 -0.756 . . . . 50.43 111.719 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -100.14 135.67 41.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.062 -0.718 . . . . 73.14 109.062 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.88 107.51 10.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 113.277 0.843 . . . . 72.21 113.277 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.675 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 58.0 pttt -104.18 170.63 7.79 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 71.41 106.324 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -39.52 73.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.497 0.665 . . . . 74.51 110.365 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.467 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . . . -64.86 -28.65 69.7 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.138 -0.937 . . . . 74.11 111.869 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.675 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 13.8 m-20 -62.91 -35.52 80.33 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 120.212 -0.595 . . . . 74.31 110.787 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -68.69 -39.3 80.62 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.588 -0.445 . . . . 61.34 110.553 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.07 -47.13 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.613 -0.514 . . . . 70.43 109.613 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -60.81 -46.63 89.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.888 -0.596 . . . . 73.22 110.657 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -65.83 -32.64 74.28 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 112.116 0.413 . . . . 74.2 112.116 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -64.57 -46.34 83.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 74.12 109.523 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.5 m -61.45 -44.17 97.58 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.088 -0.505 . . . . 64.14 110.128 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 15.2 mm100 -64.45 -35.39 80.75 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.224 -0.444 . . . . 64.43 110.701 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.556 HD13 ' HB ' ' A' ' 133' ' ' THR . 49.1 tp -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.153 -0.342 . . . . 54.33 110.445 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.466 ' HD2' ' OD1' ' A' ' 165' ' ' ASP . 70.2 mtp180 -63.27 -40.79 98.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.567 -0.288 . . . . 71.44 111.447 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.2 t -75.4 -29.78 59.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.807 0.813 . . . . 64.43 110.095 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 26' ' ' LYS . 59.6 m -71.62 -34.67 70.03 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.751 -0.659 . . . . 63.23 110.36 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.409 HD12 HD23 ' A' ' 187' ' ' LEU . 82.2 mt -85.87 4.31 37.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 74.12 111.506 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.6 138.71 31.47 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.072 -1.455 . . . . 73.31 107.072 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.73 -10.16 62.43 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 111.169 -0.772 . . . . 64.3 111.169 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.8 t -119.72 145.5 39.46 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 106.607 -1.627 . . . . 75.34 106.607 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.58 29.13 0.17 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 123.607 2.871 . . . . 74.5 114.62 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.75 128.5 34.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.833 0.349 . . . . 73.02 110.312 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 8.9 t -107.44 152.39 24.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.915 -0.584 . . . . 53.34 109.571 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -141.84 159.76 41.58 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 122.745 0.418 . . . . 71.55 110.533 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.489 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.4 pt20 -129.4 137.09 50.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.713 -0.477 . . . . 71.03 109.713 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.8 -0.64 9.75 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.143 -0.551 . . . . 51.31 114.405 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 152' ' ' ARG . 37.5 t70 65.54 19.27 11.49 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.07 0.948 . . . . 72.44 109.197 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 163' ' ' GLN . 8.4 p -71.49 138.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 CA-C-N 116.023 -0.535 . . . . 72.42 110.551 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -150.28 173.4 14.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.589 -0.732 . . . . 61.42 111.381 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 46.3 m-85 -115.52 152.02 33.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.355 -0.839 . . . . 65.43 110.314 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.0 t -114.47 120.11 39.16 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.197 -1.408 . . . . 65.01 107.197 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.41 159.21 36.09 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 110.559 -0.163 . . . . 53.4 110.559 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.046 0 N-CA-C 109.792 -1.323 . . . . 45.14 109.792 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.419 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 99.3 mtt180 . . . . . 0 CA--C 1.511 -0.519 0 N-CA-C 114.586 1.328 . . . . 71.55 114.586 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 135' ' ' PHE . 36.7 ttm180 -100.48 129.55 46.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 118.147 -1.421 . . . . 64.55 110.337 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -140.36 153.46 46.4 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.031 -1.441 . . . . 74.04 108.095 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 40.3 mt-10 -116.51 151.75 35.49 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.961 -0.755 . . . . 63.0 108.961 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.02 118.2 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.102 -1.814 . . . . 71.41 106.102 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.6 m0 -102.96 121.25 42.16 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.998 -0.742 . . . . 75.34 108.998 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 166' ' ' VAL . 36.5 tp -98.13 134.3 41.39 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.996 -1.112 . . . . 73.02 107.996 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.43 125.16 44.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 O-C-N 123.171 0.295 . . . . 71.12 110.745 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -64.02 142.49 58.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 123.639 0.587 . . . . 63.34 110.991 176.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.34 0 CA-C-O 119.065 -0.493 . . . . 63.01 110.921 179.141 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.487 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 25.6 p90 . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.8 111.28 23.95 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.674 -0.41 . . . . 74.44 110.407 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.5 t -84.05 120.41 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.469 -0.937 . . . . 61.12 108.469 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -90.3 -35.8 15.05 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.504 -0.479 . . . . 75.25 110.935 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -164.25 149.88 10.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.346 0.593 . . . . 73.41 111.233 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.524 HG22 ' CB ' ' A' ' 32' ' ' GLU . 47.7 p -132.51 155.18 49.06 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.031 -1.47 . . . . 75.42 107.031 173.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.19 103.16 2.44 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 119.198 -1.477 . . . . 74.02 112.345 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.81 -135.11 3.92 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.546 -0.835 . . . . 71.4 111.424 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -96.45 139.26 32.82 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 105.916 -1.883 . . . . 71.23 105.916 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.7 173.18 2.95 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 114.127 1.158 . . . . 74.32 114.127 -171.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 83.15 -51.88 0.16 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.666 1.587 . . . . 73.43 111.023 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.03 110.8 28.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.771 -1.196 . . . . 74.52 107.771 175.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 p -94.98 154.52 17.14 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.917 -0.583 . . . . 74.43 111.257 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.15 158.95 42.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.383 0.611 . . . . 71.41 111.626 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' CB ' HG22 ' A' ' 23' ' ' THR . 12.9 pt-20 -134.89 132.2 38.23 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.482 -1.303 . . . . 75.25 107.482 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -96.77 114.32 25.94 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.292 -1.744 . . . . 74.23 106.292 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.28 1.2 ppt_? -142.14 145.2 33.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.287 1.217 . . . . 70.35 114.287 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -80.52 137.75 36.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.526 -1.287 . . . . 72.3 107.526 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.3 t -57.27 147.75 24.58 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.782 0.676 . . . . 73.4 111.186 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -63.89 -28.13 69.63 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 124.115 0.966 . . . . 61.53 112.59 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 77.31 9.75 86.64 Favored Glycine 0 C--N 1.317 -0.512 0 C-N-CA 120.432 -0.889 . . . . 61.23 113.556 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.68 160.57 54.09 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.682 -0.771 . . . . 74.51 112.212 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -88.79 122.11 31.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.597 -0.52 . . . . 63.31 109.597 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 26.5 m-85 -126.9 166.17 17.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.467 -0.788 . . . . 72.03 111.699 -171.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.62 115.82 28.63 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.846 -0.798 . . . . 71.24 108.846 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -125.81 143.54 51.02 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-N 115.314 -0.857 . . . . 63.22 112.112 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.485 HG21 ' HD2' ' A' ' 61' ' ' LYS . 12.8 p -132.83 144.56 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 108.352 -0.981 . . . . 75.13 108.352 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.78 127.69 50.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.675 0.75 . . . . 74.43 111.032 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 46.7 t -120.64 133.15 68.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.102 -1.444 . . . . 42.24 107.102 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 97' ' ' LYS . 35.7 p -130.76 176.6 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.51 0.559 . . . . 73.55 112.51 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 69.34 4.07 4.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.903 1.281 . . . . 53.44 112.316 174.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -141.0 141.16 22.97 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 108.058 -1.09 . . . . 75.03 108.058 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.27 156.86 7.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.341 2.694 . . . . 73.13 112.364 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.574 HG13 HD13 ' A' ' 98' ' ' LEU . 71.4 t -47.67 -41.36 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.575 0.954 . . . . 44.43 113.575 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 9.9 m-20 -58.75 -50.09 75.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.413 0.625 . . . . 60.24 109.911 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.33 -40.7 81.51 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.996 -1.002 . . . . 73.11 110.871 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -61.13 -46.57 90.04 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.542 -0.753 . . . . 71.54 110.104 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.68 -31.7 70.95 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.899 -0.591 . . . . 70.25 110.906 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 36.7 mtm180 -61.25 -30.24 70.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.554 0.576 . . . . 73.32 112.554 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 37.1 mt-10 -85.61 -46.3 10.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.416 -0.513 . . . . 71.34 111.512 173.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.27 80.22 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.971 1.1 . . . . 73.3 113.971 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.56 ' HB3' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.81 -52.72 72.33 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 119.483 -0.294 . . . . 54.31 110.463 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 71.9 Cg_exo -51.75 -37.15 64.46 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.702 2.268 . . . . 72.3 112.319 173.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 88.9 mttt -67.41 -42.49 83.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.28 0.474 . . . . 75.41 112.28 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.95 -41.04 77.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.612 -0.435 . . . . 43.01 111.834 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.526 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.9 ptm -69.91 -29.63 66.85 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.795 0.665 . . . . 54.15 112.795 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -70.37 -40.83 73.79 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.928 -0.767 . . . . 74.53 108.928 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.22 -56.87 16.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.839 -0.619 . . . . 73.31 111.529 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 102' ' ' PHE . 11.8 m -78.35 -20.97 13.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 120.983 0.42 . . . . 74.3 111.284 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.05 70.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.674 -0.693 . . . . 74.55 112.89 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.69 -17.41 0.49 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.768 -1.205 . . . . 64.5 113.53 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -81.83 32.52 0.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 122.304 1.05 . . . . 74.12 110.752 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.68 168.94 9.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.782 -0.645 . . . . 62.11 109.836 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.419 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 11.0 t70 -66.06 -33.99 77.05 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.04 0.756 . . . . 71.14 113.04 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -82.22 -11.22 58.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 73.43 109.728 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.91 34.87 77.97 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.329 -0.85 . . . . 51.25 112.128 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.44 121.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.969 -0.692 . . . . 65.4 110.263 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.11 116.0 5.47 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.561 -0.828 . . . . 74.35 112.285 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.6 mmt 61.8 28.39 17.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.05 109.565 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.98 -34.54 90.19 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.589 -1.187 . . . . 73.54 113.471 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.401 ' HB2' ' CD ' ' A' ' 105' ' ' PRO . 1.2 pmm? -124.72 126.1 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 112.843 0.683 . . . . 72.24 112.843 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.0 m -125.21 117.09 23.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.993 -0.743 . . . . 72.31 108.993 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -170.22 143.32 1.95 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.296 -1.372 . . . . 75.45 107.296 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -41.4 139.84 1.73 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.994 3.129 . . . . 62.23 116.729 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 102' ' ' PHE . 10.7 p -105.74 154.23 7.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.68 -1.6 . . . . 71.32 107.145 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 48.5 m -139.7 145.18 38.05 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.436 -0.579 . . . . 75.14 109.436 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 98' ' ' LEU . 37.0 p90 -135.09 147.16 49.47 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.944 -0.472 . . . . 75.45 111.151 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.26 134.71 34.63 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.684 0.615 . . . . 74.01 109.533 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.425 ' HB ' HD12 ' A' ' 94' ' ' LEU . 32.7 m -129.7 152.9 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.825 -0.806 . . . . 71.0 108.825 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 40.6 m-85 -122.5 104.04 37.5 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.878 -0.786 . . . . 74.11 108.878 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.5 133.69 10.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.823 1.682 . . . . 55.11 113.002 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.46 166.05 15.81 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.329 -0.989 . . . . 61.44 108.329 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.76 -15.39 61.53 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 73.11 111.149 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -91.18 1.13 57.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 63.44 111.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.85 0.62 90.32 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.948 -0.644 . . . . 75.31 112.503 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 t -92.07 141.16 28.91 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.509 -1.293 . . . . 64.32 107.509 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 86' ' ' VAL . 3.0 mm? -79.29 156.71 27.94 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 120.96 0.409 . . . . 71.33 110.639 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -79.22 158.25 27.66 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.272 -0.64 . . . . 61.22 109.272 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -75.82 40.03 0.18 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.85 0.86 . . . . 63.3 112.212 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 38.4 ttmt -141.68 125.83 17.4 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.325 -0.991 . . . . 60.42 108.325 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.574 HD13 HG13 ' A' ' 51' ' ' VAL . 60.3 tp -135.47 129.14 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 110.208 -0.293 . . . . 64.44 110.208 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.37 115.51 21.09 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.219 -0.66 . . . . 44.22 109.219 174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 43' ' ' THR . 59.0 t -96.61 134.9 32.55 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-N 115.229 -0.896 . . . . 74.14 109.871 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -120.84 120.02 34.35 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.941 0.896 . . . . 72.35 109.751 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 73.5 t80 -104.08 123.85 47.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.902 -0.407 . . . . 74.41 109.902 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.582 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 42.3 ttm-85 -75.35 134.2 41.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.343 -0.844 . . . . 70.55 110.187 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CG2' ' HB2' ' A' ' 108' ' ' PHE . 65.7 mt -104.79 133.09 20.34 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 116.532 -0.304 . . . . 72.24 111.21 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' ILE . 47.5 Cg_exo -60.81 161.2 22.41 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.549 2.833 . . . . 74.44 112.6 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -57.98 -37.11 73.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.147 1.166 . . . . 72.41 114.147 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.83 -30.45 71.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.327 0.584 . . . . 75.22 111.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.453 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 96.4 m-85 -99.65 -4.95 29.79 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.948 -0.569 . . . . 71.21 110.972 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.712 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.4 -37.87 71.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 119.586 -0.846 . . . . 74.53 109.735 174.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.1 94.26 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.183 -0.917 . . . . 75.02 111.918 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -154.11 93.33 2.95 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.182 -0.673 . . . . 61.3 109.182 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 71.7 Cg_endo -77.3 146.41 24.93 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.307 2.004 . . . . 74.21 112.565 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 32.3 Cg_exo -59.62 130.17 34.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.401 2.067 . . . . 74.21 109.801 175.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -68.86 148.98 98.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.81 -0.632 . . . . 64.01 111.48 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 39.6 Cg_exo -60.59 113.14 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.709 2.273 . . . . 73.33 111.938 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -97.07 5.74 49.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.368 -0.975 . . . . 71.23 108.368 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.26 148.76 49.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.132 -1.803 . . . . 72.25 106.132 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -81.1 -25.06 37.28 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.717 0.636 . . . . 75.42 112.717 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.402 ' OG ' ' HD3' ' A' ' 61' ' ' LYS . 47.2 p -91.7 -16.42 26.98 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.78 0.659 . . . . 25.04 112.78 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 50.2 t -94.71 116.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.875 -1.157 . . . . 74.34 107.875 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -119.7 144.08 47.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 110.274 -0.269 . . . . 72.12 110.274 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.5 mm -92.85 111.98 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.964 -1.124 . . . . 74.11 107.964 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -125.57 143.35 51.05 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.909 -1.041 . . . . 62.1 109.346 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.05 143.11 40.56 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.038 -0.727 . . . . 62.02 109.038 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -135.99 127.31 28.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.235 -0.654 . . . . 73.41 109.235 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.19 171.02 14.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.668 -0.493 . . . . 75.02 109.668 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.23 7.05 62.52 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 121.009 -0.615 . . . . 42.13 112.176 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.96 145.27 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 120.095 -0.642 . . . . 73.25 110.878 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 59.5 m -109.22 135.69 49.92 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.42 157.31 32.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 108.849 -0.797 . . . . 71.31 108.849 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 40.2 m-85 -113.3 121.77 45.42 Favored 'General case' 0 N--CA 1.411 -2.381 0 N-CA-C 105.166 -2.161 . . . . 75.3 105.166 178.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 t -109.96 125.89 53.34 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.623 -0.51 . . . . 63.23 109.623 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.7 t -113.47 126.64 55.55 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.185 -1.043 . . . . 74.03 108.185 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -115.61 124.94 52.21 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.028 -1.101 . . . . 72.35 108.028 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.17 137.02 48.8 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 116.392 -0.367 . . . . 75.12 110.439 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.49 161.81 24.23 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 115.784 -0.643 . . . . 61.4 111.788 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.59 161.31 12.91 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.655 -1.378 . . . . 65.31 109.655 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -79.51 108.4 13.02 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.37 0.605 . . . . 73.33 109.886 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -112.73 145.87 39.76 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.16 -0.927 . . . . 71.22 111.844 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.491 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 18.6 ptpt -95.43 176.94 5.99 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.739 -0.838 . . . . 74.1 108.739 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 1.3 mp0 -60.32 -37.96 82.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.49 -0.559 . . . . 71.22 109.49 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.63 70.7 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.437 -0.801 . . . . 54.43 111.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.491 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 23.4 m-20 -64.4 -31.21 72.32 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 62.32 111.283 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -64.61 -46.68 81.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.68 0.276 . . . . 73.31 110.902 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.59 -46.08 95.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.457 0.646 . . . . 54.51 109.978 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.84 99.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 43.33 111.482 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -71.12 -32.52 69.11 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 112.281 0.475 . . . . 73.13 112.281 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.3 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.216 -0.661 . . . . 70.31 109.216 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.4 m -65.07 -40.97 95.44 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.355 -0.839 . . . . 71.42 110.835 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -73.73 -30.3 62.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.937 0.399 . . . . 75.42 110.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.11 -31.7 72.91 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 109.618 -0.512 . . . . 71.04 109.618 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 165' ' ' ASP . 79.9 mtp180 -63.81 -39.09 93.4 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.024 -0.534 . . . . 50.14 109.931 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 56.6 m -71.6 -30.98 66.43 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.654 0.74 . . . . 71.41 109.703 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 38.4 m -72.1 -34.87 68.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.581 -0.736 . . . . 74.45 109.091 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.08 6.66 41.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.364 -0.835 . . . . 74.34 111.137 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.13 128.14 33.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.334 -1.728 . . . . 74.14 106.334 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.32 13.47 41.83 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.268 -0.967 . . . . 64.44 111.811 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 70.9 p -117.2 163.12 24.58 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.893 -0.78 . . . . 41.01 108.893 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -86.33 12.83 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.643 2.229 . . . . 74.13 111.802 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.96 148.31 47.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.921 -0.582 . . . . 62.44 111.25 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 43.4 p -122.04 141.44 51.37 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.76 -0.83 . . . . 74.12 108.76 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -135.52 144.94 46.58 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.113 -0.367 . . . . 75.41 111.278 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.7 pt20 -106.32 110.97 23.36 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.184 0.809 . . . . 74.2 113.184 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.73 8.48 57.08 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.77 -0.729 . . . . 52.42 113.339 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.455 ' OD2' ' HD2' ' A' ' 152' ' ' ARG . 3.8 m-20 62.5 24.17 14.38 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.695 0.798 . . . . 74.25 111.263 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.57 140.24 18.09 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 119.52 -0.872 . . . . 71.42 109.283 -174.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 32.8 p90 -140.65 168.68 19.22 Favored 'General case' 0 N--CA 1.415 -2.209 0 C-N-CA 120.196 -0.602 . . . . 61.33 112.009 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 35.7 m-85 -115.32 147.26 40.66 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.423 -0.808 . . . . 73.24 109.87 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 83' ' ' SER . 41.4 t -114.44 137.38 51.91 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.75 32.79 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.921 0.391 . . . . 54.12 111.067 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.926 0 N-CA-C 108.924 -1.67 . . . . 63.05 108.924 178.341 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 122.051 0.929 . . . . 75.04 109.815 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -134.57 130.57 36.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.957 -2.238 . . . . 72.25 104.957 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -133.22 137.09 45.99 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 108.757 -0.831 . . . . 73.23 108.757 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 133' ' ' THR . 45.7 mt-10 -132.31 136.03 46.61 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.899 0.381 . . . . 45.22 111.5 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.45 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 74.4 t -124.98 124.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.806 -1.183 . . . . 71.12 107.806 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.499 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 35.1 m0 -109.42 121.3 44.89 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 120.872 -0.331 . . . . 74.52 110.244 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 67.3 mt -96.24 126.31 41.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.138 -1.06 . . . . 75.54 108.138 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.08 127.25 42.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.592 -0.521 . . . . 64.35 109.592 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -64.77 143.01 58.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.65 0.611 . . . . 75.51 112.65 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.7 0 CA-C-N 115.261 -0.881 . . . . 38.16 108.761 176.568 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.4 p90 . . . . . 0 N--CA 1.428 -1.54 0 N-CA-C 107.488 -1.301 . . . . 73.4 107.488 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 109.5 21.5 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.355 0.598 . . . . 74.1 109.497 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.7 t -93.71 119.63 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.077 -0.965 . . . . 75.13 109.122 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 21' ' ' LEU 0.257 0.4 OUTLIER -90.63 -38.17 13.3 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 113.05 0.759 . . . . 73.33 113.05 -178.887 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -158.98 149.44 19.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.247 -0.581 . . . . 72.34 111.258 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.3 p -134.0 161.38 34.98 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.28 1.032 . . . . 73.41 110.265 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.8 113.28 1.46 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.844 -0.693 . . . . 73.5 114.515 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.68 -95.19 0.32 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.84 -0.504 . . . . 61.24 111.84 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -97.99 164.4 12.37 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.277 -1.379 . . . . 75.1 107.277 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.62 153.71 27.83 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 118.752 -1.179 . . . . 74.12 111.483 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 72.21 -49.79 0.69 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.976 1.31 . . . . 70.43 111.556 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 110.61 32.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.996 0.903 . . . . 74.0 109.108 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 p -113.1 154.25 26.91 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.373 -0.83 . . . . 73.21 110.32 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -113.43 158.45 20.64 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 120.058 -0.657 . . . . 75.33 111.446 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 34.0 tt0 -143.37 124.99 14.88 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 106.187 -1.783 . . . . 70.43 106.187 175.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . 43.3 mt-10 -97.79 115.06 27.29 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.496 -1.668 . . . . 74.42 106.496 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -135.83 147.22 48.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.908 -0.717 . . . . 65.43 112.415 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.66 127.24 34.93 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.16 -2.163 . . . . 63.43 105.16 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.7 t -58.87 143.22 48.31 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.751 0.657 . . . . 30.45 111.339 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -37.32 -52.67 1.09 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.801 1.64 . . . . 71.32 112.982 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.19 9.03 54.53 Favored Glycine 0 C--N 1.286 -2.213 0 C-N-CA 119.77 -1.205 . . . . 73.23 110.94 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.8 163.09 54.42 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.396 -1.082 . . . . 61.01 110.396 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 104' ' ' ILE . 18.3 ptmt -100.91 128.82 46.78 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.358 -0.608 . . . . 54.01 109.358 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 53.2 m-85 -129.81 164.53 23.88 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.692 -0.686 . . . . 72.3 110.906 -171.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 116.36 30.84 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.223 -1.028 . . . . 72.41 108.223 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.0 t -128.81 146.63 50.87 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.35 0.595 . . . . 60.35 111.801 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.562 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 9.0 p -128.41 139.11 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.385 -0.969 . . . . 63.05 108.385 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -121.52 138.83 54.13 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.192 -1.003 . . . . 75.43 111.371 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.83 133.9 67.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.389 -1.708 . . . . 51.02 106.389 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.6 p -125.7 169.61 12.37 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.619 -0.433 . . . . 71.54 110.042 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 71.47 -2.11 2.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.032 0.933 . . . . 62.23 112.737 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.99 147.66 52.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 109.306 -0.627 . . . . 73.24 109.306 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 32.9 Cg_endo -65.13 156.35 63.35 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 122.167 1.911 . . . . 71.14 111.015 174.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 54.7 t -49.82 -37.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.931 0.893 . . . . 71.23 113.23 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.25 -49.89 63.15 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.264 0.353 . . . . 65.55 110.991 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 41.6 mt-10 -76.04 -50.54 14.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.037 -0.529 . . . . 74.14 111.266 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.1 68.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.935 0.717 . . . . 73.33 112.935 -174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 tt -62.66 -50.2 72.13 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.842 -0.799 . . . . 64.21 108.842 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.321 6.6 ppt_? -72.43 -23.86 61.14 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 114.018 1.118 . . . . 65.04 114.018 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 12.4 mm-40 -66.58 -44.06 83.23 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 71.32 111.186 172.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.562 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.75 -40.38 55.51 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.857 1.058 . . . . 72.41 113.857 -174.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . 0.253 24.7 mmt -47.07 -52.88 31.16 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 115.929 1.825 . . . . 62.44 115.929 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.44 -31.65 78.78 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.296 1.997 . . . . 71.31 112.176 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD2' HG21 ' A' ' 44' ' ' VAL . 82.5 mttt -74.31 -34.99 63.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.772 -0.649 . . . . 75.44 109.892 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.7 mm -72.85 -39.71 59.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.287 0.565 . . . . 71.12 109.625 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.34 -37.89 89.03 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.633 -0.712 . . . . 75.23 112.853 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -67.57 -31.66 71.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.08 -0.648 . . . . 74.24 110.728 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.75 -58.2 7.61 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.385 -0.37 . . . . 74.41 111.335 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.58 -23.08 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 121.224 0.535 . . . . 75.33 111.285 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.56 72.91 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.903 -0.589 . . . . 74.34 113.196 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.44 -5.08 5.56 Favored Glycine 0 CA--C 1.505 -0.565 0 C-N-CA 119.821 -1.181 . . . . 62.53 113.263 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 116' ' ' SER . 15.2 m -86.33 32.92 0.62 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 122.631 1.205 . . . . 42.41 110.053 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -97.82 177.17 5.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.229 -0.896 . . . . 73.52 109.437 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.438 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 12.6 t70 -63.97 -33.03 74.8 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.258 0.623 . . . . 63.13 111.823 -175.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.691 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 6.9 mmpt? -86.8 -11.26 51.48 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.631 -0.428 . . . . 70.24 110.777 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.22 22.5 74.51 Favored Glycine 0 CA--C 1.498 -0.99 0 CA-C-N 115.6 -0.727 . . . . 44.24 112.066 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.99 122.09 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-O 121.153 0.501 . . . . 72.51 110.907 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.16 54.36 0.82 Allowed Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.957 -0.857 . . . . 73.34 110.957 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 51.6 ttm -83.8 110.09 18.06 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.089 0.471 . . . . 62.3 110.015 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.34 82.34 0.67 Allowed Glycine 0 C--N 1.303 -1.3 0 CA-C-N 115.121 -0.945 . . . . 74.22 111.512 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -96.79 134.92 39.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.216 -0.661 . . . . 74.14 109.216 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -124.12 129.86 51.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.258 0.551 . . . . 42.31 112.052 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.438 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 10.5 p -158.63 148.82 15.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 104.107 -2.553 . . . . 74.44 104.107 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 80' ' ' VAL . 47.0 Cg_exo -34.98 138.81 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.7 2.934 . . . . 71.14 115.036 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.54 151.29 6.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.52 -1.289 . . . . 61.24 107.52 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 34.5 m -141.96 145.08 34.09 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 120.706 -0.398 . . . . 62.44 110.409 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -140.44 141.47 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.787 -0.571 . . . . 75.04 110.811 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.05 134.95 35.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.855 -0.611 . . . . 72.24 110.063 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.6 m -126.93 150.67 33.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.327 -0.852 . . . . 65.04 109.668 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 166' ' ' VAL . 91.5 m-85 -116.01 107.15 48.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 116.375 -0.375 . . . . 71.13 110.598 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.25 132.04 7.99 Favored 'Trans proline' 0 N--CA 1.428 -2.38 0 N-CA-C 108.139 -1.524 . . . . 65.04 108.139 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -93.49 167.71 11.52 Favored 'General case' 0 C--N 1.272 -2.773 0 C-N-CA 119.861 -0.736 . . . . 75.34 110.961 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.77 -17.55 56.43 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.883 0.739 . . . . 63.33 110.78 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.54 -6.8 57.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.249 1.02 . . . . 74.34 110.072 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.89 -10.14 71.57 Favored Glycine 0 C--O 1.229 -0.158 0 CA-C-N 116.048 -0.524 . . . . 73.5 112.389 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.4 m -96.06 134.35 39.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.769 0.318 . . . . 74.44 111.455 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 8.2 mp -78.77 100.09 6.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.453 0.644 . . . . 63.42 110.187 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 53.0 tt0 -148.09 169.86 19.04 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.874 -1.057 . . . . 71.02 108.981 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HB3' ' HD3' ' A' ' 97' ' ' LYS 0.264 64.8 mttp 94.93 -73.87 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.097 1.759 . . . . 63.44 112.456 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 2.4 mppt? -131.04 146.57 52.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 119.005 -1.078 . . . . 73.4 112.215 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 51' ' ' VAL . 5.8 tt -143.28 129.44 19.75 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.512 -1.222 . . . . 72.51 108.049 173.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -119.89 115.47 23.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.456 -0.572 . . . . 74.32 109.456 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 43' ' ' THR . 91.1 t -92.43 125.8 45.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.796 -0.816 . . . . 73.52 108.796 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -109.18 123.82 49.84 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.618 0.574 . . . . 70.42 109.641 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -102.76 113.49 26.95 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.458 -1.682 . . . . 74.22 106.458 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.522 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 24.4 ttt85 -76.67 132.58 39.45 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.191 -0.913 . . . . 74.34 110.606 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 40' ' ' LYS . 74.4 mt -96.67 131.95 27.15 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.092 -1.448 . . . . 54.42 107.092 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.72 146.5 54.61 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.533 2.156 . . . . 74.13 111.816 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.42 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -47.57 -39.74 17.37 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.693 1.597 . . . . 74.51 111.867 -175.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -61.2 -32.9 72.67 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.001 0.52 . . . . 71.31 112.4 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.79 -2.65 34.55 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 112.205 0.446 . . . . 75.32 112.205 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.73 -28.24 67.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.574 0.953 . . . . 74.13 113.574 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.47 59.65 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.899 -1.143 . . . . 71.21 111.578 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -142.98 87.08 8.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-O 120.95 0.405 . . . . 73.3 110.295 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -97.47 162.42 0.93 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.302 2.668 . . . . 74.23 112.128 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.39 137.36 46.77 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 122.354 2.036 . . . . 54.43 111.626 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -74.26 152.33 88.07 Favored Pre-proline 0 C--O 1.248 0.995 0 CA-C-N 116.439 -0.346 . . . . 75.14 110.787 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -81.4 121.72 3.91 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 122.103 1.869 . . . . 52.24 111.932 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 69' ' ' THR . 23.5 t -92.41 22.83 4.29 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.91 0.862 . . . . 72.1 109.66 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.403 ' HB3' HG12 ' A' ' 120' ' ' VAL . 14.5 t70 -137.17 151.27 48.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.779 -1.193 . . . . 74.31 107.779 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -88.26 -17.12 31.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.162 1.171 . . . . 63.13 114.162 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.6 m -80.92 -39.7 25.77 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.397 -0.594 . . . . 70.53 109.397 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 117' ' ' ASP . 7.1 p -97.47 123.96 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.588 -0.733 . . . . 73.14 109.809 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.77 148.91 47.85 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.917 -0.583 . . . . 72.11 110.418 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.1 mm -92.39 111.48 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.802 -1.555 . . . . 70.13 106.802 174.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -115.79 145.8 42.5 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.68 -0.691 . . . . 74.43 111.05 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 9.6 pt-20 -121.13 124.74 45.49 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.121 -1.066 . . . . 61.13 108.121 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.451 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.8 mmt180 -136.15 122.64 20.78 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.075 -0.65 . . . . 74.5 111.483 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -143.05 164.73 29.31 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.563 -0.902 . . . . 73.05 108.563 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.02 14.63 54.45 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.65 -0.98 . . . . 61.44 110.65 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.1 pt -120.65 145.17 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 109.267 -0.642 . . . . 74.53 109.267 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.2 m -108.12 128.79 55.0 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.313 -0.995 . . . . 64.41 108.313 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.19 155.28 31.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.475 -0.935 . . . . 71.22 108.475 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 64.1 m-85 -113.89 122.13 46.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.987 -1.486 . . . . 75.5 106.987 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 m -102.49 127.94 49.32 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.734 -0.469 . . . . 51.15 109.734 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 151' ' ' LEU . 13.7 t -120.03 121.9 39.92 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 108.582 -0.895 . . . . 61.11 108.582 171.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -109.67 126.78 54.03 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.194 -1.41 . . . . 75.33 107.194 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.9 p90 -129.61 152.63 48.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.672 -0.411 . . . . 74.15 112.019 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.79 106.98 2.6 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.23 -1.148 . . . . 72.11 110.23 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.68 173.75 36.75 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 111.131 -0.788 . . . . 64.23 111.131 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.2 128.48 33.81 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.146 -0.687 . . . . 64.34 109.146 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.64 125.75 54.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.385 0.883 . . . . 73.51 113.385 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -115.78 173.13 6.71 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.86 -1.533 . . . . 61.44 106.86 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.02 -43.92 70.5 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.478 0.581 . . . . 71.02 110.679 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.39 69.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.721 . . . . 72.51 111.42 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.0 -37.15 83.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.391 -0.596 . . . . 71.23 109.391 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.443 ' HD1' HG22 ' A' ' 185' ' ' VAL . 82.0 m-85 -64.94 -38.92 92.56 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.706 -0.679 . . . . 62.52 111.023 176.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.66 -47.36 93.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.771 -0.825 . . . . 73.2 108.771 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.61 86.16 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.244 -0.889 . . . . 74.14 111.094 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -68.2 -35.07 77.43 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 113.141 0.793 . . . . 75.03 113.141 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.85 88.94 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.434 0.459 . . . . 41.01 110.835 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.2 t -73.14 -33.77 65.71 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 120.309 -0.556 . . . . 71.21 110.495 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.26 -32.17 73.66 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 120.807 0.337 . . . . 54.32 110.937 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 31' ' ' TYR . 33.7 tp -74.55 -31.53 62.13 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.119 -0.632 . . . . 71.11 109.778 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.63 -37.25 79.57 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 112.616 0.599 . . . . 74.44 112.616 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.2 t -70.23 -30.04 67.02 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 73.02 109.649 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 31' ' ' TYR . 63.8 m -71.95 -38.44 69.8 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 115.268 -0.878 . . . . 70.12 109.433 176.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.1 -2.17 51.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.874 -0.603 . . . . 44.01 111.358 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.44 130.4 41.22 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.339 -1.356 . . . . 71.41 107.339 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.58 -2.09 57.22 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.834 -0.621 . . . . 64.52 112.122 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 43.4 p -107.25 164.55 14.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 107.636 -1.246 . . . . 73.44 107.636 175.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 89.2 Cg_endo -81.88 26.11 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.823 1.682 . . . . 52.21 112.301 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 138.03 58.15 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.347 0.594 . . . . 64.53 112.464 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.0 p -120.99 151.04 40.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.534 -1.284 . . . . 73.12 107.534 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.422 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 32.8 m-85 -136.36 151.86 50.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.9 0.773 . . . . 75.34 109.354 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.443 ' O ' HG12 ' A' ' 166' ' ' VAL . 4.3 pp0? -124.68 122.97 39.01 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.182 0.438 . . . . 64.43 112.182 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.38 2.78 43.94 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.659 -0.701 . . . . 50.22 113.491 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.8 14.97 5.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.704 0.802 . . . . 73.11 112.256 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.617 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.9 p -59.37 138.46 20.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 CA-C-O 121.729 0.776 . . . . 73.24 111.543 -177.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.484 ' HB3' HD23 ' A' ' 187' ' ' LEU . 55.5 p90 -139.84 163.27 33.08 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.854 -1.066 . . . . 65.11 108.721 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.94 153.18 31.04 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.098 0.475 . . . . 63.14 110.384 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 83' ' ' SER . 31.3 t -113.21 118.72 35.47 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.396 -1.705 . . . . 55.02 106.396 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -122.09 133.5 54.77 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.084 -0.71 . . . . 60.12 109.084 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.154 0 N-CA-C 110.406 -1.077 . . . . 74.12 110.406 -178.008 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 114.261 1.208 . . . . 73.22 114.261 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -101.81 127.83 48.44 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 118.367 -1.333 . . . . 63.04 109.326 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 37.5 m-80 -144.03 156.18 44.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.231 -1.026 . . . . 63.42 108.231 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 35.8 tt0 -138.94 145.92 40.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.569 0.224 . . . . 53.03 110.548 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.443 HG22 ' HD1' ' A' ' 144' ' ' TYR . 19.8 t -125.63 133.7 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.69 -0.855 . . . . 60.25 108.69 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.539 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 37.3 m0 -112.26 128.4 56.25 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.715 -0.476 . . . . 74.34 109.715 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 167' ' ' TYR . 85.3 mt -99.33 136.76 38.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.589 -1.263 . . . . 74.1 107.589 170.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.1 t -96.14 122.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.104 -0.638 . . . . 74.45 111.12 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 161' ' ' THR . 54.0 tttp -72.09 123.78 23.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.715 -0.675 . . . . 64.15 109.928 174.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.422 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 118.277 -0.868 . . . . 72.52 109.178 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 39.9 p90 . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 108.36 -0.978 . . . . 74.05 108.36 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -106.39 108.93 20.7 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.084 -0.646 . . . . 74.42 109.742 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.23 115.96 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 107.087 -1.449 . . . . 74.44 107.087 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -90.27 -37.17 14.27 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 120.332 -0.547 . . . . 65.41 112.152 -175.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.503 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 32.2 t -162.25 156.05 21.13 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.106 -0.637 . . . . 71.43 110.393 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 p -132.0 162.95 29.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.253 -1.388 . . . . 72.51 107.253 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.86 -149.55 20.62 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 119.286 -1.435 . . . . 74.44 112.635 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.92 159.73 32.61 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.098 -0.801 . . . . 65.42 111.098 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -75.51 123.1 24.87 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.05 -1.093 . . . . 73.44 108.05 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.53 133.49 51.35 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 122.534 1.159 . . . . 53.21 113.814 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t70 148.32 -48.82 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 130.83 3.652 . . . . 73.45 101.8 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 147' ' ' HIS . 3.8 p -127.8 109.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 112.611 -2.086 . . . . 75.51 106.718 169.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -117.08 151.12 37.48 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.84 -1.17 . . . . 73.13 107.84 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.589 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.3 p90 -113.57 158.48 20.73 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.899 -1.12 . . . . 75.41 112.684 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -134.47 125.21 26.94 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.589 -2.004 . . . . 73.12 105.589 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.503 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 38.2 mt-10 -98.22 114.59 26.89 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 106.832 -1.544 . . . . 73.43 106.832 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -134.79 140.91 46.25 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.559 -0.857 . . . . 75.42 111.449 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.07 133.59 35.5 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 104.415 -2.439 . . . . 72.3 104.415 169.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.593 ' SG ' HG13 ' A' ' 128' ' ' ILE . 84.1 m -58.46 138.28 56.76 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.488 0.922 . . . . 65.45 113.488 -173.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 10.6 pt-20 -58.22 -31.56 67.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.664 -1.607 . . . . 74.24 113.169 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.73 10.25 57.95 Favored Glycine 0 CA--C 1.495 -1.208 0 C-N-CA 119.045 -1.55 . . . . 30.53 112.111 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.24 52.11 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.779 -0.724 . . . . 63.01 111.931 -176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 16.7 ptpt -90.68 118.28 29.99 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.214 -0.661 . . . . 63.24 109.214 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 33.1 m-85 -119.14 164.33 15.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.022 -0.536 . . . . 72.44 111.165 -172.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 121' ' ' LYS . . . -99.47 116.22 31.11 Favored 'General case' 0 C--O 1.209 -1.037 0 N-CA-C 109.017 -0.734 . . . . 75.32 109.017 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.5 t -122.03 147.16 46.44 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.346 0.593 . . . . 55.45 111.97 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.0 m -131.85 132.32 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 124.669 1.188 . . . . 71.24 108.581 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.64 128.67 56.44 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.517 0.675 . . . . 75.32 111.927 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 12.2 t -123.99 139.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.065 -1.458 . . . . 61.21 107.065 178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.4 p -135.95 165.19 26.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.314 -0.554 . . . . 73.32 110.377 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.82 11.38 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.558 1.161 . . . . 73.43 110.654 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -133.99 137.56 28.65 Favored Pre-proline 0 N--CA 1.424 -1.747 0 N-CA-C 109.257 -0.646 . . . . 73.03 109.257 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.48 156.87 16.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.309 2.672 . . . . 73.23 111.597 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.46 HG13 HD12 ' A' ' 98' ' ' LEU . 55.1 t -47.75 -48.5 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.701 1.0 . . . . 62.51 113.701 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.37 -33.68 76.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.945 0.402 . . . . 63.41 110.932 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -75.98 -34.65 59.78 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.861 -0.609 . . . . 74.44 111.382 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -77.23 -44.47 29.86 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.332 -0.395 . . . . 71.14 110.889 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.8 tp -63.65 -37.78 88.64 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.115 -0.493 . . . . 63.41 111.872 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -59.26 -32.3 69.88 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 112.133 0.42 . . . . 72.45 112.133 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -84.68 -39.9 18.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.465 0.65 . . . . 75.51 110.923 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -75.85 -31.81 59.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.439 -0.8 . . . . 64.41 112.622 -177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.454 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -55.53 -57.65 19.76 Favored Pre-proline 0 CA--C 1.574 1.885 0 CA-C-O 119.372 -0.347 . . . . 72.54 111.5 -178.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 19.1 Cg_endo -60.42 -31.31 92.44 Favored 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 122.535 2.157 . . . . 41.43 111.147 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 41.5 ttmt -65.98 -37.03 84.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.776 -1.102 . . . . 73.11 111.276 -177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.37 -47.25 30.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.927 0.394 . . . . 71.1 110.667 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.1 ptm -63.54 -29.54 70.79 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 113.624 0.972 . . . . 75.11 113.624 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.4 -38.82 91.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 120.546 -0.462 . . . . 74.23 110.481 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.31 -58.41 7.79 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.985 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -69.41 -27.23 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 116.039 -0.528 . . . . 73.23 111.621 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.34 -18.23 73.14 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.921 -0.581 . . . . 22.04 113.358 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 134.37 -8.52 4.69 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.174 -1.488 . . . . 63.43 114.308 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 m -84.08 33.38 0.49 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-O 122.924 1.345 . . . . 75.03 110.014 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.6 163.55 12.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.107 -0.951 . . . . 74.53 108.694 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 29.8 t70 -66.28 -33.56 76.03 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.258 0.836 . . . . 74.53 113.258 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 113' ' ' PRO . 31.9 mmmt -80.14 -12.43 59.66 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.166 -0.614 . . . . 54.22 110.612 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.57 38.05 61.81 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.035 -0.602 . . . . 55.25 111.761 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 77' ' ' GLY . 94.8 t -79.56 120.78 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.034 -1.099 . . . . 61.13 108.034 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.59 -23.19 8.48 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 121.244 -0.503 . . . . 33.43 112.34 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.5 mtp -66.03 -37.85 86.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.201 0.524 . . . . 73.04 109.746 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 74' ' ' VAL . . . 69.92 -166.34 49.82 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.073 -0.967 . . . . 23.11 112.196 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.41 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 1.3 pmm? -133.05 146.35 51.62 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.181 -0.674 . . . . 73.11 109.181 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.9 m -113.08 117.61 32.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.01 0.433 . . . . 71.05 109.97 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 103' ' ' ARG . 8.2 p -165.57 151.22 8.31 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 107.492 -1.299 . . . . 73.03 107.492 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.95 140.66 61.39 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.175 1.25 . . . . 73.32 111.214 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 9.9 p -93.45 150.03 4.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.607 -0.886 . . . . 64.14 108.607 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 p -128.77 145.84 51.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.482 0.182 . . . . 64.15 110.942 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -139.78 143.6 36.98 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.475 -0.49 . . . . 73.12 110.5 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.59 134.92 34.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.891 -0.595 . . . . 65.14 110.407 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.69 151.62 28.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.156 -0.929 . . . . 74.33 108.57 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 97' ' ' LYS . 99.0 m-85 -120.22 107.83 38.93 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 120.942 -0.303 . . . . 73.44 110.404 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.22 133.09 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.581 1.521 . . . . 74.43 111.867 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 95' ' ' GLN . 38.5 m-80 -99.84 171.07 8.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.384 -0.825 . . . . 65.24 108.927 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.41 -27.75 62.65 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.981 1.104 . . . . 74.43 113.981 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.83 -7.26 58.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 119.815 -0.754 . . . . 72.42 110.878 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.04 3.6 57.89 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 120.33 -0.938 . . . . 53.43 113.38 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m -91.14 138.59 31.48 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 122.611 -0.346 . . . . 71.41 110.259 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.29 107.73 17.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.608 -1.256 . . . . 65.14 107.608 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 15.5 mm-40 -141.37 170.06 16.44 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.495 -0.558 . . . . 65.5 109.495 -173.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 35.4 mmtp 87.76 -70.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.367 1.467 . . . . 73.43 113.875 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HD3' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -136.54 154.43 50.71 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.49 -0.884 . . . . 73.13 111.822 -177.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 54' ' ' ALA . 6.4 tt -143.95 134.54 24.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.663 -1.153 . . . . 75.52 109.231 173.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -131.37 115.94 16.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.649 -0.251 . . . . 60.23 110.532 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.588 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 66.7 t -93.08 121.62 43.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.697 0.623 . . . . 75.52 109.783 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -109.65 122.53 47.67 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.832 0.853 . . . . 72.42 109.473 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.11 113.53 27.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.193 -1.41 . . . . 50.2 107.193 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.663 ' O ' HG11 ' A' ' 80' ' ' VAL . 70.6 ttt180 -75.08 137.2 41.27 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.523 -1.217 . . . . 72.24 109.269 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.0 mt -108.46 124.83 33.33 Favored Pre-proline 0 C--N 1.289 -2.053 0 O-C-N 122.388 -0.195 . . . . 74.31 111.314 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 78' ' ' MET . 83.9 Cg_exo -55.59 161.37 7.81 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.161 2.574 . . . . 51.42 113.231 172.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -47.69 -49.56 27.42 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.87 1.668 . . . . 32.54 115.028 -171.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.54 -37.49 78.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.517 . . . . 75.24 112.397 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.447 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 98.1 m-85 -86.91 -10.33 53.57 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.24 -0.584 . . . . 72.42 112.031 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.795 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.56 -31.88 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.214 -0.994 . . . . 74.11 110.081 174.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.55 96.27 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 111.605 -0.598 . . . . 72.22 111.605 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.9 t -157.21 97.84 2.02 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 108.248 -1.019 . . . . 64.02 108.248 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 63.1 Cg_endo -85.78 148.26 9.61 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 122.49 2.127 . . . . 74.03 112.782 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 24.0 Cg_exo -65.77 142.31 69.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.275 1.983 . . . . 71.22 111.109 174.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -73.19 144.17 84.28 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.578 -0.449 . . . . 63.12 110.257 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -78.02 118.4 4.4 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.364 2.042 . . . . 74.33 111.76 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.2 m -88.39 21.77 2.76 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.163 0.506 . . . . 65.32 111.13 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.521 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.4 t70 -135.21 150.3 50.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.486 -1.302 . . . . 72.41 107.486 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.43 -23.76 37.32 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.555 0.946 . . . . 73.42 113.555 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -90.02 -25.85 20.61 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.669 -0.413 . . . . 45.44 111.258 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.5 p -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.597 -0.52 . . . . 70.14 109.597 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 52.9 mtpt -128.41 152.83 47.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.346 -0.843 . . . . 72.21 110.234 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 31.0 mm -92.85 112.57 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.049 -0.723 . . . . 75.13 109.049 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -121.86 142.65 50.04 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.563 -0.744 . . . . 72.05 109.856 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -115.89 128.56 55.88 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.696 -0.683 . . . . 64.25 110.255 -178.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.39 133.0 43.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.352 0.596 . . . . 75.21 112.343 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -139.46 172.4 12.87 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.902 -1.518 . . . . 71.21 106.902 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.49 5.14 79.39 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 119.86 -1.162 . . . . 75.11 113.32 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.593 HG13 ' SG ' ' A' ' 36' ' ' CYS . 45.4 pt -121.47 145.9 27.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.109 0.454 . . . . 72.4 110.391 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.1 m -107.68 133.26 52.36 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.503 -0.925 . . . . 73.15 108.503 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.23 149.47 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 N-CA-C 108.804 -0.813 . . . . 74.12 108.804 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 36.7 m-85 -113.79 121.82 45.21 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 104.639 -2.356 . . . . 74.22 104.639 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 55.3 p -119.41 141.29 49.23 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 120.038 -0.665 . . . . 73.14 111.653 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 10.8 t -121.48 139.38 53.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 115.696 -0.684 . . . . 71.13 109.391 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -121.11 126.3 49.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.764 -0.828 . . . . 63.44 108.764 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 38.4 p90 -138.44 168.71 19.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.387 -0.598 . . . . 72.44 109.387 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.21 169.21 35.35 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.331 -0.938 . . . . 71.12 111.794 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.8 -116.79 3.86 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.636 -0.586 . . . . 73.02 111.636 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -98.65 103.0 14.91 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.424 -0.584 . . . . 74.42 109.424 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 126.83 46.95 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.882 0.848 . . . . 71.31 112.434 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.95 172.82 6.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.732 -1.122 . . . . 65.04 108.164 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -40.11 95.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.211 0.529 . . . . 73.21 112.229 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.56 -27.11 68.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.721 -0.672 . . . . 61.44 110.494 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.11 -31.93 73.3 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.873 -0.603 . . . . 63.32 110.475 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -63.48 -42.23 98.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.231 -0.44 . . . . 74.22 109.97 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.83 -45.02 88.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.86 -0.609 . . . . 72.34 109.717 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.83 -47.17 87.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 61.45 110.965 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.436 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 27.6 m80 -69.25 -35.25 75.92 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 112.734 0.642 . . . . 62.42 112.734 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.31 90.43 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.05 0.452 . . . . 74.25 110.077 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.2 m -64.94 -53.38 47.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.789 -0.642 . . . . 73.44 109.937 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -38.66 83.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.945 -0.571 . . . . 75.21 112.222 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 31' ' ' TYR . 62.9 tp -63.62 -43.16 97.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.776 -0.453 . . . . 73.01 109.776 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 39.4 ttp180 -61.85 -40.6 95.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.652 -0.704 . . . . 73.44 109.137 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.427 ' HA ' ' OE2' ' A' ' 156' ' ' GLU . 47.0 m -66.32 -35.47 80.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.462 -0.79 . . . . 71.33 110.663 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -73.08 -33.99 65.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.465 0.65 . . . . 64.33 109.873 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.73 -1.83 29.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.549 -0.75 . . . . 74.14 112.188 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 42.8 mt-10 -75.85 141.63 42.39 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.861 -0.735 . . . . 73.41 110.512 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.16 -1.18 59.03 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.054 -0.819 . . . . 73.04 111.054 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 27.7 p -114.45 166.84 10.71 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.924 -1.51 . . . . 63.34 106.924 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.13 20.29 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.648 2.232 . . . . 74.11 112.987 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.68 118.28 12.33 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 121.193 0.52 . . . . 71.14 111.736 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.3 p -103.7 158.49 16.34 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.295 -1.002 . . . . 74.41 108.295 175.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.484 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 30.0 m-85 -137.8 147.19 44.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.761 -0.829 . . . . 72.42 108.761 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.479 HE21 HG13 ' A' ' 188' ' ' VAL . 26.1 pt20 -121.72 109.21 14.44 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.269 0.557 . . . . 63.44 110.686 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.39 8.53 55.73 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.13 -1.033 . . . . 72.32 111.785 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 55.64 30.84 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.495 1.118 . . . . 71.24 111.332 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.45 139.05 21.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.21 0.528 . . . . 64.14 110.945 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.92 163.22 33.37 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.526 -0.761 . . . . 74.2 110.309 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 34.5 m-85 -115.49 149.45 38.08 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.722 -0.672 . . . . 63.4 109.29 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.44 120.28 39.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.086 -1.45 . . . . 74.34 107.086 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -123.64 135.98 54.23 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.166 -0.47 . . . . 64.24 110.633 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.7 0 N-CA-C 108.931 -1.668 . . . . 61.5 108.931 -178.944 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 . . . . . 0 CA--C 1.511 -0.526 0 N-CA-C 112.159 0.429 . . . . 75.33 112.159 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.476 ' HD3' ' OE2' ' A' ' 184' ' ' GLU . 15.1 ttm180 -139.96 130.11 25.09 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.333 -0.547 . . . . 74.42 110.881 176.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.6 m120 -137.53 134.69 35.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 105.046 -2.205 . . . . 64.03 105.046 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.6 mt-10 -129.14 137.43 51.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 110.028 -0.36 . . . . 74.21 110.028 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.11 124.24 67.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 74.01 108.352 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.3 m0 -108.58 123.3 48.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.297 -0.41 . . . . 63.52 110.142 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.7 mt -103.14 118.68 37.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.742 -1.206 . . . . 75.22 107.742 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.479 HG13 HE21 ' A' ' 163' ' ' GLN . 7.6 p -94.28 126.46 46.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.418 -0.586 . . . . 65.43 109.418 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 161' ' ' THR . 63.5 pttt -66.9 142.13 57.4 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 116.125 -0.489 . . . . 65.34 110.934 -175.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.253 1.246 0 CA-C-O 118.177 -0.916 . . . . 74.41 109.585 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.0 p90 . . . . . 0 C--O 1.244 0.804 0 N-CA-C 108.697 -0.853 . . . . 70.1 108.697 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -106.42 120.15 41.15 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.911 0.708 . . . . 64.5 112.911 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.501 HG13 ' HG3' ' A' ' 32' ' ' GLU . 91.6 t -89.19 116.89 31.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.002 -1.851 . . . . 64.41 106.002 170.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' OE1' ' A' ' 33' ' ' GLU . 4.4 pp -99.86 -27.76 13.46 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.874 -0.73 . . . . 65.13 111.931 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -161.79 149.82 14.98 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.871 0.367 . . . . 72.41 110.806 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.7 p -132.79 157.37 45.16 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.227 -0.897 . . . . 62.13 109.562 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.16 -167.0 37.94 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.365 -0.922 . . . . 74.23 111.991 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.76 177.49 15.08 Favored Glycine 0 C--O 1.243 0.659 0 C-N-CA 120.745 -0.74 . . . . 34.11 112.718 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -87.1 126.25 34.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.457 -2.053 . . . . 75.42 105.457 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -64.24 132.69 51.03 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.103 0.954 . . . . 74.34 112.393 -167.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 129.41 -39.63 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.938 3.295 . . . . 71.52 103.105 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.627 HG22 ' CD2' ' A' ' 147' ' ' HIS . 21.6 t -123.0 110.23 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 112.983 -1.917 . . . . 75.01 106.844 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' THR . 52.4 m -119.56 131.87 55.61 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.362 -1.348 . . . . 74.23 107.362 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.61 160.57 16.55 Favored 'General case' 0 N--CA 1.423 -1.789 0 C-N-CA 120.302 -0.559 . . . . 73.33 111.108 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.501 ' HG3' HG13 ' A' ' 20' ' ' VAL . 43.9 tt0 -134.98 125.44 26.61 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 106.648 -1.612 . . . . 64.45 106.648 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.521 ' OE1' HD11 ' A' ' 21' ' ' LEU . 45.5 tt0 -100.17 114.73 28.34 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.367 -1.716 . . . . 75.1 106.367 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -135.93 142.16 44.6 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.789 -1.096 . . . . 73.23 111.377 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.98 136.44 33.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.128 -1.064 . . . . 64.54 108.128 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.0 t -69.07 143.31 54.27 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 110.002 -0.37 . . . . 65.32 110.002 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.12 -20.49 64.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.576 -0.738 . . . . 73.1 112.412 -177.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 89.84 10.4 64.92 Favored Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.044 -1.55 . . . . 64.33 110.938 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -71.92 165.56 53.83 Favored Glycine 0 N--CA 1.417 -2.633 0 CA-C-N 114.788 -0.706 . . . . 72.04 112.282 -175.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.546 ' O ' HD12 ' A' ' 104' ' ' ILE . 13.4 ptpt -94.35 132.6 38.79 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.01 -1.107 . . . . 73.42 108.01 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 37.8 m-85 -131.58 163.71 27.44 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.02 0.2 . . . . 74.13 111.128 -172.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.32 117.17 33.16 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.857 -0.794 . . . . 73.32 108.857 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 6.6 t -127.75 149.52 50.2 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 115.883 -0.599 . . . . 60.41 112.19 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 100' ' ' VAL . 3.2 p -145.58 134.7 17.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 124.557 1.143 . . . . 70.4 108.026 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.552 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.8 pt-20 -122.31 128.91 51.62 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.325 -0.95 . . . . 73.31 111.43 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.421 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 47.4 t -112.42 139.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 106.547 -1.649 . . . . 55.13 106.547 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 49' ' ' LYS . 76.5 p -117.51 166.25 12.58 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 111.826 0.306 . . . . 61.21 111.826 -173.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 72.1 -33.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.117 1.367 . . . . 64.53 112.97 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.0 mttm -85.76 146.1 42.98 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 115.238 -0.892 . . . . 62.05 111.726 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.97 158.91 48.97 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.409 2.74 . . . . 71.43 110.439 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -45.65 -47.24 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.112 1.152 . . . . 54.23 114.112 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.46 -48.2 74.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.673 0.67 . . . . 71.3 111.816 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.18 -45.54 73.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.663 -0.698 . . . . 74.52 112.418 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -67.32 -37.63 83.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.09 -0.504 . . . . 72.22 111.143 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.91 -37.56 72.96 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.242 -0.435 . . . . 73.32 111.091 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.317 6.2 ppt_? -66.51 -23.94 66.32 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.058 1.133 . . . . 73.42 114.058 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 14.1 mm-40 -79.22 -43.84 23.01 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.18 0.514 . . . . 75.05 110.839 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.94 -38.37 57.67 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 114.522 1.305 . . . . 73.44 114.522 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 8.0 mmt -55.58 -53.36 63.33 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 113.305 0.854 . . . . 55.4 113.305 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 59' ' ' MET . 10.4 Cg_endo -56.13 -31.73 84.29 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.005 1.803 . . . . 63.41 112.103 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 67.5 mttm -66.37 -39.94 89.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.901 0.381 . . . . 74.04 111.27 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -43.16 78.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 120.466 -0.493 . . . . 62.33 109.706 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.41 -35.02 78.45 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.262 0.838 . . . . 72.13 113.262 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -67.5 -40.86 85.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.357 -0.609 . . . . 74.1 109.357 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -60.97 -54.51 44.11 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.458 -0.792 . . . . 75.21 111.757 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.81 -5.81 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.169 0.433 . . . . 71.42 112.169 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.76 -36.64 10.15 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.949 -0.644 . . . . 71.52 112.254 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 148.26 2.22 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.542 -1.314 . . . . 45.24 113.618 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.3 m -85.77 11.92 10.08 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.495 1.14 . . . . 73.13 109.7 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' OD1' HG12 ' A' ' 74' ' ' VAL . 7.2 p30 -78.8 176.39 9.6 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.738 -1.119 . . . . 74.33 110.449 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.09 -33.16 73.08 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.06 0.457 . . . . 52.11 111.321 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -85.15 -13.86 48.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.45 0.643 . . . . 73.42 109.878 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.17 32.52 80.44 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.343 -0.844 . . . . 33.21 111.266 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.44 HG12 ' OD1' ' A' ' 70' ' ' ASN . 6.5 p -79.57 120.95 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 120.306 -0.558 . . . . 75.45 110.777 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.46 145.48 17.64 Favored Glycine 0 CA--C 1.481 -2.059 0 N-CA-C 109.447 -1.461 . . . . 74.15 109.447 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 53.7 ttp 59.3 79.81 0.21 Allowed 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.233 -1.395 . . . . 74.41 107.233 -171.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.88 -111.96 1.21 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.965 -1.112 . . . . 72.32 113.147 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.547 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 20.8 ptt? -132.91 128.44 36.54 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.271 -0.464 . . . . 71.13 111.689 -173.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 m -125.66 117.24 23.07 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 108.932 -0.766 . . . . 73.32 108.932 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.558 HG22 ' HD2' ' A' ' 81' ' ' PRO . 2.0 p -158.87 -178.52 0.91 Allowed Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 102.85 -3.018 . . . . 72.41 102.85 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 80' ' ' VAL . 92.8 Cg_exo -47.07 136.58 17.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 CA-C-N 123.085 2.137 . . . . 72.22 116.026 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.74 142.28 26.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 113.293 -1.776 . . . . 61.11 106.48 172.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.8 p -139.24 151.41 46.49 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.765 -0.374 . . . . 75.32 110.314 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.8 137.33 31.45 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 120.552 -0.459 . . . . 54.02 110.125 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.544 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.04 134.71 34.57 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 109.123 -0.695 . . . . 64.34 109.123 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 166' ' ' VAL . 33.8 m -122.6 149.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.613 -1.254 . . . . 72.31 107.613 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -119.96 100.86 48.14 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 107.428 -1.323 . . . . 74.0 107.428 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.03 135.42 12.35 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.034 1.823 . . . . 62.12 113.444 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -78.27 159.16 28.62 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.855 -1.535 . . . . 71.32 106.855 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.28 -31.77 67.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.486 0.66 . . . . 75.44 112.492 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.14 -5.17 40.17 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.98 -1.009 . . . . 72.31 112.027 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.02 63.28 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.65 -0.786 . . . . 52.25 111.908 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -84.23 119.49 25.1 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.799 -0.815 . . . . 62.1 108.799 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.42 82.87 5.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.606 0.717 . . . . 74.5 109.35 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 16.8 tm0? -147.52 130.43 16.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.819 -1.082 . . . . 70.24 108.828 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 86.0 mttt 161.17 -63.62 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 C-N-CA 127.59 2.356 . . . . 75.1 108.92 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -160.55 158.16 28.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.849 -1.537 . . . . 73.45 106.849 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 tt -141.69 127.45 19.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 107.221 -1.4 . . . . 72.4 107.221 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.552 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.9 mttt -113.1 114.93 27.53 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.851 -0.426 . . . . 74.1 109.851 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.1 t -87.87 132.94 31.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 108.434 -0.951 . . . . 62.51 108.434 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -124.03 117.99 25.97 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.865 -1.161 . . . . 73.22 107.865 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -102.54 121.12 41.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.487 -1.301 . . . . 45.54 107.487 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.508 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 60.1 ttt180 -78.75 131.53 36.6 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 115.291 -0.868 . . . . 71.22 108.981 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 40' ' ' LYS . 68.3 mt -93.53 129.6 38.05 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.926 -0.579 . . . . 75.25 110.15 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 48.0 Cg_endo -68.61 162.32 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.135 2.557 . . . . 73.2 112.24 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -47.45 -41.62 20.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.024 1.329 . . . . 74.33 113.877 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.49 -46.9 87.49 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.344 0.498 . . . . 62.35 112.344 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.58 -4.76 59.25 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.151 -0.477 . . . . 73.43 111.472 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.217 -0.66 . . . . 65.01 109.217 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.68 -26.41 60.92 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.179 -0.919 . . . . 64.02 111.824 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.9 t -174.87 99.63 0.27 Allowed Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 122.884 0.474 . . . . 54.13 109.878 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.93 157.73 1.77 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.65 2.233 . . . . 65.22 111.968 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -71.7 158.16 53.96 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 121.756 1.638 . . . . 75.03 110.6 172.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.87 59.02 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 110.334 -0.247 . . . . 73.1 110.334 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HB2' HG13 ' A' ' 120' ' ' VAL . 45.7 Cg_endo -68.46 106.86 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.78 2.32 . . . . 74.53 111.593 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -106.3 87.61 2.59 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.757 0.789 . . . . 61.11 111.505 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.817 ' HB3' HG12 ' A' ' 120' ' ' VAL . 17.8 t70 -176.34 155.8 1.5 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 104.961 -2.236 . . . . 64.04 104.961 173.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -12.32 60.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 115.07 1.507 . . . . 72.03 115.07 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.3 p -127.57 6.77 6.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.851 1.426 . . . . 73.42 114.851 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 117' ' ' ASP . 15.0 p -103.06 127.68 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.788 -0.819 . . . . 52.53 108.788 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.522 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 9.0 mmpt? -126.15 145.17 50.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.25 -0.648 . . . . 74.4 109.25 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.8 mm -92.59 111.67 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.612 -1.255 . . . . 73.22 107.612 172.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -125.55 139.27 53.74 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.682 -0.69 . . . . 74.42 109.864 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.77 139.3 43.78 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.155 -0.93 . . . . 73.44 109.745 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.521 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 49.4 mtp180 -133.43 136.44 45.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.07 0.462 . . . . 73.01 111.761 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 157.13 46.75 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.182 -0.917 . . . . 61.34 111.519 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.02 18.63 46.12 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.096 -0.574 . . . . 72.32 113.158 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.0 pt -121.97 145.4 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.678 -0.809 . . . . 63.34 111.966 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.8 m -106.16 131.4 53.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 106.594 -1.632 . . . . 72.1 106.594 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.01 150.41 28.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.583 -0.895 . . . . 70.42 108.583 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 13.1 m-85 -115.19 121.73 43.88 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.207 -1.775 . . . . 72.42 106.207 -177.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 53.8 p -120.55 132.52 55.21 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 120.043 -0.663 . . . . 74.41 112.263 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.553 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -113.41 135.76 53.52 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.36 -0.607 . . . . 75.42 109.36 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -109.55 127.75 54.7 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.023 -1.103 . . . . 53.23 108.023 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -130.6 168.4 17.16 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.447 -0.946 . . . . 64.21 108.447 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.27 165.58 29.92 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.074 -1.06 . . . . 63.34 112.002 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.17 -133.8 7.9 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 110.968 -0.853 . . . . 71.5 110.968 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -100.71 101.32 12.17 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.169 -1.419 . . . . 63.54 107.169 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.33 107.93 17.57 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.931 0.872 . . . . 15.24 112.514 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -99.63 169.29 9.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.42 -1.326 . . . . 73.32 107.42 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.63 -29.09 69.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.842 0.83 . . . . 72.25 109.389 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.61 -30.92 70.63 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.738 -1.119 . . . . 73.25 111.093 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.17 -36.87 84.23 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 120.383 0.135 . . . . 71.52 111.28 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -66.61 -41.07 89.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.916 -0.314 . . . . 74.34 110.633 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.63 -45.35 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 72.31 109.959 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.68 90.94 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.049 -0.523 . . . . 72.43 111.366 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.627 ' CD2' HG22 ' A' ' 29' ' ' VAL . 76.5 m80 -69.14 -32.96 72.68 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.096 -0.642 . . . . 73.33 111.733 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -66.84 -47.04 73.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.506 -0.315 . . . . 62.4 110.863 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 t -63.12 -38.14 89.99 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.931 -0.308 . . . . 70.45 111.682 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.77 -35.13 78.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 112.419 0.526 . . . . 53.53 112.419 176.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.1 mt -57.6 -36.87 72.32 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 120.846 0.355 . . . . 75.24 111.2 175.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 51.2 mtm180 -65.14 -36.56 84.62 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.547 -0.751 . . . . 72.14 110.076 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 m -75.82 -43.3 46.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.615 -0.721 . . . . 74.43 110.068 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 151' ' ' LEU . 60.1 p -71.93 -33.59 68.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.753 -0.658 . . . . 75.11 112.723 -174.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.75 9.59 7.65 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.061 0.763 . . . . 74.42 113.061 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 45.5 mt-10 -88.02 145.94 25.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.298 -1.001 . . . . 70.15 108.298 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.96 -9.86 63.85 Favored Glycine 0 C--N 1.302 -1.338 0 C-N-CA 120.647 -0.787 . . . . 74.23 111.404 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 14.0 t -122.03 149.32 53.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 107.2 -1.408 . . . . 63.41 107.2 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.79 34.67 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 123.84 3.027 . . . . 60.23 114.377 -175.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.32 136.06 39.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.966 0.412 . . . . 52.21 110.547 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 25.2 m -124.45 154.14 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.04 -1.096 . . . . 50.14 108.04 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.412 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 26.2 p90 -134.21 158.84 42.68 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.794 -0.447 . . . . 75.34 109.794 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -122.22 140.56 52.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.584 0.957 . . . . 75.15 113.584 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.78 30.17 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.066 -0.97 . . . . 60.11 113.968 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.9 t70 66.27 17.15 10.65 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 122.645 1.212 . . . . 72.24 108.439 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 86' ' ' VAL . 83.0 t -72.52 139.88 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 125.83 1.652 . . . . 64.31 111.731 -176.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -146.23 167.47 23.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.497 -0.774 . . . . 65.0 109.898 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.612 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 10.7 m-85 -115.42 152.77 32.28 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.799 -0.815 . . . . 70.02 108.799 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.1 m -114.65 129.63 56.7 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 106.477 -1.675 . . . . 71.43 106.477 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.61 157.12 42.96 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.098 0.475 . . . . 71.35 111.91 -175.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . . . . . . 0 N--CA 1.429 -1.825 0 N-CA-C 108.553 -1.819 . . . . 64.11 108.553 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.697 0.284 . . . . 64.42 110.591 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.403 -0.592 . . . . 63.42 109.403 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -141.59 153.46 44.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.394 -1.706 . . . . 71.33 106.394 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 133' ' ' THR . 47.2 mt-10 -125.63 154.25 42.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.954 0.724 . . . . 61.31 112.954 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 132' ' ' SER . 51.9 t -125.45 118.9 53.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.742 -1.577 . . . . 74.15 106.742 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.9 m0 -103.73 121.15 42.4 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.027 -0.731 . . . . 65.24 109.027 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.0 tp -97.86 138.78 34.7 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.654 -1.61 . . . . 70.1 106.654 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.64 135.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.645 -0.422 . . . . 73.0 111.894 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.3 ptmm? -65.5 143.29 57.75 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.614 -0.721 . . . . 75.23 111.595 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.412 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.188 -1.042 . . . . 45.2 108.188 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.1 p90 . . . . . 0 N--CA 1.432 -1.368 0 N-CA-C 107.787 -1.19 . . . . 63.4 107.787 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 108.31 19.75 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.595 -0.729 . . . . 74.3 109.202 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.6 131.37 41.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 116.085 -0.507 . . . . 73.13 110.443 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 22' ' ' SER . 4.1 pp -90.85 -34.99 15.05 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.657 -0.817 . . . . 74.13 112.431 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.445 ' N ' HD12 ' A' ' 21' ' ' LEU . 32.6 t -177.65 164.76 2.05 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.789 -0.819 . . . . 74.53 108.789 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -131.26 156.34 45.58 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.972 -1.122 . . . . 70.4 107.972 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.0 -158.94 31.66 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.582 -1.294 . . . . 71.31 112.42 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.58 -116.59 3.16 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 121.192 -0.528 . . . . 62.13 111.794 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -108.19 171.29 7.49 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.695 0.798 . . . . 72.11 109.853 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.67 140.85 35.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 106.44 -1.689 . . . . 74.35 106.44 172.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 77.3 -53.92 0.55 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.69 1.196 . . . . 72.14 110.47 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 147' ' ' HIS . 21.9 t -97.96 108.27 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.164 -1.421 . . . . 75.13 107.164 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 133' ' ' THR . 50.3 m -130.52 140.85 50.49 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.261 -1.014 . . . . 71.22 108.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' SER . 1.6 p90 -112.15 161.46 16.52 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.075 0.464 . . . . 70.51 112.151 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.541 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -133.13 126.19 31.17 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.456 -1.313 . . . . 74.41 107.456 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.33 112.82 26.07 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.031 -1.47 . . . . 54.51 107.031 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 13.4 ptt180 -144.04 159.23 42.97 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 119.853 -0.739 . . . . 73.23 110.327 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.19 136.9 33.78 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.958 -1.497 . . . . 43.2 106.958 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.43 151.59 43.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.097 0.475 . . . . 73.55 111.122 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -67.62 -21.09 65.41 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.364 -0.834 . . . . 72.4 112.898 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 74.49 9.49 81.91 Favored Glycine 0 CA--C 1.51 -0.235 0 C-N-CA 119.873 -1.156 . . . . 72.11 113.926 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.61 165.25 53.66 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.947 -0.644 . . . . 71.14 113.574 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -93.95 135.66 35.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.21 -0.663 . . . . 65.13 109.21 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 63.1 m-85 -136.59 165.92 24.75 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.688 0.618 . . . . 74.14 110.815 -172.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.73 118.95 35.41 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.236 -1.024 . . . . 72.34 108.236 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.7 t -128.49 154.12 46.44 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 113.174 0.805 . . . . 71.21 113.174 -172.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 119' ' ' SER . 97.1 t -129.08 132.94 66.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.989 1.315 . . . . 63.43 108.63 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.38 126.67 55.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.653 0.263 . . . . 55.11 110.503 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 45.1 t -127.33 127.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.942 -1.503 . . . . 65.33 106.942 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -120.34 162.99 18.52 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.563 -0.532 . . . . 72.22 109.563 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 75.58 -31.81 0.21 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.985 1.314 . . . . 73.11 112.362 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -85.4 146.6 44.98 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.795 -0.639 . . . . 54.32 110.663 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.5 156.86 39.32 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.853 2.369 . . . . 54.3 111.113 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.52 HG13 HD12 ' A' ' 98' ' ' LEU . 37.2 t -47.8 -48.08 11.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.908 1.077 . . . . 72.43 113.908 -177.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 33.2 t70 -59.51 -49.64 76.98 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.47 -0.492 . . . . 75.24 110.832 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -61.96 -48.19 81.47 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.662 0.616 . . . . 72.11 112.662 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -60.59 -38.65 85.36 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 123.612 0.57 . . . . 54.53 110.778 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' O ' ' HG2' ' A' ' 59' ' ' MET . 65.3 tp -66.48 -42.53 87.31 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.081 -0.509 . . . . 71.13 110.302 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 20.0 mmm180 -59.43 -45.31 91.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.861 0.363 . . . . 73.53 110.595 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -66.69 -37.43 84.72 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.336 -0.847 . . . . 74.21 111.34 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.57 59.97 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.274 0.842 . . . . 74.22 113.274 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 3.2 mmt -48.32 -57.69 10.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.254 1.205 . . . . 54.0 114.254 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.55 -32.12 88.82 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.749 2.299 . . . . 63.53 112.384 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.06 -47.48 68.2 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.329 -0.619 . . . . 72.31 109.329 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.88 -38.08 79.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.901 -0.59 . . . . 75.42 110.303 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 59' ' ' MET . 9.7 mmt -66.36 -37.36 85.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 73.44 112.031 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -72.98 -33.71 66.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.699 -0.401 . . . . 71.05 110.807 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.71 -60.08 4.23 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 116.431 -0.35 . . . . 61.2 111.246 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 76' ' ' MET . 6.4 p -73.48 -25.27 20.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 120.864 0.364 . . . . 74.54 110.542 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.49 -25.05 66.56 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.261 -0.427 . . . . 45.04 113.249 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 -0.58 2.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.781 -1.2 . . . . 72.31 113.494 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -91.2 29.74 1.37 Allowed 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.609 1.195 . . . . 50.22 109.431 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.07 159.87 14.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.596 -0.891 . . . . 52.03 108.596 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 23.2 t70 -70.8 -28.04 64.34 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.081 0.4 . . . . 72.32 112.081 -172.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.84 -12.34 59.97 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.192 -0.67 . . . . 74.43 109.192 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.61 33.25 75.94 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.158 -0.928 . . . . 64.42 112.813 177.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.58 126.93 40.25 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.78 -0.768 . . . . 72.14 111.331 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.86 92.45 1.54 Allowed Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.281 -1.127 . . . . 41.32 110.281 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 56.0 ttp 70.62 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.771 1.228 . . . . 71.1 110.535 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.52 -55.62 0.68 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.837 0.695 . . . . 74.13 114.837 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.412 ' SD ' HG23 ' A' ' 104' ' ' ILE . 21.6 ptt? -124.75 126.24 45.33 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.5 m -126.1 124.5 40.72 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.33 109.652 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -165.7 145.5 5.44 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 107.465 -1.309 . . . . 72.2 107.465 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -35.61 139.98 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.177 3.251 . . . . 64.4 115.767 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.27 150.06 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 113.485 -1.689 . . . . 74.1 106.5 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 m -138.61 145.08 40.11 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.467 -0.568 . . . . 72.22 109.467 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 42.9 p90 -136.53 143.69 43.86 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.463 -0.495 . . . . 64.15 111.358 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.87 34.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.678 -0.86 . . . . 75.44 108.678 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.98 150.95 30.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.188 -0.915 . . . . 63.31 109.291 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.537 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 1.9 m-85 -117.36 102.28 52.31 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 109.231 -0.655 . . . . 64.44 109.231 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -88.67 146.8 5.91 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.235 1.957 . . . . 75.32 112.693 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.54 152.66 18.23 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.988 -1.856 . . . . 63.14 105.988 171.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.268 11.3 pt-20 -64.53 -13.36 52.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 115.683 1.734 . . . . 70.44 115.683 -172.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.6 -6.25 59.25 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 121.609 0.718 . . . . 61.02 109.866 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.22 5.14 54.84 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 72.04 112.941 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 m -83.99 126.42 33.01 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.489 -0.56 . . . . 50.22 109.489 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 78.0 mt -94.04 78.58 4.08 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.923 0.392 . . . . 63.41 111.095 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.1 tt0 -149.25 115.29 5.73 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.949 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 95.1 mttt -176.75 -62.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.278 1.831 . . . . 73.51 108.648 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.537 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 38.5 ttmt -161.31 155.0 21.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.299 -1.0 . . . . 53.12 108.299 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.52 HD12 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -143.76 143.38 31.35 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.331 -0.618 . . . . 72.53 109.331 173.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -136.92 115.47 11.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.636 -0.505 . . . . 73.0 109.636 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' THR . 84.0 t -92.15 129.88 42.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 N-CA-C 109.785 -0.45 . . . . 43.33 109.785 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.422 ' HE3' ' HB2' ' A' ' 41' ' ' PHE . 89.8 m95 -112.72 128.15 56.33 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.941 -0.763 . . . . 75.11 108.941 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -103.26 123.62 47.1 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.969 -1.123 . . . . 75.03 107.969 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.451 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 68.4 mtt-85 -75.49 132.22 40.63 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.503 0.927 . . . . 73.33 113.503 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.412 HG23 ' SD ' ' A' ' 78' ' ' MET . 72.1 mt -102.11 122.77 45.78 Favored Pre-proline 0 N--CA 1.398 -3.041 0 N-CA-C 105.98 -1.859 . . . . 74.33 105.98 172.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.16 152.01 62.75 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.236 1.958 . . . . 62.31 110.733 175.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -48.12 -37.33 15.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.564 0.746 . . . . 62.34 112.848 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.75 -31.87 70.04 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.502 0.721 . . . . 75.23 112.225 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -100.29 -8.45 23.42 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 112.498 0.555 . . . . 64.43 112.498 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -70.75 -29.24 65.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.641 1.349 . . . . 63.31 114.641 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.11 -38.59 94.1 Favored Glycine 0 C--O 1.241 0.587 0 C-N-CA 120.029 -1.082 . . . . 61.21 111.514 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -142.92 85.81 9.72 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 108.26 -1.015 . . . . 72.01 108.26 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -88.34 159.82 6.83 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.886 1.724 . . . . 73.23 112.824 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.28 130.27 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.478 2.119 . . . . 71.31 110.802 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -70.03 138.73 87.5 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 109.287 -0.634 . . . . 60.52 109.287 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 73.1 Cg_endo -77.27 111.3 3.16 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.155 1.904 . . . . 51.13 112.074 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -98.69 79.23 2.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.806 -0.813 . . . . 74.12 108.806 177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -173.89 150.26 1.63 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.792 -1.188 . . . . 72.35 107.792 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -76.27 -24.2 54.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.214 0.82 . . . . 73.21 113.214 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 44' ' ' VAL . 60.4 m -92.6 -26.21 17.97 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.57 -0.452 . . . . 73.31 110.799 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 26.8 t -94.35 118.35 40.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.849 -0.426 . . . . 75.32 109.849 -175.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -128.73 147.63 50.78 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.471 -0.937 . . . . 71.33 108.471 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.1 mm -92.71 112.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.24 -1.022 . . . . 53.44 108.24 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -122.06 149.7 43.16 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.942 -0.572 . . . . 74.44 109.769 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.74 152.52 24.24 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.814 -0.63 . . . . 62.04 109.821 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.503 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 65.0 ttt180 -151.57 123.25 7.96 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.821 -0.807 . . . . 71.34 108.821 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -138.39 166.92 23.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.545 -0.539 . . . . 72.23 109.545 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.44 61.01 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.431 -1.366 . . . . 73.23 113.282 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.6 pt -119.28 151.93 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.347 -0.941 . . . . 74.43 112.166 -175.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 92.9 m -105.78 123.35 47.81 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.943 -1.48 . . . . 73.43 107.788 178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.52 146.66 30.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 116.01 -0.541 . . . . 64.3 110.632 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 39.9 m-85 -114.47 121.92 45.0 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.707 -1.96 . . . . 73.22 105.707 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 31' ' ' TYR . 56.1 p -122.41 139.16 54.17 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 119.832 -0.747 . . . . 43.44 111.193 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.8 t -113.51 133.19 55.37 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 120.574 -0.451 . . . . 40.14 109.932 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -110.91 125.33 53.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.514 -1.291 . . . . 64.21 107.514 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.68 158.08 44.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.463 -0.199 . . . . 65.41 110.463 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -137.06 154.54 22.32 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 123.973 0.796 . . . . 74.31 111.372 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.09 -142.37 11.73 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 109.009 -1.637 . . . . 63.43 109.009 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -100.43 118.95 37.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 118.239 1.02 . . . . 63.2 108.964 174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.53 133.41 55.4 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.611 0.72 . . . . 63.3 112.177 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -112.64 177.37 4.66 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.419 -1.697 . . . . 73.32 106.419 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.55 78.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.346 0.594 . . . . 60.35 110.817 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.65 -29.29 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 74.33 111.77 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.24 -30.23 70.09 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 111.879 0.325 . . . . 64.04 111.879 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.88 -48.94 69.85 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.728 -0.841 . . . . 75.03 108.728 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.03 -41.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.841 -1.072 . . . . 54.4 110.185 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.71 88.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.841 -0.618 . . . . 63.12 110.521 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.428 ' CD2' HG22 ' A' ' 29' ' ' VAL . 62.8 m80 -66.63 -32.36 73.63 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 112.827 0.677 . . . . 75.35 112.827 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.68 -47.31 84.93 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.105 0.478 . . . . 64.53 109.921 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -65.03 -46.87 79.48 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.628 -0.715 . . . . 65.05 110.447 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.06 -40.82 86.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.118 -0.492 . . . . 74.43 111.318 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 187' ' ' LEU . 1.5 tt -62.72 -46.07 89.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.828 -1.175 . . . . 72.31 107.828 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -64.09 -39.47 94.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.068 -0.969 . . . . 74.03 110.451 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.9 m -68.55 -33.09 73.48 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.312 0.577 . . . . 72.4 110.257 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -73.02 -33.51 65.78 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.37 0.605 . . . . 74.34 109.702 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 158' ' ' THR . 98.6 mt -81.1 9.2 7.06 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.998 -0.546 . . . . 71.34 111.486 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.96 134.08 35.64 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 71.22 106.91 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.89 57.28 Favored Glycine 0 C--N 1.307 -1.028 0 C-N-CA 121.211 -0.518 . . . . 61.51 112.551 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 155' ' ' LEU . 15.3 t -125.41 146.24 53.72 Favored Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 106.879 -1.526 . . . . 72.43 106.879 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.83 34.79 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 123.744 2.963 . . . . 60.15 114.676 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.64 43.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.446 -0.576 . . . . 64.33 109.446 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 19.6 p -114.91 158.66 21.68 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.364 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -136.23 152.36 50.66 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.615 -0.883 . . . . 64.42 108.615 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -113.02 111.34 22.0 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.262 0.838 . . . . 70.02 113.262 178.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.53 4.71 46.81 Favored Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 115.658 -0.701 . . . . 61.1 112.495 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 17.8 t70 63.83 15.75 9.3 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.813 1.245 . . . . 74.54 109.565 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.14 151.56 7.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 CA-C-O 121.205 0.526 . . . . 72.44 110.516 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -146.1 170.64 16.28 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.599 -0.728 . . . . 70.14 111.215 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.494 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 97.6 m-85 -115.15 152.28 32.88 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.64 -0.504 . . . . 55.21 109.64 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.03 137.75 53.67 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.757 -1.201 . . . . 62.33 107.757 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.73 150.03 32.13 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 111.896 0.332 . . . . 73.1 111.896 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.748 0 N-CA-C 107.871 -2.092 . . . . 71.51 107.871 179.608 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 . . . . . 0 CA--C 1.498 -1.041 0 CA-C-O 120.729 0.299 . . . . 65.21 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -133.8 128.16 34.19 Favored 'General case' 0 CA--C 1.469 -2.143 0 CA-C-O 121.459 0.647 . . . . 70.3 111.231 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -144.86 134.59 23.51 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 103.743 -2.688 . . . . 75.52 103.743 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 186' ' ' TRP . 2.7 mp0 -115.71 137.22 52.3 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 119.261 -0.976 . . . . 73.54 110.334 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 89.8 t -124.99 121.06 60.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.636 -1.246 . . . . 54.23 107.636 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.502 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 6.8 m0 -119.31 120.96 38.51 Favored 'General case' 0 C--O 1.197 -1.682 0 CA-C-O 119.129 -0.462 . . . . 72.43 110.929 -174.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 151' ' ' LEU . 9.2 mp -96.95 138.83 33.88 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.822 -1.177 . . . . 73.22 107.822 171.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.16 131.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 120.323 -0.551 . . . . 74.22 110.681 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 161' ' ' THR . 4.5 tmtm? -73.46 130.74 40.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.519 -0.764 . . . . 60.13 109.997 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.252 1.199 0 CA-C-N 115.734 -0.666 . . . . 52.13 111.054 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 39.1 p90 . . . . . 0 N--CA 1.435 -1.205 0 N-CA-C 107.056 -1.461 . . . . 70.42 107.056 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -126.81 122.53 35.02 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.92 -1.112 . . . . 74.1 111.73 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.92 121.16 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 106.966 -1.494 . . . . 52.43 106.966 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.56 -33.41 15.91 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.59 -0.444 . . . . 65.04 111.044 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 46.8 t -162.26 149.86 14.14 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.401 0.619 . . . . 40.12 110.806 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.1 p -133.29 166.71 21.87 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 125.05 1.34 . . . . 73.41 108.255 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.01 76.76 0.4 Allowed Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 119.513 -1.327 . . . . 73.32 112.961 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.18 -160.34 22.45 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.226 -0.988 . . . . 74.02 111.659 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -89.96 170.58 10.25 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.781 -1.192 . . . . 73.2 107.781 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.22 148.27 51.07 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 119.652 -0.819 . . . . 63.53 109.91 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.0 t70 77.43 -62.23 0.39 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.425 1.49 . . . . 62.42 110.791 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.76 110.06 29.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.369 -0.974 . . . . 60.2 108.369 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -118.88 154.44 32.93 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.461 -0.94 . . . . 55.44 108.461 -176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.594 ' HB3' HD11 ' A' ' 151' ' ' LEU . 5.7 p90 -117.28 152.19 35.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.214 -1.394 . . . . 71.44 113.868 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -135.18 124.75 25.07 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.527 -2.027 . . . . 75.11 105.527 172.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.412 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 32.3 mt-10 -106.31 118.38 36.48 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.2 107.571 -177.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -139.04 148.34 43.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.512 0.93 . . . . 74.22 113.512 -175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.59 136.41 34.82 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.082 -1.451 . . . . 62.52 107.082 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.632 ' SG ' HG13 ' A' ' 128' ' ' ILE . 99.1 m -63.49 142.9 58.22 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.644 0.979 . . . . 70.34 113.644 -176.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -47.98 -48.25 32.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.827 1.251 . . . . 54.32 112.323 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.01 69.91 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 110.747 -0.941 . . . . 51.11 110.747 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.23 165.75 53.37 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 111.214 -0.754 . . . . 63.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 137.24 32.51 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.921 -0.311 . . . . 70.45 110.763 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 53.9 m-85 -135.34 164.22 28.23 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.766 0.827 . . . . 75.13 109.403 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.51 116.51 31.8 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.135 -0.691 . . . . 72.52 109.135 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -119.91 138.98 53.1 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 112.621 0.6 . . . . 74.13 112.621 -175.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.498 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 11.5 m -130.44 124.95 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.425 1.09 . . . . 60.42 110.393 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.55 139.06 45.01 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.086 -0.646 . . . . 64.12 112.281 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 39.4 t -126.38 141.33 46.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 N-CA-C 108.465 -0.939 . . . . 64.31 108.465 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -127.83 174.89 8.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 122.859 0.463 . . . . 71.35 110.13 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.51 -34.28 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.122 0.969 . . . . 73.33 113.202 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 3.5 mppt? -100.57 138.78 20.22 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 112.143 0.424 . . . . 62.45 112.143 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.73 159.76 4.59 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 124.589 3.526 . . . . 73.01 111.841 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.613 HG13 HD12 ' A' ' 98' ' ' LEU . 52.6 t -46.14 -48.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.708 0.803 . . . . 72.51 113.043 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.99 -45.18 91.27 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.423 0.63 . . . . 70.41 110.744 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 23.1 mm-40 -75.06 -31.84 61.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.986 -1.006 . . . . 74.11 112.585 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -73.0 -44.84 60.57 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.512 0.673 . . . . 71.12 109.669 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.304 -0.862 . . . . 62.3 111.309 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 17.0 ptm180 -64.09 -26.6 68.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 116.564 -0.289 . . . . 71.41 111.645 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 51.9 mt-10 -84.72 -41.75 15.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.982 0.42 . . . . 72.11 111.181 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.09 69.42 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.271 0.841 . . . . 74.1 113.271 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.484 ' HB2' ' HD3' ' A' ' 60' ' ' PRO . 6.6 mmt -56.07 -53.56 62.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.205 -0.426 . . . . 71.32 111.711 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 34.5 Cg_exo -55.87 -31.89 82.98 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.348 2.032 . . . . 74.35 112.129 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 43.0 mtmt -73.04 -31.02 64.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.626 -0.43 . . . . 54.55 111.589 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 66' ' ' VAL . 35.4 mm -74.34 -43.4 49.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.409 -0.96 . . . . 74.22 108.409 171.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 59' ' ' MET . 19.3 mmt -56.26 -37.73 70.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.854 0.686 . . . . 74.01 112.854 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.4 -47.62 72.69 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.439 -0.504 . . . . 72.1 110.74 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.88 -58.03 6.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.134 -0.485 . . . . 74.52 111.767 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -68.88 -17.38 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 64.34 110.897 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.62 -19.78 65.3 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.88 -0.6 . . . . 32.34 112.82 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.72 -22.28 0.4 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.096 -1.526 . . . . 51.04 113.968 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -79.37 58.02 2.5 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.439 1.114 . . . . 73.01 111.338 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -99.88 160.28 14.43 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.325 -1.361 . . . . 74.35 107.325 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -69.2 -33.57 73.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.597 0.635 . . . . 70.21 110.278 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -80.41 -9.58 59.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.746 . . . . 73.52 110.327 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.78 62.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.642 -0.708 . . . . 60.31 112.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 m -82.97 159.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 108.11 -1.07 . . . . 73.31 108.11 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -170.89 12.28 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 119.082 -1.532 . . . . 62.45 113.733 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.0 mtp 70.69 101.96 0.06 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.379 1.472 . . . . 72.24 110.466 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 66' ' ' VAL . . . -54.44 122.1 22.97 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.817 -1.083 . . . . 33.44 114.385 -174.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -96.31 126.89 41.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.645 -0.872 . . . . 72.31 108.645 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 m -123.77 123.94 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.435 0.636 . . . . 72.34 111.838 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.14 176.72 2.28 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 104.202 -2.518 . . . . 70.01 104.202 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -62.53 139.08 74.15 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 CA-C-N 121.494 1.569 . . . . 33.52 112.293 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 8.8 p -110.47 148.88 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.806 -1.183 . . . . 54.22 107.806 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 47.0 p -125.72 145.36 50.22 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 121.164 -0.214 . . . . 62.52 110.658 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -139.75 148.12 41.82 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.617 -0.433 . . . . 71.41 110.621 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.09 135.36 34.04 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.634 0.584 . . . . 73.12 110.019 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.27 151.07 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.001 -1.0 . . . . 73.23 109.577 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 76.4 m-85 -118.12 110.45 39.69 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 110.253 -0.277 . . . . 75.43 110.253 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.78 137.03 9.78 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 121.5 1.467 . . . . 64.33 110.989 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -82.77 179.31 7.82 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.745 -0.835 . . . . 75.25 108.745 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.2 -36.32 77.4 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.763 0.792 . . . . 72.44 109.807 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.31 -5.42 52.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.284 -1.325 . . . . 71.41 112.777 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.55 -4.03 83.74 Favored Glycine 0 CA--C 1.501 -0.829 0 C-N-CA 120.378 -0.915 . . . . 75.33 112.718 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.1 p -74.64 146.92 42.02 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.001 -0.741 . . . . 72.41 109.001 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.64 132.6 35.18 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.149 0.499 . . . . 73.52 110.879 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -87.35 150.95 23.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 75.44 109.923 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -74.63 77.37 2.01 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.934 1.087 . . . . 70.25 113.934 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.68 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -165.49 122.89 1.5 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 104.21 -2.515 . . . . 73.22 104.21 173.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.68 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 5.7 tt -143.88 145.26 32.18 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 121.078 -0.249 . . . . 70.12 110.571 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -142.1 130.24 22.09 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.404 -0.518 . . . . 73.24 110.726 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.8 t -91.85 139.28 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.228 -0.896 . . . . 52.1 109.944 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.265 -1.383 . . . . 75.15 107.265 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HA ' HG23 ' A' ' 82' ' ' VAL . 88.5 t80 -102.2 114.31 28.36 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.495 -0.928 . . . . 73.21 108.495 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -75.54 113.14 12.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.105 -1.443 . . . . 71.32 107.105 -175.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -78.3 135.26 61.77 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 112.276 0.473 . . . . 61.14 112.276 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.23 157.83 13.3 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.416 2.744 . . . . 73.2 112.127 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -54.59 -45.94 73.69 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.155 1.168 . . . . 62.52 114.155 -171.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -59.85 -37.92 80.66 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.214 0.531 . . . . 71.3 111.785 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.44 -3.15 57.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.696 0.628 . . . . 71.44 112.696 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.676 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.51 -33.73 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.184 -1.006 . . . . 75.53 109.91 172.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 -34.75 55.78 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.024 -0.535 . . . . 61.31 112.187 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.6 t -142.72 89.09 8.27 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 108.283 -1.006 . . . . 50.35 108.283 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 73.5 Cg_endo -87.18 141.18 5.87 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.914 1.743 . . . . 73.13 110.977 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 12.5 Cg_exo -71.25 154.67 61.5 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 121.705 1.603 . . . . 64.53 110.448 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.38 143.12 55.24 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.376 -0.972 . . . . 72.12 108.376 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.82 110.71 2.84 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.045 1.83 . . . . 71.12 111.643 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.2 t -72.76 -22.17 60.9 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.575 -0.738 . . . . 44.1 110.548 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.58 144.23 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.635 -0.876 . . . . 65.43 108.635 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.92 -33.14 74.12 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.224 0.824 . . . . 71.15 113.224 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.1 p -90.36 -12.13 38.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.991 0.424 . . . . 72.21 111.944 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.31 123.21 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.454 -2.054 . . . . 74.44 105.454 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -128.39 138.28 52.27 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.249 -0.58 . . . . 75.23 110.57 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 25.3 mm -92.01 109.49 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.541 -1.652 . . . . 62.22 106.541 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -129.87 153.14 48.59 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.395 -0.821 . . . . 63.05 109.176 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.27 137.58 54.8 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 109.501 -0.555 . . . . 73.1 109.501 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.94 127.48 28.77 Favored 'General case' 0 N--CA 1.426 -1.659 0 C-N-CA 120.555 -0.458 . . . . 61.34 111.413 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.17 175.57 9.44 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.398 -0.964 . . . . 73.12 108.398 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.71 46.11 Favored Glycine 0 C--N 1.306 -1.083 0 C-N-CA 120.836 -0.697 . . . . 72.1 111.758 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.632 HG13 ' SG ' ' A' ' 36' ' ' CYS . 36.2 pt -132.99 146.51 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.088 0.47 . . . . 75.34 110.801 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.2 m -104.06 135.16 46.08 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.98 -1.489 . . . . 61.31 106.98 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 m -123.66 145.97 29.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.355 -0.609 . . . . 71.52 109.355 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -113.48 122.53 47.57 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 105.923 -1.88 . . . . 61.53 105.923 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.7 m -110.1 146.59 35.16 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 115.867 -0.606 . . . . 73.11 110.916 -173.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.499 HG22 ' HB ' ' A' ' 185' ' ' VAL . 9.9 t -133.62 124.89 27.61 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.327 -0.619 . . . . 71.34 109.327 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -111.23 126.36 54.79 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 121.424 0.63 . . . . 74.15 109.505 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 37.3 p90 -137.24 167.43 21.59 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.974 -1.012 . . . . 72.02 109.314 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -120.62 123.21 5.5 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.09 -1.204 . . . . 22.31 110.09 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 167.03 170.84 32.43 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 111.345 -0.702 . . . . 62.3 111.345 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -93.11 100.26 12.69 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.664 -0.865 . . . . 63.21 108.664 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.69 132.2 43.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.32 0.859 . . . . 55.33 113.32 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.06 177.15 5.03 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.27 -36.49 73.34 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.729 0.3 . . . . 65.25 111.262 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.23 81.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.353 -0.385 . . . . 63.53 110.297 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.9 -42.51 99.8 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.773 -0.454 . . . . 61.54 109.773 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.759 ' HA ' ' NE2' ' A' ' 147' ' ' HIS . 63.9 m-85 -56.95 -43.96 82.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 123.365 0.416 . . . . 73.44 112.108 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.11 -49.29 77.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 123.753 0.658 . . . . 64.13 110.305 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.62 -48.27 77.85 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.778 -0.646 . . . . 74.32 112.062 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.759 ' NE2' ' HA ' ' A' ' 144' ' ' TYR . 3.2 p-80 -72.46 -32.0 65.89 Favored 'General case' 0 C--O 1.205 -1.271 0 N-CA-C 113.067 0.765 . . . . 60.3 113.067 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.31 80.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.147 0.498 . . . . 64.44 110.651 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.4 t -76.53 -32.02 57.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 120.127 -0.629 . . . . 71.21 109.758 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.96 -34.3 78.11 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 116.379 -0.373 . . . . 75.4 110.298 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 31' ' ' TYR . 57.9 tp -62.61 -41.78 99.2 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.531 -0.544 . . . . 74.23 109.531 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -62.25 -36.99 83.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.447 0.642 . . . . 65.32 110.165 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 41.1 m -72.6 -30.18 64.14 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 115.153 -0.93 . . . . 53.21 110.105 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.7 m -75.12 -33.35 61.57 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.473 0.709 . . . . 72.02 109.834 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.9 mt -72.8 13.25 0.4 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.295 1.438 . . . . 75.23 111.76 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 153' ' ' THR . 44.6 tt0 -51.11 124.24 11.08 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.481 1.112 . . . . 73.31 110.357 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.54 60.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.736 -0.745 . . . . 62.31 113.724 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 81.0 p -93.23 154.41 41.51 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 117.565 0.682 . . . . 65.14 109.742 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.86 25.7 0.69 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.676 2.251 . . . . 64.33 110.897 175.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.03 138.81 39.81 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.835 -0.62 . . . . 71.32 110.753 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.5 p -110.8 149.84 29.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.356 -0.609 . . . . 71.05 109.356 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -143.75 161.51 38.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.88 -0.785 . . . . 72.43 108.88 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.414 ' O ' HG12 ' A' ' 166' ' ' VAL . 27.8 pt20 -131.65 109.65 10.36 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.235 -0.586 . . . . 75.52 111.825 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.57 62.69 Favored Glycine 0 C--N 1.315 -0.628 0 C-N-CA 120.617 -0.802 . . . . 54.25 114.141 171.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 61.04 23.15 13.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.032 0.533 . . . . 65.11 111.185 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 163' ' ' GLN . 9.8 p -63.59 138.16 23.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 N-CA-C 109.274 -0.639 . . . . 42.43 109.274 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.405 ' HB3' HD23 ' A' ' 187' ' ' LEU . 40.6 p90 -147.2 174.61 11.45 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 121.447 0.641 . . . . 74.31 111.192 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -116.98 150.32 38.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.714 -1.13 . . . . 74.52 109.17 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 83' ' ' SER . 34.7 t -113.29 120.32 40.74 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.291 -1.003 . . . . 73.13 108.291 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 82' ' ' VAL . . . -120.62 131.79 54.8 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.446 0.466 . . . . 74.2 111.604 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.441 0 N-CA-C 108.098 -2.001 . . . . 74.22 108.098 179.511 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.49 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 2.6 tmm_? . . . . . 0 C--O 1.217 -0.623 0 N-CA-C 109.238 -0.653 . . . . 72.34 109.238 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -113.13 131.21 55.93 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.508 -0.477 . . . . 73.31 110.247 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -131.62 161.74 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.831 -0.803 . . . . 74.24 108.831 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 133' ' ' THR . 43.4 tt0 -125.27 139.23 53.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.38 -1.341 . . . . 72.54 107.38 174.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.719 HG21 ' CD2' ' A' ' 147' ' ' HIS . 59.4 t -126.7 131.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.906 -0.775 . . . . 71.52 108.906 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 36.3 m0 -111.08 123.19 49.7 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 123.322 0.389 . . . . 74.03 110.444 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 167' ' ' TYR . 91.0 mt -96.5 128.08 43.1 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.413 -1.699 . . . . 44.55 106.413 169.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.016 -0.674 . . . . 74.41 111.75 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 161' ' ' THR . 52.2 tttp -63.69 127.63 32.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.563 -1.198 . . . . 71.33 111.753 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 108.825 -0.806 . . . . 64.11 108.825 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 43.8 p90 . . . . . 0 N--CA 1.426 -1.633 0 N-CA-C 104.872 -2.269 . . . . 54.2 104.872 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 6.2 tp-100 -106.05 109.03 20.84 Favored 'General case' 0 C--N 1.279 -2.488 0 C-N-CA 118.052 -1.459 . . . . 63.53 111.177 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.485 HG22 ' HG2' ' A' ' 34' ' ' ARG . 48.1 t -91.28 115.54 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 103.299 -2.852 . . . . 75.04 103.299 169.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.98 -23.77 22.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.925 -1.51 . . . . 54.4 111.339 -171.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -174.83 168.0 3.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.427 -0.583 . . . . 63.02 109.427 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 32' ' ' GLU . 72.8 p -133.74 145.7 50.08 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.089 -1.078 . . . . 63.33 108.089 170.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.2 -139.43 6.11 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 118.997 -1.573 . . . . 45.32 113.648 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.0 -112.57 4.47 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.947 -0.861 . . . . 44.31 110.947 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HG3' HG23 ' A' ' 154' ' ' THR . 8.6 mtpm? -113.52 170.32 8.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.03 -0.359 . . . . 72.2 110.03 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -83.97 157.53 21.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.027 -1.101 . . . . 55.21 108.027 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 75.88 -61.8 0.45 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.459 1.104 . . . . 70.31 110.444 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.77 110.14 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.153 -1.795 . . . . 40.44 106.153 171.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.0 p -122.57 155.05 37.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.544 -0.753 . . . . 63.23 109.065 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.521 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -114.98 153.21 31.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 113.155 0.798 . . . . 73.04 113.155 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.589 ' OE2' ' HD2' ' A' ' 34' ' ' ARG . 35.9 tt0 -135.35 123.35 22.74 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.216 -2.142 . . . . 61.3 105.216 173.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -109.95 125.2 52.6 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.105 0.955 . . . . 74.24 111.026 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.589 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 16.4 mtp180 -127.5 140.48 52.11 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.347 -1.297 . . . . 62.31 110.414 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.11 40.5 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.515 -1.291 . . . . 75.45 107.515 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.2 m -58.94 146.05 39.27 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.794 0.683 . . . . 61.12 111.604 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -87.41 -19.43 28.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.371 -0.377 . . . . 64.23 110.054 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 98.69 11.63 46.62 Favored Glycine 0 CA--C 1.489 -1.586 0 C-N-CA 119.423 -1.37 . . . . 55.41 111.824 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 160.0 53.61 Favored Glycine 0 N--CA 1.426 -2.006 0 C-N-CA 120.522 -0.847 . . . . 71.42 112.133 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.569 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.3 ptmt -95.9 128.93 43.21 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 109.748 -0.464 . . . . 64.34 109.748 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.8 m-85 -127.17 163.81 23.03 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.977 -0.556 . . . . 75.24 110.985 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.17 116.73 32.05 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.075 -1.083 . . . . 52.33 108.075 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.9 t -127.29 147.77 50.23 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 120.329 -0.548 . . . . 74.21 112.015 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 119' ' ' SER . 95.8 t -128.18 126.63 66.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.841 -1.072 . . . . 73.12 108.446 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 43.5 tt0 -113.16 123.94 51.39 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.018 0.437 . . . . 71.43 111.088 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 34.5 t -121.4 127.54 75.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.835 -1.543 . . . . 74.04 106.835 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 72.7 p -116.09 166.19 12.29 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.551 -0.46 . . . . 61.31 110.566 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 73.3 -27.49 0.19 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.897 0.879 . . . . 72.12 113.007 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 47' ' ' THR . 63.8 mmtt -89.84 146.85 36.16 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 115.946 -0.57 . . . . 70.4 110.54 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.23 156.65 61.92 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.435 2.09 . . . . 52.0 109.926 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 98' ' ' LEU . 54.4 t -47.87 -45.71 11.79 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 113.383 0.883 . . . . 71.11 113.383 -177.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.75 -46.55 87.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.175 0.435 . . . . 73.13 112.175 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . 33.8 tt0 -74.32 -43.69 55.65 Favored 'General case' 0 N--CA 1.397 -3.118 0 CA-C-N 116.278 -0.419 . . . . 64.33 111.728 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.79 -37.76 88.56 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 120.893 0.377 . . . . 52.33 110.675 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.84 -37.97 73.17 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.398 -0.365 . . . . 73.24 111.181 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 53' ' ' GLU 0.272 6.7 ppt_? -65.27 -23.54 67.07 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 112.283 0.475 . . . . 72.42 112.283 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.4 mm-40 -81.99 -52.34 7.15 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.44 -0.8 . . . . 72.44 112.778 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.21 -40.53 64.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 114.643 1.349 . . . . 52.24 114.643 -172.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 35.5 ttm -57.74 -49.31 94.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 114.957 1.466 . . . . 55.22 114.957 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 59' ' ' MET . 13.0 Cg_endo -57.17 -31.86 91.75 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.909 1.74 . . . . 74.41 111.639 175.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 93.3 mttt -67.59 -36.08 80.2 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.315 0.578 . . . . 73.34 110.096 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.58 -43.94 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 72.33 109.884 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.67 -43.51 98.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.845 0.683 . . . . 73.1 112.845 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -64.16 -37.68 88.35 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.059 0.457 . . . . 71.04 110.507 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 115' ' ' PRO . 38.6 t80 -66.28 -59.93 3.26 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.711 -0.677 . . . . 74.02 110.443 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.93 -26.15 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-O 121.17 0.51 . . . . 75.3 111.397 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -27.91 73.34 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 116.021 -0.536 . . . . 72.33 112.731 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.4 -11.87 0.22 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.33 -1.414 . . . . 71.45 114.321 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 116' ' ' SER . 23.5 m -82.23 49.53 1.43 Allowed 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 121.934 0.873 . . . . 75.12 110.268 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 113' ' ' PRO . 35.1 m-80 -98.61 149.54 22.67 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.567 -1.642 . . . . 61.41 106.567 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.47 -32.1 71.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.092 0.472 . . . . 73.43 112.044 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -78.05 -7.47 56.96 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.042 0.449 . . . . 74.01 111.016 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.0 18.27 80.22 Favored Glycine 0 CA--C 1.509 -0.291 0 C-N-CA 121.164 -0.541 . . . . 64.33 112.118 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.94 165.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.245 -1.02 . . . . 53.02 108.245 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.95 -120.15 0.95 Allowed Glycine 0 N--CA 1.41 -3.084 0 C-N-CA 119.484 -1.341 . . . . 51.51 112.227 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 69.9 mtm 68.4 9.69 7.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.201 1.0 . . . . 54.12 111.165 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.73 92.26 1.1 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.807 -0.633 . . . . 72.44 113.961 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -95.79 125.48 40.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.602 -1.999 . . . . 73.42 105.602 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.1 p -117.1 116.96 28.34 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 115.605 1.706 . . . . 44.35 115.605 -166.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.58 155.35 45.37 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 105.206 -2.146 . . . . 72.33 105.206 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.85 140.5 85.31 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.225 1.95 . . . . 62.43 114.151 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -106.35 151.36 8.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.957 -1.497 . . . . 70.41 106.957 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.3 t -141.79 147.48 37.36 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.902 -0.777 . . . . 74.55 108.902 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.83 144.35 48.91 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 122.337 -0.227 . . . . 75.12 110.506 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 136.23 33.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.722 -0.672 . . . . 71.44 109.519 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.89 150.62 25.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.011 -1.107 . . . . 63.44 108.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.627 ' CD2' ' HE2' ' A' ' 97' ' ' LYS . 1.7 m-85 -119.84 103.54 45.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 108.746 -0.835 . . . . 75.3 108.746 -175.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 151.37 37.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.145 1.897 . . . . 75.42 114.545 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.715 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 92.2 m-20 -102.89 156.09 17.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.466 -1.243 . . . . 64.13 108.171 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.05 -17.2 62.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.597 0.713 . . . . 73.52 109.747 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.96 -5.47 46.38 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.917 -1.038 . . . . 72.21 110.8 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.96 0.71 87.25 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 121.104 -0.569 . . . . 61.31 111.988 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.5 p -92.59 152.1 19.78 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 109.228 -0.656 . . . . 71.12 109.228 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.71 85.63 2.16 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.04 0.447 . . . . 74.04 110.765 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.61 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 34.3 tt0 -148.87 113.75 5.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.174 -0.466 . . . . 61.44 111.277 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.715 ' HE3' ' OD1' ' A' ' 89' ' ' ASN . 91.3 mttt -173.14 -75.44 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.883 1.673 . . . . 64.31 107.752 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.627 ' HE2' ' CD2' ' A' ' 87' ' ' PHE . 4.0 mppt? -143.05 156.57 44.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.997 -1.001 . . . . 74.44 108.942 177.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 51' ' ' VAL . 6.3 tt -143.84 134.84 25.44 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.8 -1.185 . . . . 54.14 107.8 172.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.47 ' HD3' ' HB2' ' A' ' 45' ' ' GLU . 33.9 ttpt -140.83 116.54 10.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 120.601 -0.44 . . . . 72.1 110.943 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 43' ' ' THR . 53.7 t -87.18 132.58 32.2 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 115.679 -0.691 . . . . 71.14 109.731 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -115.8 122.06 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.453 0.701 . . . . 74.31 109.27 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 85.9 t80 -103.21 123.22 46.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.334 0.587 . . . . 72.43 110.087 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -75.12 113.42 12.44 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.375 -1.284 . . . . 72.33 110.12 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.5 mt -89.26 125.03 63.25 Favored Pre-proline 0 N--CA 1.42 -1.958 0 N-CA-C 107.254 -1.387 . . . . 65.41 107.254 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.26 148.24 42.04 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.705 2.27 . . . . 61.13 111.335 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.43 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -57.23 -36.22 70.64 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.078 0.399 . . . . 63.4 112.078 -173.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -62.93 -28.46 70.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.449 0.642 . . . . 74.24 111.364 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.14 -12.28 38.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 116.119 -0.492 . . . . 64.44 110.668 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.478 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 11.9 mm-40 -68.11 -29.42 68.33 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.591 0.589 . . . . 72.33 112.591 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.45 -39.19 97.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.15 -1.024 . . . . 62.41 111.403 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 m -153.46 87.73 3.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.36 -0.978 . . . . 54.52 108.36 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.67 151.21 11.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.278 1.985 . . . . 65.1 110.532 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -65.07 157.05 59.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.876 1.717 . . . . 73.3 110.805 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.49 147.22 71.44 Favored Pre-proline 0 N--CA 1.423 -1.808 0 N-CA-C 108.918 -0.771 . . . . 72.12 108.918 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 58.6 Cg_endo -73.18 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 121.917 1.744 . . . . 71.31 111.091 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 69' ' ' THR . 47.9 t -77.77 -28.68 50.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.34 -0.845 . . . . 75.2 111.655 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.29 152.1 25.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.281 -0.568 . . . . 65.32 110.401 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.11 -32.97 74.46 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.931 0.715 . . . . 63.32 112.931 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.56 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 20.1 m -93.44 -8.64 41.07 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.293 -0.563 . . . . 73.4 111.483 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 61.3 t -97.7 118.64 44.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.476 -1.305 . . . . 73.21 107.476 -176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -128.97 140.28 51.72 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.078 -0.712 . . . . 71.13 109.078 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.2 mm -92.08 112.0 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.271 -1.011 . . . . 72.31 108.271 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -123.44 148.41 46.18 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.553 -0.749 . . . . 72.51 109.963 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 1.7 mp0 -98.17 139.38 34.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.809 -1.182 . . . . 73.22 107.809 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -126.7 121.16 31.29 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.256 -0.978 . . . . 75.45 110.696 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.529 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -144.9 176.83 9.18 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.199 -0.909 . . . . 74.32 111.031 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.8 64.61 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.962 -0.637 . . . . 24.55 114.661 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.41 160.41 22.71 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 C-N-CA 119.386 -0.926 . . . . 70.03 112.065 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.2 m -112.88 142.97 44.93 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.027 -1.442 . . . . 73.33 107.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.78 145.39 29.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.525 -0.546 . . . . 64.02 109.525 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 56.3 m-85 -113.72 122.4 47.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.893 -2.262 . . . . 75.11 104.893 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 42.8 p -123.0 139.24 54.29 Favored 'General case' 0 C--N 1.263 -3.163 0 C-N-CA 120.092 -0.643 . . . . 62.53 110.983 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -113.21 127.41 56.17 Favored 'General case' 0 N--CA 1.402 -2.835 0 N-CA-C 108.138 -1.06 . . . . 65.21 108.138 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -110.43 125.32 53.13 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.734 -1.21 . . . . 73.31 107.734 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -147.0 153.72 40.39 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.167 0.508 . . . . 72.14 112.36 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.02 156.26 19.2 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.446 -0.797 . . . . 74.22 111.482 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.78 141.43 12.16 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.303 -1.119 . . . . 53.44 110.303 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -70.77 122.92 20.76 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.392 0.615 . . . . 73.44 111.198 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -110.95 133.5 53.33 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.589 -0.732 . . . . 51.12 109.629 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -80.95 170.21 16.55 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.718 -0.845 . . . . 62.33 108.718 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -53.29 -38.68 63.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.99 0.424 . . . . 52.4 111.185 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.06 77.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.589 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.418 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 11.8 m-20 -66.8 -31.66 72.42 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 116.24 -0.436 . . . . 62.15 110.617 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -62.78 -40.95 98.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.784 -0.367 . . . . 72.54 110.522 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.57 -44.24 90.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.903 -0.59 . . . . 52.22 109.574 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -63.8 -47.22 81.76 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.572 -0.74 . . . . 73.31 111.275 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -66.02 -33.18 75.21 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.009 0.374 . . . . 72.54 112.009 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.7 94.49 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.299 -0.63 . . . . 61.12 109.299 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.2 m -64.24 -44.5 91.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.458 -0.792 . . . . 65.21 110.458 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 98.7 mt-30 -59.3 -49.22 78.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.818 0.447 . . . . 74.22 110.561 177.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 31' ' ' TYR . 48.1 tp -58.02 -46.19 85.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.857 -0.61 . . . . 52.11 110.61 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -64.35 -34.54 78.38 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.857 -0.611 . . . . 73.45 110.216 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.5 m -73.18 -33.17 65.27 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.331 0.586 . . . . 73.04 109.837 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 26' ' ' LYS . 42.0 m -72.38 -33.72 67.42 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.239 0.542 . . . . 74.02 109.779 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 158' ' ' THR . 87.8 mt -74.66 4.99 5.32 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.061 0.944 . . . . 73.02 113.197 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.1 142.5 43.64 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.654 -0.818 . . . . 74.34 111.1 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.23 62.18 Favored Glycine 0 C--N 1.297 -1.606 0 CA-C-N 115.456 -0.793 . . . . 63.34 111.15 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 155' ' ' LEU . 11.5 t -116.55 147.34 39.52 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 108.228 -1.027 . . . . 73.13 108.228 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -70.94 36.11 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.981 3.12 . . . . 62.22 113.666 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.13 136.63 42.92 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.847 0.356 . . . . 63.33 111.02 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 69.3 p -111.82 162.91 14.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.341 -0.985 . . . . 71.44 108.341 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.8 m-85 -137.66 150.6 47.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.616 -0.883 . . . . 65.43 108.616 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -127.43 126.82 43.08 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.854 -0.738 . . . . 74.32 112.574 -177.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.84 -1.19 17.29 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.287 -0.869 . . . . 73.51 113.441 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 63.11 12.17 5.8 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 64.35 110.588 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.5 160.37 4.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.272 -0.876 . . . . 62.03 111.88 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.87 170.89 17.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.42 -0.809 . . . . 71.22 110.015 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 18.1 m-85 -115.58 153.31 31.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.252 0.548 . . . . 72.52 111.848 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 41.7 t -115.12 144.82 43.08 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.241 -1.763 . . . . 72.21 106.241 172.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.24 160.56 16.87 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 121.131 -0.228 . . . . 60.33 110.644 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.525 0 N-CA-C 110.3 -1.12 . . . . 52.04 110.3 -177.886 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.923 0.392 . . . . 64.05 111.676 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.2 134.39 29.43 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 116.325 -0.398 . . . . 73.51 111.155 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.28 143.4 46.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.85 0.46 . . . . 74.34 111.025 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -122.08 148.0 45.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.49 -0.323 . . . . 75.22 110.912 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 132' ' ' SER . 57.3 t -128.18 128.93 69.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.614 -1.254 . . . . 64.3 107.614 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 7.0 m0 -114.98 124.83 52.66 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 110.354 -0.239 . . . . 62.31 110.354 -178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.12 138.97 35.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.94 -1.133 . . . . 63.22 107.94 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 38.5 t -100.17 127.74 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 120.696 -0.401 . . . . 72.31 111.547 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.1 tmtt? -78.14 123.76 27.27 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.426 -0.806 . . . . 73.14 109.691 176.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.26 1.651 0 O-C-N 124.268 0.98 . . . . 64.31 110.183 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.1 p90 . . . . . 0 N--CA 1.433 -1.282 0 N-CA-C 106.331 -1.729 . . . . 75.03 106.331 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -119.32 120.22 36.29 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 119.148 -1.021 . . . . 75.25 112.073 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 34' ' ' ARG . 44.5 t -78.16 114.52 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 102.803 -3.036 . . . . 74.32 102.803 168.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.62 -30.13 17.36 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.288 -1.365 . . . . 65.42 112.874 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -158.67 163.07 37.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.922 -0.77 . . . . 72.34 108.922 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 32' ' ' GLU . 44.8 p -132.66 162.59 30.98 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.461 -0.57 . . . . 65.44 109.461 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.24 -145.4 10.15 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.775 -0.726 . . . . 73.34 111.831 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -156.7 16.71 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.917 -0.658 . . . . 44.44 111.905 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.01 171.87 7.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.398 0.679 . . . . 74.44 111.642 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.68 143.59 48.04 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.68 -1.6 . . . . 75.3 106.68 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 80.23 -50.58 0.35 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.305 1.042 . . . . 74.14 111.314 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.0 t -116.09 109.14 27.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.287 -0.634 . . . . 53.11 109.287 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -116.91 154.91 29.99 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.454 -0.794 . . . . 73.55 109.629 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 162.48 31.97 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.76 0.314 . . . . 75.03 111.821 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HB3' HG22 ' A' ' 23' ' ' THR . 12.6 pt-20 -154.89 139.74 17.2 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.699 -1.593 . . . . 75.31 106.699 174.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB3' ' CD2' ' A' ' 131' ' ' TYR 0.283 0.2 OUTLIER -103.53 125.6 50.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.208 -0.997 . . . . 63.45 111.93 177.251 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.446 ' HG2' HG22 ' A' ' 20' ' ' VAL . 70.7 mtt180 -115.03 127.15 55.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.616 -1.174 . . . . 75.14 109.481 -176.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.64 132.49 34.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.895 -1.52 . . . . 74.45 106.895 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.442 ' SG ' HG13 ' A' ' 128' ' ' ILE . 74.6 m -74.71 157.79 34.68 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 120.129 -0.628 . . . . 75.21 111.622 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -84.7 -25.02 28.66 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.602 -0.726 . . . . 74.31 111.522 -174.556 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 95.13 11.02 56.81 Favored Glycine 0 CA--C 1.497 -1.072 0 C-N-CA 119.49 -1.338 . . . . 30.45 111.474 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.488 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.55 165.74 51.88 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 114.114 0.406 . . . . 71.42 114.114 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -101.02 122.59 43.8 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.818 -0.691 . . . . 71.13 109.378 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 44.7 m-85 -125.57 165.65 18.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.293 -0.867 . . . . 73.54 111.894 -170.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.49 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.22 116.7 30.99 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 108.78 -0.822 . . . . 73.12 108.78 -177.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 10.1 t -124.77 143.91 50.54 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-O 121.349 0.595 . . . . 72.25 111.352 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.3 m -128.4 139.98 50.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.054 -0.975 . . . . 74.12 108.791 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.13 136.83 51.7 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.077 -0.649 . . . . 72.14 112.074 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.529 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 29.6 t -131.06 142.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.058 -0.719 . . . . 72.14 109.058 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 p -135.26 178.15 7.26 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.531 0.332 . . . . 73.04 110.311 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.0 t70 73.6 -14.99 0.59 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.448 1.099 . . . . 61.43 113.159 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -131.21 147.26 65.53 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.313 -0.625 . . . . 70.24 109.313 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.28 156.29 5.71 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.652 2.902 . . . . 74.3 112.526 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 20.5 m -56.2 -36.33 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.518 0.562 . . . . 73.04 112.518 -174.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 10.4 m-20 -58.78 -49.82 76.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.164 0.507 . . . . 75.43 110.158 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.04 -36.32 79.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.318 -0.855 . . . . 75.24 110.191 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -60.38 -47.35 86.43 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.437 -0.801 . . . . 70.4 110.59 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 59' ' ' MET . 96.1 mt -55.87 -36.97 68.18 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 122.43 0.292 . . . . 73.24 111.479 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 1.7 mmp_? -59.37 -34.29 72.23 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.307 0.575 . . . . 71.44 110.456 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -83.98 -41.41 17.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.418 -0.81 . . . . 73.43 111.338 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.01 -33.09 67.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 114.393 1.257 . . . . 74.0 114.393 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 17.8 mmt -61.31 -57.2 27.22 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 120.317 -0.553 . . . . 74.1 111.713 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.95 -38.45 86.38 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.594 2.196 . . . . 70.23 113.008 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG3' HG11 ' A' ' 44' ' ' VAL . 16.4 ptpt -69.15 -28.8 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.019 0.748 . . . . 75.34 113.019 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.5 mm -76.55 -45.11 33.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.342 -0.614 . . . . 51.11 109.342 170.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.2 mtp -62.25 -33.49 74.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.452 -0.795 . . . . 62.43 112.941 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -70.25 -40.25 74.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.872 0.368 . . . . 71.13 110.172 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -59.03 -52.09 67.25 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.801 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.87 -13.09 14.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.062 -0.517 . . . . 43.22 111.523 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.37 -16.78 70.52 Favored Glycine 0 CA--C 1.506 -0.486 0 CA-C-N 115.94 -0.573 . . . . 72.52 112.436 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . 134.4 -11.04 4.68 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 119.746 -1.216 . . . . 40.44 112.828 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 m -80.3 30.11 0.29 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 122.888 1.327 . . . . 54.11 110.369 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 68' ' ' GLY . 7.3 p30 -97.81 171.36 8.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.978 -1.01 . . . . 74.42 109.032 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 26.5 t70 -67.97 -27.55 66.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 21.52 113.084 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.55 -13.2 55.0 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.446 -0.902 . . . . 72.14 109.595 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.31 22.49 74.67 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.608 -0.724 . . . . 54.44 111.308 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 m -81.97 122.17 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 121.246 0.546 . . . . 62.21 112.293 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.02 52.76 0.62 Allowed Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.11 -1.196 . . . . 72.12 110.11 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.7 mtt -82.91 -41.74 18.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.309 0.576 . . . . 73.14 110.519 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.04 129.03 3.39 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.306 -0.95 . . . . 73.13 111.593 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.474 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 23.6 ptp -132.78 126.03 31.45 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.806 -0.442 . . . . 73.21 109.806 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.4 p -124.83 115.79 21.23 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.023 0.749 . . . . 63.42 113.023 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 15.6 m -153.59 174.54 3.67 Favored Pre-proline 0 C--N 1.313 -1.003 0 C-N-CA 125.88 1.672 . . . . 75.32 106.498 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 78.2 Cg_exo -56.72 140.36 90.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.157 1.905 . . . . 73.53 114.057 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 48.6 t -105.75 143.04 17.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.395 -1.706 . . . . 74.21 106.395 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.4 m -132.35 151.4 51.87 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.996 0.362 . . . . 71.43 110.332 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' CD2' HD21 ' A' ' 98' ' ' LEU . 52.5 p90 -145.07 146.46 31.86 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 122.036 -0.415 . . . . 74.44 111.162 174.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.42 135.33 34.13 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 116.029 -0.532 . . . . 72.21 109.943 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG12 HG11 ' A' ' 51' ' ' VAL . 30.7 m -137.81 150.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.43 -0.952 . . . . 72.23 108.43 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 39.5 m-85 -119.88 108.24 39.11 Favored Pre-proline 0 C--N 1.281 -2.378 0 N-CA-C 107.466 -1.309 . . . . 73.01 107.466 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.01 147.8 8.01 Favored 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 121.243 1.295 . . . . 60.41 113.69 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.37 154.62 18.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.71 -1.959 . . . . 71.41 105.71 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.5 -13.15 62.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 114.247 1.202 . . . . 73.05 114.247 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.66 -4.09 58.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.502 0.668 . . . . 74.42 109.763 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 -11.07 59.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.733 -0.667 . . . . 21.22 113.466 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.2 m -78.53 139.38 38.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.251 -0.58 . . . . 53.13 110.112 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.69 150.9 23.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.645 -0.422 . . . . 65.42 110.083 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -79.77 150.1 30.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.736 -1.579 . . . . 74.35 106.736 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.0 38.92 0.54 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.712 0.805 . . . . 63.01 111.956 -171.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.529 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -127.8 122.55 33.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 104.207 -2.516 . . . . 62.21 104.207 176.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.529 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 3.1 tm? -131.36 145.49 51.86 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.009 0.433 . . . . 64.11 109.993 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' N ' HD13 ' A' ' 98' ' ' LEU . 87.9 tttt -148.19 116.13 6.41 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.248 -0.887 . . . . 63.04 110.724 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.519 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 93.7 t -95.1 126.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 122.94 0.496 . . . . 71.03 110.103 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.94 122.71 46.97 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 82.5 t80 -103.5 120.17 40.31 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.315 -0.994 . . . . 63.15 108.315 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -74.99 122.33 23.33 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.783 -0.644 . . . . 62.04 109.33 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.497 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 66.7 mt -91.75 125.92 55.65 Favored Pre-proline 0 N--CA 1.415 -2.201 0 N-CA-C 107.226 -1.398 . . . . 52.45 107.226 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 78' ' ' MET . 64.9 Cg_exo -52.86 155.59 10.7 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 123.289 2.659 . . . . 64.52 113.558 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -47.29 -44.36 23.2 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.475 1.51 . . . . 75.35 112.052 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.86 -30.02 68.69 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.015 -0.539 . . . . 71.11 112.435 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -99.95 -2.69 34.0 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.719 -0.219 . . . . 74.02 111.584 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.475 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 25.3 mm-40 -70.49 -34.99 72.98 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.21 0.818 . . . . 71.52 113.21 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.49 -38.28 93.33 Favored Glycine 0 N--CA 1.466 0.64 0 C-N-CA 120.953 -0.642 . . . . 52.54 112.41 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.3 m -155.46 93.41 2.65 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.682 -0.859 . . . . 74.44 108.682 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -87.14 157.83 8.41 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.571 2.18 . . . . 65.4 111.971 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.62 151.93 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.223 1.948 . . . . 64.14 111.575 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -85.55 152.69 57.77 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-N 116.012 -0.54 . . . . 52.34 110.206 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.67 110.94 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.29 1.993 . . . . 52.1 112.561 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.7 m -80.87 -20.3 42.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.02 0.438 . . . . 75.24 110.958 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -107.88 140.57 40.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.926 -1.509 . . . . 71.23 106.926 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -76.18 -12.86 60.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.215 0.45 . . . . 64.41 112.215 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HD3' ' A' ' 61' ' ' LYS . 18.3 m -70.88 -32.23 69.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.496 . . . . 73.54 109.988 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 44' ' ' VAL . 8.4 p -105.18 130.07 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.661 -0.699 . . . . 64.11 109.176 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -127.86 133.14 49.34 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.925 -0.579 . . . . 74.15 110.275 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.7 mm -93.09 112.4 26.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.606 -0.887 . . . . 63.04 108.606 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.86 151.86 46.3 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.691 -0.855 . . . . 63.02 108.691 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.25 146.65 30.06 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.801 -0.444 . . . . 73.15 109.801 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -140.55 123.09 16.11 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.781 -0.368 . . . . 52.43 110.051 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.415 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 12.9 pt-20 -138.8 164.88 28.46 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.412 -0.958 . . . . 60.52 108.412 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.72 35.47 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.02 -1.086 . . . . 54.43 112.42 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.442 HG13 ' SG ' ' A' ' 36' ' ' CYS . 38.2 pt -135.51 145.72 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.899 0.856 . . . . 75.4 112.324 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 189' ' ' LYS . 19.8 m -115.5 140.17 49.39 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 104.992 -2.225 . . . . 74.43 104.992 173.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.16 153.9 30.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.413 0 N-CA-C 109.246 -0.65 . . . . 74.41 109.246 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.609 ' CD2' ' HB3' ' A' ' 33' ' ' GLU . 42.3 m-85 -113.11 121.49 44.71 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.144 -2.169 . . . . 52.3 105.144 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 16.6 p -112.58 134.28 54.19 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 121.581 0.705 . . . . 61.22 111.865 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.44 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 8.8 t -126.25 133.87 51.35 Favored 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 114.87 -1.059 . . . . 64.23 109.255 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 50.1 mt-30 -111.09 146.57 36.55 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.781 -0.368 . . . . 75.32 110.676 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 183' ' ' ASN . 11.0 p90 -146.93 168.16 22.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.897 -0.592 . . . . 75.33 109.476 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.12 152.15 23.42 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.815 -0.914 . . . . 75.13 110.815 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 135.68 -138.58 10.05 Favored Glycine 0 C--N 1.313 -0.73 0 N-CA-C 110.921 -0.872 . . . . 73.13 110.921 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -100.56 106.67 18.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.782 -0.821 . . . . 75.15 108.782 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.85 114.64 27.31 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.48 0.919 . . . . 72.41 113.48 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -102.14 175.56 5.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.875 -1.528 . . . . 63.41 106.875 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.1 mp0 -57.79 -44.18 86.09 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.252 -1.018 . . . . 50.41 108.252 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.33 67.36 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.191 -1.368 . . . . 35.24 112.16 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 147' ' ' HIS . 5.1 m-20 -65.72 -49.07 69.8 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 121.098 -0.241 . . . . 71.42 110.387 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 48.5 m-85 -57.96 -43.47 86.43 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.499 0.499 . . . . 74.11 110.099 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 141' ' ' GLU . 58.8 t -62.7 -51.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 120.997 0.427 . . . . 74.11 111.322 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.16 75.3 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.397 0.618 . . . . 62.02 110.41 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.567 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 7.7 t-160 -66.79 -47.89 70.7 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.457 -0.792 . . . . 62.42 108.902 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.24 92.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.589 -0.732 . . . . 70.44 110.368 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 89.0 m -64.56 -36.61 84.77 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.744 -0.662 . . . . 75.14 110.838 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -74.11 -28.62 61.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.691 -0.403 . . . . 70.35 110.161 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 81.4 mt -58.98 -34.58 71.98 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 109.938 -0.393 . . . . 54.35 109.938 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 149' ' ' THR . 30.6 mtp180 -61.33 -38.82 88.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.779 -0.646 . . . . 62.43 109.454 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -73.07 -37.41 66.8 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.147 -0.933 . . . . 74.31 110.365 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.2 m -77.41 -34.51 54.72 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.09 0.471 . . . . 74.54 110.829 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 158' ' ' THR . 95.4 mt -80.83 7.66 9.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.579 0.752 . . . . 63.42 111.136 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -82.34 130.37 35.08 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.92 -1.141 . . . . 75.23 107.92 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.56 58.3 Favored Glycine 0 C--N 1.307 -1.081 0 C-N-CA 120.649 -0.786 . . . . 74.5 112.528 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 155' ' ' LEU . 15.4 t -125.2 149.25 63.28 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 107.772 -1.196 . . . . 71.34 107.772 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -64.25 -2.77 5.24 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 123.489 2.793 . . . . 73.0 115.154 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -62.98 142.54 58.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.723 0.297 . . . . 74.35 111.361 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 46.7 p -116.56 151.72 35.6 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.085 -0.507 . . . . 73.22 109.886 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -143.91 149.29 36.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.764 -0.458 . . . . 74.4 109.764 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 5.2 pp0? -134.0 145.49 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.514 0.931 . . . . 75.44 113.514 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.84 -1.39 23.45 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.876 -1.056 . . . . 43.22 115.257 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 t70 61.16 7.99 1.84 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.024 0.93 . . . . 70.41 111.057 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.74 139.69 18.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 124.446 1.098 . . . . 55.43 110.165 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 144' ' ' TYR . 43.9 p90 -137.86 167.61 21.39 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.619 -0.719 . . . . 73.14 109.173 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 79.2 m-85 -115.69 152.78 32.53 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.308 -0.997 . . . . 64.34 108.308 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 83' ' ' SER . 59.7 m -113.62 132.34 55.78 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.616 -1.253 . . . . 73.32 107.616 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -128.23 147.19 50.57 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.032 0.444 . . . . 70.4 111.034 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.912 0 N-CA-C 110.133 -1.187 . . . . 64.01 110.133 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 CA--C 1.515 -0.377 0 CA-C-O 122.019 0.914 . . . . 70.34 109.125 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -142.27 129.51 21.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.634 -1.166 . . . . 74.41 108.211 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 38.1 m-80 -141.14 148.58 40.28 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 105.257 -2.127 . . . . 72.41 105.257 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 37.4 tt0 -126.38 141.02 52.05 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.023 -0.671 . . . . 72.03 110.486 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 132' ' ' SER . 29.0 t -124.49 129.14 73.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.744 -1.206 . . . . 74.3 107.744 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 39.0 m0 -110.15 126.9 54.57 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 110.135 -0.32 . . . . 75.14 110.135 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.83 137.74 39.72 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 172.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.46 133.18 43.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 120.554 -0.459 . . . . 74.13 112.203 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -69.64 143.38 53.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.683 -0.69 . . . . 72.44 111.92 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.305 -1.338 0 CA-C-O 118.433 -0.794 . . . . 60.15 109.123 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 109.839 -0.43 . . . . 73.25 109.839 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -103.55 135.87 44.33 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.635 -0.876 . . . . 71.14 108.635 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 9' ' ' LEU . 1.6 pt? -119.24 115.6 24.54 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.183 0.516 . . . . 75.54 111.552 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -132.1 174.98 9.64 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.927 -0.768 . . . . 73.34 108.927 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.12 -177.84 21.97 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.789 -0.924 . . . . 65.04 110.789 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.4 p -91.15 -25.84 19.37 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.13 0.491 . . . . 61.31 111.001 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.92 97.42 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 122.152 0.977 . . . . 51.52 111.163 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.27 123.16 0.8 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.237 -2.505 . . . . 73.44 104.237 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.575 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 8.9 t -142.37 -52.85 0.41 Allowed 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 118.633 -1.227 . . . . 73.55 113.203 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -140.04 95.56 8.47 Favored Pre-proline 0 CA--C 1.503 -0.832 0 CA-C-N 117.993 0.361 . . . . 73.23 110.969 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.636 ' HD2' ' OE2' ' A' ' 37' ' ' GLU . 9.9 Cg_exo -72.38 119.87 6.4 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 121.548 1.499 . . . . 74.41 109.594 173.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.583 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.2 p90 -139.94 172.0 13.39 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 54.4 tt0 -106.0 109.24 21.12 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.057 -0.657 . . . . 71.51 109.646 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.8 p -93.31 131.92 38.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.247 -1.019 . . . . 62.42 108.247 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 33' ' ' GLU . 10.2 mt -89.25 -40.93 12.5 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.12 -1.067 . . . . 71.24 108.12 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 m -173.11 169.6 4.57 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.617 1.167 . . . . 74.24 108.313 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.77 165.59 24.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.562 -1.273 . . . . 75.33 107.562 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.31 89.87 0.17 Allowed Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 118.759 -1.686 . . . . 62.04 113.78 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.68 -134.11 4.25 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.757 -0.735 . . . . 54.33 111.912 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -115.27 173.81 6.32 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 123.821 0.848 . . . . 74.41 110.411 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -64.61 141.72 58.68 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.074 -1.084 . . . . 70.33 108.074 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 73.86 -62.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.673 1.189 . . . . 73.15 110.587 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG22 ' CD2' ' A' ' 147' ' ' HIS . 23.5 t -97.32 108.82 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.07 -1.085 . . . . 62.41 108.07 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.9 m -123.53 137.56 54.74 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.093 -1.077 . . . . 74.23 108.093 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -115.75 160.84 19.57 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.497 1.295 . . . . 61.13 114.497 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -147.0 125.85 12.7 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.126 -1.852 . . . . 73.33 106.682 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -104.66 122.1 44.94 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 119.169 -1.012 . . . . 74.31 108.676 175.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 31.7 ptt180 -141.37 153.86 45.32 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.123 -0.944 . . . . 75.1 111.445 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.05 136.33 36.65 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.093 -1.077 . . . . 54.12 108.093 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.0 m -61.58 149.24 39.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.315 1.228 . . . . 62.33 114.315 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.636 ' OE2' ' HD2' ' A' ' 17' ' ' PRO . 4.4 tp10 -51.32 -50.7 58.89 Favored 'General case' 0 C--N 1.367 1.367 0 C-N-CA 124.151 0.981 . . . . 75.22 110.786 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.52 9.31 53.32 Favored Glycine 0 C--N 1.294 -1.763 0 C-N-CA 120.099 -1.048 . . . . 63.35 110.924 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -71.82 165.38 53.85 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.062 -0.569 . . . . 71.34 112.28 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 18.4 ptpt -88.54 129.69 35.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.471 -0.566 . . . . 52.1 109.471 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 58.1 m-85 -128.69 164.21 23.44 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.372 0.669 . . . . 74.41 110.549 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.97 116.87 33.02 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 108.652 -0.87 . . . . 61.31 108.652 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.4 t -125.43 143.46 50.98 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 121.141 0.496 . . . . 75.44 112.213 -175.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 14.8 m -129.65 127.74 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.077 -0.965 . . . . 71.43 109.906 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.76 128.08 56.1 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.711 0.767 . . . . 65.3 111.42 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 40.2 t -112.6 140.55 31.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.892 -1.049 . . . . 64.31 109.239 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 49' ' ' LYS . 40.9 p -132.37 172.73 12.09 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.264 -0.643 . . . . 63.25 109.264 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.22 -40.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.597 1.159 . . . . 72.32 111.626 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 36.3 mtmm -93.24 127.86 45.17 Favored Pre-proline 0 C--N 1.288 -2.066 0 CA-C-N 114.965 -1.016 . . . . 61.25 110.219 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 51.8 Cg_exo -55.3 158.95 11.2 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 124.394 3.396 . . . . 65.02 112.37 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 98' ' ' LEU . 53.0 t -46.53 -39.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.61 0.764 . . . . 71.03 112.189 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.28 -50.41 71.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.971 0.415 . . . . 72.32 111.061 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 32.4 mm-40 -75.18 -44.1 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.784 -0.644 . . . . 61.35 111.919 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -56.68 -42.97 79.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.295 0.638 . . . . 71.54 111.977 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 59' ' ' MET . 64.6 tp -63.8 -51.84 62.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.719 0.295 . . . . 41.23 110.703 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -65.82 -24.86 67.0 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 113.162 0.801 . . . . 74.1 113.162 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 49' ' ' LYS . 3.8 tm-20 -83.87 -33.85 24.72 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.657 0.741 . . . . 74.15 109.837 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.556 ' HA ' ' NZ ' ' A' ' 61' ' ' LYS . . . -75.88 -33.03 59.94 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 112.885 0.698 . . . . 65.2 112.885 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 12.4 mmt -50.79 -51.31 67.54 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 112.738 0.644 . . . . 74.43 112.738 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 89.3 Cg_exo -52.29 -39.11 73.21 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.482 2.121 . . . . 64.33 111.619 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.556 ' NZ ' ' HA ' ' A' ' 58' ' ' ALA . 35.2 mtmm -69.71 -32.19 70.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.422 . . . . 72.51 111.878 -177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 102' ' ' PHE . 31.8 mm -76.3 -45.1 35.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.001 0.429 . . . . 73.11 110.823 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.446 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.3 ptm -69.7 -30.68 68.38 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 112.275 0.472 . . . . 74.3 112.275 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 61' ' ' LYS . 20.2 ptmt -67.95 -30.52 69.83 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.704 -0.398 . . . . 72.41 109.936 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -63.11 -55.95 20.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.044 -0.525 . . . . 73.13 111.103 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.89 -15.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.894 0.378 . . . . 74.44 111.781 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.015 -0.539 . . . . 53.33 113.071 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.58 -12.75 2.71 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.438 -1.363 . . . . 72.3 113.495 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 116' ' ' SER . 21.5 m -82.77 29.55 0.45 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.724 1.25 . . . . 71.12 110.314 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.12 161.05 13.91 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.973 -1.121 . . . . 32.13 107.973 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 15.8 t70 -67.4 -33.21 74.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.724 0.639 . . . . 63.25 112.724 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -78.16 -12.47 60.0 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.266 0.555 . . . . 70.03 110.461 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 36.12 70.18 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.806 -0.634 . . . . 74.33 112.256 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -80.54 122.51 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.409 -0.589 . . . . 74.44 109.409 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.92 1.99 61.55 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.193 -0.527 . . . . 63.34 111.93 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.2 tpt -73.14 98.33 2.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.193 0.52 . . . . 74.45 110.621 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.79 89.3 0.86 Allowed Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.71 -0.956 . . . . 64.24 110.71 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.73 125.38 40.27 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.525 0.678 . . . . 62.42 111.11 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 m -127.86 118.46 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.867 1.062 . . . . 72.03 113.867 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.44 -179.62 0.66 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 104.602 -2.37 . . . . 74.11 104.602 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.27 137.8 67.96 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 122.582 1.958 . . . . 73.34 111.4 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 44.6 t -102.75 141.68 18.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.272 -1.381 . . . . 53.34 107.272 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 168' ' ' TYR . 26.1 t -126.32 146.23 50.11 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.605 -0.438 . . . . 61.23 109.859 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 43.9 p90 -135.36 142.69 45.79 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 110.135 -0.32 . . . . 61.13 110.135 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.11 134.89 34.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 123.785 0.678 . . . . 64.11 110.411 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 m -126.58 150.14 32.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.787 -1.097 . . . . 64.15 108.294 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.604 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 46.0 m-85 -120.87 104.1 42.25 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 120.371 -0.531 . . . . 62.2 110.288 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.58 133.58 3.79 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.037 1.824 . . . . 72.5 112.103 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -86.48 162.33 18.14 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.15 -1.055 . . . . 72.0 108.15 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.49 -12.95 61.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.513 0.673 . . . . 73.05 111.211 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.36 -6.09 56.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.857 -0.611 . . . . 72.34 109.917 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.88 -10.32 74.1 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 115.97 -0.559 . . . . 75.33 112.791 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.9 m -91.97 137.95 31.94 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 110.151 -0.314 . . . . 73.11 110.151 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 mp -75.14 138.68 42.21 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.266 0.555 . . . . 42.53 111.545 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.2 129.38 34.46 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.535 -2.024 . . . . 63.04 105.535 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -71.73 81.73 0.87 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.165 0.983 . . . . 74.13 113.27 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.604 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 37.8 ttmt -160.46 125.61 3.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.998 -2.223 . . . . 71.4 104.998 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 51' ' ' VAL . 6.0 tt -135.5 129.28 32.85 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 108.669 -0.863 . . . . 61.42 108.669 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -122.3 114.84 21.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.244 -0.65 . . . . 75.31 109.244 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.5 t -92.4 129.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.958 -0.565 . . . . 63.23 109.579 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -110.79 123.35 49.9 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.904 -0.776 . . . . 61.42 108.904 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HB2' HD12 ' A' ' 62' ' ' ILE . 86.4 t80 -102.53 112.48 25.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.939 -1.134 . . . . 65.24 107.939 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 39.7 ttp180 -76.91 121.26 23.19 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-N 114.376 -1.284 . . . . 61.44 109.901 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.0 mt -88.45 133.04 37.26 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 115.211 -0.904 . . . . 74.14 109.934 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.13 154.67 32.55 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.919 2.412 . . . . 74.35 111.562 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.575 ' HB2' ' HA ' ' A' ' 15' ' ' THR . 26.1 t-20 -53.42 -45.26 69.32 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.086 1.143 . . . . 73.14 114.086 -174.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.97 -31.55 71.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.225 0.536 . . . . 55.04 111.161 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.89 -5.85 49.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.18 -0.464 . . . . 73.15 111.323 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.706 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.68 -38.26 73.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.728 -0.842 . . . . 74.41 108.728 174.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.96 93.56 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.281 -0.872 . . . . 72.23 112.138 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.2 m -154.27 92.88 2.96 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 122.534 0.334 . . . . 50.12 111.049 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 84.8 Cg_endo -90.11 149.4 4.67 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.364 2.043 . . . . 70.42 111.535 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 27.3 Cg_exo -65.9 146.33 82.66 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.592 2.195 . . . . 73.14 111.407 175.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -74.22 147.01 85.19 Favored Pre-proline 0 C--O 1.255 1.36 0 C-N-CA 120.634 -0.426 . . . . 72.43 110.413 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.45 113.38 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.604 2.203 . . . . 64.53 111.547 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 69' ' ' THR . 26.5 t -91.23 -12.52 35.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.563 0.697 . . . . 72.14 109.718 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.565 ' HB3' HG12 ' A' ' 120' ' ' VAL . 9.5 t70 -100.67 136.78 40.0 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.52 -1.289 . . . . 73.43 107.52 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.434 ' O ' ' HE2' ' A' ' 121' ' ' LYS . 13.9 pt-20 -72.45 -19.12 61.63 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.234 0.827 . . . . 73.23 113.234 -173.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.8 m -86.36 -25.6 25.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.531 -0.468 . . . . 75.24 111.169 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 117' ' ' ASP . 10.7 p -97.13 129.09 47.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 120.402 -0.519 . . . . 62.2 109.627 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 118' ' ' GLU . 75.7 mmtt -124.21 143.19 50.66 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.255 -0.429 . . . . 74.41 110.22 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 23.6 mm -92.74 111.1 23.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.703 -1.221 . . . . 55.43 107.703 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -125.22 142.39 51.52 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.557 -0.747 . . . . 75.25 109.387 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 11.2 pt-20 -100.41 135.71 41.43 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.079 -0.711 . . . . 71.23 109.079 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.517 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 32.3 tpt180 -125.58 122.15 35.66 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.032 -0.667 . . . . 74.43 110.767 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.56 177.61 8.36 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.143 -1.058 . . . . 74.22 108.143 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.28 -12.8 68.75 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.514 -0.85 . . . . 63.3 114.68 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.265 2.6 pp -121.13 157.73 24.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 118.553 -1.259 . . . . 64.23 113.593 -176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.6 m -109.57 133.61 52.89 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.922 -1.49 . . . . 50.42 108.751 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 188' ' ' VAL . 32.0 m -124.0 157.06 31.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-O 121.155 0.502 . . . . 65.2 110.454 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 69.4 m-85 -113.21 121.87 45.77 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 103.618 -2.734 . . . . 61.22 103.618 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.7 m -119.46 132.24 55.76 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 120.656 -0.418 . . . . 63.35 110.353 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.9 t -112.8 128.13 56.35 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.936 -0.764 . . . . 70.53 108.936 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.04 125.34 53.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.522 -1.658 . . . . 64.4 106.522 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 26.1 p90 -141.71 154.89 45.6 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.858 -0.61 . . . . 73.31 110.491 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.86 14.75 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.79 -0.719 . . . . 51.34 113.109 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 144.17 -176.92 23.14 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.202 -1.559 . . . . 53.45 109.202 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -81.36 107.7 14.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.014 0.907 . . . . 71.23 109.288 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 175' ' ' PRO . . . -96.45 138.19 34.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.508 0.671 . . . . 70.31 112.483 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' HE3' ' OD1' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -109.98 176.66 4.98 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.562 -1.644 . . . . 53.32 106.562 172.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -36.19 80.36 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.261 0.467 . . . . 73.52 112.261 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.11 -32.56 73.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 73.43 111.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.505 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 5.4 m-20 -63.97 -34.42 77.95 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 116.365 -0.38 . . . . 64.51 111.52 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.17 -43.93 90.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.99 0.424 . . . . 74.13 110.022 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.1 t -66.17 -45.86 89.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.533 -0.758 . . . . 73.24 109.457 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.12 96.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 60.34 111.084 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.477 ' CD2' HG22 ' A' ' 29' ' ' VAL . 56.6 m80 -67.78 -33.88 75.69 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 120.729 -0.389 . . . . 73.4 111.97 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.71 82.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.505 -0.554 . . . . 70.01 109.505 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 56.3 m -60.37 -49.95 75.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.612 -0.722 . . . . 65.21 109.725 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.28 -29.73 66.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.969 -0.559 . . . . 73.34 112.16 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HA ' HG22 ' A' ' 154' ' ' THR . 34.6 tp -65.69 -36.98 85.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.653 -0.499 . . . . 71.41 109.653 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.538 ' HG2' ' CE2' ' A' ' 162' ' ' TYR . 40.3 mtp180 -69.28 -37.22 77.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.917 -0.583 . . . . 71.41 110.218 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.1 m -69.02 -35.65 76.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.632 -0.713 . . . . 64.24 110.34 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 151' ' ' LEU . 14.7 t -78.18 -33.22 50.24 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 120.65 -0.42 . . . . 65.13 111.011 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.68 6.21 9.37 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.167 0.508 . . . . 71.31 111.495 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.49 132.02 44.92 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.329 -0.619 . . . . 55.12 109.329 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.34 11.74 50.84 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 121.139 -0.553 . . . . 51.12 111.993 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.7 p -123.38 165.48 22.58 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 108.386 -0.968 . . . . 73.23 108.386 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.63 12.67 1.58 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.573 2.182 . . . . 73.44 112.312 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.52 118.84 14.84 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.943 0.401 . . . . 74.22 111.041 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.7 p -121.18 164.65 16.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.701 -1.592 . . . . 73.44 106.701 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.538 ' CE2' ' HG2' ' A' ' 152' ' ' ARG . 12.2 m-85 -130.43 152.29 50.0 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.337 -0.945 . . . . 71.42 108.847 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.431 ' HG3' ' HA ' ' A' ' 190' ' ' ALA 0.268 3.5 pp0? -102.53 115.08 29.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.295 0.569 . . . . 74.32 111.889 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.89 1.36 62.29 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.477 -0.783 . . . . 72.43 111.357 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.7 t70 59.96 20.62 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.609 1.564 . . . . 54.4 109.658 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.4 138.47 16.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 114.621 -1.172 . . . . 74.32 112.069 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.445 ' HB3' HD23 ' A' ' 187' ' ' LEU . 22.0 p90 -135.79 152.67 51.33 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.949 -1.023 . . . . 62.23 108.694 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 9.7 m-85 -115.15 140.75 48.81 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.231 -1.025 . . . . 71.34 108.231 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' SER . 61.9 m -114.22 119.54 37.38 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.85 -0.796 . . . . 74.31 108.85 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -112.32 139.65 47.7 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.092 0.473 . . . . 73.22 111.818 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.74 164.6 37.8 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 107.248 -2.341 . . . . 45.11 107.248 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -80.51 -29.64 37.29 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 118.58 1.19 . . . . 65.33 110.427 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -143.47 162.93 39.68 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 106.992 -1.484 . . . . 63.44 106.992 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -72.59 108.58 2.57 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.898 1.732 . . . . 71.21 107.947 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 4.9 Cg_exo -76.84 130.61 11.57 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.164 1.909 . . . . 72.12 113.873 -173.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 51.5 ttm -97.0 -43.35 7.48 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.819 -1.178 . . . . 72.2 107.819 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 67.4 mttm -153.87 -72.42 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 113.4 0.889 . . . . 62.24 113.4 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 177' ' ' LYS . 1.5 Cg_endo -84.3 -31.28 0.51 Allowed 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.699 1.599 . . . . 65.51 114.985 -172.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -94.79 87.8 5.13 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.67 0.748 . . . . 75.12 111.951 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 175' ' ' PRO . . . 155.68 61.03 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 108.659 -1.776 . . . . 63.55 108.659 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 80.4 mtt180 -96.13 -28.56 14.52 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.899 -0.651 . . . . 73.23 110.976 -176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -112.97 127.83 56.33 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.596 -1.261 . . . . 74.01 107.596 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 8.6 m120 -143.76 158.86 43.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.744 -0.465 . . . . 73.23 109.744 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 43.9 mt-10 -137.08 145.15 43.6 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.02 -0.733 . . . . 64.45 109.02 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 81.7 t -125.6 121.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.786 -1.191 . . . . 74.31 107.786 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 24.7 m0 -110.21 122.15 46.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.617 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 167' ' ' TYR . 87.6 mt -102.41 138.57 39.16 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.776 -1.194 . . . . 71.32 107.776 171.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 130' ' ' VAL . 27.9 t -103.47 130.59 53.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.477 -0.564 . . . . 73.44 109.477 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.9 ttpt -69.25 132.54 46.64 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.82 -0.807 . . . . 70.21 108.82 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.431 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.468 1.105 . . . . 61.03 112.054 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 . . . . . 0 C--O 1.24 0.573 0 N-CA-C 109.89 -0.411 . . . . 72.4 109.89 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.2 p -92.84 107.69 19.41 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.427 0.632 . . . . 74.22 111.047 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.5 mt -98.37 134.02 41.95 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.88 -0.785 . . . . 55.42 108.88 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -89.87 135.58 33.55 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.752 -0.379 . . . . 75.41 110.323 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.2 100.79 0.55 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.3 -1.12 . . . . 74.24 110.3 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -67.22 128.2 35.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 123.114 0.566 . . . . 42.11 111.057 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.1 m -94.3 85.52 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 122.004 0.907 . . . . 73.33 110.705 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -70.14 137.55 51.15 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.116 -0.947 . . . . 65.15 108.825 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.6 m 73.75 68.79 0.11 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 124.39 1.076 . . . . 71.34 109.839 -176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.657 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 71.9 t-105 -82.47 133.21 50.37 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 114.773 -1.103 . . . . 72.31 108.505 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.81 150.17 83.33 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 C-N-CA 122.535 2.157 . . . . 74.44 110.566 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 45.8 p90 -99.94 149.67 23.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.739 -0.784 . . . . 72.24 109.868 -176.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -105.58 109.16 21.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.253 -0.885 . . . . 73.15 110.038 -173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.13 128.22 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.724 -1.213 . . . . 74.42 107.724 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 21' ' ' LEU 0.258 0.5 OUTLIER -96.6 -32.45 12.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 113.747 1.017 . . . . 74.43 113.747 -178.998 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 32' ' ' GLU . 28.5 t -151.86 152.91 33.21 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.864 -0.735 . . . . 62.52 111.907 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 32' ' ' GLU . 27.2 p -133.81 152.91 52.01 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.171 -0.922 . . . . 70.43 110.578 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.04 -131.99 10.76 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 120.632 -0.794 . . . . 64.24 112.691 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -104.5 1.45 Allowed Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 121.116 -0.564 . . . . 65.05 112.077 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.13 171.67 7.66 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 122.827 0.451 . . . . 65.15 110.203 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.18 157.52 25.24 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.679 -1.23 . . . . 74.31 107.679 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t70 75.48 -49.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.436 1.494 . . . . 74.31 111.425 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.24 110.98 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.68 0.752 . . . . 73.0 110.03 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 p -110.8 135.9 50.66 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.731 -0.668 . . . . 73.41 109.495 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -112.1 162.25 15.62 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.129 0.49 . . . . 73.12 112.154 -175.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 22' ' ' SER . 13.1 pt-20 -153.0 129.83 10.94 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.554 -2.017 . . . . 71.23 105.554 170.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HG2' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -114.49 141.61 47.47 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 118.898 -1.121 . . . . 74.43 109.518 177.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 157.11 46.26 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 119.535 -0.866 . . . . 71.0 109.261 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 133.89 35.41 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.466 -2.05 . . . . 52.41 105.466 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.6 m -58.38 141.65 50.68 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.87 1.063 . . . . 70.11 113.87 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -70.3 -16.53 63.02 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.47 -1.695 . . . . 53.42 112.137 -175.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 87.94 12.03 66.77 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.414 -1.851 . . . . 64.43 111.664 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.03 145.98 42.25 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 120.343 -0.932 . . . . 51.42 111.72 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -96.32 117.99 31.94 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.842 -0.799 . . . . 62.43 108.842 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.9 m-85 -122.69 163.86 19.34 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.512 -0.767 . . . . 72.42 110.826 -172.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.21 116.49 31.51 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.312 -0.625 . . . . 74.21 109.312 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.7 t -122.17 145.94 47.72 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 112.477 0.547 . . . . 65.43 112.477 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.579 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 16.0 m -129.95 140.89 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 125.104 1.361 . . . . 73.43 107.776 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.59 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.3 pt-20 -128.01 135.77 50.36 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.16 -1.416 . . . . 74.11 112.22 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 41.2 t -118.41 140.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 106.386 -1.709 . . . . 74.31 106.386 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 49' ' ' LYS . 38.6 p -126.26 167.17 15.84 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.727 -0.389 . . . . 73.51 110.537 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t70 73.72 -36.97 0.36 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.436 1.094 . . . . 52.22 112.108 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 47' ' ' THR . 95.0 mttt -85.75 138.14 35.63 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.53 -0.759 . . . . 71.23 110.841 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.96 157.14 25.67 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.002 2.468 . . . . 74.31 110.748 174.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 98' ' ' LEU . 31.8 t -47.63 -43.88 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 114.952 1.464 . . . . 62.12 114.952 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.95 -33.11 74.03 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.048 -0.661 . . . . 75.13 110.675 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -74.85 -44.06 51.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.526 0.679 . . . . 73.12 110.129 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -65.23 -43.56 91.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.369 -0.832 . . . . 63.32 111.468 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.03 -40.13 82.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 111.694 0.257 . . . . 71.32 111.694 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.91 -24.82 66.92 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 121.013 -0.275 . . . . 64.01 111.431 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 30.2 tt0 -84.47 -44.72 13.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.506 0.67 . . . . 73.54 110.26 175.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.49 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.5 -40.45 70.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 114.67 1.359 . . . . 62.13 114.67 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 ttm -57.83 -46.02 99.76 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 113.078 0.77 . . . . 72.33 113.078 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 76.3 Cg_exo -50.34 -40.75 52.7 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.385 2.057 . . . . 71.24 111.923 171.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 48.2 mtmt -69.14 -34.5 75.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.862 -0.608 . . . . 63.13 110.81 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -70.96 -48.88 53.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.886 -0.597 . . . . 53.01 111.059 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.49 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.5 ptm -68.96 -30.3 68.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.069 0.766 . . . . 74.55 113.069 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -72.33 -27.98 62.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.325 -0.95 . . . . 61.23 109.989 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 93.4 t80 -63.07 -57.94 8.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.335 -0.848 . . . . 74.04 109.886 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.3 m -73.17 -20.79 18.78 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 CA-C-N 116.149 -0.478 . . . . 75.04 110.928 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.77 -25.68 69.29 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.08 -0.509 . . . . 24.33 113.264 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 143.22 -10.22 2.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.149 -1.024 . . . . 75.33 113.039 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 m -89.56 27.6 1.46 Allowed 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.115 0.959 . . . . 74.44 110.254 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.31 169.21 10.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.788 -0.642 . . . . 62.12 110.003 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.85 -32.86 73.23 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.904 0.705 . . . . 73.11 112.904 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 113' ' ' PRO . 99.5 mttt -91.23 -7.69 50.56 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.764 -0.775 . . . . 64.33 112.577 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.69 73.65 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.929 -0.578 . . . . 62.45 112.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 32.5 m -82.23 158.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.42 -0.512 . . . . 74.04 110.243 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.27 173.69 41.1 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 120.891 -0.671 . . . . 63.02 111.735 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 52.6 ttp -75.17 95.95 3.2 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.064 0.459 . . . . 71.43 110.154 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.65 10.3 9.77 Favored Glycine 0 N--CA 1.426 -1.971 0 CA-C-N 115.386 -0.824 . . . . 45.41 112.341 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -118.79 123.45 44.82 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.207 -0.597 . . . . 65.35 110.865 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.9 p -127.53 117.54 22.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.748 0.647 . . . . 70.3 112.748 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -152.99 172.82 5.17 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.503 -1.665 . . . . 65.41 106.503 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.76 139.94 25.57 Favored 'Trans proline' 0 C--O 1.253 1.225 0 C-N-CA 121.01 1.14 . . . . 73.22 110.505 175.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.86 141.43 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.815 -0.809 . . . . 73.23 108.815 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 p -119.46 145.41 46.3 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 110.203 -0.295 . . . . 70.1 110.203 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -144.44 140.62 29.08 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 122.048 -0.408 . . . . 71.33 110.822 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.68 134.55 34.91 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-N 115.68 -0.691 . . . . 70.04 109.287 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.25 159.21 30.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 114.779 -1.101 . . . . 74.45 109.158 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 97' ' ' LYS . 78.4 m-85 -125.23 106.16 28.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 110.03 -0.359 . . . . 75.12 110.03 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.07 136.15 11.47 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.502 2.135 . . . . 72.23 114.07 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 96' ' ' LYS . 49.9 m-80 -95.3 161.51 14.06 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.252 -1.388 . . . . 74.43 107.252 172.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.59 -13.35 58.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.698 0.761 . . . . 72.4 111.005 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.24 -6.32 54.58 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.832 -1.076 . . . . 54.13 110.338 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.53 -9.73 69.79 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.338 -0.458 . . . . 45.35 112.247 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.8 m -90.19 132.6 35.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 110.163 -0.31 . . . . 65.21 110.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.87 96.11 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.46 -0.941 . . . . 74.0 108.46 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -147.44 114.34 6.12 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.571 -0.899 . . . . 72.43 108.571 -178.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 87' ' ' PHE . 74.1 mmtt -176.63 -70.1 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.565 1.946 . . . . 52.2 106.478 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 87' ' ' PHE . 27.4 mtpp -153.16 159.33 42.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.279 -1.782 . . . . 72.34 107.586 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 51' ' ' VAL . 5.7 tt -143.77 128.43 18.18 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.135 -0.691 . . . . 71.11 109.135 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.7 mttt -117.56 115.55 25.35 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.592 -0.276 . . . . 73.04 110.781 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 43' ' ' THR . 90.1 t -89.09 127.02 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.039 -1.097 . . . . 53.41 108.039 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.552 ' CD1' ' HE2' ' A' ' 168' ' ' TYR . 70.1 m95 -113.97 120.59 41.18 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.734 -0.839 . . . . 75.23 108.734 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -102.78 113.28 26.57 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 108.317 -0.994 . . . . 75.4 108.317 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 81.7 mtm180 -75.12 137.91 41.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.535 -1.211 . . . . 72.4 111.803 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.568 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 63.9 mt -113.24 130.4 23.66 Favored Pre-proline 0 C--N 1.286 -2.193 0 CA-C-N 115.396 -0.82 . . . . 65.33 109.862 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.19 163.99 36.6 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.62 2.88 . . . . 74.23 112.921 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -46.46 -35.52 5.7 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.996 1.718 . . . . 75.22 112.976 -176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -46.52 86.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.968 0.413 . . . . 41.45 110.581 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -99.17 -4.5 31.99 Favored 'General case' 0 C--O 1.197 -1.666 0 N-CA-C 112.652 0.612 . . . . 75.44 112.652 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.568 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 24.5 mm-40 -70.77 -32.17 69.2 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.31 -0.556 . . . . 73.42 110.805 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.88 -35.7 90.77 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.778 -0.646 . . . . 44.14 111.598 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.8 p -161.0 92.22 1.52 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 C-N-CA 123.08 0.552 . . . . 73.24 110.117 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.99 162.33 8.82 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.203 1.935 . . . . 61.33 112.123 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.435 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 29.5 Cg_endo -68.17 156.43 65.79 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.751 1.634 . . . . 72.21 109.903 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 155.07 45.93 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.629 -0.26 . . . . 74.14 110.51 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.563 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 34.0 Cg_exo -60.48 111.55 1.06 Allowed 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.589 2.192 . . . . 62.03 111.724 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -88.0 -41.31 13.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.454 -0.793 . . . . 44.12 110.602 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.526 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.0 t70 -92.43 156.0 17.49 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.626 -1.25 . . . . 75.43 107.626 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.37 -20.29 48.08 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 120.93 0.395 . . . . 70.41 111.036 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 m -74.53 -39.71 62.19 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.944 -0.571 . . . . 63.12 110.536 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 3.2 p -107.15 116.41 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.516 0.674 . . . . 64.41 111.507 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -120.82 148.29 44.22 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.835 -1.075 . . . . 75.12 108.796 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.48 ' H ' ' HG3' ' A' ' 115' ' ' PRO . 22.6 mm -92.82 111.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.263 -1.014 . . . . 72.4 108.263 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.267 -0.878 . . . . 73.12 109.005 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.78 140.91 46.03 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.41 -0.589 . . . . 74.42 109.41 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -122.78 123.33 40.81 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 119.841 -0.744 . . . . 74.34 110.474 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -143.76 165.8 26.67 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.538 -1.21 . . . . 74.05 110.48 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.95 -1.15 69.79 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.688 -0.767 . . . . 63.2 114.681 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.89 166.42 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-N 117.774 0.787 . . . . 61.14 110.24 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 55.3 m -120.63 138.39 53.94 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.895 -0.593 . . . . 65.33 109.855 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.444 HG21 ' CE3' ' A' ' 186' ' ' TRP . 19.1 m -124.66 153.54 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 109.12 -0.696 . . . . 55.43 109.12 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 51.8 m-85 -113.03 121.6 45.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.145 -2.168 . . . . 74.13 105.145 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 p -117.91 130.02 55.98 Favored 'General case' 0 C--N 1.269 -2.896 0 C-N-CA 120.252 -0.579 . . . . 71.34 111.162 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.499 ' HB ' HD23 ' A' ' 151' ' ' LEU . 7.8 t -116.06 126.06 53.25 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.689 -0.687 . . . . 74.51 110.168 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -111.1 130.53 55.59 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.925 -1.509 . . . . 65.1 106.925 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.96 146.06 44.94 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.502 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -125.92 128.4 6.45 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.513 -0.767 . . . . 53.34 111.335 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.59 -138.13 4.95 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.21 -0.756 . . . . 64.31 111.21 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 178' ' ' PRO . 19.6 t80 -100.49 100.63 11.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.787 -1.561 . . . . 74.52 106.787 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 140.11 53.29 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.018 1.118 . . . . 62.21 114.018 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -115.68 176.86 4.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.583 -1.189 . . . . 74.31 108.318 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.71 -37.03 85.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.964 0.412 . . . . 73.12 111.356 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.07 67.2 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.236 0.541 . . . . 55.3 110.225 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.26 -30.53 71.18 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.834 -0.621 . . . . 72.24 110.642 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -61.03 -38.1 84.9 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.003 0.43 . . . . 74.52 110.565 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.63 -43.87 86.58 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 109.021 -0.733 . . . . 62.13 109.021 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -62.24 -47.79 82.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.202 -0.908 . . . . 63.22 110.266 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -66.83 -33.09 74.84 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 113.612 0.967 . . . . 72.12 113.612 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.5 80.89 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.432 0.634 . . . . 71.1 110.122 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.8 m -75.29 -44.61 44.76 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.494 -0.776 . . . . 45.31 109.641 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 53.2 mt-30 -63.85 -27.7 69.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.765 0.426 . . . . 74.33 111.486 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 133' ' ' THR . 3.3 tm? -64.87 -37.05 86.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.328 -0.99 . . . . 74.41 108.328 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.33 -33.14 67.1 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.851 -0.613 . . . . 74.32 110.447 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -35.1 79.75 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.648 -0.706 . . . . 74.04 109.952 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 151' ' ' LEU . 8.9 t -77.86 -32.87 52.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.546 -0.462 . . . . 51.54 110.568 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.01 9.26 2.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.208 0.447 . . . . 71.32 112.208 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.28 124.43 24.51 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.664 -1.606 . . . . 65.11 106.664 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.38 47.74 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.263 -0.97 . . . . 64.55 111.374 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 55.8 p -118.82 158.17 48.31 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.84 -0.8 . . . . 62.24 108.84 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.95 20.3 1.18 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.179 1.919 . . . . 73.41 112.22 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.72 127.46 31.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.124 -0.489 . . . . 44.32 111.995 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.8 p -104.56 156.34 18.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.021 -1.103 . . . . 75.03 108.021 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.447 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 31.4 m-85 -136.59 157.53 46.55 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.073 -0.651 . . . . 72.42 109.753 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -143.04 123.92 14.28 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.361 -0.536 . . . . 63.32 112.272 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.64 -0.27 28.19 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.535 -0.757 . . . . 64.35 114.417 175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 64.56 8.53 4.44 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.388 1.075 . . . . 72.42 111.765 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 87' ' ' PHE . 7.3 p -66.17 139.42 21.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.701 0.763 . . . . 60.15 111.881 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.411 ' HB3' HD22 ' A' ' 187' ' ' LEU . 47.5 p90 -143.56 168.57 19.54 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.95 -1.023 . . . . 73.43 109.179 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 94.1 m-85 -114.93 147.6 39.78 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 120.951 0.405 . . . . 71.13 110.375 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 66.0 m -114.79 123.74 49.98 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.913 -1.884 . . . . 75.32 105.913 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.98 131.41 47.45 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.498 0.666 . . . . 74.34 112.184 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.68 165.04 37.87 Favored Glycine 0 N--CA 1.422 -2.251 0 N-CA-C 108.779 -1.728 . . . . 65.44 108.779 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -66.34 -28.19 68.47 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 118.235 1.018 . . . . 64.11 108.53 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -156.15 141.83 12.72 Favored Pre-proline 0 N--CA 1.427 -1.623 0 CA-C-N 113.906 -1.497 . . . . 73.54 107.067 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -79.51 120.09 4.3 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.111 1.874 . . . . 70.11 108.488 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.4 127.54 15.87 Favored 'Trans proline' 0 N--CA 1.439 -1.706 0 C-N-CA 120.669 0.913 . . . . 72.25 113.356 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 55.9 mtm -96.75 -26.95 14.96 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.879 -1.897 . . . . 64.52 105.879 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -84.41 135.76 40.88 Favored Pre-proline 0 N--CA 1.418 -2.07 0 CA-C-N 113.037 -1.892 . . . . 74.21 107.899 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 138' ' ' TYR . 30.3 Cg_endo -58.59 -12.86 15.36 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 124.982 3.788 . . . . 71.34 118.094 -172.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -70.3 -81.8 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 119.076 0.853 . . . . 72.53 112.513 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 46.89 76.02 0.16 Allowed Glycine 0 N--CA 1.475 1.275 0 O-C-N 123.88 0.737 . . . . 73.2 113.979 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.593 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 71.9 ttt180 -75.45 -36.32 60.74 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.933 -0.707 . . . . 73.11 111.623 -176.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.631 ' O ' ' HD2' ' A' ' 182' ' ' ARG . 1.3 ppt_? -102.75 129.41 49.38 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.24 -0.984 . . . . 74.34 112.477 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -145.02 153.76 41.81 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.044 -0.525 . . . . 70.21 110.197 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 42.7 mt-10 -138.14 132.05 31.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.592 0.357 . . . . 72.24 110.288 173.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.458 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 96.5 t -128.95 118.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.271 -1.011 . . . . 74.12 108.271 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 11.3 m0 -107.65 121.03 43.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 108.918 -0.771 . . . . 72.22 108.918 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 167' ' ' TYR . 0.8 OUTLIER -100.58 134.82 42.97 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.678 -1.971 . . . . 72.53 105.678 178.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.04 124.79 45.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 120.619 -0.432 . . . . 53.0 112.068 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 161' ' ' THR . 82.8 tttt -75.45 133.27 41.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.103 -0.703 . . . . 72.55 109.103 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.255 1.353 0 CA-C-O 118.694 -0.669 . . . . 54.42 110.688 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 112.158 0.429 . . . . 63.34 112.158 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t 63.5 26.68 14.89 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 121.856 0.836 . . . . 61.42 109.704 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -102.02 94.08 5.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.843 -0.617 . . . . 52.41 110.199 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -123.24 110.18 14.9 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.111 -0.7 . . . . 75.31 109.111 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.91 -159.51 25.29 Favored Glycine 0 N--CA 1.424 -2.119 0 C-N-CA 120.084 -1.055 . . . . 73.03 112.52 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.4 t -81.65 103.86 11.65 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.004 0.43 . . . . 64.3 110.318 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.82 106.88 11.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.894 -0.594 . . . . 71.41 110.918 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 62.15 19.22 10.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.841 0.856 . . . . 75.33 111.478 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 p -96.77 98.54 10.23 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 115.489 -0.778 . . . . 73.14 111.81 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -128.05 83.81 65.04 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.507 -0.77 . . . . 71.21 111.347 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -100.19 148.89 0.44 Allowed 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 123.314 2.676 . . . . 43.03 112.404 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.521 ' CD1' ' HG3' ' A' ' 34' ' ' ARG . 37.3 p90 -102.12 149.4 24.32 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.301 -1.0 . . . . 74.01 108.301 175.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.03 0.443 . . . . 61.44 110.791 -169.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.52 123.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.528 -0.916 . . . . 65.01 108.528 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.6 -28.95 18.11 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.051 -0.66 . . . . 73.51 109.901 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t 179.08 158.74 0.59 Allowed 'General case' 0 C--O 1.248 1.011 0 CA-C-N 115.303 -0.862 . . . . 54.23 109.483 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.9 p -131.43 156.53 45.44 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.038 -1.468 . . . . 64.21 107.038 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.49 88.79 0.59 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.894 -1.622 . . . . 73.44 113.581 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.32 -139.94 10.02 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 109.248 -1.541 . . . . 22.15 109.248 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -104.84 110.03 22.23 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 102.582 -3.118 . . . . 71.4 102.582 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.93 133.04 49.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.327 -0.949 . . . . 74.0 112.565 -167.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 153.25 -45.77 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 101.844 -3.391 . . . . 53.3 101.844 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.04 111.85 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 111.788 -2.46 . . . . 72.15 104.699 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -100.48 140.2 35.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.96 -0.385 . . . . 60.22 109.96 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.45 157.71 34.54 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.579 -0.848 . . . . 64.41 112.535 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -134.0 126.67 30.72 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.172 -1.418 . . . . 75.22 107.172 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.45 113.89 26.06 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 106.69 -1.596 . . . . 74.04 106.69 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.521 ' HG3' ' CD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -138.5 145.88 41.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 118.791 -1.163 . . . . 74.0 113.382 -177.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 128' ' ' ILE . . . -86.77 138.35 31.68 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.065 -1.425 . . . . 75.53 107.784 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' SG ' HG13 ' A' ' 128' ' ' ILE . 25.6 p -57.89 168.57 0.92 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.25 0.833 . . . . 50.22 113.25 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -82.85 -18.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.304 -0.862 . . . . 61.33 111.483 -174.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.38 9.42 59.1 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 119.971 -1.109 . . . . 65.53 112.969 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.85 165.07 45.32 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.649 -0.786 . . . . 75.41 113.137 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 46.3 pttt -99.14 131.86 44.87 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.922 -0.399 . . . . 70.42 109.922 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.685 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 40.9 m-85 -127.89 165.27 20.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.527 -0.761 . . . . 71.23 112.101 -169.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.0 116.99 31.34 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.675 -0.861 . . . . 55.03 108.675 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 4.2 t -126.87 143.29 51.31 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-N 115.135 -0.938 . . . . 74.42 112.517 -175.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.2 m -133.32 146.11 32.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.4 -1.273 . . . . 72.03 108.366 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -127.88 126.31 41.32 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.63 -0.428 . . . . 70.34 110.367 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 33.2 t -120.74 130.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.988 -1.486 . . . . 74.55 106.988 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 49' ' ' LYS . 73.5 p -117.97 167.94 10.98 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.317 -0.553 . . . . 71.23 111.416 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 72.8 -25.31 0.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.898 1.279 . . . . 70.02 112.947 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 68.6 mttm -86.28 146.45 42.42 Favored Pre-proline 0 C--N 1.29 -1.985 0 CA-C-N 115.58 -0.736 . . . . 61.3 110.264 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.69 157.27 43.16 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.472 2.115 . . . . 64.31 110.032 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 98' ' ' LEU . 54.0 t -47.49 -42.52 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 113.146 0.795 . . . . 71.33 113.146 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t70 -61.62 -50.9 70.71 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 120.164 -0.614 . . . . 73.21 110.617 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 25.5 mm-40 -58.42 -51.71 68.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.827 -0.624 . . . . 75.53 111.497 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -62.4 -34.84 77.51 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.875 -0.602 . . . . 60.13 110.932 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.01 -34.16 71.06 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.644 -0.253 . . . . 71.34 110.615 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 24.3 mmm180 -67.87 -36.16 79.8 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.099 -0.704 . . . . 75.41 109.099 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.5 mm-40 -73.47 -53.31 10.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.273 -0.876 . . . . 71.11 112.587 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.89 -36.14 62.25 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.372 1.619 . . . . 75.23 115.372 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.6 tpp -55.18 -54.16 53.56 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 112.681 0.622 . . . . 74.21 112.681 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 63' ' ' MET . 14.0 Cg_endo -57.55 -30.57 88.93 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.472 2.115 . . . . 74.25 112.583 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 53.4 mtpt -65.45 -34.11 77.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.255 0.55 . . . . 73.51 110.913 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.12 -38.54 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.006 0.432 . . . . 61.44 110.824 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 87.6 mtp -66.86 -30.13 70.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.976 0.732 . . . . 73.33 112.976 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -67.75 -45.22 75.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 65.32 109.62 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -62.21 -60.95 2.84 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.16 -0.473 . . . . 70.33 112.072 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 76' ' ' MET . 16.5 m -77.13 -3.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.544 0.688 . . . . 74.43 110.759 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.57 -11.37 59.46 Favored Glycine 0 N--CA 1.418 -2.539 0 CA-C-N 114.984 -1.007 . . . . 52.02 112.392 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.33 -28.81 0.63 Allowed Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.455 -1.355 . . . . 60.11 113.518 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.4 m -81.58 55.14 2.56 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-O 122.235 1.017 . . . . 64.04 111.253 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.42 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 34.9 m-80 -98.38 149.39 22.71 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 106.061 -1.829 . . . . 62.2 106.061 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.97 -26.95 65.3 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.966 -0.693 . . . . 70.35 111.543 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HB2' HG23 ' A' ' 74' ' ' VAL . 57.3 mtpt -80.43 0.14 34.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.114 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 34.06 66.7 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 121.075 -0.583 . . . . 64.52 112.278 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 72' ' ' LYS . 48.5 t -80.1 143.6 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 107.776 -1.194 . . . . 51.14 107.776 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.84 -172.77 37.67 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.745 -0.741 . . . . 70.2 112.656 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -78.99 103.68 9.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.406 -0.961 . . . . 71.34 108.406 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -161.13 19.42 0.2 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.335 -0.936 . . . . 53.41 112.478 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.2 ptm -123.1 122.78 39.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.066 -1.053 . . . . 71.21 109.687 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.9 m -127.11 117.85 23.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.621 -0.718 . . . . 70.44 110.365 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.506 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 2.9 m -150.46 166.79 14.33 Favored Pre-proline 0 C--N 1.298 -1.665 0 C-N-CA 124.723 1.209 . . . . 75.14 107.822 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 38.3 Cg_endo -66.23 140.92 60.78 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.291 1.327 . . . . 44.32 113.588 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.9 139.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.085 -1.416 . . . . 64.34 107.94 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 p -127.38 148.79 50.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.636 -0.505 . . . . 72.13 109.636 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -144.35 142.04 30.12 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.63 -0.428 . . . . 73.54 110.157 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -91.89 134.9 34.36 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 109.174 -0.676 . . . . 33.32 109.174 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.49 150.18 26.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-N 114.869 -1.06 . . . . 73.24 108.382 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 1.9 m-85 -121.0 105.11 40.65 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.723 -0.473 . . . . 73.53 109.723 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 158.06 48.98 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.121 1.88 . . . . 75.03 112.984 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -118.09 160.7 21.07 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.578 -0.737 . . . . 71.35 110.453 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.63 -21.68 66.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.485 -0.78 . . . . 73.44 111.254 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -79.5 -6.92 57.97 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.552 0.691 . . . . 72.14 110.737 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.5 -0.48 85.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.761 -0.733 . . . . 74.15 113.272 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.6 m -96.9 136.31 37.63 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.565 -0.902 . . . . 73.13 108.565 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.4 mt -84.84 87.58 7.34 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.604 -0.438 . . . . 65.53 111.056 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -148.58 113.34 5.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.873 1.064 . . . . 64.11 113.873 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 87' ' ' PHE . 62.5 mttp -168.77 -68.79 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.749 1.22 . . . . 54.41 108.013 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HG2' HG22 ' A' ' 47' ' ' THR . 55.7 mtpt -148.87 153.93 38.75 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.837 -1.529 . . . . 73.31 108.743 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -144.16 127.44 16.74 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.634 -0.876 . . . . 74.43 108.634 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HE3' ' HE1' ' A' ' 101' ' ' TRP . 37.6 ttpt -130.01 115.58 17.33 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.081 0.467 . . . . 54.34 110.408 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' THR . 96.9 t -85.73 138.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.447 -0.797 . . . . 71.12 110.567 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.475 ' HE1' ' HE3' ' A' ' 99' ' ' LYS . 93.4 m95 -128.7 117.18 20.72 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.3 1.04 . . . . 72.25 108.278 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' HG11 ' A' ' 66' ' ' VAL . 83.7 t80 -104.32 118.18 35.99 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.604 -0.517 . . . . 72.51 109.604 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.685 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 34.5 ttm180 -74.57 131.1 40.68 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.817 -0.808 . . . . 74.05 108.817 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.17 140.67 22.51 Favored Pre-proline 0 C--N 1.296 -1.754 0 N-CA-C 109.69 -0.485 . . . . 62.42 109.69 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.47 ' HD3' HG21 ' A' ' 80' ' ' VAL . 8.2 Cg_endo -53.26 144.57 47.98 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.812 2.342 . . . . 72.3 111.523 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -55.01 -35.49 64.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.734 1.013 . . . . 55.33 113.734 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -61.34 -45.04 96.05 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.467 0.651 . . . . 75.32 109.987 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -78.82 -10.64 59.86 Favored 'General case' 0 C--O 1.196 -1.745 0 CA-C-N 115.456 -0.793 . . . . 73.35 111.141 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.69 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.0 -28.84 64.71 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.721 -0.392 . . . . 75.35 110.439 176.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.91 94.76 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.246 -0.742 . . . . 62.42 111.246 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 55.2 p -160.74 90.77 1.63 Allowed Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 109.454 -0.573 . . . . 53.45 109.454 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.29 146.61 36.05 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.346 2.031 . . . . 70.11 110.777 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 138.41 74.64 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.743 1.629 . . . . 73.43 110.109 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 140.34 96.31 Favored Pre-proline 0 C--O 1.256 1.414 0 CA-C-N 116.532 -0.304 . . . . 64.44 110.463 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.38 113.08 2.11 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.147 1.898 . . . . 74.43 110.703 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -90.69 29.89 1.25 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.603 -0.726 . . . . 65.24 109.988 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -138.53 145.98 41.36 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.379 -1.712 . . . . 62.21 106.379 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.71 -24.39 49.19 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.919 0.711 . . . . 64.42 112.919 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 61.1 p -102.95 -13.79 16.76 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.897 0.38 . . . . 71.41 111.851 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.42 116.38 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 105.399 -2.075 . . . . 75.14 105.399 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.71 146.4 50.23 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.238 -0.585 . . . . 50.24 111.212 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.0 mm -93.0 111.18 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.413 -0.958 . . . . 71.31 108.413 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -119.05 147.77 43.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.16 -0.927 . . . . 73.12 108.96 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -107.74 138.15 44.48 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.327 -0.397 . . . . 70.4 111.626 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -131.15 122.36 26.5 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.185 0.517 . . . . 64.35 110.57 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.408 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -140.23 148.61 41.76 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.574 -0.739 . . . . 62.53 109.124 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.6 20.32 78.48 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.261 -0.971 . . . . 41.55 113.746 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.509 HG13 ' SG ' ' A' ' 36' ' ' CYS . 2.2 pp -119.16 151.91 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.34 -0.944 . . . . 70.53 109.073 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' HD3' ' A' ' 189' ' ' LYS . 46.4 m -121.49 133.54 55.05 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 115.549 -0.751 . . . . 61.32 111.809 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.17 155.8 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 108.324 -0.991 . . . . 53.34 108.324 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -113.57 122.25 46.68 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.794 -1.928 . . . . 75.32 105.794 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 59.4 p -117.17 147.34 42.55 Favored 'General case' 0 C--N 1.269 -2.92 0 C-N-CA 120.344 -0.542 . . . . 73.43 111.999 -173.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.527 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -126.01 130.57 51.44 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 115.231 -0.895 . . . . 64.53 108.954 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -113.81 126.37 55.13 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.978 0.894 . . . . 74.14 109.169 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -130.81 137.81 49.59 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 114.408 -1.269 . . . . 72.22 110.65 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.77 127.32 7.19 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.337 -0.705 . . . . 72.32 111.337 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 153.79 -143.13 9.78 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 109.029 -1.628 . . . . 33.43 109.029 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -99.83 110.57 22.94 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 117.412 0.606 . . . . 73.41 110.002 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.78 139.45 44.82 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.214 -0.662 . . . . 54.2 109.214 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.43 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 22.1 ttmm -114.89 169.28 9.2 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.303 -2.11 . . . . 43.14 105.303 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.65 -39.8 58.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.207 0.527 . . . . 63.53 111.598 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.2 66.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.617 -0.72 . . . . 72.41 111.071 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 31.8 t70 -73.46 -30.29 63.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.147 -0.479 . . . . 74.34 111.01 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -59.0 -50.5 73.87 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.115 -0.698 . . . . 73.42 109.115 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.8 t -61.73 -42.09 93.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.85 -1.068 . . . . 72.24 109.459 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.39 -46.57 88.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.529 -0.76 . . . . 73.43 110.887 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.559 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 40.5 m80 -64.24 -39.81 94.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 112.489 0.551 . . . . 60.21 112.489 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -60.77 -43.22 98.31 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.242 0.544 . . . . 73.53 110.015 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.401 HG23 ' NH2' ' A' ' 152' ' ' ARG . 88.2 m -62.73 -47.12 84.94 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 123.822 0.849 . . . . 44.24 110.022 177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -58.79 -42.9 90.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.66 0.784 . . . . 73.02 109.121 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 77.5 mt -57.74 -40.89 80.73 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.431 -0.349 . . . . 62.24 111.744 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 20.8 mtm180 -65.2 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.34 0.591 . . . . 72.24 110.028 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 m -72.95 -36.91 67.26 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.267 -0.879 . . . . 71.41 109.709 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.5 m -77.77 -37.82 48.12 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 116.085 -0.507 . . . . 63.01 111.394 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.77 -5.11 41.56 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.344 0.593 . . . . 75.55 111.26 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.74 120.61 20.51 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.747 -1.205 . . . . 71.21 107.747 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.63 12.44 47.52 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.381 -0.914 . . . . 51.01 111.843 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.7 p -118.5 166.18 14.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.461 -0.941 . . . . 71.14 108.461 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 10.69 1.79 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.401 2.067 . . . . 63.22 112.759 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.9 126.15 35.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.911 0.386 . . . . 51.53 111.9 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.4 p -100.98 151.97 21.14 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.458 -0.571 . . . . 53.44 109.458 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.81 148.0 33.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.183 0.447 . . . . 72.31 110.405 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -129.14 139.37 51.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.123 0.786 . . . . 75.35 113.123 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.68 -0.08 29.5 Favored Glycine 0 C--O 1.236 0.239 0 CA-C-N 115.444 -0.798 . . . . 70.31 114.33 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 61.92 10.71 3.71 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.198 0.999 . . . . 71.35 111.676 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.56 138.28 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.41 0.624 . . . . 74.43 110.292 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -145.62 169.91 17.5 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.545 -0.752 . . . . 73.45 110.027 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 85.5 m-85 -115.52 148.35 39.61 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.056 -0.52 . . . . 74.44 110.104 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.55 125.52 53.89 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.343 -1.725 . . . . 63.23 106.343 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -130.77 149.11 52.56 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 111.747 0.277 . . . . 70.34 111.747 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.44 160.31 32.98 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 111.027 -0.829 . . . . 60.24 111.027 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 81' ' ' PRO . 2.8 m-85 -91.73 -8.98 45.37 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.051 0.54 . . . . 62.44 110.99 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -139.63 134.44 16.21 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.392 -0.595 . . . . 73.11 109.392 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.64 113.42 3.3 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.983 1.789 . . . . 64.23 108.69 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.91 130.14 26.73 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.874 1.716 . . . . 42.25 112.443 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 27.9 ttt -93.56 -36.04 12.6 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.751 -1.203 . . . . 71.41 107.751 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -96.04 173.82 3.92 Favored Pre-proline 0 N--CA 1.429 -1.523 0 N-CA-C 107.005 -1.479 . . . . 71.42 107.005 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -70.64 -14.46 33.33 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 121.908 1.739 . . . . 61.34 112.2 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -64.91 105.88 1.12 Allowed 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.521 0.729 . . . . 74.42 112.932 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -108.24 105.93 2.26 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 107.955 -2.058 . . . . 74.34 107.955 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -89.58 -40.31 12.7 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.279 1.215 . . . . 71.22 114.279 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -128.97 127.41 41.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.325 -1.732 . . . . 71.41 106.325 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -145.17 156.2 43.73 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.116 -0.633 . . . . 74.12 109.865 -171.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.4 mt-10 -129.33 147.91 51.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.793 -0.447 . . . . 74.24 109.793 170.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 132' ' ' SER . 73.9 t -125.24 118.71 53.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.091 -1.448 . . . . 61.11 107.091 173.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.4 m0 -106.45 120.83 42.95 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.473 -0.936 . . . . 74.45 108.473 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 58.3 tp -98.29 128.65 44.83 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.519 -1.289 . . . . 63.04 107.519 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.08 135.27 27.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.119 0.485 . . . . 63.13 111.646 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' THR . 21.0 pttp -77.1 143.28 39.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.78 -0.645 . . . . 71.11 111.886 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.421 0 CA-C-O 118.062 -0.97 . . . . 73.44 109.007 176.07 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.741 0.305 . . . . 72.41 110.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 m -103.81 113.37 26.84 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 109.006 -0.739 . . . . 70.34 109.006 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 12' ' ' SER . 5.5 mp -83.47 88.95 7.0 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.147 -0.479 . . . . 71.42 110.721 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -75.06 95.8 3.11 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.528 -0.916 . . . . 74.0 108.528 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.42 -4.17 5.51 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 111.179 -0.768 . . . . 73.14 111.179 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.447 ' HB2' ' CB ' ' A' ' 9' ' ' LEU . 20.8 t -70.76 134.32 47.31 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.115 -1.439 . . . . 70.51 107.115 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.1 t -110.46 94.77 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-O 121.349 0.595 . . . . 62.11 111.423 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HB2' ' HA2' ' A' ' 110' ' ' GLY . 1.1 mp0 -89.31 -37.18 15.1 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.076 -1.083 . . . . 74.43 108.076 173.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 m -88.08 82.83 7.08 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 106.189 -1.782 . . . . 72.03 106.189 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.4 t-105 -85.54 139.8 35.86 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.25 -0.886 . . . . 73.33 110.046 -172.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.0 149.85 33.26 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.909 2.406 . . . . 73.11 111.859 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.9 p90 -101.19 149.54 23.88 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.588 -0.893 . . . . 73.44 108.588 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.79 107.96 19.22 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.027 -0.731 . . . . 62.33 109.027 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.34 116.91 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.657 -1.156 . . . . 64.03 109.711 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -90.3 -29.17 18.29 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.294 0.479 . . . . 64.52 112.294 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -173.55 154.94 2.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.049 0.452 . . . . 22.33 109.818 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.6 p -132.15 157.03 45.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.316 -0.994 . . . . 73.43 108.316 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.69 -158.8 27.83 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.499 -1.334 . . . . 63.23 113.017 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.02 -119.78 4.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.415 -0.674 . . . . 60.42 111.415 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -116.44 171.28 7.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 110.134 -0.321 . . . . 74.24 110.134 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 43.9 mt-10 -85.0 156.89 20.94 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.231 -1.766 . . . . 72.13 106.231 166.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 27' ' ' GLU . 14.6 t70 78.15 -45.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.524 0.73 . . . . 73.42 110.533 -171.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.34 108.93 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 108.715 -0.846 . . . . 62.33 108.715 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.4 m -124.38 134.04 53.24 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.62 -1.252 . . . . 72.43 107.62 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -113.31 161.67 16.96 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.358 0.873 . . . . 75.13 113.358 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -133.08 125.13 28.92 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.478 -1.675 . . . . 64.04 106.478 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -99.45 114.0 26.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 106.989 -1.486 . . . . 75.2 106.989 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -141.39 144.34 34.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.402 0.519 . . . . 75.53 112.402 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.49 136.23 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.288 -1.745 . . . . 72.34 106.288 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.422 ' SG ' HG13 ' A' ' 128' ' ' ILE . 83.0 m -63.91 153.87 35.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.13 0.789 . . . . 72.24 113.13 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -75.09 -34.77 61.78 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.165 -0.925 . . . . 72.45 111.016 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 91.9 10.98 60.8 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 118.454 -1.831 . . . . 74.21 112.095 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.23 164.14 52.33 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 111.052 -0.819 . . . . 22.03 111.052 -176.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -88.64 129.67 35.46 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.939 -0.763 . . . . 74.21 108.939 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 36.3 m-85 -126.89 165.4 19.43 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.582 -0.735 . . . . 72.31 110.027 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.412 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.34 116.37 30.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.7 -1.222 . . . . 75.03 107.7 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.8 t -131.86 146.85 52.36 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.566 0.698 . . . . 72.22 112.137 -175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG21 ' HD2' ' A' ' 61' ' ' LYS . 7.5 p -133.28 138.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 107.366 -1.346 . . . . 73.25 107.366 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 16.5 pt-20 -126.71 139.07 53.42 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.264 -0.574 . . . . 62.32 111.19 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 50.0 t -127.5 140.08 50.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.385 -1.339 . . . . 62.32 107.385 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.1 p -125.49 163.22 23.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.989 0.737 . . . . 72.13 112.989 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 68.44 6.03 5.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.123 1.369 . . . . 74.44 112.877 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 88.4 mttt -124.87 147.25 55.88 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 116.513 -0.312 . . . . 75.2 110.361 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 46.9 Cg_exo -58.95 156.58 32.84 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.693 2.262 . . . . 64.32 110.829 173.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 25.1 t -48.12 -43.3 11.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 113.111 0.782 . . . . 71.23 113.111 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -59.54 -41.74 90.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.931 0.396 . . . . 34.12 111.449 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 8.3 mm-40 -73.46 -46.45 48.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 64.04 110.809 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.81 -44.02 94.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.482 -0.781 . . . . 62.3 111.073 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.1 -42.05 85.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.857 -0.611 . . . . 71.11 111.649 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -64.43 -28.11 69.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.033 0.753 . . . . 74.45 113.033 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.2 -33.8 24.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.02 0.438 . . . . 72.25 111.613 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.83 -32.7 59.91 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.556 0.576 . . . . 51.54 112.556 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.538 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 5.9 mmt -53.0 -56.84 19.58 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.32 1.23 . . . . 73.33 114.32 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.15 -31.65 84.19 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.197 1.931 . . . . 72.12 111.841 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.594 ' HD3' ' HB2' ' A' ' 119' ' ' SER . 91.3 mttt -65.45 -41.02 93.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.145 -0.479 . . . . 63.15 110.751 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.15 -38.87 35.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.343 0.592 . . . . 73.44 110.008 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.27 -30.66 71.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.207 0.817 . . . . 43.1 113.207 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.02 -29.69 60.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.218 0.533 . . . . 61.43 109.925 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -64.57 -60.97 2.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.533 -0.758 . . . . 74.01 110.957 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 p -75.48 -17.96 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.437 0.637 . . . . 64.23 110.485 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.4 -28.39 73.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.976 -0.556 . . . . 30.31 113.139 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.684 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.64 3.33 6.04 Favored Glycine 0 CA--C 1.506 -0.507 0 C-N-CA 120.189 -1.005 . . . . 73.1 112.852 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.4 m -95.23 22.41 6.82 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.811 0.815 . . . . 51.15 109.948 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.41 ' HA ' ' OG ' ' A' ' 116' ' ' SER . 7.9 p30 -88.07 172.73 9.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.651 -0.704 . . . . 74.42 110.827 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 9.2 t70 -67.72 -34.32 76.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.89 -0.595 . . . . 51.02 112.518 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -78.75 -12.45 60.02 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.434 0.635 . . . . 65.03 109.683 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.69 25.07 75.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.446 -0.797 . . . . 74.4 112.645 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.684 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 34.1 m -90.41 146.79 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 120.066 -0.653 . . . . 74.4 109.888 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.99 -153.46 19.86 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.945 -0.862 . . . . 64.5 110.945 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.6 ttt -80.57 72.08 7.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.007 0.908 . . . . 74.14 110.204 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.96 3.05 41.17 Favored Glycine 0 N--CA 1.438 -1.202 0 CA-C-N 114.729 -1.123 . . . . 71.35 110.976 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.8 ptm -125.11 121.66 34.89 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.667 -0.864 . . . . 71.35 108.667 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -126.84 116.22 20.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.218 -0.446 . . . . 64.54 111.81 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 103' ' ' ARG . 57.4 t -150.47 139.39 13.01 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 105.52 -2.03 . . . . 71.54 105.52 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.97 138.97 88.51 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 121.344 1.363 . . . . 71.12 110.427 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.85 139.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.963 -0.754 . . . . 71.31 108.963 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 m -118.98 145.05 46.14 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.864 -0.791 . . . . 74.35 108.864 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -132.42 137.0 47.14 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 119.949 -0.7 . . . . 72.12 109.658 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.94 135.14 34.42 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.499 -0.773 . . . . 52.31 109.008 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.77 149.71 25.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 54.52 107.798 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.651 ' CE2' ' HE3' ' A' ' 97' ' ' LYS . 67.5 m-85 -119.19 99.78 50.48 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 107.186 -1.413 . . . . 74.45 107.186 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.49 158.9 50.29 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.543 2.162 . . . . 63.43 114.542 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -103.53 160.15 14.98 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 106.673 -1.603 . . . . 74.23 106.673 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.2 -17.5 64.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.061 0.458 . . . . 73.11 111.795 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.54 -7.3 56.08 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.957 -0.565 . . . . 53.12 110.983 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.72 -6.06 84.01 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.696 -0.764 . . . . 72.3 112.295 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.1 m -83.94 136.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.11 0.481 . . . . 62.32 110.332 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 89.0 mt -93.59 98.63 11.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.728 0.775 . . . . 74.01 111.193 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 29.6 tt0 -148.13 170.43 17.84 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.795 -1.187 . . . . 73.11 107.795 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 105.09 -65.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 126.697 1.999 . . . . 73.31 112.255 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HE3' ' CE2' ' A' ' 87' ' ' PHE . 33.7 ttpt -159.24 150.05 19.72 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.482 -0.326 . . . . 74.31 110.649 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.472 HD12 HG13 ' A' ' 51' ' ' VAL . 5.0 tt -142.84 136.56 28.86 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.022 -1.103 . . . . 71.41 108.022 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 68.2 mttm -122.02 115.67 22.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.469 -0.567 . . . . 75.13 109.469 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 43' ' ' THR . 87.7 t -88.41 128.05 40.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.899 -1.149 . . . . 63.03 107.899 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.11 123.86 46.62 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.293 -0.632 . . . . 73.45 109.293 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -102.99 112.61 25.53 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.471 -1.677 . . . . 64.22 106.471 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 80' ' ' VAL . 1.1 tmt_? -76.84 113.06 14.11 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.957 -1.498 . . . . 70.23 106.957 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 40' ' ' LYS . 76.8 mt -73.36 138.7 78.21 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 115.926 -0.579 . . . . 60.04 110.555 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.7 161.32 45.83 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.504 2.136 . . . . 73.32 112.002 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.428 ' C ' HD22 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -50.4 -35.22 27.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.296 1.438 . . . . 74.24 111.081 -176.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.04 -42.96 99.47 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.419 0.688 . . . . 72.52 111.992 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -99.76 -1.74 36.93 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 114.011 1.115 . . . . 73.44 114.011 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.714 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -62.97 -28.75 70.3 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.421 1.267 . . . . 63.12 114.421 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 14' ' ' GLU . . . -76.1 -39.38 32.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.89 -1.147 . . . . 52.54 111.942 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.9 m -149.0 94.4 4.03 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 109.251 -0.648 . . . . 74.31 109.251 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.63 158.1 12.26 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.417 2.078 . . . . 74.23 111.638 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.46 131.68 46.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.985 1.79 . . . . 55.33 109.943 175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -66.23 140.27 96.77 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.319 -0.401 . . . . 73.24 110.358 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.61 101.5 1.04 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.438 2.092 . . . . 70.33 111.952 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 11.4 p -81.02 2.19 28.08 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.605 1.162 . . . . 72.43 111.886 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.542 ' HB3' HG12 ' A' ' 120' ' ' VAL . 13.1 t70 -113.27 152.69 29.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.415 -0.957 . . . . 74.51 108.415 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -13.16 45.5 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 115.372 1.619 . . . . 70.44 115.372 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.594 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 71.9 m -97.85 -28.84 13.66 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.152 -0.619 . . . . 73.45 111.898 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 117' ' ' ASP . 6.8 p -94.68 128.04 46.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.844 -0.743 . . . . 63.13 109.478 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -124.49 153.29 42.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.996 -0.742 . . . . 64.33 108.996 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.9 mm -92.45 111.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 72.33 107.793 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -127.0 145.74 50.6 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.519 -0.764 . . . . 53.04 109.887 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.45 144.99 33.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.845 -0.798 . . . . 55.45 108.845 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.6 tpt180 -134.85 123.06 22.91 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.445 -0.902 . . . . 63.13 109.901 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.56 173.79 11.22 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.529 -0.545 . . . . 64.13 109.529 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.11 19.03 70.64 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.822 -0.626 . . . . 51.14 112.617 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.422 HG13 ' SG ' ' A' ' 36' ' ' CYS . 43.3 pt -128.37 145.53 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 121.17 0.51 . . . . 73.5 111.02 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 60.0 m -104.07 129.72 51.74 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 107.449 -1.315 . . . . 62.13 107.449 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.25 151.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.43 -0.581 . . . . 62.5 109.43 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 72.0 m-85 -114.04 121.48 43.97 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.308 -1.738 . . . . 64.44 106.308 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.5 m -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 109.869 -0.419 . . . . 70.45 109.869 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' SER . 10.0 t -118.32 131.38 56.33 Favored 'General case' 0 N--CA 1.411 -2.4 0 C-N-CA 120.391 -0.523 . . . . 71.35 110.067 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.654 ' HG2' ' HG3' ' A' ' 184' ' ' GLU . 51.4 mt-30 -110.84 128.36 55.75 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.089 -1.078 . . . . 74.0 108.089 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.2 p90 -114.68 135.68 53.89 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 115.309 -0.86 . . . . 74.55 110.563 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.14 101.57 2.61 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.408 -1.077 . . . . 55.15 110.408 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.06 167.82 27.28 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.231 -0.748 . . . . 61.52 111.231 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 54.3 p90 -75.44 139.72 42.46 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 110.124 -0.324 . . . . 72.32 110.124 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -116.04 123.76 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.549 0.69 . . . . 34.22 112.246 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.449 ' HG2' ' OE2' ' A' ' 141' ' ' GLU . 26.3 ttpp -115.68 170.53 8.38 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 104.721 -2.326 . . . . 75.2 104.721 172.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -51.54 -42.86 62.11 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.901 0.773 . . . . 73.43 113.058 -174.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.5 67.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.469 -0.332 . . . . 64.33 111.828 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -69.07 -37.11 78.33 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.968 -0.293 . . . . 70.14 111.112 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.69 -42.55 88.83 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.672 -0.492 . . . . 73.33 109.672 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.72 -40.7 84.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.424 -0.807 . . . . 74.41 109.794 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -61.93 -47.6 84.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 74.33 111.24 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -69.04 -33.52 73.72 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 112.228 0.455 . . . . 74.31 112.228 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.29 92.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.177 0.513 . . . . 73.52 109.969 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 76.5 m -62.91 -46.93 85.49 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.675 -0.693 . . . . 64.42 110.125 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 25.8 mt-30 -59.92 -38.36 82.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.107 -0.497 . . . . 55.14 110.359 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.25 -43.58 96.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.845 -0.616 . . . . 71.53 110.995 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -63.39 -39.18 93.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 65.14 109.61 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.7 m -71.78 -30.81 65.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.203 -0.908 . . . . 74.21 111.133 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.7 m -76.74 -34.69 58.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.282 0.563 . . . . 52.25 109.67 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.96 7.71 12.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.928 -0.578 . . . . 62.51 111.027 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -74.49 130.64 39.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.331 -0.618 . . . . 64.53 109.331 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.23 3.45 58.81 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.939 -0.648 . . . . 52.52 112.128 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 54.5 p -112.18 165.64 12.55 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.764 -0.828 . . . . 73.32 108.764 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.28 14.93 0.53 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.764 2.31 . . . . 71.44 112.872 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.67 109.83 3.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.084 0.469 . . . . 44.51 110.562 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.6 p -95.97 156.54 16.29 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.909 -1.145 . . . . 74.13 107.909 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.505 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 19.9 m-85 -132.64 151.27 52.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.595 -0.842 . . . . 74.14 109.277 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -127.3 122.33 33.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.002 0.43 . . . . 74.41 111.32 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.09 0.73 37.03 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.334 -0.848 . . . . 74.3 113.352 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.63 18.47 10.56 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.561 1.172 . . . . 53.44 109.366 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.27 139.22 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 113.724 -1.58 . . . . 74.22 112.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.445 ' OH ' HD21 ' A' ' 94' ' ' LEU . 11.4 p90 -149.41 167.66 25.56 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.194 -0.912 . . . . 65.33 110.747 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 2.8 m-85 -116.0 153.47 31.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 123.586 0.754 . . . . 71.11 109.557 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.9 m -124.03 131.41 53.55 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.252 -1.388 . . . . 63.35 107.252 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.77 148.11 51.61 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.544 0.572 . . . . 74.32 112.544 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.84 165.85 39.04 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 108.647 -1.781 . . . . 73.41 108.647 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -57.56 -37.61 73.4 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.448 1.124 . . . . 71.0 109.619 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -156.36 142.81 13.23 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 106.327 -1.731 . . . . 74.35 106.327 172.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.99 117.48 3.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.536 2.158 . . . . 55.14 109.518 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -54.07 127.33 25.29 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.483 2.122 . . . . 53.02 115.526 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.57 -35.41 11.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 103.518 -2.771 . . . . 52.41 103.518 167.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -109.83 126.71 28.49 Favored Pre-proline 0 N--CA 1.421 -1.911 0 N-CA-C 104.845 -2.28 . . . . 74.34 104.845 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 138' ' ' TYR . 35.1 Cg_endo -63.16 -14.74 43.69 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.813 2.342 . . . . 51.2 113.595 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.46 147.17 53.67 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.69 0.757 . . . . 71.14 112.794 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.88 134.69 3.09 Favored Glycine 0 C--N 1.3 -1.443 0 N-CA-C 107.215 -2.354 . . . . 65.21 107.215 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -96.9 -28.39 14.23 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 115.721 1.749 . . . . 75.24 115.721 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 182' ' ' ARG . 0.7 OUTLIER -117.08 130.37 56.6 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 118.2 -1.4 . . . . 73.42 110.269 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 40.4 m-80 -144.16 148.02 34.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.854 -1.165 . . . . 74.15 107.854 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.654 ' HG3' ' HG2' ' A' ' 134' ' ' GLN . 2.5 mp0 -112.04 144.36 41.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.115 0.484 . . . . 71.11 110.873 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 57.8 t -125.52 118.84 53.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.366 -1.716 . . . . 73.14 106.366 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.495 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 27.9 m0 -106.52 120.77 42.81 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.131 -0.692 . . . . 74.33 109.131 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 tp -98.88 133.94 42.46 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.363 -1.347 . . . . 62.22 107.363 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.25 126.86 45.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.328 -0.549 . . . . 71.12 111.32 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.2 tttm -75.14 137.85 41.64 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.886 -0.597 . . . . 74.54 109.808 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.301 -1.528 0 CA-C-O 118.259 -0.877 . . . . 73.52 108.86 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 . . . . . 0 CA--C 1.501 -0.904 0 N-CA-C 109.67 -0.493 . . . . 71.11 109.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.3 p -149.04 88.62 1.61 Allowed 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.786 -0.643 . . . . 52.43 109.532 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.1 tp -153.72 -72.07 0.13 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.777 -1.194 . . . . 72.35 107.777 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 61.29 173.84 0.11 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.337 1.055 . . . . 75.55 113.467 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.97 -79.91 1.83 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.885 -0.598 . . . . 74.21 112.174 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.2 m -85.14 82.08 8.57 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.356 0.598 . . . . 73.12 111.931 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -120.28 95.46 3.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.27 -1.011 . . . . 75.44 108.27 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.2 111.58 24.38 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.333 -0.849 . . . . 71.52 112.44 -171.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 p -102.7 -69.45 0.79 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.561 -0.903 . . . . 75.12 108.561 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -138.9 81.16 22.7 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 112.27 0.47 . . . . 74.33 112.27 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -99.0 149.09 0.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.469 2.779 . . . . 62.45 111.954 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -102.46 148.66 25.23 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.47 -0.937 . . . . 74.21 108.47 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -106.63 115.44 30.21 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.371 -0.377 . . . . 73.34 111.397 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 121.05 41.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.739 0.781 . . . . 71.12 109.966 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.24 -24.16 15.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.608 -0.723 . . . . 71.31 111.754 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -165.93 148.5 7.33 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.868 0.366 . . . . 74.44 110.29 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.9 p -134.56 164.31 27.78 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.95 -1.023 . . . . 74.54 110.321 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.94 -136.34 12.86 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 119.964 -1.112 . . . . 64.55 113.809 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.31 -108.26 2.89 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.85 -1.3 . . . . 73.45 109.85 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -108.9 168.02 9.66 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.458 -1.312 . . . . 72.01 107.458 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.65 154.08 25.08 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 118.62 0.646 . . . . 65.25 111.223 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 72.58 -64.77 0.38 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.93 1.292 . . . . 74.35 110.321 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.9 t -92.6 109.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.756 -1.942 . . . . 73.13 105.756 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 m -133.4 154.31 50.87 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.907 -0.775 . . . . 52.33 108.907 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.32 160.56 18.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.513 0.673 . . . . 74.04 111.668 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.92 124.95 25.74 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.832 -1.914 . . . . 71.12 105.832 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.86 114.08 27.85 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.221 -1.77 . . . . 74.33 106.221 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.22 146.65 52.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.413 0.625 . . . . 72.33 111.652 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.82 136.14 33.51 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.745 -1.576 . . . . 71.43 106.745 172.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -60.44 162.57 6.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.53 0.937 . . . . 55.02 113.53 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -83.69 -20.77 32.91 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.656 -0.702 . . . . 64.24 110.42 -177.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 95.57 11.1 56.11 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 119.362 -1.399 . . . . 73.43 112.077 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.21 160.71 54.1 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 120.877 -0.678 . . . . 51.42 112.923 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 17.1 ptpt -96.76 130.68 43.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.948 -0.76 . . . . 74.23 108.948 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.468 ' HD1' ' H ' ' A' ' 104' ' ' ILE . 58.9 m-85 -130.66 164.43 25.02 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.509 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.34 120.09 38.14 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 107.762 -1.199 . . . . 62.11 107.762 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.638 ' OG1' ' HE2' ' A' ' 99' ' ' LYS . 9.4 t -135.19 150.49 50.14 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 119.911 -0.716 . . . . 61.32 112.038 -174.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 18.8 m -134.85 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.897 -1.047 . . . . 74.21 109.739 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HB2' ' CD ' ' A' ' 99' ' ' LYS . 34.9 tt0 -123.81 139.8 53.62 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.813 -0.439 . . . . 51.33 109.813 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 58' ' ' ALA . 52.8 t -127.32 133.12 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.328 -1.36 . . . . 74.12 107.328 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 36.2 m -133.14 157.1 46.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.336 -0.616 . . . . 73.12 109.336 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 79.6 -9.38 1.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.794 1.637 . . . . 64.21 109.359 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 47' ' ' THR . 68.5 mttm -111.22 131.53 22.18 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.16 -1.382 . . . . 63.34 109.049 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.24 158.48 35.03 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.053 2.502 . . . . 73.44 110.787 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 98' ' ' LEU . 39.3 t -45.95 -37.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.06 0.944 . . . . 71.23 112.976 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.55 -51.11 69.82 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.216 0.532 . . . . 44.13 110.561 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -76.41 -37.44 57.08 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.176 -0.92 . . . . 62.34 112.237 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.82 91.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.006 -0.543 . . . . 71.51 112.01 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -48.18 77.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.339 -0.615 . . . . 61.21 109.339 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.69 -24.29 66.24 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.792 -0.64 . . . . 73.43 111.983 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 10.4 tp10 -84.5 -45.5 12.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.515 0.674 . . . . 73.44 110.291 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -71.74 -39.65 69.91 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.596 0.961 . . . . 72.42 113.596 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.433 ' SD ' ' HG3' ' A' ' 174' ' ' PRO . 35.5 ttm -57.73 -46.72 99.72 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 114.196 1.184 . . . . 75.32 114.196 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 83.6 Cg_exo -50.89 -37.4 55.68 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.391 2.06 . . . . 74.15 111.233 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HD2' ' CB ' ' A' ' 119' ' ' SER . 43.5 mtmt -68.77 -37.01 79.03 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.683 -0.69 . . . . 75.02 110.792 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.0 mm -76.39 -47.63 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 112.18 0.437 . . . . 74.43 112.18 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 25.0 ptm -62.59 -29.58 70.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.663 0.986 . . . . 71.23 113.663 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.67 -36.27 82.13 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.196 -0.602 . . . . 64.41 110.107 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -56.69 -59.43 5.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.243 -0.435 . . . . 74.33 111.813 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.85 -17.0 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 62.33 110.264 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.86 -14.27 82.53 Favored Glycine 0 C--O 1.24 0.508 0 CA-C-N 115.92 -0.582 . . . . 72.05 113.275 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.19 4.11 2.35 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.684 -1.246 . . . . 60.21 114.552 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.0 m -91.35 23.51 3.35 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 123.077 1.418 . . . . 64.24 110.412 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 114' ' ' ALA . 7.8 p30 -98.73 170.28 8.89 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.099 -0.955 . . . . 75.44 110.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.94 -27.46 62.81 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 111.844 0.313 . . . . 72.2 111.844 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -86.05 -12.41 50.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.56 0.695 . . . . 74.11 110.525 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 31.84 63.2 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 115.319 -0.855 . . . . 63.12 112.518 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.11 123.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.319 -0.552 . . . . 72.3 110.758 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.37 -40.36 1.14 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 110.902 -0.879 . . . . 73.34 110.902 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.5 mtt -107.03 81.21 1.52 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.904 -1.517 . . . . 71.54 106.904 173.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.1 -79.32 0.54 Allowed Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.795 -1.193 . . . . 72.41 114.495 -172.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.484 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 24.1 ptt? -127.8 125.2 39.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.118 0.485 . . . . 75.31 111.945 -173.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 p -125.25 115.92 21.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.693 -0.685 . . . . 44.11 111.182 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.449 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 28.6 m -142.26 175.86 2.71 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 106.767 -1.568 . . . . 61.53 106.767 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 80' ' ' VAL . 39.8 Cg_exo -59.89 140.11 91.4 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 121.55 1.5 . . . . 71.12 113.268 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.95 153.19 8.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.085 -1.45 . . . . 75.21 107.085 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -140.01 145.23 37.53 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.888 -0.508 . . . . 50.43 109.881 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -136.61 143.11 43.38 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.149 -0.62 . . . . 60.15 111.147 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -92.66 135.6 33.95 Favored 'General case' 0 CA--C 1.478 -1.819 0 O-C-N 123.801 0.688 . . . . 70.23 109.774 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.83 149.73 33.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.156 -1.053 . . . . 64.33 108.156 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.589 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 99.3 m-85 -112.25 108.06 55.16 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.176 -0.675 . . . . 72.33 109.176 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -83.6 151.67 13.25 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.626 1.55 . . . . 54.24 112.358 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.03 168.56 10.01 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.007 . . . . 72.12 108.282 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.55 -19.76 65.86 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.069 0.461 . . . . 64.12 111.626 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -81.07 -6.91 59.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 53.01 110.08 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.36 73.37 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.883 -0.599 . . . . 74.03 111.838 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.0 m -74.46 140.48 44.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.067 -0.716 . . . . 74.31 109.067 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.7 139.65 33.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.023 0.44 . . . . 73.22 111.036 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.3 167.82 19.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 124.225 1.01 . . . . 73.24 111.891 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' THR . 63.6 pttt -70.35 21.87 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 126.224 1.81 . . . . 71.41 114.879 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.589 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 24.2 ttmm -139.66 134.72 32.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 119.449 1.022 . . . . 64.22 110.972 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.655 HD12 HG13 ' A' ' 51' ' ' VAL . 6.0 tt -143.07 130.57 21.17 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 107.998 -1.112 . . . . 53.12 107.998 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.638 ' HE2' ' OG1' ' A' ' 43' ' ' THR . 23.6 tptm -116.11 115.3 25.81 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.466 -0.938 . . . . 71.22 108.466 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.54 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 99.3 t -94.25 126.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.893 -0.41 . . . . 72.05 109.893 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -113.04 124.99 53.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.151 0.581 . . . . 61.53 109.564 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -103.12 113.66 27.31 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.639 -1.615 . . . . 65.14 106.639 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -77.29 131.3 38.08 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.461 -0.79 . . . . 75.04 110.494 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 73.3 mt -100.17 133.86 21.22 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-N 115.031 -0.986 . . . . 44.11 108.556 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 31.9 Cg_exo -58.32 151.53 59.8 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.788 2.325 . . . . 62.22 111.229 175.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.31 -34.25 60.55 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.881 0.872 . . . . 42.11 110.076 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -59.68 -34.33 72.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.903 -0.589 . . . . 73.31 111.873 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.53 -3.98 32.24 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 120.816 -0.354 . . . . 70.3 111.521 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 97.7 mt-30 -70.55 -27.89 64.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.89 0.33 . . . . 72.22 111.89 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.87 -38.16 95.71 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.438 -0.665 . . . . 62.55 111.438 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 t -158.28 90.68 2.19 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 108.724 -0.843 . . . . 72.44 108.724 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -85.85 154.86 10.07 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.026 1.817 . . . . 65.21 112.06 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.5 149.23 83.17 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.193 1.929 . . . . 60.21 110.742 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' ASN . . . -86.9 130.29 49.05 Favored Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 116.299 -0.409 . . . . 72.12 111.112 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.44 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 74.0 Cg_endo -76.89 112.59 3.47 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.904 2.403 . . . . 74.42 111.653 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 79.87 2.93 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.54 -0.864 . . . . 73.11 110.87 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.632 ' HB3' HG12 ' A' ' 120' ' ' VAL . 14.9 t70 -169.66 149.0 3.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.298 -1.742 . . . . 74.31 106.298 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.94 -14.97 59.35 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.944 0.72 . . . . 72.32 112.944 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.573 ' CB ' ' HD2' ' A' ' 61' ' ' LYS . 36.9 m -95.4 -29.71 14.29 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.88 -0.328 . . . . 65.41 111.836 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.632 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.9 p -106.25 116.46 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.54 0 CA-C-O 121.821 0.819 . . . . 74.12 110.575 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -130.74 155.24 46.98 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.144 -1.389 . . . . 74.42 110.19 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.0 mm -91.37 112.64 25.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.56 -0.904 . . . . 74.01 108.56 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -115.58 141.84 47.53 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.157 -0.682 . . . . 72.3 109.157 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -111.18 145.84 37.95 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.575 -0.739 . . . . 71.42 109.756 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -146.98 126.93 13.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.309 0.576 . . . . 62.35 110.805 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -133.76 169.96 16.28 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.106 -0.952 . . . . 75.04 110.346 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 16.38 78.7 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.373 -0.441 . . . . 63.4 113.53 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pp -121.23 162.6 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 119.542 -0.863 . . . . 75.51 109.245 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.416 ' H ' ' HG2' ' A' ' 189' ' ' LYS . 41.7 m -120.29 136.99 54.49 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 115.485 -0.78 . . . . 54.55 109.29 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.418 HG21 ' CE3' ' A' ' 186' ' ' TRP . 15.5 m -124.84 146.35 30.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.314 -0.995 . . . . 60.24 108.314 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.557 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 19.9 m-85 -114.95 121.54 43.47 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 105.932 -1.877 . . . . 75.01 105.932 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 p -117.4 131.5 56.75 Favored 'General case' 0 C--N 1.274 -2.712 0 C-N-CA 120.213 -0.595 . . . . 63.13 111.798 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.488 ' HB ' HD13 ' A' ' 151' ' ' LEU . 8.9 t -113.29 119.14 36.68 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 108.187 -1.042 . . . . 72.22 108.187 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -111.15 126.69 55.11 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 109.183 -0.673 . . . . 72.22 109.183 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 36.3 p90 -142.3 153.48 43.92 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 115.179 -0.918 . . . . 72.33 110.901 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -118.69 145.25 18.24 Favored Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 110.039 -1.224 . . . . 75.32 110.039 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.67 168.16 11.93 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 109.41 -1.476 . . . . 70.12 109.41 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.406 ' CE1' ' HA ' ' A' ' 179' ' ' TYR . 87.1 t80 -68.38 101.54 1.24 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.287 0.565 . . . . 74.23 111.574 -175.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.33 130.85 53.3 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.618 -0.882 . . . . 72.31 108.618 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -89.74 176.91 6.66 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.754 -0.832 . . . . 75.03 108.754 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.41 -31.95 71.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.244 0.545 . . . . 71.2 109.911 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.09 -29.36 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.502 -0.772 . . . . 63.01 109.784 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -69.54 -29.81 67.48 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 116.037 -0.529 . . . . 62.33 111.268 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -59.26 -41.89 89.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.67 -0.412 . . . . 75.11 110.133 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.29 -49.1 84.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.451 -0.795 . . . . 73.11 110.102 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.04 -44.49 84.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.656 . . . . 33.32 111.79 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -63.53 -31.55 72.75 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 112.538 0.57 . . . . 73.25 112.538 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.63 85.3 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.352 -0.61 . . . . 73.02 109.352 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.429 HG23 ' NH2' ' A' ' 152' ' ' ARG . 22.1 m -66.83 -41.31 87.65 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 115.654 -0.703 . . . . 74.4 111.46 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.2 -37.48 85.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.0 0.428 . . . . 72.32 109.97 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.488 HD13 ' HB ' ' A' ' 133' ' ' THR . 52.5 tp -62.18 -41.99 98.86 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.723 -0.671 . . . . 72.23 110.224 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.537 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.8 mtm105 -62.22 -46.93 86.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.568 -0.287 . . . . 72.43 111.063 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.2 m -61.59 -34.37 75.5 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.877 0.736 . . . . 72.31 110.431 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 30.0 m -76.99 -35.43 57.16 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.86 -0.609 . . . . 75.2 110.164 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.1 mt -70.05 -31.4 69.0 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 113.354 0.872 . . . . 64.22 113.354 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 46.1 mt-10 -46.31 131.1 10.67 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.621 0.6 . . . . 72.11 112.621 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.64 12.64 43.5 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.516 -1.034 . . . . 52.23 110.516 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.9 t -102.56 149.72 36.98 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 109.06 -0.719 . . . . 61.21 109.06 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -75.18 -4.82 15.91 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.594 2.196 . . . . 74.32 111.173 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.557 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -71.99 147.04 47.29 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.771 -0.65 . . . . 61.45 110.854 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 74.0 p -108.02 138.05 44.95 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.3 -0.63 . . . . 60.12 109.3 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -144.02 150.51 38.36 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 122.29 -0.256 . . . . 62.2 110.938 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.514 ' O ' HG12 ' A' ' 166' ' ' VAL . 29.0 pt20 -129.33 122.84 30.38 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.999 1.111 . . . . 71.34 113.999 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.71 12.79 62.5 Favored Glycine 0 C--N 1.309 -0.964 0 N-CA-C 115.207 0.843 . . . . 63.53 115.207 164.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.401 ' O ' ' HD1' ' A' ' 167' ' ' TYR . 25.4 t70 67.43 19.76 9.99 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.959 0.409 . . . . 41.04 110.641 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 163' ' ' GLN . 7.2 p -64.81 137.95 24.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 C-N-CA 120.367 -0.533 . . . . 62.14 109.788 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' ASP . 26.9 p90 -151.12 170.83 18.46 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.701 0.762 . . . . 74.21 111.644 -173.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 97.2 m-85 -114.64 151.65 33.19 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.216 -1.356 . . . . 75.41 109.737 175.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.54 122.16 45.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.506 -1.294 . . . . 73.45 107.506 174.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -112.18 142.41 44.69 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.153 0.283 . . . . 53.11 111.436 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.03 164.56 37.94 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.039 -1.224 . . . . 72.23 110.039 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -73.45 -39.29 65.08 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 118.034 0.917 . . . . 75.15 110.767 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -150.77 158.1 35.47 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 108.785 -0.82 . . . . 64.45 108.785 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.433 ' HG3' ' SD ' ' A' ' 59' ' ' MET . 17.8 Cg_endo -56.24 123.88 14.91 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.772 2.315 . . . . 73.41 111.467 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.55 129.82 31.04 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.727 1.618 . . . . 71.02 110.725 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.65 -21.23 18.34 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.802 0.81 . . . . 71.24 109.743 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -140.0 150.78 63.36 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 104.831 -2.285 . . . . 64.41 104.831 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.12 -14.45 2.65 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.546 2.831 . . . . 61.05 113.264 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.406 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 84.8 t80 -60.86 103.9 0.31 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 123.874 0.869 . . . . 63.21 112.436 176.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -128.73 126.52 5.33 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.166 -1.574 . . . . 71.55 109.166 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -83.78 -55.17 4.41 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 117.568 0.684 . . . . 73.25 110.069 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -109.13 132.94 53.64 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.739 -1.208 . . . . 73.33 107.739 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.442 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.7 m-80 -134.37 134.29 41.56 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.385 -0.969 . . . . 71.4 108.385 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 7.7 mp0 -128.82 136.35 50.37 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.865 -0.42 . . . . 74.3 109.865 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.1 t -124.74 121.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.468 -0.938 . . . . 70.4 108.468 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.6 m0 -103.21 123.15 46.19 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 108.087 -1.079 . . . . 72.31 108.087 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 166' ' ' VAL . 1.7 tt -97.35 138.57 34.61 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.896 -1.52 . . . . 63.11 106.896 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.483 HG22 ' CE2' ' A' ' 168' ' ' TYR . 20.7 t -87.88 131.98 34.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 110.455 -0.202 . . . . 73.24 110.455 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.578 ' HD2' ' C ' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -70.39 143.38 51.9 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 118.551 -0.738 . . . . 65.44 109.333 176.504 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.416 HD21 HD12 ' A' ' 9' ' ' LEU . 37.9 t30 . . . . . 0 CA--C 1.51 -0.562 0 N-CA-C 109.715 -0.476 . . . . 34.13 109.715 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 m -88.09 83.17 7.02 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.366 0.603 . . . . 55.44 111.896 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.416 HD12 HD21 ' A' ' 7' ' ' ASN . 86.4 mt -147.8 164.19 34.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.835 -1.075 . . . . 62.4 108.16 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -118.75 129.28 55.17 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.638 -0.875 . . . . 73.4 108.638 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.31 76.03 1.97 Allowed Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.75 -0.738 . . . . 72.45 113.215 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -76.83 153.42 34.87 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.432 -0.951 . . . . 44.11 108.432 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.68 89.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.696 0.76 . . . . 72.02 111.52 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.48 113.54 19.61 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.619 -0.882 . . . . 73.3 108.619 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.504 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 86.3 m 72.14 106.86 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 124.066 0.854 . . . . 64.42 110.572 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CD1' ' HB2' ' A' ' 37' ' ' GLU . 8.9 t-105 -93.75 99.85 3.98 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.104 -1.813 . . . . 73.51 106.104 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 15' ' ' THR . 64.8 Cg_endo -97.82 150.14 0.83 Allowed 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 123.093 2.529 . . . . 73.22 116.247 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.402 ' CD1' ' HD2' ' A' ' 34' ' ' ARG . 8.6 p90 -101.2 151.97 21.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.3 -2.111 . . . . 75.43 105.3 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -106.03 114.98 29.44 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.997 -1.081 . . . . 74.25 111.963 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.51 121.16 35.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.311 -1.737 . . . . 61.45 106.311 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.3 -26.42 20.01 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.389 -0.924 . . . . 72.24 110.758 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -175.99 165.31 2.92 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.681 -0.859 . . . . 74.15 108.681 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.4 HG22 ' HG3' ' A' ' 32' ' ' GLU . 36.4 p -132.57 150.02 52.22 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.771 -1.196 . . . . 70.15 107.771 172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.39 113.61 2.11 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.101 -1.523 . . . . 73.03 113.406 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.25 -99.49 0.49 Allowed Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 110.857 -0.897 . . . . 41.12 110.857 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -98.87 169.1 9.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.302 -0.999 . . . . 74.42 108.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.48 157.38 23.62 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.504 -0.554 . . . . 74.01 109.504 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 72.74 -58.28 0.6 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.408 1.083 . . . . 64.12 110.875 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.86 111.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 121.823 0.82 . . . . 70.01 108.791 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.5 m -106.37 136.91 45.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.826 -0.625 . . . . 72.12 109.809 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.49 160.14 18.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 119.597 -0.841 . . . . 75.12 111.405 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 34.7 tt0 -134.61 124.29 25.17 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.646 -1.613 . . . . 63.24 106.646 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.8 115.66 30.86 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.042 0.925 . . . . 73.31 110.835 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 22.1 ptt180 -128.81 138.58 52.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 114.458 -1.246 . . . . 74.21 110.871 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.22 136.94 32.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.071 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.01 148.92 28.98 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.945 0.778 . . . . 75.11 109.718 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -77.62 -13.55 59.88 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 112.496 0.554 . . . . 74.22 112.496 -175.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.29 61.68 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.219 -1.467 . . . . 53.21 113.253 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 163.65 40.17 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.616 -1.278 . . . . 72.54 112.337 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.4 ptpt -96.03 133.9 39.71 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 75.11 108.375 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 37.0 m-85 -124.52 163.12 22.54 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.269 -0.423 . . . . 73.21 111.922 -171.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -99.53 116.63 32.12 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.575 -0.898 . . . . 72.45 108.575 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.4 t -123.29 149.64 44.56 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 121.23 0.538 . . . . 72.15 110.978 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 12.4 m -127.09 123.27 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.098 -0.955 . . . . 63.23 109.41 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -109.89 132.57 54.03 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.44 0.638 . . . . 71.14 112.504 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 54' ' ' ALA . 42.1 t -129.41 136.9 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.569 -1.271 . . . . 74.02 107.569 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 49' ' ' LYS . 31.0 m -138.75 164.83 28.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.712 -1.218 . . . . 73.33 107.712 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 47' ' ' THR . 14.1 t70 76.16 -26.47 0.19 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.012 1.325 . . . . 74.55 110.309 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 47' ' ' THR . 54.0 mtmt -103.16 122.59 44.83 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 114.483 -1.235 . . . . 72.42 108.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.48 158.79 1.57 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 124.596 3.531 . . . . 73.11 114.416 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.409 HG13 HD12 ' A' ' 98' ' ' LEU . 53.6 t -46.66 -41.47 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.452 1.101 . . . . 61.42 112.055 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.688 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 24.5 t70 -58.81 -43.45 90.56 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.638 -0.256 . . . . 70.02 110.517 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -73.77 -47.67 37.33 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.335 0.654 . . . . 64.2 110.85 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -56.77 -41.56 77.85 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.442 -0.799 . . . . 74.22 111.698 -176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 59' ' ' MET . 45.1 tp -68.72 -35.71 77.49 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.342 -0.39 . . . . 74.51 110.443 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 17.6 mtp180 -56.89 -46.0 82.18 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.206 0.527 . . . . 74.3 111.624 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.58 -35.33 39.84 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.429 -0.805 . . . . 74.43 112.292 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.29 -32.91 59.03 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.37 0.878 . . . . 72.32 113.37 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.447 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 5.2 mmt -56.26 -57.91 19.86 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.121 0.786 . . . . 74.4 113.121 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.612 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 28.9 Cg_endo -63.9 -32.49 66.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 121.867 1.712 . . . . 64.22 110.552 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -58.35 -45.65 87.78 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.923 -1.035 . . . . 54.42 110.796 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.5 mm -75.63 -47.63 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.219 -0.446 . . . . 73.42 111.389 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.505 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.292 3.7 ppp? -62.85 -32.23 73.41 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.667 1.358 . . . . 75.04 114.667 -174.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 60' ' ' PRO 0.295 0.0 OUTLIER -77.65 -29.09 51.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.697 -1.201 . . . . 71.23 112.504 176.347 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' THR . 62.2 t80 -65.07 -52.23 56.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.343 0.592 . . . . 74.41 110.207 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -72.19 -15.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.556 -0.747 . . . . 73.1 111.853 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.4 -11.58 68.82 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.439 -0.801 . . . . 70.34 112.458 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.0 -23.32 1.44 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.486 -1.34 . . . . 44.44 113.577 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 58.0 m -82.0 70.01 8.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.65 1.214 . . . . 74.24 111.976 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -98.36 170.16 9.05 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.528 -2.027 . . . . 72.3 105.528 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 36.6 t70 -69.31 -33.52 73.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 119.809 -0.756 . . . . 64.33 111.723 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.2 1.91 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 72.24 110.792 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.86 28.57 72.96 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.638 -0.71 . . . . 64.21 113.656 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.16 120.73 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 109.3 -0.629 . . . . 72.43 109.3 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.76 -135.3 1.85 Allowed Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 111.0 -0.84 . . . . 54.44 111.0 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.8 ttp 178.0 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.271 0.558 . . . . 54.03 111.284 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.54 65.58 0.58 Allowed Glycine 0 CA--C 1.491 -1.414 0 N-CA-C 106.291 -2.724 . . . . 60.53 106.291 -169.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.469 ' H ' ' HG2' ' A' ' 78' ' ' MET . 11.4 ptm -97.01 121.94 39.45 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.266 -0.967 . . . . 72.55 111.448 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -128.26 134.93 49.05 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.712 -0.676 . . . . 64.53 111.589 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m -157.11 172.29 6.33 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 104.991 -2.226 . . . . 71.25 104.991 171.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 86.3 Cg_exo -54.18 139.52 72.09 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 121.431 1.42 . . . . 75.44 113.161 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.83 142.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.421 -1.326 . . . . 41.13 107.421 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.6 p -138.33 144.5 40.41 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.952 -0.299 . . . . 62.33 110.234 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 50.4 p90 -131.01 143.73 50.94 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.582 -0.447 . . . . 73.22 110.96 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.35 134.24 35.78 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.602 0.564 . . . . 74.33 110.6 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.26 150.79 32.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.438 -0.801 . . . . 74.12 109.799 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 95' ' ' GLN . 78.9 m-85 -114.75 112.69 45.1 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.951 -0.389 . . . . 74.04 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.59 158.83 2.93 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.869 1.713 . . . . 63.53 111.289 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -104.67 160.76 14.7 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.279 -1.749 . . . . 72.21 106.279 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.01 -24.73 64.73 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.49 0.662 . . . . 74.11 111.058 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.57 -5.89 47.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.01 -0.995 . . . . 73.33 110.804 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.91 -10.67 74.29 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.846 -0.502 . . . . 44.4 111.846 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 m -77.22 136.01 38.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 109.032 -0.729 . . . . 74.13 109.032 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.3 mt -84.72 136.85 33.55 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.069 0.461 . . . . 72.25 111.037 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 53.1 tt0 -81.9 144.97 30.6 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.769 -1.567 . . . . 71.53 106.769 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -92.29 80.12 5.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.364 1.246 . . . . 70.51 114.364 -174.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.645 ' HE2' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -160.42 122.37 3.18 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 103.434 -2.802 . . . . 52.44 103.434 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.645 ' N ' ' HE2' ' A' ' 97' ' ' LYS . 5.2 tt -144.11 137.62 27.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.77 0.319 . . . . 62.35 110.515 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -129.09 123.88 33.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.205 -0.598 . . . . 65.34 110.553 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.553 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 86.2 t -86.94 129.78 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.629 -0.714 . . . . 71.51 109.145 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -107.16 127.87 53.9 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.622 -0.51 . . . . 74.22 109.622 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -104.04 117.71 34.94 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.812 -1.181 . . . . 74.51 107.812 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 59.4 ttt-85 -75.34 129.46 37.42 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.023 -1.473 . . . . 74.02 107.023 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 79.7 mt -89.87 134.28 32.31 Favored Pre-proline 0 C--N 1.271 -2.831 0 N-CA-C 109.868 -0.419 . . . . 73.44 109.868 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 74.7 Cg_exo -53.59 158.84 7.34 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.021 2.481 . . . . 74.51 112.972 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.451 HD22 ' HB2' ' A' ' 16' ' ' TRP . 2.1 t-20 -46.27 -54.32 9.08 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 126.137 1.775 . . . . 73.12 115.585 -172.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -72.29 -28.15 62.91 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.053 -0.659 . . . . 72.12 112.456 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.89 -12.56 55.28 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.623 -0.431 . . . . 73.34 111.458 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 49.9 mt-30 -70.9 -28.53 64.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.748 0.309 . . . . 62.41 111.482 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -38.24 92.38 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.975 -0.631 . . . . 60.44 111.64 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -157.41 98.9 1.93 Allowed Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.6 158.95 10.73 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.75 2.3 . . . . 75.2 112.586 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.5 156.2 66.4 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.434 2.089 . . . . 74.12 111.511 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -72.74 142.46 83.47 Favored Pre-proline 0 N--CA 1.426 -1.665 0 CA-C-N 115.958 -0.565 . . . . 61.24 110.011 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.74 114.74 3.43 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.844 2.362 . . . . 63.02 112.088 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -61.14 -42.65 98.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.739 -0.664 . . . . 75.3 109.498 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.539 ' HB2' HG23 ' A' ' 120' ' ' VAL . 9.0 m-20 -91.19 161.07 15.23 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 63.32 110.256 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -87.18 -28.4 22.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.507 -0.77 . . . . 63.01 109.03 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.3 p -79.07 -12.25 60.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.657 -0.701 . . . . 55.11 112.025 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 117' ' ' ASP . 59.3 t -100.14 116.99 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 105.833 -1.914 . . . . 63.13 105.833 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -128.78 143.43 50.92 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 120.701 -0.4 . . . . 74.53 110.316 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.0 mm -92.45 112.76 26.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.462 -0.94 . . . . 75.43 108.462 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.82 153.11 38.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.862 -0.792 . . . . 71.43 108.862 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 4.5 mp0 -98.45 146.87 25.3 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.994 0.426 . . . . 74.52 110.24 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 125' ' ' ARG . 32.6 mmt180 -134.54 120.99 20.35 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.637 -0.71 . . . . 75.13 109.697 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.28 156.15 43.65 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.651 -0.87 . . . . 70.32 108.651 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.22 19.39 78.48 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.194 -1.003 . . . . 50.15 114.096 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -120.08 145.25 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 C-N-CA 119.92 -0.712 . . . . 71.31 109.588 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.0 m -112.59 138.46 49.34 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 105.646 -1.983 . . . . 52.23 105.646 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.88 148.33 26.73 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 108.3 -1.0 . . . . 52.44 108.3 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -112.56 121.05 43.66 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 103.646 -2.724 . . . . 75.42 103.646 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.2 m -122.34 135.2 54.67 Favored 'General case' 0 C--N 1.263 -3.162 0 C-N-CA 120.587 -0.445 . . . . 60.45 109.926 -174.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.6 t -112.51 136.81 51.59 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 108.727 -0.842 . . . . 53.32 108.727 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 9.3 pt20 -117.25 130.03 56.3 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.527 -0.761 . . . . 65.23 109.404 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.83 168.37 19.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.405 -0.816 . . . . 71.23 109.515 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -126.38 136.35 9.48 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.922 -0.656 . . . . 64.42 112.022 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . 152.01 -163.22 30.06 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.203 -1.159 . . . . 54.42 110.203 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -99.13 107.71 20.14 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.562 -0.903 . . . . 74.23 108.562 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.18 133.38 35.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.203 1.186 . . . . 64.23 114.203 -172.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HB3' ' OE1' ' A' ' 141' ' ' GLU . 25.4 mtpp -112.33 177.5 4.62 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.941 -1.503 . . . . 73.34 106.941 170.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -63.27 -34.46 77.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.075 0.464 . . . . 54.13 109.98 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.57 -30.0 71.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.525 -0.762 . . . . 54.03 111.254 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.2 -31.72 71.43 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.968 0.413 . . . . 54.23 110.789 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' A' ' 185' ' ' VAL . 90.8 m-85 -73.03 -43.98 61.39 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.047 -0.524 . . . . 61.54 109.935 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.22 -48.36 87.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 O-C-N 123.42 0.45 . . . . 74.33 110.38 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.51 87.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.574 -0.739 . . . . 50.14 111.546 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.444 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 65.1 m80 -71.08 -34.8 71.52 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.463 -0.495 . . . . 63.54 112.068 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.446 0.165 . . . . 73.04 110.76 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.2 t -68.73 -32.72 72.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 74.12 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -66.75 -40.61 88.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.334 0.587 . . . . 72.14 109.762 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.46 HD21 ' HB ' ' A' ' 133' ' ' THR . 65.8 mt -65.05 -33.75 76.78 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 116.149 -0.478 . . . . 72.12 111.363 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 50.3 mtt180 -56.09 -49.04 74.95 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.483 0.489 . . . . 71.21 110.847 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.588 ' HA ' ' OE1' ' A' ' 156' ' ' GLU . 11.0 t -73.7 -29.56 62.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.922 -0.581 . . . . 61.33 110.807 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 34.1 m -71.14 -34.57 71.15 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.428 0.632 . . . . 63.3 109.691 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.45 0.52 16.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.491 0.716 . . . . 75.13 111.643 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.588 ' OE1' ' HA ' ' A' ' 153' ' ' THR . 46.5 mt-10 -84.16 140.22 31.89 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.55 -0.537 . . . . 71.53 109.55 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 96.88 -10.09 66.08 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.08 -0.581 . . . . 71.41 111.957 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 12.2 t -122.2 155.59 61.32 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.198 . . . . 63.01 107.764 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 36.56 0.1 Allowed 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 124.351 3.367 . . . . 44.13 114.287 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -101.03 119.04 38.16 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.123 0.487 . . . . 75.12 110.631 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 33.5 p -123.83 144.54 49.66 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.011 -0.737 . . . . 61.01 109.011 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -131.31 150.61 52.08 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.353 -0.24 . . . . 72.25 110.353 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -120.06 148.77 43.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.752 0.649 . . . . 72.11 112.752 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.25 1.95 37.93 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 115.112 0.805 . . . . 74.45 115.112 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB3' HH22 ' A' ' 152' ' ' ARG . 21.3 m-20 65.88 0.47 1.56 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.748 0.819 . . . . 61.33 112.04 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.63 139.27 20.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.648 0.737 . . . . 53.12 112.706 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -136.24 164.0 29.09 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.095 -1.076 . . . . 60.12 108.095 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 50.8 m-85 -115.63 151.38 35.09 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.411 -0.588 . . . . 75.25 109.411 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 83' ' ' SER . 60.4 m -113.94 123.7 50.38 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.928 -1.508 . . . . 63.1 106.928 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -111.72 149.21 31.95 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.859 0.362 . . . . 74.41 111.324 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -163.26 164.73 36.25 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 108.544 -1.823 . . . . 74.22 108.544 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -85.06 -39.3 18.13 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 117.837 0.818 . . . . 64.22 109.543 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -157.47 154.38 25.31 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 106.844 -1.539 . . . . 74.14 106.844 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -41.87 111.31 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.506 2.804 . . . . 61.34 112.716 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.43 130.83 37.85 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 123.866 3.044 . . . . 73.14 113.647 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.596 ' O ' ' HG3' ' A' ' 177' ' ' LYS . 26.0 ttt -87.87 -43.35 11.88 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 115.614 -0.721 . . . . 72.3 109.25 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 176' ' ' MET . 88.9 mttt 162.4 -67.48 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.192 0 C-N-CA 129.017 2.927 . . . . 74.03 108.835 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.14 -28.84 12.3 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 121.055 1.17 . . . . 71.1 109.388 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -84.57 123.87 30.8 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.682 -1.229 . . . . 71.54 107.682 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 101.7 43.84 2.05 Favored Glycine 0 C--N 1.3 -1.435 0 N-CA-C 109.867 -1.293 . . . . 25.52 109.867 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.6 ptp180 -96.88 -15.63 21.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.992 -0.604 . . . . 74.11 111.864 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -115.12 127.91 55.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.483 -2.414 . . . . 74.15 104.483 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 10.8 m120 -139.67 160.25 40.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.15 -0.62 . . . . 74.14 110.526 -171.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 133' ' ' THR . 49.6 mt-10 -132.45 145.9 51.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 123.753 0.658 . . . . 71.21 109.823 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 132' ' ' SER . 21.8 t -123.95 120.85 60.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 106.071 -1.826 . . . . 74.34 106.071 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 13.1 m0 -104.78 121.36 43.47 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.798 -0.361 . . . . 72.51 110.932 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 84.8 mt -99.1 131.18 45.32 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.03 -1.47 . . . . 54.34 107.03 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.35 135.21 38.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.506 -0.478 . . . . 63.52 110.563 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 161' ' ' THR . 19.9 pttp -72.0 143.24 49.26 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.563 -0.455 . . . . 73.42 110.854 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 115.062 -0.972 . . . . 74.35 110.505 178.26 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 . . . . . 0 CA--C 1.511 -0.552 0 N-CA-C 109.982 -0.377 . . . . 73.13 109.982 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.9 p -149.25 160.5 43.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.902 -0.777 . . . . 70.35 108.902 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.73 90.77 3.5 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 120.791 0.329 . . . . 63.45 110.976 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -124.55 162.94 22.97 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.459 -0.571 . . . . 74.23 109.459 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.03 13.64 68.63 Favored Glycine 0 C--N 1.31 -0.879 0 N-CA-C 110.452 -1.059 . . . . 24.12 110.452 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.8 p -76.82 160.97 28.83 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 123.398 0.679 . . . . 73.32 109.87 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.07 111.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.889 -0.782 . . . . 72.53 108.889 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.14 178.33 7.12 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.24 -0.436 . . . . 71.23 111.131 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.1 m -111.35 95.95 5.83 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 120.116 -0.634 . . . . 75.42 111.619 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -115.07 88.49 17.56 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 105.975 -1.861 . . . . 74.31 105.975 170.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -87.32 148.88 7.77 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.113 1.875 . . . . 71.35 114.216 -169.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.1 p90 -101.25 136.06 41.71 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 104.378 -2.453 . . . . 72.41 104.378 173.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 91.8 mt-30 -106.17 109.28 21.16 Favored 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 118.648 -1.221 . . . . 73.4 111.542 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.91 115.87 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 108.089 -1.078 . . . . 74.23 108.089 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -96.08 -36.55 10.96 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.074 -0.966 . . . . 62.31 111.883 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.471 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 42.6 t -157.12 150.41 23.98 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.296 0.569 . . . . 73.33 111.009 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.6 p -132.45 162.45 31.13 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.431 -1.692 . . . . 43.12 106.431 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.5 99.66 0.97 Allowed Glycine 0 C--N 1.304 -1.209 0 C-N-CA 118.297 -1.906 . . . . 61.43 114.243 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.07 -147.49 5.76 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.707 -0.957 . . . . 61.41 110.707 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -86.76 170.89 11.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.065 -0.717 . . . . 65.41 109.065 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.15 155.01 39.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.551 -0.907 . . . . 72.41 108.551 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 74.35 -52.81 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.791 0.836 . . . . 72.31 111.464 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.04 109.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 122.441 1.115 . . . . 72.34 110.376 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' THR . 20.8 m -111.53 128.66 56.09 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.662 -0.866 . . . . 74.44 108.662 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.04 155.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.558 -1.257 . . . . 62.43 111.301 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 35.2 tt0 -134.36 125.63 27.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.796 -1.557 . . . . 70.31 106.796 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 36.2 mt-10 -94.73 114.86 26.83 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.436 -1.69 . . . . 62.1 106.436 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.548 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 30.2 ptt180 -140.27 132.37 27.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.435 0.636 . . . . 75.52 112.54 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 129' ' ' THR . . . -80.98 137.34 36.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.093 -1.077 . . . . 53.03 108.093 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -58.87 149.8 25.87 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.772 0.67 . . . . 73.4 110.468 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -68.99 -21.18 64.17 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.975 -0.557 . . . . 53.41 112.032 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 9.72 68.5 Favored Glycine 0 C--O 1.244 0.766 0 C-N-CA 119.966 -1.111 . . . . 75.03 112.893 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 165.81 53.12 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 121.384 -0.436 . . . . 73.01 113.139 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -98.58 118.52 35.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.771 -0.826 . . . . 73.2 108.771 179.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.531 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 22.8 m-85 -124.33 165.63 17.35 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.736 -0.665 . . . . 72.41 111.494 -170.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.77 117.94 34.39 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.954 -0.758 . . . . 60.4 108.954 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -125.03 147.66 48.85 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.911 -0.586 . . . . 54.42 111.829 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.482 HG21 ' HG2' ' A' ' 61' ' ' LYS . 7.6 p -137.75 135.33 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 41.01 108.905 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -121.78 137.64 54.69 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.092 -1.043 . . . . 73.24 110.504 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 41.7 t -118.74 131.34 71.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.037 -1.468 . . . . 71.41 107.037 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -115.16 158.27 22.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.635 0.606 . . . . 45.14 112.635 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.455 ' HA ' ' CG ' ' A' ' 96' ' ' LYS . 36.3 t70 68.73 -12.89 0.35 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.629 1.972 . . . . 64.43 113.445 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.92 23.46 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 108.458 -0.941 . . . . 72.2 108.458 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.93 156.88 11.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.877 2.385 . . . . 73.43 111.337 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 98' ' ' LEU . 55.9 t -46.49 -47.68 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.893 0.877 . . . . 73.22 113.263 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 14.1 t70 -63.35 -47.84 80.46 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.528 -0.469 . . . . 74.31 110.208 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -63.56 -41.43 98.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.34 0.656 . . . . 73.23 112.195 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -65.42 -39.78 92.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.132 0.492 . . . . 54.11 110.115 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.9 tp -66.3 -33.75 76.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.883 -0.599 . . . . 62.33 110.001 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.684 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 29.9 mmt180 -59.05 -34.36 71.84 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.853 -0.612 . . . . 64.51 110.78 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.03 -49.53 10.12 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.312 -0.858 . . . . 63.31 110.72 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -66.99 -33.06 74.75 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.317 1.228 . . . . 64.25 114.317 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.581 ' O ' ' HG2' ' A' ' 63' ' ' MET . 6.5 mmt -61.11 -58.19 20.84 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 119.752 -0.779 . . . . 75.24 112.806 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.16 -30.84 91.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.407 2.071 . . . . 73.14 111.131 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HG2' HG21 ' A' ' 44' ' ' VAL . 18.1 tppt? -61.43 -44.49 97.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.092 -0.958 . . . . 65.13 110.369 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 38.4 mm -73.57 -39.41 53.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.313 -0.555 . . . . 65.32 109.583 175.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 59' ' ' MET . 25.9 mmt -55.38 -44.15 75.81 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.453 0.538 . . . . 70.0 112.453 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.01 -38.61 91.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.183 0.516 . . . . 74.44 110.652 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -70.83 -51.02 29.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.892 -0.595 . . . . 74.13 111.159 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 62' ' ' ILE . 14.6 p -74.85 -25.46 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-O 121.07 0.462 . . . . 72.15 111.229 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.75 -30.81 67.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.88 -0.6 . . . . 74.12 113.074 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.53 -3.63 1.88 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.271 -1.443 . . . . 52.42 113.855 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 m -89.56 27.07 1.56 Allowed 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 122.627 1.203 . . . . 72.45 109.387 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.08 177.29 7.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.068 -0.969 . . . . 74.15 109.231 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.82 -31.57 72.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.965 0.728 . . . . 70.24 112.965 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -87.6 -12.88 44.33 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.911 -0.716 . . . . 73.3 110.741 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.81 28.29 73.2 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.684 -0.77 . . . . 54.54 111.566 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.01 121.84 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.01 0.433 . . . . 73.14 109.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.95 63.74 0.61 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.431 -0.89 . . . . 74.12 112.144 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.93 -26.43 48.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.51 -0.552 . . . . 75.33 109.51 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.77 83.98 0.36 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.245 -0.889 . . . . 45.42 111.554 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 19.1 ptt? -96.19 125.41 40.69 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.926 0.393 . . . . 74.32 110.048 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.7 p -113.82 116.49 29.42 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.911 -0.586 . . . . 50.12 112.267 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.54 159.57 36.1 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 106.965 -1.495 . . . . 75.2 106.965 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.67 139.46 88.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.646 1.564 . . . . 71.53 112.616 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -103.94 153.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.193 -1.41 . . . . 72.31 107.193 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.4 m -133.75 145.45 49.83 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.303 -0.628 . . . . 73.53 109.303 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 51.4 p90 -138.12 139.96 39.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.403 -0.519 . . . . 64.34 110.309 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.69 134.87 34.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.878 -0.601 . . . . 63.52 110.175 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.48 150.02 30.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.952 -1.129 . . . . 70.5 107.952 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -119.48 108.05 40.17 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.17 -0.678 . . . . 73.11 109.17 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.4 142.09 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.088 1.858 . . . . 74.43 112.546 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.17 174.54 7.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.006 -0.543 . . . . 63.12 110.323 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -23.46 67.41 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.036 0.935 . . . . 61.24 110.622 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.46 -5.31 58.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.049 -0.978 . . . . 64.03 110.607 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.76 -10.25 65.7 Favored Glycine 0 CA--C 1.504 -0.636 0 CA-C-N 116.084 -0.507 . . . . 53.25 112.214 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 p -86.1 142.19 28.87 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.545 -0.539 . . . . 72.13 109.545 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 69.6 mt -75.84 145.21 40.79 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.024 -0.534 . . . . 74.44 110.61 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.64 150.25 32.7 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.657 -0.868 . . . . 74.51 108.657 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.527 ' H ' ' HD3' ' A' ' 96' ' ' LYS 0.291 0.2 OUTLIER -83.03 75.31 9.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.651 1.215 . . . . 73.23 112.031 178.938 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -164.09 125.03 2.2 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.536 -2.024 . . . . 71.14 105.536 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.515 HD12 HG13 ' A' ' 51' ' ' VAL . 5.6 tt -140.22 135.31 32.23 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.057 -0.719 . . . . 63.03 109.057 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -124.16 115.34 20.95 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.562 -0.29 . . . . 62.44 110.237 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.7 t -91.17 134.45 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.542 -0.54 . . . . 61.31 109.542 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -117.75 122.16 42.73 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.646 -0.872 . . . . 54.11 108.646 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 75.8 t80 -102.93 111.14 23.33 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.817 -1.549 . . . . 74.3 106.817 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.531 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 34.1 ttp180 -81.56 113.21 19.43 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.714 -0.675 . . . . 71.52 110.247 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.514 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 68.7 mt -79.07 134.09 60.19 Favored Pre-proline 0 C--N 1.284 -2.253 0 CA-C-N 114.463 -1.244 . . . . 73.42 110.907 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.521 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 50.7 Cg_exo -53.4 153.75 16.77 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.328 2.685 . . . . 74.33 112.067 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -56.47 -36.28 68.91 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.012 1.116 . . . . 64.54 114.012 -174.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -62.4 -36.2 81.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.159 0.504 . . . . 75.21 111.004 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.5 -6.17 56.65 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.988 -0.551 . . . . 70.23 110.997 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.514 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 26.0 mm-40 -71.7 -30.2 65.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.829 0.347 . . . . 72.54 110.75 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.24 73.47 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.472 -0.785 . . . . 61.44 111.908 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.5 p -160.18 89.02 1.83 Allowed Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-O 120.661 0.267 . . . . 73.24 110.495 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.49 154.27 9.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.178 1.918 . . . . 52.41 110.935 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.96 158.11 58.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.341 2.027 . . . . 74.1 111.352 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.85 149.53 80.47 Favored Pre-proline 0 C--O 1.259 1.593 0 C-N-CA 120.874 -0.33 . . . . 73.41 110.205 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 24.9 Cg_exo -65.73 106.75 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.697 2.265 . . . . 60.14 111.38 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.5 t -83.16 -25.66 31.63 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.53 -0.545 . . . . 73.33 109.53 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -98.63 143.89 28.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.317 -0.994 . . . . 71.15 108.317 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.18 -24.04 60.5 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.019 0.748 . . . . 71.45 113.019 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.2 m -89.81 -19.11 25.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.002 0.429 . . . . 63.33 109.892 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 61.9 t -94.89 116.27 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 107.102 -1.444 . . . . 72.21 107.102 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -124.35 136.31 53.99 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.603 -0.726 . . . . 71.21 110.449 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.5 mm -91.68 111.19 23.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.612 -1.255 . . . . 70.22 107.612 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -124.73 143.38 50.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.806 -1.088 . . . . 70.31 109.142 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -105.23 132.58 51.25 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.624 -0.716 . . . . 75.31 109.339 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -123.2 123.1 40.03 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.291 -1.003 . . . . 72.32 108.291 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.6 158.03 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.5 -0.555 . . . . 61.02 109.5 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.36 19.2 50.57 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.626 -0.797 . . . . 71.42 112.128 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.26 145.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 121.058 0.456 . . . . 71.03 110.367 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 90.4 m -112.64 135.49 53.3 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 107.87 -1.159 . . . . 72.44 107.87 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.16 150.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 N-CA-C 107.839 -1.171 . . . . 73.14 107.839 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.35 121.12 43.43 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 104.664 -2.347 . . . . 75.43 104.664 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 24.8 m -115.93 132.75 56.56 Favored 'General case' 0 C--N 1.261 -3.246 0 C-N-CA 120.339 -0.545 . . . . 71.33 110.834 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' SER . 9.9 t -113.24 119.94 39.46 Favored 'General case' 0 N--CA 1.391 -3.421 0 CA-C-N 115.587 -0.733 . . . . 71.32 109.614 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -110.88 126.03 54.26 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.404 -1.332 . . . . 65.04 107.404 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 22.3 p90 -136.6 167.6 21.08 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 115.352 -0.84 . . . . 75.04 110.687 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -133.32 143.3 14.96 Favored Glycine 0 CA--C 1.485 -1.798 0 C-N-CA 120.484 -0.865 . . . . 52.33 111.559 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.81 -155.28 25.79 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.258 -1.137 . . . . 63.01 110.258 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -99.93 103.08 14.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.834 -0.802 . . . . 75.3 108.834 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.62 117.53 31.86 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.41 -0.359 . . . . 64.44 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HA ' ' CE2' ' A' ' 179' ' ' TYR . 40.5 ttmt -81.13 163.84 22.82 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.831 -1.174 . . . . 72.21 107.831 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.74 -35.23 42.5 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.004 0.522 . . . . 60.34 111.607 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.87 65.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.065 -0.516 . . . . 71.11 111.121 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.33 -30.89 69.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.119 -0.491 . . . . 73.44 110.433 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -59.72 -49.43 77.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.299 -0.63 . . . . 72.31 109.299 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.1 t -59.96 -42.96 91.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 115.032 -0.986 . . . . 52.52 109.341 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.16 85.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.46 -0.791 . . . . 33.42 111.179 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.511 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 29.3 m80 -66.94 -33.89 76.57 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 112.536 0.569 . . . . 71.02 112.536 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.23 -45.14 94.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.398 0.618 . . . . 62.03 109.627 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 m -66.58 -35.3 79.87 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.421 -0.809 . . . . 71.11 109.868 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.09 -29.01 61.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.752 -0.658 . . . . 74.33 111.373 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 82.6 mt -61.7 -36.71 81.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.944 -0.391 . . . . 71.14 109.944 173.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -57.42 -48.19 79.78 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.854 0.721 . . . . 72.22 110.802 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.6 t -75.72 -30.15 59.16 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.113 -0.494 . . . . 73.34 110.952 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.4 m -74.85 -34.17 62.25 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.358 0.599 . . . . 73.15 110.819 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.54 6.75 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.373 0.606 . . . . 72.13 110.36 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 131.53 34.34 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.826 -1.546 . . . . 72.04 106.826 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.89 -4.78 61.35 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.514 -0.635 . . . . 65.14 111.514 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.1 p -99.89 163.94 17.44 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 107.844 -1.169 . . . . 43.24 107.844 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 63.6 Cg_endo -73.88 0.82 7.79 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.992 1.794 . . . . 71.35 112.901 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.95 140.99 32.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.881 0.372 . . . . 73.54 111.557 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 41.0 p -118.13 153.48 33.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.212 -0.662 . . . . 64.25 109.212 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.434 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 38.8 p90 -135.3 137.81 42.85 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.139 -0.35 . . . . 75.11 110.171 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.634 ' NE2' HG13 ' A' ' 188' ' ' VAL 0.26 0.4 OUTLIER -97.92 116.63 30.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.739 1.385 . . . . 74.44 114.739 -176.455 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.81 13.16 65.82 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.773 -0.649 . . . . 75.55 112.623 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . 0.261 8.6 p-10 49.38 27.66 2.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.765 1.226 . . . . 74.52 113.22 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 187' ' ' LEU . 77.6 t -66.57 138.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 113.968 -1.469 . . . . 73.12 110.137 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -143.26 171.13 14.53 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.989 -0.55 . . . . 61.43 111.492 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 4.2 m-85 -121.75 150.54 41.68 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.671 -0.695 . . . . 64.54 109.865 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 20.4 t -115.02 146.22 41.48 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.994 -1.113 . . . . 75.01 107.994 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.36 158.5 18.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.925 0.393 . . . . 74.15 110.907 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.53 156.32 26.79 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 108.732 -1.747 . . . . 71.02 108.732 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -142.46 -38.59 0.36 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 114.051 1.13 . . . . 72.24 114.051 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.459 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 4.2 p-10 -154.26 154.9 30.35 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 108.912 -0.774 . . . . 70.33 108.912 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.29 105.59 1.63 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.233 1.955 . . . . 74.0 108.99 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 69.0 Cg_endo -74.54 149.37 38.91 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 122.197 1.932 . . . . 71.41 112.609 -173.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.6 ptm -80.67 -21.37 41.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.534 -1.284 . . . . 73.11 107.534 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -83.24 152.44 64.73 Favored Pre-proline 0 N--CA 1.431 -1.414 0 N-CA-C 104.7 -2.333 . . . . 74.42 104.7 172.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.57 -33.02 29.48 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.32 2.013 . . . . 62.35 114.107 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 140' ' ' LYS . 89.5 m-85 -152.4 172.43 16.51 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 122.949 0.5 . . . . 72.4 109.746 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.67 -179.71 49.12 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.168 -1.173 . . . . 45.24 110.168 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -86.28 -24.16 26.05 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 117.538 0.669 . . . . 73.15 111.787 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -116.6 136.06 53.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.085 0.469 . . . . 74.12 110.579 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.2 m120 -126.52 146.94 49.93 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.729 -1.582 . . . . 72.33 106.729 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 133' ' ' THR . 33.9 tt0 -142.82 132.64 24.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.965 -0.694 . . . . 53.14 110.459 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 132' ' ' SER . 82.4 t -126.49 130.18 71.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.863 0.865 . . . . 61.14 109.287 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.5 m0 -109.36 121.3 44.87 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 109.449 -0.574 . . . . 63.44 109.449 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 166' ' ' VAL . 40.3 tp -100.78 135.48 42.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.865 -1.532 . . . . 73.31 106.865 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.634 HG13 ' NE2' ' A' ' 163' ' ' GLN . 6.1 p -106.72 135.44 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 114.036 1.124 . . . . 75.35 114.036 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -63.16 144.37 56.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.015 1.326 . . . . 71.41 114.421 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HA ' ' HG3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.241 -0.89 . . . . 64.05 109.045 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 109.043 -0.725 . . . . 73.12 109.043 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.1 t 73.29 112.16 0.06 Allowed 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.962 1.305 . . . . 63.12 111.291 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 99.1 mt -108.15 136.78 47.25 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.125 -1.065 . . . . 70.43 108.125 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -95.03 103.37 15.22 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 112.605 0.594 . . . . 62.5 112.605 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.97 65.17 3.52 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 108.486 -1.846 . . . . 64.24 108.486 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.5 p -61.51 109.67 1.24 Allowed 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 113.642 0.979 . . . . 64.04 113.642 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.08 78.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-O 122.415 1.102 . . . . 63.2 109.09 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -116.08 99.95 7.6 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.606 -1.179 . . . . 72.41 111.226 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.6 p -111.88 104.95 13.27 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.368 -0.833 . . . . 74.32 110.785 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 109' ' ' GLN . 3.2 p90 -73.36 120.0 78.76 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-O 120.908 0.385 . . . . 70.23 110.73 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -87.69 150.25 7.41 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.343 2.695 . . . . 61.55 114.536 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -101.3 154.42 18.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.426 -1.694 . . . . 55.14 106.426 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -121.11 109.62 15.24 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.929 -1.109 . . . . 75.14 112.392 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.45 125.68 45.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.103 -1.814 . . . . 75.23 106.103 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 22' ' ' SER . 2.9 pp -90.22 -29.26 18.31 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.677 -1.209 . . . . 74.21 111.366 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.491 ' N ' HD12 ' A' ' 21' ' ' LEU . 30.7 t -179.32 164.59 1.37 Allowed 'General case' 0 C--O 1.25 1.117 0 O-C-N 123.575 0.547 . . . . 74.42 110.124 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -131.19 165.76 22.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.852 -1.166 . . . . 63.44 107.852 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.68 -164.38 29.87 Favored Glycine 0 C--N 1.306 -1.139 0 C-N-CA 120.577 -0.82 . . . . 54.45 111.545 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.92 -138.75 10.44 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.597 -0.811 . . . . 73.51 112.263 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -118.09 170.73 8.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.107 -1.442 . . . . 71.24 107.107 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.96 159.67 33.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 118.569 0.622 . . . . 74.4 110.07 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 76.26 -52.78 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.754 1.622 . . . . 61.14 110.426 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG11 ' HG3' ' A' ' 150' ' ' GLN . 7.7 p -120.14 110.0 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-O 122.235 1.017 . . . . 74.13 109.811 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 133' ' ' THR . 45.0 m -122.16 154.11 37.87 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.446 -0.946 . . . . 51.13 108.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.735 ' HB3' HD11 ' A' ' 151' ' ' LEU . 8.9 p90 -118.06 156.52 28.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.91 1.078 . . . . 72.23 113.91 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.32 125.9 23.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.734 -1.95 . . . . 73.11 105.734 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 115.1 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.499 -1.667 . . . . 73.1 106.499 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -131.79 133.7 45.02 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.687 -0.688 . . . . 74.34 111.403 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.63 136.27 33.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.26 -1.385 . . . . 53.04 107.26 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.43 158.08 21.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.548 0.573 . . . . 71.14 112.548 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -86.54 -18.66 30.95 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.665 -0.698 . . . . 74.45 112.858 -174.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.81 46.62 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.494 -1.813 . . . . 71.4 112.544 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.35 149.22 46.81 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.804 -0.712 . . . . 42.13 113.874 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 104' ' ' ILE . 19.5 ptmt -88.88 119.45 29.4 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.656 -0.868 . . . . 63.24 108.656 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.552 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 27.7 m-85 -127.0 166.35 17.73 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 123.693 0.797 . . . . 74.41 111.083 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -97.56 116.82 30.5 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.092 -1.077 . . . . 60.1 108.092 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.8 t -135.29 150.76 50.08 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 115.414 -0.812 . . . . 74.14 112.516 -173.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 9.2 p -141.64 142.28 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.121 -1.066 . . . . 74.21 108.121 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.3 133.05 48.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.658 -0.817 . . . . 74.32 112.572 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.58 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 52.7 t -112.08 141.87 26.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.656 -1.979 . . . . 72.52 105.656 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' LYS . 26.4 p -132.31 152.24 51.48 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.668 0.988 . . . . 52.25 113.668 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 67.6 -16.37 0.17 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 126.204 1.801 . . . . 74.23 112.141 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' THR . 48.6 mtpt -88.78 146.86 37.84 Favored Pre-proline 0 N--CA 1.422 -1.874 0 C-N-CA 124.175 0.99 . . . . 70.34 110.035 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 31.2 Cg_exo -60.23 153.05 61.91 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.509 2.139 . . . . 60.1 111.675 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 98' ' ' LEU . 32.2 t -49.89 -42.56 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 124.035 0.934 . . . . 53.23 112.316 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.698 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 13.0 t70 -61.63 -46.32 90.3 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.548 -0.461 . . . . 73.23 109.823 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -69.01 -42.13 76.83 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.199 -0.455 . . . . 74.33 111.48 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.15 -42.46 99.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.723 -0.672 . . . . 72.5 111.062 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.11 -31.97 72.79 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 116.336 -0.393 . . . . 72.55 111.156 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 5.2 mmp_? -55.95 -41.51 74.78 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.734 0.646 . . . . 75.1 110.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 44.4 mt-10 -84.41 -43.55 14.56 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.085 -0.507 . . . . 71.12 112.08 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.423 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -68.97 -41.82 77.42 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.52 1.304 . . . . 43.45 114.52 -171.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.4 ttm -57.27 -48.54 97.18 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.54 0.941 . . . . 71.53 113.54 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.68 -31.89 52.4 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.264 1.976 . . . . 75.11 112.245 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 91.0 mttt -72.12 -35.53 69.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.389 0.614 . . . . 55.33 111.058 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.05 -34.19 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 116.016 -0.538 . . . . 75.45 110.536 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 ttp -64.58 -43.31 94.26 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 124.062 0.945 . . . . 63.41 110.581 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 21.3 ptmt -69.48 -31.62 70.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.559 -0.291 . . . . 74.41 110.704 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -62.44 -60.48 3.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.46 -0.336 . . . . 74.21 111.796 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 76' ' ' MET . 14.6 p -83.86 -2.24 6.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-O 121.988 0.899 . . . . 72.13 109.859 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.01 -32.36 32.5 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.674 -0.774 . . . . 35.42 111.72 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 140.97 -2.56 2.14 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.689 -1.243 . . . . 51.22 113.52 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.5 m -92.06 34.32 1.02 Allowed 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.504 1.145 . . . . 64.52 109.156 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.48 ' OD1' HG12 ' A' ' 74' ' ' VAL . 7.2 p30 -96.8 168.93 10.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.769 -0.65 . . . . 74.24 109.759 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 23.2 t70 -71.79 -27.7 63.12 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.794 0.665 . . . . 71.14 112.794 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.91 -14.12 58.86 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.627 0.727 . . . . 70.33 109.334 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.63 78.6 Favored Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 110.847 -0.901 . . . . 75.43 110.847 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 14.5 p -93.11 153.08 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 108.127 -1.064 . . . . 74.12 108.127 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -133.48 0.41 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.736 -0.745 . . . . 54.24 112.416 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.728 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 55.7 ttp -76.61 -75.66 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.494 -0.482 . . . . 73.34 110.03 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.68 -52.01 0.68 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.541 0.977 . . . . 44.41 115.541 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.485 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 62.0 mtm -101.45 124.99 48.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 117.756 0.778 . . . . 71.04 111.356 -173.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.7 m -126.3 114.49 18.33 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.808 -0.441 . . . . 73.53 109.808 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 103' ' ' ARG . 24.9 m -148.78 167.75 12.47 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 108.125 -1.065 . . . . 73.03 108.125 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.49 146.33 84.76 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.894 1.729 . . . . 74.02 111.592 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.3 144.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.374 -0.973 . . . . 53.32 108.374 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 p -129.22 146.14 51.19 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 110.126 -0.324 . . . . 74.04 110.126 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.37 138.89 43.78 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.536 -0.465 . . . . 70.12 110.078 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.62 135.05 34.41 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.019 -0.734 . . . . 75.52 109.019 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.86 150.23 26.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 108.331 -0.988 . . . . 43.24 108.331 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 6.1 m-85 -123.52 105.11 33.52 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 121.018 -0.273 . . . . 74.23 110.573 -175.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.17 159.03 17.79 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.473 2.116 . . . . 75.03 111.871 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -104.36 166.51 10.35 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.385 -0.968 . . . . 72.21 108.385 175.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.84 -17.53 50.48 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.96 1.096 . . . . 75.23 113.96 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -98.73 -1.26 40.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.235 -0.586 . . . . 64.23 112.163 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.18 1.0 55.87 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.632 1.013 . . . . 63.22 115.632 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.2 m -83.79 136.98 33.94 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.452 1.126 . . . . 74.32 109.528 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.4 mt -93.38 78.1 4.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.165 0.507 . . . . 73.32 110.513 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -149.36 114.49 5.46 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.867 -0.606 . . . . 74.41 110.911 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 87' ' ' PHE . 56.2 tttp 178.19 -62.41 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.21 -1.033 . . . . 72.41 108.21 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.489 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 22.7 ttmm -154.31 149.34 26.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.518 -1.29 . . . . 73.14 107.518 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.592 HD12 HG13 ' A' ' 51' ' ' VAL . 5.9 tt -141.01 124.94 17.09 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.997 -1.853 . . . . 71.21 105.997 169.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 79.4 tttt -130.87 115.19 16.24 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 120.423 -0.511 . . . . 50.24 110.05 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' THR . 62.1 t -83.88 133.78 28.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.692 -0.685 . . . . 64.22 109.322 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -121.62 113.63 20.04 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.748 0.819 . . . . 73.43 109.156 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 89.6 t80 -103.74 115.97 31.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.319 -0.993 . . . . 75.01 108.319 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.552 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 29.4 ttt85 -76.11 136.35 39.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.336 -0.847 . . . . 73.44 110.416 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.436 HD11 HD12 ' A' ' 122' ' ' ILE . 77.8 mt -103.47 126.96 30.63 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 109.478 -0.564 . . . . 75.21 109.478 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 84.2 Cg_exo -46.83 151.25 2.2 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.491 2.794 . . . . 74.45 113.028 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.04 -42.58 65.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.443 1.275 . . . . 64.42 114.443 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.28 -30.96 72.0 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.353 0.597 . . . . 65.12 110.875 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.66 -2.88 55.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.912 -0.585 . . . . 63.23 110.839 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.671 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.09 -36.24 74.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.586 -0.524 . . . . 74.34 109.586 175.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.19 -31.7 78.18 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-N 115.464 -0.789 . . . . 61.02 112.026 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -160.34 97.3 1.46 Allowed Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 109.049 -0.723 . . . . 61.22 109.049 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.62 162.08 1.86 Allowed 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 123.274 2.649 . . . . 63.31 111.519 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.58 133.76 44.23 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.032 1.821 . . . . 74.14 110.093 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -74.88 152.69 86.83 Favored Pre-proline 0 C--O 1.255 1.395 0 CA-C-N 116.515 -0.311 . . . . 70.32 111.48 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 17.2 Cg_exo -69.46 111.13 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.761 2.308 . . . . 64.23 112.146 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -85.25 -8.69 58.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.827 0.822 . . . . 74.41 108.795 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.95 148.42 42.21 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.241 -1.392 . . . . 72.15 107.241 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -88.62 -9.97 50.3 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.858 1.429 . . . . 63.23 114.858 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.501 ' CB ' ' HD3' ' A' ' 61' ' ' LYS . 17.7 m -81.53 -45.03 16.51 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.813 -0.81 . . . . 74.15 108.813 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 5.9 p -95.5 115.85 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 108.83 -0.804 . . . . 73.31 108.83 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -119.0 151.22 38.59 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.842 -0.799 . . . . 74.12 108.842 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 30.8 mm -92.56 110.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.427 -1.323 . . . . 73.35 107.427 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -127.14 146.48 50.38 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.387 -0.824 . . . . 73.4 108.9 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.06 144.13 34.18 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 109.023 -0.732 . . . . 70.04 109.023 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.555 ' HA ' ' HE ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -129.74 123.13 30.3 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.169 -1.413 . . . . 71.53 110.008 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.24 156.63 45.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.105 -2.554 . . . . 72.43 104.105 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.5 8.03 62.86 Favored Glycine 0 C--N 1.281 -2.52 0 C-N-CA 120.661 -0.78 . . . . 70.43 112.859 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.0 pt -121.61 145.66 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.353 -0.539 . . . . 62.1 110.275 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.0 m -120.88 137.44 54.57 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.039 -0.982 . . . . 74.24 109.126 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.36 160.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-N 115.767 -0.651 . . . . 73.24 110.021 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.515 ' OH ' ' HE2' ' A' ' 189' ' ' LYS . 39.3 m-85 -114.03 122.56 47.27 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.232 -2.136 . . . . 75.11 105.232 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m -106.82 127.89 53.79 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.835 -0.346 . . . . 70.53 111.145 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.553 ' HB ' HD13 ' A' ' 151' ' ' LEU . 14.0 t -113.43 138.98 49.31 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.808 -0.812 . . . . 63.23 108.808 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.46 125.82 42.76 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.455 -0.793 . . . . 72.12 109.895 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -132.86 140.69 48.04 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.444 -0.798 . . . . 72.11 109.581 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 182' ' ' ARG . . . -102.8 145.99 16.53 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.842 -0.694 . . . . 63.01 112.852 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.71 -140.26 14.84 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.984 -1.103 . . . . 72.23 113.906 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 39.5 t80 -76.63 126.7 31.43 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.8 0.84 . . . . 72.35 112.006 -172.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.81 136.82 54.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.794 -0.639 . . . . 70.12 110.303 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.569 ' H ' ' HB3' ' A' ' 143' ' ' ASP . 38.8 ttmt -114.98 155.41 26.98 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.615 -1.994 . . . . 62.51 105.615 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -53.67 -45.19 70.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 118.412 0.551 . . . . 70.14 110.001 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.75 70.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 42.43 111.399 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.569 ' HB3' ' H ' ' A' ' 140' ' ' LYS . 28.2 t70 -74.73 -30.62 61.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 110.063 -0.347 . . . . 62.12 110.063 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -63.33 -44.85 93.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.827 -0.805 . . . . 53.12 108.827 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 141' ' ' GLU . 61.0 t -60.02 -51.24 75.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.058 -0.974 . . . . 71.43 109.579 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.11 86.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.586 -0.734 . . . . 64.42 111.562 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 150' ' ' GLN . 24.6 m80 -62.38 -33.45 74.76 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 113.445 0.906 . . . . 65.54 113.445 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.01 79.32 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.481 0.488 . . . . 73.33 111.409 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.5 m -78.09 -35.14 49.73 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.801 0.334 . . . . 64.45 111.015 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.517 ' HG3' HG11 ' A' ' 29' ' ' VAL . 7.1 tp60 -58.68 -36.37 74.09 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.211 0.529 . . . . 75.35 109.692 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 31' ' ' TYR . 46.1 tp -65.4 -39.12 91.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.528 -0.76 . . . . 73.24 110.127 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.0 mtm180 -63.3 -44.07 96.03 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 116.436 -0.347 . . . . 75.21 110.308 177.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.3 m -61.98 -34.78 76.78 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.521 0.677 . . . . 72.23 110.582 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.6 m -74.02 -33.97 63.95 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.552 0.691 . . . . 74.33 109.965 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 26.3 mt -83.7 6.98 19.05 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.938 0.895 . . . . 73.53 112.61 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 43.9 mt-10 -75.79 145.59 40.62 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.104 -1.038 . . . . 71.43 112.498 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.66 12.64 46.77 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.548 -1.021 . . . . 60.11 110.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 p -122.11 165.66 19.84 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 107.809 -1.182 . . . . 62.12 107.809 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 96.3 Cg_endo -81.27 21.63 0.89 Allowed 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 121.886 1.724 . . . . 74.32 111.968 174.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 121.12 24.76 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.085 0.469 . . . . 52.21 111.217 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.0 m -105.32 157.68 17.15 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.45 -1.315 . . . . 73.55 107.45 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.33 157.64 46.17 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.635 -0.876 . . . . 71.43 108.635 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.6 pt20 -119.07 109.75 16.28 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.579 -0.849 . . . . 74.43 111.064 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.51 8.08 55.03 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.39 -0.909 . . . . 44.41 114.35 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.97 26.42 14.13 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.767 0.794 . . . . 75.2 109.621 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.7 138.86 22.05 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 115.64 -0.709 . . . . 63.43 110.32 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 24.8 p90 -148.2 167.9 23.88 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.884 -0.598 . . . . 61.2 112.249 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 8.3 m-85 -115.71 153.72 30.84 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.501 -0.772 . . . . 74.21 110.259 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.65 136.77 54.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.591 -1.633 . . . . 65.24 106.591 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -132.13 156.85 45.64 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.119 0.414 . . . . 60.12 112.119 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.32 163.81 37.1 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 109.085 -1.606 . . . . 54.33 109.085 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.432 ' OH ' ' HD2' ' A' ' 181' ' ' ARG . 14.5 p90 -127.57 -32.79 2.37 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 114.235 1.198 . . . . 74.43 114.235 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -119.94 144.87 38.41 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.596 -0.89 . . . . 52.25 108.596 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.87 127.3 23.88 Favored 'Trans proline' 0 C--O 1.252 1.222 0 C-N-CA 121.96 1.773 . . . . 73.33 109.285 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.4 129.88 22.48 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 121.66 1.574 . . . . 71.13 111.9 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.36 -42.33 9.85 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 106.236 -1.765 . . . . 51.1 106.236 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -106.45 152.33 40.59 Favored Pre-proline 0 N--CA 1.419 -2.013 0 N-CA-C 107.379 -1.341 . . . . 72.32 107.379 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.77 -12.95 34.07 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.962 2.441 . . . . 65.22 112.755 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 138' ' ' TYR . 45.0 m-85 -68.37 -81.45 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.191 0.811 . . . . 72.02 113.191 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 105.12 176.76 24.43 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.873 -1.691 . . . . 74.21 108.873 -172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.432 ' HD2' ' OH ' ' A' ' 172' ' ' TYR . 79.6 mtt180 -97.38 -56.25 2.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.744 1.272 . . . . 62.33 109.322 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.512 ' HA ' ' HA2' ' A' ' 136' ' ' GLY . 14.6 ptt180 -152.13 157.65 41.84 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.521 -2.029 . . . . 73.41 105.521 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -134.72 142.97 46.93 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.882 -0.784 . . . . 52.31 108.882 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 9.3 mm-40 -111.49 132.5 54.45 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.384 -0.969 . . . . 73.23 108.384 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.494 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 88.5 t -127.06 121.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.074 -0.713 . . . . 75.14 109.074 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.599 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 33.1 m0 -107.0 124.94 50.34 Favored 'General case' 0 C--O 1.199 -1.574 0 CA-C-O 119.606 -0.235 . . . . 74.32 110.799 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 167' ' ' TYR . 82.6 mt -96.64 138.75 33.74 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.375 -0.972 . . . . 52.23 108.375 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.11 129.64 53.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 120.04 -0.664 . . . . 74.41 109.366 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.515 ' HE2' ' OH ' ' A' ' 131' ' ' TYR . 19.2 ptpt -72.94 142.99 47.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 71.43 111.422 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 118.963 -0.541 . . . . 61.13 109.773 176.568 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 CA--C 1.505 -0.758 0 N-CA-C 110.175 -0.305 . . . . 75.22 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.0 m -104.53 100.97 10.65 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.994 -0.372 . . . . 72.2 109.994 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 9' ' ' LEU . 1.9 pt? -71.09 152.6 43.33 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.411 -0.359 . . . . 62.12 110.516 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.418 ' HD2' ' O ' ' A' ' 12' ' ' SER . 59.6 t80 -83.55 147.72 27.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.147 -1.057 . . . . 75.54 108.147 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.27 -60.26 9.28 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 115.091 0.797 . . . . 54.21 115.091 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' HD2' ' A' ' 10' ' ' PHE . 32.7 p -105.54 157.24 17.52 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 117.212 0.506 . . . . 72.13 111.054 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.52 77.1 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.08 0 CA-C-O 122.616 1.198 . . . . 64.35 110.899 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -145.87 114.57 6.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.439 -1.255 . . . . 71.2 108.841 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -79.77 -31.09 40.86 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.447 -0.945 . . . . 54.32 108.447 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -155.39 123.98 2.98 Favored Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 105.842 -1.91 . . . . 75.11 105.842 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.26 134.59 25.16 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.598 1.532 . . . . 72.22 112.67 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.546 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 1.7 p90 -102.54 159.27 15.59 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.75 -0.833 . . . . 75.11 108.75 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -105.65 112.53 25.65 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.226 -0.59 . . . . 62.11 110.911 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.58 127.94 41.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.036 -1.468 . . . . 71.24 107.036 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.53 HD21 ' OE2' ' A' ' 33' ' ' GLU . 3.6 pp -95.77 -24.9 16.28 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.938 -1.105 . . . . 73.33 112.925 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.1 p -175.71 160.2 2.4 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 123.361 0.413 . . . . 73.35 111.611 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 73.9 p -131.21 154.12 48.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.283 -1.006 . . . . 63.22 108.283 174.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.59 -146.41 14.44 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 119.518 -1.325 . . . . 63.33 112.085 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.09 -118.02 5.11 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.705 -0.958 . . . . 50.33 110.705 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -117.44 169.28 9.64 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.741 -1.577 . . . . 73.03 106.741 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -87.16 157.05 19.45 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.13 -1.028 . . . . 74.52 111.911 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 82.0 -41.92 0.14 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.4 1.88 . . . . 74.04 110.053 -172.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.35 109.92 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.802 -1.184 . . . . 74.44 107.802 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 p -113.41 153.58 28.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.38 -0.6 . . . . 72.01 109.38 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 23' ' ' THR . 0.3 OUTLIER -112.88 150.87 31.15 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.587 -0.445 . . . . 71.5 111.319 178.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 36.3 tt0 -137.33 124.33 21.48 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.483 -1.673 . . . . 70.22 106.483 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' OE2' HD21 ' A' ' 21' ' ' LEU . 36.1 tt0 -100.5 117.6 34.99 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.138 -1.43 . . . . 62.53 107.138 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.531 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 28.8 ptt180 -138.4 144.71 40.34 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.096 -0.642 . . . . 72.45 110.837 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -81.96 136.61 35.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.493 -0.929 . . . . 62.2 108.493 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.47 133.81 51.17 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.65 0.241 . . . . 71.21 111.65 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' CD ' HH12 ' A' ' 103' ' ' ARG . 8.6 pt-20 -55.28 -45.11 76.18 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.945 -0.57 . . . . 70.32 112.072 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.54 10.29 50.88 Favored Glycine 0 C--N 1.311 -0.856 0 C-N-CA 119.673 -1.251 . . . . 54.42 114.682 176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.62 165.22 52.49 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.357 -0.925 . . . . 75.15 112.182 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -90.16 131.64 35.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 75.01 110.881 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 60.3 m-85 -131.33 166.04 22.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.404 0.682 . . . . 73.33 110.951 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.45 116.21 29.23 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 107.837 -1.171 . . . . 73.14 107.837 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 7.5 t -124.41 144.58 49.97 Favored 'General case' 0 N--CA 1.402 -2.867 0 CA-C-N 115.419 -0.809 . . . . 70.32 112.044 -175.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.6 m -127.85 145.08 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.913 -1.04 . . . . 74.15 109.446 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -122.34 128.61 51.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.945 0.403 . . . . 62.34 111.158 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.637 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 22.0 t -125.73 142.43 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.455 -1.313 . . . . 73.41 107.455 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 49' ' ' LYS . 17.5 p -134.32 166.81 21.97 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 122.097 0.159 . . . . 74.42 111.42 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.7 t70 71.88 -36.17 0.35 Allowed 'General case' 0 N--CA 1.514 2.769 0 C-N-CA 125.131 1.372 . . . . 72.13 112.12 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 47' ' ' THR . 25.0 mtpp -86.14 141.32 35.05 Favored Pre-proline 0 C--N 1.282 -2.36 0 C-N-CA 124.786 1.235 . . . . 75.41 109.743 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.67 155.89 40.33 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.316 2.01 . . . . 73.12 109.367 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.63 -36.18 41.39 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 113.635 0.976 . . . . 72.32 113.635 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 15.9 t70 -60.01 -47.74 84.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.739 -0.467 . . . . 74.04 109.739 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -69.7 -41.62 75.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.699 . . . . 74.4 111.3 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -61.58 -42.35 98.72 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.914 -0.585 . . . . 71.5 110.334 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 tp -60.22 -35.23 74.96 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.13 0.972 . . . . 63.21 110.759 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 26.0 mmt180 -63.83 -35.23 79.93 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.463 0.649 . . . . 72.12 109.524 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 28.0 tt0 -82.95 -32.03 27.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 73.4 110.135 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.18 60.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.306 0.854 . . . . 63.53 113.306 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 8.9 mmt -55.34 -56.16 31.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 112.796 0.665 . . . . 74.32 112.796 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.64 -31.26 69.88 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.7 2.267 . . . . 75.03 113.193 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 95.4 mttt -62.53 -49.36 75.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.027 0.441 . . . . 72.12 110.162 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.85 -38.0 81.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 120.635 -0.426 . . . . 71.42 110.836 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.3 mtt -61.01 -38.97 87.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.833 0.679 . . . . 74.41 112.833 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -72.56 -31.38 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.219 -0.592 . . . . 74.24 110.684 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.07 -55.32 22.97 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.317 -0.402 . . . . 73.23 110.783 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.79 -10.4 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.162 0.505 . . . . 53.24 111.209 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -21.98 73.65 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.606 -0.725 . . . . 73.45 111.483 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 127.88 -5.63 6.94 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.934 -1.127 . . . . 71.13 113.598 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -86.25 33.76 0.62 Allowed 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.565 1.174 . . . . 72.13 110.105 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -93.99 173.1 7.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.06 -0.973 . . . . 53.12 108.841 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.32 -34.45 78.16 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.373 0.508 . . . . 71.32 112.373 -173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.523 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -83.78 -12.6 55.47 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.508 -0.477 . . . . 75.12 109.998 -177.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.87 27.85 72.64 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.713 0.633 . . . . 52.31 112.321 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 35.8 m -86.16 122.06 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.041 -0.664 . . . . 63.23 111.31 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.62 86.63 0.7 Allowed Glycine 0 N--CA 1.432 -1.58 0 CA-C-N 115.611 -0.722 . . . . 72.54 111.323 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -150.27 116.1 5.58 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.187 0.517 . . . . 61.54 110.19 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.83 124.59 7.1 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.644 -0.707 . . . . 73.41 112.069 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.8 ptp -105.82 126.46 52.2 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.962 -0.755 . . . . 73.21 108.962 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 p -120.38 115.87 24.36 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.303 0.573 . . . . 55.4 111.302 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.608 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 10.8 m -154.03 -179.89 1.16 Allowed Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 125.801 1.64 . . . . 74.44 106.922 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 84.5 Cg_exo -51.0 140.67 39.01 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.751 2.301 . . . . 73.21 115.414 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.91 138.16 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 106.787 -1.56 . . . . 72.04 106.787 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -133.87 145.25 49.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.674 -0.491 . . . . 53.12 109.674 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 98' ' ' LEU . 52.2 p90 -145.28 138.31 26.32 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.902 -0.499 . . . . 73.02 111.169 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -93.18 135.28 34.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.461 -0.94 . . . . 70.45 108.461 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 166' ' ' VAL . 33.4 m -121.15 149.16 24.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.719 -0.845 . . . . 71.43 108.719 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.56 105.51 51.85 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 116.118 -0.492 . . . . 75.42 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.28 159.05 20.09 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.898 1.732 . . . . 65.45 110.801 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.414 HD21 ' HG2' ' A' ' 96' ' ' LYS . 50.8 m-80 -122.33 162.66 21.13 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.79 -0.818 . . . . 72.1 108.79 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.77 -13.7 59.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.557 0.694 . . . . 62.2 110.513 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.69 -6.67 58.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.845 -1.071 . . . . 75.41 110.099 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.28 10.27 83.88 Favored Glycine 0 C--O 1.218 -0.876 0 CA-C-N 115.911 -0.586 . . . . 72.51 113.192 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 m -105.24 134.76 47.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.874 0.337 . . . . 74.15 110.445 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.6 mt -88.42 75.57 8.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.784 -1.191 . . . . 75.44 107.784 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 58.9 tt0 -147.18 114.51 6.28 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.345 -0.843 . . . . 72.22 111.183 -174.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' A' ' 96' ' ' LYS . 6.1 mmpt? -178.87 -66.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.95 2.1 . . . . 72.11 106.356 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -147.28 150.64 35.21 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.435 -1.257 . . . . 64.42 107.885 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 84' ' ' PHE . 56.6 tp -127.71 124.35 37.63 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.206 -1.775 . . . . 73.24 106.206 168.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -114.31 113.78 25.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.237 -1.764 . . . . 72.44 106.237 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' THR . 97.0 t -99.85 123.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 109.438 -0.579 . . . . 52.24 109.438 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -110.25 120.69 43.25 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -104.16 124.54 49.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.621 -0.511 . . . . 72.32 109.621 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.412 HH12 ' CD ' ' A' ' 37' ' ' GLU . 19.0 mmm180 -74.57 132.67 41.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.339 -0.846 . . . . 74.33 109.019 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.6 mt -99.03 135.89 20.72 Favored Pre-proline 0 C--N 1.285 -2.204 0 N-CA-C 107.838 -1.171 . . . . 44.25 107.838 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.81 148.97 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.589 2.192 . . . . 73.42 112.312 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' C ' HD22 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -47.6 -43.18 25.37 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.472 1.509 . . . . 74.35 112.288 -174.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.13 -36.15 83.37 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.67 0.619 . . . . 62.11 112.67 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -88.93 -6.37 57.32 Favored 'General case' 0 C--O 1.205 -1.25 0 CA-C-N 116.559 -0.291 . . . . 72.32 111.605 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.629 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -70.09 -28.48 65.45 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.751 -0.204 . . . . 54.34 111.519 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.08 -38.1 92.56 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.868 -0.493 . . . . 72.44 111.868 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 p -158.67 87.77 2.26 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 123.466 0.706 . . . . 63.24 109.956 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 10.0 Cg_endo -86.63 144.71 7.74 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 122.577 2.185 . . . . 70.11 112.104 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 33.2 Cg_exo -60.79 142.84 98.86 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.767 2.312 . . . . 74.31 112.628 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . . . -76.67 144.82 73.96 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.857 -0.61 . . . . 54.51 109.997 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -80.36 126.51 6.2 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.514 2.143 . . . . 71.42 111.923 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.4 m -74.91 -23.91 58.43 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.657 -0.701 . . . . 73.13 111.606 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -99.64 135.73 40.61 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.111 -1.44 . . . . 72.02 107.111 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -77.01 -3.71 40.45 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.434 0.901 . . . . 72.42 113.434 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.525 ' O ' HG12 ' A' ' 44' ' ' VAL . 17.1 m -73.74 -26.44 60.68 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.775 -0.824 . . . . 64.45 108.775 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 61' ' ' LYS . 25.3 t -113.98 124.12 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 106.593 -1.632 . . . . 60.41 106.593 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.429 ' HA ' ' HG2' ' A' ' 115' ' ' PRO . 27.3 mtpp -129.66 145.91 51.48 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.81 -1.156 . . . . 71.11 110.568 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 26.7 mm -91.91 111.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.997 -1.483 . . . . 74.4 106.997 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -133.81 149.55 51.41 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.085 -0.961 . . . . 62.15 109.77 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.49 153.3 23.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.134 -0.691 . . . . 70.54 109.134 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 67.4 ttt180 -139.25 123.17 17.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.458 -0.897 . . . . 62.32 109.984 174.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -143.85 177.14 8.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.373 -0.83 . . . . 75.51 109.314 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.06 -1.42 84.82 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 121.134 -0.555 . . . . 35.31 113.736 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.46 162.47 32.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 117.398 0.599 . . . . 72.21 111.381 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.2 m -120.6 135.99 54.94 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.437 -0.801 . . . . 71.22 109.777 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.94 161.87 28.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 120.94 0.4 . . . . 71.24 110.413 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 67.3 m-85 -113.99 123.47 49.79 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.703 -1.962 . . . . 73.03 105.703 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 25.4 t -111.91 147.55 35.6 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 120.444 -0.502 . . . . 44.5 109.905 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 8.9 t -129.23 132.98 47.33 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.112 -0.494 . . . . 64.41 109.848 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 184' ' ' GLU . 74.2 mt-30 -110.46 131.64 54.87 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 121.258 0.552 . . . . 70.13 111.425 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.86 149.63 40.52 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.722 -1.127 . . . . 74.02 109.494 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -121.92 149.09 17.16 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.78 -0.724 . . . . 75.12 111.465 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.54 24.49 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.24 -1.144 . . . . 54.31 110.24 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -90.54 100.52 13.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.037 -0.727 . . . . 54.23 109.037 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.25 107.7 19.82 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.913 0.863 . . . . 72.0 112.672 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -100.77 169.68 8.85 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.513 -1.662 . . . . 62.41 106.513 171.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 1.6 mp0 -57.55 -42.16 82.42 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.173 0.511 . . . . 62.24 110.109 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.67 70.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.519 -0.764 . . . . 64.42 111.542 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.67 -36.85 70.77 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.653 -0.499 . . . . 74.11 109.653 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -60.47 -47.8 84.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.778 -0.646 . . . . 72.31 110.224 173.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -46.88 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.726 0.641 . . . . 65.43 110.604 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.65 87.86 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.062 0.458 . . . . 63.32 110.926 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -68.95 -33.3 73.49 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 116.325 -0.398 . . . . 74.01 111.688 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.46 -45.85 92.53 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.059 -0.349 . . . . 34.53 110.059 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.648 ' HA ' ' HE ' ' A' ' 152' ' ' ARG . 63.2 m -59.11 -46.98 86.91 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 122.818 0.447 . . . . 64.11 110.32 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.46 -39.41 93.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.827 -0.624 . . . . 72.41 110.998 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 31' ' ' TYR . 60.2 tp -64.94 -40.88 95.7 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.999 -0.371 . . . . 75.55 109.999 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.648 ' HE ' ' HA ' ' A' ' 149' ' ' THR . 88.5 mtm180 -62.22 -40.16 95.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.892 -0.594 . . . . 73.03 111.144 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.2 m -69.77 -36.03 75.42 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.428 0.632 . . . . 72.13 110.312 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 40.7 m -70.33 -33.7 71.8 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.373 0.606 . . . . 73.34 110.424 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.488 HD12 HD23 ' A' ' 187' ' ' LEU . 93.4 mt -77.63 6.69 6.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.707 -0.679 . . . . 71.43 112.54 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.22 142.38 32.74 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.004 -0.739 . . . . 62.32 109.004 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.43 -10.29 65.02 Favored Glycine 0 C--N 1.307 -1.052 0 N-CA-C 110.095 -1.202 . . . . 71.22 110.095 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 10.9 t -120.9 153.16 57.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.448 -1.686 . . . . 75.24 106.448 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.59 17.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.592 2.861 . . . . 44.33 115.199 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.41 131.7 34.35 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 122.068 -0.395 . . . . 71.51 110.097 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 32.2 p -124.94 154.94 40.37 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.754 -0.832 . . . . 52.05 108.754 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -136.73 149.25 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 118.287 0.494 . . . . 72.22 110.956 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -116.77 141.63 47.97 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.727 0.64 . . . . 72.34 112.727 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.21 -2.28 15.01 Favored Glycine 0 C--N 1.318 -0.461 0 CA-C-N 115.021 -0.99 . . . . 64.31 113.35 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.3 t70 61.22 11.72 3.72 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.549 1.14 . . . . 73.42 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 86' ' ' VAL . 7.3 p -73.79 139.38 19.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.904 1.282 . . . . 71.13 111.385 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -144.61 168.74 19.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.387 -0.824 . . . . 73.4 110.713 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 16.0 m-85 -115.29 156.42 25.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.096 -0.502 . . . . 72.11 110.451 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 64.4 m -124.19 119.84 30.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.626 -1.62 . . . . 63.43 106.626 172.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.5 154.98 49.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.62 -0.264 . . . . 31.14 110.306 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.69 141.84 9.22 Favored Glycine 0 CA--C 1.481 -2.083 0 N-CA-C 108.931 -1.668 . . . . 40.44 108.931 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 182' ' ' ARG . 13.3 m-30 -84.44 -12.79 53.71 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.757 0.789 . . . . 74.25 110.71 -177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -137.57 128.62 16.06 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 105.27 -2.122 . . . . 63.35 105.27 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 83.0 Cg_exo -47.22 110.8 0.33 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 123.227 2.618 . . . . 72.32 112.497 -176.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 179' ' ' TYR . 5.6 Cg_exo -78.15 126.67 7.93 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 121.542 1.495 . . . . 74.24 113.131 -174.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 50.6 ttm -100.16 -43.69 6.23 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.215 -1.402 . . . . 63.0 107.215 170.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.444 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 86.9 tttt 163.85 -60.84 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 127.729 2.412 . . . . 73.31 106.853 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 177' ' ' LYS . 60.1 Cg_endo -75.83 -31.75 4.98 Favored 'Trans proline' 0 C--N 1.4 3.256 0 N-CA-C 109.336 -1.063 . . . . 73.21 109.336 172.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 175' ' ' PRO . 78.8 m-85 -84.72 142.4 29.88 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 104.555 -2.387 . . . . 62.32 104.555 172.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 106.55 64.8 0.62 Allowed Glycine 0 C--N 1.284 -2.357 0 N-CA-C 108.732 -1.747 . . . . 63.41 108.732 -170.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -87.73 -39.51 14.88 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.949 0.404 . . . . 64.55 109.922 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.535 ' HB2' ' HB2' ' A' ' 172' ' ' TYR . 3.3 mmp_? -103.51 127.09 50.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.552 -1.647 . . . . 73.33 106.552 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.11 146.51 33.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.838 -0.801 . . . . 73.35 108.838 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.607 ' HG2' ' HG2' ' A' ' 134' ' ' GLN . 40.0 mt-10 -135.23 149.38 49.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.443 0.64 . . . . 62.13 111.323 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.461 ' HB ' HG22 ' A' ' 133' ' ' THR . 77.7 t -125.02 118.58 53.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.927 -1.508 . . . . 71.23 106.927 172.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 18.0 m0 -102.91 120.65 40.99 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.139 -1.06 . . . . 74.23 108.139 -178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.488 HD23 HD12 ' A' ' 155' ' ' LEU . 37.8 tp -106.05 129.95 54.06 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.303 -1.369 . . . . 64.1 107.303 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.89 125.1 40.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.565 -0.454 . . . . 63.12 110.705 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 161' ' ' THR . 13.8 pttp -71.06 145.95 49.6 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.005 -0.739 . . . . 64.14 109.005 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 108.787 -0.82 . . . . 37.68 108.787 174.671 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.506 -0.737 0 N-CA-C 109.397 -0.594 . . . . 70.55 109.397 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 m -68.43 -38.58 81.31 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.983 0.42 . . . . 72.44 110.336 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp -81.27 177.37 9.04 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.656 -0.702 . . . . 74.43 111.956 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.74 107.62 16.34 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.216 -0.661 . . . . 73.4 109.216 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.02 -25.19 58.29 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.189 -0.765 . . . . 45.32 111.189 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 p -67.68 150.73 48.33 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.693 -0.484 . . . . 74.11 109.693 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 15' ' ' THR . 27.9 m -60.78 117.8 2.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 113.598 0.962 . . . . 74.4 113.598 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.61 -27.76 37.23 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.096 -1.816 . . . . 73.14 106.096 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.544 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 5.5 t -118.94 121.66 40.45 Favored 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 114.021 -1.445 . . . . 75.13 107.698 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -74.63 138.24 73.98 Favored Pre-proline 0 C--N 1.292 -1.897 0 CA-C-N 115.448 -0.796 . . . . 74.54 109.563 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.84 141.32 84.29 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.529 1.486 . . . . 74.1 109.068 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -100.45 127.09 46.89 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 118.774 -1.17 . . . . 73.14 109.153 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -113.55 122.44 47.24 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.888 -1.051 . . . . 72.34 111.18 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.0 119.79 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 106.111 -1.811 . . . . 75.41 106.111 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -89.96 -25.78 20.73 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.123 -0.631 . . . . 71.43 111.062 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -176.84 153.85 1.09 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.511 0.507 . . . . 75.14 109.794 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.3 p -132.29 154.59 49.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.801 -0.814 . . . . 62.53 108.801 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.03 -148.82 20.1 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 119.24 -1.457 . . . . 71.51 113.313 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.2 -118.45 5.23 Favored Glycine 0 N--CA 1.427 -1.934 0 N-CA-C 110.268 -1.133 . . . . 74.04 110.268 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -99.41 169.96 8.97 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.876 -1.527 . . . . 72.41 106.876 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.3 162.86 14.11 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 75.32 109.236 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 72.72 -53.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.365 1.066 . . . . 71.43 110.12 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.63 111.75 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 107.999 -1.111 . . . . 73.2 107.999 172.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.2 p -133.69 155.82 49.03 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.594 -0.73 . . . . 61.23 110.477 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -112.01 161.8 16.07 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.233 0.539 . . . . 71.01 111.428 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' OE1' ' HD2' ' A' ' 34' ' ' ARG . 39.7 tt0 -133.81 124.86 27.27 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.159 -1.423 . . . . 73.33 107.159 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.07 114.9 26.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.84 -1.541 . . . . 75.43 106.84 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.456 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 13.7 ptm180 -134.22 143.47 47.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.32 0.581 . . . . 72.32 112.563 -172.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.78 135.78 35.45 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.194 -1.78 . . . . 72.14 106.194 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.4 t -68.99 146.74 52.47 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.356 0.598 . . . . 62.13 111.94 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.5 pm0 -67.84 0.5 3.32 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 126.162 1.785 . . . . 74.14 114.236 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 75.08 11.51 83.96 Favored Glycine 0 C--N 1.305 -1.147 0 C-N-CA 119.656 -1.259 . . . . 62.4 114.565 169.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.65 152.08 48.76 Favored Glycine 0 N--CA 1.408 -3.204 0 C-N-CA 120.349 -0.929 . . . . 72.31 113.39 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 104' ' ' ILE . 17.7 ptpt -102.96 118.93 37.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.041 -1.466 . . . . 70.33 107.041 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 59.3 m-85 -117.15 163.72 15.85 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.562 -0.745 . . . . 62.15 111.525 -168.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.03 116.91 32.34 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 108.093 -1.077 . . . . 75.24 108.093 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -124.21 146.41 48.73 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 113.033 0.753 . . . . 74.1 113.033 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.4 m -128.03 144.13 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 114.262 -1.336 . . . . 62.53 108.645 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.25 136.7 51.4 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 120.77 0.319 . . . . 73.32 111.016 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.557 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 44.4 t -130.39 141.99 44.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 105.916 -1.883 . . . . 64.41 105.916 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.468 ' C ' ' H ' ' A' ' 49' ' ' LYS . 34.1 p -130.49 159.76 36.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.651 0.612 . . . . 61.51 112.651 -171.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.3 -32.75 0.24 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.642 1.577 . . . . 72.24 112.541 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 47' ' ' THR . 52.6 mtpt -85.05 136.34 38.48 Favored Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 124.673 1.189 . . . . 72.41 109.336 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 53.0 Cg_exo -55.05 156.15 16.81 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.268 2.645 . . . . 73.02 112.111 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.66 -41.44 12.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 113.293 0.849 . . . . 75.13 113.293 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -59.7 -47.66 84.76 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 120.644 -0.422 . . . . 73.13 110.975 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.64 -39.82 73.44 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.94 -0.573 . . . . 75.31 111.702 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -67.47 -46.32 73.33 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.692 -0.686 . . . . 41.14 110.453 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.8 -45.74 85.01 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 122.423 0.289 . . . . 72.53 111.758 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 5.6 ppt_? -61.82 -28.24 69.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.813 0.672 . . . . 72.51 112.813 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 tt0 -85.64 -39.51 17.21 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.426 0.631 . . . . 71.01 111.154 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . . . -76.51 -32.17 58.14 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.95 0.722 . . . . 44.15 112.95 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.515 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -53.59 -48.05 94.41 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 112.401 0.519 . . . . 73.51 112.401 -178.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 63' ' ' MET . 36.4 Cg_exo -56.48 -34.54 95.1 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.135 1.89 . . . . 71.23 111.515 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 58' ' ' ALA . 50.6 mtmt -69.03 -32.61 72.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.117 0.484 . . . . 71.23 110.791 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 102' ' ' PHE . 29.7 mm -76.49 -48.74 26.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.1 -0.5 . . . . 73.34 111.503 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.411 ' HG3' ' HA ' ' A' ' 60' ' ' PRO 0.276 3.2 ppp? -66.01 -29.23 69.57 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.696 0.998 . . . . 63.04 113.696 -176.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.08 -29.45 69.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.24 0.543 . . . . 64.24 110.296 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.769 -0.65 . . . . 72.43 110.139 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 76' ' ' MET . 2.7 p -66.8 -27.23 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.013 0.435 . . . . 71.12 110.124 176.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.79 -20.77 62.39 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.842 -0.617 . . . . 54.5 113.686 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 131.67 -15.74 5.15 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.859 -1.162 . . . . 73.44 113.028 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -81.69 29.0 0.39 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.928 0.871 . . . . 72.25 110.502 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.01 166.02 13.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.919 -0.582 . . . . 73.12 109.908 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.76 -35.03 79.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 112.928 0.714 . . . . 71.23 112.928 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.594 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 1.6 mptm? -82.71 -10.56 58.85 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.113 0.482 . . . . 73.42 111.526 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.88 33.88 76.02 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.56 -0.746 . . . . 75.21 112.541 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 24.7 m -80.65 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.712 -0.795 . . . . 72.44 108.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.31 167.34 51.96 Favored Glycine 0 N--CA 1.435 -1.372 0 O-C-N 123.776 0.672 . . . . 44.33 113.033 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 27.1 ttt -76.14 101.25 5.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.284 -0.458 . . . . 62.43 109.968 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.57 41.86 0.18 Allowed Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.217 -0.992 . . . . 73.12 112.978 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.414 ' HG2' HG23 ' A' ' 66' ' ' VAL . 15.3 ptm -124.91 123.5 40.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.947 -1.131 . . . . 73.21 107.947 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.3 m -125.67 117.36 23.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.034 0.753 . . . . 73.33 113.034 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -156.72 159.02 31.59 Favored Pre-proline 0 C--O 1.242 0.7 0 C-N-CA 125.494 1.518 . . . . 64.22 107.311 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.16 140.12 81.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.763 1.642 . . . . 54.15 112.131 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.98 150.61 5.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.949 -1.13 . . . . 65.24 107.949 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -138.65 144.64 39.77 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.866 -0.42 . . . . 71.44 109.866 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 46.5 p90 -135.2 144.83 47.16 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 122.083 -0.386 . . . . 74.33 110.653 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.64 34.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 108.523 -0.917 . . . . 61.32 108.523 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.23 150.25 25.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 N-CA-C 107.821 -1.177 . . . . 72.43 107.821 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.435 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 2.7 m-85 -117.07 100.3 53.23 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.672 -0.862 . . . . 75.14 108.672 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.87 152.38 16.86 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 121.911 1.741 . . . . 75.01 112.677 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -100.14 158.37 15.9 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.327 -1.731 . . . . 71.32 106.327 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.25 -12.79 58.42 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.352 0.501 . . . . 70.23 112.352 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.39 -3.03 54.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.988 -0.551 . . . . 71.42 110.984 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.07 -4.01 82.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.936 -0.65 . . . . 32.51 112.984 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.0 m -83.01 131.42 35.18 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.765 0.317 . . . . 45.32 110.414 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.57 79.26 4.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.539 0.685 . . . . 52.44 110.534 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 52.0 tt0 -148.46 114.26 5.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.29 -0.868 . . . . 74.22 111.012 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 56.3 mtpt -176.82 -67.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.727 2.011 . . . . 72.13 107.048 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 64.9 mttm -145.67 158.63 43.83 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.883 -1.053 . . . . 73.15 108.518 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 84' ' ' PHE . 46.8 tp -139.14 124.74 19.45 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.964 -1.125 . . . . 71.21 107.964 171.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -123.68 114.04 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.158 -1.052 . . . . 71.54 108.158 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.508 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 58.2 t -97.15 130.14 46.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.178 -0.675 . . . . 52.44 109.178 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.45 131.65 56.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.149 -0.685 . . . . 71.31 109.149 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.421 ' HB2' HD12 ' A' ' 62' ' ' ILE . 67.8 t80 -102.98 114.67 29.16 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.022 -1.103 . . . . 73.02 108.022 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.632 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 75.9 ttt180 -75.52 133.04 41.11 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.014 -1.448 . . . . 74.11 109.755 -176.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 40' ' ' LYS . 76.1 mt -106.44 137.54 19.46 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.565 -0.902 . . . . 70.15 108.565 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.77 149.43 77.55 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.259 1.972 . . . . 63.24 110.428 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -60.99 -33.82 73.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.831 1.049 . . . . 64.3 113.831 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -66.94 -23.91 66.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 64.03 111.119 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -92.66 -7.7 46.13 Favored 'General case' 0 C--O 1.192 -1.958 0 CA-C-N 116.66 -0.246 . . . . 73.32 110.895 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.749 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.52 -33.29 69.06 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.922 -0.711 . . . . 74.04 111.478 177.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.83 -29.61 74.59 Favored Glycine 0 C--N 1.334 0.464 0 O-C-N 123.559 0.537 . . . . 42.4 111.949 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.0 t -153.69 82.56 4.58 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 108.996 -0.742 . . . . 71.11 108.996 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.73 162.14 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.468 2.112 . . . . 54.33 111.902 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.594 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.3 Cg_exo -60.45 156.98 38.37 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 C-N-CA 121.581 1.52 . . . . 72.12 109.783 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.94 154.56 37.74 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.431 -0.581 . . . . 72.22 109.431 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 27.8 Cg_exo -62.98 104.99 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.781 2.321 . . . . 75.11 111.81 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.2 p -90.67 -28.35 18.42 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.871 -0.604 . . . . 71.34 112.177 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.7 156.03 18.38 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.813 -0.81 . . . . 73.11 108.813 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.47 -31.71 63.91 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.455 0.645 . . . . 70.25 110.366 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.8 m -99.28 5.14 46.67 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.525 -0.762 . . . . 43.25 112.013 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 59.6 t -119.7 122.6 69.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.071 -1.085 . . . . 61.12 108.071 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -128.22 143.4 51.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.366 -0.379 . . . . 72.25 110.502 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.2 mm -92.75 110.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.826 -1.176 . . . . 63.53 107.826 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -108.01 144.04 35.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.23 -0.895 . . . . 62.2 109.382 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.16 127.33 45.1 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.842 -0.617 . . . . 64.52 110.492 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 125' ' ' ARG . 2.1 mmp_? -123.36 116.25 22.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 118.745 -1.182 . . . . 64.11 109.686 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.586 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -148.49 161.01 42.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.379 -0.828 . . . . 75.25 110.962 173.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.13 19.7 71.68 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.919 -0.658 . . . . 74.0 112.264 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 pt -121.14 147.67 24.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.314 0.578 . . . . 75.23 111.009 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.9 m -117.47 128.21 54.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.446 -0.946 . . . . 62.25 108.446 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.458 HG21 ' CE3' ' A' ' 186' ' ' TRP . 30.2 m -124.72 166.06 20.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 116.13 -0.486 . . . . 75.54 110.001 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 55.4 m-85 -113.75 122.18 46.33 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 106.256 -1.757 . . . . 74.34 106.256 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 p -119.73 132.73 55.72 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.773 -0.771 . . . . 71.22 110.735 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.8 t -121.76 123.84 42.79 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 109.007 -0.738 . . . . 51.33 109.007 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -110.58 136.91 48.96 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.431 -0.951 . . . . 73.02 108.431 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 43.2 p90 -145.49 144.7 30.72 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.026 -0.533 . . . . 72.33 111.561 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -106.64 138.25 14.31 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.503 -1.039 . . . . 64.45 110.503 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.11 -175.06 28.52 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.868 -0.682 . . . . 51.21 111.484 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -87.59 111.13 20.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.784 -1.191 . . . . 75.32 107.784 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.28 130.8 53.24 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.531 0.567 . . . . 55.35 112.531 -174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.15 178.21 5.32 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.702 -1.222 . . . . 73.51 107.702 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.71 77.86 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.323 0.582 . . . . 64.31 109.869 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.48 71.31 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.355 -0.839 . . . . 73.42 111.063 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.37 -30.52 70.33 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.413 0.149 . . . . 73.13 111.199 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -69.7 -41.63 75.13 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 110.036 -0.357 . . . . 72.22 110.036 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.81 -48.0 83.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.396 -0.594 . . . . 72.45 109.396 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.98 87.88 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.36 -0.836 . . . . 64.24 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -66.37 -32.43 73.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 112.402 0.519 . . . . 55.54 112.402 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 -46.7 79.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.86 0.362 . . . . 72.23 111.037 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.4 t -72.58 -33.39 66.72 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.482 0.658 . . . . 74.54 110.235 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -64.44 -37.07 86.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.168 -0.678 . . . . 74.01 109.168 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.35 -39.45 93.91 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.859 -0.609 . . . . 62.34 110.058 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -63.28 -36.54 84.01 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.372 -0.603 . . . . 75.31 109.372 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 m -70.53 -32.71 70.27 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.261 -0.881 . . . . 73.25 110.031 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.6 m -76.79 -34.33 57.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.671 -0.695 . . . . 74.11 110.06 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -85.71 11.22 11.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.58 0.752 . . . . 65.11 111.095 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -73.68 135.21 43.7 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.624 -1.621 . . . . 51.5 106.624 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.49 58.83 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.521 -0.632 . . . . 61.44 111.521 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 34.9 p -114.3 160.14 33.91 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 107.259 -1.385 . . . . 71.45 107.259 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.13 27.31 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 122.192 1.928 . . . . 53.52 112.163 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.16 101.1 0.85 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.359 0.599 . . . . 71.31 112.273 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 22.5 p -89.33 156.03 18.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.559 -0.904 . . . . 70.13 108.559 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.408 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 24.2 m-85 -138.74 150.4 46.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.2 pt20 -114.04 109.89 19.17 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.309 0.576 . . . . 73.34 110.438 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.27 41.95 Favored Glycine 0 N--CA 1.46 0.3 0 C-N-CA 120.808 -0.71 . . . . 62.44 111.901 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 59.31 25.55 14.22 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.936 1.294 . . . . 72.01 110.499 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.1 m -75.1 140.03 18.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 119.799 -0.761 . . . . 74.32 110.76 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -139.9 170.24 16.23 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.162 -0.926 . . . . 64.02 109.607 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.579 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 60.6 m-85 -115.43 148.09 39.79 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.721 -0.844 . . . . 73.54 108.721 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 63.1 m -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.522 -1.658 . . . . 75.33 106.522 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -117.59 145.45 44.29 Favored 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 123.558 0.536 . . . . 72.22 111.253 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.52 165.2 38.46 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 108.932 -1.667 . . . . 34.22 108.932 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -68.24 -31.35 70.78 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 118.042 0.921 . . . . 65.13 109.074 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -143.19 135.47 13.31 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 105.971 -1.863 . . . . 72.42 105.971 174.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.48 ' HG2' ' SD ' ' A' ' 59' ' ' MET . 50.3 Cg_exo -59.79 111.03 0.84 Allowed 'Trans proline' 0 CA--C 1.514 -0.477 0 C-N-CA 122.327 2.018 . . . . 75.32 109.522 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 174' ' ' PRO . 23.6 Cg_exo -63.68 128.37 22.05 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.839 1.692 . . . . 64.04 113.252 -172.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 58.0 ttp -96.93 -31.69 12.43 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.203 -1.777 . . . . 73.44 106.203 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -107.53 144.67 29.71 Favored Pre-proline 0 N--CA 1.424 -1.768 0 CA-C-N 113.815 -1.538 . . . . 74.5 107.485 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.48 -13.72 26.74 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.437 2.758 . . . . 71.55 113.47 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.86 94.56 0.32 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.8 0.81 . . . . 63.55 111.916 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -156.21 124.59 1.49 Allowed Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 106.847 -2.501 . . . . 72.35 106.847 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.444 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 97.0 mtt180 -79.62 -54.57 5.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 117.26 0.53 . . . . 75.52 110.998 -172.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.87 130.55 49.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 109.245 -0.65 . . . . 60.31 109.245 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.434 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 25.6 m-80 -127.47 139.34 52.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.241 -1.392 . . . . 61.54 107.241 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 39.0 tt0 -132.09 133.93 44.9 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.829 -0.348 . . . . 73.31 111.051 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.49 125.71 69.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.466 0.706 . . . . 73.04 110.062 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.8 m0 -109.08 121.13 44.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 108.904 -0.776 . . . . 73.35 108.904 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.35 124.03 49.21 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 107.522 -1.288 . . . . 64.54 107.522 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.405 HG13 HE21 ' A' ' 163' ' ' GLN . 7.1 p -95.34 132.31 39.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.782 0.325 . . . . 74.12 111.262 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 21.0 ptmt -76.45 141.95 41.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.128 -0.487 . . . . 70.21 111.288 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.408 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.809 -0.632 . . . . 65.34 110.42 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 CA--C 1.505 -0.764 0 N-CA-C 110.211 -0.292 . . . . 73.21 110.211 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.4 p -92.6 97.78 11.02 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 116.55 -0.295 . . . . 71.42 111.795 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.95 16.03 20.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.344 0.592 . . . . 73.41 109.924 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -142.35 150.68 41.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.441 -1.318 . . . . 62.33 107.441 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.69 -120.95 0.92 Allowed Glycine 0 C--N 1.301 -1.409 0 N-CA-C 110.92 -0.872 . . . . 72.15 110.92 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.2 p -90.85 95.09 9.95 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-O 121.513 0.673 . . . . 62.3 110.101 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.73 97.78 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 122.234 1.016 . . . . 75.55 112.358 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.81 -26.93 29.15 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.078 -0.964 . . . . 73.33 110.159 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.9 m -143.13 99.94 3.54 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.307 0.575 . . . . 64.34 111.84 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.617 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 49.2 t-105 -87.99 124.56 66.72 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 104.494 -2.41 . . . . 74.12 104.494 171.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.98 140.64 66.97 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.797 1.665 . . . . 63.45 114.083 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -101.87 149.99 23.64 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.501 -2.037 . . . . 73.01 105.501 174.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.83 118.75 21.23 Favored 'General case' 0 C--N 1.284 -2.273 0 C-N-CA 119.633 -0.827 . . . . 73.23 109.105 -171.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t -89.7 126.29 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.883 -0.784 . . . . 61.54 108.883 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.78 -38.57 15.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.384 -0.969 . . . . 61.42 108.384 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.5 t 179.69 165.68 1.13 Allowed 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.932 -1.031 . . . . 62.23 108.291 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 32' ' ' GLU . 68.2 p -131.64 165.13 24.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.958 -1.127 . . . . 63.24 107.958 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.99 -157.04 25.82 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 119.352 -1.404 . . . . 51.03 113.04 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.97 -138.51 14.6 Favored Glycine 0 N--CA 1.42 -2.397 0 N-CA-C 111.186 -0.766 . . . . 74.1 111.186 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.1 171.06 8.48 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.283 -1.006 . . . . 72.14 108.283 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.44 162.17 23.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.129 -1.028 . . . . 71.42 109.622 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 72.39 -54.27 0.69 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.345 1.058 . . . . 75.42 109.797 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 150' ' ' GLN . 6.2 p -110.21 109.39 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-O 122.049 0.928 . . . . 44.22 109.125 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 m -129.67 146.36 51.46 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.003 -1.11 . . . . 71.35 108.003 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' HB3' HD22 ' A' ' 151' ' ' LEU . 6.0 p90 -113.83 160.49 18.67 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 112.795 0.665 . . . . 72.2 112.795 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.573 ' OE1' ' HD3' ' A' ' 34' ' ' ARG . 39.7 tt0 -136.56 125.71 24.61 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.468 -2.049 . . . . 73.03 105.468 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -98.91 118.04 34.77 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.883 -1.525 . . . . 42.15 106.883 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HD3' ' OE1' ' A' ' 32' ' ' GLU . 27.0 mtm180 -131.68 145.76 51.82 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.931 -1.108 . . . . 72.13 111.717 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.34 136.86 34.92 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.303 -2.11 . . . . 61.45 105.303 168.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.0 t -58.25 148.45 27.19 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.349 0.406 . . . . 54.24 111.817 -175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.617 ' O ' ' HB3' ' A' ' 16' ' ' TRP . 14.8 pt-20 -73.17 -3.35 26.03 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 115.753 -0.658 . . . . 25.3 111.641 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 74.01 9.07 79.62 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 120.979 -0.629 . . . . 45.14 114.021 171.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.37 162.5 54.23 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 121.052 -0.594 . . . . 54.53 113.527 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.64 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.04 118.65 37.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.315 -1.365 . . . . 63.31 107.315 178.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.1 m-85 -121.4 165.7 15.18 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.665 -0.698 . . . . 70.14 112.05 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -97.69 116.79 30.59 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -127.66 144.24 51.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.655 0.74 . . . . 73.44 112.24 -174.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 6.5 p -127.61 133.63 67.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.298 -1.371 . . . . 73.54 107.298 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.71 123.58 45.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.072 -0.651 . . . . 73.44 111.382 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 31.6 t -118.16 123.19 71.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.261 -1.385 . . . . 52.5 107.261 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 25.0 m -117.76 159.5 22.92 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.669 -0.241 . . . . 72.01 110.532 -175.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 t70 75.58 -27.39 0.19 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.852 1.661 . . . . 72.01 112.035 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -85.19 145.05 42.08 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 109.274 -0.639 . . . . 74.21 109.274 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.57 156.84 34.69 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.927 2.418 . . . . 74.22 111.514 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG13 HD12 ' A' ' 98' ' ' LEU . 54.5 t -48.03 -44.74 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.36 0.664 . . . . 60.34 112.408 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -58.04 -44.41 87.38 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.95 0.405 . . . . 63.12 110.737 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.15 -48.79 26.98 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.505 -0.77 . . . . 62.32 111.063 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -59.7 -40.18 87.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 73.23 111.317 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 59' ' ' MET . 52.7 tp -65.61 -51.3 60.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 116.338 -0.392 . . . . 62.02 110.959 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 57' ' ' GLU . 4.9 ppt_? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.318 0.858 . . . . 64.44 113.318 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 1.3 tm-20 -74.69 -45.82 41.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.384 -0.969 . . . . 74.53 108.384 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -76.57 -33.16 58.5 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.525 1.13 . . . . 32.33 114.046 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 8.9 mmt -50.98 -55.09 30.65 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 114.918 1.451 . . . . 71.13 114.918 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.42 -30.91 75.47 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.681 2.254 . . . . 62.23 112.163 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -67.35 -48.63 66.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 54.2 111.029 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.7 mm -66.48 -40.1 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 74.04 109.767 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -48.53 79.88 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 123.666 0.787 . . . . 71.34 111.13 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -27.58 65.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.952 -0.699 . . . . 72.4 112.382 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.95 -50.52 68.3 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.576 -0.283 . . . . 52.42 110.517 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.71 -2.92 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.901 -0.591 . . . . 72.52 111.583 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.55 -21.59 36.88 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.809 -0.632 . . . . 72.23 111.929 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 136.69 -14.29 3.89 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.174 -1.012 . . . . 25.03 113.425 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 m -81.48 40.53 0.58 Allowed 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.89 1.329 . . . . 73.42 110.957 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.81 177.16 5.55 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.24 -0.891 . . . . 74.42 108.978 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.45 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 17.0 t70 -69.33 -30.88 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.859 0.361 . . . . 74.11 111.961 -175.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -81.77 -12.63 58.48 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.36 -0.382 . . . . 71.22 110.289 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.31 20.8 75.5 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.805 -0.634 . . . . 73.34 112.18 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.494 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 33.4 m -86.33 125.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.622 -0.431 . . . . 74.3 110.738 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.64 -71.13 0.96 Allowed Glycine 0 CA--C 1.499 -0.916 0 N-CA-C 111.542 -0.623 . . . . 74.3 111.542 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.5 mmt 66.43 -64.18 0.23 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.185 1.179 . . . . 72.12 114.185 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.76 60.7 5.9 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.621 -1.392 . . . . 70.32 109.621 -174.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -96.12 126.25 41.22 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.179 0.514 . . . . 64.3 110.946 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.8 t -123.45 116.6 23.5 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 122.361 1.077 . . . . 74.3 111.557 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.2 m -143.65 170.93 7.57 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 105.262 -2.125 . . . . 65.43 105.262 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.03 138.62 79.68 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.609 1.253 . . . . 72.35 113.547 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.9 p -111.88 147.22 15.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.696 -1.594 . . . . 71.4 106.696 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.0 p -132.61 144.95 50.71 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.438 -0.505 . . . . 51.43 110.22 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -131.68 141.32 49.55 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 120.199 -0.6 . . . . 71.13 110.716 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.594 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.75 135.02 34.48 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 115.54 -0.755 . . . . 54.43 109.414 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.69 150.21 32.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.696 -0.684 . . . . 62.35 109.457 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 96' ' ' LYS . 90.7 m-85 -119.48 101.88 48.42 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 110.143 -0.318 . . . . 73.01 110.143 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.95 142.55 15.69 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 122.447 2.098 . . . . 64.04 112.589 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.473 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 45.6 m-80 -96.66 162.63 13.36 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.034 -0.728 . . . . 60.22 109.034 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.1 -13.56 62.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.424 0.631 . . . . 73.51 110.232 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.51 -6.19 54.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.27 -0.877 . . . . 54.31 109.457 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -6.8 82.95 Favored Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 116.024 -0.535 . . . . 72.14 112.296 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 p -84.39 140.88 31.25 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.833 0.349 . . . . 71.21 110.48 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.47 79.11 2.46 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.302 0.573 . . . . 64.23 109.569 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 78.2 mt-30 -147.02 114.63 6.39 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.766 -0.652 . . . . 72.22 110.596 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 89.2 mttt -176.63 -63.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 126.274 1.83 . . . . 73.52 108.091 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 21.9 ttmm -161.04 153.83 20.92 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.691 -0.855 . . . . 62.03 108.691 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 5.8 tt -139.92 128.37 22.79 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.031 -1.47 . . . . 73.23 107.031 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -123.43 115.61 21.89 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.014 -0.735 . . . . 74.14 109.014 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 43' ' ' THR . 82.6 t -88.74 123.03 40.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.952 -0.388 . . . . 52.41 109.952 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -109.78 124.75 51.81 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.971 -0.751 . . . . 75.14 108.971 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 87.8 t80 -102.52 112.4 25.12 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.995 -1.113 . . . . 74.52 107.995 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.492 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 2.3 tmt_? -75.5 112.93 12.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.931 -1.507 . . . . 72.41 106.931 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.521 ' HB ' ' NE2' ' A' ' 109' ' ' GLN . 67.7 mt -85.68 137.92 35.88 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.156 -0.475 . . . . 74.32 109.9 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.29 143.36 34.08 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.63 2.22 . . . . 55.22 111.539 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -54.92 -33.39 62.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.363 1.246 . . . . 74.52 114.363 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -59.41 -31.23 69.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.893 0.378 . . . . 75.53 111.006 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.98 -2.78 49.71 Favored 'General case' 0 C--O 1.192 -1.942 0 CA-C-N 116.341 -0.39 . . . . 65.53 111.605 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.521 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 29.5 mm-40 -71.01 -28.62 64.55 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.199 -0.6 . . . . 72.13 110.608 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.04 -38.29 92.49 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.266 -0.734 . . . . 44.53 111.266 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.8 m -155.39 92.99 2.7 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 123.212 0.605 . . . . 65.2 109.52 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 77.4 Cg_endo -83.96 145.04 11.1 Favored 'Trans proline' 0 C--O 1.251 1.158 0 C-N-CA 122.472 2.115 . . . . 62.14 111.832 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 29.5 Cg_exo -63.1 130.6 29.44 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.886 1.724 . . . . 72.13 109.432 174.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -61.18 139.67 94.42 Favored Pre-proline 0 C--O 1.257 1.479 0 CA-C-O 120.767 0.318 . . . . 72.13 110.68 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 61.2 Cg_endo -72.2 108.21 2.43 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.584 2.189 . . . . 74.51 111.199 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.8 t -89.91 82.47 6.18 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 116.02 -0.536 . . . . 51.43 110.428 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.629 ' HB3' HG12 ' A' ' 120' ' ' VAL . 13.0 t70 -178.49 164.37 1.65 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 104.492 -2.41 . . . . 64.42 104.492 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.47 -28.37 22.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 118.727 0.694 . . . . 74.52 112.269 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 p -91.28 -18.46 24.32 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.704 1.001 . . . . 71.52 113.704 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 117' ' ' ASP . 2.5 p -104.37 120.64 55.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.237 0.541 . . . . 54.3 109.879 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 154.24 46.98 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.332 -0.849 . . . . 72.21 110.519 -175.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.8 mm -91.75 112.32 25.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.806 -0.813 . . . . 75.31 108.806 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -126.15 147.73 49.56 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.27 -1.011 . . . . 74.15 108.27 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 40' ' ' LYS . 14.7 pt-20 -121.24 151.2 40.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 120.948 0.404 . . . . 75.13 111.341 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -134.33 125.68 28.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.82 -0.627 . . . . 71.14 111.581 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.493 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -143.14 174.2 10.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 171.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.94 19.34 77.68 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 119.884 -1.15 . . . . 75.04 111.12 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.8 145.74 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-O 121.003 0.43 . . . . 75.42 109.912 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.1 m -115.73 131.67 56.87 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.543 -1.28 . . . . 54.2 107.543 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -123.96 154.23 30.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.073 0.463 . . . . 71.13 109.906 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 66.2 m-85 -114.03 122.04 45.71 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 105.998 -1.853 . . . . 75.05 105.998 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.6 p -112.59 143.01 44.49 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.854 0.359 . . . . 70.23 111.005 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.509 ' HB ' HD21 ' A' ' 151' ' ' LEU . 13.5 t -128.01 134.35 49.23 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 120.693 -0.403 . . . . 63.24 110.008 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.521 ' NE2' ' HG2' ' A' ' 184' ' ' GLU . 2.0 mp0 -110.84 142.18 43.2 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.552 -1.648 . . . . 72.12 106.552 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 143' ' ' ASP . 30.7 p90 -143.17 118.25 10.08 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 115.133 1.531 . . . . 73.42 115.133 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 47.74 -138.96 10.37 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.005 -1.452 . . . . 73.15 115.776 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 181' ' ' ARG . . . -124.78 -28.39 1.16 Allowed Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 111.103 -0.799 . . . . 53.11 111.103 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.6 119.43 38.06 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.002 0.43 . . . . 70.34 112.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.436 ' HB2' HD22 ' A' ' 183' ' ' ASN . . . -124.59 107.63 11.23 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.578 -0.737 . . . . 75.32 110.883 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.14 171.9 8.45 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.737 -1.209 . . . . 73.03 107.737 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.59 -39.02 75.87 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.135 0.493 . . . . 63.15 110.434 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.36 74.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.38 -0.827 . . . . 70.44 111.362 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 17.2 m-20 -65.92 -36.26 82.88 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 111.815 0.302 . . . . 74.43 111.815 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.37 -39.9 89.38 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.927 0.394 . . . . 72.44 110.709 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.99 -51.13 32.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.949 -0.569 . . . . 65.43 110.372 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -57.4 -46.52 83.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.714 -0.675 . . . . 72.32 111.667 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -65.03 -32.65 74.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.027 0.751 . . . . 74.12 113.027 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.92 86.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.342 -0.614 . . . . 74.34 109.342 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.8 m -65.59 -40.19 92.42 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.711 -0.677 . . . . 72.35 109.937 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 30.2 mm-40 -61.84 -37.02 82.92 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 116.186 -0.461 . . . . 74.34 111.938 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.509 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.0 mt -60.92 -35.03 75.64 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 120.865 -0.334 . . . . 54.32 111.752 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -59.81 -48.14 82.87 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.25 0.343 . . . . 75.14 111.276 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 156' ' ' GLU . 13.0 t -75.56 -30.61 59.75 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.201 0.524 . . . . 65.15 111.033 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.9 m -70.69 -35.35 72.75 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 120.963 0.411 . . . . 74.24 110.421 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.5 6.45 17.39 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.014 0.525 . . . . 73.21 112.283 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 153' ' ' THR . 56.5 mt-10 -68.93 138.3 54.5 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.008 -0.677 . . . . 75.13 110.082 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.09 56.6 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.756 -0.656 . . . . 74.15 111.595 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.5 p -125.37 165.33 26.97 Favored Pre-proline 0 N--CA 1.441 -0.922 0 N-CA-C 108.293 -1.002 . . . . 55.11 108.293 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -75.44 20.14 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.796 2.331 . . . . 71.21 112.451 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.73 120.73 17.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.309 0.576 . . . . 55.42 110.426 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 10.1 t -124.59 157.5 35.29 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.007 -1.849 . . . . 61.03 106.007 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -132.6 160.09 37.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 119.115 0.871 . . . . 72.23 108.893 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -128.77 132.86 47.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.125 0.417 . . . . 52.43 112.125 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.63 -0.45 27.14 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.508 -0.769 . . . . 63.14 114.12 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 60.62 10.77 2.74 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.033 0.933 . . . . 72.45 112.285 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.5 p -68.77 138.53 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.784 0.802 . . . . 74.3 111.488 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.414 ' HB3' HD23 ' A' ' 187' ' ' LEU . 36.4 p90 -135.95 161.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.8 -1.091 . . . . 71.23 108.897 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 88.4 m-85 -115.41 142.07 47.19 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.153 -0.476 . . . . 74.43 109.913 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.2 m -114.22 120.3 40.0 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.731 -1.211 . . . . 65.34 107.731 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -116.3 143.07 46.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.154 0.502 . . . . 71.44 111.708 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -169.53 165.66 39.04 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 107.279 -2.328 . . . . 54.52 107.279 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -66.41 -38.76 88.2 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 118.85 1.325 . . . . 73.53 109.057 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -155.01 154.62 29.15 Favored Pre-proline 0 C--N 1.287 -2.111 0 N-CA-C 104.762 -2.31 . . . . 73.44 104.762 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.33 113.76 1.56 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.863 1.709 . . . . 72.3 108.333 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.26 127.67 26.97 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.569 1.513 . . . . 70.01 113.481 -170.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -94.82 -21.07 18.94 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.661 -1.154 . . . . 65.13 108.896 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -112.64 147.47 37.18 Favored Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 107.03 -1.47 . . . . 75.43 107.03 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.54 -31.0 93.51 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.643 2.229 . . . . 74.15 112.676 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -82.65 123.61 29.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.382 0.61 . . . . 75.21 111.0 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.55 82.06 0.09 OUTLIER Glycine 0 C--N 1.306 -1.114 0 N-CA-C 107.338 -2.305 . . . . 61.11 107.338 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HA ' ' HA2' ' A' ' 137' ' ' GLY 0.258 19.7 ptt180 -65.34 -29.86 70.64 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 116.185 1.92 . . . . 74.11 116.185 -167.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -101.23 125.25 47.84 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 115.342 -2.543 . . . . 75.52 108.581 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.436 HD22 ' HB2' ' A' ' 139' ' ' ALA . 19.8 p30 -146.84 158.37 43.9 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.648 -1.614 . . . . 62.03 108.786 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 43.5 mt-10 -143.12 137.38 29.09 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.098 0.475 . . . . 72.13 110.537 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 84.7 t -124.22 118.5 53.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 105.913 -1.884 . . . . 74.43 105.913 171.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.526 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 49.2 m0 -106.32 124.42 49.57 Favored 'General case' 0 CA--C 1.495 -1.154 0 O-C-N 123.463 0.477 . . . . 75.34 111.413 -176.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 167' ' ' TYR . 62.4 mt -97.35 125.2 41.81 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.676 -1.601 . . . . 70.42 106.676 167.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.5 p -93.7 124.75 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 120.536 -0.466 . . . . 74.01 109.993 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 161' ' ' THR . 15.5 pttp -70.19 145.1 51.69 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.643 -0.708 . . . . 73.04 109.644 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.296 -1.76 0 C-N-CA 118.976 -1.089 . . . . 41.43 109.442 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.1 t30 . . . . . 0 C--O 1.235 0.335 0 N-CA-C 108.639 -0.875 . . . . 61.11 108.639 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.1 p -139.3 150.61 45.62 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.534 -0.913 . . . . 72.13 108.534 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.6 mt -84.54 120.58 26.5 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.725 -0.843 . . . . 72.23 108.725 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.75 151.66 19.92 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.149 0.5 . . . . 74.02 110.672 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.06 134.42 12.18 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 109.322 -1.511 . . . . 22.13 109.322 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.7 m -76.4 -27.06 56.17 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 117.102 0.451 . . . . 72.03 110.569 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t 53.97 76.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.214 1.005 . . . . 72.54 110.376 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.409 0.0 OUTLIER -91.63 78.65 5.52 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 122.754 1.264 . . . . 71.33 113.987 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.1 m -94.86 110.91 22.74 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 113.664 -1.607 . . . . 70.42 108.326 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 5.3 p90 -43.13 105.69 0.44 Allowed Pre-proline 0 CA--C 1.567 1.632 0 C-N-CA 126.151 1.78 . . . . 74.4 112.622 -177.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -95.09 121.07 0.29 Allowed 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 122.483 2.122 . . . . 73.2 112.862 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 41.2 p90 -111.66 141.02 45.78 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.375 -0.602 . . . . 61.43 109.375 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -122.91 110.0 14.86 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.943 -0.303 . . . . 60.43 110.546 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.3 116.42 30.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 106.906 -1.516 . . . . 74.2 106.906 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -91.93 -26.28 18.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.36 -0.536 . . . . 63.24 112.111 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -172.85 153.14 2.58 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.006 0.431 . . . . 64.53 110.779 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.6 p -133.03 134.58 44.6 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.867 -1.06 . . . . 71.43 110.231 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.94 132.55 7.81 Favored Glycine 0 C--N 1.304 -1.246 0 C-N-CA 120.265 -0.969 . . . . 62.5 112.752 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.46 -115.03 0.98 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.029 -0.605 . . . . 62.13 111.749 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.582 ' H ' HG23 ' A' ' 154' ' ' THR . 4.7 ttmp? -91.71 117.55 29.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.518 -1.66 . . . . 64.33 106.518 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -67.75 134.31 50.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 115.27 1.582 . . . . 73.42 115.27 -170.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 158.17 -58.87 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 129.704 3.202 . . . . 72.44 103.737 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.2 p -129.22 129.96 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 106.901 -1.518 . . . . 74.33 106.901 170.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.5 m -95.27 154.64 17.09 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.893 -0.504 . . . . 75.21 110.087 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CD2' HG22 ' A' ' 154' ' ' THR . 0.1 OUTLIER -113.47 163.37 14.98 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.983 -0.553 . . . . 74.34 110.885 178.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -132.96 124.53 27.96 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.628 -1.99 . . . . 74.5 105.628 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.4 115.27 30.13 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.552 -1.277 . . . . 71.15 107.552 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -131.3 139.79 49.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.216 -0.594 . . . . 63.0 110.933 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.39 133.65 35.44 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 104.924 -2.251 . . . . 73.51 104.924 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.27 138.92 58.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 123.674 0.609 . . . . 61.14 109.851 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.8 OUTLIER -60.69 -26.94 67.49 Favored 'General case' 0 N--CA 1.422 -1.85 0 O-C-N 124.435 1.085 . . . . 62.23 112.531 -178.193 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 84.31 10.24 80.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 118.465 -1.826 . . . . 73.24 112.247 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.22 157.27 53.4 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.822 -0.704 . . . . 61.21 111.395 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 14.4 ptpt -88.32 123.43 32.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.409 -0.96 . . . . 71.43 108.409 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.641 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 28.0 m-85 -122.32 165.45 16.23 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.588 -0.733 . . . . 65.05 110.996 -172.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.25 115.35 28.18 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.384 -0.969 . . . . 73.24 108.384 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.9 t -120.32 142.67 48.91 Favored 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 115.124 -0.943 . . . . 62.3 111.643 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 13.8 m -128.89 127.14 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 107.147 -1.427 . . . . 71.01 107.147 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.59 119.68 31.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-O 121.887 0.851 . . . . 74.05 112.093 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 39.9 t -114.72 135.8 53.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.221 -1.354 . . . . 75.33 107.616 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 49' ' ' LYS . 33.3 p -125.78 167.5 15.09 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.582 -0.281 . . . . 65.05 110.736 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.7 t70 73.64 -26.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 124.039 0.935 . . . . 71.23 112.202 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 47' ' ' THR . 94.6 mttt -96.96 143.27 25.83 Favored Pre-proline 0 C--N 1.3 -1.565 0 CA-C-N 115.808 -0.633 . . . . 64.51 110.22 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.14 158.95 36.82 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.374 2.716 . . . . 62.2 111.789 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG13 HD12 ' A' ' 98' ' ' LEU . 74.2 t -45.66 -45.66 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.131 0.972 . . . . 64.24 112.756 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.58 -50.04 75.27 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.506 0.67 . . . . 53.43 110.52 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.99 -35.73 77.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.104 -0.953 . . . . 72.21 112.273 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.463 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -71.18 -45.26 63.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.462 -0.335 . . . . 73.14 110.624 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.08 -43.64 94.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.304 -0.407 . . . . 71.12 111.413 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -64.51 -26.74 68.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.159 0.429 . . . . 62.23 112.159 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.5 ' HG2' ' HE3' ' A' ' 61' ' ' LYS . 27.5 tt0 -84.07 -30.39 26.06 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.09 -0.707 . . . . 74.25 109.09 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.58 52.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.979 -1.01 . . . . 61.0 113.49 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mmt -51.08 -55.85 24.77 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 112.504 0.557 . . . . 74.53 112.504 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.11 -31.32 74.83 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.739 2.293 . . . . 72.43 113.202 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.5 ' HE3' ' HG2' ' A' ' 57' ' ' GLU . 93.1 mttt -64.19 -48.46 75.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.77 0.319 . . . . 75.45 110.362 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.8 -38.81 83.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.341 -0.39 . . . . 74.32 110.756 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.1 mmt -59.15 -43.23 92.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.253 -0.43 . . . . 62.14 112.038 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -76.22 -29.72 57.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.834 -0.747 . . . . 75.21 111.634 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 36.9 t80 -60.91 -56.3 22.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.165 -0.471 . . . . 75.35 110.743 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.4 m -77.45 -7.56 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.391 0.615 . . . . 74.34 110.739 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.85 -20.74 62.77 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.602 -0.726 . . . . 14.2 112.436 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.32 6.55 8.11 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.028 -1.082 . . . . 75.42 113.288 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -91.85 17.73 8.74 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.777 1.275 . . . . 54.45 109.573 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.07 173.47 10.46 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.562 -1.199 . . . . 73.24 109.438 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 24.1 t70 -67.09 -33.23 75.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.541 0.571 . . . . 73.53 112.541 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.15 -12.29 59.25 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.45 -0.5 . . . . 71.04 110.554 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.25 24.76 74.81 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 115.535 -0.757 . . . . 44.11 111.884 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.61 122.02 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 C-N-CA 120.004 -0.679 . . . . 45.34 111.287 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.42 97.84 1.36 Allowed Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 109.241 -1.543 . . . . 72.1 109.241 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtt -126.41 135.53 51.53 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.625 -0.509 . . . . 53.22 109.625 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.95 70.91 1.45 Allowed Glycine 0 C--N 1.292 -1.908 0 CA-C-N 115.296 -0.865 . . . . 43.01 111.922 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' A' ' 78' ' ' MET . 18.0 ptm -96.68 122.44 39.62 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.283 -0.636 . . . . 64.53 109.283 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.8 m -127.44 133.98 49.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.758 -0.656 . . . . 74.02 110.478 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -166.43 148.29 5.84 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.044 -1.465 . . . . 62.14 107.044 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 27.8 Cg_exo -40.1 140.97 0.75 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.753 2.968 . . . . 75.44 115.133 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.26 152.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.262 -1.014 . . . . 63.32 108.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.9 m -139.3 152.32 47.13 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.202 -0.666 . . . . 62.51 109.202 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CB ' ' HA ' ' A' ' 100' ' ' VAL . 54.5 p90 -145.14 144.99 31.19 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 122.1 -0.375 . . . . 60.11 110.578 172.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.39 137.97 31.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.648 -0.501 . . . . 54.44 109.648 -177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.18 150.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 0 N-CA-C 108.744 -0.836 . . . . 72.2 108.744 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.58 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 62.7 m-85 -117.09 112.34 40.01 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 107.02 -1.474 . . . . 73.34 107.02 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.22 133.66 18.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 120.948 1.099 . . . . 73.11 112.247 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -86.35 156.57 20.16 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 107.823 -1.177 . . . . 73.44 107.823 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.01 -13.33 62.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.186 0.517 . . . . 62.3 112.147 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.16 -6.14 58.97 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.998 -0.546 . . . . 72.05 110.278 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.54 -2.45 72.5 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.335 -0.393 . . . . 54.02 113.269 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -87.36 3.56 46.46 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.881 0.697 . . . . 74.35 112.881 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt 65.3 148.29 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.108 0.963 . . . . 70.51 112.889 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 34.8 tt0 -82.08 148.57 28.5 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.707 -0.679 . . . . 75.23 109.854 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -86.06 70.43 10.59 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.752 0.786 . . . . 74.31 111.31 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 22.0 ttmm -158.26 125.5 5.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 105.483 -2.043 . . . . 71.42 105.483 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.459 HD12 HG13 ' A' ' 51' ' ' VAL . 6.1 tt -143.03 131.89 22.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.328 -0.949 . . . . 73.44 111.38 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.79 115.16 23.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.299 -0.864 . . . . 70.3 109.311 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 43' ' ' THR . 92.9 t -88.33 127.93 40.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 N-CA-C 108.041 -1.096 . . . . 44.25 108.041 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -114.79 113.61 24.47 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.359 -0.978 . . . . 75.15 108.359 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -103.04 114.08 28.08 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.682 -1.229 . . . . 74.2 107.682 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.641 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 14.8 ptp180 -75.07 138.78 42.36 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.771 -1.104 . . . . 64.24 108.085 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -97.91 141.16 22.54 Favored Pre-proline 0 C--N 1.266 -3.046 0 CA-C-N 116.264 -0.425 . . . . 72.34 110.056 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.42 146.89 9.64 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.902 2.401 . . . . 64.22 111.731 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -52.27 -40.38 61.68 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.379 1.251 . . . . 73.45 114.379 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.37 -27.87 66.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.211 0.529 . . . . 62.35 111.313 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.24 -1.66 47.67 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.203 -0.453 . . . . 61.54 112.156 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.647 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -64.72 -41.21 96.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.881 0.372 . . . . 72.42 110.507 176.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.14 -23.42 68.73 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.679 -0.691 . . . . 64.21 112.35 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -149.77 87.91 5.01 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 120.782 0.325 . . . . 54.0 110.351 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -96.42 162.56 1.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.008 2.472 . . . . 73.31 111.713 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.2 135.49 27.18 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.409 2.073 . . . . 72.35 111.402 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -71.98 150.29 92.59 Favored Pre-proline 0 C--O 1.256 1.42 0 CA-C-O 120.594 0.235 . . . . 64.22 111.441 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 2.8 Cg_exo -75.85 117.07 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.829 2.352 . . . . 74.21 112.185 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -97.79 21.62 10.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.529 -0.915 . . . . 52.11 108.529 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.575 ' HB3' HG12 ' A' ' 120' ' ' VAL . 17.4 t70 -140.26 156.22 46.56 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.402 -1.333 . . . . 73.34 107.402 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -25.33 22.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.967 -0.693 . . . . 54.43 111.89 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -78.61 -34.06 46.97 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.355 -0.384 . . . . 63.34 110.932 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 117' ' ' ASP . 7.4 p -98.77 125.23 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.364 -0.606 . . . . 61.52 109.364 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -128.21 138.43 52.46 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.341 -0.845 . . . . 52.41 109.539 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 22.9 mm -93.64 110.81 23.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.173 -1.417 . . . . 73.23 107.173 173.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.27 145.19 51.12 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.32 -0.993 . . . . 64.53 108.32 -174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.13 144.22 40.62 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.982 0.42 . . . . 73.44 110.706 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.523 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -123.97 122.68 38.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.058 -1.83 . . . . 73.41 106.058 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.73 157.01 47.37 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.855 1.057 . . . . 73.43 113.855 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.66 17.2 79.22 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.159 -0.928 . . . . 55.14 113.449 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.31 165.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 C-N-CA 120.553 -0.459 . . . . 51.2 110.54 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.54 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 28.6 m -120.13 133.09 55.6 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 109.136 -0.69 . . . . 63.41 109.136 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.99 151.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.387 -0.968 . . . . 63.42 108.387 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 41.4 m-85 -113.64 121.46 44.23 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.413 -1.699 . . . . 74.34 106.413 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 t -111.46 125.15 53.58 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.878 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.556 ' HB ' HD13 ' A' ' 151' ' ' LEU . 12.7 t -113.58 127.36 56.04 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 107.796 -1.187 . . . . 73.14 107.796 174.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -110.41 132.93 53.75 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 121.645 0.736 . . . . 74.3 110.938 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 182' ' ' ARG . 48.7 p90 -129.8 146.38 51.54 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 74.12 108.973 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 181' ' ' ARG . . . -124.54 111.03 1.49 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 111.061 -0.816 . . . . 50.22 111.061 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 175.05 -126.53 1.18 Allowed Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.712 -0.756 . . . . 50.43 111.719 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -100.14 135.67 41.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.062 -0.718 . . . . 73.14 109.062 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.88 107.51 10.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 113.277 0.843 . . . . 72.21 113.277 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.675 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 58.0 pttt -104.18 170.63 7.79 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 71.41 106.324 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -39.52 73.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.497 0.665 . . . . 74.51 110.365 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.467 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . . . -64.86 -28.65 69.7 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.138 -0.937 . . . . 74.11 111.869 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.675 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 13.8 m-20 -62.91 -35.52 80.33 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 120.212 -0.595 . . . . 74.31 110.787 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.438 ' OH ' ' HG3' ' A' ' 175' ' ' PRO . 98.9 m-85 -68.69 -39.3 80.62 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.588 -0.445 . . . . 61.34 110.553 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.07 -47.13 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.613 -0.514 . . . . 70.43 109.613 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 150' ' ' GLN . . . -60.81 -46.63 89.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.888 -0.596 . . . . 73.22 110.657 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -65.83 -32.64 74.28 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 112.116 0.413 . . . . 74.2 112.116 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -64.57 -46.34 83.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 74.12 109.523 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.5 m -61.45 -44.17 97.58 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.088 -0.505 . . . . 64.14 110.128 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 146' ' ' ALA . 15.2 mm100 -64.45 -35.39 80.75 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.224 -0.444 . . . . 64.43 110.701 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.556 HD13 ' HB ' ' A' ' 133' ' ' THR . 49.1 tp -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.153 -0.342 . . . . 54.33 110.445 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.466 ' HD2' ' OD1' ' A' ' 165' ' ' ASP . 70.2 mtp180 -63.27 -40.79 98.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.567 -0.288 . . . . 71.44 111.447 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.2 t -75.4 -29.78 59.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.807 0.813 . . . . 64.43 110.095 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 26' ' ' LYS . 59.6 m -71.62 -34.67 70.03 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.751 -0.659 . . . . 63.23 110.36 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.409 HD12 HD23 ' A' ' 187' ' ' LEU . 82.2 mt -85.87 4.31 37.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 74.12 111.506 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.6 138.71 31.47 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.072 -1.455 . . . . 73.31 107.072 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.73 -10.16 62.43 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 111.169 -0.772 . . . . 64.3 111.169 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.8 t -119.72 145.5 39.46 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 106.607 -1.627 . . . . 75.34 106.607 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.58 29.13 0.17 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 123.607 2.871 . . . . 74.5 114.62 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.75 128.5 34.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.833 0.349 . . . . 73.02 110.312 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 8.9 t -107.44 152.39 24.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.915 -0.584 . . . . 53.34 109.571 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -141.84 159.76 41.58 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 122.745 0.418 . . . . 71.55 110.533 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.489 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.4 pt20 -129.4 137.09 50.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.713 -0.477 . . . . 71.03 109.713 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.8 -0.64 9.75 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.143 -0.551 . . . . 51.31 114.405 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 152' ' ' ARG . 37.5 t70 65.54 19.27 11.49 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.07 0.948 . . . . 72.44 109.197 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 163' ' ' GLN . 8.4 p -71.49 138.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 CA-C-N 116.023 -0.535 . . . . 72.42 110.551 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -150.28 173.4 14.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.589 -0.732 . . . . 61.42 111.381 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 46.3 m-85 -115.52 152.02 33.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.355 -0.839 . . . . 65.43 110.314 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.0 t -114.47 120.11 39.16 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.197 -1.408 . . . . 65.01 107.197 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -128.41 159.21 36.09 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 110.559 -0.163 . . . . 53.4 110.559 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -161.31 150.13 19.55 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.792 -1.323 . . . . 45.14 109.792 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 m-30 -80.66 -16.6 53.59 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.912 0.863 . . . . 75.01 109.992 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -155.5 136.61 9.16 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 105.281 -2.118 . . . . 73.44 105.281 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.2 108.1 0.23 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.337 2.025 . . . . 65.11 110.726 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.438 ' HG3' ' OH ' ' A' ' 144' ' ' TYR . 55.6 Cg_endo -67.98 137.84 42.35 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.604 2.202 . . . . 63.15 113.5 -172.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.592 ' O ' ' HG3' ' A' ' 177' ' ' LYS . 65.7 mtt -89.4 -42.87 11.27 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.106 -1.442 . . . . 63.21 107.106 174.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 176' ' ' MET . 51.8 mttp 161.86 -59.72 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 130.015 3.326 . . . . 73.42 109.031 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 177' ' ' LYS . 6.1 Cg_exo -82.65 -31.47 0.79 Allowed 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.722 1.615 . . . . 54.41 110.64 175.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -94.9 141.82 28.19 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 107.747 -1.205 . . . . 74.42 107.747 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 88.76 64.03 1.32 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 107.794 -2.122 . . . . 74.5 107.794 -171.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.419 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 99.3 mtt180 -73.83 -46.68 43.6 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 114.586 1.328 . . . . 71.55 114.586 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 135' ' ' PHE . 36.7 ttm180 -100.48 129.55 46.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 118.147 -1.421 . . . . 64.55 110.337 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -140.36 153.46 46.4 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.031 -1.441 . . . . 74.04 108.095 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 40.3 mt-10 -116.51 151.75 35.49 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.961 -0.755 . . . . 63.0 108.961 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.02 118.2 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.102 -1.814 . . . . 71.41 106.102 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 20.6 m0 -102.96 121.25 42.16 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.998 -0.742 . . . . 75.34 108.998 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 166' ' ' VAL . 36.5 tp -98.13 134.3 41.39 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.996 -1.112 . . . . 73.02 107.996 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.43 125.16 44.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 O-C-N 123.171 0.295 . . . . 71.12 110.745 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -64.02 142.49 58.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 123.639 0.587 . . . . 63.34 110.991 176.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.34 0 CA-C-O 119.065 -0.493 . . . . 63.01 110.921 179.141 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 t30 . . . . . 0 C--O 1.222 -0.373 0 N-CA-C 108.751 -0.833 . . . . 73.35 108.751 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -137.45 105.31 5.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 112.941 0.719 . . . . 61.2 112.941 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.2 106.92 12.39 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.025 -1.102 . . . . 64.34 108.025 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 54.8 t80 -69.56 128.0 34.96 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.613 -0.514 . . . . 64.05 109.613 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.8 60.61 4.75 Favored Glycine 0 CA--C 1.506 -0.528 0 CA-C-N 116.044 -0.526 . . . . 62.12 113.382 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . 35.0 t -166.5 120.16 1.07 Allowed 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 105.871 -1.899 . . . . 73.22 105.871 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.63 93.17 2.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 113.082 0.771 . . . . 71.33 113.082 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -130.53 91.7 3.13 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.97 -1.493 . . . . 73.32 106.97 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 m -77.15 2.53 15.04 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.269 1.033 . . . . 64.52 111.462 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -115.31 84.54 11.71 Favored Pre-proline 0 N--CA 1.418 -2.048 0 N-CA-C 106.681 -1.6 . . . . 74.44 106.681 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -86.87 121.18 1.75 Allowed 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 121.786 1.657 . . . . 72.44 113.384 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.487 ' HB2' ' O ' ' A' ' 35' ' ' ALA . 25.6 p90 -103.88 149.91 24.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.8 111.28 23.95 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.674 -0.41 . . . . 74.44 110.407 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.5 t -84.05 120.41 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.469 -0.937 . . . . 61.12 108.469 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -90.3 -35.8 15.05 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.504 -0.479 . . . . 75.25 110.935 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -164.25 149.88 10.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.346 0.593 . . . . 73.41 111.233 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.524 HG22 ' CB ' ' A' ' 32' ' ' GLU . 47.7 p -132.51 155.18 49.06 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.031 -1.47 . . . . 75.42 107.031 173.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.19 103.16 2.44 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 119.198 -1.477 . . . . 74.02 112.345 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.81 -135.11 3.92 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.546 -0.835 . . . . 71.4 111.424 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -96.45 139.26 32.82 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 105.916 -1.883 . . . . 71.23 105.916 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.7 173.18 2.95 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 114.127 1.158 . . . . 74.32 114.127 -171.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 83.15 -51.88 0.16 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.666 1.587 . . . . 73.43 111.023 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.03 110.8 28.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.771 -1.196 . . . . 74.52 107.771 175.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 p -94.98 154.52 17.14 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.917 -0.583 . . . . 74.43 111.257 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.15 158.95 42.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.383 0.611 . . . . 71.41 111.626 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' CB ' HG22 ' A' ' 23' ' ' THR . 12.9 pt-20 -134.89 132.2 38.23 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.482 -1.303 . . . . 75.25 107.482 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -96.77 114.32 25.94 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.292 -1.744 . . . . 74.23 106.292 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.28 1.2 ppt_? -142.14 145.2 33.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.287 1.217 . . . . 70.35 114.287 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -80.52 137.75 36.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.526 -1.287 . . . . 72.3 107.526 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.3 t -57.27 147.75 24.58 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.782 0.676 . . . . 73.4 111.186 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -63.89 -28.13 69.63 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 124.115 0.966 . . . . 61.53 112.59 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 77.31 9.75 86.64 Favored Glycine 0 C--N 1.317 -0.512 0 C-N-CA 120.432 -0.889 . . . . 61.23 113.556 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.68 160.57 54.09 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.682 -0.771 . . . . 74.51 112.212 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -88.79 122.11 31.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.597 -0.52 . . . . 63.31 109.597 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 26.5 m-85 -126.9 166.17 17.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.467 -0.788 . . . . 72.03 111.699 -171.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.62 115.82 28.63 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.846 -0.798 . . . . 71.24 108.846 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 8.0 t -125.81 143.54 51.02 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-N 115.314 -0.857 . . . . 63.22 112.112 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.485 HG21 ' HD2' ' A' ' 61' ' ' LYS . 12.8 p -132.83 144.56 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 108.352 -0.981 . . . . 75.13 108.352 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.78 127.69 50.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.675 0.75 . . . . 74.43 111.032 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 46.7 t -120.64 133.15 68.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.102 -1.444 . . . . 42.24 107.102 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 97' ' ' LYS . 35.7 p -130.76 176.6 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.51 0.559 . . . . 73.55 112.51 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 69.34 4.07 4.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.903 1.281 . . . . 53.44 112.316 174.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -141.0 141.16 22.97 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 108.058 -1.09 . . . . 75.03 108.058 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.27 156.86 7.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.341 2.694 . . . . 73.13 112.364 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.574 HG13 HD13 ' A' ' 98' ' ' LEU . 71.4 t -47.67 -41.36 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.575 0.954 . . . . 44.43 113.575 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 9.9 m-20 -58.75 -50.09 75.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.413 0.625 . . . . 60.24 109.911 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.33 -40.7 81.51 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.996 -1.002 . . . . 73.11 110.871 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -61.13 -46.57 90.04 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.542 -0.753 . . . . 71.54 110.104 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.68 -31.7 70.95 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.899 -0.591 . . . . 70.25 110.906 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 36.7 mtm180 -61.25 -30.24 70.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.554 0.576 . . . . 73.32 112.554 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 37.1 mt-10 -85.61 -46.3 10.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.416 -0.513 . . . . 71.34 111.512 173.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.27 80.22 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.971 1.1 . . . . 73.3 113.971 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.56 ' HB3' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.81 -52.72 72.33 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 119.483 -0.294 . . . . 54.31 110.463 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 71.9 Cg_exo -51.75 -37.15 64.46 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.702 2.268 . . . . 72.3 112.319 173.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 88.9 mttt -67.41 -42.49 83.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.28 0.474 . . . . 75.41 112.28 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.95 -41.04 77.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.612 -0.435 . . . . 43.01 111.834 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.526 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.9 ptm -69.91 -29.63 66.85 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.795 0.665 . . . . 54.15 112.795 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -70.37 -40.83 73.79 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.928 -0.767 . . . . 74.53 108.928 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.22 -56.87 16.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.839 -0.619 . . . . 73.31 111.529 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 102' ' ' PHE . 11.8 m -78.35 -20.97 13.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 120.983 0.42 . . . . 74.3 111.284 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.05 70.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.674 -0.693 . . . . 74.55 112.89 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.69 -17.41 0.49 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.768 -1.205 . . . . 64.5 113.53 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -81.83 32.52 0.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 122.304 1.05 . . . . 74.12 110.752 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.68 168.94 9.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.782 -0.645 . . . . 62.11 109.836 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.419 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 11.0 t70 -66.06 -33.99 77.05 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.04 0.756 . . . . 71.14 113.04 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -82.22 -11.22 58.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 73.43 109.728 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.91 34.87 77.97 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.329 -0.85 . . . . 51.25 112.128 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.44 121.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.969 -0.692 . . . . 65.4 110.263 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.11 116.0 5.47 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.561 -0.828 . . . . 74.35 112.285 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.6 mmt 61.8 28.39 17.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.05 109.565 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.98 -34.54 90.19 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.589 -1.187 . . . . 73.54 113.471 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.401 ' HB2' ' CD ' ' A' ' 105' ' ' PRO . 1.2 pmm? -124.72 126.1 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 112.843 0.683 . . . . 72.24 112.843 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.0 m -125.21 117.09 23.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.993 -0.743 . . . . 72.31 108.993 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -170.22 143.32 1.95 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.296 -1.372 . . . . 75.45 107.296 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -41.4 139.84 1.73 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.994 3.129 . . . . 62.23 116.729 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 102' ' ' PHE . 10.7 p -105.74 154.23 7.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.68 -1.6 . . . . 71.32 107.145 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 48.5 m -139.7 145.18 38.05 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.436 -0.579 . . . . 75.14 109.436 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 98' ' ' LEU . 37.0 p90 -135.09 147.16 49.47 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.944 -0.472 . . . . 75.45 111.151 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.26 134.71 34.63 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.684 0.615 . . . . 74.01 109.533 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.425 ' HB ' HD12 ' A' ' 94' ' ' LEU . 32.7 m -129.7 152.9 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.825 -0.806 . . . . 71.0 108.825 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HD2' ' A' ' 97' ' ' LYS . 40.6 m-85 -122.5 104.04 37.5 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.878 -0.786 . . . . 74.11 108.878 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.5 133.69 10.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.823 1.682 . . . . 55.11 113.002 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.46 166.05 15.81 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.329 -0.989 . . . . 61.44 108.329 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.76 -15.39 61.53 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.043 0.449 . . . . 73.11 111.149 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -91.18 1.13 57.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 63.44 111.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.85 0.62 90.32 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.948 -0.644 . . . . 75.31 112.503 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 t -92.07 141.16 28.91 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.509 -1.293 . . . . 64.32 107.509 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 86' ' ' VAL . 3.0 mm? -79.29 156.71 27.94 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 120.96 0.409 . . . . 71.33 110.639 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -79.22 158.25 27.66 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.272 -0.64 . . . . 61.22 109.272 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -75.82 40.03 0.18 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.85 0.86 . . . . 63.3 112.212 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 87' ' ' PHE . 38.4 ttmt -141.68 125.83 17.4 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.325 -0.991 . . . . 60.42 108.325 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.574 HD13 HG13 ' A' ' 51' ' ' VAL . 60.3 tp -135.47 129.14 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 110.208 -0.293 . . . . 64.44 110.208 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.37 115.51 21.09 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.219 -0.66 . . . . 44.22 109.219 174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 43' ' ' THR . 59.0 t -96.61 134.9 32.55 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-N 115.229 -0.896 . . . . 74.14 109.871 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -120.84 120.02 34.35 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.941 0.896 . . . . 72.35 109.751 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 73.5 t80 -104.08 123.85 47.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.902 -0.407 . . . . 74.41 109.902 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.582 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 42.3 ttm-85 -75.35 134.2 41.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.343 -0.844 . . . . 70.55 110.187 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CG2' ' HB2' ' A' ' 108' ' ' PHE . 65.7 mt -104.79 133.09 20.34 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 116.532 -0.304 . . . . 72.24 111.21 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' ILE . 47.5 Cg_exo -60.81 161.2 22.41 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.549 2.833 . . . . 74.44 112.6 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -57.98 -37.11 73.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.147 1.166 . . . . 72.41 114.147 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.83 -30.45 71.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.327 0.584 . . . . 75.22 111.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.453 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 96.4 m-85 -99.65 -4.95 29.79 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.948 -0.569 . . . . 71.21 110.972 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.712 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.4 -37.87 71.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 119.586 -0.846 . . . . 74.53 109.735 174.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.1 94.26 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.183 -0.917 . . . . 75.02 111.918 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.8 m -154.11 93.33 2.95 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.182 -0.673 . . . . 61.3 109.182 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 71.7 Cg_endo -77.3 146.41 24.93 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.307 2.004 . . . . 74.21 112.565 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 32.3 Cg_exo -59.62 130.17 34.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.401 2.067 . . . . 74.21 109.801 175.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -68.86 148.98 98.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.81 -0.632 . . . . 64.01 111.48 -176.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 39.6 Cg_exo -60.59 113.14 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.709 2.273 . . . . 73.33 111.938 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -97.07 5.74 49.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.368 -0.975 . . . . 71.23 108.368 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.26 148.76 49.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.132 -1.803 . . . . 72.25 106.132 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -81.1 -25.06 37.28 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.717 0.636 . . . . 75.42 112.717 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.402 ' OG ' ' HD3' ' A' ' 61' ' ' LYS . 47.2 p -91.7 -16.42 26.98 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.78 0.659 . . . . 25.04 112.78 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 50.2 t -94.71 116.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.875 -1.157 . . . . 74.34 107.875 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -119.7 144.08 47.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 110.274 -0.269 . . . . 72.12 110.274 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 33.5 mm -92.85 111.98 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.964 -1.124 . . . . 74.11 107.964 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -125.57 143.35 51.05 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.909 -1.041 . . . . 62.1 109.346 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.05 143.11 40.56 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.038 -0.727 . . . . 62.02 109.038 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 75.5 ttt180 -135.99 127.31 28.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.235 -0.654 . . . . 73.41 109.235 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -143.19 171.02 14.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.668 -0.493 . . . . 75.02 109.668 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.23 7.05 62.52 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 121.009 -0.615 . . . . 42.13 112.176 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.96 145.27 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 120.095 -0.642 . . . . 73.25 110.878 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 59.5 m -109.22 135.69 49.92 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 175.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.42 157.31 32.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 108.849 -0.797 . . . . 71.31 108.849 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 40.2 m-85 -113.3 121.77 45.42 Favored 'General case' 0 N--CA 1.411 -2.381 0 N-CA-C 105.166 -2.161 . . . . 75.3 105.166 178.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.2 t -109.96 125.89 53.34 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.623 -0.51 . . . . 63.23 109.623 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 9.7 t -113.47 126.64 55.55 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.185 -1.043 . . . . 74.03 108.185 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -115.61 124.94 52.21 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.028 -1.101 . . . . 72.35 108.028 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.17 137.02 48.8 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 116.392 -0.367 . . . . 75.12 110.439 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.49 161.81 24.23 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 115.784 -0.643 . . . . 61.4 111.788 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.59 161.31 12.91 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.655 -1.378 . . . . 65.31 109.655 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 86.2 m-85 -79.51 108.4 13.02 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.37 0.605 . . . . 73.33 109.886 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -112.73 145.87 39.76 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.16 -0.927 . . . . 71.22 111.844 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.491 ' HG2' ' OD2' ' A' ' 143' ' ' ASP . 18.6 ptpt -95.43 176.94 5.99 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.739 -0.838 . . . . 74.1 108.739 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 1.3 mp0 -60.32 -37.96 82.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.49 -0.559 . . . . 71.22 109.49 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.63 70.7 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.437 -0.801 . . . . 54.43 111.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.491 ' OD2' ' HG2' ' A' ' 140' ' ' LYS . 23.4 m-20 -64.4 -31.21 72.32 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 62.32 111.283 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -64.61 -46.68 81.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.68 0.276 . . . . 73.31 110.902 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.59 -46.08 95.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.457 0.646 . . . . 54.51 109.978 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.84 99.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 43.33 111.482 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -71.12 -32.52 69.11 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 112.281 0.475 . . . . 73.13 112.281 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.3 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.216 -0.661 . . . . 70.31 109.216 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.4 m -65.07 -40.97 95.44 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.355 -0.839 . . . . 71.42 110.835 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -73.73 -30.3 62.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.937 0.399 . . . . 75.42 110.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.11 -31.7 72.91 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 109.618 -0.512 . . . . 71.04 109.618 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 165' ' ' ASP . 79.9 mtp180 -63.81 -39.09 93.4 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.024 -0.534 . . . . 50.14 109.931 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 56.6 m -71.6 -30.98 66.43 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.654 0.74 . . . . 71.41 109.703 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 38.4 m -72.1 -34.87 68.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.581 -0.736 . . . . 74.45 109.091 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.08 6.66 41.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.364 -0.835 . . . . 74.34 111.137 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.13 128.14 33.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.334 -1.728 . . . . 74.14 106.334 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.32 13.47 41.83 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.268 -0.967 . . . . 64.44 111.811 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 70.9 p -117.2 163.12 24.58 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.893 -0.78 . . . . 41.01 108.893 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -86.33 12.83 2.9 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.643 2.229 . . . . 74.13 111.802 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.96 148.31 47.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.921 -0.582 . . . . 62.44 111.25 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 43.4 p -122.04 141.44 51.37 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.76 -0.83 . . . . 74.12 108.76 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -135.52 144.94 46.58 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.113 -0.367 . . . . 75.41 111.278 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 163' ' ' GLN . 29.7 pt20 -106.32 110.97 23.36 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.184 0.809 . . . . 74.2 113.184 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.73 8.48 57.08 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.77 -0.729 . . . . 52.42 113.339 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.455 ' OD2' ' HD2' ' A' ' 152' ' ' ARG . 3.8 m-20 62.5 24.17 14.38 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.695 0.798 . . . . 74.25 111.263 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.57 140.24 18.09 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 C-N-CA 119.52 -0.872 . . . . 71.42 109.283 -174.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' TRP . 32.8 p90 -140.65 168.68 19.22 Favored 'General case' 0 N--CA 1.415 -2.209 0 C-N-CA 120.196 -0.602 . . . . 61.33 112.009 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 35.7 m-85 -115.32 147.26 40.66 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.423 -0.808 . . . . 73.24 109.87 175.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 83' ' ' SER . 41.4 t -114.44 137.38 51.91 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.75 32.79 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.921 0.391 . . . . 54.12 111.067 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.2 164.64 36.74 Favored Glycine 0 C--O 1.201 -1.926 0 N-CA-C 108.924 -1.67 . . . . 63.05 108.924 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -132.22 -18.51 2.58 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.59 1.195 . . . . 72.11 112.16 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.554 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 2.8 p30 -156.19 139.83 11.27 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 106.837 -1.542 . . . . 72.11 106.837 172.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 57.6 Cg_endo -91.91 102.97 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.366 2.044 . . . . 71.25 112.591 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 6.1 Cg_exo -83.63 149.22 12.75 Favored 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.828 2.352 . . . . 75.4 111.978 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.5 ttt -82.65 -31.31 28.8 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.219 -0.9 . . . . 74.33 110.249 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -107.5 -65.59 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 115.477 1.658 . . . . 74.41 115.477 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.66 -20.93 22.53 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 121.545 1.496 . . . . 64.4 114.853 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 60.54 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.856 0.862 . . . . 75.12 113.213 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 138' ' ' TYR . . . -130.66 124.28 4.17 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 119.859 -1.162 . . . . 40.44 112.722 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.579 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -96.39 -21.58 17.69 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.051 0.929 . . . . 75.04 109.815 174.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -134.57 130.57 36.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.957 -2.238 . . . . 72.25 104.957 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -133.22 137.09 45.99 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 108.757 -0.831 . . . . 73.23 108.757 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 133' ' ' THR . 45.7 mt-10 -132.31 136.03 46.61 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.899 0.381 . . . . 45.22 111.5 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.45 ' HB ' ' CG2' ' A' ' 133' ' ' THR . 74.4 t -124.98 124.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.806 -1.183 . . . . 71.12 107.806 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.499 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 35.1 m0 -109.42 121.3 44.89 Favored 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 120.872 -0.331 . . . . 74.52 110.244 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 67.3 mt -96.24 126.31 41.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.138 -1.06 . . . . 75.54 108.138 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.08 127.25 42.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.592 -0.521 . . . . 64.35 109.592 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -64.77 143.01 58.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.65 0.611 . . . . 75.51 112.65 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.7 0 CA-C-N 115.261 -0.881 . . . . 38.16 108.761 176.568 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 . . . . . 0 C--O 1.236 0.343 0 N-CA-C 106.515 -1.661 . . . . 73.42 106.515 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.8 m 75.1 -5.19 2.22 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.558 1.318 . . . . 61.44 114.558 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.2 mt -75.49 144.31 42.1 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 119.752 -0.779 . . . . 75.24 109.728 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 69.38 21.54 6.89 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.851 0.86 . . . . 71.2 109.818 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.25 137.15 47.79 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.42 -0.809 . . . . 63.31 111.389 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.3 m -119.44 171.68 8.16 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 110.039 -0.356 . . . . 73.11 110.039 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.75 106.05 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 109.003 -0.739 . . . . 72.51 109.003 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.8 144.96 56.52 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.455 -0.793 . . . . 63.32 111.175 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -80.01 129.85 34.81 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 104.362 -2.458 . . . . 75.03 104.362 168.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 37' ' ' GLU . 4.3 t-105 -68.17 113.42 15.02 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 123.541 0.526 . . . . 73.12 109.688 -170.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -94.93 140.21 1.11 Allowed 'Trans proline' 0 N--CA 1.432 -2.13 0 C-N-CA 122.577 2.184 . . . . 75.41 113.885 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -111.54 155.15 23.73 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.488 -1.301 . . . . 73.4 107.488 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 109.5 21.5 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.355 0.598 . . . . 74.1 109.497 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.7 t -93.71 119.63 41.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.077 -0.965 . . . . 75.13 109.122 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 21' ' ' LEU 0.257 0.4 OUTLIER -90.63 -38.17 13.3 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 113.05 0.759 . . . . 73.33 113.05 -178.887 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -158.98 149.44 19.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.247 -0.581 . . . . 72.34 111.258 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.3 p -134.0 161.38 34.98 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.28 1.032 . . . . 73.41 110.265 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.8 113.28 1.46 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.844 -0.693 . . . . 73.5 114.515 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.68 -95.19 0.32 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.84 -0.504 . . . . 61.24 111.84 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -97.99 164.4 12.37 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.277 -1.379 . . . . 75.1 107.277 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.62 153.71 27.83 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 118.752 -1.179 . . . . 74.12 111.483 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 72.21 -49.79 0.69 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.976 1.31 . . . . 70.43 111.556 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 110.61 32.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.996 0.903 . . . . 74.0 109.108 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 p -113.1 154.25 26.91 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.373 -0.83 . . . . 73.21 110.32 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -113.43 158.45 20.64 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 120.058 -0.657 . . . . 75.33 111.446 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 34.0 tt0 -143.37 124.99 14.88 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 106.187 -1.783 . . . . 70.43 106.187 175.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . 43.3 mt-10 -97.79 115.06 27.29 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.496 -1.668 . . . . 74.42 106.496 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -135.83 147.22 48.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.908 -0.717 . . . . 65.43 112.415 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.66 127.24 34.93 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.16 -2.163 . . . . 63.43 105.16 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.7 t -58.87 143.22 48.31 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.751 0.657 . . . . 30.45 111.339 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 1.1 mp0 -37.32 -52.67 1.09 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.801 1.64 . . . . 71.32 112.982 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 98.19 9.03 54.53 Favored Glycine 0 C--N 1.286 -2.213 0 C-N-CA 119.77 -1.205 . . . . 73.23 110.94 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.8 163.09 54.42 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.396 -1.082 . . . . 61.01 110.396 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 104' ' ' ILE . 18.3 ptmt -100.91 128.82 46.78 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.358 -0.608 . . . . 54.01 109.358 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 103' ' ' ARG . 53.2 m-85 -129.81 164.53 23.88 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.692 -0.686 . . . . 72.3 110.906 -171.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 116.36 30.84 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.223 -1.028 . . . . 72.41 108.223 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.0 t -128.81 146.63 50.87 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.35 0.595 . . . . 60.35 111.801 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.562 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 9.0 p -128.41 139.11 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.385 -0.969 . . . . 63.05 108.385 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -121.52 138.83 54.13 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.192 -1.003 . . . . 75.43 111.371 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.83 133.9 67.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.389 -1.708 . . . . 51.02 106.389 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.6 p -125.7 169.61 12.37 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.619 -0.433 . . . . 71.54 110.042 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 71.47 -2.11 2.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.032 0.933 . . . . 62.23 112.737 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.99 147.66 52.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 109.306 -0.627 . . . . 73.24 109.306 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 32.9 Cg_endo -65.13 156.35 63.35 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 122.167 1.911 . . . . 71.14 111.015 174.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' ' 94' ' ' LEU . 54.7 t -49.82 -37.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.931 0.893 . . . . 71.23 113.23 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.25 -49.89 63.15 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.264 0.353 . . . . 65.55 110.991 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 41.6 mt-10 -76.04 -50.54 14.5 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.037 -0.529 . . . . 74.14 111.266 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.1 68.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.935 0.717 . . . . 73.33 112.935 -174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 tt -62.66 -50.2 72.13 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.842 -0.799 . . . . 64.21 108.842 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.321 6.6 ppt_? -72.43 -23.86 61.14 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 114.018 1.118 . . . . 65.04 114.018 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 12.4 mm-40 -66.58 -44.06 83.23 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 71.32 111.186 172.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.562 ' HB1' ' CG1' ' A' ' 44' ' ' VAL . . . -75.75 -40.38 55.51 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.857 1.058 . . . . 72.41 113.857 -174.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . 0.253 24.7 mmt -47.07 -52.88 31.16 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 115.929 1.825 . . . . 62.44 115.929 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.44 -31.65 78.78 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.296 1.997 . . . . 71.31 112.176 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD2' HG21 ' A' ' 44' ' ' VAL . 82.5 mttt -74.31 -34.99 63.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.772 -0.649 . . . . 75.44 109.892 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.7 mm -72.85 -39.71 59.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.287 0.565 . . . . 71.12 109.625 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.34 -37.89 89.03 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.633 -0.712 . . . . 75.23 112.853 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -67.57 -31.66 71.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.08 -0.648 . . . . 74.24 110.728 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.75 -58.2 7.61 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.385 -0.37 . . . . 74.41 111.335 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.58 -23.08 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 121.224 0.535 . . . . 75.33 111.285 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.56 72.91 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.903 -0.589 . . . . 74.34 113.196 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.44 -5.08 5.56 Favored Glycine 0 CA--C 1.505 -0.565 0 C-N-CA 119.821 -1.181 . . . . 62.53 113.263 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 116' ' ' SER . 15.2 m -86.33 32.92 0.62 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 122.631 1.205 . . . . 42.41 110.053 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -97.82 177.17 5.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.229 -0.896 . . . . 73.52 109.437 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.438 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 12.6 t70 -63.97 -33.03 74.8 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.258 0.623 . . . . 63.13 111.823 -175.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.691 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 6.9 mmpt? -86.8 -11.26 51.48 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.631 -0.428 . . . . 70.24 110.777 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.22 22.5 74.51 Favored Glycine 0 CA--C 1.498 -0.99 0 CA-C-N 115.6 -0.727 . . . . 44.24 112.066 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.99 122.09 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-O 121.153 0.501 . . . . 72.51 110.907 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.16 54.36 0.82 Allowed Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.957 -0.857 . . . . 73.34 110.957 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 51.6 ttm -83.8 110.09 18.06 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.089 0.471 . . . . 62.3 110.015 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.34 82.34 0.67 Allowed Glycine 0 C--N 1.303 -1.3 0 CA-C-N 115.121 -0.945 . . . . 74.22 111.512 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -96.79 134.92 39.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.216 -0.661 . . . . 74.14 109.216 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 m -124.12 129.86 51.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.258 0.551 . . . . 42.31 112.052 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.438 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 10.5 p -158.63 148.82 15.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 104.107 -2.553 . . . . 74.44 104.107 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 80' ' ' VAL . 47.0 Cg_exo -34.98 138.81 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.7 2.934 . . . . 71.14 115.036 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.54 151.29 6.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.52 -1.289 . . . . 61.24 107.52 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 34.5 m -141.96 145.08 34.09 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 120.706 -0.398 . . . . 62.44 110.409 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -140.44 141.47 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.787 -0.571 . . . . 75.04 110.811 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.05 134.95 35.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.855 -0.611 . . . . 72.24 110.063 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.6 m -126.93 150.67 33.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.327 -0.852 . . . . 65.04 109.668 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 166' ' ' VAL . 91.5 m-85 -116.01 107.15 48.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 116.375 -0.375 . . . . 71.13 110.598 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.25 132.04 7.99 Favored 'Trans proline' 0 N--CA 1.428 -2.38 0 N-CA-C 108.139 -1.524 . . . . 65.04 108.139 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -93.49 167.71 11.52 Favored 'General case' 0 C--N 1.272 -2.773 0 C-N-CA 119.861 -0.736 . . . . 75.34 110.961 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.77 -17.55 56.43 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.883 0.739 . . . . 63.33 110.78 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.54 -6.8 57.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.249 1.02 . . . . 74.34 110.072 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.89 -10.14 71.57 Favored Glycine 0 C--O 1.229 -0.158 0 CA-C-N 116.048 -0.524 . . . . 73.5 112.389 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.4 m -96.06 134.35 39.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.769 0.318 . . . . 74.44 111.455 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 8.2 mp -78.77 100.09 6.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.453 0.644 . . . . 63.42 110.187 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 53.0 tt0 -148.09 169.86 19.04 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.874 -1.057 . . . . 71.02 108.981 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HB3' ' HD3' ' A' ' 97' ' ' LYS 0.264 64.8 mttp 94.93 -73.87 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 126.097 1.759 . . . . 63.44 112.456 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 2.4 mppt? -131.04 146.57 52.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 119.005 -1.078 . . . . 73.4 112.215 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 51' ' ' VAL . 5.8 tt -143.28 129.44 19.75 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.512 -1.222 . . . . 72.51 108.049 173.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -119.89 115.47 23.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.456 -0.572 . . . . 74.32 109.456 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 43' ' ' THR . 91.1 t -92.43 125.8 45.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.796 -0.816 . . . . 73.52 108.796 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -109.18 123.82 49.84 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.618 0.574 . . . . 70.42 109.641 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -102.76 113.49 26.95 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.458 -1.682 . . . . 74.22 106.458 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.522 ' HG3' ' CE1' ' A' ' 41' ' ' PHE . 24.4 ttt85 -76.67 132.58 39.45 Favored 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 115.191 -0.913 . . . . 74.34 110.606 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 40' ' ' LYS . 74.4 mt -96.67 131.95 27.15 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.092 -1.448 . . . . 54.42 107.092 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.72 146.5 54.61 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.533 2.156 . . . . 74.13 111.816 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.42 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -47.57 -39.74 17.37 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.693 1.597 . . . . 74.51 111.867 -175.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -61.2 -32.9 72.67 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.001 0.52 . . . . 71.31 112.4 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.79 -2.65 34.55 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 112.205 0.446 . . . . 75.32 112.205 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.73 -28.24 67.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.574 0.953 . . . . 74.13 113.574 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.47 59.65 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.899 -1.143 . . . . 71.21 111.578 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -142.98 87.08 8.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-O 120.95 0.405 . . . . 73.3 110.295 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -97.47 162.42 0.93 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.302 2.668 . . . . 74.23 112.128 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.39 137.36 46.77 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 122.354 2.036 . . . . 54.43 111.626 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -74.26 152.33 88.07 Favored Pre-proline 0 C--O 1.248 0.995 0 CA-C-N 116.439 -0.346 . . . . 75.14 110.787 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -81.4 121.72 3.91 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 122.103 1.869 . . . . 52.24 111.932 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 69' ' ' THR . 23.5 t -92.41 22.83 4.29 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.91 0.862 . . . . 72.1 109.66 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.403 ' HB3' HG12 ' A' ' 120' ' ' VAL . 14.5 t70 -137.17 151.27 48.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.779 -1.193 . . . . 74.31 107.779 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -88.26 -17.12 31.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.162 1.171 . . . . 63.13 114.162 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.6 m -80.92 -39.7 25.77 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.397 -0.594 . . . . 70.53 109.397 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 117' ' ' ASP . 7.1 p -97.47 123.96 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.588 -0.733 . . . . 73.14 109.809 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.77 148.91 47.85 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.917 -0.583 . . . . 72.11 110.418 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 28.1 mm -92.39 111.48 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.802 -1.555 . . . . 70.13 106.802 174.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -115.79 145.8 42.5 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.68 -0.691 . . . . 74.43 111.05 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 9.6 pt-20 -121.13 124.74 45.49 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.121 -1.066 . . . . 61.13 108.121 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.451 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.8 mmt180 -136.15 122.64 20.78 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.075 -0.65 . . . . 74.5 111.483 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -143.05 164.73 29.31 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.563 -0.902 . . . . 73.05 108.563 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.02 14.63 54.45 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.65 -0.98 . . . . 61.44 110.65 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.1 pt -120.65 145.17 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 109.267 -0.642 . . . . 74.53 109.267 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.2 m -108.12 128.79 55.0 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.313 -0.995 . . . . 64.41 108.313 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.19 155.28 31.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.475 -0.935 . . . . 71.22 108.475 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 64.1 m-85 -113.89 122.13 46.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.987 -1.486 . . . . 75.5 106.987 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 m -102.49 127.94 49.32 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.734 -0.469 . . . . 51.15 109.734 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 151' ' ' LEU . 13.7 t -120.03 121.9 39.92 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 108.582 -0.895 . . . . 61.11 108.582 171.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -109.67 126.78 54.03 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.194 -1.41 . . . . 75.33 107.194 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 183' ' ' ASN . 47.9 p90 -129.61 152.63 48.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.672 -0.411 . . . . 74.15 112.019 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.79 106.98 2.6 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.23 -1.148 . . . . 72.11 110.23 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.68 173.75 36.75 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 111.131 -0.788 . . . . 64.23 111.131 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.2 128.48 33.81 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.146 -0.687 . . . . 64.34 109.146 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.64 125.75 54.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.385 0.883 . . . . 73.51 113.385 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -115.78 173.13 6.71 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.86 -1.533 . . . . 61.44 106.86 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.02 -43.92 70.5 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.478 0.581 . . . . 71.02 110.679 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.12 -29.39 69.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.721 . . . . 72.51 111.42 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.0 -37.15 83.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.391 -0.596 . . . . 71.23 109.391 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.443 ' HD1' HG22 ' A' ' 185' ' ' VAL . 82.0 m-85 -64.94 -38.92 92.56 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.706 -0.679 . . . . 62.52 111.023 176.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.66 -47.36 93.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.771 -0.825 . . . . 73.2 108.771 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.61 86.16 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.244 -0.889 . . . . 74.14 111.094 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -68.2 -35.07 77.43 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 113.141 0.793 . . . . 75.03 113.141 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.85 88.94 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.434 0.459 . . . . 41.01 110.835 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.2 t -73.14 -33.77 65.71 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 120.309 -0.556 . . . . 71.21 110.495 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.26 -32.17 73.66 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 120.807 0.337 . . . . 54.32 110.937 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 31' ' ' TYR . 33.7 tp -74.55 -31.53 62.13 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.119 -0.632 . . . . 71.11 109.778 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -68.63 -37.25 79.57 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 112.616 0.599 . . . . 74.44 112.616 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.2 t -70.23 -30.04 67.02 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 73.02 109.649 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 31' ' ' TYR . 63.8 m -71.95 -38.44 69.8 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 115.268 -0.878 . . . . 70.12 109.433 176.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.3 mt -82.1 -2.17 51.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.874 -0.603 . . . . 44.01 111.358 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.44 130.4 41.22 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.339 -1.356 . . . . 71.41 107.339 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.58 -2.09 57.22 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.834 -0.621 . . . . 64.52 112.122 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 43.4 p -107.25 164.55 14.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 107.636 -1.246 . . . . 73.44 107.636 175.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 89.2 Cg_endo -81.88 26.11 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.823 1.682 . . . . 52.21 112.301 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 138.03 58.15 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.347 0.594 . . . . 64.53 112.464 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 23.0 p -120.99 151.04 40.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.534 -1.284 . . . . 73.12 107.534 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.422 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 32.8 m-85 -136.36 151.86 50.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.9 0.773 . . . . 75.34 109.354 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.443 ' O ' HG12 ' A' ' 166' ' ' VAL . 4.3 pp0? -124.68 122.97 39.01 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.182 0.438 . . . . 64.43 112.182 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.38 2.78 43.94 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.659 -0.701 . . . . 50.22 113.491 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.8 14.97 5.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.704 0.802 . . . . 73.11 112.256 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.617 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 7.9 p -59.37 138.46 20.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 CA-C-O 121.729 0.776 . . . . 73.24 111.543 -177.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.484 ' HB3' HD23 ' A' ' 187' ' ' LEU . 55.5 p90 -139.84 163.27 33.08 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.854 -1.066 . . . . 65.11 108.721 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.94 153.18 31.04 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.098 0.475 . . . . 63.14 110.384 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 83' ' ' SER . 31.3 t -113.21 118.72 35.47 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.396 -1.705 . . . . 55.02 106.396 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -122.09 133.5 54.77 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.084 -0.71 . . . . 60.12 109.084 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.11 165.53 38.84 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.406 -1.077 . . . . 74.12 110.406 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -77.55 -35.67 52.94 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.524 -0.917 . . . . 74.53 108.524 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -156.22 133.19 6.37 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.723 -1.126 . . . . 64.31 108.843 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.67 105.79 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.0 1.8 . . . . 74.11 107.814 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.568 ' HB3' ' HA3' ' A' ' 180' ' ' GLY . 93.2 Cg_endo -85.54 128.75 3.51 Favored 'Trans proline' 0 N--CA 1.429 -2.277 0 N-CA-C 116.385 1.648 . . . . 74.11 116.385 -166.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 ttt -97.43 -32.81 11.66 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.594 -1.632 . . . . 72.33 106.594 169.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -97.22 151.3 37.61 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 114.002 -1.454 . . . . 72.14 110.048 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.98 -13.58 32.12 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.871 3.047 . . . . 63.51 116.296 -172.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -76.8 1.84 16.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.298 1.222 . . . . 72.4 114.298 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 175' ' ' PRO . . . -87.5 67.53 3.26 Favored Glycine 0 C--N 1.314 -0.675 0 N-CA-C 108.482 -1.847 . . . . 33.0 108.482 171.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -86.69 -29.24 22.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 114.261 1.208 . . . . 73.22 114.261 -171.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -101.81 127.83 48.44 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 118.367 -1.333 . . . . 63.04 109.326 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 37.5 m-80 -144.03 156.18 44.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.231 -1.026 . . . . 63.42 108.231 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 35.8 tt0 -138.94 145.92 40.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.569 0.224 . . . . 53.03 110.548 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.443 HG22 ' HD1' ' A' ' 144' ' ' TYR . 19.8 t -125.63 133.7 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.69 -0.855 . . . . 60.25 108.69 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.539 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 37.3 m0 -112.26 128.4 56.25 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.715 -0.476 . . . . 74.34 109.715 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 167' ' ' TYR . 85.3 mt -99.33 136.76 38.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.589 -1.263 . . . . 74.1 107.589 170.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.1 t -96.14 122.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.104 -0.638 . . . . 74.45 111.12 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 161' ' ' THR . 54.0 tttp -72.09 123.78 23.58 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.715 -0.675 . . . . 64.15 109.928 174.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.422 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 118.277 -0.868 . . . . 72.52 109.178 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.1 t30 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 109.466 -0.568 . . . . 71.33 109.466 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.7 p -97.35 123.54 41.21 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.8 0.333 . . . . 71.43 110.421 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.3 mt -117.85 83.35 1.98 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.734 0.302 . . . . 72.43 110.527 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -179.2 150.71 0.46 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.403 -0.962 . . . . 74.32 108.403 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.21 147.75 16.03 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.989 -0.844 . . . . 63.22 110.989 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.4 m -78.52 95.85 5.28 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.379 -0.6 . . . . 74.51 109.379 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.77 179.52 3.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.366 -0.834 . . . . 74.04 108.94 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -145.25 126.08 14.39 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.092 -1.077 . . . . 74.41 108.092 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 m -119.91 109.65 15.8 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.116 -1.809 . . . . 55.31 106.116 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.537 ' CZ2' ' HG3' ' A' ' 109' ' ' GLN . 2.7 p90 -132.67 111.95 13.72 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-O 121.335 0.588 . . . . 74.31 110.125 -172.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -94.53 146.51 1.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.464 2.11 . . . . 75.33 113.331 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 39.9 p90 -117.84 142.55 47.18 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.36 -0.978 . . . . 74.05 108.36 173.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -106.39 108.93 20.7 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.084 -0.646 . . . . 74.42 109.742 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.23 115.96 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 107.087 -1.449 . . . . 74.44 107.087 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -90.27 -37.17 14.27 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 120.332 -0.547 . . . . 65.41 112.152 -175.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.503 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 32.2 t -162.25 156.05 21.13 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.106 -0.637 . . . . 71.43 110.393 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 p -132.0 162.95 29.48 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.253 -1.388 . . . . 72.51 107.253 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.86 -149.55 20.62 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 119.286 -1.435 . . . . 74.44 112.635 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.92 159.73 32.61 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.098 -0.801 . . . . 65.42 111.098 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -75.51 123.1 24.87 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.05 -1.093 . . . . 73.44 108.05 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.53 133.49 51.35 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 122.534 1.159 . . . . 53.21 113.814 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t70 148.32 -48.82 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 130.83 3.652 . . . . 73.45 101.8 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 147' ' ' HIS . 3.8 p -127.8 109.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 112.611 -2.086 . . . . 75.51 106.718 169.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -117.08 151.12 37.48 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.84 -1.17 . . . . 73.13 107.84 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.589 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.3 p90 -113.57 158.48 20.73 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.899 -1.12 . . . . 75.41 112.684 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -134.47 125.21 26.94 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.589 -2.004 . . . . 73.12 105.589 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.503 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 38.2 mt-10 -98.22 114.59 26.89 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 106.832 -1.544 . . . . 73.43 106.832 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -134.79 140.91 46.25 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.559 -0.857 . . . . 75.42 111.449 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.07 133.59 35.5 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 104.415 -2.439 . . . . 72.3 104.415 169.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.593 ' SG ' HG13 ' A' ' 128' ' ' ILE . 84.1 m -58.46 138.28 56.76 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.488 0.922 . . . . 65.45 113.488 -173.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 10.6 pt-20 -58.22 -31.56 67.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.664 -1.607 . . . . 74.24 113.169 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.73 10.25 57.95 Favored Glycine 0 CA--C 1.495 -1.208 0 C-N-CA 119.045 -1.55 . . . . 30.53 112.111 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.73 154.24 52.11 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 120.779 -0.724 . . . . 63.01 111.931 -176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 16.7 ptpt -90.68 118.28 29.99 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.214 -0.661 . . . . 63.24 109.214 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 33.1 m-85 -119.14 164.33 15.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.022 -0.536 . . . . 72.44 111.165 -172.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 121' ' ' LYS . . . -99.47 116.22 31.11 Favored 'General case' 0 C--O 1.209 -1.037 0 N-CA-C 109.017 -0.734 . . . . 75.32 109.017 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.5 t -122.03 147.16 46.44 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.346 0.593 . . . . 55.45 111.97 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 17.0 m -131.85 132.32 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 124.669 1.188 . . . . 71.24 108.581 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.64 128.67 56.44 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.517 0.675 . . . . 75.32 111.927 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 12.2 t -123.99 139.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.065 -1.458 . . . . 61.21 107.065 178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.4 p -135.95 165.19 26.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.314 -0.554 . . . . 73.32 110.377 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.82 11.38 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.558 1.161 . . . . 73.43 110.654 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -133.99 137.56 28.65 Favored Pre-proline 0 N--CA 1.424 -1.747 0 N-CA-C 109.257 -0.646 . . . . 73.03 109.257 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.48 156.87 16.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.309 2.672 . . . . 73.23 111.597 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.46 HG13 HD12 ' A' ' 98' ' ' LEU . 55.1 t -47.75 -48.5 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.701 1.0 . . . . 62.51 113.701 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.37 -33.68 76.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.945 0.402 . . . . 63.41 110.932 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -75.98 -34.65 59.78 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.861 -0.609 . . . . 74.44 111.382 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -77.23 -44.47 29.86 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.332 -0.395 . . . . 71.14 110.889 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.8 tp -63.65 -37.78 88.64 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.115 -0.493 . . . . 63.41 111.872 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -59.26 -32.3 69.88 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 112.133 0.42 . . . . 72.45 112.133 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -84.68 -39.9 18.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.465 0.65 . . . . 75.51 110.923 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -75.85 -31.81 59.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.439 -0.8 . . . . 64.41 112.622 -177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.454 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -55.53 -57.65 19.76 Favored Pre-proline 0 CA--C 1.574 1.885 0 CA-C-O 119.372 -0.347 . . . . 72.54 111.5 -178.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 63' ' ' MET . 19.1 Cg_endo -60.42 -31.31 92.44 Favored 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 122.535 2.157 . . . . 41.43 111.147 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 41.5 ttmt -65.98 -37.03 84.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.776 -1.102 . . . . 73.11 111.276 -177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.37 -47.25 30.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.927 0.394 . . . . 71.1 110.667 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 26.1 ptm -63.54 -29.54 70.79 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 113.624 0.972 . . . . 75.11 113.624 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.4 -38.82 91.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 120.546 -0.462 . . . . 74.23 110.481 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.31 -58.41 7.79 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.985 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -69.41 -27.23 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 116.039 -0.528 . . . . 73.23 111.621 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.34 -18.23 73.14 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.921 -0.581 . . . . 22.04 113.358 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 134.37 -8.52 4.69 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.174 -1.488 . . . . 63.43 114.308 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 m -84.08 33.38 0.49 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-O 122.924 1.345 . . . . 75.03 110.014 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.6 163.55 12.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.107 -0.951 . . . . 74.53 108.694 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 29.8 t70 -66.28 -33.56 76.03 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.258 0.836 . . . . 74.53 113.258 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 113' ' ' PRO . 31.9 mmmt -80.14 -12.43 59.66 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.166 -0.614 . . . . 54.22 110.612 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.57 38.05 61.81 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.035 -0.602 . . . . 55.25 111.761 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 77' ' ' GLY . 94.8 t -79.56 120.78 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.034 -1.099 . . . . 61.13 108.034 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.59 -23.19 8.48 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 121.244 -0.503 . . . . 33.43 112.34 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.5 mtp -66.03 -37.85 86.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.201 0.524 . . . . 73.04 109.746 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 74' ' ' VAL . . . 69.92 -166.34 49.82 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.073 -0.967 . . . . 23.11 112.196 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.41 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 1.3 pmm? -133.05 146.35 51.62 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.181 -0.674 . . . . 73.11 109.181 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.9 m -113.08 117.61 32.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.01 0.433 . . . . 71.05 109.97 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 103' ' ' ARG . 8.2 p -165.57 151.22 8.31 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 107.492 -1.299 . . . . 73.03 107.492 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.95 140.66 61.39 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.175 1.25 . . . . 73.32 111.214 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 9.9 p -93.45 150.03 4.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.607 -0.886 . . . . 64.14 108.607 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 p -128.77 145.84 51.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.482 0.182 . . . . 64.15 110.942 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -139.78 143.6 36.98 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.475 -0.49 . . . . 73.12 110.5 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.59 134.92 34.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.891 -0.595 . . . . 65.14 110.407 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.69 151.62 28.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.156 -0.929 . . . . 74.33 108.57 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 97' ' ' LYS . 99.0 m-85 -120.22 107.83 38.93 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 120.942 -0.303 . . . . 73.44 110.404 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.22 133.09 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.581 1.521 . . . . 74.43 111.867 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 95' ' ' GLN . 38.5 m-80 -99.84 171.07 8.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.384 -0.825 . . . . 65.24 108.927 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.41 -27.75 62.65 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.981 1.104 . . . . 74.43 113.981 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.83 -7.26 58.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 119.815 -0.754 . . . . 72.42 110.878 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.04 3.6 57.89 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 120.33 -0.938 . . . . 53.43 113.38 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m -91.14 138.59 31.48 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 122.611 -0.346 . . . . 71.41 110.259 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.29 107.73 17.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.608 -1.256 . . . . 65.14 107.608 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 15.5 mm-40 -141.37 170.06 16.44 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.495 -0.558 . . . . 65.5 109.495 -173.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 35.4 mmtp 87.76 -70.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.367 1.467 . . . . 73.43 113.875 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HD3' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -136.54 154.43 50.71 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.49 -0.884 . . . . 73.13 111.822 -177.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 54' ' ' ALA . 6.4 tt -143.95 134.54 24.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.663 -1.153 . . . . 75.52 109.231 173.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -131.37 115.94 16.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.649 -0.251 . . . . 60.23 110.532 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.588 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 66.7 t -93.08 121.62 43.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.697 0.623 . . . . 75.52 109.783 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -109.65 122.53 47.67 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.832 0.853 . . . . 72.42 109.473 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.11 113.53 27.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.193 -1.41 . . . . 50.2 107.193 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.663 ' O ' HG11 ' A' ' 80' ' ' VAL . 70.6 ttt180 -75.08 137.2 41.27 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.523 -1.217 . . . . 72.24 109.269 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.0 mt -108.46 124.83 33.33 Favored Pre-proline 0 C--N 1.289 -2.053 0 O-C-N 122.388 -0.195 . . . . 74.31 111.314 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 78' ' ' MET . 83.9 Cg_exo -55.59 161.37 7.81 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.161 2.574 . . . . 51.42 113.231 172.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -47.69 -49.56 27.42 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.87 1.668 . . . . 32.54 115.028 -171.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.54 -37.49 78.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.517 . . . . 75.24 112.397 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.447 ' HB2' ' CG2' ' A' ' 104' ' ' ILE . 98.1 m-85 -86.91 -10.33 53.57 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.24 -0.584 . . . . 72.42 112.031 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.795 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.56 -31.88 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.214 -0.994 . . . . 74.11 110.081 174.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.55 96.27 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 111.605 -0.598 . . . . 72.22 111.605 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.9 t -157.21 97.84 2.02 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 108.248 -1.019 . . . . 64.02 108.248 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 63.1 Cg_endo -85.78 148.26 9.61 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 122.49 2.127 . . . . 74.03 112.782 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 24.0 Cg_exo -65.77 142.31 69.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.275 1.983 . . . . 71.22 111.109 174.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -73.19 144.17 84.28 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 120.578 -0.449 . . . . 63.12 110.257 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -78.02 118.4 4.4 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.364 2.042 . . . . 74.33 111.76 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.2 m -88.39 21.77 2.76 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.163 0.506 . . . . 65.32 111.13 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.521 ' HB3' HG12 ' A' ' 120' ' ' VAL . 11.4 t70 -135.21 150.3 50.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.486 -1.302 . . . . 72.41 107.486 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.43 -23.76 37.32 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.555 0.946 . . . . 73.42 113.555 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -90.02 -25.85 20.61 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.669 -0.413 . . . . 45.44 111.258 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 117' ' ' ASP . 3.5 p -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 109.597 -0.52 . . . . 70.14 109.597 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 52.9 mtpt -128.41 152.83 47.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.346 -0.843 . . . . 72.21 110.234 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 31.0 mm -92.85 112.57 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.049 -0.723 . . . . 75.13 109.049 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -121.86 142.65 50.04 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.563 -0.744 . . . . 72.05 109.856 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -115.89 128.56 55.88 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.696 -0.683 . . . . 64.25 110.255 -178.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.39 133.0 43.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.352 0.596 . . . . 75.21 112.343 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -139.46 172.4 12.87 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.902 -1.518 . . . . 71.21 106.902 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.49 5.14 79.39 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 119.86 -1.162 . . . . 75.11 113.32 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.593 HG13 ' SG ' ' A' ' 36' ' ' CYS . 45.4 pt -121.47 145.9 27.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.109 0.454 . . . . 72.4 110.391 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.1 m -107.68 133.26 52.36 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.503 -0.925 . . . . 73.15 108.503 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.23 149.47 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 N-CA-C 108.804 -0.813 . . . . 74.12 108.804 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 189' ' ' LYS . 36.7 m-85 -113.79 121.82 45.21 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 104.639 -2.356 . . . . 74.22 104.639 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 55.3 p -119.41 141.29 49.23 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 120.038 -0.665 . . . . 73.14 111.653 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 184' ' ' GLU . 10.8 t -121.48 139.38 53.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 115.696 -0.684 . . . . 71.13 109.391 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -121.11 126.3 49.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.764 -0.828 . . . . 63.44 108.764 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 183' ' ' ASN . 38.4 p90 -138.44 168.71 19.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.387 -0.598 . . . . 72.44 109.387 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.21 169.21 35.35 Favored Glycine 0 C--N 1.307 -1.045 0 C-N-CA 120.331 -0.938 . . . . 71.12 111.794 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.8 -116.79 3.86 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.636 -0.586 . . . . 73.02 111.636 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -98.65 103.0 14.91 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.424 -0.584 . . . . 74.42 109.424 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.02 126.83 46.95 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.882 0.848 . . . . 71.31 112.434 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.95 172.82 6.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.732 -1.122 . . . . 65.04 108.164 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -40.11 95.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.211 0.529 . . . . 73.21 112.229 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.56 -27.11 68.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.721 -0.672 . . . . 61.44 110.494 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.11 -31.93 73.3 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.873 -0.603 . . . . 63.32 110.475 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -63.48 -42.23 98.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.231 -0.44 . . . . 74.22 109.97 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.83 -45.02 88.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.86 -0.609 . . . . 72.34 109.717 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.83 -47.17 87.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 61.45 110.965 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.436 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 27.6 m80 -69.25 -35.25 75.92 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 112.734 0.642 . . . . 62.42 112.734 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.31 90.43 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.05 0.452 . . . . 74.25 110.077 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.2 m -64.94 -53.38 47.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.789 -0.642 . . . . 73.44 109.937 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -38.66 83.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.945 -0.571 . . . . 75.21 112.222 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 31' ' ' TYR . 62.9 tp -63.62 -43.16 97.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.776 -0.453 . . . . 73.01 109.776 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 39.4 ttp180 -61.85 -40.6 95.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.652 -0.704 . . . . 73.44 109.137 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.427 ' HA ' ' OE2' ' A' ' 156' ' ' GLU . 47.0 m -66.32 -35.47 80.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.462 -0.79 . . . . 71.33 110.663 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -73.08 -33.99 65.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.465 0.65 . . . . 64.33 109.873 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.6 mt -76.73 -1.83 29.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.549 -0.75 . . . . 74.14 112.188 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 42.8 mt-10 -75.85 141.63 42.39 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.861 -0.735 . . . . 73.41 110.512 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.16 -1.18 59.03 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.054 -0.819 . . . . 73.04 111.054 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 27.7 p -114.45 166.84 10.71 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.924 -1.51 . . . . 63.34 106.924 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.13 20.29 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.648 2.232 . . . . 74.11 112.987 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.68 118.28 12.33 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 121.193 0.52 . . . . 71.14 111.736 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.3 p -103.7 158.49 16.34 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.295 -1.002 . . . . 74.41 108.295 175.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.484 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 30.0 m-85 -137.8 147.19 44.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.761 -0.829 . . . . 72.42 108.761 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.479 HE21 HG13 ' A' ' 188' ' ' VAL . 26.1 pt20 -121.72 109.21 14.44 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.269 0.557 . . . . 63.44 110.686 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.39 8.53 55.73 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.13 -1.033 . . . . 72.32 111.785 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 55.64 30.84 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.495 1.118 . . . . 71.24 111.332 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.45 139.05 21.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.21 0.528 . . . . 64.14 110.945 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.92 163.22 33.37 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.526 -0.761 . . . . 74.2 110.309 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 34.5 m-85 -115.49 149.45 38.08 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.722 -0.672 . . . . 63.4 109.29 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.44 120.28 39.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.086 -1.45 . . . . 74.34 107.086 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -123.64 135.98 54.23 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.166 -0.47 . . . . 64.24 110.633 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.7 165.63 38.85 Favored Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 108.931 -1.668 . . . . 61.5 108.931 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.35 -30.24 65.94 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.222 -1.029 . . . . 61.15 108.222 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -151.45 145.15 17.63 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 106.502 -1.666 . . . . 74.31 106.502 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.46 108.79 2.29 Favored 'Trans proline' 0 C--O 1.249 1.032 0 N-CA-C 106.797 -2.04 . . . . 71.33 106.797 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.46 127.98 18.36 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 C-N-CA 121.268 1.312 . . . . 65.43 114.311 -168.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 57.2 ttp -96.88 -27.61 14.6 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.601 -1.629 . . . . 71.51 106.601 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 177' ' ' LYS . 0.1 OUTLIER -92.59 125.56 55.34 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 105.612 -1.996 . . . . 73.21 105.612 172.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.94 -19.77 56.81 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.698 2.265 . . . . 63.41 114.94 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -85.3 115.49 23.09 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.346 -0.942 . . . . 70.53 110.947 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -138.15 135.08 7.26 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 108.479 -1.848 . . . . 53.13 108.479 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -84.09 -20.54 32.42 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 117.869 0.835 . . . . 75.33 112.159 -175.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.476 ' HD3' ' OE2' ' A' ' 184' ' ' GLU . 15.1 ttm180 -139.96 130.11 25.09 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.333 -0.547 . . . . 74.42 110.881 176.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 12.6 m120 -137.53 134.69 35.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 105.046 -2.205 . . . . 64.03 105.046 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 45.6 mt-10 -129.14 137.43 51.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 110.028 -0.36 . . . . 74.21 110.028 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.11 124.24 67.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 74.01 108.352 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 12.3 m0 -108.58 123.3 48.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.297 -0.41 . . . . 63.52 110.142 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.7 mt -103.14 118.68 37.35 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.742 -1.206 . . . . 75.22 107.742 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.479 HG13 HE21 ' A' ' 163' ' ' GLN . 7.6 p -94.28 126.46 46.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.418 -0.586 . . . . 65.43 109.418 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 161' ' ' THR . 63.5 pttt -66.9 142.13 57.4 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 116.125 -0.489 . . . . 65.34 110.934 -175.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.253 1.246 0 CA-C-O 118.177 -0.916 . . . . 74.41 109.585 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 CA--C 1.504 -0.812 0 N-CA-C 109.421 -0.585 . . . . 65.43 109.421 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.1 t -170.98 106.53 0.26 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.878 0.371 . . . . 64.33 111.135 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -99.44 10.05 42.11 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.585 -0.894 . . . . 74.5 108.585 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -81.77 109.45 16.17 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 114.834 -1.075 . . . . 74.15 109.826 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.64 148.97 20.32 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 110.957 -0.857 . . . . 53.04 110.957 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.416 ' HB2' ' OE2' ' A' ' 14' ' ' GLU . 45.7 m -144.95 -171.87 3.73 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.879 -1.526 . . . . 65.31 106.879 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -56.02 -43.17 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.237 0.471 . . . . 73.34 111.289 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' OE2' ' HB2' ' A' ' 12' ' ' SER . 19.0 mm-40 51.47 89.76 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 C-N-CA 124.884 1.273 . . . . 73.45 110.904 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.7 m 72.55 98.05 0.07 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.388 0.614 . . . . 63.35 110.226 -174.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.405 ' CD2' ' HD2' ' A' ' 17' ' ' PRO . 77.4 t-105 -135.83 138.71 28.61 Favored Pre-proline 0 C--N 1.311 -1.098 0 N-CA-C 108.037 -1.097 . . . . 71.45 108.037 -178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HD2' ' CD2' ' A' ' 16' ' ' TRP . 66.0 Cg_endo -75.1 148.93 35.56 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.59 2.193 . . . . 43.21 111.743 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -101.6 144.5 30.27 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.697 -0.853 . . . . 70.1 108.697 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -106.42 120.15 41.15 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.911 0.708 . . . . 64.5 112.911 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.501 HG13 ' HG3' ' A' ' 32' ' ' GLU . 91.6 t -89.19 116.89 31.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.002 -1.851 . . . . 64.41 106.002 170.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' OE1' ' A' ' 33' ' ' GLU . 4.4 pp -99.86 -27.76 13.46 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.874 -0.73 . . . . 65.13 111.931 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -161.79 149.82 14.98 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.871 0.367 . . . . 72.41 110.806 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.7 p -132.79 157.37 45.16 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.227 -0.897 . . . . 62.13 109.562 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.16 -167.0 37.94 Favored Glycine 0 C--O 1.225 -0.433 0 C-N-CA 120.365 -0.922 . . . . 74.23 111.991 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.76 177.49 15.08 Favored Glycine 0 C--O 1.243 0.659 0 C-N-CA 120.745 -0.74 . . . . 34.11 112.718 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -87.1 126.25 34.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.457 -2.053 . . . . 75.42 105.457 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -64.24 132.69 51.03 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.103 0.954 . . . . 74.34 112.393 -167.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 129.41 -39.63 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.938 3.295 . . . . 71.52 103.105 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.627 HG22 ' CD2' ' A' ' 147' ' ' HIS . 21.6 t -123.0 110.23 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 112.983 -1.917 . . . . 75.01 106.844 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' THR . 52.4 m -119.56 131.87 55.61 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.362 -1.348 . . . . 74.23 107.362 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.61 160.57 16.55 Favored 'General case' 0 N--CA 1.423 -1.789 0 C-N-CA 120.302 -0.559 . . . . 73.33 111.108 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.501 ' HG3' HG13 ' A' ' 20' ' ' VAL . 43.9 tt0 -134.98 125.44 26.61 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 106.648 -1.612 . . . . 64.45 106.648 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' OE1' HD11 ' A' ' 21' ' ' LEU . 45.5 tt0 -100.17 114.73 28.34 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 106.367 -1.716 . . . . 75.1 106.367 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -135.93 142.16 44.6 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.789 -1.096 . . . . 73.23 111.377 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.98 136.44 33.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.128 -1.064 . . . . 64.54 108.128 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.0 t -69.07 143.31 54.27 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 110.002 -0.37 . . . . 65.32 110.002 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.12 -20.49 64.05 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.576 -0.738 . . . . 73.1 112.412 -177.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 89.84 10.4 64.92 Favored Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.044 -1.55 . . . . 64.33 110.938 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -71.92 165.56 53.83 Favored Glycine 0 N--CA 1.417 -2.633 0 CA-C-N 114.788 -0.706 . . . . 72.04 112.282 -175.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.546 ' O ' HD12 ' A' ' 104' ' ' ILE . 13.4 ptpt -94.35 132.6 38.79 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.01 -1.107 . . . . 73.42 108.01 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 37.8 m-85 -131.58 163.71 27.44 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.02 0.2 . . . . 74.13 111.128 -172.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.32 117.17 33.16 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.857 -0.794 . . . . 73.32 108.857 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 6.6 t -127.75 149.52 50.2 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 115.883 -0.599 . . . . 60.41 112.19 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 100' ' ' VAL . 3.2 p -145.58 134.7 17.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 124.557 1.143 . . . . 70.4 108.026 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.552 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.8 pt-20 -122.31 128.91 51.62 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.325 -0.95 . . . . 73.31 111.43 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.421 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 47.4 t -112.42 139.35 37.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 106.547 -1.649 . . . . 55.13 106.547 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 49' ' ' LYS . 76.5 p -117.51 166.25 12.58 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 111.826 0.306 . . . . 61.21 111.826 -173.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 72.1 -33.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.117 1.367 . . . . 64.53 112.97 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 47' ' ' THR . 67.0 mttm -85.76 146.1 42.98 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 115.238 -0.892 . . . . 62.05 111.726 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.97 158.91 48.97 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.409 2.74 . . . . 71.43 110.439 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -45.65 -47.24 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.112 1.152 . . . . 54.23 114.112 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.46 -48.2 74.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.673 0.67 . . . . 71.3 111.816 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.18 -45.54 73.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.663 -0.698 . . . . 74.52 112.418 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -67.32 -37.63 83.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.09 -0.504 . . . . 72.22 111.143 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.91 -37.56 72.96 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.242 -0.435 . . . . 73.32 111.091 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.317 6.2 ppt_? -66.51 -23.94 66.32 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.058 1.133 . . . . 73.42 114.058 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 14.1 mm-40 -79.22 -43.84 23.01 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.18 0.514 . . . . 75.05 110.839 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.94 -38.37 57.67 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 114.522 1.305 . . . . 73.44 114.522 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 59' ' ' MET . 8.0 mmt -55.58 -53.36 63.33 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 113.305 0.854 . . . . 55.4 113.305 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 59' ' ' MET . 10.4 Cg_endo -56.13 -31.73 84.29 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.005 1.803 . . . . 63.41 112.103 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 67.5 mttm -66.37 -39.94 89.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.901 0.381 . . . . 74.04 111.27 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -43.16 78.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 120.466 -0.493 . . . . 62.33 109.706 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.41 -35.02 78.45 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.262 0.838 . . . . 72.13 113.262 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -67.5 -40.86 85.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.357 -0.609 . . . . 74.1 109.357 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -60.97 -54.51 44.11 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.458 -0.792 . . . . 75.21 111.757 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.81 -5.81 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.169 0.433 . . . . 71.42 112.169 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.76 -36.64 10.15 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.949 -0.644 . . . . 71.52 112.254 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 74' ' ' VAL . . . 148.26 2.22 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.542 -1.314 . . . . 45.24 113.618 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.3 m -85.77 11.92 10.08 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.495 1.14 . . . . 73.13 109.7 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' OD1' HG12 ' A' ' 74' ' ' VAL . 7.2 p30 -78.8 176.39 9.6 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.738 -1.119 . . . . 74.33 110.449 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.09 -33.16 73.08 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.06 0.457 . . . . 52.11 111.321 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -85.15 -13.86 48.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.45 0.643 . . . . 73.42 109.878 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.17 32.52 80.44 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.343 -0.844 . . . . 33.21 111.266 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.44 HG12 ' OD1' ' A' ' 70' ' ' ASN . 6.5 p -79.57 120.95 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 120.306 -0.558 . . . . 75.45 110.777 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.46 145.48 17.64 Favored Glycine 0 CA--C 1.481 -2.059 0 N-CA-C 109.447 -1.461 . . . . 74.15 109.447 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 53.7 ttp 59.3 79.81 0.21 Allowed 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.233 -1.395 . . . . 74.41 107.233 -171.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.88 -111.96 1.21 Allowed Glycine 0 N--CA 1.413 -2.874 0 C-N-CA 119.965 -1.112 . . . . 72.32 113.147 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.547 ' SD ' ' HD2' ' A' ' 105' ' ' PRO . 20.8 ptt? -132.91 128.44 36.54 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.271 -0.464 . . . . 71.13 111.689 -173.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 m -125.66 117.24 23.07 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 108.932 -0.766 . . . . 73.32 108.932 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.558 HG22 ' HD2' ' A' ' 81' ' ' PRO . 2.0 p -158.87 -178.52 0.91 Allowed Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 102.85 -3.018 . . . . 72.41 102.85 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 80' ' ' VAL . 92.8 Cg_exo -47.07 136.58 17.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 CA-C-N 123.085 2.137 . . . . 72.22 116.026 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.74 142.28 26.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 113.293 -1.776 . . . . 61.11 106.48 172.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.8 p -139.24 151.41 46.49 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.765 -0.374 . . . . 75.32 110.314 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.8 137.33 31.45 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 120.552 -0.459 . . . . 54.02 110.125 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.04 134.71 34.57 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 109.123 -0.695 . . . . 64.34 109.123 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 166' ' ' VAL . 33.8 m -122.6 149.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.613 -1.254 . . . . 72.31 107.613 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -119.96 100.86 48.14 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 107.428 -1.323 . . . . 74.0 107.428 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.03 135.42 12.35 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.034 1.823 . . . . 62.12 113.444 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -78.27 159.16 28.62 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.855 -1.535 . . . . 71.32 106.855 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.28 -31.77 67.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.486 0.66 . . . . 75.44 112.492 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.14 -5.17 40.17 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.98 -1.009 . . . . 72.31 112.027 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.02 63.28 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.65 -0.786 . . . . 52.25 111.908 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -84.23 119.49 25.1 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.799 -0.815 . . . . 62.1 108.799 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.42 82.87 5.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.606 0.717 . . . . 74.5 109.35 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 16.8 tm0? -147.52 130.43 16.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.819 -1.082 . . . . 70.24 108.828 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 86.0 mttt 161.17 -63.62 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 C-N-CA 127.59 2.356 . . . . 75.1 108.92 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -160.55 158.16 28.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.849 -1.537 . . . . 73.45 106.849 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 tt -141.69 127.45 19.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 107.221 -1.4 . . . . 72.4 107.221 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.552 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 98.9 mttt -113.1 114.93 27.53 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.851 -0.426 . . . . 74.1 109.851 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.1 t -87.87 132.94 31.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 108.434 -0.951 . . . . 62.51 108.434 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -124.03 117.99 25.97 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.865 -1.161 . . . . 73.22 107.865 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -102.54 121.12 41.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.487 -1.301 . . . . 45.54 107.487 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.508 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 60.1 ttt180 -78.75 131.53 36.6 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 115.291 -0.868 . . . . 71.22 108.981 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 40' ' ' LYS . 68.3 mt -93.53 129.6 38.05 Favored Pre-proline 0 C--N 1.282 -2.335 0 CA-C-N 115.926 -0.579 . . . . 75.25 110.15 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 48.0 Cg_endo -68.61 162.32 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.135 2.557 . . . . 73.2 112.24 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -47.45 -41.62 20.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.024 1.329 . . . . 74.33 113.877 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.49 -46.9 87.49 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.344 0.498 . . . . 62.35 112.344 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.58 -4.76 59.25 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.151 -0.477 . . . . 73.43 111.472 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.217 -0.66 . . . . 65.01 109.217 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.68 -26.41 60.92 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.179 -0.919 . . . . 64.02 111.824 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.9 t -174.87 99.63 0.27 Allowed Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 122.884 0.474 . . . . 54.13 109.878 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.93 157.73 1.77 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.65 2.233 . . . . 65.22 111.968 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -71.7 158.16 53.96 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 121.756 1.638 . . . . 75.03 110.6 172.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.87 59.02 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 110.334 -0.247 . . . . 73.1 110.334 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HB2' HG13 ' A' ' 120' ' ' VAL . 45.7 Cg_endo -68.46 106.86 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.78 2.32 . . . . 74.53 111.593 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -106.3 87.61 2.59 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.757 0.789 . . . . 61.11 111.505 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.817 ' HB3' HG12 ' A' ' 120' ' ' VAL . 17.8 t70 -176.34 155.8 1.5 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 104.961 -2.236 . . . . 64.04 104.961 173.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -12.32 60.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 115.07 1.507 . . . . 72.03 115.07 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.3 p -127.57 6.77 6.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.851 1.426 . . . . 73.42 114.851 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 117' ' ' ASP . 15.0 p -103.06 127.68 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.788 -0.819 . . . . 52.53 108.788 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.522 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 9.0 mmpt? -126.15 145.17 50.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.25 -0.648 . . . . 74.4 109.25 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 20.8 mm -92.59 111.67 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.612 -1.255 . . . . 73.22 107.612 172.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -125.55 139.27 53.74 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.682 -0.69 . . . . 74.42 109.864 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.77 139.3 43.78 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.155 -0.93 . . . . 73.44 109.745 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.521 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 49.4 mtp180 -133.43 136.44 45.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.07 0.462 . . . . 73.01 111.761 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 157.13 46.75 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.182 -0.917 . . . . 61.34 111.519 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.02 18.63 46.12 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.096 -0.574 . . . . 72.32 113.158 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.0 pt -121.97 145.4 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.678 -0.809 . . . . 63.34 111.966 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.8 m -106.16 131.4 53.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 106.594 -1.632 . . . . 72.1 106.594 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.01 150.41 28.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.583 -0.895 . . . . 70.42 108.583 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 13.1 m-85 -115.19 121.73 43.88 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.207 -1.775 . . . . 72.42 106.207 -177.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 53.8 p -120.55 132.52 55.21 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 120.043 -0.663 . . . . 74.41 112.263 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.553 ' HB ' HD21 ' A' ' 151' ' ' LEU . 10.0 t -113.41 135.76 53.52 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.36 -0.607 . . . . 75.42 109.36 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -109.55 127.75 54.7 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.023 -1.103 . . . . 53.23 108.023 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -130.6 168.4 17.16 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.447 -0.946 . . . . 64.21 108.447 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.27 165.58 29.92 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.074 -1.06 . . . . 63.34 112.002 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.17 -133.8 7.9 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 110.968 -0.853 . . . . 71.5 110.968 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -100.71 101.32 12.17 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.169 -1.419 . . . . 63.54 107.169 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.33 107.93 17.57 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.931 0.872 . . . . 15.24 112.514 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -99.63 169.29 9.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.42 -1.326 . . . . 73.32 107.42 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.63 -29.09 69.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.842 0.83 . . . . 72.25 109.389 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.61 -30.92 70.63 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.738 -1.119 . . . . 73.25 111.093 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.17 -36.87 84.23 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 120.383 0.135 . . . . 71.52 111.28 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -66.61 -41.07 89.0 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.916 -0.314 . . . . 74.34 110.633 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.63 -45.35 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 72.31 109.959 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.68 90.94 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.049 -0.523 . . . . 72.43 111.366 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.627 ' CD2' HG22 ' A' ' 29' ' ' VAL . 76.5 m80 -69.14 -32.96 72.68 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.096 -0.642 . . . . 73.33 111.733 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 152' ' ' ARG . . . -66.84 -47.04 73.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.506 -0.315 . . . . 62.4 110.863 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 t -63.12 -38.14 89.99 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.931 -0.308 . . . . 70.45 111.682 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.77 -35.13 78.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 112.419 0.526 . . . . 53.53 112.419 176.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 133' ' ' THR . 66.1 mt -57.6 -36.87 72.32 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 120.846 0.355 . . . . 75.24 111.2 175.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 51.2 mtm180 -65.14 -36.56 84.62 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.547 -0.751 . . . . 72.14 110.076 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 m -75.82 -43.3 46.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.615 -0.721 . . . . 74.43 110.068 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 151' ' ' LEU . 60.1 p -71.93 -33.59 68.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.753 -0.658 . . . . 75.11 112.723 -174.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.75 9.59 7.65 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.061 0.763 . . . . 74.42 113.061 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 45.5 mt-10 -88.02 145.94 25.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.298 -1.001 . . . . 70.15 108.298 172.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.96 -9.86 63.85 Favored Glycine 0 C--N 1.302 -1.338 0 C-N-CA 120.647 -0.787 . . . . 74.23 111.404 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 14.0 t -122.03 149.32 53.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 107.2 -1.408 . . . . 63.41 107.2 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.79 34.67 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 123.84 3.027 . . . . 60.23 114.377 -175.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.32 136.06 39.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.966 0.412 . . . . 52.21 110.547 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 25.2 m -124.45 154.14 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.04 -1.096 . . . . 50.14 108.04 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.412 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 26.2 p90 -134.21 158.84 42.68 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.794 -0.447 . . . . 75.34 109.794 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -122.22 140.56 52.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.584 0.957 . . . . 75.15 113.584 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.78 30.17 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.066 -0.97 . . . . 60.11 113.968 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.9 t70 66.27 17.15 10.65 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 122.645 1.212 . . . . 72.24 108.439 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 86' ' ' VAL . 83.0 t -72.52 139.88 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 125.83 1.652 . . . . 64.31 111.731 -176.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -146.23 167.47 23.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.497 -0.774 . . . . 65.0 109.898 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.612 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 10.7 m-85 -115.42 152.77 32.28 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.799 -0.815 . . . . 70.02 108.799 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 62.1 m -114.65 129.63 56.7 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 106.477 -1.675 . . . . 71.43 106.477 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 184' ' ' GLU . . . -129.61 157.12 42.96 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.098 0.475 . . . . 71.35 111.91 -175.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . -155.66 164.19 32.02 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 108.553 -1.819 . . . . 64.11 108.553 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.499 ' CD1' ' HG3' ' A' ' 81' ' ' PRO . 70.2 m-85 -93.76 -15.72 24.9 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 117.779 0.79 . . . . 70.54 111.193 -176.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -157.81 144.62 13.18 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 105.293 -2.114 . . . . 62.45 105.293 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 25.0 Cg_exo -64.85 106.01 0.72 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.008 1.805 . . . . 51.22 110.979 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 174' ' ' PRO . 5.0 Cg_exo -77.14 132.25 12.52 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.582 2.188 . . . . 44.43 112.243 -174.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.9 tpt -81.46 -35.76 30.16 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.573 -0.899 . . . . 74.34 108.573 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -102.76 155.81 36.08 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 114.706 -1.134 . . . . 71.12 108.797 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.39 -14.92 28.15 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.876 2.384 . . . . 64.1 113.676 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -68.07 112.71 5.2 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.45 -0.5 . . . . 64.12 110.767 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -135.28 115.96 1.46 Allowed Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 110.351 -1.1 . . . . 51.23 110.351 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -69.62 -30.69 68.48 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 122.695 -0.297 . . . . 64.42 110.591 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.403 -0.592 . . . . 63.42 109.403 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -141.59 153.46 44.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.394 -1.706 . . . . 71.33 106.394 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 133' ' ' THR . 47.2 mt-10 -125.63 154.25 42.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.954 0.724 . . . . 61.31 112.954 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 132' ' ' SER . 51.9 t -125.45 118.9 53.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.742 -1.577 . . . . 74.15 106.742 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 10.9 m0 -103.73 121.15 42.4 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.027 -0.731 . . . . 65.24 109.027 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.0 tp -97.86 138.78 34.7 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.654 -1.61 . . . . 70.1 106.654 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.64 135.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.645 -0.422 . . . . 73.0 111.894 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.3 ptmm? -65.5 143.29 57.75 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.614 -0.721 . . . . 75.23 111.595 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.412 ' HB2' ' C ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.188 -1.042 . . . . 45.2 108.188 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.7 p30 . . . . . 0 CA--C 1.508 -0.668 0 N-CA-C 109.186 -0.672 . . . . 73.04 109.186 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.5 m 66.73 -20.44 0.11 Allowed 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.413 1.635 . . . . 71.31 115.413 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.1 mt 60.84 31.77 20.05 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.206 -1.405 . . . . 54.11 107.206 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -68.47 162.27 25.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.14 -1.391 . . . . 74.44 113.152 -171.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.28 69.51 0.38 Allowed Glycine 0 N--CA 1.412 -2.916 0 N-CA-C 108.897 -1.681 . . . . 74.13 108.897 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 m -66.0 107.92 2.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.918 -0.771 . . . . 73.44 108.918 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.1 t 59.69 77.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.598 1.189 . . . . 61.45 109.123 -172.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.614 ' HG2' ' H ' ' A' ' 15' ' ' THR . 35.6 tt0 -111.2 -169.11 1.4 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.564 -1.653 . . . . 73.25 106.642 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.614 ' H ' ' HG2' ' A' ' 14' ' ' GLU . 23.2 p -63.79 106.98 1.09 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.373 0.606 . . . . 72.24 111.915 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.518 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 76.1 t-105 -110.23 127.96 26.17 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.651 -1.24 . . . . 75.43 107.651 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.85 149.68 72.82 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.066 2.51 . . . . 74.33 112.619 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -100.7 127.45 47.11 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.787 -1.19 . . . . 63.4 107.787 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 108.31 19.75 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.595 -0.729 . . . . 74.3 109.202 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.6 131.37 41.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 116.085 -0.507 . . . . 73.13 110.443 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 22' ' ' SER . 4.1 pp -90.85 -34.99 15.05 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.657 -0.817 . . . . 74.13 112.431 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.445 ' N ' HD12 ' A' ' 21' ' ' LEU . 32.6 t -177.65 164.76 2.05 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.789 -0.819 . . . . 74.53 108.789 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -131.26 156.34 45.58 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.972 -1.122 . . . . 70.4 107.972 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.0 -158.94 31.66 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.582 -1.294 . . . . 71.31 112.42 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.58 -116.59 3.16 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 121.192 -0.528 . . . . 62.13 111.794 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -108.19 171.29 7.49 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.695 0.798 . . . . 72.11 109.853 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.67 140.85 35.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 106.44 -1.689 . . . . 74.35 106.44 172.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 77.3 -53.92 0.55 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.69 1.196 . . . . 72.14 110.47 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 147' ' ' HIS . 21.9 t -97.96 108.27 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.164 -1.421 . . . . 75.13 107.164 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 133' ' ' THR . 50.3 m -130.52 140.85 50.49 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.261 -1.014 . . . . 71.22 108.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' SER . 1.6 p90 -112.15 161.46 16.52 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.075 0.464 . . . . 70.51 112.151 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.541 ' OE2' ' HD3' ' A' ' 34' ' ' ARG . 33.8 tt0 -133.13 126.19 31.17 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.456 -1.313 . . . . 74.41 107.456 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.33 112.82 26.07 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.031 -1.47 . . . . 54.51 107.031 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 13.4 ptt180 -144.04 159.23 42.97 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 119.853 -0.739 . . . . 73.23 110.327 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.19 136.9 33.78 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.958 -1.497 . . . . 43.2 106.958 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.43 151.59 43.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.097 0.475 . . . . 73.55 111.122 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -67.62 -21.09 65.41 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.364 -0.834 . . . . 72.4 112.898 -179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 125' ' ' ARG . . . 74.49 9.49 81.91 Favored Glycine 0 CA--C 1.51 -0.235 0 C-N-CA 119.873 -1.156 . . . . 72.11 113.926 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.61 165.25 53.66 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.947 -0.644 . . . . 71.14 113.574 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -93.95 135.66 35.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.21 -0.663 . . . . 65.13 109.21 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 63.1 m-85 -136.59 165.92 24.75 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.688 0.618 . . . . 74.14 110.815 -172.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.73 118.95 35.41 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.236 -1.024 . . . . 72.34 108.236 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.7 t -128.49 154.12 46.44 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 113.174 0.805 . . . . 71.21 113.174 -172.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 119' ' ' SER . 97.1 t -129.08 132.94 66.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.989 1.315 . . . . 63.43 108.63 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.38 126.67 55.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.653 0.263 . . . . 55.11 110.503 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 45.1 t -127.33 127.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.942 -1.503 . . . . 65.33 106.942 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.6 m -120.34 162.99 18.52 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.563 -0.532 . . . . 72.22 109.563 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 75.58 -31.81 0.21 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.985 1.314 . . . . 73.11 112.362 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -85.4 146.6 44.98 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.795 -0.639 . . . . 54.32 110.663 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.5 156.86 39.32 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.853 2.369 . . . . 54.3 111.113 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.52 HG13 HD12 ' A' ' 98' ' ' LEU . 37.2 t -47.8 -48.08 11.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.908 1.077 . . . . 72.43 113.908 -177.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 33.2 t70 -59.51 -49.64 76.98 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.47 -0.492 . . . . 75.24 110.832 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -61.96 -48.19 81.47 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.662 0.616 . . . . 72.11 112.662 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -60.59 -38.65 85.36 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 123.612 0.57 . . . . 54.53 110.778 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' O ' ' HG2' ' A' ' 59' ' ' MET . 65.3 tp -66.48 -42.53 87.31 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.081 -0.509 . . . . 71.13 110.302 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 20.0 mmm180 -59.43 -45.31 91.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.861 0.363 . . . . 73.53 110.595 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -66.69 -37.43 84.72 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.336 -0.847 . . . . 74.21 111.34 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.57 59.97 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.274 0.842 . . . . 74.22 113.274 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 3.2 mmt -48.32 -57.69 10.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.254 1.205 . . . . 54.0 114.254 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.55 -32.12 88.82 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.749 2.299 . . . . 63.53 112.384 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.06 -47.48 68.2 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.329 -0.619 . . . . 72.31 109.329 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.88 -38.08 79.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.901 -0.59 . . . . 75.42 110.303 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 59' ' ' MET . 9.7 mmt -66.36 -37.36 85.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 73.44 112.031 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -72.98 -33.71 66.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.699 -0.401 . . . . 71.05 110.807 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.71 -60.08 4.23 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 116.431 -0.35 . . . . 61.2 111.246 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 76' ' ' MET . 6.4 p -73.48 -25.27 20.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 120.864 0.364 . . . . 74.54 110.542 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.49 -25.05 66.56 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.261 -0.427 . . . . 45.04 113.249 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 -0.58 2.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.781 -1.2 . . . . 72.31 113.494 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -91.2 29.74 1.37 Allowed 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 122.609 1.195 . . . . 50.22 109.431 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.07 159.87 14.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.596 -0.891 . . . . 52.03 108.596 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 23.2 t70 -70.8 -28.04 64.34 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.081 0.4 . . . . 72.32 112.081 -172.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.84 -12.34 59.97 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.192 -0.67 . . . . 74.43 109.192 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.61 33.25 75.94 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.158 -0.928 . . . . 64.42 112.813 177.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.58 126.93 40.25 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.78 -0.768 . . . . 72.14 111.331 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.86 92.45 1.54 Allowed Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.281 -1.127 . . . . 41.32 110.281 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 56.0 ttp 70.62 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.771 1.228 . . . . 71.1 110.535 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.52 -55.62 0.68 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.837 0.695 . . . . 74.13 114.837 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.412 ' SD ' HG23 ' A' ' 104' ' ' ILE . 21.6 ptt? -124.75 126.24 45.33 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.5 m -126.1 124.5 40.72 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.33 109.652 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -165.7 145.5 5.44 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 107.465 -1.309 . . . . 72.2 107.465 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -35.61 139.98 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.177 3.251 . . . . 64.4 115.767 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.27 150.06 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 113.485 -1.689 . . . . 74.1 106.5 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 m -138.61 145.08 40.11 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.467 -0.568 . . . . 72.22 109.467 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 168' ' ' TYR . 42.9 p90 -136.53 143.69 43.86 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.463 -0.495 . . . . 64.15 111.358 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -92.15 134.87 34.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.678 -0.86 . . . . 75.44 108.678 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.98 150.95 30.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.188 -0.915 . . . . 63.31 109.291 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.537 ' CZ ' ' HD2' ' A' ' 97' ' ' LYS . 1.9 m-85 -117.36 102.28 52.31 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 109.231 -0.655 . . . . 64.44 109.231 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -88.67 146.8 5.91 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.235 1.957 . . . . 75.32 112.693 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.54 152.66 18.23 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.988 -1.856 . . . . 63.14 105.988 171.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.268 11.3 pt-20 -64.53 -13.36 52.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 115.683 1.734 . . . . 70.44 115.683 -172.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.6 -6.25 59.25 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 121.609 0.718 . . . . 61.02 109.866 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.22 5.14 54.84 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 72.04 112.941 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 m -83.99 126.42 33.01 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.489 -0.56 . . . . 50.22 109.489 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 78.0 mt -94.04 78.58 4.08 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.923 0.392 . . . . 63.41 111.095 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 30.1 tt0 -149.25 115.29 5.73 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.949 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 95' ' ' GLN . 95.1 mttt -176.75 -62.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.278 1.831 . . . . 73.51 108.648 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.537 ' HD2' ' CZ ' ' A' ' 87' ' ' PHE . 38.5 ttmt -161.31 155.0 21.92 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.299 -1.0 . . . . 53.12 108.299 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.52 HD12 HG13 ' A' ' 51' ' ' VAL . 6.6 tt -143.76 143.38 31.35 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.331 -0.618 . . . . 72.53 109.331 173.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -136.92 115.47 11.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.636 -0.505 . . . . 73.0 109.636 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' THR . 84.0 t -92.15 129.88 42.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 N-CA-C 109.785 -0.45 . . . . 43.33 109.785 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.422 ' HE3' ' HB2' ' A' ' 41' ' ' PHE . 89.8 m95 -112.72 128.15 56.33 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.941 -0.763 . . . . 75.11 108.941 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -103.26 123.62 47.1 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.969 -1.123 . . . . 75.03 107.969 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.451 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 68.4 mtt-85 -75.49 132.22 40.63 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.503 0.927 . . . . 73.33 113.503 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.412 HG23 ' SD ' ' A' ' 78' ' ' MET . 72.1 mt -102.11 122.77 45.78 Favored Pre-proline 0 N--CA 1.398 -3.041 0 N-CA-C 105.98 -1.859 . . . . 74.33 105.98 172.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.16 152.01 62.75 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.236 1.958 . . . . 62.31 110.733 175.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -48.12 -37.33 15.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.564 0.746 . . . . 62.34 112.848 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.75 -31.87 70.04 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 123.502 0.721 . . . . 75.23 112.225 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -100.29 -8.45 23.42 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 112.498 0.555 . . . . 64.43 112.498 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -70.75 -29.24 65.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.641 1.349 . . . . 63.31 114.641 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.11 -38.59 94.1 Favored Glycine 0 C--O 1.241 0.587 0 C-N-CA 120.029 -1.082 . . . . 61.21 111.514 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -142.92 85.81 9.72 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 108.26 -1.015 . . . . 72.01 108.26 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -88.34 159.82 6.83 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.886 1.724 . . . . 73.23 112.824 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.28 130.27 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.478 2.119 . . . . 71.31 110.802 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -70.03 138.73 87.5 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 109.287 -0.634 . . . . 60.52 109.287 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 73.1 Cg_endo -77.27 111.3 3.16 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.155 1.904 . . . . 51.13 112.074 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -98.69 79.23 2.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.806 -0.813 . . . . 74.12 108.806 177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -173.89 150.26 1.63 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.792 -1.188 . . . . 72.35 107.792 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -76.27 -24.2 54.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.214 0.82 . . . . 73.21 113.214 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 44' ' ' VAL . 60.4 m -92.6 -26.21 17.97 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.57 -0.452 . . . . 73.31 110.799 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 26.8 t -94.35 118.35 40.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.849 -0.426 . . . . 75.32 109.849 -175.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -128.73 147.63 50.78 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.471 -0.937 . . . . 71.33 108.471 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.1 mm -92.71 112.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.24 -1.022 . . . . 53.44 108.24 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -122.06 149.7 43.16 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.942 -0.572 . . . . 74.44 109.769 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.74 152.52 24.24 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.814 -0.63 . . . . 62.04 109.821 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.503 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 65.0 ttt180 -151.57 123.25 7.96 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.821 -0.807 . . . . 71.34 108.821 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -138.39 166.92 23.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.545 -0.539 . . . . 72.23 109.545 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.44 61.01 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.431 -1.366 . . . . 73.23 113.282 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.6 pt -119.28 151.93 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.347 -0.941 . . . . 74.43 112.166 -175.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 189' ' ' LYS . 92.9 m -105.78 123.35 47.81 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.943 -1.48 . . . . 73.43 107.788 178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.52 146.66 30.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 116.01 -0.541 . . . . 64.3 110.632 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 39.9 m-85 -114.47 121.92 45.0 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.707 -1.96 . . . . 73.22 105.707 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 31' ' ' TYR . 56.1 p -122.41 139.16 54.17 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 119.832 -0.747 . . . . 43.44 111.193 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.8 t -113.51 133.19 55.37 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 120.574 -0.451 . . . . 40.14 109.932 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -110.91 125.33 53.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.514 -1.291 . . . . 64.21 107.514 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.68 158.08 44.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.463 -0.199 . . . . 65.41 110.463 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -137.06 154.54 22.32 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 123.973 0.796 . . . . 74.31 111.372 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.09 -142.37 11.73 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 109.009 -1.637 . . . . 63.43 109.009 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 179' ' ' TYR . 75.0 t80 -100.43 118.95 37.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 118.239 1.02 . . . . 63.2 108.964 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.53 133.41 55.4 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.611 0.72 . . . . 63.3 112.177 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -112.64 177.37 4.66 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.419 -1.697 . . . . 73.32 106.419 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.55 78.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.346 0.594 . . . . 60.35 110.817 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.65 -29.29 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 74.33 111.77 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.24 -30.23 70.09 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 111.879 0.325 . . . . 64.04 111.879 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.88 -48.94 69.85 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.728 -0.841 . . . . 75.03 108.728 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.03 -41.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.841 -1.072 . . . . 54.4 110.185 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.71 88.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.841 -0.618 . . . . 63.12 110.521 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.428 ' CD2' HG22 ' A' ' 29' ' ' VAL . 62.8 m80 -66.63 -32.36 73.63 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 112.827 0.677 . . . . 75.35 112.827 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.68 -47.31 84.93 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.105 0.478 . . . . 64.53 109.921 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -65.03 -46.87 79.48 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.628 -0.715 . . . . 65.05 110.447 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.06 -40.82 86.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.118 -0.492 . . . . 74.43 111.318 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 187' ' ' LEU . 1.5 tt -62.72 -46.07 89.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.828 -1.175 . . . . 72.31 107.828 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -64.09 -39.47 94.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.068 -0.969 . . . . 74.03 110.451 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.9 m -68.55 -33.09 73.48 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.312 0.577 . . . . 72.4 110.257 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -73.02 -33.51 65.78 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.37 0.605 . . . . 74.34 109.702 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 158' ' ' THR . 98.6 mt -81.1 9.2 7.06 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.998 -0.546 . . . . 71.34 111.486 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.96 134.08 35.64 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 71.22 106.91 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.89 57.28 Favored Glycine 0 C--N 1.307 -1.028 0 C-N-CA 121.211 -0.518 . . . . 61.51 112.551 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 155' ' ' LEU . 15.3 t -125.41 146.24 53.72 Favored Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 106.879 -1.526 . . . . 72.43 106.879 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.83 34.79 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 123.744 2.963 . . . . 60.15 114.676 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.64 43.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.446 -0.576 . . . . 64.33 109.446 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 19.6 p -114.91 158.66 21.68 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.364 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -136.23 152.36 50.66 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.615 -0.883 . . . . 64.42 108.615 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -113.02 111.34 22.0 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.262 0.838 . . . . 70.02 113.262 178.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.53 4.71 46.81 Favored Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 115.658 -0.701 . . . . 61.1 112.495 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 17.8 t70 63.83 15.75 9.3 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.813 1.245 . . . . 74.54 109.565 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.14 151.56 7.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 CA-C-O 121.205 0.526 . . . . 72.44 110.516 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -146.1 170.64 16.28 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.599 -0.728 . . . . 70.14 111.215 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.494 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 97.6 m-85 -115.15 152.28 32.88 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.64 -0.504 . . . . 55.21 109.64 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.03 137.75 53.67 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.757 -1.201 . . . . 62.33 107.757 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.73 150.03 32.13 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 111.896 0.332 . . . . 73.1 111.896 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.9 164.23 33.11 Favored Glycine 0 C--O 1.22 -0.748 0 N-CA-C 107.871 -2.092 . . . . 71.51 107.871 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -138.99 -39.48 0.49 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 115.228 1.566 . . . . 71.41 115.228 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.81 134.54 25.98 Favored Pre-proline 0 C--N 1.306 -1.283 0 C-N-CA 120.312 -0.555 . . . . 75.45 111.319 -175.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.46 104.05 0.88 Allowed 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.295 1.996 . . . . 74.1 107.865 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -97.36 149.7 0.91 Allowed 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.333 2.022 . . . . 72.14 115.694 -168.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 85.6 mtp -81.56 -33.83 31.44 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.068 -1.827 . . . . 71.55 106.068 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -132.81 109.92 13.16 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 106.029 -1.841 . . . . 73.25 106.029 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.68 -34.33 51.49 Favored 'Trans proline' 0 CA--C 1.511 -0.657 0 C-N-CA 121.431 1.421 . . . . 61.12 113.362 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 138' ' ' TYR . 52.5 t80 46.27 -89.4 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.405 1.082 . . . . 74.33 110.633 -172.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 116.51 54.58 0.33 Allowed Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.31 -0.948 . . . . 54.23 114.848 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -70.85 -26.36 63.23 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 117.952 0.876 . . . . 65.21 111.73 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -133.8 128.16 34.19 Favored 'General case' 0 CA--C 1.469 -2.143 0 CA-C-O 121.459 0.647 . . . . 70.3 111.231 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -144.86 134.59 23.51 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 103.743 -2.688 . . . . 75.52 103.743 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.4 ' HB3' ' HE1' ' A' ' 186' ' ' TRP . 2.7 mp0 -115.71 137.22 52.3 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 119.261 -0.976 . . . . 73.54 110.334 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 168' ' ' TYR . 89.8 t -124.99 121.06 60.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.636 -1.246 . . . . 54.23 107.636 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.502 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 6.8 m0 -119.31 120.96 38.51 Favored 'General case' 0 C--O 1.197 -1.682 0 CA-C-O 119.129 -0.462 . . . . 72.43 110.929 -174.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 151' ' ' LEU . 9.2 mp -96.95 138.83 33.88 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.822 -1.177 . . . . 73.22 107.822 171.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.16 131.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 120.323 -0.551 . . . . 74.22 110.681 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 161' ' ' THR . 4.5 tmtm? -73.46 130.74 40.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.519 -0.764 . . . . 60.13 109.997 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.252 1.199 0 CA-C-N 115.734 -0.666 . . . . 52.13 111.054 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.224 -1.028 . . . . 74.45 108.224 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.7 p -165.22 136.36 3.98 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.751 0.31 . . . . 62.31 111.783 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.87 93.61 3.88 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.611 -0.885 . . . . 73.44 108.611 171.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -87.49 135.49 33.32 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.63 -0.714 . . . . 71.41 110.09 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.99 165.36 22.16 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 109.299 -1.52 . . . . 55.33 109.299 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.8 t -82.65 97.79 8.7 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.901 -0.777 . . . . 72.31 108.901 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -95.53 -36.48 6.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.397 -0.964 . . . . 64.34 108.397 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.96 163.62 13.64 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.082 -1.822 . . . . 61.51 106.082 -178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.8 m 77.21 126.1 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.323 1.449 . . . . 70.13 112.475 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -82.1 111.73 29.76 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.157 -0.929 . . . . 54.32 109.453 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -96.33 121.63 0.23 Allowed 'Trans proline' 0 N--CA 1.44 -1.664 0 C-N-CA 121.835 1.69 . . . . 60.52 113.502 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -110.07 144.71 38.27 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.056 -1.461 . . . . 70.42 107.056 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -126.81 122.53 35.02 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.92 -1.112 . . . . 74.1 111.73 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.92 121.16 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 106.966 -1.494 . . . . 52.43 106.966 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.56 -33.41 15.91 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.59 -0.444 . . . . 65.04 111.044 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB3' ' OE2' ' A' ' 33' ' ' GLU . 46.8 t -162.26 149.86 14.14 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.401 0.619 . . . . 40.12 110.806 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.1 p -133.29 166.71 21.87 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 125.05 1.34 . . . . 73.41 108.255 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.01 76.76 0.4 Allowed Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 119.513 -1.327 . . . . 73.32 112.961 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.18 -160.34 22.45 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.226 -0.988 . . . . 74.02 111.659 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -89.96 170.58 10.25 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.781 -1.192 . . . . 73.2 107.781 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.22 148.27 51.07 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 119.652 -0.819 . . . . 63.53 109.91 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.0 t70 77.43 -62.23 0.39 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.425 1.49 . . . . 62.42 110.791 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.76 110.06 29.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.369 -0.974 . . . . 60.2 108.369 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -118.88 154.44 32.93 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.461 -0.94 . . . . 55.44 108.461 -176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.594 ' HB3' HD11 ' A' ' 151' ' ' LEU . 5.7 p90 -117.28 152.19 35.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.214 -1.394 . . . . 71.44 113.868 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -135.18 124.75 25.07 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.527 -2.027 . . . . 75.11 105.527 172.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.412 ' OE2' ' HB3' ' A' ' 22' ' ' SER . 32.3 mt-10 -106.31 118.38 36.48 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.2 107.571 -177.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -139.04 148.34 43.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.512 0.93 . . . . 74.22 113.512 -175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.59 136.41 34.82 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.082 -1.451 . . . . 62.52 107.082 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.632 ' SG ' HG13 ' A' ' 128' ' ' ILE . 99.1 m -63.49 142.9 58.22 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.644 0.979 . . . . 70.34 113.644 -176.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -47.98 -48.25 32.54 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.827 1.251 . . . . 54.32 112.323 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.01 69.91 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 110.747 -0.941 . . . . 51.11 110.747 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.23 165.75 53.37 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 111.214 -0.754 . . . . 63.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 137.24 32.51 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.921 -0.311 . . . . 70.45 110.763 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 53.9 m-85 -135.34 164.22 28.23 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.766 0.827 . . . . 75.13 109.403 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.51 116.51 31.8 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.135 -0.691 . . . . 72.52 109.135 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.5 t -119.91 138.98 53.1 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 112.621 0.6 . . . . 74.13 112.621 -175.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.498 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 11.5 m -130.44 124.95 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.425 1.09 . . . . 60.42 110.393 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.55 139.06 45.01 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.086 -0.646 . . . . 64.12 112.281 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 39.4 t -126.38 141.33 46.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 N-CA-C 108.465 -0.939 . . . . 64.31 108.465 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -127.83 174.89 8.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 122.859 0.463 . . . . 71.35 110.13 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.51 -34.28 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.122 0.969 . . . . 73.33 113.202 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 3.5 mppt? -100.57 138.78 20.22 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 112.143 0.424 . . . . 62.45 112.143 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.73 159.76 4.59 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 124.589 3.526 . . . . 73.01 111.841 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.613 HG13 HD12 ' A' ' 98' ' ' LEU . 52.6 t -46.14 -48.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.708 0.803 . . . . 72.51 113.043 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.99 -45.18 91.27 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.423 0.63 . . . . 70.41 110.744 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 23.1 mm-40 -75.06 -31.84 61.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.986 -1.006 . . . . 74.11 112.585 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -73.0 -44.84 60.57 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.512 0.673 . . . . 71.12 109.669 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.304 -0.862 . . . . 62.3 111.309 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 17.0 ptm180 -64.09 -26.6 68.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 116.564 -0.289 . . . . 71.41 111.645 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 51.9 mt-10 -84.72 -41.75 15.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.982 0.42 . . . . 72.11 111.181 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.09 69.42 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.271 0.841 . . . . 74.1 113.271 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.484 ' HB2' ' HD3' ' A' ' 60' ' ' PRO . 6.6 mmt -56.07 -53.56 62.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.205 -0.426 . . . . 71.32 111.711 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 34.5 Cg_exo -55.87 -31.89 82.98 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.348 2.032 . . . . 74.35 112.129 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 43.0 mtmt -73.04 -31.02 64.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.626 -0.43 . . . . 54.55 111.589 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 66' ' ' VAL . 35.4 mm -74.34 -43.4 49.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.409 -0.96 . . . . 74.22 108.409 171.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 59' ' ' MET . 19.3 mmt -56.26 -37.73 70.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.854 0.686 . . . . 74.01 112.854 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.4 -47.62 72.69 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.439 -0.504 . . . . 72.1 110.74 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.88 -58.03 6.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.134 -0.485 . . . . 74.52 111.767 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -68.88 -17.38 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.288 0.566 . . . . 64.34 110.897 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.62 -19.78 65.3 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.88 -0.6 . . . . 32.34 112.82 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.72 -22.28 0.4 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.096 -1.526 . . . . 51.04 113.968 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -79.37 58.02 2.5 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.439 1.114 . . . . 73.01 111.338 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -99.88 160.28 14.43 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.325 -1.361 . . . . 74.35 107.325 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -69.2 -33.57 73.55 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.597 0.635 . . . . 70.21 110.278 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -80.41 -9.58 59.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.746 . . . . 73.52 110.327 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.78 62.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.642 -0.708 . . . . 60.31 112.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 m -82.97 159.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 108.11 -1.07 . . . . 73.31 108.11 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -170.89 12.28 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 119.082 -1.532 . . . . 62.45 113.733 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.0 mtp 70.69 101.96 0.06 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.379 1.472 . . . . 72.24 110.466 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 66' ' ' VAL . . . -54.44 122.1 22.97 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.817 -1.083 . . . . 33.44 114.385 -174.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -96.31 126.89 41.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.645 -0.872 . . . . 72.31 108.645 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 m -123.77 123.94 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.435 0.636 . . . . 72.34 111.838 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.14 176.72 2.28 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 104.202 -2.518 . . . . 70.01 104.202 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -62.53 139.08 74.15 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 CA-C-N 121.494 1.569 . . . . 33.52 112.293 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 8.8 p -110.47 148.88 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.806 -1.183 . . . . 54.22 107.806 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 47.0 p -125.72 145.36 50.22 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 121.164 -0.214 . . . . 62.52 110.658 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -139.75 148.12 41.82 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 120.617 -0.433 . . . . 71.41 110.621 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.09 135.36 34.04 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.634 0.584 . . . . 73.12 110.019 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.27 151.07 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.001 -1.0 . . . . 73.23 109.577 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 76.4 m-85 -118.12 110.45 39.69 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 110.253 -0.277 . . . . 75.43 110.253 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.78 137.03 9.78 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 121.5 1.467 . . . . 64.33 110.989 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -82.77 179.31 7.82 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.745 -0.835 . . . . 75.25 108.745 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.2 -36.32 77.4 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.763 0.792 . . . . 72.44 109.807 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.31 -5.42 52.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.284 -1.325 . . . . 71.41 112.777 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.55 -4.03 83.74 Favored Glycine 0 CA--C 1.501 -0.829 0 C-N-CA 120.378 -0.915 . . . . 75.33 112.718 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.1 p -74.64 146.92 42.02 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.001 -0.741 . . . . 72.41 109.001 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.64 132.6 35.18 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.149 0.499 . . . . 73.52 110.879 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -87.35 150.95 23.5 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 75.44 109.923 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -74.63 77.37 2.01 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.934 1.087 . . . . 70.25 113.934 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.68 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -165.49 122.89 1.5 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 104.21 -2.515 . . . . 73.22 104.21 173.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.68 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 5.7 tt -143.88 145.26 32.18 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 121.078 -0.249 . . . . 70.12 110.571 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -142.1 130.24 22.09 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.404 -0.518 . . . . 73.24 110.726 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' THR . 95.8 t -91.85 139.28 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.228 -0.896 . . . . 52.1 109.944 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.265 -1.383 . . . . 75.15 107.265 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HA ' HG23 ' A' ' 82' ' ' VAL . 88.5 t80 -102.2 114.31 28.36 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.495 -0.928 . . . . 73.21 108.495 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -75.54 113.14 12.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.105 -1.443 . . . . 71.32 107.105 -175.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -78.3 135.26 61.77 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 112.276 0.473 . . . . 61.14 112.276 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.23 157.83 13.3 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.416 2.744 . . . . 73.2 112.127 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -54.59 -45.94 73.69 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.155 1.168 . . . . 62.52 114.155 -171.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -59.85 -37.92 80.66 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.214 0.531 . . . . 71.3 111.785 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.44 -3.15 57.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.696 0.628 . . . . 71.44 112.696 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.676 ' HA ' HE21 ' A' ' 109' ' ' GLN . 0.0 OUTLIER -71.51 -33.73 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.184 -1.006 . . . . 75.53 109.91 172.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 -34.75 55.78 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.024 -0.535 . . . . 61.31 112.187 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.6 t -142.72 89.09 8.27 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 108.283 -1.006 . . . . 50.35 108.283 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 73.5 Cg_endo -87.18 141.18 5.87 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.914 1.743 . . . . 73.13 110.977 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 12.5 Cg_exo -71.25 154.67 61.5 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 121.705 1.603 . . . . 64.53 110.448 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.38 143.12 55.24 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.376 -0.972 . . . . 72.12 108.376 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.82 110.71 2.84 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.045 1.83 . . . . 71.12 111.643 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.2 t -72.76 -22.17 60.9 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.575 -0.738 . . . . 44.1 110.548 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.58 144.23 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.635 -0.876 . . . . 65.43 108.635 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.92 -33.14 74.12 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.224 0.824 . . . . 71.15 113.224 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.1 p -90.36 -12.13 38.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.991 0.424 . . . . 72.21 111.944 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.31 123.21 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.454 -2.054 . . . . 74.44 105.454 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -128.39 138.28 52.27 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.249 -0.58 . . . . 75.23 110.57 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 25.3 mm -92.01 109.49 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.541 -1.652 . . . . 62.22 106.541 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -129.87 153.14 48.59 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.395 -0.821 . . . . 63.05 109.176 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.27 137.58 54.8 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 109.501 -0.555 . . . . 73.1 109.501 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.94 127.48 28.77 Favored 'General case' 0 N--CA 1.426 -1.659 0 C-N-CA 120.555 -0.458 . . . . 61.34 111.413 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.17 175.57 9.44 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.398 -0.964 . . . . 73.12 108.398 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.71 46.11 Favored Glycine 0 C--N 1.306 -1.083 0 C-N-CA 120.836 -0.697 . . . . 72.1 111.758 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.632 HG13 ' SG ' ' A' ' 36' ' ' CYS . 36.2 pt -132.99 146.51 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.088 0.47 . . . . 75.34 110.801 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.2 m -104.06 135.16 46.08 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.98 -1.489 . . . . 61.31 106.98 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 m -123.66 145.97 29.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.355 -0.609 . . . . 71.52 109.355 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -113.48 122.53 47.57 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 105.923 -1.88 . . . . 61.53 105.923 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 20.7 m -110.1 146.59 35.16 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 115.867 -0.606 . . . . 73.11 110.916 -173.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.499 HG22 ' HB ' ' A' ' 185' ' ' VAL . 9.9 t -133.62 124.89 27.61 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.327 -0.619 . . . . 71.34 109.327 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -111.23 126.36 54.79 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-O 121.424 0.63 . . . . 74.15 109.505 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 37.3 p90 -137.24 167.43 21.59 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.974 -1.012 . . . . 72.02 109.314 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -120.62 123.21 5.5 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.09 -1.204 . . . . 22.31 110.09 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 167.03 170.84 32.43 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 111.345 -0.702 . . . . 62.3 111.345 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 177' ' ' LYS . 77.8 m-85 -93.11 100.26 12.69 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.664 -0.865 . . . . 63.21 108.664 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.69 132.2 43.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.32 0.859 . . . . 55.33 113.32 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.06 177.15 5.03 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.27 -36.49 73.34 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.729 0.3 . . . . 65.25 111.262 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.23 81.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.353 -0.385 . . . . 63.53 110.297 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.9 -42.51 99.8 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.773 -0.454 . . . . 61.54 109.773 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.759 ' HA ' ' NE2' ' A' ' 147' ' ' HIS . 63.9 m-85 -56.95 -43.96 82.07 Favored 'General case' 0 CA--C 1.5 -0.946 0 O-C-N 123.365 0.416 . . . . 73.44 112.108 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.11 -49.29 77.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 123.753 0.658 . . . . 64.13 110.305 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.62 -48.27 77.85 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.778 -0.646 . . . . 74.32 112.062 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.759 ' NE2' ' HA ' ' A' ' 144' ' ' TYR . 3.2 p-80 -72.46 -32.0 65.89 Favored 'General case' 0 C--O 1.205 -1.271 0 N-CA-C 113.067 0.765 . . . . 60.3 113.067 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.31 80.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.147 0.498 . . . . 64.44 110.651 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.4 t -76.53 -32.02 57.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 120.127 -0.629 . . . . 71.21 109.758 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.96 -34.3 78.11 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 116.379 -0.373 . . . . 75.4 110.298 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 31' ' ' TYR . 57.9 tp -62.61 -41.78 99.2 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.531 -0.544 . . . . 74.23 109.531 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -62.25 -36.99 83.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.447 0.642 . . . . 65.32 110.165 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 41.1 m -72.6 -30.18 64.14 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 115.153 -0.93 . . . . 53.21 110.105 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.7 m -75.12 -33.35 61.57 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.473 0.709 . . . . 72.02 109.834 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.9 mt -72.8 13.25 0.4 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.295 1.438 . . . . 75.23 111.76 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 153' ' ' THR . 44.6 tt0 -51.11 124.24 11.08 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.481 1.112 . . . . 73.31 110.357 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.54 60.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.736 -0.745 . . . . 62.31 113.724 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 81.0 p -93.23 154.41 41.51 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 117.565 0.682 . . . . 65.14 109.742 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.86 25.7 0.69 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.676 2.251 . . . . 64.33 110.897 175.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.03 138.81 39.81 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.835 -0.62 . . . . 71.32 110.753 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 31.5 p -110.8 149.84 29.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.356 -0.609 . . . . 71.05 109.356 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -143.75 161.51 38.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.88 -0.785 . . . . 72.43 108.88 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.414 ' O ' HG12 ' A' ' 166' ' ' VAL . 27.8 pt20 -131.65 109.65 10.36 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.235 -0.586 . . . . 75.52 111.825 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.57 62.69 Favored Glycine 0 C--N 1.315 -0.628 0 C-N-CA 120.617 -0.802 . . . . 54.25 114.141 171.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 61.04 23.15 13.34 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.032 0.533 . . . . 65.11 111.185 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 163' ' ' GLN . 9.8 p -63.59 138.16 23.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 N-CA-C 109.274 -0.639 . . . . 42.43 109.274 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.405 ' HB3' HD23 ' A' ' 187' ' ' LEU . 40.6 p90 -147.2 174.61 11.45 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 121.447 0.641 . . . . 74.31 111.192 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -116.98 150.32 38.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.714 -1.13 . . . . 74.52 109.17 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 83' ' ' SER . 34.7 t -113.29 120.32 40.74 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.291 -1.003 . . . . 73.13 108.291 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 82' ' ' VAL . . . -120.62 131.79 54.8 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.446 0.466 . . . . 74.2 111.604 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.49 164.91 38.18 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.098 -2.001 . . . . 74.22 108.098 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -64.73 -42.7 95.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.737 1.268 . . . . 72.12 109.377 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -155.31 150.4 20.8 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 106.703 -1.591 . . . . 75.3 106.703 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -48.0 117.24 2.36 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.293 2.662 . . . . 71.41 112.372 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.97 129.81 19.13 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.101 1.868 . . . . 72.52 112.775 -175.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 26.6 ttt -93.7 -42.31 9.23 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.789 -1.56 . . . . 62.24 106.789 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -172.51 -66.12 0.0 OUTLIER Pre-proline 0 C--O 1.208 -1.122 0 CA-C-N 114.85 -1.068 . . . . 70.31 110.284 173.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 177' ' ' LYS . 82.8 Cg_endo -76.01 -30.16 6.03 Favored 'Trans proline' 0 C--N 1.375 1.964 0 CA-C-N 120.523 1.223 . . . . 70.45 115.002 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -101.54 109.07 20.81 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.389 -0.524 . . . . 73.45 111.05 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 120.22 51.35 0.27 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.909 -0.876 . . . . 51.14 110.909 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.49 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 2.6 tmm_? -75.34 -31.05 60.44 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 109.238 -0.653 . . . . 72.34 109.238 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -113.13 131.21 55.93 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.508 -0.477 . . . . 73.31 110.247 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -131.62 161.74 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.831 -0.803 . . . . 74.24 108.831 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 133' ' ' THR . 43.4 tt0 -125.27 139.23 53.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.38 -1.341 . . . . 72.54 107.38 174.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.719 HG21 ' CD2' ' A' ' 147' ' ' HIS . 59.4 t -126.7 131.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.906 -0.775 . . . . 71.52 108.906 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 36.3 m0 -111.08 123.19 49.7 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 123.322 0.389 . . . . 74.03 110.444 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 167' ' ' TYR . 91.0 mt -96.5 128.08 43.1 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.413 -1.699 . . . . 44.55 106.413 169.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.016 -0.674 . . . . 74.41 111.75 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 161' ' ' THR . 52.2 tttp -63.69 127.63 32.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.563 -1.198 . . . . 71.33 111.753 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 108.825 -0.806 . . . . 64.11 108.825 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 108.579 -0.896 . . . . 71.41 108.579 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.9 p -149.73 170.72 18.07 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 116.522 -0.308 . . . . 65.41 111.616 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 63.33 67.34 0.66 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.805 1.242 . . . . 74.14 112.821 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -140.03 138.39 35.39 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.884 -1.154 . . . . 74.05 107.884 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.62 20.2 58.69 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 109.921 -1.272 . . . . 60.44 109.921 -175.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 m -73.26 104.93 4.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.418 -0.956 . . . . 72.11 108.418 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.75 125.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 CA-C-N 115.912 -0.585 . . . . 73.22 109.425 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -134.6 148.81 50.5 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.727 -0.67 . . . . 53.13 109.198 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HA ' HD21 ' A' ' 106' ' ' ASN . 6.3 t -104.34 86.39 2.52 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-O 122.022 0.915 . . . . 74.21 109.515 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.521 ' CZ2' ' HB3' ' A' ' 109' ' ' GLN . 35.0 p90 -79.46 126.12 81.61 Favored Pre-proline 0 N--CA 1.425 -1.708 0 CA-C-N 115.044 -0.98 . . . . 74.44 109.958 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.79 148.62 22.65 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.713 2.276 . . . . 51.34 114.595 -173.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 43.8 p90 -102.29 148.94 24.84 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 104.872 -2.269 . . . . 54.2 104.872 171.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 6.2 tp-100 -106.05 109.03 20.84 Favored 'General case' 0 C--N 1.279 -2.488 0 C-N-CA 118.052 -1.459 . . . . 63.53 111.177 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.485 HG22 ' HG2' ' A' ' 34' ' ' ARG . 48.1 t -91.28 115.54 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 103.299 -2.852 . . . . 75.04 103.299 169.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.98 -23.77 22.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.925 -1.51 . . . . 54.4 111.339 -171.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -174.83 168.0 3.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.427 -0.583 . . . . 63.02 109.427 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 32' ' ' GLU . 72.8 p -133.74 145.7 50.08 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.089 -1.078 . . . . 63.33 108.089 170.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.2 -139.43 6.11 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 118.997 -1.573 . . . . 45.32 113.648 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.0 -112.57 4.47 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.947 -0.861 . . . . 44.31 110.947 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HG3' HG23 ' A' ' 154' ' ' THR . 8.6 mtpm? -113.52 170.32 8.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.03 -0.359 . . . . 72.2 110.03 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -83.97 157.53 21.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.027 -1.101 . . . . 55.21 108.027 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 75.88 -61.8 0.45 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.459 1.104 . . . . 70.31 110.444 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.77 110.14 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.153 -1.795 . . . . 40.44 106.153 171.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.0 p -122.57 155.05 37.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.544 -0.753 . . . . 63.23 109.065 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -114.98 153.21 31.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 113.155 0.798 . . . . 73.04 113.155 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.589 ' OE2' ' HD2' ' A' ' 34' ' ' ARG . 35.9 tt0 -135.35 123.35 22.74 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 105.216 -2.142 . . . . 61.3 105.216 173.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -109.95 125.2 52.6 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.105 0.955 . . . . 74.24 111.026 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.589 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 16.4 mtp180 -127.5 140.48 52.11 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.347 -1.297 . . . . 62.31 110.414 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.11 40.5 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.515 -1.291 . . . . 75.45 107.515 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.2 m -58.94 146.05 39.27 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.794 0.683 . . . . 61.12 111.604 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -87.41 -19.43 28.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.371 -0.377 . . . . 64.23 110.054 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 98.69 11.63 46.62 Favored Glycine 0 CA--C 1.489 -1.586 0 C-N-CA 119.423 -1.37 . . . . 55.41 111.824 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 160.0 53.61 Favored Glycine 0 N--CA 1.426 -2.006 0 C-N-CA 120.522 -0.847 . . . . 71.42 112.133 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.569 ' HB3' ' HG3' ' A' ' 124' ' ' GLU . 17.3 ptmt -95.9 128.93 43.21 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 109.748 -0.464 . . . . 64.34 109.748 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.8 m-85 -127.17 163.81 23.03 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.977 -0.556 . . . . 75.24 110.985 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -99.17 116.73 32.05 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.075 -1.083 . . . . 52.33 108.075 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 9.9 t -127.29 147.77 50.23 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 120.329 -0.548 . . . . 74.21 112.015 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 119' ' ' SER . 95.8 t -128.18 126.63 66.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.841 -1.072 . . . . 73.12 108.446 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 43.5 tt0 -113.16 123.94 51.39 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.018 0.437 . . . . 71.43 111.088 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 34.5 t -121.4 127.54 75.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.835 -1.543 . . . . 74.04 106.835 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 72.7 p -116.09 166.19 12.29 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.551 -0.46 . . . . 61.31 110.566 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 73.3 -27.49 0.19 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.897 0.879 . . . . 72.12 113.007 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 47' ' ' THR . 63.8 mmtt -89.84 146.85 36.16 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 115.946 -0.57 . . . . 70.4 110.54 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.23 156.65 61.92 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.435 2.09 . . . . 52.0 109.926 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 98' ' ' LEU . 54.4 t -47.87 -45.71 11.79 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 113.383 0.883 . . . . 71.11 113.383 -177.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -58.75 -46.55 87.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.175 0.435 . . . . 73.13 112.175 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . 33.8 tt0 -74.32 -43.69 55.65 Favored 'General case' 0 N--CA 1.397 -3.118 0 CA-C-N 116.278 -0.419 . . . . 64.33 111.728 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -63.79 -37.76 88.56 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 120.893 0.377 . . . . 52.33 110.675 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.84 -37.97 73.17 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.398 -0.365 . . . . 73.24 111.181 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 53' ' ' GLU 0.272 6.7 ppt_? -65.27 -23.54 67.07 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 112.283 0.475 . . . . 72.42 112.283 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 21.4 mm-40 -81.99 -52.34 7.15 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.44 -0.8 . . . . 72.44 112.778 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.21 -40.53 64.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 114.643 1.349 . . . . 52.24 114.643 -172.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 35.5 ttm -57.74 -49.31 94.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 114.957 1.466 . . . . 55.22 114.957 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 59' ' ' MET . 13.0 Cg_endo -57.17 -31.86 91.75 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.909 1.74 . . . . 74.41 111.639 175.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 93.3 mttt -67.59 -36.08 80.2 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.315 0.578 . . . . 73.34 110.096 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.58 -43.94 70.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 72.33 109.884 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.67 -43.51 98.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.845 0.683 . . . . 73.1 112.845 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -64.16 -37.68 88.35 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.059 0.457 . . . . 71.04 110.507 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 115' ' ' PRO . 38.6 t80 -66.28 -59.93 3.26 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.711 -0.677 . . . . 74.02 110.443 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.93 -26.15 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-O 121.17 0.51 . . . . 75.3 111.397 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -27.91 73.34 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 116.021 -0.536 . . . . 72.33 112.731 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.4 -11.87 0.22 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.33 -1.414 . . . . 71.45 114.321 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 116' ' ' SER . 23.5 m -82.23 49.53 1.43 Allowed 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 121.934 0.873 . . . . 75.12 110.268 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 113' ' ' PRO . 35.1 m-80 -98.61 149.54 22.67 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.567 -1.642 . . . . 61.41 106.567 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.47 -32.1 71.08 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.092 0.472 . . . . 73.43 112.044 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -78.05 -7.47 56.96 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.042 0.449 . . . . 74.01 111.016 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.0 18.27 80.22 Favored Glycine 0 CA--C 1.509 -0.291 0 C-N-CA 121.164 -0.541 . . . . 64.33 112.118 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.94 165.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.245 -1.02 . . . . 53.02 108.245 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.95 -120.15 0.95 Allowed Glycine 0 N--CA 1.41 -3.084 0 C-N-CA 119.484 -1.341 . . . . 51.51 112.227 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 69.9 mtm 68.4 9.69 7.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.201 1.0 . . . . 54.12 111.165 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.73 92.26 1.1 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.807 -0.633 . . . . 72.44 113.961 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -95.79 125.48 40.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.602 -1.999 . . . . 73.42 105.602 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.1 p -117.1 116.96 28.34 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 115.605 1.706 . . . . 44.35 115.605 -166.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.58 155.35 45.37 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 105.206 -2.146 . . . . 72.33 105.206 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.85 140.5 85.31 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.225 1.95 . . . . 62.43 114.151 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -106.35 151.36 8.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 106.957 -1.497 . . . . 70.41 106.957 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.3 t -141.79 147.48 37.36 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.902 -0.777 . . . . 74.55 108.902 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.83 144.35 48.91 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 122.337 -0.227 . . . . 75.12 110.506 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 136.23 33.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.722 -0.672 . . . . 71.44 109.519 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.89 150.62 25.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.011 -1.107 . . . . 63.44 108.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.627 ' CD2' ' HE2' ' A' ' 97' ' ' LYS . 1.7 m-85 -119.84 103.54 45.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 108.746 -0.835 . . . . 75.3 108.746 -175.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 151.37 37.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.145 1.897 . . . . 75.42 114.545 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.715 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 92.2 m-20 -102.89 156.09 17.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.466 -1.243 . . . . 64.13 108.171 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.05 -17.2 62.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.597 0.713 . . . . 73.52 109.747 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.96 -5.47 46.38 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.917 -1.038 . . . . 72.21 110.8 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.96 0.71 87.25 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 121.104 -0.569 . . . . 61.31 111.988 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.5 p -92.59 152.1 19.78 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 109.228 -0.656 . . . . 71.12 109.228 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.71 85.63 2.16 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.04 0.447 . . . . 74.04 110.765 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.61 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 34.3 tt0 -148.87 113.75 5.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.174 -0.466 . . . . 61.44 111.277 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.715 ' HE3' ' OD1' ' A' ' 89' ' ' ASN . 91.3 mttt -173.14 -75.44 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.883 1.673 . . . . 64.31 107.752 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.627 ' HE2' ' CD2' ' A' ' 87' ' ' PHE . 4.0 mppt? -143.05 156.57 44.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.997 -1.001 . . . . 74.44 108.942 177.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 51' ' ' VAL . 6.3 tt -143.84 134.84 25.44 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.8 -1.185 . . . . 54.14 107.8 172.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.47 ' HD3' ' HB2' ' A' ' 45' ' ' GLU . 33.9 ttpt -140.83 116.54 10.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 120.601 -0.44 . . . . 72.1 110.943 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 43' ' ' THR . 53.7 t -87.18 132.58 32.2 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 115.679 -0.691 . . . . 71.14 109.731 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -115.8 122.06 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.453 0.701 . . . . 74.31 109.27 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 85.9 t80 -103.21 123.22 46.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.334 0.587 . . . . 72.43 110.087 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -75.12 113.42 12.44 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.375 -1.284 . . . . 72.33 110.12 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 40' ' ' LYS . 73.5 mt -89.26 125.03 63.25 Favored Pre-proline 0 N--CA 1.42 -1.958 0 N-CA-C 107.254 -1.387 . . . . 65.41 107.254 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.26 148.24 42.04 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.705 2.27 . . . . 61.13 111.335 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 15' ' ' THR . 0.2 OUTLIER -57.23 -36.22 70.64 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.078 0.399 . . . . 63.4 112.078 -173.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -62.93 -28.46 70.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.449 0.642 . . . . 74.24 111.364 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.14 -12.28 38.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 116.119 -0.492 . . . . 64.44 110.668 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.521 ' HB3' ' CZ2' ' A' ' 16' ' ' TRP . 11.9 mm-40 -68.11 -29.42 68.33 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.591 0.589 . . . . 72.33 112.591 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.45 -39.19 97.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.15 -1.024 . . . . 62.41 111.403 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 m -153.46 87.73 3.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.36 -0.978 . . . . 54.52 108.36 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.67 151.21 11.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.278 1.985 . . . . 65.1 110.532 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -65.07 157.05 59.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.876 1.717 . . . . 73.3 110.805 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.49 147.22 71.44 Favored Pre-proline 0 N--CA 1.423 -1.808 0 N-CA-C 108.918 -0.771 . . . . 72.12 108.918 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 58.6 Cg_endo -73.18 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 121.917 1.744 . . . . 71.31 111.091 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 69' ' ' THR . 47.9 t -77.77 -28.68 50.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.34 -0.845 . . . . 75.2 111.655 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.29 152.1 25.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.281 -0.568 . . . . 65.32 110.401 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.11 -32.97 74.46 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.931 0.715 . . . . 63.32 112.931 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.56 ' HB2' ' HD3' ' A' ' 61' ' ' LYS . 20.1 m -93.44 -8.64 41.07 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.293 -0.563 . . . . 73.4 111.483 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 61.3 t -97.7 118.64 44.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.476 -1.305 . . . . 73.21 107.476 -176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -128.97 140.28 51.72 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.078 -0.712 . . . . 71.13 109.078 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 35.2 mm -92.08 112.0 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.271 -1.011 . . . . 72.31 108.271 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -123.44 148.41 46.18 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.553 -0.749 . . . . 72.51 109.963 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 40' ' ' LYS . 1.7 mp0 -98.17 139.38 34.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.809 -1.182 . . . . 73.22 107.809 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -126.7 121.16 31.29 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.256 -0.978 . . . . 75.45 110.696 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.529 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -144.9 176.83 9.18 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.199 -0.909 . . . . 74.32 111.031 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.8 64.61 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.962 -0.637 . . . . 24.55 114.661 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.41 160.41 22.71 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 C-N-CA 119.386 -0.926 . . . . 70.03 112.065 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.2 m -112.88 142.97 44.93 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.027 -1.442 . . . . 73.33 107.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.78 145.39 29.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.525 -0.546 . . . . 64.02 109.525 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 189' ' ' LYS . 56.3 m-85 -113.72 122.4 47.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.893 -2.262 . . . . 75.11 104.893 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 42.8 p -123.0 139.24 54.29 Favored 'General case' 0 C--N 1.263 -3.163 0 C-N-CA 120.092 -0.643 . . . . 62.53 110.983 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -113.21 127.41 56.17 Favored 'General case' 0 N--CA 1.402 -2.835 0 N-CA-C 108.138 -1.06 . . . . 65.21 108.138 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -110.43 125.32 53.13 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.734 -1.21 . . . . 73.31 107.734 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -147.0 153.72 40.39 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.167 0.508 . . . . 72.14 112.36 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.02 156.26 19.2 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.446 -0.797 . . . . 74.22 111.482 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.78 141.43 12.16 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.303 -1.119 . . . . 53.44 110.303 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -70.77 122.92 20.76 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.392 0.615 . . . . 73.44 111.198 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -110.95 133.5 53.33 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.589 -0.732 . . . . 51.12 109.629 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.622 ' HA ' ' CE2' ' A' ' 179' ' ' TYR . 39.0 ttpt -80.95 170.21 16.55 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.718 -0.845 . . . . 62.33 108.718 -177.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -53.29 -38.68 63.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.99 0.424 . . . . 52.4 111.185 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.06 77.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.589 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.418 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 11.8 m-20 -66.8 -31.66 72.42 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 116.24 -0.436 . . . . 62.15 110.617 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -62.78 -40.95 98.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.784 -0.367 . . . . 72.54 110.522 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.57 -44.24 90.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.903 -0.59 . . . . 52.22 109.574 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . -63.8 -47.22 81.76 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.572 -0.74 . . . . 73.31 111.275 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -66.02 -33.18 75.21 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.009 0.374 . . . . 72.54 112.009 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.7 94.49 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.299 -0.63 . . . . 61.12 109.299 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.2 m -64.24 -44.5 91.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.458 -0.792 . . . . 65.21 110.458 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 98.7 mt-30 -59.3 -49.22 78.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.818 0.447 . . . . 74.22 110.561 177.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 31' ' ' TYR . 48.1 tp -58.02 -46.19 85.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.857 -0.61 . . . . 52.11 110.61 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -64.35 -34.54 78.38 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.857 -0.611 . . . . 73.45 110.216 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.5 m -73.18 -33.17 65.27 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.331 0.586 . . . . 73.04 109.837 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 26' ' ' LYS . 42.0 m -72.38 -33.72 67.42 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.239 0.542 . . . . 74.02 109.779 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 158' ' ' THR . 87.8 mt -74.66 4.99 5.32 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.061 0.944 . . . . 73.02 113.197 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.1 142.5 43.64 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.654 -0.818 . . . . 74.34 111.1 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.23 62.18 Favored Glycine 0 C--N 1.297 -1.606 0 CA-C-N 115.456 -0.793 . . . . 63.34 111.15 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 155' ' ' LEU . 11.5 t -116.55 147.34 39.52 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 108.228 -1.027 . . . . 73.13 108.228 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -70.94 36.11 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.981 3.12 . . . . 62.22 113.666 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.13 136.63 42.92 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.847 0.356 . . . . 63.33 111.02 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 69.3 p -111.82 162.91 14.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.341 -0.985 . . . . 71.44 108.341 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.8 m-85 -137.66 150.6 47.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.616 -0.883 . . . . 65.43 108.616 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -127.43 126.82 43.08 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.854 -0.738 . . . . 74.32 112.574 -177.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.84 -1.19 17.29 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.287 -0.869 . . . . 73.51 113.441 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 63.11 12.17 5.8 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 64.35 110.588 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.5 160.37 4.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.272 -0.876 . . . . 62.03 111.88 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.87 170.89 17.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.42 -0.809 . . . . 71.22 110.015 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 18.1 m-85 -115.58 153.31 31.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.252 0.548 . . . . 72.52 111.848 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 41.7 t -115.12 144.82 43.08 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.241 -1.763 . . . . 72.21 106.241 172.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.24 160.56 16.87 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 121.131 -0.228 . . . . 60.33 110.644 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.57 165.32 37.34 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.3 -1.12 . . . . 52.04 110.3 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -141.22 -53.23 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 112.847 0.684 . . . . 74.1 112.847 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -156.21 158.32 31.51 Favored Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 106.632 -1.618 . . . . 75.22 106.632 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.89 106.74 0.19 Allowed 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.18 1.92 . . . . 61.42 108.924 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -82.29 149.22 15.04 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 C-N-CA 122.309 2.006 . . . . 72.14 114.255 -169.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 65.0 mtt -64.27 -39.73 94.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.357 -0.838 . . . . 72.14 109.681 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.47 ' HA ' ' HE3' ' A' ' 177' ' ' LYS . 1.6 tpmt? -87.63 139.81 31.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 104.165 -2.531 . . . . 72.32 104.165 173.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.451 ' HD2' ' HE2' ' A' ' 177' ' ' LYS . 80.3 Cg_exo -38.11 -33.39 0.27 Allowed 'Trans proline' 0 N--CA 1.506 2.265 0 C-N-CA 124.393 3.395 . . . . 65.33 116.381 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.622 ' CE2' ' HA ' ' A' ' 140' ' ' LYS . 97.1 m-85 -134.61 9.96 3.68 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.987 0.422 . . . . 64.01 111.603 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.96 -174.17 37.11 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.407 -0.902 . . . . 74.3 112.032 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -97.09 -14.68 21.4 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.923 0.392 . . . . 64.05 111.676 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.2 134.39 29.43 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 116.325 -0.398 . . . . 73.51 111.155 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.28 143.4 46.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.85 0.46 . . . . 74.34 111.025 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -122.08 148.0 45.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.49 -0.323 . . . . 75.22 110.912 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 132' ' ' SER . 57.3 t -128.18 128.93 69.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.614 -1.254 . . . . 64.3 107.614 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 7.0 m0 -114.98 124.83 52.66 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 110.354 -0.239 . . . . 62.31 110.354 -178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.12 138.97 35.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.94 -1.133 . . . . 63.22 107.94 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 38.5 t -100.17 127.74 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 120.696 -0.401 . . . . 72.31 111.547 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 161' ' ' THR . 12.1 tmtt? -78.14 123.76 27.27 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.426 -0.806 . . . . 73.14 109.691 176.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.26 1.651 0 O-C-N 124.268 0.98 . . . . 64.31 110.183 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 CA--C 1.504 -0.803 0 N-CA-C 108.989 -0.745 . . . . 74.32 108.989 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t -95.54 102.99 14.84 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.76 -1.2 . . . . 74.01 107.76 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.337 1.1 pp -73.68 72.61 1.48 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 122.779 1.276 . . . . 71.33 114.203 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -83.85 145.66 28.51 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 114.695 -1.139 . . . . 73.23 108.356 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.58 -34.72 2.82 Favored Glycine 0 CA--C 1.479 -2.171 0 N-CA-C 110.045 -1.222 . . . . 72.31 110.045 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -79.48 86.89 5.12 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.52 -0.918 . . . . 65.32 108.52 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.57 169.1 6.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 109.129 -0.693 . . . . 44.24 109.129 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HA ' ' N ' ' A' ' 110' ' ' GLY . 1.1 mp0 -62.27 -40.58 96.7 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 123.581 0.55 . . . . 70.42 111.202 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.8 m -100.04 88.62 3.79 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 114.908 1.447 . . . . 75.21 114.908 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -103.6 105.11 45.81 Favored Pre-proline 0 N--CA 1.422 -1.854 0 N-CA-C 106.266 -1.753 . . . . 73.12 106.266 162.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.68 145.17 22.83 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.061 1.841 . . . . 74.12 115.053 -170.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -103.8 146.28 28.87 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.331 -1.729 . . . . 75.03 106.331 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -119.32 120.22 36.29 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 119.148 -1.021 . . . . 75.25 112.073 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 34' ' ' ARG . 44.5 t -78.16 114.52 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 102.803 -3.036 . . . . 74.32 102.803 168.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.62 -30.13 17.36 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.288 -1.365 . . . . 65.42 112.874 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -158.67 163.07 37.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.922 -0.77 . . . . 72.34 108.922 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 32' ' ' GLU . 44.8 p -132.66 162.59 30.98 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.461 -0.57 . . . . 65.44 109.461 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.24 -145.4 10.15 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.775 -0.726 . . . . 73.34 111.831 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -156.7 16.71 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.917 -0.658 . . . . 44.44 111.905 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.01 171.87 7.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.398 0.679 . . . . 74.44 111.642 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.68 143.59 48.04 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.68 -1.6 . . . . 75.3 106.68 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 80.23 -50.58 0.35 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.305 1.042 . . . . 74.14 111.314 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.0 t -116.09 109.14 27.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.287 -0.634 . . . . 53.11 109.287 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -116.91 154.91 29.99 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.454 -0.794 . . . . 73.55 109.629 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 162.48 31.97 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.76 0.314 . . . . 75.03 111.821 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HB3' HG22 ' A' ' 23' ' ' THR . 12.6 pt-20 -154.89 139.74 17.2 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.699 -1.593 . . . . 75.31 106.699 174.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB3' ' CD2' ' A' ' 131' ' ' TYR 0.283 0.2 OUTLIER -103.53 125.6 50.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.208 -0.997 . . . . 63.45 111.93 177.251 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.446 ' HG2' HG22 ' A' ' 20' ' ' VAL . 70.7 mtt180 -115.03 127.15 55.47 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.616 -1.174 . . . . 75.14 109.481 -176.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.64 132.49 34.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.895 -1.52 . . . . 74.45 106.895 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.442 ' SG ' HG13 ' A' ' 128' ' ' ILE . 74.6 m -74.71 157.79 34.68 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 120.129 -0.628 . . . . 75.21 111.622 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -84.7 -25.02 28.66 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.602 -0.726 . . . . 74.31 111.522 -174.556 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 126' ' ' GLU . . . 95.13 11.02 56.81 Favored Glycine 0 CA--C 1.497 -1.072 0 C-N-CA 119.49 -1.338 . . . . 30.45 111.474 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.488 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -70.55 165.74 51.88 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 114.114 0.406 . . . . 71.42 114.114 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -101.02 122.59 43.8 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.818 -0.691 . . . . 71.13 109.378 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 44.7 m-85 -125.57 165.65 18.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.293 -0.867 . . . . 73.54 111.894 -170.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.49 ' HA ' HD13 ' A' ' 122' ' ' ILE . . . -98.22 116.7 30.99 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 108.78 -0.822 . . . . 73.12 108.78 -177.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 10.1 t -124.77 143.91 50.54 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-O 121.349 0.595 . . . . 72.25 111.352 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 100' ' ' VAL . 19.3 m -128.4 139.98 50.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.054 -0.975 . . . . 74.12 108.791 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.13 136.83 51.7 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.077 -0.649 . . . . 72.14 112.074 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.529 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 29.6 t -131.06 142.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.058 -0.719 . . . . 72.14 109.058 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 p -135.26 178.15 7.26 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.531 0.332 . . . . 73.04 110.311 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.0 t70 73.6 -14.99 0.59 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.448 1.099 . . . . 61.43 113.159 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -131.21 147.26 65.53 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.313 -0.625 . . . . 70.24 109.313 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.28 156.29 5.71 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.652 2.902 . . . . 74.3 112.526 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 20.5 m -56.2 -36.33 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.518 0.562 . . . . 73.04 112.518 -174.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 10.4 m-20 -58.78 -49.82 76.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.164 0.507 . . . . 75.43 110.158 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.04 -36.32 79.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.318 -0.855 . . . . 75.24 110.191 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -60.38 -47.35 86.43 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.437 -0.801 . . . . 70.4 110.59 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 59' ' ' MET . 96.1 mt -55.87 -36.97 68.18 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 122.43 0.292 . . . . 73.24 111.479 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 1.7 mmp_? -59.37 -34.29 72.23 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.307 0.575 . . . . 71.44 110.456 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -83.98 -41.41 17.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.418 -0.81 . . . . 73.43 111.338 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.01 -33.09 67.78 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 114.393 1.257 . . . . 74.0 114.393 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 17.8 mmt -61.31 -57.2 27.22 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 120.317 -0.553 . . . . 74.1 111.713 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.95 -38.45 86.38 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.594 2.196 . . . . 70.23 113.008 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG3' HG11 ' A' ' 44' ' ' VAL . 16.4 ptpt -69.15 -28.8 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.019 0.748 . . . . 75.34 113.019 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.5 mm -76.55 -45.11 33.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.342 -0.614 . . . . 51.11 109.342 170.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 87.2 mtp -62.25 -33.49 74.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.452 -0.795 . . . . 62.43 112.941 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -70.25 -40.25 74.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.872 0.368 . . . . 71.13 110.172 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -59.03 -52.09 67.25 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.801 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.87 -13.09 14.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.062 -0.517 . . . . 43.22 111.523 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.37 -16.78 70.52 Favored Glycine 0 CA--C 1.506 -0.486 0 CA-C-N 115.94 -0.573 . . . . 72.52 112.436 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 70' ' ' ASN . . . 134.4 -11.04 4.68 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 119.746 -1.216 . . . . 40.44 112.828 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 m -80.3 30.11 0.29 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 122.888 1.327 . . . . 54.11 110.369 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 68' ' ' GLY . 7.3 p30 -97.81 171.36 8.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.978 -1.01 . . . . 74.42 109.032 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 26.5 t70 -67.97 -27.55 66.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 21.52 113.084 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.55 -13.2 55.0 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.446 -0.902 . . . . 72.14 109.595 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.31 22.49 74.67 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.608 -0.724 . . . . 54.44 111.308 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 m -81.97 122.17 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 121.246 0.546 . . . . 62.21 112.293 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.02 52.76 0.62 Allowed Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.11 -1.196 . . . . 72.12 110.11 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.7 mtt -82.91 -41.74 18.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.309 0.576 . . . . 73.14 110.519 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.04 129.03 3.39 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.306 -0.95 . . . . 73.13 111.593 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.474 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 23.6 ptp -132.78 126.03 31.45 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.806 -0.442 . . . . 73.21 109.806 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.4 p -124.83 115.79 21.23 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.023 0.749 . . . . 63.42 113.023 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 15.6 m -153.59 174.54 3.67 Favored Pre-proline 0 C--N 1.313 -1.003 0 C-N-CA 125.88 1.672 . . . . 75.32 106.498 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 78.2 Cg_exo -56.72 140.36 90.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.157 1.905 . . . . 73.53 114.057 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 48.6 t -105.75 143.04 17.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.395 -1.706 . . . . 74.21 106.395 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 169' ' ' CYS . 23.4 m -132.35 151.4 51.87 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.996 0.362 . . . . 71.43 110.332 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' CD2' HD21 ' A' ' 98' ' ' LEU . 52.5 p90 -145.07 146.46 31.86 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 122.036 -0.415 . . . . 74.44 111.162 174.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.42 135.33 34.13 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 116.029 -0.532 . . . . 72.21 109.943 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG12 HG11 ' A' ' 51' ' ' VAL . 30.7 m -137.81 150.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.43 -0.952 . . . . 72.23 108.43 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' A' ' 97' ' ' LYS . 39.5 m-85 -119.88 108.24 39.11 Favored Pre-proline 0 C--N 1.281 -2.378 0 N-CA-C 107.466 -1.309 . . . . 73.01 107.466 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.01 147.8 8.01 Favored 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 121.243 1.295 . . . . 60.41 113.69 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.37 154.62 18.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.71 -1.959 . . . . 71.41 105.71 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.5 -13.15 62.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 114.247 1.202 . . . . 73.05 114.247 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.66 -4.09 58.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.502 0.668 . . . . 74.42 109.763 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 -11.07 59.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.733 -0.667 . . . . 21.22 113.466 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.2 m -78.53 139.38 38.64 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.251 -0.58 . . . . 53.13 110.112 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.69 150.9 23.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.645 -0.422 . . . . 65.42 110.083 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -79.77 150.1 30.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.736 -1.579 . . . . 74.35 106.736 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.0 38.92 0.54 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.712 0.805 . . . . 63.01 111.956 -171.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.529 ' HE3' ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -127.8 122.55 33.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 104.207 -2.516 . . . . 62.21 104.207 176.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.529 ' N ' ' HE3' ' A' ' 97' ' ' LYS . 3.1 tm? -131.36 145.49 51.86 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.009 0.433 . . . . 64.11 109.993 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' N ' HD13 ' A' ' 98' ' ' LEU . 87.9 tttt -148.19 116.13 6.41 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.248 -0.887 . . . . 63.04 110.724 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.519 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 93.7 t -95.1 126.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 122.94 0.496 . . . . 71.03 110.103 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.94 122.71 46.97 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 41' ' ' PHE . 82.5 t80 -103.5 120.17 40.31 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.315 -0.994 . . . . 63.15 108.315 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -74.99 122.33 23.33 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.783 -0.644 . . . . 62.04 109.33 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.497 ' H ' ' HD1' ' A' ' 41' ' ' PHE . 66.7 mt -91.75 125.92 55.65 Favored Pre-proline 0 N--CA 1.415 -2.201 0 N-CA-C 107.226 -1.398 . . . . 52.45 107.226 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 78' ' ' MET . 64.9 Cg_exo -52.86 155.59 10.7 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 123.289 2.659 . . . . 64.52 113.558 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -47.29 -44.36 23.2 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.475 1.51 . . . . 75.35 112.052 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.86 -30.02 68.69 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.015 -0.539 . . . . 71.11 112.435 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -99.95 -2.69 34.0 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.719 -0.219 . . . . 74.02 111.584 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.475 ' NE2' ' HB ' ' A' ' 104' ' ' ILE . 25.3 mm-40 -70.49 -34.99 72.98 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.21 0.818 . . . . 71.52 113.21 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.47 ' N ' ' HA ' ' A' ' 14' ' ' GLU . . . -59.49 -38.28 93.33 Favored Glycine 0 N--CA 1.466 0.64 0 C-N-CA 120.953 -0.642 . . . . 52.54 112.41 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.3 m -155.46 93.41 2.65 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.682 -0.859 . . . . 74.44 108.682 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -87.14 157.83 8.41 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.571 2.18 . . . . 65.4 111.971 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.62 151.93 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.223 1.948 . . . . 64.14 111.575 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -85.55 152.69 57.77 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-N 116.012 -0.54 . . . . 52.34 110.206 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.67 110.94 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.29 1.993 . . . . 52.1 112.561 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.7 m -80.87 -20.3 42.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.02 0.438 . . . . 75.24 110.958 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -107.88 140.57 40.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.926 -1.509 . . . . 71.23 106.926 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -76.18 -12.86 60.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.215 0.45 . . . . 64.41 112.215 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HD3' ' A' ' 61' ' ' LYS . 18.3 m -70.88 -32.23 69.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.143 0.496 . . . . 73.54 109.988 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 44' ' ' VAL . 8.4 p -105.18 130.07 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.661 -0.699 . . . . 64.11 109.176 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -127.86 133.14 49.34 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.925 -0.579 . . . . 74.15 110.275 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 32.7 mm -93.09 112.4 26.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.606 -0.887 . . . . 63.04 108.606 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.86 151.86 46.3 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.691 -0.855 . . . . 63.02 108.691 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.25 146.65 30.06 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.801 -0.444 . . . . 73.15 109.801 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -140.55 123.09 16.11 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.781 -0.368 . . . . 52.43 110.051 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.415 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 12.9 pt-20 -138.8 164.88 28.46 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.412 -0.958 . . . . 60.52 108.412 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.72 35.47 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.02 -1.086 . . . . 54.43 112.42 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.442 HG13 ' SG ' ' A' ' 36' ' ' CYS . 38.2 pt -135.51 145.72 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.899 0.856 . . . . 75.4 112.324 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 189' ' ' LYS . 19.8 m -115.5 140.17 49.39 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 104.992 -2.225 . . . . 74.43 104.992 173.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.16 153.9 30.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.413 0 N-CA-C 109.246 -0.65 . . . . 74.41 109.246 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.609 ' CD2' ' HB3' ' A' ' 33' ' ' GLU . 42.3 m-85 -113.11 121.49 44.71 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.144 -2.169 . . . . 52.3 105.144 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 185' ' ' VAL . 16.6 p -112.58 134.28 54.19 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 121.581 0.705 . . . . 61.22 111.865 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.44 ' CG2' ' HB ' ' A' ' 185' ' ' VAL . 8.8 t -126.25 133.87 51.35 Favored 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 114.87 -1.059 . . . . 64.23 109.255 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 50.1 mt-30 -111.09 146.57 36.55 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.781 -0.368 . . . . 75.32 110.676 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 183' ' ' ASN . 11.0 p90 -146.93 168.16 22.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.897 -0.592 . . . . 75.33 109.476 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.12 152.15 23.42 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.815 -0.914 . . . . 75.13 110.815 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 135.68 -138.58 10.05 Favored Glycine 0 C--N 1.313 -0.73 0 N-CA-C 110.921 -0.872 . . . . 73.13 110.921 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -100.56 106.67 18.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.782 -0.821 . . . . 75.15 108.782 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.85 114.64 27.31 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.48 0.919 . . . . 72.41 113.48 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -102.14 175.56 5.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.875 -1.528 . . . . 63.41 106.875 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.1 mp0 -57.79 -44.18 86.09 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.252 -1.018 . . . . 50.41 108.252 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.33 67.36 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.191 -1.368 . . . . 35.24 112.16 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 147' ' ' HIS . 5.1 m-20 -65.72 -49.07 69.8 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 121.098 -0.241 . . . . 71.42 110.387 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 48.5 m-85 -57.96 -43.47 86.43 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.499 0.499 . . . . 74.11 110.099 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 141' ' ' GLU . 58.8 t -62.7 -51.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 120.997 0.427 . . . . 74.11 111.322 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.16 75.3 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.397 0.618 . . . . 62.02 110.41 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.567 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 7.7 t-160 -66.79 -47.89 70.7 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.457 -0.792 . . . . 62.42 108.902 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.24 92.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.589 -0.732 . . . . 70.44 110.368 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 89.0 m -64.56 -36.61 84.77 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.744 -0.662 . . . . 75.14 110.838 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -74.11 -28.62 61.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.691 -0.403 . . . . 70.35 110.161 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 147' ' ' HIS . 81.4 mt -58.98 -34.58 71.98 Favored 'General case' 0 C--O 1.205 -1.283 0 N-CA-C 109.938 -0.393 . . . . 54.35 109.938 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 149' ' ' THR . 30.6 mtp180 -61.33 -38.82 88.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.779 -0.646 . . . . 62.43 109.454 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -73.07 -37.41 66.8 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.147 -0.933 . . . . 74.31 110.365 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.2 m -77.41 -34.51 54.72 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.09 0.471 . . . . 74.54 110.829 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 158' ' ' THR . 95.4 mt -80.83 7.66 9.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.579 0.752 . . . . 63.42 111.136 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -82.34 130.37 35.08 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.92 -1.141 . . . . 75.23 107.92 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.56 58.3 Favored Glycine 0 C--N 1.307 -1.081 0 C-N-CA 120.649 -0.786 . . . . 74.5 112.528 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 155' ' ' LEU . 15.4 t -125.2 149.25 63.28 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 107.772 -1.196 . . . . 71.34 107.772 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -64.25 -2.77 5.24 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 123.489 2.793 . . . . 73.0 115.154 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -62.98 142.54 58.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.723 0.297 . . . . 74.35 111.361 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 189' ' ' LYS . 46.7 p -116.56 151.72 35.6 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.085 -0.507 . . . . 73.22 109.886 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -143.91 149.29 36.64 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.764 -0.458 . . . . 74.4 109.764 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 5.2 pp0? -134.0 145.49 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.514 0.931 . . . . 75.44 113.514 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.84 -1.39 23.45 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.876 -1.056 . . . . 43.22 115.257 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 t70 61.16 7.99 1.84 Allowed 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.024 0.93 . . . . 70.41 111.057 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.74 139.69 18.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 124.446 1.098 . . . . 55.43 110.165 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 144' ' ' TYR . 43.9 p90 -137.86 167.61 21.39 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.619 -0.719 . . . . 73.14 109.173 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 186' ' ' TRP . 79.2 m-85 -115.69 152.78 32.53 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.308 -0.997 . . . . 64.34 108.308 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 83' ' ' SER . 59.7 m -113.62 132.34 55.78 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.616 -1.253 . . . . 73.32 107.616 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 184' ' ' GLU . . . -128.23 147.19 50.57 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.032 0.444 . . . . 70.4 111.034 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 81' ' ' PRO . . . -142.49 141.28 10.59 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 110.133 -1.187 . . . . 64.01 110.133 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -103.99 -14.1 16.07 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.148 0.499 . . . . 75.03 110.405 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -128.21 136.01 28.4 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 107.398 -1.334 . . . . 65.35 107.398 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.33 112.79 3.1 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 121.879 1.719 . . . . 75.01 109.533 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.36 130.92 3.44 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 122.054 1.836 . . . . 73.51 114.087 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 28.1 ttt -94.47 -39.51 10.38 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.201 -1.407 . . . . 64.45 107.201 172.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.78 144.65 29.32 Favored Pre-proline 0 N--CA 1.436 -1.175 0 CA-C-N 115.044 -0.98 . . . . 62.14 108.493 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.85 -13.36 22.16 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 124.13 3.22 . . . . 54.54 115.212 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -51.06 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.443 1.275 . . . . 74.23 114.443 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 75.76 113.8 0.11 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.891 -0.671 . . . . 54.25 111.846 -176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -77.42 -15.59 59.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.019 0.914 . . . . 70.34 109.125 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -142.27 129.51 21.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.634 -1.166 . . . . 74.41 108.211 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 38.1 m-80 -141.14 148.58 40.28 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 105.257 -2.127 . . . . 72.41 105.257 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 170' ' ' ALA . 37.4 tt0 -126.38 141.02 52.05 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.023 -0.671 . . . . 72.03 110.486 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 132' ' ' SER . 29.0 t -124.49 129.14 73.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.744 -1.206 . . . . 74.3 107.744 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 168' ' ' TYR . 39.0 m0 -110.15 126.9 54.57 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 110.135 -0.32 . . . . 75.14 110.135 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.83 137.74 39.72 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 172.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.46 133.18 43.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 120.554 -0.459 . . . . 74.13 112.203 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -69.64 143.38 53.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.683 -0.69 . . . . 72.44 111.92 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--N 1.305 -1.338 0 CA-C-O 118.433 -0.794 . . . . 60.15 109.123 176.67 . . . . . . . . 1 1 . 1 stop_ save_